PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Levan, A; Black, G; Mietchen, J; Baxter, L; Kirwan, CB; Gale, SD				Levan, Ashley; Black, Garrett; Mietchen, Jonathan; Baxter, Leslie; Kirwan, C. Brock; Gale, Shawn D.			Right frontal pole cortical thickness and executive functioning in children with traumatic brain injury: the impact on social problems	BRAIN IMAGING AND BEHAVIOR			English	Article						Cortex; CPT-II; MRI; Child behavior checklist; Social function	VERBAL FLUENCY PERFORMANCE; BEHAVIOR RATING INVENTORY; SURFACE-BASED ANALYSIS; SIMPLE REACTION-TIME; HEAD-INJURY; OUTCOMES; COMPETENCE; LESIONS; DAMAGE; TERM	Cognitive and social outcomes may be negatively affected in children with a history of traumatic brain injury (TBI). We hypothesized that executive function would mediate the association between right frontal pole cortical thickness and problematic social behaviors. Child participants with a history of TBI were recruited from inpatient admissions for long-term follow-up (n = 23; average age = 12.8, average time post-injury =3.2 years). Three measures of executive function, the Trail Making Test, verbal fluency test, and the Conners' Continuous Performance Test-Second edition (CPT-II), were administered to each participant while caregivers completed the Childhood Behavior Checklist (CBCL). All participants underwent brain magnetic resonance imaging following cognitive testing. Regression analysis demonstrated right frontal pole cortical thickness significantly predicted social problems. Measures of executive functioning also significantly predicted social problems; however, the mediation model testing whether executive function mediated the relationship between cortical thickness and social problems was not statistically significant. Right frontal pole cortical thickness and omission errors on the CPT-II predicted Social Problems on the CBCL. Results did not indicate that the association between cortical thickness and social problems was mediated by executive function.	[Levan, Ashley; Black, Garrett; Mietchen, Jonathan; Kirwan, C. Brock; Gale, Shawn D.] Brigham Young Univ, Dept Psychol, 1060 SWKT, Provo, UT 84602 USA; [Kirwan, C. Brock; Gale, Shawn D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Baxter, Leslie] St Josephs Hosp, Barrow Neurol Inst, Dept Neuroimaging, Phoenix, AZ USA		Gale, SD (corresponding author), Brigham Young Univ, Dept Psychol, 1060 SWKT, Provo, UT 84602 USA.; Gale, SD (corresponding author), Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA.	shawn_gale@byu.edu		Baxter, Leslie/0000-0002-3971-863X	Barrow Neurological Foundation	Funding was provided in-house by the Barrow Neurological Foundation. (grant #: N/A).	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Bauman Johnson WL, 2010, ARCH CLIN NEUROPSYCH, V25, P601, DOI 10.1093/arclin/acq049; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Denckla M B, 1994, FRAMES REFERENCE ASS, P117; Eisenberg N, 2000, CHILD DEV, V71, P1367, DOI 10.1111/1467-8624.00233; ELIASON MJ, 1987, J LEARN DISABIL, V20, P614, DOI 10.1177/002221948702001007; ERCEGHURN DM, 2008, THE AMERICAN PSYCHOL, V63, P591, DOI DOI 10.1037/0003-066X.63.7.591; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fox NA, 1995, CHILD DEV, V66, P1770, DOI 10.1111/j.1467-8624.1995.tb00964.x; FOX NA, 1994, DEV PSYCHOPATHOL, V6, P677, DOI 10.1017/S0954579400004739; Fox NA, 2001, CHILD DEV, V72, P1, DOI 10.1111/1467-8624.00262; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; HOWES D, 1975, BRAIN, V98, P317, DOI 10.1093/brain/98.2.317; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kinney HC, 2005, J NEUROL SCI, V228, P190, DOI 10.1016/j.jns.2004.10.006; Levan A, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000040; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801; Prigatano GP, 2008, J HEAD TRAUMA REHAB, V23, P378, DOI 10.1097/01.HTR.0000341433.67251.01; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Shields A, 1998, J CLIN CHILD PSYCHOL, V27, P381, DOI 10.1207/s15374424jccp2704_2; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TARTAGLIONE A, 1986, NEUROPSYCHOLOGIA, V24, P649, DOI 10.1016/0028-3932(86)90004-7; Thaler NS, 2012, ARCH CLIN NEUROPSYCH, V27, P446, DOI 10.1093/arclin/acs042; Warschausky S, 2003, REHABIL PSYCHOL, V48, P250, DOI 10.1037/0090-5550.48.4.250; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	48	9	9	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2016	10	4					1090	1095		10.1007/s11682-015-9472-7			6	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EF0LC	WOS:000390015900014	26542618				2022-02-06	
J	Pinkernell, S; Becker, K; Lindauer, U				Pinkernell, Sarah; Becker, Katrin; Lindauer, Ute			Severity assessment and scoring for neurosurgical models in rodents	LABORATORY ANIMALS			English	Article						pain; rodent; severity; subarachnoid hemorrhage; traumatic brain injury	TRAUMATIC BRAIN-INJURY; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; CONTROLLED CORTICAL IMPACT; VIVO ANIMAL-MODELS; BEHAVIORAL DEFICITS; FACIAL EXPRESSIONS; CEREBRAL VASOSPASM; STRESS-RESPONSE; HEAD-INJURY; BLOOD-FLOW	The most important acute neurological diseases seen at neurosurgery departments are traumatic brain injuries (TBI) and subarachnoid hemorrhages (SAH). In both diseases the pathophysiological sequela are complex and have not been fully understood up to now, and rodent models using rats and mice are most suitable for the investigation of the pathophysiological details. In both models, surgery is performed under anesthesia, followed by assessment of their functional outcome and behavioral testing before brain tissue analysis after euthanasia. Postoperative analgesia is mandatory, and supplementary care is highly recommended for refinement purposes. Pain and stress assessment is mainly based on clinical and behavioral signs, and further research is needed to improve the evaluation of severity in these models.	[Pinkernell, Sarah; Becker, Katrin; Lindauer, Ute] Rhein Westfal TH Aachen, Fac Med, Translat Neurosurg, Pauwelsstr 30, D-52074 Aachen, Germany		Lindauer, U (corresponding author), Rhein Westfal TH Aachen, Fac Med, Translat Neurosurg, Pauwelsstr 30, D-52074 Aachen, Germany.	ulindauer@ukaachen.de		Becker, Katrin/0000-0001-6876-6035			Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; DIRNAGL U, 2009, NATURE PRECEDINGS; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOBRAKOVOVA M, 1993, PSYCHONEUROENDOCRINO, V18, P163, DOI 10.1016/0306-4530(93)90001-2; DONNERER J, 1990, ENDOCRINOLOGY, V126, P921, DOI 10.1210/endo-126-2-921; Feiler S, 2010, J NEUROSCI METH, V190, P164, DOI 10.1016/j.jneumeth.2010.05.005; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Friess SH, 2015, J NEUROTRAUM, V32, P791, DOI 10.1089/neu.2014.3564; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Greenhalgh AD, 2012, TRANSL STROKE RES, V3, P164, DOI 10.1007/s12975-011-0124-y; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Ho LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116513; Hockel Konstantin, 2012, Exp Transl Stroke Med, V4, P5, DOI 10.1186/2040-7378-4-5; Jennings M, 1998, LAB ANIM-UK, V32, P233, DOI 10.1258/002367798780559301; Jeon H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-103; Kamii H, 1999, STROKE, V30, P867, DOI 10.1161/01.STR.30.4.867; Kamp MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114946; Kandasamy R, 2016, J NEUROSCI METH, V263, P115, DOI 10.1016/j.jneumeth.2016.02.013; KANT GJ, 1985, PHARMACOL BIOCHEM BE, V22, P631; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kooijman E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090584; Kooijman E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-2; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Marbacher S, 2010, BRIT J NEUROSURG, V24, P415, DOI 10.3109/02688691003746274; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh TK, 1996, LAB INVEST, V74, P315; Megyesi JF, 2000, NEUROSURGERY, V46, P448, DOI 10.1097/00006123-200002000-00035; Meijer MK, 2007, LAB ANIM-UK, V41, P161, DOI 10.1258/002367707780378168; Miller AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136000; Milner E, 2014, J CEREBR BLOOD F MET, V34, P1571, DOI 10.1038/jcbfm.2014.108; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Park IS, 2008, J NEUROSCI METH, V172, P195, DOI 10.1016/j.jneumeth.2008.04.027; Paul CM, 2009, BEHAV BRAIN RES, V203, P151, DOI 10.1016/j.bbr.2009.05.022; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Prunell GF, 2002, NEUROREPORT, V13, P2553, DOI 10.1097/00001756-200212200-00034; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Sanchez C, 2003, EUR J PHARMACOL, V463, P133, DOI 10.1016/S0014-2999(03)01277-9; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; SEGGIE JA, 1975, CAN J PHYSIOL PHARM, V53, P629, DOI 10.1139/y75-087; Sehba Fatima A, 2015, Acta Neurochir Suppl, V120, P23, DOI 10.1007/978-3-319-04981-6_4; SOLOMON RA, 1985, STROKE, V16, P58, DOI 10.1161/01.STR.16.1.58; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Spani D, 2003, LAB ANIM-UK, V37, P54, DOI 10.1258/002367703762226692; Terpolilli NA, 2015, STROKE, V46, P3014, DOI 10.1161/STROKEAHA.115.006353; Thal SC, 2009, J NEUROSURG, V111, P988, DOI 10.3171/2009.3.JNS08412; Torok E, 2009, NEUROSURGERY, V65, P352, DOI 10.1227/01.NEU.0000345632.09882.FF; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Wallace VCJ, 2005, EUR J PAIN, V9, P445, DOI 10.1016/j.ejpain.2004.10.006; Ward A, 2008, RECOGNITION ALLEVIAT, P132; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Zoerle T, 2012, J CEREBR BLOOD F MET, V32, P1645, DOI 10.1038/jcbfm.2012.57; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	68	9	9	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0023-6772	1758-1117		LAB ANIM-UK	Lab. Anim.	DEC	2016	50	6					442	452		10.1177/0023677216675010			11	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	EE9BQ	WOS:000389921100007	27909194				2022-02-06	
J	Rau, CS; Kuo, PJ; Wu, SC; Chen, YC; Hsieh, HY; Hsieh, CH				Rau, Cheng-Shyuan; Kuo, Pao-Jen; Wu, Shao-Chun; Chen, Yi-Chun; Hsieh, Hsiao-Yun; Hsieh, Ching-Hua			Association between the Osteoporosis Self-Assessment Tool for Asians Score and Mortality in Patients with Isolated Moderate and Severe Traumatic Brain Injury: A Propensity Score-Matched Analysis	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						Osteoporosis Self-Assessment Tool for Asians (OSTA); mortality; traumatic brain injury (TBI); injury severity score (ISS); osteoporosis	RISK-ASSESSMENT MODEL; VERTEBRAL FRACTURES; VALIDATION; WOMEN; METAANALYSIS; OUTCOMES; MEN; DEFINITION; SINGAPORE; OSTA	Background: The purpose of this study was to use a propensity score-matched analysis to investigate the association between the Osteoporosis Self-Assessment Tool for Asians (OSTA) scores and clinical outcomes of patients with isolated moderate and severe traumatic brain injury (TBI). Methods: The study population comprised 7855 patients aged >= 40 years who were hospitalized for treatment of isolated moderate and severe TBI (an Abbreviated Injury Scale (AIS) >= 3 points only in the head and not in other regions of the body) between 1 January 2009 and 31 December 2014. Patients were categorized as high-risk (OSTA score < -4; n = 849), medium-risk (-4 <= OSTA score <= -1; n = 1647), or low-risk (OSTA score > -1; n = 5359). Two-sided Pearson's chi-squared, or Fisher's exact tests were used to compare categorical data. Unpaired Student's t-test and Mann-Whitney U test were performed to analyze normally and non-normally distributed continuous data, respectively. Propensity score-matching in a 1:1 ratio was performed using NCSS software, with adjustment for covariates. Results: Compared to low-risk patients, high-and medium-risk patients were significantly older and injured more severely. The high- and medium-risk patients had significantly higher mortality rates, longer hospital length of stay, and a higher proportion of admission to the intensive care unit than low-risk patients. Analysis of propensity score-matched patients with adjusted covariates, including gender, co-morbidity, blood alcohol concentration level, Glasgow Coma Scale score, and Injury Severity Score revealed that high- and medium-risk patients still had a 2.4-fold (odds ratio (OR), 2.4; 95% confidence interval (CI), 1.39-4.15; p = 0.001) and 1.8-fold (OR, 1.8; 95% CI, 1.19-2.86; p = 0.005) higher mortality, respectively, than low-risk patients. However, further addition of age as a covariate for the propensity score-matching demonstrated that there was no significant difference between high-risk and low-risk patients or between medium-risk and low-risk patients, implying that older age may contribute to the significantly higher mortality associated with a lower OSTA score. Conclusions: Older age may be able to explain the association of lower OSTA score and higher mortality rates in patients with isolated moderate and severe TBI.	[Rau, Cheng-Shyuan] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Rau, Cheng-Shyuan; Kuo, Pao-Jen; Wu, Shao-Chun; Chen, Yi-Chun; Hsieh, Hsiao-Yun; Hsieh, Ching-Hua] Chang Gung Univ, Coll Med, Taoyuan 33302, Taiwan; [Kuo, Pao-Jen; Chen, Yi-Chun; Hsieh, Hsiao-Yun; Hsieh, Ching-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan; [Wu, Shao-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung 83301, Taiwan		Hsieh, CH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan 33302, Taiwan.; Hsieh, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan.	ersh2127@cloud.cgmh.org.tw; bow110470@gmail.com; shaochunwu@gmail.com; libe320@yahoo.com.tw; sylvia19870714@hotmail.com; m93chinghua@gmail.com		WU, Shaochun/0000-0002-0984-6921	 [CDRPG8C0033]	This research was supported by a grant from CDRPG8C0033.	Berry C, 2010, AM SURGEON, V76, P1067; Bhat KA, 2016, J CLIN DENSITOM; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Chan SP, 2006, OSTEOPOROSIS INT, V17, P1182, DOI 10.1007/s00198-005-0051-4; Chang SF, 2014, J CLIN NURS, V23, P2628, DOI 10.1111/jocn.12483; Chao C. H., 2015, PLOS ONE, P10; Chaovisitsaree Somsak, 2007, Journal of the Medical Association of Thailand, V90, P420; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Deng QY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080825; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; JOHNELL O, 1997, AM J MED, V103, P20, DOI DOI 10.1016/S0002-9343(97)90023-1; Koh LKH, 2001, OSTEOPOROSIS INT, V12, P699, DOI 10.1007/s001980170070; Li-Yu JT, 2005, OSTEOPOROSIS INT, V16, P1789, DOI 10.1007/s00198-005-1929-x; Lin JS, 2016, CLIN INTERV AGING, V11, P461, DOI 10.2147/CIA.S101078; Lu ChunYan, 2006, J Orthop Surg Res, V1, P14, DOI 10.1186/1749-799X-1-14; Machado P, 2010, OSTEOPOROSIS INT, V21, P977, DOI 10.1007/s00198-009-1036-5; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Muslim DAJ, 2012, MALAYS ORTHOP J, V6, P35, DOI 10.5704/MOJ.1203.011; Nott MT, 2015, AUSTRALAS J AGEING, V34, pE1, DOI 10.1111/ajag.12151; Oh SM, 2016, YONSEI MED J, V57, P187, DOI 10.3349/ymj.2016.57.1.187; Oh SM, 2013, J BONE MINER METAB, V31, P423, DOI 10.1007/s00774-013-0426-0; Rau C. S., 2014, BMJ OPEN, P4; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Sjolander A, 2009, STAT MED, V28, P1416, DOI 10.1002/sim.3532; Strnad M., 2016, WIEN KLIN WOCHENSCHR; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Weitzen S, 2004, PHARMACOEPIDEM DR S, V13, P841, DOI 10.1002/pds.969; Yang Y, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-271	40	9	10	0	2	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2016	13	12							1203	10.3390/ijerph13121203			14	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	EE4KX	WOS:000389571900030		Green Published, Green Submitted, gold			2022-02-06	
J	Chen, MH; Liu, YH; Xu, H; Xu, DW; Wang, CN; Wang, Y; Duan, CW; Zhou, Y; Kan, P; Shen, AG; Wang, YH				Chen, Min-hao; Liu, Yong-hua; Xu, Hua; Xu, Da-wei; Wang, Cheng-niu; Wang, Yi-; Duan, Cheng-wei; Zhou, Ying; Kan, Peng; Shen, Ai-guo; Wang, You-hua			Lentiviral Vector-Mediated p27(kip1) Expression Facilitates Recovery After Spinal Cord Injury	MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; p27(kip1); Apoptosis; Proliferation; Cell cycle	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; CELL-CYCLE; INFLAMMATORY RESPONSE; GLIAL SCAR; NEURONAL APOPTOSIS; SECONDARY DAMAGE; ADULT-RAT; CONTUSION	Traumatic spinal cord injury (SCI) causes tissue loss and associated neurological dysfunction attributable to both mechanical damage and secondary biochemical and physiological responses. Upregulation of cell cycle proteins occurs in both neurons and glia after SCI and may contribute to these changes. Increased cell cycle protein is associated with neuronal and oligodendroglial apoptosis, reactive astrogliosis, glial scar formation, and microglial activation. Here, using lentiviral vectors (LV), we induced the expression of the cyclin-dependent kinase (CDK) inhibitor p27(kip1) in the lesioned spinal cord of adult rat. Treatment with LV-p27(kip1) significantly reduced the expression of cell cycle proteins and improved functional recovery. In addition, p27(kip1) overexpression also reduced lesion volume, decreased astrocytic reactivity, attenuated microglial activation, reduced cell death, and improved the local microenvironment. We suggest that these effects reflect the ability of p27(kip1) to inhibit cell cycle pathways. Thus, the present study provides further support for the therapeutic potential of cell cycle inhibitors in the treatment of SCI.	[Chen, Min-hao; Xu, Hua; Kan, Peng; Wang, You-hua] Nantong Univ, Affiliated Hosp, Dept Orthopaed, 20 Xi Si Rd, Nantong 226001, Jiangsu, Peoples R China; [Chen, Min-hao; Liu, Yong-hua; Xu, Hua; Duan, Cheng-wei; Zhou, Ying; Kan, Peng; Shen, Ai-guo; Wang, You-hua] Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, 20 Xi Si Rd, Nantong 226001, Jiangsu, Peoples R China; [Xu, Da-wei] Nantong Univ, Affiliated Hosp 2, Dept Orthopaed, Nantong 226001, Jiangsu, Peoples R China; [Wang, Cheng-niu] Nantong Univ, Basic Med Res Ctr, Sch Med, Nantong 226001, Jiangsu, Peoples R China; [Wang, Yi-] Nantong Univ, Sch Med, Dept Med Imaging, Nantong 226001, Jiangsu, Peoples R China		Wang, YH (corresponding author), Nantong Univ, Affiliated Hosp, Dept Orthopaed, 20 Xi Si Rd, Nantong 226001, Jiangsu, Peoples R China.; Wang, YH (corresponding author), Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, 20 Xi Si Rd, Nantong 226001, Jiangsu, Peoples R China.	wangyouhua_nt@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171140, 81471258, 31300902]; Colleges and Universities in Natural Science Research Project of Jiangsu Province [13KJB310009]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 81171140, No. 81471258, No. 31300902), the Colleges and Universities in Natural Science Research Project of Jiangsu Province (13KJB310009), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Boonstra J, 2003, J CELL BIOCHEM, V90, P244, DOI 10.1002/jcb.10617; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; Carson JH, 1998, CURR OPIN NEUROBIOL, V8, P607, DOI 10.1016/S0959-4388(98)80088-3; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Chen MH, 2014, CELL TISSUE RES, V358, P277, DOI 10.1007/s00441-014-1946-1; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Delzor A, 2013, CURR DRUG TARGETS, V14, P1714; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; DRAETTA GF, 1994, CURR OPIN CELL BIOL, V6, P842, DOI 10.1016/0955-0674(94)90054-X; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Herwig S, 1997, EUR J BIOCHEM, V246, P581, DOI 10.1111/j.1432-1033.1997.t01-2-00581.x; Iannotti C, 2004, EXP NEUROL, V189, P317, DOI 10.1016/j.expneurol.2004.05.033; Jakobsson J, 2006, MOL THER, V13, P484, DOI 10.1016/j.ymthe.2005.11.012; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nguyen MD, 2003, J NEUROSCI, V23, P2131; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; OKANO HJ, 1993, J NEUROSCI, V13, P2930; Pedraza L, 1997, NEURON, V18, P579, DOI 10.1016/S0896-6273(00)80299-8; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Qu WS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-178; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Shen AU, 2008, NEUROCHEM INT, V52, P1266, DOI 10.1016/j.neuint.2008.01.011; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith GST, 2013, J NEUROSCI RES, V91, P349, DOI 10.1002/jnr.23166; Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; White RE, 2011, J NEUROSCI, V31, P15173, DOI 10.1523/JNEUROSCI.3441-11.2011; Wu JF, 2012, CELL CYCLE, V11, P1782, DOI 10.4161/cc.20153; Wu JF, 2011, NEUROTHERAPEUTICS, V8, P221, DOI 10.1007/s13311-011-0028-2	54	9	10	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2016	53	9					6043	6056		10.1007/s12035-015-9498-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EB2ZO	WOS:000387231300021	26526846				2022-02-06	
J	Stone, JL; Patel, V; Bailes, JE				Stone, James L.; Patel, Vimal; Bailes, Julian E.			Sir Hugh Cairns and World War II British advances in head injury management, diffuse brain injury, and concussion: an Oxford tale	JOURNAL OF NEUROSURGERY			English	Article						Hugh Cairns; biomechanics; head injury; diffuse brain injury; concussion; helmets; Harvey Cushing; British neurosurgery; history	EXPERIMENTAL CEREBRAL CONCUSSION; WOUNDS; PENICILLIN; FRACTURES	The authors trace the Oxford, England, roots of World War II (WWII)-related advances in head injury management, the biomechanics of concussion and brain injury, and postwar delineation of pathological findings in severe concussion and diffuse brain injury in man. The prominent figure in these developments was the charismatic and innovative Harvey Cushing-trained neurosurgeon Sir Hugh Cairns. Cairns, who was to closely emulate Cushing's surgical and scholarly approach, is credited with saving thousands of lives during WWII by introducing and implementing innovative programs such as helmets for motorcyclists, mobile neurosurgical units near battle zones, and the military usage of penicillin. In addition, he inspired and taught a generation of neurosurgeons, neurologists, and neurological nurses in the care of brain and spinal cord injuries at Oxford's Military Hospital for Head Injuries. During this time Cairns also trained the first full-time female neurosurgeon. Pivotal in supporting animal research demonstrating the critical role of acceleration in the causation of concussion, Cairns recruited the physicist Hylas Holbourn, whose research implicated rotary acceleration and shear strains as particularly damaging. Cairns' work in military medicine and head injury remain highly influential in efforts to mitigate and manage brain injury.	[Stone, James L.; Patel, Vimal; Bailes, Julian E.] NorthShore Univ HealthSyst, NorthShore Neurol Inst, Dept Neurosurg, 2650 Ridge Ave,3rd Fl,Kellogg Bldg, Evanston, IL 60201 USA		Stone, JL (corresponding author), NorthShore Univ HealthSyst, NorthShore Neurol Inst, Dept Neurosurg, 2650 Ridge Ave,3rd Fl,Kellogg Bldg, Evanston, IL 60201 USA.	jlstone4@gmail.com		Stone, James/0000-0002-3724-7555			Aarabi B, 1999, MISSILE WOUNDS HEAD, P3; Abraham EP, 1941, LANCET, V2, P177; [Anonymous], 1944, J NEUROSURG, V1, P201; [Anonymous], 1952, LANCET, V2, P202; Ascroft PB, 1944, LANCET, V1, P594; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bailey O T, 1976, Surg Neurol, V5, P267; Bailey OT, 1984, J NEUROPATHOL EXP NE, V43, P546; Blackwood W, 1949, ATLAS NEUROPATHOLOGY; Bliss M, 2005, HARVEY CUSHING LIFE, P416; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Botterell EH, 1948, BRIT SURG PRACTICE, P349; Bucy PC, 1975, SURG NEUROL, V4, P351; CAIRNS H, 1946, BRIT MED J, V2, P322, DOI 10.1136/bmj.2.4470.322; Cairns H, 1941, BRAIN, V64, P273, DOI 10.1093/brain/64.4.273; CAIRNS H, 1947, Br J Surg, V55, P9; CAIRNS H, 1952, BRAIN, V75, P109, DOI 10.1093/brain/75.2.109; CAIRNS H, 1945, BRIT MED BULL, V3, P9, DOI 10.1093/oxfordjournals.bmb.a071873; Cairns H, 1941, BRIT MED J, V1941, P465, DOI 10.1136/bmj.2.4213.465; Cairns H, 1943, BMJ-BRIT MED J, V1943, P591, DOI 10.1136/bmj.1.4297.591; CAIRNS H, 1947, BRAIN, V70, P251, DOI 10.1093/brain/70.3.251; Cairns H, 1944, BRIT J SURG, V32, P199, DOI 10.1002/bjs.18003212539; CAMPBELL M, 1965, BRIT HEART J, V27, P453; Carey ME, 2014, J NEUROSURG, V121, P319, DOI 10.3171/2014.5.JNS122285; Carey ME, 2011, J NEUROSURG, V114, P1495, DOI 10.3171/2011.1.JNS101259; Chain E, 1940, LANCET, V2, P226; Chalif JI, 2013, NEUROSURGERY, V72, P135, DOI 10.1227/NEU.0b013e31827b9fae; Committee of the Privy Council for Medical Research, 1947, MED RES WAR REP MED; Cooke A. M., 1994, MY 1 75 YEARS MED; Curnow W.J., 2008, TRANSPORTATION ACCID, P141; Cushing H, 1918, BRIT J SURG, V5, P558; Cushing H, 1916, MIL SURG, V38, P601; Cybulski GR, 2008, NEUROSURGERY, V63, P808, DOI 10.1227/01.NEU.0000325732.58528.86; Debus AG, 1968, WORLDS WHOS WHO SCI; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1961, ARCH NEUROL-CHICAGO, V5, P1; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; ECKER AD, 1946, J NEUROSURG, V3, P1, DOI 10.3171/jns.1946.3.1.0001; Finger Stanley, 2010, Handb Clin Neurol, V95, P189, DOI 10.1016/S0072-9752(08)02114-3; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Florey HW, 1944, HYGIEA, V22, P300; Fraenkel GJ, 1991, H CAIRNS 1 NUFFIELD; Fulton J., 1946, HARVEY CUSHING BIOGR, P539; Gennarelli TA, 2014, PROG NEUROL SURG, V28, P243, DOI 10.1159/000358788; Gilkes CE, 2008, NEUROSURGERY, V62, P738, DOI 10.1227/01.neu.0000317324.71483.e5; Gurdjian ES, 1975, IMPACT HEAD INJURY M; GUTTMANN L, 1954, P ROY SOC MED, V47, P1099, DOI 10.1177/003591575404701226; Guttmann L, 1942, P ROY SOC MED, V35, P295; HARE R, 1982, MED HIST, V26, P1; Holbourn AHS, 1944, J NEUROSURG, V1, P190, DOI 10.3171/jns.1944.1.3.0190; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Holbourn AHS, 1944, LANCET, V1, P483; HORRAX G, 1952, NEUROSURGERY HIST SK; Horsley V, 1915, LANCET, V1, P359; Horsley V, 1915, T MED SOC LONDON, V38, P112; Hughes J T, 2001, J Med Biogr, V9, P236; JEFFERSON G, 1959, J NEUROL NEUROSUR PS, V22, P155; LAX E, 2004, MOLD DR FLOREYS COAT; LeCount ER, 1920, J AMER MED ASSOC, V74, P501, DOI 10.1001/jama.1920.02620080003002; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Ludovici LJ., 1952, FLEMING DISCOVER PEN; Maartens NF, 2002, NEUROSURGERY, V50, P176; Macfarlane G., 1979, H FLOREY MAKING GREA; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Medical Research Council, 1941, 4 MRC; Northfield DWC, 1973, SURGERY CENTRAL NERV, p[753, 839]; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Pennybacker J, 1975, Surg Neurol, V4, P347; Rowbotham G F, 1970, Neurol Neurocir Psiquiatr, V11, P19; Rowbotham GF, 1964, ACUTE INJURIES HEAD, P56; Russell W.R., 1961, TRAUMATIC APHASIA ST; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUSSELL WR, 1951, J NEUROL NEUROSUR PS, V14, P35, DOI 10.1136/jnnp.14.1.35; SCHORSTEIN J, 1947, Br J Surg, V55, P27; Schurr P., 1997, SO WAS LIFE BIOGRAPH; SCHURR PH, 1990, J NEUROL NEUROSUR PS, V53, P188, DOI 10.1136/jnnp.53.3.188; Schurr PH, 2005, J ROY SOC MED, V98, P423, DOI 10.1258/jrsm.98.9.423; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Symonds CP, 1943, LANCET, V1, P7; Teasdale G, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P13; Vance BM, 1927, ARCH SURG-CHICAGO, V14, P1023, DOI 10.1001/archsurg.1927.01130170071005; Walker N M, 2008, J R Army Med Corps, V154, P146; Williams ET, 1896, AUSTR DICT BIOGRAPHY	87	9	9	0	19	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2016	125	5					1301	1314		10.3171/2015.8.JNS142613			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DZ8FK	WOS:000386106100031	26894455				2022-02-06	
J	Yu, SX; Zhang, QS; Yin, Y; Liu, Z; Wu, JM; Yang, MX				Yu, S. -X.; Zhang, Q. -S.; Yin, Y.; Liu, Z.; Wu, J. -M.; Yang, M. -X.			Continuous monitoring of intracranial pressure for prediction of postoperative complications of hypertensive intracerebral hemorrhage	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Dynamic monitoring of intracranial pressure; Hypertension intracerebral hemorrhage; GCS score	TRAUMATIC BRAIN-INJURY	OBJECTIVE: This study evaluates the value of continuous dynamic monitoring of intracranial pressure (ICP) in patients with hypertensive intracerebral hemorrhage to predict early postoperative complications. PATIENTS AND METHODS: Data from 80 patients treated in our hospital from February 2014 to February 2015 were analyzed. The patients all underwent decompressive craniectomies, and their ICP changes were monitored invasively and continuously for 1 to 7 days after surgery. The average blood loss during surgery for the group of patients was 65.3 +/- 12.4 ml and the mean GCS score 8.7 +/- 2.4. Cases were divided into three groups according to ICP values to compare early postoperative complications of the groups: a normal and mildly increased group (51 cases), a moderately increased group (19 cases) and a severely increased group (10 cases). RESULTS: To validate t he a nalysis we first showed that comparisons among groups based on gender, age, systolic pressure, diastolic pressure, bleeding time, blood loss, operation time, craniectomy localization, and preoperative mannitol dosage yielded no statistically significant differences. In contrast, the following comparisons produced statistically significant differences: the comparison of postoperative Glasgow Coma Scale (GCS) scores showing that the lower intracranial pressure, the higher the GCS score; the postoperative rehemorrhage, cerebral edema and death ratios showing the higher the intracranial pressure, the higher the rehemorrhage ratio; the average ICP and the time to occurrence of rehemorrhage, cerebral edema or cerebral infarction, showing the relationship between the average ICP and the time to a complication. Patients with higher ICP averages suffered a complication of rehemorrhage within the first 9.6 +/- 2.5 hours on average. Nevertheless, the comparison of GCS scores in those patients and the others showed no significant differences. CONCLUSIONS: Based on the findings, the dynamic monitoring of intracranial pressure can early and sensitively predict postoperative complications of patients with hypertensive cerebral hemorrhage, and guide the clinical intervention actively to improve the surgery outcome.	[Yu, S. -X.; Yin, Y.; Liu, Z.; Yang, M. -X.] Second Peoples Hosp Longgang Dist, Dept Neurosurg, Shenzhen, Peoples R China; [Zhang, Q. -S.; Wu, J. -M.] Second Peoples Hosp Shenzhen, Dept Neurosurg, Shenzhen, Peoples R China		Wu, JM (corresponding author), Second Peoples Hosp Shenzhen, Dept Neurosurg, Shenzhen, Peoples R China.	nt1492028yashanhu@163.com			Shenzhen Science and Technology Innovation Commission (Shenzhen Key Laboratory of Neurosurgery) [Zdsys20140509173142601]	This work was supported by grants from Shenzhen Science and Technology Innovation Commission (Shenzhen Key Laboratory of Neurosurgery. Grant No. Zdsys20140509173142601).	Bullock R, 2008, J TRAUMA, V65, P966; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chiu YL, 2012, J NEUROSURG, V117, P729; Gong FT, 2015, EUR REV MED PHARMACO, V19, P412; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hartl R, 2013, WORLD NEUROSURG, V79, P599, DOI 10.1016/j.wneu.2013.03.046; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Liu ZM, 2015, INT J CLIN EXP MED, V8, P11456; Luitse MJ, 2010, LANCET NEUROL, V9, P167; Ropper AE, 2013, NEUROSURGERY, V72, pN19, DOI 10.1227/01.neu.0000428424.83867.87; Ropper AH, 2012, NEW ENGL J MED, V367, P2539, DOI 10.1056/NEJMe1212289; Takeuchi S, 2015, J CLIN NEUROSCI, V22, P483, DOI 10.1016/j.jocn.2014.08.033; Yang LJ, 2014, EUR REV MED PHARMACO, V18, P3653; Zivelonghi C, 2010, J NEUROL SCI, V359, P293	15	9	10	0	1	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	NOV	2016	20	22					4750	4755					6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EF1YC	WOS:000390120100019	27906426				2022-02-06	
J	Hernandez-Encinas, E; Aguilar-Morante, D; Morales-Garcia, JA; Gine, E; Sanz-SanCristobal, M; Santos, A; Perez-Castillo, A				Hernandez-Encinas, Elena; Aguilar-Morante, Diana; Morales-Garcia, Jose A.; Gine, Elena; Sanz-SanCristobal, Marina; Santos, Angel; Perez-Castillo, Ana			Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBP beta	JOURNAL OF NEUROINFLAMMATION			English	Article						C/EBP beta; C3; Excitotoxicity; Neurodegeneration; Neuroinflammation	BINDING-PROTEIN-BETA; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; TRANSCRIPTION FACTORS; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; MICE; CELLS	Background: The CCAAT/enhancer-binding protein beta (C/EBP beta) is a transcription factor implicated in the control of proliferation, differentiation, and inflammatory processes mainly in adipose tissue and liver; although more recent results have revealed an important role for this transcription factor in the brain. Previous studies from our laboratory indicated that CCAAT/enhancer-binding protein beta is implicated in inflammatory process and brain injury, since mice lacking this gene were less susceptible to kainic acid-induced injury. More recently, we have shown that the complement component 3 gene (C3) is a downstream target of CCAAT/enhancer-binding protein beta and it could be a mediator of the proinflammatory effects of this transcription factor in neural cells. Methods: Adult male Wistar rats (8-12 weeks old) were used throughout the study. C/EBP beta(+/+) and C/EBP beta(-/-) mice were generated from heterozygous breeding pairs. Animals were injected or not with kainic acid, brains removed, and brain slices containing the hippocampus analyzed for the expression of both CCAAT/enhancer-binding protein beta and C3. Results: In the present work, we have further extended these studies and show that CCAAT/enhancer-binding protein beta and C3 co-express in the CA1 and CA3 regions of the hippocampus after an excitotoxic injury. Studies using CCAAT/enhancer-binding protein beta knockout mice demonstrate a marked reduction in C3 expression after kainic acid injection in these animals, suggesting that indeed this protein is regulated by C/EBP beta in the hippocampus in vivo. Conclusions: Altogether these results suggest that CCAAT/enhancer-binding protein beta could regulate brain disorders, in which excitotoxic and inflammatory processes are involved, at least in part through the direct regulation of C3.	[Hernandez-Encinas, Elena; Aguilar-Morante, Diana; Morales-Garcia, Jose A.; Sanz-SanCristobal, Marina; Perez-Castillo, Ana] CSIC UAM, Inst Invest Biomed, Arturo Duperier 4, Madrid 28029, Spain; [Hernandez-Encinas, Elena; Morales-Garcia, Jose A.; Sanz-SanCristobal, Marina; Santos, Angel; Perez-Castillo, Ana] CIBERNED, Madrid 28031, Spain; [Santos, Angel] UCM, Fac Med, Dept Bioquim & Biol Mol, Madrid 28040, Spain; [Gine, Elena] UCM, Fac Med, Dept Biol Celular, Madrid 28040, Spain; [Aguilar-Morante, Diana] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Dept Fisiol Med & Biofis,Inst Biomed Sevilla,IBiS, Seville 41013, Spain		Perez-Castillo, A (corresponding author), CSIC UAM, Inst Invest Biomed, Arturo Duperier 4, Madrid 28029, Spain.; Santos, A; Perez-Castillo, A (corresponding author), CIBERNED, Madrid 28031, Spain.	aperez@iib.uam.es	Perez-Castillo, Ana/A-9505-2015; Morales-Garcia, Jose A/L-4552-2014; Hernandez Encinas, Elena/I-4623-2018; IBIS, FISIOPATOLOGIA/O-9510-2015; Gine, Elena/I-3205-2012; Santos, Angel/K-3744-2014; Dominguez, Elena Gine/ABF-9419-2020; Aguilar-Morante, Diana/AAE-8572-2019	Morales-Garcia, Jose A/0000-0001-9008-0056; Hernandez Encinas, Elena/0000-0003-4984-0302; Gine, Elena/0000-0001-6305-6237; Santos, Angel/0000-0002-7551-8483; Dominguez, Elena Gine/0000-0001-6305-6237; Aguilar-Morante, Diana/0000-0001-9775-0841; Perez-Castillo, Ana/0000-0002-2632-5853	MINECOSpanish Government [SAF2014-52940-R]; FEDER fundsEuropean Commission; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission; CIBERNEDInstituto de Salud Carlos III; CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)	This work was supported by MINECO, Grant SAF2014-52940-R and partially financed with FEDER funds. CIBERNED is funded by the Instituto de Salud Carlos III. JAM-G was supported by CIBERNED. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).	Aguilar-Morante D, 2011, NEUROSCIENCE, V176, P110, DOI 10.1016/j.neuroscience.2010.12.025; Aguilar-Morante D, 2015, ONCOTARGET, V6, P4369, DOI 10.18632/oncotarget.2976; Aiyaz M, 2012, IMMUNOBIOLOGY, V217, P204, DOI 10.1016/j.imbio.2011.07.023; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Asua T, 2008, ENDOCRINOLOGY, V149, P2657, DOI 10.1210/en.2007-1586; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Bodea LG, 2014, J NEUROSCI, V34, P8546, DOI 10.1523/JNEUROSCI.5002-13.2014; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.3.CO;2-9; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; Cortes-Canteli M, 2004, J BIOL CHEM, V279, P14409, DOI 10.1074/jbc.M313253200; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; Cortes-Canteli M, 2008, J CELL SCI, V121, P1224, DOI 10.1242/jcs.025031; Cortes-Canteli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024842; Croniger C, 1998, J BIOL CHEM, V273, P31629, DOI 10.1074/jbc.273.48.31629; D'Ambrosio AL, 2001, MOL MED, V7, P367, DOI 10.1007/BF03402183; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; FISCHER B, 1995, J MOL MED, V73, P465; Flierl MA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/920474; Fourgeaud L, 2007, CELL, V131, P1034, DOI 10.1016/j.cell.2007.11.031; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; Gasque P, 1998, J IMMUNOL, V160, P3543; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Hernandez-Encinas E, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0223-2; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Jamali S, 2006, BRAIN, V129, P625, DOI 10.1093/brain/awl001; Kapadia R, 2006, J NEUROCHEM, V98, P1718, DOI 10.1111/j.1471-4159.2006.04056.x; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Libbey JE, 2010, J VIROL, V84, P6452, DOI 10.1128/JVI.00422-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez ME, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-216; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Maranto J, 2011, J CELL BIOCHEM, V112, P1168, DOI 10.1002/jcb.23032; Mayer TZ, 2013, J IMMUNOL, V191, P4299, DOI 10.4049/jimmunol.1301117; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Morales-Garcia JA, 2017, STEM CELLS, V35, P458, DOI 10.1002/stem.2480; Morales-Garcia JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017240; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Perez-Alcazar M, 2014, EXP NEUROL, V253, P154, DOI 10.1016/j.expneurol.2013.12.013; Perry VH, 2008, NAT REV NEUROSCI, V9, P807, DOI 10.1038/nrn2394; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Prineas JW, 2012, ANN NEUROL, V72, P18, DOI 10.1002/ana.23634; Proitsi P, 1843, NEUROBIOL AGING, V2012; Pulido-Salgado M, 2015, PROG NEUROBIOL, V132, P1, DOI 10.1016/j.pneurobio.2015.06.003; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Ramathal C, 2010, MOL CELL BIOL, V30, P1607, DOI 10.1128/MCB.00872-09; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rininger A, 2012, CELL DEATH DIFFER, V19, P1634, DOI 10.1038/cdd.2012.41; Rosen AM, 2010, ADV EXP MED BIOL, V703, P75, DOI 10.1007/978-1-4419-5635-4_6; Rutkowski MJ, 2010, INFLAMM RES, V59, P897, DOI 10.1007/s00011-010-0220-6; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Serrat N, 2014, J IMMUNOL, V192, P418, DOI 10.4049/jimmunol.1203500; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Shinjyo N, 2009, STEM CELLS, V27, P2824, DOI 10.1002/stem.225; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Thomas A, 2000, INT IMMUNOL, V12, P1015, DOI 10.1093/intimm/12.7.1015; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Wang Y, 2011, AM J PATHOL, V178, P1509, DOI 10.1016/j.ajpath.2011.01.006; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Williams CJ, 2014, J NEUROCHEM, V129, P4, DOI 10.1111/jnc.12608; WILSON DR, 1990, MOL CELL BIOL, V10, P6181, DOI 10.1128/MCB.10.12.6181; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Yang SX, 2006, J CEREBR BLOOD F MET, V26, P1490, DOI 10.1038/sj.jcbfm.9600305; Yu JX, 2002, J NEUROIMMUNOL, V123, P91, DOI 10.1016/S0165-5728(01)00483-0; Zabel MK, 2013, AGEING RES REV, V12, P749, DOI 10.1016/j.arr.2013.02.001; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zhang ZQ, 2010, J BIOL CHEM, V285, P33092, DOI 10.1074/jbc.M110.130377	88	9	9	0	17	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	OCT 21	2016	13								276	10.1186/s12974-016-0742-0			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DZ3VI	WOS:000385777300001	27769255	Green Published, gold			2022-02-06	
J	Shepherd, DJ; Tsai, SY; O'Brien, TE; Farrer, RG; Kartje, GL				Shepherd, Daniel J.; Tsai, Shih-Yen; O'Brien, Timothy E.; Farrer, Robert G.; Kartje, Gwendolyn L.			Anti-Nogo-A Immunotherapy Does Not Alter Hippocampal Neurogenesis after Stroke in Adult Rats	FRONTIERS IN NEUROSCIENCE			English	Article						stroke; neurogenesis; Nogo-A; immunotherapy; myelin-associated inhibitor	FOCAL CEREBRAL-ISCHEMIA; TRANSIENT GLOBAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; DENTATE GYRUS; DOWN-REGULATION; STIMULATES NEUROGENESIS; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; CORTICOSPINAL TRACT; FUNCTIONAL RECOVERY	Ischemic stroke is a leading cause of adult disability, including cognitive impairment. Our laboratory has previously shown that treatment with function-blocking antibodies against the neurite growth inhibitory protein Nogo-A promotes functional recovery after stroke in adult and aged rats, including enhancing spatial memory performance, for which the hippocampus is critically important. Since spatial memory has been linked to hippocampal neurogenesis, we investigated whether anti-Nogo-A treatment increases hippocampal neurogenesis after stroke. Adult rats were subject to permanent middle cerebral artery occlusion followed 1 week later by 2 weeks of antibody treatment. Cellular proliferation in the dentate gyrus was quantified at the end of treatment, and the number of newborn neurons was determined at 8 weeks post-stroke. Treatment with both anti-Nogo-A and control antibodies stimulated the accumulation of new microglia/macrophages in the dentate granule cell layer, but neither treatment increased cellular proliferation or the number of newborn neurons above stroke-only levels. These results suggest that anti-Nogo-A immunotherapy does not increase post-stroke hippocampal neurogenesis.	[Shepherd, Daniel J.; Kartje, Gwendolyn L.] Loyola Univ Chicago, Div Hlth Sci, Neurosci Inst, Maywood, IL 60153 USA; [Shepherd, Daniel J.; Tsai, Shih-Yen; Farrer, Robert G.; Kartje, Gwendolyn L.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [O'Brien, Timothy E.] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [Kartje, Gwendolyn L.] Loyola Univ Chicago, Div Hlth Sci, Dept Mol Pharmacol & Therapeut, Maywood, IL USA		Shepherd, DJ (corresponding author), Loyola Univ Chicago, Div Hlth Sci, Neurosci Inst, Maywood, IL 60153 USA.; Shepherd, DJ (corresponding author), Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.	dishepherd@luc.edu			US Department of Veterans Affairs Rehabilitation Research and Development serviceUS Department of Veterans Affairs [5I01RX000828]; American Heart AssociationAmerican Heart Association [15PRE24470136]	This work was supported by grant 5I01RX000828 from the US Department of Veterans Affairs Rehabilitation Research and Development service to GK, and American Heart Association 15PRE24470136 to DS.	Akahoshi N, 2011, EPILEPSY BEHAV, V22, P659, DOI 10.1016/j.yebeh.2011.09.002; Aloy EM, 2006, BRAIN CELL BIOL, V35, P137, DOI 10.1007/s11068-007-9014-3; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Brenneman MM, 2008, BEHAV BRAIN RES, V187, P262, DOI 10.1016/j.bbr.2007.09.018; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Christie KJ, 2013, NEUROSCIENCE, V247, P75, DOI 10.1016/j.neuroscience.2013.05.019; Craveiro LM, 2013, EXP NEUROL, V250, P52, DOI 10.1016/j.expneurol.2013.09.015; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Gemma C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00229; Gillani RL, 2010, BEHAV BRAIN RES, V208, P415, DOI 10.1016/j.bbr.2009.12.015; Gottesman RF, 2010, LANCET NEUROL, V9, P895, DOI 10.1016/S1474-4422(10)70164-2; Huber AB, 2002, J NEUROSCI, V22, P3553; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Karlsson TE, 2016, CEREB CORTEX, V26, P1804, DOI 10.1093/cercor/bhw007; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Kellner Y, 2016, HIPPOCAMPUS, V26, P816, DOI 10.1002/hipo.22565; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746; Kluska MM, 2005, NEUROSCIENCE, V135, P723, DOI 10.1016/j.neuroscience.2005.06.082; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Kumar P, 2013, CNS NEUROL DISORD-DR, V12, P200; Kurowska Z, 2014, NEUROSCIENCE, V256, P456, DOI 10.1016/j.neuroscience.2013.10.029; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Liu JL, 1998, J NEUROSCI, V18, P7768; LUBECK MD, 1985, J IMMUNOL, V135, P1299; Luo Y, 2010, J BIOL CHEM, V285, P4232, DOI 10.1074/jbc.M109.037168; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; Matsumori Y, 2006, NEUROBIOL DIS, V22, P187, DOI 10.1016/j.nbd.2005.10.015; Meng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106238; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Papadopoulos CM, 2006, CEREB CORTEX, V16, P529, DOI 10.1093/cercor/bhi132; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petrasek T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00090; Petrasek T, 2014, NEUROBIOL LEARN MEM, V107, P42, DOI 10.1016/j.nlm.2013.10.015; Petrinovic MM, 2013, P NATL ACAD SCI USA, V110, P1083, DOI 10.1073/pnas.1214255110; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Sun GJ, 2015, P NATL ACAD SCI USA, V112, P9484, DOI 10.1073/pnas.1508545112; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Tews B, 2013, P NATL ACAD SCI USA, V110, P6583, DOI 10.1073/pnas.1217665110; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; Vadodaria Krishna C, 2013, Front Synaptic Neurosci, V5, P4, DOI 10.3389/fnsyn.2013.00004; Wahl AS, 2014, SCIENCE, V344, P1250, DOI 10.1126/science.1253050; Weinmann O, 2006, MOL CELL NEUROSCI, V32, P161, DOI 10.1016/j.mcn.2006.03.007; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Wurm F, 2007, STROKE, V38, P2833, DOI 10.1161/STROKEAHA.107.485524; Yu DX, 2014, DEVELOPMENT, V141, P2366, DOI 10.1242/dev.096776; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101; Zhu DY, 2003, J NEUROSCI, V23, P223; Zorner B, 2010, ANN NY ACAD SCI, V1198, pE22, DOI 10.1111/j.1749-6632.2010.05566.x	71	9	9	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 18	2016	10								467	10.3389/fnins.2016.00467			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY9PQ	WOS:000385466700001	27803646	Green Published, gold			2022-02-06	
J	Dambinova, SA; Maroon, JC; Sufrinko, AM; Mullins, JD; Alexandrova, EV; Potapov, AA				Dambinova, Svetlana A.; Maroon, Joseph C.; Sufrinko, Alicia M.; Mullins, John David; Alexandrova, Eugenia V.; Potapov, Alexander A.			Functional, structural, and neurotoxicity Biomarkers in integrative assessment of Concussions	FRONTIERS IN NEUROLOGY			English	Article						concussion; mild TBI; neuropsychological evaluations; advanced MRI sequences; neurotoxicity and neuroplasticity biomarkers	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; SPORT-RELATED CONCUSSION; C-TERMINAL HYDROLASE-L1; ICE HOCKEY PLAYERS; VISUAL SCREENING TOOL; ERROR SCORING SYSTEM; MINOR HEAD-INJURY; KING-DEVICK TEST; IMAGING FINDINGS	Concussion is a complex, heterogeneous process affecting the brain. Accurate assessment and diagnosis and appropriate management of concussion are essential to ensure that athletes do not prematurely return to play or others to work or active military duty, risking re-injury. To date, clinical diagnosis relies primarily on evaluating subjects for functional impairment using instruments that include neurocognitive testing, subjective symptom report, and neurobehavioral assessments, such as balance and vestibular-ocular reflex testing. Structural biomarkers, defined as advanced neuroimaging techniques and biomarkers assessing neurotoxicity and immunoexcitotoxicity, may complement the use of functional biomarkers. We hypothesize that neurotoxicity AMPA, NMDA, and kainite receptor biomarkers might be utilized as a part of comprehensive approach to concussion evaluations, with the goal of increasing diagnostic accuracy and facilitating treatment planning and prognostic assessment.	[Dambinova, Svetlana A.] DeKalb Med Ctr, Brain Biomarkers Res Lab, Decatur, GA USA; [Maroon, Joseph C.] Univ Pittsburgh, Neurol Surg, Pittsburgh, PA USA; [Sufrinko, Alicia M.] Univ Pittsburgh, Orthopaed Surg, Pittsburgh, PA USA; [Mullins, John David] Piedmont Hosp, Surg, Atlanta, GA USA; [Alexandrova, Eugenia V.; Potapov, Alexander A.] Burdenko Neurosurg Inst, Neurotrauma, Moscow, Russia		Dambinova, SA (corresponding author), DeKalb Med Ctr, Brain Biomarkers Res Lab, Decatur, GA USA.	dambinova@aol.com	Dambinova, Svetlana A/G-1724-2017	Dambinova, Svetlana A/0000-0003-4411-5726	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Skolkovo BioMed, Moscow, Russia	In parts supported by grant from US Army Medical Research and Materiel Command, 2011-2013 and grant from Skolkovo BioMed, Moscow, Russia, 2016-2017.	Alexandrova E V, 2014, Zh Vopr Neirokhir Im N N Burdenko, V78, P26; Ashby Michael C., 2008, P1; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barker J. M., 2007, Journal of Medical Engineering & Technology, V31, P161, DOI 10.1080/03091900500272781; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Blaylock RL, 2011, RSC DRUG DISCOV, V2, P45, DOI [10.1039/9781849734745-00045, DOI 10.1039/9781849734745-00045]; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chen Y, 2010, IFMBE PROC, V31, P497, DOI 10.1007/978-3-642-14515-5_127; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Dambinova SA, 1997, J NEUROL SCI, V152, P93, DOI 10.1016/S0022-510X(97)00150-0; Dambinova SA, 1998, J NEUROCHEM, V71, P2088; Dambinova SA, 2013, J MOL BIOMARK DIA S1, V3, DOI [10.4172/2155-9929.S3-003, DOI 10.4172/2155-9929.S3-003]; Dambinova SA, 2008, CLIN LAB INT, V32, P7; Dambinova SA, 2012, RSC DRUG DISCOV, V24, P134, DOI 10.1039/9781849734745-00134; Dambinova SA, 2013, MIL MED, V178, P285, DOI 10.7205/MILMED-D-12-00368; Dambinova SA, 2012, RSC DRUG DISCOV, V24, P66, DOI 10.1039/9781849734745-00066; Dambinova SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042362; Danilenko UI, 2012, RSC DRUG DISCOV, V24, P87, DOI 10.1039/9781849734745-00087; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; De Marco AP, 2016, J CHILD NEUROL, V31, P68, DOI 10.1177/0883073814559645; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Docampo J, 2013, NEURORADIOL J, V26, P493, DOI 10.1177/197140091302600501; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goryunova A V, 2007, Neurosci Behav Physiol, V37, P761, DOI 10.1007/s11055-007-0079-3; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; Hansen-Schwartz J, 2014, DAN MED J, V61; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Hayashida Y, 2014, ACTA RADIOL, V55, P201, DOI 10.1177/0284185113495836; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry NL, 2012, MOL ONCOL, V6, P140, DOI 10.1016/j.molonc.2012.01.010; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Jaber Z, 2016, METHODS MOL BIOL, V1462, P157, DOI 10.1007/978-1-4939-3816-2_10; Jin XT, 2011, ADV EXP MED BIOL, V717, P27, DOI 10.1007/978-1-4419-9557-5_3; Johnston SC, 2011, ANN NEUROL, V69, P872, DOI 10.1002/ana.22332; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Lai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maruta J, 2012, PROC SPIE, V8371, DOI 10.1117/12.927790; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mullins JD, 2013, AMSUS 118 ANN CONT E; Mullins JD, 2012, 2012 MIL HLTH SYST R, P134; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nasser M, 2016, CNS NEUROL DISORD-DR, V15, P1030, DOI 10.2174/1871527315666160815093525; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Patzig M, 2015, INVEST RADIOL, V50, P397, DOI 10.1097/RLI.0000000000000143; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Potapov A. A., 2014, NN BURDENKO J NEUROS, V78, P4; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Raad M, 2014, NEUROSCIENCE, V281, P16, DOI 10.1016/j.neuroscience.2014.08.045; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Rezaei A, 2014, INT NEUROTRAUMA LETT, V35; Sahu P., 2011, ASIAN J PHARM SCI, V1, P9; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Sharp CD, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-28; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Sorokina E G, 2009, Neurosci Behav Physiol, V39, P329, DOI 10.1007/s11055-009-9147-1; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Weissman JD, 2011, J NEUROL SCI, V300, P97, DOI 10.1016/j.jns.2010.09.023; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Zakharova N, 2014, NEUROIMAGING CLASSIF, P35; Zehtabchi S, 2007, EMERG MED J, V24, P333, DOI 10.1136/emj.2006.044578; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	133	9	11	1	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 5	2016	7								172	10.3389/fneur.2016.00172			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY4ET	WOS:000385052500002	27761129	Green Published, gold			2022-02-06	
J	Aloisi, AM; Berlincioni, V; Torta, R; Nappi, RE; Tassorelli, C; Barale, F; Ieraci, V; Giusti, EM; Pietrabissa, G; Tamburin, S; Manzoni, GM; Castelnuovo, G				Aloisi, Anna M.; Berlincioni, Vanna; Torta, Riccardo; Nappi, Rossella E.; Tassorelli, Cristina; Barale, Francesco; Ieraci, Valentina; Giusti, Emanuele M.; Pietrabissa, Giada; Tamburin, Stefano; Manzoni, Gian M.; Castelnuovo, Gianluca		Italian Consensus Conf Pain Neuror	The role of gender, psycho-social factors and anthropological-cultural dimensions on pain in neurorehabilitation Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Gender identity; Hormones; Rehabilitation; Anxiety; Depression; Catastrophization	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; LOW-BACK-PAIN; COGNITIVE-BEHAVIORAL THERAPY; PERIPHERAL NEUROPATHIC PAIN; RANDOMIZED-CONTROLLED-TRIAL; SPINAL-CORD-INJURY; FIBROMYALGIA SYNDROME; CEREBRAL-PALSY; SELF-EFFICACY	Pain is frequent in patients undergoing neurorehabilitation, but there is a number of still unanswered questions on this topic. The Italian Consensus Conference on Pain in Neurorehabilitation (ICCPN) was constituted with the purpose to identify the best practices that can be used in this context. In this article we summarize the existing evidence and recommendations provided by the ICCPN about the role of gender, psycho-social factors and anthropological-cultural dimensions on pain in neurorehabilitation. Sex, gender, psycho-social variables, anthropological and cultural features may influence pain expression, and its pharmacological and non-pharmacological outcome, but the role of these factors has not been consistently explored in neurorehabilitation. There is a number of psychological factors that can be correlated with or represent a predictor for pain, or may influence the treatment and outcome of neurorehabilitation programs. All these factors should be considered when designing these programs, and future studies should incorporate them as potential covariates that may influence outcome.	[Aloisi, Anna M.] Univ Siena, Dept Med Surg & Neurosci, Behav Neurophysiol Lab, Siena, Italy; [Berlincioni, Vanna; Barale, Francesco] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy; [Torta, Riccardo] Univ Turin, Dept Neurosci Rita Levi Montalcini, Turin, Italy; [Nappi, Rossella E.] Univ Pavia, IRCCS, Policlin San Matteo Fdn, Res Ctr Reprod Med Gynecol Endocrinol & Menopause, Pavia, Italy; [Tassorelli, Cristina] Univ Pavia, Dept Brain & Behav Sci, Neurorehabil Unit, Natl Neurol Inst C Mondino, Pavia, Italy; [Ieraci, Valentina] Univ Turin, Citta Sci & Salute, Dept Oncol & Neurosci, Turin, Italy; [Giusti, Emanuele M.; Pietrabissa, Giada; Castelnuovo, Gianluca] Catholic Univ Milan, Dept Psychol, Milan, Italy; [Pietrabissa, Giada; Manzoni, Gian M.; Castelnuovo, Gianluca] San Giuseppe Hosp, Psychol Res Lab, Ist Auxol Italiano, IRCCS, Verbania, Italy; [Tamburin, Stefano] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Manzoni, Gian M.] eCampus Univ, Fac Psychol, Novedrate, Como, Italy		Castelnuovo, G (corresponding author), San Giuseppe Hosp, IRCCS, Ist Auxol Italiano, Clin Psychol Lab, Verbania, Italy.	gianhica.castelnuovo@auxologico.it	Tassorelli, Cristina/AAC-1483-2019; Pietrabissa, Giada/AAA-2056-2019; Tamburin, Stefano/AAB-9500-2019; Giusti, Emanuele Maria/AAC-1351-2019; Aloisi, Anna Maria/AAV-7384-2021; Nappi, Rossella Elena/AAC-1793-2022; Manzoni, Gian Mauro/L-3891-2019	Tassorelli, Cristina/0000-0003-1513-2113; Pietrabissa, Giada/0000-0002-5911-5748; Giusti, Emanuele Maria/0000-0001-5767-8785; Aloisi, Anna Maria/0000-0002-9136-9983; Nappi, Rossella Elena/0000-0003-1713-6396; Manzoni, Gian Mauro/0000-0003-3384-0359	AllerganAbbVieAllergan; Grunenthal	Support for this study was kindly provided through unrestricted grants by Allergan and Grunenthal.	Aloisi AM, 2006, HORM BEHAV, V50, P1, DOI 10.1016/j.yhbeh.2005.12.002; Alschuler KN, 2012, DISABIL HEALTH J, V5, P277, DOI 10.1016/j.dhjo.2012.07.002; Andrews NE, 2012, ARCH PHYS MED REHAB, V93, P2109, DOI 10.1016/j.apmr.2012.05.029; ARNHOFF FN, 1977, ANESTHESIOLOGY, V46, P170, DOI 10.1097/00000542-197703000-00003; Arpino L, 2004, NEUROL SCI, V25, P145, DOI 10.1007/s10072-004-0248-x; Bailey BE, 2003, DISABIL REHABIL, V25, P331, DOI 10.1080/0963828021000056866; Bajwa ZH, 2009, PAIN PHYSICIAN, V12, P893; Bandura A., 1977, SOCIAL LEARNING THEO; BATES MS, 1993, PAIN, V52, P101, DOI 10.1016/0304-3959(93)90120-E; Baumann M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-105; Beaupre M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/924692; Becker N, 1998, PAIN, V77, P279, DOI 10.1016/S0304-3959(98)00105-5; Berlincioni V, 2006, DISAGIO PSICHICO MIG; Bonezzi C, 2002, LIBERI DOLORE SOFFER; Borsook D, 2005, PAIN, V117, P247, DOI 10.1016/j.pain.2005.07.006; Brochet B, 2009, CLIN J PAIN, V25, P211, DOI 10.1097/AJP.0b013e3181891347; Buchanan Robert J, 2003, J Gend Specif Med, V6, P35; Buckelew SP, 1996, ARTHRIT CARE RES, V9, P97, DOI 10.1002/1529-0131(199604)9:2<97::AID-ANR1790090205>3.0.CO;2-F; Bultz BD, 2006, PSYCHO-ONCOLOGY, V15, P93, DOI 10.1002/pon.1022; Burns JW, 1998, BEHAV RES THER, V36, P1051, DOI 10.1016/S0005-7967(98)00080-1; Burns JW, 1998, J CONSULT CLIN PSYCH, V66, P434, DOI 10.1037/0022-006X.66.2.434; Butow P, 2013, PAIN, V154, pS101, DOI 10.1016/j.pain.2013.07.048; Castelli L, 2011, EUR J CANCER CARE, V20, P528, DOI 10.1111/j.1365-2354.2010.01217.x; Castelnuovo G, 2013, ANAESTHESIA, V68, P1203, DOI 10.1111/anae.12469; Castelnuovo G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00468; Castelnuovo G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00115; Castelnuovo G, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00004; Castillo RC, 2013, PAIN, V154, P2860, DOI 10.1016/j.pain.2013.08.025; Castino A, PERCEZIONE PSICHICA; Castro-Sanchez AM, 2014, CLIN J PAIN, V30, P589, DOI 10.1097/AJP.0000000000000008; Cauda F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041929; Celestin J, 2009, PAIN MED, V10, P639, DOI 10.1111/j.1526-4637.2009.00632.x; CRAIG KD, 1978, PSYCHOL PAIN; D'Angelo C, 2010, NEUROSURGERY, V67, P265, DOI 10.1227/01.NEU.0000371971.51755.1C; Daniel HC, 2008, EUR J PAIN, V12, P731, DOI 10.1016/j.ejpain.2007.11.006; Day MA, 2014, COMPLEMENT THER MED, V22, P278, DOI 10.1016/j.ctim.2013.12.018; de Boer D, 2006, BIOL PSYCHOL, V72, P318, DOI 10.1016/j.biopsycho.2005.12.004; de Jong JR, 2011, J PAIN, V12, P1209, DOI 10.1016/j.jpain.2011.06.010; de Rooij DG, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108639; Dilek B, 2012, RHEUMATOL INT, V32, P915, DOI 10.1007/s00296-010-1714-9; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Draca S, 2012, NEUROREHABILITATION, V30, P247, DOI 10.3233/NRE-2012-0752; Draca S, 2010, REV NEUROSCIENCE, V21, P421; Draca S, 2009, MED HYPOTHESES, V73, P1051, DOI 10.1016/j.mehy.2009.04.049; Drolet M, 2010, CAN MED ASSOC J, V182, P1731, DOI 10.1503/cmaj.091711; Engel JM, 2000, PAIN, V88, P225, DOI 10.1016/S0304-3959(00)00330-4; Engel JM, 2013, J PEDIATR PSYCHOL, V38, P192, DOI 10.1093/jpepsy/jss103; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Ercolani M, 1997, MALATI DOLORE ASPETT; FERNANDEZ E, 1995, PAIN, V61, P165, DOI 10.1016/0304-3959(95)00192-U; Flink IK, 2010, EUR J PAIN, V14, P887, DOI 10.1016/j.ejpain.2010.02.003; Galli U, 2010, EUR J PAIN, V14, P550, DOI 10.1016/j.ejpain.2009.08.011; Gallien P., 2007, Annales de Readaptation et de Medecine Physique, V50, P558, DOI 10.1016/j.annrmp.2007.03.013; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Glombiewski JA, 2010, CLIN J PAIN, V26, P593, DOI 10.1097/AJP.0b013e3181e37611; Goldstein LH, 2011, PSYCHOL HEALTH, V26, P751, DOI 10.1080/08870446.2010.493217; Goossens MEJB, 2005, CLIN J PAIN, V21, P18, DOI 10.1097/00002508-200501000-00003; Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009; Grassi L, 2013, CANCER-AM CANCER SOC, V119, P1714, DOI 10.1002/cncr.27902; GROSS AR, 1986, PSYCHOSOM MED, V48, P229, DOI 10.1097/00006842-198603000-00008; Hauser W, 2010, SCHMERZ, V24, P226, DOI 10.1007/s00482-010-0931-1; Hampel P, 2009, EUR SPINE J, V18, P1867, DOI 10.1007/s00586-009-1080-z; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hasenbring MI, 2012, PAIN, V153, P211, DOI 10.1016/j.pain.2011.10.019; Hechler T, 2010, J PAIN, V11, P472, DOI 10.1016/j.jpain.2009.09.002; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hill JC, 2007, CLIN J PAIN, V23, P683, DOI 10.1097/AJP.0b013e3181468e67; Hirsh AT, 2011, AM J PHYS MED REHAB, V90, P713, DOI 10.1097/PHM.0b013e31822409b2; Hirsh AT, 2010, AM J PHYS MED REHAB, V89, P213, DOI 10.1097/PHM.0b013e3181c9f9a1; Hirsh AT, 2005, CLIN J PAIN, V21, P302, DOI 10.1097/01.ajp.0000113057.92184.90; Holroyd KA, 2009, PAIN, V143, P213, DOI 10.1016/j.pain.2009.02.019; Hosoi M, 2010, PAIN, V149, P273, DOI 10.1016/j.pain.2010.02.012; Huber A, 2009, J PSYCHOSOM RES, V66, P425, DOI 10.1016/j.jpsychores.2008.11.009; JAMISON RN, 1990, CLIN J PAIN, V6, P47, DOI 10.1097/00002508-199003000-00009; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Jensen MP, 2011, ARCH PHYS MED REHAB, V92, P146, DOI 10.1016/j.apmr.2010.09.021; Jongsma MLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023363; Judge A, 2012, RHEUMATOLOGY, V51, P1804, DOI 10.1093/rheumatology/kes075; Kashikar-Zuck S, 2013, J PAIN, V14, P492, DOI 10.1016/j.jpain.2012.12.019; Kilkens OJ, 2005, ARCH PHYS MED REHAB, V86, P2119, DOI 10.1016/j.apmr.2004.12.040; Kisialiou A, 2014, J NEUROL SCI, V339, P41, DOI 10.1016/j.jns.2014.01.014; KLEINMAN A, 1992, PAIN HUMAN EXPERIENC; KORES RC, 1990, BEHAV RES THER, V28, P165, DOI 10.1016/0005-7967(90)90029-I; Koroschetz J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-55; KOSAMBI DD, 1967, SCI AM, V216, P105; Kroner-Herwig B, 2008, HEADACHE, V48, P529, DOI 10.1111/j.1526-4610.2007.00945.x; Legrain V, 2012, NEUROPHYSIOL CLIN, V42, P325, DOI 10.1016/j.neucli.2012.06.003; Ligthart L, 2013, J PAIN, V14, P363, DOI 10.1016/j.jpain.2012.12.006; Lohnberg JA, 2013, J CLIN PSYCHOL MED S, V20, P247, DOI 10.1007/s10880-012-9322-3; Lucey BP, 2011, AIDS CARE, V23, P921, DOI 10.1080/09540121.2010.543883; Lumley MA, 2002, J PSYCHOSOM RES, V53, P823, DOI 10.1016/S0022-3999(02)00337-9; Maletic V, 2009, FRONT BIOSCI-LANDMRK, V14, P5291, DOI 10.2741/3598; McBeth J, 2014, ARTHRITIS RHEUMATOL, V66, P757, DOI 10.1002/art.38284; McCracken LM, 2002, BEHAV RES THER, V40, P585, DOI 10.1016/S0005-7967(01)00074-2; Melzack R, 1976, ENIGMA DOLORE; Miles CL, 2011, EUROPEAN J PAIN, V15, P775; Miles CL, 2011, CLIN J PAIN, V27, P461, DOI 10.1097/AJP.0b013e318208c8a2; Milling LS, 2006, J CONSULT CLIN PSYCH, V74, P253, DOI 10.1037/0022-006X.74.2.253; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Morlion B, 2011, CURR MED RES OPIN, V27, P1595, DOI 10.1185/03007995.2011.595779; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Nicholson B, 2007, SOUTH MED J, V100, P1028, DOI 10.1097/SMJ.0b013e3180f626ff; Nicholson RA, 2007, HEADACHE, V47, P413, DOI 10.1111/j.1526-4610.2006.00716.x; O'Donnell MJ, 2013, STROKE, V44, P1238, DOI 10.1161/STROKEAHA.111.671008; Pagnini F, 2012, NEUROL SCI, V33, P1193, DOI 10.1007/s10072-011-0888-6; Paolucci S, 2006, STROKE, V37, P2989, DOI 10.1161/01.STR.0000248456.41647.3d; Pizza G, 2005, ANTROPOLOGIA MEDICA; Radat F, 2013, EUR J PAIN, V17, P1547, DOI 10.1002/j.1532-2149.2013.00334.x; Radat F, 2009, CEPHALALGIA, V29, P338, DOI 10.1111/j.1468-2982.2008.01718.x; Rekleiti Maria, 2013, Glob J Health Sci, V5, P107, DOI 10.5539/gjhs.v5n5p107; Rewhorn MJ, 2014, J FOOT ANKLE SURG, V53, P256, DOI 10.1053/j.jfas.2014.01.006; Rodriguez-Mutuberria L, 2011, NEUROREHABILITATION, V29, P381, DOI 10.3233/NRE-2011-0716; Rommel O, 2005, SCHMERZ, V19, P272, DOI 10.1007/s00482-004-0337-z; Ruiz-Parraga GT, 2014, HEALTH PSYCHOL, V33, P958, DOI 10.1037/hea0000040; Samwel HJA, 2009, BRIT J HEALTH PSYCH, V14, P405, DOI 10.1348/135910708X337760; Scheidt CE, 2014, NORD J PSYCHIAT, V68, P88, DOI 10.3109/08039488.2013.782566; Seifert CL, 2013, PANMINERVA MED, V55, P1; Shaygan M, 2013, EUR J PAIN, V17, P1529, DOI 10.1002/j.1532-2149.2013.00322.x; Shin NY, 2013, J PAIN, V14, P1304, DOI 10.1016/j.jpain.2013.05.008; Subramaniam M, 2013, PAIN RES MANAG, V18, P185, DOI 10.1155/2013/798205; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Sumner LA, 2014, CHRONIC ILLN, V10, P157, DOI 10.1177/1742395313504233; Tamburin S, 2016, J PAIN RES, V9, P311, DOI 10.2147/JPR.S84646; Torta RG, 2013, J PAIN RELIEF S, VS2, P003, DOI DOI 10.4172/2167-0846.S2-003; Toth C, 2014, J PAIN RES, V7, P327, DOI 10.2147/JPR.S56883; Toth C, 2014, CLIN J PAIN, V30, P111, DOI 10.1097/AJP.0b013e31828ccd0f; Turner JA, 2007, PAIN, V127, P276, DOI 10.1016/j.pain.2006.09.005; Uher T, 2013, INT J NEUROSCI, V123, P204, DOI 10.3109/00207454.2012.746335; Vase L, 2011, PAIN, V152, P157, DOI 10.1016/j.pain.2010.10.013; Vowles KE, 2007, BEHAV THER, V38, P412, DOI 10.1016/j.beth.2007.02.001; Vowles KE, 2007, EUR J PAIN, V11, P779, DOI 10.1016/j.ejpain.2006.12.007; Warschausky S, 2001, ARCH PHYS MED REHAB, V82, P329, DOI 10.1053/apmr.2001.21510; Wasserman RA, 2014, REGION ANESTH PAIN M, V39, P13, DOI 10.1097/AAP.0000000000000024; Wen Hong-Bo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS222, DOI 10.1016/S1353-8020(11)70068-2; Wicksell RK, 2013, EUR J PAIN, V17, P599, DOI 10.1002/j.1532-2149.2012.00224.x; Wicksell R. K., 2010, EUR J PAIN, V14, P1059, DOI [10.1016/j.ejpain.2010.05.001, DOI 10.1016/J.EJPAIN.2010.05.001]; Wieser MJ, 2012, BIOL PSYCHOL, V90, P242, DOI 10.1016/j.biopsycho.2012.03.019; Wieser T, 2012, EUR J PAIN, V16, P268, DOI 10.1016/j.ejpain.2011.06.011; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Yamaguchi R, 2014, DISABIL REHABIL, V36, P125, DOI 10.3109/09638288.2013.782356; Yoshida Katsuya, 2009, Seishin Shinkeigaku Zasshi, V111, P615; Yoshida S, 2009, PSYCHIAT CLIN NEUROS, V63, P65, DOI 10.1111/j.1440-1819.2008.01889.x; Zhang Xiaoyi, 2014, Zhonghua Nei Ke Za Zhi, V53, P27	144	9	10	1	9	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	OCT	2016	52	5					730	740					11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	ET0PI	WOS:000399965500014	27636563				2022-02-06	
J	Beuriat, PA; Szathmari, A; Grassiot, B; Di Rocco, F; Mottolese, C				Beuriat, P. -A.; Szathmari, A.; Grassiot, B.; Di Rocco, F.; Mottolese, C.			Why a hydroxyapatite cranioplasty can be used to repair a cranial bone defect in children: Experience of 19 cases	NEUROCHIRURGIE			French	Article						Cranioplasty; Pediatric Bone defect; Hydroxyapatite	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; CEMENT; RECONSTRUCTION; IMPLANTS; FLAP	Introduction. - The use of an autologous bone graft to repair a cranial bone defect is sometimes impossible in pediatric cases. CUSTOMBONE made with hydroxyapatite is a good alternative in these indications for neurosurgeons. Material and methods. - We present a pediatric series of 19 children who benefited from a cranioplasty using CUSTOMBONE. Their ages ranged between 8 months and 13 years with a mean of 6 years and 2 months. The most frequent indication was a cranioplasty after a post-traumatic decompressive craniectomy. Results. No complications were reported. Cosmetic outcome was satisfactory in all patients. Only one plasty needed to be changed after a severe head trauma during the postoperative period. The assessment of cerebral blood flow was improved in all patients postoperatively. Complete ossification of the plasty is a long process. The mean time for the ossification to begin was 13 months (range: 3-22 months). The mean follow-up was 2.7 years. Discussion. - The excellent integration of the prosthesis is related to the accuracy of the reconstruction of the preoperative model. The minimum thickness of the plasty (4 mm) could represent a challenge in very young children. One limitation is the cost, which remains high. Conclusion. - CUSTOMBONE met the criteria of protection and restoration of the normal intracranial physiology with good cosmetic results, which are necessary qualities for excellent clinical outcome. (C) 2016 Published by Elsevier Masson SAS.	[Beuriat, P. -A.; Szathmari, A.; Grassiot, B.; Di Rocco, F.; Mottolese, C.] Hop Neurol & Neurochirurg P Wertheimer, Serv Neurochirurg Pediat, 69 Blvd Pinel, F-69677 Bron, France		Mottolese, C (corresponding author), Hop Neurol & Neurochirurg P Wertheimer, Serv Neurochirurg Pediat, 69 Blvd Pinel, F-69677 Bron, France.	carmine.mottolese@chu-lyon.fr					ABBOTT KH, 1953, J NEUROSURG, V10, P380, DOI 10.3171/jns.1953.10.4.0380; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Beuriat PA, 2015, REV STOMATOL CHIR, V116, P239, DOI 10.1016/j.revsto.2015.06.006; Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6; Burstein FD, 1999, PLAST RECONSTR SURG, V104, P1270, DOI 10.1097/00006534-199910000-00005; Cocchi R, 1999, BIOCERAMICS, V12, P57; Constantino P, 1991, ARCH OTOLARYNGOL, V123, P319; Costantino PD, 2000, OTOLARYNG HEAD NECK, V123, P409, DOI 10.1067/mhn.2000.107679; Donati L, 1997, INT SURG, V82, P325; Durand J L, 1997, Ann Chir Plast Esthet, V42, P75; Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01290.8E; Eppley BL, 2003, J CRANIOFAC SURG, V14, P209, DOI 10.1097/00001665-200303000-00014; FABBRI M, 1995, BIOMATERIALS, V16, P225, DOI 10.1016/0142-9612(95)92121-L; Frassanito P, 2015, ACTA NEUROCHIR, V157, P115, DOI 10.1007/s00701-014-2254-y; Geib FW, 1941, JAMA-J AM MED ASSOC, V117, P8, DOI DOI 10.1001/JAMA.1941.02820270008004; Hardy H, 2012, NEUROCHIRURGIE, V58, P25, DOI 10.1016/j.neuchi.2011.09.006; KREUZ FP, 1951, J BONE JOINT SURG AM, V33-A, P863, DOI 10.2106/00004623-195133040-00005; Lemee JM, 2013, NEUROCHIRURGIE, V59, P60, DOI 10.1016/j.neuchi.2012.10.138; Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583; MATUKAS VJ, 1988, J NEUROSURG, V69, P514, DOI 10.3171/jns.1988.69.4.0514; Messina G, 2011, ACTA NEUROCHIR, V153, P1717, DOI 10.1007/s00701-011-1014-5; ODOM GL, 1952, J NEUROSURG, V9, P606, DOI 10.3171/jns.1952.9.6.0606; RAWLINGS CE, 1993, NEUROSURGERY, V33, P935; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Stefini Roberto, 2013, Surg Neurol Int, V4, P12, DOI 10.4103/2152-7806.106290; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Venable CS, 1937, ANN SURG, V105, P917, DOI 10.1097/00000658-193706000-00006; Wegeforth P, 1919, ANN SURG, V69, P384, DOI 10.1097/00000658-191904000-00005; Wen L, 2015, BRAIN INJURY, V29, P1654, DOI 10.3109/02699052.2015.1075248; Wiltfang J, 2004, J ORAL MAXIL SURG, V62, P29, DOI 10.1016/j.joms.2003.02.002; WOOLF JI, 1945, INT ABSTR SURG, V81, P1; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	33	9	10	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	OCT	2016	62	5					25	31		10.1016/j.neuchi.2016.04.003			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EI1UC	WOS:000392262600004	27543986				2022-02-06	
J	Bombardier, CH; Lee, DC; Tan, DL; Barber, JK; Hoffman, JM				Bombardier, Charles H.; Lee, Darren C.; Tan, Debbie L.; Barber, Jason K.; Hoffman, Jeanne M.			Comorbid Traumatic Brain Injury and Spinal Cord Injury: Screening Validity and Effect on Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	American Congress of Medical Rehabilitation	OCT 25-30, 2015	Dallas, TX			Brain injuries; Cognition; Comorbidity; Rehabilitation; Sensitivity and specificity; Spinal cord injuries	CLOSED HEAD-INJURY; TBI IDENTIFICATION METHOD; REHABILITATION OUTCOMES; DIAGNOSIS; CONSCIOUSNESS; RELIABILITY; INPATIENT; ACCURACY; AMNESIA; SCALE	Objectives: To determine the diagnostic accuracy of a self-report measure of traumatic brain injury (TBI) in people with spinal cord injury (SCI), and to assess the potential effect of TBI on acute and postacute outcomes. Design: Incident TBI as determined by self-report was compared with systematic medical records review by physicians blinded to self-reported TBI. Setting: Inpatient rehabilitation unit. Participants: From 155 consecutive admissions, participants (N=105; 73% men; mean age, 45.9y; 73% white; 58% with tetraplegia) who met inclusion criteria and were admitted on the day of injury were recruited and assessed. Interventions: Not applicable. Main Outcome Measure: Step 2 of the Traumatic Brain Injury-4 (TBI-4) interview was used to estimate the presence and severity of TBI. Results: Estimated incidence of TBI was 33% by chart review and 60% based on Step 2 of the TBI-4. Ninety-one percent of those with TBI based on chart review sustained mild injuries. At the optimal cutoff of "possible TBI," the TBI-4 had a sensitivity of 83% (95% confidence interval, 66%-93%), a specificity of 51% (95% confidence interval, 39%-64%), and a Youden Index of 0.3 (95% confidence interval, 0.2-0.5). Compared with those without TBI, those with chart review-determined TBI had nonsignificant trends toward a longer acute care length of stay and a higher functional status at rehabilitation discharge, but equivalent 1-year outcomes. Conclusions: Step 2 of the TBI-4 did not meet Youden's criteria (>= 0.8) for good diagnostic accuracy in the context of recent SCI. Comorbid TBIs were almost exclusively mild and not associated with poorer outcomes 1 year after SCI. (C) 2016 by the American Congress of Rehabilitation Medicine	[Bombardier, Charles H.; Lee, Darren C.; Tan, Debbie L.; Hoffman, Jeanne M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Barber, Jason K.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Bombardier, CH (corresponding author), Harborview Med Ctr, Dept Rehabil Med, Box 359612,325 9th Ave, Seattle, WA 98104 USA.	chb@uw.edu	Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283			Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1986, PARAPLEGIA, V24, P97, DOI 10.1038/sc.1986.13; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Gordan W, 2012, J SPINAL CORD MED, V35, P565, DOI 10.1179/2045772312Y.0000000063; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kushner DS, 2014, PHYS MED REH CLIN N, V25, P681, DOI 10.1016/j.pmr.2014.04.005; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Nott Melissa T, 2014, Top Spinal Cord Inj Rehabil, V20, P225, DOI 10.1310/sci2003-225; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; RICHARDS JS, 1991, ARCH PHYS MED REHAB, V72, P275; Ricker JH, 2010, HDB REHABILITATION P; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Sherer M, 2015, ARCH PHYS MED REHAB, V96, P652, DOI 10.1016/j.apmr.2014.10.024; TEASDALE G, 1974, LANCET, V2, P81; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Viera AJ, 2005, FAM MED, V37, P360; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	31	9	10	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2016	97	10					1628	1634		10.1016/j.apmr.2016.03.008			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	DY7TX	WOS:000385333300004	27084266				2022-02-06	
J	Choi, BY; Kim, IY; Kim, JH; Kho, AR; Lee, SH; Lee, BE; Sohn, M; Koh, JY; Suh, SW				Choi, Bo Young; Kim, In Yeol; Kim, Jin Hee; Kho, A. Ra; Lee, Song Hee; Lee, Bo Eun; Sohn, Min; Koh, Jae-Young; Suh, Sang Won			Zinc transporter 3 (ZnT3) gene deletion reduces spinal cord white matter damage and motor deficits in a murine MOG-induced multiple sclerosis model	NEUROBIOLOGY OF DISEASE			English	Article						Experimental autoimmune encephalomyelitis; Zinc; Multiple sclerosis; Zinc transporter; Blood brain barrier; MMP-9	TRAUMATIC BRAIN-INJURY; INDUCED NEURONAL DEATH; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HISTOCHEMICALLY-REACTIVE ZINC; NADPH OXIDASE ACTIVATION; SYNAPTIC VESICLES; NITRIC-OXIDE; RELEASE; COPPER; MOUSE	The present study aimed to evaluate the role of zinc transporter 3 (ZnT3) on multiple sclerosis (MS) pathogenesis. Experimental autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis, was induced by immunization with myelin oligodendrocyte glycoprotein (MOG(35-55)) in female mice. Three weeks after the initial immunization, demyelination, immune cell infiltration and blood brain barrier (BBB) disruption in the spinal cord were analyzed. Clinical signs of EAE first appeared on day 11 and reached a peak level on day 19 after the initial immunization. ZnT3 gene deletion profoundly reduced the daily clinical score of EAE. The ZnT3 gene deletion-mediated inhibition of the clinical course of EAE was accompanied by suppression of inflammation and demyelination in the spinal cord. The motor deficit accompanying neuropathological changes associated with EAE were mild in ZnT3 gene deletion mice. This reduction in motor deficit was accompanied by coincident reductions in demyelination and infiltration of encephalitogenic immune cells including CD4 + T cells, CD8 + T cells, CD20 + B cells and F4/80 + microglia in the spinal cord. These results demonstrate that ZnT3 gene deletion inhibits the clinical features and neuropathological changes associated with EAE. ZnT3 gene deletion also remarkably inhibited formation of EAE-associated aberrant synaptic zinc patches, matrix metalloproteinases-9 (MMP-9) activation and BBB disruption. Therefore, amelioration of EAE-induced clinical and neuropathological changes by ZnT3 gene deletion suggests that vesicular zinc may be involved in several steps of MS pathogenesis. (C) 2016 Published by Elsevier Inc.	[Choi, Bo Young; Kim, In Yeol; Kim, Jin Hee; Kho, A. Ra; Lee, Song Hee; Lee, Bo Eun; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, 1 Okcheon Dong,39 Hallymdaehak Gil, Chunchon 200702, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea; [Koh, Jae-Young] Univ Ulsan, Dept Neurol, Sch Med, Ulsan, South Korea		Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Physiol, 1 Okcheon Dong,39 Hallymdaehak Gil, Chunchon 200702, South Korea.	swsuh@hallym.ac.kr	Koh, Jae-Young/C-9014-2011	Koh, Jae-Young/0000-0002-4318-495X; SOHN, MIN/0000-0003-4021-2051; Choi, Bo Young/0000-0002-9579-3503	Hallym University Specialization Fund [HRF-S-53]	This study was supported by a grant from the Hallym University Specialization Fund (HRF-S-53). We would like express our special thanks to Mr. Jae Nam Seo for his excellent technical assistance and Mr. Min Chul Park for operating confocal microscope.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Choi BY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0325-5; Choi BY, 2013, NEUROBIOL DIS, V54, P382, DOI 10.1016/j.nbd.2013.01.012; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; HARTTER DE, 1988, SYNAPSE, V2, P412, DOI 10.1002/syn.890020408; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Jellinger KA, 2013, INT REV NEUROBIOL, V110, P1, DOI 10.1016/B978-0-12-410502-7.00002-8; Jo SM, 2008, BIOMETALS, V21, P151, DOI 10.1007/s10534-007-9103-x; Jones MV, 2008, J NEUROIMMUNOL, V199, P83, DOI 10.1016/j.jneuroim.2008.05.013; KAPAKI E, 1989, ACTA NEUROL SCAND, V79, P373, DOI 10.1111/j.1600-0404.1989.tb03803.x; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JH, 2013, BRAIN RES, V1499, P163, DOI 10.1016/j.brainres.2013.01.007; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; McCully JD, 2004, AM J PHYSIOL-HEART C, V286, pH1923, DOI 10.1152/ajpheart.00935.2003; Melo TM, 2003, BIOL TRACE ELEM RES, V93, P1, DOI 10.1385/BTER:93:1-3:1; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Noh KM, 2000, J NEUROSCI, V20; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; RAINE CS, 1984, LAB INVEST, V50, P608; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; Ruiz A, 2004, J NEUROPHYSIOL, V91, P1091, DOI 10.1152/jn.00755.2003; RUTH RE, 1988, ACTA NEUROPATHOL, V76, P380, DOI 10.1007/BF00686975; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shevach EM, 1999, SPRINGER SEMIN IMMUN, V21, P249, DOI 10.1007/BF00812256; Steinman L, 1999, NEURON, V24, P511, DOI 10.1016/S0896-6273(00)81107-1; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Suh SW, 1999, J HISTOCHEM CYTOCHEM, V47, P969, DOI 10.1177/002215549904700715; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takeda A, 2015, BIOMETALS; Takeda A, 2014, HIPPOCAMPUS, V24, P1404, DOI 10.1002/hipo.22322; Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004; Wang ZY, 2002, NEUROSCI LETT, V321, P37, DOI 10.1016/S0304-3940(01)02560-5; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676	50	9	9	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2016	94						205	212		10.1016/j.nbd.2016.06.018			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT9QF	WOS:000381836700019	27370228				2022-02-06	
J	Dymowski, AR; Ponsford, JL; Willmott, C				Dymowski, Alicia Rhian; Ponsford, Jennie Louise; Willmott, Catherine			Cognitive training approaches to remediate attention and executive dysfunction after traumatic brain injury: A single-case series	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Computer training; Strategy training; Traumatic brain injury; Attention; Rehabilitation	CLOSED-HEAD INJURY; INFORMATION-PROCESSING SPEED; CASE EXPERIMENTAL-DESIGNS; GOAL MANAGEMENT; VISUAL ANALYSIS; N-OF-1 TRIALS; REHABILITATION; PROGRAM; INDIVIDUALS; QUALITY	Attentional deficits are common following traumatic brain injury (TBI) and interfere with daily functioning. This study employed a single-case design to examine the effects of individualised strategy training on attention beyond the effects of computerised training using Attention Process Training 3 (APT-3), and to examine the participants' subjective experience of these approaches. An ABCA (baseline, APT-3, strategy training, follow-up) design was repeated across three participants with severe TBI. Outcomes were measured on alternate versions of the oral Symbol Digit Modalities Test (SDMT) and cancellation tasks; generalisation with the Test of Everyday Attention (TEA) and self and significant other (SO) ratings on the Rating Scale of Attentional Behaviour (RSAB); and participant experiences with semi-structured interviews. Planned Tau-U analyses revealed improvements in speed of processing on the SDMT and the automatic condition of the cancellation task after APT-3 and at follow-up, but with most improvement after strategy training. Limited generalisation was evident on TEA subtests and self-RSAB ratings. SO-RSAB ratings were mixed after APT-3, but demonstrated improvement after strategy training. Variability in attentional deficits and everyday attentional requirements between patients required individualised goals and approaches to rehabilitation. This study highlights the need for individualised rehabilitation of attention to improve everyday functioning after TBI.	[Dymowski, Alicia Rhian; Ponsford, Jennie Louise; Willmott, Catherine] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Dymowski, Alicia Rhian; Ponsford, Jennie Louise; Willmott, Catherine] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia; [Ponsford, Jennie Louise] Alfred Hosp, Natl Trauma Res Inst, Ctr Excellence Traumat Brain Injury Rehabil, Prahran, Vic, Australia		Dymowski, AR (corresponding author), Epworth HealthCare, Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	alicia.dymowski@monash.edu	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035	Epworth Research Institute [80940]	This work was supported by the Epworth Research Institute under Grant 80940.	Bayley M., 2007, ABIKUS EVIDENCE BASE; Brossart DF, 2014, NEUROPSYCHOL REHABIL, V24, P464, DOI 10.1080/09602011.2013.868361; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clark-Wilson J, 2014, BRAIN INJURY, V28, P1646, DOI 10.3109/02699052.2014.946449; Covey S.R., 2004, 7 HABITS HIGHLY EFFE; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Gast D. L., 2009, SINGLE SUBJECT RES M, P199; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Hinton-Bayre A, 2005, PSYCHOL ASSESSMENT, V17, P237, DOI 10.1037/1040-3590.17.2.237; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Lane JD, 2014, NEUROPSYCHOL REHABIL, V24, P445, DOI 10.1080/09602011.2013.815636; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Palmese CA, 2000, BRAIN INJURY, V14, P535; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; Parker RI, 2011, BEHAV THER, V42, P284, DOI 10.1016/j.beth.2010.08.006; Ponsford J, 2004, SCI PRACT NEUROPSYCH, P59; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Robertson I., 1996, GOAL MANAGEMENT TRAI; Robertson I., 1994, TEST EVERYDAY ATTENT; Ruff RM., 1995, RUFF 2 7 SELECTIVE A; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Shores E A, 1995, Appl Neuropsychol, V2, P167; Sloan S., 2013, TRAUMATIC BRAIN INJU, P99; Sloan S, 2009, BRAIN IMPAIR, V10, P295, DOI 10.1375/brim.10.3.295; Smith A., 1991, SYMBOL DIGIT MODALIT; Sohlberg M. M., 2010, APT 3 ATTENTION PROC; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Zickefoose S, 2013, BRAIN INJURY, V27, P707, DOI 10.3109/02699052.2013.775484	47	9	9	0	36	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT-DEC	2016	26	5-6			SI		866	894		10.1080/09602011.2015.1102746			29	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DR9WF	WOS:000380246100010	26493353				2022-02-06	
J	Nguyen, HS; Li, LY; Patel, M; Mueller, W				Ha Son Nguyen; Li, Luyuan; Patel, Mohit; Mueller, Wade			Density measurements with computed tomography in patients with extra-axial hematoma can quantitatively estimate a degree of brain compression	NEURORADIOLOGY JOURNAL			English	Article						CT Hounsfield Units; epidural hematoma; subdural hematoma; brain compression; traumatic brain injury	EDEMA; DENSITOMETRY	Background: Extra-axial hematoma can cause significant brain compression. Guidelines for surgical evacuation include imaging findings (midline shift and hematoma thickness/volume) in conjunction with Glasgow Coma Scale (GCS) scores and/or intracranial pressure (ICP) monitoring. Physiologically, overall brain density should also change with compression. In our observational study, we explored whether overall brain density, defined using computed tomography Hounsfield Units (CT HU), changes after surgical evacuation of extra-axial hematoma. Methods and materials: Only patients with a surgical acute epidural hematoma or subacute/chronic subdural hematoma were considered. Other exclusion criteria were concurrent intraparenchymal pathology, bilateral pathology, or incomplete follow-up imaging. Between fall 2012 and spring 2015, 22 patients were included in the study. CT head imaging (pre-operative, postoperative, and at similar to 1- to 2-month clinic visit) were loaded into OsiriX (Pixmeo, Switzerland). All the intracranial regions were selected and all extra-axial features were removed; subsequently, software was used to calculate a global CT HU value. Results: A repeated-measures ANOVA found significant time effect, p < 0.01, with significance between preoperative versus postoperative CT (p = 0.03) and preoperative versus clinic visit CT (p < 0.01). Conclusion: The results from this study suggest that extra-axial hematomas, which deform the brain, can cause an elevation in global CT HU value; moreover, surgical decompression is associated with lower global CT HU values. The use of global CT HU values in selected populations may serve as an adjunct for the evaluation of surgical lesions.	[Ha Son Nguyen; Li, Luyuan; Patel, Mohit; Mueller, Wade] Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA		Nguyen, HS (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA.	hsnguyen@mcw.edu		Nguyen, Ha/0000-0002-3515-278X			Bullock M Ross, 2006, Neurosurgery, V58, pS7; Greenberg MS., 2010, HDB NEUROSURGERY, V7th; Kim H, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0186-2; Mangel L, 2002, NEOPLASMA, V49, P237; Marion DW, 2006, NEUROSURGERY, V58, P655; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; ROZSA L, 1989, NEUROSURG REV, V12, P133, DOI 10.1007/BF01741486; Schneider W, 2000, PHYS MED BIOL, V45, P459, DOI 10.1088/0031-9155/45/2/314; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711	9	9	9	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1971-4009	2385-1996		NEURORADIOL J	Neuradiology J.	OCT	2016	29	5					372	376		10.1177/1971400916658795			5	Neuroimaging	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DX5SZ	WOS:000384443500015	27385774	Green Published, hybrid			2022-02-06	
J	Kaiser, M; Eberl, R; Castellani, C; Kraus, T; Till, H; Singer, G				Kaiser, Margarita; Eberl, Robert; Castellani, Christoph; Kraus, Tanja; Till, Holger; Singer, Georg			Judet type-IV radial neck fractures in children Comparison of the outcome of fractures with and without bony contact	ACTA ORTHOPAEDICA			English	Article							METAIZEAU TECHNIQUE	Background and purpose - Heavily displaced radial neck fractures in children are sometimes associated with poor outcome. A substantial number of these fractures require open reduction. We hypothesized that Judet type-IV fractures with a completely displaced radial head would result in a worse outcome than radial neck fractures with remaining bony contact. Patients and methods - We analyzed 19 children (median age 9.7 (4-13) years) who were treated for Judet type-IV radial neck fractures between 2001 and 2014. The outcome was assessed at the latest outpatient visit using the Linscheid-Wheeler score at a median time of 3.5 (1-8) years after injury. The patients were assigned either to group A (9 fractures with remaining bony contact between the radial head and the radial neck) or to group B (10 fractures without any bony contact). Results - The 2 groups were similar concerning age and sex. The rate of additional injuries was higher in group B (7/10 vs. 1/9 in group A; p = 0.009). The rate of open reduction was higher in group B (5/10 vs. 0/9 in group A; p = 0.01). Poor outcome was more common in group B (4/10 vs. 0/9 in group A; p = 0.03). In group B, the proportion of children with poor outcome (almost half) was the same irrespective of whether open or closed reduction had been done. Interpretation - The main causes of unfavorable results of radial neck fracture in children appear to be related to the energy of the injury and the amount of displacement and not to whether open reduction was used.	[Kaiser, Margarita; Eberl, Robert; Castellani, Christoph; Kraus, Tanja; Till, Holger; Singer, Georg] Med Univ Graz, Dept Paediat & Adolescent Surg, Graz, Austria		Castellani, C (corresponding author), Med Univ Graz, Dept Paediat & Adolescent Surg, Graz, Austria.	christoph.castellani@medunigraz.at		Singer, Georg/0000-0003-4770-3144			Al-Aubaidi Z, 2012, INJURY, V43, P301, DOI 10.1016/j.injury.2011.08.001; De Mattos CB, 2016, J PEDIATR ORTHOPED, V36, P6, DOI 10.1097/BPO.0000000000000387; Eberl R, 2010, EUR J PEDIATR SURG, V20, P250, DOI 10.1055/s-0030-1249104; Eilert R E, 2006, FRACTURES CHILDREN, V11, P444; Falciglia F, 2014, J PEDIATR ORTHOPED, V34, P756, DOI 10.1097/BPO.0000000000000299; Fuentes-Salguero L, 2012, Rev Esp Cir Ortop Traumatol, V56, P300, DOI 10.1016/j.recot.2012.01.002; Gutierrez-de la Iglesia D, 2015, J PEDIAT ORTHOP; JEFFERY CC, 1950, J BONE JOINT SURG BR, V32, P314, DOI 10.1302/0301-620X.32B3.314; LINSCHEI.RL, 1965, J AMER MED ASSOC, V194, P1171, DOI 10.1001/jama.194.11.1171; Novoth B., 2002, ORTHOPAEDICS TRAUMA, P313; Okcu G, 2007, ULUS TRAVMA ACIL CER, V13, P122; Stiefel D, 2001, J BONE JOINT SURG BR, V83B, P536, DOI 10.1302/0301-620X.83B4.11060; Tan Bryan Hsi Ming, 2011, J Orthop Surg (Hong Kong), V19, P209; Ursei Monica, 2006, Acta Orthop Belg, V72, P131	14	9	10	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-3674	1745-3682		ACTA ORTHOP	Acta Orthop.	OCT	2016	87	5					529	532		10.1080/17453674.2016.1203700			4	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	EB6WM	WOS:000387526300016	27348024	Green Published, gold			2022-02-06	
J	Rush, B; Wiskar, K; Fruhstorfer, C; Hertz, P				Rush, Barret; Wiskar, Katie; Fruhstorfer, Clark; Hertz, Paul			Association between seizures and mortality in patients with aneurysmal subarachnoid hemorrhage: A nationwide retrospective cohort analysis	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Subarachnoid hemorrhage; Seizures; Outcomes; United States	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; INTRACEREBRAL HEMORRHAGE; NONCONVULSIVE SEIZURES; INPATIENT SAMPLE; ONSET SEIZURES; CONTINUOUS EEG; CASE-FATALITY; EPILEPSY; INCREASE	Purpose: The impact of seizures on outcomes in patients with subarachnoid hemorrhage (SAH) is not well understood, with conflicting results published in the literature. Method: For this retrospective cohort analysis, data from the Nationwide Inpatient Samples (NIS) for 2006-2011 were utilized. All patients aged >= 18 years with a primary admitting diagnosis of subarachnoid hemorrhage were included. Patients with a diagnosis of seizure were segregated from the initial cohort. Multivariable logistic regression modeled the risk of death while adjusting for severity of SAH as well as co-morbidities. The primary outcome of this analysis was in-hospital mortality. Results: 12,647 patients met inclusion criteria for the study, of which 1336 had a diagnosis of seizures. The unadjusted in-hospital mortality was higher for patients with seizures compared to those without (16.2% vs 11.6%, p <0.01). Compared to patients without seizures, patients with seizures were younger (52.4 years SD 13.9 vs 54.8 years, SD 13.6; p < 0.01), more likely to be male (35.6% vs 31.0%, p < 0.01) and had longer hospital stays (18.3 days, IQR 12.0-27.5 vs 14.8 days, IQR 10.0-21.9; p <0.01). After adjusting for the severity of SAH, seizures were found to be associated with increased mortality (OR 1.57, 95% CI 1.32-1.87, p < 0.01). Conclusion: In this large nationwide analysis, the presence of seizures in patients with SAH was associated with higher in-hospital mortality. This finding has potentially important implications for goals of care decision-making and prognostication, but further study in the area is needed. (C) 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Rush, Barret; Wiskar, Katie] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada; [Rush, Barret] Harvard Univ, Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Fruhstorfer, Clark] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Hertz, Paul] Univ Hlth Network, Dept Med, Div Gen Internal Med, Toronto, ON, Canada		Rush, B (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada.	bar890@mail.harvard.edu; katiewiskar@gmail.com; clark.fruhstorfer@gmail.com; paul.hertz@uhn.ca					Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Cabral NL, 2009, J NEUROL NEUROSUR PS, V80, P755, DOI 10.1136/jnnp.2009.172098; Choi KS, 2009, J KOREAN NEUROSURG S, V46, P93, DOI 10.3340/jkns.2009.46.2.93; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Dasenbrock HH, 2016, J NEUROSURG, P1; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fung C, 2015, J NEUROSURG, V122, P408, DOI 10.3171/2014.10.JNS14163; HART RG, 1981, NEUROSURGERY, V8, P417, DOI 10.1227/00006123-198104000-00002; Jette N, 2010, EPILEPSIA, V51, P62, DOI 10.1111/j.1528-1167.2009.02201.x; Lin YJ, 2008, EUR J NEUROL, V15, P451, DOI 10.1111/j.1468-1331.2008.02096.x; Mullen MT, 2013, NEUROCRIT CARE, V19, P19, DOI 10.1007/s12028-012-9791-0; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; O'Connor KL, 2014, NEUROCRIT CARE, V21, P476, DOI 10.1007/s12028-014-9974-y; Pegoli M, 2015, J NEUROSURG, V122, P414, DOI 10.3171/2014.10.JNS14290; Rhoney Denise H, 2010, J Pharm Pract, V23, P408, DOI 10.1177/0897190010372334; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; SUNDARAM MBM, 1986, CAN J NEUROL SCI, V13, P229, DOI 10.1017/S0317167100036325; UKKOLA V, 1990, ACTA NEUROCHIR, V106, P115, DOI 10.1007/BF01809452; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Washington CW, 2014, J NEUROSURG, V121, P482, DOI 10.3171/2014.4.JNS131100; Yoshimoto T, 2005, INTERNAL MED, V44, P1174, DOI 10.2169/internalmedicine.44.1174	30	9	9	0	4	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	OCT	2016	41						66	69		10.1016/j.seizure.2016.07.008			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY1MD	WOS:000384858200012	27491069	Bronze			2022-02-06	
J	Surve, RM; Muthuchellappan, R; Rao, GSU; Philip, M				Surve, R. M.; Muthuchellappan, R.; Rao, G. S. U.; Philip, M.			The effect of blood transfusion on central venous oxygen saturation in critically ill patients admitted to a neurointensive care unit	TRANSFUSION MEDICINE			English	Article						blood transfusion; brain injury; central venous oxygen saturation; Glasgow coma score; blood pressure; central venous pressure	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; CELL TRANSFUSION; HEMOGLOBIN CONCENTRATION; ANEMIA; ASSOCIATION; MORTALITY; OUTCOMES	BackgroundLiterature suggests poorer outcomes during anaemia as well as following red blood cell transfusion (BT) in brain injured patients. Recently, central venous oxygen saturation (ScvO(2)) has been proposed as a physiological trigger to guide red BT. In this study, we looked at ScvO(2) changes following BT in patients admitted to a neurointensive care unit (NICU). Study designIn this prospective, observational study, adult, acutely ill neurological patients of >18years were recruited. The following parameters were measured before and immediately after transfusion and then at 6, 12, 18 and 24h after transfusion: haemoglobin (Hb), ScvO(2) and central venous oxygen partial pressure (PcvO(2)) (blood sampled from central venous catheter). Simultaneously, hemodynamic parameters [central venous pressure (CVP), heart rate (HR), mean arterial pressure (MAP) and systolic blood pressure (SBP)] were also noted. ResultsData from 70 adult patients were analysed. Following BT, significant improvement was noted in Hb, ScvO(2) and all hemodynamic parameters. The ScvO(2) changes correlated significantly with the number of units of BT (P=0039), pre-transfusion Hb (P=0010), ScvO(2) (P=0001) and PcvO(2) (P=0001). When receiver operating characteristic (ROC) curves were drawn, optimum cut-off values of baseline ScvO(2) and Hb to predict the need for transfusion in terms of oxygen delivery were 70% and 86 gm dL(-1) respectively. DiscussionBaseline ScvO(2)<70% appears to be a useful physiological trigger for deciding the need for BT in brain injured patients. Whether improvement in ScvO(2) leads to improvement in regional brain oxygenation needs to be studied.	[Surve, R. M.; Muthuchellappan, R.; Rao, G. S. U.] Natl Inst Mental Hlth & NeuroSci NIMHANS, Dept Neuroanaesthesia, Bengaluru, India; [Philip, M.] Natl Inst Mental Hlth & NeuroSci NIMHANS, Dept Biostat, Bengaluru, India		Muthuchellappan, R (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neuroanaesthesia, Hosur Rd, Bengaluru 560029, Karnataka, India.	mrks1974@gmail.com	Philip, Mariamma/AAR-4349-2020	Philip, Mariamma/0000-0001-6047-1494			Adamczyk S, 2009, ANN FR ANESTH, V28, P522, DOI 10.1016/j.annfar.2009.03.013; Allport LE, 2005, NEUROLOGY, V65, P1382, DOI 10.1212/01.wnl.0000183057.96792.a8; Atzil S, 2008, ANESTHESIOLOGY, V109, P989, DOI 10.1097/ALN.0b013e31818ddb72; Blasco V, 2008, ANN FR ANESTH, V27, P74, DOI 10.1016/j.annfar.2007.10.031; Bloos F., 2009, APPL PHYSL INTENSIVE, V1, P53; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Kimberly WT, 2011, CEREBROVASC DIS EXTR, V1, P44, DOI 10.1159/000328219; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Reinhart K, 2004, INTENS CARE MED, V30, P1572, DOI 10.1007/s00134-004-2337-y; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Roberts DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11489; SCALEA TM, 1990, J TRAUMA, V30, P1539, DOI 10.1097/00005373-199012000-00018; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Stan Ana, 2009, Rom J Intern Med, V47, P173; Vallet B, 2010, CRIT CARE, V14, DOI 10.1186/cc8854; van Beest P, 2011, CRIT CARE, V15, DOI 10.1186/cc10351; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499	23	9	10	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-7578	1365-3148		TRANSFUSION MED	Transfus. Med.	OCT	2016	26	5					343	348		10.1111/tme.12332			6	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	EA6SF	WOS:000386758500004	27476492				2022-02-06	
J	Tubbs, RS; Fries, FN; Kulwin, C; Mortazavi, MM; Loukas, M; Cohen-Gadol, AA				Tubbs, R. Shane; Fries, Fabian N.; Kulwin, Charles; Mortazavi, Martin M.; Loukas, Marios; Cohen-Gadol, Aaron A.			Modified skin incision for avoiding the lesser occipital nerve and occipital artery during retrosigmoid craniotomy: potential applications for enhancing operative working distance and angles while minimizing the risk of postoperative neuralgias and intraoperative hemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Anatomy; Lesser occipital nerve; Nerves; Occiput; Retrosigmoid craniotomy	ACOUSTIC NEUROMA SURGERY; QUALITY-OF-LIFE; MIGRAINE HEADACHES; CUTANEOUS NERVES; ASSOCIATION	Chronic postoperative neuralgias and headache following retrosigmoid craniotomy can be uncomfortable for the patient. We aimed to better elucidate the regional nerve anatomy in an effort to minimize this postoperative complication. Ten adult cadaveric heads (20 sides) were dissected to observe the relationship between the lesser occipital nerve and a traditional linear versus modified U incision during retrosigmoid craniotomy. Additionally, the relationship between these incisions and the occipital artery were observed. The lesser occipital nerve was found to have two types of course. Type I nerves (60%) remained close to the posterior border of the sternocleidomastoid muscle and some crossed anteriorly over the sternocleidomastoid muscle near the mastoid process. Type II nerves (40%) left the posterior border of the sternocleidomastoid muscle and swung medially (up to 4.5 cm posterior to the posterior border of the sternocleidomastoid muscle) as they ascended over the occiput. The lesser occipital nerve was near a midpoint of a line between the external occipital protuberance and mastoid process in all specimens with the type II nerve configuration. Based on our findings, the inverted U incision would be less likely to injure the type II nerves but would necessarily cross over type I nerves, especially more cranially on the nerve at the apex of the incision. As the more traditional linear incision would most likely transect the type I nerves and more so near their trunk, the U incision may be the overall better choice in avoiding neural and occipital artery injury during retrosigmoid approaches. (C) 2016 Elsevier Ltd. All rights reserved.	[Tubbs, R. Shane] Seattle Sci Fdn, Seattle, WA 98122 USA; [Tubbs, R. Shane; Loukas, Marios] St Georges Univ, Dept Anat Sci, True Blue, Grenada; [Tubbs, R. Shane] Univ Dundee, Ctr Anat & Human Identificat, Dundee DD1 4HN, Scotland; [Fries, Fabian N.] Univ Saarland, Med Ctr, D-66424 Homburg, Germany; [Fries, Fabian N.] Univ Saarland, Fac Med, D-66424 Homburg, Germany; [Kulwin, Charles; Cohen-Gadol, Aaron A.] Indiana Univ Sch Med, Dept Neurol Surg, Goodman Campbell Brain & Spine, 355 W 16th St,Suite 5100, Indianapolis, IN 46202 USA; [Mortazavi, Martin M.] Los Robles Hosp & Med Ctr, Calif Brain Inst, Thousand Oaks, CA 91360 USA		Cohen-Gadol, AA (corresponding author), Indiana Univ Sch Med, Dept Neurol Surg, Goodman Campbell Brain & Spine, 355 W 16th St,Suite 5100, Indianapolis, IN 46202 USA.	acohenmd@gmail.com	Fries, Fabian N./M-8334-2015	Fries, Fabian N./0000-0002-8526-4712; Cohen-Gadol, Aaron/0000-0002-4946-1524			Baumann I, 2005, ACTA OTO-LARYNGOL, V125, P585, DOI 10.1080/00016480510026935; Betchen SA, 2003, J NEUROSURG, V99, P818, DOI 10.3171/jns.2003.99.5.0818; Capek S, 2015, CLIN ANAT, V28, P96, DOI 10.1002/ca.22427; Cesmebasi A, 2015, CLIN ANAT, V28, P101, DOI 10.1002/ca.22468; Cohen-Gadol A., 2016, J NEUROSURG; Dandy WE., 1966, BRAIN; Dash KS, 2005, PLAST RECONSTR SURG, V115, P1752, DOI 10.1097/01.PRS.0000161679.26890.EE; DELLON AL, 1986, PLAST RECONSTR SURG, V77, P427, DOI 10.1097/00006534-198603000-00016; Ducic I, 2012, HEADACHE, V52, P1136, DOI 10.1111/j.1526-4610.2011.02068.x; Ella B, 2015, CLIN ANAT, V28, P109, DOI 10.1002/ca.22369; Fukuda H, 2014, WORLD NEUROSURG, V82, pE459, DOI 10.1016/j.wneu.2013.09.015; Guyuron B, 2009, PLAST RECONSTR SURG, V124, P461, DOI 10.1097/PRS.0b013e3181adcf6a; Headache Classification Subcommittee of the International Headache S, 2004, CEPHALALGIA S, V24, P19; Janis JE, 2011, PLAST RECONSTR SURG, V128, P123, DOI 10.1097/PRS.0b013e3182173d64; Kemp William J, 2011, Surg Neurol Int, V2, P143, DOI 10.4103/2152-7806.85984; Lee M, 2013, PLAST RECONSTR SURG, V132, P1551, DOI 10.1097/PRS.0b013e3182a80721; Levo H, 2001, CLIN OTOLARYNGOL, V26, P401, DOI 10.1046/j.1365-2273.2001.00492.x; Lin K, 2013, CLIN ANAT, V26, P688, DOI 10.1002/ca.22221; Magliulo G, 2000, J OTOLARYNGOL, V29, P344; PEDROSA CA, 1994, AM J OTOL, V15, P793; Rameh C, 2010, AURIS NASUS LARYNX, V37, P546, DOI 10.1016/j.anl.2010.01.004; Rennie C, 2013, CLIN ANAT, V26, P357, DOI 10.1002/ca.22105; Ryzenman JM, 2005, LARYNGOSCOPE, V115, P703, DOI 10.1097/01.mlg.0000161331.83224.c5; Ryzenman JM, 2004, LARYNGOSCOPE, V114, P814, DOI 10.1097/00005537-200405000-00005; Schaller B, 2003, OTOLARYNG HEAD NECK, V128, P387, DOI 10.1067/mhn.2003.104; Schankin C J, 2009, Cephalalgia, V29, P760, DOI 10.1111/j.1468-2982.2008.01790.x; SCHESSEL DA, 1993, AM J OTOL, V14, P491; Schwartz M S, 1998, Neurosurg Focus, V5, pe3; Shoja MM, 2014, CLIN ANAT, V27, P131, DOI 10.1002/ca.22342; Tubbs RS, 2007, CLIN ANAT, V20, P235, DOI 10.1002/ca.20297	30	9	10	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2016	32						83	87		10.1016/j.jocn.2016.03.015			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DW3EN	WOS:000383525000016	27396377				2022-02-06	
J	Wang, J; Ding, H; Lv, Q; Chen, JH; Sun, YF; Fan, HJ; Liu, QL				Wang, Jun; Ding, Hui; Lv, Qi; Chen, Jin-hong; Sun, Yan-feng; Fan, Hao-jun; Liu, Qiu-ling			2015 Nepal Earthquake: Analysis of Child Rescue and Treatment by a Field Hospital	DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS			English	Article						disaster medicine; field hospitals; earthquakes		Objective To retrospectively analyze the rescue and treatment of pediatric patients by the Chinese Red Cross medical team during the Nepal earthquake relief. Methods The medical team set up a field hospital; the pediatric clinic consisted of 1 pediatrician and several nurses. Children younger than 18 years old were placed in the pediatric clinic for injury examination and treatment. Results During the 7-day period of medical assistance (the second to third week after the earthquake), a total of 108 pediatric patients were diagnosed and treated, accounting for 2.8% of the total patients. The earthquake-related injuries mainly required surgical dressing and debridement. No severe limb fractures or traumatic brain injuries were found. Infection of the respiratory tract, the gastrointestinal tract, and the skin were the most common ailments, accounting for 42.3%, 18.5%, and 16.7%, respectively, of the total treated patients. Conclusion Two to 3 weeks after the earthquake, the admitted pediatric patients mainly displayed respiratory and gastrointestinal infections. When developing a rescue plan and arranging medical resources, we should consider the necessity of treating non-disaster-related conditions. (Disaster Med Public Health Preparedness. 2016;page 1 of 4)	[Wang, Jun; Sun, Yan-feng; Liu, Qiu-ling] Chinese Peoples Armed Police Force, Gen Hosp, Dept Pediat, Beijing, Peoples R China; [Ding, Hui; Lv, Qi; Fan, Hao-jun] Logist Univ, Chinese Peoples Armed Police Force, Affiliated Hosp, Inst Disaster Med & Publ Hlth, Tianjin, Peoples R China; [Ding, Hui; Lv, Qi; Fan, Hao-jun] Chinese Peoples Liberat Army PLA, Key Lab Emergency & Disaster Med, Beijing, Peoples R China; [Chen, Jin-hong] Chinese Peoples Armed Police Force, Gen Hosp, Dept Res & Training, Beijing, Peoples R China		Liu, QL (corresponding author), Chinese Peoples Armed Police Force, Gen Hosp, Yongding Rd 69, Beijing 100039, Peoples R China.	liuqiuling86@163.com		Lv, Qi/0000-0001-9076-7042; Fan, Haojun/0000-0003-1111-0232	Major Projects of the National Health and Family Planning Commission of China [201302003]; Key Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [71533008]; Tianjin Natural Science Foundation of China [15JCYBJC28500]; Tianjin Key Technology Research and Development Program [12ZCZDSF00700]	This work was supported by grants from Major Projects of the National Health and Family Planning Commission of China (201302003), Key Program of National Natural Science Foundation of China (71533008), Tianjin Natural Science Foundation of China (15JCYBJC28500), and Tianjin Key Technology Research and Development Program (12ZCZDSF00700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon F, 2011, EUR J PEDIATR, V170, P519; [Anonymous], 2011, MMWR MORB MORTAL WKL, V59, P1673; Bulut M, 2005, EMERG MED J, V22, P494, DOI 10.1136/emj.2004.016295; Ding H, 2014, CHIN J DISASTER MED, V2, P191; Guha-Sapir D, 2009, PREHOSP DISASTER MED, V24, P493, DOI 10.1017/S1049023X00007391; International Search and Rescue Advisory Group, 2015, INS GUID; Norton I, 2013, CLASSIFICATION MINIM; Wang J, 2015, CHINA J EMERG RESUSC, V10, P146; Wang J, 2014, CHIN J DISASTER MED, V2, P487; Wang J, 2015, CHINESE J DISASTER M, V3, P192; [向波 XIANG Bo], 2009, [中华小儿外科杂志, Chinese Journal of Pediatric Surgery], V30, P684	11	9	10	3	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1935-7893	1938-744X		DISASTER MED PUBLIC	Dis. Med. Public Health Prep.	OCT	2016	10	5					716	719		10.1017/dmp.2016.22			4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EB6GH	WOS:000387479200006	27189801				2022-02-06	
J	Wolahan, SM; Hirt, D; Braas, D; Glenn, TC				Wolahan, Stephanie M.; Hirt, Daniel; Braas, Daniel; Glenn, Thomas C.			Role of Metabolomics in Traumatic Brain Injury Research	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Small molecules; Spectroscopy; Metabolism; Principal component analysis; Biomarkers	POSITRON-EMISSION-TOMOGRAPHY; TRICARBOXYLIC-ACID CYCLE; COMMON DATA ELEMENTS; SEVERE HEAD-INJURY; GLUCOSE-METABOLISM; CEREBRAL MICRODIALYSIS; CEREBROSPINAL-FLUID; LACTIC-ACIDOSIS; LACTATE; CRISIS	Metabolomics is an important member of the omics community in that it defines which small molecules may be responsible for disease states. This article reviews the essential principles of metabolomics from specimen preparation, chemical analysis, to advanced statistical methods. Metabolomics in traumatic brain injury has so far been underutilized. Future metabolomics-based studies focused on the diagnoses, prognoses, and treatment effects need to be conducted across all types of traumatic brain injury.	[Wolahan, Stephanie M.; Hirt, Daniel; Glenn, Thomas C.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, 10833 Le Conte Ave, Los Angeles, CA 90095 USA; [Wolahan, Stephanie M.; Hirt, Daniel; Glenn, Thomas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, 300 Stein Plaza, Los Angeles, CA 90095 USA; [Braas, Daniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, 570 Westwood Plaza, Los Angeles, CA 90095 USA; [Braas, Daniel] Univ Calif Los Angeles, Metab & Prote Ctr, 570 Westwood Plaza, Los Angeles, CA 90095 USA		Glenn, TC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 956901,300 Stein Plaza,Room 533, Los Angeles, CA 90095 USA.	TGlenn@mednet.ucla.edu		Glenn, Thomas/0000-0003-4273-3408	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS093136, R21NS057252] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS093136, R21 NS057252] Funding Source: Medline		Alonso A, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00023; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bowling FG, 2014, METHODS MOL BIOL, V1168, P31, DOI 10.1007/978-1-4939-0847-9_3; Broadhurst DI, 2006, METABOLOMICS, V2, P171, DOI 10.1007/s11306-006-0037-z; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Robinette SL, 2013, ANAL CHEM, V85, P5297, DOI 10.1021/ac4007254; Serkova NJ, 2011, AM J RESP CRIT CARE, V184, P647, DOI 10.1164/rccm.201103-0474CI; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Wolahan SM, 2015, BRAIN NEUROTRAUMA MO, P25; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zhang SC, 2010, ANALYST, V135, P1490, DOI 10.1039/c000091d	44	9	9	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					465	+		10.1016/j.nec.2016.05.006			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800008	27637396	Green Accepted			2022-02-06	
J	Bott, N; Keller, C; Kuppuswamy, M; Spelber, D; Zeier, J				Bott, Nicholas; Keller, Corey; Kuppuswamy, Malathy; Spelber, David; Zeier, Joshua			Cotard Delusion in the Context of Schizophrenia: A Case Report and Review of the Literature	FRONTIERS IN PSYCHOLOGY			English	Article						cotard delusion; schizophrenia; hyper-religiosity; violence; self-harm; traumatic brain injury (TBI)	GENITAL SELF-MUTILATION; BRAIN-INJURY	Background: The Cotard delusion (CD) is one of a variety of narrowly defined monothematic delusions characterized by nihilistic beliefs about the body's existence or life itself. The presence of CD within the context of schizophrenia is rare (<1%), and remains understudied. Case: 'Mr. C' is a 58-year-old veteran with a prior diagnosis of schizophrenia, who presented with CD in the context of significant depression, suicidal ideation, violence, and self-harm behavior. He perseverated in his belief that he was physically dead and possessed by demons for several weeks. This delusion was reinforced by his religious belief that life was an attribute of God, and by inference, he as a human, was dead. His condition gradually improved over the course of treatment with Divalproex and quetiapine with discussions about the rationale for his belief. Upon discharge, Mr. C. demonstrated awareness of his fixation on death and an ability to redirect himself. Discussion: This case highlights the need to better understand the co-occurrence of CD in schizophrenia, their differentiation, the increased risk of violence and self-harm behavior in this presentation, and how specific events and religious factors can influence delusional themes of CD. Pharmacotherapy and aspects of cognitive-behavioral therapy may be effective in ameliorating these symptoms in CD.	[Bott, Nicholas; Keller, Corey; Kuppuswamy, Malathy; Spelber, David; Zeier, Joshua] Stanford Univ, Sch Med Psychiat & Behav Sci, Stanford, CA 94305 USA; [Bott, Nicholas; Kuppuswamy, Malathy; Zeier, Joshua] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA		Bott, N (corresponding author), Stanford Univ, Sch Med Psychiat & Behav Sci, Stanford, CA 94305 USA.; Bott, N (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA USA.	nbott@stanford.edu					Abdel-Hamid Mona, 2008, Curr Psychiatry Rep, V10, P229, DOI 10.1007/s11920-008-0038-x; BERRIOS GE, 1995, COMPR PSYCHIAT, V36, P218, DOI 10.1016/0010-440X(95)90085-A; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1080/j.1440-1614.2000.00758.x; Caliyurt O, 2004, J PSYCHIATR NEUROSCI, V29, P138; CHIU HFK, 1995, GEN HOSP PSYCHIAT, V17, P54, DOI 10.1016/0163-8343(94)00066-M; Coltheart M, 2007, SCHIZOPHRENIA BULL, V33, P642, DOI 10.1093/schbul/sbm017; Debruyne H, 2009, CURR PSYCHIAT REP, V11, P197, DOI 10.1007/s11920-009-0031-z; Gerrans P, 2000, MIND LANG, V15, P111, DOI 10.1111/1468-0017.00125; Ghaffari-Nejad A, 2007, ARCH IRAN MED, V10, P540; Grover S, 2014, J NEUROSCI RURAL PRA, V5, pS59, DOI 10.4103/0976-3147.145206; Huber CG, 2012, J NEUROPSYCH CLIN N, V24, pE21, DOI 10.1176/appi.neuropsych.11070155; Ko S M, 1989, Singapore Med J, V30, P277; KRASUCKI C, 1995, BRIT J MED PSYCHOL, V68, P179, DOI 10.1111/j.2044-8341.1995.tb01824.x; Kundlur S. N. C., 2007, EUR J PSYCHIAT, V21, P99; MARTIN T, 1991, PSYCHOPATHOLOGY, V24, P170, DOI 10.1159/000284711; McKay R, 2007, CONSCIOUS COGN, V16, P349, DOI 10.1016/j.concog.2006.06.001; Morgado Pedro, 2015, Case Rep Psychiatry, V2015, P643191, DOI 10.1155/2015/643191; Nejad AG, 2013, IRAN J PSYCHIATRY BE, V7, P91; Ramirez-Bermudez J, 2010, J NEUROPSYCH CLIN N, V22, P409, DOI 10.1176/appi.neuropsych.22.4.409; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Shiraishi H, 2004, PROG NEURO-PSYCHOPH, V28, P607, DOI 10.1016/j.pnpbp.2004.01.011; Stompe T, 2013, NEUROPSYCHIATRIE, V27, P38, DOI 10.1007/s40211-012-0046-2; Teixeira EH, 2009, J AM ACAD PSYCHIATRY, V37, P225; Yamada K, 1999, ACTA PSYCHIAT SCAND, V100, P396; Young A.W., 1996, METHOD MADNESS CASE, P147; YOUNG AW, 1992, PSYCHOL MED, V22, P799, DOI 10.1017/S003329170003823X	26	9	11	1	8	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	SEP 7	2016	7								1351	10.3389/fpsyg.2016.01351			6	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	DV1ZP	WOS:000382720900001	27656159	Green Published, gold			2022-02-06	
J	Azim, A; Haider, AA; Rhee, P; Verma, K; Windell, E; Jokar, TO; Kulvatunyou, N; Meer, M; Latifi, R; Joseph, B				Azim, Asad; Haider, Ansab A.; Rhee, Peter; Verma, Ket; Windell, Elizabeth; Jokar, Tahereh Orouji; Kulvatunyou, Narong; Meer, Mary; Latifi, Rifat; Joseph, Bellal			Early feeds not force feeds: Enteral nutrition in traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; TBI; enteral nutrition; early feeds	METABOLIC-RESPONSE; HEAD; DEATHS	BACKGROUND Brain Trauma Foundation guidelines recommend the early use of enteral nutrition to optimize recovery following traumatic brain injury (TBI). Our aim was to examine the effect of early feeds (24 hours) on clinical outcomes after TBI. METHODS We performed a 3-year retrospective study of patients with severe TBI (Glasgow Coma Scale score <8) who were intubated, admitted to the intensive care unit (ICU), and received tube feeds. Early tube feeds (early TF) were defined as initiation of tube feeds within 24 hours, whereas late tube feeds (late TF) were defined as initiation of tube feeds after 24 hours. Outcome measures included pneumonia rates, days on ventilator, hospital and ICU stay, and mortality rates. RESULTS A total of 90 patients (early TF: 58, late TF: 32) were included, of which 73.3% were male, mean age was 42 (SD, 20) years, and median head Abbreviated Injury Scale score was 4 (range, 3-5). There was no difference in age (p = 0.1), head Abbreviated Injury Scale score (p = 0.5), or admission Glasgow Coma Scale score (p = 0.9) between the two groups. Patients with early TF were associated with higher number of ICU days (p = 0.03) and higher pneumonia rates (p = 0.04), but there was no significant difference in mortality (p = 0.44) as compared with those who underwent late TF. CONCLUSIONS Although early tube feeds are known to improve outcomes in TBI patients, our data suggest that early feeds in TBI patients are associated with higher rates of pneumonia and greater hospital resource utilization. LEVEL OF EVIDENCE Therapeutic study, level IV.	[Azim, Asad; Haider, Ansab A.; Rhee, Peter; Verma, Ket; Windell, Elizabeth; Jokar, Tahereh Orouji; Kulvatunyou, Narong; Meer, Mary; Latifi, Rifat; Joseph, Bellal] Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu		Latifi, Rifat/0000-0003-1091-3682			[Anonymous], 2015, TBI GUID; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS21; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hoffmann M, 2012, INJURY, V43, P184, DOI 10.1016/j.injury.2011.05.029; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005; Yanagawa T, 2002, COCHRANE DB SYST REV	17	9	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2016	81	3					520	524		10.1097/TA.0000000000001089			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DW8MX	WOS:000383911200016	27116412				2022-02-06	
J	D'Arcy, RCN; Lindsay, DS; Song, XW; Gawryluk, JR; Greene, D; Mayo, C; Hajra, SG; Mandziuk, L; Mathieson, J; Greene, T				D'Arcy, Ryan C. N.; Lindsay, D. Stephen; Song, Xiaowei; Gawryluk, Jodie R.; Greene, Debbie; Mayo, Chantel; Hajra, Sujoy Ghosh; Mandziuk, Lila; Mathieson, John; Greene, Trevor			Long-Term Motor Recovery After Severe Traumatic Brain Injury: Beyond Established Limits	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						functional MRI; neuroplasticity; recovery of motor function; rehabilitation; traumatic brain injury	NEUROPLASTICITY; ACTIVATION; STROKE; ROBUST; OPTIMIZATION; REGISTRATION; IMAGERY; FMRI	Objective: To report neural plasticity changes after severe traumatic brain injury. Setting: Case-control study. Participants: Canadian soldier, Captain Trevor Greene survived a severe open-traumatic brain injury during a 2006 combat tour in Afghanistan. Design: Longitudinal follow-up for more than 6 years. Main Measures: Twelve longitudinal functional magnetic imaging (fMRI) examinations were conducted to investigate lower limb activation changes in association with clinical examination. Trevor Greene's lower limb fMRI activation was compared with control fMRI activation of (1) mental imagery of similar movement and (2) matched control subject data. Results: Trevor Greene's motor recovery and corresponding fMRI activation increased significantly over time (F = 32.54, P <.001). Clinical measures of functional recovery correlated strongly with fMRI motor activation changes (r = 0.81, P =.001). By comparison, while Trevor Greene's mental imagery activated similar motor regions, there was no evidence of fMRI activation change over time. While comparable, control motor activation did not change over time and there was no significant mental imagery activation. Conclusion: Motor function recovery can occur beyond 6 years after severe traumatic brain injury, both in neural plasticity and clinical outcome. This demonstrates that continued benefits in physical function due to rehabilitative efforts can be achieved for many years following injury. The finding challenges current practices and assumptions in rehabilitation following traumatic brain injury.	[D'Arcy, Ryan C. N.; Song, Xiaowei; Greene, Debbie; Hajra, Sujoy Ghosh; Greene, Trevor] Simon Fraser Univ, Surrey Mem Hosp, NeuroTech Lab, Metro Vancouver, BC, Canada; [D'Arcy, Ryan C. N.; Song, Xiaowei; Greene, Debbie; Hajra, Sujoy Ghosh; Greene, Trevor] Fraser Hlth Author, Metro Vancouver, BC, Canada; [D'Arcy, Ryan C. N.; Song, Xiaowei; Gawryluk, Jodie R.; Hajra, Sujoy Ghosh] CNR, Inst Biodiagnost Atlantic, Halifax, NS, Canada; [Lindsay, D. Stephen; Gawryluk, Jodie R.; Mayo, Chantel] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Mandziuk, Lila] Pacific Occupat Therapy Serv, Victoria, BC, Canada; [Mathieson, John] Vancouver Isl Hlth Author, Dept Med Imaging, Vancouver, BC, Canada		D'Arcy, RCN (corresponding author), Innovat Blvd,Charles Barham Bldg,13750 96 Ave, Surrey, BC V3V 1Z2, Canada.	rdarcy@sfu.ca		Gawryluk, Jodie/0000-0003-4924-7517; Lindsay, D. Stephen/0000-0002-6439-987X; Ghosh Hajra, Sujoy/0000-0002-8347-6578	National Research Council of Canada (NRC); Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); BC Leading Edge Endowment Fund; Surrey Memorial Hospital Foundation	The research has been funded by The National Research Council of Canada (NRC), the Natural Sciences and Engineering Research Council (NSERC), the BC Leading Edge Endowment Fund, and the Surrey Memorial Hospital Foundation.	[Anonymous], TBI DAT STAT; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Brodtmann A, 2009, NEUROREHAB NEURAL RE, V23, P150, DOI 10.1177/1545968308321774; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Giffords G., 2011, GABBY STORY COURAGE; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Greene T, 2012, MARCH 4 INSPIRING TR; Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Lotze M, 2006, NEUROREHAB NEURAL RE, V20, P14, DOI 10.1177/1545968305282919; Lu J, 2013, J NEUROTRAUM, V30, P1925, DOI 10.1089/neu.2013.2891; Mani TM, 2007, BRAIN INJURY, V21, P1155, DOI 10.1080/02699050701687367; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Olsson C-J, 2008, Open Neuroimag J, V2, P5, DOI 10.2174/1874440000802010005; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pyun SB, 2007, NEUROCASE, V13, P417, DOI 10.1080/13554790701881715; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; World Health Organization, 2006, 3 10 TRAUM BRAIN INJ, P164; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059428, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0080969, 10.1371/journal.pone.0064689, 10.1371/journal.pone.0059254]	37	9	9	1	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					E50	E58		10.1097/HTR.0000000000000185			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600006	26360005				2022-02-06	
J	Dykiert, D; Der, G; Starr, JM; Deary, IJ				Dykiert, D.; Der, G.; Starr, J. M.; Deary, I. J.			Why is Mini-Mental state examination performance correlated with estimated premorbid cognitive ability?	PSYCHOLOGICAL MEDICINE			English	Article						Mini-Mental State Examination; National Adult Reading Test; premorbid cognitive ability; Wechsler Test of Adult Reading	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; READING-ABILITY; NART; DEMENTIA; IQ; INTELLIGENCE; VALIDITY; WTAR; AGE	Background Tests requiring the pronunciation of irregular words are used to estimate premorbid cognitive ability in patients with clinical diagnoses, and prior cognitive ability in normal ageing. However, scores on these word-reading tests correlate with scores on the Mini-Mental State Examination (MMSE), a widely used screening test for possible cognitive pathology. This study aimed to test whether the word-reading tests' correlations with MMSE scores in healthy older people are explained by childhood IQ or education. Method Wechsler Test of Adult Reading (WTAR), National Adult Reading Test (NART), MMSE scores and information about education were obtained from 1024 70-year-olds, for whom childhood intelligence test scores were available. Results WTAR and NART were positively correlated with the MMSE (r approximate to 0.40, p < 0.001). The shared variance of WTAR and NART with MMSE was significantly attenuated by similar to 70% after controlling for childhood intelligence test scores. Education explained little additional variance in the association between the reading tests and the MMSE. Conclusions MMSE, which is often used to index cognitive impairment, is associated with prior cognitive ability. MMSE score is related to scores on WTAR and NART largely due to their shared association with prior ability. Obtained MMSE scores should be interpreted in the context of prior ability (or WTAR/NART score as its proxy).	[Dykiert, D.; Der, G.; Starr, J. M.; Deary, I. J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Dykiert, D.; Deary, I. J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Der, G.] Univ Glasgow, Med Res Council, Chief Scientist Off, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Starr, J. M.] Univ Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Starr, J. M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland		Dykiert, D (corresponding author), Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	d.dykiert@ed.ac.uk	Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X; Der, Geoff/0000-0002-8677-073X	Biotechnology and Biological Sciences Research Council (BBSRC)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Age UK; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12017/13]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1001401] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K026992/1, MC_UU_12017/13, G1001401] Funding Source: researchfish; Chief Scientist Office [SPHSU13] Funding Source: researchfish	The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1). Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) is gratefully acknowledged. The Lothian Birth Cohort 1936 study was funded by Age UK (formerly Research into Aging), the MRC, and the BBSRC. Geoff Der was funded by the MRC (MC_UU_12017/13).	Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; CRAWFORD JR, 1992, BRIT J CLIN PSYCHOL, V31, P327, DOI 10.1111/j.2044-8260.1992.tb00999.x; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, INTELLIGENCE, V32, P113, DOI 10.1016/j.intell.2003.06.001; Dykiert D, 2013, PSYCHOL ASSESSMENT, V25, P1361, DOI 10.1037/a0033623; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; McFarlane J, 2006, BRIT J CLIN PSYCHOL, V45, P453, DOI 10.1348/014466505X71245; McGurn B, 2004, NEUROLOGY, V62, P1184, DOI 10.1212/01.WNL.0000103169.80910.8B; MYERS BA, 1987, J NERV MENT DIS, V175, P85, DOI 10.1097/00005053-198702000-00003; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; OCARROLL RE, 1995, BRIT J PSYCHIAT, V167, P659, DOI 10.1192/bjp.167.5.659; Patterson K., 1994, NEUROPSYCHOLOGY, V8, P395, DOI DOI 10.1037/0894-4105.8.3.395; R Core Team, 2015, LANG ENV STAT COMP; Revele W, 2015, PROCEDURES PERSONALI; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Scottish Council for Research in Education (SCRE), 1933, INT SCOTT CHILDR NAT; Scottish Council for Research in Education (SCRE), 1949, TREND SCOTT INT COMP; STARR JM, 1992, INT J GERIATR PSYCH, V7, P153, DOI 10.1002/gps.930070303; Stebbins Glenn T, 1990, Clin Neuropsychol, V4, P18, DOI 10.1080/13854049008401493; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; The Psychological Corporation, 2001, WECHSLER TEST ADULT; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x	27	9	9	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	SEP	2016	46	12					2647	2654		10.1017/S0033291716001045			8	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	DU9WA	WOS:000382567600017	27377546	Green Published, hybrid, Green Accepted			2022-02-06	
J	Fujii, T; Moriel, G; Kramer, DR; Attenello, F; Zada, G				Fujii, Tatsuhiro; Moriel, Gabriela; Kramer, Daniel R.; Attenello, Frank; Zada, Gabriel			Prognostic factors of early outcome and discharge status in patients undergoing surgical intervention following traumatic intracranial hemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Craniectomy; Craniotomy; Intracranial Hemorrhage; Prognostic Factors; Traumatic Brain Injury	ACUTE SUBDURAL-HEMATOMA; SEVERE HEAD-INJURY; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; DIABETES-INSIPIDUS; EPIDEMIOLOGY; COAGULOPATHY; HYPERTHERMIA; MORTALITY; HYPERNATREMIA	Over the past several decades, the rate of traumatic brain injury (TBI)-related emergency room visits in the United States has steadily increased, yet mortality in these patients has decreased. This improvement in outcome is largely due to advances in prehospital care, intensive care unit management, and the effectiveness of neurosurgical procedures, such as decompressive craniectomies. It is imperative to identify clinical factors predictive of patients who benefit from early mobilization of resources and operative treatment. Equally important is the identification of patients with good prognostic signs among patients receiving surgical intervention for TBI. We conducted a retrospective chart review of 181 patients requiring craniectomies and craniotomies for decompression or evacuation of an intracranial hemorrhage following TBI at a single level I trauma center between 2008-2010. Demographic features and perioperative clinical characteristics of these patients were examined in relation to favorable outcomes, defined as discharge to home or a rehabilitation facility, and unfavorable outcomes, defined as in-hospital mortality or discharge to step-down medical facilities. Younger age, greater Glasgow Coma Scale (GCS) score on admission, absence of preoperative coagulopathies, absence of hypernatremia, and absence of fever were all independent predictors of favorable outcome. Additionally, increased operative duration and increased length of hospital stay were identified as independent predictors of negative outcomes after surgery. This work supports some of the current prognostic models in the literature and identifies additional clinical variables with predictive value of early outcome and discharge status in patients undergoing surgical evacuation of traumatic intracranial hemorrhages. (C) 2016 Published by Elsevier Ltd.	[Fujii, Tatsuhiro; Moriel, Gabriela; Kramer, Daniel R.; Attenello, Frank; Zada, Gabriel] Univ Southern Calif, Dept Neurol Surg, Los Angeles, CA 90089 USA		Kramer, DR (corresponding author), 1200 N State St,Suite 3300, Los Angeles, CA 90033 USA.	drk_431@usc.edu					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Elf K, 2008, NEUROL RES, V30, P1097, DOI 10.1179/174313208X319125; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Grande PO, 2009, ACTA ANAESTH SCAND, V53, P1233, DOI 10.1111/j.1399-6576.2009.02074.x; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lemcke J, 2014, BLOOD COAGUL FIBRIN, V25, P353, DOI 10.1097/MBC.0000000000000042; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Marion DW, 2006, NEUROSURGERY, V58, P655; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	46	9	9	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2016	31						152	156		10.1016/j.jocn.2016.03.007			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT7EJ	WOS:000381649600027	27424129				2022-02-06	
J	Okazaki, T; Hifumi, T; Kawakita, K; Nakashima, R; Matsumoto, A; Shishido, H; Ogawa, D; Okauchi, M; Shindo, A; Kawanishi, M; Tamiya, T; Kuroda, Y				Okazaki, Tomoya; Hifumi, Toru; Kawakita, Kenya; Nakashima, Ryuta; Matsumoto, Atsushi; Shishido, Hajime; Ogawa, Daiske; Okauchi, Masanobu; Shindo, Atsushi; Kawanishi, Masahiko; Tamiya, Takashi; Kuroda, Yasuhiro			Association Between Comorbidities, Nutritional Status, and Anticlotting Drugs and Neurologic Outcomes in Geriatric Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Charlson Comorbidity Index; Geriatric; Neurologic outcome; Traumatic brain injury	NEUROTRAUMA-DATA-BANK; INTRACRANIAL HEMATOMAS; ELDERLY-PATIENTS; HEAD-INJURIES; MORTALITY; AGE; VALIDATION; PREDICTOR; ADULTS	BACKGROUND: Several studies using trauma data banks and registers showed that age, Glasgow Coma Scale (GCS), Injury Severity Score, and intraventricular hemorrhage were independent factors for neurologic outcomes in geriatric patients with traumatic brain injury (TBI). However, these analyses did not comprehensively evaluate factors particularly associated with geriatric patients. We aimed to identify factors particularly associated with geriatric patients that affect neurologic outcomes in TBI. METHODS: Patients aged >= 65 years who were hospitalized consecutively in Kagawa University Hospital with severe TBI between 1 January 2008 and 31 October 2015 were retrospectively reviewed. We evaluated background factors particularly associated with geriatric patients, including comorbidities (Charlson Comorbidity Index [CCI]), nutritional status (serum albumin level), and presence/absence of antiplatelet and anticoagulant drugs, in addition to baseline characteristics. Multivariate analyses were performed to identify independent predictors of unfavorable neurologic outcomes (UO), as defined as a Glasgow Outcome Scale score of 1-3 at discharge from hospital. The association between CCI and UO was evaluated in a subgroup analysis. RESULTS: UO occurred in 65.0% of 140 patients. Multivariate analyses showed that the CCI (odds ratio, 1.91; 95% confidence interval, 1.21-3.29; P = 0.011), age, and GCS were independent predictors of UO. In subgroup analyses of patients with an initial GCS score of 13-15, the rate of UO significantly increased with CCI score (CCI 0, 35.5%; CCI 1 or 2, 39.4%; CCI > 2, 83.3%; P < 0.01). CONCLUSIONS: CCI was an independent predictor of UO in geriatric patients with severe TBI.	[Okazaki, Tomoya; Hifumi, Toru; Kawakita, Kenya; Nakashima, Ryuta; Matsumoto, Atsushi; Shishido, Hajime; Kuroda, Yasuhiro] Kagawa Univ Hosp, Emergency Med Ctr, Kita Ku, Miki, Kagawa, Japan; [Ogawa, Daiske; Okauchi, Masanobu; Shindo, Atsushi; Kawanishi, Masahiko; Tamiya, Takashi] Kagawa Univ Hosp, Dept Neurosurg, Kita Ku, Miki, Kagawa, Japan		Hifumi, T (corresponding author), Kagawa Univ Hosp, Emergency Med Ctr, Kita Ku, Miki, Kagawa, Japan.	hifumitoru@gmail.com		Okazaki, Tomoya/0000-0002-0540-8772			Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Camilloni L, 2008, INT J INJ CONTROL SA, V15, P25, DOI 10.1080/17457300701800118; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Frenkel WJ, 2014, J AM GERIATR SOC, V62, P342, DOI 10.1111/jgs.12635; Garwe T, 2016, AM J SURG, V212, P109, DOI 10.1016/j.amjsurg.2015.06.013; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P793; Ross A M, 1992, J Neurosci Nurs, V24, P88; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105	24	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2016	93						336	340		10.1016/j.wneu.2016.06.070			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	EF5DX	WOS:000390352000049	27353554				2022-02-06	
J	Pape, MM; Williams, K; Kodosky, PN; Dretsch, M				Pape, Marcy M.; Williams, Kathy; Kodosky, Paula N.; Dretsch, Michael			The Community Balance and Mobility Scale: A Pilot Study Detecting Impairments in Military Service Members With Comorbid Mild TBI and Psychological Health Conditions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Activities-specific Balance Confidence scale (ABC); Community Balance and Mobility Scale (CB&M); Functional Gait Assessment (FGA); gait speed; mild traumatic brain injury; physical therapy; psychological health conditions	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL GAIT ASSESSMENT; OLDER-ADULTS; VALIDITY; RELIABILITY; WALKING; INDIVIDUALS; STROKE; COMBAT	Objective: To compare the capacity of the Community Balance and Mobility Scale (CB&M) to identify balance and mobility deficits in Service Members (SMs) with mild traumatic brain injury and comorbid psychological health conditions (mTBI/PH) to other commonly used balance assessments. Setting: A clinical research institute that provides a 4-week, outpatient, interdisciplinary program for active-duty SMs with mTBI/PH. Design: A nonrandomized, cross-sectional design that compared multiple measures between 2 groups-active duty SMs with (n = 8) and without (n = 8) the dual diagnosis of mTBI/PH. Main Measures: Gait speed, Activities-specific Balance Confidence scale (ABC), Functional Gait Assessment (FGA), and CB&M to assess functional balance among the community-dwelling, TBI population. Results: Across all measures, the mTBI/PH group performed significantly worse (P <= .01) with the exception of the FGA. The abilities of all objective measures to distinguish participants with mTBI/PH from healthy controls ranged from fair to excellent (area under the curve [AUC] = 0.66-0.94). However, the CB&M showed the largest group differences in effect size (d = 2.6) and had the highest discriminate ability (AUC = 0.98; sensitivity 100%; specificity 88%). Conclusion: The CB&M appears to have higher sensitivity and specificity than other measures of balance in SMs with mTBI/PH. A higher cut score for the CB&M is needed for this population.	[Pape, Marcy M.; Kodosky, Paula N.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Phys Therapy, 4860 South Palmer Rd, Bethesda, MD 20889 USA; [Williams, Kathy; Dretsch, Michael] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Dept Res, Bethesda, MD USA		Pape, MM (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Phys Therapy, 4860 South Palmer Rd, Bethesda, MD 20889 USA.	Marcy.M.Pape.civ@mail.mil					Balasubramanian CK, 2015, J GERIATR PHYS THER, V38, P78, DOI 10.1519/JPT.0000000000000024; Balasubramanian CK, 2012, J GERIATR PHYS THER, V36, pS1; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Dean S, 2000, PSYCHOL REP, V86, P653, DOI 10.2466/pr0.2000.86.2.653; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TRAU; Epidemiology Program Post-Deployment Health Group OoPH, 2014, REP VA FAC SPEC OP E; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Guimaraes R M, 1980, Int Rehabil Med, V2, P177; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kline Mangione Kathleen, 2008, Physiother Can, V60, P10, DOI 10.3138/physio/60/1/10; Knorr S, 2010, ARCH PHYS MED REHAB, V91, P890, DOI 10.1016/j.apmr.2010.02.010; Leddy AL, 2011, PHYS THER, V91, P102, DOI 10.2522/ptj.20100113; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Marchetti GF, 2014, J NEUROL PHYS THER, V38, P119, DOI 10.1097/NPT.0000000000000015; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Perry SB, 2014, J HEAD TRAUMA REHAB, V29, P117, DOI 10.1097/HTR.0b013e3182864f2f; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rocque R, 2005, PHYSIOTHER CAN, V57, P285; Takacs J, 2014, PHYS THER REHABIL J, V94, P866, DOI 10.2522/ptj.20130385; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Walker ML, 2007, PHYS THER, V87, P1468, DOI 10.2522/ptj.20060344; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wright FV, 2010, BRAIN INJURY, V24, P1585, DOI 10.3109/02699052.2010.523045; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	32	9	9	2	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					339	345		10.1097/HTR.0000000000000179			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600012	26291633				2022-02-06	
J	Wunderlich, A; Goossens, B; Abbey, CK				Wunderlich, Adam; Goossens, Bart; Abbey, Craig K.			Optimal Joint Detection and Estimation That Maximizes ROC-Type Curves	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Ideal observer; receiver operating characteristic; signal detection theory; expected utility theory	TRAUMATIC BRAIN-INJURY; OF-THE-ART; DETECTION-LOCALIZATION; OBSERVER-PERFORMANCE; IDEAL OBSERVERS; OPTIMIZATION; BIOMARKERS; STENOSIS; SIGNALS; LESIONS	Combined detection-estimation tasks are frequently encountered in medical imaging. Optimal methods for joint detection and estimation are of interest because they provide upper bounds on observer performance, and can potentially be utilized for imaging system optimization, evaluation of observer efficiency, and development of image formation algorithms. We present a unified Bayesian framework for decision rules that maximize receiver operating characteristic (ROC)-type summary curves, including ROC, localization ROC (LROC), estimation ROC (EROC), free-response ROC (FROC), alternative free-response ROC (AFROC), and exponentially-transformed FROC (EFROC) curves, succinctly summarizing previous results. The approach relies on an interpretation of ROC-type summary curves as plots of an expected utility versus an expected disutility (or penalty) for signal-present decisions. We propose a general utility structure that is flexible enough to encompass many ROC variants and yet sufficiently constrained to allow derivation of a linear expected utility equation that is similar to that for simple binary detection. We illustrate our theory with an example comparing decision strategies for joint detection-estimation of a known signal with unknown amplitude. In addition, building on insights from our utility framework, we propose new ROC-type summary curves and associated optimal decision rules for joint detection-estimation tasks with an unknown, potentially-multiple, number of signals in each observation.	[Wunderlich, Adam] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Wunderlich, Adam] NIST, Commun Technol Lab, Boulder, CO 80305 USA; [Goossens, Bart] Univ Ghent, Dept Telecommun & Informat Proc, TELIN IPI iMinds, B-9000 Ghent, Belgium; [Abbey, Craig K.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA		Wunderlich, A (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.; Wunderlich, A (corresponding author), NIST, Commun Technol Lab, Boulder, CO 80305 USA.	adam.wunder-lich@nist.gov	Goossens, Bart/H-4772-2018	Goossens, Bart/0000-0002-1666-5483; Wunderlich, Adam/0000-0002-8463-9156	Research Foundation Flanders (FWO, Belgium)FWO; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21-EB018939]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB018939] Funding Source: NIH RePORTER	B. Goossens acknowledges support from a postdoctoral fellowship of the Research Foundation Flanders (FWO, Belgium). C. K. Abbey was supported by the National Institutes of Health under Grant R21-EB018939. Asterisk indicates corresponding author.	Abbey CK, 2006, IEEE T MED IMAGING, V25, P198, DOI 10.1109/TMI.2005.862205; Abbey CK, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00345; Abbey CK, 2010, MED DECIS MAKING, V30, P113, DOI 10.1177/0272989X09341753; Barrett H. H., 2004, FDN IMAGE SCI; BERBAUM KS, 1990, INVEST RADIOL, V25, P133, DOI 10.1097/00004424-199002000-00006; Berger JO, 1993, STAT DECISION THEORY; BUNCH PC, 1978, J APPL PHOTOGR ENG, V4, P166; Chakraborty DP, 2004, MED PHYS, V31, P2313, DOI 10.1118/1.1769352; CHAKRABORTY DP, 1990, RADIOLOGY, V174, P873, DOI 10.1148/radiology.174.3.2305073; Clarkson E, 2007, J OPT SOC AM A, V24, pB91, DOI 10.1364/JOSAA.24.000B91; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Guglielmi G, 2011, RADIOGRAPHICS, V31, P1343, DOI 10.1148/rg.315105712; Hatt M, 2011, J NUCL MED, V52, P1690, DOI 10.2967/jnumed.111.092767; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Kay S. M, 1998, FUNDAMENTALS STAT SI, V2; Khurd P, 2005, IEEE T MED IMAGING, V24, P1626, DOI 10.1109/TMI.2005.859210; Khurd P, 2010, IEEE T MED IMAGING, V29, P375, DOI 10.1109/TMI.2009.2031840; Kirisli HA, 2013, MED IMAGE ANAL, V17, P859, DOI 10.1016/j.media.2013.05.007; Kupinski MA, 2003, J OPT SOC AM A, V20, P430, DOI 10.1364/JOSAA.20.000430; Link TM, 2012, RADIOLOGY, V263, P3, DOI 10.1148/radiol.12110462; Llado X, 2012, NEURORADIOLOGY, V54, P787, DOI 10.1007/s00234-011-0992-6; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Nguyen NQ, 2011, IEEE T MED IMAGING, V30, P28, DOI 10.1109/TMI.2010.2059035; Olmo G, 2000, SIGNAL PROCESS, V80, P57, DOI 10.1016/S0165-1684(99)00111-5; Popescu LM, 2011, MED PHYS, V38, P5690, DOI 10.1118/1.3633938; Rezai P, 2013, AM J ROENTGENOL, V201, P246, DOI 10.2214/AJR.12.9878; Savage Leonard, 1954, FDN STAT; SCOBLIONKO DP, 1984, AM J CARDIOL, V53, P689, DOI 10.1016/0002-9149(84)90387-4; SELTZER SE, 1991, INVEST RADIOL, V26, P285, DOI 10.1097/00004424-199104000-00001; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; STARR SJ, 1975, RADIOLOGY, V116, P533, DOI 10.1148/116.3.533; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; van Trees H., 1968, DETECTION ESTIMATI 1; von Neumann J., 1947, THEORY GAMES EC BEHA; Wunderlich A, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.031002; Wunderlich A, 2013, MED PHYS, V40, DOI 10.1118/1.4823755; Wunderlich A, 2012, IEEE T MED IMAGING, V31, P2050, DOI 10.1109/TMI.2012.2205015; Zhang L, 2013, J OPT SOC AM A, V30, P2422, DOI 10.1364/JOSAA.30.002422; Zhang L, 2012, IEEE T MED IMAGING, V31, P1875, DOI 10.1109/TMI.2012.2205267; Zhao BS, 2009, J NUCL MED, V50, P239, DOI 10.2967/jnumed.108.056655; Zhou L, 2008, PHYS MED BIOL, V53, P2019, DOI 10.1088/0031-9155/53/8/002; Zhou LL, 2009, PHYS MED BIOL, V54, P4423, DOI 10.1088/0031-9155/54/14/005	42	9	11	2	8	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	SEP	2016	35	9					2164	2173		10.1109/TMI.2016.2553001			10	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	DY6VK	WOS:000385266800016	27093544	Green Accepted			2022-02-06	
J	Zhou, BC; Liu, LJ; Liu, B				Zhou, Bao-chun; Liu, Li-jun; Liu, Bing			Neuroprotection of hyperbaric oxygen therapy in sub-acute traumatic brain injury: not by immediately improving cerebral oxygen saturation and oxygen partial pressure	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; hyperbaric oxygen; near-infrared spectroscopy; cerebral oxygen saturation; traumatic brain injury; oxygen partial pressure; oxygen metabolism; wound healing; neurological function; blood gas analysis; neural regeneration	NEAR-INFRARED SPECTROSCOPY; CARDIAC-ARREST; NITRIC-OXIDE; HEAD-INJURY; TOXICITY; OXIMETRY; TRIAL; CARE	Although hyperbaric oxygen (HBO) therapy can promote the recovery of neural function in patients who have suffered traumatic brain injury (TBI), the underlying mechanism is unclear. We hypothesized that hyperbaric oxygen treatment plays a neuroprotective role in TBI by increasing regional transcranial oxygen saturation (rSO(2)) and oxygen partial pressure (PaO2). To test this idea, we compared two groups: a control group with 20 healthy people and a treatment group with 40 TBI patients. The 40 patients were given 100% oxygen of HBO for 90 minutes. Changes in rSO(2) were measured. The controls were also examined for rSO(2) and PaO2, but received no treatment. rSO(2) levels in the patients did not differ significantly after treatment, but levels before and after treatment were significantly lower than those in the control group. PaO2 levels were significantly decreased after the 30-minute HBO treatment. Our findings suggest that there is a disorder of oxygen metabolism in patients with sub-acute TBI. HBO does not immediately affect cerebral oxygen metabolism, and the underlying mechanism still needs to be studied in depth.	[Zhou, Bao-chun; Liu, Li-jun] Soochow Univ, Affiliated Hosp 2, Dept Emergency, Suzhou, Jiangsu, Peoples R China; [Zhou, Bao-chun; Liu, Li-jun] Soochow Univ, Affiliated Hosp 2, Intens Care Unit, Suzhou, Jiangsu, Peoples R China; [Liu, Bing] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, High Tech Dist Branch, Suzhou, Jiangsu, Peoples R China		Liu, LJ (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Emergency, Suzhou, Jiangsu, Peoples R China.; Liu, LJ (corresponding author), Soochow Univ, Affiliated Hosp 2, Intens Care Unit, Suzhou, Jiangsu, Peoples R China.	lijunliusz@sina.com			Suzhou Key Medicine Project Fund of China [Szxk201504]	This study was supported by a grant from Suzhou Key Medicine Project Fund of China, No. Szxk201504.	Bennett M.H., 2014, COCHRANE DB SYST REV, V11; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Buchner K, 2000, ZBL NEUROCHIR, V61, P69, DOI 10.1055/s-2000-8262; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Demchenko IT, 2008, AM J PHYSIOL-LUNG C, V294, pL984, DOI 10.1152/ajplung.00420.2007; Demchenko IT, 2007, AM J PHYSIOL-LUNG C, V293, pL229, DOI 10.1152/ajplung.00450.2006; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Drayna PC, 2011, PEDIATR EMERG CARE, V27, P432, DOI 10.1097/PEC.0b013e3182188442; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Guedes VA, 2016, EXPERT REV NEUROTHER, V16, P61, DOI 10.1586/14737175.2016.1126180; Hadanny A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1034-2; Hyttel-Sorensen S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7635; Kishi K, 2003, J NEUROSURG ANESTH, V15, P302, DOI 10.1097/00008506-200310000-00002; Kolyva C, 2013, ADV EXP MED BIOL, V789, P353, DOI 10.1007/978-1-4614-7411-1_47; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Shaw FL, 2009, CLIN BIOCHEM, V42, P467, DOI 10.1016/j.clinbiochem.2008.12.024; Smith M, 2009, ANESTH ANALG, V108, P1055, DOI 10.1213/ane.0b013e31819a0301; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Suffoletto B, 2012, RESUSCITATION, V83, P986, DOI 10.1016/j.resuscitation.2012.03.021; Thorsen E, 1998, EUR RESPIR J, V12, P1442, DOI 10.1183/09031936.98.12061442; Tobias Joseph D, 2008, J Intensive Care Med, V23, P384, DOI 10.1177/0885066608324380; Vahid SN, 2014, CURR OPIN PEDIATR, V26, P299, DOI 10.1097/MOP.0000000000000098; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Watzman HM, 2000, ANESTHESIOLOGY, V93, P947, DOI 10.1097/00000542-200010000-00012; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiao F, 2004, RESUSCITATION, V63, P213, DOI 10.1016/j.resuscitation.2004.05.006; Yoshitani K, 2007, ANESTHESIOLOGY, V106, P458, DOI 10.1097/00000542-200703000-00009	33	9	13	0	7	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	SEP	2016	11	9					1445	+		10.4103/1673-5374.191218			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	EC0DP	WOS:000387768400026	27857747	gold, Green Published			2022-02-06	
J	Abbasloo, E; Dehghan, F; Khaksari, M; Najafipour, H; Vahidi, R; Dabiri, S; Sepehri, G; Asadikaram, G				Abbasloo, Elham; Dehghan, Fatemeh; Khaksari, Mohammad; Najafipour, Hamid; Vahidi, Reza; Dabiri, Shahriar; Sepehri, Gholamreza; Asadikaram, Golamreza			The anti-inflammatory properties of Satureja khuzistanica Jamzad essential oil attenuate the effects of traumatic brain injuries in rats	SCIENTIFIC REPORTS			English	Article							INFLAMMATORY RESPONSE; INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID; HORTENSIS L.; NITRIC-OXIDE; CARVACROL; ACTIVATION; EXPRESSION; ESTROGEN; DAMAGE	Traumatic brain injury (TBI) is a major health concern affecting the general public as well as military personnel. However, there is no FDA-approved therapy for the treatment of TBIs. In this work, we investigated the neurotherapeutic effects of the well-known natural Iranian medicine Satureja Khuzistanica Jamzad (SKJ) essential oil (SKEO) on the outcomes of diffused experimental TBI, with particular attention paid to its anti-inflammatory and anti-apoptotic effects. Male Wistar rats were treated with doses of 50, 100 and 200 (mg/kg, i.p) SKEO after induction of diffused TBIs. The results showed that injecting SKEO (200 mg/kg) 30 minutes after TBI significantly reduced brain oedema and damage to the blood-brain barrier (BBB) and limited the post-TBI increase in intracranial pressure. The veterinary coma scale (VCS) scores significantly improved in the treatment group. Also, inflammatory marker assays showed reduced levels of TNF-alpha, IL-1 beta, and IL-6 and increased IL-10 in the treated groups. Moreover, the immunohistochemical results indicated that SKEO not only reduced neuronal death and BBB permeability but also affected astrocytic activation. Overall, our data indicate potential clinical neurological applications for SKEO.	[Abbasloo, Elham] Kerman Univ Med Sci, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran; [Dehghan, Fatemeh] Fasa Univ Med Sci, Dept Physiol, Fasa, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Najafipour, Hamid] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Cardiovasc Res Ctr, Kerman, Iran; [Vahidi, Reza; Dabiri, Shahriar] Kerman Univ Med Sci, Pathol & Stem Cell Res Ctr, Kerman, Iran; [Sepehri, Gholamreza; Asadikaram, Golamreza] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran		Abbasloo, E (corresponding author), Kerman Univ Med Sci, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran.	elhamabbasloo@yahoo.com	Najafipour, Hamid/U-7922-2017; Vahidi, Reza/AAL-9191-2020; Sepehri, Gholamreza/AAZ-2101-2020; Sepehri, Gholamreza/AAC-9522-2019; Haddad, Mohammad Khaksari/AAB-9025-2019; Dabiri, Shahriar/AAB-1995-2019; Asadikaram, Gholamreza/AAG-4437-2021	Najafipour, Hamid/0000-0002-8030-8704; Sepehri, Gholamreza/0000-0001-7999-9934; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Dabiri, Shahriar/0000-0002-5922-3976; Asadikaram, Gholamreza/0000-0002-9100-0756; Asadi karam, Gholamreza/0000-0002-6417-5200	Physiology Research Centre of the Kerman University of the Medical Sciences [92/364]; Medical Faculty of the Kerman University of the Medical Sciences [92/364]	This study was financially supported by the Physiology Research Centre and Medical Faculty of the Kerman University of the Medical Sciences (Grant Number 92/364 Ka to Elham Abbasloo). We are grateful to Dr Heshmatollah Khosravinia and Dr Mozhgan Mazhari for their preparation of SKEO.	ABDOLLAHI M, 2003, MED SCI MONITOR, V9, P331; Akita T, 2011, J PHYSIOL-LONDON, V589, P3909, DOI 10.1113/jphysiol.2011.208173; Amanlou M, 2005, J PHARM PHARM SCI, V8, P102; BLUESTONE JA, 1987, NATURE, V326, P82, DOI 10.1038/326082a0; Calixto BJ, 2000, BRAZ J MED BIOL RES, V33, P2; Castejon OJ, 1998, J SUBMICR CYTOL PATH, V30, P145; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Conti AC, 1998, J NEUROSCI, V18, P5663; Cui ZW, 2015, ACTA PHARMACOL SIN, V36, P1426, DOI 10.1038/aps.2015.90; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dehghan Fatemeh, 2015, Iranian Biomedical Journal, V19, P165, DOI 10.7508/ibj.2015.03.006; Esmaeili-Mahani S, 2015, J NAT MED-TOKYO, V69, P165, DOI 10.1007/s11418-013-0796-6; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Ghazanfari G, 2006, TOXICOL MECH METHOD, V16, P365, DOI 10.1080/15376520600620125; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guimaraes AG, 2012, N-S ARCH PHARMACOL, V385, P253, DOI 10.1007/s00210-011-0715-x; Hadian J, 2011, CHEM BIODIVERS, V8, P902, DOI 10.1002/cbdv.201000249; Hajhashemi V, 2002, J ETHNOPHARMACOL, V82, P83, DOI 10.1016/S0378-8741(02)00137-X; Jalalvand M., 2014, Zahedan Journal of Research in Medical Sciences, V16, P31; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Jeon HK, 1999, IMMUNOPHARMACOLOGY, V41, P219, DOI 10.1016/S0162-3109(99)00033-8; Kaeidi A, 2013, J NAT MED-TOKYO, V67, P61, DOI 10.1007/s11418-012-0646-y; KATSURA K, 1994, BIOCHEM SOC T, V22, P991, DOI 10.1042/bst0220991; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khosravinia H., 2014, Biotechnology in Animal Husbandry, V30, P89; Khosravinia H, 2015, KAFKAS UNIV VET FAK, V21, P203, DOI 10.9775/kvfd.2014.12020; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li WT, 2015, NEUROCHEM INT, V90, P107, DOI 10.1016/j.neuint.2015.07.020; Lima MD, 2013, EUR J PHARMACOL, V699, P112, DOI 10.1016/j.ejphar.2012.11.040; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Malmir M, 2014, MICROSC MICROANAL, V20, P1425, DOI 10.1017/S1431927614013026; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Najafipour Hamid, 2014, Iranian Biomedical Journal, V18, P225, DOI 10.6091/ibj.13222.2014; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Parveen A, 2015, J PHARM BIOALLIED SC, V7, P329, DOI 10.4103/0975-7406.168035; Pegg CC, 2010, J NEUROSCI METH, V187, P8, DOI 10.1016/j.jneumeth.2009.12.002; Gutierrez RMP, 2010, PHARMACOGN MAG, V6, P125, DOI 10.4103/0973-1296.62901; Peters M, 2012, J NEUROTRAUM, V29, P2831, DOI 10.1089/neu.2012.2575; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Silva FV, 2012, J MED FOOD, V15, P984, DOI 10.1089/jmf.2012.0102; Takasugi Y, 2005, EXP ANIM TOKYO, V54, P193, DOI 10.1538/expanim.54.193; Trabace L, 2011, TOXICOL APPL PHARM, V255, P169, DOI 10.1016/j.taap.2011.06.011; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; Uslu C, 2003, J ETHNOPHARMACOL, V88, P225, DOI 10.1016/S0378-8741(03)00236-8; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vosough-Ghanbari S, 2010, EVID-BASED COMPL ALT, V7, P465, DOI 10.1093/ecam/nen018; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yu HL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033584, 10.1371/journal.pone.0051239]; Zhong ZH, 2013, NEUROSCI LETT, V555, P24, DOI 10.1016/j.neulet.2013.09.023; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	56	9	9	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 18	2016	6								31866	10.1038/srep31866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZU	WOS:000381563000001	27535591	Green Published, gold			2022-02-06	
J	Hunt, AW; De Feo, L; Macintyre, J; Greenspoon, D; Dick, T; Mah, K; Paniccia, M; Provvidenza, C; Reed, N				Hunt, Anne W.; De Feo, Luciano; Macintyre, Jennifer; Greenspoon, Dayna; Dick, Talia; Mah, Katherine; Paniccia, Melissa; Provvidenza, Christine; Reed, Nick			Development and feasibility of an evidence-informed self-management education program in pediatric concussion rehabilitation	BMC HEALTH SERVICES RESEARCH			English	Article						Education; Concussion; Children; Youth; Knowledge translation; Self-management; Pediatric	SPORT-RELATED CONCUSSION; CHRONIC DISEASE; BRAIN-INJURY; KNOWLEDGE TRANSFER; POPULATION; CONSENSUS; OUTCOMES; IMPACT; REST; PLAY	Background: Concussion is a considerable public health problem in youth. However, identifying, understanding and implementing best evidence informed recovery guidelines may be challenging for families given the vast amount of information available in the public domains (e.g. Internet). The objective of this study was to develop, implement and evaluate the feasibility of an evidence-informed self-management education program for concussion recovery in youth. Methods: Synthesis of best evidence, principles of knowledge translation and exchange, and expert opinion were integrated within a self-management program framework to develop a comprehensive curriculum. The program was implemented and evaluated in a children's rehabilitation hospital within a universal health care system. A retrospective secondary analysis of anonymous data from a program evaluation survey was used to evaluate program feasibility, to identify features of importance to program participants and to assess changes in participants' knowledge. Results: The program, "Concussion & You" includes a comprehensive, evidence informed, population specific curriculum that teaches participants practical strategies for management of return to school and play, sleep, nutrition, relaxation and energy conservation. A 'wheel of health' is used to facilitate participants' self-management action plan. Results from eighty-seven participant surveys indicate that the program is feasible and participant knowledge increased in all areas of the program with the highest changes reported in knowledge about sleep hygiene, rest and energy conservation. Conclusion: Findings indicate that "Concussion & You" is a feasible program that is acceptable to youth and their families, and fills a health system service gap.	[Hunt, Anne W.; Greenspoon, Dayna; Dick, Talia; Mah, Katherine; Paniccia, Melissa; Provvidenza, Christine; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd,Room 4W221, Toronto, ON M4G 1R8, Canada; [De Feo, Luciano; Macintyre, Jennifer; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Mah, Katherine; Paniccia, Melissa; Reed, Nick] Univ Toronto, Rehabil Sci Inst, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada		Reed, N (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd,Room 4W221, Toronto, ON M4G 1R8, Canada.; Reed, N (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	nreed@hollandbloorview.ca			Toronto Automobile Dealers Association (TADA); Dr. Pashby Sport Safety Fund	Funding for the Concussion & You program was provided by the Toronto Automobile Dealers Association (TADA) and Dr. Pashby Sport Safety Fund. The funding sources did not influence the program content, research study or preparation of this manuscript in any way.	Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Fahy E, 2014, AUSTRALAS MED J, V7, P24, DOI 10.4066/AMJ.2014.1900; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Goodman D, 2002, CLIN J SPORT MED, V12, P265, DOI 10.1097/00042752-200209000-00001; Government of Canada, 2015, CAN FOOD GUID; Kendrick D, 2012, BRAIN INJURY, V26, P1243, DOI 10.3109/02699052.2012.672787; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lagger G, 2010, PATIENT EDUC COUNS, V79, P283, DOI 10.1016/j.pec.2010.03.015; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Muenchberger H, 2011, BRAIN INJURY, V25, P23, DOI 10.3109/02699052.2010.531689; Nolte S, 2007, PATIENT EDUC COUNS, V65, P351, DOI 10.1016/j.pec.2006.08.016; Ontario Neurotrauma Foundation, GUID PED CONC; Parachute Canada, CONC GUID PAR CAR; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Reardon R, 2006, RES PRACTICE KNOWLED; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641	25	9	9	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	AUG 17	2016	16								400	10.1186/s12913-016-1664-3			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	DT4PM	WOS:000381463200009	27534848	Green Published, gold			2022-02-06	
J	Ikeshima-Kataoka, H; Yasui, M				Ikeshima-Kataoka, Hiroko; Yasui, Masato			Correlation between astrocyte activity and recovery from blood-brain barrier breakdown caused by brain injury	NEUROREPORT			English	Article						blood-brain barrier; bromodeoxy uridine; immunoglobulin G; reactive astrocytes; stab wound injury	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; REACTIVE ASTROCYTES; PRIMARY CULTURE; MOUSE-BRAIN; TENASCIN-C; EPILEPTOGENESIS; PROLIFERATION; OSTEOPONTIN	Glial activation is associated with cell proliferation and upregulation of astrocyte marker expression following traumatic injury in the brain. However, the biological significance of these processes remains unclear. In the present study, astrocyte activation was investigated in a murine brain injury model. Brain injury induces blood-brain barrier (BBB) breakdown and immunoglobulin G (IgG) leak into the brain parenchyma. The recovery of BBB breakdown was evaluated by analyzing immunofluorescent staining with mouse IgG antibody. IgG leakage was greatest at 1 day after stab wound injury and decreased thereafter, and almost diminished after 7 days. Bromodeoxy uridine incorporation was used, and astrocyte proliferation rates were examined by coimmunostaining with anti-bromodeoxy uridine and anti-glial fibrillary acid protein antibodies. Consistent with IgG leakage assays, astrocyte activation was the highest at day 3 and decreased after 7 days. Moreover, in reverse transcriptase-quantitative-PCR experiments, genes associated with BBB integrity were downregulated immediately after BBB breakdown and recovered to basal expression levels within 7 days. These data indicated that astrocyte activation correlated with BBB recovery from breakdown following brain injury. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Ikeshima-Kataoka, Hiroko; Yasui, Masato] Keio Univ, Sch Med, Dept Pharmacol & Neurosci, Shinanomachi, Japan; [Ikeshima-Kataoka, Hiroko] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan		Ikeshima-Kataoka, H (corresponding author), Keio Univ, Dept Pharmacol & Neurosci, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ikeshima@1988.jukiun.ac.keio.jp			Global Center of Excellence (GCOE) Program for Humanoid Metabolomic Systems Biology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15K15532]; Waseda University Grants for Special Research Projects; Kurata Memorial Hitachi Science and Technology Foundation	The authors thank Motoko Furukawa, Sayaka Inui, Yoko Honjo, and Manae Imamura for their technical support. This work was supported by the Global Center of Excellence (GCOE) Program for Humanoid Metabolomic Systems Biology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (JSPS; 15K15532), Waseda University Grants for Special Research Projects (2012, 2013, 2014, 2016), and The Kurata Memorial Hitachi Science and Technology Foundation.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Broux B, 2015, SEMIN IMMUNOPATHOL, V37, P577, DOI 10.1007/s00281-015-0516-2; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Gliem M, 2015, GLIA, V63, P2198, DOI 10.1002/glia.22885; Ikeshima-Kataoka H, 2008, IN VIVO, V22, P409; Ikeshima-Kataoka H, 2007, IN VIVO, V21, P629; Ikeshima-Kataoka H, 2015, J NEUROSCI RES, V93, P121, DOI 10.1002/jnr.23467; Ikeshima-Kataoka H, 2013, MOL CELL NEUROSCI, V56, P65, DOI 10.1016/j.mcn.2013.02.002; Keaney J, 2015, FEBS J, V282, P4067, DOI 10.1111/febs.13412; Liu W, 2011, LIFE SCI, V89, P141, DOI 10.1016/j.lfs.2011.05.011; Lukovic D, 2015, STEM CELLS, V33, P1036, DOI 10.1002/stem.1959; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898	17	9	9	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 17	2016	27	12					894	900		10.1097/WNR.0000000000000619			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ8GG	WOS:000379446500003	27362437				2022-02-06	
J	Berthier, ML; Roe-Vellve, N; Moreno-Torres, I; Falcon, C; Thurnhofer-Hemsi, K; Paredes-Pacheco, J; Torres-Prioris, MJ; De-Torres, I; Alfaro, F; Gutierrez-Cardo, AL; Baquero, M; Ruiz-Cruces, R; Davila, G				Berthier, Marcelo L.; Roe-Vellve, Nuria; Moreno-Torres, Ignacio; Falcon, Caries; Thurnhofer-Hemsi, Karl; Paredes-Pacheco, Jose; Torres-Prioris, Maria J.; De-Torres, Irene; Alfaro, Francisco; Gutierrez-Cardo, Antonio L.; Baquero, Miquel; Ruiz-Cruces, Rafael; Davila, Guadalupe			Mild Developmental Foreign Accent Syndrome and Psychiatric Comorbidity: Altered White Matter Integrity in Speech and Emotion Regulation Networks	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						developmental speech disorders; foreign accent; diffusion tensor imaging; personality; psychiatric disorders	OBSESSIVE-COMPULSIVE DISORDER; TRAUMATIC BRAIN-INJURY; VIRCHOW-ROBIN SPACES; SELF-RATING SCALE; PSYCHOMETRIC PROPERTIES; LANGUAGE IMPAIRMENT; CONVERSION DISORDER; VENOUS ANOMALIES; FUNCTIONAL MRI; FRONTAL-LOBE	Foreign accent syndrome (FAS) is a speech disorder that is defined by the emergence of a peculiar manner of articulation and intonation which is perceived as foreign. In most cases of acquired FAS (AFAS) the new accent is secondary to small focal lesions involving components of the bilaterally distributed neural network for speech production. In the past few years FAS has also been described in different psychiatric conditions (conversion disorder, bipolar disorder, and schizophrenia) as well as in developmental disorders (specific language impairment, apraxia of speech). In the present study, two adult males, one with atypical phonetic production and the other one with cluttering, reported having developmental FAS (DFAS) since their adolescence. Perceptual analysis by naive judges could not confirm the presence of foreign accent, possibly due to the mildness of the speech disorder. However, detailed linguistic analysis provided evidence of prosodic and segmental errors previously reported in AFAS cases. Cognitive testing showed reduced communication in activities of daily living and mild deficits related to psychiatric disorders. Psychiatric evaluation revealed long-lasting internalizing disorders (neuroticism, anxiety, obsessive -compulsive disorder, social phobia, depression, alexithymia, hopelessness, and apathy) in both subjects. Diffusion tensor imaging (DTI) data from each subject with DFAS were compared with data from a group of 21 age- and gender -matched healthy control subjects. Diffusion parameters (MD, AD, and RD) in predefined regions of interest showed changes of white matter microstructure in regions previously related with AFAS and psychiatric disorders. In conclusion, the present findings militate against the possibility that these two subjects have FAS of psychogenic origin. Rather, our findings provide evidence that mild DFAS occurring in the context of subtle, yet persistent, developmental speech disorders may be associated with structural brain anomalies. We suggest that the simultaneous involvement of speech and emotion regulation networks might result from disrupted neural organization during development, or compensatory or maladaptive plasticity. Future studies are required to examine whether the interplay between biological trait like diathesis (shyness, neuroticism) and the stressful experience of living with mild DFAS lead to the development of internalizing psychiatric disorders.	[Berthier, Marcelo L.; Torres-Prioris, Maria J.; De-Torres, Irene; Ruiz-Cruces, Rafael; Davila, Guadalupe] Univ Malaga, Inst Investigac Biomed Malaga IBIMA, Ctr Invest Med Sanit, Cognit Neurol & Aphasia Unit, Malaga, Spain; [Berthier, Marcelo L.; Torres-Prioris, Maria J.; De-Torres, Irene; Ruiz-Cruces, Rafael; Davila, Guadalupe] Univ Malaga, Inst Investigac Biomed Malaga IBIMA, Ctr Invest Med Sanit, Cathedra ARPA Aphasia, Malaga, Spain; [Roe-Vellve, Nuria; Thurnhofer-Hemsi, Karl; Paredes-Pacheco, Jose; Alfaro, Francisco; Gutierrez-Cardo, Antonio L.] Univ Malaga, Ctr Invest Med Sanit, Mol Imaging Unit, Malaga, Spain; [Moreno-Torres, Ignacio] Univ Malaga, Dept Spanish Language, Malaga, Spain; [Falcon, Caries] Pasqua! Maragali Fdn, Barcelonabeta Brain Res Ctr, Barcelona, Spain; [Thurnhofer-Hemsi, Karl; Paredes-Pacheco, Jose] Univ Malaga, Super Tech Sch Engn Informat, Dept Appl Math, Malaga, Spain; [Torres-Prioris, Maria J.; Davila, Guadalupe] Univ Malaga, Fac Psychol, Dept Psychobiol & Methodol Behav Sci, Malaga, Spain; [De-Torres, Irene] Reg Univ Hosp, Unit Phys Med & Rehabil, Malaga, Spain; [Baquero, Miquel] Hosp Univ & Politecn La Fe, Serv Neurol, Valencia, Spain		Berthier, ML (corresponding author), Univ Malaga, Inst Investigac Biomed Malaga IBIMA, Ctr Invest Med Sanit, Cognit Neurol & Aphasia Unit, Malaga, Spain.; Berthier, ML (corresponding author), Univ Malaga, Inst Investigac Biomed Malaga IBIMA, Ctr Invest Med Sanit, Cathedra ARPA Aphasia, Malaga, Spain.	mbt@uma.es	Moreno-Torres, Ignacio/H-2598-2015; Davila, Guadalupe/D-3050-2011; Thurnhofer-Hemsi, Karl/Q-8845-2018; Torres-Prioris, Maria Jose/AAA-1944-2020; Roe-Vellve, Nuria/J-5353-2018	Davila, Guadalupe/0000-0002-3297-4243; Thurnhofer-Hemsi, Karl/0000-0001-6519-1213; Torres-Prioris, Maria Jose/0000-0003-3795-8151; Roe-Vellve, Nuria/0000-0001-5583-8837; falcon, carles/0000-0001-5564-2025; Paredes-Pacheco, Jose/0000-0002-4982-2422; de Torres Garcia, Irene/0000-0001-8590-4057	Universidad de Malaga. Programas de Becas de Iniciacion a la Investigacion	The authors thank subjects 1 and 2 and healthy control subjects for their participation in the study. KT-H and JP-P is supported by "Universidad de Malaga. Programas de Becas de Iniciacion a la Investigacion 2014." The authors also thank Cesar Avila and Julio Gonzalez for their advice on analyzing Valencian accent.	Ackermann H, 2010, BRAIN STRUCT FUNCT, V214, P419, DOI 10.1007/s00429-010-0257-x; Aghajani M, 2014, COGN AFFECT BEHAV NE, V14, P836, DOI 10.3758/s13415-013-0224-0; Aguado G., 2011, CONTRIBUCIONES DIAGN; Alm PA, 2014, J FLUENCY DISORD, V40, P5, DOI 10.1016/j.jfludis.2014.01.004; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; ARDILA A, 1988, APHASIOLOGY, V2, P493, DOI 10.1080/02687038808248955; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aybek S, 2014, J NEUROL NEUROSUR PS, V85, P236, DOI 10.1136/jnnp-2012-304158; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bech P., 1993, RATING SCALES PSYCHO; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bergouignan L, 2009, NEUROIMAGE, V45, P29, DOI 10.1016/j.neuroimage.2008.11.006; BERTHIER ML, 1991, APHASIOLOGY, V5, P129, DOI 10.1080/02687039108249478; Bleek B, 2012, J FLUENCY DISORD, V37, P325, DOI 10.1016/j.jfludis.2012.07.003; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; Blumstein SE, 2006, J NEUROLINGUIST, V19, P346, DOI 10.1016/j.jneuroling.2006.03.003; Boddaert N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004415; Boersma P., 2010, PRAAT DOING PHONETIC; Bohland JW, 2010, J COGNITIVE NEUROSCI, V22, P1504, DOI 10.1162/jocn.2009.21306; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Botzung A, 2007, NEUROCASE, V13, P378, DOI 10.1080/13554790701851528; Briz Antonio, 2004, REV INT LINGUISTICA, V4, P119; Brockmann K, 2009, NEUROPEDIATRICS, V40, P234, DOI 10.1055/s-0029-1246158; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Caplan B., 2011, ENCY CLIN NEUROPSYCH, P928, DOI [10.1007/978-0-387-79948-3_684, DOI 10.1007/978-0-387-79948-3_684]; Carbary TJ, 2000, BRAIN COGNITION, V43, P78; Chang SE, 2010, J NEUROLINGUIST, V23, P455, DOI 10.1016/j.jneuroling.2008.11.004; Coleman J, 2006, J NEUROLINGUIST, V19, P341, DOI 10.1016/j.jneuroling.2006.03.006; Connor KM, 2000, BRIT J PSYCHIAT, V176, P379, DOI 10.1192/bjp.176.4.379; Cooper J, 1970, Psychol Med, V1, P48; Cottingham ME, 2010, CLIN NEUROPSYCHOL, V24, P1006, DOI 10.1080/13854046.2010.481636; Curlee R. F., 2007, STUTTERING RELATED D, P297; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Davila G, 2010, J NEURAL TRANSM, V117, P481, DOI 10.1007/s00702-010-0369-8; Dietrich M, 2012, INT J SPEECH-LANG PA, V14, P377, DOI 10.3109/17549507.2012.688865; Eickhoff SB, 2009, PHILOS T R SOC A, V367, P2399, DOI 10.1098/rsta.2008.0287; Fan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035889; Flege JE, 2006, J PHONETICS, V34, P153, DOI 10.1016/j.wocn.2005.05.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fridriksson J, 2005, NEUROCASE, V11, P319, DOI 10.1080/13554790591006302; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Goma-i-Freixanet M, 2008, PSYCHOL REP, V103, P845, DOI 10.2466/PR0.103.7.845-856; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GRAFFRADFORD NR, 1986, BRAIN LANG, V28, P86, DOI 10.1016/0093-934X(86)90093-3; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Gunn A, 2014, J FLUENCY DISORD, V40, P58, DOI 10.1016/j.jfludis.2013.09.002; GURD JM, 1988, NEUROPSYCHOLOGIA, V26, P237, DOI 10.1016/0028-3932(88)90077-2; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HOLLANDER E, 1990, ARCH GEN PSYCHIAT, V47, P27; INGRAM JCL, 1992, J PHONETICS, V20, P457, DOI 10.1016/S0095-4470(19)30650-3; Iverach L, 2014, J FLUENCY DISORD, V40, P69, DOI 10.1016/j.jfludis.2013.08.003; Kaplan E., 2001, BOSTON NAMING TEST; Karukivi M, 2014, WORLD J PSYCHIATR, V4, P91, DOI 10.5498/wjp.v4.i4.91; Karukivi M, 2012, COMPR PSYCHIAT, V53, P54, DOI 10.1016/j.comppsych.2011.01.012; Katz WF, 2012, NEUROCASE, V18, P199, DOI 10.1080/13554794.2011.588173; Kay J., 1992, PSYCHOLINGUISTIC ASS; Keulen S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00168; Keulen S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00065; Kimura A, 2001, Rinsho Shinkeigaku, V41, P113; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Koganemaru S, 2012, EUR J NEUROSCI, V35, P1637, DOI 10.1111/j.1460-9568.2012.08098.x; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; Lee C, 1996, AM J NEURORADIOL, V17, P61; LeWinn KZ, 2014, J AM ACAD CHILD PSY, V53, P899, DOI 10.1016/j.jaac.2014.04.021; Li F, 2014, HUM BRAIN MAPP, V35, P2643, DOI 10.1002/hbm.22357; Lippert-Gruener M, 2005, BRAIN INJURY, V19, P955, DOI 10.1080/02699050500109506; Locke JL, 1997, BRAIN LANG, V58, P265, DOI 10.1006/brln.1997.1791; Marien P, 2009, CORTEX, V45, P870, DOI 10.1016/j.cortex.2008.10.010; Martinez-Celdran E., 1998, ANALISIS ESPECTROGRA; Miller N, 2011, APHASIOLOGY, V25, P1053, DOI 10.1080/02687038.2011.573857; Miskovic V, 2012, NEUROSCI BIOBEHAV R, V36, P459, DOI 10.1016/j.neubiorev.2011.08.002; Moreno-Torres I, 2013, NEUROPSYCHOLOGIA, V51, P520, DOI 10.1016/j.neuropsychologia.2012.11.010; NAGARATNAM N, 1990, BRIT J CLIN PRACT, V44, P34; Neef NE, 2015, BRAIN, V138, P712, DOI 10.1093/brain/awu390; NORAN HH, 1945, ARCH PATHOL, V39, P393; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osborn A. G., 2004, DIAGNOSTIC IMAGING B, V1st; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P371, DOI 10.1093/arclin/acp041; Piras F, 2015, CORTEX, V62, P89, DOI 10.1016/j.cortex.2013.01.016; Poulin Stephane, 2007, Ann Gen Psychiatry, V6, P1, DOI 10.1186/1744-859X-6-1; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; Pulvermuller F, 2008, APHASIOLOGY, V22, P563, DOI 10.1080/02687030701612213; Reeves RR, 2007, J NEUROPSYCH CLIN N, V19, P70, DOI 10.1176/appi.neuropsych.19.1.70; Reeves RR, 2001, NEUROPSY NEUROPSY BE, V14, P135; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Riecker A, 2005, NEUROLOGY, V64, P700, DOI 10.1212/01.WNL.0000152156.90779.89; Santucci GM, 2008, AM J NEURORADIOL, V29, P1317, DOI 10.3174/ajnr.A1090; Scott SK, 2006, J NEUROLINGUIST, V19, P370, DOI 10.1016/j.jneuroling.2006.03.008; Servaas MN, 2013, NEUROSCI BIOBEHAV R, V37, P1518, DOI 10.1016/j.neubiorev.2013.05.005; Shin NY, 2014, PSYCHOL MED, V44, P1121, DOI 10.1017/S0033291713001803; Smith SM, 2004, BRIT J RADIOL, V77, pS167, DOI 10.1259/bjr/33553595; Snowling MJ, 2006, J CHILD PSYCHOL PSYC, V47, P759, DOI 10.1111/j.1469-7610.2006.01631.x; Song CJ, 2000, RADIOLOGY, V214, P671, DOI 10.1148/radiology.214.3.r00mr17671; Soros P, 2006, NEUROIMAGE, V32, P376, DOI 10.1016/j.neuroimage.2006.02.046; St Louis K. O., 2011, CLUTTERING RES INTER, P222; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Stein MB, 2003, DEPRESS ANXIETY, V17, P94, DOI 10.1002/da.10093; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suntrup S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089665; TAKAYAMA Y, 1993, NEUROLOGY, V43, P1361, DOI 10.1212/WNL.43.7.1361; TOGNOLA G, 1980, NEUROPSYCHOLOGIA, V18, P257, DOI 10.1016/0028-3932(80)90122-0; Tomasino B, 2013, CORTEX, V49, P18, DOI 10.1016/j.cortex.2011.10.007; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Valle F., 1995, EPLA EVALUACION PROC EPLA EVALUACION PROC; Van Borsel J, 2005, J COMMUN DISORD, V38, P421, DOI 10.1016/j.jcomdis.2005.03.004; van der Velde J, 2013, NEUROSCI BIOBEHAV R, V37, P1774, DOI 10.1016/j.neubiorev.2013.07.008; VANLANCKER DR, 1983, BRAIN LANG, V20, P12, DOI 10.1016/0093-934X(83)90028-7; Vargas C, 2013, J AFFECT DISORDERS, V150, P727, DOI 10.1016/j.jad.2013.05.083; Verhoeven J, 2005, BEHAV NEUROL, V16, P225, DOI 10.1155/2005/989602; Vuilleumier P, 2005, PROG BRAIN RES, V150, P309, DOI 10.1016/S0079-6123(05)50023-2; Ward D, 2015, J FLUENCY DISORD, V43, P1, DOI 10.1016/j.jfludis.2014.12.003; Watanabe Hirofumi, 2005, Nihon Ronen Igakkai Zasshi, V42, P450; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wheeler AL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00653; Whitaker H. A., 1982, NEUROPSYCHOLOGY COGN, V1, P168; Whitehouse AJO, 2009, INT J LANG COMM DIS, V44, P489, DOI 10.1080/13682820802708080; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zuckerman M, 2002, BIG FIVE ASSESSMENT, P377	120	9	10	2	31	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	AUG 9	2016	10								399	10.3389/fnhum.2016.00399			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DS7YQ	WOS:000380999600002	27555813	gold, Green Published			2022-02-06	
J	Can, A; Gross, BA; Smith, TR; Dammers, R; Dirven, CMF; Woodmansee, WW; Laws, ER; Du, R				Can, Anil; Gross, Bradley A.; Smith, Timothy R.; Dammers, Ruben; Dirven, Clemens M. F.; Woodmansee, Whitney W.; Laws, Edward R.; Du, Rose			Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis	NEUROSURGERY			English	Article						Diabetes insipidus; Growth hormone deficiency; Hypogonadotropic hypogonadism; Hypopituitarism; Secondary adrenal insufficiency; Secondary hypothyroidism; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; ACUTE-PHASE; NEUROENDOCRINE DYSFUNCTION; CORTISOL DYNAMICS; HIGH-RISK; HYPOPITUITARISM; PREVALENCE; DEFICIENCY; DIAGNOSIS; SURVIVORS	BACKGROUND: The prevalence of hypothalamic-pituitary dysfunction after aneurysmal subarachnoid hemorrhage has not been precisely determined, and conflicting results have been reported in the literature. OBJECTIVE: To perform a systematic review and meta-analysis investigating the prevalence of pituitary insufficiency after aneurysmal subarachnoid hemorrhage and to focus on basal serum and dynamic test differences. METHODS: The prevalence of pituitary dysfunction was quantified at 3 to 6 months and >6 months after aneurysmal subarachnoid hemorrhage. Proportions were transformed with the logit transformation. A subgroup analysis was performed focusing on the differences in outcome between basal serum and dynamic tests for the diagnosis of growth hormone deficiency (GHD) and secondary adrenal insufficiency. RESULTS: Overall prevalence of hypopituitarism differed considerably between studies, ranging from 0.05 to 0.45 in studies performed between 3 and 6 months after the event and from 0 to 0.55 in long-term studies (>6 months), with pooled frequencies of 0.31 (95% confidence interval [CI]: 0.22-0.43) and 0.25 (95% CI: 0.16-0.36), respectively. Pooled frequency of GHD at 3 to 6 months was 0.14 (95% CI: 0.08-0.24). At >6 months, GHD prevalence was 0.19 (95% CI: 0.13-0.26) overall, but ranged from 0.15 (95% CI: 0.06-0.33) with the insulin tolerance test to 0.25 (95% CI: 0.15-0.36) using the growth hormone releasing hormone 1 arginine test. CONCLUSION: Hypopituitarism is a common complication in patients with aneurysmal subarachnoid hemorrhage, with GHD being the most prevalent diagnosis. We showed that variations in prevalence rates in the literature are partly due to methodological differences among pituitary function tests.	[Can, Anil; Gross, Bradley A.; Smith, Timothy R.; Laws, Edward R.; Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Can, Anil; Gross, Bradley A.; Smith, Timothy R.; Woodmansee, Whitney W.; Laws, Edward R.; Du, Rose] Harvard Med Sch, Boston, MA USA; [Can, Anil; Dammers, Ruben; Dirven, Clemens M. F.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Woodmansee, Whitney W.] Brigham & Womens Hosp, Div Endocrinol, 75 Francis St, Boston, MA 02115 USA		Du, R (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Dammers, Ruben/AAD-9095-2021; Smith, Timothy R/N-2481-2014; Du, Rose/AAJ-2873-2020; Dammers, Ruben/AAL-8391-2021; Du, Rose/I-5402-2012	Dammers, Ruben/0000-0001-7033-0644; Smith, Timothy R/0000-0003-1976-0766; Du, Rose/0000-0003-2641-6496			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Pereira JLB, 2013, CLINICS, V68, P745, DOI 10.6061/clinics/2013(06)04; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; BJERRE P, 1986, NEUROSURGERY, V19, P1012, DOI 10.1227/00006123-198612000-00018; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Capozzi A, 2015, GYNECOL ENDOCRINOL, V31, P506, DOI 10.3109/09513590.2015.1017810; Cook DM, 2009, ENDOCR PRACT S2, P1, DOI DOI 10.4158/EP.15.S2.1; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; DANIEL PM, 1959, LANCET, V2, P927; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Dutta P, 2012, NEUROL INDIA, V60, P390, DOI 10.4103/0028-3886.100729; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Hannon MJ, 2015, CLIN ENDOCRINOL, V82, P115, DOI 10.1111/cen.12533; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Hutter BO, 1998, NEUROSURGERY, V43, P1054; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; Ioachimescu AG, 2015, WORLD NEUROSURG, V83, P1026, DOI 10.1016/j.wneu.2015.01.044; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khajeh L, 2015, J NEUROL NEUROSUR PS, V86, P905, DOI 10.1136/jnnp-2014-307897; Khajeh L, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0205-0; Khursheed N, 2013, INT J ENDOCRINOL MET, V11, P179, DOI 10.5812/ijem.8241; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Kreitschmann-Andermahr I, 2008, EXP CLIN ENDOCR DIAB, V116, P276, DOI 10.1055/s-2007-1004552; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kronvall E, 2015, WORLD NEUROSURG, V83, P574, DOI 10.1016/j.wneu.2014.12.007; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Labovitz DL, 2006, NEUROEPIDEMIOLOGY, V26, P147, DOI 10.1159/000091655; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Lammert A, 2012, PITUITARY, V15, P505, DOI 10.1007/s11102-011-0357-5; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; MAYBERG MR, 1994, CIRCULATION, V90, P2592, DOI 10.1161/01.CIR.90.5.2592; Parenti G, 2011, J ENDOCRINOL INVEST, V34, P361, DOI [10.1007/BF03347460, 10.3275/7242]; Poll EM, 2010, J NEUROTRAUM, V27, P189, DOI 10.1089/neu.2009.1014; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P772, DOI 10.1136/jnnp.72.6.772; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shea AM, 2007, NEUROSURGERY, V61, P1131, DOI 10.1227/01.neu.0000306090.30517.ae; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Stubbs B., 2017, BMJ, V7, P1, DOI [10.1038/s41467-019-10003-8, 10.1038/s41598-017-07579-w, DOI 10.1136/BMJ.B2535]; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Weant KA, 2008, NEUROSURGERY, V63, P645, DOI 10.1227/01.NEU.0000325728.50939.15	53	9	10	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2016	79	2					253	263		10.1227/NEU.0000000000001157			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DU6OS	WOS:000382335100034	26645970				2022-02-06	
J	Chauv, S; Fontaine, GV; Hoang, QP; McKinney, CB; Baldwin, M; Buckel, WR; Collingridge, DS; Majercik, S; Wohlt, PD				Chauv, Stephanie; Fontaine, Gabriel V.; Hoang, Quang P.; McKinney, Courtney B.; Baldwin, Margaret; Buckel, Whitney R.; Collingridge, Dave S.; Majercik, Sarah; Wohlt, Paul D.			Risk of Resistant Organisms and Clostridium difficile with Prolonged Systemic Antibiotic Prophylaxis for Central Nervous System Devices	NEUROCRITICAL CARE			English	Article						Central nervous system devices; Intracranial pressure monitor; Extraventricular drains; Antibiotic prophylaxis; Ventriculitis; Resistant organisms; Clostridium difficile; Infections	VENTRICULOSTOMY-RELATED INFECTIONS; INTRACRANIAL-PRESSURE MONITORS	Prolonged systemic antibiotic prophylaxis for central nervous system (CNS) devices may be associated with increased risk of antimicrobial resistance. The primary objective of this study was to determine the impact of prolonged CNS device antibiotic prophylaxis on the growth of resistant microorganisms and Clostridium difficile. This retrospective, observational, cohort study included patients admitted to intensive care units with traumatic brain injury or other neurocritical illness. Patients who received a CNS device and antibiotic prophylaxis for at least 72 h were compared to patients with similar neurologic injuries who did not receive a CNS device. Study (n = 116) and control (n = 557) patients had mean APACHE II scores of 17.7 +/- 9.2 and 15.1 +/- 10.6 (p = 0.004) with 53.4 and 24.6 % receiving craniotomies (p < 0.001), respectively. Mean CNS device duration was 9.9 days, and 73 % of patients received cefuroxime for prophylaxis. The study cohort had a higher absolute incidence of resistant organisms compared with the control cohort (15.5 vs 4.1 %; odds ratio 1.93, 95 % CI 0.93-4.03, p = 0.078), though the study was underpowered to show statistical significance in multivariate analysis. C. difficile incidence was similar between groups (2.6 vs 2.0 %; odds ratio 1.45, 95 % CI 0.35-6.12, p = 0.61). We found a higher incidence of resistant organisms in patients receiving prolonged antibiotic prophylaxis with a CNS device, but similar incidence of C. difficile compared to controls. Lack of data supporting prolonged antibiotic prophylaxis for CNS devices and the risk of nosocomial infections with resistant organisms encourage limiting prophylactic antibiotics to a short periprocedural course.	[Chauv, Stephanie; Fontaine, Gabriel V.; Hoang, Quang P.; McKinney, Courtney B.; Baldwin, Margaret; Buckel, Whitney R.; Collingridge, Dave S.; Majercik, Sarah; Wohlt, Paul D.] Intermt Med Ctr, Murray, UT 84107 USA		Chauv, S (corresponding author), Intermt Med Ctr, Murray, UT 84107 USA.	Stephanie.Chauv@imail.org		Fontaine, Gabriel/0000-0003-4680-5720			Alleyne CH, 2000, NEUROSURGERY, V47, P1124, DOI 10.1097/00006123-200011000-00020; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS26; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Camacho EF, 2011, INFECTION, V39, P47, DOI 10.1007/s15010-010-0073-5; Citerio G, 2015, CRIT CARE MED, V43, P1630, DOI 10.1097/CCM.0000000000001019; Dellit TH, 2014, INFECT CONT HOSP EP, V35, P589, DOI 10.1086/675828; Flibotte JJ, 2004, NEUROCRIT CARE, V1, P61, DOI 10.1385/NCC:1:1:61; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Jacobs DG, 1998, J NATL MED ASSOC, V90, P417; Kim JH, 2012, WORLD NEUROSURG, V77, P135, DOI 10.1016/j.wneu.2011.04.017; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; May Addison K, 2006, Surg Infect (Larchmt), V7, P409, DOI 10.1089/sur.2006.7.409; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; McCarthy PJ, 2010, NEUROCRIT CARE, V12, P220, DOI 10.1007/s12028-009-9284-y; Poon WS, 1998, ACT NEUR S, V71, P146; Prabhu VC, 1999, SURG NEUROL, V52, P226, DOI 10.1016/S0090-3019(99)00084-1; Ramanan M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0712-z; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Stenehjem E, 2012, INFECT DIS CLIN N AM, V26, P89, DOI 10.1016/j.idc.2011.09.006	20	9	9	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2016	25	1					128	132		10.1007/s12028-016-0254-x			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DR8LZ	WOS:000380150700017	26920907				2022-02-06	
J	Ko, KR; Park, HJ; Hyun, JK; Seo, IH; Kim, TU				Ko, Kyung Rok; Park, Hee Jung; Hyun, Jung Keun; Seo, In-Hyo; Kim, Tae Uk			Effect of Laryngopharyngeal Neuromuscular Electrical Stimulation on Dysphonia Accompanied by Dysphagia in Post-stroke and Traumatic Brain Injury Patients: A Pilot Study	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Dysphonia; Deglutition disorders; Electrical stimulation therapy; Stroke; Brain injuries	SYSTEM; REHABILITATION; DYSARTHRIA; OUTCOMES	Objective To investigate the effect of laryngopharyngeal neuromuscular electrical stimulation (NMES) on dysphonia in patients with dysphagia caused by stroke or traumatic brain injury (TBI). Methods Eighteen patients participated in this study. The subjects were divided into NMES (n = 12) and conventional swallowing training only (CST, n = 6) groups. The NMES group received NMES combined with CST for 2 weeks, followed by CST without NMES for the next 2 weeks. The CST group received only CST for 4 weeks. All of the patients were evaluated before and at 2 and 4 weeks into the study. The outcome measurements included perceptual, acoustic and aerodynamic analyses. The correlation between dysphonia and swallowing function was also investigated. Results There were significant differences in the GRBAS (grade, roughness, breathiness, asthenia and strain scale) total score and sound pressure level (SPL) between the two groups over time. The NMES relative to the CST group showed significant improvements in total GRBAS score and SPL at 2 weeks, though no inter-group differences were evident at 4 weeks. The improvement of the total GRBAS scores at 2 weeks was positively correlated with the improved pharyngeal phase scores on the functional dysphagia scale at 2 weeks. Conclusion The results demonstrate that laryngopharyngeal NMES in post-stroke or TBI patients with dysphonia can have promising effects on phonation. Therefore, laryngopharyngeal NMES may be considered as an additional treatment option for dysphonia accompanied by dysphagia after stroke or TBI.	[Ko, Kyung Rok; Park, Hee Jung; Hyun, Jung Keun; Kim, Tae Uk] Dankook Univ, Coll Med, Dept Rehabil Med, 201 Manghyang Ro, Cheonan 31116, South Korea; [Hyun, Jung Keun] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Hyun, Jung Keun] Dankook Univ, Plus NBM Res Ctr Regenerat Med BK21, Cheonan, South Korea; [Hyun, Jung Keun] Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea; [Seo, In-Hyo] Dankook Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Voice & Speech Clin, Cheonan, South Korea		Ko, KR (corresponding author), Dankook Univ, Coll Med, Dept Rehabil Med, 201 Manghyang Ro, Cheonan 31116, South Korea.	magnarbor@dankook.ac.kr	Hyun, Jung Keun/ABB-2173-2020	Hyun, Jung Keun/0000-0001-9254-4424			Burnett TA, 2003, J APPL PHYSIOL, V94, P128, DOI 10.1152/japplphysiol.00406.2002; Cohen SM, 2009, OTOLARYNG CLIN N AM, V42, P107, DOI 10.1016/j.otc.2008.09.010; Cohen SM, 2006, ANN OTO RHINOL LARYN, V115, P128, DOI 10.1177/000348940611500209; El Sharkawi A, 2002, J NEUROL NEUROSUR PS, V72, P31; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; Fowler LP, 2011, J VOICE, V25, P54, DOI 10.1016/j.jvoice.2009.07.006; Freed M L, 2001, Respir Care, V46, P466; Hirano M., 1981, CLIN EXAMINATION VOI; Humbert LA, 2008, LARYNGOSCOPE, V118, P14, DOI 10.1097/MLG.0b013e318155a47d; Kent RD, 2003, J COMMUN DISORD, V36, P281, DOI 10.1016/S0021-9924(03)00016-9; 이준욱, 2004, Annals of Rehabilitation Medicine, V28, P523; Ko D. H, 2003, SPEECH SCI, V10, P129; Lagorio Lisa A, 2008, Cases J, V1, P67, DOI 10.1186/1757-1626-1-67; Lee KW, 2010, ANN REHABIL MED-ARM, V34, P15; Logemann JA, 1998, EVALUATION TREATMENT; Lu FL, 2013, J VOICE, V27, DOI 10.1016/j.jvoice.2013.06.006; McFarland David H., 2006, Seminars in Speech and Language, V27, P300, DOI 10.1055/s-2006-955119; MCHENRY MA, 1985, FOLIA PHONIATR, V37, P223, DOI 10.1159/000265802; Mehta RP, 2001, ARCH OTOLARYNGOL, V127, P393, DOI 10.1001/archotol.127.4.393; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Stepp CE, 2009, THESIS; Sung DH, 2001, ARCH PHYS MED REHAB, V82, P671, DOI 10.1053/apmr.2001.21975; Tanaka T, 2013, J PHYS THER SCI, V25, P575, DOI 10.1589/jpts.25.575; Wang YT, 2010, CAN ACOUST, V38, P142; Wesling M, 2003, DYSPHAGIA, V18, P203, DOI 10.1007/s00455-002-0098-8; Yoon YS, 2006, ANN REHABIL MED-ARM, V30, P417; Yu P, 2001, J VOICE, V15, P529, DOI 10.1016/S0892-1997(01)00053-4; Zraick RI, 2012, J VOICE, V26, P164, DOI 10.1016/j.jvoice.2011.01.006; 변해원, 2012, [Journal of Korea Academia-Industrial cooperation Society, 한국산학기술학회논문지], V13, P1665, DOI 10.5762/KAIS.2012.13.4.1665	29	9	11	0	10	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	AUG	2016	40	4					600	610		10.5535/arm.2016.40.4.600			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FG9XK	WOS:000410793100006	27606266	Green Published, gold, Green Submitted			2022-02-06	
J	Mica, L; Simmen, H; Werner, CML; Plecko, M; Keller, C; Wirth, SH; Sprengel, K				Mica, Ladislav; Simmen, Hanspeter; Werner, Clement M. L.; Plecko, Michael; Keller, Catharina; Wirth, Stefan H.; Sprengel, Kai			Fresh frozen plasma is permissive for systemic inflammatory response syndrome, infection, and sepsis in multiple-injured patients	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							RECOMBINANT FACTOR VIIA; TRAUMATIC BRAIN-INJURY; PROTHROMBIN COMPLEX CONCENTRATE; BLOOD-TRANSFUSION; CARDIAC-SURGERY; MAJOR TRAUMA; APACHE-II; COAGULOPATHY; MANAGEMENT; SEVERITY	Background: The correction of coagulopathy with fresh frozen plasma (FFP) is one of the main issues in the treatment of multiple-injured patients. Infectious and septic complications contribute to an adverse outcome in multiple-injured patients. Here, we investigated the role of FFP in the development of inflammatory complications given within the first 48 hours. Methods: A total of 2033 patients with multiple injuries and an Injury Severity Score greater than 16 points and aged 16 years or older were included. The population was subdivided into 2 groups: those who received FFP and those who did not. The data were analyzed using SPSS version 22.0. Associations between the data were tested using Pearson correlation. Independent predictivity was analyzed by binary logistic regression and multivariate regression. Data were considered as significant if P < .05. Results: The prothrombin time at admission was significantly lower (68.5% +/- 23.3% vs 81.8% +/- 21.0% normal; P < .001) in the group receiving FFP. The application of FFP led to a more severe systemic inflammatory response syndrome (SIRS) grade (3.0 +/- 1.2 vs 2.2 +/- 1.4; P < .001), to a higher infection rate (48% vs 28%; P < .001), and to a higher sepsis rate (29% vs 13%; P < .001) in the patients receiving FFP. The correlations between SIRS and the incidence of infections and sepsis increased with the amount of FFP applied (P < .001). Conclusions: Treatment with FFP of bleeding patients with multiple injuries enhances the risk of SIRS, infection, and sepsis; however, a multifactorial genesis has to be postulated. (C) 2016 Elsevier Inc. All rights reserved.	[Mica, Ladislav; Simmen, Hanspeter; Werner, Clement M. L.; Plecko, Michael; Sprengel, Kai] Univ Zurich Hosp, Div Trauma Surg, Ramistr 100, CH-8091 Zurich, Switzerland; [Keller, Catharina] LVR Clin, D-51109 Cologne, Germany; [Wirth, Stefan H.] Univ Hosp Balgrist, CH-8008 Zurich, Switzerland		Mica, L (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Ramistr 100, CH-8091 Zurich, Switzerland.	ladmic@gmail.com	; Sprengel, Kai/G-4780-2014	Simmen, Hans-Peter/0000-0002-5201-4549; Sprengel, Kai/0000-0001-5921-8272			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beale E, 2006, INJURY, V37, P455, DOI 10.1016/j.injury.2005.12.008; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brown CVR, 2010, J TRAUMA, V68, P348, DOI 10.1097/TA.0b013e3181bbfb6b; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; Chassot PG, 2007, BRIT J ANAESTH, V99, P316, DOI 10.1093/bja/aem209; Despotis G, 2007, EUR J ANAESTH, V24, P15, DOI 10.1017/S0265021507000580; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2010, J TRAUMA, V68, P1151, DOI 10.1097/TA.0b013e3181b06364; Ertel W, 1995, INTEGRATED APPROACH, P78; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Fries D, 2006, HAMOSTASEOLOGIE, V26, P15; Frith D, 2010, SURG-J R COLL SURG E, V8, P159, DOI 10.1016/j.surge.2009.10.022; Gorlinger K, 2011, ANESTHESIOLOGY, V115, P1179, DOI 10.1097/ALN.0b013e31823497dd; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Innerhofer P., 2006, HAMOSTASEOLOGIE, V26, P3; Jackson CM, SCI STANDARDIZATION; Jansen JO, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1778; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lang T, 2006, HAMOSTASEOLOGIE S, V26, P21; Mica L, 2012, EUR J TRAUMA EMERG S, V38, P665, DOI 10.1007/s00068-012-0227-5; Mica Ladislav, 2013, J Trauma Manag Outcomes, V7, P6, DOI 10.1186/1752-2897-7-6; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Schmid P, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13213; Shubin NJ, 2011, CONTRIB MICROBIOL, V17, P108, DOI 10.1159/000324024; Sonntag J, 1998, TRANSFUSION MED, V8, P205; Sonntag J, 1997, TRANSFUSION, V37, P798, DOI 10.1046/j.1537-2995.1997.37897424401.x; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Szefner J, 2007, EUR J ANAESTH, V24, P59, DOI 10.1017/S0265021507000658; Theusinger OM, 2012, CURR OPIN CRIT CARE, V18, P661, DOI 10.1097/MCC.0b013e328357b209; Tsai HM, 2003, SEMIN THROMB HEMOST, V29, P479; Vincent JL, 2006, CRIT CARE, V10, DOI 10.1186/cc5026; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638	39	9	10	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	AUG	2016	34	8					1480	1485		10.1016/j.ajem.2016.04.041			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DS4LK	WOS:000380752400029	27260556				2022-02-06	
J	Hakim, S; Ahmed, K; El-Menyar, A; Jabbour, G; Peralta, R; Nabir, S; Mekkodathil, A; Abdelrahman, H; Al-Hassani, A; Al-Thani, H				Hakim, Suhail; Ahmed, Khalid; El-Menyar, Ayman; Jabbour, Gaby; Peralta, Ruben; Nabir, Syed; Mekkodathil, Ahammed; Abdelrahman, Husham; Al-Hassani, Ammar; Al-Thani, Hassan			Patterns and management of degloving injuries: a single national level 1 trauma center experience	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Degloving; Soft tissue injury; Debridement; Management; Trauma	VACUUM-ASSISTED CLOSURE; MOREL-LAVALLEE LESION	Background: Degloving soft tissue injuries (DSTIs) are serious surgical conditions. We aimed to evaluate the pattern, management and outcome of DSTIs in a single institute. Methods: A retrospective analysis was performed for patients admitted with DSTIs from 2011 to 2013. Presentation, management and outcomes were analyzed according to the type of DSTI. Results: Of 178 DSTI patients, 91 % were males with a mean age of 30.5 +/- 12.8. Three-quarter of cases was due to traffic-related injuries. Eighty percent of open DSTI cases were identified. Primary debridement and closure (62.9 %) was the frequent intervention used. Intermediate closed drainage under ultrasound guidance was performed in 7 patients; however, recurrence occurred in 4 patients who underwent closed serial drainage for recollection and ended with a proper debridement with or without vacuum assisted closure (VAC). Closed DSTIs were mainly seen in the lower extremity and back region and initially treated with conservative management as compared to open DSTIs. Infection and skin necrosis were reported in 9 cases only. Open DSTIs were more likely involving head and neck region and being treated by primary debridement/suturing and serial debridement/washout with or without VAC. All-cause DSTI mortality was 9 % that was higher in the closed DSTIs (19.4 vs 6.3 %; p = 0.01). Conclusion: The incidence of DSTIs is 4 % among trauma admissions over 3 years, with a greater predilection to males and young population. DSTIs are mostly underestimated particularly in the closed type that are usually missed at the initial presentation and associated with poor outcomes. Treatment guidelines are not well established and therefore further studies are warranted.	[Hakim, Suhail; Ahmed, Khalid; Jabbour, Gaby; Peralta, Ruben; Abdelrahman, Husham; Al-Hassani, Ammar; Al-Thani, Hassan] Hamad Gen Hosp, Trauma Surg Sect, Doha, Qatar; [El-Menyar, Ayman; Mekkodathil, Ahammed] Hamad Gen Hosp, Trauma Surg Sect, Clin Res, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Clin Med, Doha, Qatar; [Nabir, Syed] Hamad Gen Hosp, Dept Radiol, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Gen Hosp, Trauma Surg Sect, Clin Res, Doha, Qatar.; El-Menyar, A (corresponding author), Weill Cornell Med Coll, Clin Med, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015; Mekkodathil, Ahammed Abdulla/E-9629-2018	El-Menyar, Ayman/0000-0003-2584-953X; AHMED, KHALID/0000-0003-3576-0555; Mekkodathil, Ahammed Abdulla/0000-0001-8431-8937			Dimitrios Antoniou, 2005, EUR J TRAUMA EMERG S, V31, P593, DOI [10.1007/s00068-005-1059-3, DOI 10.1007/S00068-005-1059-3]; Dini M, 2012, INJURY, V43, P957, DOI 10.1016/j.injury.2011.03.020; El-Menyar A, 2015, TRAFFIC INJ PREV, V13, P1; Gilbert BC, 2004, AM J ROENTGENOL, V182, P1347, DOI 10.2214/ajr.182.5.1821347; Gummalla KM, 2014, ULUS TRAVMA ACIL CER, V20, P63, DOI 10.5505/tjtes.2014.88403; Hak DJ, 1997, J TRAUMA, V42, P1046, DOI 10.1097/00005373-199706000-00010; HUDSON DA, 1992, PLAST RECONSTR SURG, V89, P853, DOI 10.1097/00006534-199205000-00013; Khan Amir Taimur, 2004, J Coll Physicians Surg Pak, V14, P416; Kottmeier SA, 1996, CLIN ORTHOP RELAT R, P46; Krishnamoorthy R, 2011, Indian J Plast Surg, V44, P227, DOI 10.4103/0970-0358.85344; Latifi R, 2013, SOJ SURG, V1; Latifi Rifat, 2014, J Emerg Trauma Shock, V7, P228, DOI 10.4103/0974-2700.136870; Meara JG, 1999, ANN PLAS SURG, V42, P589, DOI 10.1097/00000637-199906000-00002; Mello Daniel Francisco, 2015, Rev. Col. Bras. Cir., V42, P143, DOI 10.1590/0100-69912015003003; Milcheski Dimas André, 2010, Rev. Col. Bras. Cir., V37, P199; Morris Melanie, 2009, J Trauma, V67, pE121, DOI 10.1097/TA.0b013e31803420be; Nickerson TP, 2014, J TRAUMA ACUTE CARE, V76, P493, DOI 10.1097/TA.0000000000000111; Wojcicki Piotr, 2011, Pol Przegl Chir, V83, P276, DOI 10.2478/v10035-011-0043-3; Wong LK, 2006, SOUTH MED J, V99, P628, DOI 10.1097/01.smj.0000217111.35160.09; Yan HD, 2013, J TRAUMA ACUTE CARE, V74, P604, DOI 10.1097/TA.0b013e31827d5e00	20	9	10	3	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	JUL 27	2016	11								35	10.1186/s13017-016-0093-2			8	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	DT8OY	WOS:000381751800001	27468300	Green Published, gold			2022-02-06	
J	Gamberger, D; Zenko, B; Mitelpunkt, A; Lavrac, N				Gamberger, Dragan; Zenko, Bernard; Mitelpunkt, Alexis; Lavrac, Nada		Alzheimer's Dis Neuroimaging	Homogeneous clusters of Alzheimer's disease patient population	BIOMEDICAL ENGINEERING ONLINE			English	Article; Proceedings Paper	3rd International Work-Conference on Bioinformatics and Biomedical Engineering (IWBBIO)	APR 15-17, 2015	Grenada, SPAIN	Univ Granada, CITIC, BioMed Cent, E Hlth Business Dev BULL S A, Univ Granada, Fac Sci, Dept Comp Architecture & Comp Technol		Alzheimer's disease; Clustering; Biomarker identification; Brain injuries	HEAD-INJURY	Background: Identification of biomarkers for the Alzheimer's disease (AD) is a challenge and a very difficult task both for medical research and data analysis. Methods: We applied a novel clustering tool with the goal to identify subpopulations of the AD patients that are homogeneous in respect of available clinical as well as in respect of biological descriptors. Results: The main result is identification of three clusters of patients with significant problems with dementia. The evaluation of properties of these clusters demonstrates that brain atrophy is the main driving force of dementia. The unexpected result is that the largest subpopulation that has very significant problems with dementia has besides mild signs of brain atrophy also large ventricular, intracerebral and whole brain volumes. Due to the fact that ventricular enlargement may be a consequence of brain injuries and that a large majority of patients in this subpopulation are males, a potential hypothesis is that such medical status is a consequence of a combination of previous traumatic events and degenerative processes. Conclusions: The results may have substantial consequences for medical research and clinical trial design. The clustering methodology used in this study may be interesting also for other medical and biological domains.	[Gamberger, Dragan] Rudjer Boskovic Inst, Bijenicka 54, Zagreb 10000, Croatia; [Zenko, Bernard; Lavrac, Nada] Jozef Stefan Inst, Ljubljana, Slovenia; [Mitelpunkt, Alexis] Tel Aviv Univ, Tel Aviv, Israel; [Lavrac, Nada] Univ Nova Gorica, Nova Gorica, Slovenia		Gamberger, D (corresponding author), Rudjer Boskovic Inst, Bijenicka 54, Zagreb 10000, Croatia.	dragan.gamberger@irb.hr			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG024904] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG024904] Funding Source: NIH RePORTER		Agrawal R., 1998, SIGMOD Record, V27, P94; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Doraiswamy PM, 2014, MOL PSYCHIATR, V19, P1044, DOI 10.1038/mp.2014.9; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Galili T, 2014, LECT NOTES ARTIF INT, V8777, P73, DOI 10.1007/978-3-319-11812-3_7; Gamberger D, 2015, LECT NOTES ARTIF INT, V9250, P57, DOI 10.1007/978-3-319-23344-4_6; Gamberger D, 2015, LECT N BIOINFORMAT, V9043, P134, DOI 10.1007/978-3-319-16483-0_13; Gamberger D, 2014, LECT NOTES ARTIF INT, V8777, P87, DOI 10.1007/978-3-319-11812-3_8; Gan G, 2007, ASA SIAM SER STAT AP, V20, P1, DOI 10.1137/1.9780898718348; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Langbaum JBS, 2009, NEUROIMAGE, V45, P1107, DOI 10.1016/j.neuroimage.2008.12.072; Parida L., 2005, P 20 NAT C ART INT P, P837; Pfahringer B., 2004, P WORKSH ADV IND RUL; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Shi T, 2006, J COMPUT GRAPH STAT, V15, P118, DOI 10.1198/106186006X94072; Smith G.E., 2013, MILD COGNITIVE IMPAI; von Luxburg U, 2012, JMLR WORKSH C P, V27, P65; Weiner MW, 2014, ALZHEIMERS DEMENT, V10, pS226, DOI 10.1016/j.jalz.2014.04.005; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005	21	9	9	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1475-925X		BIOMED ENG ONLINE	Biomed. Eng. Online	JUL 15	2016	15			1					S78	10.1186/s12938-016-0183-0			14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Engineering	DW5LI	WOS:000383686300009	27453981	gold, Green Published			2022-02-06	
J	Pretz, CR; Kean, J; Heinemann, AW; Kozlowski, AJ; Bode, RK; Gebhardt, E				Pretz, Christopher R.; Kean, Jacob; Heinemann, Allen W.; Kozlowski, Allan J.; Bode, Rita K.; Gebhardt, Eveline			A Multidimensional Rasch Analysis of the Functional Independence Measure Based on the National Institute on Disability, Independent Living, and Rehabilitation Research Traumatic Brain Injury Model Systems National Database	JOURNAL OF NEUROTRAUMA			English	Article						measurement; Rasch analysis; rehabilitation outcome; traumatic brain injury	SPINAL-CORD-INJURY; FIM; INSTRUMENT; VALIDITY; MOTOR	A number of studies have evaluated the psychometric properties of the Functional Independence Measure (FIM (TM)) using Rasch analysis, although none has done so using the National Institute on Disability, Independent Living, and Rehabilitation Research Traumatic Brain Injury Model Systems National Database, a longitudinal database that captures demographic and outcome information on persons with moderate to severe traumatic brain injury across the United States. In the current study, we examine the psychometric properties of the FIM as represented by persons within this database and demonstrate that the FIM comprises three subscales representing cognitive, self-care, and mobility domains. These subscales were analyzed simultaneously using a multivariate Rasch model in combination with a time dependent concurrent calibration scheme with the goal of creating a raw score-to-logit transformation that can be used to improve the accuracy of parametric statistical analyses. The bowel and bladder function items were removed because of misfit with the motor and cognitive items. Some motor items exhibited step disorder, which was addressed by collapsing Categories 1-3 for Toileting, Stairs, Locomotion, Tub/Shower Transfers; Categories 1 and 2 for Toilet and Bed Transfers; and Categories 2 and 3 for Grooming. The strong correlations (r = 0.82-0.96) among the three subscales suggest they should be modeled together. Coefficient alpha of 0.98 indicates high internal consistency. Keyform maps are provided to enhance clinical interpretation and application of study results.	[Pretz, Christopher R.] Craig Hosp, Englewood, CO 80113 USA; [Pretz, Christopher R.] Traumat Brain Injury Natl Stat & Data Ctr, Englewood, CO USA; [Kean, Jacob] Richard L Roudebush VA Med Ctr, Ctr Hlth Informat & Commun, Indianapolis, IN USA; [Kean, Jacob] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Heinemann, Allen W.; Bode, Rita K.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Med Sch, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Kozlowski, Allan J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Gebhardt, Eveline] Australian Council Educ Res, Camberwell, Vic, Australia		Pretz, CR (corresponding author), Craig Hosp, Res Dept, 3425 South Clarkson St, Englewood, CO 80113 USA.	cpretz@craighospital.org	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Kean, Jacob/0000-0002-8577-0586			Adams RJ, 1997, APPL PSYCH MEAS, V21, P1, DOI 10.1177/0146621697211001; Andrich D., 1988, RASCH MODELS MEASURE; Bode RK, 2014, ARCH PHYS MED REHAB, V95, P676, DOI 10.1016/j.apmr.2013.11.009; Bond T, 2001, APPL RASCH MODEL FUN; Boone W, 2014, RASCH ANAL HUMAN SCI; Briggs Derek C, 2003, J Appl Meas, V4, P87; Brock KA, 2002, ARCH PHYS MED REHAB, V83, P92, DOI 10.1053/apmr.2002.27348; Chen CC, 2002, ARCH PHYS MED REHAB, V83, P1514, DOI 10.1053/apmr.2002.35107; Dickson HG, 1996, SCAND J REHABIL MED, V28, P159; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Granger CV, 2000, CLIN REHABIL, V14, P110; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Lawton G, 2006, SPINAL CORD, V44, P746, DOI 10.1038/sj.sc.3101895; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lundgren-Nilsson A, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-55; Mallinson, 2011, RASCH MEAS T, V251, P1317; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Raiche G., 2005, RASCH MEASUREMENT T, V19, P1012, DOI DOI 10.1016/B978-012471352-9/50004-3; Wang W C, 1998, J Outcome Meas, V2, P240	20	9	9	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1358	1362		10.1089/neu.2015.4138			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100007	26559881	Green Submitted, Green Published			2022-02-06	
J	Geitona, M; Milioni, SO				Geitona, Mary; Milioni, Stella-Olga			Health status and access to health services of female prisoners in Greece: a cross-sectional survey	BMC HEALTH SERVICES RESEARCH			English	Article						Imprisonment; Female prisoners; Health status; Access to healthcare; Greece	SELF-REPORTED HEALTH; TRAUMATIC BRAIN-INJURY; WOMENS HEALTH; CARE; RISK; INCARCERATION; PREVALENCE; INMATES; WALES	Background: Self-reported health status of prisoners' population and access to health services during incarceration have not been adequately explored in Greece. The purpose of this study was to assess female prisoners' health status and access to healthcare in the Attica detention center "Korydallos". Methods: A cross-sectional survey was carried out in 2014. A semi-structured questionnaire was developed, including questions on the prisoners' socio-demographic characteristics, self-reported health status before and after incarceration, access to and quality of the provided health services. Inmates who were in solitary confinement, suffered from serious psychiatric problems, or were unable to understand the Greek language were excluded from the study. Data were collected via personal interviews and information received was anonymized. Descriptive statistics and bivariate analyses were used. The difference between self-reported general health status prior to and during detention was analyzed by Wilcoxon test, while the relationship between health status and access to healthcare was explored with coefficient Spearman's rho. Statistical significance was set at p = 0.05 level and statistical analysis was performed using the software SPSS 19. Results: Of the 135 prisoners, 101 participated in the study. 60.4 % mentioned a moderate or poor health status, while the respective percentage before detention was 32.7 %. Health status deterioration and poor mental health were reported by more than half of the respondents. Additionally, the vast majority expressed raised feelings such as sadness, anxiety or discomfort which affected negatively their everyday life while in prison. Regarding risk factors during imprisonment; tobacco consumption has increased by 16.6 % and 7.9 % of the sample admitted having used drugs. Moreover, the access to and the quality of provided health services in prison were described as poor/very poor by 46.5 % and 49. 5 %, respectively. A significant correlation between the access to and the quality of health care services and health status was observed. Conclusion: Healthcare provision at the "Korydallos" prison is not satisfying since the access to as well as the quality of healthcare are not adequate. Imprisonment leads to deterioration of self-reported health status. Our findings should constitute a starting point for further research in order to introduce more effective interventions aiming at meeting prisoners' health needs.	[Geitona, Mary; Milioni, Stella-Olga] Univ Peloponnese, Dept Social & Educ Policy, Damaskinou & Kolokotroni Str, Corinth 20100, Greece		Milioni, SO (corresponding author), Univ Peloponnese, Dept Social & Educ Policy, Damaskinou & Kolokotroni Str, Corinth 20100, Greece.	elinamil1@yahoo.gr	Geitona, Mary/AAZ-2346-2020				Aerts A, 2006, INT J TUBERC LUNG D, V10, P1215; Andersen HS, 2004, ACTA PSYCHIAT SCAND, V110, P4, DOI 10.1111/j.1600-0447.2004.00436_1.x; [Anonymous], 2010, IBM SPSS STAT WIND V; Bjorngaard JH, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-176; Brooker C., 2009, HLTH NEEDS ASSESSMEN; Butler T, 2004, AUST NZ J PUBL HEAL, V28, P344, DOI 10.1111/j.1467-842X.2004.tb00442.x; Butler T, 2008, AUST NZ J PUBL HEAL, V32, P73, DOI 10.1111/j.1753-6405.2008.00169.x; Carnie J, 2011, PRISON SURVEY; Christian J, 2006, J CRIM JUST, V34, P443, DOI 10.1016/j.jcrimjus.2006.05.010; COLSHER PL, 1992, AM J PUBLIC HEALTH, V82, P881, DOI 10.2105/AJPH.82.6.881; Conklin TJ, 2000, AM J PUBLIC HEALTH, V90, P1939, DOI 10.2105/AJPH.90.12.1939; Cornford C, 2007, SURVEY DELIVERY HLTH; Corston B. J., 2007, REPORT REV WOMEN PAR; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; DiCataldo F, 1995, B AM ACAD PSYCH LAW, V23, P573; Douglas N, 2006, HTLH NEEDS ASSESSMEN; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Feron JM, 2005, J EPIDEMIOL COMMUN H, V59, P651, DOI 10.1136/jech.2004.022269; Galea S, 2002, PUBLIC HEALTH REP, V117, pS135; Geitona Mary, 2007, Eur J Gen Pract, V13, P144, DOI 10.1080/13814780701541340; Greenberg GA, 2008, PSYCHIAT SERV, V59, P170, DOI 10.1176/ps.2008.59.2.170; Gupta S, 2009, J URBAN HEALTH, V86, P263, DOI 10.1007/s11524-008-9338-z; Harlow C.W., 1999, PRIOR ABUSE REPORTED; Harris F, 2007, HEALTH SOC CARE COMM, V15, P56, DOI 10.1111/j.1365-2524.2006.00662.x; Hawton K, 2014, LANCET, V383, P1147, DOI 10.1016/S0140-6736(13)62118-2; Kariminia A, 2007, MED J AUSTRALIA, V187, P387, DOI 10.5694/j.1326-5377.2007.tb01307.x; Kariminia A, 2007, AUST NZ J PUBL HEAL, V31, P366, DOI 10.1111/j.1753-6405.2007.00089.x; Kunst AE, 2005, INT J EPIDEMIOL, V34, P295, DOI 10.1093/ije/dyh342; Lee J, 2006, J HEALTH CARE POOR U, V17, P200, DOI 10.1353/hpu.2006.0028; Lindquist CH, 1999, J COMMUN HEALTH, V24, P285, DOI 10.1023/A:1018794305843; Macalino GE, 2005, AM J PUBLIC HEALTH, V95, P1739, DOI 10.2105/AJPH.2004.056291; Marshal T., 2000, HEALTHCARE PRISONS H; Marshall T, 2001, J EPIDEMIOL COMMUN H, V55, P364, DOI 10.1136/jech.55.5.364; Metzner JL, 1993, CRIM BEHAV MENT HEAL, V3, P252, DOI DOI 10.1002/CMB.1993.3.4.252; National GAINS Center, 1997, JUST FACTS SER; Nijhawan AE, 2010, J WOMENS HEALTH, V19, P17, DOI 10.1089/jwh.2009.1469; Nobile CGA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-529; Pinta ER, 1999, PREVALENCE SERIOUS M, V1, P33; Plugge E, 2006, HTLH WOMEN PRISON ST; President of the Hellenic Republic, 1999, HELLENIC GOVT NEWSPA, V291, P5123; Prison Reform Trust, 2012, WOM IN PRIS; Social Exclusion Task Force, 2009, SHORT STUD WOM OFF; Thomas JC, 2008, J URBAN HEALTH, V85, P90, DOI 10.1007/s11524-007-9231-1; van den Bergh BJ, 2011, B WORLD HEALTH ORGAN, V89, P689, DOI 10.2471/BLT.10.082842; van den Bergh BJ, 2009, B WORLD HEALTH ORGAN, V87, P406, DOI 10.2471/BLT.09.066928; Walmsley R, 2016, WORLD PRISON POPULAT; Walmsley R., 2012, WORLD FEMALE IMPRISO; Watson R, 2004, INT J NURS STUD, V41, P119, DOI 10.1016/S0020-7489(03)00128-7; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279; World Health Organization, 2009, WOM HLTH PRIS CORR G	53	9	13	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	JUL 11	2016	16								243	10.1186/s12913-016-1506-3			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	DQ8KI	WOS:000379459300003	27400658	Green Published, gold			2022-02-06	
J	Buchele, G; Rapp, K; Konig, HH; Jaensch, A; Rothenbacher, D; Becker, C; Benzinger, P				Buechele, Gisela; Rapp, Kilian; Koenig, Hans-Helmut; Jaensch, Andrea; Rothenbacher, Dietrich; Becker, Clemens; Benzinger, Petra			The Risk of Hospital Admission Due to Traumatic Brain Injury Is Increased in Older Persons With Severe Functional Limitations	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Traumatic brain injury; epidemiology; falls; nursing homes	ATRIAL-FIBRILLATION; FRACTURE RATES; HEAD-INJURIES; ADULTS; PEOPLE; ANTICOAGULATION; EPIDEMIOLOGY; PREVENTION; MANAGEMENT; OUTCOMES	Introduction: Hospital admissions due to traumatic brain injuries (TBIs) in older persons are increasing. Falls are the leading mechanism of injury in this age group. TBIs are associated with unfavorable outcomes such as mortality and institutionalization. Objectives: To estimate rates of TBIs in older persons with severe functional limitations, expressed as "care need," living in the community, and in older persons with care need living in nursing homes compared with older persons without care need. Participants: More than 1.2 million persons aged 65 years and older living in Bavaria, Germany, and insured with one of the largest German health insurances (health care and long-term care insurance). Methods: Age-standardized rates were calculated based on hospital claims data and claims data of the long-term care insurance and were compared between groups. The 3 groups were defined by claims data of the long-term care insurance. Results: TBI in older persons account for 4.8 hospital admissions per 1000 person-years. Overall TBI rates do not differ significantly between men and women. TBI rates are lowest in persons without care need and are highest for older persons living in nursing homes. Their contribution to the overall burden of TBI is lower than their contribution to the burden of fragility fractures. Conclusion: TBIs in older persons are common. Those with severe functional limitations are at increased risk for TBI. Nursing home residents have the highest rates of TBI. Fall prevention programs should seek to prevent not only fragility fractures but also head impact. (C) 2016 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Buechele, Gisela; Rapp, Kilian; Jaensch, Andrea; Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Rapp, Kilian; Becker, Clemens; Benzinger, Petra] Robert Bosch Krankenhaus Stuttgart, Dept Clin Gerontol, D-70376 Stuttgart, Germany; [Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany		Benzinger, P (corresponding author), Robert Bosch Krankenhaus, Auerbachstr 110, D-70376 Stuttgart, Germany.	petra.benzinger@rbk.de	Rapp, Kilian/AAJ-3370-2020; Konig, Hans-Helmut/P-1211-2018; Becker, Clemens/ABI-5405-2020	Rapp, Kilian/0000-0003-1625-2571; Konig, Hans-Helmut/0000-0001-5711-6862; Rothenbacher, Dietrich/0000-0002-3563-2791	Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [01EC1007A]	The analysis was funded by the Bundesministerium fur Bildung und Forschung (Forderkennzeichen: 01EC1007A).	Bahri O, 2015, J AM GERIATR SOC, V63, P71, DOI 10.1111/jgs.13200; Becker C, 1998, FACT RES INTERV GER, P55; Benzinger P, 2013, J AM MED DIR ASSOC, V14, P673, DOI 10.1016/j.jamda.2013.03.012; Brazinova A, 2015, AGE AGEING, V44, P502, DOI 10.1093/ageing/afu194; Camm AJ, 2012, EUR HEART J, V33; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Habib MA, 2014, SENSORS-BASEL, V14, P7181, DOI 10.3390/s140407181; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Jamieson LM, 2007, INJURY PREV, V13, P243, DOI 10.1136/ip.2007.015354; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000142, 10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022]; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kirchhof P, 2014, EUROPACE, V16, P6, DOI 10.1093/europace/eut263; Klenk J, 2013, Z GERONTOL GERIATR, V46, P720, DOI 10.1007/s00391-013-0554-0; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Pilote L, 2013, CAN J CARDIOL, V29, P1241, DOI 10.1016/j.cjca.2012.09.021; Pugh D, 2011, AGE AGEING, V40, P675, DOI 10.1093/ageing/afr097; Rapp K, 2012, AGE AGEING, V41, P653, DOI 10.1093/ageing/afs044; Rapp K, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.011; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z; Wolff A, 2015, AGE AGEING, V44, P874, DOI 10.1093/ageing/afv071	27	9	9	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	JUL 1	2016	17	7					609	612		10.1016/j.jamda.2016.02.032			4	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	DP5XE	WOS:000378570700009	27073040	Bronze			2022-02-06	
J	DeLoughery, E; Avery, B; DeLoughery, TG				DeLoughery, Emma; Avery, Brian; DeLoughery, Thomas G.			Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient	AMERICAN JOURNAL OF HEMATOLOGY			English	Article							PROTHROMBIN COMPLEX CONCENTRATE; RECOMBINANT FACTOR VIIA; INTERNATIONAL NORMALIZED RATIO; TRAUMATIC BRAIN-INJURY; ACTIVATED FACTOR-VII; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; REVERSAL; COAGULOPATHY; THERAPY	In case of severe bleeding, the physician must rapidly and effectively halt bleeding without the risk of thromboembolic complications. Despite widespread use, no study has directly compared recombinant activated factor VII (rFVIIa), the rFVIIa and 3-factor prothrombin complex concentrate (PCC) combination ("combination"), and 4-factor PCC on their effectiveness in improving patient outcomes. This study examined the medical records of 299 patients, 65.2% on warfarin prior to admission, who received these hemostatic agents and were admitted to an ICU or through the emergency department at Oregon Health & Science University. Mortality, length of stay, change in international normalized ratio (INR), plasma use, and number of thromboembolic complications were used to assess effectiveness. In patients receiving warfarin, the combination group had the greatest decrease in INR as well as lowest overall INR, but experienced a higher number of clotting complications, while the rFVIIa group used the most plasma. Non-warfarin patients in the combination group had the shortest length of stay among survivors, but the rFVIIa group had the lowest mortality. Based on this data, it may be prudent to further study the use of rFVIIa in treating extreme bleeding in the non-warfarin patient, while this study supports other data that 4-factor PCC may be the most prudent for the warfarin patient. (C) 2016 Wiley Periodicals, Inc.	[DeLoughery, Emma; Avery, Brian] Westminster Coll, Salt Lake City, UT USA; [DeLoughery, Emma; DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Med Oncol, Portland, OR 97201 USA; [DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Dept Pathol, Div Lab Med, Portland, OR 97201 USA; [DeLoughery, Thomas G.] Oregon Hlth & Sci Univ, Dept Pediat, Div Hematol Med Oncol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA		DeLoughery, TG (corresponding author), Oregon Hlth & Sci Univ, Hematol L586, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	delought@ohsu.edu			Westminster College Honors Program Summer Research Grant	Contract grant sponsor: Westminster College Honors Program Summer Research Grant.	Chapman SA, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-27; DeLoughery EP, 2011, BRIT J HAEMATOL, V152, P667, DOI 10.1111/j.1365-2141.2010.08437.x; Dickneite G, 2007, THROMB RES, V119, P643, DOI 10.1016/j.thromres.2006.05.011; Edavettal M, 2014, AM SURGEON, V80, P372; Elliott J, 2010, ANESTH ANALG, V110, P1419, DOI 10.1213/ANE.0b013e3181d568c8; Felton D, 2016, J EMERG MED, V50, P1, DOI 10.1016/j.jemermed.2015.07.001; Goldstein JN, 2015, LANCET, V385, P2077, DOI 10.1016/S0140-6736(14)61685-8; Goodnough LT, 2011, BLOOD, V117, P6091, DOI 10.1182/blood-2010-11-316075; Huynh TK, 2014, PHARMACOTHERAPY, V34, P260, DOI 10.1002/phar.1384; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Le Sache F, 2012, BRIT J ANAESTH, V108, P586, DOI 10.1093/bja/aer450; Logan AC, 2011, ANN INTERN MED, V154, P516, DOI 10.7326/0003-4819-154-8-201104190-00002; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Pragst I, 2010, THROMB RES, V125, P272, DOI 10.1016/j.thromres.2009.10.011; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Sarode R, 2012, J NEUROSURG, V116, P491, DOI 10.3171/2011.11.JNS11836; Schlunk F, 2012, STROKE, V43, P246, DOI 10.1161/STROKEAHA.111.629360; Sorensen B, 2003, BLOOD COAGUL FIBRIN, V14, P469, DOI 10.1097/00001721-200307000-00007; Zareh M, 2011, WEST J EMERG MED, V12, P386, DOI 10.5811/westjem.2011.3.2051	19	9	9	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	JUL	2016	91	7					705	708		10.1002/ajh.24384			4	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	DS0CC	WOS:000380261900017	27074566	Bronze			2022-02-06	
J	Lalou, DA; Czosnyka, M; Donnelly, J; Lavinio, A; Pickard, JD; Garnett, M; Czosnyka, Z				Lalou, Despina A.; Czosnyka, Marek; Donnelly, Joseph; Lavinio, Andrea; Pickard, John D.; Garnett, Matthew; Czosnyka, Zofia			Influence of general anaesthesia on slow waves of intracranial pressure	NEUROLOGICAL RESEARCH			English	Article						B-waves; Cerebrospinal fluid dynamics; General anaesthesia; Hydrocephalus	CEREBROSPINAL-FLUID PRESSURE; BLOOD-FLOW-VELOCITY; PLATEAU WAVES; SLEEP STAGES; B-WAVES; HYDROCEPHALUS; FLUCTUATIONS; REMIFENTANIL; PROPOFOL; DYNAMICS	Objective: Slow vasogenic intracranial pressure (ICP) waves are spontaneous ICP oscillations with a low frequency bandwidth of 0.3-4 cycles/min (B-waves). B-waves reflect dynamic oscillations in cerebral blood volume associated with autoregulatory cerebral vasodilation and vasoconstriction. This study quantifies the effects of general anaesthesia (GA) on the magnitude of B-waves compared to natural sleep and conscious state.Materials and methods: The magnitude of B-waves was assessed in 4 groups of 30 patients each with clinical indications for ICP monitoring. Normal pressure hydrocephalus patients undergoing Cerebrospinal Fluid (CSF) infusion studies in the conscious state (GROUP A) and under GA (GROUP B), and hydrocephalus patients undergoing overnight ICP monitoring during physiological sleep (GROUP C) were compared to deeply sedated traumatic brain injury (TBI) patients with well-controlled ICP during the first night of Intensive Care Unit (ICU) stay (GROUP D).Results: A total of 120 patients were included. During CSF infusion studies, the magnitude of slow waves was higher in conscious patients (GROUP A: 0.23+/-0.10mm Hg) when compared to anaesthetised patients (GROUP B: 0.15+/-0.10mm Hg; p=0.011). Overnight magnitude of slow waves was higher in patients during natural sleep (GROUP C: 0.20+/-0.13mm Hg) when compared to TBI patients under deep sedation (GROUP D: 0.11+/- 0.09mm Hg; p=0.002).Conclusion: GA and deep sedation are associated with a reduced magnitude of B-waves. ICP monitoring carried out under GA is affected by iatrogenic suppression of slow vasogenic waves of ICP. Accounting for the effects of anaesthesia on vasogenic waves may prevent the misidentification of potential shunt-responders as non-responders.	[Lalou, Despina A.; Czosnyka, Marek; Donnelly, Joseph; Pickard, John D.; Garnett, Matthew; Czosnyka, Zofia] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Lalou, Despina A.; Czosnyka, Marek; Donnelly, Joseph; Pickard, John D.; Garnett, Matthew; Czosnyka, Zofia] Addenbrookes Hosp, Div Neurosurg, Cambridge, England; [Lalou, Despina A.] Univ Athens, Sch Med, 72 Voutsina St, Athens 15561, Greece; [Lavinio, Andrea] Cambridge Univ Hosp NHS Fdn Trust, Dept Anesthesia, Neurosci Crit Care Unit, Cambridge, England		Lalou, DA (corresponding author), Univ Athens, Sch Med, 72 Voutsina St, Athens 15561, Greece.	alfadt.lalou@gmail.com	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018; Lavinio, Andrea/M-1778-2016; Lalou, Afroditi Despina/D-2938-2017	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Lalou, Afroditi Despina/0000-0003-3768-8681	National Institute of Health Research Senior Investigator Awards; National Institute of Health Research - CSF dynamics; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G0600986, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0001237, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	JDP is a recipient of National Institute of Health Research Senior Investigator Awards. MC is supported by National Institute of Health Research - CSF dynamics.	Balestreri M, 1996, ACTA NEUROCHIR WIEN, V138, P541; Balestreri M, 1996, ACTA NEUROCHIR WIEN, V138, P531; Burgess KR, 2013, J APPL PHYSIOL, V114, P1021, DOI 10.1152/japplphysiol.01462.2012; Burr RL, 2008, IEEE T BIO-MED ENG, V55, P2509, DOI 10.1109/TBME.2008.2001286; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; DROSTE DW, 1993, J NEUROL NEUROSUR PS, V56, P75, DOI 10.1136/jnnp.56.1.75; Eide PK, 2006, ACTA NEUROCHIR, V148, P1151, DOI 10.1007/s00701-006-0896-0; Eklund A, 2001, J NEUROSURG, V94, P392, DOI 10.3171/jns.2001.94.3.0392; Fodale V, 2008, ACTA ANAESTH SCAND, V52, P319, DOI 10.1111/j.1399-6576.2007.01566.x; Garcia M, 2013, MED ENG PHYS, V35, P1490, DOI 10.1016/j.medengphy.2013.04.002; Gavlak JC, 2013, ARCH DIS CHILD, V98, P356, DOI 10.1136/archdischild-2012-302512; Girard F, 2009, ANESTH ANALG, V109, P194, DOI 10.1213/ane.0b013e3181a3ea3a; Haubrich C, 2007, STROKE, V38, P2677, DOI 10.1161/STROKEAHA.107.485847; Higashi S, 1989, INTRACRANIAL PRESSUR, V12, P220; Kasprowicz Magdalena, 2012, Acta Neurochir Suppl, V114, P29, DOI 10.1007/978-3-7091-0956-4_6; Klimscha W, 2003, ANESTHESIOLOGY, V99, P834, DOI 10.1097/00000542-200310000-00014; KRAUSS JK, 1995, ACTA NEUROCHIR, V136, P195, DOI 10.1007/BF01410626; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; Lescot T, 2005, ACTA NEUROCHIR, V147, P125, DOI 10.1007/s00701-004-0355-8; Newell DW, 1991, 8 INT S INTR PRESS R, P16; NILSSON C, 1992, AM J PHYSIOL, V262, pR20, DOI 10.1152/ajpregu.1992.262.1.R20; Penzel T, 2003, NEUROPSYCHOPHARMACOL, V28, pS48, DOI 10.1038/sj.npp.1300146; Penzel T, 2009, CURR OPIN ANESTHESIO, V22, P547; Petersen KD, 2003, ANESTHESIOLOGY, V98, P329, DOI 10.1097/00000542-200302000-00010; Petrella G, 2008, ACTA NEUROL SCAND, V118, P182, DOI 10.1111/j.1600-0404.2008.01041.x; Pickard J.D., 1980, INTRACRANIAL PRESSUR, P498; Razavi M, 2008, J MAGN RESON IMAGING, V27, P891, DOI 10.1002/jmri.21283; RISBERG J, 1969, J NEUROSURG, V31, P303, DOI 10.3171/jns.1969.31.3.0303; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Scollato A, 2016, ACTA NEUROL SCAND, V133, P75, DOI 10.1111/ane.12419; Stephensen H, 2005, J NEUROL NEUROSUR PS, V76, P965, DOI 10.1136/jnnp.2004.039834; Swallow DMA, 2014, ACTA NEUROL SCAND, V130, P131, DOI 10.1111/ane.12246; Weerakkody RA, 2010, ACTA NEUROCHIR, V152, P1763, DOI 10.1007/s00701-010-0748-9	33	9	9	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	2016	38	7					587	592		10.1080/01616412.2016.1189200			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS6OT	WOS:000380902200005	27278507	Green Accepted			2022-02-06	
J	Liao, S; Lynall, RC; Mihalik, JP				Liao, Steven; Lynall, Robert C.; Mihalik, Jason P.			The Effect of Head Impact Location on Day of Diagnosed Concussion in College Football	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						HEAD IMPACT BIOMECHANICS; HIT SYSTEM; BRAIN INJURY; CONCUSSION RISK FACTORS	HIGH-SCHOOL; PLAYERS; EXPOSURE; FATALITIES; INJURIES; SPORTS	Introduction: Scientists and clinicians have attempted to identify and understand biomechanical factors that influence concussion likelihood. The effect of impact frequency to a given head location before the concussion has not been evaluated. The purpose of this study was to compare the frequency of impacts to a given head location on days of diagnosed concussion to the frequency of impacts to a given head location before kinematically matched nonconcussive impacts. Methods: Head impact data were gathered from 33 Division I National Collegiate Athletic Association football players. Twenty-four concussions were identified and matched with impacts of similar kinematic and injury criterion values (linear acceleration, rotational acceleration, Gadd severity index, and head injury criterion) that occurred during the same event type (game, practice, or scrimmage). In addition, these same matching criteria were used to match all players to the closest kinematic/same player group. All impacts within a session before the impact of interest (concussive or matched impact) were analyzed. Results: On days of diagnosed concussion, the concussive group sustained a lower percentage of impacts to the front of the head (34.5%) and a greater frequency of impacts to the sides (19.6%) and top (18.9%) of the head (chi(2)(3) = 10.23, P = 0.017) as compared with the matched nonconcussive group (front = 42.5%, sides = 16.6%, top = 14.0%). No significant difference in frequency was found in impacts to the back of the head. Conclusion: It may be more difficult to mitigate concussive forces sustained in impacts to the top and sides of the head than the front of the head. These findings fall in line with previous research demonstrating that reduced impact magnitudes may lessen concussion risk. Studying appropriate training paradigms to develop safer playing techniques on the field is warranted.	[Liao, Steven; Lynall, Robert C.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Lynall, Robert C.; Mihalik, Jason P.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC USA		Mihalik, JP (corresponding author), 2201 Stallings Evans Campus Box 8700, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	Centers for Disease Control and Prevention's National Centers for Injury Prevention and Control [5-R49-CE000196]; National Operating Committee on Standards for Athletic Equipment; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000196] Funding Source: NIH RePORTER	This study was made possible with data collection previously funded by grants from the Centers for Disease Control and Prevention's National Centers for Injury Prevention and Control to The University of North Carolina at Chapel Hill Injury Prevention Research Center (5-R49-CE000196) and the National Operating Committee on Standards for Athletic Equipment. The opinions expressed herein are those of the authors and do not necessarily reflect the opinions of the CDC/NCIPC or NOCSAE. The authors have no conflicts of interest to report, and none of the authors have any financial interest in any of the equipment used in this study. The results of the present study do not constitute endorsement by the American College of Sports Medicine.	Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Covassin T, 2003, J ATHL TRAINING, V38, P238; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; MUELLER FO, 1990, MED SCI SPORT EXER, V22, P737, DOI 10.1249/00005768-199012000-00001; Torg J S, 1979, Am J Sports Med, V7, P127; Torg JS, 2002, J BONE JOINT SURG AM, V84A, P112, DOI 10.2106/00004623-200201000-00017	25	9	9	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUL	2016	48	7					1239	1243		10.1249/MSS.0000000000000896			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DO9CQ	WOS:000378082300002	26871990				2022-02-06	
J	Mallinson, T; Pape, TLB; Guernon, A				Mallinson, Trudy; Pape, Theresa Louise-Bender; Guernon, Ann			Responsiveness, Minimal Detectable Change, and Minimally Clinically Important Differences for the Disorders of Consciousness Scale	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; disorders of consciousness; outcome measures; rehabilitation	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; LONG-TERM DISABILITY; INTERRATER RELIABILITY; VEGETATIVE STATE; UNITED-STATES; SCORES	Objectives: To determine the responsiveness, minimal detectable change (MDC95), and minimally clinically important difference (MCID) of the Disorders of Consciousness Scale (DOCS-25) in patients with severe traumatic brain injury (TBI) and to report the percentages of patients' change scores exceeding MDC and MCID after 3 weeks of inpatient rehabilitation. Setting: Post-acute rehabilitation hospitals. Participants: One hundred seventy-two patients with severe TBI. Ninety-two were included in the DOCS-25 3-week analysis. Design: Retrospective cohort study. Main Measure(s): Disorders of Consciousness Scale, Glasgow Coma Scale. Results: The effect size and standardized response mean of the DOCS-25 for those who improved were 0.45 and 1.3, respectively-moderate to large by Cohen criteria. The MDC95 (95% confidence interval) was 5.6. Distribution-based MCIDs for small (0.20 SD), moderate (0.33 SD), and large (0.50 SD) differences were 2.6 units, 4.4 units, and 6.6 units, respectively. The anchor-based MCID was 8.6 units. On average, patients who improved (n = 57) gained 14.5 units by week 3, exceeding the anchor-based MCID. On average, patients who did not improve (n = 35) declined by 7.2 units, which exceeds both the MDC95 and the largest distribution-based MCID. Conclusion(s): The DOCS-25 is a responsive, clinician-observed assessment tool for capturing change in neurobehavioral function in adults recovering from severe TBI. This is the first study to provide evidence for the size of neurobehavioral function change that might indicate meaningful recovery in patients with severe TBI. Results from this study may support future research by better informing sample size calculations for clinical trials and also assist clinicians in identifying when variation in level of consciousness is consequential enough to warrant changes in intervention.	[Mallinson, Trudy] George Washington Univ, Sch Med & Hlth Sci, 2100 Penn Ave,Rm 318, Washington, DC 20037 USA; [Pape, Theresa Louise-Bender; Guernon, Ann] Hines VA Hosp, Dept Vet Affairs, Res Serv, Hines, IL USA; [Pape, Theresa Louise-Bender; Guernon, Ann] Ctr Innovat Complex Chron Healthcare & Res Serv, Hines, IL USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Guernon, Ann] Marianjoy Rehabil Hosp, Res Dept, Wheaton, IL USA		Mallinson, T (corresponding author), George Washington Univ, Sch Med & Hlth Sci, 2100 Penn Ave,Rm 318, Washington, DC 20037 USA.	trudy@gwu.edu	Mallinson, Trudy/S-7381-2019	Mallinson, Trudy/0000-0002-4888-5579; Bender Pape, Theresa/0000-0001-7738-5963	Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development merit grantUS Department of Veterans Affairs [CCN 07-133-1]; Rehabilitation Research and Development Career Development Transition Award [B4949N]	This study was funded by Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development merit grant #CCN 07-133-1 and Rehabilitation Research and Development Career Development Transition Award #B4949N to T. Pape. The authors thank the study participants and their families and the Nick Kot Chartiy for TBI (www.nkc4tbi.com) for their ongoing support of severe TBI research.	American Academy of Neurology, 1995, PRACT PAR ASS MAN PA; Andrews K, 1999, POSTGRAD MED J, V75, P321, DOI 10.1136/pgmj.75.884.321; Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; Andrews K, 1990, COMA EMERGING PATIEN, P389; [Anonymous], 2014, MEDCALC STAT SOFTW 1; Barlow P, 2012, SURG-J R COLL SURG E, V10, P114, DOI 10.1016/j.surge.2011.12.003; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; Eton DT, 2004, J CLIN EPIDEMIOL, V57, P898, DOI 10.1016/j.jclinepi.2004.01.012; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hays RD, 2000, PHARMACOECONOMICS, V18, P419, DOI 10.2165/00019053-200018050-00001; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; King MT, 2011, EXPERT REV PHARM OUT, V11, P171, DOI [10.1586/ERP.11.9, 10.1586/erp.11.9]; Klein AM, 2013, J NEUROTRAUM, V30, P1476, DOI 10.1089/neu.2012.2735; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; Lin KC, 2010, NEUROREHAB NEURAL RE, V24, P486, DOI 10.1177/1545968309356295; Mallinson T, 2004, MED CARE, V42, P17, DOI 10.1097/01.mlr.0000103522.78233.c3; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; Norman GR, 2007, QUAL LIFE RES, V16, P815, DOI 10.1007/s11136-007-9180-x; Norman Geoffrey R, 2005, COPD, V2, P69; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pape T., 2011, DISORDERS CONSCIOUSN; Pape T, 2014, TXB NEURA RAPIR REHA, P385; Pape TLB, 2014, ARCH PHYS MED REHAB, V95, P1672, DOI 10.1016/j.apmr.2014.04.015; Pape TLB, 2013, REHABIL PSYCHOL, V58, P253, DOI 10.1037/a0032610; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; StataCorp, 2013, STAT STAT SOFTW REL; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Streiner DL., 2008, HLTH MEASUREMENT SCA; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Terwee CB, 2003, QUAL LIFE RES, V12, P349, DOI 10.1023/A:1023499322593; Turner D, 2010, J CLIN EPIDEMIOL, V63, P28, DOI 10.1016/j.jclinepi.2009.01.024; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; 1987, FACETS MANY FACETED	50	9	9	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					E43	E51		10.1097/HTR.0000000000000184			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000005	26360003				2022-02-06	
J	del Palacio, JP; Diaz, C; de la Cruz, M; Annang, F; Martin, J; Perez-Victoria, I; Gonzalez-Menendez, V; de Pedro, N; Tormo, JR; Algieri, F; Rodriguez-Nogales, A; Rodriguez-Cabezas, ME; Reyes, F; Genilloud, O; Vicente, F; Galvez, J				Perez del Palacio, Jose; Diaz, Caridad; de la Cruz, Mercedes; Annang, Frederick; Martin, Jesus; Perez-Victoria, Ignacio; Gonzalez-Menendez, Victor; de Pedro, Nuria; Tormo, Jose R.; Algieri, Francesca; Rodriguez-Nogales, Alba; Elena Rodriguez-Cabezas, M.; Reyes, Fernando; Genilloud, Olga; Vicente, Francisca; Galvez, Julio			High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries	JOURNAL OF BIOMOLECULAR SCREENING			English	Article						immune response; inflammation; neurodegenerative diseases; natural products; high-throughput screening	NF-KAPPA-B; NEURODEGENERATIVE DISEASES; DRUG DISCOVERY; IN-VITRO; EXPRESSION; (-)-TAN-2483A; MACROPHAGES; ACTIVATION; REVISION; CELLS	It is widely accepted that central nervous system inflammation and systemic inflammation play a significant role in the progression of chronic neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, neurotropic viral infections, stroke, paraneoplastic disorders, traumatic brain injury, and multiple sclerosis. Therefore, it seems reasonable to propose that the use of anti-inflammatory drugs might diminish the cumulative effects of inflammation. Indeed, some epidemiological studies suggest that sustained use of anti-inflammatory drugs may prevent or slow down the progression of neurodegenerative diseases. However, the anti-inflammatory drugs and biologics used clinically have the disadvantage of causing side effects and a high cost of treatment. Alternatively, natural products offer great potential for the identification and development of bioactive lead compounds into drugs for treating inflammatory diseases with an improved safety profile. In this work, we present a validated high-throughput screening approach in 96-well plate format for the discovery of new molecules with anti-inflammatory/immunomodulatory activity. The in vitro models are based on the quantitation of nitrite levels in RAW264.7 murine macrophages and interleukin-8 in Caco-2 cells. We have used this platform in a pilot project to screen a subset of 5976 noncytotoxic crude microbial extracts from the MEDINA microbial natural product collection. To our knowledge, this is the first report on an high-throughput screening of microbial natural product extracts for the discovery of immunomodulators.	[Perez del Palacio, Jose; Diaz, Caridad; de la Cruz, Mercedes; Annang, Frederick; Martin, Jesus; Perez-Victoria, Ignacio; Gonzalez-Menendez, Victor; de Pedro, Nuria; Tormo, Jose R.; Reyes, Fernando; Genilloud, Olga; Vicente, Francisca] Fdn MEDINA, Parque Tecnol Ciencias Salud,Ave Conocimiento 34, Granada 18016, Spain; [Algieri, Francesca; Rodriguez-Nogales, Alba; Elena Rodriguez-Cabezas, M.; Galvez, Julio] Univ Granada, Dept Pharmacol, CIBER EHD, Ibs Granada,Ctr Biomed Res CIBM, Granada, Spain		del Palacio, JP (corresponding author), Fdn MEDINA, Parque Tecnol Ciencias Salud,Ave Conocimiento 34, Granada 18016, Spain.	jose.perezdelpalacio@medinaandalucia.es	DE LA CRUZ MORENO, MERCEDES/M-1533-2014; Genilloud, Olga/I-2779-2015; Algieri, Francesca F/J-4281-2017; Rodriguez-Nogales, Alba/J-2782-2017; Reyes, Fernando/G-4027-2013; rodriguez-cabezas, maria elena/L-3086-2014; Martin-Serrano, Jesus/M-1937-2014; Algieri, Francesca/L-3231-2014; Tormo, Jose R/M-1044-2014	DE LA CRUZ MORENO, MERCEDES/0000-0002-2389-8576; Genilloud, Olga/0000-0002-4202-1219; Rodriguez-Nogales, Alba/0000-0003-1927-0628; Reyes, Fernando/0000-0003-1607-5106; rodriguez-cabezas, maria elena/0000-0001-9085-8147; Martin-Serrano, Jesus/0000-0001-7487-2790; Algieri, Francesca/0000-0002-0262-4867; Diaz Navarro, Caridad/0000-0003-1240-0143; Gonzalez-Menendez, Victor/0000-0001-9859-6284	Spanish Ministry of Economy and CompetitivenessSpanish Government [SAF2011-29648]; Junta de AndaluciaJunta de Andalucia [AGR-6826, CTS 164]; European UnionEuropean Commission; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission; Fundacion MEDINA, a public-private partnership of Merck Sharp & Dohme de Espana S.A./Universidad de Granada/Junta de Andalucia; Ministerio de Ciencia e InnovacionInstituto de Salud Carlos IIISpanish GovernmentEuropean Commission; European UnionEuropean Commission [INP-2011-0016-PCT-010000-ACT6]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2011-29648) and the Junta de Andalucia (AGR-6826 and CTS 164) with funds from the European Union. F. Algieri is a predoctoral fellow of the Junta de Andalucia; M. E. Rodriguez-Cabezas is a postdoctoral fellow of CIBER-EHD. The CIBER-EHD is funded by the Instituto de Salud Carlos III. The MEDINA authors disclosed the receipt of financial support from Fundacion MEDINA, a public-private partnership of Merck Sharp & Dohme de Espana S.A./Universidad de Granada/Junta de Andalucia. Moreover, some of the equipment used in this work was supported by the Ministerio de Ciencia e Innovacion and European Union (grant INP-2011-0016-PCT-010000-ACT6).	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Annang F, 2015, J BIOMOL SCREEN, V20, P82, DOI 10.1177/1087057114555846; Audoin C, 2013, MAR DRUGS, V11, P1477, DOI 10.3390/md11051477; Bills GF, 2012, MYCOLOGIA, V104, P962, DOI 10.3852/12-003; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/512926; Domling A, 2012, CHEM REV, V112, P3083, DOI 10.1021/cr100233r; Dusting GJ, 1999, BRIT J PHARMACOL, V128, P337, DOI 10.1038/sj.bjp.0702782; Elsayed EA, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/805841; Falconer M, 2002, J BIOMOL SCREEN, V7, P460, DOI 10.1177/108705702237678; Gao XL, 2004, J ORG CHEM, V69, P5517, DOI 10.1021/jo0358628; Gao XL, 2003, ORG LETT, V5, P451, DOI 10.1021/ol0273405; Garrido-Mesa N., 2010, PHARM RES, V63, P308, DOI DOI 10.1016/J.PHRS.2010.12.011; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Gibson GE, 2002, NEUROCHEM INT, V40, P493, DOI 10.1016/S0197-0186(01)00120-6; Hayashi K., 1998, Japanese Patent, Patent No. [JP 102876- 79, 10287679]; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Korhonen R, 2002, MOL PHARMACOL, V62, P698, DOI 10.1124/mol.62.3.698; Kwon DJ, 2014, BMB REP, V47, P318, DOI 10.5483/BMBRep.2014.47.6.200; Lee JA, 2015, BRIT J PHARMACOL, V172, P1087, DOI 10.1111/bph.12973; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Miller TM, 2005, SCIENCE, V307, P361, DOI 10.1126/science.1109027; Nishitani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062441; Ogasawara Y, 2008, J ANTIBIOT, V61, P496, DOI 10.1038/ja.2008.66; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Ramos S, 2011, TOXICOL IN VITRO, V25, P1771, DOI 10.1016/j.tiv.2011.09.007; Seo JY, 2009, J PHYSIOL PHARMACOL, V60, P101; Stewart AM, 2010, J ORG CHEM, V75, P6057, DOI 10.1021/jo101408s; Tan J, 2000, J BIOL CHEM, V275, P37224, DOI 10.1074/jbc.M002006200; WANG R, 1995, DEV COMP IMMUNOL, V19, P327, DOI 10.1016/0145-305X(95)00018-O; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	9	9	0	27	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0571	1552-454X		J BIOMOL SCREEN	J. Biomol. Screen	JUL	2016	21	6					567	578		10.1177/1087057116635517			12	Biochemical Research Methods; Biotechnology & Applied Microbiology; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry	DR1WF	WOS:000379694900005	26962874				2022-02-06	
J	Strosberg, DS; Nguyen, MC; Mostafavifar, L; Mell, H; Evans, DC				Strosberg, David S.; Nguyen, Michelle C.; Mostafavifar, Lisa; Mell, Howard; Evans, David C.			Development of a Prehospital Tranexamic Acid Administration Protocol	PREHOSPITAL EMERGENCY CARE			English	Article						prehospital trauma care; tranexamic acid	TRAUMATIC BRAIN-INJURY; COAGULOPATHY; TRANSFUSION; MANAGEMENT	Objective: Early administration of tranexamic acid (TXA) has been shown to reduce all-cause mortality and death secondary to trauma. Our objective was to develop a collaborative prehospital TXA administration protocol between a ground EMS and academic medical center. Methods: Physicians, pharmacists, and EMS and fire department personnel developed a prehospital TXA administration protocol between a local fire and EMS center with a Midwest tertiary care health system based on results from the CRASH-2 Trial. The protocol was initiated March 27, 2013 and the first dose of TXA was administered in September 2013. Results: Since September 2013, nineteen trauma patients received TXA. Survival rate was 89% (17/19); 2 patients expired immediately following arrival to the trauma bay. Seven patients did not receive the in-hospital maintenance dose due to the following: 3/7 (43%) due to miscommunication of pre-TXA administration; 2/7 (29%) did not meet inclusion criteria for TXA protocol; 1/7 (14%) due to protocol noncompliance; 1/7 (14%) due to a chaotic situation with an unstable patient. Conclusions: Prehospital TXA protocol based on the CRASH-2 trial is safe and feasible. The first dose of TXA administered under this protocol marks the first ground EMS administration in the USA. Conceivably, this will pose as a model to other trauma centers that receive patients from outlying areas without immediate access to care. Large multi-institutional analyses need to be performed to evaluate survival benefits of prehospital TXA administration protocol.	[Strosberg, David S.; Nguyen, Michelle C.; Mostafavifar, Lisa] Ohio State Univ, Wexner Med Ctr, 395 W 12th Ave,Suite 654, Columbus, OH 43210 USA; [Mell, Howard] Wake Forest Baptist Hlth, Winston Salem, NC USA		Strosberg, DS (corresponding author), Ohio State Univ, Wexner Med Ctr, 395 W 12th Ave,Suite 654, Columbus, OH 43210 USA.	david.strosberg@osumc.edu		Evans, David/0000-0001-7366-3567; Nguyen, Michelle/0000-0003-4827-6367			Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brown JB, 2015, PREHOSP EMERG CARE, V19, P79, DOI 10.3109/10903127.2014.936635; Cap AP, 2011, J TRAUMA, V71, pS9, DOI 10.1097/TA.0b013e31822114af; Centers for Disease Control and Prevention, 2010, LEAD CAUS DEATH; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Mayo Clinic, HEL MAYO ON; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Porta CR, 2013, J TRAUMA ACUTE CARE, V75, P954, DOI 10.1097/TA.0b013e31829e20bf; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Toner RW, 2011, APPL HEALTH ECON HEA, V9, P29, DOI 10.2165/11530740-000000000-00000; World Health Organization, 2015, TRAN AC INCL	19	9	9	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JUL-AUG	2016	20	4					462	466		10.3109/10903127.2015.1128033			5	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	DS9LG	WOS:000381103900004	26930273				2022-02-06	
J	Zhu, YF; Yin, HY; Zhang, R; Ye, XL; Wei, JR				Zhu, Youfeng; Yin, Haiyan; Zhang, Rui; Ye, Xiaoling; Wei, Jianrui			Therapeutic hypothermia versus normothermia in adult patients with traumatic brain injury: a meta-analysis	SPRINGERPLUS			English	Article						Therapeutic hypothermia; Traumatic brain injury; Mortality; Adult; Meta-analysis	MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; HEAD	Introduction: Many single-center studies and meta-analyses demonstrate that therapeutic hypothermia (TH), in which the body temperature is maintained at 32-35 degrees C, exerts significant neuroprotection and attenuates secondary intracranial hypertension after traumatic brain injury (TBI). In 2015, two well-designed multi-center, randomized controlled trials were published that did not show favorable outcomes with the use of TH in adult patients with TBI compared to normothermia treatment (NT). Therefore, we performed an updated meta-analysis to assess the effect of TH in adult patients with TBI. Methods: We reviewed the PubMed, EMbase, Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, and Wanfang Databases. We included randomized controlled trials that compared TH and NT in adult patients with TBI. Two reviewers assessed the quality of each study and independently collected the data. We performed the meta-analysis using the Cochrane Collaboration's RevMan 5.3 software. Results: We included 18 trials involving 2177 patients with TBI. There was no significant heterogeneity among the studies. TH could not decrease mortality at 3 months post-TBI (RR 0.95; 95 % CI 0.59, 1.55; z = 0.19, P = 0.85) or 6 months post-TBI (RR 0.96; 95 % CI 0.76, 1.23; z = 0.29, P = 0.77). There were no significant differences in unfavorable clinical outcomes when TH was compared to NT at 3 months post-TBI (RR 0.79; 95 % CI 0.56, 1.12; z = 1.31, P = 0.19) or 6 months post-TBI (RR 0.80; 95 % CI 0.63, 1.00; z = 1.92, P = 0.05). TH was associated with a significant increase in pneumonia (RR 1.51; 95 % CI 1.12, 2.03; z = 2.72, P = 0.006) and cardiovascular complications (RR 1.75; 95% CI 1.14, 2.70; z = 2.54, P = 0.01). Conclusions: Therapeutic hypothermia failed to demonstrate a decrease in mortality and unfavorable clinical outcomes at 3 or 6 months post-TBI. Additionally, TH might increase the risk of developing pneumonia and cardiovascular complications.	[Wei, Jianrui] Jinan Univ, Coll Med, Dept Cardiol, Guangzhou Red Cross Hosp, Guangzhou 510220, Guangdong, Peoples R China; [Zhu, Youfeng; Yin, Haiyan; Zhang, Rui; Ye, Xiaoling; Wei, Jianrui] Jinan Univ, Coll Med, Guangzhou Red Cross Hosp, Dept Intens Care Unit, Tongfuzhong Rd 396, Guangzhou 510220, Guangdong, Peoples R China		Wei, JR (corresponding author), Jinan Univ, Coll Med, Dept Cardiol, Guangzhou Red Cross Hosp, Guangzhou 510220, Guangdong, Peoples R China.	Jianruiw@163.com	Zhu, Youfeng/ABB-1394-2020	Zhu, Youfeng/0000-0001-6793-5511			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Hashiguchi N, 2003, J TRAUMA, V55, P1054, DOI 10.1097/01.TA.0000033252.43742.8B; Holzer M, 2013, BEST PRACT RES-CLIN, V27, P335, DOI 10.1016/j.bpa.2013.07.003; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Lee HC, 2010, WORLD NEUROSURG, V74, P654, DOI 10.1016/j.wneu.2010.06.019; Lee K, 2015, KOREAN J ANESTHESIOL, V68, P523, DOI 10.4097/kjae.2015.68.6.523; Li PC, 2014, BRAIN INJURY, V28, P1036, DOI 10.3109/02699052.2014.910609; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Mtaweh H, 2014, PEDIATR CRIT CARE ME, V15, P242, DOI 10.1097/PCC.0000000000000041; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; SYDENHAM E, 2009, COCHRANE DB SYST REV, V1; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Woo JH, 2014, AM J EMERG MED, V32, P150, DOI 10.1016/j.ajem.2013.10.035; Yan Y, 2001, Chin J Traumatol, V4, P8; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	35	9	10	0	12	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	JUN 21	2016	5								801	10.1186/s40064-016-2391-2			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP4OE	WOS:000378474400015	27390642	Green Published, gold			2022-02-06	
J	Winter, L; Moriarty, H; Robinson, KM; Newhart, B				Winter, Laraine; Moriarty, Helene; Robinson, Keith M.; Newhart, Brian			Rating competency in everyday activities in patients with TBI: clinical insights from a close look at patient-family differences	DISABILITY AND REHABILITATION			English	Article						traumatic brain injury; family; Caregivers; competence in activities; veterans	TRAUMATIC BRAIN-INJURY; COMMUNITY REINTEGRATION; SELF; SYMPTOMS; REHABILITATION; DEPRESSION; CAREGIVER; VETERANS; SEQUELAE; SOLDIERS	Purpose: Families of patients with traumatic brain injury (TBI) often perceive patients' functional capabilities differently from patients themselves. Research documents inconsistent findings regarding direction of differences. Differences have implications for family support and are germane to clinicians' treatment planning during rehabilitation. We compared two analytic approaches to patient-family differences in ratings of 30 functional tasks: (a) comparing patients' and families' mean scores in domains derived from factor analysis versus (b) examining differences on a task-by-task basis. Method: In-home interviews were conducted with 83 outpatients with TBI at a Veteran Affairs polytrauma clinic and for each a family member, using the Patient Competency Rating Scale with both. Results: Principal components analysis identified three functional domains - cognitive, interpersonal/emotional and physical - with significant patient-family differences in the cognitive domain only (family competency ratings were higher). By contrast, task-by-task examination showed significant veteran-family differences in 12 items, mostly in interpersonal/emotional functioning, with mixed directions of differences. The task-by-task approach thus revealed a different picture of patient-family differences than examination by functional domains. Conclusions: Grouping tasks by domains may obscure important differences in functional ratings. Examination of patient-family differences by task has clinical applications for helping patients and families to manage TBI symptoms and for treatment planning. Implications for Rehabilitation Differences in functional capacity ratings by patients with TBI and their family members are not well understood, with past research demonstrating inconsistencies in direction of difference. Differences in ratings may affect family relationships and may inform clinicians' treatment plans. The study showed that different approaches to analyzing the same data yield two distinct pictures of patient-family differences. Examining patient-family differences by specific tasks is clinically meaningful. The Competency Rating Scale could be used as a clinical tool with patients and families. Its use may improve family understanding of the patient's strengths and struggles and also guide treatment planning.	[Winter, Laraine; Moriarty, Helene] Dept Vet Affairs Med Ctr, Nursing Serv, Philadelphia, PA 19104 USA; [Winter, Laraine] Philadelphia Res & Educ Fdn, Dept Vet Affairs Med Ctr, Philadelphia, PA USA; [Moriarty, Helene] Villanova Univ, Coll Nursing, Villanova, PA 19085 USA; [Robinson, Keith M.; Newhart, Brian] Polytrauma Network Site Vet Integrated Serv Netwo, Rehabil Med Serv, Philadelphia, PA USA; [Robinson, Keith M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Winter, L (corresponding author), Philadelphia Vet Affairs Med Ctr, Univ & Woodland Ave, Philadelphia, PA 19104 USA.	laraine.winter@gmail.com			NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR018655] Funding Source: Medline		ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Barrett RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076916; Boszormenji-Nagy I, 1973, INVISIBLE LOYALTIES; Cannon BJ, 2000, ARCH CLIN NEUROPSYCH, V15, P327; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Centers for Disease Control and Prevention, 2014, TRAUMATIC BRAIN INJU; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gitlin LN, 2010, J AM GERIATR SOC, V58, P1465, DOI 10.1111/j.1532-5415.2010.02971.x; Goff BSN, 2007, J FAM PSYCHOL, V21, P344, DOI 10.1037/0893-3200.21.3.344; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Kazis LE., 2000, MED OUTCOMES TRUST M, V5, P1; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kline P, 2000, HDB PSYCHOL TESTING, P142; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Moriarty H, 2015, J AM PSYCHIAT NURSES, V21, P195, DOI 10.1177/1078390315591879; O'Neill ME, 05225 VAESP; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayers SL, 2011, COGN BEHAV PRACT, V18, P108, DOI 10.1016/j.cbpra.2010.03.002; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; United States Department of Veterans Affairs, QUAL ENH RES IN QUER; US Department of Veterans Affairs, POL TBI SYST CAR POL; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; WALKER AE, 1972, SCANDINAVIAN J REHAB, V6, P185; Walsh F., 2004, LIVING LOSS DEATH FA; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Williamson GM, 1998, HEALTH PSYCHOL, V17, P152, DOI 10.1037/0278-6133.17.2.152; Wisniewski SR, 2003, PSYCHOL AGING, V18, P375, DOI 10.1037/0882-7974.18.3.375	49	9	9	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUN 18	2016	38	13					1280	1290		10.3109/09638288.2015.1077531			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DH5OL	WOS:000372839500006	26314877				2022-02-06	
J	Kimball, BA; Cohen, AS; Gordon, AR; Opiekun, M; Martin, T; Elkind, J; Lundstrom, JN; Beauchamp, GK				Kimball, Bruce A.; Cohen, Akiva S.; Gordon, Amy R.; Opiekun, Maryanne; Martin, Talia; Elkind, Jaclynn; Lundstroem, Johan N.; Beauchamp, Gary K.			Brain Injury Alters Volatile Metabolome	CHEMICAL SENSES			English	Article						animal model; bioassay; chemical analysis; diagnosis; inflammation; traumatic brain injury; urine	CHROMATOGRAPHY-MASS SPECTROMETRY; ORGANIC-COMPOUNDS; LUNG-CANCER; CEREBROSPINAL-FLUID; ODOR DETECTION; BIOMARKERS; MICE; PHEROMONES; ODORTYPES; SCENT	Chemical signals arising from body secretions and excretions communicate information about health status as have been reported in a range of animal models of disease. A potential common pathway for diseases to alter chemical signals is via activation of immune function-which is known to be intimately involved in modulation of chemical signals in several species. Based on our prior findings that both immunization and inflammation alter volatile body odors, we hypothesized that injury accompanied by inflammation might correspondingly modify the volatile metabolome to create a signature endophenotype. In particular, we investigated alteration of the volatile metabolome as a result of traumatic brain injury. Here, we demonstrate that mice could be trained in a behavioral assay to discriminate mouse models subjected to lateral fluid percussion injury from appropriate surgical sham controls on the basis of volatile urinary metabolites. Chemical analyses of the urine samples similarly demonstrated that brain injury altered urine volatile profiles. Behavioral and chemical analyses further indicated that alteration of the volatile metabolome induced by brain injury and alteration resulting from lipopolysaccharide-associated inflammation were not synonymous. Monitoring of alterations in the volatile metabolome may be a useful tool for rapid brain trauma diagnosis and for monitoring recovery.	[Kimball, Bruce A.] USDA, APHIS, WS, NWRC,Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Cohen, Akiva S.; Elkind, Jaclynn] Childrens Hosp Philadelphia, Res Inst, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Gordon, Amy R.; Opiekun, Maryanne; Martin, Talia; Lundstroem, Johan N.; Beauchamp, Gary K.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Gordon, Amy R.; Lundstroem, Johan N.] Karolinska Inst, Dept Clin Neurosci, Nobels Vag 9, S-17177 Stockholm, Sweden		Kimball, BA (corresponding author), USDA, APHIS, WS, NWRC,Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	bruce.a.kimball@aphis.usda.gov	Lundstrom, Johan N./AAK-5002-2020; Lundstrom, Johan N/E-9482-2014	Lundstrom, Johan N./0000-0002-3529-8981; Lundstrom, Johan N/0000-0002-3529-8981	US Army Telemedicine and Advanced Technology Research Center [W81XWH-12-2-0081, EDMS 5584]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37 HD59288, RO1 NS069629]; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation [2012.0141]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD018125] Funding Source: NIH RePORTER	This work was supported in part by US Army Telemedicine and Advanced Technology Research Center grant W81XWH-12-2-0081, EDMS 5584, "Odor signals of immune activation and CNS inflammation" (G.K.B., M.O.). Additional support was provided by NIH grants R37 HD59288 and RO1 NS069629 (A.S.C.) and the Knut and Alice Wallenberg Foundation (2012.0141; J.N.L.).	Alves GJ, 2010, BEHAV BRAIN RES, V214, P357, DOI 10.1016/j.bbr.2010.06.003; Arakawa H, 2010, HORM BEHAV, V57, P330, DOI 10.1016/j.yhbeh.2010.01.002; BEAUCHAMP GK, 1994, IMMUNOGENETICS, V39, P109, DOI 10.1007/BF00188613; BEAUCHAMP GK, 1995, P NATL ACAD SCI USA, V92, P2617, DOI 10.1073/pnas.92.7.2617; Beauchamp GK, 2000, ANIM BEHAV, V60, P289, DOI 10.1006/anbe.2000.1490; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Boillat M, 2015, CURR BIOL, V25, P251, DOI 10.1016/j.cub.2014.11.061; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Burcelin R, 2009, FRONT BIOSCI-LANDMRK, V14, P5107, DOI 10.2741/3589; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Carriere KC, 2001, COMMUN STAT-SIMUL C, V30, P327, DOI 10.1081/SAC-100002370; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Faber F, 2014, IMMUNOL LETT, V162, P48, DOI 10.1016/j.imlet.2014.04.014; Hanai Y, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-7; He X, 2014, J PROTEOME RES, V13, P5281, DOI 10.1021/pr500629t; Hoffer ME, 2015, CURR OPIN NEUROL, V28, P74, DOI 10.1097/WCO.0000000000000164; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Johnston RE, 2003, J MAMMAL, V84, P1141, DOI 10.1644/BLe-010; Kang J, 2015, J NEUROIMMUNOL, V279, P25, DOI 10.1016/j.jneuroim.2015.01.001; Kim KH, 2012, TRAC-TREND ANAL CHEM, V33, P1, DOI 10.1016/j.trac.2011.09.013; Kimball BA, 2014, PHYSIOL BEHAV, V128, P80, DOI 10.1016/j.physbeh.2014.01.022; Kimball BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075411; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Kwak J, 2010, P ROY SOC B-BIOL SCI, V277, P2417, DOI 10.1098/rspb.2010.0162; Kwak J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003591; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Matsumura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008819; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Rudnicka J, 2014, SENSOR ACTUAT B-CHEM, V202, P615, DOI 10.1016/j.snb.2014.06.006; Ruijschop RMAJ, 2009, CHEM SENSES, V34, P395, DOI 10.1093/chemse/bjp011; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Slotnick B, 2007, CHEM SENSES, V32, P721, DOI 10.1093/chemse/bjm039; Sorwell KG, 2008, BEHAV NEUROSCI, V122, P788, DOI 10.1037/0735-7044.122.4.788; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Thomson CA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-73; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2; Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; YAMAZAKI K, 1983, P NATL ACAD SCI-BIOL, V80, P5685, DOI 10.1073/pnas.80.18.5685; YAMAZAKI K, 1990, P NATL ACAD SCI USA, V87, P8413, DOI 10.1073/pnas.87.21.8413; Yamazaki K, 2002, P NATL ACAD SCI USA, V99, P5612, DOI 10.1073/pnas.082093099; Zetterberg H, 2015, MOL CELL NEUROSCI, V66, P99, DOI 10.1016/j.mcn.2015.02.003; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang JX, 2008, J ETHOL, V26, P279, DOI 10.1007/s10164-007-0060-1; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	64	9	10	1	20	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	JUN	2016	41	5					407	414		10.1093/chemse/bjw014			8	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	DR2MU	WOS:000379739400003	26926034	Bronze, Green Published			2022-02-06	
J	Sandry, J; Chiou, KS; DeLuca, J; Chiaravalloti, ND				Sandry, Joshua; Chiou, Kathy S.; DeLuca, John; Chiaravalloti, Nancy D.			Individual Differences in Working Memory Capacity Predicts Responsiveness to Memory Rehabilitation After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cognition; Memory Disorders; Neurology; Rehabilitation	LONG-TERM-MEMORY; COGNITIVE RESERVE; MODERATE	Objective: To explore how individual differences affect rehabilitation outcomes by specifically investigating whether working memory capacity (WMC) can be used as a cognitive marker to identify who will and will not improve from memory rehabilitation. Design: Post hoc analysis of a randomized controlled clinical trial designed to treat learning and memory impairment after traumatic brain injury (TBI): 2 x 2 between-subjects quasiexperimental design (2 [group: treatment vs control] x 2 [WMC: high vs low]). Setting: Nonprofit medical rehabilitation research center. Participants: Participants (N=65) with moderate to severe TBI with pre- and posttreatment data. Interventions: The treatment group completed 10 cognitive rehabilitation sessions in which subjects were taught a memory strategy focusing on learning to use context and imagery to remember information. The placebo control group engaged in active therapy sessions that did not involve learning the memory strategy. Main Outcome Measure: Long-term memory percent retention change scores for an unorganized list of words from the California Verbal Learning Test-H. Results: Group and WMC interacted (P=.008, eta(2)(p)=.12). High WMC participants showed a benefit from treatment compared with low WMC participants. Individual differences in WMC accounted for 45% of the variance in whether participants with TBI in the treatment group benefited from applying the compensatory treatment strategy to learn unorganized information. Conclusions: Individuals with higher WMC showed a significantly greater rehabilitation benefit when applying the compensatory strategy to learn unorganized information. WMC is a useful cognitive marker for identifying participants with TBI who respond to memory rehabilitation with the modified Story Memory Technique. (C) 2016 by the American Congress of Rehabilitation Medicine	[Sandry, Joshua] Montclair State Univ, Dept Psychol, 1 Normal Ave, Montclair, NJ 07043 USA; [Sandry, Joshua; DeLuca, John; Chiaravalloti, Nancy D.] Kessler Fdn, Neuropsychol & Neurosci Res, W Orange, NJ USA; [Sandry, Joshua; Chiou, Kathy S.; DeLuca, John; Chiaravalloti, Nancy D.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Chiou, Kathy S.; Chiaravalloti, Nancy D.] Kessler Fdn, Traumat Brain Injury Res, W Orange, NJ USA; [DeLuca, John] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA		Sandry, J (corresponding author), Montclair State Univ, Dept Psychol, 1 Normal Ave, Montclair, NJ 07043 USA.	SandryJ@Montclair.edu		Chiaravalloti, Nancy/0000-0003-2943-7567	National Institute on Disability and Rehabilitation Research [H133A070037, H133A120030]	Supported by the National Institute on Disability and Rehabilitation Research (grant nos. H133A070037, H133A120030). However, these contents do not necessarily represent the policy of the Department of Education, and endorsement by the Federal Govemment should not be assumed.	Barrett LF, 2004, PSYCHOL BULL, V130, P553, DOI 10.1037/0033-2909.130.4.553; Chiaravalloti N. D., 2015, NEUROREHABIL NEURAL; Chiou KS, 2015, J CLIN EXP NEUROPSYC, V37, P1074, DOI 10.1080/13803395.2015.1078293; Constantinidou F, 2014, J INT NEUROPSYCH SOC, V20, P822, DOI 10.1017/S1355617714000678; Cowan N, 2004, BRAIN, V127, P825, DOI 10.1093/brain/awh107; Sandry J, 2015, NEURODEGENER DIS MAN, V5, P1, DOI [10.2217/nmt.14.51, 10.2217/NMT.14.51]; Sandry J, 2015, J NEUROL, V262, P59, DOI 10.1007/s00415-014-7523-4; Sandry J, 2014, J INT NEUROPSYCH SOC, V20, P868, DOI 10.1017/S1355617714000630; Schelble JL, 2012, MEM COGNITION, V40, P218, DOI 10.3758/s13421-011-0149-1	9	9	9	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2016	97	6					1026	1029		10.1016/j.apmr.2015.10.109			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DN7EC	WOS:000377237100019	26657213				2022-02-06	
J	Zhao, ZL; Wang, D; Jia, Y; Tian, Y; Wang, Y; Wei, YS; Zhang, JN; Jiang, RC				Zhao, Zilong; Wang, Dong; Jia, Ying; Tian, Ye; Wang, Yi; Wei, Yingsheng; Zhang, Jianning; Jiang, Rongcai			Analysis of the association of fluid balance and short-term outcome in traumatic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Fluid balance; Intracranial pressure monitoring; Acute kidney injury; Refractory intracranial hypertension	ACUTE KIDNEY INJURY; INTENSIVE-CARE; MORTALITY; PRINCIPLES; PREDICTORS; HEMORRHAGE; VOLUME	Introduction: A balance of fluid intake and output (fluid balance) influences outcomes of critical illness, but the level of such influence remains poorly understood for traumatic brain injury (TBI) and was quantitatively examined in this study. Methods: We conducted a retrospective cohort study of 351 moderate and severe TBI patients to associate the degree of fluid balance with clinical outcomes of TBI. Fluid balance and intracranial pressure (ICP) were continuously recorded for 7 days on patients admitted to neurocritical care unit (NCCU). The short-term outcome was dichotomized into improvement and deterioration groups based on changes in Glasgow Coma Scale (GCS) measured between admission and 30 days after admission. Fluid balance was calculated as: Fluid intake (mL)- fluid outputs (mL)/day x 5 and used to group patients in tertiles to study its effect on TBI outcome. Results: Patients at the low (<637 mL) and upper (>3673 mL) tertiles of fluid balance were associated with poor outcomes. Those in the upper tertile also had a higher incidence of acute kidney injury (AKI) and refractory intracranial hypertension (RIH). There was a negative correlation between the cumulative fluid balance and the short-term outcome for patients in the low tertile and a positive correlation between the cumulative fluid balance and the short-term outcome in the upper fluid balance group. Levels of fluid balance were also associated with serum creatinine (Cr, r = 0.451, P < 0.0001) and days in NCCU (r = 0.188, P = 0.001). More patients in the upper tertile had ICP higher than 20 mm Hg (P = 0.009). A fluid balance in the upper tertile is an independent predictor of poor 30-day clinical outcomes after the adjustment for confounding variables in a multivariable logistic regression model. Conclusion: We found that fluid balance in low and upper tertiles were associated with poor short-term outcomes and ICP variations. Fluid balance in the upper tertile may be an independent predictor for poor 30-day outcome, primarily due to high AKI and RIH. (C) 2016 Published by Elsevier B.V.	[Zhao, Zilong; Wang, Dong; Jia, Ying; Tian, Ye; Wang, Yi; Wei, Yingsheng; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Zhao, Zilong; Wang, Dong; Jia, Ying; Tian, Ye; Wang, Yi; Wei, Yingsheng; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China; [Zhao, Zilong; Wang, Dong; Jia, Ying; Tian, Ye; Wang, Yi; Wei, Yingsheng; Zhang, Jianning; Jiang, Rongcai] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Zhao, Zilong; Wang, Dong; Jia, Ying; Tian, Ye; Wang, Yi; Wei, Yingsheng; Zhang, Jianning; Jiang, Rongcai] Tianjin Municipal Govt, Tianjin, Peoples R China		Zhang, JN; Jiang, RC (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com; jianghope@gmail.com	Zhao, Zilong/AAZ-2196-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81271361, 81271359, 81100920]; Ontario-China Research and Innovation Fund (OCRIF) [2011DFG33430]	This work was supported by grants from National Natural Science Foundation of China State Key Program Grant 81330029 (JNZ) and National Natural Science Foundation of China research Grants 81271361 (JNZ), 81271359 (RCJ), 81100920 (DW), and the Ontario-China Research and Innovation Fund (OCRIF, 2011DFG33430).	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Davies MG, 1997, BRIT J SURG, V84, P920, DOI 10.1002/bjs.1800840707; Dutton Richard P, 2003, Curr Opin Crit Care, V9, P503, DOI 10.1097/00075198-200312000-00007; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Ibrahim GM, 2013, NEUROCRIT CARE, V19, P140, DOI 10.1007/s12028-013-9860-z; Kahle K.T., J CLIN NEUROSCIENCE, P30; Lewington A, 2011, NEPHRON CLIN PRACT, V118, pC349, DOI 10.1159/000328075; Lien YHH, 2007, AM J MED, V120, pE18, DOI 10.1016/j.amjmed.2006.09.031; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Mehta RL, 2002, JAMA-J AM MED ASSOC, V288, P2547, DOI 10.1001/jama.288.20.2547; Murugan R, 2012, CRIT CARE MED, V40, P1970, DOI 10.1097/CCM.0b013e31824e1a1f; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Prowle JR, 2010, NAT REV NEPHROL, V6, P107, DOI 10.1038/nrneph.2009.213; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Silva JM, 2013, CRIT CARE, V17, DOI 10.1186/cc13151; Stein A, 2012, CRIT CARE, V16, DOI 10.1186/cc11368; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Teixeira C, 2013, CRIT CARE, V17, DOI 10.1186/cc12484; Tian Y, 2013, J NEUROL SCI, V330, P38, DOI 10.1016/j.jns.2013.04.001; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	29	9	10	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAY 15	2016	364						12	18		10.1016/j.jns.2016.03.007			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK8GH	WOS:000375164700004	27084207				2022-02-06	
J	Albrecht, MA; Masters, CL; Ames, D; Foster, JK				Albrecht, Matthew A.; Masters, Colin L.; Ames, David; Foster, Jonathan K.		AIBL Res Grp	Impact of Mild Head Injury on Neuropsychological Performance in Healthy Older Adults: Longitudinal Assessment in the AIBL Cohort	FRONTIERS IN AGING NEUROSCIENCE			English	Article						mild traumatic brain injury; longitudinal; ageing; cognition; episodic memory; Bayesian	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; RISK-FACTOR; MULTIPLE OUTCOMES; FOOTBALL PLAYERS; EPISODIC MEMORY; LIFE-STYLE; CONCUSSION; RECOVERY	Traumatic brain injury (TBI) is suggested to be a significant risk factor for dementia. However, little research has been conducted into long-term neuropsychological outcomes after head trauma. Participants from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (AIBL) who had recovered after sustaining a mild TBI involving loss of consciousness more than 5 years previously were compared with matched controls across a 3-year period. Bayesian nested-domain modeling was used to estimate the effect of TBI on neuropsychological performance. There was no evidence for a chronic effect of mild TBI on any neuropsychological domain compared to controls. Within the TBI group, there was some evidence suggesting that the age that the head trauma occurred and the duration of unconsciousness were modulators of episodic memory. However, these findings were not robust. Taken together, these findings indicate that adults who have sustained a TBI resulting in loss of consciousness, but who recover to a healthy level of cognitive functioning, do not experience frank deficits in cognitive ability.	[Albrecht, Matthew A.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Albrecht, Matthew A.] Curtin Hlth Innovat Res Inst Biosci, Perth, WA, Australia; [Albrecht, Matthew A.] Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Masters, Colin L.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Ames, David] Univ Melbourne, St Georges Hosp, Acad Unit Psychiat Old Age, Dept Psychiat,St Vincents Aged Psychiat Serv, Parkville, Vic 3052, Australia; [Ames, David] Royal Melbourne Hosp, Natl Ageing Res Inst, Parkville, Vic 3050, Australia; [Foster, Jonathan K.] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia; [Foster, Jonathan K.] Neurosci Unit, Hlth Dept WA, Perth, WA, Australia		Albrecht, MA (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia.; Albrecht, MA (corresponding author), Curtin Hlth Innovat Res Inst Biosci, Perth, WA, Australia.; Albrecht, MA (corresponding author), Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA.; Foster, JK (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.; Foster, JK (corresponding author), Neurosci Unit, Hlth Dept WA, Perth, WA, Australia.	matthew.albrecht@curtin.edu.au; j.foster@curtin.edu.au		Albrecht, Matthew/0000-0002-6540-5979; Masters, Colin/0000-0003-3072-7940	Australian Commonwealth Scientific Industrial Research Organisation (CSIRO)Commonwealth Scientific & Industrial Research Organisation (CSIRO); Science Industry Endowment Fund; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; PfizerPfizer	We would like to thank Alzheimer's Australia for assisting with promotion, recruitment, and telephone screening for the AIBL study, the clinicians who referred patients to the study and especially the participants who took part in the current study. This work was supported by the Australian Commonwealth Scientific Industrial Research Organisation (CSIRO), the Science Industry Endowment Fund, the National Health and Medical Research Council and Pfizer.	Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Chadwick MJ, 2010, CURR BIOL, V20, P544, DOI 10.1016/j.cub.2010.01.053; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Eichenbaum H, 2012, NEUROSCI BIOBEHAV R, V36, P1597, DOI 10.1016/j.neubiorev.2011.07.006; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Foster JK, 2013, BRAIN, V136, P2201, DOI 10.1093/brain/awt127; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gelman A., 2006, DATA ANAL USING REGR, V1; Gelman A., 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kramer JH, 2006, DEMENT GERIATR COGN, V22, P306, DOI 10.1159/000095303; Kruschke JK, 2011, DOING BAYESIAN DATA; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nutter-Upham KE, 2008, ARCH CLIN NEUROPSYCH, V23, P229, DOI 10.1016/j.acn.2008.01.005; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plummer M., 2003, P 3 INT WORKSH DISTR, P1; Plummer M., 2011, RJAGS BAYESIAN GRAPH; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ranganath C, 2010, HIPPOCAMPUS, V20, P1263, DOI 10.1002/hipo.20852; Ribeiro F, 2007, J CLIN EXP NEUROPSYC, V29, P187, DOI 10.1080/13803390600629775; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Sammel M, 1999, STAT MED, V18, P2479, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2479::AID-SIM270>3.0.CO;2-F; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SHALAT SL, 1987, NEUROLOGY, V37, P1630, DOI 10.1212/WNL.37.10.1630; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Thurston SW, 2009, BIOMETRICS, V65, P1078, DOI 10.1111/j.1541-0420.2009.01224.x; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Woodard DB, 2013, BIOMETRICS, V69, P785, DOI 10.1111/biom.12037	61	9	9	1	17	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	MAY 12	2016	8								105	10.3389/fnagi.2016.00105			11	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	DL5BK	WOS:000375651600001	27242516	Green Published, gold			2022-02-06	
J	Renaud, MI; Lambregts, SAM; de Kloet, AJ; Catsman-Berrevoets, CE; van de Port, IGL; van Heugten, CM				Renaud, M. Irene; Lambregts, Suzanne A. M.; de Kloet, Arend J.; Catsman-Berrevoets, Coriene E.; van de Port, Ingrid G. L.; van Heugten, Caroline M.			Activities and participation of children and adolescents after mild traumatic brain injury and the effectiveness of an early intervention (Brains Ahead!): study protocol for a cohort study with a nested randomised controlled trial	TRIALS			English	Article						Activities; Participation; Mild traumatic brain injury; Children; Adolescents; Intervention; Study design; Randomised controlled	COMMON OUTCOME MEASURES; HEAD-INJURY; FOLLOW-UP; POSTCONCUSSIVE SYMPTOMS; POPULATION; YOUTH; EPIDEMIOLOGY; VERSION; IMPACT; RECOMMENDATIONS	Background: Approximately 20 % of children and adolescents who have sustained mild traumatic brain injuries may experience long-term consequences, including cognitive problems, post-traumatic stress symptoms and reduced load-bearing capacity. The underestimation and belated recognition of these long-term consequences may lead to chronic and disruptive problems, such as participation problems in school and in social relationships. The aim of this study is to examine the level of activities and participation of children and adolescents up to 6 months after a mild traumatic brain injury and to identify possible outcome predictors. Another aim is to investigate the effectiveness of an early psychoeducational intervention and compare the results with those obtained with usual care. Methods/design: This paper presents the Brains Ahead! study design, a randomised controlled trial nested within a multicentre, longitudinal, prospective cohort study. The eligible participants include children and adolescents between 6 and 18 years of age who have experienced a mild traumatic brain injury within the last 2 weeks. The cohort study will include 500 children and adolescents with a mild traumatic brain injury and their caregivers. A subset of 140 participants and their caregivers will be included in the randomised controlled trial. Participants in the randomised controlled trial will be randomly assigned to either the psychoeducational intervention group or the usual care control group. The psychoeducational intervention involves one face-to-face contact and one phone contact with the interventionist, during which the consequences of mild traumatic brain injury and advice for coping with these consequences to prevent long-term problems will be discussed. Information will be provided both verbally and in a booklet. The primary outcome domain is activities and participation, which will be evaluated using the Child and Adolescent Scale of Participation. Participants are evaluated 2 weeks, 3 months and 6 months after the mild traumatic brain injury. Discussion: The results of this study will provide insight into which children with mild traumatic brain injury are at risk for long-term participation problems and may benefit from a psychoeducational intervention.	[Renaud, M. Irene; Lambregts, Suzanne A. M.; van de Port, Ingrid G. L.] Revant Rehabil Ctr, Breda, Netherlands; [Lambregts, Suzanne A. M.] Sophia Childrens Univ Hosp, Erasmus Univ Hosp, Dept Rehabil Med, Rotterdam, Netherlands; [Renaud, M. Irene; van Heugten, Caroline M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, NL-6200 MD Maastricht, Netherlands; [de Kloet, Arend J.] Hague Univ Appl Sci, Expertise Grp Rehabil, The Hague, Netherlands; [de Kloet, Arend J.] Sophia Rehabil, The Hague, Netherlands; [Catsman-Berrevoets, Coriene E.] Sophia Childrens Univ Hosp, Erasmus Univ Hosp, Dept Paediat Neurol, Rotterdam, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands		Lambregts, SAM (corresponding author), Revant Rehabil Ctr, Breda, Netherlands.; Lambregts, SAM (corresponding author), Sophia Childrens Univ Hosp, Erasmus Univ Hosp, Dept Rehabil Med, Rotterdam, Netherlands.	S.Lambregts@revant.nl		de Kloet, Arend/0000-0001-9066-5601	Johanna Kinderfonds [2012/0040-1552]; Revalidatiefonds [R2012175]	The study is funded by Johanna Kinderfonds (award number 2012/0040-1552) and Revalidatiefonds (award number R2012175).	Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; Ahlander AC, 2013, J REHABIL MED, V45, P815, DOI 10.2340/16501977-1203; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Ayres A. J., 1972, SO CALIFORNIA SENSOR; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Briggs R, 2015, DEV MED CHILD NEUROL, V57, P618, DOI 10.1111/dmcn.12674; Bult MK, 2010, CLIN REHABIL, V24, P843, DOI 10.1177/0269215510367545; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; de Buy Wenniger W.F. Maillette, 1995, TIJDSCHR PSYCHIAT, V37; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; Engelen V, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-68; Foo WS, 2012, DEV NEUROREHABIL, V15, P1, DOI 10.3109/17518423.2011.623142; Gagnon I, 2009, J HEAD TRAUMA REHAB, V24, P355, DOI 10.1097/HTR.0b013e3181b97a4e; Galvin J, 2009, AM J OCCUP THER, V63, P701, DOI 10.5014/ajot.63.6.701; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Gordijn MS, 2011, QUAL LIFE RES, V20, P1103, DOI 10.1007/s11136-010-9836-9; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Imms Christine, 2008, Phys Occup Ther Pediatr, V28, P389, DOI 10.1080/01942630802307135; Kim HB, 2012, J KOREAN MED SCI, V27, P437, DOI 10.3346/jkms.2012.27.4.437; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; LAMBREGTS SAM, 2014, KINDERARTS WETENSCHA, V11, P41; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Mansfield AK, 2015, FAM PROCESS, V54, P82, DOI 10.1111/famp.12080; Mason CN, 2013, PEDIAT NURS, V39, p[82, 267]; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Moulaert VRMP, 2011, CLIN REHABIL, V25, P867, DOI 10.1177/0269215511399937; Nederlandse Vereniging voor Neurologie, 2010, RICHTL OPV PAT MET L; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sakpal Tushar Vijay, 2010, Perspect Clin Res, V1, P67; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Stock KC, 2005, OUT OF SYNC CHILD RE; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Swaine B, 2012, DEV MED CHILD NEUROL, V54, P296, DOI 10.1111/j.1469-8749.2011.04210.x; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Twisk JWR, 2004, EUR J EPIDEMIOL, V19, P769, DOI 10.1023/B:EJEP.0000036572.00663.f2; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; VanVoorhis CRW, 2007, TUTOR QUANT METHODS, V3, P43, DOI 10.20982/tqmp.03.2.p043; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Winkler R, 2015, J HEAD TRAUMA REHAB, V30, P324, DOI 10.1097/HTR.0000000000000114; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	66	9	9	1	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	MAY 6	2016	17								236	10.1186/s13063-016-1357-6			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	DL0SE	WOS:000375342100001	27150723	Green Published, gold			2022-02-06	
J	Li, CY; Waid-Ebbs, J; Velozo, CA; Heaton, SC				Li, Chih-Ying; Waid-Ebbs, Julia; Velozo, Craig A.; Heaton, Shelley C.			Factor structure and item level psychometrics of the Social Problem Solving Inventory - Revised: Short Form in traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Social problem solving; Traumatic brain injury; Factor structure; Item structure; Rasch analysis	OUTPATIENTS; INTEGRATION; PREDICTION; ABILITIES; DEFICITS; FAMILY	Social problem-solving deficits characterise individuals with traumatic brain injury (TBI), and poor social problem solving interferes with daily functioning and productive lifestyles. Therefore, it is of vital importance to use the appropriate instrument to identify deficits in social problem solving for individuals with TBI. This study investigates factor structure and item-level psychometrics of the Social Problem Solving Inventory - Revised: Short Form (SPSI-R:S), for adults with moderate and severe TBI. Secondary analysis of 90 adults with moderate and severe TBI who completed the SPSI-R:S was performed. An exploratory factor analysis (EFA), principal components analysis (PCA) and Rasch analysis examined the factor structure and item-level psychometrics of the SPSI-R:S. The EFA showed three dominant factors, with positively worded items represented as the most definite factor. The other two factors are negative problem-solving orientation and skills; and negative problem-solving emotion. Rasch analyses confirmed the three factors are each unidimensional constructs. It was concluded that the total score interpretability of the SPSI-R:S may be challenging due to the multidimensional structure of the total measure. Instead, we propose using three separate SPSI-R:S subscores to measure social problem solving for the TBI population.	[Li, Chih-Ying] Med Univ S Carolina, Coll Hlth Profess, Program Hlth & Rehabil Sci, Charleston, SC USA; [Waid-Ebbs, Julia] North Florida South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr Excellence, Gainesville, FL USA; [Velozo, Craig A.] Med Univ S Carolina, Coll Hlth Profess, Div Occupat Therapy, 151-B Rutledge Ave MSC 962, Charleston, SC 29425 USA; [Heaton, Shelley C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA		Velozo, CA (corresponding author), Med Univ S Carolina, Coll Hlth Profess, Div Occupat Therapy, 151-B Rutledge Ave MSC 962, Charleston, SC 29425 USA.	velozo@musc.edu		Li, Chih-Ying/0000-0003-4817-554X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD045869] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD045869] Funding Source: Medline		Andrich D, 1982, ED RES PERSPECT, V9, P95; Ashley MJ, 2012, NEUROREHABILITATION, V31, P31, DOI 10.3233/NRE-2012-0772; Belzer KD, 2002, PERS INDIV DIFFER, V33, P573, DOI 10.1016/S0191-8869(01)00173-8; Bond T. G., 2001, APPL RASCH MODEL APP; Bond TG, 2007, APPL RASCH MODEL FUN, P219; Brown J.D., 2009, EVAL SIG NEWSL, V13, P20; Brown TA., 2015, CONFIRMATORY FACTOR, V2; Cameron JI, 2004, J PSYCHOSOM RES, V57, P137, DOI 10.1016/S0022-3999(03)00609-3; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chang EC, 2002, COGNITIVE THER RES, V26, P581, DOI 10.1023/A:1020329625158; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; D'Zurilla T.J., 1990, PSYCHOL ASSESSMENT, V2, P156, DOI DOI 10.1037/1040-3590.2.2.156; D'Zurilla TJ., 2004, SOCIAL PROBLEM SOLVI, P11, DOI [10.1037/10805-001, DOI 10.1037/10805-001]; Drasgow F, 1990, HDB IND ORG PSYCHOL, V1, P577; Dreer LE, 2009, J CLIN PSYCHOL, V65, P653, DOI 10.1002/jclp.20573; Dreer LE, 2005, REHABIL PSYCHOL, V50, P232, DOI 10.1037/0090-5550.50.3.232; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Ghahramanlou-Holloway M, 2012, PSYCHOL MED, V42, P1185, DOI 10.1017/S0033291711002169; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hawkins D, 2009, COGNITIVE THER RES, V33, P462, DOI 10.1007/s10608-008-9209-7; Hogarty KY, 2005, EDUC PSYCHOL MEAS, V65, P202, DOI 10.1177/0013164404267287; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; Linacre J M, 1999, J Outcome Meas, V3, P103; Linacre JM, 2012, USERS GUIDE WINSTEPS; Linacre John M, 2004, J Appl Meas, V5, P95; Linacre John M, 2002, J Appl Meas, V3, P85; Linacre John M, 2010, J Appl Meas, V11, P1; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; MaydeuOlivares A, 1996, COGNITIVE THER RES, V20, P115, DOI 10.1007/BF02228030; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Proitsi P, 2011, NEUROBIOL AGING, V32, P434, DOI 10.1016/j.neurobiolaging.2009.03.005; Rath JF, 2003, REHABIL PSYCHOL, V48, P137, DOI 10.1037/0090-5550.48.3.137; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rath JF, 2011, REHABIL PSYCHOL, V56, P320, DOI 10.1037/a0025817; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; van Sonderen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068967; Velozo C. A., 2006, RES OCCUPATIONAL THE, P177; Velozo CA, 2008, DISABIL REHABIL, V30, P458, DOI 10.1080/09638280701617317; Wang J, 2013, J PSYCHOEDUC ASSESS, V31, P585, DOI 10.1177/0734282913480470; Wang WC, 2005, EDUC PSYCHOL MEAS, V65, P376, DOI 10.1177/0013164404268673; Wu Margaret, 2013, J Appl Meas, V14, P339	50	9	9	1	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 3	2016	26	3					446	463		10.1080/09602011.2015.1044458			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DG2RO	WOS:000371915600006	26052731	Green Accepted			2022-02-06	
J	Zhang, K; Jiang, WJ; Ma, TL; Wu, HR				Zhang, Kai; Jiang, Wenjie; Ma, Tieliang; Wu, Haorong			Comparison of early and late decompressive craniectomy on the long-term outcome in patients with moderate and severe traumatic brain injury: a meta-analysis	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Decompressive craniectomy; meta-analysis; outcome; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; IMPACT; SCALE	Background Several studies have searched whether early decompressive craniectomy (DC) can improve the long-term outcome of patients with moderate and severe traumatic brain injury (TBI). However, the effects of early DC remain unclear. The purpose of this meta-analysis was to assess whether early DC (time to surgery after injury<24h) is better than late DC (>24h) after moderate and severe TBI. Method Two reviewers independently searched Pubmed, Embase, ISI web of science, the Cochrane Library and Scopus databases from inception to 4 November 2014. Studies comparing the long-term outcome of patients following early and late DC after TBI were included. The long-term outcomes were evaluated by Glasgow Outcome Score, Extended Glasgow Outcome Score. Newcastle-Ottawa Scale was used to assess the methodological quality of included studies. Characteristics of the selected studies were extracted. Pooled results were presented by odds ratios (ORs) with 95% CIs. I-2 was used to test heterogeneity. Pearson correlation coefficient was used to detect the relationship between bilateral pupil abnormality and unfavourable outcome. Results Five articles were eligible for this meta-analysis. The pooled results of comparison of unfavourable outcome and mortality revealed no significant difference in the early and late groups (ORs: 1.469; 95% CIs: 0.495-4.362; p>0.05; I-2=70.5% and ORs: 1.262; 95% CIs: 0.385-4.137; p>0.05; I-2=77.6%, respectively). Pearson correlation coefficient indicated that bilateral pupil abnormality was positive related to the unfavourable outcomes and mortality (r=0.833; p<0.05) (0.829; p<0.05). Conclusion Bilateral pupil abnormality is positive related to unfavourable outcome and mortality in the patients following DC after moderate and severe TBI. Early DC may be more helpful to improve the long-term outcome of patients with refractory raised intracranial cerebral pressure after moderate and severe TBI. However, more RCTs with better control of patients with bilateral pupil abnormality divided into the early and late groups are needed in the future.	[Zhang, Kai; Wu, Haorong] Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou 215004, Jiangsu, Peoples R China; [Zhang, Kai] Jiangsu Univ, Affiliated Yixing Hosp, Dept Hepatobiliary Surg, Yixing, Jiangsu, Peoples R China; [Jiang, Wenjie] Jiangsu Univ, Affiliated Yixing Hosp, Dept Anesthesiol, Yixing, Jiangsu, Peoples R China; [Ma, Tieliang] Jiangsu Univ, Affiliated Yixing Hosp, Cent Lab, Yixing, Jiangsu, Peoples R China		Wu, HR (corresponding author), Soochow Univ, Affiliated Hosp 2, 1055 Sanxiang Rd, Suzhou 215004, Jiangsu, Peoples R China.	2726562302@qq.com			Fund of Science and Technology of Yixing [2014-14]; Fund of Six Best Talent of Jiangsu [WSN-025]	This work was supported by Fund of Science and Technology of Yixing (2014-14), and Fund of Six Best Talent of Jiangsu (WSN-025).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Ahlgren P, 2003, J AM SOC INF SCI TEC, V54, P550, DOI 10.1002/asi.10242; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cianchi Giovanni, 2012, J Trauma Manag Outcomes, V6, P8, DOI 10.1186/1752-2897-6-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cushing H, 1905, ESTABLISHMENT CEREBR; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Spiller WG, 1906, J AMER MED ASSOC, V47, P679; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Wells G, 2015, NEWCASTLE OTTAWA SCA; Wen L, 2011, BRAIN INJURY, V25, P1318, DOI 10.3109/02699052.2011.608214	27	9	9	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2016	30	2					251	257		10.3109/02688697.2016.1139052			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3LK	WOS:000373399900017	26828333				2022-02-06	
J	Bryant, RA; O'Donnell, ML; Forbes, D; McFarlane, AC; Silove, D; Creamer, M				Bryant, Richard A.; O'Donnell, Meaghan L.; Forbes, David; McFarlane, Alexander C.; Silove, Derrick; Creamer, Mark			The Course of Suicide Risk Following Trauma Injury	JOURNAL OF CLINICAL PSYCHIATRY			English	Article						Suicide	POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD ADVERSITIES; BRAIN-INJURY; CHRONIC PAIN; BEHAVIOR; HEALTH; MODEL	Objective: Although traumatic injuries affect millions of patients each year and increase risk for psychiatric disorder, no evidence currently exists regarding associated suicidal risk. This study reports a longitudinal investigation of suicidal risk in the 2 years after traumatic injury. Methods: A prospective design cohort study was conducted in 4 major trauma hospitals across Australia. A total of 1,129 traumatically injured patients were assessed during hospital admission between April 2004 and February 2006 and were followed up at 3 months (88%), 12 months (77%), and 24 months (72%). Lifetime psychiatric disorder was assessed in hospital using the Mini-International Neuropsychiatric Interview, version 5.5, which was also used to assess the prevalence of suicidality, psychiatric disorder, and exposure to adverse life events at 3, 12, and 24 months after traumatic injury. Results: Approximately 6% of patients reported moderate/high suicidal risk at each assessment. At each assessment, half of suicidal patients reported no suicidal risk at the previous assessment. Suicidality at 24 months was predicted by current pain levels (odds ratio [OR] = 1.16; 95% CI, 1.09-1.23), recent life events (OR = 1.30; 95% CI, 1.17-1.44), and current psychiatric disorder (OR = 17.07; 95% CI, 7.03-41.42), whereas only 36.6% of suicidal patients had consulted a mental health professional in the previous month, and 66.2% had consulted a primary care physician. Conclusions: Suicidal risk affects a significant proportion of patients who experience a traumatic injury, and the risk for suicide fluctuates markedly in the initial years following the injury. Primary care physicians need to be trained to assess for suicidal risk in the initial years after a traumatic injury. (C) Copyright 2016 Physicians Postgraduate Press, Inc.	[Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [O'Donnell, Meaghan L.; Forbes, David; Creamer, Mark] Australian Ctr Posttraumat Mental Hlth, Carlton, Vic, Australia; [O'Donnell, Meaghan L.; Forbes, David; Creamer, Mark] Univ Melbourne, Dept Psychiat, Melbourne, Vic 3010, Australia; [O'Donnell, Meaghan L.; Forbes, David] Natl Trauma Res Inst, Melbourne, Vic, Australia; [McFarlane, Alexander C.] Ctr Mil & Vet Hlth, Adelaide, SA, Australia; [Silove, Derrick] Univ New S Wales, Dept Psychiat, Sydney, NSW, Australia		Bryant, RA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	r.bryant@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; O'Donnell, Meaghan/0000-0003-4349-0022; Forbes, David/0000-0001-9145-1605	NHMRC (National Health and Medical Research Council, Australia)National Health and Medical Research Council of Australia [568970]	This study was supported by an NHMRC (National Health and Medical Research Council, Australia) program grant (568970).	[Anonymous], NON FATAL INJURY REP; [Anonymous], 1990, THE ABBREVIATED INJU; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Fazaa N, 2009, ARCH SUICIDE RES, V13, P31, DOI 10.1080/13811110802572122; Hassett AL, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0436-1; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hooley JM, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0435-2; Horesh N, 2003, COMPR PSYCHIAT, V44, P277, DOI 10.1016/S0010-440X(03)00091-9; Johnson JG, 2002, ARCH GEN PSYCHIAT, V59, P741, DOI 10.1001/archpsyc.59.8.741; Johnston AK, 2009, AUST NZ J PSYCHIAT, V43, P635, DOI 10.1080/00048670902970874; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; McGuffin P, 2001, Crisis, V22, P61, DOI 10.1027//0227-5910.22.2.61; Molnar BE, 2001, PSYCHOL MED, V31, P965, DOI 10.1017/S0033291701004329; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Pirkis J, 1998, BRIT J PSYCHIAT, V173, P462, DOI 10.1192/bjp.173.6.462; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Slade T, 2009, THE MENTAL HEALTH OF	31	9	9	0	8	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	MAY	2016	77	5					E648	E653		10.4088/JCP.14m09661			6	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	DQ6GH	WOS:000379302000020	27249074				2022-02-06	
J	Chien, JH; Mukherjee, M; Siu, KC; Stergiou, N				Chien, Jung Hung; Mukherjee, Mukul; Siu, Ka-Chun; Stergiou, Nicholas			Locomotor Sensory Organization Test: How Sensory Conflict Affects the Temporal Structure of Sway Variability During Gait	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Posture; Sway variability; Nonlinear; Sample entropy	ACHILLES-TENDON VIBRATION; HUMAN POSTURAL SWAY; APPROXIMATE ENTROPY; CEREBRAL CONCUSSION; SAMPLE ENTROPY; SURROGATE DATA; TIME-SERIES; COMPLEXITY; DISEASE; ADAPTATION	When maintaining postural stability temporally under increased sensory conflict, a more rigid response is used where the available degrees of freedom are essentially frozen. The current study investigated if such a strategy is also utilized during more dynamic situations of postural control as is the case with walking. This study attempted to answer this question by using the Locomotor Sensory Organization Test (LSOT). This apparatus incorporates SOT inspired perturbations of the visual and the somatosensory system. Ten healthy young adults performed the six conditions of the traditional SOT and the corresponding six conditions on the LSOT. The temporal structure of sway variability was evaluated from all conditions. The results showed that in the anterior posterior direction somatosensory input is crucial for postural control for both walking and standing; visual input also had an effect but was not as prominent as the somatosensory input. In the medial lateral direction and with respect to walking, visual input has a much larger effect than somatosensory input. This is possibly due to the added contributions by peripheral vision during walking; in standing such contributions may not be as significant for postural control. In sum, as sensory conflict increases more rigid and regular sway patterns are found during standing confirming the previous results presented in the literature, however the opposite was the case with walking where more exploratory and adaptive movement patterns are present.	[Chien, Jung Hung; Mukherjee, Mukul; Stergiou, Nicholas] Univ Nebraska, Coll Educ, Biomech Res Bldg,6160 Univ Dr, Omaha, NE 68182 USA; [Chien, Jung Hung; Stergiou, Nicholas] Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Environm Agr & Occupat Hlth, Omaha, NE USA; [Siu, Ka-Chun] Univ Nebraska, Med Ctr, Coll Allied Hlth, Div Phys Therapy Educ, Omaha, NE USA		Stergiou, N (corresponding author), Univ Nebraska, Coll Educ, Biomech Res Bldg,6160 Univ Dr, Omaha, NE 68182 USA.	nstergiou@unomaha.edu	Siu, Ka-chun/N-9940-2016	Siu, Ka-chun/0000-0002-6968-5760; Chien, Jung/0000-0001-7792-9764; Mukherjee, Mukul/0000-0001-9653-0556	Center for Research in Human Movement Variability of the University of Nebraska Omaha; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20GM109090, R01AG034995]; NASA EPSCoRNational Aeronautics & Space Administration (NASA) [NNX11AM06A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034995] Funding Source: NIH RePORTER	This work was supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the NIH (P20GM109090 and R01AG034995). Additional support was provided by NASA EPSCoR NNX11AM06A. We specially thank for authors from the previous publication ( Jung Hung Chien, Diderik-Jan Anthony Eikema, Mukul Mukherjee, and Nicholas Stergiou, Annual of Biomechanics of Engineering, 2014) to allow us to modify several figures.	Abasolo D, 2007, P ANN INT IEEE EMBS, P1953, DOI 10.1109/IEMBS.2007.4352700; BLACK FO, 1988, PROG BRAIN RES, V76, P263; Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chien JH, 2014, ANN BIOMED ENG, V42, P2512, DOI 10.1007/s10439-014-1112-7; Clark DJ, 2014, J GERONTOL A-BIOL, V69, P1422, DOI 10.1093/gerona/glu125; Day BL, 2002, BRAIN, V125, P2081, DOI 10.1093/brain/awf212; Decker LM, 2011, KNEE SURG SPORT TR A, V19, P1620, DOI 10.1007/s00167-011-1484-2; Dettmer M, 2013, HUM MOVEMENT SCI, V32, P214, DOI 10.1016/j.humov.2012.12.002; Glenn T, 2006, BIPOLAR DISORD, V8, P424, DOI 10.1111/j.1399-5618.2006.00373.x; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Graci V, 2010, OPTOMETRY VISION SCI, V87, P21, DOI 10.1097/OPX.0b013e3181c1d547; Graci V, 2009, GAIT POSTURE, V30, P370, DOI 10.1016/j.gaitpost.2009.06.011; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Katsavelis D, 2010, NONLIN DYNAM PSYCHOL, V14, P239; Mawase F, 2013, J NEUROPHYSIOL, V109, P2216, DOI 10.1152/jn.00938.2012; Newell K. M., 1997, APPL NONLINEAR DYNAM, P63; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Nocera J, 2009, PARKINSONISM RELAT D, V15, P742, DOI 10.1016/j.parkreldis.2009.07.002; Perry SD, 2001, BRAIN RES, V913, P27, DOI 10.1016/S0006-8993(01)02748-2; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; RICCIO GE, 1993, VARIABILITY AND MOTOR CONTROL, P317; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Riley MA, 2003, NEUROSCI LETT, V342, P45, DOI 10.1016/S0304-3940(03)00229-5; Rossi-Izquierdo M, 2011, EUR ARCH OTO-RHINO-L, V268, P1569, DOI 10.1007/s00405-011-1532-z; Small M, 2002, PHYSICA D, V164, P187, DOI 10.1016/S0167-2789(02)00382-2; Small M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.188101; Smania N, 2008, NEUROL SCI, V29, P313, DOI 10.1007/s10072-008-0988-0; Stergiou N, 2004, INNOVATIVE ANAL HUMA; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Turnock MJE, 2010, J MOTOR BEHAV, V42, P61, DOI 10.1080/00222890903397103; Turvey MT, 2012, J EXP PSYCHOL HUMAN, V38, P1014, DOI 10.1037/a0027853; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P27, DOI 10.1016/S0197-4580(01)00310-4; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Yeragani VK, 2003, BIPOLAR DISORD, V5, P279, DOI 10.1034/j.1399-5618.2003.00012.x	41	9	9	0	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	MAY	2016	44	5					1625	1635		10.1007/s10439-015-1440-2			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	DK1IO	WOS:000374665900023	26329924	Green Accepted			2022-02-06	
J	Connery, AK; Peterson, RL; Baker, DA; Randolph, C; Kirkwood, MW				Connery, Amy K.; Peterson, Robin L.; Baker, David A.; Randolph, Christopher; Kirkwood, Michael W.			The Role of Neuropsychological Evaluation in the Clinical Management of Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Mild TBI; Postconcussion syndrome; Neuropsychological assessment; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; GOOD OLD DAYS; SPORTS-RELATED CONCUSSION; WORD MEMORY TEST; POSTCONCUSSION SYNDROME; TEST-PERFORMANCE; SUBOPTIMAL EFFORT; SYMPTOMS; CHILDREN	Most people are expected to recover quickly and completely after sustaining a single, uncomplicated concussion. When unexpected difficulties are apparent or recovery is not progressing as expected, a neuropsychological evaluation may help to clarify the injury and noninjury variables that could be serving to prolong recovery. Interventions tailored to the needs of a specific patient can then be implemented to assist in improving functioning and minimizing distress.	[Connery, Amy K.; Peterson, Robin L.; Baker, David A.; Kirkwood, Michael W.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Randolph, Christopher] Loyola Univ, Dept Neurol, Med Ctr, 2160 S,First Ave, Maywood, IL 60153 USA		Connery, AK (corresponding author), Childrens Hosp Colorado, Dept Rehabil Med, 13123 East 16th Ave, Aurora, CO 80045 USA.	amy.connery@childrenscolorado.org					Alsalaheen B, 2015, J HEAD TRAUMA REHABI; Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Children's Hospital Colorado, 2014, RET TO LEARN PLAN; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Connery A, 2015, VALIDITY TESTING CHI, P145; DiFazio M, 2015, CLIN PEDIAT; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Dunn AL, 2001, MED SCI SPORT EXER, V33, pS587, DOI 10.1097/00005768-200106001-00027; Etherton JL, 2005, ASSESSMENT, V12, P101, DOI 10.1177/1073191104270789; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kirkwood M. W., 2015, VALIDITY TESTING CHI, P3; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Kirkwood MW, 2015, J PEDIAT; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nicholson K, 2001, NEUROREHABILITATION, V16, P225; O'Brien LM, 2004, PEDIATR CLIN N AM, V51, P187, DOI 10.1016/S0031-3955(03)00184-6; Phillips T, 2015, SPORT J, P8; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yeates K. O., 2012, MILD TRAUMATIC BRAIN, P124; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008	91	9	9	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2016	27	2					475	+		10.1016/j.pmr.2015.12.001			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	DN4RU	WOS:000377055700009	27154857				2022-02-06	
J	Riggs, BJ; Trimboli-Heidler, C; Spaeder, MC; Miller, MM; Dean, NR; Cohen, JS				Riggs, Becky J.; Trimboli-Heidler, Carmelina; Spaeder, Michael C.; Miller, Marijean M.; Dean, Nathan R.; Cohen, Joanna S.			The Use of Ophthalmic Ultrasonography to Identify Retinal Injuries Associated With Abusive Head Trauma	ANNALS OF EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; CHILDREN; MALTREATMENT; HEMORRHAGES	Abusive head trauma includes any nonaccidental injury inflicted to a child's head and body. It is often characterized by, but not limited to, the repetitive acceleration-deceleration forces with or without blunt head impact. It has a mortality rate of 30%, and 80% of survivors experience permanent neurologic damage. In this case series, we hypothesize that bedside ultrasonography, can be useful in the identification of retinal injuries that are consistent with abusive head trauma. Ocular manifestations of abusive head trauma are identified by dilated ophthalmic examination showing retinal hemorrhages that are too numerous to count, multilayered, and extending to the periphery. Traumatic retinoschisis, splitting of the retinal layers with or without blood accumulating in the intervening space, is exclusive for abusive head trauma in infants without a history of significant cerebral crush injury. Direct visualization of intraocular structures is difficult when the eyelids are swollen shut or when dilatation must be delayed. We present a series of 11 patients with brain injuries who underwent ophthalmic point-of-care ultrasonography that revealed traumatic retinoschisis on average 60 hours earlier than direct ophthalmic visualization. Dilated ophthalmic examinations and autopsy reports confirmed retinoschisis and other forms of retinal hemorrhages that were too numerous to count, multilayered, and extending to the periphery in all 11 patients. One patient did not have a dilated ophthalmic examination; however, traumatic retinoschisis and retinal hemorrhages were confirmed on autopsy. Ocular point-of-care ultrasonography is a promising tool to investigate abusive head trauma through the identification of traumatic retinoschisis and retinal hemorrhages when pupillary dilatation and direct ophthalmic examination is delayed.	[Riggs, Becky J.; Spaeder, Michael C.; Dean, Nathan R.] Childrens Natl Hlth Syst, Div Crit Care Med, Washington, DC USA; [Trimboli-Heidler, Carmelina; Miller, Marijean M.] Childrens Natl Hlth Syst, Div Ophthalmol, Washington, DC USA; [Cohen, Joanna S.] Childrens Natl Hlth Syst, Div Emergency Med, Washington, DC USA; [Riggs, Becky J.] Johns Hopkins Univ, Div Pediat Anesthesiol & Crit Care Med, Baltimore, MD USA; [Spaeder, Michael C.; Miller, Marijean M.; Dean, Nathan R.; Cohen, Joanna S.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA		Riggs, BJ (corresponding author), Childrens Natl Hlth Syst, Div Crit Care Med, Washington, DC USA.; Riggs, BJ (corresponding author), Johns Hopkins Univ, Div Pediat Anesthesiol & Crit Care Med, Baltimore, MD USA.	rriggs6@jhmi.edu	Spaeder, Michael C./I-7764-2019	Spaeder, Michael C./0000-0002-6175-8435; Cohen, Joanna/0000-0001-9318-8927			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kivlin JD, 2008, ARCH OPHTHALMOL-CHIC, V126, P800, DOI 10.1001/archopht.126.6.800; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Maguire SA, 2013, EYE, V27, P28, DOI 10.1038/eye.2012.213; Newton AW, 2005, CURR OPIN PEDIATR, V17, P246, DOI 10.1097/01.mop.0000158730.56669.b1; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; US Department of Health and Human Services Children's Bureau, CHILD MALTR 2012; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031	12	9	9	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	MAY	2016	67	5					620	624		10.1016/j.annemergmed.2015.09.027			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DL1DU	WOS:000375373200015	26481265				2022-02-06	
J	Zhu, F; Gatti, DL; Yang, KH				Zhu, Feng; Gatti, Domenico L.; Yang, King H.			Nodal versus Total Axonal Strain and the Role of Cholesterol in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cholesterol; diffuse axonal injury; finite element models; myelin; Ranvier node	CORPUS-CALLOSUM; MICROTUBULE ORGANIZATION; DIAMETER DISTRIBUTION; MECHANICAL-PROPERTIES; COMPUTER-SIMULATIONS; UNMYELINATED AXONS; LATERAL DIFFUSION; FIBER COMPOSITION; MYELIN; MODEL	Traumatic brain injury (TBI) is a health threat that affects every year millions of people involved in motor vehicle and sporting accidents, and thousands of soldiers in battlefields. Diffuse axonal injury (DAI) is one of the most frequent types of TBI leading to death. In DAI, the initial traumatic event is followed by a cascade of biochemical changes that take time to develop in full, so that symptoms may not become apparent until days or weeks after the original injury. Hence, DAI is a dynamic process, and the opportunity exists to prevent its progression provided the initial trauma can be predicted at the molecular level. Here, we present preliminary evidence from micro-finite element (FE) simulations that the mechanical response of central nervous system myelinated fibers is dependent on the axonal diameter, the ratio between axon diameter and fiber diameter (g-ratio), the microtubules density, and the cholesterol concentration in the axolemma and myelin. A key outcome of the simulations is that there is a significant difference between the overall level of strain in a given axonal segment and the level of local strain in the Ranvier nodes contained in that segment, with the nodal strain being much larger than the total strain. We suggest that the acquisition of this geometric and biochemical information by means of already available high resolution magnetic resonance imaging techniques, and its incorporation in current FE models of the brain will enhance the models capacity to predict the site and magnitude of primary axonal damage upon TBI.	[Zhu, Feng; Yang, King H.] Wayne State Univ, Dept Biomed Engn, 818 W Hancock, Detroit, MI USA; [Gatti, Domenico L.] Wayne State Univ, Dept Biochem & Mol Biol, Detroit, MI USA; [Gatti, Domenico L.] Wayne State Univ, Cardiovasc Res Inst, Detroit, MI USA; [Zhu, Feng] Embry Riddle Aeronaut Univ, Dept Mech Engn, Daytona Beach, FL USA		Yang, KH (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 W Hancock, Detroit, MI USA.	king.yang@wayne.edu					ABOITIZ F, 1992, BRAIN, V115, P1521, DOI 10.1093/brain/115.5.1521; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ABOITIZ F, 1992, BRAIN RES, V598, P154, DOI 10.1016/0006-8993(92)90179-D; Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Anchisi L, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00486; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Baoukina S, 2013, FARADAY DISCUSS, V161, P63, DOI 10.1039/c2fd20117h; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bennett WFD, 2013, BBA-BIOMEMBRANES, V1828, P1765, DOI 10.1016/j.bbamem.2013.03.004; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Burgoyne R. D, 1991, NEURONAL CYTOSKELETO; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Caminiti R, 2009, P NATL ACAD SCI USA, V106, P19551, DOI 10.1073/pnas.0907655106; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen X, 2008, BIOPHYS J, V95, P563, DOI 10.1529/biophysj.107.128488; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; CRAWFORD GE, 1987, BIOPHYS J, V52, P87, DOI 10.1016/S0006-3495(87)83191-0; Deriu MA, 2010, BIOPHYS J, V99, P2190, DOI 10.1016/j.bpj.2010.06.070; DEVRIES GH, 1981, J LIPID RES, V22, P208; DeVries GH, 1999, J NEUROSCI RES, V57, P670; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Espinosa G, 2011, P NATL ACAD SCI USA, V108, P6008, DOI 10.1073/pnas.1018572108; FADIC R, 1985, J COMP NEUROL, V236, P258, DOI 10.1002/cne.902360209; Filippov A, 2003, BIOPHYS J, V84, P3079, DOI 10.1016/S0006-3495(03)70033-2; Fitzpatrick MO, 1998, J NEUROL NEUROSUR PS, V64, P285, DOI 10.1136/jnnp.64.3.285; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Hagen SJ, 2010, CURR PROTEIN PEPT SC, V11, P385; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Heredia A, 2007, NEUROIMAGE, V37, P1218, DOI 10.1016/j.neuroimage.2007.06.007; Hianik T, 1998, COLLOID SURFACE A, V139, P189, DOI 10.1016/S0927-7757(98)00280-5; HIANIK T, 1993, GEN PHYSIOL BIOPHYS, V12, P271; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Honerkamp-Smith AR, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.038103; Huang WC, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/27/275101; Innocenti GM, 2014, CEREB CORTEX, V24, P2178, DOI 10.1093/cercor/bht070; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kabara J J, 1973, Prog Brain Res, V40, P363; Kemper T. L., 1994, CLIN NEUROLOGY AGING, P3; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Korade Z, 2008, NEUROPHARMACOLOGY, V55, P1265, DOI 10.1016/j.neuropharm.2008.02.019; Li JM, 2007, J BIOMECH, V40, P569, DOI 10.1016/j.jbiomech.2006.02.009; Lindblom G, 2009, BBA-BIOMEMBRANES, V1788, P234, DOI 10.1016/j.bbamem.2008.08.016; Liu JP, 2010, MOL CELL NEUROSCI, V43, P33, DOI 10.1016/j.mcn.2009.07.013; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; MACRAE TH, 1992, BIOCHIM BIOPHYS ACTA, V1160, P145, DOI 10.1016/0167-4838(92)90001-T; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meaney S, 2001, J LIPID RES, V42, P70; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Nicolson GL, 2014, BBA-BIOMEMBRANES, V1838, P1451, DOI 10.1016/j.bbamem.2013.10.019; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Orth M, 2012, CHOLESTEROL, DOI 10.1155/2012/292598; Ouyang H, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-21; Pampaloni F, 2006, P NATL ACAD SCI USA, V103, P10248, DOI 10.1073/pnas.0603931103; Perrot R, 2007, J NEUROSCI, V27, P9573, DOI 10.1523/JNEUROSCI.1224-07.2007; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Peters A, 2001, J COMP NEUROL, V435, P241, DOI 10.1002/cne.1205; Peters A, 2000, J COMP NEUROL, V419, P364, DOI 10.1002/(SICI)1096-9861(20000410)419:3<364::AID-CNE8>3.0.CO;2-R; Peters A., 1991, FINE STRUCTURE NERVO, V3rd ed.; Peters A, 2010, J COMP NEUROL, V518, P3962, DOI 10.1002/cne.22434; Peters A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.011.2009; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Quarles RH, 2006, BASIC NEUROCHEMISTRY; Quinn PJ, 2009, BBA-BIOMEMBRANES, V1788, P33, DOI 10.1016/j.bbamem.2008.08.005; Rauscher A. A., 2013, INTERNAL FRICTION EN; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rog T, 2014, CHEM PHYS LIPIDS, V184, P82, DOI 10.1016/j.chemphyslip.2014.10.004; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; RUNQUIST M, 1995, J NEUROCHEM, V65, P2299; Rvachev Marat M., 2010, Biophysical Reviews and Letters, V5, P73, DOI 10.1142/S1793048010001147; Saatman K. E., 1993, ISOLATED SINGLE MYEL; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Saher G, 2011, NEUROSCIENTIST, V17, P79, DOI 10.1177/1073858410373835; Sandell JH, 2003, J COMP NEUROL, V466, P14, DOI 10.1002/cne.10859; Shahinnejad A, 2013, PROCEDIA ENGINEER, V59, P16, DOI 10.1016/j.proeng.2013.05.088; Shkulipa SA, 2005, BIOPHYS J, V89, P823, DOI 10.1529/biophysj.105.062653; Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y; Siegel GJ, 2006, BASIC NEUROCHEMISTRY; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Stikov N, 2011, NEUROIMAGE, V54, P1112, DOI 10.1016/j.neuroimage.2010.08.068; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tamura A, 2007, STAPP CAR CRASH JO, V51, P139; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tettoni L, 1996, J NEUROSCI METH, V67, P1, DOI 10.1016/0165-0270(95)00095-X; Thelen KM, 2006, NEUROSCI LETT, V403, P15, DOI 10.1016/j.neulet.2006.04.034; Tierney KJ, 2005, BIOPHYS J, V89, P2481, DOI 10.1529/biophysj.104.057943; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Valentine MT, 2005, BIOPHYS J, V88, P680, DOI 10.1529/biophysj.104.048025; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124; VERGARA I, 1986, J COMP NEUROL, V248, P550, DOI 10.1002/cne.902480407; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028097; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875; White R, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00284; Wortman JC, 2014, BIOPHYS J, V106, P813, DOI 10.1016/j.bpj.2013.12.047; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100; YU WQ, 1994, J NEUROSCI, V14, P2818; Zhang J, 2014, BIOMECH MODEL MECHAN, V13, P1175, DOI 10.1007/s10237-014-0564-x; Zhang YY, 1996, NEUROBIOL AGING, V17, P869, DOI 10.1016/S0197-4580(96)00076-0	139	9	9	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					859	870		10.1089/neu.2015.4007			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800008	26393780				2022-02-06	
J	Bouman, Z; Hendriks, MPH; Schmand, BA; Kessels, RPC; Aldenkamp, AP				Bouman, Zita; Hendriks, Marc P. H.; Schmand, Ben A.; Kessels, Roy P. C.; Aldenkamp, Albert P.			Indicators of suboptimal performance embedded in the Wechsler Memory Scale-Fourth Edition (WMS-IV)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						logistic regression.; suboptimal performance; malingering; Assessment; effort indicators	RARELY MISSED INDEX; TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; SYMPTOM VALIDITY TESTS; DIGIT SPAN; NEUROPSYCHOLOGICAL ASSESSMENT; AMERICAN-ACADEMY; RESPONSE BIAS; 3RD EDITION; HEAD-INJURY	Introduction. Recognition and visual working memory tasks from the Wechsler Memory Scale-Fourth Edition (WMS-IV) have previously been documented as useful indicators for suboptimal performance. The present study examined the clinical utility of the Dutch version of the WMS-IV (WMS-IV-NL) for the identification of suboptimal performance using an analogue study design. Method. The patient group consisted of 59 mixed-etiology patients; the experimental malingerers were 50 healthy individuals who were asked to simulate cognitive impairment as a result of a traumatic brain injury; the last group consisted of 50 healthy controls who were instructed to put forth full effort. Results. Experimental malingerers performed significantly lower on all WMS-IV-NL tasks than did the patients and healthy controls. A binary logistic regression analysis was performed on the experimental malingerers and the patients. The first model contained the visual working memory subtests (Spatial Addition and Symbol Span) and the recognition tasks of the following subtests: Logical Memory, Verbal Paired Associates, Designs, Visual Reproduction. The results showed an overall classification rate of 78.4%, and only Spatial Addition explained a significant amount of variation (p < .001). Subsequent logistic regression analysis and receiver operating characteristic (ROC) analysis supported the discriminatory power of the subtest Spatial Addition. A scaled score cutoff of Conclusion. The WMS-IV-NL Spatial Addition subtest may provide clinically useful information for the detection of suboptimal performance.	[Bouman, Zita; Hendriks, Marc P. H.; Aldenkamp, Albert P.] Acad Ctr Epileptol, Kempenhaeghe, Heeze, Netherlands; [Bouman, Zita; Hendriks, Marc P. H.; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands; [Schmand, Ben A.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Schmand, Ben A.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands; [Aldenkamp, Albert P.] Univ Hosp Gent, Dept Neurol, Ghent, Belgium; [Aldenkamp, Albert P.] Tech Univ Eindhoven, Fac Elect Engn, Signal Proc Syst Grp, POB 513, NL-5600 MB Eindhoven, Netherlands; [Aldenkamp, Albert P.] Maastricht Univ, Med Ctr, Dept Neurol, NL-6200 MD Maastricht, Netherlands; [Aldenkamp, Albert P.] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands		Bouman, Z (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands.	z.bouman@donders.ru.nl	Kessels, Roy P.C./D-1902-2010; Hendriks, Marc P.H./D-9688-2012	Kessels, Roy P.C./0000-0001-9500-9793; Hendriks, Marc P.H./0000-0002-5321-7970	Pearson Assessment BV; Academic Centre for Epileptology, Kempenhaeghe, Heeze, the Netherlands	This study was funded by Pearson Assessment BV and Academic Centre for Epileptology, Kempenhaeghe, Heeze, the Netherlands. The funder had no role in study design, analyses, or the decision to publish the results.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bouman Z, 2015, ARCH CLIN NEUROPSYCH, V30, P228, DOI 10.1093/arclin/acv013; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Brennan AM, 2006, APPL NEUROPSYCHOL, V13, P1, DOI 10.1207/s15324826an1301_1; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Central Office of Statistics for the Netherlands [Centraal Bureau voor Statistiek], 2011, DAT ENQ BER; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Glassmire DM, 2003, J CLIN EXP NEUROPSYC, V25, P465, DOI 10.1076/jcen.25.4.465.13875; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hendriks M., 2014, WECHSLER MEMORY SCAL; Holdnack J. A., 2009, ADV CLIN SOLUTIONS U; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Jelicic M, 2007, INT J NEUROSCI, V117, P1185, DOI 10.1080/00207450600934697; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Lange RT, 2006, J CLIN EXP NEUROPSYC, V28, P294, DOI 10.1080/13803390490918156; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P412, DOI 10.1080/13803390490520319; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P3; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; Merckelbach H, 2009, J FORENSIC PSYCHI PS, V20, P378, DOI 10.1080/14789940802456686; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; Nelson H.E., 1982, NATL ADULT READING T; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rogers R., 2007, CLIN ASSESSMENT MALI; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schenk K, 2010, J CLIN EXP NEUROPSYC, V32, P752, DOI 10.1080/13803390903512678; SCHMAND B, 2005, AMSTERDAM SHORT TERM; Schmand B, 1992, DUTCH ADULT READING; Schwartz SM, 1998, INT J LAW PSYCHIAT, V21, P261, DOI 10.1016/S0160-2527(98)00004-1; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Swihart AA, 2008, J CLIN EXP NEUROPSYC, V30, P120, DOI 10.1080/13803390701249044; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; UNESCO UIS, 2011, INT STAND CLASS ED I; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Weinborn M, 2012, CLIN NEUROPSYCHOL, V26, P832, DOI 10.1080/13854046.2012.686630; Williams JM, 1998, CRIT ISS NE, P105; Young JC, 2012, ARCH CLIN NEUROPSYCH, V27, P159, DOI 10.1093/arclin/acr109; [No title captured]	60	9	9	1	23	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR 20	2016	38	4					455	466		10.1080/13803395.2015.1123226			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DF0LJ	WOS:000371030300007	26882178	hybrid, Green Published			2022-02-06	
J	Roy, A; Campbell, C; Bernier, RA; Hillary, FG				Roy, Arnab; Campbell, Colin; Bernier, Rachel A.; Hillary, Frank G.			An Evolutionary Computation Approach to Examine Functional Brain Plasticity	FRONTIERS IN NEUROSCIENCE			English	Article						fMRI; evolutionary computation; network plasticity; voxel-based approach; traumatic brain injury	DEFAULT MODE NETWORK; RESTING-STATE FMRI; STRUCTURAL CONNECTIVITY; ALZHEIMERS-DISEASE; COGNITIVE CONTROL; NEURAL-NETWORKS; INJURY; MRI; CORTEX; CHARACTERIZE	One common research goal in systems neurosciences is to understand how the functional relationship between a pair of regions of interest (ROls) evolves over time. Examining neural connectivity in this way is well-suited for the study of developmental processes, learning, and even in recovery or treatment designs in response to injury. For most fMRI based studies, the strength of the functional relationship between two ROls is defined as the correlation between the average signal representing each region. The drawback to this approach is that much information is lost due to averaging heterogeneous voxels, and therefore, the functional relationship between a ROI-pair that evolve at a spatial scale much finer than the ROls remain undetected. To address this shortcoming, we introduce a novel evolutionary computation (EC) based voxel-level procedure to examine functional plasticity between an investigator defined ROI-pair by simultaneously using subject-specific BOLD-fMRI data collected from two sessions seperated by finite duration of time. This data-driven procedure detects a sub-region composed of spatially connected voxels from each ROI (a so-called sub-regional-pair) such that the pair shows a significant gain/loss of functional relationship strength across the two time points. The procedure is recursive and iteratively finds all statistically significant sub-regional-pairs within the ROls. Using this approach, we examine functional plasticity between the default mode network (DMN) and the executive control network (ECN) during recovery from traumatic brain injury (TBI); the study includes 14 TBI and 12 healthy control subjects. We demonstrate that the EC based procedure is able to detect functional plasticity where a traditional averaging based approach fails. The subject-specific plasticity estimates obtained using the EC-procedure are highly consistent across multiple runs. Group-level analyses using these plasticity estimates showed an increase in the strength of functional relationship between DMN and ECN for TBI subjects, which is consistent with prior findings in the TBI-literature. The EC-approach also allowed us to separate sub-regional-pairs contributing to positive and negative plasticity; the detected sub-regional-pairs significantly overlap across runs thus highlighting the reliability of the EC-approach. These sub-regional-pairs may be useful in performing nuanced analyses of brain-behavior relationships during recovery from TBI.	[Roy, Arnab; Bernier, Rachel A.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Roy, Arnab; Bernier, Rachel A.; Hillary, Frank G.] Penn State Univ, Social Life & Engn Imaging Ctr, University Pk, PA 16802 USA; [Campbell, Colin] Washington Coll, Dept Phys, Chestertown, MD USA; [Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Roy, A; Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.; Roy, A; Hillary, FG (corresponding author), Penn State Univ, Social Life & Engn Imaging Ctr, University Pk, PA 16802 USA.; Hillary, FG (corresponding author), Hershey Med Ctr, Dept Neurol, Hershey, PA USA.	aroy2@binghamton.edu; fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Campbell, Colin/0000-0003-3770-7432; Bernier, Rachel/0000-0002-2759-9186	Social Sciences Research Institute, in University Park, PA; Penn State CBI from Grant the National Center for Advancing Translational Sciences, National Institutes of Health [UL Tr000127]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002014, UL1TR000127] Funding Source: NIH RePORTER	This project was supported by the Social Sciences Research Institute, in University Park, PA and the Penn State CBI Grant (UL Tr000127) from the National Center for Advancing Translational Sciences, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIEL	Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Davoian K., 2006, TRAINING, V6, P13; De Jong Kenneth A, 2006, EVOLUTIONARY COMPUTA; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; DIAMOND MC, 1981, EXP NEUROL, V71, P261, DOI 10.1016/0014-4886(81)90087-X; Eshelman L.J., 1991, FDN GENETIC ALGORITH, VVolume 1, P265, DOI [DOI 10.1016/B978-0-08-050684-5.50020-3, 10.1016/B978-0-08-050684-5.50020-3]; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fogel DB, 2003, MODELING AND SIMULATION: THEORY AND PRACTICE, P217; Fogel L.J, 1999, INTELLIGENCE SIMULAT; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Greenough WT, 1988, CEREB CORTEX, P391, DOI DOI 10.1007/978-1-4615-6619-9_11; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; GRUAU F, 1994, ADAPT BEHAV, V3, P151, DOI 10.1177/105971239400300202; Gruau F, 1993, EVOL COMPUT, V1, P213, DOI 10.1162/evco.1993.1.3.213; Hebb, 1947, AM PSYCHOL, V2, P306, DOI DOI 10.1037/H0028720; Heller R, 2006, NEUROIMAGE, V33, P599, DOI 10.1016/j.neuroimage.2006.04.233; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Kobayashi K., 1999, IJCNN'99. International Joint Conference on Neural Networks. Proceedings (Cat. No.99CH36339), P4409, DOI 10.1109/IJCNN.1999.830879; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Lindquist MA, 2008, HUM BRAIN MAPP, V29, P1276, DOI 10.1002/hbm.20475; Luo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036568; Mazaika P., 2009, HUM BRAIN MAPP, DOI DOI 10.1016/S1053-8119(09)70238-1; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nguyen X. V., 2009, P 26 ICML ICML 09 NY, P1073, DOI DOI 10.1145/1553374.1553511; Nugent AC, 2015, J CEREBR BLOOD F MET, V35, P583, DOI 10.1038/jcbfm.2014.228; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajtmajer SM, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.7015.00097, 10.3389/fnana.2015.00097]; RECHENBERG I, 1971, THESIS; Roy A, 2013, PROCEDIA COMPUT SCI, V20, P27, DOI 10.1016/j.procs.2013.09.234; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Schaffer J. D., 1991, FDN GENETIC ALGORITH, V1, P102; Schwefel H. P., 1974, ADAPTIVE MECH BIOL E; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Sorensen T., 1948, KONGELIGE DANSKE VID, V5, P4; TEASDALE G, 1974, LANCET, V2, P81; Thirion B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00167; Tijms BM, 2013, NEUROBIOL AGING, V34, P2023, DOI 10.1016/j.neurobiolaging.2013.02.020; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Wang ZI, 2015, ANN NEUROL, V77, P1060, DOI 10.1002/ana.24407; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Yan XD, 2011, J NEUROSCI METH, V199, P108, DOI 10.1016/j.jneumeth.2011.05.001; Yeo BTT, 2014, NEUROIMAGE, V88, P212, DOI 10.1016/j.neuroimage.2013.10.046; Zalesky A, 2012, HUM BRAIN MAPP, V33, P2535, DOI 10.1002/hbm.21379	59	9	9	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	APR 5	2016	10								146	10.3389/fnins.2016.00146			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI2JR	WOS:000373322400001	27092047	gold, Green Published			2022-02-06	
J	Assis-Nascimento, P; Umland, O; Cepero, ML; Liebl, DJ				Assis-Nascimento, Poincyane; Umland, Oliver; Cepero, Maria L.; Liebl, Daniel J.			A flow cytometric approach to analyzing mature and progenitor endothelial cells following traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Flow cytometry; Endothelial cells; Endothelial progenitor cells; Blood; Vessels; Traumatic brain injury	RAT MODEL; ANGIOGENESIS; TISSUE; PERFUSION; IDENTITY	Background: Traumatic brain injury (TBI) continues to be a major source of death and disability worldwide, and one of the earliest and most profound deficits comes from vascular damage and breakdown of the blood-brain barrier (BBB). Cerebral vascular endothelial cells (cvECs) and endothelial progenitor cells (EPCs) have been shown to play essential roles in vessel repair and BBB stability, although their individual contributions remain poorly defined. New method: We employ TruCount beads with flow cytometry to precisely quantify cvECs, EPCs, and peripheral leukocytes in the murine cortex after controlled cortical impact (CCI) injury. Results: We found a significant reduction in the number of cvECs at 3 days post-injury (dpi), whereas the EPCs and invading peripheral leukocytes were significantly increased compared with sham controls. Proliferation studies demonstrate that both cvECs and EPCs are undergoing cell expansion in the first week post-injury. Furthermore, analysis of protein expression using mean fluorescence intensity found increases in PECAM-1, VEGFR-2, and VE-Cadherin expression per cell at 3 dpi, which is consistent with western blot analysis. Comparison with existing methods: Classic methods of cell analysis, such as histological cell counts, in the traumatic injured brain are labor intensive, time-consuming, and potentially biased; whereas flow cytometry provides an efficient, non-biased approach to simultaneously quantify multiple cell types. However, conventional flow cytometry that employs capped events can provide misleading results in CNS injured tissues. Conclusions: We demonstrate that TruCount quantification using flow cytometry is a powerful tool for quantifying mature and progenitor endothelial cell changes after TBI. (C) 2016 Elsevier B.V. All rights reserved.	[Assis-Nascimento, Poincyane; Cepero, Maria L.; Liebl, Daniel J.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Umland, Oliver] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA		Liebl, DJ (corresponding author), Univ Miami, Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	dliebl@miami.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS049545, F31NS089325] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS030291, R01 NS049545, F31 NS089325] Funding Source: Medline		Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen X, 2013, ACTA RADIOL, V54, P313, DOI 10.1258/ar.2012.120605; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Toklu HZ, 2015, BRAIN NEUROTRAUMA MO; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Wylot B, 2015, CYTOM PART A, V87A, P908, DOI 10.1002/cyto.a.22677; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	28	9	9	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	APR 1	2016	263						57	67		10.1016/j.jneumeth.2016.01.025			11	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DJ4SY	WOS:000374199500007	26854397	Green Accepted			2022-02-06	
J	Giammarinaro, B; Coulouvrat, F; Pinton, G				Giammarinaro, B.; Coulouvrat, F.; Pinton, G.			Numerical Simulation of Focused Shock Shear Waves in Soft Solids and a Two-Dimensional Nonlinear Homogeneous Model of the Brain	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; VISCOELASTIC PROPERTIES; TRANSIENT ELASTOGRAPHY; SOUND BEAMS; SONIC-BOOM; TISSUE; ULTRASOUND; DEFORMATION; PROPAGATION; MODULUS	Shear waves that propagate in soft solids, such as the brain, are strongly nonlinear and can develop into shock waves in less than one wavelength. We hypothesize that these shear shock waves could be responsible for certain types of traumatic brain injuries (TBI) and that the spherical geometry of the skull bone could focus shear waves deep in the brain, generating diffuse axonal injuries. Theoretical models and numerical methods that describe nonlinear polarized shear waves in soft solids such as the brain are presented. They include the cubic nonlinearities that are characteristic of soft solids and the specific types of nonclassical attenuation and dispersion observed in soft tissues and the brain. The numerical methods are validated with analytical solutions, where possible, and with self-similar scaling laws where no known solutions exist. Initial conditions based on a human head X-ray microtomography (CT) were used to simulate focused shear shock waves in the brain. Three regimes are investigated with shock wave formation distances of 2: 54m; 0: 018 m, and 0: 0064 m. We demonstrate that under realistic loading scenarios, with nonlinear properties consistent with measurements in the brain, and when the shock wave propagation distance and focal distance coincide, nonlinear propagation can easily overcome attenuation to generate shear shocks deep inside the brain. Due to these effects, the accelerations in the focal are larger by a factor of 15 compared to acceleration at the skull surface. These results suggest that shock wave focusing could be responsible for diffuse axonal injuries.	[Giammarinaro, B.] Univ Paris 06, Sorbonne Univ, Inst Jean Le Rond dAlembert, UMR 7190, F-75005 Paris, France; [Coulouvrat, F.] Inst Jean Le Rond dAlembert, CNRS, UMR 7190, F-75005 Paris, France; [Pinton, G.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Pinton, G.] N Carolina State Univ, Chapel Hill, NC 27599 USA		Giammarinaro, B (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Jean Le Rond dAlembert, UMR 7190, F-75005 Paris, France.	giam@dalembert.upmc.fr; francois.coulouvrat@upmc.fr; gia@email.unc.edu	Giammarinaro, Bruno/AAB-6558-2019	Coulouvrat, Francois/0000-0002-7395-0088; Giammarinaro, Bruno/0000-0001-9968-1915	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS091195-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091195] Funding Source: NIH RePORTER	The authors would like to acknowledge support from the NIH R01 NS091195-01.	Arbogast K., 1997, 952716 SAE; Averkiou MA, 1997, J ACOUST SOC AM, V102, P2539, DOI 10.1121/1.420308; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; BORIS JP, 1973, J COMPUT PHYS, V11, P38, DOI 10.1016/0021-9991(73)90147-2; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; Catheline S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.164301; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Chinn B., 1999, INT RES COUNC BIOM I, V27, P53; Coulouvrat F, 2000, WAVE MOTION, V32, P233, DOI 10.1016/S0165-2125(00)00045-7; Coulouvrat F, 2009, WAVE MOTION, V46, P97, DOI 10.1016/j.wavemoti.2008.09.002; Dagrau F, 2011, J ACOUST SOC AM, V130, P20, DOI 10.1121/1.3583549; Destrade M, 2010, J ACOUST SOC AM, V128, P3334, DOI 10.1121/1.3505102; Duck FA., 2013, PHYS PROPERTIES TISS; Fu MJ, 2015, IEEE ENG MED BIO, P1568, DOI 10.1109/EMBC.2015.7318672; Gadd C, 1966, 660793 SAE; Gennisson JL, 2007, J ACOUST SOC AM, V122, P3211, DOI 10.1121/1.2793605; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GUIRAUD JP, 1965, J MECANIQUE, V4, P215; Hamhaber U, 2010, J MAGN RESON IMAGING, V32, P577, DOI 10.1002/jmri.22294; Hamilton MF, 2004, J ACOUST SOC AM, V116, P41, DOI 10.1121/1.1736652; HART TS, 1988, J ACOUST SOC AM, V84, P1488, DOI 10.1121/1.396595; Hosey R. R., 1982, FINITE ELEMENTS BIOM, P379; Jacob X, 2007, J ACOUST SOC AM, V122, P1917, DOI 10.1121/1.2775871; Jiang Y, 2015, BIOMECH MODEL MECHAN, V14, P1119, DOI 10.1007/s10237-015-0658-0; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Khokhlova VA, 2006, ACOUST PHYS+, V52, P481, DOI 10.1134/S1063771006040178; KUZNETSOV VP, 1971, SOV PHYS ACOUST+, V16, P467; Landau L. D., 1959, THEORY ELASTICITY, V7; LEE YS, 1995, J ACOUST SOC AM, V97, P906, DOI 10.1121/1.412135; LeVeque RJ, 2002, FINITE VOLUME METHOD, V31; Loubeau A, 2009, AIAA J, V47, P2632, DOI 10.2514/1.41337; Marchiano R, 2003, J ACOUST SOC AM, V114, P1758, DOI 10.1121/1.1610459; Marchiano R., 2003, PHYS REV LETT, V91; MARSTON PL, 1992, PHYS ACOUSTICS, V21, P1; MCDONALD BE, 1984, J COMPUT PHYS, V56, P448, DOI 10.1016/0021-9991(84)90106-2; Mendis K, 1992, THESIS; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Nyein M., 2008, ADA504193 DTIC MIT; Pearcey T., 1946, Philosophical Magazine, V37, P311; Pinton G, 2014, IEEE T ULTRASON FERR, V61, P1489, DOI 10.1109/TUFFC.2014.3063; Pinton G, 2010, J ACOUST SOC AM, V127, P683, DOI 10.1121/1.3277202; Pinton GF, 2006, IEEE T ULTRASON FERR, V53, P1103, DOI 10.1109/TUFFC.2006.1642509; Prange M T, 2000, Stapp Car Crash J, V44, P205; Raymond D, 2009, J BIOMECH, V42, P2479, DOI 10.1016/j.jbiomech.2009.07.018; Renier M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2979875; Sandrin L, 2002, IEEE T ULTRASON FERR, V49, P426, DOI 10.1109/58.996560; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Shugar T., 1977, DOTHS2893500 NAT HIG; STRANG G, 1968, SIAM J NUMER ANAL, V5, P506, DOI 10.1137/0705041; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; WALKER WF, 1995, IEEE T ULTRASON FERR, V42, P301, DOI 10.1109/58.365243; WHITHAM G. B, 1979, LECT WAVE PROPAGATIO; Wochner MS, 2008, J ACOUST SOC AM, V123, P2488, DOI 10.1121/1.2890739; Yang LX, 2013, WAVE MOTION, V50, P334, DOI 10.1016/j.wavemoti.2012.09.002; Yang XM, 2005, J ACOUST SOC AM, V117, P113, DOI 10.1121/1.1828671; Zabolotskaya EA, 2004, J ACOUST SOC AM, V116, P2807, DOI 10.1121/1.1802533; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	63	9	9	0	8	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	APR	2016	138	4							041003	10.1115/1.4032643			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	DP1OE	WOS:000378258500003	26833489	Green Published, Green Submitted			2022-02-06	
J	Kim, JY; Choi, K; Shaker, MR; Lee, JH; Lee, B; Lee, E; Park, JY; Lim, MS; Park, CH; Shin, KS; Kim, H; Geum, D; Sun, W				Kim, Joo Yeon; Choi, Kyuhyun; Shaker, Mohammed R.; Lee, Ju-Hyun; Lee, Boram; Lee, Eunsoo; Park, Jae-Yong; Lim, Mi-Sun; Park, Chang-Hwan; Shin, Ki Soon; Kim, Hyun; Geum, Dongho; Sun, Woong			Promotion of Cortical Neurogenesis from the Neural Stem Cells in the Adult Mouse Subcallosal Zone	STEM CELLS			English	Article						Subcallosal zone; Traumatic brain injury; Adult neurogenesis; Adult neural stem cells; Brain-derived neurotropic factor; Bcl-xL	TRAUMATIC BRAIN-INJURY; SUBCORTICAL WHITE-MATTER; KNOCK-OUT MICE; SUBVENTRICULAR ZONE; NERVOUS-SYSTEM; SYNAPSE FORMATION; PROGENITOR CELLS; MAMMALIAN BRAIN; RAT-BRAIN; FOREBRAIN NEUROGENESIS	Neurogenesis occurs spontaneously in the subventricular zone (SVZ) of the lateral ventricle in adult rodent brain, but it has long been debated whether there is sufficient adult neurogenesis in human SVZ. Subcallosal zone (SCZ), a posterior continuum of SVZ closely associated with posterior regions of cortical white matter, has also been reported to contain adult neural stem cells (aNSCs) in both rodents and humans. However, little is known whether SCZ-derived aNSC (SCZ-aNSCs) can produce cortical neurons following brain injury. We found that SCZ-aNSCs exhibited limited neuronal differentiation potential in culture and after transplantation in mice. Neuroblasts derived from SCZ initially migrated toward injured cortex regions following brain injury, but later exhibited apoptosis. Overexpression of anti-apoptotic bcl-xL in the SCZ by retroviral infection rescued neuroblasts from cell death in the injured cortex, but neuronal maturation was still limited, resulting in atrophy. In combination with Bcl-xL, infusion of brain-derived neurotropic factor rescued atrophy, and importantly, a subset of such SCZ-aNSCs differentiated and attained morphological and physiological characteristics of mature, excitatory neurons. These results suggest that the combination of anti-apoptotic and neurotrophic factors might enable the use of aNSCs derived from the SCZ in cortical neurogenesis for neural replacement therapy. Stem Cells2016;34:888-901	[Kim, Joo Yeon; Shaker, Mohammed R.; Lee, Ju-Hyun; Lee, Boram; Lee, Eunsoo; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Kim, Joo Yeon; Shaker, Mohammed R.; Lee, Ju-Hyun; Lee, Boram; Lee, Eunsoo; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Div Brain Korea Plus Biomed Sci 21, Seoul 136705, South Korea; [Geum, Dongho] Korea Univ, Coll Med, Dept Biomed Sci, Seoul 136705, South Korea; [Choi, Kyuhyun; Shin, Ki Soon] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Dept Biol, Seoul, South Korea; [Park, Jae-Yong] Korea Univ, Coll Hlth Sci, Sch Biosyst & Biomed Sci, Seoul, South Korea; [Lim, Mi-Sun; Park, Chang-Hwan] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Lim, Mi-Sun; Park, Chang-Hwan] Hanyang Univ, Hanyang Biomed Res Inst, Seoul 133791, South Korea; [Park, Chang-Hwan] Hanyang Univ, Coll Med, Dept Microbiol, Seoul 133791, South Korea		Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea.; Geum, D (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Seoul 136705, South Korea.	geumd@korea.ac.kr; woong-sun@korea.ac.kr	Shin, Ki Soon/AAK-1939-2020; Shaker, Mohammed/AAI-9852-2021	Shin, Ki Soon/0000-0002-5701-3596; Shaker, Mohammed/0000-0002-3675-4598; Lee, Boram/0000-0003-4631-7372; sun, woong/0000-0003-1792-4894; Kim, Hyun/0000-0002-7210-5798	Brain Research Program through the National Research Foundation (NRF) - Korean Ministry of Science, ICT, and Future Planning [NRF-2012M3A9C6049933, NRF-2010-0020237, NRF-2015M3C7A1028790, NRF-2013R1A1A3011896]	We thank Dr. Eun Mi Hur at Korea Institute of Science and Technology for critical reading of the manuscript and Dr. Magdalena Gotz for providing us CAG-GFP-IRES-DsRed. This work was supported by the Brain Research Program through the National Research Foundation (NRF) funded by the Korean Ministry of Science, ICT, and Future Planning (Grants NRF-2012M3A9C6049933, NRF-2010-0020237, NRF-2015M3C7A1028790, and NRF-2013R1A1A3011896).	Ahmed AI, 2012, J NEUROTRAUM, V29, P828, DOI 10.1089/neu.2011.1923; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Andsberg G, 2002, NEUROBIOL DIS, V9, P187, DOI 10.1006/nbdi.2001.0456; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Chang MY, 2007, MOL CELL BIOL, V27, P4293, DOI 10.1128/MCB.00031-07; Collin T, 2005, EXP NEUROL, V195, P71, DOI 10.1016/j.expneurol.2005.03.017; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferrere A, 2006, ANAT REC PART A, V288A, P158, DOI 10.1002/ar.a.20284; Frade JM, 1996, NATURE, V383, P166; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Jablonska B, 2010, NAT NEUROSCI, V13, P541, DOI 10.1038/nn.2536; Jessberger S, 2014, TRENDS CELL BIOL, V24, P558, DOI 10.1016/j.tcb.2014.07.003; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Jin G, 2003, NEUROL RES, V25, P249, DOI 10.1179/016164103101201454; Jovanov-Milosevic N, 2010, EUR J NEUROSCI, V32, P1423, DOI 10.1111/j.1460-9568.2010.07400.x; Judas M, 2010, J ANAT, V217, P381, DOI 10.1111/j.1469-7580.2010.01284.x; Jung AR, 2008, J NEUROSCI, V28, P2941, DOI 10.1523/JNEUROSCI.3897-07.2008; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim HJ, 2012, NEUROCHEM INT, V61, P879, DOI 10.1016/j.neuint.2012.02.027; Kim TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025346; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Kim WR, 2011, DEV GROWTH DIFFER, V53, P225, DOI 10.1111/j.1440-169X.2010.01226.x; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; KOSTOVIC I, 1980, J NEUROCYTOL, V9, P219, DOI 10.1007/BF01205159; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Suarez-Sola ML, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.007.2009; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merkle FT, 2014, NAT NEUROSCI, V17, P207, DOI 10.1038/nn.3610; Moon Y, 2013, STEM CELLS, V31, P1696, DOI 10.1002/stem.1420; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ohira K, 2011, CELL MOL LIFE SCI, V68, P1645, DOI 10.1007/s00018-010-0552-y; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Quadrato G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00017; Rao MS, 2006, NEUROBIOL DIS, V21, P276, DOI 10.1016/j.nbd.2005.07.009; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Sun W, 2003, MOL CELL NEUROSCI, V24, P875, DOI 10.1016/S1044-7431(03)00219-7; Sun W, 2003, J NEUROSCI, V23, P7298, DOI 10.1523/jneurosci.23-19-07298.2003; Sun X, 2012, NEUROBIOL DIS, V45, P601, DOI 10.1016/j.nbd.2011.09.018; Takemura NU, 2005, NEUROSCIENCE, V134, P121, DOI 10.1016/j.neuroscience.2005.04.033; Toni N, 2011, EUR J NEUROSCI, V33, P1062, DOI 10.1111/j.1460-9568.2011.07604.x; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Ziv Y, 2007, STROKE, V38, P774, DOI 10.1161/01.STR.0000255784.27298.23	66	9	10	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	APR	2016	34	4					888	901		10.1002/stem.2276			14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	DK1TR	WOS:000374697700008	26701067	Bronze			2022-02-06	
J	Ohmori, T; Kitamura, T; Onishi, H; Ishihara, J; Nojima, T; Yamamoto, K				Ohmori, Takao; Kitamura, Taisuke; Onishi, Hirokazu; Ishihara, Junko; Nojima, Tsuyoshi; Yamamoto, Koutarou			Effect of pre-injury anticoagulant and antiplatelet agents on blood loss in elderly patients with severe trauma	ACUTE MEDICINE & SURGERY			English	Article						Anticoagulant agent; antiplatelet agent; blood loss; elderly; trauma	PREINJURY WARFARIN USE; HEAD TRAUMA; CLOPIDOGREL PLAVIX; MORTALITY; IMPACT; INCREASE; OUTCOMES; SURGERY; RISK	AimIt has been widely reported that pre-injury use of anticoagulant and antiplatelet agents can affect traumatic brain injury and the associated risk of mortality, however, the effect of these agents on non-head injury site-related blood loss remains unclear. Therefore, we investigated the effects of pre-injury anticoagulant and antiplatelet agents on the transfusion amount and the need for massive transfusion in elderly patients with severe trauma. MethodsWe retrospectively reviewed a cohort of elderly patients with severe trauma (age, 65 years; Injury Severity Score, 16) between September 2006 and March 2014. The selected patients were subsequently divided into patients who were: only taking warfarin, aspirin, or clopidogrel; taking various combinations of these agents; and a control group who were not taking any of these agents. ResultsDuring the study period, 67 patients (20%) were taking anticoagulant and antiplatelet agents and 272 patients were included in the control group. Among these patients, 10 were receiving only warfarin, 28 were receiving only aspirin, 14 were receiving only clopidogrel, and 13 were receiving various combinations of these medications. The amount of red cell concentrate and need for massive transfusions were only significantly increased in the warfarin group (P<0.05). Furthermore, the warfarin group had a significantly higher risk of needing a massive transfusion with multivariate logistic regression analysis (odds ratio, 5.03; 95% confidence interval, 1.25-20.20; P<0.05). ConclusionPatients who were receiving only warfarin before their injury had an increased risk of bleeding due to non-head injuries.	[Ohmori, Takao; Kitamura, Taisuke; Onishi, Hirokazu; Ishihara, Junko; Nojima, Tsuyoshi; Yamamoto, Koutarou] Kochi Hlth Sci Ctr, Emergency & Crit Care Ctr, 2125-1 Ike, Kochi 7818555, Japan		Ohmori, T (corresponding author), Kochi Hlth Sci Ctr, Emergency & Crit Care Ctr, 2125-1 Ike, Kochi 7818555, Japan.	takao771577157715@yahoo.co.jp					Aschkenasy MT, 2006, EMERG MED CLIN N AM, V24, P413, DOI 10.1016/j.emc.2006.01.005; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Callaway DW, 2007, EMERG MED CLIN N AM, V25, P837, DOI 10.1016/j.emc.2007.06.005; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Chechik O, 2011, INJURY, V42, P1277, DOI 10.1016/j.injury.2011.01.011; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Collinge CA, 2012, J ORTHOP TRAUMA, V26, P568, DOI 10.1097/BOT.0b013e318240d70f; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Ferraris VA, 2012, J TRAUMA ACUTE CARE, V73, P492, DOI 10.1097/TA.0b013e31825b85f1; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Grandhi R, 2008, AM SURGEON, V74, P802; Heffernan DS, 2010, J TRAUMA, V69, P813, DOI 10.1097/TA.0b013e3181f41af8; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Nydick JA, 2010, J ORTHOP TRAUMA, V24, P383, DOI 10.1097/BOT.0b013e3181c3f3d9; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	20	9	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2052-8817			ACUTE MED SURG	Acute Med. Surg.	APR	2016	3	2					114	119		10.1002/ams2.152			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	DK7ER	WOS:000375088200009	29123762	Bronze, Green Published			2022-02-06	
J	Strahle, J; Geh, N; Selzer, BJ; Bower, R; Himedan, M; Strahle, M; Wetjen, NM; Muraszko, KM; Garton, HJL; Maher, CO				Strahle, Jennifer; Geh, Ndi; Selzer, Bela J.; Bower, Regina; Himedan, Mai; Strahle, MaryKathryn; Wetjen, Nicholas M.; Muraszko, Karin M.; Garton, Hugh J. L.; Maher, Cormac O.			Sports participation with Chiari I malformation	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						Chiari malformation; concussion; incidence; injury; safety; sports	SCHOOL FOOTBALL PLAYERS; SPINAL-CORD-INJURY; MINOR HEAD TRAUMA; CLINICAL ARTICLE; CONCUSSION RATES; NATURAL-HISTORY; SUDDEN-DEATH; NECK TRAUMA; SYRINGOMYELIA; CONVERSION	OBJECTIVE There is currently no consensus on the safety of sports participation for patients with Chiari I malformation (CM-I). The authors' goal was to define the risk of sports participation for children with the imaging finding of CM-I. METHODS A prospective survey was administered to 503 CM-I patients at 2 sites over a 46-month period. Data were gathered on imaging characteristics, treatment, sports participation, and any sport-related injuries. Additionally, 81 patients completed at least 1 subsequent survey following their initial entry into the registry and were included in a prospective group, with a mean prospective follow-up period of 11 months. RESULTS Of the 503 CM-I patients, 328 participated in sports for a cumulative duration of 4641 seasons; 205 of these patients participated in contact sports. There were no serious or catastrophic neurological injuries. One patient had temporary extremity paresthesias that resolved within hours, and this was not definitely considered to be related to the CM-I. In the prospective cohort, there were no permanent neurological injuries. CONCLUSIONS No permanent or catastrophic neurological injuries were observed in CM-I patients participating in athletic activities. The authors believe that the risk of such injuries is low and that, in most cases, sports participation by children with CM-I is safe.	[Strahle, Jennifer; Geh, Ndi; Selzer, Bela J.; Himedan, Mai; Strahle, MaryKathryn; Muraszko, Karin M.; Garton, Hugh J. L.; Maher, Cormac O.] Univ Michigan, Dept Neurosurg, 1500 E Med Ctr Dr,Rm 3552 Taubman Ctr, Ann Arbor, MI 48109 USA; [Bower, Regina; Wetjen, Nicholas M.] Mayo Clin, Dept Neurosurg, Rochester, MN USA		Maher, CO (corresponding author), Univ Michigan, Dept Neurosurg, 1500 E Med Ctr Dr,Rm 3552 Taubman Ctr, Ann Arbor, MI 48109 USA.	cmaher@med.umich.edu					Ajis A, 2004, BRIT J NEUROSURG, V18, P398, DOI 10.1080/02688690400005297; ALEGRE S, 1994, INT J CARDIOL, V46, P286, DOI 10.1016/0167-5273(94)90253-4; [Anonymous], 1988, PEDIATRICS, V81, P737; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Benglis D, 2011, J NEUROSURG-PEDIATR, V7, P375, DOI 10.3171/2011.1.PEDS10341; Benzel EC, 2008, NEUROSURGERY, V63, P753; BONDURANT CP, 1993, J NEUROSURG, V79, P833, DOI 10.3171/jns.1993.79.6.0833; Bunc G, 2001, J NEUROTRAUM, V18, P645, DOI 10.1089/089771501750291882; Callaway GH, 1996, MED SCI SPORT EXER, V28, P1218, DOI 10.1097/00005768-199610000-00002; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Couldwell WT, 1998, NEUROL RES, V20, P93; ELSTER AD, 1992, RADIOLOGY, V183, P347, DOI 10.1148/radiology.183.2.1561334; ERLICH V, 1989, NEUROSURGERY, V25, P102, DOI 10.1227/00006123-198907000-00019; FROGAMENI AD, 1994, ORTHOPEDICS, V17, P552; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gomez E, 1996, AM J SPORT MED, V24, P684, DOI 10.1177/036354659602400521; Haroun RI, 2000, PEDIATR NEUROSURG, V33, P311, DOI 10.1159/000055977; Harrell BR, 2010, CLIN J SPORT MED, V20, P215, DOI 10.1097/JSM.0b013e3181dafc14; James DS, 1995, FORENSIC SCI INT, V75, P217, DOI 10.1016/0379-0738(95)01786-0; Kirschen Matthew P, 2014, Continuum (Minneap Minn), V20, P1683, DOI 10.1212/01.CON.0000458965.17777.b0; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MAMPALAM TJ, 1988, NEUROSURGERY, V23, P760, DOI 10.1227/00006123-198812000-00014; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; Meehan WP, 2015, CLIN J SPORT MED, V25, P133, DOI 10.1097/JSM.0000000000000107; Miele Vincent J, 2006, Neurosurg Focus, V21, pE9; Murano T, 2006, J EMERG MED, V30, P295, DOI 10.1016/j.jemermed.2005.05.025; Novegno F, 2008, J NEUROSURG-PEDIATR, V2, P179, DOI 10.3171/PED/2008/2/9/179; OLIVERO WC, 1992, NEUROSURGERY, V30, P758; Pasternack JS, 1996, PEDIATRICS, V98, P445; Proctor MR, 2012, CLIN SPORT MED, V31, P521, DOI 10.1016/j.csm.2012.03.008; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; RISSER WL, 1994, PEDIATRICS, V94, P757; RIVIELLO J J JR, 1990, Pediatric Emergency Care, V6, P113, DOI 10.1097/00006565-199006000-00012; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schijman E, 2004, CHILD NERV SYST, V20, P341, DOI 10.1007/s00381-003-0882-2; Smith BW, 2013, J NEUROSURG, V119, P812, DOI 10.3171/2013.5.JNS121825; Strahle J, 2011, J NEUROSURG-PEDIATR, V8, P205, DOI 10.3171/2011.5.PEDS1121; Strahle J, 2015, J NEUROSURG-PEDIATR, V16, P21, DOI 10.3171/2014.12.PEDS14463; Strahle J, 2011, J NEUROSURG-PEDIATR, V8, P214, DOI 10.3171/2011.5.PEDS1122; TOMASZEK DE, 1984, ANN EMERG MED, V13, P136, DOI 10.1016/S0196-0644(84)80579-X; Tubbs RS, 2011, J NEUROSURG-PEDIATR, V7, P248, DOI 10.3171/2010.12.PEDS10379; VLCEK BW, 1987, ANN NEUROL, V21, P100, DOI 10.1002/ana.410210119; Wan MJ, 2008, NEUROSURGERY, V63, P748, DOI 10.1227/01.NEU.0000325498.04975.C0; Washington RL, 2001, PEDIATRICS, V107, P1205; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wolf DA, 1998, J FORENSIC SCI, V43, P1241; Yarbrough CK, 2011, J NEUROSURG-PEDIATR, V7, P244, DOI 10.3171/2010.11.PEDS1097; Zar J H, 1996, BIOSTAT ANAL, P524	52	9	11	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2016	17	4					403	409		10.3171/2015.8.PEDS15188			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DH3EF	WOS:000372669600006	26636249	Bronze			2022-02-06	
J	Ahmed, HH; Salem, AM; Atta, HM; Eskandar, EF; Farrag, ARH; Ghazy, MA; Salem, NA; Aglan, HA				Ahmed, Hanaa H.; Salem, Ahmed M.; Atta, Hazem M.; Eskandar, Emad F.; Farrag, Abdel Razik H.; Ghazy, Mohamed A.; Salem, Neveen A.; Aglan, Hadeer A.			Updates in the pathophysiological mechanisms of Parkinson's disease: Emerging role of bone marrow mesenchymal stem cells	WORLD JOURNAL OF STEM CELLS			English	Article						Parkinson's disease; Pathophysiology; Bone marrow derived mesenchymal stem cells; Rotenone; Anti-inflammatory action; Ovariectomy; Anti-apoptotic effect; Neurogenic potential	AMYOTROPHIC-LATERAL-SCLEROSIS; CATENIN SIGNALING PATHWAY; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; RAT MODEL; STROMAL CELLS; INTRASTRIATAL TRANSPLANTATION; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL DYSFUNCTION	AIM: To explore the approaches exerted by mesenchymal stem cells (MSCs) to improve Parkinson's disease (PD) pathophysiology. METHODS: MSCs were harvested from bone marrow of femoral bones of male rats, grown and propagated in culture. Twenty four ovariectomized animals were classified into 3 groups: Group (1) was control, Groups (2) and (3) were subcutaneously administered with rotenone for 14 d after one month of ovariectomy for induction of PD. Then, Group (2) was left untreated, while Group (3) was treated with single intravenous dose of bone marrow derived MSCs (BM-MSCs). SRY gene was assessed by PCR in brain tissue of the female rats. Serum transforming growth factor beta-1 (TGF-beta 1), monocyte chemoattractant protein-1 (MCP-1) and brain derived neurotrophic factor (BDNF) levels were assayed by ELISA. Brain dopamine DA level was assayed fluorometrically, while brain tyrosine hydroxylase (TH) and nestin gene expression were detected by semi-quantitative real time PCR. Brain survivin expression was determined by immunohistochemical procedure. Histopathological investigation of brain tissues was also done. RESULTS: BM-MSCs were able to home at the injured brains and elicited significant decrease in serum TGF-beta 1 (489.7 +/- 13.0 vs 691.2 +/- 8.0, P < 0.05) and MCP-1 (89.6 +/- 2.0 vs 112.1 +/- 1.9, P < 0.05) levels associated with significant increase in serum BDNF (3663 +/- 17.8 vs 2905 +/- 72.9, P < 0.05) and brain DA (874 +/- 15.0 vs 599 +/- 9.8, P < 0.05) levels as well as brain TH (1.18 +/- 0.004 vs 0.54 +/- 0.009, P < 0.05) and nestin (1.29 +/- 0.005 vs 0.67 +/- 0.006, P < 0.05) genes expression levels. In addition to, producing insignificant increase in the number of positive cells for survivin (293.2 +/- 15.9 vs 271.5 +/- 15.9, P > 0.05) expression. Finally, the brain sections showed intact histological structure of the striatum as a result of treatment with BM-MSCs. CONCLUSION: The current study sheds light on the therapeutic potential of BM-MSCs against PD pathophysiology via multi-mechanistic actions.	[Ahmed, Hanaa H.; Eskandar, Emad F.; Aglan, Hadeer A.] Natl Res Ctr, Div Med Res, Hormones Dept, Giza 12622, Egypt; [Salem, Ahmed M.; Ghazy, Mohamed A.] Ain Shams Univ, Dept Biochem, Fac Sci, Cairo 1156, Egypt; [Atta, Hazem M.] King Abdulaziz Univ, Dept Clin Biochem, Fac Med, Jeddah 21589, Saudi Arabia; [Atta, Hazem M.] Cairo Univ, Med Biochem & Mol Biol Dept, Fac Med, Cairo 11562, Egypt; [Farrag, Abdel Razik H.] Natl Res Ctr, Div Med Res, Dept Pathol, Giza 12622, Egypt; [Salem, Neveen A.] Natl Res Ctr, Div Med Res, Narcot Ergogen Aids & Poisons Dept, Giza 12622, Egypt		Ahmed, HH (corresponding author), Natl Res Ctr, Div Med Res, Hormones Dept, Biochem, 33 El Bohouth St, Giza 12622, Egypt.	hanaaomr@yahoo.com	Atta, Hazem M/J-5886-2012; Farrag, Abdel Razik H./F-3322-2011				Abdipranoto A, 2008, CNS NEUROL DISORD-DR, V7, P187, DOI 10.2174/187152708784083858; Ahmed HH, 2014, HUM EXP TOXICOL, V33, P1217, DOI 10.1177/0960327114524238; Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Aloe L, 1999, CYTOKINE, V11, P45, DOI 10.1006/cyto.1998.0397; Antkiewicz-Michaluk L, 2003, EUR J PHARMACOL, V466, P263, DOI 10.1016/S0014-2999(03)01565-6; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bancroft J, 2008, THEORY PRACTICE HIST, P433; Bancroft JD, 1996, THEORY PRACTICE HIST, P25; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blandini F, 2010, CELL TRANSPLANT, V19, P203, DOI 10.3727/096368909X479839; Blondheim NR, 2006, STEM CELLS DEV, V15, P141, DOI 10.1089/scd.2006.15.141; Borchelt DR, 2006, NEW ENGL J MED, V355, P1611, DOI 10.1056/NEJMcibr064358; Boucherie C, 2008, EXP NEUROL, V212, P557, DOI 10.1016/j.expneurol.2008.04.030; Bouchez G, 2008, NEUROCHEM INT, V52, P1332, DOI 10.1016/j.neuint.2008.02.003; Bousquet M, 2012, NEUROBIOL DIS, V45, P529, DOI 10.1016/j.nbd.2011.09.009; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; CIARLONE EA, 1978, AM J PHYSIOL, V125, P731; Corrigan FM, 1998, EXP NEUROL, V150, P339, DOI 10.1006/exnr.1998.6776; Crews L, 2008, J NEUROSCI, V28, P4250, DOI 10.1523/JNEUROSCI.0066-08.2008; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002; Gaytan F, 2004, J CLIN ENDOCR METAB, V89, P400, DOI 10.1210/jc.2003-031375; Gorell JM, 2004, J NEUROL SCI, V217, P169, DOI 10.1016/j.jns.2003.09.014; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; Han C, 2014, CHINESE MED J-PEKING, V127, P329, DOI 10.3760/cma.j.issn.0366-6999.20120064; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iarlori C, 2005, EXP GERONTOL, V40, P605, DOI 10.1016/j.exger.2005.04.007; Jenner P, 2001, TRENDS NEUROSCI, V24, P245, DOI 10.1016/S0166-2236(00)01789-6; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Jin GZ, 2008, CELL BIOL INT, V32, P1433, DOI 10.1016/j.cellbi.2008.08.014; Johnson VJ, 2003, NEUROTOXICOLOGY, V24, P261, DOI 10.1016/S0161-813X(02)00194-8; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kim YS, 2012, PATHOLOGY NEURODEGEN, V2012, P99, DOI DOI 10.5772/38028]; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Kropf J, 1997, CLIN CHEM, V43, P1965; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Laske C, 2007, J PSYCHIATR RES, V41, P600, DOI 10.1016/j.jpsychires.2006.02.007; Lattanzi W, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/468705; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; Liu L, 2010, NEUROSCIENCE, V167, P1115, DOI 10.1016/j.neuroscience.2010.01.057; McGuire SO, 2001, EXP NEUROL, V169, P219, DOI 10.1006/exnr.2001.7688; Mizuno Y, 2001, ADV NEUROL, V86, P13; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Nagatsu T, 1995, ESSAYS BIOCHEM, V30, P15; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Offen D, 2007, J NEURAL TRANSM-SUPP, P133; Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Payne NL, 2013, CELL TRANSPLANT, V22, P1409, DOI 10.3727/096368912X657620; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Rota E, 2006, NEUROL SCI, V27, P33, DOI 10.1007/s10072-006-0562-6; Sai Y, 2009, ENVIRON TOXICOL PHAR, V27, P366, DOI 10.1016/j.etap.2008.12.004; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sambrook L, 1989, MOL CLONING LAB MANU, DOI [10.1016/0092-8674(90)90210-6, DOI 10.1016/0092-8674(90)90210-6]; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shetty P, 2009, CELL BIOL INT, V33, P830, DOI 10.1016/j.cellbi.2009.05.002; Si YL, 2011, AGEING RES REV, V10, P93, DOI 10.1016/j.arr.2010.08.005; Tanna T, 2014, CURR STEM CELL RES T, V9, P513, DOI 10.2174/1574888X09666140923101110; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; Tanner CM, 2003, ADV NEUROL, V91, P133; Teismann P, 2003, MOVEMENT DISORD, V18, P121, DOI 10.1002/mds.10332; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wu F, 2013, NEUROCHEM INT, V63, P133, DOI 10.1016/j.neuint.2013.05.006; Wu GD, 2003, TRANSPLANTATION, V76, P609, DOI 10.1097/01.TP.0000066362.37931.6D; Xu L, 2009, BRIT J PHARMACOL, V158, P738, DOI 10.1111/j.1476-5381.2009.00361.x; Yao SC, 2013, OSTEOPATH FAM PHYS, V5, P96, DOI DOI 10.1016/J.OSFP.2013.01.003; Ye M, 2007, PARKINSONISM RELAT D, V13, P44, DOI 10.1016/j.parkreldis.2006.07.013; Yoon JK, 2010, NUCL MED BIOL, V37, P381, DOI 10.1016/j.nucmedbio.2009.12.001; Zhang L, 2013, INT J MOL MED, V32, P867, DOI 10.3892/ijmm.2013.1456; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhao DC, 2005, WORLD J GASTROENTERO, V11, P3431, DOI 10.3748/wjg.v11.i22.3431	84	9	9	0	7	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1948-0210			WORLD J STEM CELLS	World J. Stem Cells	MAR 26	2016	8	3					106	117		10.4252/wjsc.v8.i3.106			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FA4AN	WOS:000405386300005	27022441	Green Published, hybrid			2022-02-06	
J	Boman, IL; Persson, AC; Bartfai, A				Boman, Inga-Lill; Persson, Ann-Christine; Bartfai, Aniko			First steps in designing an all-in-one ICT-based device for persons with cognitive impairment: evaluation of the first mock-up	BMC GERIATRICS			English	Article						Aging; Ambient assisted living; Assistive technology; Informal caregivers; Services; Quality of life	TRAUMATIC BRAIN-INJURY; ASSISTIVE TECHNOLOGY; MEMORY AID; PEOPLE; REHABILITATION; HEALTH; INDIVIDUALS; USERS; VIDEOPHONE; USABILITY	Background: This project Smart Assisted Living involving Informal careGivers++ (SALIG) intends to develop an ICT-based device for persons with cognitive impairment combined with remote support possibilities for significant others and formal caregivers. This paper presents the identification of the target groups' needs and requirements of such device and the evaluation of the first mock-up, demonstrated in a tablet. Methods: The inclusive design method that includes end-users in the design process was chosen. First, a scoping review was conducted in order to examine the target group's need of an ICT-based device, and to gather recommendations regarding its design and functionalities. In order to capture the users' requirements of the design and functionalities of the device three targeted focus groups were conducted. Based on the findings from the publications and the focus groups a user requirement specification was developed. After that a design concept and a first mock-up was developed in an iterative process. The mock-up was evaluated through interviews with persons with cognitive impairment, health care professionals and significant others. Data were analysed using content analysis. Results: Several useful recommendations of the design and functionalities of the SALIG device for persons with cognitive impairment were identified. The main benefit of the mock-up was that it was a single device with a set of functionalities installed on a tablet and designed for persons with cognitive impairment. An additional benefit was that it could be used remotely by significant others and formal caregivers. Conclusion: The SALIG device has the potentials to facilitate everyday life for persons with cognitive impairment, their significant others and the work situation for formal caregivers. The results may provide guidance in the development of different types of technologies for the target population and for people with diverse disabilities. Further work will focus on developing a prototype to be empirically tested by persons with cognitive impairment, their significant others and formal caregivers.	[Boman, Inga-Lill; Persson, Ann-Christine; Bartfai, Aniko] Danderyd Hosp, Univ Dept Rehabil Med, S-18288 Stockholm, Sweden; [Boman, Inga-Lill; Bartfai, Aniko] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18288 Danderyd, Sweden		Boman, IL (corresponding author), Danderyd Hosp, Univ Dept Rehabil Med, S-18288 Stockholm, Sweden.; Boman, IL (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18288 Danderyd, Sweden.	inga-lill.boman@ds.se		Boman, Inga-Lill/0000-0002-4533-1036; Persson, Ann-Christine/0000-0003-1143-6777			Agree EM, 2014, DISABIL HEALTH J, V7, pS33, DOI 10.1016/j.dhjo.2013.09.004; Arksey H., 2005, INT J SOC RES METHOD, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Arthanat S, 2012, CAN J OCCUP THER, V79, P309, DOI 10.2182/cjot.2012.79.5.7; Astell AJ, 2010, INTERACT COMPUT, V22, P267, DOI 10.1016/j.intcom.2010.03.003; Baldwin VN, 2014, NEUROPSYCHOL REHABIL, P1; Boman IL, 2012, DISABIL REHABIL-ASSI, V7, P356, DOI 10.3109/17483107.2011.635750; Boman IL, 2015, DISABIL REHABIL-ASSI, V10, P365, DOI 10.3109/17483107.2014.913712; Boman IL, 2014, DISABIL REHABIL-ASSI, V9, P164, DOI 10.3109/17483107.2013.769124; Boman IL, 2010, SCAND J OCCUP THER, V17, P140, DOI 10.3109/11038120902875144; Cahill S., 2007, TECHNOL DISABIL, V19, P133, DOI DOI 10.3233/TAD-2007-192-310; Charters E, 2015, NEUROPSYCHOL REHABIL, V25, P82, DOI 10.1080/09602011.2014.942672; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Clarkson PJ, 2007, INCLUSIVE DESIGN TOO; Connell B., 1997, PRINCIPLES UNIVERSAL; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; EDLUND C, 2011, TECHNOL DISABIL, V23, P205; Edwards B, 2009, MED J AUSTRALIA, V190, pS61; Emiliani P.L., 2006, TECHNOL DISABIL, V18, P19, DOI 10.3233/TAD-2006-18104; Evald L, 2015, NEUROPSYCHOL REHABIL, V25, P283, DOI 10.1080/09602011.2014.970557; Faife D, 2006, J DEMENTIA CARE, V14, P14; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Glaser B., 1967, DISCOVERY GROUNDED T; Goldstein CM, 2014, J TELEMED TELECARE, V20, P293, DOI 10.1177/1357633X14541039; Gosman-Hedstrom G, 2012, SCAND J CARING SCI, V26, P587, DOI 10.1111/j.1471-6712.2012.00975.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Ivanoff Synneve Dahlin, 2006, Scand J Occup Ther, V13, P125, DOI 10.1080/11038120600691082; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Johnson CM, 2005, J BIOMED INFORM, V38, P75, DOI 10.1016/j.jbi.2004.11.005; Kintsch A, 2002, FRAMEWORK ADOPTION A, P1; Lindberg B, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/461829; Lindqvist E, 2015, NEUROREHABILITATION, V36, P135, DOI 10.3233/NRE-141201; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Meiland FJM, 2014, INT PSYCHOGERIATR, V26, P769, DOI 10.1017/S1041610214000088; Migo EM, 2014, J MENT HEALTH, P1, DOI DOI 10.3109/09638237.2014.951479; Orpwood R., 2007, TECHNOLOGY DISABILIT, V19, P103; Orpwood R.D., 2004, DEMENTIA INT J SOCIA, V3, P263, DOI [10.1177/1471301204045160, DOI 10.1177/1471301204045160]; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Salter K, 2010, DISABIL REHABIL, V32, P273, DOI 10.3109/09638280903114394; Savage KR, 2013, CLIN REHABIL, V27, P521, DOI 10.1177/0269215512464230; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; Stephens JA, 2015, OTJR-OCCUP PART HEAL, V35, P5, DOI 10.1177/1539449214561765; Svoboda E, 2015, NEUROPSYCHOL REHABIL, V25, P353, DOI 10.1080/09602011.2014.927368; Williamson T, 2015, DISABIL REHABIL-ASSI, V10, P258, DOI 10.3109/17483107.2014.908247; Wolpin Seth, 2011, Semin Oncol Nurs, V27, P183, DOI 10.1016/j.soncn.2011.04.003; Xiao B, 2014, LECT NOTES ELECTR EN, V308, P99, DOI 10.1007/978-3-642-54900-7_14	45	9	9	0	22	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2318			BMC GERIATR	BMC Geriatr.	MAR 7	2016	16								61	10.1186/s12877-016-0238-x			11	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	DG0QY	WOS:000371771900002	26951709	Green Published, gold			2022-02-06	
J	Ibanez-Molina, AJ; Iglesias-Parro, S				Ibanez-Molina, Antonio J.; Iglesias-Parro, Sergio			Neurocomputational Model of EEG Complexity during Mind Wandering	FRONTIERS IN COMPUTATIONAL NEUROSCIENCE			English	Article						neural dynamics; mind wandering; Kuramoto model; synchrony; EEG complexity	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE; FRONTOPARIETAL CONTROL; CORTICAL NETWORKS; SALIENCE NETWORK; PHASE SYNCHRONY; INSULAR CORTEX; CONNECTIVITY; COGNITION; DYNAMICS	Mind wandering (MW) can be understood as a transient state in which attention drifts from an external task to internal self-generated thoughts. MW has been associated with the activation of the Default Mode Network (DMN). In addition, it has been shown that the activity of the DMN is anti-correlated with activation in brain networks related to the processing of external events (e.g., Salience network, SN). In this study, we present a mean field model based on weakly coupled Kuramoto oscillators. We simulated the oscillatory activity of the entire brain and explored the role of the interaction between the nodes from the DMN and SN in MW states. External stimulation was added to the network model in two opposite conditions. Stimuli could be presented when oscillators in the SN showed more internal coherence (synchrony) than in the DMN, or, on the contrary, when the coherence in the SN was lower than in the DMN. The resulting phases of the oscillators were analyzed and used to simulate EEG signals. Our results showed that the structural complexity from both simulated and real data was higher when the model was stimulated during periods in which DMN was more coherent than the SN. Overall, our results provided a plausible mechanistic explanation to MW as a state in which high coherence in the DMN partially suppresses the capacity of the system to process external stimuli.	[Ibanez-Molina, Antonio J.; Iglesias-Parro, Sergio] Univ Jaen, Dept Psychol, Jaen, Spain		Ibanez-Molina, AJ (corresponding author), Univ Jaen, Dept Psychol, Jaen, Spain.	anjoibanez@gmail.com	Ibanez Molina, Antonio Jose/ABE-2989-2021; Iglesias-Parro, Sergio/A-6958-2012; Iglesias-Parro, Sergio/N-8126-2019	Ibanez Molina, Antonio Jose/0000-0001-6673-0012; Iglesias-Parro, Sergio/0000-0001-9153-8743; Iglesias-Parro, Sergio/0000-0001-9153-8743			Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Baird B, 2014, J COGNITIVE NEUROSCI, V26, P2596, DOI 10.1162/jocn_a_00656; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Breakspear M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00190; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cabral J, 2014, PROG NEUROBIOL, V114, P102, DOI 10.1016/j.pneurobio.2013.12.005; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Corey DM, 1998, J GEN PSYCHOL, V125, P245, DOI 10.1080/00221309809595548; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Escudero J., 2015, 37 ANN INT C IEEE EN, P7873; Fisher SRA, 1973, STAT METHODS RES WOR; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hellyer PJ, 2014, J NEUROSCI, V34, P451, DOI 10.1523/JNEUROSCI.1853-13.2014; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hu NT, 2012, CONSCIOUS COGN, V21, P139, DOI 10.1016/j.concog.2011.12.007; Hudetz AG, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00234; Ibanez-Molina AJ, 2014, BRAIN COGNITION, V87, P69, DOI 10.1016/j.bandc.2014.03.002; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Knyazev GG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00264; Kuramoto Y., 2003, CHEM OSCILLATIONS WA; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LUTZENBERGER W, 1995, NEUROSCI LETT, V183, P39, DOI 10.1016/0304-3940(94)11109-V; Marzetti L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00832; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayhew SD, 2013, NEUROIMAGE, V75, P68, DOI 10.1016/j.neuroimage.2013.02.028; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mooneyham BW, 2013, CAN J EXP PSYCHOL, V67, P11, DOI 10.1037/a0031569; Nakagawa TT, 2013, NEUROIMAGE, V80, P318, DOI 10.1016/j.neuroimage.2013.04.055; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sadaghiani S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00020; Scott G, 2015, HUM BRAIN MAPP, V36, P1348, DOI 10.1002/hbm.22706; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shanahan M, 2010, CHAOS, V20, DOI 10.1063/1.3305451; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2012, BRAIN RES, V1428, P60, DOI 10.1016/j.brainres.2011.03.072; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Uddin LQ, 2014, J COGNITIVE NEUROSCI, V26, P16, DOI 10.1162/jocn_a_00462; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vasa F, 2015, NEUROIMAGE, V118, P456, DOI 10.1016/j.neuroimage.2015.05.042; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wildie M, 2012, CHAOS, V22, DOI 10.1063/1.4766592; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012	61	9	9	1	26	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5188			FRONT COMPUT NEUROSC	Front. Comput. Neurosci.	MAR 4	2016	10								20	10.3389/fncom.2016.00020			10	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	DF4SK	WOS:000371340500001	26973505	Green Published, gold			2022-02-06	
J	Makani, V; Jang, YG; Christopher, K; Judy, W; Eckstein, J; Hensley, K; Chiaia, N; Kim, DS; Park, J				Makani, Vishruti; Jang, Yong-gil; Christopher, Kevin; Judy, Wesley; Eckstein, Jacob; Hensley, Kenneth; Chiaia, Nicolas; Kim, Dong-Shik; Park, Joshua			BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CELL-ADHESION MOLECULE; GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMERS-DISEASE IMPLICATIONS; FACTOR RECEPTOR ACTIVATION; CULTURED CORTICAL-NEURONS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA; TRANSGENIC MODEL	An enormous amount of efforts have been poured to find an effective therapeutic agent for the treatment of neurodegenerative diseases including Alzheimer's disease (AD). Among those, neurotrophic peptides that regenerate neuronal structures and increase neuron survival show a promise in slowing neurodegeneration. However, the short plasma half-life and poor blood-brain-barrier (BBB)-permeability of neurotrophic peptides limit their in vivo efficacy. Thus, an alternative neurotrophic agent that has longer plasma half-life and better BBB-permeability has been sought for. Based on the recent findings of neuroprotective polysaccharides, we searched for a BBB-permeable neuroprotective polysaccharide among natural polysaccharides that are approved for human use. Then, we discovered midi-GAGR, a BBB-permeable, long plasma half-life, strong neuroprotective and neurotrophic polysaccharide. Midi-GAGR is a 4.7kD cleavage product of low acyl gellan gum that is approved by FDA for human use. Midi-GAGR protected rodent cortical neurons not only from the pathological concentrations of co-/post-treated free reactive radicals and A beta(42) peptide but also from activated microglial cells. Moreover, midi-GAGR showed a good neurotrophic effect; it enhanced neurite outgrowth and increased phosphorylated cAMP-responsive element binding protein (pCREB) in the nuclei of primary cortical neurons. Furthermore, intra-nasally administered midi-GAGR penetrated the BBB and exerted its neurotrophic effect inside the brain for 24 h after one-time administration. Midi-GAGR appears to activate fibroblast growth factor receptor 1 (FGFR1) and its downstream neurotrophic signaling pathway for neuroprotection and CREB activation. Additionally, 14-day intranasal administration of midi-GAGR not only increased neuronal activity markers but also decreased hyperphosphorylated tau, a precursor of neurofibrillary tangle, in the brains of the AD mouse model, 3xTg-AD. Taken together, midi-GAGR with good BBB-permeability, long plasma half-life, and strong neuroprotective and neurotrophic effects has a great therapeutic potential for the treatment of neurodegenerative diseases, especially AD.	[Makani, Vishruti; Jang, Yong-gil; Christopher, Kevin; Judy, Wesley; Eckstein, Jacob; Chiaia, Nicolas; Park, Joshua] Univ Toledo, Coll Med & Life Sci, Dept Neurosci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Hensley, Kenneth] Univ Toledo, Coll Med & Life Sci, Dept Pathol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Kim, Dong-Shik] Univ Toledo, Dept Chem Engn, Coll Engn, 2801 W Bancroft St, Toledo, OH 43606 USA		Park, J (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Neurosci, 2801 W Bancroft St, Toledo, OH 43606 USA.	Joshua.park2@utoledo.edu	Makani, Vishruti/K-7950-2019		Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K22HD056137-01A1]; NIH American Recovery & Reinvestment Act (ARRA) grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K22HD056137] Funding Source: NIH RePORTER	JP - Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD) K22 (1K22HD056137-01A1) https://www.nichd.nih.gov/grants-funding/Pages/default.aspx. JP - NIH American Recovery & Reinvestment Act (ARRA) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyare EK, 2014, J CONTROL RELEASE, V185, P121, DOI 10.1016/j.jconrel.2014.04.010; Akagi M, 2015, J PHARMACOL SCI, V127, P155, DOI 10.1016/j.jphs.2014.12.015; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Anand R, 2007, CLIN PHARMACOKINET, V46, P351, DOI 10.2165/00003088-200746040-00007; ANDERSON DMW, 1988, FOOD ADDIT CONTAM, V5, P237, DOI 10.1080/02652038809373701; ASAI T, 1993, MOL BRAIN RES, V17, P174, DOI 10.1016/0169-328X(93)90088-7; Barco A, 2011, MOL NEUROBIOL, V44, P330, DOI 10.1007/s12035-011-8209-x; Barde YA, 1987, PROG BRAIN RES <D>, V71, P185; Baskin F, 1997, J NEUROL SCI, V148, P15, DOI 10.1016/S0022-510X(96)05335-X; Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Bush MA, 2001, J CLIN PHARMACOL, V41, P378, DOI 10.1177/00912700122010230; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Chen Y, 2011, INT J BIOL MACROMOL, V49, P681, DOI 10.1016/j.ijbiomac.2011.06.031; Chen YS, 2010, J NEUROSCI RES, V88, P1882, DOI 10.1002/jnr.22374; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Christopher K, 2015, METHODSX, V2, P174, DOI 10.1016/j.mex.2015.03.006; Ciesler J., 2013, OPEN J NEUROSCI, V3, P3; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; de Leon MJ, 2006, NEUROBIOL AGING, V27, P394, DOI 10.1016/j.neurobiolaging.2005.07.003; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Domanskyi A, 2015, HUM GENE THER, V26, P550, DOI 10.1089/hum.2015.065; Emery AC, 2012, FASEB J, V26, P3199, DOI 10.1096/fj.11-203042; Fagan AM, 2010, BIOMARK MED, V4, P51, DOI 10.2217/BMM.09.83; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Faulkner MA, 2014, EXPERT OPIN DRUG SAF, V13, P1055, DOI 10.1517/14740338.2014.931369; Feng CC, 2012, INT J PHARMACEUT, V423, P226, DOI 10.1016/j.ijpharm.2011.12.008; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Gao YL, 2012, ENVIRON TOXICOL PHAR, V33, P304, DOI 10.1016/j.etap.2011.12.022; Garcia P, 2010, J NEUROSCI, V30, P7516, DOI 10.1523/JNEUROSCI.4182-09.2010; Ghezzi L, 2013, DRUG DES DEV THER, V7, P1471, DOI 10.2147/DDDT.S41431; Gill JC, 2006, BIOL REPROD, V74, P463, DOI 10.1095/biolreprod.105.046904; Graham BM, 2010, BEHAV NEUROSCI, V124, P337, DOI 10.1037/a0019582; Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Ho YS, 2010, J ALZHEIMERS DIS, V19, P813, DOI 10.3233/JAD-2010-1280; Hogan DB, 2014, CAN J PSYCHIAT, V59, P618, DOI 10.1177/070674371405901202; Hosseini SMR, 2014, EUR NEUROPSYCHOPHARM, V24, P846, DOI 10.1016/j.euroneuro.2014.02.001; Ikegaya Y, 2000, NEUROSCIENCE, V97, P215, DOI 10.1016/S0306-4522(00)00098-1; Iqbal K, 2011, ACTA NEUROPATHOL, V122, P543, DOI 10.1007/s00401-011-0878-z; Jafarieh O, 2015, DRUG DEV IND PHARM, V41, P1674, DOI 10.3109/03639045.2014.991400; Jessen U, 2001, J NEUROCHEM, V79, P1149, DOI 10.1046/j.1471-4159.2001.00636.x; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Joodi G, 2011, INT J BIOL MACROMOL, V48, P726, DOI 10.1016/j.ijbiomac.2011.02.011; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; Katsouri L, 2015, NEUROBIOL AGING, V36, P821, DOI 10.1016/j.neurobiolaging.2014.10.004; Katsuki H, 2000, BRAIN RES, V885, P240, DOI 10.1016/S0006-8993(00)02953-X; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kiyota T, 2011, P NATL ACAD SCI USA, V108, pE1339, DOI 10.1073/pnas.1102349108; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Knafo S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001262; Kolkova K, 2000, J NEUROSCI, V20, P2238; Li GF, 2014, INT J PHARMACEUT, V471, P234, DOI 10.1016/j.ijpharm.2014.05.038; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li Y, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009444.pub3; Liebner R, 2014, EUR J PHARM BIOPHARM, V87, P378, DOI 10.1016/j.ejpb.2014.03.010; Liu Rong, 2009, Pathophysiology, V16, P273, DOI 10.1016/j.pathophys.2009.02.008; Liu X, 1999, MOL BRAIN RES, V71, P210, DOI 10.1016/S0169-328X(99)00186-2; Longo Frank M., 2005, Current Alzheimer Research, V2, P167, DOI 10.2174/1567205053585819; Lovell MA, 1997, NEUROBIOL AGING, V18, P457, DOI 10.1016/S0197-4580(97)00108-5; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; MATSUO A, 1994, NEUROSCIENCE, V60, P49, DOI 10.1016/0306-4522(94)90203-8; McGrath LT, 2001, QJM-MON J ASSOC PHYS, V94, P485, DOI 10.1093/qjmed/94.9.485; Mehta PD, 2001, NEUROSCI LETT, V304, P102, DOI 10.1016/S0304-3940(01)01754-2; Miltenburg AMM, 2013, BRIT J CLIN PHARMACO, V75, P1221, DOI 10.1111/j.1365-2125.2012.04460.x; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Molina-Holgado F, 2008, CNS NEUROL DISORD-DR, V7, P110; Nagahara AH, 2013, J NEUROSCI, V33, P15596, DOI 10.1523/JNEUROSCI.5195-12.2013; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x; Noshita T, 2012, EUR J PHARMACOL, V695, P76, DOI 10.1016/j.ejphar.2012.09.020; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Park JJ, 2008, MOL CELL NEUROSCI, V39, P63, DOI 10.1016/j.mcn.2008.05.016; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Popov M, 2013, EUR J PHARM BIOPHARM, V85, P381, DOI 10.1016/j.ejpb.2013.06.005; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Reddy PH, 2010, J ALZHEIMERS DIS, V20, pS499, DOI 10.3233/JAD-2010-100504; Rockenstein E, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-90; Ronn LCB, 2000, J NEUROCHEM, V75, P665, DOI 10.1046/j.1471-4159.2000.0750665.x; Ruther E, 2000, J NEURAL TRANSM, V107, P815, DOI 10.1007/s007020070061; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Secher T, 2006, NEUROSCIENCE, V141, P1289, DOI 10.1016/j.neuroscience.2006.04.059; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Shineman DW, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt90; Sivanesan S, 2013, CURR ALZHEIMER RES, V10, P316, DOI 10.2174/1567205011310030011; Sivasubramanian M, 2013, J NANOSCI NANOTECHNO, V13, P7306, DOI 10.1166/jnn.2013.8090; Skibo GG, 2005, EUR J NEUROSCI, V22, P1589, DOI 10.1111/j.1460-9568.2005.04345.x; Sperling MR, 2014, EPILEPSIA, V55, P1544, DOI 10.1111/epi.12755; Steiner JP, 2014, J NEUROIMMUNE PHARM, V9, P182, DOI 10.1007/s11481-014-9533-5; STOPA EG, 1990, BIOCHEM BIOPH RES CO, V171, P690, DOI 10.1016/0006-291X(90)91201-3; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Teich AF, 2015, NEUROTHERAPEUTICS, V12, P29, DOI 10.1007/s13311-014-0327-5; Tepper SJ, 2013, HEADACHE, V53, P62, DOI 10.1111/head.12181; Tereshchenko J, 2014, NEUROBIOL DIS, V65, P35, DOI 10.1016/j.nbd.2014.01.009; Tiwari SK, 2014, CURR MED CHEM, V21, P2610, DOI 10.2174/0929867321666140217125857; Torres-Lista V, 2013, BEHAV BRAIN RES, V247, P153, DOI 10.1016/j.bbr.2013.03.021; Tuszynski MH, 2007, ALZ DIS ASSOC DIS, V21, P179, DOI 10.1097/WAD.0b013e318068d6d2; van Velthoven CTJ, 2014, MOL THER, V22, P645, DOI 10.1038/mt.2013.260; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Wang ZJ, 2007, ACTA PHARMACOL SIN, V28, P315, DOI 10.1111/j.1745-7254.2007.00512.x; Wober-Bingol C, 2013, PEDIATR DRUGS, V15, P235, DOI 10.1007/s40272-013-0019-3; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Woodbury ME, 2014, J NEUROIMMUNE PHARM, V9, P92, DOI 10.1007/s11481-013-9501-5; Wu B, 2004, J NEUROCHEM, V91, P1164, DOI 10.1111/j.1471-4159.2004.02805.x; Xu SJ, 2014, J ALZHEIMERS DIS, V39, P239, DOI 10.3233/JAD-130680; Yacila G, 2014, CURR MED CHEM, V21, P3583, DOI 10.2174/0929867321666140601162710; Yemisci M, 2015, J CEREBR BLOOD F MET, V35, P469, DOI 10.1038/jcbfm.2014.220; Zecchini S, 2010, ADV EXP MED BIOL, V663, P319, DOI 10.1007/978-1-4419-1170-4_20; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	130	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2016	11	3							e0149715	10.1371/journal.pone.0149715			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG0EB	WOS:000371735200034	26939023	Green Submitted, Green Published, gold			2022-02-06	
J	Castillo, I; Wolf, K; Rakowsky, A				Castillo, Iris; Wolf, Kimberly; Rakowsky, Alexander			Concussions and Osteopathic Manipulative Treatment: An Adolescent Case Presentation	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article								Concussions commonly occur in adolescents. Although the majority of adolescent patients' symptoms resolve, about 11% continue to experience symptoms at 3 months. Standard treatment options for prolonged symptoms are not available, and the role of osteopathic manipulative treatment in the management of adolescent concussions is unclear. The authors describe a case of a 16-year-old girl with a history of 3 head injuries who presented with concussion symptoms. After 6 weekly osteopathic manipulative treatment sessions, the patient was able to return to her normal activities. Further research on the role of osteopathic manipulative treatment to manage concussions is needed.	[Castillo, Iris] Nationwide Childrens Hosp, Residency Program, Columbus, OH USA; [Castillo, Iris] Doctors Hosp, Columbus, OH USA; [Wolf, Kimberly; Rakowsky, Alexander] Primary Care Network Associates, Nationwide Childrens Hosp, Pediat Ambulatory, Columbus, OH USA		Castillo, I (corresponding author), Nationwide Childrens Hosp, 700 Childrens Or, Columbus, OH 43205 USA.	iris.castillo@nationwidechildrens.org					Chappell C, 2015, OSTEOPATH FAM PHYS, V7, P30; Choe MC, 2016, J CHILD NEUROL, V31, P109, DOI 10.1177/0883073815572685; Ettlinger H, 2005, OSTEOPATHIC APPROACH, P549; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Laker SR, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0510-3; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Pope, 2003, AM ACAD OSTEOPATHY J, V14, P19; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	8	9	9	0	2	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	MAR	2016	116	3					178	181		10.7556/jaoa.2016.034			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	DT8NE	WOS:000381746700007	26927911				2022-02-06	
J	Cournoyer, J; Post, A; Rousseau, P; Hoshizaki, B				Cournoyer, Janie; Post, Andrew; Rousseau, Philippe; Hoshizaki, Blaine			The Ability of American Football Helmets to Manage Linear Acceleration With Repeated High-Energy Impacts	JOURNAL OF ATHLETIC TRAINING			English	Article						head injuries; material fatigue; education	HEAD IMPACTS; PLAYERS; INJURY; DESIGN	Context: Football players can receive up to 1400 head impacts per season, averaging 6.3 impacts per practice and 14.3 impacts per game. A decrease in the capacity of a helmet to manage linear acceleration with multiple impacts could increase the risk of traumatic brain injury. Objective: To investigate the ability of football helmets to manage linear acceleration with multiple high-energy impacts. Design: Descriptive laboratory study. Setting: Laboratory. Main Outcome Measure(s): We collected linear-acceleration data for 100 impacts at 6 locations on 4 helmets of different models currently used in football. Impacts 11 to 20 were compared with impacts 91 to 100 for each of the 6 locations. Results: Linear acceleration was greater after multiple impacts (91 - 100) than after the first few impacts (11 - 20) for the front, front-boss, rear, and top locations. However, these differences are not clinically relevant as they do not affect the risk for head injury. Conclusions: American football helmet performance deteriorated with multiple impacts, but this is unlikely to be a factor in head-injury causation during a game or over a season.	[Cournoyer, Janie; Post, Andrew; Rousseau, Philippe; Hoshizaki, Blaine] Univ Ottawa, 200 Lees Ave,Room A106, Ottawa, ON K1S 5S9, Canada		Cournoyer, J (corresponding author), Univ Ottawa, 200 Lees Ave,Room A106, Ottawa, ON K1S 5S9, Canada.	jcour016@uottawa.ca					Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P193, DOI 10.1177/1754337111431024; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; National Operating Committee on Standards for Athletic Equipment, 2007, D00104M05 NOCSAE; Nuscholtz GS, 1987, AVIAT SPACE ENV MED, V58, P1157; Popov, 1990, ENG MECH SOLIDS, P82; PRASAD P, 1985, 851246 SAE; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; White SW, 2000, NONLINEAR DYNAM, V22, P281, DOI 10.1023/A:1008302208269; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	15	9	9	0	10	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2016	51	3					258	263		10.4085/1062-6050-51.4.08			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DK2PB	WOS:000374755800008	26967549	Bronze, Green Published			2022-02-06	
J	Dickson, TJ; Trathen, S; Waddington, G; Terwiel, FA; Baltis, D				Dickson, Tracey J.; Trathen, Stephen; Waddington, Gordon; Terwiel, F. Anne; Baltis, Daniel			A human factors approach to snowsport safety: Novel research on pediatric participants' behaviors and head injury risk	APPLIED ERGONOMICS			English	Article						Snowsports; Helmet design; Head injury; Participant behavior; Methods	SPORTS INJURIES; HELMET USE; SNOWBOARDERS; SKIERS; SEVERITY; CONCUSSION; PREVENTION; ATTITUDES; CLIMATE	Objective: This study applied a human factors approach to snowsport resort systems to contribute to the understanding of the incidence and severity of pediatric snowsport head accelerations. Background: Previous research indicates low magnitude head accelerations are common among snowsport participants. This study adds to the knowledge of snowsport safety by measuring aspects of participants' snowsport behavior and linking this with head acceleration data. Method: School-aged students (n = 107) wore telemetry-fitted helmets and Global Positioning System (GPS) devices during snowsport activity. Data was collected over 159 sessions (total hours 701). Head accelerations recorded by the telemetry units were compared with GPS-generated data. Results: This study found speeds attained normally exceed the testing rating for which helmets are designed; lower rates of head accelerations compared to earlier studies and that when head accelerations did occur they were generally below the threshold for concussions. Conclusion: Pediatric snowsport head accelerations are rare and are generally of low magnitude. Those most at risk of a head acceleration >40 g were male snowboarders. Given the recorded speeds in first time participants, increased targeting of novice snowsport participants to encourage education about the use of protective equipment, including helmets, is warranted. Post event recall was not a good indicator of having experienced a head impact. Consideration should be given to raising the standard design speed testing for snowsport helmet protective devices to reflect actual snowsport behaviors. (C) 2015 Elsevier Ltd and The Ergonomics Society. All rights reserved.	[Dickson, Tracey J.; Trathen, Stephen; Waddington, Gordon] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT 2601, Australia; [Terwiel, F. Anne] Thompson Rivers Univ, Fac Adventure Culinary Arts & Tourism, Kamloops, BC V2C 5N3, Canada; [Baltis, Daniel] Univ Canberra, Fac Hlth, Canberra, ACT 2601, Australia		Trathen, S (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Univ Ave, Canberra, ACT 2601, Australia.	Tracey.Dickson@canberra.edu.au; Stephen.Trathen@canberra.edu.au; Gordon.Waddington@canberra.edu.au; aterwiel@tru.ca	Dickson, Tracey/Z-5352-2019	Dickson, Tracey/0000-0002-9889-1512; Terwiel, Anne/0000-0003-4621-201X; Waddington, Gordon/0000-0002-4306-9193	New South Wales Sporting Injuries Committee grant	This work was supported by a New South Wales Sporting Injuries Committee grant. Our thanks go to the students and teachers of all the schools involved in this research.	Amesberger G., 2012, SKIING AND SCI, P69; [Anonymous], 2011, INQ DEATHS HANN TAYL; [Anonymous], 2018, 31000 ISO; ASTM International, 2000, F2040 ASTM INT; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Bussewitz C., 2010, US TODAY; Cundy TP, 2010, J TRAUMA, V69, P1486, DOI 10.1097/TA.0b013e3181fee31c; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Dannenberg AL, 2011, MAKING HLTH PLACES D; Dickson T. J., 2013, AUST J OUTDOOR ED, V16, P24; Dickson T. J., 2008, J ASTM INT, V5; Dickson TJ, 2012, AM SOC TEST MATER, V1553, P184, DOI 10.1520/STP104490; Eccles DW, 2011, HUM FACTORS, V53, P180, DOI 10.1177/0018720811403731; Ellis E., 2013, VANCOUVER SUN; European Committee for Standardization, 1996, 10771996 EN EUR COMM; Finch CF, 2011, SPORTS MED, V41, P59, DOI 10.2165/11537260-000000000-00000; Flood L, 2006, HOSP SPORTS INJURY A; Gao C, 2008, APPL ERGON, V39, P385, DOI 10.1016/j.apergo.2007.08.001; Gissane C, 2001, MED SCI SPORT EXER, V33, P1999, DOI 10.1097/00005768-200112000-00004; Gizmag Team, 2007, REAL TIM ATHL MON FU; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Greenwald R. M., 2009, 18 C INT SOC SKIING; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Human Factors and Ergonomics Society, 2010, DEF HUM FACT ERG; Langran M., 2011, 19 C INT SOC SKIING; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P215; Munro C., 2006, SYDNEY MORNING HERAL; Rajan GP, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2004.011882; Ruedl G, 2011, SPORTVERLETZ SPORTSC, V25, P211, DOI 10.1055/s-0031-1273300; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Shealy JE., 2008, SKI CAN, V37, P50; SHEALY JE, 2005, J ASTM INT, V2, P12092; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; Sleet D., 2011, MAKING HLTH PLACES D, P77; Standards Australia, 2001, 48012001 ASNZS NSW; Steiger R, 2012, J SUSTAIN TOUR, V20, P867, DOI 10.1080/09669582.2012.680464; Terwiel F. A., 2015, STP ASTM, V1582, P3; Vanat L., 2014, 2014 INT REPORT SNOW; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Velani N, 2012, APPL ERGON, V43, P883, DOI 10.1016/j.apergo.2011.12.010; Warda LJ, 2012, PAED CHILD HEALT-CAN, V17, P38, DOI 10.1093/pch/17.1.35; Williams R, 2007, WILD ENVIRON MED, V18, P102, DOI 10.1580/06-WEME-OR-037R1.1	53	9	9	0	35	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0003-6870	1872-9126		APPL ERGON	Appl. Ergon.	MAR	2016	53		A				79	86		10.1016/j.apergo.2015.08.006			8	Engineering, Industrial; Ergonomics; Psychology, Applied	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Psychology	DA4NI	WOS:000367776200010	26674407				2022-02-06	
J	Gupta, DK; Singla, R; Kale, SS; Sharma, BS				Gupta, Deepak K.; Singla, Raghav; Kale, Shashank S.; Sharma, Bhawani S.			Intracerebral hypoglycemia and its clinical relevance as a prognostic indicator in severe traumatic brain injury: A cerebral microdialysis study from India	NEUROLOGY INDIA			English	Article						Decompressive craniectomy; glucose; microdialysis; traumatic brain injury	GLUCOSE; HYPERGLYCEMIA; METABOLISM; IMPACT	Context: Traumatic brain injury (TBI) remains a major cause of morbidity and mortality worldwide. Largely, the prognosis is dependent on the nonmodifiable factors such as severity of the initial injury, Glasgow coma scale score, pupillary response, age, and presence of additional physiological derangements such as hypoxia or hypotension. However, secondary insults continue to take place after the initial injury and resuscitation. The study hypothesis in the present research article was that hypoglycemia is an independent outcome prognosticator in severe traumatic brain injury. The study aimed to assess the role of glucose monitoring in the brain parenchyma as an independent outcome prognosticator and also to study its association with plasma glucose levels. Aims: The aim of the study was to analyze the relationship of intracerebral glucose measured by intraparenchymal cerebral microdialysis (CMD), and also to study its relationship with blood glucose levels. We also evaluated the relationship of these values to the outcome of patients. Settings and Design: Prospective nonrandomized study conducted at a tertiary care trauma center in India. Subjects and Methods: Twenty-five patients with severe TBI, who underwent decompressive craniectomy, were prospectively monitored with CMD catheters. Twenty cases had unilateral catheters placed intraparenchymally (20 mm inside the brain parenchyma to accommodate 10 mm of the semipermeable catheter tip and another 10 mm of extra catheter length). Frontotemporal contusions were noted in 21 cases and an acute subdural hematoma (with/without associated contusions) were noted in 15 cases in the present series. Bilateral CMD catheters were placed during bifrontal decompressive craniectomies in five patients (two patients had peri-contusional catheters placement; these patients had bilateral frontal contusions); while, the remaining 3 patients had a contralateral catheter placement in the normal brain parenchyma [Table 1]. The position of the catheters was confirmed on postoperative computerized tomographic scan carried out in these subjects. However, bilateral catheter placement to compare the difference in cerebral biochemical values of glucose in the penumbric zone as well as the normal brain could not be done in all cases due to cost restraints. The relation between plasma glucose and CMD-measured interstitial brain glucose concentrations, as well as the temporal pattern of CMD glucose was studied for 3-5 days following a decompressive craniectomy using a CMD analyzer at the patient's bedside at 1 hourly intervals. Statistical Analysis Used: All data were tabulated in Microsoft Excel 2011 and analyzed using SPSS version 21. To calculate the correlation between plasma and CMD glucose, Pearson's correlation was used with a two-tailed test of significance. Student's t-test was used to calculate the difference in means between the two groups. Significance was assumed at P <= 0.05. Results: Fifteen patients (60%) had a good outcome in terms of the Glasgow Outcome Scale (GOS) at 3 months while the rest (10 patients) had a poor GOS at 3 months. There was a significant difference in the incidence of hyperglycemia (random blood sugar >10 mmol/L) between the two groups (P < 0.0001). The difference between the two groups while comparing episodes of hypoglycemia was also significant (P = 0.0026). The good outcome group had fewer episodes of brain hypoglycemia during the presence of systemic hypoglycemia (P = 0.0026). Neither the mean blood glucose values nor the mean cerebral glucose values predicted the outcome at 3 months. Conclusions: After decompressive craniectomy in severe TBI, there was a poor correlation between the plasma and CMD glucose concentration. A higher degree of variation was seen in the correlations for individual patients. Neither the mean blood glucose values nor the mean cerebral glucose values predicted the outcome at 3 months. The good outcome group had fewer episodes of both hyperglycemia and hypoglycemia.	[Gupta, Deepak K.; Singla, Raghav; Kale, Shashank S.; Sharma, Bhawani S.] All India Inst Med Sci, Dept Neurosurg, New Delhi, India		Gupta, DK (corresponding author), All India Inst Med Sci, Dept Neurosurg, CN Ctr, Room 720, New Delhi, India.	drdeepakgupta@gmail.com		Singla, Raghav/0000-0003-4426-5089			Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; Choi IY, 2001, J CEREBR BLOOD F MET, V21, P653, DOI 10.1097/00004647-200106000-00003; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Strong AJ, 2007, CURR OPIN CRIT CARE, V13, P126, DOI 10.1097/MCC.0b013e32807faffb; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	12	9	10	0	5	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAR-APR	2016	64	2					259	264		10.4103/0028-3886.177617			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DG6DN	WOS:000372172500013	26954803				2022-02-06	
J	Hanel, RM; Palmer, L; Baker, J; Brenner, JA; Crowe, DT; Dorman, D; Gicking, JC; Gilger, B; Otto, CM; Robertson, SA; Rozanski, E; Trumpatori, B				Hanel, Rita M.; Palmer, Lee; Baker, Janice; Brenner, Jo-Anne; Crowe, Dennis T. (Tim); Dorman, David; Gicking, John C.; Gilger, Brian; Otto, Cynthia M.; Robertson, Sheilah A.; Rozanski, Elizabeth; Trumpatori, Brian		ACVECC's Vet Comm Trauma VetCOT	Best practice recommendations for prehospital veterinary care of dogs and cats	JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE			English	Article						cat; dog; first response; trauma; VetCOT	KNOWLEDGE GAP ANALYSIS; EMERGENCY-DEPARTMENT THORACOTOMY; UPPER AIRWAY-OBSTRUCTION; SMOKE-INHALATION INJURY; TRAUMATIC BRAIN-INJURY; SEVERE BURN INJURY; RECOVER EVIDENCE; PRACTICE GUIDELINES; HEATSTROKE VICTIMS; HYPERTONIC SALINE	ObjectiveTo examine available evidence on prehospital care in human and veterinary trauma and emergency medicine and develop best practice guidelines for use by both paramedical and nonparamedical personnel in the approach to the prehospital care of dogs and cats. DesignSystematic evaluation of the literature gathered via medical databases searches of Medline, CAB abstracts, and Google Scholar. SynthesisFrom a review and systematic evaluation of the available evidence, consensus guidelines on the approach to prehospital care of dogs and cats in 18 scenarios were developed. ConclusionsDue to the lack of current evidence in the veterinary prehospital arena, best practice guidelines were developed as an initial platform. Recommendations were based on a review of pertinent human and available veterinary literature as well as a consensus of the authors' professional opinions. It is anticipated that evidence-based additions will be made in the future.	[Hanel, Rita M.; Gilger, Brian] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27607 USA; [Dorman, David] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27607 USA; [Palmer, Lee] K9 Tact Emergency Casualty Care Working Grp, Auburn, AL 36830 USA; [Baker, Janice] Vet Tact Grp, Vass, NC 28394 USA; [Brenner, Jo-Anne] K9 MEDIC, Walnut, CA 91789 USA; [Crowe, Dennis T. (Tim)] Reg Inst Vet Emergencies & Referrals, Chattanooga, TN 37406 USA; [Gicking, John C.] BluePearl Vet Partners, Tampa, FL 33614 USA; [Otto, Cynthia M.] Univ Penn, Penn Vet Working Dog Ctr, Philadelphia, PA 19146 USA; [Robertson, Sheilah A.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Rozanski, Elizabeth] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA; [Trumpatori, Brian] Vet Specialty Hosp Carolinas, Cary, NC 27518 USA		Hanel, RM (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Clin Sci, 1060 William Moore Dr, Raleigh, NC 27606 USA.	rmhanel@ncsu.edu	Gilger, Brian/D-8776-2014	Gilger, Brian/0000-0002-7771-9166; Trumpatori, Brian/0000-0003-3434-1586			Adamik KN, 2015, J VET EMERG CRIT CAR, V25, P20, DOI 10.1111/vec.12283; AMSTERDAM JT, 1986, AM J EMERG MED, V4, P399, DOI 10.1016/0735-6757(86)90186-5; [Anonymous], 2015, DHS AUSTERE EMERGENC; [Anonymous], 2014, TACTICAL EMERGENCY C; Ashbaugh EA, 2012, J VET EMERG CRIT CAR, V22, P361, DOI 10.1111/j.1476-4431.2012.00759.x; Baker JL, 2013, J VET EMERG CRIT CAR, V23, P47, DOI 10.1111/j.1476-4431.2012.00823.x; Baker Janice L, 2012, J Spec Oper Med, V12, P8; Baker Janice L, 2009, J Spec Oper Med, V9, P105; Baker JL, 2013, J VET EMERG CRIT CAR, V1, P47; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bizikova P, 2008, VET DERMATOL, V19, P348, DOI 10.1111/j.1365-3164.2008.00697.x; Bord SP, 2008, EMERG MED CLIN N AM, V26, P97, DOI 10.1016/j.emc.2007.11.006; Bordelon JT, 2005, VET CLIN N AM-SMALL, V35, P1169, DOI 10.1016/j.cvsm.2005.05.007; Borron SW, 2006, CLIN TOXICOL, V44, P5, DOI 10.1080/15563650600811672; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Bouchama A, 2007, COOLING HEMODYNAMIC; Briganti A, 2010, J VET EMERG CRIT CAR, V20, P503, DOI 10.1111/j.1476-4431.2010.00579.x; Brown JE, 2009, J VET EMERG CRIT CAR, V19, P416, DOI 10.1111/j.1476-4431.2009.00458.x; Bruchim Y, 2006, J VET INTERN MED, V20, P38, DOI 10.1892/0891-6640(2006)20[38:HSIDAR]2.0.CO;2; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bulger EM, 2014, PREHOSP EMERG CARE, V18, P163, DOI 10.3109/10903127.2014.896962; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butler FK, 1996, MIL MED, V161, P3, DOI 10.1093/milmed/161.suppl_1.3; Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Callaway DW, 2011, J SPECIAL OPERATIONS, V11, P84; Canine Tactical Combat casualty Care (C-TCCC), 2014, J SPEC OPER MED, P243; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; Cazzolli D, 2015, J VET EMERG CRIT CAR, V25, P6, DOI 10.1111/vec.12281; Centers for Disease Control and Prevention, 2011, BOD MASS IND CONS PR, P1; Centers for Disease Control & Prevention, 2014, INJ PREV CONTR DAT S; Chau JPC, 2012, WORLDV EVID-BASED NU, V9, P129, DOI 10.1111/j.1741-6787.2011.00220.x; Choo KJL, 2010, ALLERGY, V65, P1205, DOI 10.1111/j.1398-9995.2010.02424.x; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; CRAWFORD LM, 1977, ANN RECH VET, V8, P315; DELACOUSSAYE JE, 1994, J NEUROSURG ANESTH, V6, P111; DiFazio J, 2013, VET CLIN N AM-SMALL, V43, P915, DOI 10.1016/j.cvsm.2013.03.002; Diggs LA, 2014, RESUSCITATION, V85, P885, DOI 10.1016/j.resuscitation.2014.02.032; Doty RL, 2004, OTOLARYNG CLIN N AM, V37, P1229, DOI 10.1016/j.otc.2004.05.002; Drobatz KJ, 1999, J AM VET MED ASSOC, V215, P1312; Drobatz KJ, 1999, J AM VET MED ASSOC, V215, P1306; Eagleson JS, 2012, AM J VET RES, V73, P539, DOI 10.2460/ajvr.73.4.539; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Ellerton JA, 2009, WILD ENVIRON MED, V20, P169, DOI 10.1580/08-WEME-REV-205R1.1; Ellis B Craig, 2014, J Spec Oper Med, V14, P1; Ellis BC, 2013, EMERG MED AUSTRALAS, V25, P92, DOI 10.1111/1742-6723.12028; Epstein M, 2015, J AM ANIM HOSP ASSOC, V51, P67, DOI 10.5326/JAAHA-MS-7331; EZEH PI, 1992, PHYSIOL BEHAV, V51, P1183, DOI 10.1016/0031-9384(92)90306-M; Fitzgibbons PG, 2012, J AM ACAD ORTHOP SUR, V20, P310, DOI 10.5435/JAAOS-20-05-310; Fletcher DJ, 2012, J VET EMERG CRIT CAR, V22, pS102, DOI 10.1111/j.1476-4431.2012.00757.x; Fortin JL, 2006, CLIN TOXICOL, V44, P37, DOI 10.1080/15563650600811870; Fullington RJ, 1997, J AM VET MED ASSOC, V210, P658; Garzotto CK, 2015, SMALL ANIMAL CRITICA; Goodrich ZJ, 2013, J SMALL ANIM PRACT, V54, P75, DOI 10.1111/jsap.12019; GUENTERT TW, 1986, J PHARMACOL EXP THER, V238, P295; Guenther-Yenke CL, 2007, J FELINE MED SURG, V9, P451, DOI 10.1016/j.jfms.2007.06.002; Gwaltney-Brant SM, 2003, J AM VET MED ASSOC, V222, P292, DOI 10.2460/javma.2003.222.292; Hammesfahr R, 2014, TACTICAL EMERGENCY M; Hansen IK, 2014, VET REC, V174, P17, DOI 10.1136/vr.101244; Hayes G, 2016, J VET EMERG CRIT CAR, V26, P35, DOI 10.1111/vec.12412; Hohenhaus AE, 2012, FLUID ELECTROLYTE AC, P585; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Hopper, 2015, SMALL ANIMAL CRITICA, P649; Hopper, 2015, SMALL ANIMAL CRITICA, P807; Hopper K, 2013, VET CLIN N AM-SMALL, V43, P955, DOI 10.1016/j.cvsm.2013.03.009; Hopper K, 2012, J VET EMERG CRIT CAR, V22, pS26, DOI 10.1111/j.1476-4431.2012.00753.x; James T, 2015, VET J, V203, P187, DOI 10.1016/j.tvjl.2014.12.021; Jasani S, 2015, SMALL ANIMAL CRITICA, P785; Jenkins EK, 2014, J VET INT MED, V28, P1091; Joint Trauma System, 2012, JOINT THEATER TRAUMA; K9 Tactical Emergency Casualty Care, 2015, K9 TECC GUID; Kakiuchi H, 2014, AM J VET RES, V75, P1099, DOI 10.2460/ajvr.75.12.1099; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kapur GB, 2010, PREHOSP DISASTER MED, V25, P595, DOI 10.1017/S1049023X00008815; Kelmer E, 2015, J VET EMERG CRIT CAR, V25, P495, DOI 10.1111/vec.12319; Kheirabadi BS, 2013, J TRAUMA ACUTE CARE, V75, P150, DOI 10.1097/TA.0b013e3182988afe; Khorsandi M, 2013, INTERACT CARDIOV TH, V16, P509, DOI 10.1093/icvts/ivs540; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Latenser BA, 2009, CRIT CARE MED, V37, P2819, DOI 10.1097/CCM.0b013e3181b3a08f; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lee JA, 2013, VET CLIN N AM-SMALL, V43, P757, DOI 10.1016/j.cvsm.2013.03.010; Leon LR, 2015, COMPR PHYSIOL, V5, P611, DOI 10.1002/cphy.c140017; Levy JK, 2015, J FELINE MED SURG, V17, P950, DOI 10.1177/1098612X15582081; Leybell I., 2015, CYANIDE AVAILABLE; Littlejohn LF, 2011, ACAD EMERG MED, V18, P340, DOI 10.1111/j.1553-2712.2011.01036.x; Liu S, 2011, CRIT CARE MED, V39, P1467, DOI 10.1097/CCM.0b013e3182120d13; MAGAZANIK A, 1980, AVIAT SPACE ENVIR MD, V51, P864; Mazzaferro E., 2015, SMALL ANIMAL CRITICA, V2nd ed., P77; Mistry N, 2009, EMERG MED J, V26, P738, DOI 10.1136/emj.2008.065599; Morley MG, 2010, DISASTER MED PUBLIC, V4, P154, DOI 10.1001/dmp.v4n2.hra10003; Muir WW, 2004, AM J VET RES, V65, P1189, DOI 10.2460/ajvr.2004.65.1189; Muir WW, 2003, AM J VET RES, V64, P1155, DOI 10.2460/ajvr.2003.64.1155; Murphy LA, 2003, J AM VET MED ASSOC, V222, P296, DOI 10.2460/javma.2003.222.296; Musulin SE, 2011, J VET PHARMACOL THER, V34, P17, DOI 10.1111/j.1365-2885.2010.01186.x; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; National Association of Emergency Medical Technicians (NAEMT), 2016, PREH TRAUM LIF SUPP, P647; National Association of Emergency Medical Technicians (NAEMT), 2016, PREH TRAUM LIF SUPP, P474; National Association of Emergency Medical Technicians. (NAEMT), 2016, PREH TRAUM LIF SUPP; Nicholson I, 2012, J SMALL ANIM PRACT, V53, P108, DOI 10.1111/j.1748-5827.2011.01167.x; Nurmatov UB, 2014, ANN ALLERG ASTHMA IM, V112, P126, DOI 10.1016/j.anai.2013.11.010; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; OGINO S, 1992, ORL J OTO-RHINO-LARY, V54, P152, DOI 10.1159/000276286; Olby NJ, 2016, J VET INTERN MED, V30, P206, DOI 10.1111/jvim.13657; Olsen LE, 2014, JAVMA-J AM VET MED A, V245, P923, DOI 10.2460/javma.245.8.923; Palmer LE, 2015, J SPECIAL OPER MED, V15, P33; Palmer L, 2014, J VET EMERG CRIT CAR, V24, P75, DOI 10.1111/vec.12138; Palmer L, 2014, J VET EMERG CRIT CAR, V24, P63, DOI 10.1111/vec.12130; Park EH, 2012, J VET EMERG CRIT CAR, V22, P160, DOI 10.1111/j.1476-4431.2012.00723.x; Pham TN, 2008, J BURN CARE RES, V29, P257, DOI 10.1097/BCR.0b013e31815f3876; Rankin KA, 2013, TOXINS, V5, P1051, DOI 10.3390/toxins5061051; Roush JK, 2005, VET CLIN N AM-SMALL, V35, P1137, DOI 10.1016/j.cvsm.2005.06.001; Rozanski EA, 2012, J VET EMERG CRIT CAR, V22, pS44, DOI 10.1111/j.1476-4431.2012.00755.x; Russell KW, 2014, WILD ENVIRON MED, V25, pS96, DOI 10.1016/j.wem.2014.07.016; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sanna T, 2008, RESUSCITATION, V76, P226, DOI 10.1016/j.resuscitation.2007.08.001; Santillanes G, 2010, EVIDENCE BASED REV P; Schimelpjenig T, 2012, NOLS WILDERNESS MED, P3; Seamon MJ, 2007, J TRAUMA, V63, P113, DOI 10.1097/TA.0b013e31806842a1; Sheikh A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006160.pub2; Shelah M, 2007, VET OPHTHALMOL, V10, P196, DOI 10.1111/j.1463-5224.2007.00533.x; Shepherd G, 2008, ANN PHARMACOTHER, V42, P661, DOI 10.1345/aph.1K559; Shmuel DL, 2013, J VET EMERG CRIT CAR, V23, P377, DOI 10.1111/vec.12066; Silverstein DC, 2005, J VET EMERG CRIT CAR, V15, P185, DOI 10.1111/j.1476-4431.2005.00138.x; Silverstein DC., 2015, SMALL ANIMAL CRITICA, V2; Smith ER, 2013, JEMS, V38, P54; Smith ER, 2013, JEMS, V38, P48; Smith ER, 2013, JEMS, V38, P52; Smith JE, 2005, BRIT J SPORT MED, V39, P503, DOI 10.1136/bjsm.2004.013466; Spector J, 2008, EMERG MED CLIN N AM, V26, P125, DOI 10.1016/j.emc.2007.11.002; Staffieri F, 2014, J VET EMERG CRIT CAR, V24, P578, DOI 10.1111/vec.12210; Stepnik MW, 2009, JAVMA-J AM VET MED A, V234, P638, DOI 10.2460/javma.234.5.638; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Taylor WM, 2008, J SPEC OPER MED, V8, P54; US Army Institute of Surgical Research, 2014, TCCC GUID; van Oostrom H, 2013, VET ANAESTH ANALG, V40, P265, DOI 10.1111/vaa.12015; Vaughn L, 2012, J VET EMERG CRIT CAR, V22, P187, DOI 10.1111/j.1476-4431.2012.00728.x; Vaughn L, 2012, J VET EMERG CRIT CAR, V22, P179, DOI 10.1111/j.1476-4431.2012.00727.x; Walthall K, 2012, EMERG MED J, V29, P342, DOI 10.1136/emermed-2012-201159.4; Waydhas C, 2007, RESUSCITATION, V72, P11, DOI 10.1016/j.resuscitation.2006.06.025; Wiederstein I, 2008, VET ANAESTH ANALG, V35, P374, DOI 10.1111/j.1467-2995.2008.00398.x; Wismer TA, 2003, J AM VET MED ASSOC, V222, P305, DOI 10.2460/javma.2003.222.305; Zitz J, 2007, VET MED-US, V102, P307	142	9	9	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1479-3261	1476-4431		J VET EMERG CRIT CAR	J. Vet. Emerg. Crit. Care	MAR-APR	2016	26	2					166	233		10.1111/vec.12455			68	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	DI0ND	WOS:000373192400002	26994496				2022-02-06	
J	Iorio-Morin, C; Fortin, D; Blanchard, J				Iorio-Morin, Christian; Fortin, David; Blanchard, Jocelyn			TBI prognosis calculator: A mobile application to estimate mortality and morbidity following traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Crash; IMPACT; Trauma; Neurosurgery; Neurology; Neurointensive care	EXTERNAL VALIDATION; HEAD-INJURY; INTERNATIONAL MISSION; INTRACRANIAL-PRESSURE; OUTCOME PREDICTION; MODELS; IMPACT; CRASH; MULTICENTER; MODERATE	Objective: Traumatic Brain Injury (TBI) is a significant public health problem and a leading cause of worldwide mortality and morbidity. Although effective evidence-based guidelines are available to help with management, the first question clinicians and family face is whether or not it is appropriate to intervene at all. To facilitate prognostic assessment and family counseling, we developed mobile application integrating validated TBI prognostic models. Methods: The medical literature was reviewed to identify existing and validated prognostic models of mortality and morbidity following TBI. After approbation by the selected original model authors, a mobile application incorporating these models was developed. Results: Of more than 100 published models, we identified the MRC CRASH trial-derived models as the most appropriate TBI prognosis tools for mobile use. These were integrated into an application we called "TBI Prognosis Calculator", which allows quick and interactive estimation of 14-days mortality and 6 months mortality and morbidity using demographic, clinical and radiologic variables. The application was programmed both for iOS-and Android-compatible devices and released as free applications in the platforms' respective distribution channels. Conclusions: Prompt and accurate prognosis estimation in TBI is promising. Mobile applications have the potential to enable easier and quicker point-of-care access to validated models, providing additional information to improve management and family counseling. We anticipate that clinicians will find "TBI Prognosis Calculator" useful as an adjunct in their prognostic assessment and family counseling. (C) 2016 Elsevier B.V. All rights reserved.	[Iorio-Morin, Christian; Fortin, David; Blanchard, Jocelyn] Univ Sherbrooke, Dept Surg, Div Neurosurg, Sherbrooke, PQ J1K 2R1, Canada; [Iorio-Morin, Christian] Hyperexis, Sherbrooke, PQ, Canada; [Fortin, David] Ctr Hosp Univ Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada		Iorio-Morin, C (corresponding author), Univ Sherbrooke, Ctr Hosp, Div Neurosurg, 3001,12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	christian.iorio-morin@usherbrooke.ca	Iorio-Morin, Christian/I-8696-2019	Iorio-Morin, Christian/0000-0003-2995-7255	funds de recherche du Quebec Sante (FRQS)	CI-M a stakeholder in Hyperexis, a mobile application development company. He received no funding nor financial support from Hyperexis for his work on the TBI Prognosis Calculator and the application described herein is available free of charge. CI-M receives an M.D.-Ph.D. scholarship from the funds de recherche du Quebec-Sante (FRQS).	Akhtar JI, 2010, CRIT CARE MED, V38, P1605, DOI 10.1097/CCM.0b013e3181e4b771; Boulos Maged N Kamel, 2014, Online J Public Health Inform, V5, P229, DOI 10.5210/ojphi.v5i3.4814; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Ferrero P, 2015, INT J CARDIOL, V188, P1, DOI 10.1016/j.ijcard.2015.03.154; Gonzalez-Mao MC, 2011, CLIN LAB, V57, P587; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Honeybul S, 2014, J NEUROSURG, V120, P1131, DOI 10.3171/2014.1.JNS131559; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1976, LANCET, V1, P1031; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEE KL, 1986, AM J MED, V80, P553, DOI 10.1016/0002-9343(86)90807-7; LEMESHOW S, 1995, INTENS CARE MED, V21, P770, DOI 10.1007/BF01704747; Lesko MM, 2013, J NEUROTRAUM, V30, P2021, DOI 10.1089/neu.2013.2988; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Martinez-Perez B, 2014, J MED SYST, V38, DOI 10.1007/s10916-013-0004-y; MRC CRASH Trial Collaborators, 2008, PROGN MOD PRED OUTC; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Oh Hyun Soo, 2006, Taehan Kanho Hakhoe Chi, V36, P621; Olivecrona M, 2013, J CLIN NEUROSCI, V20, P996, DOI 10.1016/j.jocn.2012.09.015; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Ronning PA, 2011, J TRAUMA, V70, pE56, DOI 10.1097/TA.0b013e3181e80f0a; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Soreide E, 2013, CRIT CARE MED, V41, P1158, DOI 10.1097/CCM.0b013e31827bfa2c; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Turner-McGrievy GM, 2013, J AM MED INFORM ASSN, V20, P513, DOI 10.1136/amiajnl-2012-001510; Vigue B, 2014, ANN FR ANESTH, V33, P110, DOI 10.1016/j.annfar.2013.11.008; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Yuan Q, 2013, BRAIN INJURY, V27, P664, DOI 10.3109/02699052.2013.775497; Zaki Michael, 2014, Surg Neurol Int, V5, P113, DOI 10.4103/2152-7806.137534	51	9	9	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2016	142						48	53		10.1016/j.clineuro.2016.01.021			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DH3HF	WOS:000372677400009	26808078				2022-02-06	
J	Jang, SH; Lee, AY; Shin, SM				Jang, Sung Ho; Lee, Ah Young; Shin, So Min			Injury of the Arcuate Fasciculus in the Dominant Hemisphere in Patients With Mild Traumatic Brain Injury A Retrospective Cross-Sectional Study	MEDICINE			English	Article							WHITE-MATTER TRACTS; STROKE PATIENTS; FIBER DENSITY; DIFFUSION; APHASIA; LANGUAGE; DAMAGE; ABNORMALITIES; TRACTOGRAPHY; ASYMMETRY	Little is known about injury of the arcuate fasciculus (AF) in patients with mild traumatic brain injury (TBI). We investigated injury of the AF in the dominant hemisphere in patients with mild TBI, using diffusion tensor tractography (DTT). We recruited 25 patients with injury of the left AF among 64 right-handed consecutive patients with mild TBI and 20 normal control subjects. DTTs of the left AF were reconstructed, and fractional anisotropy (FA), apparent diffusion coefficient (ADC), and fiber number of the AF were measured. Among 64 consecutive patients, 25 (39%) patients showed injury of the left AF. The patient group showed lower FA value and fiber number with higher ADC value than the control group (P < 0.05). On K-WAB evaluation, aphasia quotient and language quotient were 95.9 +/- 4.1 (range 85-100) and 95.0 +/- 5.4 (range 80-100), respectively. However, 23 (92.0%) of 25 patients complained of language-related symptoms after TBI; paraphasia in 12 (48.0%) patients, deficits of comprehension in 4 (16.0%) patients, deficits of speech production in 1 (4.0%) patient, and > 2 language symptoms in 6 (24.0%) patients. We found that a significant number (39%) of patients with mild TBI had injury of the AF in the dominant hemisphere and these patients had mild language deficit. These results suggest that DTT could provide useful information in detecting injury of the AF and evaluation of the AF using DTT would be necessary even in the case of a patient with mild TBI who complains of mild language deficit.	[Jang, Sung Ho; Lee, Ah Young; Shin, So Min] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu, South Korea.	nocturne27@naver.com			National Research Foundation (NRF) of Korea Grant - Korean Government (MSIP) [2015R1A2A2A01004073]	this work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MSIP) (2015R1A2A2A01004073).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bernal B, 2009, BRAIN, V132, P2309, DOI 10.1093/brain/awp206; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Breier JI, 2008, AM J NEURORADIOL, V29, P483, DOI 10.3174/ajnr.A0846; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; Hosomi A, 2009, NEURORADIOLOGY, V51, P549, DOI 10.1007/s00234-009-0534-7; Jang SH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00749; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kim SH, 2013, AM J NEURORADIOL, V34, P785, DOI 10.3174/ajnr.A3259; Kim SH, 2011, NEUROREHABILITATION, V29, P305, DOI 10.3233/NRE-2011-0706; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Liegeois FJ, 2013, BRAIN LANG, V127, P388, DOI 10.1016/j.bandl.2013.05.003; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makris N, 2009, BRAIN STRUCT FUNCT, V213, P343, DOI 10.1007/s00429-008-0199-8; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Na DL, 2012, REVISED KOREAN VERSI; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Nucifora PGP, 2005, NEUROREPORT, V16, P791, DOI 10.1097/00001756-200505310-00002; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; Shin YI, 2013, BRAIN NEUROREHAB, V6, P17; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tak HJ, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-46; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Wesson Ashford J, 2009, MIL MED, V174, pv; Zhang YM, 2010, NEUROL RES, V32, P775, DOI 10.1179/016164109X12478302362653	40	9	10	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR	2016	95	9							e3007	10.1097/MD.0000000000003007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK8WI	WOS:000375208900040	26945425	gold, Green Published			2022-02-06	
J	Sun, ZQ; Dai, XY; Li, Y; Jiang, SW; Lou, GF; Cao, QY; Hu, RD; Huang, YD; Su, ZJ; Chen, MW; Luo, HM; Lin, X; Sun, J; Xiao, F				Sun, Zhongqing; Dai, Xiaoyong; Li, Yu; Jiang, Shuwen; Lou, Guofeng; Cao, Qiaoyu; Hu, Rendong; Huang, Yadong; Su, Zhijian; Chen, Meiwan; Luo, Huanmin; Lin, Xi; Sun, Jun; Xiao, Fei			A novel Nogo-66 receptor antagonist peptide promotes neurite regeneration in vitro	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Nogo-66 receptor; Antagonist peptide; Neurite regeneration; Phage display	SYNAPTIC PLASTICITY; FUNCTIONAL RECOVERY; OUTGROWTH INHIBITOR; PHAGE DISPLAY; AMYLOID-BETA; IDENTIFICATION; CANCER	The Nogo-66 receptor (NgR1), a receptor for Nogo-A, contributes to the inhibition of axonal regeneration in the adult central nervous system after traumatic injuries. Thus, NgR1 has been considered a critical target in axon regeneration therapy. Here, we identified a specific NgR1 antagonist peptide (HIYTALV, named NAP2) which promotes neurite regeneration in vitro from a phage display heptapeptide library. NAP2 was co-localized with NgR1 on the surface of PC12 cells and cerebellar granule cells (CGCs) by immunofluorescence assay. Horseradish peroxidase (HRP)-streptavidin-biotin assay further showed that NAP2 binds to NgR1 and the dissociation constant (Kd) was 0.45 mu M Functional analyses indicated that NAP2 could reduce the inhibitory effects of Nogo-66 on neurite outgrowth in differentiated PC12 cells and CGCs by blocking the Nogo-66-induced activation of Rho associated coiled coil-containing protein kinase (ROCK), collapsin response mediator protein 2 (CRMP2) and myosin light chain (MLC). Taken together, the small molecule NgR1 antagonist peptide NAP2 (MW: 815.98 Da) has a potential ability in crossing blood brain barrier and will be a promising therapeutic agent for the treatment of spinal cord injury and neurodegenerative diseases. (C) 2015 Elsevier Inc All rights reserved.	[Sun, Zhongqing; Li, Yu; Jiang, Shuwen; Hu, Rendong; Luo, Huanmin; Lin, Xi; Xiao, Fei] Jinan Univ, Sch Med, Dept Pharmacol, Guangzhou 510632, Guangdong, Peoples R China; [Dai, Xiaoyong; Lou, Guofeng; Cao, Qiaoyu; Huang, Yadong; Su, Zhijian] Jinan Univ, Ctr Res & Dev, Inst Biomed, Dept Biopharmaceut, Guangzhou 510632, Guangdong, Peoples R China; [Chen, Meiwan] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China; [Sun, Jun] Jinan Univ, Inst Hydrobiol, Guangzhou 510632, Guangdong, Peoples R China; [Lin, Xi; Xiao, Fei] Jinan Univ, Guangzhou Key Lab Environm Exposure & Hlth, Guangzhou 510632, Guangdong, Peoples R China		Xiao, F (corresponding author), Jinan Univ, Sch Med, Dept Pharmacol, Guangzhou 510632, Guangdong, Peoples R China.; Sun, J (corresponding author), Jinan Univ, Inst Hydrobiol, Guangzhou 510632, Guangdong, Peoples R China.	tsunjun@jnu.edu.cn; xiaofei@jnu.edu.cn	Lou, Guofeng/C-8898-2012	Lou, Guofeng/0000-0003-3873-0247	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81202519, 81403120]; Guangdong Province [S2011040002140]; National High Technology Research and Development Program of ChinaNational High Technology Research and Development Program of China [2014AA020534]; Science and Technology Planning Project of Guangdong Province [2013B010404030, 2014A010105029]; Macao Science and Technology Development Fund [102/2012/A3]; Fundamental Research Funds for Central Universities Project [11615494]; Ocean and Fisheries Foundation of Guangdong Province [A201301B09]; National Key New Drug Creation of China [2012ZX09103301-034]	This study was funded by the Natural Science Foundation of China (No. 81202519 and No. 81403120) and Guangdong Province (No. S2011040002140). This study was supported by National High Technology Research and Development Program of China (2014AA020534) and Science and Technology Planning Project of Guangdong Province (2013B010404030, 2014A010105029). This study was funded by the Macao Science and Technology Development Fund (102/2012/A3) and Fundamental Research Funds for the Central Universities Project (No. 11615494). This study was supported by Ocean and Fisheries Foundation of Guangdong Province (No. A201301B09) and National Key New Drug Creation of China (No. 2012ZX09103301-034).	Cao Y, 2008, NEUROREHAB NEURAL RE, V22, P262, DOI 10.1177/1545968307308550; Cao ZX, 2010, MOL CELL NEUROSCI, V43, P1, DOI 10.1016/j.mcn.2009.07.008; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Dai X., 2015, APPL MICROBIOL BIOTE; Dai XY, 2014, BIOCHEM BIOPH RES CO, V445, P795, DOI 10.1016/j.bbrc.2014.02.022; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; GrandPre T., 2004, NATURE, V403, P444; Hamzeh-Mivehroud M, 2013, DRUG DISCOV TODAY, V18, P1144, DOI 10.1016/j.drudis.2013.09.001; Kandel E, 2010, ONCOTARGET, V1, P84, DOI 10.18632/oncotarget.112; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Kempf A, 2013, PHYSIOLOGY, V28, P151, DOI 10.1152/physiol.00052.2012; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Mitchell PJ, 2007, J NEUROSCI METH, V164, P350, DOI 10.1016/j.jneumeth.2007.04.021; Moeller A., 2013, J NEUROL DISORD, V01; Park JH, 2006, J NEUROSCI, V26, P13279, DOI 10.1523/JNEUROSCI.4504-06.2006; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Petratos S, 2012, BRAIN, V135, P1794, DOI 10.1093/brain/aws100; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Tews B, 2013, P NATL ACAD SCI USA, V110, P6583, DOI 10.1073/pnas.1217665110; Wang H, 2013, BIOTECHNOL LETT, V35, P671, DOI 10.1007/s10529-013-1145-2; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Xu Y. Q, 2015, CNS NEUROSCI THER; Yang YH, 2010, ANN NEUROL, V67, P498, DOI 10.1002/ana.21935; Zagrebelsky M., 2014, NEUROSCIENCE; zur Nedden S, 2014, J NEUROCHEM, V128, P111, DOI 10.1111/jnc.12397	33	9	11	3	31	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	MAR	2016	71						80	91		10.1016/j.mcn.2015.12.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF6CR	WOS:000371443900008	26711806				2022-02-06	
J	Xu, LY; Schaefer, ML; Linville, RM; Aggarwal, A; Mbuguiro, W; Wester, BA; Koliatsos, VE				Xu, Leyan; Schaefer, Michele L.; Linville, Raleigh M.; Aggarwal, Ayushi; Mbuguiro, Wangui; Wester, Brock A.; Koliatsos, Vassilis E.			Neuroinflammation in primary blast neurotrauma: Time course and prevention by torso shielding	EXPERIMENTAL NEUROLOGY			English	Article						Primary blast injury; Traumatic axonal injury; Neurotrauma; Microglia; Optic tract	TRAUMATIC BRAIN-INJURY; MICROGLIAL ACTIVATION; REACTIVE ASTROCYTES; AXONAL INJURY; MOUSE MODEL; IN-VIVO; INDUCED NEURODEGENERATION; INFLAMMATORY RESPONSE; MICE; TRANSFORMATION	Mechanisms of primary blast injury caused by overpressure are not fully understood. In particular, the presence and time course of neuroinflammation are unknown and so are the signatures of reactive inflammatory cells, especially the neuroprotective versus injurious roles of microglia. In general, chronic microglial activation in the injured brain suggests a pro-degenerative role for these reactive cells. In this study, we investigated the temporal dynamics of microglial activation in the brain of mice exposed to mild-moderate blast in a shock tube. Because, in our previous work, we had found that torso shielding with rigid Plexiglas attenuates traumatic axonal injury in the brain, we also evaluated neuroinflammatoty microglial responses in animals with torso protection at 7 days post blast injury. Because of the prominent involvement of the visual system in blast TBI in rodents, activated microglial cells were counted in the optic tract at various time points post-injury with stereological methods. Cell counts (activated microglial cell densities) from subjects exposed to blast TBI were compared with counts from corresponding sham animals. We found that mild-moderate blast injury causes focal activation of microglia in certain white matter tracts, including the visual pathway. In the optic tract, the density of activated microglial profiles gradually intensified from 3 to 15 days post-injury and then became attenuated at 30 days. Torso protection significantly reduced microglial activation at 7 days. These findings shed light into mechanisms of primary blast neurotrauma and may suggest novel diagnostic and monitoring methods for patients. They leave open the question of whether microglial activation post blast is protective or detrimental, although response is time limited. Finally, our findings confirm the protective role of torso shielding and stress the importance of improved or optimized body gear for warfighters or other individuals at risk for blast exposure. (C) 2016 Elsevier Inc. All rights reserved.	[Xu, Leyan; Aggarwal, Ayushi; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, 720 Rutland Ave,Ross Res Bldg 558, Baltimore, MD 21205 USA; [Schaefer, Michele L.; Linville, Raleigh M.; Mbuguiro, Wangui; Wester, Brock A.; Koliatsos, Vassilis E.] Johns Hopkins Univ, Appl Phys Lab, Natl Secur Technol, Johns Hopkins Rd, Laurel, MD 20723 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Schaefer, Michele L.; Linville, Raleigh M.; Aggarwal, Ayushi; Mbuguiro, Wangui; Wester, Brock A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA		Xu, LY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, 720 Rutland Ave,Ross Res Bldg 558, Baltimore, MD 21205 USA.	lxu9@jhmi.edu; mschae11@jhmi.edu; raleigh@bu.edu; ayushi1@umbc.edu; wmbuguiro@gmail.com; Brock.Wester@jhuapl.edu; koliat@jhmi.edu		Aggarwal, Ayushi/0000-0003-0458-5619; Mbuguiro, Wangui/0000-0001-7943-3017	DODUnited States Department of Defense [DM102465]; Maryland TEDCO [2011-MSCRF-11 0067-00, 110902]	This work was supported by DOD DM102465 (Cernak, PI, Koliatsos, subcontract PI) and also by Maryland TEDCO (2011-MSCRF-11 0067-00; 110902).	Acosta S.A., 2015, STROKE; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Dibaj P, 2011, NEUROSCI LETT, V497, P148, DOI 10.1016/j.neulet.2011.04.049; Dickens AM, 2014, J NUCL MED, V55, P466, DOI 10.2967/jnumed.113.125625; Dissing-Olesen L, 2007, NEUROSCIENCE, V149, P112, DOI 10.1016/j.neuroscience.2007.06.037; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Koliatsos V.E., 2015, REGEN MED; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; SUZUMURA A, 1991, BRAIN RES, V545, P301, DOI 10.1016/0006-8993(91)91302-H; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yamada J, 2013, J COMP NEUROL, V521, P1184, DOI 10.1002/cne.23228; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039	52	9	11	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2016	277						268	274		10.1016/j.expneurol.2016.01.010			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF2ST	WOS:000371194800027	26784004	Bronze			2022-02-06	
J	Bosch, M; Tavender, EJ; Brennan, SE; Knott, J; Gruen, RL; Green, SE				Bosch, Marije; Tavender, Emma J.; Brennan, Sue E.; Knott, Jonathan; Gruen, Russell L.; Green, Sally E.			The Many Organisational Factors Relevant to Planning Change in Emergency Care Departments: A Qualitative Study to Inform a Cluster Randomised Controlled Trial Aiming to Improve the Management of Patients with Mild Traumatic Brain Injuries	PLOS ONE			English	Article							HEALTH-CARE; KNOWLEDGE TRANSLATION; PROMOTING ACTION; IMPLEMENTATION; FRAMEWORK; GUIDELINES; INNOVATION; DIFFUSION; SERVICES; PROFESSIONALS	Background The Neurotrauma Evidence Translation (NET) Trial aims to design and evaluate the effectiveness of a targeted theory-and evidence-informed intervention to increase the uptake of evidence-based recommended practices for the management of patients who present to an emergency department (ED) with mild head injuries. When designing interventions to bring about change in organisational settings such as the ED, it is important to understand the impact of the context to ensure successful implementation of practice change. Few studies explicitly use organisational theory to study which factors are likely to be most important to address when planning change processes in the ED. Yet, this setting may have a unique set of organisational pressures that need to be taken into account when implementing new clinical practices. This paper aims to provide an in depth analysis of the organisational context in which ED management of mild head injuries and implementation of new practices occurs, drawing upon organisational level theory. Methods Semi-structured interviews were conducted with ED staff in Australia. The interviews explored the organisational context in relation to change and organisational factors influencing the management of patients presenting with mild head injuries. Two researchers coded the interview transcripts using thematic content analysis. The "model of diffusion in service organisations" was used to guide analyses and organisation of the results. Results Nine directors, 20 doctors and 13 nurses of 13 hospitals were interviewed. With regard to characteristics of the innovation (i.e. the recommended practices) the most important factor was whether they were perceived as being in line with values and needs. Tension for change (the degree to which stakeholders perceive the current situation as intolerable or needing change) was relatively low for managing acute mild head injury symptoms, and mixed for managing longer-term symptoms (higher change commitment, but relatively low change efficacy). Regarding implementation processes, the importance of (visible) senior leadership for all professions involved was identified as a critical factor. An unpredictable and hectic environment brings challenges in creating an environment in which team-based and organisational learning can thrive (system antecedents for innovation). In addition, the position of the ED as the entry-point of the hospital points to the relevance of securing buy-in from other units. Conclusions We identified several organisational factors relevant to realising change in ED management of patients who present with mild head injuries. These factors will inform the intervention design and process evaluation in a trial evaluating the effectiveness of our implementation intervention.	[Bosch, Marije; Tavender, Emma J.; Gruen, Russell L.] Monash Univ, Cent Clin Sch, Dept Surg, Melbourne, Vic 3004, Australia; [Bosch, Marije; Tavender, Emma J.; Gruen, Russell L.] Monash Univ, Natl Trauma Res Inst, Alfred, Melbourne, Vic 3004, Australia; [Brennan, Sue E.; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Knott, Jonathan] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Knott, Jonathan] Royal Melbourne Hosp, Dept Emergency Med, Melbourne, Vic, Australia; [Gruen, Russell L.] Alfred Hosp, Alfred Trauma Serv, Melbourne, Vic, Australia; [Gruen, Russell L.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore		Bosch, M (corresponding author), Monash Univ, Cent Clin Sch, Dept Surg, Melbourne, Vic 3004, Australia.; Bosch, M (corresponding author), Monash Univ, Natl Trauma Res Inst, Alfred, Melbourne, Vic 3004, Australia.	marije.bosch@monash.edu		Tavender, Emma/0000-0002-7230-712X; Brennan, Sue/0000-0003-1789-8809; Green, Sally Elizabeth/0000-0002-9564-9050	Transport Accident Commission (TAC), Australia [D166]; Australian Postgraduate AwardAustralian Government	The NET Program is funded by the Transport Accident Commission (TAC), Australia (grant number D166, RLG, SEG, JK); https://www.tac.vic.gov.au/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EJT is supported by an Australian Postgraduate Award.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson NR, 1998, J ORGAN BEHAV, V19, P235, DOI 10.1002/(SICI)1099-1379(199805)19:3<235::AID-JOB837>3.3.CO;2-3; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; Armenakis AA, 1999, RES ORGAN C, V12, P97; Ashford AJ, 1998, BEHAV CHANGE PROFESS; Australian Bureau of Statistics, 2011, 1216 0 AUSTR STAT GE; Baker DP, 2006, HEALTH SERV RES, V41, P1576, DOI 10.1111/j.1475-6773.2006.00566.x; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; Boudreaux ED, 2009, ACAD EMERG MED, V16, P1120, DOI 10.1111/j.1553-2712.2009.00543.x; Buetow S, 2010, J HEALTH SERV RES PO, V15, P123, DOI 10.1258/jhsrp.2009.009081; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Chaix-Couturier C, 2000, INT J QUAL HEALTH C, V12, P133, DOI 10.1093/intqhc/12.2.133; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Compton S, 2007, ACAD EMERG MED, V14, P991, DOI 10.1197/j.aem.2007.06.031; Croskerry P, 2000, ACAD EMERG MED, V7, P1232, DOI 10.1111/j.1553-2712.2000.tb00468.x; Curran J, 2007, COCHRANE DB SYST REV; Dalrymple PW, 2010, HEALTH INFORM J, V16, P177, DOI 10.1177/1460458210377469; DAMANPOUR F, 1991, ACAD MANAGE J, V34, P555, DOI 10.2307/256406; Ferlie E, 2005, ACAD MANAGE J, V48, P117, DOI 10.5465/amj.2005.15993150; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Foy R, 2002, J CLIN EPIDEMIOL, V55, P717, DOI 10.1016/S0895-4356(02)00403-1; Foy R, 2011, BMJ QUAL SAF, V20, P453, DOI 10.1136/bmjqs.2010.047993; Frambach RT, 2002, J BUS RES, V55, P163, DOI 10.1016/S0148-2963(00)00152-1; Francis JJ, 2009, PSYCHOL HEALTH, P1; French B, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-28; Garavelli AC, 2002, TECHNOVATION, V22, P269, DOI 10.1016/S0166-4972(01)00009-8; Gershon RRM, 2004, J NURS ADMIN, V34, P33, DOI 10.1097/00005110-200401000-00008; Green SE, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-74; Greenfield D, 2011, BMJ QUAL SAF, V20, P332, DOI 10.1136/bmjqs.2010.044545; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; GRILLI R, 1994, MED CARE, V32, P202, DOI 10.1097/00005650-199403000-00002; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Gruen RL, 2012, BRIT J SURG, V99, P97, DOI 10.1002/bjs.7754; Ham C, 2003, LANCET, V361, P1978, DOI 10.1016/S0140-6736(03)13593-3; Helfrich CD, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-82; Helfrich CD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-38; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Holroyd BR, 2007, ACAD EMERG MED, V14, P942, DOI 10.1197/j.aem.2007.06.023; Holt DT, 2010, J GEN INTERN MED, V25, P50, DOI 10.1007/s11606-009-1112-8; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kitson A, 1998, QUAL HEALTH CARE, V7, P149, DOI 10.1136/qshc.7.3.149; Kitson AL, 2009, J ADV NURS, V65, P217, DOI 10.1111/j.1365-2648.2008.04864.x; Klein KJ, 1996, ACAD MANAGE REV, V21, P1055, DOI 10.2307/259164; Kuper A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1035; Lemieux-Charles L, 2006, MED CARE RES REV, V63, P263, DOI 10.1177/1077558706287003; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makowsky MJ, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-109; McDonald R, 2005, QUAL SAF HEALTH CARE, V14, P290, DOI 10.1136/qshc.2005.013912; McMullen H, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0755-5; Meurer WJ, 2011, BMC EMERG MED, P11; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Muntlin A, 2010, J EMERG NURS, V36, P317, DOI 10.1016/j.jen.2009.09.003; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; Musacchio NS, 2009, J ADOLESCENT HEALTH, V44, P81, DOI 10.1016/j.jadohealth.2008.05.011; NEVIS EC, 1995, SLOAN MANAGE REV, V36, P73; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Nugus P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5201; Ortenblad A, 2002, MANAGE LEARN, V33, P213, DOI 10.1177/1350507602332004; Ovretveit J, 2008, INT J CLIN LEADER, V16, P9; Ovretveit J, 2009, LEADING IMPROVEMENT; Pham JC, 2007, ACAD EMERG MED, V14, P856, DOI 10.1197/j.aem.2007.06.035; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Quiros D, 2007, HEART LUNG, V36, P287, DOI 10.1016/j.hrtlng.2006.08.005; Rogers EM., 2003, DIFFUSION INNOVATION, V5; Rousseau V, 2006, SMALL GR RES, V37, P540, DOI 10.1177/1046496406293125; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Rycroft-Malone J, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-28; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P42, DOI 10.1017/S0317167100006296; Sandelowski M, 2000, RES NURS HEALTH, V23, P246, DOI 10.1002/1098-240X(200006)23:3<246::AID-NUR9>3.0.CO;2-H; Scott SD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-65; Scott Tim, 2003, J Health Serv Res Policy, V8, P105, DOI 10.1258/135581903321466085; Scott W R, 1990, Med Care Rev, V47, P165, DOI 10.1177/107755879004700203; Stetler CB, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-30; Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Tavender EJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0264-7; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Weiner BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-78; Wensing M, 2005, FACTORS THEORIES BEH; West E, 1999, SOC SCI MED, V48, P633, DOI 10.1016/S0277-9536(98)00361-X; West E, 2005, CAN J NURS RES, V37, P132; Yang B., 2004, HRDQ, V15, P23; Zwarenstein M, 2006, J CONTIN EDUC HEALTH, V26, P46, DOI 10.1002/chp.50	88	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148091	10.1371/journal.pone.0148091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	WOS:000369552800028	26845772	gold, Green Published, Green Submitted			2022-02-06	
J	Chou, D; Harada, MY; Barmparas, G; Ko, A; Ley, EJ; Margulies, DR; Alban, RF				Chou, Daisy; Harada, Megan Y.; Barmparas, Galinos; Ko, Ara; Ley, Eric J.; Margulies, Daniel R.; Alban, Rodrigo F.			Field intubation in civilian patients with hemorrhagic shock is associated with higher mortality	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Field intubation; massive transfusion; hemorrhagic shock	TRAUMATIC BRAIN-INJURY; HOSPITAL ENDOTRACHEAL INTUBATION; RAPID-SEQUENCE INTUBATION; PREHOSPITAL INTUBATION; PENETRATING TRAUMA; LIFE-SUPPORT; AIRWAY; MANAGEMENT; MODEL; VENTILATION	BACKGROUND: Field intubation (FI) by emergency medical service personnel on severely injured trauma patients remains a contentious practice. Clinical studies suggest an association between FI and adverse outcomes in patients with traumatic brain injury. Military tactical emergency casualty care recommends deferring intubation and providing supplemental oxygenation until reaching a more equipped destination. In addition, animal models with penetrating hemorrhagic shock demonstrate increased acidosis with intubation before resuscitation. The purpose of this study was to evaluate the impact of FI on outcomes in trauma patients with hemorrhagic shock requiring massive transfusion. METHODS: The Los Angeles County Trauma System Database was retrospectively queried for all trauma patients 16 years or older with hemorrhagic shock requiring massive transfusion (>= 6 U packed red blood cells in the first 24 hours) between January 1, 2012, and June 30, 2014. Demographics, clinical and transfusion data, and outcomes were compared between patients who received FI and those who did not (NO-FI). Multivariate regression analysis was used to adjust for confounders. RESULTS: Of 552 trauma patients meeting inclusion criteria, 63 (11%) received FI, and the remaining 489 (89%) were NO-FI. Age, sex, and incidence of blunt injury were similar between the FI and the NO-FI group. The FI cohort presented with a lower median Glasgow Coma Scale (GCS) score (3 vs. 14, p < 0.001), a lower median systolic blood pressure (86 mm Hg vs. 104 mm Hg, p < 0.001), and a higher median Injury Severity Score (ISS) (41 vs. 29, p < 0.001). Mortality was significantly higher in FI patients (83% vs. 43%, p < 0.001). Transfusion patterns and total field times were similar in both groups. After adjusting for confounders, FI patients had increased odds of mortality (adjusted odds ratio, 2.89; 95% confidence interval, 1.08-7.78; p = 0.035). In addition, FI was identified as an independent predictor of mortality (adjusted odds ratio, 3.41; 95% confidence interval, 1.35-8.59; p = 0.009). CONCLUSION: FI may be associated with higher mortality in trauma patients with hemorrhagic shock requiring massive transfusion. Less invasive airway interventions and rapid transport might improve outcomes for these patients. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Chou, Daisy; Harada, Megan Y.; Barmparas, Galinos; Ko, Ara; Ley, Eric J.; Margulies, Daniel R.; Alban, Rodrigo F.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Alban, RF (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215 N, Los Angeles, CA 90048 USA.	Rodrigo.Alban@cshs.org	Barmparas, Galinos/L-6530-2019				American College of Surgeons' Committee on Trauma, 2014, RES OPT TRAUM CAR; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Brambrink AM, 2004, CRIT CARE, V8, P3, DOI 10.1186/cc2420; Bukur M, 2011, J SURG RES, V170, pE117, DOI 10.1016/j.jss.2011.04.005; Carr BG, 2008, PREHOSP EMERG CARE, V12, P327, DOI 10.1080/10903120802096928; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Rajani Ravi R, 2009, Am J Surg, V198, P863, DOI 10.1016/j.amjsurg.2009.08.013; Seamon MJ, 2007, J TRAUMA, V63, P113, DOI 10.1097/TA.0b013e31806842a1; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Taghavi S, 2014, J TRAUMA ACUTE CARE, V77, P14, DOI 10.1097/TA.0000000000000278; Taghavi S, 2014, AM SURGEON, V80, P9; Taghavi S, 2013, J TRAUMA ACUTE CARE, V74, P1246, DOI 10.1097/TA.0b013e31828dab10; Taghavi S, 2012, J TRAUMA ACUTE CARE, V73, P332, DOI 10.1097/TA.0b013e3182584447; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2014, EMERG MED J, V31, P186, DOI 10.1136/emermed-2012-202101; Warner KJ, 2009, J EMERG MED, V36, P257, DOI 10.1016/j.jemermed.2007.10.058; Wirtz DD, 2007, PREHOSP EMERG CARE, V11, P213, DOI 10.1080/10903120701205935	22	9	9	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2016	80	2					278	282		10.1097/TA.0000000000000901			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DK9EY	WOS:000375234800021	26491803				2022-02-06	
J	Li, CY; Wu, ZZ; Limnuson, K; Cheyuo, C; Wang, P; Ahn, CH; Narayan, RK; Hartings, JA				Li, Chunyan; Wu, Zhizhen; Limnuson, Kanokwan; Cheyuo, Cletus; Wang, Ping; Ahn, Chong H.; Narayan, Raj K.; Hartings, Jed A.			Development and application of a microfabricated multimodal neural catheter for neuroscience	BIOMEDICAL MICRODEVICES			English	Article						Flexible substrate; Brain temperature; Oxygen tension; Regional cerebral blood flow; Direct-current electrocorticography; Cortical spreading depression; Multimodal monitoring	TRAUMATIC BRAIN-INJURY; SPREADING DEPOLARIZATIONS; CEREBRAL-CORTEX; DEPRESSION; HEMORRHAGE; ISCHEMIA; STROKE; TUBE	We present a microfabricated neural catheter for real-time continuous monitoring of multiple physiological, biochemical and electrophysiological variables that are critical to the diagnosis and treatment of evolving brain injury. The first generation neural catheter was realized by polyimide-based micromachining and a spiral rolling packaging method. The mechanical design and electrical operation of the microsensors were optimized and tailored for multimodal monitoring in rat brain such that the potential thermal, chemical and electrical crosstalk among the microsensors as well as errors from micro-environmental fluctuations are minimized. In vitro cytotoxicity analyses suggest that the developed neural catheters are minimally toxic to rat cortical neuronal cultures. In addition, in vivo histopathology results showed neither acute nor chronic inflammation for 7 days post implantation. The performance of the neural catheter was assessed in an in vivo needle prick model as a translational replica of a "mini" traumatic brain injury. It successfully monitored the expected transient brain oxygen, temperature, regional cerebral blood flow, and DC potential changes during the passage of spreading depolarization waves. We envisage that the developed multimodal neural catheter can be used to decipher the causes and consequences of secondary brain injury processes with high spatial and temporal resolution while reducing the potential for iatrogenic injury inherent to current use of multiple invasive probes.	[Li, Chunyan; Limnuson, Kanokwan; Narayan, Raj K.] Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY 11030 USA; [Narayan, Raj K.] Hofstra North Shore LIJ Sch Med, Dept Neurosurg, Hempstead, NY 11549 USA; [Wu, Zhizhen; Ahn, Chong H.] Univ Cincinnati, Microsyst & BioMEMS Lab, Cincinnati, OH 45221 USA; [Cheyuo, Cletus; Wang, Ping] Hofstra North Shore LIJ Sch Med, Dept Surg, Hempstead, NY 11549 USA; [Hartings, Jed A.] Univ Cincinnati, Neurosci Inst, Dept Neurosurg, Coll Med, Cincinnati, OH 45219 USA		Li, CY (corresponding author), Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY 11030 USA.	cli11@nshs.edu	Cheyuo, Cletus/AAM-5785-2021	Hartings, Jed/0000-0001-8583-3471; Wang, Ping/0000-0002-1557-0394	U.S. Army CDMRP PH/TBI Research Program [W81XWH-10-1-0978, W81XWH-10-1-0977]	This research was supported by the U.S. Army CDMRP PH/TBI Research Program (Awards NOs. W81XWH-10-1-0978 and W81XWH-10-1-0977).	Alivisatos AP, 2013, ACS NANO, V7, P1850, DOI 10.1021/nn4012847; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Du J., 2011, PLOS ONE, V6; Fekete Z, 2015, SENSOR ACTUAT B-CHEM, V215, P300, DOI 10.1016/j.snb.2015.03.055; FRAZIER AB, 1995, IEEE T IND ELECTRON, V42, P442, DOI 10.1109/41.464605; Frontera J, 2015, NEUROCRIT CARE, V22, P348, DOI 10.1007/s12028-015-0133-x; HajjHassan M, 2008, SENSORS-BASEL, V8, P6704, DOI 10.3390/s8106704; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hassler C, 2011, J POLYM SCI POL PHYS, V49, P18, DOI 10.1002/polb.22169; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Jeong JW, 2015, NEURON, V86, P175, DOI 10.1016/j.neuron.2014.12.035; Lau WS, 2008, MICROELECTRON RELIAB, V48, P187, DOI 10.1016/j.microrel.2007.05.003; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Li CY, 2008, BIOMED MICRODEVICES, V10, P671, DOI 10.1007/s10544-008-9178-3; Li CY, 2007, BIOSENS BIOELECTRON, V22, P1988, DOI 10.1016/j.bios.2006.08.043; Li CY, 2016, BIOSENS BIOELECTRON, V77, P62, DOI 10.1016/j.bios.2015.09.021; Li CY, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9992-3; Li CY, 2012, BIOMED MICRODEVICES, V14, P759, DOI 10.1007/s10544-012-9646-7; Li CY, 2012, BIOMED MICRODEVICES, V14, P109, DOI 10.1007/s10544-011-9589-4; Li CY, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3669705; Li CY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3299003; Li CY, 2009, BIOSENS BIOELECTRON, V25, P173, DOI 10.1016/j.bios.2009.06.032; Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f; Liu C, 2007, ADV MATER, V19, P3783, DOI 10.1002/adma.200701709; Marzouk SAM, 1998, ANAL CHEM, V70, P5054, DOI 10.1021/ac980608e; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Richter F, 2003, J NEUROPHYSIOL, V90, P2163, DOI 10.1152/jn.00388.2003; Richter F, 2002, NEUROSCI LETT, V334, P123, DOI 10.1016/S0304-3940(02)01120-5; Ruther P, 2010, IEEJ T ELECTR ELECTR, V5, P505, DOI 10.1002/tee.20566; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Ueda Morikazu, 1997, Neurologia Medico-Chirurgica, V37, P441, DOI 10.2176/nmc.37.441; Vespa PM, 2005, CURR OPIN CRIT CARE, V11, P133, DOI 10.1097/01.ccx.0000155353.01489.58; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002	39	9	9	1	10	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	FEB	2016	18	1							8	10.1007/s10544-016-0034-6			10	Engineering, Biomedical; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics	DE7HM	WOS:000370806600008	26780443				2022-02-06	
J	Miyata, K; Ohnishi, H; Maekawa, K; Mikami, T; Akiyama, Y; Iihoshi, S; Wanibuchi, M; Mikuni, N; Uemura, S; Tanno, K; Narimatsu, E; Asai, Y				Miyata, Kei; Ohnishi, Hirofumi; Maekawa, Kunihiko; Mikami, Takeshi; Akiyama, Yukinori; Iihoshi, Satoshi; Wanibuchi, Masahiko; Mikuni, Nobuhiro; Uemura, Shuji; Tanno, Katsutoshi; Narimatsu, Eichi; Asai, Yasufumi			Therapeutic temperature modulation in severe or moderate traumatic brain injury: a propensity score analysis of data from the Nationwide Japan Neurotrauma Data Bank	JOURNAL OF NEUROSURGERY			English	Article						therapeutic temperature modulation; traumatic brain injury; propensity; neurocritical care; hypothermia; normothermia	SEVERE HEAD-INJURY; MILD HYPOTHERMIA; MORTALITY; AGE; MANAGEMENT; INDUCTION; OUTCOMES; RISK	OBJECTIVE In patients with severe traumatic brain injury (TBI), a randomized controlled trial revealed that outcomes did not significantly improve after therapeutic hypothermia (TH) or normothermia (TN). However, avoiding pyrexia, which is often associated with intracranial disorders, might improve clinical outcomes. The objective of this study was to compare neurological outcomes among patients with moderate and severe TBI after therapeutic temperature modulation (TTM) in the absence of other interventions. METHODS Data from 1091 patients were obtained from the Japan Neurotrauma Data Bank Project 2009, a cohort observational study. Patients with cardiac arrest, those with a Glasgow Coma Scale score of 3 and dilated fixed pupils, and those whose cause of death was injury to another area of the body were excluded, leaving 687 patients aged 16 years or older in this study. The patients were divided into 2 groups: the TTM group underwent TN (213 patients) or TH (82 patients), and the control group (392 patients) did not receive TTM. The primary end point for this study was the rate of poor outcome at hospital discharge, and the secondary end point was in -hospital death. Out of the 208 total items in the database, 29 variables that could potentially affect outcome were matched using the propensity score (PS) method in order to reduce selection bias and balance the baseline characteristics. RESULTS From each group, 141 patients were extracted using the PS -matching process. Among the patients in the TTM group, 29 had undergone TH and 112 had undergone TN. In a log -rank test using Kaplan -Meier survival curves, no significant differences in patient outcome or death were observed between the 2 groups (poor outcome, p = 0.83; death, p = 0.18). A Cox proportional -hazards regression analysis established the HR for poor outcome and mortality at 1.03 (95% CI 0.78-1.36, p = 0.83) and 1.34 (95% CI 0.87-2.07, p = 0.18), respectively. CONCLUSIONS There was no clear improvement in neurological outcomes after TTM in patients with moderate or severe TBI. To elucidate the role of TTM in patients with these injuries, a prospective study is needed with long-term follow-up using specific target temperatures.	[Miyata, Kei; Uemura, Shuji; Tanno, Katsutoshi; Narimatsu, Eichi; Asai, Yasufumi] Sapporo Med Univ, Dept Emergency Med, Sapporo, Hokkaido, Japan; [Miyata, Kei; Mikami, Takeshi; Akiyama, Yukinori; Iihoshi, Satoshi; Wanibuchi, Masahiko; Mikuni, Nobuhiro] Sapporo Med Univ, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Ohnishi, Hirofumi] Sapporo Med Univ, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Maekawa, Kunihiko] Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Sapporo, Hokkaido 060, Japan; [Miyata, Kei; Narimatsu, Eichi; Asai, Yasufumi] Japan Soc Neurotraumatol, Japan Neurotrauma Data Bank Comm, Tokyo, Japan		Miyata, K (corresponding author), Sapporo Med Univ, Dept Neurosurg, Chuo Ku, South 1 West 16, Sapporo, Hokkaido 0608543, Japan.	miyata@sapmed.ac.jp		Ohnishi, Hirofumi/0000-0002-5873-6438	General Insurance Association of Japan	This work was supported by a grant from the General Insurance Association of Japan.	Arrich J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub3; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chikuda H, 2014, EMERG MED J, V31, P201, DOI 10.1136/emermed-2012-202058; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Fox JL, 2010, CAN J EMERG MED, V12, P355; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Karamanos E, 2014, PREHOSP DISASTER MED, V29, P32, DOI 10.1017/S1049023X13008947; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Suehiro E, 2014, J NEUROTRAUM, V31, P315, DOI 10.1089/neu.2013.3057; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Yan Y, 2010, J CLIN NEUROSCI, V17, P196, DOI 10.1016/j.jocn.2009.05.022; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	28	9	10	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2016	124	2					527	537		10.3171/2015.3.JNS141895			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DB9VR	WOS:000368866300036	26381247	Bronze			2022-02-06	
J	Valdez, C; Radomski, M; Renne, C; Amdur, R; Dunne, J; Sarani, B				Valdez, Carrie; Radomski, Michal; Renne, Christian; Amdur, Richard; Dunne, James; Sarani, Babak			Alcohol level and injury severity: is the floppy patient myth true?	JOURNAL OF SURGICAL RESEARCH			English	Article						Blood alcohol level; Injury severity score; Mechanism of injury	TRAUMA SYSTEMS; BRAIN-INJURY; MORTALITY; EPIDEMIOLOGY; DRINKING	Background: The impact of inebriation on severity of injury is unclear. The few studies to date on this topic are limited to a particular mechanism of injury (MOI), injury pattern, or blood alcohol level (BAL). Therefore, we sought to determine the impact of BAL on injury pattern and severity across all MOI. We hypothesize that there is no relationship between BAL and injury severity when controlling for MOI. Materials and methods: After institutional review board approval, a retrospective study was performed at an adult trauma center from January 1, 2012-December 31, 2012. All MOI were included. Injury severity was assessed using the injury severity score (ISS). Chi square and analysis of variance were used to examine the relationship between BAL, injury pattern, and ISS within each MOI. Multivariate regression analysis examined the BALeISS association adjusting for MOI, gender, and age. Results: Of 1397 patients, the mean age was 44 +/- 19, ISS was 7.5 +/- 6.8, BAL was 93 +/- 130 mg/dL, and 70% were male. Rib fracture (P = 0.002) and hemothorax and/or pneumothorax (P = 0.0009) were negatively associated with BAL, whereas concussion and soft tissue injury had a positive association with BAL (P < 0.0001). An increasing BAL had a negative correlation with ISS after fall from standing (P < 0.001), whereas bicycle collisions had a positive association (P = 0.027). Across all MOI, there was no significant association between BAL and ISS. Conclusions: BAL is associated with ISS, in specific MOI; however, across all MOI, there was no significant association between BAL and ISS. Inebriated patients should be triaged with the same clinical index of suspicion for injury as sober patients. (C) 2016 Elsevier Inc. All rights reserved.	[Valdez, Carrie; Radomski, Michal; Renne, Christian; Amdur, Richard; Dunne, James; Sarani, Babak] George Washington Univ, Ctr Trauma & Crit Care, Dept Surg, Washington, DC 20037 USA		Sarani, B (corresponding author), George Washington Univ, Med Ctr, Dept Surg, 2150 Penn Ave NW,Suite 6B, Washington, DC 20037 USA.	bsarani@mfa.gwu.edu	Amdur, Richard L/AAE-5345-2019	Sarani, Babak/0000-0001-6247-3004			BLOSE JO, 1991, AM J PUBLIC HEALTH, V81, P1571, DOI 10.2105/AJPH.81.12.1571; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Gmel G, 2007, SWISS MED WKLY, V137, P642; Kowalenko T, 2013, AM J EMERG MED, V31, P705, DOI 10.1016/j.ajem.2012.12.032; McLeod R, 2003, ACCIDENT ANAL PREV, V35, P71, DOI 10.1016/S0001-4575(01)00091-4; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; National Center for Injury Prevention and Control Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Sise RG, 2014, J TRAUMA ACUTE CARE, V76, P913, DOI 10.1097/TA.0000000000000169; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Toschlog EA, 2007, ARCH SURG-CHICAGO, V142, P77, DOI 10.1001/archsurg.142.1.77; Velmahos GC, 2001, J AM COLL SURGEONS, V192, P147, DOI 10.1016/S1072-7515(00)00790-0	17	9	9	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2016	200	2					664	668		10.1016/j.jss.2015.10.001			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CZ1BU	WOS:000366841500031	26521676				2022-02-06	
J	Wang, CC; Kuo, JR; Chen, YC; Chio, CC; Wang, JJ; Lin, BS				Wang, Che-Chuan; Kuo, Jinn-Rung; Chen, Yu-Chih; Chio, Chung-Ching; Wang, Jhi-Joung; Lin, Bor-Shyh			Brain tissue oxygen evaluation by wireless near-infrared spectroscopy	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Partial pressure of oxygen in brain tissue; Near-infrared spectroscopy; Oxyhemoglobin; Deoxyhemoglobin	CEREBRAL AUTOREGULATION; ISCHEMIA; INJURY; HYPEREMIA	Background: Monitoring the partial pressure of oxygen in brain tissue (PbtO(2)) is an important tool for traumatic brain injury (TBI) but is invasive and inconvenient for real time monitoring. Near-infrared spectroscopy (NIRS), which can monitor hemoglobin parameters in the brain tissue, has been used widely as a noninvasive tool for assessing cerebral ischemia and hypoxia. Therefore, it may have the potential as a noninvasive tool for estimating the change of PbtO(2). In this study, a novel wireless NIRS system was designed to monitor hemoglobin parameters of rat brains under different impact strengths and was used to estimate the change of PbtO(2) noninvasively in TBI. Materials and methods: The proposed wireless NIRS system and a PbtO(2) monitoring system were used to monitor the oxygenation of rat brains under different impact strengths. Rats were randomly assigned to four different impact strength groups (sham, 1.6 atm, 2.0 atm, and 2.4 atm; n = 6 per group), and the relationships of concentration changes in oxyhemoglobin (HbO(2)), deoxyhemoglobin (HbR), and total hemoglobin (HbT), and PbtO(2) during and after TBI with different impact strengths were investigated. Triphenyltetrazolium chloride (TTC) staining was also used to evaluate infarction volume. Results: Concentration changes in HbO(2), HbR, and HbT dropped immediately after the impact, increased gradually, and then became stable. Changes in PbtO(2) had a similar tendency with the hemoglobin parameters. There was significant correlation between changes in PbtO(2) and HbO(2) (correlation = 0.76) but not with changes in HbR (correlation = 0.06). In triphenyltetrazolium chloride staining, the infarction volume was highly but negatively associated with oxygen-related parameters like PbtO(2) and HbO(2). Conclusions: Changes in HbO(2) under TBI was highly and positively correlated with changes in PbtO(2). By using the relative changes in HbO(2) as a reference parameter, the proposed	[Wang, Che-Chuan] Natl Chiao Tung Univ, Inst Photon Syst, Tainan 711, Taiwan; [Wang, Che-Chuan; Kuo, Jinn-Rung; Wang, Jhi-Joung; Lin, Bor-Shyh] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Che-Chuan; Kuo, Jinn-Rung; Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Div Neurosurg, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Chen, Yu-Chih; Lin, Bor-Shyh] Natl Chiao Tung Univ, Inst Imaging & Biomed Photon, Tainan 711, Taiwan		Lin, BS (corresponding author), Natl Chiao Tung Univ, Inst Imaging & Biomed Photon, 301 Gaofa 3rd Rd, Tainan 711, Taiwan.	borshyhlin@gmail.com			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [103-2221-E-009-035-MY2]	The authors thank the Chi Mei Medical Center and Institute of Photonic System, Imaging and Biomedical Photonics, and Lighting and Energy Photonics, National Chiao-Tung University, Tainan, Taiwan, for their instrumental support. The authors are also greatly indebted to the Ministry of Science and Technology, Taiwan, for the support of the research through contracts in 103-2221-E-009-035-MY2.	ABERMAN A, 1973, J APPL PHYSIOL, V35, P570, DOI 10.1152/jappl.1973.35.4.570; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Francesco C, 2005, J NEUROSCI METH, V145, P11; Franreschini MA, 1999, P SOC PHOTO-OPT INS, V3597, P52; Gill AS, 2011, J NEUROSURG, V114, P470, DOI 10.3171/2010.2.JNS091017; Herrmann MJ, 2003, BIOL PSYCHOL, V64, P255, DOI 10.1016/S0301-0511(03)00095-4; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Joshi B, 2012, ANESTH ANALG, V114, P503, DOI 10.1213/ANE.0b013e31823d292a; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kuo JR, 2014, IEEE J BIOMED HEALTH, V18, P167, DOI 10.1109/JBHI.2013.2261310; Kurth CD, 2002, J CEREBR BLOOD F MET, V22, P335, DOI 10.1097/00004647-200203000-00011; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Merzagora AC, 2011, J INNOV OPT HEAL SCI, V4, P251, DOI 10.1142/S1793545811001551; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Pennekamp CWA, 2009, EUR J VASC ENDOVASC, V38, P539, DOI 10.1016/j.ejvs.2009.07.008; Petrova A, 2006, PEDIATR CRIT CARE ME, V7, P449, DOI 10.1097/01.PCC.0000235248.70482.14; Quaresima V, 2003, J SPORT MED PHYS FIT, V43, P1; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Tanosaki M, 2003, NEUROSCI LETT, V352, P1, DOI 10.1016/j.neulet.2003.08.055; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf T, 1997, J CEREBR BLOOD F MET, V17, P950, DOI 10.1097/00004647-199709000-00004; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002	30	9	9	0	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2016	200	2					669	675		10.1016/j.jss.2015.10.005			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CZ1BU	WOS:000366841500032	26521677				2022-02-06	
J	Jacobsson, L; Lexell, J				Jacobsson, Lars; Lexell, Jan			Life satisfaction after traumatic brain injury: comparison of ratings with the Life Satisfaction Questionnaire (LiSat-11) and the Satisfaction With Life Scale (SWLS)	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Brain injuries; Outcome assessment; Quality of life; Questionnaires; Rehabilitation	18-TO 64-YEAR-OLD SWEDES; NORTHERN SWEDEN	Background: An optimal life satisfaction (LS) is considered an important long-term outcome after a traumatic brain injury (TBI). It is, however, not clear to what extent a single instrument captures all aspects of LS, and different instruments may be needed to comprehensively describe LS. The aim of this study was to compare self-ratings of life satisfaction after a TBI with two commonly used instruments. Methods: Life Satisfaction Questionnaire (LiSat-11), comprising eleven items and Satisfaction With Life Scale (SWLS), comprising five items, were administered to 67 individuals (51 men and 16 women). Secondary analysis of data collected as part of a survey of individuals with TBI 6 to 15 years post TBI. Results: Item 1 in LiSat-11 ('Life as a whole') and the total SWLS score was strongly correlated (Spearman's rho=0.66; p < 0.001). The total score in SWLS had the strongest correlation with items in LiSat-11. All items in LiSat-11, except 'Family life' and 'Partner relationship', were moderately to strongly correlated with items in SWLS. The item 'Partner relationship' in LiSat-11 did not correlate with any of the items in SWLS or the total score. The item 'If I could live my life over, I would change nothing' in SWLS had the weakest correlations with items in LiSat-11. Items 'Vocation' and 'Leisure' in LISat-11 were most strongly correlated with items in SWLS, whereas the item 'ADL' in LiSat-11 was more weakly correlated with items in SWLS. Conclusions: The strength of the relationships implies that the two instruments assess similar but not identical aspects of LS and therefore complement each other when it is rated.	[Jacobsson, Lars; Lexell, Jan] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Jacobsson, Lars] Sunderby Hosp, Dept Rehabil Med, Lulea, Sweden; [Jacobsson, Lars; Lexell, Jan] Lulea Univ Technol, Dept Hlth Sci, S-95187 Lulea, Sweden; [Lexell, Jan] Skane Univ Hosp Lund, Dept Rehabil Med, Lund, Sweden		Jacobsson, L (corresponding author), Lund Univ, Dept Hlth Sci, Lund, Sweden.	lars.jacobsson@med.lu.se		Jacobsson, Lars/0000-0002-1127-1178	Norrbotten County Council	The study was supported by grants from Norrbotten County Council.	Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Jacobsson L., 2010, THESIS; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jacobsson L, 2013, J REHABIL MED, V45, P1010, DOI 10.2340/16501977-1204; Melin R, 2003, J REHABIL MED, V35, P84, DOI 10.1080/16501970306119; Moons P, 2006, INT J NURS STUD, V43, P891, DOI 10.1016/j.ijnurstu.2006.03.015; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Post MW, 2012, ARCH PHYS MED REHAB, V93, P1832, DOI 10.1016/j.apmr.2012.03.025	13	9	9	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1477-7525			HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	JAN 15	2016	14								10	10.1186/s12955-016-0405-y			5	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	DA9PL	WOS:000368141700001	26769019	Green Published, gold			2022-02-06	
J	Auvergne, L; Bortsov, AV; Ulirsch, JC; Peak, DA; Jones, JS; Swor, RA; Domeier, RM; Lee, DC; Rathlev, NK; Hendry, PL; McLean, SA				Auvergne, Lauriane; Bortsov, Andrey V.; Ulirsch, Jacob C.; Peak, David A.; Jones, Jeffrey S.; Swor, Robert A.; Domeier, Robert M.; Lee, David C.; Rathlev, Niels K.; Hendry, Phyllis L.; McLean, Samuel A.			Association of Epidemiologic Factors and Genetic Variants Influencing Hypothalamic-Pituitary-Adrenocortical Axis Function With Postconcussive Symptoms After Minor Motor Vehicle Collision	PSYCHOSOMATIC MEDICINE			English	Article						postconcussive symptoms; minor traumatic brain injury; FKBP5; stress response	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PERITRAUMATIC DISTRESS INVENTORY; CONCUSSION SYMPTOMS; FKBP5 POLYMORPHISMS; HEAD-INJURY; PAIN; DEPRESSION; ANXIETY; SCALE	Objectives To determine the influence of epidemiologic factors and the influence of genetic variants affecting FKBP5, a protein known to modulate hypothalamic-pituitary-adrenocortical axis function, on the severity of somatic symptoms commonly termed postconcussive 6 and 12 months after motor vehicle collision (MVC). Methods European Americans 18 to 65 years of age who presented to one of eight emergency departments (EDs) after MVC were enrolled. Exclusion criteria included hospital admission. Blood samples were collected in the ED for genotyping. Participants completed evaluations including an adapted Rivermead Post-Concussive Symptoms Questionnaire in the ED and at 6 weeks, 6 months, and 1 year. Repeated-measures analysis of covariance was used to evaluate the association between epidemiologic factors (sociodemographic, pre-MVC health, collision characteristics, head injury, peritraumatic pain, and stress), FKBP5 genetic variants, and postconcussive symptom severity. Results Among 943 patients recruited in the ED, follow-up was completed on 835 (88%) at 6 months and 857 (90%) at 1 year. Self-reported head impact during collision was not associated with chronic postconcussive symptom severity. After correction for multiple testing, three FKBP5 single-nucleotide polymorphisms (rs3800373, rs7753746, and rs9380526) predicted chronic postconcussive symptom severity, with an average symptom severity of 1.10 (95% confidence interval = 0.96-1.24), 1.36 (1.21-1.51), and 1.55 (1.23-1.88) for one, two, or three copies of minor allele at rs3800373 (p = .001). Similar effect sizes were observed for the minor alleles of rs7753746 and rs9380526. Conclusions Postconcussive symptoms after minor MVC are not generally related to the severity of mild brain injury. This study shows that neurobiologic stress systems may play a role in the pathogenesis of postconcussive symptoms.	[Auvergne, Lauriane; Bortsov, Andrey V.; Ulirsch, Jacob C.; McLean, Samuel A.] Univ N Carolina, Sch Med, Dept Anesthesiol, Chapel Hill, NC 27599 USA; [McLean, Samuel A.] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27599 USA; [Bortsov, Andrey V.; Ulirsch, Jacob C.; McLean, Samuel A.] TRYUMPH Res Program, Chapel Hill, NC USA; [Peak, David A.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Jones, Jeffrey S.] Spectrum Hlth Hosp Butterworth, Dept Emergency Med, Grand Rapids, MI USA; [Swor, Robert A.] William Beaumont Hosp, Dept Emergency Med, Royal Oak, MI 48072 USA; [Domeier, Robert M.] St Joseph Mercy Hosp, Dept Emergency Med, Ann Arbor, MI 48104 USA; [Lee, David C.] North Shore Univ, Dept Emergency Med, Manhasset, NY USA; [Rathlev, Niels K.] Baystate Med Ctr, Dept Emergency Med, Springfield, MA USA; [Hendry, Phyllis L.] Univ Florida, Hlth Sci Ctr, Dept Emergency Med, Jacksonville, FL 32209 USA		McLean, SA (corresponding author), Univ N Carolina, Sch Med, Wing C CB 7010, Chapel Hill, NC 27599 USA.	smclean@aims.unc.edu		Ulirsch, Jacob/0000-0002-7947-0827	National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health [1RO1 AR056328]; University of North Carolina School of Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR056328] Funding Source: NIH RePORTER	Dr. McLean received funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, under Award Number 1RO1 AR056328. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Auvergne received funding through the Scott Neil Schwirck Research Fellowship at the University of North Carolina School of Medicine. Dr. McLean had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. No conflicts of interest exist for any of the authors.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Ballina LE, 2013, J PAIN, V14, P165, DOI 10.1016/j.jpain.2012.10.013; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bortsov AV, 2014, NEUROMOL MED, V16, P83, DOI 10.1007/s12017-013-8255-9; Bortsov AV, 2013, PAIN, V154, P1419, DOI 10.1016/j.pain.2013.04.037; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Castro William H M, 2003, Pain Res Manag, V8, P76; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Devall AJ, 2009, PSYCHONEUROENDOCRINO, V34, P587, DOI 10.1016/j.psyneuen.2008.10.021; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Diatchenko L, 2007, PAIN, V129, P366, DOI 10.1016/j.pain.2007.02.012; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Kang JI, 2012, PSYCHONEUROENDOCRINO, V37, P1569, DOI 10.1016/j.psyneuen.2012.02.017; Khasar SG, 2008, J NEUROSCI, V28, P5721, DOI 10.1523/JNEUROSCI.0256-08.2008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Krebs EE, 2007, J GEN INTERN MED, V22, P1453, DOI 10.1007/s11606-007-0321-2; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Le Roy C, 2011, J PAIN, V12, P1069, DOI 10.1016/j.jpain.2011.04.011; Lee YM, 2012, WEST J EMERG MED, V13, P329, DOI 10.5811/westjem.2011.9.6621; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; McAllister TW, 2011, TXB TRAUMATIC BRAIN; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McLean SA, 2011, SPINE, V36, pS226, DOI 10.1097/BRS.0b013e3182387fb4; McLean SA, 2011, J PAIN, V12, P101, DOI 10.1016/j.jpain.2010.05.008; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meyer S, 1994, VERKEHRSUNFALL FAHRZ, V32, P187; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nishi D, 2010, PSYCHIAT CLIN NEUROS, V64, P149, DOI 10.1111/j.1440-1819.2010.02065.x; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pervanidou P, 2010, PROG BRAIN RES, V182, P149, DOI 10.1016/S0079-6123(10)82005-9; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Platts-Mills TF, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-14; Platts-Mills TF, 2012, ACAD EMERG MED, V19, P821, DOI 10.1111/j.1553-2712.2012.01383.x; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Russell S., 1979, PRELIMINARY MANUAL S; Ryb Gabriel E, 2009, Ann Adv Automot Med, V53, P177; Spielberger CD, 2009, APPL PSYCHOL-HLTH WE, V1, P271, DOI 10.1111/j.1758-0854.2009.01017.x; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; World Health Organization, 1993, ICD 10 CLASS MENT BE; Zannas AS, 2014, GENES BRAIN BEHAV, V13, P25, DOI 10.1111/gbb.12104	63	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	JAN	2016	78	1					68	78		10.1097/PSY.0000000000000253			11	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	DA5DT	WOS:000367823400008	26588823	Green Submitted, Green Accepted			2022-02-06	
J	Buster, TW; Chernyavskiy, P; Harms, NR; Kaste, EG; Burnfield, JM				Buster, Thad W.; Chernyavskiy, Pavel; Harms, Nolan R.; Kaste, E. Grace; Burnfield, Judith M.			Computerized dynamic posturography detects balance deficits in individuals with a history of chronic severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; rehabilitation; assessment; measurement; disability	RATING-SCALE RESPONSIVENESS; COMMUNITY-DWELLING PERSONS; RELIABILITY; STROKE; VALIDITY; REHABILITATION; PROBABILITY; FALLS; GAIT	Background: Mild balance deficits can be challenging to detect in individuals with long-standing traumatic brain injuries. This study compared Computerized Dynamic Posturography (CDP) scores from individuals with traumatic brain injuries (TBI) to controls to determine if CDP could differentiate between the two groups and determine if there was a learning effect associated with testing that could be used to guide evaluation of baseline balance.Methods: Ten ambulatory individuals with a history of severe TBI and 10 individuals without participated in three CDP sessions (24-72 hours apart). During each session, participants performed the Berg Balance Test, Dynamic Gait Index and three trials of a standardized balance assessment and Dynamic Movement Analysis (DMA) scores were recorded for each test.Results: Individuals with TBI scored 93% higher (i.e. reflecting poorer balance) than the control group. The group with TBI exhibited 6.6-times more variability compared to the control group, with estimated variances of 0.3407 and 0.0517, respectively. A learning effect was detected in the group with TBI on the first day of testing ((TBI F) = -0.1241, p-value < 0.01).Discussion: The CDP system detected balance differences between individuals with TBI and controls. Given the documented learning effect, the best of three trials should be used to accurately assess baseline scores.	[Buster, Thad W.; Burnfield, Judith M.] Madonna Rehabil Hosp, Inst Rehabil Sci & Engn, Movement & Neurosci Ctr, Lincoln, NE 68506 USA; [Chernyavskiy, Pavel] NCI, Radiat Epidemiol Branch, NIH, Rockville, MD USA; [Chernyavskiy, Pavel] NCI, Biostat Branch, NIH, Rockville, MD USA; [Harms, Nolan R.] Concordia Univ, Hlth & Human Performance Dept, Seward, NE USA; [Kaste, E. Grace] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA		Buster, TW (corresponding author), Madonna Rehabil Hosp, Inst Rehabil Sci & Engn, 5401 South St, Lincoln, NE 68506 USA.	tbuster@madonna.org	Burnfield, Judith M/K-6087-2015	Burnfield, Judith/0000-0001-6184-5179			Adlerton AK, 1996, SCAND J MED SCI SPOR, V6, P211; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beninato M, 2009, PHYS THER, V89, P816, DOI 10.2522/ptj.20080160; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG K, 1989, Physiotherapy Canada, V41, P304; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Buster T, 2013, J NEUROL PHYS THER, V37, P176, DOI 10.1097/NPT.0000000000000022; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Cano SJ, 2006, NEUROLOGY, V67, P2056, DOI 10.1212/01.wnl.0000247664.97643.e8; Cattaneo D, 2007, DISABIL REHABIL, V29, P1920, DOI 10.1080/09638280701191859; Conradsson M, 2007, PHYS THER, V87, P1155, DOI 10.2522/ptj.20060343; Downs S, 2013, J PHYSIOTHER, V59, P93, DOI 10.1016/S1836-9553(13)70161-9; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GOLDIE PA, 1992, ARCH PHYS MED REHAB, V73, P348, DOI 10.1016/0003-9993(92)90008-K; GRABINER MD, 1993, PHYS THER, V73, P316, DOI 10.1093/ptj/73.5.316; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Jonsdottir J, 2007, ARCH PHYS MED REHAB, V88, P1410, DOI 10.1016/j.apmr.2007.08.109; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Major MJ, 2013, ARCH PHYS MED REHAB, V94, P2194, DOI 10.1016/j.apmr.2013.07.002; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Myers AM, 1996, J GERONTOL A-BIOL, V51, pM37, DOI 10.1093/gerona/51A.1.M37; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Noren A M, 2001, Physiother Res Int, V6, P193; O'Connor RJ, 2004, NEUROLOGY, V62, P1842, DOI 10.1212/01.WNL.0000116136.22922.D6; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Qutubuddin AA, 2007, NEUROREHABILITATION, V22, P261; Schmidt RA, 2003, RES Q EXERCISE SPORT, V74, P366, DOI 10.1080/02701367.2003.10609106; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Tyson SF, 2004, CLIN REHABIL, V18, P916, DOI 10.1191/0269215504cr821oa; Vearrier LA, 2005, GAIT POSTURE, V22, P154, DOI 10.1016/j.gaitpost.2004.09.001; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wirz M, 2010, NEUROREHAB NEURAL RE, V24, P70, DOI 10.1177/1545968309341059; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3; Yaggie JA, 2006, J STRENGTH COND RES, V20, P422; Yaggie JA, 2001, J SPORT REHABIL, V10, P174, DOI 10.1123/jsr.10.3.174	41	9	9	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1249	1255		10.1080/02699052.2016.1183822			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300013	27386896				2022-02-06	
J	Charry, JD; Rubiano, AM; Nikas, CV; Ortiz, JC; Puyana, JC; Carney, N; Adelson, PD				Charry, Jose D.; Rubiano, Andres M.; Nikas, Christine V.; Ortiz, Juan C.; Puyana, Juan C.; Carney, Nancy; Adelson, P. David			Results of early cranial decompression as an initial approach for damage control therapy in severe traumatic brain injury in a hospital with limited resources	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Cranial decompression; damage control; traumatic brain injury	HEAD-INJURY; CRANIECTOMY; SCALE; MORTALITY; OUTCOMES; SCORES; CARE	Introduction: Severe traumatic brain injury (sTBI) is a disease that generates significant mortality and disability in Latin America, and specifically in Colombia. The purpose of this study was to evaluate the 12-month clinical outcome in patients with sTBI managed with an early cranial decompression (ECD) as the main procedure for damage control (DC) therapy, performed in a University Hospital in Colombia over a 4-year period. Materials and Methods: A database of 106 patients who received the ECD procedure, and were managed according to the strategy for DC in neurotrauma, was analyzed. Variables were evaluated, and the patient outcome was determined according to the Glasgow Outcome Score (GOS) at 12 months postinjury. This was used to generate a dichotomous variable with "favorable" (GOS of 4 or 5) or "unfavorable" (GOS of 1-3) outcomes; analysis of variance was performed with the Chi-square, Wilcoxon-Mann-Whitney and Fisher tests. Results: An overall survival rate of 74.6% was observed for the procedure, At 12 months postsurgery, a favorable clinical outcome (GOS 4-5) was found in 70 patients (66.1%), Unfavorable outcomes in patients were associated with the following factors: Closed trauma, an Injury Severity Score > 16, obliterated basal cisterns, subdural hematoma as the main injury seen on the admission computed tomography, and nonreactive pupils observed in the emergency department. Conclusion: Twelve months outcome of patients with sTBI managed with ECD in a neuromonitoring limited resource University Hospital in Colombia shows an important survival rate with favorable clinical outcome measure with GOS.	[Charry, Jose D.; Rubiano, Andres M.; Ortiz, Juan C.] South Colombian Univ, Dept Basic & Clin Sci Neurosci & Neurosurg, Neiva, Colombia; [Charry, Jose D.; Rubiano, Andres M.; Ortiz, Juan C.] Univ Hosp, Neiva, Colombia; [Charry, Jose D.; Rubiano, Andres M.; Ortiz, Juan C.] MEDITECH Fdn, Neurotrauma Res Grp, Neiva, Colombia; [Nikas, Christine V.; Puyana, Juan C.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ USA		Rubiano, AM (corresponding author), MEDITECH Fdn, Calle 5 11-19, Neiva, Huila, Colombia.	andresrubiano@aol.com	Adelson, David/W-2083-2019; RUBIANO, ANDRES M/K-6704-2012	RUBIANO, ANDRES M/0000-0001-8931-3254; Charry, Jose D./0000-0002-8789-7281			Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; Cavusoglu H, 2010, ULUS TRAVMA ACIL CER, V16, P119; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; De la Hoz GA, 2013, FORENSIS, V1, P79; Girotto D, 2011, COLLEGIUM ANTROPOL, V35, P255; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; JENNETT B, 1975, LANCET, V1, P480; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Kim DR, 2014, J KOREAN NEUROSURG S, V55, P26, DOI 10.3340/jkns.2014.55.1.26; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nambiar M, 2015, CRIT CARE RESUSC, V17, P67; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Ojo O A, 2015, Niger Postgrad Med J, V22, P45; Rubiano AM, 2007, NEUROTRAUMA NEUROINT, P231; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	27	9	9	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN-MAR	2016	7	1					7	12		10.4103/0976-3147.172151			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DJ2TV	WOS:000374058900004	26933337	gold, Green Published			2022-02-06	
J	Dye, JL; Eskridge, SL; Tepe, V; Clouser, MC; Galarneau, M				Dye, Judy L.; Eskridge, Susan L.; Tepe, Victoria; Clouser, Mary C.; Galarneau, Michael			Characterization and Comparison of Combat-Related Injuries in Women During OIF and OEF	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; PROGESTERONE; SEVERITY; PERSONNEL; SYMPTOMS; OUTCOMES; GENDER; IRAQ	Although historically restricted from combat roles, women suffer from combat-related injuries, especially in recent conflicts where asymmetrical warfare erases distinctions between forward and rear operating areas. U.S. service-women who sustained combat-related injury in Operation Iraqi Freedom (OIF) or Operation Enduring Freedom (OEF) between January 2003 and May 2014 were identified from the Expeditionary Medical Encounter Database. Injuries were characterized using Abbreviated Injury Scale and International Classification of Diseases, 9th Revision codes. Of the 844 combat-related injury episodes in women, 51% (n = 433) were OIF injuries and 49% (n = 411) were OEF injuries. Blast events were responsible for 90% of injuries. The average Injury Severity Score was 3, with no statistical difference in means between OIF and OEF. Of significance were increased head injuries in OEF compared with OIF (80% vs. 48%; p < 0.001). Although the majority of combat-related injuries suffered by women were mild, some women suffered life-threatening injuries, and nearly 65% of the injury episodes resulted in more than one injury. More research is needed as the roles of women in the military continue to expand. Future studies will investigate quality of life outcomes and gender differences in combat-related injuries.	[Dye, Judy L.; Eskridge, Susan L.; Clouser, Mary C.; Galarneau, Michael] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA; [Tepe, Victoria] Dept Def Hearing Ctr Excellence HCE, Jbsa Lackland, TX 78236 USA		Dye, JL (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.			Eskridge, Susan/0000-0002-1817-8355	U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill, and Injured/Psychological Health/Traumatic Brain Injury Program, Washington, DC, Work Unit [60808]	Report No. 14-xx, supported by the U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill, and Injured/Psychological Health/Traumatic Brain Injury Program, Washington, DC, Work Unit No. 60808. The views expressed in this presentation are those of the author(s) and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government. Approved for public release; distribution is unlimited. U.S. Government Work (17 USC 105). Not copyrighted in the U.S. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research (Protocol NHRC.2003.0025).	[Anonymous], 2011, FEM LION PROGR TRAIN; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barry B, 2013, SURVIVAL, V55, P19, DOI 10.1080/00396338.2013.784461; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Center for Military Readiness, 2013, GRIM TOLL MIL WOM KI; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Defense Manpower Data Center, 2012 DEM PROF MIL CO; Dougherty AL, 2009, INJURY, V40, P772, DOI 10.1016/j.injury.2009.02.014; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Fitts J, FEMALE SOLDIERS PROT; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2005, ABBREVIATED INJURY S; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Harris OA, 2013, S WOM VET EMPL SKILL; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LINN S, 1993, INT J EPIDEMIOL, V22, P905, DOI 10.1093/ije/22.5.905; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; McBride K, 2012, HUMANITY, V3, P199, DOI 10.1353/hum.2012.0012; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Osler TM, 2013, J TRAUMA ACUTE CARE, V74, P921, DOI 10.1097/TA.0b013e31827e1d5e; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tepe V, WOMEN AT WAR, P211; Trego L, 2010, BIOL RES NURS, V12, P171, DOI 10.1177/1099800410375299; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zouris JM, 2008, MIL MED, V173, P247, DOI 10.7205/MILMED.173.3.247; Zouris JM, 2006, MIL MED, V171, P246, DOI 10.7205/MILMED.171.3.246	42	9	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2016	181			1			92	98		10.7205/MILMED-D-15-00237			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3NW	WOS:000373406400014	26741907	Bronze			2022-02-06	
J	Garber, BG; Rusu, C; Zamorski, MA; Boulos, D				Garber, Bryan G.; Rusu, Corneliu; Zamorski, Mark A.; Boulos, David			Occupational outcomes following mild traumatic brain injury in Canadian military personnel deployed in support of the mission in Afghanistan: a retrospective cohort study	BMJ OPEN			English	Article						Brain injuries; *diagnoses; Disabled Persons; statistics & numerical data; occupations; prognosis	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PTSD CHECKLIST; SELF-REPORT; CONCUSSION; SYMPTOMS; IRAQ; DEPRESSION; VETERANS	Objective Deployment-related mild traumatic brain injury (MTBI) occurs in a significant number of military personnel but its long-term impacts are unclear. This study explores the impact of deployment-related MTBI on continued fitness-for-duty, with the ultimate intent of identifying potential targets for intervention to attenuate its effects. Participants Consisted of 16193 Canadian Armed Forces (CAF) personnel who deployed in support of the mission in Afghanistan and completed an enhanced postdeployment screening (EPDS) questionnaire over the period January 2009-July 2012. Primary outcome The primary outcome was development of permanent medical unfitness defined as a career-limiting medical condition' (CL-MC). The secondary outcome was the diagnostic categories recorded for each individual at the time a CL-MC was established. Design This study used a retrospective cohort design. Linked administrative and health data provided the primary outcome and the diagnoses responsible for it. Survival analysis was used to estimate the risk of a CL-MC and Cox regression provided adjusted HRs (aHRs) for the association between a CL-MC and MTBI, accounting for key covariates and confounders. Diagnostic categories associated with CL-MCs were identified. Results Over a median follow-up period of 3.42years, 6.57% of the study population developed a CL-MC. MTBI was independently associated with CL-MCs (aHR=1.65, 95% CI 1.35 to 2.03). Mental disorders and musculoskeletal conditions were the primary diagnoses associated with CL-MCs (identified as the primary diagnosis in 55.4% and 25.9%, respectively), and a neurological condition was only documented in 5.8% of those with MTBI who developed a CL-MC Conclusions Deployment-related MTBI was associated with adverse occupational outcome but mental disorders and musculoskeletal conditions primarily drove subsequent medical unfitness. These findings support a diagnostic and treatment approach focusing on these comorbidities as the most promising strategy to minimise the burden of disability in MTBI-exposed military personnel.	[Garber, Bryan G.; Rusu, Corneliu; Zamorski, Mark A.; Boulos, David] Canadian Forces Hlth Serv Grp Headquarters, Ottawa, ON, Canada; [Zamorski, Mark A.] Univ Ottawa, Dept Family Med, Fac Med, Ottawa, ON, Canada		Garber, BG (corresponding author), Canadian Forces Hlth Serv Grp Headquarters, Ottawa, ON, Canada.	bryan.garber@forces.gc.ca		Boulos, David/0000-0001-7585-0681	Canadian Forces Surgeon General's Health Research Program [2012-08-089-003-001]	This study was funded by 'The Canadian Forces Surgeon General's Health Research Program' (Protocol# 2012-08-089-003-001).	[Anonymous], NAT DEF CAN ARM FORC; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boulos D, 2016, CAN J PSYCH IN PRESS; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cancelliere C, 2014, ARCH PHYS MED REHA S, V95; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castro CA, 2007, TRAUMATOLOGY, V13, P6, DOI [DOI 10.1177/1534765607309950, 10.1177/1534765607309950]; Garber BG, 2008, CANADIAN FORCES HLTH; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Hertzmark E, 2015, SAS MEDIATE MACRO; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2015, COGN REH THER TRAUM; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; May S., 2008, APPL SURVIVAL ANAL R; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ontario Neurotrauma Foundation, 2011, GUID MILD TRAUM BRAI; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schoenfeld AJ, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01050; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, P1; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; WCB Evidence-Based Practice Group, 2003, MILD TRAUM BRAIN INJ; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Zamorski M. A., 2011, REPORT FINDINGS ENHA; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319, DOI 10.1177/070674371405900605	42	9	9	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	5							e010780	10.1136/bmjopen-2015-010780			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP3SF	WOS:000378414700080	27147386	Green Published, gold			2022-02-06	
J	Gattu, R; Akin, FW; Cacace, AT; Hall, CD; Murnane, OD; Haacke, EM				Gattu, Ramtilak; Akin, Faith W.; Cacace, Anthony T.; Hall, Courtney D.; Murnane, Owen D.; Haacke, E. Mark			Vestibular, balance, microvascular and white matter neuroimaging characteristics of blast injuries and mild traumatic brain injury: Four case reports	BRAIN INJURY			English	Article						Mild brain injury; vestibular; neuroimaging; balance	EVOKED MYOGENIC POTENTIALS; DWELLING OLDER-ADULTS; NOISE EXPOSURE; HEAD-INJURY; DIZZINESS; PERFORMANCE; DYSFUNCTION; CONCUSSION; INTEGRITY; SYMPTOMS	Background: Case reports are presented on four Veterans, aged 29-46 years, who complained of chronic dizziness and/or postural instability following blast exposures. Two of the four individuals were diagnosed with mild traumatic brain injury and three of the four were exposed to multiple blasts. Comprehensive vestibular, balance, gait, audiometry and neuroimaging procedures were used to characterize their injuries.Case report: Vestibular assessment included videonystagmography, rotary chair and cervical and ocular vestibular evoked myogenic potentials. Balance and gait testing included the sensory organization test, preferred gait speed and the dynamic gait index. Audiometric studies included pure tone audiometry and middle-ear measurements. Neuroimaging procedures included high resolution structural magnetic resonance imaging, susceptibility-weighted imaging and diffusion-tensor imaging.Findings: Based on the neuroimaging and vestibular and balance test results, it was found that all individuals had diffuse axonal injuries and all had one or more micro-hemorrhages or vascular anomalies. Three of the four individuals had abnormal vestibular function, all had abnormally slow walking speeds and two had abnormal gait and balance dysfunction.Conclusion: The use of contemporary neuroimaging studies in conjunction with comprehensive vestibular and balance assessment provided a better understanding of the pathophysiology and pathoanatomy of dizziness following blast exposures than standard vestibular and balance testing alone.	[Gattu, Ramtilak; Haacke, E. Mark] Wayne State Univ, Sch Med, Dept Diagnost Radiol, Detroit, MI 48202 USA; [Akin, Faith W.; Murnane, Owen D.] James A Quillen VA Med Ctr, Vestibular Lab, Mt Home, Johnson City, TN USA; [Akin, Faith W.; Murnane, Owen D.] East Tennessee State Univ, Dept Audiol & Speech Language Pathol, Johnson City, TN 37614 USA; [Cacace, Anthony T.] Wayne State Univ, Dept Commun Sci Disorders, Detroit, MI USA; [Hall, Courtney D.] James A Quillen VA Med Ctr, Gait & Balance Lab, Johnson City, TN USA; [Hall, Courtney D.] East Tennessee State Univ, Dept Phys Therapy, Johnson City, TN 37614 USA; [Haacke, E. Mark] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA		Akin, FW (corresponding author), James A Quillen VA Med Ctr, Vestibular & Balance Lab, Johnson City, TN 37684 USA.	faith.akin@va.gov			Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, D.CUS Department of Veterans Affairs [C6841R]	Support for this study was provided by a Merit Review (C6841R) sponsored by the Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, D.C. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Akdogan O, 2009, AURIS NASUS LARYNX, V36, P2, DOI 10.1016/j.anl.2008.03.003; Akin FW, 2012, EAR HEARING, V33, P458, DOI 10.1097/AUD.0b013e3182498c5f; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; American National Standards Institute, 2004, S3212004 ANSI; Arriaga MA, 2005, OTOLARYNG HEAD NECK, V133, P329, DOI 10.1016/j.otohns.2005.05.002; Ashburner J, 2009, NEUROIMAGE, V45, P333, DOI 10.1016/j.neuroimage.2008.12.008; Benson RR, 2014, HEARING RES, V309, P8, DOI 10.1016/j.heares.2013.10.005; Blakley BW, 2015, OTOL NEUROTOL, V36, P1069, DOI 10.1097/MAO.0000000000000752; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; CAVENESS W F, 1961, N Y State J Med, V61, P871; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; COLEBATCH JG, 1992, NEUROLOGY, V42, P1635, DOI 10.1212/WNL.42.8.1635; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hsu WC, 2008, ARCH OTOLARYNGOL, V134, P1099, DOI 10.1001/archotol.134.10.1099; Iwasaki S, 2008, CLIN NEUROPHYSIOL, V119, P2135, DOI 10.1016/j.clinph.2008.05.028; Iwasaki S, 2009, CLIN NEUROPHYSIOL, V120, P588, DOI 10.1016/j.clinph.2008.12.036; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JONGKEES LBW, 1948, ARCH OTOLARYNGOL, V48, P402; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kallakuri S, 2015, J NEUROSCI RURAL PRA, V6, P481, DOI 10.4103/0976-3147.169767; KERR AG, 1975, J LARYNGOL OTOL, V89, P131, DOI 10.1017/S002221510008018X; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee JD, 2011, EUR ARCH OTO-RHINO-L, V268, P1427, DOI 10.1007/s00405-010-1426-5; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Maskell F, 2007, BRAIN INJURY, V21, P741, DOI 10.1080/02699050701472109; Murnane OD, 2009, EAR HEARING, V30, P313, DOI 10.1097/AUD.0b013e31819c3ec7; NASHNER LM, 1982, J NEUROSCI, V2, P536; Pardasaney PK, 2012, PHYS THER, V92, P388, DOI 10.2522/ptj.20100398; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; ShumwayCook A, 1997, PHYS THER, V77, P46, DOI 10.1093/ptj/77.1.46; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Wang YP, 2006, OTOL NEUROTOL, V27, P956, DOI 10.1097/01.mao.0000231590.57348.4b; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Whitney SL, 2000, J VESTIBUL RES-EQUIL, V10, P99; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089	46	9	11	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1501	1514		10.1080/02699052.2016.1219056			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100012	27834534				2022-02-06	
J	Golos, A; Bedell, G				Golos, Anat; Bedell, Gary			Psychometric properties of the Child and Adolescent Scale of Participation (CASP) across a 3-year period for children and youth with traumatic brain injury	NEUROREHABILITATION			English	Article						Measurement; participation; children; youth; psychometrics; validity; reliability	QUALITY-OF-LIFE; CONCEPTUALIZATION; DISABILITIES; PERSPECTIVES; STUDENTS; OUTCOMES	BACKGROUND: Children with traumatic brain injury are often restricted in their participation due to impairments and environmental barriers. Reliable and valid instruments are essential for monitoring their participation over time. OBJECTIVE: To examine the construct validity and internal consistency of the Child and Adolescent Scale of Participation (CASP) across a 3-year period. METHODS: A longitudinal prospective cohort study (USA) that included 926 children (0-18 years) with TBI and arm injury. Three measures were administered at 3, 12, 24, and 36 months post-injury: The CASP, Pediatric Quality of Life Inventory (PedsQL), and Adaptive Behavior Assessment Scale II (ABAS). RESULTS: Associations between the CASP and PedsQL and ABAS were moderate-to-high at all time periods. Internal consistency of the CASP and its sub-sections was high, with a pattern of gradual increase over time. Factor analyses indicated a clearer four factor solution at 3, 12 and 24 months resembling the four CASP sub-sections. CONCUSIONS: Results provide evidence of convergent validity and internal consistency of the CASP and support its use for assessing participation of children with TBI over time. Prudence should be taken when considering use of factor scores due to differences in factor solutions found in this study and prior studies.	[Golos, Anat] Sch Occupat Therapy Hadassah, POB 24026, IL-91240 Jerusalem, Israel; [Golos, Anat] Hebrew Univ Jerusalem, POB 24026, IL-91240 Jerusalem, Israel; [Bedell, Gary] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA		Golos, A (corresponding author), Sch Occupat Therapy Hadassah, POB 24026, IL-91240 Jerusalem, Israel.; Golos, A (corresponding author), Hebrew Univ Jerusalem, POB 24026, IL-91240 Jerusalem, Israel.	anat.golos@mail.huji.ac.il		Bedell, Gary/0000-0002-9555-8861	CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CE 001021]	We thank Fred P. Rivara, MD., MPH, Department of Pediatrics, University of Washington, who provided selected de identified data to us to examine the psychometric properties of the CASP from his prior longitudinal study (CDC grant R49 CE 001021).	Anaby D, 2013, DISABIL REHABIL, V35, P1589, DOI 10.3109/09638288.2012.748840; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Bedell G., 2012, DEV SOCIAL NEUROSCIE; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P220, DOI 10.1097/01.HTR.0000327254.61751.e7; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Coster W, 2013, CHILD CARE HLTH DEV, V39, P535, DOI 10.1111/cch.12046; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Fougeyrollas P., 2014, OPEN J THERAPY REHAB, V2, DOI [10.4236/ojtr.2014.24021, DOI 10.4236/OJTR.2014.24021]; Granlund M, 2013, CHILD CARE HLTH DEV, V39, P470, DOI 10.1111/cch.12080; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hwang AW, 2013, INT J REHABIL RES, V36, P211, DOI 10.1097/MRR.0b013e32835d0b27; King G, 2013, CHILD CARE HLTH DEV, V39, P466, DOI 10.1111/cch.12083; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Simeonsson RJ, 2001, DISABIL REHABIL, V23, P49; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Thompson H, 2012, J NEUROTRAUM, V29, pA189; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Ziviani J, 2010, BRAIN IMPAIR, V11, P93, DOI 10.1375/brim.11.2.93	31	9	9	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	4					311	319		10.3233/NRE-161322			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DP5PI	WOS:000378549100001	27061159				2022-02-06	
J	Jang, SH; Lee, HD				Jang, Sung Ho; Lee, Han Do			Central pain due to spinothalamic tract injury caused by indirect head trauma following a pratfall	BRAIN INJURY			English	Article						Diffusion tensor tractography; spinothalamic tract; central pain; mild traumatic brain injury	CENTRAL POSTSTROKE PAIN; BRAIN-INJURY; AXONAL INJURY; MILD; PATHOPHYSIOLOGY; PATIENT; PATHWAY	Objectives: This study reports on patients who showed central pain due to injury of the spinothalamic tract (STT) caused by fall without direct head trauma. Design: Prospective study. Participants: Two patients with mild traumatic brain injury (TBI) resulting from a fall were enrolled. Patient 1 was a 21-year-old female who had suffered a pratfall with no history of direct head trauma. She had begun to feel pain in both upper trunk and lower back and the left leg since similar to 5 days after onset: constant tingling and throbbing sensation with allodynia. Patient 2 was a 39-year-old male who had suffered a pratfall without direct head trauma. He had begun to feel pain in both arms and legs since similar to 4 days after the fall: constant tingling and pricking sensation without allodynia or hyperalgesia. Results: On diffusion tensor tractograhpy (DTT) of patient 1, partial tearing of the right STT was observed at the subcortical white matter. On DTT of patient 2, partial tearing at the subcortical white matter was observed in the right STT and partial narrowing at the subcortical white matter was observed in the left STT. Conclusions: This study demonstrated injury of the STT in patients who suffered from central pain following a fall. The results suggest that minor indirect head trauma can cause traumatic axonal injury of the brain.	[Jang, Sung Ho; Lee, Han Do] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea		Lee, HD (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	lhd890221@hanmail.net			Medical Research Center Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Hong JH, 2010, EUR NEUROL, V64, P163, DOI 10.1159/000319040; Jang SH, 2015, SOMATOSENS MOT RES, V32, P67, DOI 10.3109/08990220.2014.966899; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Lee HD, 2015, BRAIN INJURY, V23, P1; Miller M D, 1993, Fam Pract Res J, V13, P15; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Seghier ML, 2005, J PAIN, V6, P208, DOI 10.1016/j.jpain.2004.11.004; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Seo JP, 2013, BRAIN INJURY, V27, P749, DOI 10.3109/02699052.2013.771794; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Walker WC, 2004, J HEAD TRAUMA REHAB, V19, P72, DOI 10.1097/00001199-200401000-00007	22	9	9	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	7					933	936		10.3109/02699052.2016.1146966			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DP2MI	WOS:000378322400014	27058675				2022-02-06	
J	Johnson, VE				Johnson, Victoria E.			"Together, We Make Football": The NFL's "feminine" discourses	POPULAR COMMUNICATION			English	Article							SPORT	This article presents an analysis of the National Football League's (NFL's) contemporary address to female fans through gendered appeals. These are designed to build and strengthen affective bonds between women and the league and mitigate acute public criticism regarding the sport's current concussion, domestic violence, and other brand crises. The essay uses Stuart Hall's conceptualization of critical conjuncture with humanistic television studies methods of formal/textual analysis to contextualize advertisements for the NFL's charitable initiatives, its "NFL for Her" merchandise promotions, and its advertising campaigns with Verizon Wireless. Beyond the NFL, analyzing the league's appeals to female fans allows consideration of how female athleticism and athletic fandom have increasingly become critical sites to visualize neoliberal logic.	[Johnson, Victoria E.] Univ Calif Irvine, Irvine, CA 92697 USA		Johnson, VE (corresponding author), Univ Calif Irvine, Dept Film & Media Studies, 2000 Humanities Gateway Bldg, Irvine, CA 92697 USA.	v.e.johnson@uci.edu					Banet-Weiser, 2012, AUTHENTIC POLITICS A; Banet--Weiser Sarah, 2014, GENDERING RECESSION, P81; Berlant Lauren., 2008, FEMALE COMPLAINT UNF; Brown W, 2005, EDGEWORK: CRITICAL ESSAYS ON KNOWLEDGE AND POLITICS, P1; Burke M., 2013, FORBES; Dyer R., 1993, CULTURAL STUDIES REA, P371; Giroux HA, 2011, SOC IDENT, V17, P587, DOI 10.1080/13504630.2011.587310; Gray H, 2013, COMMUN CRIT-CULT STU, V10, P253, DOI 10.1080/14791420.2013.821641; HALL S, 1992, BLACK POPULAR CULTUR, P21; Hall S., 1988, HARD ROAD RENEWAL TH; Harte S., 1994, ATLANTA J CONST 0130, pF2; Heywood L., 2003, BUILT WIN FEMALE ATH; Jhally S., 1989, MEDIA SPORTS SOC, P70; Kim Susanna, 2014, RENEWED SPOTLIGHT WH; King S., 2006, PINK RIBBONS INC BRE; Kuhn A., 2000, FEMINISM FILM, P437; McCarthy Anna, 2010, CITIZEN MACHINE GOVE; McCarthy M., 2001, USA TODAY       0226, V4B; MILLER T, 2001, SPORTSEX; Modleski Tania, 1991, FEMINISM WOMEN CULTU; National Football League, 2014, A CRUC CATCH; National Football League Foundation, 2013, HEADS UP FOOTB; Newman M. Z., 2014, ANTENNA; Oates TP, 2012, FEM MEDIA STUD, V12, P603, DOI 10.1080/14680777.2012.723929; Oates TP, 2009, SOCIOL SPORT J, V26, P31, DOI 10.1123/ssj.26.1.31; ORIARD M, 2007, BRAND NFL MAKING SEL; Oriard Michael, 1993, READING FOOTBALL POP; Ouellette Laurie., 2008, BETTER LIVING REALIT; ROSE A, 1994, SCREEN, V35, P22, DOI 10.1093/screen/35.1.22; Together We Make Football, 2014, TEAM FEL; VOGAN T, 2014, KEEP FLAM NFL FILMS, P1; Williams Raymond., 1977, MARXISM LIT	32	9	9	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1540-5702	1540-5710		POP COMMUN	Pop. Commun.		2016	14	1			SI		12	20		10.1080/15405702.2015.1084622			9	Communication	Emerging Sources Citation Index (ESCI)	Communication	DN5MB	WOS:000377111200003		Green Published			2022-02-06	
J	Lang, KP; Veazey-Morris, K; Berlin, KS; Andrasik, F				Lang, Katie P.; Veazey-Morris, Katherine; Berlin, Kristoffer S.; Andrasik, Frank			Factors Affecting Health Care Utilization in OEF/OIF Veterans: The Impact of PTSD and Pain	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; GENDER-DIFFERENCES; AFGHANISTAN; IRAQ; DEPRESSION; PREVALENCE; SERVICES	Objectives: Returning Operation Enduring Freedom and Operation Iraqi Freedom veterans are at a high risk for physical and mental health symptoms including pain (90%) and post-traumatic stress disorder (PTSD) (58%). These often present concurrently and result in many health problems, functional impairments, and overall poor rehabilitation. To address postdeployment health, effective and efficient allocation of health care resources is needed. Methods: Retrospective study of 144 veterans who completed a second-level screening in the Polytrauma clinic. Veterans completed the PTSD Checklist-Civilian Version. Their pain rating and health care utilization (sum of visits during 12 months, categorized as medical or mental health) was extracted through chart review. Results: The majority of veterans reported significant PTSD (72%) and pain (87%) symptoms; 45% received adequate mental health treatment, defined as >= 8 sessions in 12 months. PTSD and the interaction with pain predicted medical utilization; at high pain levels veterans' PTSD severity predicted utilization. PTSD alone predicted mental health utilization. Conclusions: The results show the increased influence of PTSD symptoms on medical health care services when pain ratings are high and suggest the need for interdisciplinary pain clinics that are able to address the overlapping symptoms of pain and common mental health conditions. Implication of results for VA planning are discussed.	[Lang, Katie P.; Veazey-Morris, Katherine; Berlin, Kristoffer S.; Andrasik, Frank] Univ Memphis, Dept Psychol, 202 Psychology Bldg, Memphis, TN 38152 USA; [Veazey-Morris, Katherine] Memphis Vet Affairs Med Ctr, 1030 Jefferson Ave 116A, Memphis, TN 38104 USA		Lang, KP (corresponding author), Univ Memphis, Dept Psychol, 202 Psychology Bldg, Memphis, TN 38152 USA.			Andrasik, Frank/0000-0001-6625-479X			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; ANDRASIK F, 1981, HEADACHE, V21, P218, DOI 10.1111/j.1526-4610.1981.hed2105218.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Dunn AS, 2009, MIL MED, V174, P578, DOI 10.7205/MILMED-D-02-3508; Foa E.B., 2007, PROLONGED EXPOSURE T; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Karazsia BT, 2008, J PEDIATR PSYCHOL, V33, P1076, DOI 10.1093/jpepsy/jsn055; Kaur S, 2007, J GEN INTERN MED, V22, P228, DOI 10.1007/s11606-006-0048-5; Kerns RD, 2000, PAIN 5 VITAL SIGN TO, V2; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; N-Hoffmant VLF, 2007, J PAIN, V8, P954, DOI 10.1016/j.jpain.2007.07.003; Naragon-Gainey K, 2012, PSYCHIAT SERV, V63, P942, DOI 10.1176/appi.ps.201100349; Otis JD, 2010, PSYCHOL SERV, V7, P126, DOI 10.1037/a0020512; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Shipherd JC, 2003, J TRAUMA STRESS, V16, P451, DOI 10.1023/A:1025754310462; Sibley CG, 2013, ANAL SOC ISS PUB POL, V13, P245, DOI 10.1111/asap.12008; Stapleton JA, 2006, MIL MED, V171, P562, DOI 10.7205/MILMED.171.6.562; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Veterans Health Administration, 2012, LOC IMPL EV BAS PSYC; Veterans Health Administration, 2008, AN VA HLTH CAR UT US; Veterans Health Administration and Department of Defense, 2004, VA DODCLINICAL PRACT	28	9	9	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2016	181	1					50	55		10.7205/MILMED-D-14-00444			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI3MZ	WOS:000373404100011	26741476	Bronze			2022-02-06	
J	Lange, RT; Brickell, TA; Bailie, JM; Tulsky, DS; French, LM				Lange, Rael T.; Brickell, Tracey A.; Bailie, Jason M.; Tulsky, David S.; French, Louis M.			Clinical Utility and Psychometric Properties of the Traumatic Brain Injury Quality of Life Scale (TBI-QOL) in US Military Service Members	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health-related quality of life; military; mild traumatic brain injury; reliability; validity	POSTTRAUMATIC-STRESS-DISORDER; MILD HEAD-INJURY; OUTCOMES MEASUREMENT; NATIONAL-GUARD; SYMPTOMS; CONCUSSION; DEPRESSION; IRAQ; IDENTIFICATION; INDIVIDUALS	Objective: To examine the clinical utility and psychometric properties of the Traumatic Brain Injury Quality of Life (TBI-QOL) scale in a US military population. Participants: One hundred fifty-two US military service members (age: M = 34.3, SD = 9.4; 89.5% men) prospectively enrolled from the Walter Reed National Military Medical Center and other nationwide community outreach initiatives. Participants included 99 service members who had sustained a mild traumatic brain injury (TBI) and 53 injured or noninjured controls without TBI (n = 29 and n = 24, respectively). Procedure: Participants completed the TBI-QOL scale and 5 other behavioral measures, on average, 33.8 months postinjury (SD = 37.9). Main Outcome Measures: Fourteen TBI-QOL subscales; Neurobehavioral Symptom Inventory; Posttraumatic Stress Disorder Checklist-Civilian version; Alcohol Use Disorders Identification Test; Combat Exposure Scale. Results: The internal consistency reliability of the TBI-QOL scales ranged from alpha = .91 to alpha = .98. The convergent and discriminant validity of the 14 TBI-QOL subscales was high. The mild TBI group had significantly worse scores on 10 of the 14 TBI-QOL subscales than the control group (range, P < .001 to P = .043). Effect sizes ranged from medium to very large (d = 0.35 to d = 1.13). The largest differences were found on the Cognition-General Concerns (d = 1.13), Executive Function (d = 0.94), Grief-Loss (d = 0.88), Pain Interference (d = 0.83), and Headache Pain (d = 0.83) subscales. Conclusion: These results support the use of the TBI-QOL scale as a measure of health-related quality of life in a mild TBI military sample. Additional research is recommended to further evaluate the clinical utility of the TBI-QOL scale in both military and civilian settings.	[Lange, Rael T.; Brickell, Tracey A.; Bailie, Jason M.; French, Louis M.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Ctr Assessment Res & Translat, Newark, DE USA; [Tulsky, David S.] Kessler Fdn Res Ctr, W Orange, NJ USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Bailie, Jason M.] Naval Med Ctr San Diego, San Diego, CA USA		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 8,Room 2264,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rael.lange@gmail.com	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Tulsky, David/0000-0002-4335-4509			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Armistead-Jehle P, 2014, CLIN UTILITY MBIAS D; Babor TF, 2001, AUDIT ALCOHOL USE DI; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; National Institute of Neurological Disorders and Stroke, 2014, NINDS COMM DAT EL; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Tanielian T, 2008, INVISIBLE WOUNDS WAR, P391; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; Tulsky DS, J HEAD TRAU IN PRESS; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	43	9	9	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					62	78		10.1097/HTR.0000000000000149			17	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000015	26716697				2022-02-06	
J	Lee, SY; Chou, CL; Hsu, SPC; Shih, CC; Yeh, CC; Hung, CJ; Chen, TL; Liao, CC				Lee, Shang-Yi; Chou, Chia-Lun; Hsu, Sanford P. C.; Shih, Chun-Chuan; Yeh, Chun-Chieh; Hung, Chih-Jen; Chen, Ta-Liang; Liao, Chien-Chang			Outcomes after Stroke in Patients with Previous Pressure Ulcer: A Nationwide Matched Retrospective Cohort Study	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Complications; mortality; outcomes; pressure ulcer; stroke	TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; RISK; MORTALITY; SORES; MORBIDITY; ADMISSION; HEALTH	Background: Factors associated with poststroke adverse events were not completely understood. The purpose of this study was to investigate whether stroke patients with previous pressure ulcers had more adverse events after stroke. Methods: Using the claims data from Taiwan's National Health Insurance Research Database, we conducted a retrospective cohort study matched by propensity score. Three thousand two first-ever stroke patients with previous pressure ulcer and 3002 first-ever stroke patients without pressure ulcer were investigated between 2002 and 2009. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of complications and 30-day mortality after stroke associated with previous pressure ulcer were calculated in the multivariate logistic regressions. Results: Patients with pressure ulcer had significantly higher risk than control for poststroke urinary tract infection (OR: 1.56, 95% CI: 1.38-1.78), pneumonia (OR: 1.35, 95% CI: 1.16-1.58), gastrointestinal bleeding (OR: 1.31, 95% CI: 1.04-1.66), and epilepsy (OR: 1.84, 95% CI: 1.83-1.85). Stroke patients with pressure ulcer had increased 30-day poststroke mortality (OR: 2.01, 95% CI: 1.55-2.61), particularly in those treated with debridement (OR: 2.87, 95% CI: 1.85-4.44) or high quantity of antibiotics (OR: 4.01, 95% CI: 2.10-7.66). Pressure ulcer was associated with poststroke mortality in both genders and patients aged 60 years or older. Conclusions: This study showed increased poststroke complications and mortality in patients with previous pressure ulcer, which suggests the urgent need for monitoring stroke patients for pressure ulcer history.	[Lee, Shang-Yi; Hung, Chih-Jen] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Chou, Chia-Lun] Taipei Med Univ, Shuang Ho Hosp, Dept Dermatol, New Taipei, Taiwan; [Hsu, Sanford P. C.] Taipei Vet Gen Hosp, Neurosurg Neurol Inst, Taipei, Taiwan; [Shih, Chun-Chuan] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Shih, Chun-Chuan] Taipei Med Univ, PhD Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Shih, Chun-Chuan] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei 110, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei 110, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan		Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan.	ccliao@tmu.edu.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	Taipei Medical University; Shuan Ho Hospital [104TMU-SHH-23]; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [NSC102-2314-B-038-021-MY3, MOST104-2314-B-038-027-MY2]	This study was supported in part by grants from Taipei Medical University and Shuan Ho Hospital (104TMU-SHH-23), and the Ministry of Science and Technology, Taiwan (NSC102-2314-B-038-021-MY3; MOST104-2314-B-038-027-MY2).	BARSAN WG, 1988, ANN EMERG MED, V17, P1192, DOI 10.1016/S0196-0644(88)80067-2; BERGSTROM N, 1992, J AM GERIATR SOC, V40, P747, DOI 10.1111/j.1532-5415.1992.tb01845.x; BERLOWITZ DR, 1989, J AM GERIATR SOC, V37, P1043, DOI 10.1111/j.1532-5415.1989.tb06918.x; BRYAN CS, 1983, ARCH INTERN MED, V143, P2093, DOI 10.1001/archinte.143.11.2093; Chou YC, 2014, J HEAD TRAUMA REHAB, V29, P514, DOI 10.1097/HTR.0000000000000007; Cushing CA, 2013, PLAST RECONSTR SURG, V132, P1720, DOI 10.1097/PRS.0b013e3182a808ba; Dennis M, 2003, STROKE, V34, P1450, DOI 10.1161/01.STR.0000074037.49197.8C; Desilles JP, 2013, STROKE, V44, P1915, DOI 10.1161/STROKEAHA.111.000813; Di Napoli M, 2005, STROKE, V36, P1316, DOI 10.1161/01.STR.0000165929.78756.ed; DITUNNO JF, 1994, NEW ENGL J MED, V330, P550, DOI 10.1056/NEJM199402243300808; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; GALPIN JE, 1976, AM J MED, V61, P346, DOI 10.1016/0002-9343(76)90371-5; Glozier N, 2008, STROKE, V39, P1526, DOI 10.1161/STROKEAHA.107.503219; Gorecki C, 2009, J AM GERIATR SOC, V57, P1175, DOI 10.1111/j.1532-5415.2009.02307.x; Grey JE, 2006, BMJ-BRIT MED J, V332, P472, DOI 10.1136/bmj.332.7539.472; GURALNIK JM, 1988, J AM GERIATR SOC, V36, P807, DOI 10.1111/j.1532-5415.1988.tb04264.x; INMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P1139; Jiang L, 2014, SPINAL CORD, V52, P145, DOI 10.1038/sc.2013.132; Kimberly WT, 2013, NEUROLOGY, V80, P719, DOI 10.1212/WNL.0b013e31828250ff; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Levine DA, 2014, NEUROLOGY, V82, P914, DOI 10.1212/WNL.0000000000000214; Liao CC, 2014, DIABETES CARE, V37, P2246, DOI 10.2337/dc13-2957; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Manzano F, 2010, J CRIT CARE, V25, P469, DOI 10.1016/j.jcrc.2009.09.002; Meretoja A, 2010, STROKE, V41, P1102, DOI 10.1161/STROKEAHA.109.577718; MURPHY S, 1992, J AM GERIATR SOC, V40, P213, DOI 10.1111/j.1532-5415.1992.tb02070.x; O'Brien DD, 2014, CRIT CARE MED, V42, P40, DOI 10.1097/CCM.0b013e318298a849; RUDMAN D, 1993, J AM GERIATR SOC, V41, P1317, DOI 10.1111/j.1532-5415.1993.tb06482.x; Sackley C, 2008, STROKE, V39, P3329, DOI 10.1161/STROKEAHA.108.518563; Salzberg CA, 1996, AM J PHYS MED REHAB, V75, P96, DOI 10.1097/00002060-199603000-00004; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; SCHECKLER WE, 1986, ARCH INTERN MED, V146, P1981, DOI 10.1001/archinte.146.10.1981; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Szummer KE, 2005, EUR HEART J, V26, P2114, DOI 10.1093/eurheartj/ehi352	37	9	10	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2016	25	1					220	227		10.1016/j.jstrokecerebrovasdis.2015.09.022			8	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Cardiovascular System & Cardiology	CZ9AH	WOS:000367389700032	26500174				2022-02-06	
J	Lee, YM; Wu, A; Zuckerman, SL; Stanko, KM; LaChaud, GY; Solomon, GS; Sills, AK				Lee, Young M.; Wu, Adela; Zuckerman, Scott L.; Stanko, Kevin M.; LaChaud, Gregory Y.; Solomon, Gary S.; Sills, Allen K.			Obesity and neurocognitive recovery after sports-related concussion in athletes: a matched cohort study	PHYSICIAN AND SPORTSMEDICINE			English	Article						Concussion; sports; body mass index; BMI; obesity; mild traumatic brain injury; ImPACT; neurocognitive function; symptoms	BODY-MASS INDEX; TEST-RETEST RELIABILITY; HIGH-SCHOOL; UNITED-STATES; MULTIPLE CONCUSSIONS; SEX-DIFFERENCES; SLEEP DURATION; NEUROPSYCHOLOGICAL FUNCTION; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT	Objectives: Sports-related concussions (SRCs) are a significant public health concern in athletes. Data exist suggesting a link between obesity and decreased neurocognitive function, yet the effect of body mass index (BMI) on neurocognitive function and recovery after a SRC is unknown. The goal of our study was to discern the effect of BMI on recovery after SRC. Methods: This study was a retrospective observational cohort study. Between 2013 and 2014, 7,606 athletes between the ages of 13-20years valid baseline neurocognitive testing performed at multiple regional concussion centers sustained a concussion. Out of these athletes, 711 normal weight athletes and 711 obese athletes were matched by age, gender, number of previous concussions, and sport. The proportions of athletes returning to baseline within two weeks between the groups were defined by using 80% confidence reliable change index (RCI) criteria and were compared using Fisher's Exact Test. Kaplan-Meier survival curve analysis with log-rank test was used to compare the median time to neurocognitive recovery between groups. Results: Fewer obese athletes returned to baseline within 2 weeks on measures of verbal memory, visual motor speed, reaction time, postconcussion symptom scale (PCSS), and overall recovery compared to normal weight athletes. Obese athletes also had greater median time of return to baseline with respect to reaction time, PCSS, and overall recovery. Conclusion: Using RCI methodology, there exists an association between obesity and increased time to return to neurocognitive and symptom baseline after SRC in athletes, specifically reaction time, symptom scores, and overall recovery.	[Lee, Young M.; LaChaud, Gregory Y.] Vanderbilt Univ, Sch Med, Dept Neurosurg, Nashville, TN 37212 USA; [Wu, Adela] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Zuckerman, Scott L.; Solomon, Gary S.; Sills, Allen K.] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN USA; [Stanko, Kevin M.] Dartmouth Coll, Dept Neurosurg, Hanover, NH 03755 USA		Lee, YM (corresponding author), Vanderbilt Univ, Sch Med, 1161 21st Ave S,T1217, Nashville, TN 37232 USA.	young.lee@ucsf.edu	Solomon, Gary/K-9011-2019				Bjorvatn B, 2007, J SLEEP RES, V16, P66, DOI 10.1111/j.1365-2869.2007.00569.x; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown CN, 2007, J ATHL TRAINING, V42, P515; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fedor A, 2013, OBESITY FACTS, V6, P185, DOI 10.1159/000351138; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Li YF, 2008, OBESITY, V16, P1809, DOI 10.1038/oby.2008.296; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moraes W, 2013, SLEEP MED, V14, P312, DOI 10.1016/j.sleep.2012.11.010; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patradoon-Ho P, 2005, Pediatr Rehabil, V8, P303, DOI 10.1080/13638490500049578; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Sivertsen B, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-204; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Wheaton AG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-295; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; Wu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16686; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	40	9	9	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2016	44	3					217	222		10.1080/00913847.2016.1216718			6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	DW3AW	WOS:000383515400003	27456455				2022-02-06	
J	Li, X; Wang, HD; Gao, YY; Li, LW; Tang, C; Wen, GD; Yang, YQ; Zhuang, Z; Zhou, ML; Mao, L; Fan, YW				Li, Xiang; Wang, Handong; Gao, Yongyue; Li, Liwen; Tang, Chao; Wen, Guodao; Yang, Youqing; Zhuang, Zong; Zhou, Mengliang; Mao, Lei; Fan, Youwu			Quercetin induces mitochondrial biogenesis in experimental traumatic brain injury via the PGC-1 alpha signaling pathway	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Quercetin; traumatic brain injury; PGC-1 alpha; mitochondria	PGC-1 COACTIVATORS; OXIDATIVE STRESS; NEUROPROTECTION; PROTECTION; APOPTOSIS; EPIDEMIOLOGY; ACTIVATION; MECHANISMS; INHIBITION; DISEASE	Quercetin, a dietary flavonoid used as a food supplement, has been found to have protective effect against mitochondria damage after traumatic brain injury (TBI) in mice. However, the mechanisms underlying these effects are still not well understood. The aim of the present study was to investigate the effect of quercetin on the potential mechanism mediating these effects in the weight-drop model of TBI in male mice that were treated with quercetin or vehicle via intraperitoneal injection administration 30 min after TBI. Brain samples were collected 24 h later for analysis. Quercetin treatment upregulated the expression of PGC-1 alpha and restored the level of cytochrome c, malondialdehyde (MDA) and superoxide dismutase (SOD). These results demonstrate that quercetin improves mitochondrial function in mice by improving the level of PGC-1 alpha following TBI.	[Li, Xiang; Wang, Handong; Gao, Yongyue; Li, Liwen; Tang, Chao; Wen, Guodao; Yang, Youqing; Zhuang, Zong; Zhou, Mengliang; Mao, Lei; Fan, Youwu] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China		Mao, L; Fan, YW (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com; njmaolei@126.com; njywfan@163.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371357]; Nanjing Military Region Foundation, PLA [14MS104, 15MS126]	Supported by grants from the National Natural Science Foundation of China (81371357) and the Nanjing Military Region Foundation, PLA Grant (14MS104, 15MS126).	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Ba-Diop A, 2014, LANCET NEUROL, V13, P1029, DOI 10.1016/S1474-4422(14)70114-0; Baburamani AA, 2015, INT J MOL SCI, V16, P22509, DOI 10.3390/ijms160922509; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Cheng G, 2013, MED HYPOTHESES, V80, P115, DOI 10.1016/j.mehy.2012.11.004; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608; Espinosa A., 2016, CELL CALCIUM; Filograna R, 2016, J BIOL CHEM, V291, P9257, DOI 10.1074/jbc.M115.708057; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Gutsaeva DR, 2008, J NEUROSCI, V28, P2015, DOI 10.1523/JNEUROSCI.5654-07.2008; Jin W, 2011, ANN CLIN LAB SCI, V41, P25; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Jin W, 2009, EXP BIOL MED, V234, P181, DOI 10.3181/0807-RM-232; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Kim HJ, 2016, J PEDIATR SURG, V51, P1192, DOI 10.1016/j.jpedsurg.2016.01.009; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; Lee WJ, 2015, ARCH TOXICOL, V89, P1103, DOI 10.1007/s00204-014-1300-0; Leiphon LJ, 2007, NEUROTOXICOLOGY, V28, P143, DOI 10.1016/j.neuro.2006.08.008; Li YY, 2001, CIRCULATION, V104, P2492, DOI 10.1161/hc4501.098944; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu P, 2015, RESTOR NEUROL NEUROS, V33, P143, DOI 10.3233/RNN-140446; Margeli A., 2003, Angiogenesis, V6, P165, DOI 10.1023/B:AGEN.0000021377.13669.c0; Negrette-Guzman M, 2013, FREE RADICAL BIO MED, V65, P1078, DOI 10.1016/j.freeradbiomed.2013.08.182; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Qi H, 2016, MED HYPOTHESES, V89, P28, DOI 10.1016/j.mehy.2016.01.022; Qu XB, 2014, BRAIN RES, V1553, P31, DOI 10.1016/j.brainres.2014.01.035; Rayamajhi N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/154279; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Sandoval-Acuna C, 2012, CHEM-BIOL INTERACT, V199, P18, DOI 10.1016/j.cbi.2012.05.006; Schultke E, 2005, J NEUROTRAUM, V22, P1475, DOI 10.1089/neu.2005.22.1475; Senoo N, 2015, J LIPID RES, V56, P2286, DOI 10.1194/jlr.M060533; Sharma DR, 2015, NEUROTOXICOLOGY, V51, P116, DOI 10.1016/j.neuro.2015.10.002; Theodosakis N, 2014, ARCH BIOCHEM BIOPHYS, V563, P56, DOI 10.1016/j.abb.2014.06.028; Tsai CJ, 2015, STRUCTURE, V23, P139, DOI 10.1016/j.str.2014.10.016; Villalba N, 2016, J NEUROTRAUMA; Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175; Voigt C, 2012, NEUROPATH APPL NEURO, V38, P354, DOI 10.1111/j.1365-2990.2011.01211.x; Wang RS, 2013, CELL METAB, V17, P685, DOI 10.1016/j.cmet.2013.03.016; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Young JA, 2012, PHARMACOL THERAPEUT, V134, P1, DOI 10.1016/j.pharmthera.2011.08.003	46	9	10	0	10	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2016	8	8					3558	3566					9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	DW3NJ	WOS:000383548000026	27648146				2022-02-06	
J	Li, X; Zheng, W; Bai, HY; Wang, J; Wei, RL; Wen, HT; Ning, HB				Li, Xin; Zheng, Wei; Bai, Hongying; Wang, Jin; Wei, Ruili; Wen, Hongtao; Ning, Hanbing			Intravenous administration of adipose tissue-derived stem cells enhances nerve healing and promotes BDNF expression via the TrkB signaling in a rat stroke model	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						stroke; adipose tissue-derived stem cells; brain-derived neurotrophic factor; TrkB	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; MARROW STROMAL CELLS; FORCED ARM USE; NEUROTROPHIC FACTOR; CEREBRAL-ISCHEMIA; TRANSPLANTATION; RECOVERY; RECEPTORS; PROTECT	Previous studies have shown the beneficial effects of adipose-derived stem cells (ADSCs) transplantation in stroke. However, the molecular mechanism by which transplanted ADSCs promote nerve healing is not yet elucidated. In order to make clear the molecular mechanism for the neuroprotective effects of ADSCs and investigate roles of the BDNF-TrkB signaling in neuroprotection of ADSCs, we, therefore, examined the neurological function, brain water content, and the protein expression in middle cerebral artery occlusion (MCAO) rats with or without ADSCs transplantation. ADSCs were transplanted intravenously into rats at 30 minutes after MCAO. K252a, an inhibitor of TrkB, was administered into rats by intraventricular and brain stereotaxic injection. Modified neurological severity score tests were performed to measure behavioral outcomes. The results showed that ADSCs significantly alleviated neurological deficits and reduced brain water content in MCAO rats. The protein expression levels of BDNF and TrkB significantly increased in the cortex of MCAO rats with ADSCs treatment. However, K252a administration reversed the ADSCs-induced elevation of BDNF, TrkB, and Bcl-2 and reduction of Bax protein in MCAO rats. ADSCs promote BDNF expression via the TrkB signaling and improve functional neurological recovery in stroke rats.	[Li, Xin; Bai, Hongying; Wei, Ruili] Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou 450052, Peoples R China; [Zheng, Wei] Zhengzhou Univ, Affiliated Hosp 2, Dept Nursing, Zhengzhou 450052, Peoples R China; [Wang, Jin; Wen, Hongtao; Ning, Hanbing] Zhengzhou Univ, Affiliated Hosp 1, Dept Digest Dis, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China		Ning, HB (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Digest Dis, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China.	nhbing419@163.com			Key Project of Natural Science Foundation of Henan Province Department of Education [13A320445]	This study was supported by the Key Project of Natural Science Foundation of Henan Province Department of Education (13A320445).	Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Chan TM, 2014, CELL TRANSPLANT, V23, P541, DOI 10.3727/096368914X678409; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012; Dubow J, 2011, CURR ATHEROSCLER REP, V13, P298, DOI 10.1007/s11883-011-0187-y; Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6; Glavaski-Joksimovic A, 2010, J NEUROSCI RES, V88, P2669, DOI 10.1002/jnr.22435; Gu LJ, 2014, CNS NEUROSCI THER, V20, P67, DOI 10.1111/cns.12160; Gutierrez-Fernandez M, 2013, DISCOV MED, V16, P37; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Leu S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-63; Liu GB, 2011, INT J MOL MED, V28, P565, DOI 10.3892/ijmm.2011.725; Liu XL, 2014, INT J CLIN EXP PATHO, V7, P174; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Mahmood A, 2007, NEUROSURGERY, V61, P206, DOI 10.1227/01.neu.0000279914.37559.de; Mantilla CB, 2013, EXP NEUROL, V247, P101, DOI 10.1016/j.expneurol.2013.04.002; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Muller HD, 2008, STROKE, V39, P1012, DOI 10.1161/STROKEAHA.107.495069; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Shehadah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054083; Shyu WC, 2007, STROKE, V38, P367, DOI 10.1161/01.STR.0000254463.24655.14; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Yeh DC, 2015, CELL TRANSPLANT, V24, P487, DOI 10.3727/096368915X686940; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhou F, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0078-1	33	9	11	2	8	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2016	12						1287	1293		10.2147/NDT.S104917			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	DN7KV	WOS:000377255600001	27330296	gold, Green Published, Green Submitted			2022-02-06	
J	Longaud-Vales, A; Chevignard, M; Dufour, C; Grill, J; Puget, S; Sainte-Rose, C; Valteau-Couanet, D; Dellatolas, G				Longaud-Vales, A.; Chevignard, M.; Dufour, C.; Grill, J.; Puget, S.; Sainte-Rose, C.; Valteau-Couanet, D.; Dellatolas, G.			Assessment of executive functioning in children and young adults treated for frontal lobe tumours using ecologically valid tests	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Executive functions; Ecological assessment; Frontal lobe; Brain tumour; Questionnaires	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY CAPACITY; QUALITY-OF-LIFE; FLUID INTELLIGENCE; PREFRONTAL CORTEX; NEUROCOGNITIVE DEFICITS; CHILDHOOD EPILEPSY; PARENT-REPORT; ATTENTION; SURVIVORS	There is a lack of studies assessing executive functions (EF) using ecologically valid tests in children with frontal lobe lesions. This study aimed to (1) evaluate EF in children, adolescents and young adults treated for childhood frontal lobe tumours, (2) identify factors influencing performance, such as age at diagnosis or type of treatment, and (3) examine correlations between intellectual ability and classical and ecological tests of EF. Twenty-one patients, aged 8-27 years, treated for a childhood benign or malignant frontal lobe tumour, and 42 healthy controls (matched for gender, age and socio-economic status) were assessed using classical tests of EF, and the BADS-C ecological battery. Patients also underwent assessment of intellectual ability and parent and teacher ratings of the BRIEF questionnaire. IQ scores ranged from 45 to 125 (mean FSIQ=84) and were lower in case of epilepsy, hydrocephalus and lower parental education. Patients displayed deficits in most, but not all measures of EF. Most classical and ecological measures of EF were strongly correlated to IQ. This study confirms the frequency of EF deficits in this population; it also highlights the utility of ecological measures of EF and some limitations of classical tests of EF in children.	[Longaud-Vales, A.; Dufour, C.; Grill, J.; Valteau-Couanet, D.] Pediat Teenager & Young Adult Oncol Dept, Gustave Roussy Canc Campus, Villejuif, France; [Longaud-Vales, A.; Chevignard, M.; Dellatolas, G.] Univ Paris, UPMC, Univ Paris 04, INSERM CNRS, Paris, France; [Chevignard, M.] St Maurice Hosp, Rehabil Dept Children Acquired Neurol Injury, St Maurice, France; [Puget, S.; Sainte-Rose, C.] Hop Necker Enfants Malad, Dept Neurosurg, Paris, France		Longaud-Vales, A (corresponding author), Gustave Rouss Canc Campus, F-94805 Villejuif, France.	audrey.longaud@gustaveroussy.fr	Dellatolas, Georges/AAW-1377-2021				Allain P, 2007, REV NEUROL-FRANCE, V163, P222, DOI 10.1016/S0035-3787(07)90393-8; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Arffa S, 2007, ARCH CLIN NEUROPSYCH, V22, P969, DOI 10.1016/j.acn.2007.08.001; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blair C, 2006, BEHAV BRAIN SCI, V29, P109; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; Bonnier C, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/765780; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Christ SE, 2010, MOL GENET METAB, V99, pS22, DOI 10.1016/j.ymgme.2009.10.007; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Daigneault S, 1997, DEV NEUROPSYCHOL, V13, P1, DOI 10.1080/87565649709540665; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 1996, J NEURO-ONCOL, V29, P91, DOI 10.1007/BF00165522; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Emslie H., 2003, BEHAV ASSESSMENT DYS; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Garlick D, 2006, BEHAV BRAIN SCI, V29, P134, DOI 10.1017/S0140525X0630903X; Garth J, 1997, Pediatr Rehabil, V1, P99; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gerber NU, 2014, CANCER TREAT REV, V40, P356, DOI 10.1016/j.ctrv.2013.11.010; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Gleichgerrcht E, 2009, BEHAV NEUROL, V21, P181, DOI [10.3233/BEN-2009-0249, 10.1155/2009/516796]; Gupta N, 2003, PEDIATR NEUROSURG, V38, P302, DOI 10.1159/000070414; Hernandez MT, 2003, EPILEPSY BEHAV, V4, P522, DOI 10.1016/j.yebeh.2003.07.014; Howarth RA, 2013, J INT NEUROPSYCH SOC, V19, P380, DOI 10.1017/S1355617712001567; Jacobs R, 2011, CORTEX, V47, P808, DOI 10.1016/j.cortex.2010.06.002; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kennedy C, 2014, INT J RADIAT ONCOL, V88, P292, DOI 10.1016/j.ijrobp.2013.09.046; Kieffer V, 2012, BRAIN INJURY, V26, P1014, DOI 10.3109/02699052.2012.661116; Koivisto AM, 2013, NEUROSURGERY, V72, P1, DOI 10.1227/NEU.0b013e31827414b3; Krasnegor N.A., 1996, ATTENTION MEMORY EXE, P263; Lacy M, 2012, PEDIATR NEUROSURG, V48, P73, DOI 10.1159/000339313; Lassonde M, 2000, EPILEPTIC DISORD, V2, P3; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lindquist B, 2008, ACTA PAEDIATR, V97, P596, DOI 10.1111/j.1651-2227.2008.00747.x; Longo CA, 2013, EPILEPSY BEHAV, V26, P102, DOI 10.1016/j.yebeh.2012.11.003; Mabbott DJ, 2008, NEUROPSYCHOLOGY, V22, P159, DOI 10.1037/0894-4105.22.2.159; Mataro M, 2001, ARCH NEUROL-CHICAGO, V58, P1139, DOI 10.1001/archneur.58.7.1139; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Moore BD, 2005, J PEDIATR PSYCHOL, V30, P51, DOI 10.1093/jpepsy/jsi016; Mu YG, 2012, NEURO-ONCOLOGY, V14, P81, DOI 10.1093/neuonc/nos215; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Palmer SL, 2009, EUR J ONCOL NURS, V13, P171, DOI 10.1016/j.ejon.2008.09.002; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Reddick WE, 2003, CANCER-AM CANCER SOC, V97, P2512, DOI 10.1002/cncr.11355; Reeves CB, 2006, J PEDIATR PSYCHOL, V31, P272, DOI 10.1093/jpepsy/jsj019; Reitan RM, 1985, TRAIL MAKING TEST; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Waber DP, 2007, J CLIN ONCOL, V25, P4914, DOI 10.1200/JCO.2007.10.8464; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; Ward C, 2009, CHILD NERV SYST, V25, P663, DOI 10.1007/s00381-009-0832-8; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weierink L, 2013, RES DEV DISABIL, V34, P1678, DOI 10.1016/j.ridd.2013.01.035; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WELSH MC, 1990, CHILD DEV, V61, P1697, DOI 10.1111/j.1467-8624.1990.tb03560.x; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; Wochos GC, 2014, CLIN NEUROPSYCHOL, V28, P1243, DOI 10.1080/13854046.2014.971875; Wolfe KR, 2012, DEV NEUROPSYCHOL, V37, P153, DOI 10.1080/87565641.2011.632462; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	82	9	9	0	16	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2016	26	4					558	583		10.1080/09602011.2015.1048253			26	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DL8HK	WOS:000375881600005	26272265				2022-02-06	
J	Matarazzo, BB; Signoracci, GM; Brenner, LA; Olson-Madden, JH				Matarazzo, Bridget B.; Signoracci, Gina M.; Brenner, Lisa A.; Olson-Madden, Jennifer H.			Barriers and Facilitators in Providing Community Mental Health Care to Returning Veterans with a History of Traumatic Brain Injury and Co-occurring Mental Health Symptoms	COMMUNITY MENTAL HEALTH JOURNAL			English	Article						Traumatic brain injury; Mental health Veterans; Providers	REHABILITATION; DEPRESSION; IRAQ; TBI	As Veterans from recent conflicts return from deployments, increasing numbers are seeking care for physical (e.g., history of traumatic brain injury) and mental health (e.g., depression, anxiety) symptoms. Data suggest that only about half of recent Veterans are seeking care within the Veterans Health Administration. As such, providers within the community are likely to require additional training to meet the unique needs of these Veterans and their families. Towards this end, meetings were held with administrators and clinicians at Colorado Community Mental Health Centers (CMHCs) to identify current barriers and facilitators, as they relate to working with Veterans with a history of TBI and co-occurring mental health conditions. On-whole, CMHC employees had limited experience with providing care to the cohort of interest. Additional training will assist with increasing capacity and a web-based toolkit was developed to facilitate the transfer of knowledge (www.mirecc.va.gov/visn19/tbi_toolkit).	[Matarazzo, Bridget B.; Signoracci, Gina M.; Brenner, Lisa A.; Olson-Madden, Jennifer H.] Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, 1055 Clermont St, Denver, CO 80220 USA; [Matarazzo, Bridget B.; Signoracci, Gina M.; Olson-Madden, Jennifer H.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Signoracci, Gina M.; Brenner, Lisa A.; Olson-Madden, Jennifer H.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Dept Neurol, Anschutz Med Campus, Aurora, CO USA		Matarazzo, BB (corresponding author), Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, 1055 Clermont St, Denver, CO 80220 USA.; Matarazzo, BB (corresponding author), Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA.	bridget.matarazzo@va.gov	Brenner, Lisa A./AAG-2442-2019; Signoracci, Gina M./Q-3782-2019		U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA)United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)	Support for this project was provided by the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA). Our partner in this endeavor is Judy L. Dettmer, Director, Traumatic Brain Injury Program, Colorado Department of Human Services, Division of Vocational Rehabilitation.	Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P387, DOI 10.1037/a0012998; Department of Veterans Affairs, 2012, AN VA HLTH CAR UT OP; Faul M, 2010, TRAUMATIC BRAIN INJU; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Johnson R. L., 2010, STATE INJURY INDICAT; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Olson-Madden JH, 2013, COMMUNITY MENT HLT J, V49, P220, DOI 10.1007/s10597-012-9572-4; Rubin H., 1995, QUALITATIVE INTERVIE; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Signoracci GM, 2014, J HOLIST NURS, V32, P161, DOI 10.1177/0898010114524484; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8	17	9	9	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0010-3853	1573-2789		COMMUNITY MENT HLT J	Community Ment. Health J.	JAN	2016	52	2					158	164		10.1007/s10597-015-9926-9			7	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	DC7UX	WOS:000369427100005	26308836				2022-02-06	
J	McDonald, S; Fisher, A; Flanagan, S				McDonald, Skye; Fisher, Alana; Flanagan, Sharon			When diplomacy fails: difficulty understanding hints following severe traumatic brain injury	APHASIOLOGY			English	Article						traumatic brain injury; communication disorders; social cognition; conversational inference	CLOSED-HEAD-INJURY; TRAINING COMMUNICATION PARTNERS; RANDOMIZED CONTROLLED-TRIAL; ASSESSING SOCIAL-PERCEPTION; EMOTION RECOGNITION; NARRATIVE DISCOURSE; VERBAL IMPAIRMENT; DEFICITS; PEOPLE; COGNITION	Background: In the absence of aphasia, many people with severe traumatic brain injuries (TBI) have difficulty with communication. In particular, they have difficulty understanding conversational inference. Poor social cognition is also prevalent following TBI.Aims: This study aimed to examine the role of social cognition in the ability to recognise conversational inference in the form of hints.Methods and procedures: 31 adults (22 men: mean age 45years) with chronic (mean time since injury=15.12years) and severe TBI (mean post traumatic amnesia (PTA) of 32.74days) and 24 adults (14 men: mean age 46.1years) from the community participated. They were compared for their comprehension of two kinds of video vignettes in which professional actors made progressively more explicit hints. In one version, the conversational tone was neutral, in the other emotional. They were also assessed on an independent measure of social cognition (TASIT).Outcomes &results: The adults with TBI recognised neutral hints at a normal rate but, unlike the community controls, were not facilitated by overtly emotional hints. Social cognition performance was related to performance on both types of hint. Improved performance on the emotional hints was not uniquely predicted by social cognition but, rather, by processing speed and possibly also stress in the group with TBI.Conclusions: People with TBI appear to have difficulty using emotional cues to infer speaker meaning. This may reflect cognitive slowing and also anxiety and stress. This has implications for both remediation of such deficits and for educating others who interact with people with TBI.	[McDonald, Skye; Fisher, Alana; Flanagan, Sharon] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	s.mcdonald@unsw.edu.au	Fisher, Alana/T-1869-2019	Fisher, Alana/0000-0002-6027-659X	Australian Research CouncilAustralian Research Council	This research was funded by the Australian Research Council.	Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Boals A, 2012, COGNITION EMOTION, V26, P1335, DOI 10.1080/02699931.2011.651100; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Brown P., 1978, QUESTIONS POLITENESS; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; GODFREY H P D, 1991, Brain Injury, V5, P207, DOI 10.3109/02699059109008091; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; HAGAN C, 1984, LANGUAGE DISORDERS A; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Honan C. A., BRAIN LANGU IN PRESS; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Kelly M, 2014, J CLIN EXP NEUROPSYC, V36, P897, DOI 10.1080/13803395.2014.955784; Kret ME, 2015, NEUROSCI BIOBEHAV R, V52, P153, DOI 10.1016/j.neubiorev.2015.02.011; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milton S. B., 1984, CLIN APHASIOLOGY, V14, P114; MILTON SB, 1986, CLIN NEUROPSYCHOLOGY; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; Reitan RM, 1992, TRAIL MAKING TEST; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Van Dam NT, 2012, EMOTION, V12, P796, DOI 10.1037/a0024648; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	57	9	9	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2016	30	7					801	814		10.1080/02687038.2015.1070948			14	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	DL2LX	WOS:000375467500002					2022-02-06	
J	McKechnie, D; Fisher, MJ; Pryor, J				McKechnie, Duncan; Fisher, Murray J.; Pryor, Julie			The characteristics of falls in an inpatient traumatic brain injury rehabilitation setting	JOURNAL OF CLINICAL NURSING			English	Article						brain injury; falls; head injury; rehabilitation	RISK-FACTORS; PATIENT; FACILITY; EPIDEMIOLOGY; PREVENTION; MEDICATION; HOSPITALS; WARDS; UNIT	Aims and objectives. To describe the nature of falls in an inpatient traumatic brain injury rehabilitation setting. Background. Falls are the most frequently recorded patient safety incident in the inpatient context. However, higher rates of falls are reported in rehabilitation settings compared to acute care settings. In the rehabilitation setting, patients with a traumatic brain injury have been identified as at a high risk of falling. However to date, research into the nature of falls involving this patient population is limited. Design. Five-year retrospective cohort study design. Methods. Falls data from an inpatient traumatic brain injury rehabilitation unit were retrieved from the NSW Ministry of Health Incident Information Management System and patient clinical notes; nursing shift data were retrieved from the local rostering system. Results. The fall rate was 5.18 per 1000 patient bed days. Over a 24-hour period falls (n = 103) occurred in a trimodal pattern. The median fall free period after admission was 14 days and 22% of traumatic brain injury patients had at least one fall. 53% of falls occurred in the patient's bedroom and 57% were attributed to loss of balance. At time of fall, 93% of fallers had impaired mobility and 85% required assistance for transfers. Conclusion. Falls within inpatient traumatic brain injury rehabilitation are a significant and complex clinical issue. While many patients continued to be at risk of falling several months after admission, a repeat faller's first fall occurred earlier in their admission than a single faller's. Relevance to clinical practice. Generic falls prevention measures are insufficient for preventing falls in the brain injury rehabilitation population. Falls prevention initiatives should target times of high patient activity and situations where there is decreased nursing capacity to observe patients. Rehabilitation clinicians need to be mindful that a patient's risk of falling is not static and in fact, may increase over time.	[McKechnie, Duncan; Fisher, Murray J.; Pryor, Julie] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia; [McKechnie, Duncan] Royal Rehab, Brain Injury Unit, Sydney, NSW 1680, Australia; [Fisher, Murray J.; Pryor, Julie] Royal Rehab, Nursing Res & Dev, Sydney, NSW 1680, Australia		McKechnie, D (corresponding author), Royal Rehab, Brain Injury Unit, POB 6, Sydney, NSW 1680, Australia.	duncan.mckechnie@royalrehab.com.au		Pryor, Julie/0000-0003-4907-8530			Aisen M L, 1994, J Am Paraplegia Soc, V17, P179; Australian Commission on Safety and Quality in Healthcare, 2009, PREV FALLS HARM FALL; Australian National Ageing and Research Institute, 2004, AN RES PREV FALLS FA; Clinical Excellence Commission, 2013, CLIN FOC REP FALLS; DeVincenzo D K, 1987, Rehabil Nurs, V12, P248; Forrest G, 2012, REHABIL NURS, V37, P56, DOI 10.1002/RNJ.00010; Frisina PG, 2010, REHABIL NURS, V35, P141, DOI 10.1002/j.2048-7940.2010.tb00039.x; GAEBLER S, 1993, J ADV NURS, V18, P1895, DOI 10.1046/j.1365-2648.1993.18121895.x; Grant J S, 1987, Rehabil Nurs, V12, P74; Halfon P, 2001, J CLIN EPIDEMIOL, V54, P1258, DOI 10.1016/S0895-4356(01)00406-1; Healey F, 2008, QUAL SAF HEALTH CARE, V17, P424, DOI 10.1136/qshc.2007.024695; Hill AM, 2010, J AM GERIATR SOC, V58, P1347, DOI 10.1111/j.1532-5415.2010.02856.x; Krauss MJ, 2005, J GEN INTERN MED, V20, P116, DOI 10.1111/j.1525-1497.2005.40171.x; Kwan F, 2012, REHABIL NURS, V37, P30, DOI 10.1002/RNJ.00004; Lake J, 2006, WESTERN J NURS RES, V28, P654; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; McKechnie D, 2015, DISABIL REHABIL, V37, P2291, DOI 10.3109/09638288.2014.1002578; Mion L C, 1989, Rehabil Nurs, V14, P17; MORSE JM, 1987, GERONTOLOGIST, V27, P516, DOI 10.1093/geront/27.4.516; Murphy MP, 2014, REHABIL NURS, V39, P113, DOI 10.1002/rnj.89; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; NSW Department of Health and the Clinical Excellence Commission, 2009, INC MAN NSW PUBL HLT; NSW Department of Health and the Clinical Excellence Commission, 2006, PAT SAF CLIN INC MAN; NSW Department of Health and the Clinical Excellence Commission, 2010, INC MAN NSW PUBL HLT; Oliver D, 2004, AGE AGEING, V33, P328, DOI 10.1093/ageing/afh145; Oliver D, 2007, REV CLIN GERONTOL, V17, P75, DOI 10.1017/S0959259808002451; Pauley T, 2006, AM J PHYS MED REHAB, V85, P521, DOI 10.1097/01.phm.0000219119.58965.8c; Rosario ER, 2014, REHABIL NURS, V39, P86, DOI 10.1002/rnj.114; Ross MK, 2012, PHYS MED REH CLIN N, V23, P305, DOI 10.1016/j.pmr.2012.02.006; Saverino A, 2015, DISABIL REHABIL, V37, P355, DOI 10.3109/09638288.2014.923520; Tutuarima JA, 1997, STROKE, V28, P297, DOI 10.1161/01.STR.28.2.297; Vassallo M, 2003, AGE AGEING, V32, P338, DOI 10.1093/ageing/32.3.338; Vassallo M, 2009, GERIATR GERONTOL INT, V9, P41, DOI 10.1111/j.1447-0594.2008.00506.x; VLAHOV D, 1990, ARCH PHYS MED REHAB, V71, P8; World Health Organization, 2007, WHO GLOB REP FALLP	35	9	9	0	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	JAN	2016	25	1-2					213	222		10.1111/jocn.13087			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DB1OP	WOS:000368278200021	26621788				2022-02-06	
J	Meehan, A; Searing, E; Weaver, LK; Lewandowski, A				Meehan, Anna; Searing, Elizabeth; Weaver, Lindell K.; Lewandowski, Andrew			Baseline vestibular and auditory findings in a trial of post-concussive syndrome	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						vestibular tests; vestibulo-ocular reflex; central auditory dysfunction; mild traumatic brain injury; post-concussive symptoms; hearing	TRAUMATIC BRAIN-INJURY; HYPERBARIC-OXYGEN; CONSEQUENCES; VERTIGO; DESIGN	Previous studies have reported high rates of auditory and vestibular-balance deficits immediately following head injury. This study uses a comprehensive battery of assessments to characterize auditory and vestibular function in 71 U.S. military service members with chronic symptoms following mild traumatic brain injury that did not resolve with traditional interventions. The majority of the study population reported hearing loss (70%) and recent vestibular symptoms (83%). Central auditory deficits were most prevalent, with 58% of participants failing the SCAN3:A screening test and 45% showing abnormal responses on auditory steady-state response testing presented at a suprathreshold intensity. Only 17% of the participants had abnormal hearing (>25 dB hearing loss) based on the pure-tone average. Objective vestibular testing supported significant deficits in this population, regardless of whether the participant self-reported active symptoms. Composite score on the Sensory Organization Test was lower than expected from normative data (mean 69.6 +/- 15.6). High abnormality rates were found in funduscopy torsion (58%), oculomotor assessments (49%), ocular and cervical vestibular evoked myogenic potentials (46% and 33%, respectively), and monothermal calorics (40%). It is recommended that a full peripheral and central auditory, oculomotor, and vestibular-balance evaluation be completed on military service members who have sustained head trauma.	[Meehan, Anna] Lovelace Biomed Res, Albuquerque, NM USA; [Searing, Elizabeth] Henry M Jackson Fdn, Bethesda, MD USA; [Weaver, Lindell K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT USA; [Weaver, Lindell K.] Intermt LDS Hosp, Salt Lake City, UT USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA; [Lewandowski, Andrew] Emmes Corp, Rockville, MD USA		Meehan, A (corresponding author), Lovelace Biomed Res, Albuquerque, NM USA.	ameehan@lrri.org			U.S. Army Medical Materiel Development Activity	This work was supported by the U.S. Army Medical Materiel Development Activity. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the US Army or its subordinate activities. Because the BIMA study is still ongoing, clinical trial data summarized in this publication have not yet been locked and is therefore subject to change.	Akin FW, 2011, J AM ACAD AUDIOL, V22, P460, DOI 10.3766/jaaa.22.7.6; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Akin FW, 2013, MILD TBI DIAGNOSIS M; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; [Anonymous], BAL MAN R SYST CLIN; Basta D, 2005, HUM MOVEMENT SCI, V24, P268, DOI 10.1016/j.humov.2005.04.002; Brey R. H., 2008, BALANCE FUNCTION ASS, P253; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Felipe L, 2014, INT ARCH OTORHINOLAR, V18, P77, DOI 10.1055/s-0033-1352503; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Fischer H., 2014, GUIDE US MILITARY CA; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; IOM (Institute of Medicine), 2014, GULF WAR AND WEALTH, V9; Jacobson G, 2008, BALANCE FUNCTION ASS; Janky KL, 2009, J AM ACAD AUDIOL, V20, P514, DOI 10.3766/jaaa.20.8.6; Kantner C, 2012, HEARING RES, V294, P55, DOI 10.1016/j.heares.2012.10.008; Katz J., 2002, HDB CLIN AUDIOLOGY, V5th; Kothari Mihir T., 2005, Indian Journal of Ophthalmology, V53, P43; Lee C T, 1998, SPUMS J, V28, P125; Lee JD, 2011, EUR ARCH OTO-RHINO-L, V268, P1427, DOI 10.1007/s00405-010-1426-5; Lefevre F, 2007, J FR OPHTALMOL, V30, P598, DOI 10.1016/S0181-5512(07)89664-1; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Mills K, 2012, AM SPEECH LANGUAGE H, V16, P26; Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; OLEARY DP, 1990, NEUROL CLIN, V8, P297, DOI 10.1016/S0733-8619(18)30357-8; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Orji FT, 2008, CLIN OTOLARYNGOL, V33, P420, DOI 10.1111/j.1749-4486.2008.01764.x; Schairer K., 2012, AM SPEECH LANGUAGE H, V16, P18, DOI DOI 10.1044/HHD16.1.18; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; SCHERER MR, 2009, J AM PHYS THER ASSOC, V89, P980, DOI DOI 10.2522/PTJ.20080353; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stebbins W C, 1979, Am J Otolaryngol, V1, P15, DOI 10.1016/S0196-0709(79)80004-6; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Tirelli G, 2004, Acta Otorhinolaryngol Ital, V24, P58; Vander Werff KR, 2012, AM SPEECH LANGUAGE H, V16, P3; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P491; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807	38	9	9	0	8	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.		2016	43	5			SI		567	584					18	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	EA8EE	WOS:000386867300007	28771392				2022-02-06	
J	Moore, TL; Pessina, MA; Finklestein, SP; Killiany, RJ; Bowley, B; Benowitz, L; Rosene, DL				Moore, Tara L.; Pessina, Monica A.; Finklestein, Seth P.; Killiany, Ronald J.; Bowley, Bethany; Benowitz, Larry; Rosene, Douglas L.			Inosine enhances recovery of grasp following cortical injury to the primary motor cortex of the rhesus monkey	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Inosine; cortical injury; rhesus monkey; recovery; motor function	ADULT SQUIRREL-MONKEYS; TRAUMATIC BRAIN-INJURY; RETINAL GANGLION-CELLS; GROWTH-ASSOCIATED GENE; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; ISCHEMIC-STROKE; MOVEMENT REPRESENTATIONS; DEXTEROUS MOVEMENTS; BEHAVIORAL RECOVERY	Background: Inosine, a naturally occurring purine nucleoside, has been shown to stimulate axonal growth in cell culture and promote corticospinal tract axons to sprout collateral branches after stroke, spinal cord injury and TBI in rodent models. Objective: To explore the effects of inosine on the recovery of motor function following cortical injury in the rhesus monkey. Methods: After being trained on a test of fine motor function of the hand, monkeys received a lesion limited to the area of the hand representation in primary motor cortex. Beginning 24 hours after this injury and continuing daily thereafter, monkeys received orally administered inosine (500 mg) or placebo. Retesting of motor function began on the 14th day after injury and continued for 12 weeks. Results: During the first 14 days after surgery, there was evidence of significant recovery within the inosine-treated group on measures of fine motor function of the hand, measures of hand strength and digit flexion. While there was no effect of treatment on the time to retrieve a reward, the treated monkeys returned to asymptotic levels of grasp performance significantly faster than the untreated monkeys. Additionally, the treated monkeys evidenced a greater degree of recovery in terms of maturity of grasp pattern. Conclusion: These findings demonstrate that inosine can enhance recovery of function following cortical injury in monkeys.	[Moore, Tara L.; Pessina, Monica A.; Killiany, Ronald J.; Bowley, Bethany; Rosene, Douglas L.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Moore, Tara L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Rosene, Douglas L.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Finklestein, Seth P.] Stemetix Inc, Needham, MA USA; [Benowitz, Larry] Harvard Med Sch, Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Benowitz, Larry] Harvard Med Sch, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA		Moore, TL (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.; Moore, TL (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	tlmoore@bu.edu	Killiany, Ronald/Y-7251-2019	Killiany, Ronald/0000-0003-4740-2181; Benowitz, Larry/0000-0002-0277-7222; Rosene, Douglas/0000-0001-8719-1441; Moore, Tara/0000-0003-3869-3837	NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS081261]; Advanced Technologies and Regenerative Medicine (ATRM), LLC [101115-PR]	This study was supported by NIH-NINDS R21NS081261 and a grant from Advanced Technologies and Regenerative Medicine (ATRM), LLC. RR# 101115-PR. On December 30, 2012, ATRM merged into DePuy Orthopaedics, Inc. We would like to thank Karen Slater, Reese Edwards, Penny Shultz for their technical assistance with this study.	Barbay S, 2006, EXP BRAIN RES, V169, P106, DOI 10.1007/s00221-005-0129-4; Barbay S, 2006, NEUROREHAB NEURAL RE, V20, P455, DOI 10.1177/1545968306290773; Barbay S, 2015, STROKE, V46, P1620, DOI 10.1161/STROKEAHA.114.008088; Barratt HE, 2014, J CEREBR BLOOD F MET, V34, P1463, DOI 10.1038/jcbfm.2014.107; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Benowitz LI, 2002, PROG BRAIN RES, V137, P389; Benowitz LI, 1998, J BIOL CHEM, V273, P29626, DOI 10.1074/jbc.273.45.29626; Buga AM, 2008, ROM J MORPHOL EMBRYO, V49, P279; Caleo M, 2015, NEUROSCIENCE, V311, P180, DOI 10.1016/j.neuroscience.2015.10.029; Carmichael ST, 2017, EXP NEUROL, V287, P384, DOI 10.1016/j.expneurol.2016.02.007; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chollet F., 2014, Annals of Physical and Rehabilitation Medicine, V57, P509, DOI 10.1016/j.rehab.2014.08.002; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Cipriani S, 2014, NEUROSCIENCE, V274, P242, DOI 10.1016/j.neuroscience.2014.05.038; Conta AC, 2008, SPINAL CORD, V46, P39, DOI 10.1038/sj.sc.3102057; Corbetta D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004433.pub3; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Cramer SC, 2011, HEAD NECK-J SCI SPEC, V33, pS5, DOI 10.1002/hed.21840; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dancause N, 2006, J NEUROPHYSIOL, V96, P3506, DOI 10.1152/jn.00792.2006; Dancause N, 2011, PROG BRAIN RES, V192, P273, DOI 10.1016/B978-0-444-53355-5.00015-4; Darling WG, 2016, EXP NEUROL, V281, P37, DOI 10.1016/j.expneurol.2016.04.004; Darling WG, 2011, J INTEGR NEUROSCI, V10, P353, DOI 10.1142/S0219635211002737; Darling WG, 2011, EXP NEUROL, V231, P56, DOI 10.1016/j.expneurol.2011.05.015; Darling WG, 2009, EXP NEUROL, V220, P90, DOI 10.1016/j.expneurol.2009.07.034; Dhawan J, 2011, FUTUR NEUROL, V6, P823, DOI 10.2217/FNL.11.55; Di Pino G, 2014, NAT REV NEUROL, V10, P597, DOI 10.1038/nrneurol.2014.162; Duricki DA, 2016, BRAIN, V139, P259, DOI 10.1093/brain/awv341; Eisner-Janowicz I, 2008, J NEUROPHYSIOL, V100, P1498, DOI 10.1152/jn.90447.2008; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Friel KM, 2007, NEUROREHAB NEURAL RE, V21, P51, DOI 10.1177/1545968306291851; Friel KM, 2000, NEUROREHAB NEURAL RE, V14, P187, DOI 10.1177/154596830001400304; Friel KM, 1998, SOMATOSENS MOT RES, V15, P173, DOI 10.1080/08990229870745; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Fukushima J, 2007, J PHYS THER SCI, V19, P33, DOI 10.1589/jpts.19.33; George PM, 2015, NEURON, V87, P297, DOI 10.1016/j.neuron.2015.05.041; Gleichman AJ, 2014, NEUROSCI LETT, V565, P47, DOI 10.1016/j.neulet.2013.10.055; Grefkes C, 2014, NEUROSCIENTIST, V20, P56, DOI 10.1177/1073858413491147; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Higo Noriyuki, 2010, Keio Journal of Medicine, V59, P4; Hoogewoud F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00101; Iaci JF, 2016, J NEUROSCI RES, V94, P253, DOI 10.1002/jnr.23699; Iaci JF, 2010, NEUROPHARMACOLOGY, V59, P640, DOI 10.1016/j.neuropharm.2010.07.017; Irwin N, 2006, P NATL ACAD SCI USA, V103, P18320, DOI 10.1073/pnas.0605135103; Kaeser M, 2010, J NEUROPHYSIOL, V103, P1630, DOI 10.1152/jn.00459.2009; Kim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081948; Kluver H, 1935, J PSYCHOL, V1, P123; Ko SB, 2013, FRONT NEUROL NEUROSC, V32, P1, DOI 10.1159/000346405; Kwakkel G, 2016, NEUROREHABIL NEURAL; Lapa FD, 2013, PURINERG SIGNAL, V9, P325, DOI 10.1007/s11302-013-9351-x; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Li SL, 2006, NEUROBIOL DIS, V23, P362, DOI 10.1016/j.nbd.2006.03.011; Liu Y, 1999, EXP BRAIN RES, V128, P149, DOI 10.1007/s002210050830; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Lorber B, 2009, NAT NEUROSCI, V12, P1407, DOI 10.1038/nn.2414; Lum PS, 2009, TOP STROKE REHABIL, V16, P237, DOI 10.1310/tsr1604-237; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Markowitz CE, 2009, J ALTERN COMPLEM MED, V15, P619, DOI 10.1089/acm.2008.0513; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Meng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106238; Metz GA, 2005, BEHAV BRAIN RES, V162, P71, DOI 10.1016/j.bbr.2005.03.002; Milliken GW, 2013, J NEUROPHYSIOL, V109, P1268, DOI 10.1152/jn.00044.2012; Moon SK, 2009, EXP NEUROL, V218, P145, DOI 10.1016/j.expneurol.2009.04.021; Moore TL, 2013, SOMATOSENS MOT RES, V30, P185, DOI 10.3109/08990220.2013.790806; Moore TL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.005; Moore TL, 2010, SOMATOSENS MOT RES, V27, P121, DOI 10.3109/08990220.2010.485963; Morecraft RJ, 2016, J COMP NEUROL, V524, P380, DOI 10.1002/cne.23861; Nishibe M, 2015, NEUROREHAB NEURAL RE, V29, P472, DOI 10.1177/1545968314543499; Nouri S, 2011, NEUROLOGY, V77, P1076, DOI 10.1212/WNL.0b013e31822e1482; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Nudo RJ, 2003, ILAR J, V44, P161, DOI 10.1093/ilar.44.2.161; Nudo RJ, 1999, REV NEUROL, V155, P713; Nudo RJ, 1999, CURR OPIN NEUROBIOL, V9, P740, DOI 10.1016/S0959-4388(99)00027-6; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; Papadopoulos CM, 2009, STROKE, V40, P294, DOI 10.1161/STROKEAHA.108.519769; Petrausch B, 2000, J NEUROSCI, V20, P8031; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Plautz EJ, 2005, P ANN INT IEEE EMBS, P4145, DOI 10.1109/IEMBS.2005.1615376; Plautz EJ, 2016, NEUROREHAB NEURAL RE, V30, P159, DOI 10.1177/1545968315619701; Qu ZB, 2007, ONKOLOGIE, V30, P256, DOI 10.1159/000101010; Roitberg B, 2003, NEUROL RES, V25, P68, DOI 10.1179/016164103101200950; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; ROSENE DL, 1986, J HISTOCHEM CYTOCHEM, V34, P1301, DOI 10.1177/34.10.3745909; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarzschild MA, 2014, JAMA NEUROL, V71, P141, DOI 10.1001/jamaneurol.2013.5528; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Souza WC, 2015, NEUROL INT, V7, DOI 10.4081/ni.2015.5430; Starkey ML, 2014, NEUROSCIENTIST, V20, P359, DOI 10.1177/1073858413514636; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; TIGGES J, 1988, AM J PRIMATOL, V15, P263, DOI 10.1002/ajp.1350150308; Touvykine B, 2016, NEUROREHAB NEURAL RE, V30, P280, DOI 10.1177/1545968315585356; Ueno Y, 2012, STROKE, V43, P2221, DOI 10.1161/STROKEAHA.111.646224; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2; Whishaw IQ, 2002, BEHAV BRAIN RES, V133, P165, DOI 10.1016/S0166-4328(01)00479-X; Wyss AF, 2013, RESTOR NEUROL NEUROS, V31, P733, DOI 10.3233/RNN-130344; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Zai LL, 2011, J NEUROSCI, V31, P5977, DOI 10.1523/JNEUROSCI.4498-10.2011; Zai LL, 2009, J NEUROSCI, V29, P8187, DOI 10.1523/JNEUROSCI.0414-09.2009; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; ZURN AD, 1988, P NATL ACAD SCI USA, V85, P8301, DOI 10.1073/pnas.85.21.8301	117	9	10	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2016	34	5					827	848		10.3233/RNN-160661			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY8IU	WOS:000385374000012	27497459	Green Accepted			2022-02-06	
J	Morgalla, MH; Magunia, H				Morgalla, Matthias H.; Magunia, Harry			Noninvasive Measurement of Intracranial Pressure via the Pulsatility Index on Transcranial Doppler Sonography: Is Improvement Possible?	JOURNAL OF CLINICAL ULTRASOUND			English	Article						intracranial pressure; pulsatility index; transcranial Doppler sonography; measurement accuracy; cerebral blood flow	HEAD-INJURY; REACTIVITY	Purpose. We hypothesized that using hemodynamic variables could improve the prediction of intracranial pressure (ICP) from the middle cerebral artery pulsatility index (PI) measured with transcranial Doppler sonography. Methods. In this prospective study, 39 patients with traumatic brain injury were routinely examined with transcranial Doppler sonography, and the middle cerebral artery PI was calculated. A multivariate model including hematocrit, mean arterial blood pressure, heart rate, and arterial CO2 pressure (PaCO2) was evaluated. Results. Thirty-nine comatose patients (16 women and 23 men; age range 18-73 years; median 44 years) were included, and 234 data pairs (consisting of ICP and corresponding PI values) were analyzed. ICP ranged from -3 mmHg to +52 mmHg, and PI from 0.6 to 2.85. We found a significant but weak correlation between PI and the square root of ICP (R-2 between 0.29 and 0.34, p < 0.0001). A slightly stronger correlation was detected when hemodynamic variables were incorporated (R-2 between 0.37 and 0.43). Of these variables, mean arterial blood pressure had the most significant influence. Conclusions. In this study, PI was not a sufficiently strong predictor of ICP to be used in clinical practice. Its reliability did not improve even when hemodynamic variables were considered. Therefore, we recommend abandoning the use of PI for the noninvasive measurement of ICP in clinical practice. (C) 2015 Wiley Periodicals, Inc.	[Morgalla, Matthias H.] Univ Tubingen, Clin Neurosurg, D-72076 Tubingen, Germany; [Magunia, Harry] Univ Tubingen, Clin Anaesthet, D-72076 Tubingen, Germany		Morgalla, MH (corresponding author), Univ Tubingen, Clin Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.		Magunia, Harry/R-1199-2019	Magunia, Harry/0000-0001-9576-6399			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R, 1986, TRANSCRANIAL DOPPLER, P147; Behrens A, 2011, NEUROSURGERY, V69, pE1033, DOI 10.1227/NEU.0b013e31822999b7; Behrens A, 2010, NEUROSURGERY, V66, P1050, DOI 10.1227/01.NEU.0000369519.35932.F2; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; BRASS LM, 1988, STROKE, V19, P1466, DOI 10.1161/01.STR.19.12.1466; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; GIULIONI M, 1988, NEUROSURGERY, V22, P807, DOI 10.1227/00006123-198805000-00001; Glenn Thomas C, 2012, Acta Neurochir Suppl, V114, P11, DOI 10.1007/978-3-7091-0956-4_3; Gortler M, 2004, ARTERIES OF THE BRAI, P95; GOSLING RG, 1976, I ELECTRICAL ENG MED, V21, P73; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Moreno J, 2000, NEUROSURG FOCUS, V8, P8; Oertel M, 2002, ACT NEUR S, V81, P69; Razumovsky A, 2011, NEUROSURGERY, V68, pE289, DOI 10.1227/NEU.0b013e3181ff35ae; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 2003, EUR J ULTRASOUND, V16, P265; Schmidt Bernhard, 2002, Eur J Ultrasound, V16, P37, DOI 10.1016/S0929-8266(02)00044-7; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Tan H, 2001, Chin J Traumatol, V4, P156; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Von Reutern GM, 2000, DOPPLERSONOGRAPHY AR, P25; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49	26	9	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2751	1097-0096		J CLIN ULTRASOUND	J. Clin. Ultrasound	JAN	2016	44	1					40	45		10.1002/jcu.22279			6	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	DB1PR	WOS:000368281500006	26366515				2022-02-06	
J	Petkus, V; Krakauskaite, S; Preiksaitis, A; Rocka, S; Chomskis, R; Ragauskas, A				Petkus, Vytautas; Krakauskaite, Solventa; Preiksaitis, Aidanas; Rocka, Saulius; Chomskis, Romanas; Ragauskas, Arminas			Association between the outcome of traumatic brain injury patients and cerebrovascular autoregulation, cerebral perfusion pressure, age, and injury grades	MEDICINA-LITHUANIA			English	Article						Outcome; Traumatic brain injury; Cerebrovascular autoregulation monitoring; Optimal cerebral perfusion pressure	SEVERE HEAD-INJURY; CLINICAL ARTICLE; REACTIVITY; MORTALITY	Background and objective: The aim of this study was to explore the association of cerebrovascular autoregulation (CA) and optimal cerebral perfusion pressure (CPP) managing conditions with the outcome of traumatic brain injury (TBI) patients including additional information about the patients' age and grade of diffuse axonal injury (DAI). Materials and methods: The CA monitoring of 28 TBI patients was performed by using ICM+ software (Cambridge, UK). The CA status estimating pressure reactivity indexes (PRx) and CPP data were processed in order to obtain information on the patient-specific treatment conditions by calculating the optimal CPP. Results: There was a negative correlation between the Glasgow outcome scale (GOS) score and PRx (r = -0.448 at hospital discharge and r = -0.402 after 6 months). The estimated threshold value PRx of >0.24 was associated with mortality. The correlation coefficients between the GOS score and the difference CPP-optimal CPP were 0.549 at hospital discharge and 0.484 after 6 months. The threshold value of CPP declination from Delta CPPopt per -6 mmHg was associated with mortality. Poorer outcome was predicted for elderly TBI patients (aged >47 years) and patients having a DAI grade of 3. Conclusions: The association of the GOS score with CPP, CA impairment conditions, age and diffuse axonal injury (DAI) grade showed that the outcomes of TBI patients were associated with patient-specific CPP management and better outcomes were obtained for younger patients, for patients having lower DAI grade and for patients whose CPP was kept within the range from the optimal CPP to the optimal CPP + 10 mmHg. (C) 2016 The Lithuanian University of Health Sciences. Production and hosting by Elsevier B.V.	[Petkus, Vytautas; Krakauskaite, Solventa; Chomskis, Romanas; Ragauskas, Arminas] Kaunas Univ Technol, Hlth Telemat Sci Inst, K Barsausko 59,A553-A561, LT-51423 Kaunas, Lithuania; [Preiksaitis, Aidanas; Rocka, Saulius] Vilnius State Univ, Fac Med, Clin Neurol & Neurosurg, Ctr Neuroangiosurg, Vilnius, Lithuania		Petkus, V (corresponding author), Kaunas Univ Technol, Hlth Telemat Sci Inst, K Barsausko 59,A553-A561, LT-51423 Kaunas, Lithuania.	vytautas.petkus@ktu.lt			Research Council of LithuaniaResearch Council of Lithuania (LMTLT) [MIP-118/2012]; Lithuanian-Swiss cooperation program "Research and development"Research Council of Lithuania (LMTLT) [CH-3-SMM-01/06]	This research was funded by a grant from the Research Council of Lithuania (No. MIP-118/2012) and a grant according to the Lithuanian-Swiss cooperation program "Research and development" (No. CH-3-SMM-01/06).	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Brain Trauma Foundation: American association of Neurological surgeons, 2007, J NEUROTRAUMA S1, V24, pS59; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Crach Trial MRC Collaborators, 2008, BMJ-BRIT MED J, V336, P425; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2007, NEUROL RES, V29, P672, DOI 10.1179/016164107X240053; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kasprowicz M, 2010, PHYSIOL MEAS, V31, P1217, DOI 10.1088/0967-3334/31/9/011; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; Lang EW, 2005, REV CEREBRAL AUTOREG, P161; Lavinio A, 2008, ACTA NEUROCHIR SUPPL, V102, P3, DOI 10.1007/978-3-211-85578-2_1; Menon DK, 2003, ANESTHESIOLOGY, V98, P805, DOI 10.1097/00000542-200304000-00002; Palomares SM, 2011, J NEUROL NEUROPHYSIO, pS1; Petkus V, 2014, COMP MED SY, P427, DOI 10.1109/CBMS.2014.44; Ragauskas A, 2003, MED ENG PHYS, V25, P667, DOI 10.1016/S1350-4533(03)00082-1; Ragauskas A, 2011, European Patent, Patent No. [2111787 B1, 2111787]; Ragauskas A., 2009, Patent No. [European US Patent 20090270734, 20090270734]; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; Schmidt B, 2014, IJCNMH S1, V1, pS18; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sviri G.E., 2010, J OPEN NEUROSURGERY, V3, P6	29	9	9	1	4	ELSEVIER URBAN & PARTNER SP Z O O	WROCLAW	UL MIGDALOWA 4, LOK 59, WROCLAW, 02-796, POLAND	1010-660X			MEDICINA-LITHUANIA	Med. Lith.		2016	52	1					46	53		10.1016/j.medici.2016.01.004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI7BT	WOS:000373654800007	26987500	gold			2022-02-06	
J	Polrola, P; Kaczmarek, BLJ; Goral-Polrola, J; Kropotov, JD; Herman-Sucharska, I; Pachalska, M				Polrola, Pawel; Kaczmarek, Bozydar L. J.; Goral-Polrola, Jolanta; Kropotov, Juri D.; Herman-Sucharska, Izabela; Pachalska, Maria			EVENT-RELATED POTENTIAL STUDIES OF COMBINED MILD TRAUMATIC BRAIN INJURY/POST-TRAUMATIC STRESS DISORDER IN A RETIRED POLISH ARMY LIEUTENANT COLONEL	ACTA NEUROPSYCHOLOGICA			English	Article						attention; memory; executive functions; flashback	SALIVARY CORTISOL; PTSD; SYMPTOMS; VETERANS; ANXIETY	Background The extensive Medline search performed allowed us to state that the majority of reports support evidence of information processing abnormalities in patients with Mild Traumatic Brain Injury/Post-Traumatic Stress Disorder. Studies of event-related potentials (ERPs) are the main tool in any real time examination of information processing in miliseconds. Based on the available data, and our own research, we suggest that QEEG and ERPs abnormalities may result in a better understanding of the mechanism by which the symptoms of these disturbances overlap with each other. Case study: The patient, a 57-year-old man, retired Polish Army lieutenant colonel, who had seen active service twice in Lebanon, was diagnosed with Mild Traumatic Brain Injury/Post-Traumatic Stress Disorder, in accordance with the DSM 5 criteria. MR neuroimaging research showed cerebral-subcortical structural dystrophy. The neuropsychological tests confirmed an increasing degree of disturbance within cognitive and emotional processes as well as behavioural disturbances. Through the appliance of QEEG methodology as well as the potentials connected with the event (ERPs) it appeared that: (1) rare low-voltage rapid EEG occured; (2) increased activity in the subcortical areas, (3) weakened activity in the cerebral areas. The patient completely lost cognitive and emotional control which meant that he was unable to function in everyday life. Conclusions: The conducting of ERPs on the patient made it possible to understand the brain mechanisms lying at the basis of the overlapping symptoms of Mild Traumatic Brain Injury/Post-Traumatic Stress Disorder. The appearance of a low-voltage, rapid EEG could possible be a factor enhancing the development of PTSD, particularly in patients who have experienced Mild Traumatic Brain Injury. The results obtained show the need to exclude low-voltage EEG in soldiers despatched to see service in regions of armed conflict.	[Polrola, Pawel] Jan Kochanowski Univ Humanities & Sci, Kielce, Poland; [Kaczmarek, Bozydar L. J.; Goral-Polrola, Jolanta] Univ Econ & Innovat, Lublin, Poland; Old Polish Univ, Kielce, Poland; [Kropotov, Juri D.] Russian Acad Sci, Inst Human Brain, Lab Neurobiol Act Programming, St Petersburg, Russia; [Herman-Sucharska, Izabela] Jagiellonian Univ, Fac Hlth Sci, Dept Electroradiol, Krakow, Poland; [Pachalska, Maria] Andrzej Frycz Modrzewski Univ, Chair Neuropsychol, Krakow, Poland; [Pachalska, Maria] Ctr Cognit & Commun, New York, NY USA		Pachalska, M (corresponding author), Andrzej Frycz Modrzewski Krakow Univ, Chair Neuropsychol, Andrzeja Herlinga Grudzinskiego 1, PL-30750 Krakow, Poland.	neuropsychologia23@o2.pl	Kaczmarek, Bozydar/AAI-3301-2020				Aardal-Eriksson E, 2001, BIOL PSYCHIAT, V50, P986, DOI 10.1016/S0006-3223(01)01253-7; Association A.P., 2013, DIAGN STAT MAN MENT, P271; BOHNEN N, 1991, J PSYCHOSOM RES, V35, P141, DOI 10.1016/0022-3999(91)90068-Y; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; Brown J, 2010, J CONSCIOUSNESS STUD, V17, P7; Cesur R, 2011, 5615 IZA DP; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; de Kloet CS, 2007, PROG BRAIN RES, V167, P287, DOI 10.1016/S0079-6123(07)67025-3; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; Hamner M B, 1999, Depress Anxiety, V9, P1; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Horner M. D., 2002, NEUROPSYCHOLOGY REV, V12; Jatzko A, 2006, J AFFECT DISORDERS, V94, P121, DOI 10.1016/j.jad.2006.03.010; Javanbakht A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-5; Kaplan HI, 1994, KAPLAN SADOCKS SYNOP, P606; Kertesz A, 2000, J INT NEUROPSYCH SOC, V6, P460, DOI 10.1017/S1355617700644041; Koenen KC, 2007, PSYCHOL MED, V37, P181, DOI 10.1017/S0033291706009019; Kropotov J. D., 2009, QUANTITATIVE EEG EVE; Kropotov J.D, 2016, FUNCTIONAL NEURMARKE; Kropotov JD, 2005, INT J PSYCHOPHYSIOL, V55, P23, DOI 10.1016/j.ijpsycho.2004.05.011; Kropotov JD, 2012, ACTA NEUROPSYCHOL, V10, P25, DOI 10.5604/17307503.995083; Kropotov JD, 2009, ACTA NEUROPSYCHOL, V7, P169; Lindley SE, 2004, BIOL PSYCHIAT, V55, P940, DOI 10.1016/j.biopsych.2003.12.021; MASON JW, 1988, J NERV MENT DIS, V176, P498, DOI 10.1097/00005053-198808000-00008; Meade Barbara J., 2013, MISSION CRITICAL GET; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mintz S., 2007, DIGIAL HIST; Misterska E., 2013, ZABURZENIA PAMIECI U, V6, P211; Monastra VJ, 1999, NEUROPSYCHOLOGY, V13, P424, DOI 10.1037/0894-4105.13.3.424; Olszewski TM, 2005, J PSYCHOSOC NURS MEN, V43, P40; PACHALSKA M, 2014, NEUROPSYCHOLOGIA KLI; Pachalska Maria, 2002, Ortop Traumatol Rehabil, V4, P81; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Rothschild B., 2000, BODY REMEMBERS PSYCH; Sautter FJ, 2003, BIOL PSYCHIAT, V54, P1382, DOI 10.1016/S0006-3223(03)00571-7; Skelton K, 2012, NEUROPHARMACOLOGY, V62, P628, DOI 10.1016/j.neuropharm.2011.02.013; Spoont M., 2013, SCREENING POSTTRAUMA; Stein MB, 2009, BIOL PSYCHIAT, V66, P1072, DOI 10.1016/j.biopsych.2009.09.023; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; WHO, 2004, MORT BURD DIS EST WH; Yehuda R, 2004, PSYCHONEUROENDOCRINO, V29, P389, DOI 10.1016/S0306-4530(03)00052-0; Yehuda R, 2002, BIOL PSYCHIAT, V52, P393, DOI 10.1016/S0006-3223(02)01357-4; Yehuda R, 2002, PSYCHIAT QUART, V73, P123, DOI 10.1023/A:1015055711424; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41; Zohar J, 2008, CURR OPIN PSYCHIATR, V21, P74, DOI 10.1097/YCO.0b013e3282f269ee; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	46	9	9	0	8	MEDSPORTPRESS PUBLISHING HOUSE	WARSAW	UL MARYMONCKA 34 SKR 23, WARSAW, 01813, POLAND	1730-7503	2084-4298		ACTA NEUROPSYCHOL	Acta Neuropsychol.	JAN-MAR	2016	14	1					69	91		10.5604/17307503.1201710			23	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	EA4EO	WOS:000386562600006					2022-02-06	
J	Prinz, V; Finger, T; Bayerl, S; Rosenthal, C; Wolf, S; Liman, T; Vajkoczy, P				Prinz, Vincent; Finger, Tobias; Bayerl, Simon; Rosenthal, Christoph; Wolf, Stefan; Liman, Thomas; Vajkoczy, Peter			High prevalence of pharmacologically induced platelet dysfunction in the acute setting of brain injury	ACTA NEUROCHIRURGICA			English	Article						Intracranial hemorrhage; Traumatic brain injury; Antiplatelet therapy; Acetylsalicylic acid; ADP receptor antagonists; Platelet function; Point of care	MULTIPLE ELECTRODE AGGREGOMETRY; INTRACEREBRAL HEMORRHAGE; ANTIPLATELET THERAPY; LIGHT TRANSMISSION; ASPIRIN RESISTANCE; WHOLE-BLOOD; HEAD-INJURY; CLOPIDOGREL; TRANSFUSION; AGGREGATION	The management of patients with traumatic brain injury (TBI), primary intracerebral hemorrhage (pICH) and primary subarachnoid hemorrhage (pSAH) remains a highly demanding challenge in critical care medicine. Antithrombotic agents are one of the most relevant risk factors for poor outcome. However, in the acute setting of brain injury, information on preexisting medication might not be available. This group of patients is insufficiently characterized regarding pharmacologically induced platelet impairment. We retrospectively analyzed consecutive patients with TBI, pICH and pSAH admitted to our department with unknown preexisting medication. The impact of acetylsalicylic acid and ADP-receptor antagonists on platelet function was tested via the Multiplate analyzer. Patients' characteristics, management and the influence of platelet impairment on outcome were evaluated. Within 25 months 103 patients with TBI (61), pICH (32) or pSAH (10) and unknown antithrombotic medication were admitted to our department. In 54 (52.4 %) of the patients reduced platelet function was detected, mainly caused by acetylsalicylic acid. In the TBI group, 30 patients (49.2 %) were identified, while Multiplate analysis detected platelet dysfunction in 19 (59.4 %) subjects in the pICH group and 5 in the pSAH group (50 %). In multivariable analysis the pathological Multiplate result was not associated with worse outcome; however, in our cohort 47 (87 %) patients received hemostatic therapy following detection of impaired platelet function. Our results demonstrate the high frequency of pharmacologically impaired platelet function in patients with unknown preexisting medication. Early assessment of platelet function is an important tool to allow optimized treatment in these patients.	[Prinz, Vincent; Finger, Tobias; Bayerl, Simon; Wolf, Stefan; Liman, Thomas; Vajkoczy, Peter] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Prinz, Vincent; Finger, Tobias; Bayerl, Simon; Wolf, Stefan; Liman, Thomas; Vajkoczy, Peter] Charite, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [Rosenthal, Christoph] Charite, Dept Anesthesia & Intens Care Med, D-13353 Berlin, Germany		Vajkoczy, P (corresponding author), Charite, Dept Neurosurg, Augustenburger Pl 1, D-13353 Berlin, Germany.	peter.vajkoczy@charite.de		Liman, Thomas/0000-0002-8471-8049; Vajkoczy, Peter/0000-0003-4350-392X	Charite-Universitatsmedizin Berlin; Berlin Institute of Health	V.P. is a participant in the Charite Clinical Scientist Program funded by the Charite-Universitatsmedizin Berlin and the Berlin Institute of Health. All authors declare that they have no conflict of interest.	Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Bansal V, 2011, J TRAUMA, V70, P65, DOI 10.1097/TA.0b013e318204fdae; Beynon C, 2015, J CLIN NEUROSCI, V22, P252, DOI 10.1016/j.jocn.2014.07.029; Beynon C, 2013, CRIT CARE, V17, DOI 10.1186/cc12597; Beynon C, 2013, CLIN NEUROL NEUROSUR, V115, P2003, DOI 10.1016/j.clineuro.2013.06.002; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Bhal V, 2015, THROMB RES; Cai TQ, 2015, EUR J PHARMACOL, V758, P107, DOI 10.1016/j.ejphar.2015.03.073; Ebinger M, 2014, JAMA-J AM MED ASSOC, V311, P1622, DOI 10.1001/jama.2014.2850; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Hazarbasanov D, 2012, J THROMB THROMBOLYS, V34, P85, DOI 10.1007/s11239-012-0684-z; Jussen D, 2013, CEREBROVASC DIS, V35, P355, DOI 10.1159/000348649; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naidech AM, 2011, NEUROCRIT CARE, V15, P442, DOI 10.1007/s12028-011-9557-0; Naidech AM, 2009, ANN NEUROL, V65, P352, DOI 10.1002/ana.21618; Paniccia R, 2009, AM J CLIN PATHOL, V131, P834, DOI 10.1309/AJCPTE3K1SGAPOIZ; Patrono C, 2004, EUR HEART J, V25, P166, DOI 10.1016/j.ehj.2003.10.013; Scharbert G, 2015, TRANSFUSION, V55, P1320, DOI 10.1111/trf.12977; Sibbing D, 2008, THROMB HAEMOSTASIS, V99, P121, DOI 10.1160/TH07-07-0478; Stead LG, 2010, CLIN NEUROL NEUROSUR, V112, P275, DOI 10.1016/j.clineuro.2009.12.002; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Ulehlova J, 2011, INT J LAB HEMATOL, V33, P305, DOI 10.1111/j.1751-553X.2010.01286.x; Vilahur G, 2007, J THROMB HAEMOST, V5, P82, DOI 10.1111/j.1538-7836.2006.02245.x	29	9	9	0	7	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2016	158	1					117	123		10.1007/s00701-015-2645-8			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CZ2ZY	WOS:000366975000015	26611691				2022-02-06	
J	Reynolds, E; Fazio, VC; Sandel, N; Schatz, P; Henry, LC				Reynolds, Erin; Fazio, Vanessa C.; Sandel, Natalie; Schatz, Philip; Henry, Luke C.			Cognitive Development and the Immediate Postconcussion Assessment and Cognitive Testing: A Case for Separate Norms in Preadolescents	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						cognitive development; concussion; neuropsychology; preadolescent	SPORT-RELATED CONCUSSION; TEST-RETEST RELIABILITY; COLLEGIATE FOOTBALL PLAYERS; IMPACT TEST BATTERY; HIGH-SCHOOL; PROCESSING SPEED; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; RECOVERY-TIME; BASE-LINE	With youth sports participation and concern about sports-related concussions both on the rise, it is important to properly measure cognitive function to ensure the clinical utility of baseline testing. Computerized testing batteries are often employed as baseline and postinjury measures of cognitive function, with the Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) being the most used of all the current testing platforms. The current study compared 10- to 12-year-old children across the composite scores yielded by the ImPACT and provided normative data on each of the subtests used to calculate the composite scores. Normative data are separated by gender for athletes aged 10 to 12 years old, as this is the current age bracket used by the ImPACT. These norms may be helpful in the interpretation of the ImPACT clinical report and further delineation of areas of neurocognitive dysfunction.	[Reynolds, Erin; Fazio, Vanessa C.; Henry, Luke C.] Univ Pittsburgh, Med Ctr, Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15203 USA; [Sandel, Natalie] Widener Univ, Inst Grad Clin Psychol, Chester, PA 19013 USA; [Schatz, Philip] St Josephs Univ, Psychol, Philadelphia, PA 19131 USA		Henry, LC (corresponding author), Univ Pittsburgh, Med Ctr, Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15203 USA.	lch32@pitt.edu					ARDILA A, 1994, DEV NEUROPSYCHOL, V10, P97, DOI 10.1080/87565649409540571; Axon Sports, 2013, SPORTS CONC PROGR; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Camarata S, 2006, INTELLIGENCE, V34, P231, DOI 10.1016/j.intell.2005.12.001; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; CNS Vital Signs, 2015, CNS VITAL SIGNS; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Foley C, 2014, CURR SPORT MED REP, V13, P390, DOI 10.1249/JSR.0000000000000104; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P184, DOI 10.1136/bjsports-2012-091941corr1; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; ImPACT Applications, 2011, TECHN MAN IMPACT 200; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; KAIL R, 1991, PSYCHOL BULL, V109, P490, DOI 10.1037/0033-2909.109.3.490; Kail RV, 2007, CHILD DEV, V78, P1760, DOI 10.1111/j.1467-8624.2007.01088.x; Kail RV, 2007, PSYCHOL SCI, V18, P312, DOI 10.1111/j.1467-9280.2007.01895.x; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Meuller F. O., 2013, ANN SURVEY FOOTBALL; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Rice V. J., 2011, AUTOMATED NEUROPSYCH, P1; Sandel N, 2015, APPL NEUROPSYCH-CHIL, V4, P211, DOI 10.1080/21622965.2013.850692; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; SHEINGOLD K, 1973, J EXP CHILD PSYCHOL, V16, P1, DOI 10.1016/0022-0965(73)90057-X; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Stevens MC, 2009, NEUROIMAGE, V48, P738, DOI 10.1016/j.neuroimage.2009.06.065; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; WILSON JTL, 1987, BRIT J DEV PSYCHOL, V5, P249, DOI 10.1111/j.2044-835X.1987.tb01060.x	76	9	9	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2016	5	4					283	293		10.1080/21622965.2015.1057637			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DR9SX	WOS:000380237500005	26980277				2022-02-06	
J	Salinas, CM; Dean, P; LoGalbo, A; Dougherty, M; Field, M; Webbe, FM				Salinas, Christine M.; Dean, Preston; LoGalbo, Anthony; Dougherty, Michael; Field, Melvin; Webbe, Frank M.			Attention-Deficit Hyperactivity Disorder Status and Baseline Neurocognitive Performance in High School Athletes	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						ADHD; children; concussion; neuropsychology; sport; traumatic brain injury	SPORTS-RELATED CONCUSSION; AGE; RECOVERY; ADHD; CHILDREN; IMPACT	Approximately 136,000 concussions occur annually in American high school sports. Neuropsychological data indicate that children with preexisting cognitive difficulties, such as attention-deficit hyperactivity disorder (ADHD), may have protracted recovery from concussion. ADHD, with an estimated prevalence of 11% in youth, may increase an athlete's vulnerability to sustaining sports-related traumatic brain injury (TBI). The preponderance of evidence focusing on TBI and ADHD has derived from motor vehicle accidents rather than sports-related incidents. Thus, it is paramount to explore how ADHD may relate to injury in the sports concussion context, as well as to assess how ADHD may affect baseline neurocognitive testing. Adolescent athletes with ADHD (n=256) demonstrated significantly reduced Verbal Memory, Visual Motor, and Impulse Control index scores compared with their peers without ADHD (n=256). Athletes with ADHD were nearly twice as likely to have sustained a prior concussion (ADHD, 14.1%; non-ADHD, 7.8%). Knowledge regarding the unique neurocognitive profile of athletes with ADHD may enhance clinical management decisions.	[Salinas, Christine M.] Florida Hosp Children, Comprehens Epilepsy Ctr, Orlando, FL USA; [Salinas, Christine M.; Dean, Preston] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Salinas, Christine M.; LoGalbo, Anthony; Dougherty, Michael; Field, Melvin] Florida Hosp, Sports Concuss Program, Orlando, FL USA; [Salinas, Christine M.; Webbe, Frank M.] Florida Inst Technol, Psychol, Melbourne, FL 32901 USA; [Field, Melvin] Florida Hosp, Dept Neurosurg, Orlando, FL USA		Salinas, CM (corresponding author), Boston Childrens Hosp, Epilepsy Div, 300 Longwood Ave,Fegan 9, Boston, MA 02115 USA.	christine.salinas@childrens.harvard.edu		Webbe, Frank/0000-0002-4370-5698			Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2011, MMWR-MORBID MORTAL W, V60, P1337; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson G., 2004, NAT ASS SCH PSYCH DA; Johnson R., 2000, J ATTEN DISORD, V4, P150, DOI [10.1177/108705470000400302, DOI 10.1177/108705470000400302]; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Piek JP, 1999, DEV MED CHILD NEUROL, V41, P159, DOI 10.1017/S0012162299000341; Rennie B, 2014, J CLIN EXP NEUROPSYC, V36, P621, DOI 10.1080/13803395.2014.921284; Salinas CM, 2012, J CLIN SPORT PSYCHOL, V6, P363, DOI 10.1123/jcsp.6.4.363; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Sjowall D, 2013, J CHILD PSYCHOL PSYC, V54, P619, DOI 10.1111/jcpp.12006; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	26	9	9	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2016	5	4					264	272		10.1080/21622965.2015.1052814			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DR9SX	WOS:000380237500003	26980407				2022-02-06	
J	Semple, BD; Sadjadi, R; Carlson, J; Chen, YR; Xu, D; Ferriero, DM; Noble-Haeusslein, LJ				Semple, Bridgette D.; Sadjadi, Raha; Carlson, Jaclyn; Chen, Yiran; Xu, Duan; Ferriero, Donna M.; Noble-Haeusslein, Linda J.			Long-Term Anesthetic-Dependent Hypoactivity after Repetitive Mild Traumatic Brain Injuries in Adolescent Mice	DEVELOPMENTAL NEUROSCIENCE			English	Article						Mild traumatic brain injury; Impact; Concussion; Adolescent; Mouse; Microglia; Behavior; Pathology; Anesthetic	SPORT-RELATED CONCUSSION; PROFESSIONAL SOCCER PLAYERS; SCHOOL FOOTBALL PLAYERS; DEFAULT MODE NETWORK; STATES HIGH-SCHOOL; MOUSE-BRAIN; PRECLINICAL RESEARCH; TRANSGENIC MICE; MALE RATS; VULNERABILITY	Recent evidence supports the hypothesis that repetitive mild traumatic brain injuries (rmTBIs) culminate in neurological impairments and chronic neurodegeneration, which have wide-ranging implications for patient management and return-to-play decisions for athletes. Adolescents show a high prevalence of sports-related head injuries and may be particularly vulnerable to rmTBIs due to ongoing brain maturation. However, it remains unclear whether rmTBIs, below the threshold for acute neuronal injury or symptomology, influence long-term outcomes. To address this issue, we first defined a very mild injury in adolescent mice (postnatal day 35) as evidenced by an increase in lba-1-labeled microglia in white matter in the acutely injured brain, in the absence of indices of cell death, axonal injury, and vasogenic edema. Using this level of injury severity and Avertin (2,2,2-tribromoethanol) as the anesthetic, we compared mice subjected to either a single mTBI or 2 rmTBIs, each separated by 48 h. Neurobehavioral assessments were conducted at 1 week and at 1 and 3 months postimpact. Mice subjected to rmTBIs showed transient anxiety and persistent and pronounced hypoactivity compared to sham control mice, alongside normal sensorimotor, cognitive, social, and emotional function. As isoflurane is more commonly used than Avertin in animal models of TBI, we next examined long-term outcomes after rmTBIs in mice that were anesthetized with this agent. However, there was no evidence of abnormal behaviors even with the addition of a third rnnTBI. To determine whether isoflurane may be neuroprotective, we compared the acute pathology after a single mTBI in mice anesthetized with either Avertin or isoflurane. Pathological findings were more pronounced in the group exposed to Avertin compared to the isoflurane group. These collective findings reveal distinct behavioral phenotypes (transient anxiety and prolonged hypoactivity) that emerge in response to rmTBIs. Our findings further suggest that selected anesthetics may confer early neuroprotection after rmTBIs, and as such mask long-term abnormal phenotypes that may otherwise emerge as a consequence of acute pathogenesis. (C) 2016 S. Karger AG, Basel	[Semple, Bridgette D.; Sadjadi, Raha; Carlson, Jaclyn; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, Room HSE 860,513 Parnassus Ave, San Francisco, CA 94143 USA; [Sadjadi, Raha; Ferriero, Donna M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Chen, Yiran; Xu, Duan] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA		Noble-Haeusslein, LJ (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Room HSE 860,513 Parnassus Ave, San Francisco, CA 94143 USA.	Linda.Noble@ucsf.edu		Xu, Duan/0000-0003-0550-4235	CJ Martin Early Career Fellowship from the National Health and Medical Research Council of Australia; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS050159, NS077767, R01EB009756]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB009756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077767, R01NS050159] Funding Source: NIH RePORTER	This project was conducted with the generous financial support of Mr. and Mrs. D. Wong. B.D. Semple was supported by a CJ Martin Early Career Fellowship from the National Health and Medical Research Council of Australia. Research in the Noble-Haeusslein Laboratory and the Xu Laboratory was additionally supported by the National Institutes of Health (grants R01 NS050159 and NS077767 and grant R01EB009756, respectively). The authors would also like to thank S.A. Canchola (Neurobehavioral Core for Rehabilitation Research, UCSF) for assistance with behavioral assays.	Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; Dean PJ, 2015, BRAIN INJURY, P1; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gomez-Nicola D, 2015, NEUROSCIENTIST, V21, P169, DOI 10.1177/1073858414530512; Greco T, 2015, DEV NEUROBIOL, V75, P193, DOI 10.1002/dneu.22218; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hertle Daniel, 2012, Acta Neurochir Suppl, V114, P383, DOI 10.1007/978-3-7091-0956-4_74; Hosseini-Sharifabad M, 2007, J NEUROSCI METH, V162, P206, DOI 10.1016/j.jneumeth.2007.01.009; Huang SN, 2009, NEUROIMAGE, V46, P589, DOI 10.1016/j.neuroimage.2009.02.027; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Li K, 2014, J NEUROSCI, V34, P7622, DOI 10.1523/JNEUROSCI.4690-13.2014; Lieggi CC, 2005, CONTEMP TOP LAB ANIM, V44, P17; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Stoffels B, 2011, NEUROGASTROENT MOTIL, V23, P76, DOI 10.1111/j.1365-2982.2010.01603.x; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tong DC, 2015, J CLIN NEUROSCI, V22, P747, DOI 10.1016/j.jocn.2014.11.018; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Watanabe T, 2013, NMR BIOMED, V26, P1870, DOI 10.1002/nbm.3042; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Zeller W, 1998, LAB ANIM, V32, P407, DOI 10.1258/002367798780599811; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	75	9	9	0	11	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2016	38	3					220	238		10.1159/000448089			19	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	DY7WK	WOS:000385339800006	27548472				2022-02-06	
J	Stewart, LA; Wilton, G; Sapers, J				Stewart, Lynn A.; Wilton, Geoff; Sapers, Jeremy			Offenders with Cognitive Deficits in a Canadian Prison Population: Prevalence, Profile, and Outcomes	INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY			English	Article						Cognitive deficits; offender; recidivism; institutional adjustment	TRAUMATIC BRAIN-INJURY; STATUS EXAMINATION COGNISTAT; INTELLECTUAL DISABILITY; PSYCHOMETRIC PROPERTIES; ALCOHOL; IMPAIRMENT; INDIVIDUALS; PATTERNS; BEHAVIOR; COCAINE	Impaired cognitive function has been associated with criminal behavior. In Canada it is unknown the extent to which this disorder affects federal inmates or its impact on key correctional outcomes. In this study, 488 incoming male offenders were assessed on the Cognistat, a neuropsychological screening tool. Twenty-five percent of offenders were found to have some level of cognitive deficit. Lower levels of educational achievement, unstable employment history, learning disability, serious alcohol problems, and symptoms of Attention Deficit Hyperactivity Disorder (ADHD) were significantly associated with the, presence of cognitive deficits in this sample. Although there was a significant trend for offenders with cognitive deficits to have more admissions to segregation, level of cognitive deficit was not consistently related to rates of institutional charges or rates of completion of required correctional programs. On release, cognitive deficits were not related to returns to custody or returns to custody with an offence. These results indicate that while offenders with cognitive deficits may require assistance with educational upgrading and employment to improve their reintegration potential, they do not pose a particular management problem in the community after release relative to offenders without cognitive deficits. Crown Copyright (C) 2015 Published by Elsevier Ltd. All rights reserved.	[Stewart, Lynn A.; Wilton, Geoff; Sapers, Jeremy] Correct Serv Canada, 340 Laurier Ave W, Ottawa, ON K1A 0P9, Canada		Stewart, LA (corresponding author), Correct Serv Canada, 340 Laurier Ave W, Ottawa, ON K1A 0P9, Canada.	lynn.stewart@csc-scc.gc.ca; geoff.wilton@csc-scc.gc.ca					Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; [Anonymous], 2012, CORP REP SYST; Bolla KI, 2000, NEUROLOGY, V54, P2285, DOI 10.1212/WNL.54.12.2285; Broomhall L., 2005, PSYCHIAT PSYCHOL LAW, V12, P367, DOI DOI 10.1375/PPLT.12.2.367; Cairney S, 2007, ADDICTION, V102, P909, DOI 10.1111/j.1360-0443.2007.01840.x; Cardenas VA, 2005, PSYCHIAT RES-NEUROIM, V138, P115, DOI 10.1016/j.pscychresns.2005.01.002; Cohen J., 2013, STAT POWER ANAL BEHA; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Doninger NA, 2006, REHABIL PSYCHOL, V51, P281, DOI 10.1037/0090-5550.51.4.281; Endicott O. R, 1991, R14 CORR SERV CAN; ENGELHART C, 1994, CLIN NEUROPSYCHOL, V8, P405, DOI 10.1080/13854049408402043; Engelhart C, 1999, CLIN NEUROPSYCHOL, V13, P109, DOI 10.1076/clin.13.1.109.1975; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; FARRINGTON DP, 1992, BRIT J CRIMINOL, V32, P521, DOI 10.1093/oxfordjournals.bjc.a048255; Fazel S, 2008, INT J LAW PSYCHIAT, V31, P369, DOI 10.1016/j.ijlp.2008.06.001; Fishbein D, 2009, LAW HUMAN BEHAV, V33, P419, DOI 10.1007/s10979-008-9163-7; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Gupta A, 2009, INDIAN J NEUROTRAUM, V6, P123, DOI 10.1016/S0973-0508(09)80006-3; Halldorsson JG, 2012, BRAIN INJURY, V26, P1, DOI 10.3109/02699052.2011.635359; Hancock M, 2010, AGGRESSIVE BEHAV, V36, P338, DOI 10.1002/ab.20353; Harmon K, 2012, SCI AM; Hayes SC, 1997, J INTELLECT DEV DIS, V22, P71, DOI 10.1080/13668259700033311; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Leeson VC, 2010, SCHIZOPHRENIA BULL, V36, P400, DOI 10.1093/schbul/sbn100; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MacPherson PH, 2011, R247 CORR SERV CAN; Marceau R, 2008, J OFFENDER REHABIL, V47, P41, DOI 10.1080/10509670801940409; McIlwain D, 1988, PREVALENCE INTELLECT; MOFFITT TE, 1993, DEV PSYCHOPATHOL, V5, P135, DOI 10.1017/S0954579400004302; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Motiuk L.L., 1997, FORUM CORRECTIONS RE, V9, P18; MOTIUK LL, 1991, R24 CORR SERV CAN; Mueller J., 2011, COGNISTAT COGNISTAT; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; NAFEKH M, 2002, R126 CORR SERV CAN; Naglieri J. A., 2006, GAMA GEN ABILITY MEA; Paschall MJ, 2002, AGGRESS VIOLENT BEH, V7, P215, DOI 10.1016/S1359-1789(00)00044-6; Peters RH, 2000, J SUBST ABUSE TREAT, V18, P349, DOI 10.1016/S0740-5472(99)00081-1; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Rea L.M., 1992, DESIGNING CONDUCTING; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Rodriguez-Sanchez E, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-147; Scruggs TE, 2010, REM SPEC EDUC, V31, P437, DOI 10.1177/0741932508327465; Simpson MK, 2001, J INTELL DISABIL RES, V45, P384, DOI 10.1046/j.1365-2788.2001.00345.x; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Skinner HA., 1984, ALCOHOL DEPENDENCE S; Statistics Canada, 2011, POP DWELL COUNTS; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Stewart, 2015, NATL PREVALENCE MENT; Stewart LA, 2014, CRIM JUSTICE STUD, V27, P63, DOI 10.1080/1478601X.2013.873205; Usher AM, 2013, INT J LAW PSYCHIAT, V36, P311, DOI 10.1016/j.ijlp.2013.04.005; Visser J. P., 2006, PRINCIPLES PRACTICE; Weekes J., 2009, RES SNIPPET 09 02; White AM, 2003, ALCOHOL RES HEALTH, V27, P186; Wilton G, 2012, R277 CORR SERV CAN; Zeigler DW, 2005, PREV MED, V40, P23, DOI 10.1016/j.ypmed.2004.04.044	58	9	9	0	42	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-2527	1873-6386		INT J LAW PSYCHIAT	Int. J. Law Psychiatr.	JAN-FEB	2016	44						7	14		10.1016/j.ijlp.2015.08.026			8	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	DC8GX	WOS:000369459000002	26341309				2022-02-06	
J	Takada, K; Sashika, H; Wakabayashi, H; Hirayasu, Y				Takada, Kaoruko; Sashika, Hironobu; Wakabayashi, Hidetaka; Hirayasu, Yoshio			Social participation and quality-of-life of patients with traumatic brain injury living in the community: A mixed methods study	BRAIN INJURY			English	Article						Post-TBI; rehabilitation; family support; housewife	SATISFACTION; DISABILITY; RETURN; WORK	Objective: To investigate the quality-of-life (QoL) and social participation of patients with traumatic brain injury (TBI) living in the community in Japan. Methods: A mixed-methods study of 29 post-TBI patients and 12 family members was conducted. Objective scales were used to evaluate QoL (Short Form Health Survey SF-36), depression (Zung Self-rating Depression Scale) and psychosocial function (Sydney Psychosocial Reintegration Scale, 2nd edition). Subjective views of changes in social functioning, participation and suitability of family support were obtained by a semi-structured interview. Participants were classified into 'change' and 'no-change' groups for social participation and between group comparisons of QoL and determinant factors of QoL were evaluated. Results: The SF-36 social role component was significantly associated with the suitability of family support, followed by their understanding. However, QoL was not significantly associated with changes in social participation. Social participation was particularly influenced by the absence of rehabilitation support for low-skill labourers and housewives, whether they lost their employment or not. Conclusions: Advances in rehabilitation services are required, particularly to meet the specific needs of housewives and low-skill labourers. Families should receive sufficient education and short- and long-term strategies for providing suitable support to patients and their families should be implemented.	[Takada, Kaoruko; Sashika, Hironobu; Wakabayashi, Hidetaka] Yokohama City Univ, Dept Rehabil Med, Yokohama, Kanagawa, Japan; [Takada, Kaoruko; Hirayasu, Yoshio] Yokohama City Univ, Dept Psychiat, Yokohama, Kanagawa, Japan		Takada, K (corresponding author), Yokohama City Univ, Med Ctr, Dept Rehabil Med, Minami Ku, 4-57 Urafune Chou, Yokohama, Kanagawa 2320024, Japan.	takada.ruko@hotmail.co.jp		Wakabayashi, Hidetaka/0000-0002-0364-0818	Ministry of Education, Science, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24500599]	This work was supported by a research Grant-in-Aid for Scientific Research C (no. 24500599) from the Ministry of Education, Science, Culture, Sports, Science, and Technology of Japan. We would like to thank Editage (www.editage.jp) for English language editing.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Blair H, 2010, BRAIN INJURY, V24, P833, DOI 10.3109/02699051003789203; Conneeley AL., 2003, BRIT J OCCUP THER, V66, P440; Di Battista A, 2015, BRAIN INJURY, V29, P573, DOI 10.3109/02699052.2014.989905; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Goto A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-129; Gould KR, 2015, BRAIN INJURY, V29, P283, DOI 10.3109/02699052.2014.974671; Hachisuka K., 2007, SOGO REHABIL, V35, P851; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Jones JA, 2011, DISABIL REHABIL, V33, P1568, DOI 10.3109/09638288.2010.537803; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Nalder E, 2016, ARCH PHYS MED REHAB, V97, pS46, DOI 10.1016/j.apmr.2014.07.428; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Polinder S, 2015, POPUL HEALTH METR, V17, P13; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; Saito S, 2014, PLOS ONE, V19, pe9; SCAT: Steps for Coding and Theorization, 2015, QUAL DAT AN METH; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Suzukamo Y, 2011, J CLIN EPIDEMIOL, V64, P301, DOI 10.1016/j.jclinepi.2010.04.017; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586	25	9	9	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1590	1598		10.1080/02699052.2016.1199901			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800011	27630033				2022-02-06	
J	Tegeler, CH; Tegeler, CL; Cook, JF; Lee, SW; Gerdes, L; Shaltout, HA; Miles, CM; Simpson, SL				Tegeler, Charles H.; Tegeler, Catherine L.; Cook, Jared F.; Lee, Sung W.; Gerdes, Lee; Shaltout, Hossam A.; Miles, Christopher M.; Simpson, Sean L.			A Preliminary Study of the Effectiveness of an Allostatic, Closed-Loop, Acoustic Stimulation Neurotechnology in the Treatment of Athletes with Persisting Post-concussion Symptoms	SPORTS MEDICINE-OPEN			English	Article						Sports concussion; Persisting post-concussion symptoms; Post-concussion syndrome; Allostasis; Neurotechnology; HIRREM; Baroreflex sensitivity; Heart rate variability; Reaction time; Return to play	SPORT-RELATED CONCUSSION; CEREBRAL AUTOREGULATION; CLINICAL-TRIALS; BRAIN; DYSFUNCTION; VARIABILITY; STATEMENT; RECOVERY; EXERCISE; PLACEBO	Background: Effective interventions are needed for individuals with persisting post-concussion symptoms. High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM (R)) is an allostatic, closed-loop, acoustic stimulation neurotechnology, designed to facilitate relaxation and self-optimization of neural oscillations. Methods: Fifteen athletes (seven females, mean age 18.1 years, SD 2.6) with persisting post-concussion symptoms received 18.7 (SD 6.0) HIRREM sessions over a mean of 29.6 (SD 23.2) days, including 11.3 (SD 4.6) in office days. Pre- and post-HIRREM measures included the Rivermead Post-Concussion Symptoms Questionnaire (RPQ, n = 12), the Insomnia Severity Index (ISI, n = 15), the Center for Epidemiologic Studies Depression Scale (CES-D, n = 10), short-term blood pressure and heart rate recordings for measures of autonomic cardiovascular regulation (n = 15), and reaction time by the drop-stick method (n = 7). All participants were asked about their physical activity level and sports participation status at their post-HIRREM data collection visit and 1 to 3 months afterward. Results: At the post-HIRREM visit, subjects reported improvements in all three inventories (RPQ mean change 19.7, SD 11.4, Wilcoxon p = 0.001; ISI mean change -4.1, SD 4.1, Wilcoxon p = 0.003; CES-D mean change -12.0, SD 10.0, Wilcoxon p = 0.004), including statistically significant reductions in 14 of the 16 individual items of the RPQ. There were also statistically significant improvements in baroreflex sensitivity, heart rate variability in the time domain (SDNN), and drop-stick reaction testing (baseline mean distance of 23.8 cm, SD 5.6, decreased to 19.8 cm, SD 4.6, Wilcoxon p = 0.016). Within 3 months of the post-HIRREM data collection, all 15 had returned to full exercise and workouts, and ten had returned to full participation in their athletic activity. Conclusions: The use of HIRREM by a series of athletes with persisting post-concussion symptoms was associated with a range of improvements including, for the majority, return to full participation in their sport. The findings do not appear to be consistent with constituents of the placebo effect. A larger controlled trial is warranted.	[Tegeler, Charles H.; Tegeler, Catherine L.; Cook, Jared F.] Wake Forest Sch Med, Dept Neurol, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Lee, Sung W.; Gerdes, Lee] Brain State Technol LLC, Scottsdale, AZ USA; [Shaltout, Hossam A.] Wake Forest Sch Med, Hypertens & Vasc Res Ctr, Dept Obstet & Gynecol, Winston Salem, NC 27101 USA; [Miles, Christopher M.] Wake Forest Sch Med, Dept Family & Community Med, Sports Med, Winston Salem, NC 27101 USA; [Simpson, Sean L.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27101 USA		Tegeler, CH (corresponding author), Wake Forest Sch Med, Dept Neurol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	ctegeler@wakehealth.edu	; Shaltout, Hossam/F-6903-2013	Tegeler, Catherine/0000-0002-2943-6719; Shaltout, Hossam/0000-0001-7948-3815	Susanne Marcus Collins Foundation, Inc.; NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K25 EB012236-01A1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K25EB012236] Funding Source: NIH RePORTER	This study was supported by a research grant from The Susanne Marcus Collins Foundation, Inc. Sean Simpson was supported by NIBIB K25 EB012236-01A1.	Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Devins G., 1988, PSYCHOL HEALTH, V2, P139, DOI DOI 10.1080/08870448808400349; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gerdes L, 2013, BRAIN BEHAV, V3, P193, DOI 10.1002/brb3.116; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kurowski BG, 2016, J HEAD TRAUMA REHABI; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lee SW, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00843; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Maestri R, 2005, PHYSIOL MEAS, V26, P1125, DOI 10.1088/0967-3334/26/6/021; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Morin CM, 1993, INSOMNIA PSYCHOL ASS; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; PARATI G, 1995, AM J PHYSIOL-HEART C, V268, pH1606, DOI 10.1152/ajpheart.1995.268.4.H1606; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rees CA, 2014, ARCH DIS CHILD, V99, P552, DOI 10.1136/archdischild-2012-301863; Schedlowski M, 2015, PHARMACOL REV, V67, P697, DOI 10.1124/pr.114.009423; Sterling P, 2014, JAMA PSYCHIAT, V71, P1192, DOI 10.1001/jamapsychiatry.2014.1043; Sterling P, 2012, PHYSIOL BEHAV, V106, P5, DOI 10.1016/j.physbeh.2011.06.004; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Tator CH, 2016, J NEUROSURG, P1; Tegeler CH, 2015, BRAIN BEHAV, V1, P5; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408	41	9	9	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open		2016	2								39	10.1186/s40798-016-0063-y			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VI8CQ	WOS:000514829300024	27747793	Green Published, gold			2022-02-06	
J	Weddell, RA; Wood, RL				Weddell, Rodger A.; Wood, Rodger L.			Exploration of correlates of self-reported personality change after moderate-severe traumatic brain injury	BRAIN INJURY			English	Article						Emotion recognition; empathy; frontal lobe; executive functioning; depression	SEVERE HEAD-INJURY; ORBITOFRONTAL CORTEX; EXPRESSED EMOTION; PREFRONTAL CORTEX; FOLLOW-UP; DEPRESSION; ANXIETY; DAMAGE; SCALE; ADJUSTMENT	Objective: Individuals with traumatic brain injury (TBI) often express concern that their personality has changed. Factors generating that conclusion are rarely explored quantitatively. Accordingly, this study examines neurobehavioural correlates of self-reported personality change.Methods: Seventy-one participants and informants were interviewed M = 57.9 (SD = 46.9) months after a moderate-severe TBI. The degree of self-reported personality change was correlated with scores on measures of general cognitive functioning, executive functioning, olfaction, social-emotional behaviour, emotional distress and the Expressed Emotion close informants directed towards them.Results: As expected, self-reported personality change correlated with dysexecutive symptoms and depression. Although anosmia (a putative index of ventral frontal damage) correlated with reduced self-reported emotional recognition and empathy, against prediction, the latter measures did not correlate with self-reported personality change. Neither were the predicted positive correlations found between high Expressed Emotion (criticism and emotional over-involvement) and self-reported personality change.Discussion: These findings are discussed in the context of previous work. A need to replicate and extend the present findings is suggested. A strategy to further clarify the relationships perceived personality change have with (a) self-reported change in specific behaviours and (b) identity change is advocated. Implications for intervention are suggested.	[Weddell, Rodger A.] Morriston Hosp, Neuropsychol Dept, Swansea SA6 6NL, W Glam, Wales; [Weddell, Rodger A.; Wood, Rodger L.] Swansea Univ, Brain Injury Res Grp, Swansea, W Glam, Wales		Weddell, RA (corresponding author), Morriston Hosp, Neuropsychol Dept, Swansea SA6 6NL, W Glam, Wales.	r.a.weddell@swansea.ac.uk					Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Barrash J, 2011, J CLIN EXP NEUROPSYC, V33, P833, DOI 10.1080/13803395.2011.561300; Beck AT., 1979, COGNITIVE THERAPY DE; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brown G.K., 2000, BECK DEPRESSION INVE; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Corruble E, 2002, PSYCHIAT RES, V109, P17, DOI 10.1016/S0165-1781(01)00366-3; Crowe SF, 2013, J CLIN EXP NEUROPSYC, V35, P298, DOI 10.1080/13803395.2013.771616; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; FRANKLIN SB, 1995, J VEG SCI, V6, P99, DOI 10.2307/3236261; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Green P., 2003, GREENS WORD MEMORY T; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Karsten J, 2012, J PSYCHIATR RES, V46, P644, DOI 10.1016/j.jpsychires.2012.01.024; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Lannoo E, 1997, J PSYCHOSOM RES, V43, P505, DOI 10.1016/S0022-3999(97)00152-9; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McGrath J, 1997, NEUROPSYCHOL REHABIL, V7, P231, DOI 10.1080/713755532; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Schiehser DM, 2001, J CLIN EXPT NEUROPSY, V33, P704; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; SNAITH RP, 1976, BRIT J PSYCHIAT, V128, P156, DOI 10.1192/bjp.128.2.156; Spielberger C. D., 1999, STATE TRAIT ANGER EX; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Tyerman AD, 1987, THESIS; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020; Wiedemann G, 2002, PSYCHIAT RES, V109, P265, DOI 10.1016/S0165-1781(02)00023-9; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	9	10	1	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	11					1362	1371		10.1080/02699052.2016.1195921			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DZ8TP	WOS:000386144900009	27541376				2022-02-06	
J	Wozniak, B; Wozniak, A; Mila-Kierzenkowska, C; Kasprzak, HA				Wozniak, Bartosz; Wozniak, Alina; Mila-Kierzenkowska, Celestyna; Kasprzak, Heliodor Adam			Correlation of Oxidative and Antioxidative Processes in the Blood of Patients with Cervical Spinal Cord Injury	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							LIPID-PEROXIDATION; CREATINE-PHOSPHOKINASE; STRESS; METHYLPREDNISOLONE; MECHANISMS; THERAPIES; APOPTOSIS; SERUM	The effect of cervical spinal cord injury (CSCI) on oxidative stress parameters was assessed. The study was conducted in 42 patients with CSCI (studied group), 15 patients with cerebral concussion, without CSCI (Control II), and 30 healthy volunteers (Control I). Blood was taken from the basilic vein: before and seven days after the spinal cord decompression surgery (mean time from CSCI to surgery: 8 hours) in the studied group and once in the controls. Thiobarbituric acid reactive substances (TBARS) and conjugated dienes (CD) concentrations, and glutathione peroxidase (GPx), catalase (CAT), and creatine kinase (CK) activities before the surgery were higher in the studied group than in the controls. Reduced glutathione concentration was similar in all groups. Superoxide dismutase (SOD) in the studied group was 16% lower (P <= 0.001) than in Control I. Lipid peroxidation products, and GPx and CAT activities in erythrocytes seven days after the surgery were lower (P <= 0.001), while SOD was 25% higher (P <= 0.001) than before the surgery. CK in blood plasma after the surgery was 34% lower (P <= 0.001) than before it. CSCI is accompanied by oxidative stress. Surgical and pharmacological treatment helps to restore the oxidant-antioxidant balance.	[Wozniak, Bartosz; Kasprzak, Heliodor Adam] Stanislaw Stasz Specialist Hosp, Dept Neurosurg, Rydygiera 1, PL-64920 Pila, Poland; [Wozniak, Alina; Mila-Kierzenkowska, Celestyna] Nicolaus Copernicus Univ, Coll Med, Chair Med Biol, Karlowicza 24, PL-85092 Bydgoszcz, Poland		Mila-Kierzenkowska, C (corresponding author), Nicolaus Copernicus Univ, Coll Med, Chair Med Biol, Karlowicza 24, PL-85092 Bydgoszcz, Poland.	celestyna@o2.pl	Wozniak, Alina/H-4699-2014; Mila-Kierzenkowska, Celestyna/F-1858-2014	Wozniak, Alina/0000-0002-4492-4796; Mila-Kierzenkowska, Celestyna/0000-0002-8271-2874			ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Anderson ME, 1989, GLUTATHIONE CHEM BIO, P339; Ates O, 2006, ACTA PHARMACOL SIN, V27, P1317, DOI 10.1111/j.1745-7254.2006.00416.x; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bao F, 2004, NEUROSCIENCE, V126, P285, DOI 10.1016/j.neuroscience.2004.03.054; Bastani NE, 2012, ARCH PHYS MED REHAB, V93, P2223, DOI 10.1016/j.apmr.2012.06.021; BEERS RF, 1952, J BIOL CHEM, V195, P133; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Buege J A, 1978, Methods Enzymol, V52, P302; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Fatima G, 2015, SPINAL CORD, V53, P3, DOI 10.1038/sc.2014.178; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Hall E. D., 2015, J BIOENERG BIOMEMBR, P1; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Halliwell B, 1993, FREE RADICALS BIOL M; Hu ZQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/831490; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kaynar Mehmet Yasar, 1994, Tokushima Journal of Experimental Medicine, V41, P133; Li J, 2013, INT J MOL SCI, V14, P24438, DOI 10.3390/ijms141224438; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; McAdoo DJ, 2005, BRAIN RES, V1038, P92, DOI 10.1016/j.brainres.2005.01.024; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Nas K, 2015, WORLD J ORTHOP, V6, P8, DOI 10.5312/wjo.v6.i1.8; OLIVER IT, 1955, BIOCHEM J, V61, P116, DOI 10.1042/bj0610116; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Rahimi-Movaghar V, 2013, NEUROEPIDEMIOLOGY, V41, P65, DOI 10.1159/000350710; Ray SK, 2000, NEUROCHEM RES, V25, P1191, DOI 10.1023/A:1007631826160; ROSALKI SB, 1967, J LAB CLIN MED, V69, P696; SERGENT O, 1993, CHEM PHYS LIPIDS, V65, P133, DOI 10.1016/0009-3084(93)90046-6; Springer JE, 1997, J NEUROCHEM, V68, P2469; SZASZ G, 1976, CLIN CHEM, V22, P650; Takenaga M, 2006, J CONTROL RELEASE, V110, P283, DOI 10.1016/j.jconrel.2005.10.022; Wozniak A, 2003, BIOL SPORT, V20, P93; Wozniak Alina, 2003, Neurol Neurochir Pol, V37, P1025; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x	37	9	10	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2016	2016								6094631	10.1155/2016/6094631			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH8DV	WOS:000373024600001	26881034	Green Published, Green Submitted, gold			2022-02-06	
J	Zhao, H; Yin, ZY; Li, K; Liao, ZK; Xiang, HY; Zhu, F				Zhao, Hui; Yin, Zhiyong; Li, Kui; Liao, Zhikang; Xiang, Hongyi; Zhu, Feng			Mechanical Characterization of Immature Porcine Brainstem in Tension at Dynamic Strain Rates	MEDICAL SCIENCE MONITOR BASIC RESEARCH			English	Article						Brain Injuries; Brain Stem; Viscoelastic Substances	BEHAVIOR; TISSUE; MODEL; DEFORMATION; ELASTICITY; SHEAR	Background: Many brain injury cases involve pediatric road traffic accidents, and among these, brainstem injury causes disastrous outcomes. A thorough understanding of the tensile characterization of immature brainstem tissue is crucial in modeling traumatic brain injury sustained by children, but limited experimental data in tension is available for the immature brain tissue at dynamic strain rates. Material/Methods: We harvested brainstem tissue from immature pigs (about 4 weeks old, and at a developmental stage similar to that of human toddlers) as a byproduct from a local slaughter house and very carefully prepared the samples. Tensile tests were performed on specimens at dynamic strain rates of 2/s, 20/s, and 100/s using a biological material instrument. The constitutive models, Fung, Ogden, Gent, and exponential function, for immature brainstem tissue material property were developed for the recorded experimental data using OriginPro((R)) 8.0 software. The t test was performed for infinitesimal shear modules. Results: The curves of stress-versus-stretch ratio were convex in shape, and inflection points were found in all the test groups at the strain of about 2.5%. The average Lagrange stress of the immature brainstem specimen at the 30% strain at the strain rates of 2, 20, and 100/s was 273 +/- 114, 515 +/- 107, and 1121 +/- 197 Pa, respectively. The adjusted R-Square (R-2) of Fung, Ogden, Gent, and exponential model was 0.820 +/- R-2 <= 0.933, 0.774 <= R-2 <= 0.940, 0.650 <= R-2 <= 0.922, and 0.852 <= R-2 <= 0.981, respectively. The infinitesimal shear modulus of the strain energy functions showed a significant association with the strain rate ( p<0.01). Conclusions: The immature brainstem is a rate-dependent material in dynamic tensile tests, and the tissue becomes stiffer with increased strain rate. The reported results may be useful in the study of brain injuries in children who sustain injuries in road traffic accidents. Further research in more detail should be performed in the future.	[Zhao, Hui; Yin, Zhiyong; Li, Kui; Liao, Zhikang; Xiang, Hongyi] Third Mil Med Univ, Daping Hosp, Chongqing Key Lab Vehicle Biol Crash Secur, Res Inst Traff Med, Chongqing, Peoples R China; [Zhu, Feng] Wayne State Univ, Bioengn Ctr, Detroit, MI USA; [Zhu, Feng] Embry Riddle Aeronaut Univ, Dept Mech Engn, Daytona Beach, FL USA		Zhao, H (corresponding author), Third Mil Med Univ, Daping Hosp, Chongqing Key Lab Vehicle Biol Crash Secur, Res Inst Traff Med, Chongqing, Peoples R China.	box.zhaohui@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81072504, 31470913]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education MinistryScientific Research Foundation for the Returned Overseas Chinese Scholars	This study was sponsored partly by the National Natural Science Foundation of China (No. 81072504 and 31470913) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Begonia MT, 2010, ANN BIOMED ENG, V38, P3043, DOI 10.1007/s10439-010-0072-9; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Coats B, 2007, STAPP CAR CRASH J, P51; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Crandall JR, 2012, MEANEY DF PEDIAT INJ, V59, P44; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; FUNG YC, 1979, AM J PHYSIOL, V237, pH620, DOI 10.1152/ajpheart.1979.237.5.H620; Fung YC, 1993, J APPL MECH, V49, P1306; FUNG YCB, 1967, AM J PHYSIOL, V213, P1532, DOI 10.1152/ajplegacy.1967.213.6.1532; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Kui L, 2015, PLOS ONE, V10; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lippert SA, 2004, BIORHEOLOGY, V41, P681; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2001, J BIOMECH, V34, P651, DOI 10.1016/S0021-9290(00)00236-0; Miller K, 2011, BIOL MED PHYS BIOMED, V12, P189; Mizuno Y, 2005, 19 ESV; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Ogden R.W., 1997, NONLINEAR ELASTIC DE; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Prange M, 2002, THESIS, P186; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Tamura A, 2007, 635 MECH CHARACTERIZ, V2006, P452; Tamura A, 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; Thibault KL, 1999, BIOMECH, V31, P1119; Thibault KL, 1997, THESIS; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; World Health Organization, 2013, GLOB STAT REP ROAD S	39	9	9	4	17	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	2325-4416	2325-4394		MED SCI MONIT BASIC	Med. Sci. Monit. Basic Res.		2016	22						6	13		10.12659/MSMBR.896368			8	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	ER9PH	WOS:000399158100004	26790497	Green Published			2022-02-06	
J	Zhou, DY; Zhao, YM; Wan, YF; Wang, YR; Xie, DJ; Lu, Q; Yang, SX; Qi, XC				Zhou, Daoyang; Zhao, Yiming; Wan, Yingfeng; Wang, Yirong; Xie, Dajiang; Lu, Qin; Yang, Shuxu; Qi, Xuchen			Neuroendocrine dysfunction and insomniain mild traumatic brain injury patients	NEUROSCIENCE LETTERS			English	Article						Mild traumatic brain injury; Pittsburgh Sleep Quality; Polysomnography; Low-dose short synacthen test	SLEEP QUALITY INDEX; DISCREPANCY	Mild traumatic brain injury (mTBI) has been a growing public health concern in the worldwide. To investigate the subjective and objective characteristics of insomnia following mTBI and the association between insomnia and hypothalamic-pituitary-adrenal (HPA) function of mTBI patients, 59 patients with mTBI (mTBI group) were compared with 50 healthy participants (control group) in the present study. The subjective and objective measures of insomnia were respectively obtained from Pittsburgh Sleep Quality (PSQI) and polysomnography (PSG). HPA function was measured with low-dose short synacthen test (LDSST). According to the comparative and correlation analysis of the two groups, for PSQL the scores of sleep syndrome, sleep latency, sleep efficiency, overall sleep quality and daytime dysfunction of mTBI patients were all higher, however only sleep efficiency and daytime dysfunction of mTBI patients were related with peak cortisol on 1DSST; while for PSG, sleep efficiency (SE) was lower and wake after sleep onset (WASO) was longer in mTBI patients, moreover SE and WASO of mTBI patients were correlated with peak cortisol on LDSTT; for HPA function indexes, only peak cortisol on LDSST was lower in mTBI patients. These findings suggested that mTBI patients experienced more serious subjective insomnia symptoms than objective measurement, which were associated with HPA dysfunction. This study may contribute to identifying better treatment for mTBI patients with insomnia. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Zhou, Daoyang; Zhao, Yiming] Zhejiang Univ, Coll Med Sci, Sir Run Run Shaw Hosp, Dept Emergency, Hangzhou 310016, Zhejiang, Peoples R China; [Wan, Yingfeng; Wang, Yirong; Xie, Dajiang; Lu, Qin; Yang, Shuxu; Qi, Xuchen] Zhejiang Univ, Coll Med Sci, Sir Run Run Shaw Hosp, Dept Neurosurg, Hangzhou 310016, Zhejiang, Peoples R China		Qi, XC (corresponding author), Zhejiang Univ, Coll Med Sci, Sir Run Run Shaw Hosp, Dept Neurosurg, Hangzhou 310016, Zhejiang, Peoples R China.	qxc664516@163.com	LU, QIN/AAU-1992-2021	LU, QIN/0000-0001-8211-6127; Wan, Yingfeng/0000-0002-1176-2065	Zhejiang Provincial Medicines Health Science and Technology Program Foundation of China [2013KYB162, 2015KYB223]	This work was generously supported by Zhejiang Provincial Medicines Health Science and Technology Program Foundation of China (Grant No. 2013KYB162 and No. 2015KYB223).	Bianchi MT, 2012, J CLIN SLEEP MED, V8, P547, DOI 10.5664/jcsm.2154; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Duclos C, 2015, AUST OCCUP THER J, V62, P2, DOI 10.1111/1440-1630.12164; Edmed S.L, 2015, J CLIN EXP NEUROPSYC, P1; Frieboes R.-M., 2014, J NEUROPSYCHIATRY CL; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Harvey AG, 2012, PSYCHOL BULL, V138, P77, DOI 10.1037/a0025730; Hori T, 2001, PSYCHIAT CLIN NEUROS, V55, P305; Kay DB, 2015, J SLEEP RES, V24, P32, DOI 10.1111/jsr.12220; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Lu W., 2015, BRAIN INJURY, P1; Lu W, 2014, NEUROREHABILITATION, V35, P245, DOI 10.3233/NRE-141117; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Pigeon W.R., 2014, F1000PRIME REP, V6; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; Roth T, 2009, AM J MANAG CARE, V15, pS6; SullivanKaren A., 2015, J NEUROTRAUMA; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Theadom A., 2015, SLEEP MED; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Vanable PA, 2000, SLEEP, V23, P71; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; WU X, 2004, J TRAUMA ACUTE CARE, V64, P1313; Xia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071065	30	9	10	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 1	2016	610						154	159		10.1016/j.neulet.2015.10.055			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DA0LA	WOS:000367487400027	26520461				2022-02-06	
J	Ahmadi, N; Hajsadeghi, F; Yehuda, R; Anderson, N; Garfield, D; Ludmer, C; Vaidya, N				Ahmadi, Naser; Hajsadeghi, Fereshteh; Yehuda, Rachel; Anderson, Nils; Garfield, David; Ludmer, Charles; Vaidya, Nutan			Traumatic brain injury, coronary atherosclerosis and cardiovascular mortality	BRAIN INJURY			English	Article							BETA-BLOCKER EXPOSURE; IMPROVED SURVIVAL; ARTERY CALCIUM; HEAD-INJURY; MECHANISMS; AFGHANISTAN; DYSFUNCTION; PROGRESSION; PREDICTOR; ADULTS		[Ahmadi, Naser; Hajsadeghi, Fereshteh] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; [Ahmadi, Naser; Anderson, Nils; Garfield, David; Ludmer, Charles; Vaidya, Nutan] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL USA; [Yehuda, Rachel] Mt Sinai Sch Med, James J Peters Vet Affairs Med Ctr, New York, NY USA		Ahmadi, N (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 1124 W Carson St,RB3, Torrance, CA 90503 USA.	drnaserahmadi@gmail.com	Ahmadi, Naser/B-2304-2009	Ahmadi, Naser/0000-0003-0510-2965			Ahmadi N, 2010, AM J CARDIOL, V105, P459, DOI 10.1016/j.amjcard.2009.09.052; Ahmadi Naser, 2008, J Cardiovasc Comput Tomogr, V2, P382, DOI 10.1016/j.jcct.2008.09.001; *ASS SECR DEF HLTH, 2007, TRAUM BRAIN INJ DEF; Baker GR, 2008, VETERANS AFFAIRS NEW, P71; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Brown ER, 2008, RADIOLOGY, V247, P669, DOI 10.1148/radiol.2473071469; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; Cordeiro MAS, 2006, INT J CARDIOVAS IMAG, V22, P507, DOI 10.1007/s10554-005-9044-9; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Defense and Veterans Brain Injury Center, MAN CONC MILD TRAUM; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Enderson BL, 2007, J TRAUMA, V62, P33; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Groen JM, 2008, INT J CARDIOVAS IMAG, V24, P547, DOI 10.1007/s10554-007-9282-0; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Murray CJL, 1996, GLOBAL HLTH STAT; Nelson KM, 2006, J GEN INTERN MED, V21, P915, DOI 10.1007/BF02743137; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Saleem JJ, AMIA ANN S P 2007, P640; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Weathers F, 1996, MEASUREMENT STRESS T; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	40	9	9	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1635	1641		10.3109/02699052.2015.1075149			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800014	26399477				2022-02-06	
J	Moran, LM; Bigler, E; Dennis, M; Gerhardt, CA; Rubin, KH; Stancin, T; Taylor, HG; Vannatta, KA; Yeates, KO				Moran, Lisa M.; Bigler, Erin; Dennis, Maureen; Gerhardt, Cynthia A.; Rubin, Kenneth H.; Stancin, Terry; Taylor, H. Gerry; Vannatta, Kathryn A.; Yeates, Keith Owen			Social problem-solving and social adjustment in paediatric traumatic brain injury	BRAIN INJURY			English	Article							FRIENDSHIP QUALITY; EXECUTIVE FUNCTION; SELF-REGULATION; CHILDREN; CHILDHOOD; BEHAVIOR; OUTCOMES; SKILLS; ASSOCIATIONS; ADOLESCENTS		[Moran, Lisa M.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Hlth, Los Angeles, CA USA; [Bigler, Erin] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Dennis, Maureen] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Columbus, OH USA; [Gerhardt, Cynthia A.; Vannatta, Kathryn A.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Gerhardt, Cynthia A.; Vannatta, Kathryn A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Rubin, Kenneth H.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Rubin, Kenneth H.] Univ Maryland, Ctr Children Relationships & Culture, College Pk, MD 20742 USA; [Stancin, Terry; Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Pediat, Cleveland, OH USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada		Yeates, KO (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kyeates@ucalgary.ca	Rubin, Kenneth H/M-5276-2018; Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD 04946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	No competing financial interests exist. This work was supported by grant R01 HD 04946 from the National Institute of Child Health and Human Development (Dr. Yeates).	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ASHER SR, 1979, DEV PSYCHOL, V15, P443, DOI 10.1037/0012-1649.15.4.443; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Bowker JC, 2010, J APPL DEV PSYCHOL, V31, P231, DOI 10.1016/j.appdev.2010.01.001; Bowker JC, 2007, EUR J DEV PSYCHOL, V4, P1, DOI 10.1080/17405620701632069; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Bukowski WM, 1989, PEER RELATIONSHIPS C; Burgess KB, 2006, CHILD DEV, V77, P371, DOI 10.1111/j.1467-8624.2006.00876.x; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DODGE KA, 1994, CHILD DEV, V65, P1385, DOI 10.2307/1131505; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Dwyer KM, 2010, J SOC PERS RELAT, V27, P91, DOI 10.1177/0265407509346420; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Harrison P.L., 2003, ABAS 2 ADAPTIVE BEHA, V2nd ed.; Hayes, 2018, INTRO MEDIATION MODE; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Howard I, 2005, ETHNIC DIS, V15, pS51; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kuss O, 2007, COMPUT METH PROG BIO, V87, P262, DOI 10.1016/j.cmpb.2007.06.002; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lansford JE, 2010, DEV PSYCHOPATHOL, V22, P593, DOI 10.1017/S0954579410000301; Lemerise EA, 2005, J EXP CHILD PSYCHOL, V90, P344, DOI 10.1016/j.jecp.2004.12.003; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Mathieu JE, 2006, J ORGAN BEHAV, V27, P1031, DOI 10.1002/job.406; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Mayeux L, 2003, J GENET PSYCHOL, V164, P153, DOI 10.1080/00221320309597975; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Noll RB, 2007, AM J MED GENET A, V143A, P2261, DOI 10.1002/ajmg.a.31923; Parker J., 2006, DEV PSYCHOPATHOL RIS, V2, P419, DOI DOI 10.1002/9780470939383.CH12; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Payne C., 2009, HDB DEVEOPMENTAL SOC, P38; Rah Y, 2008, SOC DEV, V17, P341, DOI 10.1111/j.1467-9507.2007.00428.x; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rubin KH., 2006, HDB CHILD PSYCHOL, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Spencer SV, 2013, MERRILL PALMER QUART, V59, P106; Vannatta K, 2007, PEDIATR BLOOD CANCER, V49, P716, DOI 10.1002/pbc.21062; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531	56	9	9	1	25	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1682	1690		10.3109/02699052.2015.1075140			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800021	26378419	Green Accepted			2022-02-06	
J	Ashkenazi, I; Zeina, AR; Kessel, B; Peleg, K; Givon, A; Khashan, T; Dudkiewicz, M; Oren, M; Alfici, R; Olsha, O				Ashkenazi, I.; Zeina, A. R.; Kessel, B.; Peleg, K.; Givon, A.; Khashan, T.; Dudkiewicz, M.; Oren, M.; Alfici, R.; Olsha, O.			Effect of teleradiology upon pattern of transfer of head injured patients from a rural general hospital to a neurosurgical referral centre: follow-up study	EMERGENCY MEDICINE JOURNAL			English	Article						Trauma; head; risk management	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; CARE; MANAGEMENT; PROTOCOL; LINK	Introduction The optimal management strategy for patients with head injury admitted to a non-specialist hospital is uncertain. The aim of this study was to evaluate the outcomes of victims of head injury requiring hospitalisation but initially admitted to a rural level II trauma centre without a neurosurgical facility but with a system for neurosurgical consultation via teleradiology. Methods Patients admitted for head injury during 2006-2011 were included. Late transfer of patients initially hospitalised in the level II trauma centre was evaluated for treatment failure, defined as clinical or radiological deterioration. Results Five hundred and sixty-two patients were initially hospitalised in the level II trauma centre. Evaluation of late transfers showed that only 23 (4.1%) represented real treatment failures due to clinical or radiological deterioration. The clinical course was altered by primary intent to hospitalise patients in the level II trauma centre in only one patient. Conclusions Selected patients with head trauma who have a pathological CT scan may be safely managed in level II trauma centres following neurosurgical consultation using teleradiology. Review of treatment failures is necessary to ensure proper ongoing management of a system in which neurosurgical patients are selectively transferred to trauma centres with neurosurgical capacity.	[Ashkenazi, I.; Zeina, A. R.; Kessel, B.; Khashan, T.; Dudkiewicz, M.; Oren, M.; Alfici, R.] Hillel Yaffe Med Ctr, IL-38100 Hadera, Israel; [Peleg, K.; Givon, A.] Gertner Inst, Israel Natl Ctr Trauma & Emergency Med Res, Tel Hashomer, Israel; [Olsha, O.] Shaare Zedek Med Ctr, Jerusalem, Israel		Ashkenazi, I (corresponding author), Hillel Yaffe Med Ctr, Dept Surg B, POB 169, IL-38100 Hadera, Israel.	i_ashkenazi@yahoo.com	, ita/AAG-5879-2020; Oren, Meir/AAF-4940-2020	, ita/0000-0002-6305-4159; 			Aharonson-Daniel L, 2003, INJURY PREV, V9, P156, DOI 10.1136/ip.9.2.156; Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; ELJAMEL MS, 1992, BRIT J NEUROSURG, V6, P559, DOI 10.3109/02688699209002373; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Hassan R, 2014, MALAYS J MED SCI, V21, P54; Hunyh T, 2006, AM SURGEON, V72, P1162; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Kreutzer J, 2008, J TELEMED TELECARE, V14, P67, DOI 10.1258/jtt.2007.060605; Lecky FE, 2002, EMERG MED J, V19, P520, DOI 10.1136/emj.19.6.520; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Mrak G, 2009, J TELEMED TELECARE, V15, P142, DOI 10.1258/jtt.2009.003012; Petsas A, 2010, J NEUROSURG ANESTH, V22, P354, DOI 10.1097/ANA.0b013e3181f0da95; Poca MA, 2004, NEUROCIRUGIA, V15, P17; Servadei F, 2002, BRIT J NEUROSURG, V16, P36, DOI 10.1080/02688690120114255; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sinha Virendra Deo, 2012, Asian J Neurosurg, V7, P75, DOI 10.4103/1793-5482.98648; Teig M, 2010, J NEUROSURG ANESTH, V22, P357, DOI 10.1097/ANA.0b013e3181f0dada	20	9	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	DEC	2015	32	12					946	950		10.1136/emermed-2014-203930			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DA0AU	WOS:000367459900010	26446312				2022-02-06	
J	Chiu, HY; Lin, EY; Wei, L; Lin, JH; Lee, HC; Fan, YC; Tsai, PS				Chiu, Hsiao-Yean; Lin, En-Yuan; Wei, Li; Lin, Jiann-Her; Lee, Hsin-Chien; Fan, Yen-Chun; Tsai, Pei-Shan			Hypnotics use but not insomnia increased the risk of dementia in traumatic brain injury patients	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Article						Dementia; Hypnotics; Insomnia; Population-based study; Traumatic brain injury	ALZHEIMERS-DISEASE; BENZODIAZEPINE USE; UNITED-STATES; POPULATION; SLEEP; PREVALENCE; PERFORMANCE; IMPAIRMENT; OBESITY; AGE	This study was intended to determine whether the use of hypnotics is associated with dementia in traumatic-brain-injury (TBI) patients. Data retrieved from the Longitudinal Health Insurance Database 2000. TBI patients who received a diagnosis of insomnia at 2 or more independent examinations after the index date of TBI were included. The comparison cohort consisted of randomly selected TBI patients who were matched to insomnia cohort patients based on sex and age. The 2 cohorts of TBI patients were subsequently divided into the following 4 study groups: hypnotics users with insomnia (TBI-IH, N=599), insomniacs who did not use hypnotics (TBI-I, N=931), hypnotics users without insomnia (TBI-H, N=199), and people without insomnia who did not use hypnotics (TBI-C, N=4271). Cox proportional-hazards regression models were used to determine the difference in dementia-free survival among the 4 study groups, after adjusting for the propensity score. The adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of the TBI-IH and TBI-H groups showed that they had a higher risk of dementia (aHRs: 1.86 and 3.98; 95% Cls: 1.15-3.00 and 2.44-6.47, respectively), compared with that of the TBI-C group. However, the risk of dementia in the TB I-I group was not significantly different from that of the TBI-C group (aHR: 1.36; 95% CI: 0.85-2.19). This study suggests that the use of hypnotics is associated with an increased risk of dementia in TBI patients with or without insomnia, whereas insomnia alone is not. (C) 2015 Elsevier B.V. and ECNP. All rights reserved.	[Chiu, Hsiao-Yean; Tsai, Pei-Shan] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Lin, En-Yuan; Lin, Jiann-Her] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Wei, Li] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Lee, Hsin-Chien; Tsai, Pei-Shan] Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan; [Fan, Yen-Chun] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Anesthesiol, Taipei, Taiwan		Tsai, PS (corresponding author), Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan.	ptsai@tmu.edu.tw	Fan, Yen-Chun/AAG-7183-2021	Tsai, Pei-Shan/0000-0003-1274-574X; lee, hsin-chien/0000-0002-7557-8259			Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Breitner JCS, 2009, NEUROLOGY, V72, P1899, DOI 10.1212/WNL.0b013e3181a18691; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Chen P.L., 2012, PLOS ONE, V7; Cheng PY, 2012, J DIABETES COMPLICAT, V26, P382, DOI 10.1016/j.jdiacomp.2012.06.003; Chi NF, 2013, NEUROLOGY, V80, P705, DOI 10.1212/WNL.0b013e31828250af; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Gage SB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6231; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; Huang WS, 2014, DEMENT GERIATR COGN, V37, P357, DOI 10.1159/000357701; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kessing LV, 2009, J AFFECT DISORDERS, V117, P24, DOI 10.1016/j.jad.2008.11.020; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lagnaoui R, 2002, J CLIN EPIDEMIOL, V55, P314, DOI 10.1016/S0895-4356(01)00453-X; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lobo A, 2008, NEUROTOX RES, V14, P263, DOI 10.1007/BF03033815; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Meyer JS, 2000, ANN NY ACAD SCI, V903, P411, DOI 10.1111/j.1749-6632.2000.tb06393.x; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Osorio RS, 2011, J AM GERIATR SOC, V59, P559, DOI 10.1111/j.1532-5415.2010.03288.x; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; SHIMOHAMA S, 1988, ANN NEUROL, V23, P404, DOI 10.1002/ana.410230419; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Wan H, 2004, EUR J NEUROSCI, V20, P2214, DOI 10.1111/j.1460-9568.2004.03688.x; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412	38	9	10	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0924-977X	1873-7862		EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	DEC	2015	25	12					2271	2277		10.1016/j.euroneuro.2015.09.011			7	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CZ2PO	WOS:000366947300009	26454682				2022-02-06	
J	Deepika, A; Mathew, MJ; Kumar, SA; Devi, BI; Shukla, D				Deepika, Akhil; Mathew, Manish Joseph; Kumar, S. Arun; Devi, Bhagavatula Indira; Shukla, Dhaval			Paroxysmal sympathetic hyperactivity in pediatric traumatic brain injury: A case series of four patients	AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL			English	Article						Paroxysmal sympathetic hyperactivity; Autonomic dysregulation; Diffuse axonal injury; Traumatic brain injury	INTENSIVE-CARE-UNIT; DYSAUTONOMIA; SCALE; CHILD; COMA	Paroxysmal sympathetic hyperactivity (PSH) is a condition in which there is extreme autonomic dysregulation leading to multiple episodes of sympathetic hyperactivity. Its occurrence after traumatic brain injury (TBI) in pediatric population is a neglected scenario. In our series, all pediatric patients with moderate and severe head injuries were studied and those patients who developed PSH were monitored for the PSH episodes. Four children out of 36 cases of pediatric severe traumatic brain injury developed features of PSH. Admission GCS of 3 children were 4/15 and 1 child was 6/15 and each of them had an ICU stay of more than 2 weeks and a poor DRS score at discharge. The presence of PSH is known to produce poorer outcome in terms of overall mortality, time needed for recovery, chances of developing infections, etc. which was also seen in these cases presented here. Though some studies have provided guidelines for the management of PSH like symptomatic management and use of drugs like clonidine, bromocriptine, benzodiazepines, and gabapentin, strict management guidelines are not established and exact incidence in pediatric population is not determined. (C) 2015 Elsevier B.V. All rights reserved.	[Deepika, Akhil] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Neurosci, Bengaluru 560029, India; [Mathew, Manish Joseph; Kumar, S. Arun; Devi, Bhagavatula Indira; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bengaluru 560029, India		Shukla, D (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bengaluru 560029, India.	neurodhaval@rediffmail.com		MATHEW, MANISH JOSEPH/0000-0002-8566-5954; Shukla, Dhaval/0000-0001-7613-1929			Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Deepika A, 2014, J NEUROSURG ANESTH, V26, P87, DOI 10.1097/ANA.0b013e3182983b83; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Goh KYC, 1999, PEDIATR NEUROL, V21, P742, DOI 10.1016/S0887-8994(99)00069-7; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Mehta NM, 2008, JPEN-PARENTER ENTER, V32, P281, DOI 10.1177/0148607108316196; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pozzi M, 2014, J HEAD TRAUMA REHABI; Rabinstein AA, 2004, ARCH NEUROL-CHICAGO, V61, P1625, DOI 10.1001/archneur.61.10.1625-a; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519	20	9	9	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-0702	1872-7484		AUTON NEUROSCI-BASIC	Auton. Neurosci-Basic Clin.	DEC	2015	193						149	151		10.1016/j.autneu.2015.08.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CY0DZ	WOS:000366077800024	26277041				2022-02-06	
J	Farias-Moeller, R; Carpenter, JL; Dean, N; Wells, EM				Farias-Moeller, Raquel; Carpenter, Jessica L.; Dean, Nathan; Wells, Elizabeth M.			Paroxysmal Sympathetic Hyperactivity in Critically Ill Children with Encephalitis and Meningoencephalitis	NEUROCRITICAL CARE			English	Article						Paroxysmal sympathetic hyperactivity; Dysautonomia; Central fever; Sympathetic storm; Meningoencephalitis; Encephalitis	TRAUMATIC BRAIN-INJURY; RECEPTOR ENCEPHALITIS; AUTONOMIC INSTABILITY; DYSTONIA	Autonomic dysfunction in pediatric patients with acquired brain injury is often encountered and greatly understudied. We sought to identify the incidence of Paroxysmal Sympathetic Hyperactivity (PSH) in critically ill pediatric patients with meningoencephalitis and encephalitis, associated risk factors and influence on outcome. Children admitted to the pediatric intensive care unit (PICU) with a diagnosis of meningoencephalitis and/or encephalitis were identified from a single institution Neurocritical Care database. The patients were stratified as having a bacterial or non-bacterial cause of their meningoencephalitis/encephalitis. Data from their hospitalization was supplemented with a retrospective review of the electronic medical record. PSH was defined as episodic lability in heart rate and/or blood pressure, hyperthermia, diaphoresis, dystonic posturing, tachypnea and/or agitation without any other cause. Statistical analysis was performed using t-test and chi-squared to compare outcomes and risk factors between patients with PSH and without. PSH was found in 41 % of children studied. Subgroup analysis revealed patients with non-bacterial encephalitis were more likely to experience PSH (51 %) as compared to those with bacterial causes (27 %). Fever and/or seizures on presentation and female gender were associated with higher occurrence of PSH but only in the non-bacterial etiology group. There were trends toward increased length of PICU and overall hospital stay for patients with PSH. PSH was found in a high percentage of our patients with significant variation in risk factors and outcome noted between patients with bacterial and nonbacterial causes of their meningoencephalitis/encephalitis.	[Farias-Moeller, Raquel; Carpenter, Jessica L.; Wells, Elizabeth M.] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Dean, Nathan] Childrens Natl Med Ctr, Dept Crit Care Med, Washington, DC 20010 USA		Wells, EM (corresponding author), Childrens Natl Med Ctr, Dept Neurol, 111 Michigan Ave NW, Washington, DC 20010 USA.	ewells@cnmc.org	Farias-Moeller, Raquel/AAG-1185-2020				Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; BHIGJEE AI, 1985, J NEUROL SCI, V71, P77, DOI 10.1016/0022-510X(85)90038-3; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; CARMEL PW, 1985, ACTA NEUROCHIR, V75, P113, DOI 10.1007/BF01406331; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Dean NP, 2014, J PEDIATR INFECT DIS, V3, P175, DOI 10.1093/jpids/piu007; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Graus F, 2008, NEUROLOGY, V71, P930, DOI 10.1212/01.wnl.0000325917.48466.55; Hinson HE, 2013, CLIN AUTON RES, V23, P109, DOI 10.1007/s10286-012-0184-4; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Kestenbaum LA, 2010, PEDIATRICS, V125, P257, DOI 10.1542/peds.2009-1181; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Penfield W, 1934, CAN MED ASSOC J, V30, P589; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; TALMAN WT, 1988, ARCH NEUROL-CHICAGO, V45, P1037, DOI 10.1001/archneur.1988.00520330129022; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8	21	9	11	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2015	23	3					380	385		10.1007/s12028-015-0124-y			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV8WN	WOS:000364569000012	25724178				2022-02-06	
J	Langford, S; Panigrahy, A; Narayanan, S; Hwang, M; Fitz, C; Flom, L; Lee, VK; Zuccoli, G				Langford, Stacey; Panigrahy, Ashok; Narayanan, Srikala; Hwang, Misun; Fitz, Charles; Flom, Lynda; Lee, Vincent Kyu; Zuccoli, Giulio			Multiplanar reconstructed CT images increased depiction of intracranial hemorrhages in pediatric head trauma	NEURORADIOLOGY			English	Article						Craniocerebral trauma; Brain hemorrhage, traumatic; Abusive head trauma; Pediatrics	COMPUTED-TOMOGRAPHY SCANS; CHILDHOOD; INJURY; INFANT; RISK	The benefits of multiplanar reconstructed images (MPR) of unenhanced axial head computed tomography (CT) data have not been established in trauma patients younger than 3 years old, a population in which a reliable history and physical examination may be most difficult. We retrospectively evaluated unenhanced head CTs in pediatric trauma patients to investigate the various benefits of MPR in this age group. A total of 221 unenhanced head CTs performed for any case of head trauma (HT) on children younger than 3 years old were independently reviewed by two radiologists. Studies were reviewed first in the standard axial plane alone and then with the addition of MPR. Reviewers were asked to determine if the MPR affected the ability to make findings of hemorrhage, incidental findings, and artifacts. MPR improved the detection of hemorrhage in 14 cases (6.5 %, p-value < 0.01) and incidental findings in five cases (2.3 %, p-value < 0.05) as well as helped prove artifacts in five cases (2.3 %, p-value < 0.05). Routine use of MPR in HT patients younger than 3 years old has the potential to increase the detection of acute and incidental imaging findings.	[Langford, Stacey; Panigrahy, Ashok; Narayanan, Srikala; Hwang, Misun; Fitz, Charles; Flom, Lynda; Lee, Vincent Kyu; Zuccoli, Giulio] UPMC, Childrens Hosp Pittsburgh, Neuroradiol Sect, Dept Radiol, Pittsburgh, PA 15224 USA		Zuccoli, G (corresponding author), UPMC, Childrens Hosp Pittsburgh, Neuroradiol Sect, Dept Radiol, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	giulio.zuccoli@gmail.com		/0000-0001-9734-8035			Aitken LA, 2009, PEDIATR NEUROL, V40, P449, DOI 10.1016/j.pediatrneurol.2009.01.003; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Ortega HW, 2012, CLIN PEDIATR, V51, P872, DOI 10.1177/0009922812450508; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Vorona GA, 2013, AM J NEURORADIOL, V34, P205, DOI 10.3174/ajnr.A3122; Wei SC, 2010, AM J NEURORADIOL, V31, P334, DOI 10.3174/ajnr.A1824; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6	13	9	9	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	DEC	2015	57	12					1263	1268		10.1007/s00234-015-1584-7			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CW8BB	WOS:000365222500009	26320000				2022-02-06	
J	Schelhorn, J; Gramsch, C; Deuschl, C; Quick, HH; Nensa, F; Moenninghoff, C; Schlamann, M				Schelhorn, Juliane; Gramsch, Carolin; Deuschl, Cornelius; Quick, Harald H.; Nensa, Felix; Moenninghoff, Christoph; Schlamann, Marc			Intracranial hemorrhage detection over time using susceptibility-weighted magnetic resonance imaging	ACTA RADIOLOGICA			English	Article						Intracranial hemorrhage; hemosiderin; susceptibility-weighted imaging (SWI); magnetic resonance imaging (MRI)	TRAUMATIC INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; BRAIN-INJURY; MRI; HEMOSIDERIN; MICROBLEEDS; CHILDREN; LESIONS; SWI	Background: The reliable detection of intracranial hemorrhages is important, but just 1 year after the hemorrhage onset it might be missed using T2-weighted spin-echo and gradient-echo sequences. Susceptibility-weighted imaging (SWI) is a new magnetic resonance imaging sequence that is extremely sensitive in hemorrhage detection and that might improve the detection of hemorrhages over time. Purpose: To investigate whether the detectability of intracranial blood and its degradation products is independent of the time span after intracranial hemorrhage using SWI. Material and Methods: Sixty-six consecutive patients (28 men, 38 women) with definitely known time point of intracranial hemorrhage and available SWI sequence (1.5 or 3 T) were analyzed retrospectively. Twenty-one patients had a SWI follow-up. All SWI images were assessed by two radiologists in consensus regarding hemorrhage visibility using a 5-point scale. Statistical analysis was performed using Spearman's correlation test. Results: Median time interval between hemorrhage and first available SWI measurement was 819 days (range, 0 days to 13.2 years). Nine of 66 patients had an isolated subarachnoid hemorrhage (iSAH) and were therefore analyzed separately. In eight of these nine patients the hemorrhage could clearly be detected, the remaining one had minor iSAH. Spearman analysis showed no significant correlation between time span and visibility (P = 0.660). In the remaining 57 patients (no iSAH) the hemorrhage was always visible achieving at least 3/5 points on the 5-point scale, and Spearman's analysis revealed only a weak correlation between time span and visibility (r = 0.493, P < 0.001). Conclusion: The detectability of blood and its degradation products using SWI is reliably possible over a long period after intracranial hemorrhage.	[Schelhorn, Juliane; Gramsch, Carolin; Deuschl, Cornelius; Nensa, Felix; Moenninghoff, Christoph; Schlamann, Marc] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, D-45147 Essen, Germany; [Quick, Harald H.] Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Quick, Harald H.] Univ Hosp Essen, Highfield & Hybrid MR Imaging, Essen, Germany		Schelhorn, J (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Hufelandstr 55, D-45147 Essen, Germany.	Juliane.Schelhorn@uk-essen.de		Nensa, Felix/0000-0002-5811-7100			Dammann P, 2013, J NEUROL NEUROSUR PS, V84, P194, DOI 10.1136/jnnp-2012-302599; Deistung A, 2006, Z MED PHYS, V16, P261, DOI 10.1078/0939-3889-00324; Fisher M, 2010, STROKE, V41, P2782, DOI 10.1161/STROKEAHA.110.593657; Goos JDC, 2011, STROKE, V42, P1894, DOI 10.1161/STROKEAHA.110.599837; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Inoue T, 2013, CEREBROVASC DIS, V36, P421, DOI 10.1159/000355897; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; OGAWA T, 1995, AM J ROENTGENOL, V165, P1257, DOI 10.2214/ajr.165.5.7572514; Rauscher A, 2005, AM J NEURORADIOL, V26, P736; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Tatsumi S, 2008, CEREBROVASC DIS, V26, P142, DOI 10.1159/000139661; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Wiesmann M, 2004, ROFO-FORTSCHR RONTG, V176, P500; Wiesmann M, 2006, MRT ZENTRALNERVENSYS, P154; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022; Yuan Mei-Kang, 2005, J Chin Med Assoc, V68, P131	23	9	10	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	DEC	2015	56	12					1501	1507		10.1177/0284185114559958			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CX0PX	WOS:000365400200014	25425725				2022-02-06	
J	Stehman, CR; Moromizato, T; McKane, CK; Mogensen, KM; Gibbons, FK; Christopher, KB				Stehman, Christine R.; Moromizato, Takuhiro; McKane, Caitlin K.; Mogensen, Kris M.; Gibbons, Fiona K.; Christopher, Kenneth B.			Association between blood alcohol concentration and mortality in critical illness	JOURNAL OF CRITICAL CARE			English	Article						Alcohol; Ethanol; Critical care; Intensive care; Mortality; Sepsis	ACUTE ETHANOL EXPOSURE; TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; LOCALLY WEIGHTED REGRESSION; NEIGHBORHOOD POVERTY RATE; CELL DISTRIBUTION WIDTH; GEOCODING PROJECT US; ADULT INTENSIVE-CARE; HOSPITAL MORTALITY; UNITED-STATES	Objective: In animal models of renal, intestinal, liver, cardiac, and cerebral ischemia, alcohol exposure is shown to reduce ischemia-reperfusion injury. Inpatient mortality of trauma patients is shown to be decreased in a dose-dependent fashion relative to blood alcohol concentration (BAC) at hospital admission. In this study, we examined the association between BAC at hospital admission and risk of 30-day mortality in critically ill patients. Design: We performed a 2-center observational study of patients treated in medical and surgical intensive care units in Boston, Massachusetts. Setting: Medical and surgical intensive care units in 2 teaching hospitals in Boston, Massachusetts. Patients: We studied 11850 patients, 18 years or older, who received critical care between 1997 and 2007. The exposure of interest was the BAC determined in the first 24 hours of hospital admission and categorized a priori as BAC less than 10mg/dL (below level of detection), 10 to 80 mg/dL, 80 to 160 mg/dL, and greater than 160 mg/dL. The primary outcome was all-cause mortality in the 30 days after critical care initiation. Secondary outcomes included 90- and 365-day mortality after critical care initiation. Mortality was determined using the US Social Security Administration Death Master File, and 365-day follow-up was present in all cohort patients. Adjusted odds ratios (ORs) were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both BAC and mortality. Adjustment included age, sex, race (white or nonwhite), type (surgical vs medical), Deyo-Charlson index, sepsis, acute organ failure, trauma, and chronic liver disease. Results: Thirty-day mortality of the cohort was 13.7%. Compared to patients with BAC levels less than 10 mg/dL, patients with levels greater than or equal to 10 mg/dL had lower odds of 30-day mortality; for BAC levels 10 to 79.9 mg/dL, the OR was 0.53 (95% confidence interval [CI], 0.40-0.70); for BAC levels 80 to 159.9 mg/dL, it was 0.36 (95% CI, 0.26-0.49); and for BAC levels greater than or equal to 160 mg/dL, it was 0.35 (95% CI, 0.27-0.44). After multivariable adjustment, the OR of 30-day mortality was 0.97 (0.72-1.31), 0.79 (0.57-1.10), and 0.69 (0.54-0.90), respectively. When the cohort was analyzed with sepsis as the outcome of interest, the multivariable adjusted odds of sepsis in patients with BAC 80 to 160 mg/dL or greater than 160mg/dL were 0.72 (0.50-1.04) or 0.68 (0.51-0.90), respectively, compared to those with BAC less than 10mg/dL. In a subset of patients with blood cultures drawn (n = 4065), the multivariable adjusted odds of bloodstream infection in patients with BAC 80 to 160mg/dL or greater than 160 mg/dL were 0.53 (0.27-1.01) or 0.49 (0.29-0.83), respectively, compared to those with BAC less than 10 mg/dL. Conclusions: Analysis of 11850 adult patients showed that having a detectable BAC at hospitalization was associated with significantly decreased odds of 30-day mortality after critical care. Furthermore, BAC greater than 160 mg/dL is associated with significantly decreased odds of developing sepsis and bloodstream infection. (C) 2015 Elsevier Inc. All rights reserved.	[Stehman, Christine R.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Moromizato, Takuhiro] Okinawa Hokubu Prefectural Hosp, Dept Med, Okinawa, Japan; [McKane, Caitlin K.] Brigham & Womens Hosp, Dept Nursing, Boston, MA 02115 USA; [Mogensen, Kris M.] Brigham & Womens Hosp, Dept Nutr, Boston, MA 02115 USA; [Gibbons, Fiona K.] Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02114 USA; [Christopher, Kenneth B.] Brigham & Womens Hosp, Dept Med, Div Renal, Nathan E Hellman Mem Lab, Boston, MA 02115 USA		Christopher, KB (corresponding author), Brigham & Womens Hosp, Dept Med, Div Renal, 75 Francis St,MRB 418, Boston, MA 02115 USA.	kbchristopher@partners.org	Christopher, Kenneth B./C-5243-2012; Mogensen, Kris M./ABI-4502-2020; Christopher, Kenneth/AAD-6801-2021	Christopher, Kenneth B./0000-0001-6067-972X; Mogensen, Kris M./0000-0001-9510-3018; Christopher, Kenneth/0000-0001-6067-972X; Stehman, Christine/0000-0002-4678-0263			AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexandre PK, 2001, RECENT DEV ALCOHOL, V15, P285; BALDWIN WA, 1993, CHEST, V103, P21, DOI 10.1378/chest.103.1.21; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Beier K, 2011, CRIT CARE MED, V39, P305, DOI 10.1097/CCM.0b013e3181ffe22a; Blaine KP, 2010, DIAGN MICR INFEC DIS, V68, P28, DOI 10.1016/j.diagmicrobio.2010.04.013; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf; Braun AB, 2012, CRIT CARE MED, V40, P3170, DOI 10.1097/CCM.0b013e318260c928; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen GM, 2010, DIABETES RES CLIN PR, V89, P189, DOI 10.1016/j.diabres.2010.03.007; Christophersen AS, 2002, DRUG ALCOHOL DEPEN, V66, P85, DOI 10.1016/S0376-8716(01)00187-9; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Collins MA, 2009, ALCOHOL CLIN EXP RES, V33, P206, DOI 10.1111/j.1530-0277.2008.00828.x; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Cryer PC, 1999, ADDICTION, V94, P1523, DOI 10.1046/j.1360-0443.1999.941015238.x; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dayton C, 2004, MICROCIRCULATION, V11, P709, DOI 10.1080/10739680490521014; de Wit Marjolein, 2007, BMC Anesthesiol, V7, P3, DOI 10.1186/1471-2253-7-3; Duncan DT, 2014, ENVIRON HEALTH PERSP, V122, P1359, DOI 10.1289/ehp.1307704; Elias KM, 2015, CRIT CARE MED, V43, P856, DOI 10.1097/CCM.0000000000000858; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Fabbri A, 2001, J TRAUMA, V50, P521, DOI 10.1097/00005373-200103000-00018; Fitzgerald DJ, 2007, ALCOHOL CLIN EXP RES, V31, P317, DOI 10.1111/j.1530-0277.2006.00307.x; Friedman LS, 2012, ALCOHOL, V46, P769, DOI 10.1016/j.alcohol.2012.08.006; Gacouin A, 2008, CRIT CARE MED, V36, P1735, DOI 10.1097/CCM.0b013e318174dd75; Greiffenstein P, 2008, J TRAUMA, V64, P230, DOI 10.1097/TA.0b013e318158a4ad; Harwood HJ., 2000, UPDATING ESTIMATES E; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hug BL, 2009, SWISS MED WKLY, V139, P737, DOI smw-12686; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Kind AJH, 2007, J AM GERIATR SOC, V55, P365, DOI 10.1111/j.1532-5415.2007.01091.x; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Krieger N, 2003, PUBLIC HEALTH REP, V118, P240, DOI 10.1093/phr/118.3.240; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Leuven E., 2003, PSMATCH2 STATA MODUL; Louboutin JP, 2012, ALCOHOL, V46, P441, DOI 10.1016/j.alcohol.2012.02.001; Madan AK, 1999, J TRAUMA, V47, P568, DOI 10.1097/00005373-199909000-00026; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maxson PM, 1999, MAYO CLIN PROC, V74, P448; McMahon GM, 2012, INTENS CARE MED, V38, P1834, DOI 10.1007/s00134-012-2636-7; Mendu ML, 2012, CRIT CARE MED, V40, P1427, DOI 10.1097/CCM.0b013e318241e51e; Miller RS, 2010, J TRAUMA, V68, P23, DOI 10.1097/TA.0b013e3181c82678; Miyamae M, 1998, AM J PHYSIOL-HEART C, V275, pH50, DOI 10.1152/ajpheart.1998.275.1.H50; Miyamae M, 1997, P NATL ACAD SCI USA, V94, P3235, DOI 10.1073/pnas.94.7.3235; Moromizato T, 2014, CRIT CARE MED, V42, P97, DOI 10.1097/CCM.0b013e31829eb7af; Moss M, 2003, CRIT CARE MED, V31, P869, DOI 10.1097/01.CCM.0000055389.64497.11; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Pagel PS, 2002, ANESTH ANALG, V94, P841, DOI 10.1097/00000539-200204000-00012; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Radek KA, 2005, AM J PHYSIOL-HEART C, V289, pH1084, DOI 10.1152/ajpheart.00080.2005; Radek KA, 2008, AM J PHYSIOL-HEART C, V295, pH174, DOI 10.1152/ajpheart.00699.2007; Radek KA, 2007, ALCOHOL CLIN EXP RES, V31, P1045, DOI 10.1111/j.1530-0277.2007.00386.x; RAPOPORT J, 1992, ARCH INTERN MED, V152, P2207, DOI 10.1001/archinte.152.11.2207; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Robinson MK, 2015, CRIT CARE MED, V43, P87, DOI 10.1097/CCM.0000000000000602; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Schisterman Enrique F, 2004, Popul Health Metr, V2, P2, DOI 10.1186/1478-7954-2-2; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Shorr AF, 2005, CHEST, V127, P1722, DOI 10.1378/chest.127.5.1722; Smothers BA, 2004, ARCH INTERN MED, V164, P749, DOI 10.1001/archinte.164.7.749; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Subramanian SV, 2005, AM J PUBLIC HEALTH, V95, P260, DOI 10.2105/AJPH.2003.034132; Suchyta MR, 2008, INTENS CARE MED, V34, P2264, DOI 10.1007/s00134-008-1263-9; Taylor B, 2012, ALCOHOL CLIN EXP RES, V36, P1827, DOI 10.1111/j.1530-0277.2012.01785.x; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Wang Q, 2007, FREE RADICAL BIO MED, V43, P1048, DOI 10.1016/j.freeradbiomed.2007.06.018; Wang Q, 2010, MICROCIRCULATION, V17, P427, DOI 10.1111/j.1549-8719.2010.00041.x; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; World Health Organization, 2007, INT CLASS DIS REL HL; Yaghoubian A, 2009, AM SURGEON, V75, P950; Yamaguchi T, 2003, FREE RADICAL BIO MED, V34, P365, DOI 10.1016/S0891-5849(02)01292-3; Yamaguchi T, 2002, AM J PHYSIOL-HEART C, V283, pH1019, DOI 10.1152/ajpheart.00173.2002; Yuan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025811; Zager S, 2011, CHEST, V139, P1368, DOI 10.1378/chest.10-2594; Zakhari S, 1999, ALCOHOL CLIN EXP RES, V23, P1108, DOI 10.1111/j.1530-0277.1999.tb04232.x; Zeckey C, 2011, ALCOHOL, V45, P245, DOI 10.1016/j.alcohol.2010.08.004; Zgibor JC, 2007, DIABETES RES CLIN PR, V75, P313, DOI 10.1016/j.diabres.2006.07.007	97	9	9	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2015	30	6					1382	1389		10.1016/j.jcrc.2015.08.023			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0MX	WOS:000363945900041	26483354				2022-02-06	
J	McKechnie, D; Pryor, J; Fisher, MJ				McKechnie, Duncan; Pryor, Julie; Fisher, Murray J.			Falls and fallers in traumatic brain injury (TBI) rehabilitation settings: an integrative review	DISABILITY AND REHABILITATION			English	Article						Brain injury; fall; faller; head injury; TBI	INPATIENT REHABILITATION; RISK-FACTORS; POSTTRAUMATIC AMNESIA; COGNITIVE IMPAIRMENT; PREVALENCE; PREDICTORS; PREVENTION; FACILITY; ADULTS; UNIT	Purpose: To critically appraise the research literature on the nature of falls and fallers in traumatic brain injury (TBI) rehabilitation settings. Method: An integrative review of the literature using thematic analysis was undertaken. Papers identified via a systematic search strategy were independently appraised by two reviewers. A data extraction instrument was developed to record results and to aid identification of themes in the literature. Critical Appraisal Skills Programme instruments were utilised to conduct a methodological critique of the papers included. Results: Thirteen studies were identified as having between 4% and 100% TBI patients in their study cohorts. From these papers, up to 71% of falls took place in a patient's bedroom occurring in peaks and troughs over a 24-h period. With some divergent results, nine themes were identified describing faller characteristics including: (1) functional mobility impairments; (2) dizziness; (3) bladder and bowel dysfunction; (4) certain medications and number of medications prescribed; (5) executive functioning; (6) patient age; (7) fear of falling; (8) coma length following TBI; and (9) Functional Independence Measure (FIM) total score, subscale scores and particular individual items. Conclusions: Being a multifactorial phenomenon, falls are a complex clinical issue. Despite the heterogeneity of diagnosis related groups (DRGs) in the included studies, TBI patients were identified as a high falls risk patient population in several studies.Implications for RehabilitationDue to multisystem impairments, falls in the traumatic brain injury (TBI) rehabilitation context are a multifactorial and significant clinical issue.When interpreting and generalising results from research into falls, clinicians need to be mindful that falls and faller characteristics may be dependent on study setting and patient population.There is need for context specific research into faller characteristics following a TBI; particularly in relation to post-traumatic amnesia.	[McKechnie, Duncan; Pryor, Julie; Fisher, Murray J.] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia; [McKechnie, Duncan] Royal Rehab, Brain Injury Unit, Sydney, NSW, Australia; [Pryor, Julie; Fisher, Murray J.] Royal Rehab, Nursing Res & Dev, Sydney, NSW, Australia		McKechnie, D (corresponding author), Univ Sydney, Sydney Nursing Sch, POB 6, Ryde, NSW 1680, Australia.	duncan.mckechnie@royalrehab.com.au		Pryor, Julie/0000-0003-4907-8530			Aisen M L, 1994, J Am Paraplegia Soc, V17, P179; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Biggs J, 2013, REHAB MANAG, P12; Booth S, 2007, ADV PRACTICE REHABIL, P1; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; *BRAIN INJ ASS QUE, 2002, SURV ACQ BRAIN INJ; Carmine H, 2005, BRAIN INJ PROFESS, V2, P26; Ciliska D, 2008, INTRO EVIDENCE INFOR; Coughlan M., 2013, DOING LIT REV NURSIN; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Forrest G, 2012, REHABIL NURS, V37, P56, DOI 10.1002/RNJ.00010; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Frisina PG, 2010, REHABIL NURS, V35, P141, DOI 10.1002/j.2048-7940.2010.tb00039.x; Gilewski MJ, 2007, REHABIL NURS, V32, P234, DOI 10.1002/j.2048-7940.2007.tb00180.x; Gleeny C., 2009, BMC GETRIATRICS, V9, P1; Grant J S, 1987, Rehabil Nurs, V12, P74; GRIFFITHS K, 1997, GUIDE UNDERSTANDING; Halfon P, 2001, J CLIN EPIDEMIOL, V54, P1258, DOI 10.1016/S0895-4356(01)00406-1; Healey F, 2008, QUAL SAF HEALTH CARE, V17, P424, DOI 10.1136/qshc.2007.024695; Hendrich AL, 2003, APPL NURS RES, V16, P9, DOI 10.1053/apnr.2003.YAPNR2; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kwan F, 2012, REHABIL NURS, V37, P30, DOI 10.1002/RNJ.00004; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; Lin Julie T, 2005, Phys Med Rehabil Clin N Am, V16, P109, DOI 10.1016/j.pmr.2004.06.005; Maskell F, 2007, BRAIN INJURY, V21, P741, DOI 10.1080/02699050701472109; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McGrath JC, 2008, CLIN REHABIL, V22, P635, DOI 10.1177/0269215507086432; Mckechnie D, 2014, JARNA, V17, P14; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Murphy MP, 2014, REHABIL NURS, V39, P113, DOI 10.1002/rnj.89; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; *NAT AG RES I, 2004, AN RES PREV FALLS FA; NSW Department of Health and the Clinical Excellence Commission, 2009, CLIN INC MAN NSW PUB; Oliver D, 2004, AGE AGEING, V33, P122, DOI 10.1093/ageing/afh017; Pauley T, 2006, AM J PHYS MED REHAB, V85, P521, DOI 10.1097/01.phm.0000219119.58965.8c; Perell KL, 2001, J GERONTOL A-BIOL, V56, pM761, DOI 10.1093/gerona/56.12.M761; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; Rosario ER, 2014, REHABIL NURS, V39, P86, DOI 10.1002/rnj.114; Salamon LA, 2012, REHABIL NURS, V37, P292, DOI 10.1002/rnj.036; Saverino A, 2006, Eura Medicophys, V42, P179; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Seel R, 2013, 83 AM C REH MED ANN; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Tyson BT, 2012, PHYS MED REH CLIN N, V23, P315, DOI 10.1016/j.pmr.2012.02.007; VLAHOV D, 1990, ARCH PHYS MED REHAB, V71, P8; Ward A, 2009, OXFORD HDB CLIN REHA; Watson W, 2010, INCIDENCE COST FALLS; Wilson B, 1994, BRAIN INJURY NEUROPS, P85	54	9	9	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	NOV 20	2015	37	24					2291	2299		10.3109/09638288.2014.1002578			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DD2IT	WOS:000369746700008	25613355				2022-02-06	
J	Suri, AK; Fleysher, R; Lipton, ML				Suri, Asif K.; Fleysher, Roman; Lipton, Michael L.			Subject Based Registration for Individualized Analysis of Diffusion Tensor MRI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ALGORITHMS; FSL; DTI	Registration of subject and control brains to a common anatomical space or template is the basis for quantitatively delineating regions of abnormality in an individual brain. Normally, a brain atlas is chosen as the template. Limitations in the registration process result in persistent differences between individual subject brains and template, which can be a source of error in an analysis. We propose a new approach to the registration process where the subject of interest is the registration template. Through this change, we eliminate errors due to differences between a brain template and a subject's brain. We applied this method to the analysis of FA values derived from DTI data of 20 individual mTBI patients as compared to 48 healthy controls. Subject-centered analysis resulted in identification of significantly fewer regions of abnormally low FA compared to two separate atlas-centered analyses, with subject-centered abnormalities essentially representing the common subset of abnormal low FA regions detected by the two atlas-centered methods. Whereas each atlas-centered approach demonstrated abnormalities in nearly every subject (19/20 and 20/20), the subject-centered approach demonstrated abnormalities in fewer than half the subjects (9/20). This reduction of diffusion abnormalities observed using the subject-centered approach is due to elimination of misregistration errors that occur when registering the subject of interest to a template. Evaluation of atlas-centered analyses demonstrated that 9.8% to 13.3% of subject GM and CSF was misregistered onto the WM of the brain atlas, resulting in the observation of additional low FA clusters compared to the subject-centered approach. Without careful evaluation, these misregistrations could be misinterpreted as pathology. An additional benefit of the subject-centered approach is that diffusion abnormalities can now be visualized directly in the subject's anatomical space, rather than interpolating results from the brain atlas space, and can thereby enhance correlation with other components of an imaging protocol.	[Suri, Asif K.; Fleysher, Roman; Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, New York, NY 10010 USA; [Suri, Asif K.] Bronx Psychiat Ctr, Dept Psychiat, New York, NY USA; [Suri, Asif K.; Lipton, Michael L.] Montefiore Med Ctr, Dept Radiol, New York, NY USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Radiol, New York, NY 10010 USA.	Michael.Lipton@einstein.yu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082432] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health, National Institutes of Neurological Disorders and Stroke (grant R01 NS082432) and the Dana Foundation David Mahoney Neuroimaging Program.	Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Aubert-Broche B, 2006, NEUROIMAGE, V32, P138, DOI 10.1016/j.neuroimage.2006.03.052; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Naidich TP, 2001, AM J NEURORADIOL, V22, P885; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Sabuncu MR, 2009, LECT NOTES COMPUT SC, V5761, P565; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yeo BTT, 2008, MED IMAGE ANAL, V12, P603, DOI 10.1016/j.media.2008.06.005	24	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142288	10.1371/journal.pone.0142288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	WOS:000365154600044	26580077	Green Submitted, Green Published, gold			2022-02-06	
J	Viano, DC; Parenteau, CS				Viano, David C.; Parenteau, Chantal S.			Concussion, Diffuse Axonal Injury, and AIS4+Head Injury in Motor Vehicle Crashes	TRAFFIC INJURY PREVENTION			English	Article						head injury; concussion; DAI; seat belts; restraint effectiveness; motor vehicle crashes	SIDE-IMPACT; AIRBAG DEPLOYMENT; ROLLOVER CRASHES; FRONTAL CRASHES; HEAD-INJURIES; COLLISIONS; RISK; ASSOCIATION; SYSTEMS	Purpose: This is a descriptive study of the annual incidence of brain injuries in motor vehicle crashes by type, seat belt use, and crash severity (delta V) using national accident data. The risk for concussion, diffuse axonal injury (DAI), and severe head injury was determined.Methods: 1994-2011 NASS-CDS was analyzed to estimate the number of brain injuries annually in nonejected adults involved in motor vehicle crashes. Crashes were grouped by front, side, rear, and rollover, and the effect of belt use was investigated. Light vehicles were included with model year 1994+. Head injuries were identified as concussion, DAI, severe head injury (Abbreviated Injury Scale [AIS] 4+), and skull fracture. The annual incidence, risk, and rate for different types of head injury were estimated with standard errors.Results: Motor vehicle crashes involved 33,191 7,815 occupants with concussion, 5,665 +/- 996 with AIS 4+ head injuries, 986 +/- 446 with DAI, and 3,300 +/- 531 with skull fracture annually. The risk was 1.64 +/- 0.39% for concussion, 0.28 +/- 0.05% for severe head injury (AIS 4+), 0.05 +/- 0.02% for DAI, and 0.16 +/- 0.03% for skull fracture in tow-away crashes. The risk for severe head injury (AIS 4+) was highest in rollovers (0.74 +/- 0.16%) and lowest in rear impacts (0.17 +/- 0.05%). Head injury risk depended on seat belt use, crash type, and crash severity (delta V). Seat belt use lowered the risk for AIS 4+ head injury by 74.8% and skull fracture by 73.2%.Conclusions: Concussions occur in about one out of 61 occupants in tow-away crashes. The risk was highest in rollover crashes (4.73 +/- 1.09%) and it was reduced 69.2% by seat belt use. Severe brain injuries occurred less often and the risk was also reduced by seat belt use.	[Viano, David C.; Parenteau, Chantal S.] ProBiomechanics LLC, Bloomfield Hills, MI USA		Viano, DC (corresponding author), 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.	dviano@comcast.net					Cox D, 2004, J ORAL MAXIL SURG, V62, P571, DOI 10.1016/j.joms.2003.12.005; D'Elia A, 2013, ACCIDENT ANAL PREV, V54, P67, DOI 10.1016/j.aap.2013.02.020; Duma SM, 2003, OPHTHAL PLAST RECONS, V19, P107, DOI 10.1097/01.IOP.0000056021.24630.A6; Eppinger R., 2000, SUPPLEMENT DEV IMPRO; Funk JR, 2012, ACCIDENT ANAL PREV, V45, P67, DOI 10.1016/j.aap.2011.11.009; Griffin R, 2012, J TRAUMA ACUTE CARE, V73, P914, DOI 10.1097/TA.0b013e31825a7636; Huber C D, 2005, Traffic Inj Prev, V6, P170, DOI 10.1080/15389580590931644; Kahane C, 2000, 809199 NHTSA DOT HS; Levine DN, 1971, UNCHSRC71112; Mallory Ann, 2010, Ann Adv Automot Med, V54, P51; Mattos GA, 2013, TRAFFIC INJ PREV, V14, P360, DOI 10.1080/15389588.2012.722735; McCartt Anne T, 2007, Traffic Inj Prev, V8, P162, DOI 10.1080/15389580601173875; McGwin G, 2003, J TRAUMA, V55, P430, DOI 10.1097/01.TA.0000083478.98648.C8; Pal C, 2014, ACCIDENT ANAL PREV, V72, P193, DOI 10.1016/j.aap.2014.06.020; Parenteau CS, 2014, TRAFFIC INJ PREV, V15, P694, DOI 10.1080/15389588.2013.867434; Pintar F A, 2000, Annu Proc Assoc Adv Automot Med, V44, P149; Sunnevang C, 2009, TRAFFIC INJ PREV, V10, P194, DOI 10.1080/15389580802594127; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Talmor D, 2006, ACCIDENT ANAL PREV, V38, P767, DOI 10.1016/j.aap.2006.01.008; Viano DC, 2010, TRAFFIC INJ PREV, V11, P382, DOI 10.1080/15389581003751623; Yoganandan Narayan, 2011, Ann Adv Automot Med, V55, P267	21	9	9	0	19	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	NOV 17	2015	16	8					747	753		10.1080/15389588.2015.1013188			7	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	CR7LU	WOS:000361532200001	25664958	Green Submitted			2022-02-06	
J	Butz, RC; Knowles, BM; Newman, JA; Dennison, CR				Butz, Robert C.; Knowles, Brooklynn M.; Newman, James A.; Dennison, Christopher R.			Effects of external helmet accessories on biomechanical measures of head injury risk: An ATD study using the HYBRIDIII headform	JOURNAL OF BIOMECHANICS			English	Article						Biomechanics; Head; Brain; Helmet; Injury prevention	ANGULAR ACCELERATION; IMPACT PERFORMANCE; BRAIN RESPONSES; SKULL FRACTURE; CONCUSSION; MODEL	Competitive cycling is a popular activity in North America for which injuries to the head account for the majority of hospitalizations and fatalities. In cycling, use of helmet accessories (e.g. cameras) has become widespread. As a consequence, standards organizations and the popular media are discussing the role these accessories could play in altering helmet efficacy and head injury risk. We conducted impacts to a helmeted anthropomorphic headform, with and without camera accessories, at speeds of 4 m/s and 6 m/s, and measured head accelerations, forces on the head-form skull, and used the Simulated Injury Monitor to estimate brain tissue strain. The presence of the camera reduced peak linear head acceleration (51% - 4 m/s impacts, 61% - 6 m/s, p < 0.05). Skull fracture risk based on kinematics was always less than 1%. For 4 m/s impacts, peak angular accelerations were lower (47%, p < 0.05), as were peak angular velocities (14%) with the velocity effect approaching significance (p=0.06), with the camera accessory. For 6 m/s impacts, accelerations were on average higher (5%, p > 0.05) as were velocities (77%, p < 0.05). Skull forces were never greater than 443.2 N, well below forces associated with fracture. Brain tissue strain, the cumulative strain damage measure at 25% (CSDM-25), was lower (56%, p < 0.05) in 4 m/s but higher (125%, p > 0.05) in 6 m/s impacts with the camera accessory. Based on CSDM-25 for 4 m/s tests, the risk of severe concussion was reduced (p < 0.05) from 25% (no camera) to 7% (camera). For 6 m/s tests, risks were on average increased (p > 0.05) from 18% (no camera) to 58% (camera). (C) 2015 Elsevier Ltd. All rights reserved.	[Butz, Robert C.; Knowles, Brooklynn M.; Dennison, Christopher R.] Univ Alberta, Biomed Instrumentat Lab, Edmonton, AB, Canada; [Butz, Robert C.; Knowles, Brooklynn M.; Newman, James A.; Dennison, Christopher R.] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada		Dennison, CR (corresponding author), Univ Alberta, Biomed Instrumentat Lab, Edmonton, AB, Canada.	cdenniso@ualberta.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [435921-2013, 458535-2014]; Pashby Sport Safety Fund [0022740]; Faculty of Engineering and Department of Mechanical Engineering at the University of Alberta [0019396]	We gratefully acknowledge funding from the Natural Sciences and Engineering Research Council of Canada (Discovery Grant (Grant ID:435921-2013) and Research Tools and Instruments Programs(Grant ID:458535-2014)), the Pashby Sport Safety Fund (ID:0022740), the Faculty of Engineering and Department of Mechanical Engineering at the University of Alberta(Fund: 0019396). The authors would also like to acknowledge the US National Highway Traffic Safety Administration (NHTSA), Dr Takhounts and Dr Eppinger for invention and ongoing development of the Simulated Injury Monitor.	[Anonymous], 2007, J211 SAE; [Anonymous], 2011, TRAUMA REGISTRIES CY; [Anonymous], 1998, SAFETY STANDARD BICY; [Anonymous], 2014, NHTSA TRAFFIC SAFETY; [Anonymous], 2012, NEISS DATA HIGHLIGHT; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Butz R.C., J LIGHTWAVE TECHNOLO, V33, P2831; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Delye H, 2007, J NEUROTRAUM, V24, P1576, DOI 10.1089/neu.2007.0283; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787, DOI DOI 10.1177/1753193412460139; Gennarelli T, 1971, P 15 STAPP CAR CRASH; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1987, P 31 STAPP CAR CRASH, P49; Gennarelli TA, 1972, P 16 STAPP CAR CRASH, P296; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holbourn AHS, 1943, LANCET, V2, P438; Hootman JM, 2007, J ATHL TRAINING, V42, P311; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Newman J. A, 2000, PROPOSED NEW BIOMECH; Newman J. A., 2002, ACCIDENTAL INJURY BI, P303; Ouckama R, 2012, P I MECH ENG P-J SPO, V226, P185, DOI 10.1177/1754337111435625; Ouckama R, 2011, J BIOMECH, V44, P904, DOI 10.1016/j.jbiomech.2010.11.035; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Takhounts EG, 2011, P 22 INT TECHN C ENH; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thompson D., 1999, COCHRANE DATABASE SY; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Williams A., 2014, M SCHUMACHER SKIING; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Yoganandan N, 2009, J TRAUMA, V66, P309, DOI 10.1097/TA.0b013e3181692104; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	37	9	9	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	NOV 5	2015	48	14					3816	3824		10.1016/j.jbiomech.2015.09.032			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CX9YZ	WOS:000366064000012	26477409				2022-02-06	
J	Gravel, J; Gouin, S; Chalut, D; Crevier, L; Decarie, JC; Elazhary, N; Masse, B				Gravel, Jocelyn; Gouin, Serge; Chalut, Dominic; Crevier, Louis; Decarie, Jean-Claude; Elazhary, Nicolas; Masse, Benoit			Derivation and validation of a clinical decision rule to identify young children with skull fracture following isolated head trauma	CANADIAN MEDICAL ASSOCIATION JOURNAL			English	Article							INJURED INFANTS; INTRACRANIAL INJURY; X-RAY; EMERGENCY; MANAGEMENT; RISK; COMPLICATIONS; PREDICTORS; HEMATOMAS; ALGORITHM	Background: There is no clear consensus regarding radiologic evaluation of head trauma in young children without traumatic brain injury. We conducted a study to develop and validate a clinical decision rule to identify skull fracture in young children with head trauma and no immediate need for head tomography. Methods: We performed a prospective cohort study in 3 tertiary care emergency departments in the province of Quebec. Participants were children less than 2 years old who had a head trauma and were not at high risk of clinically important traumatic brain injury (Glasgow Coma Scale score < 15, altered level of consciousness or palpable skull fracture). The primary outcome was skull fracture. For each participant, the treating physician completed a standardized report form after physical examination and before radiologic evaluation. The decision to order skull radiography was at the physician's discretion. The clinical decision rule was derived using recursive partitioning. Results: A total of 811 patients (49 with skull fracture) were recruited during the derivation phase. The 2 predictors identified through recursive partitioning were parietal or occipital swelling or hematoma and age less than 2 months. The rule had a sensitivity of 94% (95% confidence interval [CI] 83%-99%) and a specificity of 86% (95% CI 84%-89%) in the derivation phase. During the validation phase, 856 participants (44 with skull fracture) were recruited. The rule had a sensitivity of 89% and a specificity of 87% during this phase. Interpretation: The clinical decision rule developed in this study identified about 90% of skull fractures among young children with mild head trauma who had no immediate indication for head tomography. Use of the rule would have reduced the number of radiologic evaluations by about 60%.	[Gravel, Jocelyn; Gouin, Serge] Univ Montreal, Dept Pediat, Ctr Hosp Univ CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Crevier, Louis] Univ Montreal, Dept Chirurg, Ctr Hosp Univ CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Decarie, Jean-Claude] Univ Montreal, Dept Radiol, Ctr Hosp Univ CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Chalut, Dominic] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Elazhary, Nicolas] Univ Sherbrooke, CHU Sherbrooke, Hop Fleurimont, Dept Urgence, Sherbrooke, PQ J1K 2R1, Canada; [Masse, Benoit] Univ Montreal, Ctr Rech, CHU St Justine, Montreal, PQ, Canada		Gravel, J (corresponding author), Univ Montreal, Dept Pediat, Ctr Hosp Univ CHU St Justine, Montreal, PQ H3C 3J7, Canada.	graveljocelyn@hotmail.com		Gravel, Jocelyn/0000-0001-5901-4990	Fond de recherche du Quebec - Sante	The study was funded by a grant from the Fond de recherche du Quebec - Sante.	Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Bin SS, 2010, PEDIATR EMERG CARE, V26, P633, DOI 10.1097/PEC.0b013e3181ef0440; BOULIS ZF, 1978, BRIT J RADIOL, V51, P851, DOI 10.1259/0007-1285-51-611-851; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; Browning JG, 2005, EMERG MED J, V22, P33, DOI 10.1136/emj.2004.016196; Carriere B, 2014, CAN J EMERG MED, V16, P281, DOI 10.2310/8000.2013.131081; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CHAN KH, 1990, CHILD NERV SYST, V6, P27, DOI 10.1007/BF00262262; CIAMPI A, 1988, COMPUT METH PROG BIO, V26, P239, DOI 10.1016/0169-2607(88)90004-1; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Ersahin Y, 2000, NEUROSURG REV, V23, P139, DOI 10.1007/PL00011945; Ersahin Y, 1996, CHILD NERV SYST, V12, P323, DOI 10.1007/BF00301021; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Gupta SK, 1997, ACTA NEUROCHIR, V139, P928, DOI 10.1007/BF01411301; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEONIDAS JC, 1982, PEDIATRICS, V69, P139; Macgregor DM, 2005, EMERG MED J, V22, P541, DOI 10.1136/emj.2004.017160; MANN KS, 1986, CHILD NERV SYST, V2, P258; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pezzotta S, 1985, J Neurosurg Sci, V29, P129; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; RIVARA FP, 1984, DEV MED CHILD NEUROL, V26, P81; Sacchetti A, 2007, ACAD EMERG MED, V14, P41, DOI 10.1197/j.aem.2006.05.023; Sanford RA, 2010, J NEUROSURG-PEDIATR, V5, P213, DOI 10.3171/2009.9.PEDS09180; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Scottish Intercollegiate Guidelines Network, 2009, EARL MAN PAT HEAD IN; Shane SA, 1997, PEDIATR EMERG CARE, V13, P198, DOI 10.1097/00006565-199706000-00006; STEWART G, 1993, PEDIATR EMERG CARE, V9, P199, DOI 10.1097/00006565-199308000-00004; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; TAVERAS JM, 1953, J NEUROSURG, V10, P233, DOI 10.3171/jns.1953.10.3.0233; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306	42	9	9	0	1	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0820-3946	1488-2329		CAN MED ASSOC J	Can. Med. Assoc. J.	NOV 3	2015	187	16					1202	1208		10.1503/cmaj.150540			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3UI	WOS:000364191200001	26350911	gold, Green Published			2022-02-06	
J	Donlon, K; Jones, RT				Donlon, Katharine; Jones, Russell T.			Applying a traumatic stress approach to understanding PCS following pediatric mild TBI	CHILD NEUROPSYCHOLOGY			English	Article						Brain injury; Posttraumatic stress; Postconcussive; Children; Appraisals	PERSISTENT POSTTRAUMATIC-STRESS; POST-CONCUSSIVE SYMPTOMS; OF-THE-LITERATURE; BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; NEUROCOGNITIVE OUTCOMES; ACCIDENT SURVIVORS; HEAD-INJURY; CHILDREN; DISORDER	Pediatric traumatic brain injury is a significant public health concern affecting hundreds of thousands of children each year. The majority of children who sustain traumatic brain injuries are classified as having a mild traumatic brain injury, and a subset of these children go on to experience persistent physical, cognitive, and emotional symptoms. These symptoms, known as postconcussive symptoms, can endure for months and even years after injury. The outcomes of mild traumatic brain injury are variable and not well understood for a small percentage of children who experience persistent symptoms. The current article explores the potential influence of children's posttraumatic stress symptoms on persistent postconcussive symptoms. Despite the high incidence of posttraumatic stress symptoms after pediatric accidental injury, they have not yet been identified as an important factor for consideration in the understanding of pediatric postconcussive outcomes. The article will review the literature on posttraumatic stress and postconcussive symptoms after pediatric injury and consider neurobiological and cognitive factors to propose a model explaining a pathway through which posttraumatic stress reactions may serve as the mechanism for the expression and maintenance of postconcussive symptoms after mild traumatic brain injury. The clinical implications for the proposed relationship between posttraumatic stress symptoms and postconcussive symptoms are considered prior to the conclusion of the article, which acknowledges limitations in the current literature and provides suggestions for future research.	[Donlon, Katharine; Jones, Russell T.] Virginia Polytech Inst & State Univ, Dept Psychol, Blacksburg, VA 24061 USA		Donlon, K (corresponding author), Virginia Polytech Inst & State Univ, Dept Psychol, Blacksburg, VA 24061 USA.	kdonlon@vt.edu		Jones, Russell/0000-0003-4309-5356			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Anderson V., 2008, EXECUTIVE FUNCTIONS; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bay Esther H, 2009, Res Theory Nurs Pract, V23, P42; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2007, BEHAV RES THER, V45, P2502, DOI 10.1016/j.brat.2007.04.009; Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Coyne Imelda, 2006, J Child Health Care, V10, P326, DOI 10.1177/1367493506067884; Dalgleish T, 2005, BEHAV COGN PSYCHOTH, V33, P459, DOI 10.1017/S1352465805002389; Dalgleish T, 2001, PSYCHOL MED, V31, P541, DOI 10.1017/S0033291701003567; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; Drotar, 2006, TRAUMATOLOGY, V12, P148, DOI [DOI 10.1177/1534765606294562, 10.77/1534765606294562]; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 2003, BEHAV RES THER, V41, P1, DOI 10.1016/S0005-7967(01)00126-7; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fein JA, 2002, ARCH PEDIAT ADOL MED, V156, P836, DOI 10.1001/archpedi.156.8.836; Grogan S, 2011, J CHILD ADOL PS NURS, V24, P58, DOI 10.1111/j.1744-6171.2010.00266.x; Gulotta C S, 2000, Clin Child Fam Psychol Rev, V3, P25, DOI 10.1023/A:1009515402351; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Hensley L, 2008, J CLIN CHILD ADOLESC, V37, P542, DOI 10.1080/15374410802148186; Hildenbrand AK, 2011, J PEDIATR ONCOL NURS, V28, P344, DOI 10.1177/1043454211430823; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iselin G, 2010, J ANXIETY DISORD, V24, P774, DOI 10.1016/j.janxdis.2010.05.011; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; Kazak AE, 2006, J PEDIATR PSYCHOL, V31, P343, DOI 10.1093/jpepsy/jsj054; Kazak AE, 2005, J PEDIATR PSYCHOL, V30, P644, DOI 10.1093/jpepsy/jsi051; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kilic EZ, 2008, J PSYCHOSOM RES, V65, P81, DOI 10.1016/j.jpsychores.2008.02.013; Kimble M, 2012, J PSYCHIATR RES, V46, P849, DOI 10.1016/j.jpsychires.2012.03.023; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Kraus J. F., 1996, NEUROLOGY AND TRAUMA, V2, P3, DOI DOI 10.1055/s-2008-1041052; Landolt MA, 2003, J CHILD PSYCHOL PSYC, V44, P1199, DOI 10.1111/1469-7610.00201; Langeland W, 2008, NEUROSCI BIOBEHAV R, V32, P161, DOI 10.1016/j.neubiorev.2007.07.002; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meiser-Stedman R, 2007, J ABNORM CHILD PSYCH, V35, P191, DOI 10.1007/s10802-006-9068-1; Meiser-Stedman R, 2009, J ABNORM PSYCHOL, V118, P778, DOI 10.1037/a0016945; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; National Child Traumatic Stress Network, 2004, PED MED TRAUM STRESS; Nugent NR, 2007, J PEDIATR PSYCHOL, V32, P309, DOI 10.1093/jpepsy/jsl005; Nugent NR, 2006, J CHILD PSYCHOL PSYC, V47, P919, DOI 10.1111/j.1469-7610.2006.01648.x; Olff M, 2005, PSYCHONEUROENDOCRINO, V30, P974, DOI 10.1016/j.psyneuen.2005.04.009; Olff M, 2005, NEUROSCI BIOBEHAV R, V29, P457, DOI 10.1016/j.neubiorev.2004.12.006; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Ostrowski SA, 2007, J PEDIATR PSYCHOL, V32, P338, DOI 10.1093/jpepsy/jsl003; Pennington B.F., 1991, DIAGNOSING LEARNING; Peterson L, 1997, BEHAV RES THER, V35, P179, DOI 10.1016/S0005-7967(96)00100-3; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schacter D. L., 1997, DEBATES PSYCHOL, P63; Scheeringa MS, 2011, DEPRESS ANXIETY, V28, P770, DOI 10.1002/da.20736; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Smith D. P., 2010, POSTTRAUMATIC STRESS; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stallard P, 2007, J CHILD PSYCHOL PSYC, V48, P194, DOI 10.1111/j.1469-7610.2006.01692.x; Sturms LM, 2005, CLIN REHABIL, V19, P312, DOI 10.1191/0269215505cr867oa; Suendermann O, 2010, PSYCHOSOM MED, V72, P301, DOI 10.1097/PSY.0b013e3181d07db8; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; Verger K, 2000, BRAIN INJURY, V14, P495; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Ward-Begnoche W, 2007, J SPEC PEDIATR NURS, V12, P84, DOI 10.1111/j.1744-6155.2007.00097.x; Werba BE, 2009, J PEDIATR PSYCHOL, V34, P27, DOI 10.1093/jpepsy/jsn050; Winston FK, 2003, JAMA-J AM MED ASSOC, V290, P643, DOI 10.1001/jama.290.5.643; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	99	9	9	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	NOV 2	2015	21	6					803	822		10.1080/09297049.2014.944491			20	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CQ5AE	WOS:000360614900006	25103672				2022-02-06	
J	Anderson, KM; Welsh, CJ; Young, C; Levine, GJ; Kerwin, SC; Boudreau, CE; Reyes, I; Mondragon, A; Griffin, JF; Cohen, ND; Levine, JM				Anderson, Kimberly M.; Welsh, C. Jane; Young, Colin; Levine, Gwendolyn J.; Kerwin, Sharon C.; Boudreau, C. Elizabeth; Reyes, Ismael; Mondragon, Armando; Griffin, John F.; Cohen, Noah D.; Levine, Jonathan M.			Acute Phase Proteins in Cerebrospinal Fluid from Dogs with Naturally-Occurring Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; canine; neurotrauma; secondary injury	C-REACTIVE PROTEIN; TRAUMATIC BRAIN-INJURY; RESPONSIVE MENINGITIS-ARTERITIS; MULTIPLE-SCLEROSIS; NEUROMYELITIS-OPTICA; ALZHEIMERS-DISEASE; HAPTOGLOBIN LEVEL; IMMUNE-RESPONSE; DISK HERNIATION; SERUM	Spinal cord injury (SCI) affects thousands of people each year and there are no treatments that dramatically improve clinical outcome. Canine intervertebral disc herniation is a naturally-occurring SCI that has similarities to human injury and can be used as a translational model for evaluating therapeutic interventions. Here, we characterized cerebrospinal fluid (CSF) acute phase proteins (APPs) that have altered expression across a spectrum of neurological disorders, using this canine model system. The concentrations of C-reactive protein (CRP), haptoglobin (Hp), alpha-1-glycoprotein, and serum amyloid A were determined in the CSF of 42 acutely injured dogs, compared with 21 healthy control dogs. Concentrations of APPs also were examined with respect to initial injury severity and motor outcome 42 d post-injury. Hp concentration was significantly higher (p < 0.0001) in the CSF of affected dogs, compared with healthy control dogs. Additionally, the concentrations of CRP and Hp were significantly (p = 0.0001 and p = 0.0079, respectively) and positively associated with CSF total protein concentration. The concentrations of CRP and Hp were significantly higher (p = 0.0071 and p = 0.0197, respectively) in dogs with severe injury, compared with those with mild-to-moderate SCI, but there was no significant correlation between assessed CSF APP concentrations and 42 d motor outcome. This study demonstrated that CSF APPs were dysregulated in dogs with naturally-occurring SCI and could be used as markers for SCI severity. As Hp was increased following severe SCI and is neuroprotective across a number of model systems, it may represent a viable therapeutic target.	[Anderson, Kimberly M.; Kerwin, Sharon C.; Boudreau, C. Elizabeth; Levine, Jonathan M.] Texas A&M Univ, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [Welsh, C. Jane; Young, Colin; Reyes, Ismael; Mondragon, Armando] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Griffin, John F.; Cohen, Noah D.] Texas A&M Univ, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Levine, Gwendolyn J.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA		Levine, JM (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA.	jlevine@cvm.tamu.edu			Helen McWhorter Chair in Small Animal Clinical Sciences	The authors wish to thank Elizabeth Scanlin and Alisha Selix for their assistance in data collection and sample archiving. Funding for completion of this study was provided by the Helen McWhorter Chair in Small Animal Clinical Sciences.	BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Bathen-Noethen A, 2008, J VET INTERN MED, V22, P1149, DOI 10.1111/j.1939-1676.2008.0164.x; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Boekhoff TMA, 2012, J NEUROTRAUM, V29, P1000, DOI 10.1089/neu.2011.1821; Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x; Chang KH, 2007, PROTEOM CLIN APPL, V1, P467, DOI 10.1002/prca.200600949; Chang KH, 2013, CLIN CHIM ACTA, V417, P26, DOI 10.1016/j.cca.2012.12.008; Cioffi Michele, 2015, World J Gastrointest Pathophysiol, V6, P13, DOI 10.4291/wjgp.v6.i1.13; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; de la Fuente C, 2012, J VET INTERN MED, V26, P1365, DOI 10.1111/j.1939-1676.2012.00991.x; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Gensel J. C., 2015, BRAIN RES; Gibson AE, 2008, SPINAL CORD, V46, P616, DOI 10.1038/sc.2008.32; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Jung SM, 2008, NEUROSCI LETT, V436, P153, DOI 10.1016/j.neulet.2008.03.010; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176, DOI 10.1097/01.wcb.0000037989.07114.d1; Levine GJ, 2014, VET CLIN PATH, V43, P437, DOI 10.1111/vcp.12165; Levine GJ, 2009, PREV VET MED, V89, P121, DOI 10.1016/j.prevetmed.2009.02.016; Levine JM, 2006, AM J VET RES, V67, P283, DOI 10.2460/ajvr.67.2.283; Levine JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096408; Levine JM, 2011, J NEUROTRAUM, V28, P675, DOI 10.1089/neu.2010.1645; Lowrie M, 2009, J VET INTERN MED, V23, P862, DOI 10.1111/j.1939-1676.2009.0337.x; Lowrie M, 2009, VET J, V182, P125, DOI 10.1016/j.tvjl.2008.05.001; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Morse LR, 2008, ARCH PHYS MED REHAB, V89, P726, DOI 10.1016/j.apmr.2007.09.046; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; O'Connor E, 2004, ANAESTH INTENS CARE, V32, P465, DOI 10.1177/0310057X0403200402; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Shih AWY, 2014, AM J HEMATOL, V89, P443, DOI 10.1002/ajh.23623; Spitzbarth I, 2011, J NEUROPATH EXP NEUR, V70, P703, DOI 10.1097/NEN.0b013e3182270f8e; Taylor AR, 2014, J NEUROTRAUM, V31, P1561, DOI 10.1089/neu.2014.3405; The National SCI Statistical Center, 2014, SPIN CORD INJ SCI FA; Wang HH, 2013, MULT SCLER J, V19, P926, DOI 10.1177/1352458512457845; Watterson C, 2009, TOXICOL PATHOL, V37, P28, DOI 10.1177/0192623308329286; Yang SG, 2013, J NEUROSCI RES, V91, P230, DOI 10.1002/jnr.23159; Yarchoan M, 2013, J NEUROL SCI, V333, P9, DOI 10.1016/j.jns.2013.05.028; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009	47	9	9	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2015	32	21					1658	1665		10.1089/neu.2015.3895			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CU9TT	WOS:000363889000003	26186466	Green Published			2022-02-06	
J	Bradford, LS				Bradford, Lonnie S.			Misconceptions About Traumatic Brain Injury Among US Army Behavioral Health Professionals	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; military; concussion; misconceptions	MILD HEAD-INJURY; NEUROPSYCHOLOGICAL OUTCOMES; POSTCONCUSSIVE SYMPTOMS; COMMON MISCONCEPTIONS; COGNITIVE SEQUELAE; CONCUSSION; BLAST; KNOWLEDGE; RECOVERY; IMPACT	Purpose/Objective: To investigate the knowledge and misconceptions about traumatic brain injury (TBI) held by behavioral health care professionals providing services to an active-duty military population. Research Method/Design: Active duty U.S. Army psychologists, psychiatrists, social workers, and psychiatric nurses from locations across the Department of Defense, and behavioral health professionals from a major military hospital (N = 181) were surveyed on 19 common myths and misconceptions about TBI (Gouvier, Prestholdt, & Warner, 1988). Eight new items were added to the survey to more specifically assess misconceptions pertaining to mild TBI (mTBI). Results: Mean percentages for the subcomponents of the questionnaire suggested that responses were generally accurate for general information about brain damage (83.61% correct) but less accurate for unconsciousness (45.81%), amnesia or memory loss (53%), and recovery items (64.8%). The total percent correct was 51% on the new mTBI items with a sizable minority of the sample viewing mTBI as being associated with lengthier recovery and poorer outcome than what has been indicated by recent research. Conclusion/Implications: Overall, misconceptions, particularly about mTBI, are prevalent among U.S. Army behavioral health providers. These findings raise concern about the dissemination of TBI information to health care professionals in the U.S. Army and to military personnel who may not be receiving accurate information about TBI recovery.	[Bradford, Lonnie S.] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA		Bradford, LS (corresponding author), Brooke Army Med Ctr, MCHE DBM, Neuropsychol Serv, 3551 Roger Brooke Dr,Bldg 3600, Ft Sam Houston, TX 78234 USA.	lonnie.bradford@us.army.mil					Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Defense and Veterans Brain Injury Center, 2013, TBI 201 DEF VET BRAI; Department of the Army, 2011, 4211 HQDA EXORD; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Evans K., 2009, CONT ISSUES COMMUNIC, V25, P166; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Langlois J., 2012, INJURY RES THEORIES, P61; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	40	9	9	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2015	60	4					344	352		10.1037/rep0000057			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	CX4YL	WOS:000365706800005	26436992				2022-02-06	
J	Fahlenkamp, AV; Rossaint, R; Coburn, M				Fahlenkamp, A. V.; Rossaint, R.; Coburn, M.			Neuroprotection by noble gases. New developments and insights	ANAESTHESIST			German	Article						Neuroprotective agents; Inflammation; Neuron; Neuroglia; Apoptosis	TRAUMATIC BRAIN-INJURY; REDUCES NEUROHISTOPATHOLOGICAL DAMAGE; ISCHEMIA-REPERFUSION INJURY; IN-VITRO MODEL; CARDIAC-ARREST; NEONATAL ASPHYXIA; THERAPEUTIC HYPOTHERMIA; XENON NEUROPROTECTION; CEREBRAL-ISCHEMIA; CORTICAL-NEURONS	Noble gases are chemically inert elements, some of which exert biological activity. Experimental neuroprotection in particular has been widely shown for xenon, argon and helium. The underlying mechanisms of action are not yet fully understood. Besides an interference with neuronal ion-gated channels and cellular signaling pathways as well as anti-apoptotic effects, the modulation of neuroinflammation seems to play a crucial role. This review presents the current knowledge on neuroprotection by noble gases with a focus on interactions with the neuronal-glial network and neuroinflammation and the perspectives on clinical applications.	[Fahlenkamp, A. V.; Rossaint, R.; Coburn, M.] Univ Klinikum Aachen, RWTH, Anasthesiol Klin, D-52074 Aachen, Germany		Fahlenkamp, AV (corresponding author), Univ Klinikum Aachen, RWTH, Anasthesiol Klin, Pauwelsstr 30, D-52074 Aachen, Germany.	afahlenkamp@ukaachen.de		Coburn, Mark/0000-0002-7930-0270			Arola OJ, 2013, CRIT CARE MED, V41, P2116, DOI 10.1097/CCM.0b013e31828a4337; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Bantel C, 2009, ANESTHESIOLOGY, V110, P986, DOI 10.1097/ALN.0b013e31819dadc7; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Brucken A, 2014, RESUSCITATION, V85, P826, DOI 10.1016/j.resuscitation.2014.02.014; Cattano D, 2008, NEUROSCI LETT, V440, P217, DOI 10.1016/j.neulet.2008.05.086; Chakkarapani E, 2010, ANN NEUROL, V68, P330, DOI 10.1002/ana.22016; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Coburn M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-180; David HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030934; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Dinse A, 2005, BRIT J ANAESTH, V94, P479, DOI 10.1093/bja/aei080; Fahlenkamp AV, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-11; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Fahlenkamp AV, 2011, J MOL NEUROSCI, V45, P48, DOI 10.1007/s12031-010-9432-z; Faulkner S, 2011, ANN NEUROL, V70, P133, DOI 10.1002/ana.22387; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Fries M, 2008, CRIT CARE MED, V36, P2420, DOI 10.1097/CCM.0b013e3181802874; Fries M, 2012, CRIT CARE MED, V40, P1297, DOI 10.1097/CCM.0b013e31823c8ce7; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hobbs C, 2008, STROKE, V39, P1307, DOI 10.1161/STROKEAHA.107.499822; Hoellig A, 2014, INT J MOL SCI, V15, P18175, DOI 10.3390/ijms151018175; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Koblin DD, 1998, ANESTH ANALG, V87, P419, DOI 10.1097/00000539-199808000-00035; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liu Y, 2011, BRAIN RES, V1376, P122, DOI 10.1016/j.brainres.2010.12.068; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Natale G, 2006, ANN NY ACAD SCI, V1074, P650, DOI 10.1196/annals.1369.063; Pan Y, 2007, EXP NEUROL, V205, P587, DOI 10.1016/j.expneurol.2007.03.023; Pan Y, 2011, NEUROSCI LETT, V497, P144, DOI 10.1016/j.neulet.2011.04.048; Petzelt C, 2003, LIFE SCI, V72, P1909, DOI 10.1016/S0024-3205(02)02439-6; Ristagno G, 2014, SHOCK, V41, P72, DOI 10.1097/SHK.0000000000000049; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Sabir H, 2013, ANESTHESIOLOGY, V119, P345, DOI 10.1097/ALN.0b013e318294934d; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; Ulbrich F, 2015, J NEUROCHEM, V134, P717, DOI 10.1111/jnc.13115; Ulbrich F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115984; Yang YW, 2014, BRIT J ANAESTH, V113, P168, DOI 10.1093/bja/aet352; Yang YW, 2012, ACTA ANAESTH SCAND, V56, P1325, DOI 10.1111/j.1399-6576.2012.02718.x; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	50	9	9	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	NOV	2015	64	11					855	858		10.1007/s00101-015-0079-6			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	CW4PC	WOS:000364972600007	26329914				2022-02-06	
J	Schmidt, JD; Guskiewicz, KM; Mihalik, JP; Blackburn, JT; Siegmund, GP; Marshall, SW				Schmidt, Julianne D.; Guskiewicz, Kevin M.; Mihalik, Jason P.; Blackburn, J. Troy; Siegmund, Gunter P.; Marshall, Stephen W.			Does Visual Performance Influence Head Impact Severity Among High School Football Athletes?	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mild traumatic brain injury; concussion; head impact biomechanics; sport vision; head protection	TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; COLLEGIATE; EPIDEMIOLOGY; BIOMECHANICS; CONCUSSION; PLAYERS; SYSTEM; ANTICIPATION; SKILLS	Objective: To compare the odds of sustaining moderate and severe head impacts, rather than mild, between high school football players with high and low visual performance. Design: Prospective quasi-experimental. Setting: Clinical Research Center/On-field. Participants: Thirty-seven high school varsity football players. Interventions: Athletes completed the Nike SPARQ Sensory Station visual assessment before the season. Head impact biomechanics were captured at all practices and games using the Head Impact Telemetry System. Main Outcome Measures: Each player was classified as either a high or low performer using a median split for each of the following visual performance measures: visual clarity, contrast sensitivity, depth perception, near-far quickness, target capture, perception span, eye-hand coordination, go/no go, and reaction time. We computed the odds of sustaining moderate and severe head impacts against the reference odds of sustaining mild head impacts across groups of high and low performers for each of the visual performance measures. Results: Players with better near-far quickness had increased odds of sustaining moderate [odds ratios (ORs), 1.27; 95% confidence intervals (CIs), 1.04-1.56] and severe head impacts (OR, 1.45; 95% CI, 1.05-2.01) as measured by Head Impact Technology severity profile. High and low performers were at equal odds on all other measures. Conclusions: Better visual performance did not reduce the odds of sustaining higher magnitude head impacts. Visual performance may play less of a role than expected for protecting against higher magnitude head impacts among high school football players. Further research is needed to determine whether visual performance influences concussion risk.	[Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30606 USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.; Blackburn, J. Troy] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Blackburn, J. Troy] Univ N Carolina, Neuromuscular Res Lab, Chapel Hill, NC USA; [Siegmund, Gunter P.] MEA Forens Engineer & Scientists, Richmond, BC, Canada; [Siegmund, Gunter P.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Guskiewicz, Kevin M.; Mihalik, Jason P.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30606 USA.	schmidtj@uga.edu	Siegmund, Gunter P/B-7003-2013	Guskiewicz, Kevin/0000-0002-8682-2130; Marshall, Stephen/0000-0002-2664-9233; Siegmund, Gunter/0000-0003-2387-941X; Mihalik, Jason/0000-0001-6085-8322			Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Canal-Bruland R, 2011, RES Q EXERCISE SPORT, V82, P667, DOI 10.1080/02701367.2011.10599803; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chu YC, 2012, MIL MED, V177, P41, DOI 10.7205/MILMED-D-11-00134; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Erickson GB, 2011, OPTOMETRY, V82, P528, DOI 10.1016/j.optm.2011.01.012; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Higuchi T, 2011, HUM MOVEMENT SCI, V30, P534, DOI 10.1016/j.humov.2010.08.003; Hitzeman S A, 1993, Optom Clin, V3, P145; Ida H, 2011, PERCEPTION, V40, P1221, DOI 10.1068/p7041; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Killebrew SS, 2013, J STRENGTH COND RES, V27, P495, DOI 10.1519/JSC.0b013e3182577091; King D, 2012, RES SPORTS MED, V20, P86, DOI 10.1080/15438627.2012.660824; Laby DM, 1996, AM J OPHTHALMOL, V122, P476, DOI 10.1016/S0002-9394(14)72106-3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maxwell J, 2012, VISION RES, V62, P93, DOI 10.1016/j.visres.2012.03.013; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Metoyer R, 2008, IEEE T VIS COMPUT GR, V14, P173, DOI 10.1109/TVCG.2007.70427; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Roca A, 2013, J SPORT EXERCISE PSY, V35, P144, DOI 10.1123/jsep.35.2.144; Roca A, 2011, COGN PROCESS, V12, P301, DOI 10.1007/s10339-011-0392-1; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; STINE CD, 1982, J AM OPTOM ASSOC, V53, P627; Uchida Y, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/JOURNAL.PONE.0031530; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zimmerman AB, 2011, EYE CONTACT LENS, V37, P153, DOI 10.1097/ICL.0b013e31820d12f4	35	9	9	0	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2015	25	6					494	501		10.1097/JSM.0000000000000143			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	CV5KZ	WOS:000364310700006	25380282				2022-02-06	
J	Ponschab, M; Schochl, H; Keibl, C; Fischer, H; Redl, H; Schlimp, CJ				Ponschab, Martin; Schoechl, Herbert; Keibl, Claudia; Fischer, Henrik; Redl, Heinz; Schlimp, Christoph J.			Preferential effects of low volume versus high volume replacement with crystalloid fluid in a hemorrhagic shock model in pigs	BMC ANESTHESIOLOGY			English	Article						Crystalloid fluid; Fluid resuscitation; Haemorrhage; Thromboelastometry; Experimental pig model	TRAUMATIC BRAIN-INJURY; HYPERCHLOREMIC ACIDOSIS; BLOOD-PRESSURE; RESUSCITATION; COAGULOPATHY; PLASMA; MANAGEMENT; COAGULATION; SALINE; TIME	Background: Fluid resuscitation is a core stone of hemorrhagic shock therapy, and crystalloid fluids seem to be associated with lower mortality compared to colloids. However, as redistribution starts within minutes, it has been suggested to replace blood loss with a minimum of a three-fold amount of crystalloids. The hypothesis was that in comparison to high volume (HV), a lower crystalloid volume (LV) achieves a favorable coagulation profile and exerts sufficient haemodynamics in the acute phase of resuscitation. Methods: In 24 anaesthetized pigs, controlled arterial blood loss of 50 % of the estimated blood volume was either (n = 12) replaced with a LV (one-fold) or a HV (three-fold) volume of a balanced, acetated crystalloid solution at room temperature. Hemodynamic parameters, dilution effects and coagulation profile by standard coagulation tests and thromboelastometry at baseline and after resuscitation were determined in both groups. Results: LV resuscitation increased MAP significantly less compared to the HV, 61 +/- 7 vs. 82 +/- 14 mmHg (p < 0.001) respectively, with no difference between lactate and base excess between groups. Haematocrit after fluid replacement was 0.20 vs. 0.16 (LV vs. HV, p < 0.001), suggesting a grade of blood dilution of 32 vs. 42 % (p < 0.001) compared to baseline values. Compared to LV, HV resulted in decreased core temperature (37.5 +/- 0.2 vs. 36.0 +/- 0.6 degrees C, p < 0.001), lower platelet count (318 +/- 77 vs. 231 +/- 53 K/mu L, p < 0.01) and lower plasma fibrinogen levels (205 +/- 19 vs. 168 +/- 24 mg/dL, p < 0.001). Thromboelastometric measurements showed a significant impairment on viscoelastic clot properties following HV group. While prothrombin time index decreased significantly more in the HV group, activated partial thromboplastin time did not differ between both groups. HV did not result in hyperchloraemic acidosis. Discussion: Coagulation parameters represented by plasma fibrinogen and ROTEM parameters were also less impaired with LV. With regrad to hematocrit, 60 % of LV remained intracascular, while in HV only 30 % remained in circulation within the first hour of administration. In the acute setting of 50 % controlled blood loss, a one fold LV crystalloid replacement strategy is sufficient to adequately raise blood pressure up to a mean arterial pressure >50 mm Hg. The concept of damage control resuscitation (DCR) with permissive hypotension may be better met by using LV as compared to a three fold HV resuscitation strategy. Conclusion: High volume administration of an acetated balanced crystalloid does not lead to hyperchloraemic acidosis, but may negatively influence clinical parameters, such as higher blood pressure, lower body temperature and impaired coagulation parameters, which could potentially increase bleeding after trauma. Replacement of acute blood loss with just an equal amount of an acetated balanced crystalloid appears to be the preferential treatment strategy in the acute phase after controlled bleeding.	[Ponschab, Martin; Schoechl, Herbert; Keibl, Claudia; Redl, Heinz; Schlimp, Christoph J.] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria; [Ponschab, Martin] AUVA Trauma Hosp, Dept Anaesthesiol & Intens Care, Linz, Austria; [Schoechl, Herbert] AUVA Trauma Ctr, Dept Anaesthesiol & Intens Care, Salzburg, Austria; [Fischer, Henrik] Fed Minist Interior, Dept I 10, Vienna, Austria; [Schlimp, Christoph J.] AUVA Trauma Hosp, Dept Anaesthesiol & Intens Care, Klagenfurt, Austria		Ponschab, M (corresponding author), AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria.	martin.ponschab@auva.at	Redl, Heinz/AAD-8157-2019		Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna	Departmental funding was provided by the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna.	Aleman MM, 2011, J THROMB HAEMOST, V9, P2251, DOI 10.1111/j.1538-7836.2011.04488.x; American College of Surgeons Committee on Trauma, 2012, ATLS STUD MAN; Brauer KI, 2002, ANESTHESIOLOGY, V96, P442, DOI 10.1097/00000542-200202000-00033; Chambers LA, 2011, AM J CLIN PATHOL, V136, P364, DOI 10.1309/AJCPH16YXJEFSHEO; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Davis JS, 2014, AM SURGEON, V80, P301; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; Drummond JC, 2005, ANESTH ANALG, V100, P645, DOI 10.1213/01.ANE.0000144069.36647.3D; Duan KP, 2014, TRANSFUS APHER SCI, V50, P399, DOI 10.1016/j.transci.2014.03.008; Dunser MW, 2013, CRIT CARE, V17, DOI 10.1186/cc12727; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; European Resuscitation Council, 2010, EUR TRAUM COURS COUR; Gries A, 2008, ANAESTHESIST, V57, P562, DOI 10.1007/s00101-008-1373-3; Guidet B, 2010, CRIT CARE, V14, DOI 10.1186/cc9230; Hagemo JS, 2014, CRIT CARE, V18, DOI 10.1186/cc13798; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Jacob M, 2012, CRIT CARE, V16, DOI 10.1186/cc11344; Kermode JC, 1999, BLOOD, V94, P199, DOI 10.1182/blood.V94.1.199.413k14_199_207; Khan S, 2015, INTENS CARE MED, V41, P239, DOI 10.1007/s00134-014-3584-1; Kozek-Langenecker SA, 2013, EUR J ANAESTH, V30, P270, DOI 10.1097/EJA.0b013e32835f4d5b; Liumbruno GM, 2011, BLOOD TRANSFUS-ITALY, V9, P189, DOI 10.2450/2011.0075-10; McIlroy DR, 2003, ANESTH ANALG, V96, P1572, DOI [10.1213/01.ANE.0000061460.59320B0, 10.1213/01.ANE.0000061460.59320.B0]; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Moore HB, 2015, SHOCK, V43, P39, DOI 10.1097/SHK.0000000000000245; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Perel P, 2012, COCHRANE DB SYST REV, V6; Ponschab M, 2015, ANAESTHESIA, V70, P528, DOI 10.1111/anae.13067; Rehm M, 2003, ANESTH ANALG, V96, P1201, DOI 10.1213/01.ANE.0000048824.85279.41; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; Rowland MR, 2014, SURGERY, V156, P861, DOI 10.1016/j.surg.2014.06.019; Ruttmann TG, 2001, ANAESTH INTENS CARE, V29, P489, DOI 10.1177/0310057X0102900507; Schlimp CJ, 2013, ANESTH ANALG, V117, P23, DOI 10.1213/ANE.0b013e3182937b91; Schlimp CJ, 2013, BLOOD TRANSFUS-ITALY, V11, P510, DOI 10.2450/2012.0171-12; Schochl H, 2013, J CARDIOTHOR VASC AN, V27, pS35, DOI 10.1053/j.jvca.2013.05.015; Sillesen M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0046-2; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Story DA, 2006, ANESTH ANALG, V103, P144, DOI 10.1213/01.ane.0000221449.67354.52; Weiss G, 2010, BRIT J ANAESTH, V105, P429, DOI 10.1093/bja/aeq199; White NJ, 2010, RESUSCITATION, V81, P111, DOI 10.1016/j.resuscitation.2009.09.017; Young JB, 2014, ANN SURG, V259, P255, DOI 10.1097/SLA.0b013e318295feba	43	9	11	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	OCT 16	2015	15								133	10.1186/s12871-015-0114-9			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	CT9CN	WOS:000363113700002	26445090	Green Published, gold			2022-02-06	
J	Vanderploeg, RD; Nazem, S; Brenner, LA; Belanger, HG; Donnell, AJ; Scott, SG				Vanderploeg, Rodney D.; Nazem, Sarra; Brenner, Lisa A.; Belanger, Heather G.; Donnell, Alison J.; Scott, Steven G.			Suicidal Ideation among Florida National Guard Members: Combat Deployment and Non-Deployment Risk and Protective Factors	ARCHIVES OF SUICIDE RESEARCH			English	Article						blast injury; deployment; mental disorders; military personnel; PTSD; suicidal ideation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; FUNCTIONAL IMPAIRMENT; SOCIAL SUPPORT; UNITED-STATES; US ARMY; SOLDIERS; VETERANS; PREVALENCE	This study examined relationships among risk/protective factors and suicidal ideation (SI) in deployed and non-deployed National Guard members, particularly examining for possible differential effects of deployment on SI. A total of 3,098 Florida National Guard members completed an anonymous online survey that assessed variables associated with SI including demographics, current psychiatric diagnoses, and pre-, during, and post-deployment experiences. Those deployed had significantly higher rates of SI (5.5%) than those not deployed (3.0%; p<.001). In multivariate analyses, among those not deployed, SI was significantly associated with major depressive disorder (p<.001), posttraumatic stress disorder (PTSD) (p<.001), prior psychological trauma (p<.01), and heavy/hazardous alcohol consumption (p<.05). In contrast, in the deployed, only PTSD (p<.001) and deployment-related mild traumatic brain injury (p<.05) were independently associated with SI. Risk and protective factors differed by deployment status in National Guard members suggesting the possible need for cohort-specific treatment targets to minimize SI.	[Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley Vet Hosp, Ctr Excellence Maximizing Rehabil Outcomes, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley Vet Hosp, Ctr Excellence Maximizing Rehabil Outcomes, Dept Hlth Serv Res & Dev HSR&D Rehabil Res & Dev, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.; Donnell, Alison J.; Scott, Steven G.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Nazem, Sarra; Brenner, Lisa A.] Vet Integrated Serv Network 19, Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Nazem, Sarra; Brenner, Lisa A.] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Phys Med & Rehabil, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA; [Donnell, Alison J.] James A Haley Vet Hosp, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Scott, Steven G.] James A Haley Vet Hosp, Ctr Excellence Maximizing Rehabil Outcomes, Phys Med & Rehabil Serv, Tampa, FL 33612 USA; [Scott, Steven G.] James A Haley Vet Hosp, Ctr Excellence Maximizing Rehabil Outcomes, Hlth Serv Res & Dev HSR&D Rehabil Res & Dev RR&D, Tampa, FL 33612 USA; [Scott, Steven G.] Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Mental Hlth & Behav Sci Psychol Serv 116B, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Rodney.Vanderploeg@va.gov	Brenner, Lisa A./AAG-2442-2019		Department of Veterans Affairs, Veterans Health Administration (VHA)US Department of Veterans Affairs; VA HSRD Grant [CCN 06-164]; James A. Haley Veterans' Hospital, and its HSR&D/RR&D Center of Excellence; VISN 19 Mental Illness Research Education and Clinical Center (MIRECC)	The research reported here was supported by the Department of Veterans Affairs, Veterans Health Administration (VHA) and by a VA HSR&D Grant CCN 06-164 to Steven G. Scott, D.O. Further support was provided by the James A. Haley Veterans' Hospital, and its HSR&D/RR&D Center of Excellence, as well as the VISN 19 Mental Illness Research Education and Clinical Center (MIRECC). The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Veterans Affairs or U.S. Government. No potential conflict of interest relevant to this article was reported.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bachynski KE, 2012, INJURY PREV, V18, P405, DOI 10.1136/injuryprev-2011-040112; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Black SA, 2011, MIL PSYCHOL, V23, P433, DOI 10.1080/08995605.2011.590409; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brenner L.A., 2008, J MENTAL HEALTH COUN, V30, P211, DOI [10.17744/mehc.30.3.n6418tm72231j606, DOI 10.17744/MEHC.30.3.N6418TM72231J606]; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, DEPRESS ANXIETY, V30, P55, DOI 10.1002/da.22002; Calabrese JR, 2011, J CLIN PSYCHIAT, V72, P1072, DOI 10.4088/JCP.11m06956; CDC, 2012, SUIC FACTS GLANC; Crosby Alex E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Deployment Health Clinical Center, 2010, POSTD HLTH ASS PDHA; Grant M., 1992, AUDIT ALCOHOL USE DI; Griffith J, 2012, MIL PSYCHOL, V24, P568, DOI 10.1080/08995605.2012.736324; Griffith J, 2012, MIL PSYCHOL, V24, P488, DOI 10.1080/08995605.2012.716269; Griffith J, 2010, APPL PREV PSYCHOL, V14, P86, DOI 10.1016/j.appsy.2011.11.003; Griffith J, 2012, SUICIDE LIFE-THREAT, V42, P453, DOI 10.1111/j.1943-278X.2012.00104.x; Griffith J, 2012, SUICIDE LIFE-THREAT, V42, P104, DOI 10.1111/j.1943-278X.2011.00075.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kehle SM, 2010, J TRAUMA STRESS, V23, P33, DOI 10.1002/jts.20480; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kessler RC, 2014, JAMA PSYCHIAT, V71, P504, DOI 10.1001/jamapsychiatry.2014.28; Kline A, 2011, J NERV MENT DIS, V199, P914, DOI 10.1097/NMD.0b013e3182392917; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; Moscicki EK, 1997, PSYCHIAT CLIN N AM, V20, P499, DOI 10.1016/S0193-953X(05)70327-0; MURPHY GE, 1992, ARCH GEN PSYCHIAT, V49, P459; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Pompili M, 2013, J NERV MENT DIS, V201, P802, DOI 10.1097/NMD.0b013e3182a21458; Riviere LA, 2011, BRIT J PSYCHIAT, V198, P136, DOI 10.1192/bjp.bp.110.084863; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Shea MT, 2010, J TRAUMA STRESS, V23, P100, DOI 10.1002/jts.20497; Sherman MD, 2005, PROF PSYCHOL-RES PR, V36, P626, DOI 10.1037/0735-7028.36.6.626; Smolenski D. J., 2013, DEP DEFENSE SUICIDE; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030	52	9	9	0	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1381-1118	1543-6136		ARCH SUICIDE RES	Arch. Suicide Res.	OCT 2	2015	19	4					453	471		10.1080/13811118.2014.957454			19	Psychiatry; Psychology; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	CX4QF	WOS:000365684700005	25517207				2022-02-06	
J	Dang, Q; Simon, J; Catino, J; Puente, I; Habib, F; Zucker, L; Bukur, M				Dang, Quoc; Simon, Joshua; Catino, Joe; Puente, Ivan; Habib, Fahim; Zucker, Lloyd; Bukur, Marko			More fateful than fruitful ? Intracranial pressure monitoring in elderly patients with traumatic brain injury is associated with worse outcomes	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Elderly; Intracranial pressure monitoring; Outcomes; Mortality	SEVERE HEAD-INJURY; INTENSIVE-CARE MANAGEMENT; INCREASED MORTALITY; HYPERVENTILATION; MIDAZOLAM; SURVIVAL; SEDATION; HYPOXIA; CENTERS; IMPACT	Background: In an expanding elderly population, traumatic brain injury (TBI) remains a significant cause of death and disability. Guidelines for management of TBI, according to the Brain Trauma Foundation (BTF), include intracranial pressure (ICP) monitoring. Whether ICP monitoring contributes to outcomes in the elderly patients with TBI has not been explored. Methods: This is a retrospective study extracted from the National Trauma Database 2007-2008 research datasets. Patients were included if aged >55 y and they met BTF indications for ICP monitoring. Patients that had nonsurvivable injuries (any body region, abbreviated injury score = 6), were dead on arrival, had withdrawal of care, or length of stay <48 h were excluded. Outcomes were then stratified based on ICP monitoring. The primary outcomes were inhospital mortality and favorable discharge. Logistic regression was used to analyze the effect of ICP monitoring on outcomes. Results: A total of 4437 patients were included with 11.2% having an ICP monitor placed. Patients requiring an ICP monitor were younger overall, more likely to present hypertensive, had higher injury severity, and more likely to require operative intervention. Median initial Glasgow coma scale (3) was similar between groups. Of those patients with ICP monitoring, overall mortality was significantly higher, and they were less likely to have favorable discharge status. Craniotomy itself was not associated with increased mortality (P = 0.450). Conclusions: Our findings suggest that the use of ICP monitoring according to BTF guidelines in elderly TBI patients does not provide outcomes superior to treatment without monitoring. The ideal group to benefit from ICP monitor placement remains to be elucidated. (C) 2015 Elsevier Inc. All rights reserved.	[Dang, Quoc; Simon, Joshua] Larkin Community Hosp, Dept Surg, South Miami, FL 33143 USA; [Dang, Quoc; Simon, Joshua; Catino, Joe; Puente, Ivan; Habib, Fahim; Zucker, Lloyd; Bukur, Marko] Delray Med Ctr, Div Trauma & Crit Care, Delray Beach, FL USA; [Catino, Joe; Puente, Ivan; Habib, Fahim; Bukur, Marko] Broward Gen Hosp, Div Trauma & Crit Care, Ft Lauderdale, FL USA		Dang, Q (corresponding author), Larkin Community Hosp, Dept Surg, 7000 SW 62nd Ave Suite 401, South Miami, FL 33143 USA.	dangq3@gmail.com		Catino, Joseph/0000-0002-6572-9316; Bukur, Marko/0000-0002-1850-7147			Akopian G, 2007, AM SURGEON, V73, P447; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Barmparas G, 2012, AM SURGEON, V78, P1166; BarrientosVega R, 1997, CRIT CARE MED, V25, P33, DOI 10.1097/00003246-199701000-00009; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Traumatic Foundation, 2007, GUID MAN TRAUM BRAIN; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BUXTON RL, 1970, LANCET, V2, P498; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Dings J, 1996, ZBL NEUROCHIR, V57, P177; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Ghajar J, 1995, New Horiz, V3, P395; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Karimi-Nejad A, 1970, J NEUROL NEUROSUR PS, V33, P714; Krbila S, 2013, BRATISL MED J, V114, P696, DOI 10.4149/BLL_2013_147; Krbila S, 2011, ANEST INTENZIV MED, V22, P272; Lane PL, 2000, CAN J SURG, V43, P442; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Ley EJ, 2011, AM SURGEON, V77, P1342; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NORTH B, 1986, NEUROSURGERY, V18, P730, DOI 10.1227/00006123-198606000-00009; Salim A, 2008, AM SURGEON, V74, P1088; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Shafer A, 1998, CRIT CARE MED, V26, P947, DOI 10.1097/00003246-199805000-00034; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; US Department of Health and Human Services, HLTH PEOPL 2010; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; Wilberger J, 2014, GERIATRIC TRAUMA CRI, P237	55	9	11	2	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2015	198	2					482	488		10.1016/j.jss.2015.03.092			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CQ6IM	WOS:000360708000035	25972315				2022-02-06	
J	Kofman, I; Abookasis, D				Kofman, Itamar; Abookasis, David			Dual-wavelength laser speckle imaging for monitoring brain metabolic and hemodynamic response to closed head traumatic brain injury in mice	JOURNAL OF BIOMEDICAL OPTICS			English	Article						closed head injury; laser speckle imaging; hemodynamics; cerebral blood flow; neuroprotective drug	CEREBRAL-BLOOD-FLOW; ARTERIOVENOUS OXYGEN DIFFERENCE; HYPERTONIC SALINE; CONTRAST; PATHOPHYSIOLOGY; ISCHEMIA; EXPOSURE; VOLUME; AUTOREGULATION; SPECTROSCOPY	The measurement of dynamic changes in brain hemodynamic and metabolism events following head trauma could be valuable for injury prognosis and for planning of optimal medical treatment. Specifically, variations in blood flow and oxygenation levels serve as important biomarkers of numerous pathophysiological processes. We employed the dual-wavelength laser speckle imaging (DW-LSI) technique for simultaneous monitoring of changes in brain hemodynamics and cerebral blood flow (CBF) at early stages of head trauma in a mouse model of intact head injury (n = 10). For induction of head injury, we used a weight-drop device involving a metal mass (similar to 50 g) striking the mouse's head in a regulated manner from a height of similar to 90 cm. In comparison to baseline measurements, noticeable dynamic variations were revealed immediately and up to 1 h postinjury, which indicate the severity of brain damage and highlight the ability of the DW-LSI arrangement to track brain pathophysiology induced by injury. To validate the monitoring of CBF by DW-LSI, measurements with laser Doppler flowmetry (LDF) were also performed (n = 5), which confirmed reduction in CBF following injury. A secondary focus of the study was to investigate the effectiveness of hypertonic saline as a neuroprotective agent, inhibiting the development of complications after brain injury in a subgroup of injured mice (n = 5), further demonstrating the ability of DW-LSI to monitor the effects upon brain dynamics of drug treatment. Overall, our findings further support the use of DW-LSI as a noninvasive, cost-effective tool to assess changes in hemodynamics under a variety of pathological conditions, suggesting its potential contribution to the biomedical field. To the best of our knowledge, this work is the first to make use of the DW-LSI modality in a small animal model to (1) investigate brain function during the critical first hour of closed head injury trauma, (2) correlate between injury parameters of LDF measurements, and (3) monitor brain hemodynamic and metabolic response to neuroprotective drug treatment. (C) 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Kofman, Itamar; Abookasis, David] Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel		Abookasis, D (corresponding author), Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel.	davida@ariel.ac.il					Abookasis D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.116007; Abookasis D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.045003; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Bale G, 2014, BIOMED OPT EXPRESS, V5, P3450, DOI 10.1364/BOE.5.003450; Berger S., 2005, TRANSFUS ALTERN TRAN, V6, P59; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Boas D.A., 2011, HDB BIOMEDICAL OPTIC; Boas DA, 2003, PHYS MED BIOL, V48, P2405, DOI 10.1088/0031-9155/48/15/311; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Bouma G J, 1995, New Horiz, V3, P384; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Briers D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.066018; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R., 1997, HEAD INJURY, P89; Busl KM, 2010, NEUROREHABILITATION, V26, P5, DOI 10.3233/NRE-2010-0531; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P249, DOI 10.1111/j.1399-6576.1978.tb01299.x; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Du CW, 2005, J CEREBR BLOOD F MET, V25, P1078, DOI 10.1038/sj.jcbfm.9600102; Dunn AK, 2005, NEUROIMAGE, V27, P279, DOI 10.1016/j.neuroimage.2005.04.024; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; Faul M, 2010, TRAUMATIC BRAIN INJU; FERCHER AF, 1981, OPT COMMUN, V37, P326, DOI 10.1016/0030-4018(81)90428-4; Feyen BFE, 2012, MINERVA ANESTESIOL, V78, P949; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Friess S. H., 2012, CRIT CARE RES PRACT, V2012, P1; Fujimoto J.G., 2009, BIOMEDICAL OPTICAL I; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950312; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lee SJ, 2009, J PHYSIOL-LONDON, V587, P2033, DOI 10.1113/jphysiol.2009.166983; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luo ZC, 2009, OPT LETT, V34, P1480, DOI 10.1364/OL.34.001480; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; Maikala RV, 2010, INT J IND ERGONOM, V40, P125, DOI 10.1016/j.ergon.2009.02.011; McIntosh TK, 1996, LAB INVEST, V74, P315; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Mortimer Diane Schretzman, 2006, J Neurosci Nurs, V38, P142; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1994, CAN J NEUROL SCI, V21, pS6, DOI 10.1017/S0084255900003685; MUTTAQIN Z, 1993, ACTA NEUROCHIR, V123, P76, DOI 10.1007/BF01476289; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Oliveira Carla Oliveira de, 2008, Rev Bras Ter Intensiva, V20, P411; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qin J, 2012, OPT LETT, V37, P4005, DOI 10.1364/OL.37.004005; Qiu JJ, 2013, OPT EXPRESS, V21, P28902, DOI 10.1364/OE.21.028902; Rice TB, 2013, BIOMED OPT EXPRESS, V4, P2880, DOI 10.1364/BOE.4.002880; Richardson J.T.E., 2002, CLIN NEUROPSYCHOLOGI, V2nd; Ringuette D, 2015, BIOMED OPT EXPRESS, V6, P266, DOI 10.1364/BOE.6.000266; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Rodnitzky R.L., 1982, ARCH NEUROL-CHICAGO, V39, P675; Singh A., 2013, J DENT MED SCI, V3, P75; Sviri G.E., 2010, J OPEN NEUROSURGERY, V3, P6; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Tichauer KM, 2009, J APPL PHYSIOL, V106, P1506, DOI 10.1152/japplphysiol.91156.2008; TSUDA Y, 1987, EUR NEUROL, V27, P155, DOI 10.1159/000116149; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Wang J, 2013, OPT LETT, V38, P3690, DOI 10.1364/OL.38.003690; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Winter JD, 2009, PEDIATR RES, V65, P181, DOI 10.1203/PDR.0b013e31818f06fb; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yuan S, 2005, APPL OPTICS, V44, P1823, DOI 10.1364/AO.44.001823; Yuan ZJ, 2011, NEUROIMAGE, V54, P1130, DOI 10.1016/j.neuroimage.2010.08.045; Zhang K, 2014, J CEREBR BLOOD F MET, V34, P1373, DOI 10.1038/jcbfm.2014.92; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	72	9	9	0	16	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	OCT	2015	20	10							106009	10.1117/1.JBO.20.10.106009			11	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CX9HW	WOS:000366017100030	26502232				2022-02-06	
J	Zhang, ZM; Yang, ZC; Zhang, ZR				Zhang, Zhi-Ming; Yang, Zicheng; Zhang, Zhiren			Distribution and characterization of tumor-associated macrophages/microglia in rat C6 glioma	ONCOLOGY LETTERS			English	Article						glioblastoma; microglia; macrophages; endothelial monocyte-activating polypeptide II; CD68; CD8	MONOCYTE CHEMOATTRACTANT PROTEIN-1; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; EMAP-II; MICROGLIA; CELLS; EXPRESSION; CD8; IMMUNOTHERAPY; INFILTRATION	Immunity responses and immunotherapy are novel areas of research for the pathological development and treatment of glioma, the most common brain cancer. Characterization of the subpopulations of infiltrated immune cells may aid in our understanding of the tumor immune response and contribute to the identification of cellular targets for selective immunotherapy. Using a rat C6 glioma model, the present study observed a significant heterogeneity of active macrophages and microglia, including cluster of differentiation 8 (CD8)(+), endothelial monocyte-activating polypeptide II (EMAPII)(+) and EDP cells, mostly in the areas of compact tumor growth and inside or around the pannecrosis. Moreover, the CD8(+) cells were similar to reactive ED1(+) and EMAPII(+) microglia/macrophages in morphology and distribution, but different from the W3/13(+) T cells. These observations suggest that different subtypes of macrophages and microglia are involved in glioma development and thus, may be potential targets for immunotherapeutic antitumor strategies.	[Zhang, Zhi-Ming] Shunde Polytech, Dept Med, Foshan 528300, Guangdong, Peoples R China; [Yang, Zicheng; Zhang, Zhiren] Third Mil Med Univ Peoples Liberat Army, Inst Immunol, Chongqing 400038, Peoples R China		Zhang, ZR (corresponding author), Third Mil Med Univ Peoples Liberat Army, Inst Immunol, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China.	zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835	National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170851]	The authors would like to thank Professor H. J. Schluesener for providing the C6 glioma rat brain tissue library and for assistance with immunostaining. This study was supported by the National Nature Science Foundation of China (grant no. 31170851).	ATKINSON LL, 1989, NEUROSURGERY, V25, P805, DOI 10.1227/00006123-198911000-00019; Badie B, 2001, MICROSC RES TECHNIQ, V54, P106, DOI 10.1002/jemt.1125; BALTUCH GH, 1994, NEUROSURGERY, V35, P450, DOI 10.1227/00006123-199409000-00013; Brabeck C, 2002, EXP NEUROL, V177, P341, DOI 10.1006/exnr.2002.7985; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Fang KM, 2011, J NEUROSCI RES, V89, P199, DOI 10.1002/jnr.22538; Glass R, 2014, ACTA NEUROPATHOL, V128, P347, DOI 10.1007/s00401-014-1274-2; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Gupta S, 2014, EXP GERONTOL, V54, P47, DOI 10.1016/j.exger.2013.12.009; Hirji N, 1998, J IMMUNOL, V160, P6004; Jackson CM, 2014, CLIN CANCER RES, V20, P3651, DOI 10.1158/1078-0432.CCR-13-2057; Jovcevska I, 2013, MOL CLIN ONCOL, V1, P935, DOI 10.3892/mco.2013.172; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lerch JK, 2014, SEMIN IMMUNOL, V26, P409, DOI 10.1016/j.smim.2014.03.004; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; Onore CE, 2014, BRAIN BEHAV IMMUN, V38, P220, DOI 10.1016/j.bbi.2014.02.007; Perrin G, 1999, INT IMMUNOL, V11, P1337, DOI 10.1093/intimm/11.8.1337; Platten M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0440-1; Popovich PG, 2003, EXP NEUROL, V182, P275, DOI 10.1016/S0014-4886(03)00120-1; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Schroeter M, 2003, AM J PATHOL, V163, P1517, DOI 10.1016/S0002-9440(10)63508-0; Sloan A E, 2000, Neurosurg Focus, V9, pe9; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Tardieu M, 2013, HAND CLINIC, V112, P1087, DOI 10.1016/B978-0-444-52910-7.00026-X; Weissenbock H, 2000, BRAIN PATHOL, V10, P260, DOI 10.1111/j.1750-3639.2000.tb00259.x; YAMASHIRO S, 1994, AM J PATHOL, V145, P856; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zhou WC, 2014, CANCERS, V6, P723, DOI 10.3390/cancers6020723	31	9	9	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	OCT	2015	10	4					2442	2446		10.3892/ol.2015.3533			5	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	CT7MT	WOS:000362999500089	26622867	Green Published, gold			2022-02-06	
J	Spadoni, AD; Kosheleva, E; Buchsbaum, MS; Simmons, AN				Spadoni, Andrea D.; Kosheleva, Elena; Buchsbaum, Monte S.; Simmons, Alan N.			Neural correlates of malingering in mild traumatic brain injury: A positron emission tomography study	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						PET; Test of memory malingering; Ventromeclial prefrontal cortex; Mild traumatic brain injury; Effort; Combat trauma	CEREBRAL GLUCOSE-METABOLISM; SPONTANEOUS CONFABULATIONS; COGNITIVE IMPAIRMENT; STRATEGIC RETRIEVAL; ROBUST; CONNECTIVITY; OPTIMIZATION; REGISTRATION; PERFORMANCE; ACTIVATION	The detection of malingering in cognitive performance is a challenge in clinical and legal environments. Neuroimaging may provide an objective method to determine the source of failure On tests of symptom validity. Participants comprised 45 combat veterans, 31 with mild traumatic brain injury (mTBI), not seeking medical or legal compensation, who completed the Tombaugh Test of Memory Malingering (TOMM) and a positron emission tomography (PET) scan. Based on TOMM performance (i.e., less than 45 of 50 total correct, suggesting suboptimal effort or malingering), subjects were separated into poor TOMM score (PT; n = 10) and good TOMM score (GT; n = 35) groups. Voxel-based multiple regression analysis with Group (GT/PT) predicting uptake of fluorodeoxyglucose revealed decreased brain metabolism in the ventromedial prefrontal cortex of poor performers. The current findings may suggest that poor TOMM performance in those with combat trauma and mTBI may be related to ventromedial prefrontal cortical dysfunction. These findings have important implications for the disentanglement of feigned versus actual memory impairment, where the latter may be secondary to neural mechanisms not consistent with forgetting or deception. Published by Elsevier Ireland Ltd.	[Spadoni, Andrea D.; Kosheleva, Elena; Simmons, Alan N.] San Diego VA Hlth Care Syst, Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA; [Spadoni, Andrea D.; Kosheleva, Elena; Buchsbaum, Monte S.; Simmons, Alan N.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA		Simmons, AN (corresponding author), Univ Calif San Diego, Dept Psychiat, Mailcode 0151B,Gilman Dr, La Jolla, CA 92093 USA.	ansimmons@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112; Spadoni, Andrea/0000-0002-8367-6406	Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs [ANS 1101CX0007, ADS IK2CX00084]; VA-Center of Excellence in Stress and Mental Health; Veterans AffairsUS Department of Veterans Affairs [IK2CX000864, I01CX000292, I01CX000715] Funding Source: NIH RePORTER	This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research. This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (CSR&D Merit Review Award to ANS 1101CX0007; in part by CSR&D Career Development Award to ADS IK2CX00084) and the VA-Center of Excellence in Stress and Mental Health (A.N.S., E.K., A.D.S.),	Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Browndyke Jeffrey, 2012, FUNCTIONAL NEUROANAT, P303; Buchsbaum M. S., 2015, J NEUROTRAUMA; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Gilboa A, 2006, BRAIN, V129, P1399, DOI 10.1093/brain/awl093; Gilboa A, 2009, J NEUROSCI, V29, P4871, DOI 10.1523/JNEUROSCI.5210-08.2009; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Hazlett EA, 2010, NEUROBIOL AGING, V31, P826, DOI 10.1016/j.neurobiolaging.2008.10.005; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kim YW, 2010, CHINESE MED J-PEKING, V123, P2853, DOI 10.3760/cma.j.issn.0366-6999.2010.20.020; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larsen JD, 2010, BRAIN INJURY, V24, P89, DOI 10.3109/02699050903508218; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Melo B, 1999, COGNITIVE NEUROPSYCH, V16, P343, DOI 10.1080/026432999380825; Moscovitch DA, 2002, NEUROPSYCHOLOGIA, V40, P1335, DOI 10.1016/S0028-3932(01)00213-5; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Moscovitch M., 2002, HDB MEMORY DISORDERS, V2, P315; Pankratz L., 1997, CLIN ASSESSMENT MALI, P223; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Ruff R. M., 1989, NEUROPSY NEUROPSY BE, V2, P103; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Schnider A, 2000, NEUROLOGY, V55, P74, DOI 10.1212/WNL.55.1.74; Schnider A, 1996, BRAIN, V119, P1627, DOI 10.1093/brain/119.5.1627; Schnider A, 2001, BRAIN RES REV, V36, P150, DOI 10.1016/S0165-0173(01)00090-X; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vitacco M. J., 2002, FORENSIC PSYCHOL CLA, P83; Wahlen A, 2011, CEREB CORTEX, V21, P2589, DOI 10.1093/cercor/bhr049; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085460; Wechsler D., 2008, WECHSLER ADULT INTEL; Willis PF, 2011, MIL MED, V176, P1426, DOI 10.7205/MILMED-D-11-00168; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049	53	9	9	0	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	SEP 30	2015	233	3					367	372		10.1016/j.pscychresns.2015.06.007			6	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	CQ4GX	WOS:000360563800009	26184458				2022-02-06	
J	Mann, K; Power, E; Barnes, S; Togher, L				Mann, Kate; Power, Emma; Barnes, Scott; Togher, Leanne			Questioning in conversations before and after communication partner training for individuals with traumatic brain injury	APHASIOLOGY			English	Article						discourse analysis; traumatic brain injury; questions; communication partner training; conversation analysis	CONTROLLED-TRIAL; CLINICAL-TRIAL; APHASIA; PEOPLE; ORGANIZATION; ADULTS; CONSTRUCTION; PERSPECTIVES; DISCOURSE; PROTOCOL	Background: Social communication training involving individuals with traumatic brain injury (TBI) and their everyday communication partner(s) facilitates improvements in the quality of their interactions and information transfer. Recent research has indicated that the ways conversation partners use questions may play an important role in this improvement. Aims: This study aimed to describe questioning patterns during casual conversations before and after communication partner training using Conversation Analysis. Methods & Procedures: Samples of casual conversations involving four individuals with TBI and their everyday communication partners were examined. These samples were collected before and after intervention in the course of a larger clinical trial investigating the efficacy of a communication partner training program entitled TBI Express. Four dyads were chosen based on their Adapted Kagan Scale scores; a primary outcome measure in the clinical trial. Two dyads with the greatest change on these scales ("Kagan plus") and two dyads with the least change ("Kagan neutral") were selected. Approximately 10minutes of casual conversations per dyad were transcribed in detail. Questions in each sample were identified and analysed qualitatively using conversation-analytic practices, focusing on aspects of sequence organisation. Outcomes & Results: "Kagan plus" dyads had obvious changes in their questioning practices following training. These changes facilitated selection of topics and the development of related talk, i.e., improved communication. Conversely, the "Kagan neutral" dyads exhibited less obvious differences in their questioning practices after training, which meant that improved communication in the postintervention samples was less apparent. Conclusions: The present study provides detailed insight into how everyday communication partners' questioning practices contribute to communicative success. This information has the potential to help clinicians assess and improve interactions involving individuals with TBI and their everyday communication partners.	[Mann, Kate; Power, Emma; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Speech Pathol, Lidcombe, Australia; [Barnes, Scott] Macquarie Univ, Dept Linguist, N Ryde, NSW, Australia		Power, E (corresponding author), Univ Sydney, Fac Hlth Sci, Speech Pathol, Lidcombe, Australia.	emma.power@sydney.edu.au	Power, Emma/A-9263-2015; Togher, Leanne/AAC-7083-2019	Power, Emma/0000-0002-2638-0406; Togher, Leanne/0000-0002-4518-6748; Barnes, Scott/0000-0001-5299-0550	National Health and Medical Research Council project grant [NHMRC Project] [402687]	This trial was supported by a National Health and Medical Research Council project grant [NHMRC Project Grant 402687].	Adamovich B. B., 1992, SCALES COGNITIVE ABI; Atkinson J.Maxwell., 1984, STRUCTURES SOCIAL AC; Barnes S., 2013, RES METHODS CLIN LIN, P126; Barnes S, 2012, J INTERACT RES COM D, V3, P115, DOI 10.1558/jircd.v3i2.115; Beckley F, 2013, INT J LANG COMM DIS, V48, P220, DOI 10.1111/j.1460-6984.2012.00204.x; Beeke S, 2015, APHASIOLOGY, V29, P355, DOI 10.1080/02687038.2014.881459; Beeke S, 2013, CLIN LINGUIST PHONET, V27, P784, DOI 10.3109/02699206.2013.808267; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bull, 1989, CONVERSATION INTERDI, P21; BUTTON G, 1985, HUM STUD, V8, P3, DOI 10.1007/BF00143022; Carlsson E, 2014, INT J LANG COMM DIS, V49, P722, DOI 10.1111/1460-6984.12106; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Denman A, 2011, DISABIL REHABIL, V33, P243, DOI 10.3109/09638288.2010.511686; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Hayano K., 2013, HDB CONVERSATION ANA, P395, DOI [10.1002/9781118325001.ch19, DOI 10.1002/9781118325001.CH19]; Heritage J., 1984, GARFINKEL ETHNOMETHO; Heritage J., 2010, TALK ACTION INTERACT, V38; Heritage J, 2012, RES LANG SOC INTERAC, V45, P1, DOI 10.1080/08351813.2012.646684; Hopper T, 2005, TOP GERIATR REHABIL, V21, P315; Jefferson G., 2004, CONVERSATION ANAL ST, P13, DOI [10.1075/pbns.125.02jef, DOI 10.1080/13613320902995475]; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Labov William, 1978, SOCIOLINGUISTIC PATT; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Raymond G, 2003, AM SOCIOL REV, V68, P939, DOI 10.2307/1519752; Rispoli MJ, 2010, DEV NEUROREHABIL, V13, P141, DOI 10.3109/17518420903468464; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; SACKS H, **DROPPED REF**; Saldert C, 2013, APHASIOLOGY, V27, P271, DOI 10.1080/02687038.2012.710317; Schegloff E., 2007, SEQUENCE ORG INTERAC, V1; SCHEGLOFF EA, 1977, LANGUAGE, V53, P361, DOI 10.2307/413107; Schegloff Emanuel A., 2006, ROOTS HUMAN SOCIALIT, P70; Selting M, 2000, LANG SOC, V29, P477, DOI 10.1017/S0047404500004012; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Simmons-Mackie N, 1999, APHASIOLOGY, V13, P807, DOI 10.1080/026870399401894; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Stivers T, 2010, J PRAGMATICS, V42, P2772, DOI 10.1016/j.pragma.2010.04.011; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2010, TBI EXPRESS PEOPLE T; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Wilkinson R, 2010, APHASIOLOGY, V24, P869, DOI 10.1080/02687030903501958; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	51	9	9	0	28	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	SEP 2	2015	29	9					1082	1109		10.1080/02687038.2015.1035226			28	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	CJ9EW	WOS:000355806300004					2022-02-06	
J	Aziz, H; Siordia, JA; Rhee, P; Pandit, V; O'Keeffe, T; Kulvatunyou, N; Joseph, B				Aziz, Hassan; Siordia, Juan A.; Rhee, Peter; Pandit, Viraj; O'Keeffe, Terence; Kulvatunyou, Narong; Joseph, Bellal			Traumatic panhypopituitarism resulting in acute adrenal crisis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article							UNITED-STATES; BRAIN-INJURY; ALCOHOL-USE; DRUG		[Aziz, Hassan; Siordia, Juan A.; Rhee, Peter; Pandit, Viraj; O'Keeffe, Terence; Kulvatunyou, Narong; Joseph, Bellal] Univ Arizona, Med Ctr, Dept Surg, Div Trauma Burns & Acute Care Surg, Tucson, AZ 85727 USA		Joseph, B (corresponding author), Univ Arizona, Med Ctr, Dept Surg, Div Trauma Burns & Acute Care Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu		Aziz, Hassan/0000-0003-0406-1946			Bethell C, 2001, MED CARE, V39, P478, DOI 10.1097/00005650-200105000-00008; Cherpitel CJ, 2013, ALCOHOL RES-CURR REV, V35, P150; Cowperthwaite Matthew C, 2011, J Trauma Manag Outcomes, V5, P3, DOI 10.1186/1752-2897-5-3; Draus JM, 2008, J PEDIATR SURG, V43, P208, DOI 10.1016/j.jpedsurg.2007.09.046; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Greenblatt J., 1999, PATTERNS ALCOHOL USE; Grunbaum JA, 2002, J SCHOOL HEALTH, V72, P313, DOI 10.1111/j.1746-1561.2002.tb07917.x; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; Heron Melonie, 2012, Natl Vital Stat Rep, V61, P1; Kelleher DC, 2013, J TRAUMA ACUTE CARE, V74, P671, DOI 10.1097/TA.0b013e31827d5f80; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Millstein SG, 2003, PEDIATRICS, V111, P114, DOI 10.1542/peds.111.1.114; Minino Arialdi M, 2010, Natl Vital Stat Rep, V59, P1; National Highway Traffic Safety Administration, 2014, TRAFF SAF FACTS 2012; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Pompili M, 2012, EUR CHILD ADOLES PSY, V21, P111, DOI 10.1007/s00787-011-0238-5; Psoter KJ, 2014, J ADOLESCENT HEALTH, V55, P195, DOI 10.1016/j.jadohealth.2014.01.018; Roudsari B, 2011, INJURY, V42, P66, DOI 10.1016/j.injury.2010.01.097; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Sanford A, 2014, J SUBST ABUSE TREAT, V47, P233, DOI 10.1016/j.jsat.2014.05.011; Shrier LA, 2003, PEDIATRICS, V111, pE699, DOI 10.1542/peds.111.6.e699; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; White AM, 2011, J STUD ALCOHOL DRUGS, V72, P774, DOI 10.15288/jsad.2011.72.774	23	9	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2015	79	3					463	467		10.1097/TA.0000000000000777			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CQ4JV	WOS:000360571900023	26307881				2022-02-06	
J	Hankins, AB; Reid, CA				Hankins, A. Bentley; Reid, Christine A.			Development and Validation of a Clinical Prediction Rule of the Return-to-Work Status of Injured Employees in Minnesota	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Return to work; Decision support model; Disability evaluation; Vocational rehabilitation; Workers' compensation	LOW-BACK-PAIN; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; HEALTH-CARE; DISABILITY; OUTCOMES; DETERMINANTS; MULTICENTER; PROGNOSIS; WORKPLACE	Purpose Vocational rehabilitation services can be a valuable resource to injured employees at risk for sustaining permanent disability. The aim of this study was to develop and validate a predictive model of return-to-work (RTW) status at workers' compensation claim closure that may assist rehabilitation counselors tasked with determining how to allocate such services. Methods A cross-sectional, retrospective study was conducted using data obtained from 15,372 workers' compensation claims in Minnesota's administrative claims database. The association between a set of 15 predictor variables representing medical and contextual factors and the RTW status as of claim closure of the accessible population was assessed using backward stepwise logistic regression. The most parsimonious set of variables that reliably predicted the outcome was selected as the optimal RTW model. This model was then internally validated via a split-dataset approach. Results Risk factors for failure to RTW by claim closure include the following: (1) attorney involvement; (2) higher level of permanent impairment (PI); (3) shorter job tenure; (4) lower pre-injury average weekly wage (AWW); (5) injury affecting the head and neck or the back; and (6) lower level of educational attainment. The optimal RTW model included four main effects (attorney involvement; severity of PI; age; job tenure) and three first-order interaction effects (pre-injury AWW x pre-injury industry; attorney involvement x severity of PI; attorney involvement x job tenure). When applied to the full dataset, the overall classification rate was 74.7 %. Conclusions This study's optimal RTW model offers further support for evaluating disability from a biopsychosocial perspective. Given the model's performance, it may be of value to those assessing rehabilitation potential within Minnesota's, and possibly other, workers' compensation system(s).	[Hankins, A. Bentley] Hankins & Hankins Vocat Consulting, Jonesborough, TN 37659 USA; [Reid, Christine A.] Virginia Commonwealth Univ, Sch Allied Hlth Profess, Dept Rehabil Counseling, Richmond, VA 23298 USA		Hankins, AB (corresponding author), Hankins & Hankins Vocat Consulting, 115 West Main St, Jonesborough, TN 37659 USA.	abhankins@hankinsvoccon.com		Reid, Christine/0000-0001-9208-5491			Baldwin ML, 1996, AM J IND MED, V29, P632; Berry D, 2003, 2003 MINNESOTA WORKE; Berry D, 2014, 2012 MINNESOTA WORKE; Berry D, 2011, 2011 MINNESOTA WORKE; Blackwell TL, 2003, REHABIL COUNS BULL, V46, P54; Butterfield PG, 1998, AM J IND MED, V34, P559, DOI 10.1002/(SICI)1097-0274(199812)34:6<559::AID-AJIM3>3.3.CO;2-V; Clay FJ, 2014, J OCCUP REHABIL, V24, P111, DOI 10.1007/s10926-013-9435-z; Cohen J., 2013, STAT POWER ANAL BEHA; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Dasinger LK, 2000, J OCCUP ENVIRON MED, V42, P323, DOI 10.1097/00043764-200003000-00015; Dawis R. V., 1964, MINNESOTA STUDIES VO, VXV, P1; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Feuerstein M, 2001, AM J IND MED, V40, P627, DOI 10.1002/ajim.10000; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Foreman P., 2006, BARRIERS FACILITATOR; GARDNER JA, 1991, REHABIL COUNS BULL, V34, P197; Grove WM, 2000, PSYCHOL ASSESSMENT, V12, P19, DOI 10.1037/1040-3590.12.1.19; Hackett ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041795; Hess DW, 2000, ARCH PHYS MED REHAB, V81, P359, DOI 10.1053/apmr.2000.0810359; HESTER EJ, 1986, PREDICTING WHICH DIS; Heymans MW, 2006, J OCCUP REHABIL, V16, P685, DOI 10.1007/s10926-006-9058-8; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; IBM Corp. Released, 2012, IBM SPSS STAT WIND V; Jette AM, 2006, PHYS THER, V86, P726, DOI 10.1093/ptj/86.5.726; Kirsh Bonnie, 2003, Work, V21, P221; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Krause JS, 1998, ARCH PHYS MED REHAB, V79, P615, DOI 10.1016/S0003-9993(98)90033-8; Krause N, 2001, AM J IND MED, V40, P464, DOI 10.1002/ajim.1116; MEEHL PE, 1959, J COUNS PSYCHOL, V6, P102, DOI 10.1037/h0049190; Murphy GC, 2003, J REHABIL MED, V35, P276, DOI 10.1080/16501970310015209; Nagi SZ., 1965, SOCIOLOGY REHABILITA, P100; Nagi SZ., 1991, DISABILITY AM NATL A, P309; National Council on Compensation Insurance, 2012, ANN STAT B, V2012th; National Safety Council, 2012, INJ FACTS; Nguyen TH, 2011, SPINE, V36, P320, DOI 10.1097/BRS.0b013e3181ccc220; Personick ME, 1995, 891 BUR LAB US DEP L, P23; Pransky GS, 2006, SPINE, V31, P690, DOI 10.1097/01.brs.0000202761.20896.02; Rea L.M., 1992, DESIGNING CONDUCTING; SAWYER J, 1966, PSYCHOL BULL, V66, P178, DOI 10.1037/h0023624; Schultz IZ, 2002, SPINE, V27, P2720, DOI 10.1097/00007632-200212010-00012; Sengupta I, 2012, WORKERS COMPENSATION; Shaw WS, 2001, DISABIL REHABIL, V23, P815; Steenstra IA, 2005, J OCCUP REHABIL, V15, P591, DOI 10.1007/s10926-005-8037-9; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Sullivan MJL, 2005, J OCCUP REHABIL, V15, P475, DOI 10.1007/s10926-005-8029-9; Talley WB., 1988, THESIS SO ILLINOIS U; Truchon M, 2012, J OCCUP REHABIL, V22, P27, DOI 10.1007/s10926-011-9318-0; Turner JA, 2000, AM J IND MED, V38, P707, DOI 10.1002/1097-0274(200012)38:6<707::AID-AJIM10>3.0.CO;2-9; United States. Department of Commerce Bureau of Census, 2012, 2012 N AM IND CLASS; United States. Department of Labor Bureau of Labor Statistics, 2010, TABL 2 NUMB NONF OCC; United States. Department of Labor Bureau of Labor Statistics, 2012, OCC INJ ILLN CLASS M; United States. Department of Labor Bureau of Labor Statistics, 2010, 2010 STAND OCC CLASS; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wasiak R, 2007, J OCCUP REHABIL, V17, P766, DOI 10.1007/s10926-007-9101-4; World Health Organization, 2007, INT CLASS FUNCT DIS; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0	57	9	9	1	13	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	SEP	2015	25	3					599	616		10.1007/s10926-015-9568-3			18	Rehabilitation; Social Issues	Social Science Citation Index (SSCI)	Rehabilitation; Social Issues	CP5TR	WOS:000359948000014	25663518				2022-02-06	
J	Liu, HC; Zhang, Y; Zhang, S; Xin, T; Li, WH; Wu, WL; Pang, Q; Chen, YZ				Liu, H. -C.; Zhang, Y.; Zhang, S.; Xin, T.; Li, W. -H.; Wu, W. -L.; Pang, Q.; Chen, Y. -Z.			Correlation research on the protein expression (p75NTR, bax, bcl-2, and caspase-3) and cortical neuron apoptosis following mechanical injury in rat	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Apoptosis; p75NTR; Bax; Bcl-2; Caspase-3	TRAUMATIC BRAIN-INJURY; CELLS; ERYTHROPOIETIN; ACTIVATION; P75(NTR); DEATH	OBJECTIVE: In this study, we aimed to survey the role of p75NTR, bax, bcl-2, and caspase-3 in the progress of traumatic brain injury (TBI). MATERIALS AND METHODS: A mechanical trauma model of vital neurons was established by putting external pressure, contusion and centrifugal acceleration on neurons. Morphological change, survival rate, assay of LDH activity, and apoptosis rate were evaluated for mild, medium and severe injury models. The expression of bax, bcl-2, caspase-3, p75NTR, p75NTR mRNA was determined by immunohistochemistry, immunofluorescence, Western blotting and RT-PCR. RESULTS: There was a transient high level Bcl-2 protein within 2 h after injury to increase neuronal tolerance and avoid apoptosis. Subsequently p75NTR, Bax/Bcl-2, and Caspase-3 reached their peaks from 48 to 72 h accompanied with the maximum apoptosis rate. CONCLUSIONS: Our results suggest that apoptosis ratio in varying degree injury groups are correlated with the expression level of p75NTRmRNA, p75NTR, Caspase-3, Bax/Bcl-2 ratio.	[Liu, H. -C.; Wu, W. -L.; Chen, Y. -Z.] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Peoples R China; [Zhang, Y.] 309 Hosp PLA, Dept Endocrinol, Beijing, Peoples R China; [Zhang, S.] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Zhang, S.] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xin, T.; Pang, Q.] Shandong Univ, Prov Hosp, Dept Neurosurg, Jinan 250100, Peoples R China; [Li, W. -H.] Shandong Univ, Qilu Hosp, Dept Expt Surg Lab, Jinan 250100, Peoples R China		Chen, YZ (corresponding author), Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Peoples R China.	yunzhenchen2011@hotmail.com		Zhang, Yuanqiang/0000-0002-4592-4966			Bandtlow Christine, 2004, Sci STKE, V2004, ppe24, DOI 10.1126/stke.2352004pe24; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Coulson EJ, 1999, J BIOL CHEM, V274, P16387, DOI 10.1074/jbc.274.23.16387; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Griesmaier E, 2010, BRAIN RES, V1355, P31, DOI 10.1016/j.brainres.2010.07.095; Hou Q, 2003, APOPTOSIS, V8, P617, DOI 10.1023/A:1026187526113; Khoury CM, 2007, GENE, V391, P233, DOI 10.1016/j.gene.2006.12.039; Lai BQ, 2011, NEUROSCI LETT, V502, P209, DOI 10.1016/j.neulet.2011.07.046; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; Liao ZB, 2009, NEUROL INDIA, V57, P722, DOI 10.4103/0028-3886.59466; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Park JK, 2005, LIFE SCI, V76, P1013, DOI 10.1016/j.lfs.2004.10.011; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; SMITH JR, 1991, PHYS REV C, V44, P1118, DOI 10.1103/PhysRevC.44.1118; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Wang YJ, 2002, J NEUROTRAUM, V19, P1487, DOI 10.1089/089771502320914714; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Zhu CL, 2010, BRAIN BEHAV IMMUN, V24, P822, DOI 10.1016/j.bbi.2009.09.013	24	9	18	1	4	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	SEP	2015	19	18					3459	3467					9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CT1RA	WOS:000362577000023	26439043				2022-02-06	
J	Vanderploeg, RD; Belanger, HG				Vanderploeg, Rodney D.; Belanger, Heather G.			Stability and Validity of the Veterans Health Administration's Traumatic Brain Injury Clinical Reminder Screen	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; traumatic brain injury; screening; Veterans Health Administration	POSTTRAUMATIC-STRESS-DISORDER	Objective: Determine the test-retest stability and validity of the Veterans Health Administration's Traumatic Brain Injury Clinical Reminder (VHA-TBI-CR) screen. Design: Criterion-standard. Setting: Veterans Health Administration. Participants: Ninety-five Operations Enduring Freedom and Iraqi Freedom veterans who had previously completed the VHA-TBI-CR screen were recruited from the Tampa Veterans Affairs Medical Center. Participants were primarily male (89.5%), with a mean age of 41.6 (SD = 11.14) years; 86% completed at least some college and over half were employed (56.8%). The majority of the participants were enlisted (83.2%). Main Outcome Measures: Phi coefficients of stability were calculated comparing the original clinically administered VHA-TBI-CR screen, with a paper-and-pencil version of the screen completed as part of the current study. Validity analyses were conducted by comparing the results from both screens to the study's TBI Identification Clinical Interview findings regarding a history of deployment-related traumatic brain injury (TBI). Sensitivity, specificity, positive predictive value, and negative predictive value of the screen were computed. Kappas were also calculated to examine agreement between screens and the study's "criterion standard" TBI diagnosis. Interventions: None. Results: The VHA-TBI-CR screen had poor test-retest stability (phi = 0.34). The clinically administered VHA-TBI-CR screen had only moderate sensitivity (0.61) but relatively good specificity (0.88). Historical drift was present in the data. Clinical VHA-TBI-CR screens completed within the past 24 months were less accurate (kappa = 0.27) than screens completed between 25 and 38 months earlier (kappa = 0.63) or those completed between 38 and 57 months earlier (kappa = 0.53). Conclusion: The VHA-TBI-CR screen has poor test-retest stability and poor validity when compared with a semistructured TBI identification interview. In this sample, sensitivity was unacceptably low such that the screen failed to identify 39% of veterans who were determined to have had a deployment-related TBI.	James A Haley Vet Hosp, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; Def & Vet Brain Injury Ctr, Silver Spring, MD USA; James A Haley Vet Hosp, Ctr Excellence Maximizing Rehabil Outcomes, HSR&D, RR&D, Tampa, FL 33612 USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, Tampa, FL 33612 USA.	Rodney.Vanderploeg@va.gov			Department of Veterans Affairs, Veterans Health Administration (VHA), through SDR Screening Instruments and Processes [HSRD #08-411-TBI]; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; James A. Haley Veterans HospitalUS Department of Veterans Affairs;  [08-411]	The research reported here was supported by the Department of Veterans Affairs, Veterans Health Administration (VHA), through SDR HSR&D #08-411-TBI Screening Instruments and Processes, and the Defense and Veterans Brain Injury Center (DVBIC). Further support was provided by the James A. Haley Veterans Hospital. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Veterans Affairs or US government. The authors thank Joseph Gutmann, MD, and Keith White, MD, who served as the research assistants conducting the semistructured clinical interviews. The authors also thank Shirley Groer, PhD, who was originally coprincipal investigator, and Valerie Larson, who served as the study coordinator for the SDR HSR&D #08-411 grant that supported this study.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cifu DX, 2010, VHA POL C ORL FL; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fleiss J.L., 1981, STAT METHODS RATES P; Fortier CB, J HEAD TRAUMA REHABI; Hsee CK, 2004, J PERS SOC PSYCHOL, V86, P680, DOI 10.1037/0022-3514.86.5.680; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314	16	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2015	30	5					E29	E39		10.1097/HTR.0000000000000095			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JE	WOS:000369605400004	25310297				2022-02-06	
J	Han, GM; Newmyer, A; Qu, M				Han, Guang-Ming; Newmyer, Ashley; Qu, Ming			Seat Belt Use to Save Face: Impact on Drivers' Body Region and Nature of Injury in Motor Vehicle Crashes	TRAFFIC INJURY PREVENTION			English	Article						seat belt; motor vehicle crashes; Barell matrix; injury	SEVERITY; STATE	Background: Seat belt use is the single most effective way to save lives and reduce injuries in motor vehicle crashes. However, some case reports described seat belt use as a double-edged sword because some injuries are related to seat belt use in motor vehicle crashes. To comprehensively understand the effects of seat belt use, we systemically investigated the association between seat belt use and injuries based on anatomic body region and type of injury in drivers involved in motor vehicle crashes. Methods: The injury information was obtained by linking crash reports with hospital discharge data and categorized by using the diagnosis codes based on the Barell injury diagnosis matrix. A total of 10,479 drivers (>= 15years) in passenger vehicles involved in motor vehicle crashes from 2006 to 2011 were included in this study. Results: Seat belt use significantly reduced the proportions of traumatic brain injury (10.4% non-seat belt; 4.1% seat belt) and other head, face, and neck injury (29.3% non-seat belt; 16.6% seat belt) but increased the proportion of spine: thoracic to coccyx injury (17.9% non-seat belt; 35.5% seat belt). Although the proportion of spine: thoracic to coccyx injury was increased in drivers with seat belt use, the severity of injury was decreased, such as fracture (4.2% with seat belt use; 22.0% without seat belt use). Furthermore, the total medical charges decreased due to the change of injury profiles in drivers with seat belt use from a higher percentage of fractures (average cost for per case $26,352) to a higher percentage of sprains and/or strains ($1,897) with spine: thoracic to coccyx injury. Conclusion: This study provide a comprehensive picture for understanding the protective effect of seat belt use on injuries based on anatomic body region and type of injury in drivers involved in motor vehicle crashes.	[Han, Guang-Ming; Newmyer, Ashley; Qu, Ming] Nebraska Dept Hlth & Human Serv, Div Publ Hlth, Lincoln, NE 68509 USA		Han, GM (corresponding author), Nebraska Dept Hlth & Human Serv, Div Publ Hlth, Lincoln, NE 68509 USA.	guangming.han@nebraska.gov	Han, Guangming/C-6500-2017	Han, Guangming/0000-0001-8901-5222	Nebraska Office of Highway safety	We thank the Nebraska Office of Highway safety for providing funds for this project.	Aharonson-Daniel L, 2003, INJURY PREV, V9, P156, DOI 10.1136/ip.9.2.156; Arbogast Kristy B, 2012, Ann Adv Automot Med, V56, P213; Bakker A, 2013, J TRAUMA ACUTE CARE, V74, P687, DOI 10.1097/TA.0b013e31827e1857; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Campos-Outcalt D, 2003, INJURY PREV, V9, P251, DOI 10.1136/ip.9.3.251; Centers for Disease Control and Prevention, INT CLASS DIS 9 REV; Centers for Disease Control and Prevention (CDC), 2011, AD SEAT BELT US; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Derrig RA, 2002, ACCIDENT ANAL PREV, V34, P101, DOI 10.1016/S0001-4575(01)00004-5; Deutsch RJ, 2008, PEDIATR EMERG CARE, V24, P105, DOI 10.1097/PEC.0b013e318163dbe1; Evans L, 1996, ACCIDENT ANAL PREV, V28, P423, DOI 10.1016/0001-4575(96)00006-1; FOSS RD, 1994, AM J PUBLIC HEALTH, V84, P1732, DOI 10.2105/AJPH.84.11.1732; Freni L, 2013, VASC ENDOVASC SURG, V47, P138, DOI 10.1177/1538574412469446; Hillary F, 2001, ARCH CLIN NEUROPSYCH, V16, P171, DOI 10.1016/S0887-6177(00)00050-0; MARINE WM, 1994, J TRAUMA, V36, P96, DOI 10.1097/00005373-199401000-00015; Molnar LJ, 2012, ACCIDENT ANAL PREV, V47, P78, DOI 10.1016/j.aap.2012.01.006; Nebraska Office of Highway Safety, NEBR SAF BELT US RAT; NHTSA, 2013, TRAFF SAF FACTS 2011; NHTSA, 1997, 808649 NHTSA US DOT; Raychaudhuri P, 2012, CASE REP PEDIAT, V2012, DOI 10.1155/2012/326936; Reed Mark A, 2006, Traffic Inj Prev, V7, P256, DOI 10.1080/15389580600660641; Shults RA, 2012, J SAFETY RES, V43, P417, DOI 10.1016/j.jsr.2012.10.010; SWIERZEWSKI MJ, 1994, J TRAUMA, V37, P404, DOI 10.1097/00005373-199409000-00012; VIANO DC, 1995, J TRAUMA, V38, P538, DOI 10.1097/00005373-199504000-00013; Vivoda JM, 2011, HANDBOOK OF TRAFFIC PSYCHOLOGY, P215, DOI 10.1016/B978-0-12-381984-0.10016-5	25	9	9	0	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	AUG 18	2015	16	6					605	610		10.1080/15389588.2014.999856			6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	CE3XW	WOS:000351764400012	25671580				2022-02-06	
J	Zhang, Z; Wang, H; Jin, Z; Cai, X; Gao, N; Cui, X; Liu, P; Zhang, J; Yang, S; Yang, X				Zhang, Z.; Wang, H.; Jin, Z.; Cai, X.; Gao, N.; Cui, X.; Liu, P.; Zhang, J.; Yang, S.; Yang, X.			DOWNREGULATION OF SURVIVIN REGULATES ADULT HIPPOCAMPAL NEUROGENESIS AND APOPTOSIS, AND INHIBITS SPATIAL LEARNING AND MEMORY FOLLOWING TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						survivin; RNAi; adult neurogenesis; dentate gyrus; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; DENTATE GYRUS; BETA-CATENIN; PROLIFERATION; RATS; DIFFERENTIATION; ASTROCYTES; EXPRESSION; PROTECTS	Survivin, a unique member of the inhibitor of the apoptosis protein (IAP) family, has been suggested to play a crucial role in promoting the cell cycle and mediates mitosis during embryonic development. However, the role of survivin following traumatic brain injury (TBI) in adult neurogenesis and apoptosis in the mouse dentate gyrus (DG) remains only partially understood. We adopted adenovirus-mediated RNA interference (RNAi) as a means of suppressing the expression of survivin and observed its effects on adult regeneration and neurological function in mice after brain injury. The mice were subjected to TBI, and the ipsilateral hippocampus was then examined using reverse transcription polymerase chain reaction (RT-PCR) and Western blotting analyses. Brain slices were stained for 5'-bromo-2'-deoxyuridine (BrdU) and doublecortin (DCX). Our data showed that survivin knockdown inhibits the proliferation and differentiation of neural precursor cells (NPCs) in the DG of the hippocampus soon after TBI. Furthermore, downregulation of survivin results in a significant increase in programmed cell death in the DG, as assessed using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and 4',6-diamidino-2-pheny lindole (DAPI) double staining. The Morris water maze (MWM) test was adopted to evaluate neurological function, which confirmed that knockdown of survivin worsened the memory capacity that was already compromised following TBI. Survivin in adult mice brains after TBI can be successfully down-regulated by RNAi, which inhibited adult hippocampal neurogenesis, promoted apoptotic cell death, and resulted in a negative role in the recovery of dysfunction following injury. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Yang, X.] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; Tianjin Neurol Inst, Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China		Yang, X (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	yangxinyu@tijmu.edu.cn			National Natural Science Foundation of China - ChinaNational Natural Science Foundation of China (NSFC) [30973090]; Science and Technology Foundation of Tianjin [10JCYBJC25700]	We thank Jia Li, Xiaokui Kang, Lin Zhang, Rong Yan, Feng Gao, Wentao Dong, Litong Zhang for their helpful comments on the manuscript. This study was supported by grants obtained from the National Natural Science Foundation of China - China (No. 30973090) and Science and Technology Foundation of Tianjin (No. 10JCYBJC25700).	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Coremans V, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-2; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Feng RP, 2013, BIOCHEM J, V450, P459, DOI 10.1042/BJ20120924; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Guidi S, 2011, BRAIN RES BULL, V85, P169, DOI 10.1016/j.brainresbull.2011.03.028; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Iscru E, 2013, NEUROSCIENCE, V231, P413, DOI 10.1016/j.neuroscience.2012.10.049; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Johnson EA, 2004, J NEUROTRAUM, V21, P1183, DOI 10.1089/neu.2004.21.1183; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Raad M, 2014, NEUROSCIENCE, V281, P16, DOI 10.1016/j.neuroscience.2014.08.045; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Scholzke MN, 2007, J MOL MED, V85, P577, DOI 10.1007/s00109-007-0196-z; Solberg N, 2008, DEV DYNAM, V237, P1799, DOI 10.1002/dvdy.21586; Su P, 2014, BRAIN RES BULL, V109, P32, DOI 10.1016/j.brainresbull.2014.09.005; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00095; Tamm I, 1998, CANCER RES, V58, P5315; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang HT, 2015, NEUROSCIENCE, V284, P273, DOI 10.1016/j.neuroscience.2014.08.055; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Yan R, 2012, J VIROL METHODS, V186, P1, DOI 10.1016/j.jviromet.2012.07.012; Yeung ST, 2014, NEUROSCIENCE, V259, P214, DOI 10.1016/j.neuroscience.2013.11.054; Zhang L, 2013, INT J MOL MED, V32, P867, DOI 10.3892/ijmm.2013.1456; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	43	9	10	1	39	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 6	2015	300						219	228		10.1016/j.neuroscience.2015.05.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL2IQ	WOS:000356767400021	25987205				2022-02-06	
J	Areskoug-Josefsson, K; Gard, G				Areskoug-Josefsson, Kristina; Gard, Gunvor			Physiotherapy as a promoter of sexual health	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article						Education; health promotion; physical therapy; physiotherapy; rehabilitation; sexuality; sexual well-being	TRAUMATIC BRAIN-INJURY; PROSTATE-CANCER; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; DISCUSSING SEXUALITY; URINARY-INCONTINENCE; OBESE MEN; WOMEN; DYSFUNCTION; EXERCISE	Despite the holistic intention of physiotherapy, sexual health receives insufficient attention by physiotherapists. Sexual health is an important part of general health and well-being, which is often negatively affected by physical and psychological disorders. There are several reasons why sexual health should be addressed by physiotherapists, and this article aims to describe the role of the physiotherapist as a promoter of good sexual health and implementation of sexual health in clinical physiotherapy.	[Areskoug-Josefsson, Kristina; Gard, Gunvor] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Areskoug-Josefsson, Kristina] Jonkoping Cty Council, Futurum Acad Hlth Care, Jonkoping, Sweden; [Areskoug-Josefsson, Kristina] Varnamo Sjukhus, Samrehab, S-33185 Varnamo, Sweden; [Gard, Gunvor] Lulea Univ Technol, Dept Hlth Sci, S-95187 Lulea, Sweden		Areskoug-Josefsson, K (corresponding author), Varnamo Sjukhus, Samrehab, S-33185 Varnamo, Sweden.	kristina.areskoug.josefsson@rjl.se	Josefsson, Kristina Areskoug/H-2910-2019	Josefsson, Kristina Areskoug/0000-0002-7669-4702			Anastasiadis AG, 2002, WORLD J UROL, V20, P74, DOI 10.1007/s00345-002-0272-5; Annon J. S., 1974, BEHAV TREATMENT SEXU; Baillot A, 2013, OBES SURG, V23, P882, DOI 10.1007/s11695-013-0875-5; Bitzer J, 2007, J SEX MED, V4, P29, DOI 10.1111/j.1743-6109.2006.00395.x; Jorge RTB, 2010, MOD RHEUMATOL, V20, P491, DOI 10.1007/s10165-010-0316-4; Bortz WM, 1999, WESTERN J MED, V170, P167; Britto MT, 2000, ARCH PEDIAT ADOL MED, V154, P478, DOI 10.1001/archpedi.154.5.478; Collier A, 2012, AM J CLIN ONCOL-CANC, V35, P504, DOI 10.1097/COC.0b013e318201a406; Cormie P, 2013, NAT REV UROL, V10, P731, DOI 10.1038/nrurol.2013.206; Couldrick L, 2010, INT J THER REHABIL, V17, P290, DOI 10.12968/ijtr.2010.17.6.48152; Davison SL, 2009, J SEX MED, V6, P2690, DOI 10.1111/j.1743-6109.2009.01406.x; de Visser RO, 2013, HEALTH PSYCHOL, V32, P5, DOI 10.1037/a0029045; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Dyer K, 2013, J SEX MED, V10, P2658, DOI 10.1111/j.1743-6109.2012.02856.x; Dzierzanowski M, 2013, ADV CLIN EXP MED, V22, P93; Field N, 2013, LANCET, V382, P1830, DOI 10.1016/S0140-6736(13)62222-9; Fode M, 2012, ASIAN J ANDROL, V14, P61, DOI 10.1038/aja.2011.70; Galvao DA, 2007, PROSTATE CANCER P D, V10, P340, DOI 10.1038/sj.pcan.4500975; Giami A, 2002, ANN REV SEX RES, V13, P1; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Haboubi NHJ, 2003, DISABIL REHABIL, V25, P291, DOI 10.1080/0963828021000031188; Han TS, 2011, EUR J ENDOCRINOL, V164, P1003, DOI 10.1530/EJE-10-1129; Hedlund L, 2010, J BODYW MOV THER, V14, P245, DOI 10.1016/j.jbmt.2009.03.002; Helland Y, 2013, SCAND J RHEUMATOL, V42, P20, DOI 10.3109/03009742.2012.709274; Hsiao W, 2012, J SEX MED, V9, P524, DOI 10.1111/j.1743-6109.2011.02560.x; Jones Mairwen K, 2005, Occup Ther Int, V12, P95, DOI 10.1002/oti.18; Josefsson KA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-240; Josefsson KA, 2012, MUSCULOSKELET CARE, V10, P76, DOI 10.1002/msc.1002; Khan ZA, 2013, J OBSTET GYNAECOL, V33, P710, DOI 10.3109/01443615.2013.813913; Khoo J, 2013, J SEX MED, V10, P1823, DOI 10.1111/jsm.12154; La Vignera S, 2012, J ANDROL, V33, P154, DOI 10.2164/jandrol.111.013649; Lamont J, 2012, J OBSTET GYNAECOL CA, V34, P769, DOI 10.1016/S1701-2163(16)35341-5; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Martinez CS, 2014, ACTA OBSTET GYN SCAN, V93, P497, DOI 10.1111/aogs.12379; Matthias RE, 1997, GERONTOLOGIST, V37, P6, DOI 10.1093/geront/37.1.6; McGuire BE, 2011, CURR OPIN PSYCHIATR, V24, P398, DOI 10.1097/YCO.0b013e328349bbcb; McInnes RA, 2003, MED J AUSTRALIA, V179, P263, DOI 10.5694/j.1326-5377.2003.tb05535.x; Meiri R, 2014, SEX MED-UK, V2, P159, DOI 10.1002/sm2.35; Moin V, 2009, SEX DISABIL, V27, P83, DOI 10.1007/s11195-009-9112-5; Monga TN, 1998, DISABIL REHABIL, V20, P317, DOI 10.3109/09638289809166089; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Nicholls David A, 2012, Physiother Theory Pract, V28, P418, DOI 10.3109/09593985.2012.692557; Palmer Deborah, 2011, Br J Nurs, V20, P1134; Penwell-Waines L, 2014, J INTERPROF CARE, V28, P317, DOI 10.3109/13561820.2014.884553; Post MWM, 2008, SEX DISABIL, V26, P3, DOI 10.1007/s11195-007-9068-2; Pujols Y, 2010, J SEX MED, V7, P905, DOI 10.1111/j.1743-6109.2009.01604.x; Ratner ES, 2011, MATURITAS, V70, P210, DOI 10.1016/j.maturitas.2011.07.015; Reinseth L, 2011, SCAND J OCCUP THER, V18, P210, DOI 10.3109/11038128.2010.514941; Reissing ED, 2013, J SEX MARITAL THER, V39, P306, DOI 10.1080/0092623X.2012.697535; Rivalta M, 2009, J SEX MED, V6, P1674, DOI 10.1111/j.1743-6109.2009.01238.x; Rosenbaum TY, 2011, MINERVA UROL NEFROL, V63, P101; Rosenbaum T, 2014, J SEX MED, V11, P15, DOI 10.1111/jsm.12343; Rosenbaum T, 2011, J SEX MARITAL THER, V37, P89, DOI 10.1080/0092623X.2011.547340; Rosenbaum TY, 2007, J SEX MED, V4, P4, DOI 10.1111/j.1743-6109.2006.00393.x; Rosenbaum TY, 2010, J SEX MED, V7, P645, DOI 10.1111/j.1743-6109.2009.01490.x; Rosenbaum TY, 2005, J SEX MARITAL THER, V31, P329, DOI 10.1080/00926230590950235; Rosman L, 2014, CIRCULATION, V129, pE313, DOI 10.1161/CIRCULATIONAHA.113.004846; Ryan S, 2005, MUSCULOSKELET CARE, V3, P44, DOI 10.1002/msc.25; Sanders T, 2014, J HEALTH ORGAN MANAG, V28, P96, DOI 10.1108/JHOM-10-2011-0102; Satinsky S, 2012, BODY IMAGE, V9, P137, DOI 10.1016/j.bodyim.2011.09.007; Saunamaki N, 2014, J CLIN NURS, V23, P531, DOI 10.1111/jocn.12155; Saunamaki N, 2010, J ADV NURS, V66, P1308, DOI 10.1111/j.1365-2648.2010.05260.x; Sharma R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-66; Shaw James A., 2012, Physiotherapy Theory and Practice, V28, P420, DOI 10.3109/09593985.2012.676941; Speck RM, 2010, BREAST CANCER RES TR, V121, P421, DOI 10.1007/s10549-009-0550-7; Stausmire Julie M, 2004, Am J Hosp Palliat Care, V21, P33, DOI 10.1177/104990910402100109; Tajar A, 2011, J RHEUMATOL, V38, P370, DOI 10.3899/jrheum.100604; Taylor Bridget, 2006, Nurs Stand, V21, P35; Ussher JM, 2013, PSYCHOL HEALTH, V28, P1370, DOI 10.1080/08870446.2013.811242; Wittenberg A, 2009, J SEX MED, V6, P362, DOI 10.1111/j.1743-6109.2008.01046.x; World Health Organization (WHO), 2002, DEFINING SEXUAL HLTH; Zahariou AG, 2008, INT UROGYNECOL J, V19, P401, DOI 10.1007/s00192-007-0452-3; Zaider T, 2012, J SEX MED, V9, P2724, DOI 10.1111/j.1743-6109.2012.02897.x	73	9	9	1	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.	AUG	2015	31	6					390	395		10.3109/09593985.2015.1023876			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CO5EG	WOS:000359181800003	26196697				2022-02-06	
J	Bhattacharyya, S; Zhang, XL; Feferman, L; Johnson, D; Tortella, FC; Guizzetti, M; Tobacman, JK				Bhattacharyya, Sumit; Zhang, Xiaolu; Feferman, Leo; Johnson, David; Tortella, Frank C.; Guizzetti, Marina; Tobacman, Joanne K.			Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						arylsulfatase B; astrocytes; chondroitin 4-sulfate; CHST11; glycosaminoglycans; neurocan	ENZYME REPLACEMENT THERAPY; SULFATE PROTEOGLYCANS; MUCOPOLYSACCHARIDOSIS-VI; REACTIVE ASTROGLIOSIS; OXYGEN-TENSION; GROWTH-FACTOR; ASTROCYTES; MODEL; EXPRESSION; PROLIFERATION	In an established rat model of penetrating ballistic-like brain injury (PBBI), arylsulfatase B (ARSB; N-acetylgalactosamine 4-sulfatase) activity was significantly reduced at the ipsilateral site of injury, but unaffected at the contralateral site or in sham controls. In addition, the ARSB substrate chondroitin 4-sulfate (C4S) and total sulfated glycosaminoglycans increased. The mRNA expression of chondroitin 4-sulfotransferase 1 (C4ST1; CHST11) and the sulfotransferase activity rose at the ipsilateral site of injury (PBBI-I), indicating contributions from both increased production and reduced degradation to the accumulation of C4S. In cultured, fetal rat astrocytes, following scratch injury, the ARSB activity declined and the nuclear hypoxia inducible factor-1 increased significantly. In contrast, sulfotransferase activity and chondroitin 4-sulfotransferase expression increased following astrocyte exposure to TGF-1, but not following scratch. These different pathways by which C4S increased in the cell preparations were both evident in the response to injury in the PBBI-I model. Hence, findings support effects of injury because of mechanical disruption inhibiting ARSB and to chemical mediation by TGF-1 increasing CHST11 expression and sulfotransferase activity. The increase in C4S following traumatic brain injury is because of contributions from impaired degradation and enhanced synthesis of C4S which combine in the pathogenesis of the glial scar.	[Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL USA; [Bhattacharyya, Sumit; Zhang, Xiaolu; Feferman, Leo; Guizzetti, Marina; Tobacman, Joanne K.] Jesse Brown VA Med Ctr, Chicago, IL USA; [Zhang, Xiaolu; Guizzetti, Marina] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Johnson, David; Tortella, Frank C.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Guizzetti, Marina] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Guizzetti, Marina] VA Portland Hlth Care Syst, Portland, OR USA		Tobacman, JK (corresponding author), 840 S Wood St,CSN 440,MC 718, Chicago, IL 60612 USA.	jkt@uic.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CTSA ULI RR029879]; NIH/NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA021876]; VHAUS Department of Veterans Affairs [I01BX001819]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA021876] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001819] Funding Source: NIH RePORTER	This work was supported by the NIH CTSA ULI RR029879 (to JKT), by NIH/NIAAA AA021876 (to MG), and by VHA I01BX001819 (to MG). The authors declare no competing financial interests.	Asher R A, 2001, Prog Brain Res, V132, P611; Asher RA, 2000, J NEUROSCI, V20, P2427; Bhattacharyya S, 2014, ONCOGENE, V33, P5467, DOI 10.1038/onc.2013.483; Bhattacharyya S, 2015, BBA-GENE REGUL MECH, V1849, P342, DOI 10.1016/j.bbagrm.2014.12.009; Bhattacharyya S, 2014, J BIOL CHEM, V289, P17564, DOI 10.1074/jbc.M114.561589; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; Bhattacharyya S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-303; Bhattacharyya S, 2010, AM J RESP CELL MOL, V42, P51, DOI 10.1165/rcmb.2008-0482OC; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; Cartagena CM, 2014, MOL CELL NEUROSCI, V60, P81, DOI 10.1016/j.mcn.2014.04.005; Chen J, 2013, BBA-MOL CELL BIOL L, V1831, P263, DOI 10.1016/j.bbalip.2012.09.007; Choudhury GR, 2014, BRAIN RES, V1551, P45, DOI 10.1016/j.brainres.2014.01.013; Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001; de Vellis J, 2010, SPRINGER PROTOC HAND, P193, DOI 10.1007/978-1-60761-292-6_11; Feferman L, 2013, PROSTATE CANCER P D, V16, P277, DOI 10.1038/pcan.2013.18; Guizzetti M, 1996, J NEUROCHEM, V67, P2236; Guizzetti M, 1996, EUR J PHARMACOL, V297, P265, DOI 10.1016/0014-2999(95)00746-6; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Harmatz P, 2008, MOL GENET METAB, V94, P469, DOI 10.1016/j.ymgme.2008.04.001; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Leung LY, 2013, J NEUROTRAUM, V30, P1288, DOI 10.1089/neu.2012.2715; Malhotra SK, 1997, CYTOBIOS, V89, P115; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Mitsunaga-Nakatsubo K, 2009, MED MOL MORPHOL, V42, P63, DOI 10.1007/s00795-009-0447-x; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; O'Toole DA, 2007, CELL MOL LIFE SCI, V64, P1303, DOI 10.1007/s00018-007-7106-y; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; Prabhu SV, 2011, J HISTOCHEM CYTOCHEM, V59, P328, DOI 10.1369/0022155410395511; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Siebert JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/845323; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Welser-Alves JV, 2013, NEUROCHEM INT, V63, P47, DOI 10.1016/j.neuint.2013.04.007; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Yao CP, 2008, BRAIN INJURY, V22, P723, DOI 10.1080/02699050802304706; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yin JR, 2009, BRAIN RES, V1263, P10, DOI 10.1016/j.brainres.2009.01.042; Yoo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057415; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang XL, 2014, GLIA, V62, P259, DOI 10.1002/glia.22604; Zhao RR, 2013, NEUROSCI BULL, V29, P477, DOI 10.1007/s12264-013-1359-2	51	9	9	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134	4					728	739		10.1111/jnc.13156			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CN8KI	WOS:000358688700012	25943740	Green Accepted, Green Submitted			2022-02-06	
J	Hoffer, ME; Schubert, MC; Balaban, CD				Hoffer, Michael E.; Schubert, Michael C.; Balaban, Carey D.			Early Diagnosis and Treatment of Traumatic Vestibulopathy and Postconcussive Dizziness	NEUROLOGIC CLINICS			English	Article						Mild traumatic brain injury (mTBI); Neurosensory sequelae; Dizziness; Vestibular rehabilitation	BRAIN-INJURY; HEAD-INJURY; BLAST; REHABILITATION; CONCUSSION; SYMPTOMS; TRACKING; VISITS	Mild traumatic brain injury (mTBI) is a common health condition in amateur and professional sports and in military operations but can occur in everyday life. Dizziness is the most common disorder seen after mTBI followed closely by headache. This article examines the diagnosis and treatment of vestibular disorders after mTBI. Data are included from the literature, and conclusions are drawn from the literature review and the experience of the authors. Much of what is known about this disorder comes from recent military experience, but the link to more common civilian injuries is detailed in this article.	[Hoffer, Michael E.] Univ Miami, Dept Otolaryngol, Miami, FL 33136 USA; [Schubert, Michael C.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Schubert, Michael C.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21287 USA; [Balaban, Carey D.] Univ Pittsburgh, Inst Eye & Ear, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Balaban, Carey D.] Univ Pittsburgh, Inst Eye & Ear, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Balaban, Carey D.] Univ Pittsburgh, Inst Eye & Ear, Dept Commun Sci & Disorders, Pittsburgh, PA 15213 USA; [Balaban, Carey D.] Univ Pittsburgh, Inst Eye & Ear, Dept Bioengn, Pittsburgh, PA 15213 USA		Hoffer, ME (corresponding author), Univ Miami, Dept Otolaryngol, 1120 Northwest 14th St,CRB 5th Floor, Miami, FL 33136 USA.	Michael.hoffer@miami.edu	Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844			Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Balaban CD, 2015, 2015 MIDW M ASS RES; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hoffer ME, 2015, 2015 MIDW M ASS RES; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Honaker JA, 2014, OTOL NEUROTOL, V35, P1111, DOI 10.1097/MAO.0000000000000432; Hosek B, 2011, DEPLOYMENT IRAQ AFGH; Johnson CM, 2014, OTOLARYNG HEAD NECK, V150, P437, DOI 10.1177/0194599813515184; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kiderman A, 2015, 2015 MIDW M ASS RES; Lagbas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143092; Lee RR, 2014, PROG NEUROL SURG, V28, P94, DOI 10.1159/000358768; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McDonnell MN, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005397.pub4; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Olson D, 2013, CURR SPORT MED REP, V12, P381, DOI 10.1249/JSR.0000000000000015; Pisani V, 2015, INT J AUDIOL, V54, P329, DOI 10.3109/14992027.2014.989454; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Shah A, 2014, LARYNGOSCOPE, V124, P272, DOI 10.1002/lary.24169; Silverberg N.D., 2014, BRAIN INJURY, V5, P1; Stuhmiller JH, 1990, TXB MILITARY MED CON, P241; Suarez H, 2011, ACTA OTO-LARYNGOL, V131, P377, DOI 10.3109/00016489.2010.534113; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	43	9	11	0	21	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2015	33	3					661	+		10.1016/j.ncl.2015.04.004			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ0YP	WOS:000360324800010	26231278				2022-02-06	
J	King, H; Campbell, S; Herzog, M; Popoli, D; Reisner, A; Polikandriotis, J				King, Harold; Campbell, Stephen; Herzog, Makenzie; Popoli, David; Reisner, Andrew; Polikandriotis, John			Epidemiology of Injuries in High School Football: Does School Size Matter?	JOURNAL OF PHYSICAL ACTIVITY & HEALTH			English	Article						adolescent; pediatrics; athletic therapy; injury management	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; UNITED-STATES; RECURRENT CONCUSSION; COLLEGIATE; PLAYERS; RISK; PATTERNS; COHORT	Background: More than 1 million US high school students play football. Our objective was to compare the high school football injury profiles by school enrollment size during the 2013-2014 season. Methods: Injury data were prospectively gathered on 1806 student athletes while participating in football practice or games by certified athletic trainers as standard of care for 20 high schools in the Atlanta Metropolitan area divided into small (<1600 students enrolled) or large (>= 1600 students enrolled) over the 2013-2014 football season. Results: Smaller schools had a higher overall injury rate (79.9 injuries per 10,000 athletic exposures vs. 46.4 injuries per 10,000 athletic exposures; P <.001). In addition, smaller schools have a higher frequency of shoulder and elbow injuries (14.3% vs. 10.3%; P =.009 and 3.5% vs. 1.5%; P =.006, respectively) while larger schools have more hip/upper leg injuries (13.3% vs. 9.9%; P =.021). Lastly, smaller schools had a higher concussion distribution for offensive lineman (30.6% vs. 13.4%; P =.006) and a lower rate for defensive backs/safeties (9.2% vs. 25.4%; P =.008). Conclusions: This study is the first to compare and show unique injury profiles for different high school sizes. An understanding of school specific injury patterns can help drive targeted preventative measures.	[King, Harold; Campbell, Stephen; Herzog, Makenzie; Popoli, David] Childrens Healthcare Atlanta, Dept Sport Med, Atlanta, GA 30322 USA; [Reisner, Andrew] Childrens Healthcare Atlanta, Dept Neurosurg, Atlanta, GA USA; [Polikandriotis, John] Childrens Healthcare Atlanta, Dept Ambulatory Operat, Atlanta, GA USA		King, H (corresponding author), Childrens Healthcare Atlanta, Dept Sport Med, Atlanta, GA 30322 USA.	john.polikandriotis@choa.org		Herzog, Mackenzie/0000-0002-6810-4485			Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; CULPEPPER MI, 1983, SOUTHERN MED J, V76, P873, DOI 10.1097/00007611-198307000-00014; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Datalys Center (Datalys Center for Sports Injury Research and Prevention Inc), 2013, NATA NAT PREL CONC R; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Dick R, 2007, J ATHL TRAINING, V42, P221; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P117, DOI 10.1111/j.1600-0838.2010.01221.x; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; National Foundation of State High School Association, HIGH SCH ATHL PART S; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 1999, J ATHL TRAINING, V34, P277; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Ramirez M, 2006, AM J SPORT MED, V34, P1147, DOI 10.1177/0363546505284385; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shirreffs SM, 2010, SCAND J MED SCI SPOR, V20, P90, DOI 10.1111/j.1600-0838.2010.01213.x; Stocker B D, 1997, J Ky Med Assoc, V95, P458; Weistroffer JK, 2011, AM J SPORT MED, V39, P632, DOI 10.1177/0363546510388901; Wham GS, 2010, J ATHL TRAINING, V45, P75, DOI 10.4085/1062-6050-45.1.75	34	9	9	1	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1543-3080	1543-5474		J PHYS ACT HEALTH	J. Phys. Act. Health	AUG	2015	12	8					1162	1167		10.1123/jpah.2014-0356			6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CY1CZ	WOS:000366145600017	25329725				2022-02-06	
J	Sohlberg, MM; Griffiths, GG; Fickas, S				Sohlberg, McKay Moore; Griffiths, Gina G.; Fickas, Stephen			An Exploratory Study of Reading Comprehension in College Students After Acquired Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							EDITION CVLT-II; CONFIRMATORY FACTOR-ANALYSIS; VERBAL-LEARNING TEST; SPOT-THE-WORD; HEAD-INJURY; UNIVERSITY-STUDENTS; ADULTS; IMPAIRMENT; MECHANISMS; DEFICITS	Purpose: This exploratory study builds on the small body of existing research investigating reading comprehension deficits in college students with acquired brain injury (ABI). Method: Twenty-four community college students with ABI completed a battery of questionnaires and standardized tests to characterize self-perceptions of academic reading ability, performance on a standardized reading comprehension measure, and a variety of cognitive functions of this population. Half of the participants in the sample reported traumatic brain injury (n = 12) and half reported nontraumatic ABI (n = 12). Results: College students with both traumatic and nontraumatic ABI cite problems with reading comprehension and academic performance postinjury. Mean performance on a standardized reading measure, the Nelson-Denny Reading Test (Brown, Fischo, & Hanna, 1993), was low to below average and was significantly correlated with performance on the Speed and Capacity of Language Processing Test (Baddeley, Emslie, & Nimmo-Smith, 1992). Injury status of traumatic versus nontraumatic ABI did not differentiate results. Regression analysis showed that measures of verbal attention and suppression obtained from the California Verbal Language Test-II (Delis, Kramer, Kaplan, & Ober, 2000) predicted total scores on the Nelson-Denny Reading Test. Conclusions: College students with ABI are vulnerable to reading comprehension problems. Results align with other research suggesting that verbal attention and suppression problems may be contributing factors.	[Sohlberg, McKay Moore; Griffiths, Gina G.; Fickas, Stephen] Univ Oregon, Eugene, OR 97403 USA		Sohlberg, MM (corresponding author), Univ Oregon, Eugene, OR 97403 USA.	mckay@uoregon.edu			National Science FoundationNational Science Foundation (NSF) [208710]	This study was supported by Grant 208710 from the National Science Foundation.	Ackerman R., 2009, NEW DIRECTIONS STUDE, V126, P5, DOI [https://doi.org/10.1002/ss.311, DOI 10.1002/SS.311]; BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Baddeley A., 1992, SPEED CAPACITY LANGU; Banos JH, 2004, NEUROPSYCHOLOGY, V18, P60, DOI 10.1037/0894-4105.18.1.60; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brown J, 1993, NELSON DENNY READING; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Coleman C, 2010, J LEARN DISABIL-US, V43, P244, DOI 10.1177/0022219409345017; Conners C. K., 2000, CONNERS CONTINUOUS P; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; *ED TEST SERV, 2007, POL STAT DOC LEARN D; Faul M, 2010, TRAUMATIC BRAIN INJU; George Mary G, 2011, Ann Neurol, V70, P713, DOI 10.1002/ana.22539; GERNSBACHER MA, 1991, PSYCHOL LEARN MOTIV, V27, P217, DOI 10.1016/S0079-7421(08)60125-5; Gernsbacher MA, 1997, DISCOURSE PROCESS, V23, P265, DOI 10.1080/01638539709544994; GERNSBACHER MA, 1991, J EXP PSYCHOL LEARN, V17, P245, DOI 10.1037/0278-7393.17.2.245; Griffiths GG, 2016, NEUROPSYCHOL REHABIL, V26, P161, DOI 10.1080/09602011.2015.1007878; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Gronwall D., 1977, PERCEPT MOTOR SKILL, V44, P363; Harrison LH, 2010, CLIN INFECT DIS, V50, pS37, DOI 10.1086/648963; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Kintsch W., 1998, COMPREHENSION PARADI; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Lezak MD, 2012, NEUROPSYCHOLOGICAL A; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Mann L., 2006, THESIS U MICHIGAN AN; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; National Institutes of Health, 2003, STROK SCAL; Numan B, 2000, J CLIN PSYCHOL, V56, P553, DOI 10.1002/(SICI)1097-4679(200004)56:4<553::AID-JCLP8>3.0.CO;2-Q; Office of Management and Budget, 2009, FED REG, V74; Radford A. W., 2009, 2009182 NCES I ED SC; Ramirez R.R., 2011, OVERVIEW RACE HISPAN; RAND Reading Study Group, 2002, READING UNDERSTANDIN; Rashotte C.A ., 2012, TEST WORD READING EF; Ready RE, 2013, J LEARN DISABIL-US, V46, P377, DOI 10.1177/0022219412468160; Relkin N, 2014, ADULT HYDROCEPHALUS, P70; Salmen D. J., 2004, THESIS U UTAH SALT L; Samuelsson S, 2004, J LEARN DISABIL-US, V37, P155, DOI 10.1177/00222194040370020601; Saxton J A, 2001, Appl Neuropsychol, V8, P193, DOI 10.1207/S15324826AN0804_1; Schaapsmeerders P, 2013, STROKE, V44, P1621, DOI 10.1161/STROKEAHA.111.000792; Shalev L., 2012, J VISION, V12, P672; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M. M., 2011, AM SPEECH LANG HEAR; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Sohlberg MM, 2014, AM J SPEECH-LANG PAT, V23, P160, DOI 10.1044/2013_AJSLP-12-0005; Steele J. L., 2010, MILITARY VETERANS EX; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Stine-Morrow EAL, 2001, PSYCHOL AGING, V16, P69, DOI 10.1037//0882-7974.16.1.69; Sullivan M., 2014, J MED SPEECH-LANG PA, V21, P413; Sullivan MP, 2014, J SPEECH LANG HEAR R, V57, P1731, DOI 10.1044/2014_JSLHR-L-13-0238; Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Tompkins CA, 2000, J SPEECH LANG HEAR R, V43, P62, DOI 10.1044/jslhr.4301.62; Turkstra L., 2004, PERSPECTIVES SCH BAS, V5, P19; Wechsler D., 1997, WECHSLER MEMORY SCAL; Yuspeh RL, 2000, ARCH CLIN NEUROPSYCH, V15, P319, DOI 10.1016/S0887-6177(99)00020-7	68	9	9	0	5	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	AUG	2015	24	3					358	373		10.1044/2015_AJSLP-14-0033			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	CV5UX	WOS:000364337800003	25763799				2022-02-06	
J	Taha, Z; Hassan, MHA; Hasanuddin, I				Taha, Zahari; Hassan, Mohd Hasnun Arif; Hasanuddin, Iskandar			Analytical modelling of soccer heading	SADHANA-ACADEMY PROCEEDINGS IN ENGINEERING SCIENCES			English	Article						Soccer heading; head impact; brain injury; mathematical model	BALL; HEADGEAR; PLAYERS; BRAIN; ACCELERATIONS; CONCUSSIONS; IMPAIRMENT; FREQUENCY; FOOTBALL	Heading occur frequently in soccer games and studies have shown that repetitive heading of the soccer ball could result in degeneration of brain cells and lead to mild traumatic brain injury. This study proposes a two degree-of-freedom linear mathematical model to study the impact of the soccer ball on the brain. The model consists of a mass-spring-damper system, in which the skull, the brain and the soccer ball are modelled as a mass and the neck modelled as a spring-damper system. The proposed model was compared with previous dynamic model for soccer ball-to-head impact. Moreover, it was also validated against drop ball experiment on an instrumented dummy skull and also compared with head acceleration data from previous studies. Comparison shows that our proposed model is capable of describing both the skull and brain accelerations qualitatively and quantitatively. This study shows that a simple linear mathematical model can be useful in giving a preliminary insight on the kinematics of human skull and brain during a ball-to-head impact. The model can be used to investigate the important parameters during soccer heading that affect the brain displacement and acceleration, thus providing better understanding of the mechanics behind it.	[Taha, Zahari; Hassan, Mohd Hasnun Arif] Univ Malaysia Pahang, Fac Mfg Engn, Innovat Mfg Mechatron & Sports Lab iMAMS, Pekan 26600, Pahang, Malaysia; [Hasanuddin, Iskandar] Univ Syiah Kuala, Dept Mech Engn, Banda Aceh 32111, Indonesia		Hassan, MHA (corresponding author), Univ Malaysia Pahang, Fac Mfg Engn, Innovat Mfg Mechatron & Sports Lab iMAMS, Pekan 26600, Pahang, Malaysia.	hasnun@ump.edu.my	Hassan, Mohd Hasnun Arif/H-1020-2016; Hasanuddin, Iskandar/Q-9186-2018	Hassan, Mohd Hasnun Arif/0000-0002-6681-1784; Hasanuddin, Iskandar/0000-0003-0899-7485			Baghaei S M, 2009, 25 SO BIOM ENG C 200; Bayly PV, 2002, P ANN INT IEEE EMBS, P2577, DOI 10.1109/IEMBS.2002.1053434; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dirisala V, 2012, INT J NUMER METH BIO, V28, P472, DOI 10.1002/cnm.1480; Hibbeler R C, 2009, ENG MECH DYNAMICS SI; Koerte I., 2012, JAMA-J AM MED ASSOC, V308, P2006; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; Nagurka M., 2006, INT J ENG EDUC, V22, P9; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Riches PE, 2006, SPORTS ENG, V9, P39, DOI 10.1007/BF02844261; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	23	9	9	3	17	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0256-2499	0973-7677		SADHANA-ACAD P ENG S	Sadhana-Acad. Proc. Eng. Sci.	AUG	2015	40	5					1567	1578		10.1007/s12046-015-0383-5			12	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CU1EA	WOS:000363261200009		Bronze			2022-02-06	
J	Wolf, A; Mulier, KE; Iyegha, UP; Asghar, JI; Beilman, GJ				Wolf, Andrea; Mulier, Kristine E.; Iyegha, Uroghupatei P.; Asghar, Javariah I.; Beilman, Gregory J.			SAFETY OF D-beta-HYDROXYBUTYRATE AND MELATONIN FOR THE TREATMENT OF HEMORRHAGIC SHOCK WITH POLYTRAUMA	SHOCK			English	Article						Resuscitation; intraosseous infusion; ketone bodies; antioxidant; ischemia; reperfusion; drug safety	TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL RESPIRATION; PORCINE MODEL; RATS; RESUSCITATION; MANAGEMENT; LACTATE; LIVER; DIMETHYLSULFOXIDE; HIBERNATION	D-beta-hydroxybutyrate (BHB) and melatonin (M) treatment improves survival in animal models of hemorrhagic shock. Here, we evaluated the safety of BHB/M via 2 routes of administration in a porcine hemorrhagic shock/polytrauma model. Furthermore, we assessed BHB/M serum concentrations after intravenous and intraosseous infusion of different BHB/M doses in healthy pigs. Pigs underwent pulmonary contusion, liver injury, and hemorrhage. Injured animals were treated with an intravenous or intraosseous bolus of BHB/M or lactated Ringer's solution (LR), followed by 4 h of continuous infusion of the respective fluid (n = 12 per group). Pigs were resuscitated with LR (1 h) and then LR and shed blood (20 h). Physiological data and blood samples were analyzed throughout the experiment. In a second study, we infused healthy pigs intravenously or intraosseously with BHB/M at 3 different doses (n = 4 per group). There were no differences between groups in physiologic measurements (heart rate, mean arterial pressure, and cardiac output), organ function markers (alanine aminotransferase, aspartate aminotransferase, serum urea nitrogen, total creatinine kinase, and lactate dehydrogenase), or histopathology. The BHB/M-treated animals exhibited transient changes in blood Na+, K+, pH, and lactate. Differences in survival were not statistically significant. There was a trend toward decreased survival after intraosseous infusion, potentially related to lower circulating BHB and melatonin levels. Healthy pigs had higher drug serum concentrations after intravenous than after intraosseous infusion of BHB/M at the standard, but not the double dose. D-beta-hydroxybutyrate /M in doses previously shown to be associated with improved survival is safe in a porcine hemorrhagic shock/polytrauma model. Intravenous infusion is the preferred route of administration at standard doses.	[Wolf, Andrea; Mulier, Kristine E.; Iyegha, Uroghupatei P.; Asghar, Javariah I.; Beilman, Gregory J.] Univ Minnesota, Dept Surg, 420 Delaware St SE,MMC 195, Minneapolis, MN 55455 USA		Wolf, A (corresponding author), Univ Minnesota, Dept Gen Surg, Div Crit Care & Acute Care Surg, 420 Delaware St SE,MMC 195, Minneapolis, MN 55455 USA.	awolf@umn.edu		Beilman, Gregory/0000-0001-5036-3027	USDOD ARMY [W81XWH-10-2-0121]	This work was supported by USDOD ARMY, Grant W81XWH-10-2-0121.	Alfonzo AVM, 2006, RESUSCITATION, V70, P10, DOI 10.1016/j.resuscitation.2005.11.002; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Buck ML, 2007, ANN PHARMACOTHER, V41, P1679, DOI 10.1345/aph.1K168; CHIOLERO R, 1993, AM J CLIN NUTR, V58, P608, DOI 10.1093/ajcn/58.5.608; DELATORRE JC, 1981, J TOXICOL ENV HEALTH, V7, P49, DOI 10.1080/15287398109529957; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; DuBose JJ, 2010, J TRAUMA, V68, P1172, DOI 10.1097/TA.0b013e3181d76d40; Hildebrand F, 2013, SHOCK, V40, P247, DOI 10.1097/SHK.0b013e3182a3cd74; Holcomb JB, 1999, J TRAUMA, V46, P49, DOI 10.1097/00005373-199901000-00009; Hsu JT, 2012, J PINEAL RES, V53, P410, DOI 10.1111/j.1600-079X.2012.01011.x; JAIMOVICH DG, 1989, ANN EMERG MED, V18, P842, DOI 10.1016/S0196-0644(89)80208-2; KAYE TS, 1983, LIFE SCI, V33, P1223, DOI 10.1016/0024-3205(83)90002-4; Klein AH, 2010, SHOCK, V34, P565, DOI 10.1097/SHK.0b013e3181e15063; Larkin JE, 2003, PHYSIOL BIOCHEM ZOOL, V76, P577, DOI 10.1086/375436; Lippi G, 2013, SEMIN THROMB HEMOST, V39, P83, DOI 10.1055/s-0032-1328936; Mathes AM, 2010, WORLD J GASTROENTERO, V16, P6087, DOI 10.3748/wjg.v16.i48.6087; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Mulier KE, 2012, RESUSCITATION, V83, P253, DOI 10.1016/j.resuscitation.2011.08.003; Pan JW, 2000, J CEREBR BLOOD F MET, V20, P1502, DOI 10.1097/00004647-200010000-00012; Phillips CR, 2009, CRIT CARE, V13, DOI 10.1186/cc7736; Pope A, 1999, FLUID RESUSCITATION; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x; RELMAN AS, 1972, KIDNEY INT, V1, P347, DOI 10.1038/ki.1972.46; REUTER A, 1992, EXP TOXICOL PATHOL, V44, P339, DOI 10.1016/S0940-2993(11)80224-1; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Tan DX, 1999, BBA-GEN SUBJECTS, V1472, P206, DOI 10.1016/S0304-4165(99)00125-7; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Waxman K, 1996, New Horiz, V4, P153; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	35	9	9	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	AUG	2015	44			1			79	89		10.1097/SHK.0000000000000315			11	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	DO3NA	WOS:000377687100013	25692249				2022-02-06	
J	Rossi, JL; Todd, T; Daniels, Z; Bazan, NG; Belayev, L				Rossi, Janet L.; Todd, Tracey; Daniels, Zachary; Bazan, Nicolas G.; Belayev, Ludmila			Interferon-Stimulated Gene 15 Upregulation Precedes the Development of Blood-Brain Barrier Disruption and Cerebral Edema after Traumatic Brain Injury in Young Mice	JOURNAL OF NEUROTRAUMA			English	Article						behavior; cerebral edema; ISG15; MLCK; traumatic brain injury; young mice	PROTEIN; UBIQUITIN; UBIQUITYLATION	Recent studies show that myosin light chain kinase (MLCK) plays a pivotal role in development of cerebral edema, a known complication following traumatic brain injury (TBI) in children and a contributing factor to worsened neurologic recovery. Interferon-stimulated gene 15 (ISG15) is upregulated after cerebral ischemia and is neuroprotective. The significant role of ISG15 after TBI has not been studied. Postnatal Day (PND) 21 and PND24 mice were subjected to lateral closed-skull injury with impact depth of 2.0 or 2.25mm. Behavior was examined at 7d using two-object novel recognition and Wire Hang tests. Mice were sacrificed at 6h, 12h, 24h, 48h, 72h, and 7d. ISG15 and MLCK were analyzed by Western blot and immunohistochemistry, blood-brain barrier (BBB) disruption with Evans Blue (EB), and cerebral edema with wet/dry weights. EB extravasation and edema peaked at 72h in both ages. PND21 mice had more severe neurological deficits, compared with PND24 mice. PND24 mice showed peak ISG15 expression at 6h, and PND21 mice at 72h. MLCK peaked in both age groups at 12h and co-localized with ISG15 on immunohistochemistry and co-immunoprecipitation. These studies provide evidence, ISG15 is elevated following TBI in mice, preceding MLCK elevation, development of BBB disruption, and cerebral edema.	[Rossi, Janet L.; Bazan, Nicolas G.; Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Childrens Hosp New Orleans, New Orleans, LA 70112 USA; [Rossi, Janet L.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA; [Todd, Tracey; Daniels, Zachary; Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, New Orleans, LA 70112 USA		Rossi, JL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, Lions Bldg 2020 Gravier 8th Floor,Suite D, New Orleans, LA 70112 USA.	jross5@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30 GM103340]; Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103340] Funding Source: NIH RePORTER	This study was supported in part by P30 GM103340 (JLR and NGB) from the National Institute of General Medical Sciences and the Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans.	Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Desai SD, 2012, EXP BIOL MED, V237, P38, DOI 10.1258/ebm.2011.011236; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; Faul M, 2010, TRAUMATIC BRAIN INJU; Galmiche G, 2013, CIRC RES, V112, P1035, DOI 10.1161/CIRCRESAHA.113.301076; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Maas A, 2014, LANCET, V7, P728; Nakka VP, 2011, J CEREBR BLOOD F MET, V31, P2375, DOI 10.1038/jcbfm.2011.103; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; National Hospital Discharge Survey [NHDS], 2010, NAT HOSP AMB MED CAR; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Rossi J., 2013, J NEUROTRAUM, V30, P1; Rossi JL, 2011, J NEUROSCI RES, V89, P852, DOI 10.1002/jnr.22600; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schaefer A., 2012, BIOCHEM J, V15, P12; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Wang Ren-Gang, 2012, Shengli Xuebao, V64, P577; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	31	9	10	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2015	32	14					1101	1108		10.1089/neu.2014.3611			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0TB	WOS:000363965000009	25669448	Green Published			2022-02-06	
J	Sung, KC; Liang, FW; Cheng, TJ; Lu, TH; Kawachi, I				Sung, Kuan-Chin; Liang, Fu-Wen; Cheng, Tain-Junn; Lu, Tsung-Hsueh; Kawachi, Ichiro			Trends in Unintentional Fall-Related Traumatic Brain Injury Death Rates in Older Adults in the United States, 1980-2010: A Joinpoint Analysis	JOURNAL OF NEUROTRAUMA			English	Article						accidents and injuries; cause of death; death certificate; falls; mortality; traumatic brain injury	SURVEILLANCE; EPIDEMIOLOGY	Unintentional fall-related traumatic brain injury (TBI) death rate is high in older adults in the United States, but little is known regarding trends of these death rates. We sought to examine unintentional fall-related TBI death rates by age and sex in older adults from 1980 through 2010 in the United States. We used multiple-cause mortality data from 1980 through 2010 (31 years of data) to identify fall-related TBI deaths. Using a joinpoint regression program, we determined the joinpoints (years at which trends change significantly) and annual percentage changes (APCs) in mortality trends. The fall-related TBI death rates (deaths per 100,000 population) in older adults ages 65-74, 75-84, and 85 years and above were 2.7, 9.2, and 21.5 for females and 8.5, 18.2, and 40.8 for males, respectively, in 1980. The rate was about the same in 1992, yet increased markedly to 5.9, 23.4, and 68.9 for females and 11.6, 41.2, and 112.4 for males, respectively, in 2010. For males all 65 years years of age and above, we found the first joinpoint in 1992, when the APC for 1980 through 1992, -0.8%, changed to 6.2% for 1992-2005. The second joinpoint occurred in 2005, when the APC decreased to 3.7% for 2005-2010. For all females 65 years of age and above, the first joinpoint was in 1993 when the APC for 1980 through 1993, -0.2%, changed to 7.6% from 1993 to 2005. The second joinpoint occurred in 2005 when the APC decreased to 3.8% for 2005-2010. This descriptive epidemiological study suggests increasing fall-related TBI death rates from 1992 to 2005 and then a slowdown of increasing trends between 2005 and 2010. Continued monitoring of fall-related TBI death rate trends is needed to determine the burden of this public health problem among older adults in the United States.	[Sung, Kuan-Chin] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Liang, Fu-Wen; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, Coll Med, NCKU Ctr Hlth Data, Tainan 701, Taiwan; [Liang, Fu-Wen; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 701, Taiwan; [Cheng, Tain-Junn] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Cheng, Tain-Junn] Chia Nan Univ Pharm & Sci, Inst Ind Safety & Disaster Prevent, Tainan, Taiwan; [Kawachi, Ichiro] Harvard Univ, Harvard Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA		Lu, TH (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, 1 Dah Hsueh Rd, Tainan 701, Taiwan.	robertlu@mail.ncku.edu.tw		Liang, Fu-Wen/0000-0002-3396-037X			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Faul M, 2010, TRAUMATIC BRAIN INJU; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Hu GQ, 2012, PUBLIC HEALTH REP, V127, P275, DOI 10.1177/003335491212700307; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; National Center for Health Statistics, VIT STAT DAT AV ONL; Rodriguez SR, 2006, PUBLIC HEALTH REP, V121, P282, DOI 10.1177/003335490612100310; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Stevens JA, 2001, JAMA-J AM MED ASSOC, V286, P2665, DOI 10.1001/jama.286.21.2665; Surveillance Research National Cancer Institute, JOINP REGR PROGR; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	18	9	9	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2015	32	14					1078	1082		10.1089/neu.2014.3509			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CV0TB	WOS:000363965000006	25331344				2022-02-06	
J	Ma, LX; Li, ZF; Liu, ZH; Li, M; Sui, DH; Liu, YL; Shao, W; Wang, B; Liu, PF; Li, G				Ma, Lixin; Li, Zefu; Liu, Zhihui; Li, Meng; Sui, Dehua; Liu, Yongliang; Shao, Wei; Wang, Bo; Liu, Pengfei; Li, Gang			17AAG improves histological and functional outcomes in a rat CCI model through autophagy activation and apoptosis attenuation	NEUROSCIENCE LETTERS			English	Article						TBI; 17-AAG; Autophagy; Apoptosis; Functional recovery	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; NEUROPROTECTION; ISCHEMIA; INDUCTION; RAPAMYCIN; PROTEIN; DEATH; CELLS	Traumatic brain injury (TBI) is caused by both primary and secondary injury mechanisms, all of which cause neuronal cell death and functional deficits. Both apoptosis and autophagy participated in neuronal cell death and functional loss induced following TBI. Preclinical findings implicate that 17-allylamino-demethoxygeldanamycin (17-AAG), an anticancer drug in clinical, present neuroprotection actions in multiple neurological disorders, but whether 17-AAG is capable of modulating neuronal autophagy has never been addressed. The present study was designed to determine the hypothesis that17-AAG treatment could confer neuroprotection in a rat model of TBI. We also used an autophagy inhibitor 3-methyladenine (3-MA) as well as an autophagy inducer rapamycin (RAPA) to test its underlining mechanisms. Our results showed that post-TBI administration of 17-AAG could attenuate brain edema, decrease neuronal death, as well as improve the recovery of motor function. Afterwards, in our model, 17-AAG treatment protected against TBI-induced apoptosis activation as well as enhanced neuronal autophagy. The present study provides novel clues in understanding the mechanisms of which 17-AAG exerts its neuroprotective activity on neurological disorders. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ma, Lixin; Li, Gang] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan 250012, Shandong, Peoples R China; [Ma, Lixin; Li, Zefu; Li, Meng; Sui, Dehua; Liu, Yongliang; Shao, Wei; Wang, Bo; Liu, Pengfei] Binzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Binzhou 256603, Shandong, Peoples R China; [Liu, Zhihui] Binzhou Med Coll, Affiliated Hosp, Dept Obstet & Gynaecol, Binzhou 256603, Shandong, Peoples R China		Li, G (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurosurg, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	mlx_182019@163.com					Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Batulan Z, 2006, NEUROBIOL DIS, V24, P213, DOI 10.1016/j.nbd.2006.06.017; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cordaro M., 2014, J NEUROTRAUMA; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Harrison EM, 2008, AM J PHYSIOL-RENAL, V295, pF397, DOI 10.1152/ajprenal.00361.2007; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; RINK A, 1995, AM J PATHOL, V147, P1575; Samokhvalov V, 2008, AUTOPHAGY, V4, P1034, DOI 10.4161/auto.6994; SHIGENO T, 1982, J NEUROSURG, V57, P99, DOI 10.3171/jns.1982.57.1.0099; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Won SJ, 2012, J NEUROTRAUM, V29, P1401, DOI 10.1089/neu.2011.2228; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhao HP, 2012, ADV PHARMACOL, V64, P1, DOI 10.1016/B978-0-12-394816-8.00001-5	27	9	10	1	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUL 10	2015	599						1	6		10.1016/j.neulet.2015.05.004			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM2WL	WOS:000357542900001	25957556				2022-02-06	
J	Logan, DM; Hill, KR; Larson, MJ				Logan, Dustin M.; Hill, Kyle R.; Larson, Michael J.			Cognitive control of conscious error awareness: error awareness and error positivity (Pe) amplitude in moderate-to-severe traumatic brain injury (TBI)	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						traumatic brain injury; TBI; cognitive control; error awareness; post-error positivity; Pe; ERP; event-related potential	CINGULATE CORTEX; FUNCTIONAL-SIGNIFICANCE; POSTTRAUMATIC AMNESIA; SELF-AWARENESS; PERFORMANCE; ATTENTION; INDIVIDUALS; VALIDATION; MECHANISMS; COMPONENTS	Poor awareness has been linked to worse recovery and rehabilitation outcomes following moderate-to-severe traumatic brain injury (M/S TBI). The error positivity (Pe) component of the event-related potential (ERP) is linked to error awareness and cognitive control. Participants included 37 neurologically healthy controls and 24 individuals with M/S TBI who completed a brief neuropsychological battery and the error awareness task (EAT), a modified Stroop go/no-go task that elicits aware and unaware errors. Analyses compared between-group no-go accuracy (including accuracy between the first and second halves of the task to measure attention and fatigue), error awareness performance, and Pe amplitude by level of awareness. The M/S TBI group decreased in accuracy and maintained error awareness over time; control participants improved both accuracy and error awareness during the course of the task. Pe amplitude was larger for aware than unaware errors for both groups; however, consistent with previous research on the Pe and TBI, there were no significant between-group differences for Pe amplitudes. Findings suggest possible attention difficulties and low improvement of performance over time may influence specific aspects of error awareness in M/S TBI.	[Logan, Dustin M.; Hill, Kyle R.; Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA		Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	Brigham Young University College of Family, Home, and Social Sciences	This study was supported by funds from the Brigham Young University College of Family, Home, and Social Sciences.	Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Bond M. R., 1986, NEUROPSYCHOLOGICAL A; Charles L, 2013, NEUROIMAGE, V73, P80, DOI 10.1016/j.neuroimage.2013.01.054; Clark J, 1924, AM J PHYSL OPTICS; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clayson PE, 2012, PSYCHOPHYSIOLOGY, V49, P627, DOI 10.1111/j.1469-8986.2011.01345.x; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dien J, 2006, BRAIN LANG, V97, P91, DOI 10.1016/j.bandl.2005.08.002; Dien J, 2010, BRAIN RES, V1355, P126, DOI 10.1016/j.brainres.2010.07.099; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Endrass T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00178; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hester R, 2005, NEUROIMAGE, V27, P602, DOI 10.1016/j.neuroimage.2005.04.035; Hester R, 2007, NEUROPSYCHOPHARMACOL, V32, P1974, DOI 10.1038/sj.npp.1301326; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Holdnack H.A., 2001, WECHSLER TEST ADULT; Hughes G, 2011, NEUROPSYCHOLOGIA, V49, P405, DOI 10.1016/j.neuropsychologia.2010.11.036; Keselman HJ, 2003, PSYCHOPHYSIOLOGY, V40, P586, DOI 10.1111/1469-8986.00060; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2009, NEUROREPORT, V20, P1486, DOI 10.1097/WNR.0b013e32833283fe; Larson MJ, 2009, NEUROPSYCHOLOGY, V23, P433, DOI 10.1037/a0015723; Leuthold H, 1999, CLIN NEUROPHYSIOL, V110, P342, DOI 10.1016/S1388-2457(98)00058-3; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Orr C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00177; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Ridderinkhof KR, 2009, PSYCHOPHYSIOLOGY, V46, P531, DOI 10.1111/j.1469-8986.2009.00790.x; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Samyn V, 2014, BIOL PSYCHOL, V99, P160, DOI 10.1016/j.biopsycho.2014.03.006; Shalgi S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00150; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; TEASDALE G, 1974, LANCET, V2, P81; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; Wessel JR, 2011, J COGNITIVE NEUROSCI, V23, P3021, DOI 10.1162/jocn.2011.21635; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8	59	9	10	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUL 7	2015	9								397	10.3339/fnhum.2015.00397			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CO1YB	WOS:000358951100001	26217212				2022-02-06	
J	Khan, A; Prince, M; Brayne, C; Prina, AM				Khan, A.; Prince, M.; Brayne, C.; Prina, A. M.			Lifetime Prevalence and Factors Associated with Head Injury among Older People in Low and Middle Income Countries: A 10/66 Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POPULATION-BASED SURVEY; ALZHEIMERS-DISEASE; RISK-FACTORS; HEALTH-CARE; FOLLOW-UP; DEMENTIA; ADULTS; EPIDEMIOLOGY; DISABILITY	Introduction Traumatic brain injury (TBI) is a growing public health problem around the world, yet there is little information on the prevalence of head injury in low and middle income countries (LMICs). We utilised data collected by the 10/66 research group to investigate the lifetime prevalence of head injury in defined sites in low and middle income countries, its risk factors and its relationship with disability. Methods We analysed data from one-phase cross-sectional surveys of all residents aged 65 years and older (n = 16430) distributed across twelve sites in eight low and middle income countries (China, Cuba, Dominican Republic, India, Venezuela, Mexico, Peru, and Puerto Rico). Self-reported cases of head injury with loss of consciousness were identified during the interview. A sensitivity analysis including data provided by informants of people with dementia was also used to estimate the impact of this information on the estimates. Prevalence ratios (PR) from Poisson regressions were used to identify associated risk factors. Results The standardised lifetime prevalence of TBI ranged from 0.3% in China to 14.6% in rural Mexico and Venezuela. Being male (PR: 1.6, 95% CI: 1.29-1.82), younger (PR: 0.95, 95% CI: 0.92-0.99), with lower education (PR 0.91, 95% CI: 0.86-0.96), and having fewer assets (PR 0.92, 95% CI: 0.88-0.96), was associated with a higher prevalence of TBI when pooling estimates across sites. Discussion Our analysis revealed that the prevalence of TBI in LMICs is similar to that of developed nations. Considering the growing impact of TBI on health resources in these countries, there is an urgent need for further research.	[Khan, A.; Brayne, C.; Prina, A. M.] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 0SR, England; [Prince, M.; Prina, A. M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Global Mental Hlth, Hlth Serv & Populat Res Dept, London SE5 8AF, England		Prina, AM (corresponding author), Univ Cambridge, Inst Publ Hlth, Forvie Site,Robinson Way, Cambridge CB2 0SR, England.	matthew.prina@kcl.ac.uk	Brayne, Carol/AAA-4285-2020; Prince, Martin J/A-9170-2010	Brayne, Carol/0000-0001-5307-663X; Prince, Martin J/0000-0003-1379-7146; Prina, Matthew/0000-0001-6698-3263	Wellcome Trust (UK)Wellcome Trust [GR066133]; World Health OrganizationWorld Health Organization; US Alzheimer's AssociationAlzheimer's Association [IIRG - 04 - 1286]; Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela); NIHR Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K021907/1]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K021907/1] Funding Source: UKRI; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0611-10084] Funding Source: researchfish	The 10/66 Dementia Research Group population based surveys were supported by: the Wellcome Trust (UK) (GR066133); the World Health Organization; the US Alzheimer's Association (IIRG - 04 - 1286); and the Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela). RS is funded by the NIHR Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Matthew Prina is funded by the Medical Research Council (Grant number = MR/K021907/1).	Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Faul M, 2010, TRAUMATIC BRAIN INJU; Fox WC, 2013, NEUROL RES, V35, P223, DOI 10.1179/1743132813Y.0000000162; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hsiao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002621; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kraus J, 1996, EPIDEMIOLOGY OF BRAI; LI G, 1992, NEUROLOGY, V42, P1481, DOI 10.1212/WNL.42.8.1481; Lu TH, 2012, INJURY PREV, V18, P150, DOI 10.1136/injuryprev-2011-040135; Ma S, 2012, TRAFFIC INJ PREV, V13, P57, DOI 10.1080/15389588.2011.633945; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Prina AM, 2011, PSYCHOL MED, V41, P2047, DOI 10.1017/S0033291711000444; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith K, 2010, AUST NZ J PSYCHIAT, V44, P888, DOI 10.3109/00048674.2010.491816; Sousa RM, 2010, INT J METH PSYCH RES, V19, P1, DOI 10.1002/mpr.299; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timmons SD, 2012, J NEUROSURG SCI, V56, P191; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; World Health Organization, 2006, NEUROLOGICAL DISORDE	43	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132229	10.1371/journal.pone.0132229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	WOS:000358157600222	26146992	Green Submitted, Green Published, gold			2022-02-06	
J	Van Vleet, TM; Chen, A; Vernon, A; Novakovic-Agopian, T; D'Esposito, MT				Van Vleet, Thomas M.; Chen, Anthony; Vernon, Alana; Novakovic-Agopian, Tatjana; D'Esposito, Mark T.			Tonic and phasic alertness training: a novel treatment for executive control dysfunction following mild traumatic brain injury	NEUROCASE			English	Article						executive function; traumatic brain injury; sustained attention; attention; rehabilitation	CLOSED-HEAD-INJURY; SUSTAINED ATTENTION; SPATIAL NEGLECT; REACTION-TIME; HEMISPATIAL NEGLECT; VISUAL-ATTENTION; RIGHT-HEMISPHERE; WORKING-MEMORY; DEFICITS; REHABILITATION	Many individuals with traumatic brain injury (TBI) suffer difficulty regulating fundamental aspects of attention (focus, sustained attention) and may also exhibit hypo- or hyper-states of alertness. Deficits in the state of attention may underlie or exacerbate higher order executive dysfunction. Recent studies indicate that computerized cognitive training targeting attentional control and alertness can ameliorate attention deficits evident in patients with TBI or acquired brain injury. The current study examined whether improvements in attentional state following training can also influence performance on higher-order executive function and mood in individuals with mild TBI (mTBI). The current study examined five patients with executive control deficits as a result of mTBI, with or without persistent anxiety. Three patients engaged in ~5hours of an executive control training task targeting inhibitory control and sustained attention; two additional patients were re-tested following the same period of time. Performance on standard neuropsychological measures of attention, executive function, and mood were evaluated pre- and post-training. The results indicate that tonic and phasic alertness training may improve higher-order executive function and mood regulation in individuals with TBI.	[Van Vleet, Thomas M.; Chen, Anthony; Vernon, Alana; Novakovic-Agopian, Tatjana; D'Esposito, Mark T.] Vet Adm Med Ctr, Martinez, CA 94553 USA; [Chen, Anthony; Novakovic-Agopian, Tatjana] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [D'Esposito, Mark T.] Univ Calif Berkeley, Helen Willis Neurosci Inst, Berkeley, CA 94720 USA; [Van Vleet, Thomas M.; Vernon, Alana] Brain Plast Inst, San Francisco, CA USA		Van Vleet, TM (corresponding author), Vet Adm Med Ctr, Martinez, CA 94553 USA.	tomvanvleet@gmail.com			Veterans AdministrationUS Department of Veterans Affairs [B4605I]; Veterans AffairsUS Department of Veterans Affairs [I01RX001111] Funding Source: NIH RePORTER	This work was supported by Veterans Administration, Merit Award [grant number B4605I].	Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; DeGutis JM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00060; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hester R, 2005, MEM COGNITION, V33, P221, DOI 10.3758/BF03195311; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Honzel N, 2014, COGN AFFECT BEHAV NE, V14, P792, DOI 10.3758/s13415-013-0219-x; Husain M, 1997, NATURE, V385, P154, DOI 10.1038/385154a0; Hyndman D, 2003, DISABIL REHABIL, V25, P817, DOI 10.1080/0963828031000122221; List A, 2008, J INT NEUROPSYCH SOC, V14, P243, DOI 10.1017/S1355617708080284; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2011, INT J PSYCHOPHYSIOL, V82, P107, DOI 10.1016/j.ijpsycho.2011.06.022; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ozdemir F, 2001, AM J PHYS MED REHAB, V80, P410, DOI 10.1097/00002060-200106000-00003; Perona P., 2007, CALTECH 256 OBJECT C; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P1527, DOI 10.1016/S0028-3932(97)00084-5; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P434, DOI 10.1016/j.neuropsychologia.2003.09.001; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tang YY, 2009, TRENDS COGN SCI, V13, P222, DOI 10.1016/j.tics.2009.01.009; TATEMICHI TK, 1994, STROKE, V25, P1915, DOI 10.1161/01.STR.25.10.1915; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Thimm M, 2006, NEUROPSYCHOLOGIA, V44, P1230, DOI 10.1016/j.neuropsychologia.2005.09.008; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Van Vleet TM, 2006, J COGNITIVE NEUROSCI, V18, P1368, DOI 10.1162/jocn.2006.18.8.1368; Van Vleet TM, 2013, CORTEX, V49, P679, DOI 10.1016/j.cortex.2012.03.020; Van Vleet TM, 2011, NEUROPSYCHOLOGIA, V49, P352, DOI 10.1016/j.neuropsychologia.2010.11.021; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Zomet A., 2013, COGN NEUR SOC ANN M	76	9	9	0	21	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	JUL 4	2015	21	4					489	498		10.1080/13554794.2014.928329			10	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	CG6IN	WOS:000353403300011	24984231				2022-02-06	
J	Patel, MB; Wilson, LD; Bregman, JA; Leath, TC; Humble, SS; Davidson, MA; de Riesthal, MR; Guillamondegui, OD				Patel, Mayur B.; Wilson, Laura D.; Bregman, Jana A.; Leath, Taylor C.; Humble, Stephen S.; Davidson, Mario A.; de Riesthal, Michael R.; Guillamondegui, Oscar D.			Neurologic Functional and Quality of Life Outcomes after TBI: Clinic Attendees versus Non-Attendees	JOURNAL OF NEUROTRAUMA			English	Article						neurologic function outcome; quality of life outcome; rehabilitation; TBI clinic; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; SCALE; VALIDITY; HEAD	This investigation describes the relationship between TBI patient demographics, quality of life outcome, and functional status outcome among clinic attendees and non-attendees. Of adult TBI survivors with intracranial hemorrhage, 63 attended our TBI clinic and 167 did not attend. All were telephone surveyed using the Extended-Glasgow Outcome Scale (GOSE), the Quality of Life after Brain Injury (QOLIBRI) scale, and a post-discharge therapy questionnaire. To determine risk factors for GOSE and QOLIBRI outcomes, we created multivariable regression models employing covariates of age, injury characteristics, clinic attendance, insurance status, post-discharge rehabilitation, and time from injury. Compared with those with severe TBI, higher GOSE scores were identified in individuals with both mild (odds ratio [OR]=2.0; 95% confidence interval [CI]: 1.1-3.6) and moderate (OR=4.7; 95% CI: 1.6-14.1) TBIs. In addition, survivors with private insurance had higher GOSE scores, compared with those with public insurance (OR=2.0; 95% CI: 1.1-3.6), workers' compensation (OR=8.4; 95% CI: 2.6-26.9), and no insurance (OR=3.1; 95% CI: 1.6-6.2). Compared with those with severe TBI, QOLIBRI scores were 11.7 points (95% CI: 3.7-19.7) higher in survivors with mild TBI and 17.3 points (95% CI: 3.2-31.5) higher in survivors with moderate TBI. In addition, survivors who received post-discharge rehabilitation had higher QOLIBRI scores by 11.4 points (95% CI: 3.7-19.1) than those who did not. Survivors with private insurance had QOLIBRI scores that were 25.5 points higher (95% CI: 11.3-39.7) than those with workers' compensation and 16.8 points higher (95% CI: 7.4-26.2) than those without insurance. Because neurologic injury severity, insurance status, and receipt of rehabilitation or therapy are independent risk factors for functional and quality of life outcomes, future directions will include improving earlier access to post-TBI rehabilitation, social work services, affordable insurance, and community resources.	[Patel, Mayur B.] Vet Affairs VA Tennessee Valley Healthcare Syst, Nashville, VA USA; [Patel, Mayur B.; Bregman, Jana A.; Leath, Taylor C.; Humble, Stephen S.; Guillamondegui, Oscar D.] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA; [Patel, Mayur B.; Bregman, Jana A.; Leath, Taylor C.; Humble, Stephen S.; Guillamondegui, Oscar D.] Vanderbilt Univ, Sch Med, Dept Neurosurg, Nashville, TN 37212 USA; [Wilson, Laura D.; de Riesthal, Michael R.] Vanderbilt Univ, Sch Med, Dept Hearing & Speech Sci, Nashville, TN 37212 USA; [Davidson, Mario A.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA		Patel, MB (corresponding author), 1211 21st Ave South,404 Med Arts Bldg, Nashville, TN 37212 USA.	mayur.b.patel@vanderbilt.edu	Davidson, Mario/AAX-1102-2021	Humble, Stephen/0000-0002-4666-8503	AHRQ Health Services [5T32HS013833-08]; AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality; Vanderbilt Physician-Scientist Development Grant; REDCap from NCATS/NIH [UL1 TR000445]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [T32HS013833] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445] Funding Source: NIH RePORTER	No competing financial interests exist. Disclosure of financial support: AHRQ Health Services 5T32HS013833-08, AHRQ (MBP); Vanderbilt Physician-Scientist Development Grant (MBP); REDCap, UL1 TR000445 from NCATS/NIH (all authors).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barker MD, 2014, J HEAD TRAUMA REHAB, V29, P400, DOI 10.1097/HTR.0b013e31828a0a45; Black KL, 2002, J HEAD TRAUMA REHAB, V17, P489, DOI 10.1097/00001199-200212000-00001; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jennett B., 2002, TRAUMA, V4, P91, DOI DOI 10.1191/1460408602TA2330A; Jeyaraj J. A., 2013, BRAIN INJURY, V27, P1; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Vikane E, 2014, BRAIN INJURY, V28, P1374, DOI 10.3109/02699052.2014.919532; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Zafonte RD, 1997, BRAIN INJURY, V11, P403	17	9	9	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					984	989		10.1089/neu.2014.3652			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200007	25683481	Green Published			2022-02-06	
J	Zupan, B; Neumann, D; Babbage, DR; Willer, B				Zupan, Barbra; Neumann, Dawn; Babbage, Duncan R.; Willer, Barry			Exploration of a new tool for assessing emotional inferencing after traumatic brain injury	BRAIN INJURY			English	Article						Emotional inferencing; context; traumatic brain injury	FACIAL AFFECT RECOGNITION; ASSESSING SOCIAL-PERCEPTION; NONVERBAL-COMMUNICATION; EXECUTIVE DYSFUNCTION; DIFFERENT MEDIA; VOCAL AFFECT; MIND; IMPAIRMENTS; LANGUAGE; CONTEXT	Objective: To explore validity of an assessment tool under development the Emotional Inferencing from Stories Test (EIST). This measure is being designed to assess the ability of people with traumatic brain injury (TBI) to make inferences about the emotional state of others solely from contextual cues. Methods and procedures: Study 1: 25 stories were presented to 40 healthy young adults. From this data, two versions of the EIST (EIST-1; EIST-2) were created. Study 2: Each version was administered to a group of participants with moderate-to-severe TBI EIST 1 group: 77 participants; EIST-2 group: 126 participants. Participants also completed a facial affect recognition (DANVA2-AF) test, Participants with facial affect recognition impairment returned 2 weeks later and were re-administered both tests. Main outcomes: Participants with TBI scored significantly lower than the healthy group mean for EIST-1, F(1,114) = 68.49, p<0.001, and EIST-2, F(1,163)=177.39, p<0.001. EIST scores in the EIST-2 group were significantly lower than the EIST-1 group, t=4.47, p<0.001. DANVA2-AF scores significantly correlated with EIST scores, EIST-1: r=0.50, p<0.001; EIST-2: r=0.31, p<0.001. Test-re-test reliability scores for the EIST were adequate. Conclusions: Both versions of the EIST were found to be sensitive to deficits in emotional inferencing. After further development, the EIST may provide clinicians valuable information for intervention planning.	[Zupan, Barbra] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada; [Neumann, Dawn] Rehabil Hosp Indiana, Dept Phys Med & Rehabil, Indiana Sch Med, Indianapolis, IN USA; [Babbage, Duncan R.] Auckland Univ Technol, Ctr eHlth, Auckland, New Zealand; [Willer, Barry] SUNY Buffalo, Sch Med, Dept Psychiat, Buffalo, NY 14260 USA		Zupan, B (corresponding author), Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada.	bzupan@brocku.ca		Barbra, Zupan/0000-0002-4603-333X; Babbage, Duncan/0000-0002-9259-9246	National Institute on Disability and Rehabilitation Research [H0133G080043]	This study was supported by the National Institute on Disability and Rehabilitation Research (grant no. H0133G080043).	[Anonymous], 2012, SUPERLAB VERS 5; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barrett LF, 2000, PERS SOC PSYCHOL B, V26, P1027, DOI 10.1177/01461672002611001; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bird J, 2014, NEUROREHABILITATION, V34, P39, DOI 10.3233/NRE-131006; Biszak AM, 2014, BRAIN INJURY, V28, P97, DOI 10.3109/02699052.2013.856475; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Brookshire R. H., 1993, DISCOURSE COMPREHENS; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Dethier M, 2013, J INT NEUROPSYCH SOC, V19, P367, DOI 10.1017/S1355617712001555; Downing S, 2009, STAT TESTING ASSESSM, P93; Duke M.P., 2008, MANUAL RECEPTIVE TES; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kincaid JPJ., 1975, DERIVATION NEW READA; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Lindquist KA, 2013, EMOT REV, V5, P66, DOI 10.1177/1754073912451351; Mallery P., 2003, SPSS WINDOWS STEP ST, V4th; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1999, BRAIN LANG, V68, P486, DOI 10.1006/brln.1999.2124; McDonald S, 2000, APHASIOLOGY, V14, P339, DOI 10.1080/026870300401397; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Neumann D, 2014, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000054, DOI 10.1097/HTR.0000000000000054.[EPUB]; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Osterlind SJ., 1998, CONSTRUCTING TEST IT, V2; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rosip JC, 2004, J NONVERBAL BEHAV, V28, P267, DOI 10.1007/s10919-004-4159-6; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560; Zupan B, 2009, J COMMUN DISORD, V42, P1, DOI 10.1016/j.jcomdis.2008.06.001	59	9	9	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					877	887		10.3109/02699052.2015.1011233			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800013	25950265	Green Submitted			2022-02-06	
J	Perez-Barcena, J; Romay, E; Llompart-Pou, JA; Ibanez, J; Brell, M; Llinas, P; Gonzalez, E; Merenda, A; Ince, C; Bullock, R				Perez-Barcena, Jon; Romay, Eduardo; Llompart-Pou, Juan Antonio; Ibanez, Javier; Brell, Malta; Llinas, Pedro; Gonzalez, Elsa; Merenda, Amedeo; Ince, Can; Bullock, Ross			Direct observation during surgery shows preservation of cerebral microcirculation in patients with traumatic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Brain contusion; Subdural hematoma; Microcirculation; Pericontusional penumbra; SDF imaging	ISCHEMIA; METABOLISM; VELOCITY; COMMON; DAMAGE; FLOW	Objective: To describe the alterations of the cortical microcirculation of the brain (blood flow and vessel density) in TBI patients who and compare them with a control group. Methods: Prospective and observational study in a third-level university hospital. Cortical microcirculation in the brain was directly observed using sidestream dark-field (SDF) imaging in 14 patients who underwent surgery: 5 subdural hematomas (SDH) and 9 parenchymal lesions (contusions/hematomas). In this last set of patients, images were recorded in the "pericontusional" areas and in the "surrounding" brain (areas that were as far from the lesion as the craniotomy allowed). These patients were compared to five patients who underwent craniotomy for a disease that did not affect the cortex. Results: There were fewer "pericontusional" images that could be analyzed due to the presence of subarachnoid hemorrhage. The proportion or perfused vessels was similar in all groups: control 99.5% +/- 13%; SDH 98.6% +/- 2.4%; "pericontusional" area 98.2% +/- 2.4%; "surrounding" area 98.4% +/- 2.5% (p = 0.145). The perfused vessel density index was smaller in the "pericontusional" area: control 6.5 +/- 1.6 1/mm; SDH 6.5 +/- 2.5 l/mm; "pericontusional" area 5.4 +/- 2.61/mm; "surrounding" 6.6 +/- 2.1 l/mm (p = 0.07). Conclusions: Although the analysis of pericontusional zone was difficult, there were fewer vessels than in the controls and there was no change in the flow. In the surrounding zone and in patients with SDH, we did not document alterations in the microcirculation. Direct imaging of cerebral microcirculation in TBI patients showed that despite serious brain injury the cerebral microcirculation was remarkably well preserved. (C) 2015 Elsevier B.V. All rights reserved.	[Perez-Barcena, Jon] Univ Miami, Jackson Mem Hosp, Neurocrit Care Unit, Miami, FL 33136 USA; [Romay, Eduardo; Ince, Can] Univ Amsterdam, Acad Med Ctr, Dept Translat Physiol, NL-1012 WX Amsterdam, Netherlands; [Llompart-Pou, Juan Antonio] Son Espases Univ Hosp, Dept Intens Care Med, Cadiz, Spain; [Ibanez, Javier; Brell, Malta; Llinas, Pedro; Gonzalez, Elsa] Son Espases Univ Hosp, Dept Neurosurg, Cadiz, Spain; [Merenda, Amedeo; Bullock, Ross] Univ Miami, Jackson Mem Hosp, Dept Neurosurg, Miami, FL 33136 USA		Perez-Barcena, J (corresponding author), Univ Miami, Jackson Mem Hosp, Miller Sch Med, Dept Neurol,Neurocrit Care Unit, 1120 NW 14th St, Miami, FL 33136 USA.	juan.perezbacerna@jhsmiami.org; edromay@gmail.com; juanantonio.llompart@ssib.es; javier.ibanez@ssib.es; marta.brell@ssib.es; pedro.llinas@ssib.es; elsa.gonzalez@ssib.es; amerenda@med.miami.edu; c.ince@amc.uva.nl; rbullock@med.miami.edu		Ibanez, Javier/0000-0003-3735-8332			Bezemer R, 2012, CRIT CARE, V16, DOI 10.1186/cc11236; Boerma EC, 2005, CRIT CARE, V9, pR601, DOI 10.1186/cc3809; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Chesnut R M, 1995, New Horiz, V3, P366; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Dobbe JGG, 2008, MED BIOL ENG COMPUT, V46, P659, DOI 10.1007/s11517-008-0349-4; Dubin A, 2009, INTENS CARE MED, V35, P556, DOI 10.1007/s00134-008-1385-0; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Marion DW, 2006, NEUROSURGERY, V58, P655; Mathura KR, 2001, LANCET, V358, P1698, DOI 10.1016/S0140-6736(01)06722-8; Menon DK, 2006, CURR OPIN CRIT CARE, V12, P85, DOI 10.1097/01.ccx.0000216572.19062.8f; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Pennings FA, 2004, STROKE, V35, P1284, DOI 10.1161/01.STR.0000126039.91400.cb; Pennings FA, 2006, NEUROSURGERY, V59, P167, DOI 10.1227/01.NEU.0000219242.92669.3B; Pennings FA, 2009, STROKE, V40, P317, DOI 10.1161/STROKEAHA.108.522375; Perez-Barcena J, 2011, CRIT CARE MED, V39, P1126, DOI 10.1097/CCM.0b013e31820ead5e; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Seylaz J, 1999, J CEREBR BLOOD F MET, V19, P863, DOI 10.1097/00004647-199908000-00005; Stocchetti N, 2004, CRIT CARE MED, V32, P1429, DOI 10.1097/01.CCM.0000128957.69536.A5; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019	27	9	9	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUN 15	2015	353	1-2					38	43		10.1016/j.jns.2015.03.044			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK3PK	WOS:000356127800005	25911020				2022-02-06	
J	Lakkaraju, SK; Mbatia, H; Hanscom, M; Zhao, ZR; Wu, JF; Stoica, B; MacKerell, AD; Faden, AI; Xue, FT				Lakkaraju, Sirish K.; Mbatia, Hannah; Hanscom, Marie; Zhao, Zaorui; Wu, Junfang; Stoica, Bogdan; MacKerell, Alexander D., Jr.; Faden, Alan I.; Xue, Fengtian			Cyclopropyl-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Traumatic brain injury; Metabotropic glutamate receptor; Neuroprotection; Computer-aided drug design; Positive allosteric modulator	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; EXCITATORY AMINO-ACIDS; IN-VIVO; ACTIVATION; DISCOVERY; INHIBITORS; NEURODEGENERATION; ANTAGONISTS; EXPRESSION	Positive allosteric modulators (PAMs) binding to the transmembrane (TM) domain of metabotropic glutamate receptor 5 (mGluR5) are promising therapeutic agents for psychiatric disorders and traumatic brain injury (TBI). Novel PAMs based on a trans-2-phenylcyclopropane amide scaffold have been designed and synthesized. Facilitating ligand design and allowing estimation of binding affinities to the mGluR5 TM domain was the novel computational strategy, site identification by ligand competitive saturation (SILCS). The potential protective activity of the new compounds was evaluated using nitric oxide (NO) production in BV2 microglial cell cultures treated with lipopolysaccharide (LPS), and the toxicity of the new compounds tested using a cell viability assay. One of the new compounds, 3a, indicated promising activity with potency of 30 mu M, which is 4.5-fold more potent than its lead compound 3,3'-difluorobenzaldazine (DFB), and showed no detectable toxicity with concentrations as high as 1000 mu M. Thus this compound represents a new lead for possible development as treatment for TBI and related neurodegenerative disorders. (C) 2015 Elsevier Ltd. All rights reserved.	[Lakkaraju, Sirish K.; Mbatia, Hannah; MacKerell, Alexander D., Jr.; Xue, Fengtian] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA; [Hanscom, Marie; Zhao, Zaorui; Wu, Junfang; Stoica, Bogdan; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Hanscom, Marie; Zhao, Zaorui; Wu, Junfang; Stoica, Bogdan; Faden, Alan I.] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA		Xue, FT (corresponding author), Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, 20 Penn St, Baltimore, MD 21201 USA.	fxue@rx.umaryland.edu	STOICA, BOGDAN/H-9782-2013; MacKerell, Alex/Y-2469-2019; MacKerell, Alex/AAA-2560-2020	STOICA, BOGDAN/0000-0002-2501-6434; MacKerell, Alex/0000-0001-8287-6804; Lakkaraju, Sirish Kaushik/0000-0003-1553-5780; Hanscom, Marie/0000-0001-8308-135X; Faden, Alan I./0000-0003-0128-2348	UMB Pilot & Exploratory Interdisciplinary Research (IDR); University of Maryland Computer-Aided Drug Design Center; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R43GM109635]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R43GM109635] Funding Source: NIH RePORTER	This work was supported by the UMB Pilot & Exploratory Interdisciplinary Research (IDR) and University of Maryland Computer-Aided Drug Design Center and NIH Grant R43GM109635.	BRABET I, 1995, NEUROPHARMACOLOGY, V34, P895, DOI 10.1016/0028-3908(95)00079-L; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; DEMEDIUK P, 1989, J NEUROCHEM, V52, P1529, DOI 10.1111/j.1471-4159.1989.tb09204.x; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; Engers DW, 2009, CHEMMEDCHEM, V4, P505, DOI 10.1002/cmdc.200800357; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guvench O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000435; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; He X., 2015, BIOORG MED IN PRESS; Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335; Lakkaraju SK, 2015, J CHEM INF MODEL, V55, P700, DOI 10.1021/ci500729k; Lakkaraju SK, 2014, J CHEM THEORY COMPUT, V10, P2281, DOI 10.1021/ct500201y; Lakkaraju SK, 2013, J CHEM INF MODEL, V53, P1337, DOI 10.1021/ci400160x; Li HY, 2013, BIOORGAN MED CHEM, V21, P1333, DOI 10.1016/j.bmc.2012.12.019; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; McPhillie MJ, 2011, ACS MED CHEM LETT, V2, P729, DOI 10.1021/ml200087m; O'Brien JA, 2004, J PHARMACOL EXP THER, V309, P568, DOI 10.1124/jpet.103.061747; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Pearlman DA, 2001, J MED CHEM, V44, P3417, DOI 10.1021/jm0100279; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Pryde DC, 2007, BIOORGAN MED CHEM, V15, P142, DOI 10.1016/j.bmc.2006.10.002; Raman EP, 2013, J CHEM INF MODEL, V53, P3384, DOI 10.1021/ci4005628; Ritzen A, 2009, BIOORG MED CHEM LETT, V19, P3275, DOI 10.1016/j.bmcl.2009.04.095; Rodriguez AL, 2010, MOL PHARMACOL, V78, P1105, DOI 10.1124/mol.110.067207; Sekiyama N, 1996, BRIT J PHARMACOL, V117, P1493, DOI 10.1111/j.1476-5381.1996.tb15312.x; Sharma S, 2009, J MED CHEM, V52, P4103, DOI 10.1021/jm900654c; Spranger M, 1996, NEUROSCIENTIST, V2, P293, DOI 10.1177/107385849600200515; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wisniewski K, 2002, CNS DRUG REV, V8, P101; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xue FT, 2014, CNS NEUROL DISORD-DR, V13, P558, DOI 10.2174/18715273113126660199; Zhao ZJ, 2007, BIOORG MED CHEM LETT, V17, P1386, DOI 10.1016/j.bmcl.2006.11.081	40	9	9	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUN 1	2015	25	11					2275	2279		10.1016/j.bmcl.2015.04.042			5	Chemistry, Medicinal; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Pharmacology & Pharmacy; Chemistry	CH5ZR	WOS:000354115400003	25937015	Green Accepted			2022-02-06	
J	Mann, A; Smoum, R; Trembovler, V; Alexandrovich, A; Breuer, A; Mechoulam, R; Shohami, E				Mann, Aniv; Smoum, Reem; Trembovler, Victoria; Alexandrovich, Alexander; Breuer, Aviva; Mechoulam, Raphael; Shohami, Esther			Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury	JOURNAL OF NEUROIMMUNE PHARMACOLOGY			English	Article						TBI; CHI; Endocannabinoid; FAAA; PalmS; 2-AG	CLOSED-HEAD INJURY; NEURAL PROGENITOR PROLIFERATION; ARACHIDONOYL-L-SERINE; MICE; MODEL; EXPRESSION; RECOVERY; DEFICITS; SYSTEM; IMPACT	The endocannabinoid (eCB) system helps recovery following traumatic brain injury (TBI). Treatment with 2-arachidonoylglycerol (2-AG), a cerebral eCB ligand, was found to ameliorate the secondary damage. Interestingly, the fatty acid amino acid amide (FAAA) N-arachidonoyl-L-serine (AraS) exerts similar eCB dependent neuroprotective. The present study aimed to investigate the effects of the FAAA palmitoyl-serine (PalmS) following TBI. We utilized the TBI model in mice to examine the therapeutic potential of PalmS, injected 1 h following closed head injury (CHI). We followed the functional recovery of the injured mice for 28 days post-CHI, and evaluated cognitive and motor function, lesion volume, cytokines levels, molecular signaling, and infarct volume at different time points after CHI. PalmS treatment led to a significant improvement of the neurobehavioral outcome of the treated mice, compared with vehicle. This effect was attenuated in the presence of eCBR antagonists and in CB2-/- mice, compared to controls. Unexpectedly, treatment with PalmS did not affect edema and lesion volume, TNF alpha and IL1 beta levels, anti-apoptotic mechanisms, nor did it exert improvement in cognitive and motor function. Finally, co-administration of PalmS, AraS and 2-AG, did not enhance the effect of the individual drugs. We suggest that the neuroprotective action of PalmS is mediated by indirect activation of the eCB receptors following TBI. One such mechanism may involve receptor palmitoylation which has been reported to result in structural stabilization of the receptors and to an increase in their activity. Further research is required in order to establish this assumption.	[Mann, Aniv; Smoum, Reem; Trembovler, Victoria; Alexandrovich, Alexander; Breuer, Aviva; Mechoulam, Raphael; Shohami, Esther] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, IL-91120 Jerusalem, Israel		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, IL-91120 Jerusalem, Israel.	esty.shohami@mail.huji.ac.il			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA-9789]; Kessler Foundation; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P01DA009789] Funding Source: NIH RePORTER	This study was supported by a NIH grant DA-9789; RM thanks the Kessler Foundation for financial support.	Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Garcia MD, 2009, EUR J PHARMACOL, V610, P75, DOI 10.1016/j.ejphar.2009.03.021; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Hansen HS, 2002, PHARMACOL THERAPEUT, V95, P119, DOI 10.1016/S0163-7258(02)00251-6; Hanus L, 2014, BIOFACTORS, V40, P381, DOI 10.1002/biof.1166; Javadi-Paydar M, 2011, BRAIN RES, V1386, P89, DOI 10.1016/j.brainres.2011.02.057; Ker K, 2008, COCHRANE DB SYST REV, V23; Kuhla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068778; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Mechoulam R, 2013, BRIT J PHARMACOL, V170, P1363, DOI 10.1111/bph.12400; Milman G, 2006, P NATL ACAD SCI USA, V103, P2428, DOI 10.1073/pnas.0510676103; Mohan M. L., 2012, CURR MOL PHARM; Oddi S, 2012, BRIT J PHARMACOL, V165, P2635, DOI 10.1111/j.1476-5381.2011.01658.x; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Przybylkowski A, 2013, NEUROCHEM RES, V38, P2037, DOI 10.1007/s11064-013-1111-3; Smoum R, 2010, P NATL ACAD SCI USA, V107, P17710, DOI 10.1073/pnas.0912479107; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Tsutsumi Ryouhei, 2008, Seikagaku, V80, P1119; van der Stelt M, 2002, MOL NEUROBIOL, V26, P317, DOI 10.1385/MN:26:2-3:317; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Weiss L, 2008, NEUROPHARMACOLOGY, V54, P244, DOI 10.1016/j.neuropharm.2007.06.029; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	42	9	12	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1890	1557-1904		J NEUROIMMUNE PHARM	J. Neuroimmune Pharm.	JUN	2015	10	2					356	363		10.1007/s11481-015-9595-z			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CK5WF	WOS:000356296100016	25721934				2022-02-06	
J	Ebrahimi, I; Golnaraghi, F; Wang, GG				Ebrahimi, Iman; Golnaraghi, Farid; Wang, G. Gary			Factors Influencing the Oblique Impact Test of Motorcycle Helmets	TRAFFIC INJURY PREVENTION			English	Article						linear acceleration; oblique impact; motorcycle helmet; rotational acceleration	DIFFUSE AXONAL INJURY; HEAD	Purpose: Oblique impact tests can provide important information regarding the level of protection of a helmet. Two factors that influence the results of oblique impact tests on motorcycle helmets are discussed in this work. The first factor is the angle of the anvil on which the helmet impacts. The second one is the friction between the headform and the helmet's interior. Methods: To study the first factor, 2 anvil angles are provided, one 30 degrees and the other one 15 degrees to the vertical. To analyze the second factor, we consider 2 types of headform surfaces: the original metal surface of the standard headform and the same headform covered uniformly with a layer of silicone rubber that is 1mm thick. Results: The results show that varying the anvil's angle and surface friction can directly affect the linear and rotational acceleration of the headform. Conclusion: Testing helmets for different oblique impact angles can help assess their protection capability. The coefficient of friction between the helmet's interior and the headform plays an important role in the headform's rotational acceleration during an impact. Using a standard surface friction for headform similar or close to that of the human scalp can ensure that the results of the oblique impact tests are more consistent and realistic.	[Ebrahimi, Iman; Golnaraghi, Farid; Wang, G. Gary] Simon Fraser Univ, Sch Mechatron Syst Engn, Surrey, BC V3T 0A3, Canada		Ebrahimi, I (corresponding author), Simon Fraser Univ, Sch Mechatron Syst Engn, 13450 102nd Ave, Surrey, BC V3T 0A3, Canada.	imane@sfu.ca			NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); MITACS; Innovata Labs	The authors thank NSERC, MITACS and Innovata Labs for supporting this research project.	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; [Anonymous], 2001, COST327 EUR COMM; [Anonymous], 2010, STAND PROT HEADG; [Anonymous], 1985, BS6658; Department of Transportation. Motorcycle Helmets, 2010, 218 DEP TRANSP; Faul M, 2010, TRAUMATIC BRAIN INJU; GAMBAROTTA L, 2002, P 5 WORLD C COMP MEC; Hilyard J., 1976, HDB HUMAN TOLERANCE, P143; Holbourn AHS, 1943, LANCET, V2, P438; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P835, DOI 10.1080/15389588.2013.774083; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mills NJ, 2010, INT J CRASHWORTHINES, V15, P331, DOI 10.1080/13588260903251000; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; Otte D., 1991, 912911 SAE; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; United Nations Economic Commission for Europe, 2002, UNECE2205; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071	23	9	9	0	20	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	MAY 19	2015	16	4					404	408		10.1080/15389588.2014.937804			5	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	AY8ES	WOS:000347787800012	25023929				2022-02-06	
J	Baschera, D; Rad, H; Collopy, D; Zellweger, R				Baschera, Dominik; Rad, Hooman; Collopy, Dermot; Zellweger, Rene			Incidence and clinical relevance of heterotopic ossification after internal fixation of acetabular fractures: retrospective cohort and case control study	JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH			English	Article						Acetabular fractures; Heterotopic ossification; Prophylaxis; Internal fixation; Trauma	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; OSTEOARTHRITIS OUTCOME SCORE; TRAUMATIC BRAIN-INJURY; TOTAL HIP-REPLACEMENT; OPERATIVE TREATMENT; RISK-FACTORS; INDOMETHACIN PROPHYLAXIS; BONE-FORMATION; SURGERY; DISABILITY	Objective: The aim of the study was to evaluate predictors and clinical relevance of heterotopic ossification (HO) in patients treated for acetabular fractures in a tertiary referral centre. Patients and methods: The study is a retrospective cohort study with a nested case-control study. All patients treated with internal fixation of acetabular fractures from January 2004 to October 2013. Ninety patients had postoperative imaging available at 6 and 12 months postoperatively and received no prophylaxis. Plain radiographs were used to grade HO. The Hip disability and Osteoarthritis Outcome Score (HOOS) was used to compare outcomes between patients suffering from HO with patients who did not. Results: Sixteen patients (17.7%) suffered from HO. According to the Brooker classification, 5 had class I, 4 class II, 3 class III and 4 class IV HO. Traumatic brain injury (TBI) was the only significant risk factor for developing HO (odds ratio (OR) 8.6, 95% confidence interval (CI) (1.693-43.753), p = 0.014). The HO rate in patients with an anterior (ilioinguinal) or posterior (Kocher-Langenbeck) surgical approach was 20% and 21% respectively, and the HO rate in patients with a combined approach was much lower at 11%. Neither fracture type nor gender nor age increased the risk of HO significantly. The outcome measured by HOOS was not significantly different between patients with HO and patients in the control group. Patients with HO Brooker class II-IV had slightly lower (effect estimate +4.25, 95% CI (-10.2 to +12.10), p = 0.220) HOOS compared to the majority of the control group. Conclusion: A very low rate of HO was found compared to the HO rates described in other studies with similar patient cohorts who received prophylaxis. Based on our findings and the current literature, we do not recommend giving prophylaxis against HO to patients after internal fixation of acetabular fractures.	[Baschera, Dominik; Rad, Hooman; Collopy, Dermot; Zellweger, Rene] Royal Perth Hosp, Dept Orthopaed & Trauma Surg, Perth, WA 6000, Australia; [Zellweger, Rene] Univ Western Australia, Crawley, WA 6009, Australia		Baschera, D (corresponding author), Royal Perth Hosp, Dept Orthopaed & Trauma Surg, Perth, WA 6000, Australia.	dbaschera@bluewin.ch	Dominik, Baschera/AAI-1953-2021	Dominik, Baschera/0000-0002-9634-9922			BOSSE MJ, 1988, J BONE JOINT SURG AM, V70A, P1231, DOI 10.2106/00004623-198870080-00016; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Burd TA, 2003, J BONE JOINT SURG BR, V85B, P700, DOI 10.1302/0301-620X.85B5.13970; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; Daum W J, 1992, J Orthop Trauma, V6, P427, DOI 10.1097/00005131-199212000-00006; Firoozabadi R, 2014, CLIN ORTHOP RELAT R, V472, P3383, DOI 10.1007/s11999-014-3719-2; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; GHALAMBOR N, 1994, CLIN ORTHOP RELAT R, P96; Giannoudis PV, 2005, J BONE JOINT SURG BR, V87B, P2, DOI 10.1302/0301-620X.87B1.15605; Griffin SM, 2013, CLIN ORTHOP RELAT R, V471, P2776, DOI 10.1007/s11999-013-2871-4; Kaempffe F A, 1991, J Orthop Trauma, V5, P439, DOI 10.1097/00005131-199112000-00009; Karunakar MA, 2006, J BONE JOINT SURG BR, V88B, P1613, DOI 10.1302/0301-620X.88B12.18151; Klassbo M, 2003, SCAND J RHEUMATOL, V32, P46, DOI 10.1080/03009740310000409; Macfarlane RJ, 2008, EXPERT OPIN PHARMACO, V9, P767, DOI 10.1517/14656566.9.5.767; Matta JM, 1997, J BONE JOINT SURG BR, V79B, P959, DOI 10.1302/0301-620X.79B6.6889; MCLAREN AC, 1990, J BONE JOINT SURG AM, V72A, P245, DOI 10.2106/00004623-199072020-00012; Mears DC, 2003, CLIN ORTHOP RELAT R, P173, DOI 10.1097/01.blo.0000043057.62337.3a; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; OATES JA, 1988, NEW ENGL J MED, V319, P689, DOI 10.1056/NEJM198809153191106; Oertel S, 2008, STRAHLENTHER ONKOL, V184, P212, DOI 10.1007/s00066-008-1757-y; Sagi HC, 2014, J ORTHOP TRAUMA, V28, P377, DOI 10.1097/BOT.0000000000000049; Schneider V, 2006, AM J EPIDEMIOL, V164, P881, DOI 10.1093/aje/kwj331; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; THOMAS BJ, 1992, ORTHOP CLIN N AM, V23, P347; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; TONNA EA, 1961, P SOC EXP BIOL MED, V107, P719; Vuolteenaho K, 2008, BASIC CLIN PHARMACOL, V102, P10, DOI 10.1111/j.1742-7843.2007.00149.x; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	29	9	11	0	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1749-799X			J ORTHOP SURG RES	J. Orthop. Surg. Res.	MAY 9	2015	10								60	10.1186/s13018-015-0202-z			7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	CI0NF	WOS:000354433200001	25956896	Green Published, gold			2022-02-06	
J	Johnstone, B; Cohen, D; Bryant, KR; Glass, B; Christ, SE				Johnstone, Brick; Cohen, Dan; Bryant, Kirk R.; Glass, Bret; Christ, Shawn E.			Functional and Structural Indices of Empathy: Evidence for Self-Orientation as a Neuropsychological Foundation of Empathy	NEUROPSYCHOLOGY			English	Article						affective empathy; cognitive empathy; self-orientation; right parietal lobe; neuropsychology	CEREBRAL-BLOOD-FLOW; COGNITIVE FLEXIBILITY; PROSOCIAL PERSONALITY; ROLE-IDENTITY; HUMAN BRAIN; SYSTEMS; NEUROSCIENCE; LESIONS; RECOGNITION; IMPAIRMENT	Objective: To evaluate a model that hypothesizes that empathy is associated with decreased right parietal lobe (RPL)-related self-orientation (i.e., increased selflessness), which allows individuals to more easily empathize with others. Methods: Participants: Thirty one individuals with documented neuroradiological abnormalities due to traumatic brain injury (TBI) referred for clinical evaluations. Measures: Cerebral integrity was measured with both functional (i.e., neuropsychological tests) and structural indices (i.e., MRI). Participants were administered comprehensive neuropsychological tests associated with general bilateral frontal, temporal, and parietal lobe functioning, a self-report measure of empathy (i.e., Penner's Prosocial Personality Battery), and an objective measure of empathy (i.e., Prisoner's Dilemma). Twenty participants also completed structural MRI analysis of the bilateral frontal, temporal, parietal, and insular cortices measured in terms of volume. Results: Pearson correlations indicated that empathy was related to increased neuropsychological indices of RPL and frontal lobe (primarily left frontal) functioning. The only MRI indices associated with empathy were the bilateral insula. Neither functional nor structural cerebral indices were significantly related to objective measures of empathy. Conclusions: Contrary to hypotheses, empathy appears to be associated with increased RPL functioning. It is suggested that to incorporate the experiences of others into the experience of the self (i.e., to be empathetic), one must have an intact sense of the self.	[Johnstone, Brick; Bryant, Kirk R.] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65212 USA; [Cohen, Dan] Univ Missouri, Dept Religious Studies, Columbia, MO 65212 USA; [Glass, Bret; Christ, Shawn E.] Univ Missouri, Dept Psychol Sci, Columbia, MO 65212 USA		Johnstone, B (corresponding author), Univ Missouri, Dept Hlth Psychol, DC116-88, Columbia, MO 65212 USA.	johnstoneg@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649			Austin JH, 2009, SELFLESS INSIGHT: ZEN AND THE MEDITATIVE TRANSFORMATIONS OF CONSCIOUSNESS, P1; Banissy MJ, 2012, NEUROIMAGE, V62, P2034, DOI 10.1016/j.neuroimage.2012.05.081; Batson CD, 1999, EUR J SOC PSYCHOL, V29, P909, DOI 10.1002/(SICI)1099-0992(199911)29:7<909::AID-EJSP965>3.0.CO;2-L; Beadle JN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00069; Benedict R., 1997, BRIEF VISUOSPATIAL M; BENTON A, 1975, NEUROLOGY, V25, P907, DOI 10.1212/WNL.25.10.907; Benton A., 1983, JUDGEMENT LINE ORIEN; Brasure M., 2012, AGENCY HEALTHCARE RE, V72, pES1; Cozolino L., 2006, NEUROSCIENCE HUMAN R; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2009, MORAL BRAIN: ESSAYS ON THE EVOLUTIONARY AND NEUROSCIENTIFIC ASPECTS OF MORALITY, P109, DOI 10.1007/978-1-4020-6287-2_5; Delis DC., 2001, DELIS KAPLAN EXECUTI; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Feinberg T., 2005, LOST SELF PATHOLOGIE; Feinberg TE, 2005, CONSCIOUS COGN, V14, P661, DOI 10.1016/j.concog.2005.01.002; Finkelstein MA, 2005, SOC BEHAV PERSONAL, V33, P403, DOI 10.2224/sbp.2005.33.4.403; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; GRATTAN LM, 1994, NEUROPSY NEUROPSY BE, V7, P251; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Heaton R. K., 2004, REVISED COMPREHENSIV; Johnstone B, 1995, Appl Neuropsychol, V2, P24, DOI 10.1207/s15324826an0201_4; Johnstone B., 2014, RELIG BRAIN BEHAV; Johnstone B, 2012, INT J PSYCHOL RELIG, V22, P267, DOI 10.1080/10508619.2012.657524; Johnstone B, 2008, ZYGON, V43, P861, DOI 10.1111/j.1467-9744.2008.00964.x; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Keenan JP, 2001, BRAIN COGNITION, V47, P87; Lee KH, 2012, SOC COGN AFFECT NEUR, V7, P521, DOI 10.1093/scan/nsp001; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MEADOR KJ, 1993, J CLIN EXP NEUROPSYC, V15, P832, DOI 10.1080/01688639308402599; Mesulam MM, 2000, PRINCIPLES BEHAV COG; Mutschler I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00177; Newberg A, 2003, PERCEPT MOTOR SKILL, V97, P625, DOI 10.2466/PMS.97.5.625-630; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg A, 1997, J NUCL MED, V38, P77; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Penner LA, 2002, J SOC ISSUES, V58, P447, DOI 10.1111/1540-4560.00270; Penner LA, 1998, J PERS SOC PSYCHOL, V74, P525, DOI 10.1037/0022-3514.74.2.525; PENNER LA, 1995, ADV PERSONALITY ASSE, V10; Platek SM, 2008, BRAIN RES, V1232, P173, DOI 10.1016/j.brainres.2008.07.010; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Rankin KP, 2005, COGN BEHAV NEUROL, V18, P28, DOI 10.1097/01.wnn.0000152225.05377.ab; Reitan RM, 1992, TRAIL MAKING TEST MA; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Schmand B, 2014, J ALZHEIMERS DIS, V40, P409, DOI 10.3233/JAD-131484; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Skoe EEA, 2002, SEX ROLES, V46, P295, DOI 10.1023/A:1020224512888; Tranel D., 2002, HDB MEMORY DISORDERS; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Urgesi C, 2010, NEURON, V65, P309, DOI 10.1016/j.neuron.2010.01.026; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	74	9	9	0	28	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2015	29	3					463	472		10.1037/neu0000155			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CH3CX	WOS:000353905300015	25401998				2022-02-06	
J	Kennedy, JE; Cooper, DB; Reid, MW; Tate, DF; Lange, RT				Kennedy, Jan E.; Cooper, Douglas B.; Reid, Matthew W.; Tate, David F.; Lange, Rael T.			Profile Analyses of the Personality Assessment Inventory Following Military-Related Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Personality assessment inventory; Postconcussion; Military; Cluster analysis	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; PTSD CHECKLIST PCL; PSYCHOMETRIC PROPERTIES; ENDURING FREEDOM; IRAQI FREEDOM; RISK-FACTORS; HEAD-INJURY; VETERANS; HEALTH	Personality Assessment Inventory (PAI) profiles were examined in 160 U.S. service members (SMs) following mild-severe traumatic brain injury (TBI). Participants who sustained a mild TBI had significantly higher PAI scores than those with moderate-severe TBI on eight of the nine clinical scales examined. A two-step cluster analysis identified four PAI profiles, heuristically labeled "High Distress", "Moderate Distress", "Somatic Distress," and "No Distress". Postconcussive and posttraumatic stress symptom severity was highest for the High Distress group, followed by the Somatic and Moderate Distress groups, and the No Distress group. Profile groups differed in age, ethnicity, rank, and TBI severity. Findings indicate that meaningful patterns of behavioral and personality characteristics can be detected in active duty military SMs following TBI, which may prove useful in selecting the most efficacious rehabilitation strategies.	[Kennedy, Jan E.; Cooper, Douglas B.; Reid, Matthew W.; Tate, David F.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, Ft Sam Houston, TX USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada		Kennedy, JE (corresponding author), Brooke Army Med Ctr, MCHE MDU DVBIC, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA.	jan.e.kennedy2.ctr@mail.mil	Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; Henry M. Jackson Foundation for the Advancement of Military Medicine and General Dynamics Information Technology	This work was supported by the Defense and Veterans Brain Injury Center and the Henry M. Jackson Foundation for the Advancement of Military Medicine and General Dynamics Information Technology.	Aldenderfer FA, 1984, CLUSTER ANAL; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2009, VA DOD CLIN PRACTICE; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Defense and Veterans Brain Injury Center, 2015, PROGR RET ACT FOLL A; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW TBI NUMB; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Denning LA., 2014, PREVENTING PSYCHOL D; Everitt B. S., 1993, CLUSTER ANAL; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kleinstauber M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010628.pub2; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Lange R. T., 2002, J COGNITIVE REHABILI, V20, P16; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lind AB, 2014, J PSYCHOSOM RES, V77, P516, DOI 10.1016/j.jpsychores.2014.07.015; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; MacManus D, 2012, SOC PSYCH PSYCH EPID, V47, P1353, DOI 10.1007/s00127-011-0443-z; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Morey, 1991, PERSONALITY ASSESSME; Morey L. C., 2003, ESSENTIALS PAI ASSES; Morey LC, 2011, PSYCHOL ASSESSMENT, V23, P456, DOI 10.1037/a0022173; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; MORRIS R, 1981, Journal of Clinical Neuropsychology, V3, P79, DOI 10.1080/01688638108403115; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Picardi Angelo, 2014, Clin Pract Epidemiol Ment Health, V10, P140, DOI 10.2174/1745017901410010140; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Piotrowski C, 2000, PSYCHOL REP, V86, P65, DOI 10.2466/PR0.86.1.65-66; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schinka J A, 1997, J Int Neuropsychol Soc, V3, P120; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seguin M, 2007, PSYCHOL MED, V37, P1575, DOI 10.1017/S0033291707000955; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Whiteside DM, 2012, J CLIN EXP NEUROPSYC, V34, P172, DOI 10.1080/13803395.2011.630648; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	54	9	9	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2015	30	3					236	247		10.1093/arclin/acv014			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CH1ZO	WOS:000353822600008	25857403	Green Published, Bronze			2022-02-06	
J	McDonald, S; Fisher, A; Togher, L; Tate, R; Rushby, J; English, T; Kelly, M; Mathersul, D; Froreich, F; Francis, H				McDonald, Skye; Fisher, Alana; Togher, Leanne; Tate, Robyn; Rushby, Jacqueline; English, Therese; Kelly, Michelle; Mathersul, Danielle; Froreich, Francesca; Francis, Heather			Adolescent Performance on The Awareness of Social Inference Test: TASIT	BRAIN IMPAIRMENT			English	Article						adolescence; social cognition; The Awareness of Social Inference Test; normative data	TRAUMATIC BRAIN-INJURY; HIGH-FUNCTIONING AUTISM; EMOTION RECOGNITION; FRONTOTEMPORAL DEMENTIA; FACIAL EXPRESSION; ASPERGER-SYNDROME; RIGHT-HEMISPHERE; SEX-DIFFERENCES; EYES TEST; MIND	Primary objective: Social cognition underlies social skills and can be disrupted in numerous developmental and acquired brain disorders during childhood and adolescence. Despite this, there are few tools to assess social cognition clinically in this age group. This study examined adolescent performance on The Awareness of Social Inference Test (TASIT), a valid measure of social cognition in adults. Design: Cross-sectional design examining performance on Parts 1, 2 and 3 of TASIT (and alternate forms) in Australian girls and boys with varying levels of English familiarity. Methods: 665 schoolchildren from private and government schools were administered TASIT subtests. Of these, 464 students aged 13-15 were selected to provide normative data. Scores from a further 97 provided information about the effects of lack of English familiarity. Results: The two Forms of TASIT were statistically equivalent for two of the three parts. Adolescents performed lower than adults, although the differences were not large. Some incremental effects were seen for chronological age. Gender effects were apparent on all subtests. Lack of English familiarity (i.e., English not spoken at home) reduced scores a further 6-13% relative to high English proficiency. Conclusions: TASIT appears to be suitable for adolescents. Norms are best aggregated across ages in adolescence and stratified according to gender.	[McDonald, Skye; Fisher, Alana; Rushby, Jacqueline; English, Therese; Kelly, Michelle; Mathersul, Danielle; Froreich, Francesca; Francis, Heather] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Tate, Robyn] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Kelly, Michelle/J-9739-2019; Fisher, Alana/T-1869-2019; Togher, Leanne/AAC-7083-2019; Rushby, Jacqueline/D-1820-2010	Kelly, Michelle/0000-0003-0375-816X; Rushby, Jacqueline/0000-0002-5018-638X; Togher, Leanne/0000-0002-4518-6748; Francis, Heather/0000-0002-7223-7782; Mathersul, Danielle/0000-0003-2372-8654; Fisher, Alana/0000-0002-6027-659X			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P1, DOI DOI 10.1023/A:1005653411471; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Blake ML, 2009, J SPEECH LANG HEAR R, V52, P359, DOI 10.1044/1092-4388(2009/07-0012); Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bosacki SL, 2000, J EDUC PSYCHOL, V92, P709, DOI 10.1037//0022-0663.92.4.709; Bowers D., 1991, FLORIDA AFFECT BATTE; Bowers L., 2010, SOCIAL LANGUAGE DEV; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Couture SM, 2010, PSYCHOL MED, V40, P569, DOI 10.1017/S003329170999078X; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; DEMOREST A, 1984, CHILD DEV, V55, P1527, DOI 10.2307/1130022; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M., 2000, AUTISM INT J RES PRA, V4, P370, DOI DOI 10.1177/1362361300004004003; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dews S, 1996, CHILD DEV, V67, P3071, DOI 10.2307/1131767; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Fournier NM, 2008, EPILEPSY BEHAV, V12, P460, DOI 10.1016/j.yebeh.2007.12.009; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hughes C, 1998, DEV PSYCHOL, V34, P1026, DOI 10.1037/0012-1649.34.5.1026; Jellesma FC, 2009, PSYCHOL HEALTH, V24, P881, DOI 10.1080/08870440801998970; Johnston L, 2008, AUST J PSYCHOL, V60, P135, DOI 10.1080/00049530701449521; Kern RS, 2009, PSYCHOL MED, V39, P645, DOI 10.1017/S0033291708003966; Keulers EHH, 2010, DEV NEUROPSYCHOL, V35, P555, DOI 10.1080/87565641.2010.494920; Kincaid J. P., 1975, 875 CHIEF NAV TECHN; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; KOLB B, 1992, BRAIN COGNITION, V20, P74, DOI 10.1016/0278-2626(92)90062-Q; Kosmidis MH, 2008, BEHAV NEUROL, V19, P65, DOI 10.1155/2008/157356; Lee NC, 2013, EMOTION, V13, P1030, DOI 10.1037/a0033560; Mathersul D, 2013, J CLIN EXP NEUROPSYC, V35, P655, DOI 10.1080/13803395.2013.809700; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S., 2011, AWARENESS SOCIAL INF; MCDONALD S, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI DOI 10.1017/S1355617713000428.PUBMED:23351330; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; PETTIT GS, 1988, CHILD DEV, V59, P107, DOI 10.2307/1130393; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Rosenberg-Kima RB, 2010, CHILD NEUROPSYCHOL, V16, P388, DOI 10.1080/09297041003671192; Sparks A, 2010, SCHIZOPHR RES, V122, P172, DOI 10.1016/j.schres.2010.06.011; Stronach ST, 2008, APHASIOLOGY, V22, P1054, DOI 10.1080/02687030701632187; Taylor SJ, 2013, DEV PSYCHOL, V49, P1253, DOI 10.1037/a0029871; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Vetter NC, 2013, CHILD NEUROPSYCHOL, V19, P615, DOI 10.1080/09297049.2012.718324; Wiig E. H., 1989, TEST LANGUAGE COMPET; Williams LM, 2009, J CLIN EXP NEUROPSYC, V31, P257, DOI 10.1080/13803390802255635; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; WINNER E, 1991, BRIT J DEV PSYCHOL, V9, P257, DOI 10.1111/j.2044-835X.1991.tb00875.x; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; YEATES KO, 1991, MERRILL PALMER QUART, V37, P369	67	9	9	2	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2015	16	1					3	18		10.1017/BrImp.2015.7			16	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	CK7PG	WOS:000356424000002		Green Submitted			2022-02-06	
J	Pfefferbaum, A; Zahr, NM; Mayer, D; Rohlfing, T; Sullivan, EV				Pfefferbaum, Adolf; Zahr, Natalie M.; Mayer, Dirk; Rohlfing, Torsten; Sullivan, Edith V.			Dynamic Responses of Selective Brain White Matter Fiber Tracts to Binge Alcohol and Recovery in the Rat	PLOS ONE			English	Article							TRAUMATIC AXONAL INJURY; DIFFUSION-TENSOR MRI; CORPUS-CALLOSUM; IN-VIVO; MICROSTRUCTURAL RECOVERY; PHYSICAL-DEPENDENCE; UNITED-STATES; ETHANOL; ANISOTROPY; DISRUPTION	To determine the dynamics of white matter vulnerability to excessive alcohol consumption, diffusion tensor imaging (DTI) was used in an animal model of alcohol exposure. Quantitative, in vivo fiber tracking results are presented from rats with DTI conducted at 3 time points: baseline; after 4 days of intragastric alcohol to blood alcohol levels of similar to 250mg/dL; and after one week of recovery. Binge alcohol followed by a week of sobriety resulted in rapidly reversible decreases in fractional anisotropy (FA), a measure of the coherence of fiber tracts, in callosal genu and fimbria-fornix but not splenium; and increases in mean diffusivity (MD), an index of freely diffusing water in tissue, selective to the fimbria-fornix. These effects were confirmed with tract-based spatial statistics (TBSS). The directionality of changes in DTI metrics reproduce those observed in human alcoholism. That a single exposure to binge alcohol can cause substantial transient changes detectable in DTI metrics demonstrates the potential for rapid neuroplasticity.	[Pfefferbaum, Adolf; Zahr, Natalie M.; Mayer, Dirk; Rohlfing, Torsten] SRI Int, Neurosci Program, Menlo Pk, CA 94025 USA; [Pfefferbaum, Adolf; Zahr, Natalie M.; Sullivan, Edith V.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Mayer, Dirk] Univ Maryland, Dept Diagnost Radiol, Sch Med, Baltimore, MD 21201 USA		Zahr, NM (corresponding author), SRI Int, Neurosci Program, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	nzahr@stanford.edu	Mayer, Dirk/AAJ-5906-2020; Sullivan, Edith V/ABD-5684-2021; Zahr, Natalie/W-5292-2019	Mayer, Dirk/0000-0001-7557-9019; Sullivan, Edith V/0000-0001-6739-3716; 	National Institute on Alcohol Abuse and Alcoholism: Integrative Neuroscience Initiative on Neuroscience (INIA) [AA005965, AA012388, AA017168, AA013521]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K05AA017168, R01AA005965, R01AA012388, U01AA013521, R37AA005965] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism: AA005965, AA012388, AA017168, AA013521-Integrative Neuroscience Initiative on Neuroscience (INIA). SRI International is a nonprofit center (http://www.sri.com/about). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson E, 2004, NEUROIMAGE, V22, P381, DOI 10.1016/j.neuroimage.2003.12.046; Alhassoon OM, 2012, ALCOHOL CLIN EXP RES, V36, P1922, DOI 10.1111/j.1530-0277.2012.01808.x; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bell RL, 2006, ALCOHOL, V40, P3, DOI 10.1016/j.alcohol.2006.10.001; Bell RL, 2013, BINGE EATING BINGE D; Bodammer N, 2004, MAGNET RESON MED, V51, P188, DOI 10.1002/mrm.10690; Chanraud S, 2010, NEUROPSYCHOL REV, V20, P209, DOI 10.1007/s11065-010-9129-7; Chanraud S, 2009, NEUROPSYCHOPHARMACOL, V34, P1223, DOI 10.1038/npp.2008.101; Chen CM, 2004, ALCOHOL RES HEALTH, V28, P269; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; Chronik BA, 2000, MAGNET RESON MED, V44, P955, DOI 10.1002/1522-2594(200012)44:6<955::AID-MRM18>3.0.CO;2-1; Chronik B, 2000, MAGN RESON MATER PHY, V10, P131; DELAMONTE SM, 1988, ARCH NEUROL-CHICAGO, V45, P990, DOI 10.1001/archneur.1988.00520330076013; Dodero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076655; Faingold Carl L, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0928s44; Gozzi A, 2013, NEUROIMAGE, V69, P112, DOI 10.1016/j.neuroimage.2012.12.015; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grant KA, 2003, PHARMACOL THERAPEUT, V100, P235, DOI 10.1016/j.pharmthera.2003.08.004; HARPER C, 1985, J NEUROL NEUROSUR PS, V48, P211, DOI 10.1136/jnnp.48.3.211; HARPER CG, 1988, BRIT J ADDICT, V83, P577; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; Hofstetter S, 2013, J NEUROSCI, V33, P12844, DOI 10.1523/JNEUROSCI.4520-12.2013; HUNT WA, 1977, J PHARMACOL EXP THER, V201, P103; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jones D.K., 2010, DIFFUSION MRI THEORY; Kelso ML, 2011, NEUROSCIENCE, V197, P381, DOI 10.1016/j.neuroscience.2011.09.019; Kong LM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/798261; Konrad A, 2012, ALCOHOL ALCOHOLISM, V47, P118, DOI 10.1093/alcalc/agr157; Kril JJ, 1997, HEPATOLOGY, V26, P837, DOI 10.1002/hep.510260405; Li T K, 1987, Alcohol Alcohol Suppl, V1, P91; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; MAJCHROWICZ E, 1976, PSYCHOPHARMACOLOGY, V50, P107, DOI 10.1007/BF00430477; Martin-Fardon R, 2013, CURR TOP BEHAV NEURO, V13, P403, DOI 10.1007/7854_2012_202; Mayer D, 2007, NEUROIMAGE, V35, P1077, DOI 10.1016/j.neuroimage.2007.01.006; McBride WJ, 2010, ALCOHOL, V44, P171, DOI 10.1016/j.alcohol.2009.12.001; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 1999, P 7 ISMRM PHIL, P320; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Neighbors C, 2006, INT J DRUG POLICY, V17, P304, DOI 10.1016/j.drugpo.2006.05.004; O'Brien CP, 2009, ALCOHOLISM DANA GUID; Oster SM, 2006, ALCOHOL, V38, P155, DOI 10.1016/j.alcohol.2006.06.001; PAULABARBOSA MM, 1985, BRAIN RES, V339, P195, DOI 10.1016/0006-8993(85)90645-6; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pfefferbaum A, 2005, NEUROPSYCHOPHARMACOL, V30, P423, DOI 10.1038/sj.npp.1300623; Pfefferbaum A, 2004, J MAGN RESON IMAGING, V20, P779, DOI 10.1002/jmri.20181; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; Pfefferbaum A, 2001, NEUROREPORT, V12, P1677, DOI 10.1097/00001756-200106130-00032; Pfefferbaum A, 2006, NEUROBIOL AGING, V27, P994, DOI 10.1016/j.neurobiolaging.2005.05.007; Pfefferbaum A, 2007, BRAIN, V130, P48, DOI 10.1093/brain/awl242; Pfefferbaum A, 2014, LANCET PSYCHIAT, V1, P202, DOI 10.1016/S2215-0366(14)70301-3; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Putzke J, 1998, MOL BRAIN RES, V62, P196, DOI 10.1016/S0169-328X(98)00253-8; Rodd ZA, 2004, PHARMACOL BIOCHEM BE, V79, P439, DOI 10.1016/j.pbb.2004.08.018; Rodd ZA, 2009, ADDICT BIOL, V14, P152, DOI 10.1111/j.1369-1600.2008.00140.x; Rohlfing T, 2003, IEEE T INF TECHNOL B, V7, P16, DOI 10.1109/TITB.2003.808506; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutledge PC, 2008, J CONSULT CLIN PSYCH, V76, P511, DOI 10.1037/0022-006X.76.3.511; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Satriotomo I, 2000, BRAIN RES, V879, P55, DOI 10.1016/S0006-8993(00)02729-3; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sorg SF, 2012, BIOL PSYCHIAT, V71, P262, DOI 10.1016/j.biopsych.2011.09.022; Sullivan EV, 2006, CEREB CORTEX, V16, P1030, DOI 10.1093/cercor/bhj045; Sullivan EV, 2011, NEUROIMAGE, V57, P214, DOI 10.1016/j.neuroimage.2011.04.003; Sullivan EV, 2013, NEUROBIOLOG IN PRESS; TARNOWSKADZIDUSZKO E, 1995, FOLIA NEUROPATHOL, V33, P25; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Touquet R, 2008, EMERG MED J, V25, P752, DOI 10.1136/emj.2008.062711; URSO T, 1981, LIFE SCI, V28, P1053, DOI 10.1016/0024-3205(81)90752-9; USDHHS, 2006, ROL BIOM TREATM ALC; Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Zahr NM, 2013, NEUROPSYCHOPHARMACOL, V38, P1121, DOI 10.1038/npp.2013.11; Zhai GH, 2003, RADIOLOGY, V229, P673, DOI 10.1148/radiol.2293021462	80	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124885	10.1371/journal.pone.0124885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	WOS:000353211700127	25894968	Green Published, Green Submitted, gold			2022-02-06	
J	Chen, SY; Meng, FJ; Chen, ZZ; Tomlinson, BN; Wesley, JM; Sun, GY; Whaley-Connell, AT; Sowers, JR; Cui, JK; Gu, ZZ				Chen, Shanyan; Meng, Fanjun; Chen, Zhenzhou; Tomlinson, Brittany N.; Wesley, Jennifer M.; Sun, Grace Y.; Whaley-Connell, Adam T.; Sowers, James R.; Cui, Jiankun; Gu, Zezong			Two-Dimensional Zymography Differentiates Gelatinase Isoforms in Stimulated Microglial Cells and in Brain Tissues of Acute Brain Injuries	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; POSTTRANSLATIONAL MODIFICATIONS; NADPH OXIDASE; MMP-9; PROTEIN; ROLES; ACTIVATION; INHIBITION; INDUCTION; RAT	Excessive activation of gelatinases (MMP-2/-9) is a key cause of detrimental outcomes in neurodegenerative diseases. A single-dimension zymography has been widely used to determine gelatinase expression and activity, but this method is inadequate in resolving complex enzyme isoforms, because gelatinase expression and activity could be modified at transcriptional and posttranslational levels. In this study, we investigated gelatinase isoforms under in vitro and in vivo conditions using two-dimensional (2D) gelatin zymography electrophoresis, a protocol allowing separation of proteins based on isoelectric points (pI) and molecular weights. We observed organomercuric chemical 4-aminophenylmercuric acetate-induced activation of MMP-2 isoforms with variant pI values in the conditioned medium of human fibrosarcoma HT1080 cells. Studies with murine BV-2 microglial cells indicated a series of proform MMP-9 spots separated by variant pI values due to stimulation with lipopolysaccharide (LPS). The MMP-9 pI values were shifted after treatment with alkaline phosphatase, suggesting presence of phosphorylated isoforms due to the proinflammatory stimulation. Similar MMP-9 isoforms with variant pI values in the same molecular weight were also found in mouse brains after ischemic and traumatic brain injuries. In contrast, there was no detectable pI differentiation of MMP-9 in the brains of chronic Zucker obese rats. These results demonstrated effective use of 2D zymography to separate modified MMP isoforms with variant pI values and to detect posttranslational modifications under different pathological conditions.	[Chen, Shanyan; Meng, Fanjun; Chen, Zhenzhou; Tomlinson, Brittany N.; Wesley, Jennifer M.; Sun, Grace Y.; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Chen, Shanyan; Meng, Fanjun; Chen, Zhenzhou; Tomlinson, Brittany N.; Wesley, Jennifer M.; Sun, Grace Y.; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO USA; [Chen, Shanyan] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA; [Tomlinson, Brittany N.] Univ Missouri, Grad Sch, Pathol Program, Columbia, MO USA; [Sun, Grace Y.] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO USA; [Whaley-Connell, Adam T.; Sowers, James R.] Univ Missouri, Sch Med, Dept Internal Med, Diabet & Cardiovasc Ctr, Columbia, MO USA; [Sowers, James R.; Cui, Jiankun; Gu, Zezong] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA		Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	guze@health.missouri.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Whaley-Connell, Adam/0000-0001-8955-5560	American Heart Association National Scientist Development awardAmerican Heart Association [09SDG2260983]; Dana Foundation; National Football Leagues (NFL) Charities Foundation; University of Missouri Mizzou Advantage One Health One Medicine Program; Department of Pathology Research funds	Funding was provided by American Heart Association National Scientist Development award (09SDG2260983) to ZG; The Dana Foundation to ZG, http://www.dana.org/grants/; The National Football Leagues (NFL) Charities Foundation to ZG, https://www.nflcharities.org/; The University of Missouri Mizzou Advantage One Health One Medicine Program, http://mizzouadvantage.missouri.edu/medicine/; and the Department of Pathology Research funds to ZG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroor AR, 2013, ENDOCRINOLOGY, V154, P2501, DOI 10.1210/en.2013-1096; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brussee V, 2008, DIABETES, V57, P1664, DOI 10.2337/db07-1737; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Chander PN, 2004, J AM SOC NEPHROL, V15, P2391, DOI 10.1097/01.ASN.0000135971.88164.2C; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen JL, 2011, STROKE, V42, P445, DOI 10.1161/STROKEAHA.110.596486; Chen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092133; Choi NS, 2004, J BIOCHEM MOL BIOL, V37, P298; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Chuang DY, 2014, ASN NEURO, V6, DOI 10.1177/1759091414554946; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; Gibbs DF, 1999, AM J RESP CELL MOL, V20, P1145, DOI 10.1165/ajrcmb.20.6.3482; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayden MR, 2013, CARDIORENAL MED, V3, P265, DOI 10.1159/000357113; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jacob Archana M., 2008, V446, P21, DOI 10.1007/978-1-60327-084-7_2; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Labrie M, 2013, CELL MOL LIFE SCI, V70, P3109, DOI 10.1007/s00018-012-1214-z; Larocca M, 2010, J SCI FOOD AGR, V90, P2411, DOI 10.1002/jsfa.4100; Launer LJ, 2009, STROKE, V40, pS53, DOI 10.1161/STROKEAHA.108.533075; Lee EJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-116; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; Lodemel JB, 2004, COMP BIOCHEM PHYS B, V139, P253, DOI 10.1016/j.cbpc.2004.08.004; Okamoto T, 2001, J BIOL CHEM, V276, P29596, DOI 10.1074/jbc.M102417200; Opdenakker G, 2003, LANCET NEUROL, V2, P747, DOI 10.1016/S1474-4422(03)00587-8; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Leme AFP, 2009, PROTEOMICS, V9, P733, DOI 10.1002/pmic.200800484; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rossano R, 2014, J CELL MOL MED, V18, P242, DOI 10.1111/jcmm.12181; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931; Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Tsioufis C, 2012, CURR TOP MED CHEM, V12, P1159, DOI 10.2174/1568026611208011159; Tyagi SC, 1996, J MOL CELL CARDIOL, V28, P1415, DOI 10.1006/jmcc.1996.0132; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; Wilkesman JG, 2007, ELECTROPHORESIS, V28, P429, DOI 10.1002/elps.200600332; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Yim HE, 2012, J NUTR BIOCHEM, V23, P937, DOI 10.1016/j.jnutbio.2011.04.020; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807	59	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123852	10.1371/journal.pone.0123852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	WOS:000352590300116	25859655	gold, Green Published, Green Submitted			2022-02-06	
J	Jones, A; Cohen, D; Johnstone, B; Yoon, DP; Schopp, LH; McCormack, G; Campbell, J				Jones, Angela; Cohen, Daniel; Johnstone, Brick; Yoon, Dong Pil; Schopp, Laura H.; McCormack, Guy; Campbell, James			Relationships Between Negative Spiritual Beliefs and Health Outcomes for Individuals With Heterogeneous Medical Conditions	JOURNAL OF SPIRITUALITY IN MENTAL HEALTH			English	Article						SF-36; negative spirituality; BMMRS; positive spirituality; religion; health	BRIEF MULTIDIMENSIONAL MEASURE; BREAST-CANCER; MENTAL-HEALTH; PHYSICAL HEALTH; PSYCHOLOGICAL ADJUSTMENT; CONGREGATIONAL SUPPORT; RELIGIOUS PRACTICES; RELIGIOUSNESS/SPIRITUALITY; FATALISM; LOCUS	This study determined the degree to which any negative spiritual beliefs, regardless of one's positive spiritual beliefs, are associated with health outcomes. Participants included 199 individuals with heterogeneous health conditions (i.e., traumatic brain injury, spinal cord injury, stroke, cancer, primary care disorders, healthy). Two groups were identified: a negative spirituality group (n = 61), that self-endorsed any degree of negative spiritual belief (i.e., feeling abandonment/punishment from a higher power) and a no negative spirituality group (n = 138), with no endorsement of any degree of negative spiritual belief. Measures included the Brief Multidimensional Measure of Religiousness/Spirituality and the Short-Form 36. Results indicated that the negative spirituality group endorsed significantly worse bodily pain, physical health, and mental health, as well as significantly less positive spirituality, less frequent religious practices, and a lower level of forgiveness. Negative spirituality was also significantly correlated with worse physical health, mental health, and pain, while positive spirituality was significantly correlated only with better mental health. It was concluded that any degree of negative spiritual belief, regardless of positive spiritual beliefs, is associated with worse health outcomes. The need exists to develop targeted interventions to specifically address negative spiritual beliefs, which have been shown to be related to increased pain and physical disability in several studies.	[Jones, Angela] St Johns Hosp, Springfield, MO USA; [Cohen, Daniel] Univ Missouri, Dept Religious Studies, Columbia, MO USA; [Johnstone, Brick; Schopp, Laura H.] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65212 USA; [Yoon, Dong Pil] Univ Missouri, Sch Social Work, Columbia, MO 65212 USA; [McCormack, Guy] Samuel Merritt Coll, Dept Occupat Therapy, San Francisco, CA USA; [Campbell, James] Univ Missouri, Dept Family & Community Med, Columbia, MO 65212 USA		Jones, A (corresponding author), Univ Missouri, MU Dept Hlth Psychol, DC116-88, Columbia, MO 65212 USA.	Johnstoneg@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649	Pew Charitable Trusts	This article was supported with funding from the Pew Charitable Trusts.	Ai AL, 2007, PERS SOC PSYCHOL B, V33, P867, DOI 10.1177/0146167207301008; Ano GG, 2005, J CLIN PSYCHOL, V61, P461, DOI 10.1002/jclp.20049; Campbell JD, 2010, J RELIG HEALTH, V49, P3, DOI 10.1007/s10943-008-9227-5; Cohen D, 2009, INT J PSYCHOL RELIG, V19, P121, DOI 10.1080/10508610802711335; Exline J J, 1999, J Health Psychol, V4, P365, DOI 10.1177/135910539900400306; Fetzer Institute/National Institute on Aging Working Group, 1999, MULT MEAREL SPIR U; Fitchett G, 1999, REHABIL PSYCHOL, V44, P333, DOI 10.1037//0090-5550.44.4.333; Fitchett G, 2004, INT J PSYCHIAT MED, V34, P179, DOI 10.2190/UCJ9-DP4M-9C0X-835M; Fitchett G., 2009, J PASTORAL CARE COUN, V63, P1; Franklin MD, 2008, J HEALTH PSYCHOL, V13, P323, DOI 10.1177/1359105307088137; Franklin MD, 2007, AM J HEALTH BEHAV, V31, P563, DOI 10.5993/AJHB.31.6.1; Gall Terry Lynn, 2003, J Pastoral Care Counsel, V57, P211; Gall TL, 2009, J BEHAV MED, V32, P174, DOI 10.1007/s10865-008-9182-3; Gall TL, 2005, CAN PSYCHOL, V46, P88, DOI 10.1037/h0087008; George LK, 2002, PSYCHOL INQ, V13, P190, DOI 10.1207/S15327965PLI1303_04; Gerber MM, 2011, PSYCHOL RELIG SPIRIT, V3, P298, DOI 10.1037/a0023016; Hackney CH, 2003, J SCI STUD RELIG, V42, P43, DOI 10.1111/1468-5906.t01-1-00160; Hall TW, 2002, J SCI STUD RELIG, V41, P341, DOI 10.1111/1468-5906.00121; Hebert R, 2009, J PALLIAT MED, V12, P537, DOI 10.1089/jpm.2008.0250; Holt CL, 2003, HEALTH PSYCHOL, V22, P294, DOI 10.1037/0278-6133.22.3.294; Ironson G, 2011, J BEHAV MED, V34, P414, DOI 10.1007/s10865-011-9314-z; Johnstone B, 2009, REHABIL PSYCHOL, V54, P422, DOI 10.1037/a0017758; Johnstone B, 2009, J RELIG HEALTH, V48, P146, DOI 10.1007/s10943-008-9179-9; Koenig HaroldG., 2001, HDB RELIG HLTH; Koenig HG, 1998, J NERV MENT DIS, V186, P513, DOI 10.1097/00005053-199809000-00001; Maltby J., 2007, PERSONALITY INDIVIDU; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Norman P, 1995, PREDICTING HLTH BEHA, P62; Novotni M., 2001, ANGRY WITH GOD; Pargament K., 1997, PSYCHOL RELIG COPING; Pargament K I, 1999, J Health Psychol, V4, P327, DOI 10.1177/135910539900400303; Pargament K. I., 2007, SPIRITUALLY INTEGRAT; Pargament KI, 2007, J CLIN PSYCHOL, V63, P903, DOI 10.1002/jclp.20405; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.3.CO;2-T; Pargament KI, 1998, J SCI STUD RELIG, V37, P710, DOI 10.2307/1388152; Pargament KI, 2001, ARCH INTERN MED, V161, P1881, DOI 10.1001/archinte.161.15.1881; Park, 2005, HDB PSYCHOL RELIG SP, P315; Park CL, 2007, J BEHAV MED, V30, P319, DOI 10.1007/s10865-007-9111-x; Park CL, 2011, J BEHAV MED, V34, P426, DOI 10.1007/s10865-011-9315-y; Piedmont RL., 2007, RES SOCIAL SCI STUDY, V17, P177; Powe BD, 2003, CANCER NURS, V26, P454; Powell LH, 2003, AM PSYCHOL, V58, P36, DOI 10.1037/0003-066X.58.1.36; Reid-Arndt S. A., 2011, J RELIG DISABILITY H, V15, P175, DOI DOI 10.1080/15228967.2011; Rippentrop AE, 2005, REHABIL PSYCHOL, V50, P278, DOI 10.1037/0090-5550.50.3.278; Rippentrop AE, 2005, PAIN, V116, P311, DOI 10.1016/j.pain.2005.05.008; Romero C, 2006, J BEHAV MED, V29, P29, DOI 10.1007/s10865-005-9038-z; Schreiber JA, 2012, J CANCER SURVIV, V6, P82, DOI 10.1007/s11764-011-0193-7; Sherman, 2001, FAITH HLTH PSYCHOL P; Skolarus LE, 2012, J RELIG HEALTH, V51, P1293, DOI 10.1007/s10943-010-9438-4; Smith BW, 2000, J COMMUNITY PSYCHOL, V28, P169, DOI 10.1002/(SICI)1520-6629(200003)28:2<169::AID-JCOP5>3.0.CO;2-I; Stewart C., 2006, INT J PSYCHOL RELIG, V16, P181, DOI [DOI 10.1207/S15327582IJPR1603_3, 10.1207/s15327582ijpr1603_3]; Tarakeshwar N, 2006, J PALLIAT MED, V9, P646, DOI 10.1089/jpm.2006.9.646; Wallston KA, 2005, J HEALTH PSYCHOL, V10, P623, DOI 10.1177/1359105305055304; Wallston KA, 1999, COGNITIVE THER RES, V23, P131, DOI 10.1023/A:1018723010685; Ware J.E., 1994, SF 36 PHYS MENTAL SU	55	9	9	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1934-9637	1934-9645		J SPIRITUAL MENT HE	J. Spiritual. Ment. Health	APR 3	2015	17	2					135	152		10.1080/19349637.2015.1023679			18	Psychology, Applied	Emerging Sources Citation Index (ESCI)	Psychology	CH8AF	WOS:000354257300005					2022-02-06	
J	Amoros-Aguilar, L; Portell-Cortes, I; Costa-Miserachs, D; Torras-Garcia, M; Coll-Andreu, M				Amoros-Aguilar, Laura; Portell-Cortes, Isabel; Costa-Miserachs, David; Torras-Garcia, Meritxell; Coll-Andreu, Margalida			Traumatic Brain Injury in Late Adolescent Rats: Effects on Adulthood Memory and Anxiety	BEHAVIORAL NEUROSCIENCE			English	Article						controlled cortical impact; emotional reactivity; object recognition memory; rat; traumatic brain injury	CONTROLLED CORTICAL IMPACT; OBJECT RECOGNITION MEMORY; ELEVATED PLUS-MAZE; CLOSED-HEAD INJURY; IMMATURE RAT; COGNITIVE DEFICITS; BEHAVIORAL DEFICITS; DYNAMIC CHANGES; MICE; SEVERITY	The consequences of traumatic brain injury (TBI) sustained during late adolescence (7 weeks old) on spontaneous object recognition memory and on anxiety-like behaviors in the elevated plus maze were tested in rats during adulthood. Testing took place at 2 different postinjury times, in separate groups: 3 and 6 weeks, when animals were 10 and 13 weeks old, respectively. The rats were either submitted to controlled cortical impact injury, an experimental model of focal TBI with contusion, or were sham-operated. TBI animals failed to remember the familiar object and had a significantly lower performance than sham-operated animals, indicating memory disruption, when the retention delay was 24 hr, but not when it was 3 hr. TBI did not have any significant effect on the main anxiety-related behaviors, but it reduced time in the central platform of the elevated plus maze. The effects of TBI on memory and on anxiety-like behaviors were similar at the 2 postinjury times. In both TBI and sham-operated groups, animals tested 6 weeks after surgery had lower anxiety-related indices than those tested at 3 weeks, an effect that might be indicative of reduced anxiety levels with increasing age. In summary, focal TBI with contusion sustained during late adolescence led to object recognition memory deficits in a 24-hr test during adulthood but did not have a major impact on anxiety-like behaviors. Memory deficits persisted for at least 6 weeks after injury, indicating that spontaneous modifications of these functional disturbances did not take place along this time span.	[Amoros-Aguilar, Laura; Portell-Cortes, Isabel; Costa-Miserachs, David; Torras-Garcia, Meritxell; Coll-Andreu, Margalida] Univ Autonoma Barcelona, Inst Neurociencies, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain		Coll-Andreu, M (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain.	margalida.coll@uab.cat	Torras-Garcia, Meritxell/K-9068-2014; Costa-Miserachs, David/N-2794-2019; Costa-Miserachs, David/E-1318-2011; Coll-Andreu, Margalida/C-9119-2011; Portell-Cortes, Isabel/C-5991-2011	Torras-Garcia, Meritxell/0000-0003-2511-8788; Costa-Miserachs, David/0000-0001-5781-0774; Costa-Miserachs, David/0000-0001-5781-0774; Coll-Andreu, Margalida/0000-0003-4106-2606; Portell-Cortes, Isabel/0000-0002-7710-0101	Ministerio de Ciencia e InnovacionInstituto de Salud Carlos IIISpanish GovernmentEuropean Commission [PSI 2009-08034]	This work was supported by the Ministerio de Ciencia e Innovacion (PSI 2009-08034). We thank Timothy P. Morris for his kind assistance with English editing.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brown MW, 2012, NEUROPSYCHOLOGIA, V50, P3122, DOI 10.1016/j.neuropsychologia.2012.07.034; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Casarrubea M, 2013, BEHAV BRAIN RES, V250, P166, DOI 10.1016/j.bbr.2013.05.016; Chen MF, 2013, J PHYSIOL-LONDON, V591, P985, DOI 10.1113/jphysiol.2012.241125; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Darwish H, 2014, BRAIN INJURY, V28, P211, DOI 10.3109/02699052.2013.862737; Fellows I, 2012, J STAT SOFTW, V49, P1; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Greco T, 2015, DEV NEUROBIOL, V75, P193, DOI 10.1002/dneu.22218; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hartman RE, 2011, TRANSL STROKE RES, V2, P433, DOI 10.1007/s12975-011-0132-y; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2011, J NEUROTRAUM, V28, P245, DOI 10.1089/neu.2010.1639; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Jacotte-Simancas A, 2014, J NEUROTRAUMA; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Luine V.N., 2014, BEHAV BRAIN RES; Lynn DA, 2010, DEV PSYCHOBIOL, V52, P731, DOI 10.1002/dev.20468; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; Masel B. S., 2014, J NEUROTRAUMA; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; Mehan ND, 2012, NEUROBIOL AGING, V33, P1857, DOI 10.1016/j.neurobiolaging.2011.09.029; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Osier N., 2014, JOURNAL OF NEUROTRAU; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Park MS, 2014, J EXERC REHABIL, V10, P148, DOI 10.12965/jer.140109; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; R Development Core Team, 2011, R LANG ENV STAT COMP; Saha B, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00014; Saul ML, 2012, BEHAV BRAIN RES, V229, P226, DOI 10.1016/j.bbr.2012.01.022; Schneider M, 2013, CELL TISSUE RES, V354, P99, DOI 10.1007/s00441-013-1581-2; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Thurman D. J., 2014, J CHILD NEUROL; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Warburton E.C., 2014, BEHAV BRAIN RES; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108518; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	73	9	9	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7044	1939-0084		BEHAV NEUROSCI	Behav. Neurosci.	APR	2015	129	2					149	159		10.1037/bne0000046			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CE1XX	WOS:000351607300007	25730123	Green Submitted, Green Accepted			2022-02-06	
J	Butts, CC; Rostas, JW; Lee, YL; Gonzalez, RP; Brevard, SB; Frotan, MA; Ahmed, N; Simmons, JD				Butts, C. Caleb; Rostas, Jack W.; Lee, Y. L.; Gonzalez, Richard P.; Brevard, Sidney B.; Frotan, M. Amin; Ahmed, Naveed; Simmons, Jon D.			Larger ATV engine size correlates with an increased rate of traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						ATV; Traumatic brain injury; Helmet; Prevention; Intracranial haemorrhage	TERRAIN-VEHICLE INJURIES; SAFETY EDUCATION; RISK-TAKING; CHILDREN; STATE; REGULATIONS; LEGISLATION; ACCIDENTS; MORTALITY; PATTERNS	Introduction: Since the introduction of all-terrain vehicles (ATV) to the United States in 1971, injuries and mortalities related to their use have increased significantly. Furthermore, these vehicles have become larger and more powerful. As there are no helmet requirements or limitations on engine-size in the State of Alabama, we hypothesised that larger engine size would correlate with an increased incidence of traumatic brain injury (TBI) in patients following an ATV crash. Methods: Patient and ATV data were prospectively collected on all ATV crashes presenting to a level one trauma centre from September 2010 to May 2013. Collected data included: demographics, age of driver, ATV engine size, presence of helmet, injuries, and outcomes. The data were grouped according to the ATV engine size in cubic centimetres (cc). For the purposes of this study, TBI was defined as any type of intracranial haemorrhage on the initial computed tomography scan. Results: There were 61 patients identified during the study period. Two patients (3%) were wearing a helmet at the time of injury. Patients on an ATV with an engine size of 350 cc or greater had higher Injury Severity Scores (13.9 vs. 7.5, p <= 0.05) and an increased incidence of TBI (26% vs. 0%, p <= 0.05) when compared to patients on ATV's with an engine size less than 350 cc. Conclusions: Patients on an ATV with an engine size of 350 cc or greater were more likely to have a TBI. The use of a helmet was rarely present in this cohort. Legislative efforts to implement rider protection laws for ATVs are warranted. (C) 2014 Elsevier Ltd. All rights reserved.	[Butts, C. Caleb; Rostas, Jack W.; Lee, Y. L.; Gonzalez, Richard P.; Brevard, Sidney B.; Frotan, M. Amin; Simmons, Jon D.] Univ S Alabama, Dept Surg, Mobile, AL 36617 USA; [Ahmed, Naveed] Univ Mississippi, Med Ctr, Dept Surg, University, MS 38677 USA		Simmons, JD (corresponding author), Univ S Alabama, Div Trauma Burn Acute Care Surg & Surg Crit Care, 2451 Fillingim St,Suite 10-I, Mobile, AL 36617 USA.	cbutts@health.southalabama.edu; jrostas@health.southalabama.edu; yllee@southalabama.edu; rgonzalez@health.southalabama.edu; sbrevard@health.southalabama.edu; afrotan@health.southalabama.edu; nahmed@umc.edu; jdsimmons@health.southalabama.edu			American Heart AssociationAmerican Heart Association [14CRP19010032]; American College of Surgeons (Clowes Award); American Association for the Surgery of Trauma (AAST Research and Education Foundation Scholarship)	Dr Simmons' research is supported by grants from American Heart Association (14CRP19010032), American College of Surgeons (Clowes Award), and the American Association for the Surgery of Trauma (AAST Research and Education Foundation Scholarship).	Adams LE, 2013, J TRAUMA ACUTE CARE, V75, pS296, DOI 10.1097/TA.0b013e318292421f; Aitken ME, 2004, INJURY PREV, V10, P303, DOI 10.1136/ip.2003.004176; Bansal V, 2008, AM J SURG, V195, P789, DOI 10.1016/j.amjsurg.2007.05.049; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Burgus SK, 2009, J AGROMEDICINE, V14, P97, DOI 10.1080/10599240902751047; Clarke DD, 2005, ACCIDENT ANAL PREV, V37, P523, DOI 10.1016/j.aap.2005.01.007; Denning GM, 2013, INJURY PREV, V19, P250, DOI 10.1136/injuryprev-2012-040548; GANOS D, 1988, AM SURGEON, V54, P429; Garland S., 2011, 2011 ANN REPORT ATV; Helmkamp JC, 2001, AM J PUBLIC HEALTH, V91, P1792, DOI 10.2105/AJPH.91.11.1792; Jennissen CA, 2012, ANN EMERG MED, V60, pS99, DOI 10.1016/j.annemergmed.2012.06.257; Keenan HT, 2004, PEDIATRICS, V113, pE330, DOI 10.1542/peds.113.4.e330; Kellum E, 2008, J PEDIATR ORTHOPED, V28, P854, DOI 10.1097/BPO.0b013e31818e198f; Larson AN, 2012, MED SPORT SCI, V58, P158, DOI 10.1159/000338728; Mattei TA, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11176; Miller M, 2014, W V MED J, V108, P96; RODGERS GB, 1990, ACCIDENT ANAL PREV, V22, P47, DOI 10.1016/0001-4575(90)90006-7; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; RODGERS GB, 1993, ACCIDENT ANAL PREV, V25, P335, DOI 10.1016/0001-4575(93)90027-T; Rodgers GB, 2008, ACCIDENT ANAL PREV, V40, P725, DOI 10.1016/j.aap.2007.09.021; Rostas Jack W, 2014, J Trauma Acute Care Surg, V76, P201, DOI 10.1097/TA.0b013e3182a994ff; Shah SR, 2012, J TRAUMA ACUTE CARE, V73, pS273, DOI 10.1097/TA.0b013e318270360c; Stolz U, 2009, J SAFETY RES, V40, P149, DOI 10.1016/j.jsr.2009.02.005; Su W, 2006, J PEDIATR SURG, V41, P931, DOI 10.1016/j.jpedsurg.2006.01.011; U.S. Consumer Product Safety Commission, 2014, 2012 ANN REP ATV DEA; Upperman JS, 2003, J PEDIATR SURG, V38, P1284, DOI 10.1016/S0022-3468(03)00383-X; Williams RS, 2011, J RURAL HEALTH, V27, P255, DOI 10.1111/j.1748-0361.2010.00327.x; Winfield RD, 2010, AM SURGEON, V76, P149	28	9	9	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	APR	2015	46	4					625	628		10.1016/j.injury.2014.11.007			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CD7MZ	WOS:000351275900018	25527458				2022-02-06	
J	Crisco, JJ; Costa, L; Rich, R; Schwartz, JB; Wilcox, B				Crisco, Joseph J.; Costa, Laura; Rich, Ryan; Schwartz, Joel B.; Wilcox, Bethany			Surrogate Headform Accelerations Associated With Stick Checks in Girls' Lacrosse	JOURNAL OF APPLIED BIOMECHANICS			English	Article						lacrosse; female; impacts; headgear	WOMENS LACROSSE; INJURIES; FOOTBALL; CONCUSSION; EPIDEMIOLOGY; PERFORMANCE; IMPACTS; FACE	Girls' lacrosse is fundamentally a different sport than boys' lacrosse, and girls are not required to wear protective headgear. Recent epidemiological studies have found that stick checks are the leading cause of concussion injury in girls' lacrosse. The purpose of this study was to determine stick check speeds and estimate the head acceleration associated with direct checks to the head. In addition, we briefly examine if commercially available headgear can mitigate the accelerations. Seven (n = 7) experienced female lacrosse players checked, with varying severity, a NOSCAE and an ASTM headform. Stick speed at impact and the associated peak linear accelerations of the headform were recorded. The NOCSAE headform was fitted with four commercially available headgear and similar stick impact testing was performed. The median stick impact speed was 8.1 m/s and 777 deg/s. At these speeds, peak linear acceleration was approximately 60g. Three out of the four headgear significantly reduced the peak linear acceleration when compared with the bare headform. These data serve as baseline for understanding the potential mechanism and reduction of concussions from stick impacts in girls' lacrosse.	[Crisco, Joseph J.; Costa, Laura; Rich, Ryan; Schwartz, Joel B.; Wilcox, Bethany] Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Bioengn Lab, Providence, RI 02912 USA		Crisco, JJ (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Bioengn Lab, Providence, RI 02912 USA.	joseph_crisco@brown.edu		Crisco, Joseph/0000-0002-8786-0905	US Lacrosse; National Operating Committee on Standards for Athletic Equipment (NOCSAE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104937] Funding Source: NIH RePORTER	Funding was provided by US Lacrosse and the National Operating Committee on Standards for Athletic Equipment (NOCSAE). The opinions expressed in this manuscript are solely those of the authors and do not necessarily reflect those of US Lacrosse or NOCSAE.	Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Chong A, 2011, PELTZMAN ICE EVIDENC; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Crisco JJ, 2002, MED SCI SPORT EXER, V34, P1675, DOI 10.1097/00005768-200210000-00021; Crisco JJ, 2009, J APPL BIOMECH, V25, P184, DOI 10.1123/jab.25.2.184; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P262; Gadd C, SAE 10 STAPP C, P164; Goldenberg Michael S., 1995, Journal of Athletic Training, V30, P37; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Luckstead EF, 2002, PEDIATR CLIN N AM, V49, P581, DOI 10.1016/S0031-3955(02)00006-8; Matz SO, 2004, AM J SPORT MED, V32, P608, DOI 10.1177/0363546503262172; Otago L, 2007, Int J Inj Contr Saf Promot, V14, P259, DOI 10.1080/17457300701602381; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schwarz A, 2011, NY TIMES, P16; US Lacrosse, 2010, OFF RUL GIRLS WOM LA; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Voo LM, 1998, J BIOMECH ENG-T ASME, V120, P693, DOI 10.1115/1.2834880; Webster DA, 1999, MED SCI SPORT EXER, V31, P938, DOI 10.1097/00005768-199907000-00004	24	9	9	0	7	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	APR	2015	31	2					122	127		10.1123/JAB.2014-0102			6	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	CF1UV	WOS:000352334300008	25411762				2022-02-06	
J	Flynn-O'Brien, KT; Fawcett, VJ; Nixon, ZA; Rivara, FP; Davidson, GH; Chesnut, RM; Ellenbogen, RG; Vavilala, MS; Bulger, EM; Maier, RV; Arbabi, S				Flynn-O'Brien, Katherine T.; Fawcett, Vanessa J.; Nixon, Zeynep A.; Rivara, Frederick P.; Davidson, Giana H.; Chesnut, Randall M.; Ellenbogen, Richard G.; Vavilala, Monica S.; Bulger, Eileen M.; Maier, Ronald V.; Arbabi, Saman			Temporal Trends in Surgical Intervention for Severe Traumatic Brain Injury Caused by Extra-axial Hemorrhage, 1995 to 2012	NEUROSURGERY			English	Article						Brain injuries; Epidemiology; Mortality; Neurosurgery; Outcome assessment; Wounds and injuries	EARLY DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; HEAD-INJURY; NONOPERATIVE MANAGEMENT; PREHOSPITAL MANAGEMENT; EASTERN ASSOCIATION; SPLENIC INJURY; OUTCOMES; IMPACT; CLASSIFICATION	BACKGROUND:Surgical intervention for severe traumatic brain injury (TBI) caused by extra-axial hemorrhage has declined in recent decades. The effect of this change on patient outcomes is unknown.OBJECTIVE:To determine the change over time in surgical intervention in this population and to assess changes in patient outcomes.METHODS:In this retrospective cohort study, the Washington State Trauma Registry was queried from 1995 to 2012 for patients with extra-axial hemorrhage and head Abbreviated Injury Scale score of 3 to 5. Data were linked to the state-wide death registry to analyze long-term mortality. The primary outcome was inpatient mortality. Secondary outcomes included 6- and 12-month mortality and modified Functional Independence Measure at discharge. Multivariable analyses were completed for all outcomes.RESULTS:A total of 22974 patients met inclusion criteria. Over the study period, surgical intervention for severe TBI declined from 36% to 7%. There was a decline in case fatality from 22% to 12%. In 2012, the relative risk of inpatient mortality was 23% lower compared with 1995 (adjusted mortality risk ratio, 0.77; 95% confidence interval, 0.63-0.94). Changes in 6- and 12-month adjusted mortality and modified Functional Independence Measure were not statistically significant.CONCLUSION:The decline in surgical intervention for severe TBI caused by extra-axial hemorrhage in Washington State was ubiquitous across regional, demographic, and injury characteristic strata. There was concurrently a reduction in inpatient mortality in this population. Functional status and long-term mortality, however, have remained the same. Future studies are needed to better identify modifiable risk factors for improvement in functional status and long-term mortality in this population.ABBREVIATIONS:AIS, Abbreviated Injury ScaleED, emergency departmentFIM, Functional Independence MeasureGCS, Glasgow Coma ScaleICD-9, International Classification of Disease, Ninth Revision, Clinical ModificationIMPACT I, International Mission for Prognosis and Clinical TrialRescueICP, Randomised Evaluation of Surgery With Craniectomy for Uncontrollable Elevation of ICPSAH, subarachnoid hemorrhageTBI, traumatic brain injuryWSTR, Washington State Trauma Registry	[Flynn-O'Brien, Katherine T.; Rivara, Frederick P.; Vavilala, Monica S.; Bulger, Eileen M.; Arbabi, Saman] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Flynn-O'Brien, Katherine T.; Davidson, Giana H.; Bulger, Eileen M.; Maier, Ronald V.; Arbabi, Saman] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; [Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Pediat, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98195 USA; [Fawcett, Vanessa J.] Univ Virginia, Med Ctr, Dept Surg, Charlottesville, VA USA; [Nixon, Zeynep A.] Washington State Dept Hlth, Olympia, WA USA		Arbabi, S (corresponding author), Univ Washington, Harborview Med Ctr, Dept Surg, 325 9Th Ave,Box 359796, Seattle, WA 98104 USA.	sarbabi@uw.edu			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32-HD057822]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER	Dr Flynn-O'Brien received fellowship support from the National Institute of Child Health and Human Development (T32-HD057822) during the preparation of this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2006.0209; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bullock MR, 2006, NEUROSURGERY, V58, pS2; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clark DE, 2010, ICDPIC STATA MODULE; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; De Georgia MA, 2015, J INTENSIVE CARE MED, V30, P473, DOI 10.1177/0885066614529254; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P308, DOI 10.1001/archsurg.2011.1327; Green JA, 2013, NEUROCRIT CARE, V18, P20, DOI 10.1007/s12028-012-9797-7; Hamlat CA, 2012, ANN SURG, V255, P165, DOI 10.1097/SLA.0b013e31823840ca; Harbrecht BG, 2006, J TRAUMA, V61, P254; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Hurtuk M, 2006, J TRAUMA, V61, P243, DOI 10.1097/01.ta.0000231353.06095.8d; Hutchinson P, RANDOMIZED EVALUATIO; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Lu J, 2005, ACT NEUR S, V95, P281; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Nwachuku EL, 2014, NEUROCRIT CARE, V20, P49, DOI 10.1007/s12028-013-9885-3; Pachter HL, 1998, ANN SURG, V227, P708, DOI 10.1097/00000658-199805000-00011; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS09324; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS288, DOI 10.1097/TA.0b013e318270160d; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; van der Meer Catrien, 2012, Acta Neurochir Suppl, V114, P305, DOI 10.1007/978-3-7091-0956-4_59; Washington State Department of Health, 2011, WASH STAT TRAUM REG; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d	44	9	9	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2015	76	4					451	460		10.1227/NEU.0000000000000693			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CE1ZX	WOS:000351613000037	25710105				2022-02-06	
J	Johansson, B; Bjuhr, H; Ronnback, L				Johansson, Birgitta; Bjuhr, Helena; Ronnback, Lars			Evaluation of an Advanced Mindfulness Program Following a Mindfulness-Based Stress Reduction Program for Participants Suffering from Mental Fatigue After Acquired Brain Injury	MINDFULNESS			English	Article						Mindfulness; Mental fatigue; TBI; Stroke; Cognition	QUALITY-OF-LIFE; INTERVENTION; MBSR; DISORDERS; SYMPTOMS; BENEFITS; ANXIETY; STROKE; IMPACT; MILD	Mental fatigue is, for many, a very distressing and long-term problem after a traumatic brain injury (TBI) or stroke. This will make it more difficult for the individual to return to work and resume social activities, and it can take several years to find the right balance between rest and activity in daily life, to find strategies and to accept the new situation. The aim of this study was to evaluate the effect of an advanced mindfulness program following a MBSR program, designed for subjects suffering from long-term mental fatigue after a brain injury. The advanced program was based on The Brahma Viharas, meditative practices known for cultivating four mental states: compassion, metta, appreciative joy, and equanimity. Fourteen participants followed the 8-month advanced mindfulness program, with group visits once a month and a final all-day retreat. All the participants were suffering from mental fatigue at least 1 year after a brain injury following a stroke or a TBI. The assessments after the advanced program showed a significant and sustained positive effect on mental fatigue and on tests measuring information processing speed and attention. With mindfulness practice it was possible to improve wakefulness during meditation and, above all, improve the mental fatigue levels. We propose that mindfulness is a promising treatment for mental fatigue after a stroke or TBI.	[Johansson, Birgitta; Bjuhr, Helena; Ronnback, Lars] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, S-41345 Gothenburg, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Per Dubbsgatan 14, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se			AFA Insurance; Local Research and Development Board for Gothenburg and Sodra Bohuslan	This work was supported by grants from AFA Insurance and The Local Research and Development Board for Gothenburg and Sodra Bohuslan.	Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard M, 2005, J COGN REHABIL, V23, P8, DOI DOI 10.1080/0963828031000090489; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Carlson LE, 2005, INT J BEHAV MED, V12, P278, DOI 10.1207/s15327558ijbm1204_9; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Cullen M., 2011, MINDFULNESS BASED IN, V2, P186, DOI [DOI 10.1007/S12671-011-0058-1, 10.1007/s12671-011-0058-1]; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Geary C, 2011, J ALTERN COMPLEM MED, V17, P939, DOI 10.1089/acm.2010.0335; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Grossman P, 2007, PSYCHOTHER PSYCHOSOM, V76, P226, DOI 10.1159/000101501; Grossmana P., 2004, J PSYCHOSOM RES, V57, P57; Hanson R., 2009, BUDDHAS BRAIN PRACTI; Hartmann M, 2012, DIABETES CARE, V35, P945, DOI 10.2337/dc11-1343; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson Birgitta, 2012, ISRN Psychiatry, V2012, P686425, DOI 10.5402/2012/686425; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Joo HM, 2010, J KOREAN NEUROSURG S, V47, P345, DOI 10.3340/jkns.2010.47.5.345; Kabat-Zinn J., 2001, FULL CATASTROPHE LIV, V15; KABATZINN J, 1985, J BEHAV MED, V8, P163, DOI 10.1007/BF00845519; Kilpatrick LA, 2011, NEUROIMAGE, V56, P290, DOI 10.1016/j.neuroimage.2011.02.034; Kramer G., 2008, MINDFULNESS THERAPEU, P176; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; MILLER JJ, 1995, GEN HOSP PSYCHIAT, V17, P192, DOI 10.1016/0163-8343(95)00025-M; Moore A, 2009, CONSCIOUS COGN, V18, P176, DOI 10.1016/j.concog.2008.12.008; Peacock J., 2008, OPENING TALK METTA R; Reibel DK, 2001, GEN HOSP PSYCHIAT, V23, P183, DOI 10.1016/S0163-8343(01)00149-9; Reitan R, 1985, HALSTEAD REITAN NEUR; Ronnback L, 2012, LONG LASTING MENTAL; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Smith BW, 2008, J ALTERN COMPLEM MED, V14, P251, DOI 10.1089/acm.2007.0641; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Wechsler D., 2003, WECHSLER ADULT INTEL; Yee R., 1998, LIVING YOGA BACK CAR; Young S., 2005, BREAK PAIN STEP BY S; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	40	9	9	2	55	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1868-8527	1868-8535		MINDFULNESS	Mindfulness	APR	2015	6	2					227	233		10.1007/s12671-013-0249-z			7	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	CD7YI	WOS:000351311400010					2022-02-06	
J	Kahraman, S; Siegel, A; Polster, BM; Fiskum, G				Kahraman, Sibel; Siegel, Alex; Polster, Brian M.; Fiskum, Gary			Permeability transition pore-dependent and PARP-mediated depletion of neuronal pyridine nucleotides during anoxia and glucose deprivation	JOURNAL OF BIOENERGETICS AND BIOMEMBRANES			English	Article						Mitochondria; Metabolism; Oxidative stress; Nitric oxide	TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; NAD(+) DEPLETION; NADH FLUORESCENCE; OXIDATIVE STRESS; INHIBITOR; ISCHEMIA; DAMAGE	Exposure of rat cortical neurons to combined oxygen and glucose deprivation results in loss of NAD(P)H autofluorescence that is only partially reversible following restoration of oxygen and glucose, suggesting catabolism of pyridine nucleotides. This study tested the hypothesis that metabolic inhibition caused by cyanide-induced chemical anoxia plus glucose deprivation promotes both release of mitochondrial NAD(H) in response to opening of the permeability transition pore (PTP) and NAD(P)(H) degradation through activation of poly (ADP-ribose) polymerase (PARP). The NAD(P)H autofluorescence of rat neonatal cortical neurons was monitored during and following acute (10-30 min) exposure to the respiratory inhibitor, cyanide, in the absence and presence of glucose. Because nitric oxide-derived peroxynitrite is a known activator of PARP, we additionally assessed the effect of a nitric oxide generating agent on the NAD(P)H autofluorescence response to chemical anoxia plus glucose deprivation. Cyanide induced a rapid increase in autofluorescence, followed by a steady decline promoted by the presence of nitric oxide. This decline was primarily due to NAD(H) catabolism, as verified by measurements of total NAD(H) present in cellular extracts. Catabolism was partially blocked by an inhibitor of PARP, by a PTP inhibitor, and by either glucose or pyruvate as a source of reducing power. Overall, data suggest that metabolic, oxidative, and nitrosative stress during in vitro neuronal anoxia and glucose deprivation result in release of mitochondrial pyridine nucleotides in response to PTP opening and rapid, extensive NAD(H) degradation mediated by PARP activation. These events may contribute to the metabolic dysfunction that occurs in vivo during cerebral ischemia and reperfusion and therefore represent prime targets for neuroprotection.	[Kahraman, Sibel; Siegel, Alex; Polster, Brian M.; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Kahraman, Sibel; Siegel, Alex; Polster, Brian M.; Fiskum, Gary] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res, Baltimore, MD 21201 USA		Fiskum, G (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 685 W Baltimore St, Baltimore, MD 21201 USA.	gfiskum@anes.umm.edu		Polster, Brian/0000-0003-2571-7510	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS34152, P01 HD16596, NS 07375, R01 NS085165]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034152, T32NS007375, R01NS085165] Funding Source: NIH RePORTER	Supported by NIH grants R01 NS34152 and P01 HD16596 (GF), NS 07375 (SK), and R01 NS085165 (BMP).	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Ali AAE, 2012, NAT STRUCT MOL BIOL, V19, P685, DOI 10.1038/nsmb.2335; Baek SH, 2013, MOL CELLS, V36, P258, DOI 10.1007/s10059-013-0172-0; Balan IS, 2010, BRAIN RES, V1316, P112, DOI 10.1016/j.brainres.2009.12.042; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; CHANCE B, 1962, NATURE, V195, P1073, DOI 10.1038/1951073a0; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Dodoni G, 2004, BBA-BIOENERGETICS, V1658, P58, DOI 10.1016/j.bbabio.2004.05.005; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Fink EL, 2008, J CEREBR BLOOD F MET, V28, P1523, DOI 10.1038/jcbfm.2008.52; Greco T, 2010, J BIOENERG BIOMEMBR, V42, P491, DOI 10.1007/s10863-010-9312-9; Kahraman S, 2007, NEUROCHEM RES, V32, P799, DOI 10.1007/s11064-006-9206-8; Kaundal RK, 2006, LIFE SCI, V79, P2293, DOI 10.1016/j.lfs.2006.07.034; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; Kristian T, 2004, BRAIN RES PROTOC, V13, P176, DOI 10.1016/j.brainresprot.2004.05.001; Kristian T, 2011, J NEUROSCI RES, V89, P1946, DOI 10.1002/jnr.22626; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Li D, 2008, OPT LETT, V33, P2365, DOI 10.1364/OL.33.002365; Love S, 1999, NEUROPATH APPL NEURO, V25, P98; Matsuura S, 2011, BRAIN RES, V1410, P122, DOI 10.1016/j.brainres.2011.05.069; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Meli E, 2004, MOL CELL NEUROSCI, V25, P172, DOI 10.1016/j.mcn.2003.09.016; Mills EM, 1996, J NEUROCHEM, V67, P1039; NIKNAHAD H, 1995, CHEM-BIOL INTERACT, V98, P27, DOI 10.1016/0009-2797(95)03631-U; Owens K, 2013, TRANSL STROKE RES, V4, P618, DOI 10.1007/s12975-013-0278-x; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Prieto R, 2011, BRAIN RES, V1404, P39, DOI 10.1016/j.brainres.2011.06.006; Roemgens A, 2011, NEUROTOX RES, V20, P1, DOI 10.1007/s12640-010-9213-z; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Shuttleworth CW, 2010, NEUROCHEM INT, V56, P379, DOI 10.1016/j.neuint.2009.12.015; Shuttleworth CW, 2003, J NEUROSCI, V23, P3196; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Takahashi K, 1999, BRAIN RES, V829, P46, DOI 10.1016/S0006-8993(99)01335-9; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Xia WL, 2009, CURR PHARM DESIGN, V15, P12, DOI 10.2174/138161209787185832; YAVIN Z, 1980, DEV BIOL, V75, P454, DOI 10.1016/0012-1606(80)90176-1; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038; Yuan M, 2009, EXP NEUROL, V217, P210, DOI 10.1016/j.expneurol.2009.02.012	48	9	9	0	12	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0145-479X	1573-6881		J BIOENERG BIOMEMBR	J. Bioenerg. Biomembr.	APR	2015	47	1-2					53	61		10.1007/s10863-014-9588-2			9	Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Cell Biology	CB3UO	WOS:000349554700005	25341378	Green Accepted			2022-02-06	
J	Sherer, M; Sander, AM; Maestas, KL; Pastorek, NJ; Nick, TG; Li, JY				Sherer, Mark; Sander, Angelle M.; Maestas, Kacey Little; Pastorek, Nicholas J.; Nick, Todd G.; Li, Jingyun			Accuracy of Self-reported Length of Coma and Posttraumatic Amnesia in Persons With Medically Verified Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Amnesia; Brain injuries; traumatic; Coma; Rehabilitation; Self-report; Severity	PSYCHIATRIC-SYMPTOMS; VETERANS; RELIABILITY; VALIDITY; SCALE	Objective: To determine the accuracy of self-reported length of coma and posttraumatic amnesia (PTA) in persons with medically verified traumatic brain injury (TBI) and to investigate factors that affect self-report of length of coma and PTA duration. Design: Prospective cohort study. Setting: Specialized rehabilitation center with inpatient and outpatient programs. Participants: Persons (N=242) with medically verified TBI who were identified from a registry of persons who had previously participated in TBI-related research. Intervention: Not applicable. Main Outcome Measures: Self-reported length of coma and self-reported PTA duration. Results: Review of medical records revealed that the mean medically documented length of coma and PTA duration was 6.9 +/- 12 and 19.2 +/- 22 days, respectively, and the mean self-reported length of coma and PTA duration was 16.7 +/- 22 and 106 +/- 194 days, respectively. The average discrepancy between self-report and medical record for length of coma and PTA duration was 8.2 +/- 21 and 64 +/- 176 days, respectively. Multivariable regression models revealed that time since injury, performance on cognitive tests, and medical record values were associated with self-reported values for both length of coma and PTA duration. Conclusions: In this investigation, persons with medically verified TBI showed poor accuracy in their self-report of length of coma and PTA duration. Discrepancies were large enough to affect injury severity classification. Caution should be exercised when considering self-report of length of coma and PTA duration. Archives of Physical Medicine and Rehabilitation 2015;96:652-8 (C) 2015 by the American Congress of Rehabilitation Medicine	[Sherer, Mark; Sander, Angelle M.; Maestas, Kacey Little] TIRR Mem Hermann, Houston, TX 77030 USA; [Sherer, Mark; Sander, Angelle M.; Maestas, Kacey Little; Pastorek, Nicholas J.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Ctr Trauma Rehabil, Dept Phys Med & Rehabil, Houston, TX USA; [Pastorek, Nicholas J.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Nick, Todd G.; Li, Jingyun] Univ Arkansas Med Sci, Dept Pediat & Biostat, Little Rock, AR 72205 USA		Sherer, M (corresponding author), TIRR Mem Hermann, 1333 Moursund, Houston, TX 77030 USA.	Mark.Sherer@memorialhermann.org		Sherer, Mark/0000-0003-1784-7008; Pastorek, Nicholas/0000-0002-9290-380X	National Institute on Disability and Rehabilitation Research, U.S. Department of EducationUS Department of Education [H133B090023, H133A120020]	Supported by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grants nos. H133B090023 and H133A120020).	Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green P., 1996, WORD MEMORY TEST USE; Harrell F, 2009, RMS S FUNCTIONS BIOS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1958, EXAMIN CLIN PSYCHOL; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	22	9	9	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2015	96	4					652	658		10.1016/j.apmr.2014.10.024			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CE9RC	WOS:000352180100011	25461819				2022-02-06	
J	Purushothuman, S; Stone, J				Purushothuman, Sivaraman; Stone, Jonathan			The reaction of cerebral cortex to a nearby lesion: Damage, survival, self-protection	BRAIN RESEARCH			English	Article						Microhemorrhage; Oxidative stress; Neurotrophic factors; Self-protection	FIBROBLAST-GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; AMYLOID OLIGOMERS IMPLIES; FLUORO-JADE-B; ALZHEIMERS-DISEASE; OXIDATIVE DAMAGE; LIPID-PEROXIDATION; MITOCHONDRIAL-DNA; COMMON MECHANISM; UP-REGULATION	A needlestick injury to cerebral cortex causes immediate damage along the track of the needle (haemorrhage, cell death) and sequelae (the formation of amyloid-positive plaques, extracellular deposits of hyperphosphorylated tau protein, microglial proliferation, astrogliosis) that are long lasting, and mimic the neuropathology associated with Alzheimer's disease. We report here that the same injury also elicits a distinctive response in the cortex flanking (up to 1 mm from) the direct injury. Needlestick injury was made in the neo- and hippocampal cortex of young (3 months) healthy Sprague-Dawley rats. After survival times of up to 7 d, the response of the cortex was assessed with histology, immunohistochemistry and stereology. Uptake of FluoroJade B at 1 d survival and labelling for 4-hydroxynonenal (4-HNE) gave measures of membrane damage; labelling for 8-hydroxy-2'-deoxyguanosine (8-OHDG) gave a measure of DNA damage, and labelling with the AT8 antibody gave a measure of the hyperphosphorylation of tau. Two probes, for neuroglobin and basic fibroblast growth factor (FGF-2), gave measures of a self-protective response in the tissue. Results indicate that neurones in the flanking region are damaged by the nearby lesion, and within 1 d upregulate self-protective mechanisms. Over the next 6 d survival, evidence of neuronal damage reduces markedly. In summary, cells in the region flanking a lesion are stressed by the lesion, and react to the stress with a self-protective response, which prevents their death. This response may be an important, previously unrecognised feature of brain tissue close to a focus of stress, such as a microhaemorrhage. (C) 2015 Elsevier B.V. All rights reserved.	[Purushothuman, Sivaraman; Stone, Jonathan] Univ Sydney, Discipline Physiol, Sch Med Sci, Fac Med, Camperdown, NSW 2006, Australia; [Purushothuman, Sivaraman; Stone, Jonathan] Univ Sydney, Bosch Inst, Sch Med Sci, Fac Med, Camperdown, NSW 2006, Australia; [Purushothuman, Sivaraman] Univ Sydney, Discipline Clin Ophthalmol, Sydney, NSW 2000, Australia; [Purushothuman, Sivaraman] Univ Sydney, Save Sight Inst, Sydney, NSW 2000, Australia; [Purushothuman, Sivaraman] Sydney Eye Hosp, Sydney, NSW 2000, Australia		Purushothuman, S (corresponding author), Univ Sydney, Discipline Physiol, Sydney Med Sch, Rm N654,Anderson Stuart Bldg F13,Univ Ave, Camperdown, NSW 2006, Australia.	sivap@physiol.usyd.edu.au; jonstone@eye.usyd.edu.au		Purushothuman, Sivaraman/0000-0002-0880-5060	Sir Zelman Cowen Universities Fund; Sydney Medical Foundation/Bluesand Foundation	We thank the Sir Zelman Cowen Universities Fund for our funding sources. We are grateful to Bosch Advanced Microscopy facility for the use of the microscope and MetaMorph software. Sharon Spana was splendid for her technical help. SP was supported by the Sydney Medical Foundation/Bluesand Foundation. JS is a director of CSCM Ply Ltd.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Bishop GM, 2003, J NEUROSCI RES, V73, P316, DOI 10.1002/jnr.10661; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cao W, 1997, EXP EYE RES, V65, P241, DOI 10.1006/exer.1997.0328; Cao W, 2001, EXP EYE RES, V72, P591, DOI 10.1006/exer.2001.0990; Castellani RJ, 2008, J ALZHEIMERS DIS, V14, P377; Castellani Rudy J, 2006, Am J Alzheimers Dis Other Demen, V21, P126, DOI 10.1177/153331750602100213; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Chen XQ, 2005, GLIA, V50, P182, DOI 10.1002/glia.20147; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Fahmy GH, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00129; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Gargini C, 1999, INVEST OPHTH VIS SCI, V40, P2088; Gargini C, 2004, NEUROSCIENCE, V126, P775, DOI 10.1016/j.neuroscience.2004.04.028; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; GomezPinilla F, 1997, NEUROSCIENCE, V76, P137; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Kontush A, 2001, FREE RADICAL BIO MED, V30, P119, DOI 10.1016/S0891-5849(00)00458-5; Kontush A, 2001, FREE RADICAL BIO MED, V31, P1120, DOI 10.1016/S0891-5849(01)00688-8; Lee HG, 2005, TRENDS MOL MED, V11, P164, DOI 10.1016/j.molmed.2005.02.008; Lovell MA, 1999, J NEUROCHEM, V72, P771, DOI 10.1046/j.1471-4159.1999.0720771.x; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Moftah M, 2008, J NEUROSCI RES, V86, P3348, DOI 10.1002/jnr.21776; Montine TJ, 2002, FREE RADICAL BIO MED, V33, P620, DOI 10.1016/S0891-5849(02)00807-9; Nagotani S, 2005, STROKE, V36, P670, DOI 10.1161/01.STR.0000155732.27333.3c; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Purushothuman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059740; Santos RX, 2013, ANTIOXID REDOX SIGN, V18, P2444, DOI 10.1089/ars.2012.5039; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith C, 2001, EUR J NEUROSCI, V13, P443, DOI 10.1046/j.1460-9568.2001.01400.x; Smith MA, 2002, FREE RADICAL BIO MED, V33, P1194, DOI 10.1016/S0891-5849(02)01021-3; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stone J., 2015, J ALZHEIMER IN PRESS, V44, P2015, DOI DOI 10.3233/JAD-141884; Stone J, 2008, MED HYPOTHESES, V71, P347, DOI 10.1016/j.mehy.2008.04.007; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; VICKERS JC, 1994, NEUROSCIENCE, V62, P1, DOI 10.1016/0306-4522(94)90310-7; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wasserman JK, 2008, EUR J NEUROSCI, V28, P1316, DOI 10.1111/j.1460-9568.2008.06442.x; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67; Zhao XC, 2013, NEUROCHEM RES, V38, P530, DOI 10.1007/s11064-012-0945-4	56	9	9	2	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 19	2015	1601						52	63		10.1016/j.brainres.2015.01.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD2TD	WOS:000350931000006	25591482				2022-02-06	
J	Abdanipour, A; Schluesener, HJ; Tiraihi, T; Noori-Zadeh, A				Abdanipour, Alireza; Schluesener, Hermann J.; Tiraihi, Taki; Noori-Zadeh, Ali			Systemic administration of valproic acid stimulates overexpression of microtubule-associated protein 2 in the spinal cord injury model to promote neurite outgrowth	NEUROLOGICAL RESEARCH			English	Article						Neurite; Valproic acid; MAP2; Circuit; Histone deacetylase inhibitor	LOW-MOLECULAR-WEIGHT; NEURONAL CYTOSKELETON; RAT-BRAIN; STEM-CELLS; GROWTH; MAP2; EXPRESSION; DIFFERENTIATION; PLASTICITY; INDUCTION	Objectives: Growing body of evidence suggests that neurite outgrowth is a key determinant in the re-networking of damaged neuronal circuits as well as synaptogenesis. The essential molecule in this interesting process is microtubule-associated protein 2 (MAP2) studies demonstrated that inhibition of MAP2 by antisense Oligonucleotide hinders neurite outgrowth. Methods: In the current study, we evaluated the effects of valproic acid (VPA), a histone deacetylase inhibitor on the expression of MAP2 in the rat spinal cord injury model by real time RT-PCR and immunoreactivity assays. Results: We revealed that a significant increase in the MAP2 overexpression occurred in VPA-treated group compared to the sham group by quantative real-time reverse transcription polymerase chain reaction (RTPCR) and immunoreactivity assays for MAP2 gene expression. Discussion: The present findings indicated that systemic administration of VPA stimulated MAP2 gene expression and also supports the involvement of the MAP2-mediated de novo re-arborization and neurite outgrowth of neurons, which might contribute to successful neuronal re-wirings. Thus, VPA has promising applications in the treatment of many neurological problems, such as neurotrauma, Alzheimer and Parkinson's disease, and others.	[Abdanipour, Alireza; Tiraihi, Taki; Noori-Zadeh, Ali] Khatam Al Anbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Abdanipour, Alireza] Islamic Azad Univ, Ardabil Branch, Dept Med Sci, Stem Cells Res Lab, Tehran, Iran; [Schluesener, Hermann J.] Univ Tubingen, Div Immunopathol Nervous Syst, Tubingen, Germany		Abdanipour, A (corresponding author), Khatam Al Anbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran.	abdani.anatomy@yahoo.com	abdanipour, Alireza/I-4964-2016; Noori-Zadeh, Ali/Q-4998-2017	abdanipour, Alireza/0000-0002-2975-3423; Noori-Zadeh, Ali/0000-0002-4897-7684	Shefa Neurosciences Research Center, Khatam Al-Anbia Hospital, Tehran, Iran	This work was supported by a research grant from Shefa Neurosciences Research Center, Khatam Al-Anbia Hospital, Tehran, Iran.	ALBALA JS, 1995, J NEUROCHEM, V64, P2480; Almutawaa W, 2014, BASIC CLIN PHARMACOL, V115, P216, DOI 10.1111/bcpt.12201; AVILA J, 1994, INT J DEV BIOL, V38, P13; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bella AJ, 2006, J SEX MED, V3, P815, DOI 10.1111/j.1743-6109.2006.00291.x; BIGOT D, 1991, NEUROSCI LETT, V131, P21, DOI 10.1016/0304-3940(91)90328-Q; Brandt R, 1998, CELL TISSUE RES, V292, P181, DOI 10.1007/s004410051049; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; BRUNI J, 1979, ARCH NEUROL-CHICAGO, V36, P393, DOI 10.1001/archneur.1979.00500430023002; Bustin SA, 2004, AZ QUANT PCR, V1, P89, DOI DOI 10.1186/1471-2199-11-57; CHARRIEREBERTRAND C, 1991, J NEUROCHEM, V56, P385, DOI 10.1111/j.1471-4159.1991.tb08163.x; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Chung WJ, 1996, J NEUROCHEM, V66, P1273; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; Cross D, 1999, BIOCHEMISTRY-US, V130, P4362; Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011; Di Daniel E, 2005, BIPOLAR DISORD, V7, P33; DOERING LC, 1993, MOL NEUROBIOL, V7, P265, DOI 10.1007/BF02769179; EDSON K, 1993, DEVELOPMENT, V117, P689; Felgner H, 1997, J CELL BIOL, V138, P1067, DOI 10.1083/jcb.138.5.1067; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; Fleming JA, 2000, GENETICS, V156, P69; Gomes C, 2011, J BIOL CHEM, V286, P4357, DOI 10.1074/jbc.M110.170134; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Gordon-Weeks PR, 2014, J NEUROCHEM, V129, P206, DOI 10.1111/jnc.12502; Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003; Hall AC, 2002, MOL CELL NEUROSCI, V20, P257, DOI 10.1006/mcne.2002.1117; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Hayashi K, 1996, J NEUROSCI, V16, P7161; Heidemann SR, 1996, INT REV CYTOL, V165, P235, DOI 10.1016/S0074-7696(08)62224-X; HEIMANN R, 1985, J BIOL CHEM, V260, P2160; Heo Hye Young, 2010, Exp Neurobiol, V19, P97, DOI 10.5607/en.2010.19.2.97; Jeong SG, 2013, NEUROSCI LETT, V554, P22, DOI 10.1016/j.neulet.2013.08.059; Kaech S, 1996, NEURON, V17, P1189, DOI 10.1016/S0896-6273(00)80249-4; Kalcheva N, 1998, CELL MOTIL CYTOSKEL, V40, P272, DOI 10.1002/(SICI)1097-0169(1998)40:3<272::AID-CM6>3.0.CO;2-F; Kalil K, 2014, NAT REV NEUROSCI, V15, P7, DOI 10.1038/nrn3650; KOSIK KS, 1994, CELL MOTIL CYTOSKEL, V28, P195, DOI 10.1002/cm.970280302; Kurihara Y, 2014, J VET MED SCI, V76, P15, DOI 10.1292/jvms.13-0219; KURZ JC, 1995, BIOCHEMISTRY-US, V34, P13374, DOI 10.1021/bi00041a014; LANGKOPF A, 1995, J NEUROCHEM, V64, P1045; Langnaese K, 1996, MOL BRAIN RES, V42, P118, DOI 10.1016/S0169-328X(96)00147-7; Letourneau PC, 1996, PERSPECT DEV NEUROBI, V4, P111; Lev DL, 1997, EUR J NEUROSCI, V9, P280, DOI 10.1111/j.1460-9568.1997.tb01398.x; Loveland KL, 1996, BIOL REPROD, V54, P896, DOI 10.1095/biolreprod54.4.896; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.ne.11.030188.000333; MEICHSNER M, 1993, NEUROSCIENCE, V54, P873, DOI 10.1016/0306-4522(93)90581-Y; Milde Stefan, 1800, Bioarchitecture, V3, P133, DOI 10.4161/bioa.27049; Nielsen J, 2009, J NEUROSCI, V29, P11360, DOI 10.1523/JNEUROSCI.3239-09.2009; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; PRYER NK, 1992, J CELL SCI, V103, P965; Rehbein M, 2000, MOL BRAIN RES, V79, P192, DOI 10.1016/S0169-328X(00)00114-5; Ring RH, 2006, J NEUROBIOL, V66, P361, DOI 10.1002/neu.20223; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Shafit-Zagardo B, 1998, MOL NEUROBIOL, V16, P149, DOI 10.1007/BF02740642; Shih PY, 2014, J CELL SCI, V127, P3521, DOI 10.1242/jcs.149476; Solomon F, 1992, Curr Opin Neurobiol, V2, P613, DOI 10.1016/0959-4388(92)90027-I; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; TUCKER RP, 1988, J NEUROSCI, V8, P4503; VALDIVIA MM, 1982, BIOCHEM BIOPH RES CO, V105, P1241, DOI 10.1016/0006-291X(82)90920-2; Vandecandelaere A, 1996, CELL MOTIL CYTOSKEL, V35, P134, DOI 10.1002/(SICI)1097-0169(1996)35:2<134::AID-CM6>3.3.CO;2-8; WICHE G, 1989, BIOCHEM J, V259, P1; WICHE G, 1984, EMBO J, V3, P991, DOI 10.1002/j.1460-2075.1984.tb01918.x; Yamauchi J, 2007, EXP CELL RES, V313, P1886, DOI 10.1016/j.yexcr.2007.02.019; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200	66	9	9	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2015	37	3					223	228		10.1179/1743132814Y.0000000438			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX3ER	WOS:000346823700006	25203772				2022-02-06	
J	Auxemery, Y				Auxemery, Yann			For each war its syndrome and each syndrome its war	ANNALES MEDICO-PSYCHOLOGIQUES			French	Article						Gulf war syndrome; Mental contagion; Post-concussive syndrome; Post-traumatic stress disorder; Post-Vietnam syndrome; Post-war syndrome; Psychic trauma; Psychopathology	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION-LIKE SYMPTOMS; TRAUMATIC BRAIN-INJURY; MECHANISMS; VETERANS; HEALTH; DEATH	The clinical is not fixed within immutable guidelines; the uniqueness is the very interest of this clinical. A new syndrome does not occur by chance, it blossoms within a cultural and social context. Following an armed conflict, the description of a new illness has a social meaning. War-related mental disorders have been known since Antiquity. In the first edition of the DSM, the American classification introduced the term Gross stress reaction. This category then disappeared in the following edition to re-emerge under the aegis of Post-traumatic stress disorder in 1980 following the publication of DSM-III. The successive denominations of the "Post-Vietnam syndrome" then post-traumatic stress disorder were criticized by a few authors who considered their existence from an anthropological point of view. Far from new semiotics, the neologisms successively formulated are used for causes other than that of the clinical. Why change the signifier? Renaming a disorder enables its medical and social treatment to be changed. A few decades later, the Gulf war syndrome has again come to repudiate the possibility of psychological suffering of war to finally constitute a model of epidemic misconduct. In the weeks and the months that followed the operation, a certain number of soldiers developed nonspecific, multi-systematised functional symptoms. Numerous aetiopathogenic hypotheses were put forward attempting to incriminate the exposure to multiple poisons and vaccines. But despite the extremely in-depth scientific investigations, no marker of objective physical suffering was revealed. The media disinformation of this possibility may have finally had an effect just as deleterious as if a few chemical weapons had been used: minds have been poisoned. To spare the bother of a group psychological reflection, the scientific and political authorities chose to investigate the implication of environmental factors in the genesis of the disorder. Rather than toxic exposure to such and such a substance, the nonspecific syndrome called "Gulf War Syndrome" is the result of exposure to the eponymous operational theatre. Finally, post-concussion syndrome is rediscovered thanks to the progress in medical techniques, which enable the "invisible broken faces" of days gone by to be seen. There again, if numerous subjects were brain-injured, others were shocked by the fighting and found a socially acceptable expression of their pain through a syndrome named for that purpose. Yet a return to individual subjectivity would enable a soldier to escape the functional symptoms... For civil society, calling into question "the somatic word" of veterans is difficult: why were they sent to face these hardships? It would be better to grant a pension to these men to spare an overall reflection, societal reflection on the war and psychopathological reflection on the subject who enlists. What could we learn from these soldiers that we do not want to listen to? The horror of the war, the aggressive impulse of man, the confrontation with death. How can the inexpressible and the unimaginable be recounted, particularly if the social context does not allow it? Another obstacle to this reflection is the idea of stress being the unique source of the psychological trauma. This theoretical orientation, which considers that the psychotraumatic disorder is a normal reaction to an abnormal situation, leads finally to discrediting the subject and society and disempowering them by freezing them in a passive status of victim. This approach, which represents in our opinion an additional denial acquired throughout history, increases the risk of appearance and chronicity of a repetition syndrome in the absence of the introduction of psychotherapy. The notions of stress and trauma are by no means equivalent. A new nosographic entity can thus spread throughout the population like an epidemic through, mechanisms of identification, imitation and suggestion. Such acknowledgement could help prevent the risk of diffusion of other unexplained syndromes, which may occur following future armed conflicts. This will enable discussions to be refocused on the suffering subject. If a new nosographic entity has meaning in mass history, the psychological trauma holds meaning in the subject's life history. Another fight awaits the psychological casualty of war on their route to reconstruction: a retrospective of themselves, which will bring meaning to the traumatic event, itself initially, experienced as insane. Far from being purely the normal reaction to an abnormal situation, the psychological trauma is incorporated in a singular life course. A single event experienced by numerous individuals will only be traumatic for a few of them. If.however the same traumatising event can lead to a trauma in two control subjects, the themes of the repetition syndrome will be different and the sensory perceptions of the revivifications will be far from identical. You are never psycho-traumatized by chance. The psychotraumatised subject is subjectively involved in the scene they experienced. Sometimes the scene imposes itself on him, but more often the subject pre-empts the traumatic risk himself. The biographical overlap is the core of the trauma, which again brings the subject face to face with a previous impasse concerning death and its consequences: paternity, bereavement and access to sexuality. Through this echo of intimacy, the traumatic event imposes itself on the individual who was involved in the scene they experienced. Self-reconstruction thus takes time, due to individual but also social defence mechanisms, as we have seen. If a new nosographic entity has meaning in collective history, the psychological trauma holds meaning in the life history of a subject. Towards their reconstruction another fight awaits the psychological casualty of war: a retrospective of himself, which will bring meaning to the senselessness of the trauma. (C) 2013 Elsevier Massori SAS. All rights reserved.	[Auxemery, Yann] Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, F-57070 Metz 3, France; [Auxemery, Yann] Univ Paris 07, UFR Sci Humaines Clin, Ecole Doctorale Rech Psychanalyse, CRPMS, F-75010 Paris, France; [Auxemery, Yann] Ecole Val De Grace, F-75005 Paris, France		Auxemery, Y (corresponding author), Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, 27 Ave Plantieres,BP 90001, F-57070 Metz 3, France.	yann.auxemery@hotmail.fr					Artiss KL, 2010, MIL MED, V175, P259, DOI 10.7205/MILMED-D-10-00045; Auxemery Y, 2012, ENCEPHALE, V38, P329, DOI 10.1016/j.encep.2011.07.003; Auxemery Y, 2012, ANN MED-PSYCHOL, V170, P306, DOI 10.1016/j.amp.2011.03.017; Auxemery Y, 2013, EVOL PSYCHIAT; Auxemery Y, 2012, ANN MED-PSYCHOL, V170, P527, DOI 10.1016/j.amp.2011.09.017; Briole G, 1994, 42 SESS C PSYCH NEUR; Brown D, 1994, DIAGNOSIS UNKNOWN GU; Chidiac N, 2010, ANN MED-PSYCHOL, V168, P311, DOI 10.1016/j.amp.2010.03.013; Clauw DJ, 2003, J OCCUP ENVIRON MED, V45, P1040, DOI 10.1097/01.jom.0000091693.43121.2f; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Gray GC, 1996, NEW ENGL J MED, V335, P1505, DOI 10.1056/NEJM199611143352007; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; Lebigot F, 1997, ANN MED-PSYCHOL, V155, P522; MARSHALL GN, 2000, REV SCI LIT PERTAINS, V4; *PRES ADV COMM GUL, 1996, FIN REP; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rechtman R, 2002, EVOL PSYCHIATR, V67, P775; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Shatan C. F., 1972, NY TIMES; Summerfield D, 2001, BRIT MED J, V322, P95, DOI 10.1136/bmj.322.7278.95; Taber KH, 2007, J NEUROPSYCH CLIN N, V19, P100; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WHITE P, 1989, MIL MED, V154, P66; Wolfe J, 1999, PSYCHOSOM MED, V61, P532, DOI 10.1097/00006842-199907000-00018; Young Allan, 1995, HARMONY ILLUSIONS IN	31	9	9	1	29	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0003-4487	1769-6631		ANN MED-PSYCHOL	Ann. Med.-Psychol.	MAR	2015	173	2					174	179		10.1016/j.amp.2012.01.022			6	Pharmacology & Pharmacy; Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Psychiatry; Psychology	CG6TA	WOS:000353434100008					2022-02-06	
J	Bengualid, V; Talari, G; Rubin, D; Albaeni, A; Ciubotaru, RL; Berger, J				Bengualid, Victoria; Talari, Goutham; Rubin, David; Albaeni, Aiham; Ciubotaru, Ronald L.; Berger, Judith			FEVER IN TRAUMA PATIENTS: EVALUATION OF RISK FACTORS, INCLUDING TRAUMATIC BRAIN INJURY	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							INFECTION	Background The role of fever in trauma patients remains unclear. Fever occurs as a response to release of cytokines and prostaglandins by white blood cells. Many factors, including trauma, can trigger release of these factors. Objectives To determine whether (1) fever in the first 48 hours is related to a favorable outcome in trauma patients and (2) fever is more common in patients with head trauma. Method Retrospective study of trauma patients admitted to the intensive care unit for at least 2 days. Data were analyzed by using multivariate analysis. Results Of 162 patients studied, 40% had fever during the first 48 hours. Febrile patients had higher mortality rates than did afebrile patients. When adjusted for severity of injuries, fever did not correlate with mortality. Neither the incidence of fever in the first 48 hours after admission to the intensive care unit nor the number of days febrile in the unit differed between patients with and patients without head trauma (traumatic brain injury). About 70% of febrile patients did not have a source found for their fever. Febrile patients without an identified source of infection had lower peak white blood cell counts, lower maximum body temperature, and higher minimum platelet counts than did febrile patients who had an infectious source identified. The most common infection was pneumonia. Conclusions No relationship was found between the presence of fever during the first 48 hours and mortality. Patients with traumatic brain injury did not have a higher incidence of fever than did patients without traumatic brain injury. About 30% of febrile patients had an identifiable source of infection. Further studies are needed to understand the origin and role of fever in trauma patients.	[Bengualid, Victoria] St Barnabas Hosp, Internal Med, Bronx, NY USA; [Talari, Goutham] UK Healthcare, Lexington, KY USA; [Rubin, David] St Barnabas Hosp, Pediat, Bronx, NY USA; [Albaeni, Aiham] Johns Hopkins Med, Med, Baltimore, MD USA; [Ciubotaru, Ronald L.] St Barnabas Hosp, Med, Bronx, NY USA; [Berger, Judith] St Barnabas Hosp, Div Infect Dis, 4422 Third Ave, Bronx, NY 10457 USA		Bengualid, V (corresponding author), St Barnabas Hosp, Div Infect Dis, 4422 Third Ave, Bronx, NY 10457 USA.	vbengualid@sbhny.org		Albaeni, Aiham/0000-0003-3876-333X			[Anonymous], 2015, AM J CRITICAL CARE, V24; Bohman LE, 2014, CURR OPIN CRIT CARE, V20, P182, DOI 10.1097/MCC.0000000000000070; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Circiumaru B, 1999, INTENS CARE MED, V25, P668, DOI 10.1007/s001340050928; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; LaPar DJ, 2012, J AM COLL SURGEONS, V214, P478, DOI 10.1016/j.jamcollsurg.2011.12.015; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Rincon F, 2015, J INTENSIVE CARE MED, V30, P107, DOI 10.1177/0885066613508266; Swenson BR, 2007, J AM COLL SURGEONS, V204, P815, DOI 10.1016/j.jamcollsurg.2007.01.033; Young PJ, 2012, INTENS CARE MED, V38, P437, DOI 10.1007/s00134-012-2478-3	10	9	9	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	MAR 1	2015	24	2					E1	E5		10.4037/ajcc2015856			5	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Nursing	EF2ZP	WOS:000390194500001	25727281	Bronze			2022-02-06	
J	Ehsaei, M; Khajavi, M; Arjmand, MH; Abuee, MA; Ghayour-Mobarhan, M; Alamdari, DH				Ehsaei, Mohamadreza; Khajavi, Mehdi; Arjmand, Mohammad Hassan; Abuee, Mohammad Ali; Ghayour-Mobarhan, Majid; Alamdari, Daryoush Hamidi			Prooxidant-antioxidant balance in patients with traumatic brain injury	ACTA NEUROLOGICA BELGICA			English	Article						Prooxidant-antioxidant balance; Trumatic brain injury; Oxidative stress	OXIDATIVE STRESS; HEAD-INJURY; NEURODEGENERATION; PATHOPHYSIOLOGY	Brain trauma is an important cause of mortality and disability among young people worldwide. One of the mechanisms of post-traumatic secondary brain damage is related to free radical release and oxidative stress (OS). OS is the consequence of an imbalance between pro-oxidants and antioxidants in favor of pro-oxidants. This imbalance may lead to macromolecule damage including lipid peroxidation, protein crosslinking, DNA damage and changes in growth and function of cells in brain. Free radical release and subsequent lipid peroxidation are early events following neural tissues injury and are associated with hypo-perfusion, edema, and disruption of axonal guidance. In this study, we determined the prooxidant-antioxidant balance (PAB) in patients with brain injury, and its correlation with number of demographic and clinical parameters. Sera from 98 patients with traumatic brain and 100 healthy subjects were collected. The serum PAB was measured. Age, sex, GCS (Glasgow coma scale), mechanism of injury, brain lesions found on CT scan and lesions in other parts of the body, caused by trauma, were determined. A significantly higher PAB value was observed in the patient group (138.97 +/- 15.9 HK unit) compared to the controls (60.82 +/- 12.6 HK) (P = 0.001). In the patient group, there was no significant correlation of PAB with GCS, brain lesion characteristic, mechanism of injury, other accompanying traumatic injury, age and gender. When patients were classified into three groups according to GCS: group 1 (GCS>13, n = 28, PAB serum value = 138.51 +/- 62.66 HK), group 2 (GCS between 8 and 12, n = 29, PAB serum value = 162.7 +/- 50.6 HK) and group 3 (GCS <8, n = 41, PAB serum value = 155.56 +/- 58.21 HK); there was no significant difference between groups. The serum PAB values were higher in patients with traumatic brain injury, although this was not associated with the extent of injury.	[Ehsaei, Mohamadreza] Mashhad Univ Med Sci, Sch Med, Dept Neurosurg, Mashhad, Iran; [Khajavi, Mehdi; Abuee, Mohammad Ali] Mashhad Univ Med Sci, Sch Med, Emdad Hosp, Neurosurg,Dept Neurosurg, Mashhad, Iran; [Arjmand, Mohammad Hassan] Mashhad Univ Med Sci, Sch Med, Ghaem Hosp, Biochem,Dept Surg, Mashhad, Iran; [Ghayour-Mobarhan, Majid] Mashhad Univ Med Sci, Sch Med, Biochem Nutr Res Ctr, Mashhad, Iran; [Alamdari, Daryoush Hamidi] Mashhad Univ Med Sci, Sch Med, Dept Biochem, Biochem & Nutr Res Ctr, Mashhad, Iran		Alamdari, DH (corresponding author), Mashhad Univ Med Sci, Sch Med, Dept Biochem, Biochem & Nutr Res Ctr, Mashhad, Iran.	Hamidiad@mums.ac.ir	Arjmand, mohammad-Hassan/ABD-7671-2020	Arjmand, Mohammad-Hassan/0000-0001-9775-1414			Alamdari DH, 2008, CLIN BIOCHEM, V41, P375, DOI 10.1016/j.clinbiochem.2007.12.008; Alamdari DH, 2007, CLIN BIOCHEM, V40, P248, DOI 10.1016/j.clinbiochem.2006.10.017; Delanty N, 1998, ACTA NEUROL SCAND, V98, P145, DOI 10.1111/j.1600-0404.1998.tb07285.x; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Erel O, 2004, CLIN BIOCHEM, V37, P112, DOI 10.1016/j.clinbiochem.2003.10.014; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Freire MAM, 2012, W INDIAN MED J, V61, P751; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Han SN, 2000, J INFECT DIS, V182, pS74, DOI 10.1086/315915; Hanafy KA, 2012, NEUROTHERAPEUTICS, V9, P44, DOI 10.1007/s13311-011-0085-6; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Nayak CD, 2008, NEUROL INDIA, V56, P31, DOI 10.4103/0028-3886.39309; Ramana Kota V, 2011, Biomol Concepts, V2, P103; Razmkon Ali, 2011, Clin Neurosurg, V58, P133; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	17	9	10	0	17	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	MAR	2015	115	1					69	73		10.1007/s13760-014-0300-4			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD5XR	WOS:000351162600009	25027161				2022-02-06	
J	Lu, D; Chen, EYT; Lee, P; Wang, YC; Ching, W; Markey, C; Gulstrom, C; Chen, LC; Nguyen, T; Chin, WC				Lu, David; Chen, Eric Y. T.; Lee, Philip; Wang, Yung-Chen; Ching, Wendy; Markey, Christopher; Gulstrom, Chase; Chen, Li-Ching; Nguyen, Thien; Chin, Wei-Chun			Accelerated Neuronal Differentiation Toward Motor Neuron Lineage from Human Embryonic Stem Cell Line (H9)	TISSUE ENGINEERING PART C-METHODS			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; NERVE GROWTH-FACTOR; IN-VITRO; NEUROTROPHIC FACTOR; IRON HOMEOSTASIS; NA+/H+ EXCHANGE; REDOX STATE; BRAIN; PROLIFERATION; TRANSFERRIN	Motor neurons loss plays a pivotal role in the pathoetiology of various debilitating diseases such as, but not limited to, amyotrophic lateral sclerosis, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, pseudobulbar palsy, and spinal muscular atrophy. However, advancement in motor neuron replacement therapy has been significantly constrained by the difficulties in large-scale production at a cost-effective manner. Current methods to derive motor neuron heavily rely on biochemical stimulation, chemical biological screening, and complex physical cues. These existing methods are seriously challenged by extensive time requirements and poor yields. An innovative approach that overcomes prior hurdles and enhances the rate of successful motor neuron transplantation in patients is of critical demand. Iron, a trace element, is indispensable for the normal development and function of the central nervous system. Whether ferric ions promote neuronal differentiation and subsequently promote motor neuron lineage has never been considered. Here, we demonstrate that elevated iron concentration can drastically accelerate the differentiation of human embryonic stem cells (hESCs) toward motor neuron lineage potentially via a transferrin mediated pathway. HB9 expression in 500 nM iron-treated hESCs is approximately twofold higher than the control. Moreover, iron treatment generated more matured and functional motor neuron-like cells that are similar to 1.5 times more sensitive to depolarization when compared to the control. Our methodology renders an expedited approach to harvest motor neuron-like cells for disease, traumatic injury regeneration, and drug screening.	[Lu, David; Chen, Eric Y. T.; Lee, Philip; Wang, Yung-Chen; Ching, Wendy; Markey, Christopher; Gulstrom, Chase; Chin, Wei-Chun] Univ Calif, Sch Engn, Bioengn Program, Merced, CA 95343 USA; [Chen, Eric Y. T.] Chang Gung Univ, Biomed Engn Res Ctr, Taoyuan, Taiwan; [Chen, Eric Y. T.] MicroBase Technol Corp, Taoyuan, Taiwan; [Chen, Li-Ching] Taipei Med Univ, Shuang Ho Hosp, Minist Hlth & Welf, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Nguyen, Thien] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA		Chin, WC (corresponding author), Univ Calif, Sch Engn, Bioengn Program, 5200 North Lake Rd, Merced, CA 95343 USA.	wchin2@ucmerced.edu	Chin, Wei-Chun/A-6068-2008	Chin, Wei-Chun/0000-0003-4881-9085	Muscular Dystrophy Association (MDA)Muscular Dystrophy Association; Linkou Chang Gung Memorial Hospital [CMRPD1C0031]	This study was supported in part by grants from the Muscular Dystrophy Association (MDA) and Linkou Chang Gung Memorial Hospital (CMRPD1C0031).	Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Axell MZ, 2009, J NEUROSCI METH, V184, P275, DOI 10.1016/j.jneumeth.2009.08.015; Barg S, 2001, J CELL SCI, V114, P2145; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Benarroch EE, 2009, NEUROLOGY, V72, P1436, DOI 10.1212/WNL.0b013e3181a26b30; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; BOMFORD A, 1985, BIOCHEMISTRY-US, V24, P3472, DOI 10.1021/bi00335a013; Britton RS, 2002, INT J HEMATOL, V76, P219, DOI 10.1007/BF02982791; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CAZZOLA M, 1990, BLOOD, V75, P1903; Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157; Chen EYT, 2012, J BIOMED MATER RES A, V100A, P2006, DOI 10.1002/jbm.a.34201; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; DAUTRYVARSAT A, 1986, BIOCHIMIE, V68, P375, DOI 10.1016/S0300-9084(86)80004-9; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Dringen R, 2007, NEUROCHEM RES, V32, P1884, DOI 10.1007/s11064-007-9375-0; DYSON SE, 1984, DEV BRAIN RES, V13, P125, DOI 10.1016/0165-3806(84)90084-1; Erceg S, 2009, STEM CELLS, V27, P78, DOI 10.1634/stemcells.2008-0543; Gertz CC, 2010, DEV NEUROBIOL, V70, P589, DOI 10.1002/dneu.20792; Hasan MR, 2006, EXP CELL RES, V312, P1950, DOI 10.1016/j.yexcr.2006.02.023; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hirobe T, 2009, J HEALTH SCI, V55, P447, DOI 10.1248/jhs.55.447; Hirobe T, 2009, J HEALTH SCI, V55, P86, DOI 10.1248/jhs.55.86; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Krieger J, 2001, SLEEP MED REV, V5, P277, DOI 10.1053/smrv.2001.0156; LEIGH PN, 1994, J NEUROL NEUROSUR PS, V57, P886, DOI 10.1136/jnnp.57.8.886; LEVI A, 1980, P NATL ACAD SCI-BIOL, V77, P3469, DOI 10.1073/pnas.77.6.3469; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li Y, 2011, J NUTR, V141, P2133, DOI 10.3945/jn.111.145946; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; Mazur-Kolecka B, 2009, NEUROTOX RES, V16, P87, DOI 10.1007/s12640-009-9052-y; Meguro R, 2008, ARCH HISTOL CYTOL, V71, P205, DOI 10.1679/aohc.71.205; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; MOOLENAAR WH, 1983, NATURE, V304, P645, DOI 10.1038/304645a0; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Nguyen T, 2009, J NEUROSCI, V29, P630, DOI 10.1523/JNEUROSCI.5204-08.2009; OKEEFFE ST, 1994, AGE AGEING, V23, P200, DOI 10.1093/ageing/23.3.200; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; PATERSON S, 1984, J CELL PHYSIOL, V120, P225, DOI 10.1002/jcp.1041200217; Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9; Quinn DA, 1996, AM J RESP CELL MOL, V14, P139, DOI 10.1165/ajrcmb.14.2.8630263; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sadrzadeh S M Hossein, 2004, Am J Clin Pathol, V121 Suppl, pS64; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Salis C, 2012, NEUROCHEM INT, V61, P798, DOI 10.1016/j.neuint.2012.06.023; Schonberg DL, 2012, J NEUROSCI, V32, P5374, DOI 10.1523/JNEUROSCI.3517-11.2012; Shelton FDAP, 2001, STROKE, V32, P107, DOI 10.1161/01.STR.32.1.107; Singh AV, 2012, J NEUROSCI RURAL PRA, V3, P301, DOI 10.4103/0976-3147.102611; Skalnikova H, 2007, PROTEOMICS, V7, P1825, DOI 10.1002/pmic.200600867; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Stacpoole SRL, 2011, NAT PROTOC, V6, P1229, DOI 10.1038/nprot.2011.380; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; SWAIMAN KF, 1984, ANN NEUROL, V16, P66, DOI 10.1002/ana.410160113; Todorich B, 2011, GLIA, V59, P927, DOI 10.1002/glia.21164; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Tran PV, 2008, J NUTR, V138, P2495, DOI 10.3945/jn.108.091553; Vodouhe C, 2005, BIOMATERIALS, V26, P545, DOI 10.1016/j.biomaterials.2004.02.057; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang DS, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-92; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	69	9	9	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	MAR 1	2015	21	3					242	252		10.1089/ten.tec.2013.0725			11	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering; Materials Science	CC0RL	WOS:000350043400002	25036750	Green Published			2022-02-06	
J	Major, EH; O'Connor, P; Mullan, B				Major, E. H.; O'Connor, P.; Mullan, B.			Single bolus 30 % hypertonic saline for refractory intracranial hypertension	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Hypertonic saline solutions; Intracranial hypertension; Intensive care; Traumatic brain injuries; Cerebral edema; Mannitol	CEREBRAL OXYGEN DELIVERY; HEMORRHAGIC-SHOCK; SODIUM-CHLORIDE; BLOOD-FLOW; PRESSURE; FLUID; MANNITOL; DEXTRAN; RESUSCITATION	In recent years hypertonic saline has attracted increasing interest in the treatment of traumatic intracranial hypertension, and has a number of documented and theoretical advantages over other hyperosmolar agents. To date, no consensus has been achieved on the safest and most effective HTS concentration for administration. The purpose of this paper was to evaluate the efficacy of intravenous bolus administration of highly concentrated (30 %) hypertonic saline (HTS) in the treatment of refractory intracranial hypertension secondary to traumatic brain injury. Patients were treated with an intravenous bolus of 10 ml of 30 % hypertonic saline. Multiple physiological parameters were measured throughout, including intracranial pressure, mean arterial pressure, cerebral perfusion pressure, pulse and inotrope/pressor requirements. Laboratory investigation pre and post HTS administration included: arterial pH, pCO(2), HCO3, base excess; serum biochemistry measurements of sodium, potassium, chloride, urea and creatinine; and coagulation studies. TBI patients saw a rapid and significant reduction in ICP from a baseline value of 28 +/- A 5.31 to 18.44 +/- A 6.17 mmHg at 1 h post HTS, a statistically significant reduction that was maintained for up to 7 h. This response was maintained even with repeated HTS administration, which was also associated with an augmented cerebral perfusion pressure from a baseline of 58.0 +/- A 6.48 to 76.33 mmHg within 1 h of HTS administration. No associated harmful biochemical or haematological abnormalities were noted. In conclusion, highly concentrated 30 % HTS appears to be both effective and safe in the management of refractory intracranial hypertension.	[Major, E. H.; O'Connor, P.; Mullan, B.] Royal Victoria Hosp, Reg Intens Care Unit, Belfast BT12 6BA, Antrim, North Ireland		Major, EH (corresponding author), Royal Victoria Hosp, Reg Intens Care Unit, Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland.	e.major@qub.ac.uk					[Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; FENSTERMACHER JD, 1966, AM J PHYSIOL, V211, P341, DOI 10.1152/ajplegacy.1966.211.2.341; Hartl R, 1997, ACT NEUR S, V70, P126; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; MAZZONI MC, 1990, CIRC SHOCK, V31, P407; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Ninomiya Y, 2007, BIOMETRICS, V63, P1135, DOI 10.1111/j.1541-0420.2007.00821.x; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; SCHMOKER JD, 1992, J TRAUMA, V33, P476, DOI 10.1097/00005373-199209000-00024; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Suarez Jose I, 2004, Cleve Clin J Med, V71 Suppl 1, pS9; Tollofsrud S, 1998, ACTA ANAESTH SCAND, V42, P145, DOI 10.1111/j.1399-6576.1998.tb05100.x; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White H, 2008, EUR J ANAESTH, V25, P104, DOI 10.1017/S0265021507003420; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	28	9	9	0	7	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	MAR	2015	184	1					159	165		10.1007/s11845-014-1080-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE5AB	WOS:000351840900021	24532091				2022-02-06	
J	Tan, ET; Marinelli, L; Sperl, JI; Menzel, MI; Hardy, CJ				Tan, Ek T.; Marinelli, Luca; Sperl, Jonathan I.; Menzel, Marion I.; Hardy, Christopher J.			Multi-directional Anisotropy From Diffusion Orientation Distribution Functions	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						diffusion imaging; fractional anisotropy; diffusion spectrum imaging; diffusion tensor imaging; multi-directional anisotropy	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; MULTIPLE-SCLEROSIS; WATER DIFFUSION; WEIGHTED MRI; TENSOR; STROKE	PurposeTo evaluate a model-independent, multi-directional anisotropy (MDA) metric that is analytically and experimentally equivalent to fractional anisotropy (FA) in single-direction diffusivity, but potentially superior to FA in its sensitivity to the underlying anisotropy of multi-directional diffusivity. Materials and MethodsAn expression for MDA was defined from the orientation distribution function (ODF) and its analytical relation to FA was derived. Simulations of single and crossed double-fibers were performed using a compressed-sensing-accelerated diffusion-spectrum-imaging (CS-DSI) scheme. In vivo brain imaging using CS-DSI was performed on eight healthy subjects. MDA was compared with FA and with another ODF-based metric known as generalized FA (GFA). ResultsIn simulated single-direction fibers, MDA was shown to be equivalent to FA (from FA=0.2 to 0.8). In crossed fibers, MDA provided superior differentiation of the underlying anisotropy as compared to FA and GFA. In vivo analysis shows that the MDA was superior to both FA (P=0.015) and GFA (P=0.021) in terms of its relative accuracy in crossed fiber regions. ConclusionMDA provides a potentially superior measure of fiber anisotropy relative to conventional FA or GFA, and may be used to improve the assessment of disease in regions with multi-directional brain fibers. J. Magn. Reson. Imaging 2015;41:841-850. (c) 2014 Wiley Periodicals, Inc.	[Tan, Ek T.; Marinelli, Luca; Hardy, Christopher J.] GE Global Res, Niskayuna, NY 12309 USA; [Sperl, Jonathan I.; Menzel, Marion I.] GE Global Res, Garching, Bavaria, Germany		Tan, ET (corresponding author), GE Global Res, Diagnost & Biomed Technol, One Res Circle, Niskayuna, NY 12309 USA.	ek.tan@ge.com	Menzel, Marion Irene/H-8952-2016; Tan, Ek Tsoon/H-8603-2019; Marinelli, Luca/AAB-5933-2021	Menzel, Marion Irene/0000-0003-0087-9134; Tan, Ek Tsoon/0000-0003-2847-9378			[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 2002, MAGN RESON MED, V47, P392, DOI 10.1002/mrm.10052; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; CALLAGHAN PT, 1990, J MAGN RESON, V90, P177, DOI 10.1016/0022-2364(90)90376-K; CHENEVERT TL, 1990, RADIOLOGY, V177, P401, DOI 10.1148/radiology.177.2.2217776; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Fung SH, 2011, NEUROIMAG CLIN N AM, V21, P345, DOI 10.1016/j.nic.2011.03.001; Gonzalez JEI, 2011, MED PHYS, V38, P4350, DOI 10.1118/1.3599724; Guo AC, 2002, RADIOLOGY, V222, P729, DOI 10.1148/radiol.2223010311; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones Derek K, 2010, Top Magn Reson Imaging, V21, P87, DOI 10.1097/RMR.0b013e31821e56ac; Khare K, 2012, MAGN RESON MED, V68, P1450, DOI 10.1002/mrm.24143; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; Leow AD, 2009, MAGN RESON MED, V61, P205, DOI 10.1002/mrm.21852; Leow AD, 2009, IEEE INT S BIOM IM, P623; LesBihan D, 1986, RADIOLOGY, V161, P401; Lin GX, 2001, CHEM PHYS LETT, V335, P249, DOI 10.1016/S0009-2614(01)00013-6; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Menzel MI, 2011, MAGN RESON MED, V66, P1226, DOI 10.1002/mrm.23064; MITRA PP, 1995, J MAGN RESON SER A, V113, P94, DOI 10.1006/jmra.1995.1060; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Rathi Y, 2010, MAGN RESON MED, V64, P138, DOI 10.1002/mrm.22292; Thoeny HC, 2010, J MAGN RESON IMAGING, V32, P2, DOI 10.1002/jmri.22167; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; White NS, 2013, HUM BRAIN MAPP, V34, P327, DOI 10.1002/hbm.21454; Xu D, 2013, MAGN RESON MED, V70, P1293, DOI 10.1002/mrm.24589	36	9	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	MAR	2015	41	3					841	850		10.1002/jmri.24589			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CB9QT	WOS:000349967700032	24753055				2022-02-06	
J	Dehghan, S; Asadi, S; Hajikaram, M; Soleimani, M; Mowla, SJ; Fathollahi, Y; Ahmadiani, A; Javan, M				Dehghan, Samaneh; Asadi, Sareh; Hajikaram, Maryam; Soleimani, Masoud; Mowla, Seyed Javad; Fathollahi, Yaghoub; Ahmadiani, Abolhassan; Javan, Mohammad			Exogenous Oct4 in combination with valproic acid increased neural progenitor markers: An approach for enhancing the repair potential of the brain	LIFE SCIENCES			English	Article						Valproic acid; Oct4; Reprogramming factors; Endogenous neural progenitors	PLURIPOTENT STEM-CELLS; ADULT HUMAN FIBROBLASTS; TUMOR-FORMATION; SOMATIC-CELLS; REGENERATION; INDUCTION; MOLECULES; MOUSE	Aims: Attempts are aimed to introduce new approaches toward enhancing the brain's potential for repair in neurodegenerative diseases and traumatic injuries. Here we report an increased expression of pluripotency and progenitor markers within the brain following pretreatment with valproic acid (VPA) and in vivo transfection of inducible Oct4-expressing viral particles. Materials and methods: Systemic administration of VPA was performed for one week prior to an intracerebroventricular injection of the Oct4-expressing vector into the right side of the brain. Oct4 expression was induced by doxycycline from day 1 post-transfection for an additional week. Real time-PCR and immunohistofluorescence were used for evaluation of marker expression. Key findings: Real time-PCR analyses of samples collected from the area of transfection within the injected-lateral ventricle revealed increased expression of some stem cell and progenitor markers, which included endogenous Oct4, Nanog, Klf4, c-Myc, Pax6 and Sox1. Expressions of Oct4, SSEA1 and Nanog were further confirmed by immunohistofluorescence. The increased neural progenitor and pluripotency markers due to Oct4 overexpression did not lead to teratoma formation during a 100 day follow-up. Significance: Our findings suggest that the application of Oct4 as a reprogramming factor in conjunction with VPA, an epigenetic modifier, might be a potential strategy for increasing the brain's capability to repair itself. (C) 2014 Elsevier Inc. All rights reserved.	[Dehghan, Samaneh; Asadi, Sareh; Fathollahi, Yaghoub; Javan, Mohammad] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Hajikaram, Maryam] ACECR, Cell Sci Res Ctr, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Tehran, Iran; [Soleimani, Masoud] Tarbiat Modares Univ, Fac Med Sci, Dept Hematol, Tehran, Iran; [Mowla, Seyed Javad] Tarbiat Modares Univ, Fac Basic Sci, Dept Mol Genet, Tehran, Iran; [Mowla, Seyed Javad] Shahid Beheshti Med Univ, Neurosci Res Ctr, Tehran, Iran		Javan, M (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, POB 14115-331, Tehran, Iran.	mjavan@modares.ac.ir	Dehghan, Samaneh/S-9047-2019; fathollahi, yaghoub/C-1670-2010; Javan, Mohammad/C-6758-2008; Ahmadiani, Abolhassan/AAP-9004-2021	Javan, Mohammad/0000-0003-2045-6171; Mowla, Seyed Javad/0000-0002-3300-6332; fathollahi, yghoub/0000-0002-3695-4805; Dehghan, Samaneh/0000-0001-9070-6792; Asadi, Sareh/0000-0003-0924-5779	Iran Council of Stem Cell Technology, Tarbiat Modares University; Royan Institute	This research was supported by the Iran Council of Stem Cell Technology, Tarbiat Modares University (as a PhD thesis) and Royan Institute. We are also grateful to Professor H. Baharvand and Dr. Mehdi Totonchi for their support and comments and to Miss S Hashemi for editing the manuscript	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Chung S, 2006, J NEUROCHEM, V97, P1467, DOI 10.1111/j.1471-4159.2006.03841.x; Cox JL, 2010, EXP BIOL MED, V235, P148, DOI 10.1258/ebm.2009.009267; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Fukuda H, 2006, STEM CELLS, V24, P763, DOI 10.1634/stemcells.2005-0137; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grande A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3373; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JB, 2009, NAT PROTOC, V4, P1464, DOI 10.1038/nprot.2009.173; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Matsui T, 2012, EXP NEUROL; Mitchell RR, 2014, STEM CELLS DEV, V23, P1937, DOI 10.1089/scd.2014.0023; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Pazhoohan S, 2014, NEURODEGENER DIS, V13, P45, DOI 10.1159/000352021; Powell C, 2012, J NEUROSCI, V32, P1096, DOI 10.1523/JNEUROSCI.5603-11.2012; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zhu S, 2014, CELL RES, V24, P126, DOI 10.1038/cr.2013.156	25	9	10	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	FEB 1	2015	122						108	115		10.1016/j.lfs.2014.12.007			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	CB3DN	WOS:000349508500015	25529151				2022-02-06	
J	Feinberg, M; Mai, JC; Ecklund, J				Feinberg, Michelle; Mai, Jeffrey C.; Ecklund, James			Neurosurgical Management in Traumatic Brain Injury	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; subdural hematoma; epidural hematoma; craniotomy	REFRACTORY INTRACRANIAL HYPERTENSION; ACUTE SUBDURAL-HEMATOMA; DECOMPRESSIVE CRANIECTOMY; MULTICENTER; MORTALITY; EFFICACY	Severe traumatic brain injury (TBI) is one of the most complex and diverse pathologic medical conditions. Each year, approximately 100,000 patients require neurosurgical evacuation of an intracranial hematoma in the United States. It is essential, early in the clinical course, to distinguish those patients with severe TBI who require operative intervention from those who can be managed with only conservative measures. The surgical technique employed is determined primarily by the specific underlying pathology in conjunction with the patient's other comorbidities.	[Feinberg, Michelle; Mai, Jeffrey C.; Ecklund, James] George Washington Univ, Dept Neurosurg, Washington, DC 20037 USA; [Mai, Jeffrey C.; Ecklund, James] Inova Fairfax Hosp, Dept Neurosci, Falls Church, VA USA		Feinberg, M (corresponding author), George Washington Univ, Dept Neurosurg, 2201 L St NW,Apt 516, Washington, DC 20037 USA.	MichlFeinberg@gmail.com					Beaumont A, 2001, J NEUROTRAUM, V18, P1359, DOI 10.1089/08977150152725650; Bierbrauer K, 2011, ATLAS NEUROSURGICAL, P906; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Forsyth RJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub2; Grandhi R, 2012, SCHMIDEK SWEET OPERA, V2, P1495, DOI [10.1016/B978-1-4160-6839-6.10132-7, DOI 10.1016/B978-1-4160-6839-6.10132-7]; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; JAMJOOM A, 1992, INJURY, V23, P518, DOI 10.1016/0020-1383(92)90149-M; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Karasawa H, 1997, J NEUROSURG, V86, P629, DOI 10.3171/jns.1997.86.4.0629; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Li G, 2008, CHIN J TRAUMATOL, V11, P253, DOI 10.1016/S1008-1275(08)60052-8; Lu J, 2005, ACT NEUR S, V95, P281; Marion DW, 2006, NEUROSURGERY, V58, P655; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Pascual JM, 2012, SCHMIDEK SWEET OPERA, P1513; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sakabe T, 2007, HDB NEUROANESTHESIA, P91; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Victor M, 2001, ADAMS VICTORS PRINCI, P925; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; Zacko J, 2011, YOUMANS WINN NEUROLO, P3424	33	9	9	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					50	56		10.1055/s-0035-1544244			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC4AP	WOS:000350293300008	25714867				2022-02-06	
J	Fisher, AC; Rushby, JA; McDonald, S; Parks, N; Piguet, O				Fisher, Alana C.; Rushby, Jacqueline A.; McDonald, Skye; Parks, Nicklas; Piguet, Olivier			Neurophysiological correlates of dysregulated emotional arousal in severe traumatic brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						Emotional arousal; Severe traumatic brain injury; EEG alpha power; Skin conductance level; Insula; Amygdala	AFFECTIVE RESPONSIVITY; ORIENTING REFLEX; ALPHA-RHYTHM; VALENCE; EMPATHY; ACTIVATION; GENERATION; ATTENTION; NETWORKS; AMYGDALA	Objective: This study aimed to elucidate relationships between dysregulated emotional arousal after severe traumatic brain injury (TBI), alpha power and skin conductance levels (SCL), and brain atrophy. Methods: Nineteen adults with severe TBI and 19 age-, education-, and gender-matched controls (all p's > 0.05) participated. Magnetic resonance imaging (MRI) scan established bilateral insulae and amygdale volumes. Mean EEG alpha power and SCLs were recorded simultaneously across four, 2 min conditions: eyes-closed pre-task baseline, view neutral face, happy face and angry face. Results: Scalp-wide alpha suppression occurred from pre-task baseline to the face-viewing conditions (p <.001), but was diminished in TBI (p =.04). TBI participants exhibited marginally significantly lower SCL (p =.051), and elevated alpha power hemispherically, contrasting with controls' midline dominance (p <.01). Significant atrophy was observed in most structures in TBI participants (p's = .004-0.04). Larger left insula, left amygdala and right amygdala correlated positively with alpha power and alpha suppression, and SCLs; all structures uniquely contributed to variance in arousal. Conclusions: Findings suggest that alpha power provides a sensitive measure of dysregulated emotional arousal post-TBI. Atrophy in pertinent brain structures may contribute to these disturbances. Significance: These findings have potential implications for the assessment and remediation of TBI-related arousal deficits, by directing more targeted remediation, and better assessing post-TBI recovery. Crown Copyright (C) 2014 Published by Elsevier Ireland Ltd. on behalf of International Federation of Clinical Neurophysiology. All rights reserved.	[Fisher, Alana C.; Rushby, Jacqueline A.; McDonald, Skye; Parks, Nicklas] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Piguet, Olivier] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Piguet, Olivier] UNSW, Sch Med Sci, Sydney, NSW 2052, Australia; [Piguet, Olivier] ARC Ctr Excellence Cognit & Disorders, Sydney, NSW 2052, Australia		Rushby, JA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	j.rushby@unsw.edu.au	Fisher, Alana/T-1869-2019; Rushby, Jacqueline/D-1820-2010; McDonald, Skye/G-4118-2014; Piguet, Olivier/C-9658-2011	Rushby, Jacqueline/0000-0002-5018-638X; McDonald, Skye/0000-0003-0723-6094; Fisher, Alana/0000-0002-6027-659X; Piguet, Olivier/0000-0002-6696-1440	Australian Research Council (ARC Discovery Project )Australian Research Council [ID1094183]; Australian National Health and Medical Research Council (NHMRC) Postdoctoral FellowshipNational Health and Medical Research Council of Australia [APP1013796]; NHMRC Career Development FellowshipNational Health and Medical Research Council of Australia [APP1022684]	This research was funded by the Australian Research Council (ARC Discovery Project ID1094183). Author J.A.R. is supported by an Australian National Health and Medical Research Council (NHMRC) Postdoctoral Fellowship (Clinical Training; APP1013796). O.P. is supported by an NHMRC Career Development Fellowship (APP1022684). We are grateful to the Ryde, Westmead and Liverpool Brain Injury Units in Sydney, Australia, for their assistance with recruitment. We are indebted to the people with traumatic brain injuries and their families, as well as our volunteers from the general community, who gave willingly of their time to make this research possible.	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Barry RJ, 2005, CLIN NEUROPHYSIOL, V116, P2693, DOI 10.1016/j.clinph.2005.08.008; BARRY RJ, 1993, INT J PSYCHOPHYSIOL, V15, P39, DOI 10.1016/0167-8760(93)90093-5; Barry RJ, 2008, BIOL PSYCHOL, V77, P304, DOI 10.1016/j.biopsycho.2007.11.002; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berntson GG, 2011, PSYCHOL SCI, V22, P80, DOI 10.1177/0956797610391097; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P1469; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Harmon-Jones E, 2003, PERS INDIV DIFFER, V35, P995, DOI 10.1016/S0191-8869(02)00313-6; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; James W., 1884, MIND, V9, P188, DOI 10.1093/mind/os-IX.34.188, os-IX; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Lange C, 1887, UEBER GEMUTHSBEWGUNG, V3, P8; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MACNIVEN E, 1994, BRAIN INJURY, V8, P457, DOI 10.3109/02699059409150997; MALMO RB, 1959, PSYCHOL REV, V66, P367, DOI 10.1037/h0047858; McDonald S, 2011, INT J PSYCHOPHYSIOL, V82, P124, DOI 10.1016/j.ijpsycho.2011.01.014; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Prigatano GP, 2005, ACT NEUR S, V93, P39; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Reitan R, 1985, HALSTEAD REITAN NEUR; Rushby JA, 2007, BIOL PSYCHOL, V75, P248, DOI 10.1016/j.biopsycho.2007.03.003; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P460, DOI 10.1016/j.ijpsycho.2013.05.009; Rushby JA, 2009, INT J PSYCHOPHYSIOL, V74, P120, DOI 10.1016/j.ijpsycho.2009.08.003; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Singh RN, 2006, ESSENTIAL PHYS MED R; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Styliadis C, 2013, INT J PSYCHOPHSIOL; Tabachnick B. G., 1989, USING MULTIVARIATE S; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vianna EPM, 2006, INT J PSYCHOPHYSIOL, V61, P70, DOI 10.1016/j.ijpsycho.2005.10.019; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; WECHLER D, 1997, WECHSLER ADULT INTEL; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	55	9	9	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	FEB	2015	126	2					314	324		10.1016/j.clinph.2014.05.033			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AZ9UL	WOS:000348562000013	25018009				2022-02-06	
J	Ivins, BJ; Lange, RT; Cole, WR; Kane, R; Schwab, KA; Iverson, GL				Ivins, Brian J.; Lange, Rael T.; Cole, Wesley R.; Kane, Robert; Schwab, Karen A.; Iverson, Grant L.			Using Base Rates of Low Scores to Interpret the ANAM4 TBI-MIL Battery Following Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Cognitive testing; Military; Low scores; Base rates	HEALTHY OLDER-ADULTS; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; COGNITIVE IMPAIRMENT; MEMORY SCORES; VALIDATION; DIAGNOSIS; CRITERIA; TESTS	Base rates of low ANAM4 TBI-MIL scores were calculated in a convenience sample of 733 healthy male active duty soldiers using available military reference values for the following cutoffs: <= 2nd percentile (2 SDs), <= 5th percentile, <10th percentile, and <16th percentile (1 SD). Rates of low scores were also calculated in 56 active duty male soldiers who sustained an mTBI an average of 23 days (SD = 36.1) prior. 22.0% of the healthy sample and 51.8% of the mTBI sample had two or more scores below 1 SD (i.e., 16th percentile). 18.8% of the healthy sample and 44.6% of the mTBI sample had one or more scores <= 5th percentile. Rates of low scores in the healthy sample were influenced by cutoffs and race/ethnicity. Importantly, some healthy soldiers obtain at least one low score on ANAM4. These base rate analyses can improve the methodology for interpreting ANAM4 performance in clinical practice and research.	[Ivins, Brian J.; Schwab, Karen A.] Def & Vet Brain Injury Ctr, Headquarters, Div Res, Silver Spring, MD 20910 USA; [Ivins, Brian J.; Lange, Rael T.; Cole, Wesley R.] GDIT, Fairfax, VA USA; [Lange, Rael T.; Iverson, Grant L.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Cole, Wesley R.] Womack Army Med Ctr, Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Kane, Robert] Georgetown Univ, Washington, DC USA; [Schwab, Karen A.] ARK Solut Inc, Reston, AR USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil,Red Sox Fdn, Spaulding Rehabil Hosp,Massachusetts Gen Hosp,Spo, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA		Ivins, BJ (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway,Suite 6-100, Silver Spring, MD 20910 USA.	brian.j.ivins.ctr@mail.mil		Iverson, Grant/0000-0001-7348-9570			[Anonymous], 2010, IBM SPSS STAT VERS 1; Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; BECK JR, 1984, MED DECIS MAKING, V4, P449, DOI 10.1177/0272989X8400400408; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Brooks BL, 2007, J INT NEUROPSYCH SOC, V13, P490, DOI 10.1017/D1355617707070531; Brooks BL, 2009, J INT NEUROPSYCH SOC, V15, P613, DOI 10.1017/S1355617709090651; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Center for the Study of Human Operator Performance, 2007, AUT NEUR ASS METR VE; Center for the Study of Human Operator Performance, 2008, APR ANAM PERF REP QU; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Cognitive Science Research Center, 2009, MIL NORM REF DAT MIL; Cognitive Science Research Center, 2011, ANAM4 REP MEAS QUICK; Cohen J., 2013, STAT POWER ANAL BEHA; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Diaz-Asper CM, 2004, J INT NEUROPSYCH SOC, V10, P82; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Iverson G. L., 2011, HDB SPORT NEUROPSYCH; Iverson GL, 2012, NEUROPSYCHOLOGICAL A, P360; Iverson GL, 2011, J AFFECT DISORDERS, V132, P360, DOI 10.1016/j.jad.2011.03.001; Kianifard F, 1995, J Biopharm Stat, V5, P115, DOI 10.1080/10543409508835101; LEDLEY RS, 1959, SCIENCE, V130, P9, DOI 10.1126/science.130.3366.9; LUSTED LB, 1991, MED DECIS MAKING, V11, P76, DOI 10.1177/0272989X9101100202; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; O'Neil ME, 2012, COMPLICATIONS MILD T; Palmer BW, 1998, ARCH CLIN NEUROPSYCH, V13, P503, DOI 10.1016/S0887-6177(97)00037-1; Patton DE, 2003, CLIN NEUROPSYCHOL, V17, P515, DOI 10.1076/clin.17.4.515.27948; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Sahai H., 1996, STAT EPIDEMIOLOGY ME; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; SOX HC, 1986, ANN INTERN MED, V104, P60, DOI 10.7326/0003-4819-104-1-60; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289	38	9	9	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2015	30	1					26	38		10.1093/arclin/acu072			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CE6BA	WOS:000351919400003	25526791	Bronze, Green Published			2022-02-06	
J	Purgina, B; Milroy, CM				Purgina, Bibianna; Milroy, Christopher Mark			Fatal traumatic aneurysm of the posterior inferior cerebellar artery with delayed rupture	FORENSIC SCIENCE INTERNATIONAL			English	Article						Aneurysm; Traumatic; Intracranial; False; Rupture PICA	INTRACRANIAL ANEURYSMS; CEREBRAL-ARTERY; INJURY	Traumatic aneurysms of intracranial arteries are rare, forming less than 1% of all intracranial arteries. They may be associated with penetrating and non-penetrating trauma. Most cases are associated with fracturing of the skull. Rupture of traumatic aneurysms occur in up to 50% of cases and are typically delayed from days to weeks following the initiating trauma. We report a case of a 22-year-old man who was punched to the head. He was rendered unconscious but recovered and had a GCS of 14 on admission. CT scans showed subarachnoid hemorrhage. An initial angiogram was negative but on day 7 following the incident he was noted to have a 1 mm aneurysm of the posterior inferior cerebellar artery on CT angiogram. On day 9 he collapsed and was found to have new subarachnoid hemorrhage and to have a 4.0 mm x 3.7 mm. He did not recover and was declared brain dead on day 12. At autopsy, there was a 4.0 mm aneurysm of the left PICA just after the origin of the artery. Histological examination confirmed the presence of a traumatic false aneurysm in the left PICA. This case study shows sequential radiological imaging with pathologiocal correlation. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Purgina, Bibianna; Milroy, Christopher Mark] Ottawa Hosp, Dept Anat Pathol, Ontario Forens Pathol Serv, Eastern Ontario Reg Lab Serv,Eastern Ontario Fore, Ottawa, ON K1H 8L6, Canada; [Purgina, Bibianna; Milroy, Christopher Mark] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada		Milroy, CM (corresponding author), Ottawa Hosp, Div Anat Pathol, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	cmilroy@toh.on.ca					ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; Frusco M.R., 2011, NEUROSURGERY, V68, P517; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Kallmes DF, 1997, AM J ROENTGENOL, V169, P1169, DOI 10.2214/ajr.169.4.9308484; Mao ZQ, 2012, ACTA NEUROCHIR, V154, P2187, DOI 10.1007/s00701-012-1487-x; MORARD M, 1991, NEUROSURGERY, V29, P438, DOI 10.1227/00006123-199109000-00018; Nishioka T, 2002, ACTA NEUROCHIR, V144, P839, DOI 10.1007/s00701-002-0952-3; OPESKIN K, 1995, AM J FOREN MED PATH, V16, P11, DOI 10.1097/00000433-199503000-00002; Paiva W.S., 2011, J TRAUMA, V72, pE115; Quintana F, 1996, AM J NEURORADIOL, V17, P283; Yamakawa H, 2005, CLIN NEUROL NEUROSUR, V107, P117, DOI 10.1016/j.clineuro.2004.01.007; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970	16	9	10	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	FEB	2015	247						E1	E5		10.1016/j.forsciint.2014.11.003			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	AZ2CC	WOS:000348041200001	25549847				2022-02-06	
J	Viscomi, MT; Latini, L; Bisicchia, E; Sasso, V; Molinari, M				Viscomi, Maria Teresa; Latini, Laura; Bisicchia, Elisa; Sasso, Valeria; Molinari, Marco			Remote Degeneration: Insights from the Hemicerebellectomy Model	CEREBELLUM			English	Article; Proceedings Paper	SIXTH INTERNATIONAL SYMPOSIUM OF SRC	JUL 03-04, 2014	Rome, ITALY			Remote damage; Autophagy; Apoptosis; Inflammation; Hemicerebellectomy	CELL-DEATH; AUTOPHAGY; AXOTOMY; NEURONS; NEURODEGENERATION; PATHWAY	When CNS lesions develop, neuronal degeneration occurs locally but in regions that are remote, yet functionally connected, to the primary lesion site. This process, known as "remote damage," significantly affects long-term outcomes in many CNS pathologies, such as stroke, multiple sclerosis, and traumatic brain and spinal cord injuries. Remote damage can last several days or months after the primary lesion, providing a window during which therapeutic approaches can be implemented to effect neuroprotection. The recognition of the importance of remote damage in determining disease outcomes has prompted considerable interest in examining remote damage-associated mechanisms, most of which is derived from the potential of this research to develop innovative pharmacological approaches for preserving neurons and improving functional outcomes. To this end, the hemicerebellectomy (HCb) experimental paradigm has been instrumental in highlighting the complexity and variety of the systems that are involved, identifying mechanisms of life/death decisions, and providing a testing ground for novel neuroprotective approaches. Inflammation, oxidative stress, apoptosis, autophagy, and neuronal changes in receptor mosaics are several remote damage mechanisms that have been identified and examined using the HCb model. In this review, we discuss our current understanding of remote degeneration mechanisms and their potential for exploitation with regard to neuroprotective approaches, focusing on HCb studies.	[Viscomi, Maria Teresa; Latini, Laura; Bisicchia, Elisa; Sasso, Valeria; Molinari, Marco] IRCCS Santa Lucia Fdn, I-00143 Rome, Italy; [Viscomi, Maria Teresa] IRCCS Santa Lucia Fdn, Maria Teresa Viscomi Lab Expt Neurorehabil, I-00143 Rome, Italy		Viscomi, MT (corresponding author), IRCCS Santa Lucia Fdn, Maria Teresa Viscomi Lab Expt Neurorehabil, Via Fosso di Fiorano 65, I-00143 Rome, Italy.	mt.viscomi@hsantalucia.it	Viscomi, Maria Teresa/AAL-6625-2021; Latini, Laura/AAA-7654-2019; Molinari, Marco/A-9624-2010; Bisicchia, Elisa/AAC-3703-2022; Viscomi, Maria Teresa/G-4173-2011; Viscomi, Maria Teresa/AAB-9412-2022	Molinari, Marco/0000-0001-9808-9688; Viscomi, Maria Teresa/0000-0002-9096-4967; Viscomi, Maria Teresa/0000-0002-9096-4967; Latini, Laura/0000-0001-6480-0355	Italian Ministry of Health (Ricerca Corrente-MM); International Foundation for Research in Paraplegia (IFP); program Young Researchers of Italian Ministry of Health [GR10.184]	This work was supported by the Italian Ministry of Health (Ricerca Corrente-MM), by the International Foundation for Research in Paraplegia (IFP) (MTV), and by the program Young Researchers of Italian Ministry of Health (GR10.184; MTV). The professional editorial work of Blue Pencil Science is also acknowledged.	Bisicchia E, 2013, CELL MOL LIFE SCI, V70, P2191, DOI 10.1007/s00018-012-1253-5; Block F, 2005, PROG NEUROBIOL, V75, P347; Buffo A, 1998, NEUROSCIENCE, V85, P587, DOI 10.1016/S0306-4522(98)00049-9; Esiri MM, 2007, J NEUROIMMUNOL, V184, P4, DOI 10.1016/j.jneuroim.2006.11.013; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Oddi S, 2012, J MOL MED, V90, P371, DOI 10.1007/s00109-011-0846-z; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Viscomi MT, 2008, NEUROSCIENCE, V154, P1267, DOI 10.1016/j.neuroscience.2008.04.024; Viscomi MT, 2009, CEREBELLUM, V8, P184, DOI 10.1007/s12311-009-0107-7; Viscomi MT, 2012, MOL NEUROBIOL, V46, P513, DOI 10.1007/s12035-012-8296-3; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Viscomi MT, 2004, NEUROSCIENCE, V123, P393, DOI 10.1016/j.neuroscience.2003.09.030; Viscomi MT, 2014, MOL NE IN PRESS 0119	15	9	9	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	FEB	2015	14	1					15	18		10.1007/s12311-014-0603-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	CB1SN	WOS:000349408400005	25253422				2022-02-06	
J	Yu, CG; Boutte, A; Yu, XP; Dutta, B; Feala, JD; Schmid, K; Dave, J; Tawa, GJ; Wallqvist, A; Reifman, J				Yu, Chenggang; Boutte, Angela; Yu, Xueping; Dutta, Bhaskar; Feala, Jacob D.; Schmid, Kara; Dave, Jitendra; Tawa, Gregory J.; Wallqvist, Anders; Reifman, Jaques			A Systems Biology Strategy to Identify Molecular Mechanisms of Action and Protein Indicators of Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; systems biology; pathway analysis; protein-protein interaction networks; biomarkers	NITRIC-OXIDE SYNTHASE; POSTSYNAPTIC DENSITY; INTERACTION DATABASE; PSYCHIATRIC DISEASE; SYNAPTIC PROTEINS; OXIDATIVE STRESS; RAT MODEL; EXPRESSION; CORTEX; DISC1	The multifactorial nature of traumatic brain injury (TBI), especially the complex secondary tissue injury involving intertwined networks of molecular pathways that mediate cellular behavior, has confounded attempts to elucidate the pathology underlying the progression of TBI. Here, systems biology strategies are exploited to identify novel molecular mechanisms and protein indicators of brain injury. To this end, we performed a meta-analysis of four distinct high-throughput gene expression studies involving different animal models of TBI. By using canonical pathways and a large human protein-interaction network as a scaffold, we separately overlaid the gene expression data from each study to identify molecular signatures that were conserved across the different studies. At 24 hr after injury, the significantly activated molecular signatures were nonspecific to TBI, whereas the significantly suppressed molecular signatures were specific to the nervous system. In particular, we identified a suppressed subnetwork consisting of 58 highly interacting, coregulated proteins associated with synaptic function. We selected three proteins from this subnetwork, postsynaptic density protein 95, nitric oxide synthase 1, and disrupted in schizophrenia 1, and hypothesized that their abundance would be significantly reduced after TBI. In a penetrating ballistic-like brain injury rat model of severe TBI, Western blot analysis confirmed our hypothesis. In addition, our analysis recovered 12 previously identified protein biomarkers of TBI. The results suggest that systems biology may provide an efficient, high-yield approach to generate testable hypotheses that can be experimentally validated to identify novel mechanisms of action and molecular indicators of TBI. (c) 2014 Wiley Periodicals, Inc.	[Yu, Chenggang; Yu, Xueping; Dutta, Bhaskar; Feala, Jacob D.; Tawa, Gregory J.; Wallqvist, Anders; Reifman, Jaques] US Army Med Res & Mat Command, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA; [Boutte, Angela; Schmid, Kara; Dave, Jitendra] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Dept Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD USA		Reifman, J (corresponding author), US Army Med Res & Mat Command, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, MCMR TT 504 Scott St, Ft Detrick, MD 21702 USA.	jaques.reifman.civ@mail.mil	wallqvist, anders/W-2584-2019	wallqvist, anders/0000-0002-9775-7469	U.S. Department of Defense Medical Research and Development Program [D61_I_10_J6_126]; U.S. Army Network Science Initiative; Combat Casualty Care Research Area Directorate of the U.S. Army Medical Research and Materiel Command	Contract grant sponsor: U.S. Department of Defense Medical Research and Development Program; Contract grant number: D61_I_10_J6_126; Contract grant sponsor: U.S. Army Network Science Initiative; Contract grant sponsor: Combat Casualty Care Research Area Directorate of the U.S. Army Medical Research and Materiel Command.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bezprozvanny I, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-23; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Deckel AW, 2001, J NEUROSCI RES, V64, P99, DOI 10.1002/jnr.1057; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dutta B, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-10; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gilman CP, 2003, NEUROMOL MED, V3, P159, DOI 10.1385/NMM:3:3:159; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Law A, 2001, BRAIN RES REV, V35, P73, DOI 10.1016/S0165-0173(00)00051-5; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; Yu CG, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-143; Yu XP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-79; Yu XP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012500; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang J-Y, 2011, PLOS ONE, V6; Zhang KX, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001114; Zinman GE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-134	72	9	10	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB	2015	93	2					199	214		10.1002/jnr.23503			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AW7XS	WOS:000346475600002	25399920	Green Published, hybrid			2022-02-06	
J	Kim, JH; Lee, DW; Choi, BY; Sohn, M; Lee, SH; Choi, HC; Song, HK; Suh, SW				Kim, Jin Hee; Lee, Dong Won; Choi, Bo Young; Sohn, Min; Lee, Song Hee; Choi, Hui Chul; Song, Hong Ki; Suh, Sang Won			Cytidine 5 '-diphosphocholine (CDP-choline) adversely effects on pilocarpine seizure-induced hippocampal neuronal death	BRAIN RESEARCH			English	Article						Temporal lobe epilepsy; Seizure; Blood brain barrier; Neuron death; Microglia; Citicoline; Kainate; Pilocarpine	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; KAINIC ACID; STATUS EPILEPTICUS; CEREBRAL-ISCHEMIA; FOCAL ISCHEMIA; RAT-BRAIN; CITICOLINE; STROKE; ACETYLCHOLINE	Citicoline (CDP-choline; cytidine 5'-diphosphocholine) is an important intermediate in the biosynthesis of cell membrane phospholipids. Citicoline serves as a choline donor in the biosynthetic pathways of acetylcholine and neuronal membrane phospholipids, mainly phosphatidylcholine. The ability of citicoline to reverse neuronal injury has been tested in animal models of cerebral ischemia and clinical trials have been performed in stroke patients. However, no studies have examined the effect of citicoline on seizure-induced neuronal death. To clarify the potential therapeutic effects of citicoline on seizure-induced neuronal death, we used an animal model of pilocarpine-induced epilepsy. Temporal lobe epilepsy (TLE) was induced by intraperitoneal injection of pilocarpine (25 mg/kg) in adult male rats. Citicoline (100 or 300 mg/kg) was injected into the intraperitoneal space two hours after seizure onset and a second injection was performed 24 h after the seizure. Citicoline was injected once per day for one week after pilocarpine- or kainate-induced seizure. Neuronal injury and microglial activation were evaluated at 1 week post-seizure. Surprisingly, rather than offering protection, citicoline treatment actually enhanced seizure-induced neuronal death and microglial activation in the hippocampus compared to vehicle treated controls. Citicoline administration after seizure-induction increased immunoglobulin leakage via BBB disruption in the hippocampus compared with the vehicle-only group. To clarify if this adverse effect of citicoline is generalizable across alternative seizure models, we induced seizure by kainate injection (10 mg/kg, i.p.) and then injected citicoline as in pilocarpine-induced seizure. We found that citicoline did not modulate kainate seizure-induced neuronal death, BBB disruption or microglial activation. These results suggest that citicoline may not have neuroprotective effects after seizure and that clinical application of citicoline after seizure needs careful consideration. (C) 2014 Elsevier B.V. All rights reserved.	[Kim, Jin Hee; Choi, Bo Young; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea; [Lee, Dong Won; Lee, Song Hee; Choi, Hui Chul; Song, Hong Ki] Hallym Univ, Coll Med, Dept Neurol, Chunchon, South Korea; [Choi, Hui Chul; Song, Hong Ki; Suh, Sang Won] Hallym Univ, Hallym Inst Epilepsy Res, Chunchon 200702, South Korea		Song, HK (corresponding author), Hallym Univ, Coll Med, Dept Neurol, Chunchon, South Korea.	hksong0@paran.com; swsuh@hallym.ac.kr		Choi, Bo Young/0000-0002-9579-3503; SOHN, MIN/0000-0003-4021-2051	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120202]; Hallym University Fund [HRF-201402-011]	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A120202) and by Hallym University Fund (HRF-201402-011).	Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; Adibhatla Rao Muralikrishna, 2013, Nat Rev Neurol, V9, P173, DOI 10.1038/nrneurol.2012.166-c1; Adibhatla RM, 2005, BRAIN RES, V1058, P193, DOI 10.1016/j.brainres.2005.07.067; Adibhatla RM, 2002, J NEUROCHEM, V80, P12; Alvarez XA, 1999, METHOD FIND EXP CLIN, V21, P535, DOI 10.1358/mf.1999.21.8.794835; BENARI Y, 1979, BRAIN RES, V165, P362, DOI 10.1016/0006-8993(79)90571-7; Cai AL, 2006, EUR J NEUROSCI, V24, P2169, DOI 10.1111/j.1460-9568.2006.05110.x; Carlezon WA, 2002, BIOL PSYCHIAT, V51, P882, DOI 10.1016/S0006-3223(01)01344-0; Chang YC, 2003, ANN NEUROL, V54, P706, DOI 10.1002/ana.10789; Clark WM, 2012, NAT REV NEUROL, V8, P484, DOI 10.1038/nrneurol.2012.166; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; FRESTA M, 1995, PHARMACEUT RES, V12, P1769, DOI 10.1023/A:1016234226404; Ghosh S, 2010, NEUROSCIENCE, V171, P1287, DOI 10.1016/j.neuroscience.2010.09.049; GRIMES L, 1988, J NEUROSCI, V8, P256; Holmes GL, 1998, ANN NEUROL, V44, P845, DOI 10.1002/ana.410440602; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Inamasu J, 2000, ACT NEUR S, V76, P525; JOPE RS, 1987, J NEUROCHEM, V49, P944, DOI 10.1111/j.1471-4159.1987.tb00985.x; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim JE, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.331; Kim JH, 2013, BRAIN RES, V1499, P163, DOI 10.1016/j.brainres.2013.01.007; Maslarova A, 2013, NEUROBIOL DIS, V56, P14, DOI 10.1016/j.nbd.2013.02.016; Nairismagi J, 2006, EPILEPSIA, V47, P479, DOI 10.1111/j.1528-1167.2006.00455.x; PERSINGER MA, 1988, PHYSIOL BEHAV, V44, P27, DOI 10.1016/0031-9384(88)90342-3; RACINE RJ, 1972, BRAIN RES, V47, P262, DOI 10.1016/0006-8993(72)90268-5; Rao AM, 2000, J NEUROCHEM, V75, P2528, DOI 10.1046/j.1471-4159.2000.0752528.x; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; RUTH RE, 1988, ACTA NEUROPATHOL, V76, P380, DOI 10.1007/BF00686975; Sahin S, 2010, J CLIN NEUROSCI, V17, P227, DOI 10.1016/j.jocn.2009.05.016; Schabitz WR, 1996, J NEUROL SCI, V138, P21, DOI 10.1016/0022-510X(95)00341-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Secades J. J., 2006, METHODS FIND EXP SB, V28, pS1; Shapiro L. A., 2008, EPILEPSIA S2, V49, pS33; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Suh SW, 2003, J NEUROSCI, V23, P10681; Suh SW, 2001, NEUROREPORT, V12, P1523, DOI 10.1097/00001756-200105250-00044; Tayebati SK, 2011, J NEUROL SCI, V302, P49, DOI 10.1016/j.jns.2010.11.028; TEITELBAUM H, 1975, Science (Washington D C), V188, P1114, DOI 10.1126/science.175440; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Warach S, 2000, ANN NEUROL, V48, P713, DOI 10.1002/1531-8249(200011)48:5<713::AID-ANA4>3.0.CO;2-#; Wurtman RJ, 2000, BIOCHEM PHARMACOL, V60, P989, DOI 10.1016/S0006-2952(00)00436-6; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zimmerman G, 2008, EUR J NEUROSCI, V27, P965, DOI 10.1111/j.1460-9568.2008.06070.x	50	9	9	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 21	2015	1595						156	165		10.1016/j.brainres.2014.11.011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA8UY	WOS:000349197600015	25446447				2022-02-06	
S	Ash, JS; Cottrell, E; Saxton, L; Newman, L; Gebhardt, E; Helfand, M		Courtney, KL; Kuo, A; Shabestari, O		Ash, Joan S.; Cottrell, Erika; Saxton, Lauren; Newman, Lucas; Gebhardt, Eric; Helfand, Mark			Patient Narratives Representing Patient Voices to Inform Research: A Pilot Qualitative Study	DRIVING QUALITY IN INFORMATICS: FULFILLING THE PROMISE	Studies in Health Technology and Informatics		English	Article; Book Chapter						Consumer health; patient narratives; research design; usability	HEALTH	We are investigating the feasibility and effectiveness of establishing a library of patient narratives to inform patient-centered research in the U.S. Veterans Affairs organization. Using qualitative methods, we conducted a needs assessment of 15 researchers and then interviewed and videotaped 11 veterans with traumatic brain injury or diabetes. We developed a method for displaying the narratives to researchers modeled after a UK initiative called DIPEx and then performed preliminary usability testing. We found that it is not only feasible to provide researchers with patient narratives that could help guide their research, but that similar narratives might be useful to practitioners, health system decision makers, and other patients as well.	[Ash, Joan S.; Cottrell, Erika; Saxton, Lauren; Newman, Lucas; Gebhardt, Eric; Helfand, Mark] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Helfand, Mark] Portland VA Med Ctr, Portland, OR USA		Ash, JS (corresponding author), Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	ash@ohsu.edu			NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R25LM011168] Funding Source: NIH RePORTER; NLM NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R25 LM011168] Funding Source: Medline		[Anonymous], 2010, TRAUMATIC BRAIN INJU; Atkinson S., 2012, CRITICAL REV ONCO S2, V84, P511; Banks J, 2012, PREV MED, V55, P394, DOI 10.1016/j.ypmed.2011.10.015; Crabtree B. F., 1999, DOING QUALITATIVE RE; Diabetes QUERI Center, 2011, DIAB QUERI CTR 2011; Glaser B. G., 1967, DISCOVER GROUNDED TH; Merritt S, 2013, RURAL REMOTE HEALTH, V13; PCORI. (Patient-Centered Outcomes Research Institute) Methodology Committee, 2013, PCORI METH REP; Pullman D, 2005, TEACH LEARN MED, V17, P279, DOI 10.1207/s15328015tlm1703_14; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	10	9	9	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0926-9630	1879-8365	978-1-61499-488-6; 978-1-61499-487-9	STUD HEALTH TECHNOL			2015	208						55	60		10.3233/978-1-61499-488-6-55			6	Health Care Sciences & Services; Medical Informatics	Book Citation Index – Science (BKCI-S)	Health Care Sciences & Services; Medical Informatics	BJ9UC	WOS:000429894900012	25676947				2022-02-06	
J	Bell, ED; Sullivan, JW; Monson, KL				Bell, E. David; Sullivan, Jacob W.; Monson, Kenneth L.			Subfailure overstretch induces persistent changes in the passive mechanical response of cerebral arteries	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						traumatic brain injury; stroke; sheep cerebral arteries; arterial softening; tissue damage	TRAUMATIC BRAIN-INJURY; SMOOTH-MUSCLE; BEHAVIOR; DAMAGE; TISSUE; DEFORMATION; RELAXATION; RECOVERY; ELASTIN	Cerebral blood vessels are critical in maintaining the health of the brain, but their function can be disrupted by traumatic brain injury (TBI). Even in cases without hemorrhage, vessels are deformed with the surrounding brain tissue. This subfailure deformation could result in altered mechanical behavior. This study investigates the effect of overstretch on the passive behavior of isolated middle cerebral arteries (MCAs), with the hypothesis that axial stretch beyond the in vivo length alters this response. Twenty nine MCA sections from 11 ewes were tested. Vessels were subjected to a baseline test consisting of an axial stretch from a buckled state to 1.05* in vivo stretch (lambda(IV)) while pressurized at 13.3 kPa. Specimens were then subjected to a target level of axial overstretch between 1.05*lambda(IV) (lambda(z) = 1.15) and 1.52*lambda(IV) (lambda(z) = 1.63). Following overstretch, baseline tests were repeated immediately and then every 10 min, for 60 min, to investigate viscoelastic recovery. Injury was defined as an unrecoverable change in the passive mechanical response following overstretch. Finally, pressurized MCAs were pulled axially to failure. Post-overstretch response exhibited softening such that stress values at a given level of stretch were lower after injury. The observed softening also generally resulted in increased non-linearity of the stress-stretch curve, with toe region slope decreasing and large deformation slope increasing. There was no detectable change in reference configuration or failure values. As hypothesized, the magnitude of these alterations increased with overstretch severity, but only once overstretch exceeded 1.2*lambda(IV) (p < 0.001). These changes were persistent over 60 min. These changes may have significant implications in repeated TBI events and in increased susceptibility to stroke post-TBI.	[Bell, E. David; Monson, Kenneth L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Bell, E. David; Sullivan, Jacob W.; Monson, Kenneth L.] Univ Utah, Dept Mech Engn, Lab Head Injury & Vessel Biomech, 50 S Cent Campus Dr,MEB 2110, Salt Lake City, UT 84112 USA		Monson, KL (corresponding author), Univ Utah, Dept Mech Engn, Lab Head Injury & Vessel Biomech, 50 S Cent Campus Dr,MEB 2110, Salt Lake City, UT 84112 USA.	ken.monson@utah.edu			Primary Children's Medical Center Foundation [PCMCF-ISA-KM-01-2012-02]	The authors gratefully acknowledge Kurt Albertine and Mar Janna Dahl for their help with tissue acquisition. This work was partially supported by a grant from the Primary Children's Medical Center Foundation (PCMCF-ISA-KM-01-2012-02).	Alastrue V, 2008, J BIOMECH, V41, P3038, DOI 10.1016/j.jbiomech.2008.07.008; Amin M, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004415; Austin N, 2010, J MANIP PHYSIOL THER, V33, P14, DOI 10.1016/j.jmpt.2009.11.006; Bell ED, 2013, J BIOMECH, V46, P91, DOI 10.1016/j.jbiomech.2012.10.015; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chalupnik J. D., 1971, MAT PROPERTIES CEREB; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Chow MJ, 2011, J SURG RES, V171, P434, DOI 10.1016/j.jss.2010.04.007; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Coulson RJ, 2004, J BIOMECH ENG-T ASME, V126, P76, DOI 10.1115/1.1645525; Coulson RJ, 2002, AM J PHYSIOL-HEART C, V283, pH2268, DOI 10.1152/ajpheart.00542.2002; COX RH, 1978, AM J PHYSIOL, V234, pH533, DOI 10.1152/ajpheart.1978.234.5.H533; Cyron CJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0680; DOBRIN PB, 1984, ANN BIOMED ENG, V12, P497, DOI 10.1007/BF02363919; Duenwald SE, 2010, BIORHEOLOGY, V47, P1, DOI 10.3233/BIR-2010-0559; Duenwald SE, 2009, ANN BIOMED ENG, V37, P1131, DOI 10.1007/s10439-009-9687-0; Duenwald-Kuehl S, 2012, ANN BIOMED ENG, V40, P1692, DOI 10.1007/s10439-012-0538-z; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gonzalez JM, 2005, EXP PHYSIOL, V90, P463, DOI 10.1113/expphysiol.2005.030056; Gregersen H, 1998, ANN BIOMED ENG, V26, P850, DOI 10.1114/1.109; GRIENDLING KK, 1985, AM J PHYSIOL, V248, pH658, DOI 10.1152/ajpheart.1985.248.5.H658; HERLIHY JT, 1973, CIRC RES, V33, P275, DOI 10.1161/01.RES.33.3.275; Hills NK, 2012, ANN NEUROL, V72, P850, DOI 10.1002/ana.23688; HOGESTATT ED, 1983, ACTA PHYSIOL SCAND, V117, P49, DOI 10.1111/j.1748-1716.1983.tb07178.x; Holzapfel GA, 2007, INT J CARDIOL, V116, P78, DOI 10.1016/j.ijcard.2006.03.033; Horny L., 2010, MULLINS EFFECT AORTA; Humphrey JD, 1995, CRIT REV BIOMED ENG, V23, P1; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; Maher E, 2012, J MECH BEHAV BIOMED, V12, P9, DOI 10.1016/j.jmbbm.2012.03.001; Maher E, 2012, J BIOMECH, V45, P1393, DOI 10.1016/j.jbiomech.2012.02.026; Monson K. L. V., 2001, MECH FAILURE PROPERT; Monson KL, 2008, ANN BIOMED ENG, V36, P2028, DOI 10.1007/s10439-008-9578-9; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Panjabi MM, 1996, J ORTHOP RES, V14, P216, DOI 10.1002/jor.1100140208; Pena E, 2010, J BIOMECH, V43, P984, DOI 10.1016/j.jbiomech.2009.10.046; Pena E, 2011, J MECH PHYS SOLIDS, V59, P1808, DOI 10.1016/j.jmps.2011.05.013; Pena E, 2009, INT J SOLIDS STRUCT, V46, P1727, DOI 10.1016/j.ijsolstr.2008.12.015; Pollock RG, 2000, J SHOULDER ELB SURG, V9, P427, DOI 10.1067/mse.2000.108388; Quinn KP, 2007, STAPP CAR CRASH JO, V51, P169; Stemper BD, 2007, J SURG RES, V139, P236, DOI 10.1016/j.jss.2006.09.001; VANLOON P, 1977, BIORHEOLOGY, V14, P181; Weisbecker H, 2013, J BIOMECH, V46, P1859, DOI 10.1016/j.jbiomech.2013.04.025; Weisbecker H, 2012, J MECH BEHAV BIOMED, V12, P93, DOI 10.1016/j.jmbbm.2012.03.012; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	45	9	9	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.		2015	3								2	10.3389/fbioe.2015.00002			10	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	VJ1EU	WOS:000536548500002	25674561	Green Published, gold			2022-02-06	
B	Chauhan, NB; Mehla, J		Watson, RR; Preedy, VR		Chauhan, Neelima B.; Mehla, Jogender			Ameliorative Effects of Nutraceuticals in Neurological Disorders	BIOACTIVE NUTRACEUTICALS AND DIETARY SUPPLEMENTS IN NEUROLOGICAL AND BRAIN DISEASE: PREVENTION AND THERAPY			English	Article; Book Chapter							AGED GARLIC EXTRACT; DECREASED GABA RECEPTOR; TRAUMATIC BRAIN-INJURY; WITHANIA-SOMNIFERA GLYCOWITHANOLIDES; SUPPLEMENTATION IMPROVES MEMORY; SCOPOLAMINE-INDUCED AMNESIA; TYPE-2 DIABETES-MELLITUS; BACOPA-MONNIERA BRAHMI; PERSICA L. BATSCH; ALZHEIMERS-DISEASE		[Chauhan, Neelima B.] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA; Univ Illinois, Childrens Hosp, Dept Pediat, Chicago, IL USA		Chauhan, NB (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL 60612 USA.		Mehla, Jogender/M-1055-2019				Agarwal KC, 1996, MED RES REV, V16, P111, DOI 10.1002/(SICI)1098-1128(199601)16:1&lt;111::AID-MED4&gt;3.0.CO;2-5; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Agrawal R, 2010, PHARMACOL RES, V61, P247, DOI 10.1016/j.phrs.2009.12.008; Ahmad M, 2013, SAUDI J BIOL SCI, V20, P155, DOI 10.1016/j.sjbs.2013.01.002; Ahmed T, 2014, PHYTOTHER RES, V28, P517, DOI 10.1002/ptr.5030; Ahmed T, 2011, BRAIN RES, V1400, P1, DOI 10.1016/j.brainres.2011.05.022; Allan JJ, 2007, FOOD CHEM TOXICOL, V45, P1928, DOI 10.1016/j.fct.2007.04.010; Amagase H, 2006, J NUTR, V136, p716S, DOI 10.1093/jn/136.3.716S; ARSECULERATNE SN, 1985, J ETHNOPHARMACOL, V13, P323, DOI 10.1016/0378-8741(85)90078-9; Arunkumar R, 2012, PHYTOMEDICINE, V19, P912, DOI 10.1016/j.phymed.2012.04.009; Asadi-Shekaari Majid, 2012, Avicenna Journal of Medical Biotechnology, V4, P155; Ashafaq M, 2012, NUTR RES, V32, P133, DOI 10.1016/j.nutres.2011.12.014; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Awad AS, 2011, J STROKE CEREBROVASC, V20, P541, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.008; Awasthi H, 2010, LIFE SCI, V86, P87, DOI 10.1016/j.lfs.2009.11.007; Baitharu I, 2013, J ETHNOPHARMACOL, V145, P431, DOI 10.1016/j.jep.2012.10.063; Barreira JCM, 2010, FOOD SCI TECHNOL INT, V16, P209, DOI 10.1177/1082013209353983; Berginc K, 2012, EXPERT OPIN DRUG MET, V8, P295, DOI 10.1517/17425255.2012.659662; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; Bhattacharya S K, 1997, Indian J Exp Biol, V35, P236; Bhattacharya S K, 1997, J Altern Complement Med, V3, P327, DOI 10.1089/acm.1997.3.327; Bhattacharya SK, 2000, PHYTOMEDICINE, V7, P463, DOI 10.1016/S0944-7113(00)80030-6; Bolling BW, 2011, NUTR RES REV, V24, P244, DOI 10.1017/S095442241100014X; Borek C., 2001, Journal of Nutrition, V131, P1010; Borek Carmia, 2006, Adv Nurse Pract, V14, P35; Caesar I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031424; Calabrese C, 2008, J ALTERN COMPLEM MED, V14, P707, DOI 10.1089/acm.2008.0018; Calderon-Garciduenas L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/161687; Cazzola R, 2011, INT J FOOD SCI NUTR, V62, P175, DOI 10.3109/09637486.2010.529068; Cemil B, 2012, ULUS TRAVMA ACIL CER, V18, P463, DOI 10.5505/tjtes.2012.84829; Chainani-Wu N, 2003, J ALTERN COMPLEM MED, V9, P161, DOI 10.1089/107555303321223035; Chan JYY, 2013, PHYTOTHER RES, V27, P637, DOI 10.1002/ptr.4796; Chaudhary G, 2003, CLIN EXP PHARMACOL P, V30, P399, DOI 10.1046/j.1440-1681.2003.03849.x; Chauhan NB, 2005, J NUTR HEALTH AGING, V9, P421; Chauhan NB, 2006, J ETHNOPHARMACOL, V108, P385, DOI 10.1016/j.jep.2006.05.030; Chauhan NB, 2007, PHYTOTHER RES, V21, P629, DOI 10.1002/ptr.2122; Chauhan Neelima B., 2003, Journal of Herbal Pharmacotherapy, V3, P95, DOI 10.1080/J157v03n01_05; Chauhan Neha, 2004, Current Alzheimer Research, V1, P183, DOI 10.2174/1567205043332144; Cheng B, 2013, BBA-GEN SUBJECTS, V1830, P4860, DOI 10.1016/j.bbagen.2013.06.029; Cheng M, 1990, Zhongguo Zhong Yao Za Zhi, V15, P595; Ching SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-148; Choudhary KM, 2013, EUR J PHARMACOL, V704, P33, DOI 10.1016/j.ejphar.2013.02.012; Cicero AFG, 2012, EXPERT OPIN DRUG SAF, V11, P753, DOI 10.1517/14740338.2012.705827; Clark D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047792; Cole GM, 2004, ANN NY ACAD SCI, V1035, P68, DOI 10.1196/annals.1332.005; Colin-Gonzalez AL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/907162; Czepukojc B, 2014, FOOD CHEM TOXICOL, V64, P249, DOI 10.1016/j.fct.2013.10.020; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Devaraj S, 2010, MOLECULES, V15, P2925, DOI 10.3390/molecules15042925; Dias BD, 2011, PRION, V5, P126, DOI 10.4161/pri.5.3.17025; Downey LA, 2013, PHYTOTHER RES, V27, P1407, DOI 10.1002/ptr.4864; Du P, 2012, CHINESE MED J-PEKING, V125, P1975, DOI 10.3760/cma.j.issn.0366-6999.2012.11.025; Dudhatra GB, 2012, SCI WORLD J, DOI 10.1100/2012/637953; Duffy KB, 2008, NEUROBIOL AGING, V29, P1680, DOI 10.1016/j.neurobiolaging.2007.04.002; Dwivedi S, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/294501; Ebrahimi M, 2013, CELL J, V15, P65; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Essa MM, 2012, NEUROCHEM RES, V37, P1829, DOI 10.1007/s11064-012-0799-9; Fang L, 2014, BIOORG MED CHEM LETT, V24, P40, DOI 10.1016/j.bmcl.2013.12.011; Frautschy SA, 2010, MOL NEUROBIOL, V41, P392, DOI 10.1007/s12035-010-8137-1; GRANDHI A, 1994, J ETHNOPHARMACOL, V44, P131, DOI 10.1016/0378-8741(94)01119-2; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Grynkiewicz G, 2012, ACTA BIOCHIM POL, V59, P201; Guo YS, 2011, BRAIN RES, V1374, P110, DOI 10.1016/j.brainres.2010.12.014; Gupta Yogendra K, 2009, Indian J Physiol Pharmacol, V53, P39; Haider S, 2012, NUTR HOSP, V27, P2109, DOI 10.3305/nh.2012.27.6.6140; Haider S, 2011, PLANT FOOD HUM NUTR, V66, P335, DOI 10.1007/s11130-011-0260-2; Hasani-Ranjbar Shirin, 2009, Inflammation & Allergy Drug Targets, V8, P2; Hernandez CM, 2012, CURR DRUG TARGETS, V13, P613, DOI 10.2174/138945012800398973; Holcomb LA, 2006, J ALZHEIMERS DIS, V9, P243; Holmes BB, 2012, CURR OPIN NEUROL, V25, P721, DOI 10.1097/WCO.0b013e32835a3ee0; HOLZGARTNER H, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1473; Hosamani R, 2010, INDIAN J BIOCHEM BIO, V47, P75; Hosamani R, 2009, NEUROTOXICOLOGY, V30, P977, DOI 10.1016/j.neuro.2009.08.012; Inglis F, 2002, INT J CLIN PRACT, P45; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Isik AT, 2009, AGE, V31, P39, DOI 10.1007/s11357-008-9078-8; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P605, DOI 10.1016/j.bbrc.2011.09.010; Jain S, 2001, PHYTOTHER RES, V15, P544, DOI 10.1002/ptr.802; Jayaprakasam B, 2010, PHYTOTHER RES, V24, P859, DOI 10.1002/ptr.3033; Jeong HY, 2010, ARCH PHARM RES, V33, P1655, DOI 10.1007/s12272-010-1015-6; Jeong HR, 2013, J MED FOOD, V16, P968, DOI 10.1089/jmf.2013.2881; Jeong JH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-268; Joseph JA, 2003, NUTR NEUROSCI, V6, P153, DOI 10.1080/1028415031000111282; Joseph J, 2009, J NEUROSCI, V29, P12795, DOI 10.1523/JNEUROSCI.3520-09.2009; Joseph JA, 2009, J NUTR, V139, p1813S, DOI 10.3945/jn.109.108266; Karalis F, 2011, BRAIN RES, V1425, P98, DOI 10.1016/j.brainres.2011.09.044; Kaur P, 2001, Indian J Clin Biochem, V16, P195, DOI 10.1007/BF02864860; Kennedy DO, 2011, ADV NUTR, V2, P32, DOI 10.3945/an.110.000117; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Kiasalari Z, 2013, PHARM BIOL, V51, P1572, DOI 10.3109/13880209.2013.803128; Kim Darrick S H L, 2012, Recent Pat CNS Drug Discov, V7, P184; Kim DSHL, 2001, NEUROSCI LETT, V303, P57, DOI 10.1016/S0304-3940(01)01677-9; Kim HJ, 2013, NEUROCHEM RES, V38, P117, DOI 10.1007/s11064-012-0897-8; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073877; Kim YK, 2003, J ETHNOPHARMACOL, V87, P149, DOI 10.1016/S0378-8741(03)00106-5; Kishore Kamal, 2005, Indian Journal of Experimental Biology, V43, P640; KLOEVER E, 1965, Med Klin, V60, P213; KNAPP MJ, 1994, JAMA-J AM MED ASSOC, V271, P985, DOI 10.1001/jama.271.13.985; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kongkeaw C, 2014, J ETHNOPHARMACOL, V151, P528, DOI 10.1016/j.jep.2013.11.008; Krikorian R, 2010, J AGR FOOD CHEM, V58, P3996, DOI 10.1021/jf9029332; Krikorian R, 2010, BRIT J NUTR, V103, P730, DOI 10.1017/S0007114509992364; Krishnaswamy K, 2008, ASIA PAC J CLIN NUTR, V17, P265; Kuboyama T, 2006, EUR J NEUROSCI, V23, P1417, DOI 10.1111/j.1460-9568.2006.04664.x; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kuboyama T, 2002, NEUROREPORT, V13, P1715, DOI 10.1097/00001756-200210070-00005; Kulkarni KS, 2010, INDIAN J PHARMACOL, V42, P168, DOI 10.4103/0253-7613.66841; Kumar R, 2013, DIABET METAB SYND OB, V6, P49, DOI 10.2147/DMSO.S38888; Kumar S, 2012, PHYTOTHER RES, V26, P113, DOI 10.1002/ptr.3512; Kumar V, 2006, PHYTOTHER RES, V20, P1023, DOI 10.1002/ptr.1970; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lapchak PA, 2011, EXPERT OPIN INV DRUG, V20, P13, DOI 10.1517/13543784.2011.542410; Lee DY, 2012, J MED FOOD, V15, P992, DOI 10.1089/jmf.2012.2275; Lee DR, 2012, INT J GERIATR PSYCH, V27, P989, DOI 10.1002/gps.2823; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lin GH, 2012, J ALZHEIMERS DIS, V29, P659, DOI 10.3233/JAD-2012-111709; Lin XM, 2012, NEUROL RES, V34, P32, DOI 10.1179/1743132811Y.0000000054; Lin Y, 2013, J MOL NEUROSCI, V50, P504, DOI 10.1007/s12031-013-9977-8; Liu LJ, 2002, J NUTR, V132, P1129, DOI 10.1093/jn/132.6.1129; Liu XJ, 2013, RESTOR NEUROL NEUROS, V31, P109, DOI 10.3233/RNN-120228; Liu ZJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/470975; Lodha R., 2000, Annals Academy of Medicine Singapore, V29, P37; Long JG, 2009, REJUV RES, V12, P321, DOI 10.1089/rej.2009.0877; Malhotra C L, 1965, Indian J Physiol Pharmacol, V9, P127; Malin DH, 2011, NUTRITION, V27, P338, DOI 10.1016/j.nut.2010.05.001; Mansouri Z, 2012, J MOL NEUROSCI, V47, P234, DOI 10.1007/s12031-012-9727-3; Masters SL, 2011, TRENDS MOL MED, V17, P276, DOI 10.1016/j.molmed.2011.01.005; Mathew BC, 2008, LIBYAN J MED, V3, P23, DOI 10.4176/071110; Mathew J, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-25; Mathew J, 2011, NEUROCHEM RES, V36, P7, DOI 10.1007/s11064-010-0253-9; Mathew J, 2010, J ETHNOPHARMACOL, V130, P255, DOI 10.1016/j.jep.2010.04.043; Mathew J, 2010, FITOTERAPIA, V81, P315, DOI 10.1016/j.fitote.2009.11.005; Mathew J, 2010, EPILEPSY BEHAV, V17, P441, DOI 10.1016/j.yebeh.2010.01.012; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Maurya R, 2010, J PHARM PHARMACOL, V62, P153, DOI 10.1211/jpp.62.02.0001; Mehla J, 2010, LIFE SCI, V87, P596, DOI 10.1016/j.lfs.2010.09.006; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mousa SA, 2010, METHODS MOL BIOL, V663, P229, DOI 10.1007/978-1-60761-803-4_9; Munchberg U, 2007, ORG BIOMOL CHEM, V5, P1505, DOI 10.1039/b703832a; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; Muthaiyah B, 2011, NEUROCHEM RES, V36, P2096, DOI 10.1007/s11064-011-0533-z; Nakamura T, 2007, CELL DEATH DIFFER, V14, P1305, DOI 10.1038/sj.cdd.4402138; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Nathan PJ, 2001, HUM PSYCHOPHARM CLIN, V16, P345, DOI 10.1002/hup.306; Neale C, 2013, BRIT J CLIN PHARMACO, V75, P728, DOI 10.1111/bcp.12002; Nishiyama N, 2001, J NUTR, V131, p1093S, DOI 10.1093/jn/131.3.1093S; Noor NA, 2012, EPILEPSY BEHAV, V24, P199, DOI 10.1016/j.yebeh.2012.03.026; Orhan IE, 2011, INT J FOOD SCI NUTR, V62, P781, DOI 10.3109/09637486.2011.585964; Orsu P, 2013, J NEURAL TRANSM, V120, P1217, DOI 10.1007/s00702-013-0982-4; Pandey R, 2010, SEIZURE-EUR J EPILEP, V19, P439, DOI 10.1016/j.seizure.2010.06.005; Parihar MS, 2004, J CLIN NEUROSCI, V11, P397, DOI 10.1016/j.jocn.2003.09.008; Parihar MS, 2003, J BIOSCIENCES, V28, P121, DOI 10.1007/BF02970142; Peden AH, 2012, CURR DRUG TARGETS, V13, P1548; Per S, 2013, ACTA PHYSIOL HUNG, V100, P224, DOI 10.1556/APhysiol.100.2013.006; Peth-Nui T, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/606424; Pravina K, 2007, PHYTOMEDICINE, V14, P301, DOI 10.1016/j.phymed.2007.03.010; Prince M., 2013, WORLD ALZHEIMER REPO; QURESHI S, 1992, PLANTA MED, V58, P124, DOI 10.1055/s-2006-961412; Raghav Sangeeta, 2006, Indian J Psychiatry, V48, P238, DOI 10.4103/0019-5545.31555; Rahman K, 2001, J NUTR, V131, p977S, DOI 10.1093/jn/131.3.977S; RajaSankara S, 2009, NEUROSCI LETT, V454, P11, DOI 10.1016/j.neulet.2009.02.044; Rajeswari A., 2008, Inflammopharmacology, V16, P96, DOI 10.1007/s10787-007-1614-0; Ramanan Vijay K, 2013, Am J Neurodegener Dis, V2, P145; Rastogi M, 2012, BIOGERONTOLOGY, V13, P183, DOI 10.1007/s10522-011-9367-y; Rastogi M, 2012, NEUROCHEM RES, V37, P869, DOI 10.1007/s11064-011-0681-1; Rathore P, 2008, NEUROCHEM RES, V33, P1672, DOI 10.1007/s11064-007-9515-6; Ray B, 2011, CURR MED CHEM, V18, P3306, DOI 10.2174/092986711796504664; Ray B, 2011, J NEUROCHEM, V117, P388, DOI 10.1111/j.1471-4159.2010.07145.x; Reeta KH, 2010, EUR J PHARMACOL, V644, P106, DOI 10.1016/j.ejphar.2010.07.022; Reeta KH, 2009, BRAIN RES, V1301, P52, DOI 10.1016/j.brainres.2009.09.027; Rehni AK, 2007, INDIAN J EXP BIOL, V45, P764; Rendeiro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063535; Rendeiro C, 2012, PSYCHOPHARMACOLOGY, V223, P319, DOI 10.1007/s00213-012-2719-8; Ried K, 2013, NUTR REV, V71, P282, DOI 10.1111/nure.12012; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; Rodrigues AD, 2012, NEUROCHEM INT, V60, P799, DOI 10.1016/j.neuint.2012.01.009; Rojas P, 2011, J NUTR BIOCHEM, V22, P937, DOI 10.1016/j.jnutbio.2010.08.005; Roodenrys S, 2002, NEUROPSYCHOPHARMACOL, V27, P279, DOI 10.1016/S0893-133X(01)00419-5; Saini N, 2012, INDIAN J PHARM SCI, V74, P24, DOI 10.4103/0250-474X.102539; Saini N, 2012, NEUROCHEM RES, V37, P1928, DOI 10.1007/s11064-012-0811-4; Samini F, 2013, PHARMACOL BIOCHEM BE, V110, P238, DOI 10.1016/j.pbb.2013.07.019; Sankar SR, 2007, CELL MOL BIOL LETT, V12, P473, DOI 10.2478/s11658-007-0015-0; Saraf MK, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq038; Saraf MK, 2010, PHARMACOL BIOCHEM BE, V97, P192, DOI 10.1016/j.pbb.2010.07.017; Saraf MK, 2010, NEUROCHEM RES, V35, P279, DOI 10.1007/s11064-009-0051-4; Schafer G, 2014, ANTI-CANCER AGENT ME, V14, P233, DOI 10.2174/18715206113136660370; Schliebs R, 1997, NEUROCHEM INT, V30, P181, DOI 10.1016/S0197-0186(96)00025-3; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; Shin DY, 2014, ENVIRON TOXICOL PHAR, V37, P74, DOI 10.1016/j.etap.2013.11.002; Shin JH, 2013, FOOD CHEM TOXICOL, V58, P545, DOI 10.1016/j.fct.2013.04.002; Shivashankara AR, 2012, FOOD FUNCT, V3, P101, DOI 10.1039/c1fo10170f; Shobana C, 2012, CELL MOL NEUROBIOL, V32, P1099, DOI 10.1007/s10571-012-9833-3; Shukitt-Hale B, 2009, NUTR NEUROSCI, V12, P135, DOI 10.1179/147683009X423292; Simao F, 2013, NEUROL RES, V35, P59, DOI 10.1179/1743132812Y.0000000116; Singh Amanpreet, 2002, Journal of Medicinal Food, V5, P211; Singh HK, 2013, NUTRIENTS, V5, P478, DOI 10.3390/nu5020478; SINGH HK, 1982, J ETHNOPHARMACOL, V5, P205, DOI 10.1016/0378-8741(82)90044-7; Singh M, 2013, NEUROCHEM INT, V62, P530, DOI 10.1016/j.neuint.2013.01.030; Singh M, 2012, TOXICOL SCI, V125, P219, DOI 10.1093/toxsci/kfr255; Singh R, 2008, BIOGERONTOLOGY, V9, P369, DOI 10.1007/s10522-008-9185-z; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Song Y, 2010, FOOD CHEM TOXICOL, V48, P373, DOI 10.1016/j.fct.2009.10.025; Sonkusare SK, 2005, PHARMACOL RES, V51, P1, DOI 10.1016/j.phrs.2004.05.005; Srinivasan K, 2014, CRIT REV FOOD SCI, V54, P352, DOI 10.1080/10408398.2011.585525; Stabler SN, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007653.pub2; Stough C, 2001, PSYCHOPHARMACOLOGY, V156, P481, DOI 10.1007/s002130100815; Stough C, 2013, J PHARM PHARM SCI, V16, P254, DOI 10.18433/J35G6M; Suh SJ, 2006, J MOL NEUROSCI, V29, P101, DOI 10.1385/JMN:29:2:101; Takechi R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-73; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; Tohda C, 2009, BRIT J PHARMACOL, V157, P1427, DOI 10.1111/j.1476-5381.2009.00313.x; Tripanichkul W, 2013, EUR REV MED PHARMACO, V17, P1360; Uabundit N, 2010, J ETHNOPHARMACOL, V127, P26, DOI 10.1016/j.jep.2009.09.056; Villaflores OB, 2012, TAIWAN J OBSTET GYNE, V51, P515, DOI 10.1016/j.tjog.2012.09.005; Vollala VR, 2011, BRATISL MED J, V112, P663; Wang CK, 2010, J MED FOOD, V13, P170, DOI 10.1089/jmf.2009.1162; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang J, 2010, J ALZHEIMERS DIS, V22, P653, DOI 10.3233/JAD-2010-101074; Wang Q, 2009, J NUTR BIOCHEM, V20, P369, DOI 10.1016/j.jnutbio.2008.04.007; Wang YC, 2010, BIOFACTORS, V36, P394, DOI 10.1002/biof.126; West T, 2007, DEV NEUROSCI-BASEL, V29, P363, DOI 10.1159/000105477; Williams CM, 2008, FREE RADICAL BIO MED, V45, P295, DOI 10.1016/j.freeradbiomed.2008.04.008; Willis LM, 2010, INFLAMMATION, V33, P325, DOI 10.1007/s10753-010-9189-0; Willis LM, 2009, BRIT J NUTR, V101, P1140, DOI 10.1017/S0007114508059369; Wollen KA, 2010, ALTERN MED REV, V15, P223; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Wu Z, 2009, NEUROCHEM RES, V34, P1393, DOI 10.1007/s11064-009-9920-0; Yadav CS, 2010, INDIAN J BIOCHEM BIO, V47, P117; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yasuhara T, 2008, REJUV RES, V11, P201, DOI 10.1089/rej.2007.0608; Yu LS, 2012, BRAIN RES, V1475, P88, DOI 10.1016/j.brainres.2012.07.055; Zbarsky V, 2005, FREE RADICAL RES, V39, P1119, DOI 10.1080/10715760500233113; Zemva J., 2013, CNS NEUROL DISORD-DR; Zeng T, 2013, CRIT REV FOOD SCI, V53, P215, DOI 10.1080/10408398.2010.523148; Zhang J, 2014, BIOFACTORS, V40, P258, DOI 10.1002/biof.1149; Zhang X, 2011, PHARMACOL REP, V63, P1101, DOI 10.1016/S1734-1140(11)70629-6; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y; Zhao YN, 2013, BIOCHEM BIOPH RES CO, V435, P597, DOI 10.1016/j.bbrc.2013.05.025; Zhou YF, 2014, BRAIN RES BULL, V100, P14, DOI 10.1016/j.brainresbull.2013.10.013; Zhu JW, 2012, NEUROCHEM INT, V61, P640, DOI 10.1016/j.neuint.2012.06.021	245	9	9	0	4	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			978-0-12-411529-3; 978-0-12-411462-3				2015							245	260		10.1016/B978-0-12-411462-3.00027-8			16	Neurosciences; Nutrition & Dietetics	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Nutrition & Dietetics	BB9QB	WOS:000348561000028					2022-02-06	
J	Chen, GS; Huang, KF; Huang, CC; Wang, JY				Chen, Gunng-Shinng; Huang, Kuo-Feng; Huang, Chien-Chu; Wang, Jia-Yi			Thaliporphine Derivative Improves Acute Lung Injury after Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							NEUROGENIC PULMONARY-EDEMA; AQUAPORIN WATER CHANNELS; GLANDULAR TISSUES; COMPLEX TISSUES; TIME-COURSE; EXPRESSION; CLEARANCE	Acute lung injury (ALI) occurs frequently in patients with severe traumatic brain injury (TBI) and is associated with a poor clinical outcome. Aquaporins (AQPs), particularly AQP1 and AQP4, maintain water balances between the epithelial and microvascular domains of the lung. Since pulmonary edema (PE) usually occurs in the TBI-induced ALI patients, we investigated the effects of a thaliporphine derivative, TM-1, on the expression of AQPs and histological outcomes in the lung following TBI in rats. TM-1 administered (10 mg/kg, intraperitoneal injection) at 3 or 4 h after TBI significantly reduced the elevated mRNA expression and protein levels of AQP1 and AQP4 and diminished the wet/dry weight ratio, which reflects PE, in the lung at 8 and 24 h after TBI. Postinjury TM-1 administration also improved histopathological changes at 8 and 24 h after TBI. PE was accompanied with tissue pathological changes because a positive correlation between the lung injury score and the wet/dry weight ratio in the same animal was observed. Postinjury administration of TM-1 improved ALI and reduced PE at 8 and 24 h following TBI. The pulmonary-protective effect of TM-1 may be attributed to, at least in part, downregulation of AQP1 and AQP4 expression after TBI.	[Chen, Gunng-Shinng; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Chen, Gunng-Shinng] Triserv Gen Hosp, Dept Dent, Div Orthodont & Dentofacial Orthoped & Pedodont, Taipei 114, Taiwan; [Huang, Kuo-Feng] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Surg, Div Neurosurg, New Taipei City 23142, Taiwan; [Huang, Kuo-Feng] Tzu Chi Univ, Sch Med, Hualien 97004, Taiwan; [Huang, Chien-Chu] China Med Univ, Teaching Dept Med, Taichung 40402, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei 110, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan.	jywang2010@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology [MOST 103-2321-B-038-002, NSC 102-2321-B-038-003]	This study was financially supported in part by Grants from the Ministry of Science and Technology (MOST 103-2321-B-038-002 and NSC 102-2321-B-038-003 to Jia-Yi Wang).	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Bai Chunxue, 2001, Zhonghua Jiehe He Huxi Zazhi, V24, P105; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Borok Z, 2002, J APPL PHYSIOL, V93, P2199, DOI 10.1152/japplphysiol.01171.2001; Cao Chun-shui, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P426; Chang WL, 2005, J BIOMED SCI, V12, P611, DOI 10.1007/s11373-005-7401-2; Chen C, 2009, ENVIRON SCI ENG TECH, P29; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chiao CW, 2005, N-S ARCH PHARMACOL, V371, P34, DOI 10.1007/s00210-004-1014-6; Du HC, 2007, LUNG, V185, P325, DOI 10.1007/s00408-007-9023-0; Filho MBL, 2005, NEUROSCI LETT, V373, P165, DOI 10.1016/j.neulet.2004.10.019; Flynn G. A., 2011, Patent, Patent No. [US20110172195 A1, 20110172195]; Gajic O, 2007, CRIT CARE MED, V35, P1979, DOI 10.1097/01.CCM.0000277254.12230.7D; Hung LM, 2001, DRUG DEVELOP RES, V52, P446, DOI 10.1002/ddr.1146; Kandatsu N, 2005, ANESTHESIOLOGY, V102, P1182, DOI 10.1097/00000542-200506000-00018; King LS, 1997, AM J PHYSIOL-CELL PH, V273, pC1541, DOI 10.1152/ajpcell.1997.273.5.C1541; Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Leal MB, 2005, ARQ NEURO-PSIQUIAT, V63, P990, DOI 10.1590/S0004-282X2005000600016; Liu Y., 2012, J VOICE, V26, pe815; Martin GS, 2012, COMPR PHYSIOL, V2, P2471, DOI 10.1002/cphy.c100050; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mullertz KM, 2011, LUNG, V189, P157, DOI 10.1007/s00408-010-9276-x; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Rassler B, 2007, RESP PHYSIOL NEUROBI, V159, P45, DOI 10.1016/j.resp.2007.05.008; Rassler Beate, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P197; Singha O, 2013, J TOXICOL PATHOL, V26, P283, DOI 10.1293/tox.26.283; Song YL, 2000, AM J PHYSIOL-CELL PH, V279, pC1744, DOI 10.1152/ajpcell.2000.279.6.C1744; SU MJ, 1994, EUR J PHARMACOL, V254, P141, DOI 10.1016/0014-2999(94)90381-6; Verkman AS, 2002, ANN MED, V34, P192, DOI 10.1080/713782138; Verkman AS, 2000, AM J PHYSIOL-LUNG C, V278, pL867, DOI 10.1152/ajplung.2000.278.5.L867; Wang Q, 2012, FORENSIC SCI INT, V220, P154, DOI 10.1016/j.forsciint.2012.02.013; Wen LL, 2007, EXP NEUROL, V205, P270, DOI 10.1016/j.expneurol.2007.02.011; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; YU SM, 1994, BIOCHEM J, V303, P289, DOI 10.1042/bj3030289; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhu Li-hua, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P707; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	39	9	9	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								729831	10.1155/2015/729831			10	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CB6DO	WOS:000349717300001	25705683	Green Published, gold, Green Submitted			2022-02-06	
J	Rodriguez-Acosta, ED; Calva-Mercado, JJ; Alberu-Gomez, J; Vilatoba-Chapa, M; Dominguez-Cherit, J				Dalia Rodriguez-Acosta, Elva; Jose Calva-Mercado, Juan; Alberu-Gomez, Josefina; Vilatoba-Chapa, Mario; Dominguez-Cherit, Judith			Patients with solid organ transplants and skin cancer: determination of risk factors with emphasis on exposure to sunlight and immunosuppressive regimen. Experience of a tertiary hospital	GACETA MEDICA DE MEXICO			Spanish	Article						Skin cancer; Renal transplantation; Immunosuppression; Sun exposure; Prevention	RECIPIENTS; EPIDEMIOLOGY; MANAGEMENT; LESIONS; FOCUS	Background: Non-melanoma skin cancer (NMSC) is the most common malignancy in transplant patients. The incidence of basal cell carcinoma (BCC) is 10 times greater than in the general population, while squamous cell carcinoma (SCC) is 100 times greater. The relationship between the BCC and SCC reverses and increases according to the degree of immunosuppression and sun exposure. One way to predict the risk of NMSC should be based on factors such as: total sun burden factor (TSB). Objective: To determine the influence of various risk factors in the development of NMSC and its relation to the type and duration of immunosuppressive treatment, type of transplant, and TSB. Methods: We worked with a fledgling historical cohort in which patients with kidney or liver transplant were identified and recorded if they developed some form of skin cancer. To study the factors associated with NMSC, we resorted to the strategy of a case-control study. Dermatological examination was performed and a questionnaire of risk factors made in both groups. Results: Of the 140 patients enrolled, 51 were women and 89 men, 120 were renal transplant recipients and 20 liver transplants. Of patients who developed NMSC, 100% were renal transplant recipients. The median age was 48.5 years. Most cancer patients worked outdoors. A total of 78 lesions were found in 40 NMSC patients, 59 (76%) of them were SCC, and 19 (24%) BCC; 45% of all skin cancer patients had more than one injury. The worst affected areas were those photoexposed: 60% head and neck, trunk and upper extremities 18% 50%. In 30% of patients (12/40) 22 new tumors were identified (SCC 18 and BCC 4). No lesions were identified for melanoma. In multivariate logistic regression analysis, statistically significant features were: type-based immunosuppressive regimen of cyclosporine A, azathioprine and prednisone (OR: 59.7; 95% CI: 10.2-348), TSB > 10 (OR: 19; 95% CI: 3-120) and duration of use of immunosuppressive therapy (OR: 1.06; 95% CI: 0.9-1.1). The mean time from transplantation to first dermatological assessment was six years (+5.4). Of the patients, 93% had not regularly used sunscreen before and after transplantation. Conclusions: The dermatological assessment is convenient and easy to perform. Primary prevention, close monitoring, diagnosis, and treatment of skin lesions are essential components of a comprehensive program for the evaluation of transplant recipients, the purpose of which is to reduce the incidence and morbidity associated with cancer.	[Dalia Rodriguez-Acosta, Elva; Jose Calva-Mercado, Juan] Inst Nacl Ciencias Med & Nutr Salvador Zubiran IN, Dept Infectol, Mexico City, DF, Mexico; [Alberu-Gomez, Josefina; Vilatoba-Chapa, Mario] Inst Nacl Ciencias Med & Nutr Salvador Zubiran IN, Dept Trasplantes, Mexico City, DF, Mexico; [Dominguez-Cherit, Judith] Inst Nacl Ciencias Med & Nutr Salvador Zubiran IN, Dept Dermatol, Mexico City, DF, Mexico		Dominguez-Cherit, J (corresponding author), Vasco de Quiroga,15 Col Secc 16, Mexico City 14000, DF, Mexico.	judom59@hotmail.com	CHERIT, JUDITH DOMINGUEZ/ABG-1313-2020				Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Dinh QQ, 2007, AUSTRALAS J DERMATOL, V48, P199, DOI 10.1111/j.1440-0960.2007.00387.x; Espana A, 2000, J INVEST DERMATOL, V115, P1158, DOI 10.1046/j.1523-1747.2000.0202a-3.x; EUVRARD S, 1995, J AM ACAD DERMATOL, V33, P222, DOI 10.1016/0190-9622(95)90239-2; Euvrard S, 2004, DERMATOL SURG, V30, P628, DOI 10.1111/j.1524-4725.2004.30148.x; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Fekecs T, 2010, TRANSPL P, V42, P2333, DOI 10.1016/j.transproceed.2010.05.021; Gomez-Roel X, 2005, REV INVEST CLIN, V57, P225; HOLMAN CDJ, 1983, CLIN EXP DERMATOL, V8, P269, DOI 10.1111/j.1365-2230.1983.tb01779.x; Ismail F, 2006, BRIT J DERMATOL, V155, P916, DOI 10.1111/j.1365-2133.2006.07454.x; Lee HI, 2009, BRIT J DERMATOL, V161, P96, DOI 10.1111/j.1365-2133.2009.09456.x; Moloney FJ, 2005, ARCH DERMATOL, V141, P978, DOI 10.1001/archderm.141.8.978; Murphy GM, 2009, BRIT J DERMATOL, V161, P90, DOI 10.1111/j.1365-2133.2009.09455.x; Perera GK, 2006, BRIT J DERMATOL, V154, P868, DOI 10.1111/j.1365-2133.2006.07154.x; RIVAS JM, 1992, J IMMUNOL, V149, P3865; Schwartz RA, 2008, J EUR ACAD DERMATOL, V22, P606, DOI 10.1111/j.1468-3083.2008.02579.x; Strauss DC, 2010, LANCET ONCOL, V11, P790, DOI 10.1016/S1470-2045(10)70024-3; Terhorst D, 2009, BRIT J DERMATOL, V161, P85, DOI 10.1111/j.1365-2133.2009.09454.x; Ulrich C, 2004, DERMATOL SURG, V30, P622, DOI 10.1111/j.1524-4725.2004.30147.x; Zattra E, 2009, MELANOMA RES, V19, P63, DOI 10.1097/CMR.0b013e328322fc20; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P253, DOI 10.1016/j.jaad.2010.11.062	22	9	9	0	1	ACAD NACIONAL MEDICINA MEXICO	MEXICO	CENTRO MEDICO NACIONAL SIGLO XXI, UNIDAD CONGRESOS, GLOQUE B, PROMER PISO, MEXICO, DF 06725, MEXICO	0016-3813			GAC MED MEX	Gac. Med. Mex.	JAN-FEB	2015	151	1					20	26					7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9MJ	WOS:000351422100004	25739480				2022-02-06	
J	Degeneffe, CE; Bursnall, S				Degeneffe, Charles Edmund; Bursnall, Samantha			Quality of Professional Services following Traumatic Brain Injury: Adult Sibling Perspectives	SOCIAL WORK			English	Article						adult siblings; family caregiving; professional services; qualitative research; traumatic brain injury	MENTAL-RETARDATION; FAMILY NEEDS; FUTURE; LIFE	This study examined the quality and availability of professional supports provided to individuals with traumatic brain injury (TBI) and their families from the perspective of a national sample of 267 adult siblings. Using a constant comparative approach to text analysis, the authors analyzed what siblings perceived to have been beneficial or in need of improvement with regard to the TBI professional services provided to their injured brother or sister and their family. The siblings' comments suggested that the system-level response to TBI serving injured people and their families was inadequate, that many professionals lacked the skills and understanding to provide effective services, and that professionals did not provide sufficient information to the people with TBI or their families. However, most siblings endorsed a positive view of at least one of the professional services provided. Clinical, advocacy, and research implications of these findings are discussed.	[Degeneffe, Charles Edmund] San Diego State Univ, Rehabil Counseling Program, San Diego, CA 92108 USA; [Bursnall, Samantha] Griffith Univ, Griffith Hlth Inst, Nathan, Qld 4111, Australia		Degeneffe, CE (corresponding author), San Diego State Univ, Rehabil Counseling Program, 3590 Camino del Rio North, San Diego, CA 92108 USA.	cdegenef@mail.sdsu.edu					Becker H., 1993, J HEAD TRAUMA REHAB, V8, P88; Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Bistany D. V., 1994, BRAIN INJURY NEUROPS, P245; Brain Injury Association of America, 2011, ENS RET SERV MEMB RE; Degeneffe C.E., 2008, J APPL REHABIL COUS, V39, P42; Degeneffe C. E., 2012, ANN M AM PSYCH ASS O; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Degeneffe CE, 2009, AUST J REHABIL COUNS, V15, P12, DOI 10.1375/jrc.15.1.12; Degeneffe CE, 2008, J REHABIL, V74, P10; Degeneffe CE, 2010, J REHABIL, V76, P27; Degeneffe CE, 2010, BRAIN INJURY, V24, P1416, DOI 10.3109/02699052.2010.514317; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; Depuis P. R., 2007, HYPERRESEARCH VERSIO; Faul M, 2010, TRAUMATIC BRAIN INJU; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; Gilson S., 2008, J SOCIAL WORK VALUES, V5; Greenwald B. D., 2010, TRAUMATIC BRAIN INJU; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; GRIFFITHS DL, 1994, FAM RELAT, V43, P221, DOI 10.2307/585326; HAGNER DC, 1994, REHABIL COUNS BULL, V37, P290; HEPWORTH D. H., 2009, DIRECT SOCIAL WORK P; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; *NIH, 1999, NIH CONS DEV C REH P; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SACHS PR, 1991, TREATING FAMILIES BR; SELTZER GB, 1991, FAM RELAT, V40, P310, DOI 10.2307/585017; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Starr J., 2001, FUNDING TRAUMATIC BR; Strauss A., 1990, BASICS QUALITATIVE R; Tucker, 2013, J APPL REHABILITATIO, V44, P32, DOI [10.1891/0047-2220.44.3.32, DOI 10.1891/0047-2220.44.3.32]; Walker NW, 1999, CHILD NEUROPSYCHOL, V5, P137, DOI 10.1076/chin.5.2.137.3168	35	9	9	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0037-8046	1545-6846		SOC WORK	Soc. Work	JAN	2015	60	1					19	27		10.1093/sw/swu047			9	Social Work	Social Science Citation Index (SSCI)	Social Work	CC1PJ	WOS:000350113200003	25643572				2022-02-06	
J	Eirale, C; Tol, JL; Targett, S; Holmich, P; Chalabi, H				Eirale, Cristiano; Tol, Johannes L.; Targett, Steve; Holmich, Per; Chalabi, Hakim			Concussion Surveillance: Do Low Concussion Rates in the Qatar Professional Football League Reflect a True Difference or Emphasize Challenges in Knowledge Translation?	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						soccer; football; concussions; head injuries	CONSENSUS STATEMENT; INTERNATIONAL-CONFERENCE; HEAD-INJURIES; SPORT HELD; SOCCER; ZURICH	Objective: To investigate concussion epidemiology in the first football (soccer) division of Qatar. Design: Prospective cohort study. Setting: Professional First Division Football League of Qatar. Participants: All first team players were included at the beginning of each season. Interventions: Daily collection of training and match exposure from August 2008 until April 2012 by club medical staff. Head injuries during training and match play were recorded on standardized injury cards. Main Outcome Measures: Injury incidence was calculated as number of injuries per hour exposed to risk and expressed as rate per 1000 hours. Results: The incidence of concussions in professional club football in Qatar is 0.016 (0.000-0.033) per 1000 hours of exposure. Conclusions: The concussion incidence is only 25% of that in the previous European studies using the same time loss injury definition. This raises the possibility that concussions are underreported. Further research is necessary. In the meantime, concussion education of players, club medical, and support staff is warranted, in keeping with the Zurich concussion consensus call for the need for an increase in knowledge translation.	[Eirale, Cristiano; Tol, Johannes L.; Targett, Steve; Holmich, Per] Aspetar Qatar Orthopaed & Sport Med Hosp, Sport Med Dept, Doha, Qatar; [Chalabi, Hakim] Aspetar Qatar Orthopaed & Sport Med Hosp, CMO Off, Doha, Qatar		Eirale, C (corresponding author), Aspetar Hosp, Sport Med Dept, POB 29222, Doha, State Of Qatar, Qatar.	cristiano.eirale@aspetar.com		Holmich, Per/0000-0003-2098-0272			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Delaney JS, 2005, CLIN J SPORT MED, V15, P212; Eirale C, 2013, J SCI MED SPORT, V16, P113, DOI 10.1016/j.jsams.2012.07.001; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; GAIL MH, 2000, ENCY EPIDEMIOLOGIC M; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Walden M, 2013, SCAND J MED SCI SPOR, V23, P424, DOI 10.1111/j.1600-0838.2011.01409.x	11	9	9	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2015	25	1					73	74		10.1097/JSM.0000000000000066			2	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	AX7BX	WOS:000347072800017	24451694				2022-02-06	
J	Fremont, P; Bradley, L; Tator, CH; Skinner, J; Fischer, LK				Fremont, Pierre; Bradley, Lindsay; Tator, Charles H.; Skinner, Jill; Fischer, Lisa K.		Canadian Concussion Collaborative	Recommendations for policy development regarding sport-related concussion prevention and management in Canada	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; ZURICH	The Canadian Concussion Collaborative (CCC) is composed of health-related organisations concerned with the recognition, treatment and management of concussion. Its mission is to create synergy between organisations concerned with concussion to improve education and implementation of best practices for the prevention and management of concussions. Each of the organisations that constitute the CCC has endorsed two recommendations that address the need for relevant authorities to develop policies about concussion management in sports. The recommendations were developed to support advocacy for regulations, policies or legislation to improve concussion prevention and management at all levels of sport.	[Fremont, Pierre] Univ Laval, Dept Rehabil, Fac Med, Quebec City, PQ G1V 2M2, Canada; [Bradley, Lindsay] Carleton Univ, Sport Med Ctr, Ottawa, ON K1S 5B6, Canada; [Tator, Charles H.] Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Tator, Charles H.] Univ Toronto, Toronto, ON, Canada; [Tator, Charles H.] Toronto Western Hosp, Canadian Sports Concuss Project, Toronto, ON M5T 2S8, Canada; [Skinner, Jill] Canadian Med Assoc, Dept Publ Hlth, Ottawa, ON, Canada; [Fischer, Lisa K.] Univ Western Ontario, Dept Family Med, Schulich Sch Med & Dent, London, ON, Canada		Fremont, P (corresponding author), Univ Laval, Dept Rehabil, Fac Med, 2875 Blvd Laurier, Quebec City, PQ G1V 2M2, Canada.	pierre.fremont@fmed.ulaval.ca	Fischer, Lisa K/H-3999-2015	Fischer, Lisa K/0000-0001-5992-0176; Fremont, Pierre/0000-0003-2810-8382			McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039	4	9	9	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2015	49	2					88	89		10.1136/bjsports-2014-093961			2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AX7OW	WOS:000347105900005	25016603	Green Published, Bronze			2022-02-06	
J	Lin, CM; Lin, MC; Huang, SJ; Chang, CK; Chao, DP; Lui, TN; Ma, HI; Liu, MY; Chung, WY; Shih, YH; Tsai, SH; Chiou, HY; Lin, MR; Jen, SL; Wei, L; Wu, CC; Lin, EY; Liao, KH; Chiang, YH; Chiu, WT; Lin, JW				Lin, Chien-Min; Lin, Ming-Chin; Huang, Sheng-Jean; Chang, Cheng-Kuei; Chao, Dan-Ping; Lui, Tai-Ngar; Ma, Hsin-I; Liu, Ming-Ying; Chung, Wen-Yuh; Shih, Yang-Hsin; Tsai, Shin-Han; Chiou, Hung-Yi; Lin, Mau-Roung; Jen, Sen-Li; Wei, Li; Wu, Chung-Che; Lin, En-Yuan; Liao, Kuo-Hsing; Chiang, Yung-Hsiao; Chiu, Wen-Ta; Lin, Jia-Wei			A Prospective Randomized Study of Brain Tissue Oxygen Pressure-Guided Management in Moderate and Severe Traumatic Brain Injury Patients	BIOMED RESEARCH INTERNATIONAL			English	Article							SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; BLOOD-FLOW; INTRACEREBRAL HEMORRHAGE; INSPIRED OXYGEN; METABOLISM; HYPOXIA; HYPEROXIA; ISCHEMIA; INSULTS	The purpose of this study was to compare the effect of PbtO(2)-guided therapy with traditional intracranial pressure-(ICP-) guided treatment on the management of cerebral variables, therapeutic interventions, survival rates, and neurological outcomes of moderate and severe traumatic brain injury (TBI) patients. From 2009 to 2010, TBI patients with a Glasgow coma scale <12 were recruited from 6 collaborative hospitals in northern Taiwan, excluding patients with severe systemic injuries, fixed and dilated pupils, and other major diseases. In total, 23 patients were treated with PbtO(2)-guided management (PbtO(2) > 20 mmHg), and 27 patients were treated with ICP-guided therapy (ICP < 20 mmHg and CPP > 60 mmHg) in the neurosurgical intensive care unit (NICU); demographic characteristics were similar across groups. The survival rate in the PbtO(2)-guided group was also significantly increased at 3 and 6 months after injury. Moreover, there was a significant correlation between the PbtO(2) signal and Glasgow outcome scale-extended in patients from 1 to 6 months after injury. This finding demonstrates that therapy directed by PbtO(2) monitoring is valuable for the treatment of patients with moderate and severe TBI and that increasing PaO2 to 150 mmHg may be efficacious for preventing cerebral hypoxic events after brain trauma.	[Lin, Chien-Min; Lin, Ming-Chin; Chang, Cheng-Kuei; Tsai, Shin-Han; Lin, Jia-Wei] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei, Taiwan; [Lin, Chien-Min; Chiang, Yung-Hsiao; Lin, Jia-Wei] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Lin, Ming-Chin] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ & Hosp, Dept Surg, Taipei, Taiwan; [Chang, Cheng-Kuei; Tsai, Shin-Han; Lin, Mau-Roung; Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chao, Dan-Ping] China Univ Technol, Dept Tourism & Leisure Management, Taipei, Taiwan; [Lui, Tai-Ngar; Wei, Li; Liao, Kuo-Hsing] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Ma, Hsin-I; Liu, Ming-Ying] Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Ma, Hsin-I; Liu, Ming-Ying] Natl Def Med Ctr, Taipei, Taiwan; [Chung, Wen-Yuh; Shih, Yang-Hsin; Jen, Sen-Li] Taipei Vet Gen Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Wu, Chung-Che; Lin, En-Yuan; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiu, Wen-Ta] Execut Yuan, Dept Hlth, Taipei, Taiwan		Lin, JW (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei, Taiwan.	ns246@tmu.edu.tw		Chiou, Hung Yi/0000-0002-4545-9697	National Health Research InstitutesNational Health Research Institutes, Japan [NHRI-EX100-9707PI]; Department of HealthEuropean Commission [DOH100-TD-B-111-003]; National Science Council in TaiwanMinistry of Science and Technology, Taiwan [NSC98-2321-B-038-003-MY3]	The authors would like to thank the TBI patients and the nursing and research staffs from each of the 6 collaborative hospitals in northern Taiwan for their dedication to this study. Funding for this study was provided by the National Health Research Institutes (NHRI-EX100-9707PI), the Department of Health (DOH100-TD-B-111-003), and the National Science Council (NSC98-2321-B-038-003-MY3) in Taiwan.	Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Bardt TF, 1998, ACT NEUR S, V71, P153; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; Dings J, 1998, NEUROL RES, V20, pS71; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Gelabert-Gonzalez M, 2002, ACTA NEUROCHIR, V144, P863, DOI 10.1007/s00701-002-0975-9; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mayer SA, 1998, STROKE, V29, P1791, DOI 10.1161/01.STR.29.9.1791; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menzel M, 1998, ACT NEUR S, V71, P183; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; NEHLS DG, 1988, NEUROSURGERY, V23, P439, DOI 10.1227/00006123-198810000-00006; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wright D.W., 2007, J NEUROTRAUM, V24, pS37; Zhao XQ, 2006, NEUROL RES, V28, P66, DOI 10.1179/016164106X91898	38	9	11	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								529580	10.1155/2015/529580			8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CQ6TB	WOS:000360735800001	26413530	Green Published, Green Submitted, gold			2022-02-06	
J	Mao, X; Miao, GZ; Hao, SY; Tao, XG; Hou, ZG; Li, H; Tian, RF; Zhang, H; Lu, T; Ma, J; Zhang, XD; Cheng, HW; Liu, BY				Mao, Xiang; Miao, Guozhuan; Hao, Shuyu; Tao, Xiaogang; Hou, Zonggang; Li, Huan; Tian, Runfa; Zhang, Hao; Lu, Te; Ma, Jun; Zhang, Xiaodong; Cheng, Hongwei; Liu, Baiyun			Decompressive craniectomy for severe traumatic brain injury patients with fixed dilated pupils	THERAPEUTICS AND CLINICAL RISK MANAGEMENT			English	Article						decompressive craniectomy; severe traumatic brain injury; fixed dilated pupils; intracranial pressure	GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURIES; STRUCTURED INTERVIEWS; SURGERY; MANAGEMENT; HEMATOMA; CRANIOTOMY; THERAPY	Objective: The outcome of decompressive craniectomy (DC) for severe traumatic brain injury (sTBI) patients with fixed dilated pupils (FDPs) is not clear. The objective of this study was to validate the outcome of DC in sTBI patients with FDPs. Patients: We retrospectively collected data from 207 sTBI patients with FDPs during the time period of May 4, 2003-October 22, 2013: DC group (n=166) and conservative care (CC) group (n=41). Measurements: Outcomes that were used as indicators in this study were mortality and favorable outcome. The analysis was based on the Glasgow Outcome Scale recorded at 6 months after trauma. Results: A total of 49.28% patients died (39.76% [DC group] vs 87.80% [CC group]). The mean increased intracranial pressure values after admission before operation were 36.20 +/- 7.55 mmHg in the DC group and 35.59 +/- 8.18 mmHg in the CC group. After performing DC, the mean ICP value was 14.38 +/- 2.60 mmHg. Approximately, 34.34% sTBI patients with FDPs in the DC group gained favorable scores and none of the patients in the CC group gained favorable scores. Conclusion: We found that DC plays a therapeutic role in sTBI patients with FDPs, and it is particularly important to reduce intracranial pressure as soon as possible after trauma. For the patients undergoing DC, favorable outcome and low mortality could be achieved.	[Mao, Xiang; Zhang, Hao; Zhang, Xiaodong; Cheng, Hongwei] Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei, Anhui, Peoples R China; [Hao, Shuyu; Tao, Xiaogang; Hou, Zonggang; Li, Huan; Tian, Runfa; Zhang, Hao; Lu, Te; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Mao, Xiang; Hao, Shuyu; Tao, Xiaogang; Hou, Zonggang; Li, Huan; Tian, Runfa; Zhang, Hao; Lu, Te; Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Mao, Xiang; Hao, Shuyu; Tao, Xiaogang; Hou, Zonggang; Li, Huan; Tian, Runfa; Zhang, Hao; Lu, Te; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing 100050, Peoples R China; [Mao, Xiang; Hao, Shuyu; Tao, Xiaogang; Hou, Zonggang; Li, Huan; Tian, Runfa; Zhang, Hao; Lu, Te; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Miao, Guozhuan; Zhang, Hao; Liu, Baiyun] Gen Hosp Armed Police Forces, Dept Neurotrauma, Beijing, Peoples R China; [Ma, Jun] Capital Med Univ, Beijing Tian Tan Hosp, Imaging Ctr Neurosci, Beijing 100050, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China.	liubaiyun1212@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171144, 81471238, 81341059, 81371610]; Beijing Nova programBeijing Municipal Science & Technology Commission [2012033]; National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2013BAI09B03]	This study was supported by National Natural Science Foundation of China (No 81171144, No 81471238, No 81341059, No 81371610), Beijing Nova program (No 2012033), and National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Goksu E, 2012, ULUS TRAVMA ACIL CER, V18, P231, DOI 10.5505/tjtes.2012.79059; Grady MS, 2006, J NEUROSURG, V104, P467, DOI 10.3171/jns.2006.104.4.467; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Kofke W Andrew, 2007, Anesthesiol Clin, V25, P579; KRIEGER D, 1993, CRIT CARE MED, V21, P1944, DOI 10.1097/00003246-199312000-00024; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Liu B, 2008, J NEUROSURG, V24, P153; Liu Wei-guo, 2004, Chin J Traumatol, V7, P175; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Marion DW, 2006, NEUROSURGERY, V58, P655; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; ROPPER AH, 1990, NEUROLOGY, V40, P1707; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Wan J, 2003, CHINESE J CLIN NEURO, V8, P115; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	33	9	11	1	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-203X			THER CLIN RISK MANAG	Therap. Clin. Risk Manag.		2015	11						1627	1633		10.2147/TCRM.S89820			7	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	CU0PU	WOS:000363220400001	26543370	Green Submitted, gold, Green Published			2022-02-06	
J	Michelson, EA; Hanley, D; Chabot, R; Prichep, LS				Michelson, Edward A.; Hanley, Daniel; Chabot, Robert; Prichep, Leslie S.			Identification of Acute Stroke Using Quantified Brain Electrical Activity	ACADEMIC EMERGENCY MEDICINE			English	Article							ISCHEMIC-STROKE; CEREBRAL-ISCHEMIA; CONTINUOUS EEG; INJURY; CLASSIFICATION; TOMOGRAPHY; ALGORITHMS; DIAGNOSIS; MRI; CT	ObjectivesAcute stroke is a leading cause of brain injury and death and requires rapid and accurate diagnosis. Noncontrast head computed tomography (CT) is the first line for diagnosis in the emergency department (ED). Complicating rapid triage are presenting conditions that clinically mimic stroke. There is an extensive literature reporting clinical utility of brain electrical activity in early diagnosis and management of acute stroke. However, existing technologies do not lend themselves to easily acquired rapid evaluation. This investigation used an independently derived classifier algorithm for the identification of traumatic structural brain injury based on brain electrical activity recorded from a reduced frontal montage to explore the potential clinical utility of such an approach in acute stroke assessment. MethodsAdult patients (age 18 to 95years) presenting with stroke-like and/or altered mental status symptoms were recruited from urban academic EDs as part of a large research study evaluating the clinical utility of quantitative brain electrical activity in acutely brain-injured patients. All patients from the parent study who had confirmed strokes, and a control group of stroke mimics (those with final ED diagnoses of migraine or syncope), were selected for this study. All stroke patients underwent head CT scans. Some patients with negative CTs had further imaging with magnetic resonance imaging (MRI). Ten minutes of electroencephalographic data were acquired on a hand-held device in development, from five frontal electrodes. Data analyses were done offline. A Structural Brain Injury Index (SBII) was derived using an independently developed binary discriminant classification algorithm whose input was specified features of brain electrical activity. The SBII was previously found to have high accuracy in the identification of traumatic brain-injured patients who were found to have brain injury on CT (CT+). This algorithm was applied to patients in this study and used to classify patients as CT+ or not CT+. Performance was assessed using sensitivity, specificity, and negative and positive predictive values (NPV, PPV). ResultsForty-eight stroke patients (31 ischemic and 17 hemorrhagic) and 135 stroke mimic controls were included. Within the ischemic population, approximately half were CT- but later confirmed for stroke with MRI (CT-/MRI+). Sensitivity to stroke was 91.7%, specificity 50.4% (to stroke mimic), NPV 94.4%, and PPV 39.6%. Eighty percent of the CT-/MRI+ ischemic strokes were correctly identified at the time of the CT- scan. ConclusionsDespite a small population and the use of a classifier without the benefit of training on a stroke population, these data suggest that a rapidly acquired, easy-to-use system to assess brain electrical activity at the time of evaluation of acute stroke could be a valuable adjunct to current clinical practice.	[Michelson, Edward A.] Univ Hosp Case Med Ctr, Dept Emergency Med, Cleveland, OH USA; [Hanley, Daniel] Johns Hopkins Univ, Sch Med, Div Brain Injury Outcomes, Baltimore, MD USA; [Chabot, Robert; Prichep, Leslie S.] NYU, Sch Med, Dept Psychiat, Quantitat Neurophysiol Brain Res Labs, New York, NY 10003 USA		Prichep, LS (corresponding author), NYU, Sch Med, Dept Psychiat, Quantitat Neurophysiol Brain Res Labs, New York, NY 10003 USA.	Leslie.prichep@nyumc.org		Hanley, Daniel/0000-0002-9536-4258	BrainScope Co., Inc.; BrainScope	Data acquisition for this study was supported by research grants from BrainScope Co., Inc., to the clinical sites. Dr. Michelson was a principal investigator at one of the clinical data acquisition sites at the time of this study. Dr. Prichep serves as a consultant to BrainScope Co., Inc., and holds potential financial interest through patented technology licensed by BrainScope from NYU School of Medicine. Drs. Hanley and Michelson sit on the Medical Advisory Board of BrainScope Co., Inc. Dr. Chabot was a paid consultant to BrainScope. BrainScope had no role in the conduct of the studies, analysis of the data, or preparation of manuscripts. Strict adherence to ethical concerns was followed and all subjects signed written informed consent forms for participation in the study.	Brazzelli M, 2009, COCHRANE DATAB SYS R, V7, P1; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; Forster A, 2012, J NEUROL, V259, P1347, DOI 10.1007/s00415-011-6354-9; Hanley DF, 2013, J NEUROTRAUM, V30, P2051, DOI 10.1089/neu.2013.3062; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; Machado C, 2004, CLIN EEG NEUROSCI, V35, P116, DOI 10.1177/155005940403500303; Malloy, 1998, Semin Clin Neuropsychiatry, V3, P186; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Rajajee V, 2008, J NEUROIMAGING, V18, P66, DOI 10.1111/j.1552-6569.2007.00150.x; Rehme AK, 2013, J PHYSIOL-LONDON, V591, P17, DOI 10.1113/jphysiol.2012.243469; Reid JM, 2012, SCOT MED J, V57, P209, DOI 10.1258/smj.2012.012119; Scharf J, 2006, J COMPUT ASSIST TOMO, V30, P105, DOI 10.1097/01.rct.0000187417.15321.ca; Totaro P, 2010, EUR NEUROL, V63, P94, DOI 10.1159/000276399	17	9	10	1	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JAN	2015	22	1					67	72		10.1111/acem.12561			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AY2WW	WOS:000347447900008	25565489				2022-02-06	
J	Nelson, DV; Esty, ML				Nelson, David V.; Esty, Mary Lee			Neurotherapy for chronic headache following traumatic brain injury	MILITARY MEDICAL RESEARCH			English	Article						Chronic headache; Posttraumatic headache; Traumatic brain injury; Neurotherapy; Electroencephalograph (EEG) biofeedback; Neurofeedback	POSTTRAUMATIC HEADACHE; VETERANS; PTSD; IRAQ; AFGHANISTAN; MILITARY; SOLDIERS	Background: Chronic headache following traumatic brain injury (TBI) sustained in military service, while common, is highly challenging to treat with existing pharmacologic and non-pharmacologic interventions and may be complicated by co-morbid posttraumatic stress. Recently, a novel form of brainwave-based intervention known as the Flexyx Neurotherapy System (FNS) that involves minute pulses of electromagnetic energy stimulation of brainwave activity has been suggested as a means to address symptoms of TBI. This study reports on a clinical series of patients with chronic headache following service-connected TBI treated with FNS. Methods: Nine veterans of the wars in Afghanistan and Iraq with moderate to severe chronic headaches following service-connected TBI and complicated by posttraumatic stress symptoms were treated in 20 individual FNS sessions at the Brain Wellness and Biofeedback Center of Washington (in Bethesda, Maryland, USA). They periodically completed measures including the Brief Pain Inventory-Headache (BPI-HA) past week worst and average pain ratings, the Posttraumatic Stress Disorder Checklist-Military version (PCL-M), and individual treatment session numerical rating scale (NRS) for degree of cognitive dysfunction. Data analyses included beginning to end of treatment t-test comparisons for the BPI-HA, PCL-M, and cognitive dysfunction NRS. Results: All beginning to end of treatment t-test comparisons for the BPI-HA, PCL-M, and cognitive dysfunction NRS indicated statistically significant decreases. All but one participant experienced reduction in headaches along with reductions in posttraumatic stress and perceived cognitive dysfunction, with a subset experiencing virtual elimination of headaches. One participant obtained modest headache relief but no improvement in posttraumatic stress or cognitive dysfunction. Conclusions: FNS may be a potentially efficacious treatment for chronic posttraumatic headache sustained in military service. Further research is needed to investigate the efficacy of FNS within a randomized, controlled clinical trial, to identify characteristics of those most likely to respond, and to explore underlying mechanisms that may contribute to improvement.	[Nelson, David V.] Sam Houston State Univ, Dept Psychol & Philosophy, Box 2447, Huntsville, TX 77341 USA; [Esty, Mary Lee] Brain Wellness & Biofeedback Ctr Washington, Bethesda, MD 20814 USA		Nelson, DV (corresponding author), Sam Houston State Univ, Dept Psychol & Philosophy, Box 2447, Huntsville, TX 77341 USA.	nelsondv@shsu.edu					Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cleeland C. S., 1989, MEASUREMENT PAIN SUB, P391; Collura T., 2014, TECHNICAL FDN NEUROF; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Evans RW, 2014, NEUROL CLIN, V32, P283, DOI 10.1016/j.ncl.2013.11.010; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; Mullally WJ, 2009, PAIN PHYSICIAN, V12, P1005; Nelson DV, 2012, J NEUROPSYCH CLIN N, V24, P237, DOI 10.1176/appi.neuropsych.11020041; Nestoriuc Y, 2008, APPL PSYCHOPHYS BIOF, V33, P125, DOI 10.1007/s10484-008-9060-3; Ochs L., 1997, FLEXYX NEUROTHERAPY; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tavel ME, 2014, AM J MED, V127, P484, DOI 10.1016/j.amjmed.2014.02.002; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	23	9	9	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2095-7467	2054-9369		MILITARY MED RES	MILITARY MED. RES.		2015	2								22	10.1186/s40779-015-0049-y			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V33AG	WOS:000215737700022	26328060	Green Published, gold			2022-02-06	
J	Ozdemir, B; Celik, C; Oznur, T				Ozdemir, Barbaros; Celik, Cemil; Oznur, Taner			Assessment of dissociation among combat-exposed soldiers with and without posttraumatic stress disorder	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						Combat exposure; posttraumatic stress disorder; dissociation; dissociative symptoms; physical injury	TRAUMATIC BRAIN-INJURY; PERITRAUMATIC DISSOCIATION; SYMPTOMS; PTSD; HYPNOTIZABILITY; VETERANS; MEMORY; EVENT; RISK	Background: Dissociation is a disruption of and/or discontinuity in the normal, subjective integration of one or more aspects of psychological functioning, including memory, identity, consciousness, perception, and motor control. A limited number of studies investigated combat-related dissociation. Objective: The primary aim of this study was to evaluate the relationship between dissociative symptoms and combat-related trauma. Method: This study included 184 individuals, including 84 patients who were exposed to combat and diagnosed with posttraumatic stress disorder (PTSD) (Group I), 50 subjects who were exposed to combat but were not diagnosed with PTSD (Group II), and 50 healthy subjects without combat exposure (Group III). The participants were evaluated using the Dissociative Experiences Scale (DES) to determine their total and sub-factor (i.e., amnesia, depersonalization/derealization, and absorption) dissociative symptom levels. In addition, Group I and Group II were compared with respect to the relationship between physical injury and DES scores. Results: The mean DES scores (i.e., total and sub-factors) of Group I were higher than those of Group II (p<0.001), and Group II's mean DES scores (i.e., total and sub-factors) were higher than those of Group III (p<0.001). Similarly, the number of subjects with high total DES scores (i.e., >30) was highest in Group I, followed by Group II and Group III. When we compared combat-exposed subjects with high total DES scores, Group I had higher scores than Group II. In contrast, no relationship between the presence of bodily injury and total DES scores could be demonstrated. In addition, our results demonstrated that high depersonalization/derealization factor scores were correlated with bodily injury in PTSD patients. A similar relationship was found between high absorption factor scores and bodily injury for Group II. Conclusions: Our results demonstrated that the level of dissociation was significantly higher in subjects with combat-related PTSD than in subjects without combat-related PTSD. In addition, combat-exposed subjects without PTSD also had higher dissociation levels than healthy subjects without combat experience.	[Ozdemir, Barbaros; Celik, Cemil; Oznur, Taner] Gulhane Mil Med Fac, Dept Psychiat, TR-06018 Ankara, Turkey		Ozdemir, B (corresponding author), Gulhane Mil Med Fac, Dept Psychiat, TR-06018 Ankara, Turkey.	ozdemirbarbaros@yahoo.com					Akyuz C., 1999, COMPR PSYCHIAT, V40, P151; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Blevins C. A., 2014, JOURNAL OF TRAUMATIC, V27, P1; Bowins Brad, 2004, Am J Psychoanal, V64, P1, DOI 10.1023/B:TAJP.0000017989.72521.26; Branscomb LL, 1991, DISSOCIATION, V4, P13; BREMNER JD, 1992, AM J PSYCHIAT, V149, P328; Bremner JD, 1997, J TRAUMA STRESS, V10, P37, DOI 10.1002/jts.2490100105; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1011; Briere J, 2005, AM J PSYCHIAT, V162, P2295, DOI 10.1176/appi.ajp.162.12.2295; Briere J, 2005, J TRAUMA STRESS, V18, P221, DOI 10.1002/jts.20024; Brinker M, 2007, J NERV MENT DIS, V195, P655, DOI 10.1097/NMD.0b013e31811f4076; Candel I, 2004, COMPR PSYCHIAT, V45, P44, DOI 10.1016/j.comppsych.2003.09.012; Carlson E. B., 2010, PSYCHOLOGICAL TRAUMA, V4, P479; Elhai JD, 2003, J CLIN PSYCHOL, V59, P385, DOI 10.1002/jclp.10135; First MB, 1997, STRUCTURED CLINICAL; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gulsun M, 2009, ANADOLU PSIKIYATR DE, V10, P34; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HYER LA, 1993, PSYCHOL REP, V73, P519, DOI 10.2466/pr0.1993.73.2.519; Keane T. M., 2001, CONTROVERSIES IN PSY, P21; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kulka R. A., 1990, TRAUMA VIETNAM WAR G, P73; Lanius RA, 2012, DEPRESS ANXIETY, V29, P701, DOI 10.1002/da.21889; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; MARMAR CR, 1994, AM J PSYCHIAT, V151, P902; McCarthy ML, 2003, J BONE JOINT SURG AM, V85A, P1689, DOI 10.2106/00004623-200309000-00006; Ozkurkcugil A., 1999, ILAC TEDAVI DERGISI, V12, P233; PITMAN RK, 1989, AM J PSYCHIAT, V146, P667; Putnam F., 1988, DISSOCIATION, V1, P17; Putnam F.W., 1985, CHILDHOOD ANTECEDENT, P66; Putnam FW, 1996, J NERV MENT DIS, V184, P673, DOI 10.1097/00005053-199611000-00004; Ross C. A., 1988, AMERICAN JOURNAL OF, V147, P1547; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SPIEGEL D, 1988, AM J PSYCHIAT, V145, P301; Starr AJ, 2004, J BONE JOINT SURG AM, V86A, P1115, DOI 10.2106/00004623-200406000-00001; STUTMAN RK, 1985, AM J PSYCHIAT, V142, P741; Suliman S, 2013, J AFFECT DISORDERS, V149, P277, DOI 10.1016/j.jad.2013.01.041; Tutkun H, 1998, AM J PSYCHIAT, V155, P800; ULMAN RB, 1987, J AM ACAD PSYCHOAN, V15, P175, DOI 10.1521/jaap.1.1987.15.2.175; vanderKolk BA, 1996, AM J PSYCHIAT, V153, P83; Waelde LC, 2005, J TRAUMA STRESS, V18, P359, DOI 10.1002/jts.20034; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Wolf EJ, 2012, ARCH GEN PSYCHIAT, V69, P698, DOI 10.1001/archgenpsychiatry.2011.1574; Yargic LI, 1995, DISSOCIATION PROGR D, V8, P10	48	9	9	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8198	2000-8066		EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.		2015	6								26657	10.3402/ejpt.v6.26657			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	CG9ME	WOS:000353638900001	25925021	gold, Green Published			2022-02-06	
J	Patel, BR				Patel, Bina R.			Caregivers of Veterans with "Invisible" Injuries: What We Know and Implications for Social Work Practice	SOCIAL WORK			English	Article						caregivers; Iraq; Afghanistan caregivers; military caregivers; Operation Iraqi Freedom and Operation Enduring Freedom caregivers; veteran caregivers	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; WAR VETERANS; BRAIN-INJURY; MILITARY; PARTNERS; SUPPORT; BURDEN; IMPACT; LIFE	Today, as a result of the longest volunteer-fought conflict in U.S. history, there are many wounded coming home not only with posttraumatic stress disorder (PTSD), but also with traumatic brain injury (TBI), which together have been called the "signature" or "invisible" injuries of the Iraq and Afghanistan wars. Caregivers are an important part of their recovery, yet little is known about them, as previous research on caregivers mostly focused on geriatric populations. According to one estimate 275,000 to 1 million people are currently caring or have cared for loved ones who have returned from Iraq and Afghanistan. These caregivers are unique in that they are younger, some with children, and they are caring for a unique understudied population for longer periods of time. This article summarizes literature on caregivers of veterans who suffer from PTSD, TBI, or both; provides a theoretical framework; and discusses implications for social workers in assisting caregivers and their families.	US Dept Vet Affairs, Social Work, Gainesville, FL 32608 USA		Patel, BR (corresponding author), US Dept Vet Affairs, Social Work, 1601 SW Archer Rd,Mail Code 116A-4, Gainesville, FL 32608 USA.	beepat617@hotmail.com					Baker BL, 2003, J INTELL DISABIL RES, V47, P217, DOI 10.1046/j.1365-2788.2003.00484.x; Beckham JC, 1996, J CONSULT CLIN PSYCH, V64, P1068, DOI 10.1037/0022-006X.64.5.1068; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Clay OJ, 2013, REHABIL PSYCHOL, V58, P28, DOI 10.1037/a0031726; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Dow B., 2003, AUSTR SOCIAL WORK, V56, P197, DOI DOI 10.1046/j.0312-407x.2003.00083.x; Evans L, 2010, J CONSULT CLIN PSYCH, V78, P611, DOI 10.1037/a0020457; Evans SW, 2009, J ATTEN DISORD, V12, P516, DOI 10.1177/1087054708322987; Fairweather A., 2007, DEFINING NEW AGE VET; Fischer EP, 2013, PROF PSYCHOL-RES PR, V44, P127, DOI 10.1037/a0032024; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; Folkman S., 1984, STRESS; Gordon PA, 2004, J REHABIL, V70, P27; Harben J., 2006, MENTAL HLTH ADVISORY; Hayes J, 2010, J REHABIL RES DEV, V47, P825, DOI 10.1682/JRRD.2009.04.0049; Hutchison E. D., 2011, DIMENSION HUMAN BEHA; Jakupcak M, 2011, COGN BEHAV PRACT, V18, P85, DOI 10.1016/j.cbpra.2009.08.007; Jakupcak M, 2010, DEPRESS ANXIETY, V27, P1001, DOI 10.1002/da.20722; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Lambert JE, 2012, J FAM PSYCHOL, V26, P729, DOI 10.1037/a0029341; Levin A., 2008, PSYCHIAT NEWS, V43, P23; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Link PE, 2013, CLIN CHILD FAM PSYCH, V16, P376, DOI 10.1007/s10567-013-0145-z; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; Mental Health Advisory Team, 2006, OP IR FREED 04 06 RE; Miller T. W., 1994, J DEV PHYS DISABIL, V6, P43; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Monahan DJ, 1997, SOC WORK, V42, P278, DOI 10.1093/sw/42.3.278; National Alliance for Caregiving, 2010, CAR VET SERV HOM; Navaie-Waliser M, 2002, MED CARE, V40, P1249, DOI 10.1097/00005650-200212000-00012; O'Donnell L, 2011, J LOSS TRAUMA, V16, P284, DOI 10.1080/15325024.2010.519269; Pearlin LI, 2010, J GERONTOL B-PSYCHOL, V65, P207, DOI 10.1093/geronb/gbp106; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pemberton JR, 2013, PSYCHOL SERV, V10, P194, DOI 10.1037/a0029995; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; RABIN C, 1991, COMMUNITY MENT HLT J, V27, P209, DOI 10.1007/BF00752422; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Ray SL, 2009, INT J NURS STUD, V46, P838, DOI 10.1016/j.ijnurstu.2009.01.002; Savundranayagam MY, 2010, RES AGING, V32, P175, DOI 10.1177/0164027509351473; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schulze B, 2005, CURR OPIN PSYCHIATR, V18, P684, DOI 10.1097/01.yco.0000179504.87613.00; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Tanielian T, 2013, MILITARY CAREGIVERS; Thoresen S, 2006, ARCH SUICIDE RES, V10, P353, DOI 10.1080/13811110600791106; U.S. Department of Veterans Affairs, 2012, VA MOB HLTH PIL PROG; U.S. Department of Veterans Affairs, 2014, MOND MORN WORKL REP; U.S. Department of Veterans Affairs National Center for PTSD, 2007, WHAT IS PTSD; U.S. Department of Veterans Affairs Polytrauma Center, 2007, POL SYST OF CAR; WHEATON B, 1985, J HEALTH SOC BEHAV, V26, P352, DOI 10.2307/2136658; Zarit S.H., 2007, MENTAL DISORDERS OLD	52	9	9	1	22	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0037-8046	1545-6846		SOC WORK	Soc. Work	JAN	2015	60	1					9	17		10.1093/sw/swu043			9	Social Work	Social Science Citation Index (SSCI)	Social Work	CC1PJ	WOS:000350113200002	25643571				2022-02-06	
J	Reed, N; Greenspoon, D; Iverson, GL; DeMatteo, C; Fait, P; Gauvin-Lepage, J; Hunt, A; Gagnon, IJ				Reed, Nick; Greenspoon, Dayna; Iverson, Grant L.; DeMatteo, Carol; Fait, Philippe; Gauvin-Lepage, Jerome; Hunt, Anne; Gagnon, Isabelle J.			Management of persistent postconcussion symptoms in youth: a randomised control trial protocol	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; GENERIC CORE SCALES; PHYSICAL-ACTIVITY; ACUTE CONCUSSION; AEROBIC FITNESS; EXERCISE; RELIABILITY; PERFORMANCE; CHILDREN; VALIDITY	Introduction: Current management of concussion consists of early education, rest until symptom free, with gradual return to school and physical activity protocols. Although this management strategy is effective for most youth who sustain a concussion, it is not an appropriate strategy for youth with persistent postconcussion symptoms. Prolonged rest and periods of restricted activity may place youth at risk for secondary issues and contribute to the chronicity of postconcussion symptoms. The purpose of this study is to evaluate the efficacy of an active rehabilitation protocol for youth who are slow to recover from concussion. It is hypothesised that an active rehabilitation intervention can reduce persistent postconcussion symptoms, improve function and facilitate return to activity. This article describes the research protocol. Methods and analysis: This is a randomised clinical trial with blinded outcome measurement. Participants will be recruited and randomly assigned to 1 of 2 treatment groups, an active rehabilitation intervention or a standard care education group. Both groups will receive standard care education. However, the active rehabilitation group will participate in an additional low-intensity exercise programme consisting of aerobic, coordination and visualisation exercises. Both the active rehabilitation and the standard care education interventions will be 6 weeks in duration. The primary outcome measure is postconcussion symptoms. Secondary outcome measures include functional recovery (cognitive, motor, psychosocial and emotional functioning) and return to activity. Outcome measures will be administered preintervention and postintervention. The primary outcome measure will also be repeated 2 weeks into the intervention period. Ethics and dissemination: This study has been approved by the Holland Bloorview Kids Rehabilitation Hospital research ethics board (REB # 13-459). The findings from this study will be shared with the general public, sport associations, relevant brain injury organisations and healthcare professionals.	[Reed, Nick; Hunt, Anne] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Res Ctr, Toronto, ON, Canada; [Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Greenspoon, Dayna] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Res Ctr, Ctr Leadership ABI, Toronto, ON, Canada; [Iverson, Grant L.] Harvard Univ, Dept Phys Med & Rehabil, Sch Med, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [DeMatteo, Carol] CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Dept Human Kinet Sci, Trois Rivieres, PQ GA9 5H7, Canada; [Fait, Philippe] UQTR, Res Grp Neuromusculoskeletal Dysfunct, Trois Rivieres, PQ, Canada; [Fait, Philippe] Ctr Rech Neuropsychol, Montreal, PQ, Canada; [Fait, Philippe] Clin Cortex Med & Readaptat, Quebec City, PQ, Canada; [Gauvin-Lepage, Jerome] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Gagnon, Isabelle J.] McGill Univ, Sch Phys & Occupat Therapy, Fac Med, Montreal, PQ, Canada; [Gagnon, Isabelle J.] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Trauma, Montreal, PQ H3H 1P3, Canada		Reed, N (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Res Ctr, Toronto, ON, Canada.	nreed@hollandbloorview.ca	Meijer, Anna/K-5118-2016; Gauvin-Lepage, Jerome/AAD-6699-2020	Gagnon, Isabelle/0000-0003-2043-1644; Iverson, Grant/0000-0001-7348-9570	Fonds de recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec	Funding for the pilot study informing this protocol was provided by Fonds de recherche du Quebec-Sante.	Achenback TM, 1991, MANUAL CHILD BEHAV C; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Brand S, 2009, J HEALTH PSYCHOL, V14, P1144, DOI 10.1177/1359105309342602; Bruininks RH, 2005, BRUININKS OSERETSKY; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Ekeland E., 2004, COCHRANE DATABASE SY; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2015, SCAND J MED SCI SPOR; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Iverson GL, 2012, MILD TRAUMATIC BRAIN, P281; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon JC, 2000, NEUROSURGERY, V47, P669; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Mead GE, 1996, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004366.PUB4/ABSTRACT; Roemmich JN, 2006, MED SCI SPORT EXER, V38, P1014, DOI 10.1249/01.mss.0000218123.81079.49; Sady MD, 2014, ARCH CLIN NEUROPSYCH; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Spielberger C.D., 1980, TEST ANXIETY INVENTO; Steer, 2005, BECK YOUTH INVENTORI; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Varni JW, 2004, J DEV BEHAV PEDIATR, V25, P10, DOI 10.1097/00004703-200402000-00002; Youngstedt SD, 2005, CLIN SPORT MED, V24, P355, DOI 10.1016/j.csm.2004.12.003; Zemek R, 2014, GUIDELINES DIAGNOSIN	39	9	9	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	7							e008468	10.1136/bmjopen-2015-008468			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4FH	WOS:000363482000073	26231756	Green Published, gold			2022-02-06	
J	Schmidt, AK; Reich, A; Falkenburger, B; Schulz, JB; Brandenburg, LO; Ribes, S; Tauber, SC				Schmidt, Anna Kathrin; Reich, Arno; Falkenburger, Bjoern; Schulz, Joerg B.; Brandenburg, Lars Ove; Ribes, Sandra; Tauber, Simone C.			Adjuvant Granulocyte Colony-Stimulating Factor Therapy Results in Improved Spatial Learning and Stimulates Hippocampal Neurogenesis in a Mouse Model of Pneumococcal Meningitis	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Bacterial meningitis; Brain-derived neurotrophic factor (BDNF); Hippocampal neurogenesis; Granulocyte colony-stimulating factor; Spatial learning; Streptococcus pneumoniae; TrK	STREPTOCOCCUS-PNEUMONIAE MENINGITIS; PREVENTS COGNITIVE IMPAIRMENT; ELEMENT-BINDING PROTEIN; TRAUMATIC BRAIN-INJURY; NEONATAL-RAT BRAIN; BACTERIAL-MENINGITIS; PERINATAL HYPOXIA; FUNCTION RECOVERY; MURINE MODEL; MEMORY	Despite the development of new antibiotic agents, mortality of pneumococcal meningitis remains high. In addition, meningitis results in severe long-term morbidity, most prominently cognitive deficits. Granulocyte colony-stimulating factor (G-CSF) stimulates proliferation and differentiation of hematopoietic progenitor cells and increases the number of circulating neutrophil granulocytes. This study investigated the effect of adjuvant G-CSF treatment on cognitive function after pneumococcal meningitis. C57BL/6 mice were infected by subarachnoid injection of Streptococcus pneumoniae serotype 3 and treated with ceftriaxone and G-CSF subcutaneously or ceftriaxone alone for 5 days. Clinical scores, motor performance, and mortality during bacterial meningitis were unaffected by adjuvant G-CSF treatment. No effect of G-CSF treatment on production of proinflammatory cytokines or activation of microglia or astrocytes was observed. The G-CSF treatment did, however, result in hippocampal neurogenesis and improved spatial learning performance 6 weeks after meningitis. These results suggest that G-CSF might offer a new adjuvant therapeutic approach in bacterial meningitis to reduce long-term cognitive deficits.	[Schmidt, Anna Kathrin; Reich, Arno; Falkenburger, Bjoern; Schulz, Joerg B.; Tauber, Simone C.] RWTH Univ Hosp, Dept Neurol, D-52074 Aachen, Germany; [Falkenburger, Bjoern; Schulz, Joerg B.] JARA Translat Brain Med, Aachen, Germany; [Falkenburger, Bjoern; Schulz, Joerg B.] JARA Translat Brain Med, Julich, Germany; [Brandenburg, Lars Ove] RWTH Univ, Dept Anat & Cell Biol, Aachen, Germany; [Ribes, Sandra] Univ Med Ctr, Inst Neuropathol, Gottingen, Germany		Tauber, SC (corresponding author), RWTH Univ Hosp, Dept Neurol, Pauwelsstr 30, D-52074 Aachen, Germany.	stauber@ukaachen.de	Schulz, Jorg B/D-9786-2012	Schulz, Jorg B/0000-0002-8903-0593; Falkenburger, Bjoern/0000-0002-2387-526X	Else Kroner-Fresenius-Stiftung [2010_A102]	This investigation was supported by Grant No. 2010_A102 from the Else Kroner-Fresenius-Stiftung.	Barichello T, 2014, TRANSL RES, V163, P503, DOI 10.1016/j.trsl.2013.12.008; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brandt CT, 2004, INFECT IMMUN, V72, P4647, DOI 10.1128/IAI.72.8.4647-4653.2004; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chaudhuri J, 2012, J CLIN NEONATOL, V1, P202, DOI 10.4103/2249-4847.105993; Chen CH, 2013, NEUROSCIENCE, V242, P39, DOI 10.1016/j.neuroscience.2013.02.017; Chen WF, 2011, PEDIATR RES, V70, P589, DOI 10.1203/PDR.0b013e3182324424; Dallaire F, 2001, J INFECT DIS, V183, P70, DOI 10.1086/317652; Diederich K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005303; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Gerber J, 2003, J NEUROSCI RES, V73, P441, DOI 10.1002/jnr.10682; Gerber J, 2009, NEUROLOGY, V73, P1026, DOI 10.1212/WNL.0b013e3181b9c892; Guo Y, 2013, NEUROSCIENCE, V238, P1, DOI 10.1016/j.neuroscience.2013.01.047; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Lu F, 2014, BRAIN RES, V1548, P49, DOI 10.1016/j.brainres.2013.12.010; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Ostergaard C, 1999, INFECT IMMUN, V67, P3430; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; Prakash A, 2013, PHARMACOL BIOCHEM BE, V110, P46, DOI 10.1016/j.pbb.2013.05.015; Schmidt H, 2006, BRAIN, V129, P333, DOI 10.1093/brain/awh711; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sikoglu EM, 2014, BEHAV BRAIN RES, V259, P354, DOI 10.1016/j.bbr.2013.11.008; Taguchi A, 2007, EUR J NEUROSCI, V26, P126, DOI 10.1111/j.1460-9568.2007.05640.x; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; Tauber SC, 2009, J NEUROSCI RES, V87, P1877, DOI 10.1002/jnr.22010; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wellmer A, 2000, NEUROSCI LETT, V296, P137, DOI 10.1016/S0304-3940(00)01645-1; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yang YN, 2013, PEDIATR NEONATOL, V54, P380, DOI 10.1016/j.pedneo.2013.04.011; Zhang Y, 2010, BIOL PHARM BULL, V33, P572, DOI 10.1248/bpb.33.572; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101	35	9	9	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JAN	2015	74	1					85	94		10.1097/NEN.0000000000000152			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	AX0IA	WOS:000346634900008	25470346	Bronze			2022-02-06	
J	Tung, JY; Chee, JN; Zabjek, KF; McIlroy, WE				Tung, James Y.; Chee, Justin N.; Zabjek, Karl F.; McIlroy, William E.			Combining ambulatory and laboratory assessment of rollator use for balance and mobility in neurologic rehabilitation in-patients	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Ambulation aids; falling; gait stability; quiet standing; stroke; traumatic brain injury; wheeled walker	RECOVERY; DEMANDS; WALKERS; PEOPLE; CANES	Purpose: Despite the common use of rollators (four-wheeled walkers), understanding their effects on gait and balance is limited to laboratory testing rather than everyday use. This study evaluated the utility of an ambulatory assessment approach to examine balance and mobility in everyday conditions compared to a laboratory assessment. Methods: Standing and walking with a rollator was assessed in three neurological rehabilitation in-patients under two conditions: (1) in laboratory (i.e. forceplate, GaitRite), and (2) while performing a natural walking course within and outside of the institution. An instrumented rollator (iWalker) was used to measure variables related to the balance control (e.g. upper limb kinetics), destabilizing events (e.g. stumbling), and environmental context. Results: Two of three patients demonstrated greater reliance on the rollator for standing balance (2.3-5.9 times higher vertical loading, 72-206% increase in COP excursion) and 29-42% faster gait during the walking course compared to the laboratory. Importantly, destabilizing events (collisions, stumbling) were recorded during the walking course. Such events were not observed in the laboratory. Conclusion: This study illustrated a greater reliance on the rollator during challenges in everyday use compared to laboratory assessment and provided evidence of specific circumstances associated with destabilizing events that may precipitate falls in non-laboratory settings.	[Tung, James Y.; McIlroy, William E.] Univ Waterloo, Dept Kinesiol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada; [Tung, James Y.] Univ Waterloo, David Cheriton Sch Comp Sci, Waterloo, ON, Canada; [Tung, James Y.; Chee, Justin N.; Zabjek, Karl F.; McIlroy, William E.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Tung, James Y.; Chee, Justin N.; Zabjek, Karl F.; McIlroy, William E.] Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada; [Chee, Justin N.; Zabjek, Karl F.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada		Tung, JY (corresponding author), Univ Waterloo, Dept Kinesiol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	james.tung@uwaterloo.ca	Tung, James/J-6728-2019	Tung, James/0000-0002-0771-2313	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Toronto Rehabilitation InstituteUniversity of Toronto; Ministry of Health and Long Term Care in OntarioMinistry of Health and Long-Term Care, Ontario; National Institute on Disability and Rehabilitation Research (NIDRR) through Rehabilitation Engineering Research Center on Universal Design and the Built Environment [H133E050004-08A]; Centre for Inclusive Design and Environmental Access (IDEA)	We acknowledge the support of the Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and the Toronto Rehabilitation Institute which receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long Term Care in Ontario. We acknowledge the support from the National Institute on Disability and Rehabilitation Research (NIDRR) through the Rehabilitation Engineering Research Center on Universal Design and the Built Environment (grant #H133E050004-08A), a partnership with the Centre for Inclusive Design and Environmental Access (IDEA).	Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Bateni H, 2004, EXP BRAIN RES, V157, P49, DOI 10.1007/s00221-003-1815-8; Bateni H, 2004, GAIT POSTURE, V20, P74, DOI 10.1016/S0966-6362(03)00098-5; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Donovan K, 2008, CLIN REHABIL, V22, P556, DOI 10.1177/0269215507085378; Finkel J, 1997, Assist Technol, V9, P116; Frizera-Neto A, 2011, INT J ADV ROBOT SYST, V8, P34; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Lee G., 2013, IEEE T SYST MAN CYBE; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; Najafi B, 2009, GAIT POSTURE, V29, P261, DOI 10.1016/j.gaitpost.2008.09.002; Patel M, 2012, P IEEE RAS-EMBS INT, P1071, DOI 10.1109/BioRob.2012.6290936; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Schulz BW, 2005, GAIT POSTURE, V22, P198, DOI 10.1016/j.gaitpost.2004.09.004; Stevens JA, 2009, J AM GERIATR SOC, V57, P1464, DOI 10.1111/j.1532-5415.2009.02365.x; Tung JY, 2014, ASSIST TECHNOL, V26, P15, DOI 10.1080/10400435.2013.789456; Tung JY, 2011, J BIOMECH, V44, P1466, DOI 10.1016/j.jbiomech.2011.03.015; Tung JY, DEV EVALUATION IWALK; Zettel JL, 2007, NEUROSCI LETT, V422, P207, DOI 10.1016/j.neulet.2007.06.020	19	9	9	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2015	10	5					407	414		10.3109/17483107.2014.908243			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V07PF	WOS:000214019000007	24734996				2022-02-06	
J	Wu, X; Liu, Q; Jiang, XF; Zhang, T				Wu, Xing; Liu, Qin; Jiang, Xiaofei; Zhang, Tao			Prevention options for ventriculoperitoneal shunt infections: a retrospective analysis during a five-year period	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						VP shunt infection; CSF; perioperative antibiotic prophylaxis; vancomycin	CEREBROSPINAL-FLUID SHUNTS; CLINICAL ARTICLE; HYDROCEPHALUS; IMIPENEM; INFANTS	Shunt infection is the most common and dreaded complication in patients with hydrocephalus. For the purpose of reducing the high morbidity and mortality, how to prevent is a vital step. A retrospective analysis of 384 CSF cerebrospinal fluid (CSF) shunt procedures was undertaken from 2006 to 2010 in our neurosurgery department. Infection diagnosis was established by subjecting the CSF to biochemical and microbiological parameters. The patients' demographic and clinical characteristics, various treatment procedures and outcome were evaluated. The infection rate of ventriculoperitoneal (VP) shunt was 12.5% in 2006, which dropped to 2% and stabilized at lower level from 2008. The most common causes of hydrocephalus were traumatic injury and brain tumor. Fever and consciousness disturbance were the major clinical symptoms. Gram-negative rods episodes was the most frequently isolated microorganisms accounting for 58%, followed by S. aureus, S. epidermidis and Staphylococcus haemolyticus. With the removal of shunt and intravenous antibiotics therapy, 82% of the patients survived. Majority of the isolates were sensitive to the carbopenem antibiotics and vancomycin. The mean length of hospital stay was 47 days. Prompt shunt removal and perioperative antibiotic prophylaxis seems to be essential for the survival of patients with VP shunt infection.	[Wu, Xing] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Liu, Qin; Jiang, Xiaofei; Zhang, Tao] Fudan Univ, Huashan Hosp, Dept Lab Med, 12 Cent Urumqi Rd, Shanghai 200040, Peoples R China		Zhang, T (corresponding author), Fudan Univ, Huashan Hosp, Dept Lab Med, 12 Cent Urumqi Rd, Shanghai 200040, Peoples R China.	shmuzt@126.com			National Clinical Key Subject; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81072070, 81471241, 81171133, 81271375]; Natural Science Foundation of ShanghaiNatural Science Foundation of Shanghai [15ZR1405600]	This work was supported by the National Clinical Key Subject, the National Natural Science Foundation of China ( grant number 81072070, 81471241, 81171133, and 81271375) and the Natural Science Foundation of Shanghai ( grant number 15ZR1405600).	AUBERT G, 1991, J ANTIMICROB CHEMOTH, V28, P316, DOI 10.1093/jac/28.2.316; Bayston R, 2012, ANTIMICROB AGENTS CH, V56, P2842, DOI 10.1128/AAC.06326-11; Bisno Alan L., 1994, P91; Conen A, 2008, CLIN INFECT DIS, V47, P73, DOI 10.1086/588298; DALLACASA P, 1995, CHILD NERV SYST, V11, P643, DOI 10.1007/BF00300722; Demetriades AK, 2011, BRIT J NEUROSURG, V25, P671, DOI 10.3109/02688697.2011.575478; Drake JM, 1998, NEUROSURGERY, V43, P294, DOI 10.1097/00006123-199808000-00068; FANHAVARD P, 1987, CLIN PHARMACY, V6, P866; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Mullan E, 2014, SCOT MED J, V59, P198, DOI 10.1177/0036933014548665; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; POPLE IK, 1992, J NEUROSURG, V77, P29, DOI 10.3171/jns.1992.77.1.0029; Reddy GK, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.10.034; Tomio R, 2013, SURG INFECT, V14, P433, DOI 10.1089/sur.2012.087; Tuan TJ, 2011, PEDIATR INFECT DIS J, V30, P731, DOI 10.1097/INF.0b013e318218ac0e; Turgut M, 2005, PEDIATR NEUROSURG, V41, P131, DOI 10.1159/000085869; VALLEE E, 1990, PRESSE MED, V19, P588; Wang KW, 2004, JPN J INFECT DIS, V57, P44; Warf BC, 2012, J NEUROSURG-PEDIATR, V10, P463, DOI 10.3171/2012.9.PEDS1236	19	9	9	1	2	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2015	8	10					19775	19780					6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DA3BB	WOS:000367669800351	26770643				2022-02-06	
J	Wu, XM; Wang, GL; Miao, J; Feng, JC				Wu, Xue-mei; Wang, Guang-liang; Miao, Jing; Feng, Jia-chun			EFFECT OF CONNEXIN 36 BLOCKERS ON THE NEURONAL CYTOSKELETON AND SYNAPTIC PLASTICITY IN KAINIC ACID-KINDLED RATS	TRANSLATIONAL NEUROSCIENCE			English	Article						Epilepsy; microtubule-associated protein-2 (MAP-2); synaptophysin (SYP); Connexin 36	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; GAP-JUNCTION BLOCKERS; SYNAPTOPHYSIN IMMUNOREACTIVITY; PENTYLENETETRAZOLE MODEL; STATUS EPILEPTICUS; PROTEIN-2 MAP2; IN-VIVO; HIPPOCAMPUS; SEIZURE	In this study we investigated the potential anti-epileptogenic effect of neuronal connexin Cx36 gap junction blockage via inhibition of microtubule-associated protein 2 (MAP-2) and synaptophysin (SYP) overexpression. Thirty adult male Wistar rats were divided into five groups (six animals per group): control, sham, carbenoxolone (CBX), quinine (QN), and quinidine (QND). An epilepsy model was produced by injecting kainic acid (KA) into the rat amygdala. Broad-spectrum and selective blockers of the Cx36 channel (CBX, QN, and QND) were administered via intraperitoneal injection. Expression of MAP-2 and SYP was assessed by immunofluorescent and immunohistochemical examination. Expression of MAP-2 and SYP was significantly increased after KA administration in the sham group compared with the control group. Expression of MAP-2 and SYP was significantly decreased in the CBX, QN, and QND groups compared with the sham group. The results provide new evidence regarding the key role of MAP-2 and SYP overexpression in three important mechanisms: the modulation of neuronal plasticity, hyperexcitability of the hippocampal neuronal network, and persistent seizure discharge. Furthermore, the reversal of MAP-2 and SYP overexpression following administration of Cx36 channel blockers indicates a potential role for Cx36 channel blockers in anti-epileptogenic treatment and in doing so, highlights a critical need for further investigation of these compounds.	[Wu, Xue-mei] Jilin Univ, Hosp 1, Dept Pediat Neurol, Changchun 130023, Peoples R China; [Wang, Guang-liang] Peking Univ, Int Hosp, Dept Cardiol, Beijing, Peoples R China; [Miao, Jing; Feng, Jia-chun] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Peoples R China		Wu, XM (corresponding author), Jilin Univ, Hosp 1, Dept Pediat Neurol, Changchun 130023, Peoples R China.	fengjiachun323@sina.com	Wu, Xue-mei/K-4975-2019				ALDER J, 1992, SCIENCE, V257, P657, DOI 10.1126/science.1353905; BALLOUGH GPH, 1995, J NEUROSCI METH, V61, P23, DOI 10.1016/0165-0270(95)00019-Q; Bezgina E N, 2003, Tsitologiia, V45, P1005; Cavazos JE, 2003, J COMP NEUROL, V458, P272, DOI 10.1002/cne.10581; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Gajda Z, 2005, EPILEPSIA, V46, P1581, DOI 10.1111/j.1528-1167.2005.00254.x; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; Iwata M, 2005, NEUROSCI LETT, V386, P145, DOI 10.1016/j.neulet.2005.06.004; Jalava NS, 2007, INT J DEV NEUROSCI, V25, P121, DOI 10.1016/j.ijdevneu.2006.12.001; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kato K, 2001, BRAIN RES, V901, P281, DOI 10.1016/S0006-8993(01)02299-5; Li S, 2002, NEUROSCIENCE, V115, P1221, DOI 10.1016/S0306-4522(02)00485-2; Looney MR, 1999, ACTA NEUROPATHOL, V98, P179, DOI 10.1007/s004010051067; Mallozzi C, 2013, BBA-MOL CELL RES, V1833, P110, DOI 10.1016/j.bbamcr.2012.10.022; Medina-Ceja L, 2010, SEIZURE-EUR J EPILEP, V19, P507, DOI 10.1016/j.seizure.2010.07.009; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Mullany PM, 1998, NEUROREPORT, V9, P2489, DOI 10.1097/00001756-199808030-00012; Nassiri-Asl M, 2008, PROG NEURO-PSYCHOPH, V32, P1496, DOI 10.1016/j.pnpbp.2008.05.007; Nassiri-Asl M, 2009, SEIZURE-EUR J EPILEP, V18, P129, DOI 10.1016/j.seizure.2008.08.002; NUNEZ J, 1988, TRENDS NEUROSCI, V11, P477, DOI 10.1016/0166-2236(88)90004-5; Pereno GI, 2010, BRAIN RES, V1328, P130, DOI 10.1016/j.brainres.2010.01.087; Piret G, 2013, BIOMATERIALS, V34, P875, DOI 10.1016/j.biomaterials.2012.10.042; Proper EA, 2000, BRAIN, V123, P19, DOI 10.1093/brain/123.1.19; Ribak CE, 2000, J COMP NEUROL, V428, P240, DOI 10.1002/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sanchez C, 2001, NEUROSCIENCE, V107, P25, DOI 10.1016/S0306-4522(01)00338-4; Sliwa A, 2012, NEUROSCI LETT, V509, P105, DOI 10.1016/j.neulet.2011.12.051; SUTULA TP, 1992, EPILEPSY RES, P251; Tang L, 2014, J MOL NEUROSCI, V53, P103, DOI 10.1007/s12031-013-0204-4; Vaidya V, 2000, SYNAPSE, V35, P137, DOI 10.1002/(SICI)1098-2396(200002)35:2<137::AID-SYN6>3.0.CO;2-F; Voss LJ, 2009, EPILEPSIA, V50, P1971, DOI 10.1111/j.1528-1167.2009.02087.x; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Zhang F, 2014, INT J HYDROGEN ENERG, V01, P1; Zhu Wen-zeng, 2010, Zhongguo Zhen Jiu, V30, P46	34	9	9	0	4	DE GRUYTER POLAND SP ZOO	WARSAW	BOGUMILA ZUGA 32A STR., 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2015	6	1					252	258		10.1515/tnsci-2015-0027			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DD3IO	WOS:000369815700003	28123810	gold, Green Published			2022-02-06	
J	Yildirim, T; Eylen, A; Lule, S; Erdener, SE; Vural, A; Karatas, H; Ozveren, MF; Dalkara, T; Gursoy-Ozdemir, Y				Yildirim, Timur; Eylen, Alpaslan; Lule, Sevda; Erdener, Sefik Evren; Vural, Atay; Karatas, Hulya; Ozveren, Mehmet Faik; Dalkara, Turgay; Gursoy-Ozdemir, Yasemin			Poloxamer-188 and citicoline provide neuronal membrane integrity and protect membrane stability in cortical spreading depression	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						cortical spreading depression; megachannels; neuroprotection; poloxamer-188; citicoline	TRANSIENT FOREBRAIN ISCHEMIA; TRAUMATIC BRAIN-INJURY; CDP-CHOLINE; CLINICAL-RELEVANCE; MECHANISMS; NEUROPROTECTION; MIGRAINE; DAMAGE; RAT; DEPOLARIZATION	Under pathological conditions such as brain trauma, subarachnoid hemorrhage and stroke, cortical spreading depression (CSD) or peri-infarct depolarizations contribute to brain damage in animal models of neurological disorders as well as in human neurological diseases. CSD causes transient megachannel opening on the neuronal membrane, which may compromise neuronal survival under pathological conditions. Poloxamer-188 (P-188) and citicoline are neuroprotectants with membrane sealing properties. The aim of this study is to investigate the effect of P-188 and citicoline on the neuronal megachannel opening induced by CSD in the mouse brain. We have monitored megachannel opening with propidium iodide, a membrane impermeable fluorescent dye and, demonstrate that P-188 and citicoline strikingly decreased CSD-induced neuronal PI influx in cortex and hippocampal dentate gyrus. Therefore, these agents may be providing neuroprotection by blocking megachannel opening, which may be related to their membrane sealing action and warrant further investigation for treatment of traumatic brain injury and ischemic stroke.	[Yildirim, Timur] Ankara Ataturk Educ & Res Hosp, Dept Neurosurg, Ankara, Turkey; [Eylen, Alpaslan] Konya Numune Hosp, Dept Neurosurg, Konya, Turkey; [Lule, Sevda; Erdener, Sefik Evren; Vural, Atay; Karatas, Hulya; Dalkara, Turgay; Gursoy-Ozdemir, Yasemin] Hacettepe Univ, Inst Neurol Sci & Psychiat, Ankara, Turkey; [Erdener, Sefik Evren; Vural, Atay; Karatas, Hulya; Dalkara, Turgay; Gursoy-Ozdemir, Yasemin] Hacettepe Univ, Fac Med, Dept Neurol, Ankara 06100, Turkey; [Ozveren, Mehmet Faik] Ordu Univ, Fac Med, Dept Neurosurg, Ordu, Turkey		Gursoy-Ozdemir, Y (corresponding author), Hacettepe Univ, Fac Med, Dept Neurol, Ankara 06100, Turkey.; Gursoy-Ozdemir, Y (corresponding author), Koc Univ, Sch Med, Dept Neurol, Istanbul, Turkey.	yozdemir@hacettepe.edu.tr	Lule, Sevda/N-8229-2017; Erdener, Sefik Evren/B-2924-2014; Karatas, Hulya/J-1459-2013; Gursoy-Ozdemir, Yasemin/X-2778-2019; Vural, Atay/K-7388-2012; ERDENER, SEFIK EVREN/I-9202-2013	Lule, Sevda/0000-0001-7066-6471; Erdener, Sefik Evren/0000-0002-5141-7899; Karatas, Hulya/0000-0003-4838-6320; Gursoy-Ozdemir, Yasemin/0000-0002-0860-8964; Vural, Atay/0000-0003-3222-874X; ERDENER, SEFIK EVREN/0000-0002-5141-7899; Dalkara, Turgay/0000-0003-3943-7819			Adibhatla RM, 2002, J NEUROSCI RES, V70, P133, DOI 10.1002/jnr.10403; Ayata C, 2009, CEPHALALGIA, V29, P1095, DOI 10.1111/j.1468-2982.2009.01982.x; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Borgens RB, 2004, J NEUROSCI RES, V76, P141, DOI 10.1002/jnr.20053; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Curry DJ, 2004, NEUROSURGERY, V55, P943, DOI 10.1227/01.NEU.0000137890.29862.2C; Curry DJ, 2004, J NEUROSURG, V101, P91, DOI 10.3171/ped.2004.101.2.0091; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Dalkara T, 2006, NEUROL SCI, V27, pS86, DOI 10.1007/s10072-006-0577-z; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; DORLANDO KJ, 1995, NEUROL RES, V17, P281, DOI 10.1080/01616412.1995.11740327; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Fischer SM, 2011, EUR J PHARM BIOPHARM, V79, P416, DOI 10.1016/j.ejpb.2011.04.010; Frim DM, 2004, NEUROREPORT, V15, P171, DOI 10.1097/00001756-200401190-00033; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Guldali O, 2011, LIFE SCI, V88, P473, DOI 10.1016/j.lfs.2011.01.002; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Hunter RL, 2010, ANN CLIN LAB SCI, V40, P115; Hurtado O, 2008, NEUROBIOL DIS, V29, P123, DOI 10.1016/j.nbd.2007.08.004; Juneman EB, 2012, J CARDIOVASC PHARM, V60, P293, DOI 10.1097/FJC.0b013e31825f6f88; JUSTICZ AG, 1991, AM HEART J, V122, P671, DOI 10.1016/0002-8703(91)90510-O; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Lauritzen M, 2001, CEPHALALGIA, V21, P757, DOI 10.1046/j.1468-2982.2001.00244.x; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Maskarinec SA, 2005, ANN NY ACAD SCI, V1066, P310, DOI 10.1196/annals.1363.018; MEZROW CK, 1992, J THORAC CARDIOV SUR, V103, P1143; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Rao AM, 2000, J NEUROCHEM, V75, P2528, DOI 10.1046/j.1471-4159.2000.0752528.x; Rao AM, 1999, J NEUROSCI RES, V58, P697, DOI 10.1002/(SICI)1097-4547(19991201)58:5<697::AID-JNR11>3.0.CO;2-B; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Takasaki K, 2011, J PHARMACOL SCI, V116, P232, DOI 10.1254/jphs.11013FP; Zhang R, 2009, SHOCK, V32, P442, DOI 10.1097/SHK.0b013e31819e13b1	40	9	9	1	11	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.		2015	125	12					941	946		10.3109/00207454.2014.979289			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK2VA	WOS:000374771300010	25340256				2022-02-06	
J	Zanello, M; Charlier, P; Corns, R; Devaux, B; Berche, P; Pallud, J				Zanello, Marc; Charlier, Philippe; Corns, Robert; Devaux, Bertrand; Berche, Patrick; Pallud, Johan			The death of Henry II, King of France (1519-1559). From myth to medical and historical fact	ACTA NEUROCHIRURGICA			English	Article						King Henry II; Medical history; Ambroise Pare; Andreas Vesalius; Subdural empyema; Retrospective diagnosis	TRAUMATIC BRAIN-INJURY; HEMATOMA	On 30 June 1559, Henry II, King of France, was mortally wounded in the head by a lance during a jousting match. Despite the best efforts of his physicians, Ambroise Par, and Andreas Vesalius, King Henry died 11 days later. This article, based on previously unpublished evidence, aims at examining the historical account of his death against modern medical practice to establish the probable cause of the king's death. We also discuss what treatments the doctors in the sixteenth century may have had to offer. Historical accounts of the joust provide details of the incident including the position of the visor of the king's helmet. Descriptions of the wood fragments removed from the right orbit by Italian observers and a new translation of the autopsy by Andreas Vesalius allow an accurate description of the actual injury. Our research counters previous theories and concludes that Henry II was the victim of craniofacial trauma involving the right eye and that he died from periorbital cellulitis caused by a retained foreign body in the wound, complicated by a left interhemispheric empyema preceded by a traumatic interhemispheric haematoma. It would appear that the royal court doctors advocated a wait-and-see strategy, with little actual input from Ambroise Par, or Andreas Vesalius, with a clearly regrettable outcome.	[Zanello, Marc; Devaux, Bertrand; Pallud, Johan] Hop St Anne, Dept Neurosurg, F-75674 Paris, France; [Zanello, Marc; Devaux, Bertrand; Berche, Patrick; Pallud, Johan] Univ Paris 05, Paris, France; [Pallud, Johan] Inst Pasteur, Dept Histopathol & Anim Models, Paris, France; [Charlier, Philippe] UFR Hlth Sci, Dept Medicolegal & Med Anthropol, Montigny Le Bretonneux, France; [Charlier, Philippe] Versailles St Quentin Univ, Versailles, France; [Corns, Robert] Leeds Gen Infirm, Dept Neurosurg, Leeds, W Yorkshire, England; [Berche, Patrick] Hop Necker Enfants Malad, Paris, France		Pallud, J (corresponding author), Hop St Anne, Dept Neurosurg, F-75674 Paris, France.	johanpallud@hotmail.com					Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Buchon JAC, 1791, E SCIENTIFIQUE 1838; Cabanes A, 1930, MORTS MYSTERIEUSES D; De Bodin Galembert LCM, 1869, FUNERAILLES DU ROY H; de Serres J, 1599, HISTOIRE DES CHOSES; Donaldson IML, 2013, J ROY COLL PHYS EDIN, V43, P278, DOI 10.4997/JRCPE.2013.317; FARIA MA, 1992, J NEUROSURG, V77, P964, DOI 10.3171/jns.1992.77.6.0964; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Haton C, 1857, MEMOIRES DE CLAUDE H; Kim JH, 2009, J KOREAN NEUROSURG S, V45, P53, DOI 10.3340/jkns.2009.45.1.53; Lafaist L, 1834, PETITOT ET LEBER SER, V1; Lalanne L, 1896, BRANTOME SA VIE ET S; Louis Gonzaga Duke of Nevers, 1559, COMMUNICATION; Martin G, 2001, AUST NZ J SURG, V71, P318, DOI 10.1046/j.1440-1622.2001.02102.x; MILLER CF, 1977, SURG NEUROL, V7, P95; Nasr AM, 1999, OPHTHALMOLOGY, V106, P523, DOI 10.1016/S0161-6420(99)90111-2; Nikolic S D, 2009, Leg Med (Tokyo), V11 Suppl 1, pS321, DOI 10.1016/j.legalmed.2009.01.079; Nishio Y, 2004, ACTA NEUROCHIR, V146, P847, DOI 10.1007/s00701-004-0283-7; NORWICH I, 1991, S AFR MED J, V80, P245; O'Malley CD, 1964, ANDREAS VESALIUS OF; Pare A, 1561, LA METHODE CURATIVE; Perez S, 2006, LA MORT DES ROIS DOC; ROMIER L, 1913, REV SEIZ SIECLE 1913, P99; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Tainmont J, 2010, B-ENT, V6, P229; Vrankovic D, 2000, NEUROSURG REV, V23, P156, DOI 10.1007/PL00011948	26	9	9	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2015	157	1					145	149		10.1007/s00701-014-2280-9			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AX8GC	WOS:000347147100023	25421951				2022-02-06	
J	Zhang, B; Zhao, J				Zhang, Biao; Zhao, Jin			Red blood cell distribution width as a prognostic biomarker for mortality in traumatic brain injury	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Traumatic brain injury; red blood cell distribution width; prognostic biomarker; mortality; glasgow coma scale scores	NEURON-SPECIFIC ENOLASE; DIAGNOSIS; S100B	Objective: Traumatic brain injury (TBI) often cause morbidity and mortality, but it is hard to obtained predictive biomarkers. Red blood cell distribution width (RDW) has been reported as a mortalmarker in cardiovascular disease. But it is unknown whethr RDW is associated with the mortality of TBI patients. The aim of this study is to identify whether RDW is a prognostic biomarker for TBI mortality. Methods: A total of 122 patients with TBI were included retrospectively. Patients were divided into Survival Group and Non-survival Group, RDW was compared between 2 groups. Receiver Operating Curve (ROC) was used to evaluate the mortality predictive performances. Results: 122 patients were included, the male-female ratio was 2.59 (88/34) with their median age of 49.5 (17-89) years. 13 (11.93%) of them were divided into Non-survival Group. We observed significant difference in RDW between two groups (P < 0.05). The cut-off level for RDW in TBI was >= 12.85, with the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) were 65.4%, 95.7%, 69.7%, 82.6%, respectively; and area under the curve was 0.805 (95% confidence interval [CI]: 0.703-0.906). Conclusions: Red cell distribution width is a predictor of mortality in patients with TBI.	[Zhang, Biao; Zhao, Jin] Suzhou Integrated Chinese & Western Med Hosp, Dept Crit Care Med, 39 Xiashatang Rd, Suzhou, Jiangsu, Peoples R China		Zhao, J (corresponding author), Suzhou Integrated Chinese & Western Med Hosp, Dept Crit Care Med, 39 Xiashatang Rd, Suzhou, Jiangsu, Peoples R China.	zhaoj-clh@163.com					Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Aslan D, 2002, AM J HEMATOL, V69, P31, DOI 10.1002/ajh.10011; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Demir A, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-16; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Narci H, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-46; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Senol K, 2013, AM J EMERG MED, V31, P687, DOI 10.1016/j.ajem.2012.12.015; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179	14	9	9	0	3	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2015	8	10					19172	19175					4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DA3BB	WOS:000367669800259	26770551				2022-02-06	
J	Dillahunt-Aspillaga, C; Finch, D; Massengale, J; Kretzmer, T; Luther, SL; McCart, JA				Dillahunt-Aspillaga, Christina; Finch, Dezon; Massengale, Jill; Kretzmer, Tracy; Luther, Stephen L.; McCart, James A.			Using Information from the Electronic Health Record to Improve Measurement of Unemployment in Service Members and Veterans with mTBI and Post-Deployment Stress	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION; MILITARY VETERANS; SELF-EFFICACY; US ARMY; RETURN; WORK; WAR; REHABILITATION; OUTCOMES	Objective: The purpose of this pilot study is 1) to develop an annotation schema and a training set of annotated notes to support the future development of a natural language processing (NLP) system to automatically extract employment information, and 2) to determine if information about employment status, goals and work-related challenges reported by service members and Veterans with mild traumatic brain injury (mTBI) and post-deployment stress can be identified in the Electronic Health Record (EHR). Design: Retrospective cohort study using data from selected progress notes stored in the EHR. Setting: Post-deployment Rehabilitation and Evaluation Program (PREP), an inpatient rehabilitation program for Veterans with TBI at the James A. Haley Veterans' Hospital in Tampa, Florida. Participants: Service members and Veterans with TBI who participated in the PREP program (N=60). Main Outcome Measures: Documentation of employment status, goals, and work-related challenges reported by service members and recorded in the EHR. Results: Two hundred notes were examined and unique vocational information was found indicating a variety of self-reported employment challenges. Current employment status and future vocational goals along with information about cognitive, physical, and behavioral symptoms that may affect return-to-work were extracted from the EHR. The annotation schema developed for this study provides an excellent tool upon which NLP studies can be developed. Conclusions: Information related to employment status and vocational history is stored in text notes in the EHR system. Information stored in text does not lend itself to easy extraction or summarization for research and rehabilitation planning purposes. Development of NLP systems to automatically extract text-based employment information provides data that may improve the understanding and measurement of employment in this important cohort.	[Dillahunt-Aspillaga, Christina; Finch, Dezon; Luther, Stephen L.; McCart, James A.] James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL 33612 USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL USA; [Massengale, Jill; Kretzmer, Tracy] James A Haley Vet Hosp, Tampa, FL 33612 USA		Dillahunt-Aspillaga, C (corresponding author), James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL 33612 USA.	cdillahuntas@usf.edu		Dillahunt-Aspillaga, Christina/0000-0002-1231-2023	VHA QUERI RRP [12-450]	Funding for this work was provided by VHA QUERI RRP 12-450. The views expressed in this work are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; [Anonymous], 2008, MILD TRAUM BRAIN INJ; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benshoff J, 2008, REHABIL RES POLI ED, V22, P227; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carbonell JG, 1987, ENCY ARTIFICIAL INTE, P660; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Cerrito P.B., 2006, DATA TEXT MINING ELE; Chiarini-Tremblay M, 2005, AMCIS 2005 P, P109; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Clemens EV, 2008, CAREER DEV Q, V56, P246, DOI 10.1002/j.2161-0045.2008.tb00039.x; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Defense and Veterans Brain Injury Center, 2013, DOD WORLDW TBI NUMB; DeJong G., 1982, STRATEGIES NATURAL L, V113, P149; Department of Veterans Affairs, 2010, VET HLTH ADM HDB; Dillahunt-Aspillaga C., 2014, SGRJARC, V45, P25; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Frain MP, 2010, J REHABIL, V76, P13; Frain MP, 2011, VOC EVAL WORK ADJ AS, V38, P34; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Freeman M., 2014, J INT NEUROPSYCHOL S, V5, P1; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Guillen R, 2009, P I2B2 WORKSH CHALL, P868; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Institute of Medicine, 2008, GULF WAR HLTH, V7; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jaycox, 2008, INVISIBLE WOUNDS WAR; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kretzmer T, 2013, MILITARY TBI CASE MA, V4, P8; Kupersmith J, 2009, J REHABIL RES DEV, V46, pXVII, DOI 10.1682/JRRD.2009.06.0085; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; LEHNERT W, 1995, J EXP THEOR ARTIF IN, V7, P49, DOI 10.1080/09528139508953800; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; National Research Council, 2014, GULF WAR HLTH, V9; Ness BM, 2014, J HEAD TRAUMA REHAB, V29, P33, DOI 10.1097/HTR.0b013e3182a1cd4e; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ogren PV, 2006, P HUM LANG TECHN C N, P273, DOI DOI 10.3115/1225785.1225791]; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pakhomov S., 2005, P 43 ANN M ASS COMP, P25, DOI [DOI 10.3115/1225753.1225760, 10.3115/1225753.1225760]; Pakhomov SVS, 2008, J AM MED INFORM ASSN, V15, P198, DOI 10.1197/jamia.M2585; Pogoda T, 2014, J HEAD TRAUMA REHABI; Ponsford J., 2014, J HEAD TRAUMA REHABI; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Rao RB, 2006, SIGKDD EXPLOR NEWS, V8, P3, DOI DOI 10.1145/1147234.1147236; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sayer N, 2012, STRATEGIC PLAN FY 20; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Spackman KA, 1997, J AM MED INFORM ASSN, P640; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Office of Patient Care Services, 2005, VHA HDB; THOMPSON K, 1968, COMMUN ACM, V11, P419, DOI 10.1145/363347.363387; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Turchin A, 2006, J AM MED INFORM ASSN, V13, P691, DOI 10.1197/jamia.M2078; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vocational Rehabilitation Institute, 2011, CAR V10; Waljas M, 2013, J HEAD TRAU IN PRESS; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Xu H, 2010, J AM MED INFORM ASSN, V17, P19, DOI 10.1197/jamia.M3378; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30	86	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115873	10.1371/journal.pone.0115873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9RO	WOS:000347239900101	25541956	gold, Green Published, Green Submitted			2022-02-06	
J	Calabrese, B; Halpain, S				Calabrese, Barbara; Halpain, Shelley			Lithium prevents aberrant NMDA-induced F-actin reorganization in neurons	NEUROREPORT			English	Article						actin; bipolar disorder; cellular stress; cytoskeleton; glutamate; lithium; mood stabilizers; neuronal activity; neuroprotection; N-methyl-D-aspartate	TRAUMATIC BRAIN-INJURY; DENDRITIC SPINES; BIPOLAR DISORDER; RECEPTORS; DISEASE; EXCITOTOXICITY; CYTOSKELETON; ACTIVATION; MECHANISMS; THERAPY	Increasing evidence suggests that cellular stress may underlie mood disorders such as bipolar disorder and major depression, particularly as lithium and its targets can protect against neuronal cell death. Here we describe N-methyl-D-aspartate (NMDA)-induced filamentous actin reorganization (NIFAR) as a useful in-vitro model for studying acute neurocellular stress and investigating the effects of mood stabilizers. Brief incubation of cultured neurons with NMDA (50 mu M, 5 min) induces marked reorganization of F-actin within the somatodendritic domain of a majority of neurons. During NIFAR, F-actin is rapidly depleted from dendritic spines and aberrantly aggregates within the dendrite shaft. The widely used mood stabilizer lithium chloride prevented NIFAR in a time-dependent and dose-dependent manner, consistent with its known efficacy in treating bipolar disorder. Inhibitors of the lithium target glycogen synthase kinase 3 and its upstream activator phosphoinositide-3-kinase also prevented NIFAR. The antidepressant compounds imipramine and fluoxetine also attenuated NIFAR. These findings have potential relevance to neuropsychiatric diseases characterized by excessive glutamate receptor activity and synaptotoxicity. We propose that protection of the dendritic actin cytoskeleton may be a common mechanism shared by various mood stabilizers. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Calabrese, Barbara; Halpain, Shelley] Univ Calif San Diego, Sanford Consortium Regenerat Med, Div Biol Sci, La Jolla, CA 92037 USA		Halpain, S (corresponding author), Univ Calif San Diego, Sanford Consortium Regenerat Med, Div Biol Sci, La Jolla, CA 92037 USA.	shalpain@ucsd.edu			Novartis AG at The Scripps Research Institute [SFP 1563]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH087823]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH087823] Funding Source: NIH RePORTER	The authors thank Dr Johannes Mosbacher for advice and encouragement in these studies. They also thank Julia Braga for assisting with blinded morphological analyses. This work was supported in part by Novartis AG as a specifically funded project at The Scripps Research Institute (SFP 1563) and by NIH grant MH087823.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bachmann RF, 2005, MOL NEUROBIOL, V32, P173, DOI 10.1385/MN:32:2:173; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Calabrese B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094787; Can A, 2014, PHARMACOL BIOCHEM BE, V123, P3, DOI 10.1016/j.pbb.2014.02.004; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Dodd S, 2013, PROG NEURO-PSYCHOPH, V42, P135, DOI 10.1016/j.pnpbp.2012.11.007; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Graber S, 2004, NEUROPHARMACOLOGY, V47, P706, DOI 10.1016/j.neuropharm.2004.08.004; Halpain S, 1998, J NEUROSCI, V18, P9835; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Lamprecht R, 2014, PROG NEUROBIOL, V117, P1, DOI 10.1016/j.pneurobio.2014.02.001; Leeds PR, 2014, ACS CHEM NEUROSCI, V5, P422, DOI 10.1021/cn500040g; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Malhi GS, 2013, CNS DRUGS, V27, P135, DOI 10.1007/s40263-013-0039-0; Massot O, 1999, NEUROPSYCHOPHARMACOL, V21, P530, DOI 10.1016/S0893-133X(99)00042-1; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Penzes P, 2012, ADV EXP MED BIOL, V970, P81, DOI 10.1007/978-3-7091-0932-8_4; Rajendran P, 2014, CLIN CHIM ACTA, V436, P332, DOI 10.1016/j.cca.2014.06.004; Schell MJ, 2006, EUR J NEUROSCI, V24, P2491, DOI 10.1111/j.1460-9568.2006.05125.x; Sekino Y, 2006, MOL CELL NEUROSCI, V31, P493, DOI 10.1016/j.mcn.2005.11.003; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x	29	9	10	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	DEC 3	2014	25	17					1331	1337		10.1097/WNR.0000000000000268			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AT2AG	WOS:000344732400001	25304495	Green Accepted			2022-02-06	
J	Coyan, GN; Moncure, M; Thomas, JH; Wood, JG				Coyan, Garrett N.; Moncure, Michael; Thomas, James H.; Wood, John G.			INDUCED HYPOTHERMIA DURING RESUSCITATION FROM HEMORRHAGIC SHOCK ATTENUATES MICROVASCULAR INFLAMMATION IN THE RAT MESENTERIC MICROCIRCULATION	SHOCK			English	Article						Hemorrhagic shock; resuscitation; hypothermia; leukocyte adherence; mast cell degranulation; mesenteric microcirculation	LEUKOCYTE-ENDOTHELIAL ADHERENCE; MAST-CELL DEGRANULATION; TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; REACTIVE OXIDANTS; MODERATE HYPOTHERMIA; FLUID RESUSCITATION; REPERFUSION INJURY; SYSTEMIC HYPOXIA	Microvascular inflammation occurs during resuscitation following hemorrhagic shock, causing multiple organ dysfunction and mortality. Preclinical evidence suggests that hypothermia may have some benefit in selected patients by decreasing this inflammation, but this effect has not been extensively studied. Intravital microscopy was used to visualize mesenteric venules of anesthetized rats in real time to evaluate leukocyte adherence and mast cell degranulation. Animals were randomly allocated to normotensive or hypotensive groups and further subdivided into hypothermic and normothermic resuscitation (n = 6 per group). Animals in the shock groups underwent mean arterial blood pressure reduction to 40 to 45 mmHg for 1 h via blood withdrawal. During the first 2 h following resuscitation by infusion of shed blood plus double that volume of normal saline, rectal temperature of the hypothermic groups was maintained at 32 degrees C to 34 degrees C, whereas the normothermic groups were maintained between 36 degrees C to 38 degrees C. The hypothermic group was then rewarmed for the final 2 h of resuscitation. Leukocyte adherence was significantly lower after 2 h of hypothermic resuscitation compared with normothermic resuscitation: (2.8 +/- 0.8 vs. 8.3 +/- 1.3 adherent leukocytes, P = 0.004). Following rewarming, leukocyte adherence remained significantly different between hypothermic and normothermic shock groups: (4.7 +/- 1.2 vs. 9.5 +/- 1.6 adherent leukocytes, P = 0.038). Mast cell degranulation index (MDI) was significantly decreased in the hypothermic (1.02 +/- 0.04 MDI) versus normothermic (1.22 +/- 0.07 MDI) shock groups (P = 0.038) after the experiment. Induced hypothermia during resuscitation following hemorrhagic shock attenuates microvascular inflammation in rat mesentery. Furthermore, this decrease in inflammation is carried over after rewarming takes place.	[Coyan, Garrett N.; Moncure, Michael; Thomas, James H.; Wood, John G.] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66103 USA; [Coyan, Garrett N.] Univ Kansas, Med Ctr, Dept Prevent Med & Publ Hlth, Kansas City, KS 66103 USA; [Wood, John G.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA		Wood, JG (corresponding author), 3901 Rainbow Blvd,Mailstop 3043, Kansas City, KS 66160 USA.	gcoyan@kumc.edu; jwood2@kumc.edu		Coyan, Garrett/0000-0003-0889-1592	Department of Surgery Research Fund; Department of Molecular & Integrative Physiology; Department of Preventive Medicine and Public Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000001, TL1TR000120] Funding Source: NIH RePORTER	The authors thank Naomi Holloway for invaluable technical support in conducting the experiments. In addition, they thank the Department of Surgery Research Fund, the Department of Molecular & Integrative Physiology, and the Department of Preventive Medicine and Public Health for financial support.	Abonia JP, 2005, J IMMUNOL, V174, P7285, DOI 10.4049/jimmunol.174.11.7285; Alam HB, 2012, BRIT J SURG, V99, P29, DOI 10.1002/bjs.7756; Alam HB, 2012, J TRAUMA ACUTE CARE, V73, P809, DOI 10.1097/TA.0b013e318265d1b8; BARROSOARANDA J, 1988, CIRC RES, V63, P437, DOI 10.1161/01.RES.63.2.437; Childs EW, 2005, SHOCK, V23, P565, DOI 10.1097/01.shk.0000164188.46364.2a; Childs EW, 2005, J TRAUMA, V58, P271, DOI 10.1097/01.TA.0000119203.24601.7E; Childs EW, 2002, SHOCK, V18, P423, DOI 10.1097/00024382-200211000-00006; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Dix R, 2003, J APPL PHYSIOL, V95, P2495, DOI 10.1152/japplphysiol.00735.2003; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; George ME, 2010, J TRAUMA, V68, P662, DOI 10.1097/TA.0b013e3181d3cbc0; HOUSE SD, 1987, MICROVASC RES, V34, P363, DOI 10.1016/0026-2862(87)90068-9; Iyegha UP, 2012, SHOCK, V38, P387, DOI 10.1097/SHK.0b013e3182657a21; Kasacka I, 2004, EUR J HISTOCHEM, V48, P167; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Kentner R, 2002, SHOCK, V17, P521, DOI 10.1097/00024382-200206000-00014; Kimura M, 1999, PHARMACOL RES, V39, P397, DOI 10.1006/phrs.1999.0451; Li T, 2012, ANESTHESIOLOGY, V116, P1288, DOI 10.1097/ALN.0b013e318256f09d; Morita Y, 1995, AM J PHYSIOL-HEART C, V269, pH1833, DOI 10.1152/ajpheart.1995.269.6.H1833; MORITA Y, 1995, SHOCK, V4, P41, DOI 10.1097/00024382-199507000-00006; Neligan Patrick J, 2013, Anesthesiol Clin, V31, P21, DOI 10.1016/j.anclin.2012.10.007; Nishi K, 2012, J TRAUMA ACUTE CARE, V72, P130, DOI 10.1097/TA.0b013e31821e61d8; Prueckner S, 2001, J TRAUMA, V50, P253, DOI 10.1097/00005373-200102000-00010; Santone DJ, 2008, AM J PHYSIOL-HEART C, V294, pH2456, DOI 10.1152/ajpheart.00925.2007; Sasaki H, 2007, SHOCK, V27, P354, DOI 10.1097/01.shk.0000248601.11292.14; Schaser KD, 2006, J TRAUMA, V61, P642, DOI 10.1097/01.ta.0000174922.08781.2f; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Stefanutti G, 2005, SHOCK, V24, P159, DOI 10.1097/01.shk.0000168871.60531.6f; Steiner DRS, 2003, J APPL PHYSIOL, V94, P325, DOI 10.1152/japplphysiol.00637.2002; Subeq YM, 2012, CYTOKINE, V60, P68, DOI 10.1016/j.cyto.2012.06.009; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Takasu A, 2000, CRIT CARE MED, V28, P2465, DOI 10.1097/00003246-200007000-00047; Takasu A, 2005, RESUSCITATION, V67, P119, DOI 10.1016/j.resuscitation.2005.04.014; TIKIZ H, 1991, PHARMACOLOGY, V43, P47, DOI 10.1159/000138826; Tisherman SA, 2013, CURR OPIN CRIT CARE, V19, P594, DOI 10.1097/MCC.0000000000000034; Tuma MA, 2011, J TRAUMA, V71, P1524, DOI 10.1097/TA.0b013e31823c5a06; US Department of Health and Human Services CDC National Center for Injury Prevention and Control: CDC, 2012, CDC WEB BAS INJ STAT; WANG P, 1990, CIRC SHOCK, V32, P307; Wu XR, 2003, J TRAUMA, V55, P308, DOI 10.1097/01.TA.0000079366.23533.1E; Wu XR, 2002, J TRAUMA, V53, P654, DOI 10.1097/00005373-200210000-00006; Zilberberg J, 2001, MICROVASC RES, V62, P215, DOI 10.1006/mvre.2001.2327	41	9	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	DEC	2014	42	6					518	524		10.1097/SHK.0000000000000241			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	AT9FX	WOS:000345234400005	25046540	Green Accepted, Green Submitted			2022-02-06	
J	Fournier, AJ; Rajbhandari, L; Shrestha, S; Venkatesan, A; Ramesh, KT				Fournier, Adam J.; Rajbhandari, Labchan; Shrestha, Shiva; Venkatesan, Arun; Ramesh, K. T.			In vitro and in situ visualization of cytoskeletal deformation under load: traumatic axonal injury	FASEB JOURNAL			English	Article						traumatic brain injury; spinal cord injury; cyto-skeleton micromechanics; microfluidics; confocal	STRETCH-INJURY; DYNAMIC INSTABILITY; MICROTUBULES; ORGANIZATION; MECHANISMS; PROTEIN; DAMAGE	It is difficult to obtain insight into the mechanisms occurring within live cells during mechanical loading, because this complex environment is dynamic and evolving. This is a particular challenge from a subcellular mechanics perspective, where temporal and spatial information on the evolving cytoskeletal structures is required under loading. Using fluorescently labeled proteins, we visualize 3-dimensional live subcellular cytoskeletal populations under mechanical loading using a high-resolution confocal microscope. The mechanical forces are determined using a computational (finite element) model that is validated by integrating instrumentation into the testing platform. Transfected microtubules and neurofilaments of E17 rat neuronal axons are imaged before, during, and after loading. Comparisons between unloaded and loaded live cells demonstrate both spatial and temporal changes for cytoskeletal populations within the imaged volume. NF signal decreases by 24%, yet the microtubule signal exhibits no significant change 20-35 s after loading. Transmission electron microscopy assesses cytoskeletal structure spatial distribution for undeformed and deformed axons. While cytoskeletal degeneration occurs at prolonged time intervals following loads, our data provides insights into real time cytoskeletal evolution occurring in situ. Our findings suggest that, for axons undergoing traumatic injury in response to applied mechanical loads, changes at the substructural level of neurofilaments may precede microtubule rupture and degeneration.	[Fournier, Adam J.; Ramesh, K. T.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Rajbhandari, Labchan; Shrestha, Shiva; Venkatesan, Arun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA		Ramesh, KT (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Latrobe 200, Baltimore, MD 21218 USA.	avenkat2@jhmi.edu; ramesh@jhu.edu	Ramesh, KT/D-5451-2009	Ramesh, KT/0000-0003-2659-4698	Hopkins Extreme Materials Institute (HEMI); U.S. ArmyUnited States Department of Defense	The authors thank Professor Nitish Thakor (Department of Biomedical Engineering, Johns Hopkins University) and his student, Bhaskar Chennuri, for assistance with building the microcompression platform used in this research. The authors also thank the Johns Hopkins University School of Medicine Microscope Facility for usage of the imaging equipment, technical expertise, and invaluable advice in performing this research, Dr. Suneil Hosmane for providing discussion and direction labeling methodologies, and Aman Shah and Kyle Kirwan for their technical assistance. This work is supported by funding from the Hopkins Extreme Materials Institute (HEMI) and the U.S. Army.	Aberts B, 2008, MOL BIOL CELL; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; BLACK MM, 1989, J NEUROSCI, V9, P358; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cai Q, 2000, Space Med Med Eng (Beijing), V13, P263; Chang R, 2009, J MOL BIOL, V391, P648, DOI 10.1016/j.jmb.2009.06.045; Chetta J, 2010, CYTOSKELETON, V67, P650, DOI 10.1002/cm.20478; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gennarelli T. A., 1993, HEAD INJURY, V2, P108; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Koike T, 2008, NEUROCHEM INT, V52, P751, DOI 10.1016/j.neuint.2007.09.007; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Li Jin-sheng, 2002, Space Med Med Eng (Beijing), V15, P339; Ludin B, 1998, TRENDS CELL BIOL, V8, P72, DOI 10.1016/S0962-8924(97)01169-0; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Mukhopadhyay R, 2004, BIOESSAYS, V26, P1017, DOI 10.1002/bies.20088; OBRIEN ET, 1990, BIOCHEMISTRY-US, V29, P6648, DOI 10.1021/bi00480a014; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Ouyang H, 2010, MICR UGIM 2010 18 BI, P1; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Taber K. H., 2007, J NEUROPSYCHIATRY CL, V19; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; Uribe J. A. H., 2011, P 26 INT S BALL MIAM, P187	45	9	10	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5277	5287		10.1096/fj.14-251942			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	WOS:000345894500022	25205740				2022-02-06	
J	Newman, JRB; Boyle, RS; O'Sullivan, JD; Silburn, PA; Mellick, GD				Newman, Jeremy R. B.; Boyle, Richard S.; O'Sullivan, John D.; Silburn, Peter A.; Mellick, George D.			Risk factors for idiopathic dystonia in Queensland, Australia	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cigarette smoking; Dystonia; Head trauma; Questionnaires; Risk factors	TRAUMATIC BRAIN-INJURY; FOCAL HAND DYSTONIA; PARKINSONS-DISEASE; TORSION DYSTONIA; PSYCHIATRIC-DISORDERS; MOVEMENT-DISORDERS; ONSET DYSTONIA; PLASTICITY; POLYMORPHISMS; PREVALENCE	It is currently hypothesised that a combination of genetic and environmental factors underlies the development of idiopathic isolated dystonia (IID). In this study, we examined several possible environmental or other non-genetic factors that may influence the risk for IID in Queensland, Australia. We surveyed several environmental exposures, lifestyle factors, medical and family histories to investigate potential risk factors for IID. Associations between putative risk factors and IID were assessed using a total of 184 dystonia patients and 1048 neurologically-normal control subjects sampled from Queensland between 2005 and 2012. Our analyses revealed that anxiety disorders, depression, tremor, cigarette smoking and head injuries with a loss of consciousness were associated with increased risk for IID (p < 0.05), all of which remained statistically significant following an adjustment for multiple hypothesis testing except for depression. We also observed that the risk for dystonia increased with higher cigarette smoking pack-year quartiles in our analyses. Our results suggest possible environmental factors that influence the development of IID and complement the findings of similar dystonia risk factor studies. Further investigation defining the environmental and other non-genetic risk factors for IID may provide insight into the development of the disorder in genetically-susceptible individuals. (C) 2014 Elsevier Ltd. All rights reserved.	[Newman, Jeremy R. B.; Mellick, George D.] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia; [Boyle, Richard S.; Mellick, George D.] Princess Alexandra Hosp, Dept Neurol, Woolloongabba, Qld 4102, Australia; [O'Sullivan, John D.; Silburn, Peter A.; Mellick, George D.] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia; [Silburn, Peter A.] Univ Queensland, Royal Brisbane & Womens Hosp, Clin Res Ctr, Sch Med, Brisbane, Qld, Australia		Mellick, GD (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Don Young Rd, Nathan, Qld 4111, Australia.	g.mellick@griffith.edu.au	O'Sullivan, John/C-6119-2013; Mellick, George D./A-7650-2010; Newman, Jeremy/L-9938-2013	Mellick, George D./0000-0002-7211-4651; Newman, Jeremy/0000-0001-8486-2801; O'Sullivan, John/0000-0003-0422-8590	Department of Neurology Princess Alexandra Hospital	This study was supported by internal funding sources from the Department of Neurology Princess Alexandra Hospital to A/Prof G.D. Mellick.	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Behari M, 2000, NEUROEPIDEMIOLOGY, V19, P275, DOI 10.1159/000026265; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruno MK, 2007, NEUROLOGY, V68, P1782, DOI 10.1212/01.wnl.0000262029.91552.e0; Carbon M, 2008, MOVEMENT DISORD, V23, P234, DOI 10.1002/mds.21806; Couch J R, 1976, Adv Neurol, V14, P245; Defazio G, 1998, J NEUROL NEUROSUR PS, V64, P25, DOI 10.1136/jnnp.64.1.25; Defazio G, 2007, J NEUROL NEUROSUR PS, V78, P877, DOI 10.1136/jnnp.2007.119891; Defazio Giovanni, 2013, Tremor Other Hyperkinet Mov (N Y), V3, DOI 10.7916/D8QN65GQ; Deng YF, 2004, ANN NEUROL, V55, P897, DOI 10.1002/ana.20143; Di Giuda D, 2012, EUR J NUCL MED MOL I, V39, P1937, DOI 10.1007/s00259-012-2232-7; Dissanayaka NN, 2011, J NEUROL SCI, V310, P208, DOI 10.1016/j.jns.2011.06.031; Dissanayaka NNW, 2010, MOVEMENT DISORD, V25, P838, DOI 10.1002/mds.22833; Fabbrini G, 2010, MOVEMENT DISORD, V25, P459, DOI 10.1002/mds.22983; FLETCHER NA, 1991, MOVEMENT DISORD, V6, P304, DOI 10.1002/mds.870060406; FLETCHER NA, 1991, J NEUROL NEUROSUR PS, V54, P713, DOI 10.1136/jnnp.54.8.713; Frucht S, 2000, MOVEMENT DISORD, V15, P348, DOI 10.1002/1531-8257(200003)15:2<348::AID-MDS1028>3.0.CO;2-7; Gartner CE, 2005, PARKINSONISM RELAT D, V11, P287, DOI 10.1016/j.parkreldis.2005.04.002; Lauterbach EC, 2004, J NEUROPSYCH CLIN N, V16, P29, DOI 10.1176/appi.neuropsych.16.1.29; LeDoux MS, 2003, MOVEMENT DISORD, V18, P60, DOI 10.1002/mds.10301; Lehn A, 2014, J NEUROL, V261, P668, DOI 10.1007/s00415-014-7244-8; LORENZANA L, 1992, NEUROSURGERY, V31, P1108, DOI 10.1227/00006123-199212000-00019; MCCRAE RR, 1978, BRIT J SOC CLIN PSYC, V17, P269, DOI 10.1111/j.2044-8260.1978.tb00277.x; Newman JRB, 2013, MOVEMENT DISORD, V28, P1752, DOI 10.1002/mds.25479; Newman JRB, 2012, PARKINSONISM RELAT D, V18, P351, DOI 10.1016/j.parkreldis.2011.11.024; Nicaretta DH, 2011, ARQ NEURO-PSIQUIAT, V69, P564, DOI 10.1590/S0004-282X2011000400030; Perlmutter JS, 1997, NEUROLOGY, V49, P1432, DOI 10.1212/WNL.49.5.1432; Quartarone A, 2008, J NEUROL NEUROSUR PS, V79, P985, DOI 10.1136/jnnp.2007.121632; Quartarone A, 2006, TRENDS NEUROSCI, V29, P192, DOI 10.1016/j.tins.2006.02.007; Roze E, 2009, BRAIN, V132, P756, DOI 10.1093/brain/awn363; Rudzinska M, 2013, NEUROL NEUROCHIR POL, V47, P223, DOI 10.5114/ninp.2013.35584; SILVER JK, 1994, ARCH PHYS MED REHAB, V75, P885, DOI 10.1016/0003-9993(94)90113-9; Sutherland GT, 2009, MOVEMENT DISORD, V24, P833, DOI 10.1002/mds.22214; Tamura Y, 2009, BRAIN, V132, P749, DOI 10.1093/brain/awn348; Tanner K, 2012, LARYNGOSCOPE, V122, P1082, DOI 10.1002/lary.22471; Tanner K, 2011, J VOICE, V25, pE35, DOI 10.1016/j.jvoice.2009.09.004; Valente EM, 2003, MOVEMENT DISORD, V18, P1047, DOI 10.1002/mds.10476; Wu CC, 2010, J NEUROL NEUROSUR PS, V81, P659, DOI 10.1136/jnnp.2009.185637	40	9	9	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2014	21	12					2145	2149		10.1016/j.jocn.2014.03.032			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX0DF	WOS:000346622900017	25082409				2022-02-06	
J	Shang, JL; Cheng, Q; Yang, WF; Zhang, M; Cui, Y; Wang, YF				Shang, J. L.; Cheng, Q.; Yang, W. F.; Zhang, M.; Cui, Y.; Wang, Y. F.			Possible roles of COX-1 in learning and memory impairment induced by traumatic brain injury in mice	BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH			English	Article						Traumatic brain injury; COX-1; Learning and memory; SC560	INFLAMMATION; EXPRESSION; CYCLOOXYGENASE; ACCUMULATION; INHIBITION; DEFICITS; CELLS; MODEL; MOTOR; RATS	People who suffer from traumatic brain injury (TBI) often experience cognitive deficits in spatial reference and working memory. The possible roles of cyclooxygenase-1 (COX-1) in learning and memory impairment in mice with TBI are far from well known. Adult mice subjected to TBI were treated with the COX-1 selective inhibitor SC560. Performance in the open field and on the beam walk was then used to assess motor and behavioral function 1, 3, 7, 14, and 21 days following injury. Acquisition of spatial learning and memory retention was assessed using the Morris water maze on day 15 post-TBI. The expressions of COX-1, prostaglandin E2 (PGE2), interleukin (IL)-6, brain-derived neurotrophic factor (BDNF), platelet-derived growth factor BB (PDGF-BB), synapsin-I, and synaptophysin were detected in TBI mice. Administration of SC560 improved performance of beam walk tasks as well as spatial learning and memory after TBI. SC560 also reduced expressions of inflammatory markers IL-6 and PGE2, and reversed the expressions of COX-1, BDNF, PDGF-BB, synapsin-I, and synaptophysin in TBI mice. The present findings demonstrated that COX-1 might play an important role in cognitive deficits after TBI and that selective COX-1 inhibition should be further investigated as a potential therapeutic approach for TBI.	[Shang, J. L.; Zhang, M.; Cui, Y.; Wang, Y. F.] Changzhi Med Coll, Peace Hosp, Dept Neurol, Changzhi 046000, Peoples R China; [Cheng, Q.] Changzhi City Peoples Hosp, Dept Neurol, Changzhi, Peoples R China; [Yang, W. F.] Peoples Hosp Dali, Dept Neurol, Dali, Peoples R China		Wang, YF (corresponding author), Changzhi Med Coll, Peace Hosp, Dept Neurol, Changzhi 046000, Peoples R China.	ssf0221@163.com					Choi SH, 2013, J NEUROCHEM, V124, P59, DOI 10.1111/jnc.12059; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; GIERSE JK, 1995, BIOCHEM J, V305, P479, DOI 10.1042/bj3050479; Griffin EW, 2013, J NEUROSCI, V33, P15248, DOI 10.1523/JNEUROSCI.6361-11.2013; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Moore AH, 2005, INT J RADIAT ONCOL, V62, P267, DOI 10.1016/j.ijrobp.2005.01.035; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Schwab JM, 2001, J NEUROTRAUM, V18, P377, DOI 10.1089/089771501750170930; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Tropea D, 2003, J NEUROSCI, V23, P7034, DOI 10.1523/JNEUROSCI.23-18-07034.2003; Valente P, 2012, J NEUROSCI, V32, P5868, DOI 10.1523/JNEUROSCI.5275-11.2012; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Wang TTH, 2006, NEUROSCIENCE, V140, P1169, DOI 10.1016/j.neuroscience.2006.03.008; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075	18	9	9	2	9	ASSOC BRAS DIVULG CIENTIFICA	SAO PAULO	FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL	0100-879X	1678-4510		BRAZ J MED BIOL RES	Brazilian J. Med. Biol. Res.	DEC	2014	47	12					1050	1056		10.1590/1414-431X20143601			7	Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine	AT7YL	WOS:000345150500006	25387671	Green Published, gold			2022-02-06	
J	Swartz, EM; Holmes, GM				Swartz, E. M.; Holmes, G. M.			Gastric vagal motoneuron function is maintained following experimental spinal cord injury	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						DMV; gastroparesis; neurotrauma; TRH; vago-vagal reflexes	DORSAL MOTOR NUCLEUS; THYROTROPIN-RELEASING-HORMONE; NECROSIS-FACTOR-ALPHA; BRAIN-STEM CIRCUITS; VAGUS NERVE; AUTONOMIC DYSREFLEXIA; LEPTIN ACTION; NEURONS; RAT; TRH	BackgroundClinical reports indicate that spinal cord injury (SCI) initiates profound gastric dysfunction. Gastric reflexes involve stimulation of sensory vagal fibers, which engage brainstem circuits that modulate efferent output back to the stomach, thereby completing the vago-vagal reflex. Our recent studies in a rodent model of experimental high thoracic (T3-) SCI suggest that reduced vagal afferent sensitivity to gastrointestinal (GI) stimuli may be responsible for diminished gastric function. Nevertheless, derangements in efferent signals from the dorsal motor nucleus of the vagus (DMV) to the stomach may also account for reduced motility. MethodsWe assessed the anatomical, neurophysiological, and functional integrity of gastric-projecting DMV neurons in T3-SCI rats using: (i) retrograde labeling of gastric-projecting DMV neurons; (ii) whole cell recordings from gastric-projecting neurons of the DMV; and, (iii) in vivo measurements of gastric contractions following unilateral microinjection of thyrotropin-releasing hormone (TRH) into the DMV. Key ResultsImmunohistochemical analysis of gastric-projecting DMV neurons demonstrated no difference between control and T3-SCI rats. Whole cell in vitro recordings showed no alteration in DMV membrane properties and the neuronal morphology of these same, neurobiotin-labeled, DMV neurons were unchanged after T3-SCI with regard to cell size and dendritic arborization. Central microinjection of TRH induced a significant facilitation of gastric contractions in both control and T3-SCI rats and there were no significant dose-dependent differences between groups. Conclusions & InferencesOur data suggest that the acute, 3day to 1week post-SCI, dysfunction of vagally mediated gastric reflexes do not include derangements in the efferent DMV motoneurons.	[Swartz, E. M.; Holmes, G. M.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA		Holmes, GM (corresponding author), Penn State Coll Med, Dept Neural & Behav Sci, 500 Univ Dr,MC H109, Hershey, PA 17033 USA.	gmh16@psu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS 49177, NINDS 87834]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049177, F31NS087834] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants NINDS 49177 (G.M. Holmes) and NINDS 87834 (E.M. Swartz).	Adak A, 2014, Z GASTROENTEROL, V52, P180, DOI 10.1055/s-0033-1336007; Ammori JB, 2008, SURGERY, V144, P149, DOI 10.1016/j.surg.2008.03.042; Aydin MD, 2011, EXP NEUROL, V230, P90, DOI 10.1016/j.expneurol.2010.09.018; Babic T, 2014, EUR J PHARMACOL, V722, P38, DOI 10.1016/j.ejphar.2013.08.047; BLACKSHAW LA, 1987, J AUTONOM NERV SYST, V18, P19; Blevins JE, 2010, FORUM NUTR, V63, P133, DOI 10.1159/000264401; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Boeckxstaens G, 2013, Handb Clin Neurol, V117, P119, DOI 10.1016/B978-0-444-53491-0.00011-0; Bohm M, 2013, NUTR CLIN PRACT, V28, P289, DOI 10.1177/0884533613485882; Browning KN, 2013, J PHYSIOL-LONDON, V591, P1563, DOI 10.1113/jphysiol.2012.246827; Browning KN, 2010, NEUROGASTROENT MOTIL, V22, P1154, DOI 10.1111/j.1365-2982.2010.01592.x; Browning KN, 1999, J PHYSIOL-LONDON, V517, P521, DOI 10.1111/j.1469-7793.1999.0521t.x; Browning KN, 2001, J PHYSIOL-LONDON, V531, P425, DOI 10.1111/j.1469-7793.2001.0425i.x; Cailotto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087785; CHOU CC, 1983, FED PROC, V42, P1658; Cottrell GT, 2004, REGUL PEPTIDES, V117, P11, DOI 10.1016/j.regpep.2003.09.004; DEVIVO MJ, 1989, ARCH INTERN MED, V149, P1761, DOI 10.1001/archinte.149.8.1761; Emch GS, 2002, BRAIN RES, V951, P311, DOI 10.1016/S0006-8993(02)03178-5; Fynne L, 2012, ACTA NEUROL SCAND, V125, P123, DOI 10.1111/j.1600-0404.2011.01508.x; Gamboa-Esteves FO, 2001, BRAIN RES, V921, P195, DOI 10.1016/S0006-8993(01)03118-3; GARRICK T, 1987, LIFE SCI, V40, P649, DOI 10.1016/0024-3205(87)90266-9; Gourcerol G, 2011, PEPTIDES, V32, P737, DOI 10.1016/j.peptides.2011.01.007; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; GROSS PM, 1990, AM J PHYSIOL, V259, pR1131, DOI 10.1152/ajpregu.1990.259.6.R1131; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; HERMANN G, 1995, NEUROIMMUNOMODULAT, V2, P74, DOI 10.1159/000096874; Hermann GE, 1999, AM J PHYSIOL-REG I, V276, pR59, DOI 10.1152/ajpregu.1999.276.1.R59; Hermann GE, 2002, AM J PHYSIOL-GASTR L, V283, pG634, DOI 10.1152/ajpgi.00412.2001; Hitzig SL, 2011, SPINAL CORD, V49, P684, DOI 10.1038/sc.2010.178; Holmes GM, 2014, JOVE-J VIS EXP, V31, P1563; Holmes GM, 2012, FRONT PHYSIOL, V3, P1; HORNBY PJ, 1989, AM J PHYSIOL, V257, pG454, DOI 10.1152/ajpgi.1989.257.3.G454; IGGO A, 1955, J PHYSIOL-LONDON, V128, P593, DOI 10.1113/jphysiol.1955.sp005327; Inskip JA, 2009, SPINAL CORD, V47, P2, DOI 10.1038/sc.2008.61; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; Kirshblum SC, 2002, ARCH PHYS MED REHAB, V83, pS50, DOI 10.1053/apmr.2002.32156; Krassioukov A, 2009, RESP PHYSIOL NEUROBI, V169, P157, DOI 10.1016/j.resp.2009.08.003; KROWICKI ZK, 1994, AM J PHYSIOL, V266, pG870, DOI 10.1152/ajpgi.1994.266.5.G870; Leal PRL, 2008, AUTON NEUROSCI-BASIC, V141, P66, DOI 10.1016/j.autneu.2008.05.006; Liu JW, 2004, SPINE, V29, P164, DOI 10.1097/01.BRS.0000107234.74249.CD; Lu CL, 1998, AM J GASTROENTEROL, V93, P2391, DOI 10.1016/S0002-9270(98)00574-7; Luo H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046291; MCCANN MJ, 1989, J AUTONOM NERV SYST, V26, P107, DOI 10.1016/0165-1838(89)90158-6; MCTIGUE DM, 1992, NEUROSCI LETT, V144, P61, DOI 10.1016/0304-3940(92)90716-K; MENETREY D, 1987, J COMP NEUROL, V255, P439, DOI 10.1002/cne.902550310; MILLER LS, 1975, ARCH PHYS MED REHAB, V56, P405; Morton GJ, 2005, J CLIN INVEST, V115, P703, DOI 10.1172/JCI200522081; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; Pan W., 2004, BLOOD SPINAL CORD BR, P395; Pan WH, 2000, EXP NEUROL, V170, P357, DOI 10.1006/exnr.2001.7702; Park MI, 2006, AM J GASTROENTEROL, V101, P1129, DOI 10.1111/j.1572-0241.2006.00640.x; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Phillips RJ, 2007, AUTON NEUROSCI-BASIC, V136, P1, DOI 10.1016/j.autneu.2007.04.005; Phillips RJ, 2010, AUTON NEUROSCI-BASIC, V153, P90, DOI 10.1016/j.autneu.2009.07.009; Price CJ, 2008, NEUROSCIENTIST, V14, P182, DOI 10.1177/1073858407311100; Primeaux SD, 2007, AM J PHYSIOL-REG I, V293, pR1102, DOI 10.1152/ajpregu.00224.2007; Qualls-Creekmore E, 2010, NEUROGASTROENT MOTIL, V22, P62, DOI 10.1111/j.1365-2982.2009.01347.x; RAYBOULD HE, 1992, NEUROANATOMY PHYSL A, P193; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Rogers RC, 1996, NEUROSCI BIOBEHAV R, V20, P57, DOI 10.1016/0149-7634(95)00040-L; STONE JM, 1990, AM J GASTROENTEROL, V85, P1114; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Swartz EM, 2014, NEUROGASTROENT MOTIL, V125, P2; Swartz EM, 2013, J NEUROTRAUM, V30, pA11; Tache Y, 2006, AUTON NEUROSCI-BASIC, V125, P42, DOI 10.1016/j.autneu.2006.01.014; TAY SSW, 1994, ACTA ANAT, V150, P274; The FO, 2011, BRIT J PHARMACOL, V163, P1007, DOI 10.1111/j.1476-5381.2011.01296.x; Tong M, 2011, NEUROGASTROENT MOTIL, V23, pe69, DOI 10.1111/j.1365-2982.2010.01616.x; Tong M, 2009, NEUROGASTROENT MOTIL, V21, P197, DOI 10.1111/j.1365-2982.2008.01215.x; TRAVAGLI RA, 1992, AM J PHYSIOL, V263, pG508, DOI 10.1152/ajpgi.1992.263.4.G508; TRAVAGLI RA, 1991, AM J PHYSIOL, V260, pG531, DOI 10.1152/ajpgi.1991.260.3.G531; Tsuchiya Y, 2012, DIGEST DIS SCI, V57, P2555, DOI 10.1007/s10620-012-2210-8; Weaver LC, 2006, PROG BRAIN RES, V152, P245, DOI 10.1016/S0079-6123(05)52016-8; Wolf C, 2003, SPINAL CORD, V41, P347, DOI 10.1038/sj.sc.3101440; Wu X, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01641.x; Yan BB, 2009, EXP NEUROL, V220, P34, DOI 10.1016/j.expneurol.2009.07.006; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Zhang JH, 2010, NEUROBIOL DIS, V40, P251, DOI 10.1016/j.nbd.2010.05.032	78	9	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	DEC	2014	26	12					1717	1729		10.1111/nmo.12452			13	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Neurosciences & Neurology	AU6BR	WOS:000345688100006	25316513	Green Accepted			2022-02-06	
J	Ross, DE; Ochs, AL; Zannoni, MD; Seabaugh, JM				Ross, David E.; Ochs, Alfred L.; Zannoni, Megan D.; Seabaugh, Jan M.		Alzheimers Dis Neuroimaging Initia	Back to the future: Estimating pre-injury brain volume in patients with traumatic brain injury	NEUROIMAGE			English	Article						Traumatic brain injury; Mild traumatic brain injury; Magnetic resonance imaging; Volumetry; Cortical atrophy; Longitudinal study; Medicolegal; Forensic; NeuroQuant (R)	NEUROIMAGING INITIATIVE ADNI; QUANTITATIVE-ANALYSIS; MILD; ATROPHY; MRI; PERFORMANCE	Introduction: A recent meta-analysis by Hedman et al. allows for accurate estimation of brain volume changes throughout the life span. Additionally, Tate et al. showed that intracranial volume at a later point in life can be used to estimate reliably brain volume at an earlier point in life. These advancements were combined to create a model which allowed the estimation of brain volume just prior to injury in a group of patients with mild or moderate traumatic brain injury (TBI). This volume estimation model was used in combination with actual measurements of brain volume to test hypotheses about progressive brain volume changes in the patients. Methods: Twenty six patients with mild or moderate TBI were compared to 20 normal control subjects. NeuroQuant (R) was used to measure brain MRI volume. Brain volume after the injury (from MRI scans performed at t1 and t2) was compared to brain volume just before the injury (volume estimation at t0) using longitudinal designs. Groups were compared with respect to volume changes in whole brain parenchyma (WBP) and its 3 major subdivisions: cortical gray matter (GM), cerebral white matter (CWM) and subcortical nuclei + infratentorial regions (SCN + IFT). Results: Using the normal control data, the volume estimation model was tested by comparing measured brain volume to estimated brain volume; reliability ranged from good to excellent. During the initial phase after injury (t0-t1), the TBI patients had abnormally rapid atrophy of WBP and CWM, and abnormally rapid enlargement of SCN + IFT. Rates of volume change during t0-t1 correlated with cross-sectional measures of volume change at t1, supporting the internal reliability of the volume estimation model. A logistic regression analysis using the volume change data produced a function which perfectly predicted group membership (TBI patients vs. normal control subjects). Conclusions: During the first few months after injury, patients with mild or moderate TBI have rapid atrophy of WBP and CWM, and rapid enlargement of SCN + IFT. The magnitude and pattern of the changes in volume may allow for the eventual development of diagnostic tools based on the volume estimation approach. (c) 2014 Elsevier Inc. All rights reserved.	[Ross, David E.; Ochs, Alfred L.; Zannoni, Megan D.; Seabaugh, Jan M.] Virginia Inst Neuropsychiat, Midlothian, VA 23114 USA; [Ross, David E.; Ochs, Alfred L.] Virginia Commonwealth Univ, Richmond, VA USA		Ross, DE (corresponding author), Virginia Inst Neuropsychiat, 364 Browns Hill Court, Midlothian, VA 23114 USA.	DRoss@VaNeuropsychiatry.org		Ochs, Alfred/0000-0003-3932-876X			Bigler E.D., 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; Bigler E.D., 2011, TXB TRAUMATIC BRAIN, P73, DOI DOI 10.1177/1753193410381840; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Brewer JB, 2009, BEHAV NEUROL, V21, P21, DOI [10.1155/2009/616581, 10.3233/BEN-2009-0226]; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; Hedman AM, 2012, HUM BRAIN MAPP, V33, P1987, DOI 10.1002/hbm.21334; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Huppertz HJ, 2010, NEUROIMAGE, V49, P2216, DOI 10.1016/j.neuroimage.2009.10.066; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kovacevic S, 2009, ALZ DIS ASSOC DIS, V23, P139, DOI 10.1097/WAD.0b013e318192e745; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Ross D.E., 2012, PSYCHOL INJURY LAW, V5, P1; Ross DE, 2013, BRAIN INJURY, V27, P634, DOI 10.3109/02699052.2013.767939; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2012, J NEUROPSYCH CLIN N, V24, pE33, DOI 10.1176/appi.neuropsych.11020044; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Talairach J., 1988, COPLANAR STEREOTAXIC; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	25	9	9	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	NOV 15	2014	102		2				565	578		10.1016/j.neuroimage.2014.07.043			14	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AU1PD	WOS:000345391700031	25109528				2022-02-06	
J	Bonilla, C; Zurita, M; Aguayo, C; Rodriguez, A; Vaquero, J				Bonilla, Celia; Zurita, Mercedes; Aguayo, Concepcion; Rodriguez, Alicia; Vaquero, Jesus			Is the subarachnoid administration of mesenchymal stromal cells a useful strategy to treat chronic brain damage?	CYTOTHERAPY			English	Article						cell engraftment; mesenchymal stromal cells; subarachnoid administration; traumatic brain injury	SPINAL-CORD-INJURY; NEURAL STEM-CELLS; NEUROLOGICAL DISEASES; LUMBAR PUNCTURE; INTRATHECAL TRANSPLANTATION; MARROW; THERAPY; STROKE; RATS; MODEL	Background aims. Traumatic brain injury (TBI) is a leading cause of mortality and morbidity worldwide. Developing effective protocols for the administration of mesenchymal stromal cells (MSCs) is a promising therapeutic strategy to treat TBI. It is important to develop alternatives to direct parenchymal injection at the injury site because direct injection is an expensive and invasive technique. Subarachnoid transplantation, a minimally invasive and low-risk procedure, may be an important and clinically applicable strategy. The aim of this study was to test the therapeutic effect of subarachnoid administration of MSCs on functional outcome 2 months after an experimental TBI in rats. Methods. Two months after TBI, 30 female Wistar rats were divided into 3 groups (n = 10 in each group): sham, MSC (received 2 x 106 MSCs) and saline (received only saline) groups. Neurological function, brain and spinal cords samples and cerebrospinal fluid were studied. Results. No significant differences were found in neurological evaluation and after histological analysis; differences in the expression of neurotrophins were present but were not statistically significant. MSCs survived in the host tissue, and some expressed neural markers. Conclusions. Similar to direct parenchymal injections, transplanted MSCs survive, migrate to the injury cavity and differentiate into mature neural cell types for at least 6 months after engraftment. These results open the possibility that MSC administration through subarachnoid administration may be a treatment for the consequences of TBI. The transplantation technique and cell number should be adjusted to obtain functional outcome and neurotrophin production differences.	[Bonilla, Celia; Zurita, Mercedes; Aguayo, Concepcion; Rodriguez, Alicia; Vaquero, Jesus] Puerta de Hierro Hosp, Neurosci Res Unit, Madrid, Spain; [Vaquero, Jesus] Puerta de Hierro Hosp, Neurosurg Serv, Madrid, Spain		Bonilla, C (corresponding author), Hosp Puerta de Hierro Majadahonda, Unidad Invest Neurociencias, Joaquin Rodrigo 2, Madrid 28222, Spain.	cbonilla@idiphim.org			Rafael del Pino Foundation; Ramon Areces Foundation; al and Carlos III Institute [FIS 04/1281, FIS 07/0621, FIS PS09/01105]	This work was supported by grants from Rafael del Pino Foundation, Ramon Areces Foundation, al and Carlos III Institute (FIS 04/1281, FIS 07/0621, FIS PS09/01105).	Baek W, 2012, J NEUROSURG SCI, V56, P261; Bakshi A, 2006, J NEUROTRAUM, V23, P55, DOI 10.1089/neu.2006.23.55; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bonilla C, 2012, J TRAUMA ACUTE CARE, V72, P1203, DOI 10.1097/TA.0b013e318248bdcf; Bonilla C, 2012, J NEUROTRAUM, V29, P394, DOI 10.1089/neu.2011.2101; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Farin A, 2009, NEUROSURGERY, V65, P831, DOI 10.1227/01.NEU.0000351721.81175.0B; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Guest J, 2011, BRAIN RES BULL, V84, P267, DOI 10.1016/j.brainresbull.2010.11.007; Hernandez J, 2011, CURR STEM CELL RES T, V6, P273, DOI 10.2174/157488811796575323; Kim JW, 2013, SPINE, V38, pE1065, DOI 10.1097/BRS.0b013e31829839fa; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lepore AC, 2005, BRAIN RES, V1045, P206, DOI 10.1016/j.brainres.2005.03.050; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lim JY, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt79; Liu WP, 2008, NEUROSCI LETT, V434, P160, DOI 10.1016/j.neulet.2007.12.067; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Momin EN, 2010, CURR STEM CELL RES T, V5, P326; Neuhuber B, 2008, J NEUROSURG-SPINE, V9, P390, DOI 10.3171/SPI.2008.9.10.390; Opydo-Chanek M, 2011, NEUROSCI LETT, V487, P163, DOI 10.1016/j.neulet.2010.10.014; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Shyu WC, 2006, FRONT BIOSCI-LANDMRK, V11, P899, DOI 10.2741/1846; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu Q, 2013, ANN CLIN LAB SCI, V43, P154; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Yu FG, 2011, CURR STEM CELL RES T, V6, P190, DOI 10.2174/157488811796575341	39	9	9	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	NOV	2014	16	11					1501	1510		10.1016/j.jcyt.2014.07.007			10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	AR1PC	WOS:000343356100006	25287600				2022-02-06	
J	Coulter, ID				Coulter, Ian D.			The Response of an Expert Panel to Nutritional Armor for the Warfighter: Can Omega-3 Fatty Acids Enhance Stress Resilience, Wellness, and Military Performance?	MILITARY MEDICINE			English	Article								Background: Recommendations of an Expert Panel on 5 central questions addressed during the workshop. Methods: The Panel reviewed available scientific literature, workshop presentations, and comments from workshop guests. Results: The Panel unanimously agreed that a military Daily Recommended Intake for long-chain omega-3 fatty acids (FAs) should be established within the context of lowering current intakes of omega-6 FAs. The Panelists also felt that there was sufficient evidence to support increasing omega-3 intake to receive cardiovascular, immunological, and surgical benefits. In addition, research indicates that preloading with omega-3 FAs before combat exposure may be beneficial. Evidence for reduction of depressive symptoms and suicide prevention was felt to be strong. Insufficient data were available to evaluate post-traumatic stress disorder and impulsive aggression. Benefits for traumatic brain injury were promising. Adverse side effects were deemed negligible. Conclusion: The Panel concluded that based on studies analyzing omega-3 and omega-6 FA balance, it would be unethical to not attempt elevating the omega-3 status among U.S. military personnel.	RAND Corp, RAND Samueli Chair Integrat Med, Santa Monica, CA 90401 USA		Coulter, ID (corresponding author), RAND Corp, RAND Samueli Chair Integrat Med, 1776 Main St, Santa Monica, CA 90401 USA.						COULTER I, 1995, HEALTH SERV RES, V30, P577; Coulter ID, 1992, AM CHIRO ASS J C DEC, V23, P52; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Hibbeln JR, 2009, PROSTAG LEUKOTR ESS, V81, P179, DOI 10.1016/j.plefa.2009.06.005; Leape L L, 1992, Qual Assur Health Care, V4, P151; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607	6	9	9	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2014	179	11		S			192	198		10.7205/MILMED-D-14-00189			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7LS	WOS:000349099400021	25373106	Bronze			2022-02-06	
J	Gunduz, RC; Sahin, S; Uysal-Yazici, M; Ayar, G; Yakut, HI; Akman, AO; Hirfanoglu, IM; Kalkan, G				Gunduz, Ramiz Coskun; Sahin, Sanliay; Uysal-Yazici, Mutlu; Ayar, Ganime; Yakut, Halil Ibrahim; Akman, Alkim Oden; Hirfanoglu, Ibrahim Murat; Kalkan, Gokhan			Brain death and organ donation of children	TURKISH JOURNAL OF PEDIATRICS			English	Article						brain death; children; organ donation; pediatric intensive care unit	DIAGNOSIS; INFANTS	We aimed to define the demographic characteristics, clinical features and outcome of patients with brain death, and to emphasize the importance of organ donation from children. Data for the period from September 2009 to October 2012 were collected retrospectively. Twenty children who were diagnosed as brain death were included. Data including demographics, major cause leading to brain death, duration of brain death evaluation, ancillary tests used to confirm brain death, complications and outcome, duration of hospitalization and organ donation were collected for statistical evaluation. The mean age was 6.2 years, and the male/female ratio 1.85. The major cause leading to brain death was most often traumatic brain injury, seen in 11 patients (55%). The mean duration of brain death evaluation was 6.7 and 1.7 days in Centers I and II respectively. The mean duration of hospitalization was 12.5 days. Electroencephalography (EEG) was used in 18 patients (90%). Complications included hyperglycemia in 13 cases and diabetes incipitus in 7 cases (65% and 35%, respectively). Mean duration of survival was 9.8 days. In Center I, one of the patients' parents gave consent to organ donation, while four parents in Center II agreed to organ donation. The study demonstrated that the duration of brain death evaluation was longer in Center I than in Center II (p<0.05). When both centers were compared, there was no significant difference in regard to obtaining consent for organ donation, survival after diagnosis of brain death and length of stay in the PICU (p>0.05). Early diagnosis of brain death and prompt evaluation of patients by ICU physicians once the diagnosis is taken into consideration will probably yield better organs and reduce costs. Training PICU physicians, nurses and organ donation coordinators, and increasing children's awareness of the need for organ donation via means of public communication may increase families' rate of agreement to organ donation in the future.	[Gunduz, Ramiz Coskun; Sahin, Sanliay; Ayar, Ganime; Yakut, Halil Ibrahim; Akman, Alkim Oden] Ankara Childrens Hematol Oncol Training & Res Hos, Pediat Intens Care Unit, Ankara, Turkey; [Uysal-Yazici, Mutlu] Hacettepe Univ, Ihsan Dogramaci Childrens Hosp, Dept Pediat Intens Care, Ankara, Turkey; [Hirfanoglu, Ibrahim Murat] Gazi Univ, Fac Med, Dept Neonatol, Ankara, Turkey; [Kalkan, Gokhan] Gazi Univ, Fac Med, Pediat Intens Care Unit, Ankara, Turkey		Gunduz, RC (corresponding author), Ankara Childrens Hematol Oncol Training & Res Hos, Pediat Intens Care Unit, Ankara, Turkey.	coskungunduz@gmail.com	Sahin, Sanliay/O-1284-2018; /M-8395-2019; Akman, A/AAF-4283-2021	Sahin, Sanliay/0000-0001-8418-1889; /0000-0001-6946-4995; 			[Anonymous], 1997, Epidemiol Bull, V18, P1; [Anonymous], 2000, TC ORG DOK NAKL HIZM; Ashwal S, 2006, CRIT CARE NURSE, V26, P117; Au AK, 2011, PEDIATR CRIT CARE ME, V12, P566, DOI 10.1097/PCC.0b013e3181fe3420; Banasiak KJ, 2003, CURR OPIN PEDIATR, V15, P288, DOI 10.1097/00008480-200306000-00011; Baxter R C, 1996, J Pediatr Nurs, V11, P136, DOI 10.1016/S0882-5963(96)80076-5; Bayrakci B., 2004, YOGUN BAKIM DERGISI, V4, P186; Brierley J, 2011, ACTA PAEDIATR, V100, P1175, DOI 10.1111/j.1651-2227.2011.02380.x; Joffe AR, 2013, PEDIATR CRIT CARE ME, V14, P1, DOI 10.1097/PCC.0b013e31825b5485; Kerridge IH, 2002, J MED ETHICS, V28, P89, DOI 10.1136/jme.28.2.89; Kim HB, 2013, PEDIATRICS, V131, pE1946, DOI 10.1542/peds.2013-1005; McQuay J E, 1995, Crit Care Nurs Clin North Am, V7, P581; Ministry of Health, BRAIN DEATH STAT TUR; Mori K, 2000, ANESTHESIOLOGY, P2560; Nakagawa TA, 2012, ANN NEUROL, V71, P573, DOI 10.1002/ana.23552; Neff JM, 2002, PEDIATRICS, V109, P982; Rios A, 2010, TRANSPL P, V42, P3113, DOI 10.1016/j.transproceed.2010.05.069; Rodriguez Rosendo A., 2002, Pediatr Crit Care Med, V3, P153, DOI 10.1097/00130478-200204000-00012; Ruiz-Garcia M, 2000, CHILD NERV SYST, V16, P40, DOI 10.1007/s003810050010; Schindler N, 2008, ANASTH INTENSIV NOTF, V43, P552, DOI 10.1055/s-0028-1083099; Shemie SD, 2007, LANCET NEUROL, V6, P87, DOI 10.1016/S1474-4422(06)70680-9; Stevens RD, 2008, NEUROL CLIN, V26, P469, DOI 10.1016/j.ncl.2008.02.004; Teitelbaum J, 2011, NEUROL CLIN, V29, P787, DOI 10.1016/j.ncl.2011.08.003; Tsai E, 2000, Pediatr Crit Care Med, V1, P156, DOI 10.1097/00130478-200010000-00012; Tsai Wen-Hsin, 2005, Acta Paediatrica Taiwanica, V46, P132	25	9	10	0	8	TURKISH J PEDIATRICS	ANKARA	P K 66 SAMANPAZARI, 06240 ANKARA, TURKEY	0041-4301			TURKISH J PEDIATR	Turk. J. Pediatr.	NOV-DEC	2014	56	6					597	603					7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CW9XY	WOS:000365352700004	26388589				2022-02-06	
J	Li, BC; Li, Y; Xu, C; Wang, JM; Chen, ZQ; Li, GH; Zhang, JY; Hu, SL; Wang, L; Feng, H				Li, Bing Cang; Li, Yue; Xu, Chuan; Wang, Jianmin; Chen, Zhiqiang; Li, Guanhua; Zhang, Jieyuan; Hu, Shenli; Wang, Long; Feng, Hua			Blast-induced traumatic brain injury of goats in confined space	NEUROLOGICAL RESEARCH			English	Article						Traumatic brain injury; Shock wave; Explosive blast; Confined space	MODEL	Objective: To study blast-induced traumatic brain injury (bTBI) characteristics in confined space. Methods: The goats were placed at the column-like buildings with trinitrotoluene (TNT) as the source of the blast wave. The pressure was recorded at 2-8 m from the explosion center. The systemic physiology, electroencephalogram (EEG), serum level of S-100beta, and neuron specific enolase (NSE) were determined pre and post the exposure. Neuroanatomy and neuropathology were observed 4 hours after the exposure. Results: The blast waveform was composed of two peaks from the incident and reflection wave with a range of pressure-duration from 555/913 kPa-0.663 milliseconds at 2 m to 45/71 kPa-2.7/2.367 milliseconds at 8 m. At 2 m, the goats experienced brain depression while the heart rate and respiratory rate concomitantly increased with bloody foam fluid emission from the nose and the mouth. Of the goats, 88.89% were burned. The distinctive gross neuroanatomical changes were congestive expansion of surface vessels on the hemisphere cerebellum and brainstem along with subarachnoid hemorrhage on the frontal lobe, mesencephalon, and brainstem. Subarachnoid hemorrhage, enlarged perivascular space, vascular dilatation and congestion, and parenchymal hemorrhagic could be easily observed microscopically. High amplitude and low frequency of waveforms appeared in the EEG. The serum concentration of S-100beta and NSE were elevated. Although these pathophysiological changes diminished with increasing distance from the explosive center, these changes existed for the 8 m subjects. Conclusions: Blast-induced traumatic brain injury can be induced by a complex blast wave with a pressure and duration of 45/71 kPa and 2.7/2.367 milliseconds. Its severity is related to the features and waveforms of the blast.	[Li, Bing Cang; Xu, Chuan; Wang, Jianmin; Chen, Zhiqiang; Li, Guanhua; Zhang, Jieyuan] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Chongqing 400042, Peoples R China; [Li, Bing Cang; Xu, Chuan; Wang, Jianmin; Chen, Zhiqiang; Li, Guanhua; Zhang, Jieyuan] State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Li, Yue] PLA, Hosp 451, Xian, Shanxi, Peoples R China; [Hu, Shenli; Wang, Long; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400042, Peoples R China		Li, BC (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China.	bcli1118@yahoo.com	Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217	State Key Laboratory of Trauma, Burn and Combined Injury [SKLZZ201003]; Special Funds for Major State Basic Research Project, China [2012CB518106]	The Funds of the State Key Laboratory of Trauma, Burn and Combined Injury (SKLZZ201003). Special Funds for Major State Basic Research Project, China (2012CB518106).	Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Garner JP, 2009, WORLD J SURG, V33, P2194, DOI 10.1007/s00268-009-0105-4; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Sook-Kyung CK, 2011, FRONT NEUROL, V2, P1; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Toth Z, 1997, J NEUROSCI, V17, P8106; Yarnell Angela M, 2013, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0941s62	19	9	12	2	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	NOV	2014	36	11					974	982		10.1179/1743132813Y.0000000314			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AQ0WU	WOS:000342504200007	24730755				2022-02-06	
J	Pandya, U; Polite, N; Wood, T; Lieber, M				Pandya, Urmil; Polite, Nathan; Wood, Teresa; Lieber, Michael			Increased Total Serum Random Cortisol Levels Predict Mortality in Critically Ill Trauma Patients	AMERICAN SURGEON			English	Article							RELATIVE ADRENAL INSUFFICIENCY; SEPTIC SHOCK; HEMORRHAGIC-SHOCK; SEVERE SEPSIS; CORTICOSTEROID INSUFFICIENCY; ADRENOCORTICAL FUNCTION; CRITICAL ILLNESS; CORTICOTROPIN; HYDROCORTISONE; POPULATION	Dysfunction in the hypothalamopituitary adrenal axis is thought to exist; however, there continues to be controversy about what level of serum cortisol corresponds to adrenal insufficiency. Few studies have focused on the significance of serum random cortisol in the critically ill trauma patient. Trauma patients with total serum random cortisol levels drawn in the intensive care unit within the first seven days of hospitalization were retrospectively reviewed. The primary outcome measured was in-hospital mortality. Two hundred forty-two patients were analyzed. Non-survivors had significantly higher mean cortisol levels than survivors (28.7 +/- 15.80 mu g/dL vs 22.9 +/- 12.35 mu g/dL, P = 0.01). Patients with cortisol 30 mu g/dL or greater were more likely to die with odds ratio of 2.7 (95% confidence interval [CI], 1.5 to 5). The odds ratio increased to 4.0 and 3.8 (95% CI, 1.4 to 11.4 and 1.3 to 10.9) when cortisol was drawn on hospital Day 2 and Days 3 through 7, respectively. Among nonsurvivors, patients with an injury severity score less than 25 had significantly higher cortisol levels than patients with an Injury Severity Score 25 or higher (35.3 +/- 19.21 mu g/dL vs 25.7 +/- 13.21 mu g/dL, P = 0.009). Patients with massive transfusion, traumatic brain injury, spinal cord injury, or solid organ injury did not have significantly different cortisol levels. The covariate-adjusted area under the receiver operating characteristic curve indicated that cortisol level has a 77 per cent accuracy in differentiating survivors from nonsurvivors. Higher cortisol levels were predictive of mortality in critically ill trauma patients. Whether serum cortisol level is a marker that can be modified remains an area of interest for future study.	[Pandya, Urmil; Polite, Nathan; Wood, Teresa; Lieber, Michael] Grant Med Ctr, Trauma Serv, Columbus, OH 43215 USA		Pandya, U (corresponding author), Grant Med Ctr, Trauma Serv, 111 South Grant Ave, Columbus, OH 43215 USA.	Upandya2@ohiohealth.com					Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2006, AM J RESP CRIT CARE, V174, P1319, DOI 10.1164/rccm.200509-1369OC; Aygen B, 1997, EXP CLIN ENDOCR DIAB, V105, P182, DOI 10.1055/s-0029-1211749; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Bollaert PE, 2003, SHOCK, V19, P13, DOI 10.1097/00024382-200301000-00003; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; BOUACHOUR G, 1995, INTENS CARE MED, V21, P57, DOI 10.1007/BF02425155; Cohen J, 2010, ANAESTH INTENS CARE, V38, P425, DOI 10.1177/0310057X1003800304; Cotton BA, 2008, ARCH SURG-CHICAGO, V143, P62, DOI 10.1001/archsurg.143.1.62; de Jong MFC, 2007, CRIT CARE MED, V35, P1896, DOI 10.1097/01.CCM.0000275387.51629.ED; de Jong MFC, 2007, CLIN ENDOCRINOL, V66, P732, DOI 10.1111/j.1365-2265.2007.02814.x; DRUCKER D, 1985, CRIT CARE MED, V13, P477, DOI 10.1097/00003246-198506000-00007; FINLAY WEI, 1982, LANCET, V1, P1414; Gannon TA, 2006, AM SURGEON, V72, P373; Guillamondegui OD, 2009, AM SURGEON, V75, P287; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Hoyt D, 2002, AM J SURG, V184, P653; JAREK MJ, 1993, CRIT CARE MED, V21, P543, DOI 10.1097/00003246-199304000-00015; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Offner PJ, 2002, AM J SURG, V184, P649, DOI 10.1016/S0002-9610(02)01101-7; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; Rushing GD, 2006, AM SURGEON, V72, P552; Sam S, 2004, CLIN ENDOCRINOL, V60, P29, DOI 10.1111/j.1365-2265.2004.01923.x; SCHEIN RMH, 1990, CRIT CARE MED, V18, P259, DOI 10.1097/00003246-199003000-00002; Schroeder S, 2001, CRIT CARE MED, V29, P310, DOI 10.1097/00003246-200102000-00017; SIBBALD WJ, 1977, ANN SURG, V186, P29, DOI 10.1097/00000658-197707000-00005; SPAN LFR, 1992, INTENS CARE MED, V18, P93, DOI 10.1007/BF01705039; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Stein DM, 2013, J TRAUMA ACUTE CARE, V74, P363, DOI 10.1097/TA.0b013e31827e2aaf; Walker ML, 2011, AM SURGEON, V77, P579; Wang P, 1999, ARCH SURG-CHICAGO, V134, P394, DOI 10.1001/archsurg.134.4.394	33	9	10	0	4	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	NOV	2014	80	11					1112	1118					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AW2TQ	WOS:000346142300026	25347501				2022-02-06	
J	Batailler, P; Hours, M; Maza, M; Charnay, P; Tardy, H; Tournier, C; Javouhey, E				Batailler, Pierre; Hours, Martine; Maza, Maud; Charnay, Pierrette; Tardy, Helene; Tournier, Charlene; Javouhey, Etienne			Health status recovery at one year in children injured in a road accident: A cohort study	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Cohort study; One year follow-up; Child; Road traffic accident; Injury; Recovery of function	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; QUESTIONNAIRE; CONSEQUENCES; ADOLESCENTS; POPULATION; BURDEN; COSTS	Despite the frequency of traumatic injuries due to road accidents and potential importance of identifying children at risk of impaired recovery one year after a road accident, there is a lack of data on long-term recovery of health status, except in children with severe traumatic brain injury. The aim of the present study was to evaluate predictive factors of recovery in children one year after road traffic injuries. The prospective cohort study was composed of children aged <16 years, admitted to public or private sector hospitals in the Rhone administrative area of France following a road accident. Recovery of health status one year after the accident and information concerning quality of life and the consequences of the accident for the child or family 1 year after the accident were collected by questionnaire, usually completed by the parents. Victims were in majority male (64.6%) and had mild or moderate injuries (81.9% with Maximum Abbreviated Injury Scale (M-AIS) <3). One year after the accident, 75.0% of the mild-to-moderate and 34.8% of the severe cases estimated health status as fully recovered. After adjustment, severity score (M-AIS >= 3) and lower limb injury (AIS > 1) were associated with incomplete recovery of health status: weighted odds ratio (ORw), 4.3 [95% confidence interval (95% CI), 1.3-14.6] and ORw 6.5 [95% Cl, 1.9-21.71, respectively. Recovery status correlated significantly with quality of life physical scores (r=0.46), especially body pain (r=0.48) and role/social-physical (r=0.50) and, to a lesser extent, quality of life psychosocial scores (r=0.21). In a cohort of children injured in a road accident, those with high injury severity score and those with lower limb injuries are less likely to recover full health status by 1 year. Impaired health status was associated with a lower physical quality of life score at 1 year. (C) 2014 Published by Elsevier Ltd.	[Batailler, Pierre; Hours, Martine; Maza, Maud; Charnay, Pierrette; Tardy, Helene; Tournier, Charlene; Javouhey, Etienne] Univ Lyon, Epidemiol Res & Surveillance Unit Transport Occup, F-69622 Lyon, France; [Batailler, Pierre; Hours, Martine; Maza, Maud; Charnay, Pierrette; Tardy, Helene; Tournier, Charlene; Javouhey, Etienne] Univ Lyon 1, UMRESTTE, F-69373 Lyon, France; [Batailler, Pierre; Hours, Martine; Maza, Maud; Charnay, Pierrette; Tardy, Helene; Tournier, Charlene; Javouhey, Etienne] IFSTTAR, UMRESTTE, F-69675 Bron, France; [Javouhey, Etienne] Hop Femme Mere Enfant, Hosp Civils Lyon, Pediat Intens Care Unit, F-69677 Bron, France		Javouhey, E (corresponding author), Hop Femme Mere Enfant, Hosp Civils Lyon, Pediat Emergency & Intens Care Unit, 59 Blvd Pinel, F-69677 Bron, France.	etienne.javouhey@chu-lyon.fr	Javouhey, Etienne/G-3651-2013; TARDY, HELENE/AAE-6287-2019	TARDY, HELENE/0000-0001-8351-9825			Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Aitken ME, 2002, PEDIATRICS, V110, P337, DOI 10.1542/peds.110.2.337; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Barnes Jo, 2006, Annu Proc Assoc Adv Automot Med, V50, P253; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Charnay P., 2002, REGISTRE VICTIMES AC; Ding R, 2006, J PEDIATR ORTHOPED, V26, P157, DOI 10.1097/01.bpo.0000218521.98244.7e; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Gofin R, 1999, J TRAUMA, V47, P15, DOI 10.1097/00005373-199907000-00004; Haukeland JV, 1996, ACCIDENT ANAL PREV, V28, P63, DOI 10.1016/0001-4575(95)00045-3; Health Act CHQ, 2008, CHQ SCOR INT MAN; Nhac-Vu HT, 2011, J REHABIL MED, V43, P776, DOI 10.2340/16501977-0854; Hours M, 2010, ACCIDENT ANAL PREV, V42, P412, DOI 10.1016/j.aap.2009.09.002; Javouhey E., 2012, URGENCES 2012, P1; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Pander S., 2005, PEDIATRICS, V116, pe810; Peden M., 2008, WORLD REPORT CHILD I; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Sturms LM, 2003, ARCH PHYS MED REHAB, V84, P431, DOI 10.1053/apmr.2003.50015; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Waters EB, 2001, J ADOLESCENT HEALTH, V29, P140, DOI 10.1016/S1054-139X(01)00211-7; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015	27	9	10	0	18	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	OCT	2014	71						267	272		10.1016/j.aap.2014.06.001			6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	AN0WF	WOS:000340304000030	24956131	Green Submitted			2022-02-06	
J	Grabenstatter, HL; Carlsen, J; Raol, YH; Yang, T; Hund, D; Del Angel, YC; White, AM; Gonzalez, MI; Longo, FM; Russek, SJ; Brooks-Kayal, AR				Grabenstatter, H. L.; Carlsen, J.; Raol, Y. H.; Yang, T.; Hund, D.; Del Angel, Y. Cruz; White, A. M.; Gonzalez, M. I.; Longo, F. M.; Russek, S. J.; Brooks-Kayal, A. R.			Acute Administration of the Small-Molecule p75(NTR) Ligand Does Not Prevent Hippocampal Neuron Loss or Development of Spontaneous Seizures After Pilocarpine-Induced Status Epilepticus	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						status epilepticus; pilocarpine; neurotrophin; seizure; LM11A-31 p75(NTR)	P75 NEUROTROPHIN RECEPTOR; MESSENGER-RNA EXPRESSION; EPILEPSY; LONG; DEATH; PRONGF; DEGENERATION; MODULATION; FOREBRAIN; INCREASES	Neurotrophins, such as brain-derived neurotrophic factor (BDNF), are initially expressed in a precursor form (e.g., pro-BDNF) and cleaved to form mature BDNF (mBDNF). After pilocarpine-induced status epilepticus (SE), increases in neurotrophins regulate a wide variety of cell-signaling pathways, including prosurvival and cell-death machinery in a receptorspecific manner. Pro-BDNF preferentially binds to the p75 neurotrophin receptor (p75 NTR), whereas mBDNF is the major ligand of the tropomyosin-related kinase receptor. To elucidate a potential role for p75 NTR in acute stages of epileptogenesis, rats were injected prior to and at onset of SE with LM11A-31, a small-molecule ligand that binds to p75 NTR to promote survival signaling and inhibit neuronal cell death. Modulation of early p75 NTR signaling and its effects on electrographic SE, SE-induced neurodegeneration, and subsequent spontaneous seizures were examined after LM11A-31 administration. Despite an established neuroprotective effect of LM11A-31 in several animal models of neurodegenerative disorders (e.g., Alzheimer's disease, traumatic brain injury, and spinal cord injury), high-dose LM11A-31 administration prior to and at onset of SE did not reduce the intensity of electrographic SE, prevent SE-induced neuronal cell injury, or inhibit the progression of epileptogenesis. Further studies are required to understand the role of p75 NTR activation during epileptogenesis and in seizure-induced cell injury in the hippocampus, among other potential cellular pathologies contributing to the onset of spontaneous seizures. Additional studies utilizing more prolonged treatment with LM11A-31 are required to reach a definite conclusion on its potential neuroprotective role in epilepsy. (C) 2014 Wiley Periodicals, Inc.	[Grabenstatter, H. L.; Carlsen, J.; Raol, Y. H.; Hund, D.; Del Angel, Y. Cruz; White, A. M.; Gonzalez, M. I.; Brooks-Kayal, A. R.] Univ Colorado, Sch Med, Dept Pediat, Div Neurol, Aurora, CO 80045 USA; [Grabenstatter, H. L.; Carlsen, J.; Raol, Y. H.; Hund, D.; Del Angel, Y. Cruz; White, A. M.; Gonzalez, M. I.; Brooks-Kayal, A. R.] Univ Colorado, Sch Med, Translat Epilepsy Res Program, Aurora, CO 80045 USA; [Yang, T.; Longo, F. M.] Stanford Univ, Dept Neurol, Palo Alto, CA 94304 USA; [Russek, S. J.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Brooks-Kayal, A. R.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO 80045 USA; [Brooks-Kayal, A. R.] Childrens Hosp Colorado, Aurora, CO 80045 USA		Brooks-Kayal, AR (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Div Neurol, 13001 E 17th Pl, Aurora, CO 80045 USA.	amy.brooks-kayal@childrenscolorado.org			NIH/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051710]; Citizens United for Research in Epilepsy (CURE); Epilepsy Foundation; Jean Perkins Foundation; AES Research Initiative award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051710] Funding Source: NIH RePORTER	Contract grant sponsor: NIH/National Institute of Neurological Disorders and Stroke; Contract grant number: R01NS051710 (to A.R.B.-K., S.J.R.); Contract grant sponsor: Citizens United for Research in Epilepsy (CURE to A.R.B.-K., S.J.R.); Contract grant sponsor: Epilepsy Foundation (to H.L.G.); Contract grant sponsor: Jean Perkins Foundation (to F.M.L.).; Contract grant sponsor: AES Research Initiative award (to A.R.B.-K. and F.M.L)	Aicardi J, 1983, Adv Neurol, V34, P115; Andsberg G, 2001, EXP NEUROL, V169, P351, DOI 10.1006/exnr.2001.7646; Arzimanoglou A, 2002, EPILEPTIC DISORD, V4, P173; Balosso S, 2005, ANN NEUROL, V57, P804, DOI 10.1002/ana.20480; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Barrett GL, 2010, HIPPOCAMPUS, V20, P145, DOI 10.1002/hipo.20598; Bauer J, 2001, SEIZURE-EUR J EPILEP, V10, P239, DOI 10.1053/seiz.2000.0499; BENGZON J, 1993, NEUROSCIENCE, V53, P433, DOI 10.1016/0306-4522(93)90207-V; Berg AT, 2003, NEUROLOGY, V60, P186, DOI 10.1212/01.WNL.0000031792.89992.EC; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; England MJ, 2012, EPILEPSY BEHAV, V25, P266, DOI 10.1016/j.yebeh.2012.06.016; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; HUMPEL C, 1993, NEUROSCIENCE, V53, P909, DOI 10.1016/0306-4522(93)90476-V; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Knowles JK, 2013, NEUROBIOL AGING, V34, P2052, DOI 10.1016/j.neurobiolaging.2013.02.015; Longo FM, 2008, CNS NEUROL DISORD-DR, V7, P63, DOI 10.2174/187152708783885093; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; Meyer A, 1996, BRAIN RES, V732, P121, DOI 10.1016/0006-8993(96)00502-1; Olney J W, 1986, Adv Neurol, V44, P857; Priel MR, 1996, EPILEPSY RES, V26, P115, DOI 10.1016/S0920-1211(96)00047-2; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; REPRESA A, 1995, J NEUROBIOL, V26, P413, DOI 10.1002/neu.480260313; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Shi J, 2013, STEM CELLS, V31, P2561, DOI 10.1002/stem.1516; Sillanpaa M, 2006, BRAIN, V129, P617, DOI 10.1093/brain/awh726; Tep C, 2013, J NEUROSCI, V33, P397, DOI 10.1523/JNEUROSCI.0399-12.2013; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; TURSKI L, 1987, POL J PHARMACOL PHAR, V39, P545; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Unsain N, 2008, NEUROSCIENCE, V154, P978, DOI 10.1016/j.neuroscience.2008.04.038; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604	40	9	10	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2014	92	10					1307	1318		10.1002/jnr.23402			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN3QX	WOS:000340504500008	24801281	Green Accepted			2022-02-06	
J	Kirk, JW; Hutaff-Lee, CF; Connery, AK; Baker, DA; Kirkwood, MW				Kirk, John W.; Hutaff-Lee, Christa F.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.			The Relationship Between the Self-Report BASC-2 Validity Indicators and Performance Validity Test Failure After Pediatric Mild Traumatic Brain Injury	ASSESSMENT			English	Article						BASC-2 Validity Scales; MSVT; symptom validity testing; performance validity testing; response bias; postconcussion; pediatric mild traumatic brain injury	RESPONSE BIAS SCALE; FAKE BAD SCALE; SYMPTOM VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; PERSONALITY-INVENTORY; MMPI-A; CHILDREN; TOMM; SAMPLE; ADOLESCENTS	In adult populations, research on methodologies to identify noncredible performance and exaggerated symptoms during neuropsychological evaluations has grown exponentially in the past two decades. Far less work has focused on methods appropriate for children. Although several recent studies have used stand-alone performance validity tests with younger populations, a near absence of pediatric work has investigated other indices to identify response bias. The present study examined the relationship between the validity scales from the self-report Behavior Assessment System for Children, Second Edition (BASC-2) and performance on the Medical Symptom Validity Test (MSVT), a stand-alone performance validity test. The sample consisted of 274 clinically referred patients with mild traumatic brain injuries aged 8 through 17 years. Fifty patients failed the MSVT based on actuarial criteria. The majority of these patients (92%) provided valid self-report BASC-2 profiles, with only three patients (6%) producing an invalid profile due to an elevated F index. Analysis of valid/invalid self-report BASC-2 profiles and MSVT pass/fail did not reveal a significant relationship (p = 0.471, two-tailed Fisher's exact test). These findings suggest that performance validity tests like the MSVT provide substantively different information about the validity of a neuropsychological profile than that provided by the self-report validity scales of the BASC-2.	[Kirk, John W.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO 80045 USA; [Kirk, John W.; Hutaff-Lee, Christa F.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Hutaff-Lee, Christa F.] Childrens Hosp Colorado, Dept Pediat, Sect Child Neurol, Aurora, CO 80045 USA		Kirk, JW (corresponding author), Childrens Hosp Colorado, Concuss Program, B285,13123 E 16th Ave, Aurora, CO 80045 USA.	drjohnkirk@comcast.net					Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone K.B., 2007, ASSESSMENT FEIGNED C; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Dionysus KE, 2011, ARCH CLIN NEUROPSYCH, V26, P81, DOI 10.1093/arclin/acq096; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2004, MANUAL MED SYMPTOM V; Greiffenstein MF, 2010, ASSESSMENT, V17, P269, DOI 10.1177/1073191109358823; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2002, PSYCHOL REP, V90, P131, DOI 10.2466/PR0.90.1.131-136; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lucio E, 2002, ASSESSMENT, V9, P62, DOI 10.1177/1073191102009001008; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Rogers R, 1996, J PERS ASSESS, V67, P244, DOI 10.1207/s15327752jpa6702_2; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; STEIN LAR, 1995, J PERS ASSESS, V65, P415, DOI 10.1207/s15327752jpa6503_3; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D., 2011, WECHSLER ABBREVIATED; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wrobel TA, 1999, ASSESSMENT, V6, P367, DOI 10.1177/107319119900600407; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]	42	9	9	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	OCT	2014	21	5					562	569		10.1177/1073191114520626			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	AQ4GL	WOS:000342751400004	24532649				2022-02-06	
J	Majidi, S; Hassan, AE; Adil, MM; Jadhav, V; Qureshi, AI				Majidi, Shahram; Hassan, Ameer E.; Adil, Malik M.; Jadhav, Vikram; Qureshi, Adnan I.			Incidence and Outcome of Vertebral Artery Dissection in Trauma Setting: Analysis of National Trauma Data Base	NEUROCRITICAL CARE			English	Article						Vertebral artery dissection; Head trauma; Stroke; Endovascular treatment	INJURY; FRACTURE	The natural history and epidemiological aspects of traumatic vertebral artery dissection (VAD) are not fully understood. We determined the prevalence of VAD and impact on outcome of patients with head and neck trauma. All the patients who were admitted with traumatic brain injury or head and neck trauma were identified by ICD-9-CM codes from the National Trauma Data Bank (NTDB), using data files from 2009 to 2010. NTDB represents one of the largest trauma databases and contains data from over 900 trauma centers across the United States. Presence of VAD was identified in these patients by using ICD-9-CM codes. Admission Glasgow Coma Scale (GCS) score, injury severity score (ISS), in-hospital complications, and treatment outcome were compared between patients with and without VAD. A total of 84 VAD patients were identified which comprised 0.01 % of all patients admitted with head and neck trauma. The mean age (in years) for patients with VAD was significantly higher than patients without dissection [46 (95 % CI 41-50) vs. 41.3 (95 % CI 41.2-41.4); p = 0.003]. The proportion of patients presenting with GCS score < 9 was significantly higher in patients with VAD (31 vs. 12 %, p < 0.0001). The rate of cervical vertebral fracture was significantly higher in patients with VAD (71 vs. 11 %, p < 0.0001). Patients with VAD had higher rates of in-hospital stroke than patients without dissection (5 vs. 0.2 %, p < 0.0001). Numbers of ICU days, ventilator days, and hospital length of stays were all significantly higher in patients with VAD. These differences remained significant after adjusting for the demographics, admission GCS score, and ISS (p < 0.0001). A total of 7 % (N = 6) of the patients with VAD received endovascular treatment and there was no in-hospital stroke in these patients. Patients with VAD had a higher chance of discharge to nursing facilities in comparison to head trauma patients without VAD (OR: 2.1; 95 % CI 1.4-3.5; p < 0.0001). Although infrequent, VAD in head and neck trauma is associated with higher rates of in-hospital stroke and longer length of ICU stay and total hospital stay. Early diagnosis and endovascular treatment may be an alternative option to reduce the rate of in-hospital stroke in these patients.	[Majidi, Shahram] George Washington Univ, Dept Neurol, Washington, DC 20037 USA; [Majidi, Shahram; Adil, Malik M.; Qureshi, Adnan I.] Zeenat Qureshi Stroke Inst, St Cloud, MN USA; [Hassan, Ameer E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol & Radiol, Valley Baptist Brain & Spine Network, Harlingen, TX 78550 USA; [Jadhav, Vikram] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA		Majidi, S (corresponding author), George Washington Univ, Dept Neurol, 2150 Penn Ave NW,9th Floor, Washington, DC 20037 USA.	majidis@gwu.edu	Adil, Malik M/I-8355-2019	Adil, Malik M/0000-0002-4635-6462; Qureshi, Adnan/0000-0003-4962-540X; Hassan, Ameer/0000-0002-7148-7616	American Heart AssociationAmerican Heart Association [13CRP17330020, 0840053N]; National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	Dr. Majidi is supported by American Heart Association Clinical Research Program Award 13CRP17330020, Brain Edema at Cerebral Hemorrhage (BEACH) study. Dr. Qureshi is supported by National Institute of Neurological Diseases and Stroke. Principal Investigator, Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)-II. 1R01NS062091-01A2 (medication provided by EKR therapeutics) and American Heart Association Established Investigator Award 0840053N, Innovative Strategies for Treating Cerebral Hemorrhage.	ANSON J, 1991, NEUROSURGERY, V29, P89, DOI 10.1227/00006123-199107000-00015; Aries MJH, 2010, CLIN NEUROL NEUROSUR, V112, P691, DOI 10.1016/j.clineuro.2010.05.015; Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Cohen JE, 2013, J CLIN NEUROSCI, V20, P731, DOI 10.1016/j.jocn.2012.05.042; Crompton JG, 2012, ARCH SURG-CHICAGO, V147, P674, DOI 10.1001/archsurg.2012.894; Fassett DR, 2008, J SPINAL DISORD TECH, V21, P252, DOI 10.1097/BSD.0b013e3180cab162; Flis CM, 2007, EUR RADIOL, V17, P820, DOI 10.1007/s00330-006-0346-7; Franz RW, 2012, J AM COLL SURGEONS, V214, P313, DOI 10.1016/j.jamcollsurg.2011.11.012; Gottesman RF, 2012, NEUROLOGIST, V18, P245, DOI 10.1097/NRL.0b013e31826754e1; Harrop JS, 2001, SPINE, V26, P340, DOI 10.1097/00007632-200102150-00008; Inamasu J, 2006, SURG NEUROL, V65, P238, DOI 10.1016/j.surneu.2005.06.043; Kashiwazaki D, 2013, NEURORADIOLOGY, V55, P201, DOI 10.1007/s00234-012-1114-9; Kral T, 2002, ZBL NEUROCHIR, V63, P153, DOI 10.1055/s-2002-36433; Mohan IV, 2014, ANGIOLOGY, V65, P274, DOI 10.1177/0003319712475154; Parbhoo AH, 2001, INJURY, V32, P565, DOI 10.1016/S0020-1383(00)00232-1; Price RF, 1998, AM J NEURORADIOL, V19, P1677; Qureshi AI, 2011, ARCH NEUROL-CHICAGO, V68, P1536, DOI 10.1001/archneurol.2011.213; Rodriguez M, 2001, ACTA NEUROCHIR, V143, P939, DOI 10.1007/s007010170025; Schellinger PD, 2001, SPINE, V26, P314, DOI 10.1097/00007632-200102010-00019; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; Schoenfeld AJ, 2012, SPINE J, V12, P777, DOI 10.1016/j.spinee.2011.01.029; Spain DA, 2006, J TRAUMA, V60, P751; SUECHTING RL, 1955, J NEUROSURG, V12, P187, DOI 10.3171/jns.1955.12.2.0187; Sugiu K, 2005, NEURORADIOLOGY, V47, P158, DOI 10.1007/s00234-005-1341-4; WILLIS BK, 1994, NEUROSURGERY, V34, P435, DOI 10.1227/00006123-199403000-00008; Yu W, 2003, NEUROLOGY, V61, P1421, DOI 10.1212/WNL.61.10.1421	30	9	9	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					253	258		10.1007/s12028-013-9937-8			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900012	24549934				2022-02-06	
J	Sibolt, G; Curtze, S; Melkas, S; Pohjasvaara, T; Kaste, M; Karhunen, PJ; Oksala, NKJ; Strandberg, T; Erkinjuntti, T				Sibolt, Gerli; Curtze, Sami; Melkas, Susanna; Pohjasvaara, Tarja; Kaste, Markku; Karhunen, Pekka J.; Oksala, Niku K. J.; Strandberg, Timo; Erkinjuntti, Timo			White Matter Lesions Are Associated With Hospital Admissions Because of Hip-Fractures and Trauma After Ischemic Stroke	STROKE			English	Article						cerebral small vessel diseases; hip fractures; trauma	RISK; FALLS; COMPLICATIONS; DEMENTIA; PEOPLE; IMPACT; DEATH; LADIS	Background and Purpose-Cerebral white matter lesions (WMLs), a surrogate for cerebral small-vessel disease, have been shown to be associated with decreasing mobility, gait instability, and falls. The aim of this study was to investigate whether WMLs of the brain are associated with increased incidence of hospital admissions because of any trauma and hip-fractures in a cohort of patients with stroke. Methods-We included 383 consecutive patients aged 55 to 85 years with ischemic stroke admitted to the Helsinki University Central Hospital (The Stroke Aging Memory cohort) with a 12-year follow-up. National register data were reviewed for hip-fractures, other traumatic injuries, survival data, and causes of death. WMLs were rated using MRI and dichotomized as none to mild and moderate to severe. The data were analyzed using Kaplan-Meier plots (log-rank) and a complex Cox multivariable hazards models for multiple cases per subject to assess hazard ratios with their 95% confidence intervals. Results-During the 12-year follow-up, there were more hip-fractures (13.5% versus 6.5%; log-rank, P=0.01) and more hospital admissions because of traumatic injury (22.2% versus 16.7%; log-rank, P=0.04) in the moderate-to-severe than in the none-to-mild WMLs group. In the complex samples, Cox multivariable model adjusting for age, sex, National Institutes of Health Stroke Scale, infarct size, and poststroke dementia, moderate-to-severe WMLs were associated with increased incidences of hospital admissions because of hip-fractures (hazard ratio, 3.98; 95% confidence interval, 1.55-10.21) and traumatic injuries including hip-fractures (hazard ratio, 1.72; 95% confidence interval, 1.03-2.87). Conclusions-Patients with ischemic stroke and moderate-to-severe WMLs are at high risk, who experience serious traumatic injuries and especially hip-fractures requiring hospital treatment.	[Sibolt, Gerli; Curtze, Sami; Melkas, Susanna; Pohjasvaara, Tarja; Kaste, Markku; Erkinjuntti, Timo] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki 00029, Finland; [Sibolt, Gerli; Curtze, Sami; Melkas, Susanna; Pohjasvaara, Tarja; Kaste, Markku; Erkinjuntti, Timo] Univ Helsinki, Dept Neurol Sci, Helsinki 00029, Finland; [Karhunen, Pekka J.; Oksala, Niku K. J.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Karhunen, Pekka J.; Oksala, Niku K. J.] Tampere Univ Hosp Reg, FimLab Labs Ltd, Tampere, Finland; [Oksala, Niku K. J.] Tampere Univ Hosp, Div Vasc Surg, Dept Surg, Tampere, Finland; [Strandberg, Timo] Univ Helsinki, Geriatr Clin, Dept Med, Helsinki 00029, Finland; [Strandberg, Timo] Univ Cent Hosp, Helsinki, Finland; [Strandberg, Timo] Univ Hosp & Hlth Ctr Oulu, Inst Hlth Sci Geriatr, Oulu, Finland		Sibolt, G (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurol, Haartmaninkatu 4,POB 340, Helsinki 00029, Finland.	gerli.sibolt@hus.fi	Curtze, Sami/AAK-8595-2020	Curtze, Sami/0000-0003-1545-8500; strandberg, timo/0000-0001-6299-925X; Melkas, Susanna/0000-0003-0564-9637; Kaste, Markku/0000-0001-6557-6412	Clinical Research Institute, Helsinki University Central Hospital; Medical Research Fund of Helsinki University Central Hospital	This study was supported by the Clinical Research Institute, Helsinki University Central Hospital, and the Medical Research Fund of Helsinki University Central Hospital.	Ashburn A, 2008, AGE AGEING, V37, P270, DOI 10.1093/ageing/afn066; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Blahak C, 2009, J NEUROL NEUROSUR PS, V80, P608, DOI 10.1136/jnnp.2008.154633; Corti MC, 2007, ARCH INTERN MED, V167, P1745, DOI 10.1001/archinte.167.16.1745; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; Inzitari D, 2003, STROKE, V34, P2067, DOI 10.1161/01.STR.0000080934.68280.82; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Melkas S, 2012, INT J GERIATR PSYCH, V27, P401, DOI 10.1002/gps.2733; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Oksala NKJ, 2009, J NEUROL NEUROSUR PS, V80, P762, DOI 10.1136/jnnp.2008.154104; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Pohjasvaara T, 2000, STROKE, V31, P2952, DOI 10.1161/01.STR.31.12.2952; Sackley C, 2008, STROKE, V39, P3329, DOI 10.1161/STROKEAHA.108.518563; Sibolt G, 2013, J NEUROL NEUROSUR PS, V84, P722, DOI 10.1136/jnnp-2012-304084; Srikanth V, 2009, STROKE, V40, P175, DOI 10.1161/STROKEAHA.108.524355; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; Zheng JJJ, 2011, STROKE, V42, P2086, DOI 10.1161/STROKEAHA.110.610360	17	9	10	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499	1524-4628		STROKE	Stroke	OCT	2014	45	10					2948	2951		10.1161/STROKEAHA.114.006116			4	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	AQ4UH	WOS:000342794700029	25169948				2022-02-06	
J	Solovieva, TI; Walls, RT				Solovieva, Tatiana I.; Walls, Richard T.			Barriers to Traumatic Brain Injury Services and Supports in Rural Settings	JOURNAL OF REHABILITATION			English	Article							NEEDS; PEOPLE; STATE; TBI	Traumatic Brain Injury (TBI) is defined as: "an alteration in brain function, or other evidence of brain pathology, caused by an external force" (Brain Injury Association of America (BIAA), 2011). The TBI program at the Center for Excellence in Disabilities at West Virginia University conducted a survey of consumers with a TBI who have been placed on the state TBI Registry. Responses were obtained from 722 consumers with a response rate of 11%. Results of the survey indicate that the top barriers for those receiving services include: (a) lack of knowledge of available services and resources (reported by 36% of respondents), (b) cost of services (33%), (c) difficulty navigating the system (33%), (d) difficulty finding qualified providers who are knowledgeable of TBI (28%), and (e) proximity to services (28%). To overcome these barriers, rural states should be making a concerted effort to provide needed services to individuals with TBI.	[Solovieva, Tatiana I.; Walls, Richard T.] W Virginia Univ, Morgantown, WV 26505 USA		Solovieva, TI (corresponding author), W Virginia Univ, CED, 959 Hartman Run Rd,POB 6870, Morgantown, WV 26505 USA.	tatiana.solovieva@hotmail.com					Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; BIAA (Brain Injury Association of America), 2011, BIAA AD NEW TBI DEF; Centers for Disease Control, 2012, TRAUM BRAIN INJ FACT; Centers for Disease Control and Prevention, WHAT AR LEAD CAUS TB; Christiadi, 2010, W VIRGINIA DEMOGRAPH; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; El Allaki F, 2012, EPIDEMIOL HEALTH, V34, DOI 10.4178/epih/e2012007; Faul M, 2010, TRAUMATIC BRAIN INJU; Iezzoni LI, 2006, HEALTH SERV RES, V41, P1258, DOI 10.1111/j.1475-6773.2006.00534.x; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lustig DC, 2004, J REHABIL, V70, P13; Murphy J., 2004, TOPICS EMERG MED, V26, P231; North American Brain Injury Society, 2012, BRAIN INJ FACTS; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1295, DOI 10.1080/02699050701721802; Sample PL, 2005, J HEAD TRAUMA REHAB, V20, P270, DOI 10.1097/00001199-200505000-00009; Sample PL, 2004, BRAIN INJURY, V18, P1177, DOI 10.1080/02699050410001719925; Schopp LH, 2005, PROF PSYCHOL-RES PR, V36, P158, DOI 10.1037/0735-7028.36.2.158; Spearman RC, 2007, BRAIN INJURY, V21, P837, DOI 10.1080/02699050701426857; U.S. Census Bureau, 2010, POP HOUS NARR PROF 2; U.S. Department of Education Institute of Education Sciences National Center for Education Statistics, 2003, NAT ASS AD LIT; U.S. Department of Health and Human Services, 2013, FIND SHORT AR MUA P; US. Census Bureau, 2010, 2010 CENS URB AR FAQ; West Virginia Bureau of Senior Services, 2008, W VIRG SEN COMM SERV	28	9	9	0	4	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	OCT-DEC	2014	80	4					10	18					9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	CC7FP	WOS:000350533400003					2022-02-06	
J	Pruitt, D; Hays, S; Schmid, A; Choua, C; Kim, L; Trieu, J; Kilgard, MP; Rennaker, RL				Pruitt, David; Hays, Seth; Schmid, Ariel; Choua, Connie; Kim, Lily; Trieu, Jenny; Kilgard, Michael P.; Rennaker, Robert L., II			Controlled-cortical impact reduces volitional forelimb strength in rats	BRAIN RESEARCH			English	Article						Traumatic brain injury; Controlled cortical impact; Recovery; Behavior; Rat	TRAUMATIC BRAIN-INJURY; MOTOR CORTEX; COGNITIVE DEFICITS; STROKE; SEVERITY; RECOVERY	Traumatic brain injury (TBI) is one of the largest health problems in the United States and affects both cognitive and motor function. Although weakness is common in TBI patients, few studies have demonstrated a reduction in strength in models of brain injury. We have developed a behavioral method to measure volitional forelimb strength and quantify forelimb weakness following traumatic brain injury. In this paper, we report the ability of the isometric pull task to measure both acute and chronic impairments in forelimb motor function following a controlled cortical impact (CCI) in rodents. Following CCI, volitional forelimb strength is reduced by 36% and remains significantly reduced after 6 weeks of post-lesion training. We also show that CCI results in impairment of multiple additional measures of forelimb function for several weeks post-injury. (C) 2014 Elsevier B.V. All rights reserved.	[Pruitt, David; Hays, Seth; Schmid, Ariel; Choua, Connie; Kim, Lily; Kilgard, Michael P.; Rennaker, Robert L., II] Univ Texas Dallas, Sch Behav Brain Sci, Richardson, TX 75080 USA; [Hays, Seth; Trieu, Jenny; Rennaker, Robert L., II] Univ Texas Dallas, Erik Jonsson Sch Engn & Comp Sci, Richardson, TX 75080 USA; [Pruitt, David; Hays, Seth; Schmid, Ariel; Choua, Connie; Kim, Lily; Trieu, Jenny; Kilgard, Michael P.; Rennaker, Robert L., II] Univ Texas Dallas, Texas Biomed Device Ctr, Richardson, TX 75080 USA		Pruitt, D (corresponding author), Univ Texas Dallas, Sch Behav Brain Sci, 800 West Campbell Rd,GR41, Richardson, TX 75080 USA.	dtp110020@utdallas.edu	, David/ABG-7327-2020; Hays, Seth/U-4701-2019; Rennaker II, Robert/K-9049-2013	, David/0000-0001-8356-0887; Hays, Seth/0000-0003-4225-241X; Kilgard, Michael/0000-0002-6699-1818; Rennaker II, Robert/0000-0003-1260-1973			Alaverdashvili M, 2008, NEUROSCIENCE, V157, P297, DOI 10.1016/j.neuroscience.2008.09.015; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Canning CG, 2004, CLIN REHABIL, V18, P300, DOI 10.1191/0269215504cr715oa; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Ding Y., 2001, NEUROL RES, V23, P2; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faul M, 2010, TRAUMATIC BRAIN INJU; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hays SA, 2013, J NEUROSCI METH, V212, P329, DOI 10.1016/j.jneumeth.2012.11.007; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Khodaparast N, 2013, NEUROBIOL DIS, V60, P80, DOI 10.1016/j.nbd.2013.08.002; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Whishaw IQ, 2008, BEHAV BRAIN RES, V192, P124, DOI 10.1016/j.bbr.2007.12.026; Whishaw IQ, 2004, J NEUROTRAUM, V21, P1584, DOI 10.1089/neu.2004.21.1584; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	24	9	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 25	2014	1582						91	98		10.1016/j.brainres.2014.07.039			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR1PM	WOS:000343357100009	25091640				2022-02-06	
J	Amara, J; Pogoda, TK; Krengel, M; Iverson, KM; Baker, E; Hendricks, A				Amara, Jomana; Pogoda, Terri K.; Krengel, Maxine; Iverson, Katherine M.; Baker, Errol; Hendricks, Ann			Determinants of Utilization and Cost of VHA Care by OEF/OIF Veterans Screened for Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							WOMEN VETERANS; COMBAT; IRAQ	Objective: To determine the demographic and service characteristics that differentially impact utilization and cost of Veterans Health Administration (VHA) services for Operation Enduring Freedom and Operation Iraq Freedom (OEF/OIF) Veterans screened or evaluated for traumatic brain injury (TBI). Setting: We examined Department of Defense (DoD) and VHA administrative records of OEF/OIF Veterans who were screened or evaluated for TBI. Participants: Our study population was OEF/OIF Veterans who separated from DoD in Fiscal Years 2003-2009 and who were screened or evaluated in VHA for TBI between October 2008 and July 2009. Design: We describe the demographics and service characteristics of separated Veterans and those who accessed the VHA. We report the cost of VHA utilization and estimate a probit regression model to assess determinants of VHA utilization and costs by OEF/OIF Veterans screened and evaluated for TBI by VHA. Results: Females and Veterans older than 37 years utilize VHA services more intensely. Across all services, the Reserve Components utilize health services more than the Active Components placing more demand on VHA for services. Conclusion: VHA utilization and costs is impacted by the demographic and service characteristics of Veterans. The variation in Veteran groups incurring higher costs and utilization indicates different usage patterns of VHA services by each group with implications for patient load as the DoD deploys higher numbers of females and the Reserve Components.	[Amara, Jomana] Naval Postgrad Sch, Def Resources Management Inst, Monterey, CA 93943 USA; [Pogoda, Terri K.; Krengel, Maxine; Baker, Errol] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Jamaica, MA 02130 USA; [Iverson, Katherine M.] VA Boston Hlth Care Syst, Natl Ctr PTSD, Jamaica, MA 02130 USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Jamaica, MA 02130 USA		Amara, J (corresponding author), Naval Postgrad Sch, Def Resources Management Inst, 699 Dyer Rd,205A Halligan Hall, Monterey, CA 93943 USA.		; Pogoda, Terri/F-6243-2012	Krengel, Maxine/0000-0001-7632-590X; Pogoda, Terri/0000-0003-1397-8780	Office of Research and Development, Health Services R&D Service, Department of Veterans AffairsUS Department of Veterans Affairs [SDR 08-405]; Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Services Career Development AwardUS Department of Veterans Affairs [CDA 10-029]	This article is based on work supported by the Office of Research and Development, Health Services R&D Service, Department of Veterans Affairs, through SDR 08-405. Dr. Iverson's contribution to this article was supported by a Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Services Career Development Award (CDA 10-029).	Amara J, 2014, WOMEN HEALTH ISS, V24, P174; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Burelli DF, 2012, WOMEN COMBAT ISSUES; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Congressional Budget Office, 2010, POT COSTS VET HLTH C; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Frayne SM, 2006, J GEN INTERN MED, V21, pS40, DOI 10.1111/j.1525-1497.2006.00373.x; Frayne SM, 2010, SOURCEBOOK WOMEN VET, V1; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; HARRELL MC, 2002, STATUS GENDER INTEGR; Hendricks A, BRAIN INJ, V27, P125; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kapp L, 2012, RESERVE COMPONENT PE; Mattocks KM, 2012, SOC SCI MED, V74, P537, DOI 10.1016/j.socscimed.2011.10.039; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Office of the Assistant Secretary of Defense Reserve Affairs, 2008, MAN RES COMP OP FORC; Office of the Deputy Under Secretary of Defense (Military Community and Family Policy), 2010, DEM 2010 PROF MIL CO; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Phibbs CS, 2003, MED CARE RES REV, V60, p54S, DOI 10.1177/1077558703256725; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wagner TH, 2010, HERCS AVERAGE COST D; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Westat, 2010, NAT SURV VET ACT DUT	28	9	9	0	3	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP	2014	179	9					964	972		10.7205/MILMED-D-13-00559			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA7LF	WOS:000349098100011	25181713	Bronze			2022-02-06	
J	Dipietro, L; Poizner, H; Krebs, HI				Dipietro, Laura; Poizner, Howard; Krebs, Hermano I.			Spatiotemporal Dynamics of Online Motor Correction Processing Revealed by High-density Electroencephalography	JOURNAL OF COGNITIVE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; MOVEMENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; KINEMATIC PROPERTIES; CORTICAL POTENTIALS; EEG DYNAMICS; HAND; REACH; RECOVERY; STROKE	The ability to control online motor corrections is key to dealing with unexpected changes arising in the environment with which we interact. How the CNS controls online motor corrections is poorly understood, but evidence has accumulated in favor of a submovement-based model in which apparently continuous movement is segmented into distinct submovements. Although most studies have focused on submovements' kinematic features, direct links with the underlying neural dynamics have not been extensively explored. This study sought to identify an electroencephalographic signature of submovements. We elicited kinematic submovements using a double-step displacement paradigm. Participants moved their wrist toward a target whose direction could shift mid-movement with a 50% probability. Movement kinematics and cortical activity were concurrently recorded with a low-friction robotic device and high-density electroencephalography. Analysis of spatiotemporal dynamics of brain activation and its correlation with movement kinematics showed that the production of each kinematic submovement was accompanied by (1) stereotyped topographic scalp maps and (2) frontoparietal ERPs time-locked to submovements. Positive ERP peaks from frontocentral areas contralateral to the moving wrist preceded kinematic submovement peaks by 220-250 msec and were followed by positive ERP peaks from contralateral parietal areas (140-250 msec latency, 0-80 msec before submovement peaks). Moreover, individual subject variability in the latency of frontoparietal ERP components following the target shift significantly predicted variability in the latency of the corrective submovement. Our results are in concordance with evidence for the intermittent nature of continuous movement and elucidate the timing and role of frontoparietal activations in the generation and control of corrective submovements.	[Dipietro, Laura; Krebs, Hermano I.] MIT, Cambridge, MA 02139 USA; [Poizner, Howard] Univ Calif San Diego, La Jolla, CA 92093 USA		Dipietro, L (corresponding author), MIT, Dept Mech Engn, 77 Massachusetts Ave 3-147, Cambridge, MA 02139 USA.	lauradp@mit.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HD045343, R01-NS036449]; ONR MURIMURIOffice of Naval Research [N000140811114]; NSFNational Science Foundation (NSF) [SMA-1041755]; NSF Science of Learning CenterNational Science Foundation (NSF)NSF - Office of the Director (OD);  [ENG-1137279 (EFRI M3C)]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036449] Funding Source: NIH RePORTER	We thank Markus Plank for his helpful comments on the manuscript and Klaus Gramman for his help with EEGLAB. This study was supported in part by NIH R01-HD045343, NIH R01-NS036449, ONR MURI Award N000140811114, NSF Grant SMA-1041755 to the Temporal Dynamics of Learning Center and NSF Science of Learning Center, and ENG-1137279 (EFRI M3C). H. I. Krebs is a coinventor in several MIT-held patents for the robotic technology. He holds equity positions in Interactive Motion Technologies, Watertown, MA, USA, the company that manufactures robotic technology under license to MIT.	ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Ang KK, 2010, IEEE ENG MED BIO, P5549, DOI 10.1109/IEMBS.2010.5626782; Archambault PS, 2011, J NEUROSCI, V31, P742, DOI 10.1523/JNEUROSCI.2623-10.2011; Archambault PS, 2009, CEREB CORTEX, V19, P2848, DOI 10.1093/cercor/bhp058; Baldauf D, 2008, J NEUROSCI, V28, P10081, DOI 10.1523/JNEUROSCI.3423-08.2008; BARRINGER CW, 2008, SIMULATED REACHING S; Battaglia-Mayer A, 2013, CEREB CORTEX, V23, P2644, DOI 10.1093/cercor/bhs250; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bernier PM, 2009, NEUROIMAGE, V47, P1767, DOI 10.1016/j.neuroimage.2009.05.028; Cui RQ, 1999, NEUROIMAGE, V9, P124, DOI 10.1006/nimg.1998.0388; d'Avella A, 2011, J NEUROPHYSIOL, V106, P2796, DOI 10.1152/jn.00675.2010; DEECKE L, 1969, EXP BRAIN RES, V7, P158; DEECKE L, 1987, J NEUROL NEUROSUR PS, V50, P1430, DOI 10.1136/jnnp.50.11.1430; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Desmurget M, 2001, J NEUROSCI, V21, P2919, DOI 10.1523/JNEUROSCI.21-08-02919.2001; DETTMERS C, 1995, J NEUROPHYSIOL, V74, P802, DOI 10.1152/jn.1995.74.2.802; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Dipietro L, 2009, CORTEX, V45, P318, DOI 10.1016/j.cortex.2008.02.008; Doeringer JA, 1998, J NEUROPHYSIOL, V80, P1787, DOI 10.1152/jn.1998.80.4.1787; Eliassen JC, 2008, TOP STROKE REHABIL, V15, P427, DOI 10.1310/tsr1505-427; EVARTS EV, 1977, NEUROSCI LETT, V5, P267, DOI 10.1016/0304-3940(77)90077-5; Fabiani M, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P85, DOI 10.1017/CBO9780511546396.004; Fishbach A, 2005, EXP BRAIN RES, V164, P442, DOI 10.1007/s00221-005-2264-3; FISHBACH A, 2003, NEURAL CORRELATES ON; Fishbach A, 2007, EXP BRAIN RES, V177, P45, DOI 10.1007/s00221-006-0652-y; Fize D, 2005, BRAIN COGNITION, V59, P145, DOI 10.1016/j.bandc.2005.06.002; Flanders M, 2011, BIOL CYBERN, V104, P1, DOI 10.1007/s00422-011-0419-9; FLASH T, 1991, J COGNITIVE NEUROSCI, V3, P220, DOI 10.1162/jocn.1991.3.3.220; GEORGOPOULOS AP, 1983, EXP BRAIN RES, V49, P327; Gerloff C., 2003, BEREITSCHAFTSPOTENTI, P175; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Grea H, 2002, NEUROPSYCHOLOGIA, V40, P2471, DOI 10.1016/S0028-3932(02)00009-X; Green JB, 1999, STROKE, V30, P2659, DOI 10.1161/01.STR.30.12.2659; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; Gwin JT, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-35; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; Hammon PS, 2008, IEEE SIGNAL PROC MAG, V25, P69, DOI 10.1109/MSP.2008.4408443; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; HENIS EA, 1995, BIOL CYBERN, V72, P407, DOI 10.1007/BF00201416; Hoffmann H, 2011, EXP BRAIN RES, V208, P73, DOI 10.1007/s00221-010-2461-6; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; Ifft Peter J, 2012, Front Neuroeng, V5, P16, DOI 10.3389/fneng.2012.00016; Jankelowitz SK, 2005, EXP BRAIN RES, V161, P104, DOI 10.1007/s00221-004-2051-6; Jankelowitz SK, 2002, EXP BRAIN RES, V147, P98, DOI 10.1007/s00221-002-1220-8; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kitamura JI, 1996, ELECTROEN CLIN NEURO, V98, P149, DOI 10.1016/0013-4694(95)00218-9; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; Krakauer JW, 2004, J NEUROPHYSIOL, V91, P924, DOI 10.1152/jn.00675.2003; Krebs H I, 1998, IEEE Trans Rehabil Eng, V6, P75, DOI 10.1109/86.662623; Krebs HI, 2007, IEEE T NEUR SYS REH, V15, P327, DOI 10.1109/TNSRE.2007.903899; Krebs HI, 1999, P NATL ACAD SCI USA, V96, P4645, DOI 10.1073/pnas.96.8.4645; Krebs HI, 1998, HUM BRAIN MAPP, V6, P59; Krigolson OE, 2007, BRAIN RES, V1155, P70, DOI 10.1016/j.brainres.2007.04.024; Krigolson OE, 2008, EXP BRAIN RES, V190, P401, DOI 10.1007/s00221-008-1482-x; Lindner A, 2010, J NEUROSCI, V30, P11715, DOI 10.1523/JNEUROSCI.2849-09.2010; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; MILNER TE, 1992, NEUROSCIENCE, V49, P487, DOI 10.1016/0306-4522(92)90113-G; MILNER TE, 1990, NEUROSCIENCE, V35, P365, DOI 10.1016/0306-4522(90)90090-Q; MORASSO P, 1981, EXP BRAIN RES, V42, P223; MORASSO P, 1982, BIOL CYBERN, V45, P131, DOI 10.1007/BF00335240; Naranjo JR, 2007, NEUROIMAGE, V34, P1673, DOI 10.1016/j.neuroimage.2006.07.049; Nasir SM, 2009, P NATL ACAD SCI USA, V106, P20470, DOI 10.1073/pnas.0907032106; NESHIGE R, 1988, BRAIN, V111, P719; Novak KE, 2002, EXP BRAIN RES, V144, P351, DOI 10.1007/s00221-002-1060-6; Novak KE, 2000, EXP BRAIN RES, V132, P419, DOI 10.1007/s002210000366; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; PLATZ T, 1994, NEUROPSYCHOLOGIA, V32, P1209, DOI 10.1016/0028-3932(94)90103-1; Platz T, 2000, BRAIN, V123, P2475, DOI 10.1093/brain/123.12.2475; Poizner H., 2012, C P BIOM ROB BIOM RO; Rohrer B, 2004, MOTOR CONTROL, V8, P472, DOI 10.1123/mcj.8.4.472; Rohrer B, 2002, J NEUROSCI, V22, P8297; ROY SA, 2003, NEURAL CORRELATES CO; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; SAINBURG RL, 1993, J NEUROPHYSIOL, V70, P2136, DOI 10.1152/jn.1993.70.5.2136; SHIBASAKI H, 1978, J NEUROL, V219, P15, DOI 10.1007/BF00313365; SOECHTING JF, 1981, J NEUROSCI, V1, P710, DOI 10.1523/JNEUROSCI.01-07-00710.1981; Spraker MB, 2007, J NEUROPHYSIOL, V98, P821, DOI 10.1152/jn.00239.2007; Swann N, 2011, J NEUROSCI, V31, P5721, DOI 10.1523/JNEUROSCI.6135-10.2011; TARKKA IM, 1991, J CLIN NEUROPHYSIOL, V8, P331, DOI 10.1097/00004691-199107010-00009; Torres EB, 2010, J NEUROPHYSIOL, V104, P2375, DOI 10.1152/jn.00089.2010; Tunik E, 2005, NAT NEUROSCI, V8, P505, DOI 10.1038/nn1430; Tunik E, 2007, J NEUROPHYSIOL, V97, P2107, DOI 10.1152/jn.00405.2006; Tunik E, 2009, NEUROIMAGE, V47, P1757, DOI 10.1016/j.neuroimage.2009.04.077; Vaisman L, 2013, IEEE T NEUR SYS REH, V21, P756, DOI 10.1109/TNSRE.2012.2231943; VALLBO AB, 1993, J PHYSIOL-LONDON, V469, P673, DOI 10.1113/jphysiol.1993.sp019837; Wiese H, 2005, STROKE, V36, P1474, DOI 10.1161/01.STR.0000170639.26891.30; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Wisleder D, 2007, EXP BRAIN RES, V176, P132, DOI 10.1007/s00221-006-0603-7; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1	102	9	9	1	11	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0898-929X	1530-8898		J COGNITIVE NEUROSCI	J. Cogn. Neurosci.	SEP	2014	26	9					1966	1980		10.1162/jocn_a_00593			15	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AN4GI	WOS:000340545300007	24564462	Green Submitted, Green Accepted			2022-02-06	
J	Pretz, CR; Kozlowski, AJ; Charlifue, S; Chen, Y; Heinemann, AW				Pretz, C. R.; Kozlowski, A. J.; Charlifue, S.; Chen, Y.; Heinemann, A. W.			Using rasch motor FIM individual growth curves to inform clinical decisions for persons with paraplegia	SPINAL CORD			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; CURRENT RESEARCH OUTCOMES; NATIONAL INSTITUTE; LONGITUDINAL DESCRIPTION; MODEL; REHABILITATION; DISABILITY; SCALE	Study Design: A longitudinal retrospective study. Objective: To better understand individual-level temporal change in functional status for participants with paraplegia in the National Spinal Cord Injury Database (NSCID), as measured by Rasch Transformed Motor Functional Indepedence Measure (FIM) scores. Setting: Multicenter/Multistate longitudinal study across the United States. Methods: Non-linear random effects modeling, that is, individual growth curve analysis of retrospective data obtained from the National Institute on Disability and Rehabilitation Research (NIDRR) NSCID. Results: We generated non-linear individual level trajectories of recovery for Rasch Transformed Motor FIM scores that rise rapidly from inpatient rehabilitation admission to a plateau. Trajectories are based on relationships between growth parameters and patient and injury factors: race, gender, level of education at admission, age at injury, neurological level at discharge, American Spinal Injury Association Impairment Scale (AIS) at discharge, days from injury to first system inpatient rehabilitation admission, rehabilitation length of stay, marital status and etiology. On the basis of study results, an interactive tool was developed to represent individual level longitudinal outcomes as trajectories based upon an individual's given baseline characteristics, that is, information supplied by the covariates and provides a robust description of temporal change for those with paraplegia within the NSCID. Conclusions: This methodology allows researchers and clinicians to generate and better understand patient-specific trajectories through the use of an automated interactive tool where a nearly countless number of longitudinal paths of recovery can be explored. Projected trajectories holds promise in facilitating planning for inpatient and outpatient services, which could positively impact long term outcomes.	[Pretz, C. R.; Charlifue, S.] Craig Hosp, Res Dept, Englewood, CO 80132 USA; [Pretz, C. R.] Traumat Brain Injury Natl Data & Stat Ctr, Englewood, CO USA; [Kozlowski, A. J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Chen, Y.] Univ Alabama Birmingham, Natl Spinal Cord Injury Stat Ctr, Birmingham, AL USA; [Heinemann, A. W.] Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, Chicago, IL 60611 USA		Pretz, CR (corresponding author), Craig Hosp, Res Dept, 3425 South Clarkson St, Englewood, CO 80132 USA.	cpretz@craighospital.org	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326	National Institute on Disability and Rehabilitation Research (NIDRR) Traumatic Brain Injury Model Systems National Data and Statistical Center [H133A110006]; National Spinal Cord Injury Statistical Center [H133A110002]; National Institutes of Health through the Center for Rehabilitation Research using Large Datasets [R24-HD065702]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065702] Funding Source: NIH RePORTER	This work was funded by the National Institute on Disability and Rehabilitation Research (NIDRR) Traumatic Brain Injury Model Systems National Data and Statistical Center (Grant Number H133A110006), the National Spinal Cord Injury Statistical Center (Grant Number H133A110002) and the National Institutes of Health through the Center for Rehabilitation Research using Large Datasets (Grant Number R24-HD065702). This work was prepared at the Traumatic Brain Injury Model Systems National Data and Statistical Center, Englewood CO and at the National Spinal Cord Injury Statistical Center University of Alabama at Birmingham, Birmingham, AL, USA.	Backus D, 2013, ARCH PHYS MED REHAB, V94, pS165, DOI 10.1016/j.apmr.2013.01.012; Bode RK, 2014, ARCH PHYS MED REHAB, V95, P676, DOI 10.1016/j.apmr.2013.11.009; Chen YY, 2011, ARCH PHYS MED REHAB, V92, P329, DOI 10.1016/j.apmr.2010.12.011; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1363, DOI 10.1016/S0003-9993(99)90245-9; Horn SD, 2013, ARCH PHYS MED REHAB, V94, pS75, DOI 10.1016/j.apmr.2012.10.036; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, pS154, DOI 10.1016/j.apmr.2012.11.050; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Stover SL, 1999, ARCH PHYS MED REHAB, V80, P1365, DOI 10.1016/S0003-9993(99)90246-0; Warschausky S, 2001, ARCH PHYS MED REHAB, V82, P329, DOI 10.1053/apmr.2001.21510; Whiteneck GG, 2013, ARCH PHYS MED REHAB, V94, pS67, DOI 10.1016/j.apmr.2012.12.022; Wilson JR, 2012, J NEUROTRAUM, V29, P2263, DOI 10.1089/neu.2012.2417	17	9	9	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	SEP	2014	52	9					671	676		10.1038/sc.2014.94			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	AP3OP	WOS:000341986400006	24937699	Green Accepted, Bronze			2022-02-06	
J	Robeson, R; King, NMP				Robeson, Richard; King, Nancy M. P.			Loss of Possession: Concussions, Informed Consent, and Autonomy	JOURNAL OF LAW MEDICINE & ETHICS			English	Article								The recent explosion of publicity about the dangers of concussion in contact sports particularly in football represents the unraveling of a disinformation campaign by the NFL amid growing public and professional concern about the game's long-term risks of harm. The persistence of controversy and denial reflects a cultural view of football players as serving the needs of the team, a resulting evidentiary skepticism, and resistance to rule changes as excessive or unenforceable. This article considers the cultural context of informed decision making by parents of youth football players and suggests that policy changes designed to lower (although they cannot eliminate) risks of brain injury have the potential to change both the culture of football and the way the benefits and harms of the game are regarded for its players, without loss of its essential excitement and appeal.	[Robeson, Richard] Wake Forest Univ, Dept Commun, Winston Salem, NC 27109 USA; [Robeson, Richard; King, Nancy M. P.] Wake Forest Univ, Ctr Bioeth Hlth & Soc, Winston Salem, NC 27109 USA; [King, Nancy M. P.] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC USA		Robeson, R (corresponding author), Wake Forest Univ, Dept Commun, Winston Salem, NC 27109 USA.						[Anonymous], UPMC SPORTS CONCUSSI; [Anonymous], RICH HOFMANN DEATH O; [Anonymous], 2013, PBS; [Anonymous], PBS; Associated Press, GOODELL ISSUES MEMO; Belson K., 2014, NEW YORK TIMES; Brandt AM., 2007, THE CIGARETTE CENTUR; Breslow J. M., PBS; Cole J., ROLLES COMMITMENT CA; Coleman C.H., 2005, VANDERBILT LAW REV, V58, P387; Committee on Sports-Related Concussions in Youth Institute of Medicine National Research Council, 2013, SPORTS RELATED CONCU; Dakss B., CBS NEWS; Dreger A., 2009, BIOETHICS FORUM; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Faden RR, 1986, HIST THEORY INFORM C; Farmer S., 2014, LOS ANGELES TIMES; Farrington D., NFL SAYS IT BACKS RE; Feinstein John, 2013, CBS RADIO; Glauberman L., HUFFINGTON POST; Goldberg DS, 2013, J LEGAL MED, V34, P157, DOI 10.1080/01947648.2013.800792; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Henderson GE, 2004, MOL THER, V10, P225, DOI 10.1016/j.ymthe.2004.05.013; Jones James H., 1992, BAD BLOOD THE TUSKEG; King N. M. P., 2007, STUDIES IN LAW ETHIC, V1, P1, DOI DOI 10.2202/1941-6008.1006; King Nancy M P, 2005, IRB, V27, P1, DOI 10.2307/3563865; King NMP, 2013, AM J BIOETHICS, V13, P13, DOI 10.1080/15265161.2013.828126; Koyfman Shlomo A, 2009, IRB, V31, P1; Maitland H. S., 1928, JAMA-J AM MED ASSOC, V91, P1103; Maske M., ROBERT GRIFFIN SIGNS; Matthew Gfeller Foundation, ABOUT; Mihoces G., USA TODAY; Mihoces M., USA TODAY; Orentlicher D., 2013, FLORIDA INTERNATIONA, V8, P17; Petrochko C., MEDPAGE TODAY; Pollock G., THE EVIL GENIUS OF F; Rivara F. P., 2013, JAMA-J AM MED ASSOC, V311, P239; Ruddy E. Zammett, CAN YOUTH FOOTBALL R; Scwarz A., NEW YORK TIMES; Testoni D, 2013, AM J BIOETHICS, V13, P4, DOI 10.1080/15265161.2013.828114; Wemple E., CAN THE MEDIA COVER; Wilner B., 2013, HUFFINGTON POST	42	9	9	1	23	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	FAL	2014	42	3			SI		334	343		10.1111/jlme.12150			10	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	AQ4ED	WOS:000342745000008	25264091				2022-02-06	
J	Camfield, PR; Bahi-Buisson, N; Trinka, E				Camfield, Peter R.; Bahi-Buisson, Nadia; Trinka, Eugen			Transition issues for children with diffuse cortical malformations, multifocal postnatal lesions, (infectious and traumatic) and Lennox-Gastaut and similar syndromes	EPILEPSIA			English	Article						Transition; Lennox-Gastaut; Cortical malformation; Meningitis; Ence-phalitis; Traumatic brain injury	PRESURGICAL EVALUATION; PERIVENTRICULAR HETEROTOPIA; POSTENCEPHALITIC EPILEPSY; CLINICAL CHARACTERISTICS; INTRACTABLE EPILEPSY; NODULAR HETEROTOPIA; BAND HETEROTOPIA; RISK-FACTORS; MENINGITIS; SURGERY	Patients with epilepsy may have diffuse, serious brain disorders including genetically determined, multilobar malformations, traumatic brain injury, encephalitis and meningitis, and the many causes of Lennox-Gastaut syndrome. Transition to adult care needs to consider concomitant intellectual disability, refractory epilepsy, underlying cause, and other nonneurologic but significant problems, especially for genetic etiologies. Adult epilepsy care coupled with dedicated primary/family care is essential. A multidisciplinary setting may be optimal to address the many issues of clinical care, decision making, custody, and ongoing supervision.	[Camfield, Peter R.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Camfield, Peter R.] IWK Hlth Ctr, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Bahi-Buisson, Nadia] Univ Paris 05, INSERM, U781, Dept Pediat Neurol,Imaging Inst, Paris, France; [Trinka, Eugen] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria		Camfield, PR (corresponding author), IWK Hlth Ctr, 5850 Univ Ave, Halifax, NS B3K 6R8, Canada.	camfield@dal.ca	Bahi-Buisson, Nadia/H-5207-2017	Bahi-Buisson, Nadia/0000-0002-5352-0929; Trinka, Eugen/0000-0002-5950-2692			ANNEGERS JF, 1988, NEUROLOGY, V38, P1407, DOI 10.1212/WNL.38.9.1407; Arzimanoglou A, 2009, LANCET NEUROL, V8, P82, DOI 10.1016/S1474-4422(08)70292-8; Bahi-Buisson N, 2013, HAND CLINIC, V111, P653, DOI 10.1016/B978-0-444-52891-9.00068-3; Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bigby C, 2008, J INTELLECT DEV DIS, V33, P148, DOI 10.1080/13668250802094141; Camfield C, 2008, DEV MED CHILD NEUROL, V50, P859, DOI 10.1111/j.1469-8749.2008.03165.x; Camfield P, 2012, EPILEPSY CURR, V12, P13, DOI 10.5698/1535-7511-12.4s.13; Camfield PR, 2011, EPILEPSIA, V52, P21, DOI 10.1111/j.1528-1167.2011.03179.x; Davies KG, 1996, BRIT J NEUROSURG, V10, P567; Davies KG, 1995, BRIT J NEUROSURG, V9, P759; Dobyns WB, 2010, EPILEPSIA, V51, P5, DOI 10.1111/j.1528-1167.2009.02433.x; Donaire A, 2007, EPILEPTIC DISORD, V9, P127, DOI 10.1684/epd.2007.0098; DUBEAU F, 1995, BRAIN, V118, P1273, DOI 10.1093/brain/118.5.1273; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gilliam F, 2009, EPILEPSY BEHAV, V16, P315, DOI 10.1016/j.yebeh.2009.07.039; Grant AC, 2002, EPILEPSIA, V43, P403, DOI 10.1046/j.1528-1157.2002.42601.x; Jennet B, 1976, HDB CLIN NEUROLOGY, V24, P445; Jennett B, 1979, Adv Neurol, V22, P137; Lancman ME, 1996, EPILEPSY RES, V25, P285, DOI 10.1016/S0920-1211(96)00086-1; Lee WT, 2007, EUR J PAEDIATR NEURO, V11, P302, DOI 10.1016/j.ejpn.2007.02.011; Malinger G, 2007, ULTRASOUND OBST GYN, V29, P178, DOI 10.1002/uog.3906; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; Messori A, 2005, EPILEPSIA, V46, P1472, DOI 10.1111/j.1528-1167.2005.34004.x; Oostenbrink R, 2002, ACTA PAEDIATR, V91, P391, DOI 10.1080/080352502317371616; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Schuh LA, 1998, ARCH NEUROL-CHICAGO, V55, P1325, DOI 10.1001/archneur.55.10.1325; Sellner J, 2013, EUR J NEUROL, V20, P429, DOI 10.1111/j.1468-1331.2012.03842.x; Sellner J, 2012, J NEUROL, V259, P2019, DOI 10.1007/s00415-012-6494-6; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Trinka E, 2000, NEUROLOGY, V54, P2170, DOI 10.1212/WNL.54.11.2170; Trinka E, 2000, EPILEPTIC DISORD, V2, P153; TRINKA E, 2004, HAND CLIN N, V3, P423	33	9	9	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	AUG	2014	55			3	SI		24	28		10.1111/epi.12704			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP5OX	WOS:000342129600007	25209082	Bronze			2022-02-06	
J	Christmas, AB; Freeman, E; Chisolm, A; Fischer, PE; Sachdev, G; Jacobs, DG; Sing, RF				Christmas, A. Britton; Freeman, Elizabeth; Chisolm, Angela; Fischer, Peter E.; Sachdev, Gaurav; Jacobs, David G.; Sing, Ronald F.			Trauma Intensive Care Unit 'Bouncebacks': Identifying Risk Factors for Unexpected Return Admission to the Intensive Care Unit	AMERICAN SURGEON			English	Article							READMISSION; OUTCOMES; HOSPITALS; MORTALITY; SEVERITY	Return transfer (RT) to the intensive care unit (ICU) negatively impacts patient outcomes, length of stay (LOS), and hospital costs. This study assesses the most common events necessitating RT in trauma patients. We performed a retrospective chart review of ICU RT from 2004 to 2008. Patient demographics, injuries and injury severity, reason for transfer, LOS, interventions, and outcomes datawere collected. Overall, 158 patients required readmission to the ICU. Respiratory insufficiency/failure (48%) was the most common reason for RT followed by cardiac (16%) and neurological (13%) events. The most commonly associated injuries were traumatic brain injuries (TBIs) (32%), rib fractures (30%), and pulmonary contusions (20%). Initial ICU LOS was 6.6 +/- 8 days (range, 1 to 44 days) with 4.4 +/- 7.8 ventilator days. Mean floor time before ICU RT was 5.7 +/- 6.3 days (range, 0 to 33 days). Forty-nine patients (31%) required intubation and mechanical ventilation on RT. ICU RT incurred an additional ICU LOS of 8 +/- 8.5 days (range, 1 to 40 days) and 5.2 +/- 7.5 ventilator days. Mortality after a single RT was 10 per cent (n = 16). RT to the ICU most often occurs as a result of respiratory compromise, and patients with TBI are particularly vulnerable. Trauma pulmonary hygiene practices should be evaluated to determine strategies that could decrease RT.	[Christmas, A. Britton; Freeman, Elizabeth; Chisolm, Angela; Fischer, Peter E.; Sachdev, Gaurav; Jacobs, David G.; Sing, Ronald F.] Carolinas Med Ctr, FH Sammy Ross Jr Trauma Ctr, Dept Surg, Charlotte, NC 28232 USA		Christmas, AB (corresponding author), Carolinas Med Ctr, FH Sammy Ross Jr Trauma Ctr, POB 32861, Charlotte, NC 28232 USA.	Ashley.Christmas@carolinashealthcare.org		sachdev, gaurav/0000-0003-4779-8681			Alban RF, 2006, J TRAUMA, V60, P1027, DOI 10.1097/01.ta.0000218217.42861.b7; Bhatia N, 2010, J ANAETH CLIN PHARM, V26, P91; CHALFIN DB, 1995, INTENS CARE MED, V21, P952, DOI 10.1007/BF01712339; Chan KS, 2009, SURG TODAY, V39, P295, DOI 10.1007/s00595-008-3876-6; Chen LM, 1998, CRIT CARE MED, V26, P1834, DOI 10.1097/00003246-199811000-00025; Fakhry SM, 2013, J TRAUMA ACUTE CARE, V74, P1528, DOI 10.1097/TA.0b013e31829247e7; Frost SA, 2009, RESUSCITATION, V80, P505, DOI 10.1016/j.resuscitation.2009.02.015; Ho KM, 2006, J CRIT CARE, V21, P259, DOI 10.1016/j.jcrc.2006.01.005; HOFER TP, 1995, MED CARE, V33, P234, DOI 10.1097/00005650-199503000-00003; Johns TJ, 2014, J TRAUMA NURS, V21, P14, DOI 10.1097/JTN.0000000000000023; Kramer AA, 2012, CRIT CARE MED, V40, P3, DOI 10.1097/CCM.0b013e31822d751e; Metnitz PGH, 2003, INTENS CARE MED, V29, P241, DOI 10.1007/s00134-002-1584-z; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Siddiqui Shahla, 2013, Int Arch Med, V6, P18, DOI 10.1186/1755-7682-6-18; Utzolino S, 2010, J CRIT CARE, V25, P375, DOI 10.1016/j.jcrc.2009.09.009	15	9	9	0	8	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	AUG	2014	80	8					778	782					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AP1FL	WOS:000341812500027	25105397				2022-02-06	
J	Guo, Y; Wang, Y; Huang, X; Lv, HY; Fan, R; Huang, W; Gan, PP; Liu, W; Yan, KP; Xia, Z; Liu, JF				Guo, Yong; Wang, Yang; Huang, Xi.; Lv, Huiying; Fan, Rong; Huang, Wei; Gan, Pingping; Liu, Wei; Yan, Kuipo; Xia, Zian; Liu, Jinfang			Determination of hydroxysafflor yellow A in biological fluids of patients with traumatic brain injury by UPLC-ESI-MS/MS after injection of Xuebijing	BIOMEDICAL CHROMATOGRAPHY			English	Article						hydroxysafflor yellow A; Xuebijing injection; UPLC-MS/MS; traumatic brain injury; biological fluids	LIQUID-CHROMATOGRAPHY; PLASMA; RATS; HPLC	A simple, novel, specific, rapid and reproducible ultra-performance liquid chromatography electrospray ionization tandem mass spectrometry method has been developed and validated for the determination of hydroxysafflor yellow A (HSYA) in biological fluids (plasma, urine and cerebrospinal fluid) of patients with traumatic brain injury after intravenous injection of Xuebijing (XBJ). Liquid-liquid extraction was performed, and separation was carried out on an Acquity UPLC (TM) BEH C-18 column, with gradient elution using a mobile phase composed of methanol and 0.1% formic acid at a flow rate of 0.3 mL/min. A triple quadrupole tandem mass spectrometer with electrospray ionization was used for the detection of HSYA. The mass transition followed was m/z 611.0 -> 491. The retention time was less than 3.0 min. The calibration curve was linear in the concentration range from 2 to 6125 ng/mL for cerebrospinal fluid, plasma and urine. The intra-and inter-day precisions were <10%, and the relative standard deviation of recovery was <15% for HSYA in biological matrices. The method was successfully applied for the first time to quantify HSYA in the biological fluids (especially in cerebrospinal fluid) of patients with traumatic brain injury following intravenous administration of XBJ. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Guo, Yong; Liu, Jinfang] Cent S Univ, Dept Neurosurg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Wang, Yang; Huang, Xi.; Fan, Rong; Huang, Wei; Liu, Wei; Xia, Zian] Cent S Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410008, Hunan, Peoples R China; [Lv, Huiying] Hunan Acad Agr Sci, Hunan Agr Product Proc Inst, Changsha 410125, Hunan, Peoples R China; [Lv, Huiying] Hunan Food Test & Anal Ctr, Changsha 410125, Hunan, Peoples R China; [Gan, Pingping] Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha 410008, Hunan, Peoples R China; [Yan, Kuipo] Henan Coll TCM, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450008, Peoples R China		Liu, JF (corresponding author), Cent S Univ, Dept Neurosurg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China.	569920672@qq.com			Administration of Traditional Chinese Medicine of Hunan Province, China [2010003, 201152, 201141]; Natural Science Foundation of Hunan Province of ChinaNatural Science Foundation of Hunan Province [12JJ5060]; Fundamental Research Funds for the Central University [2012QNZT110]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81202781, 81303074]	This work was supported by supported by the Administration of Traditional Chinese Medicine of Hunan Province, China (nos 2010003, 201152 and 201141), the Natural Science Foundation of Hunan Province of China (no. 12JJ5060), the Fundamental Research Funds for the Central University (no. 2012QNZT110) and the National Natural Science Foundation of China (nos 81202781 and 81303074). Jinfang Liu, Xi Huang, Yong Guo, Yang Wang, Rong Fan, Pingping Gan, Kuipo Yan, Huiying Lv and Zian Xia performed the research; Xi Huang and Jingfang Liu designed the research; Yong Guo analyzed the data; Xi Huang, Yong Guo and Yang Wang wrote the paper.	Bie XD, 2010, J ASIAN NAT PROD RES, V12, P239, DOI 10.1080/10286020903510636; Guo Yong, 2012, Journal of Medicinal Plants Research, V6, P893, DOI 10.5897/JMPR11.1542; Huang H, 2011, PHYTOCHEM ANALYSIS, V22, P330, DOI 10.1002/pca.1284; Huang X, 2009, J ETHNOPHARMACOL, V121, P68, DOI 10.1016/j.jep.2008.10.029; Lei M, 2008, CHINESE J TRADITIONA, V15, P225; Li Y, 2007, BIOMED CHROMATOGR, V21, P326, DOI 10.1002/bmc.769; Li ZJ, 2007, LINGNAN J CRITICAL C, V12, P263; Sun ML, 2009, J ALTERN COMPLEM MED, V15, P1375, DOI 10.1089/acm.2009.0049; The State Pharmacopoeia Commission of China, 2005, PHARM PEOPL REP CH 1, P10; Wang Y, 2011, J ETHNOPHARMACOL, V133, P735, DOI 10.1016/j.jep.2010.11.006; Wen AD, 2008, J CHROMATOGR B, V876, P41, DOI 10.1016/j.jchromb.2008.10.007; Wu T, 2008, CHROMATOGRAPHIA, V68, P803, DOI 10.1365/s10337-008-0788-y; Zhang P., 2002, CHINA J INTEGRATED T, V9, P21; 王学谦, 1999, [中国危重病急救医学, Chinese Critical Care Medicine], V11, P105	14	9	11	2	22	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-3879	1099-0801		BIOMED CHROMATOGR	Biomed. Chromatogr.	AUG	2014	28	8					1090	1095		10.1002/bmc.3124			6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	AL9RE	WOS:000339477600008	24535782				2022-02-06	
J	Miller, BF; Keles, E; Tien, L; Zhang, J; Kaplan, D; Lo, EH; Whalen, MJ				Miller, Benjamin F.; Keles, Eyup; Tien, Lee; Zhang, Jimmy; Kaplan, David; Lo, Eng H.; Whalen, Michael J.			The pharmacokinetics and pharmacodynamics of Kollidon VA64 dissociate its protective effects from membrane resealing after controlled cortical impact in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain injury; controlled cortical impact; Kollidon VA64; mice; models	TRAUMATIC BRAIN-INJURY; CELL-DEATH; PLASMALEMMA PERMEABILITY; REDUCES HISTOPATHOLOGY; MECHANICAL TRAUMA; CEREBRAL-ISCHEMIA; POLOXAMER 188; NEURONS; INFLAMMASOME; PANNEXIN	Membrane-resealing agents such as poloxamer P188 improve the outcome in experimental brain injury paradigms; however, whether membrane resealing is a key mechanism for protection has not been shown in vivo. We previously reported that Kollidon VA64, a polymeric membrane-resealing agent, reduces cell membrane permeability and improves brain edema, brain tissue damage, and functional outcome after controlled cortical impact in mice, without rescuing resealed cells from death. To reconcile these disparate findings, we used a dual-pulse labeling protocol to determine membrane-resealing kinetics by VA64/P188 in vivo. Membrane resealing after controlled cortical impact in mice by intravenous or intracerebroventricular VA64 and poloxamer P188 was transient, with most cells becoming repermeabilized within 2 hours, even with multiple-dose paradigms that maintained high VA64 blood levels. Moreover, VA64 reduced cytotoxic brain edema in a water intoxication model devoid of plasmalemma permeability (P<0.05 versus P188, VA30, mannitol, and vehicle). We conclude that VA64 reduces cytotoxic and traumatic brain edema independent of membrane resealing. The results suggest that classic membrane-resealing agents such as poloxamer P188, and the newly discovered VA64, exert protective effects in central nervous system injury paradigms by mechanisms other than or in addition to maintaining permeable cell membranes sealed.	[Miller, Benjamin F.; Keles, Eyup; Zhang, Jimmy; Lo, Eng H.; Whalen, Michael J.] Massachusetts Gen Hosp, Ctr Neurosci, Harvard Med Sch, Charlestown, MA USA; [Miller, Benjamin F.; Keles, Eyup; Zhang, Jimmy; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Charlestown, MA 02129 USA; [Tien, Lee; Kaplan, David] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA		Whalen, MJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Charlestown, MA 02129 USA.	mwhalen@partners.org		Miller, Benjamin/0000-0003-1647-0122	 [RO1NS061255]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061255, P01NS055104] Funding Source: NIH RePORTER	This work was supported by RO1NS061255 (MJW).	Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bargiotas P, 2012, CHANNELS, V6, P453, DOI 10.4161/chan.22315; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; BLESSING MH, 1974, VIRCHOWS ARCH A, V362, P115, DOI 10.1007/BF00432390; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Dahl G, 2012, BRAIN RES, V1487, P150, DOI 10.1016/j.brainres.2012.04.058; Dalkara T, 2011, ACTA NEUROPATHOL, V122, P1, DOI 10.1007/s00401-011-0847-6; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kilinc D, 2007, P ANN INT IEEE EMBS, P5395, DOI 10.1109/IEMBS.2007.4353562; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; MULLER K, 1968, PHARM ACTA HELV, V43, P107; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Xiong XX, 2014, NEUROCHEM RES, V39, P216, DOI 10.1007/s11064-013-1212-z; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhu XX, 2012, STROKE, V43, P524, DOI 10.1161/STROKEAHA.111.635672	32	9	9	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2014	34	8					1347	1353		10.1038/jcbfm.2014.89			7	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AM4ZG	WOS:000339864100011	24824916	Green Published, Bronze			2022-02-06	
J	Qin, J; Zhang, RX; Li, JL; Wang, JX; Hou, J; Yang, X; Zhu, WL; Shi, J; Lu, L				Qin, Jing; Zhang, Ruo-Xi; Li, Jia-Li; Wang, Jian-Xin; Hou, Jia; Yang, Xu; Zhu, Wei-Li; Shi, Jie; Lu, Lin			cRGD mediated liposomes enhanced antidepressant-like effects of edaravone in rats	EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						cRGD liposomes; Edaravone; Cytokine; Antidepressant; Brain targeting drug delivery	TRAUMATIC BRAIN-INJURY; FREE-RADICAL SCAVENGER; MAJOR DEPRESSION; DRUG-DELIVERY; IN-VITRO; CONVERTING-ENZYME; NERVOUS-SYSTEM; THP-1 CELLS; TNF-ALPHA; C-FOS	The delayed onset of therapeutic outcomes is a major drawback of the current antidepressants. The blood-brain barrier is the most important bottleneck impeding drug transport into the brain. Therefore, development of novel antidepressant medications with rapid onset and sustained activity is urgent. RGD liposomes showed an excellent effect of brain-targeting drug delivery and increased the entering rate to the brain. In the present study, we prepared cyclic RGD liposomes loaded with edaravone (cRGD-ERLs) and evaluated the potential antidepressant-like effects of this drug delivery system in rats. The results showed single injection of cRGD-ERLs produced significant antidepressant-like effects in both forced swim and novelty suppressed feeding test. Moreover, acute cRGD-ERLs increased the expression of c-fos in the medial prefrontal cortex, suggesting that cRGD-ERLs could activate the neuronal function. Furthermore, cRGD-ERLs reversed the increase of lipopolysaccharides (LPS)-induced plasma cytokine IL-1 beta and IL-6, suggesting that normalization of cytokine level might be involved in the behavioral response of cRGD-ERLs. Finally, cRGD-ERLs prevented the increase of immobility induced by LPS in the forced swim test. Overall, the current data revealed a novel brain-target drug delivery system, which can be used to improve the therapeutic outcomes of antidepressants by increase of crossing rate to the brain. (C) 2014 Elsevier B.V. All rights reserved.	[Qin, Jing; Wang, Jian-Xin; Hou, Jia; Yang, Xu] Fudan Univ, Sch Pharm, Dept Pharmaceut, Key Lab Smart Drug Delivery,Minist Educ, Shanghai 201203, Peoples R China; [Zhang, Ruo-Xi; Li, Jia-Li; Zhu, Wei-Li; Shi, Jie; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100191, Peoples R China		Zhu, WL (corresponding author), Peking Univ, Natl Inst Drug Dependence, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	zhu_wl@bjmu.edu.cn	Wang, Jianxin/C-9435-2016		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81102386, 81371489]; Specialized Research Fund for the Doctoral Program of Higher EducationSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20110071120042]; School of Pharmacy, Fudan University & The Open Project Program of Key Lab of Smart Drug Delivery (Fudan University), Ministry of Education, China; Beijing Higher Education Young Elite Teacher Project [YETP0068]	This work was supported by National Natural Science Foundation of China (No. 81102386, 81371489), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20110071120042), School of Pharmacy, Fudan University & The Open Project Program of Key Lab of Smart Drug Delivery (Fudan University), Ministry of Education, China and Beijing Higher Education Young Elite Teacher Project (YETP0068).	Adham KG, 2012, NEUROENDOCRINOL LETT, V33, P713; Afergan E, 2008, J CONTROL RELEASE, V132, P84, DOI 10.1016/j.jconrel.2008.08.017; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2009, PHYSIOL BEHAV, V98, P351, DOI 10.1016/j.physbeh.2009.06.013; Batrakova EV, 2011, EXPERT OPIN DRUG DEL, V8, P415, DOI 10.1517/17425247.2011.559457; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Besedovsky H O, 1988, Recenti Prog Med, V79, P300; Beumer W, 2012, J LEUKOCYTE BIOL, V92, P959, DOI 10.1189/jlb.0212100; Blume J, 2011, BRAIN BEHAV IMMUN, V25, P221, DOI 10.1016/j.bbi.2010.10.008; BODNOFF SR, 1988, PSYCHOPHARMACOLOGY, V95, P298; Brynskikh AM, 2010, NANOMEDICINE-UK, V5, P379, DOI [10.2217/nnm.10.7, 10.2217/NNM.10.7]; Chen Y, 2012, ADV DRUG DELIVER REV, V64, P640, DOI 10.1016/j.addr.2011.11.010; Cumurcu BE, 2009, PSYCHIAT CLIN NEUROS, V63, P639, DOI 10.1111/j.1440-1819.2009.02004.x; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dong J, 2005, NEUROTOXICOLOGY, V26, P417, DOI 10.1016/j.neuro.2005.03.003; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Fossati P, 2004, EUR NEUROPSYCHOPHARM, V14, pS503, DOI 10.1016/j.euroneuro.2004.09.001; Galecki P, 2009, PHARMACOL REP, V61, P436; Gawryluk JW, 2011, INT J NEUROPSYCHOPH, V14, P123, DOI 10.1017/S1461145710000805; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Cohn DWH, 2012, ANN NY ACAD SCI, V1262, P67, DOI 10.1111/j.1749-6632.2012.06635.x; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; Hironaka K, 2011, EUR J PHARM BIOPHARM, V79, P119, DOI 10.1016/j.ejpb.2011.01.019; Hwang SH, 1999, INT J PHARM, V179, P85, DOI 10.1016/S0378-5173(98)00392-5; Isahaya K, 2012, J STROKE CEREBROVASC, V21, P102, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.009; Johnson JD, 2008, BRAIN BEHAV IMMUN, V22, P1078, DOI 10.1016/j.bbi.2008.03.007; Jonsdottir G, 2013, NEUROBIOL AGING, V34, P1389, DOI 10.1016/j.neurobiolaging.2012.11.012; Kaur C, 2008, CURR MED CHEM, V15, P3068, DOI 10.2174/092986708786848640; Kikuta M, 2013, J PHARMACOL SCI, V121, P74, DOI 10.1254/jphs.12162FP; Kim YK, 2008, PROG NEURO-PSYCHOPH, V32, P356, DOI 10.1016/j.pnpbp.2007.08.041; Klyachko N.L., 2013, NANOMEDICINE LONDON; Ko YT, 2009, J CONTROL RELEASE, V133, P230, DOI 10.1016/j.jconrel.2008.10.013; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Li P, 1997, J CELL BIOCHEM, V64, P27, DOI 10.1002/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Maslanik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050636; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Motivala SJ, 2005, PSYCHOSOM MED, V67, P187, DOI 10.1097/01.psy.0000149259.72488.09; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Pardridge William M, 2005, NeuroRx, V2, P3; Perry VH, 1997, MOL MED TODAY, V3, P335, DOI 10.1016/S1357-4310(97)01077-0; PERRY VH, 1995, CURR OPIN NEUROBIOL, V5, P636, DOI 10.1016/0959-4388(95)80069-7; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Qin J, 2008, DRUG DEV IND PHARM, V34, P602, DOI 10.1080/03639040701833559 ; Qin J, 2007, YAKUGAKU ZASSHI, V127, P1497, DOI 10.1248/yakushi.127.1497; Qin J, 2007, CHEM PHARM BULL, V55, P1192, DOI 10.1248/cpb.55.1192; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Sitrin RG, 2000, J IMMUNOL, V165, P3341, DOI 10.4049/jimmunol.165.6.3341; Sundquist SJ, 2005, J NEUROSCI METH, V141, P9, DOI 10.1016/j.jneumeth.2004.05.007; Suzuki K, 2009, ADV DRUG DELIVER REV, V61, P287, DOI 10.1016/j.addr.2009.03.002; Tajima S, 2008, RESPIROLOGY, V13, P646, DOI 10.1111/j.1440-1843.2008.01322.x; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Xu CM, 2009, J NEUROCHEM, V111, P1357, DOI 10.1111/j.1471-4159.2009.06414.x; Yao JH, 1997, MOL BRAIN RES, V51, P170, DOI 10.1016/S0169-328X(97)00235-0; Yin J, 2011, J DRUG TARGET, V19, P25, DOI 10.3109/10611861003663531; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006; Zhan CY, 2011, J DRUG TARGET, V19, P573, DOI 10.3109/1061186X.2010.542244; Zhan CY, 2010, J CONTROL RELEASE, V143, P136, DOI 10.1016/j.jconrel.2009.12.020; Zhu YQ, 2005, AM J PHYSIOL-CELL PH, V289, pC1085, DOI 10.1152/ajpcell.00185.2005	64	9	11	2	29	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-0987	1879-0720		EUR J PHARM SCI	Eur. J. Pharm. Sci.	JUL 16	2014	58						63	71		10.1016/j.ejps.2014.03.006			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AI4IL	WOS:000336828800008	24704101				2022-02-06	
J	Feddermann-Demont, N; Straumann, D; Dvorak, J				Feddermann-Demont, Nina; Straumann, Dominik; Dvorak, Jiri			Return to play management after concussion in football: recommendations for team physicians	JOURNAL OF SPORTS SCIENCES			English	Article						sports; soccer; mild traumatic brain injury; head injury; recovery	CHRONIC TRAUMATIC ENCEPHALOPATHY; SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; HIGH-SCHOOL; NEUROPSYCHOLOGICAL ASSESSMENT; PROFESSIONAL FOOTBALL; CONSENSUS STATEMENT; POSITION STATEMENT; HEAD IMPACTS; SOCCER	A concussion is a rare but potentially serious injury of football players. Thus, an immediate and valid diagnosis, estimate of severity and therapeutic management is required. To summarise the published information on management of concussion with respect to a safe return to play (RTP), a literature search was conducted. Current guidelines on concussion in sports and significant studies on concussion in football were analysed. After concussion, management and RTP decision should remain in the area of clinical judgement on an individualised basis according to the current international guidelines. If a concussion is suspected, the player should not be allowed to RTP the same day. The RTP programme should follow a gradual step-wise procedure. A concussed player should not RTP unless he/she is asymptomatic and the neurological and neuropsychological examinations are normal. Untimely RTP bears an increased risk of sustaining another more severe brain injury and repetitive brain injury of long-term sequelae. In football, the management of concussion should primarily follow the recommendations proposed by the Concussion in Sports Group. Information and education of players and their medical and coaching team help to protect the players' health. Future studies on concussion should include validated and detailed information on RTP protocols.	[Feddermann-Demont, Nina; Straumann, Dominik] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Feddermann-Demont, Nina; Dvorak, Jiri] FIFA Med Assessment & Res Ctr, Zurich, Switzerland; [Dvorak, Jiri] Schulthess Clin, Dept Neurol, Zurich, Switzerland; [Dvorak, Jiri] FIFA, Zurich, Switzerland		Feddermann-Demont, N (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	Nina.Feddermann@usz.ch					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Aubry M, 2013, BRIT J SPORT MED, V47, P249, DOI 10.1136/bjsports-2012-092114; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Cantu RC, 2006, NEUROSURG FOCUS, V21, P1, DOI [10.3171/foc.2006.21.4.4, DOI 10.3171/FOC.2006.21.4.4]; Casson IR, 2009, PHYS MED REH CLIN N, V20, P195, DOI 10.1016/j.pmr.2008.10.006; Casson IR, 2009, ARCH NEUROL-CHICAGO, V66, P419, DOI 10.1001/archneurol.2008.592; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kutcher JS, 2010, SPORTS HEALTH, V2, P197, DOI 10.1177/1941738109357305; Kutcher Jeffrey S, 2010, Continuum (Minneap Minn), V16, P41, DOI 10.1212/01.CON.0000391452.30299.67; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2013, NAT REV NEUROL, V9, P361, DOI 10.1038/nrneurol.2013.88; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Price J, 2012, BRIT J SPORT MED, V46, P1000, DOI 10.1136/bjsports-2011-090687; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; SMITH HK, 1991, NEUROSURGERY, V29, P258, DOI 10.1227/00006123-199108000-00016; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; TEASDALE G, 1974, LANCET, V2, P81; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	69	9	9	1	41	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	JUL	2014	32	13					1217	1228		10.1080/02640414.2014.918273			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AM8FP	WOS:000340107900004	24902964				2022-02-06	
J	Huang, X; Sun, Y; Xu, J; Wen, L; Cao, YL; Yang, XF				Huang Xin; Sun Yun; Xu Jun; Wen Liang; Cao Ye-Lin; Yang Xiao-Feng			Long-term Outcomes After Shunt Implantation in Patients With Posttraumatic Hydrocephalus and Severe Conscious Disturbance	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Traumatic brain injury; posttraumatic hydrocephalus; chronic unconscious; shunt implantation; outcomes	VEGETATIVE STATE; HEAD-INJURY; NEUROPATHOLOGY; PRESSURE	Background: Posttraumatic hydrocephalus (PTH) is a frequent complication secondary to traumatic brain injury, especially among patients keeping chronic unconscious. And effects of shunt implantation on improving outcomes among these patients are still controversial. This study was aimed to assess the long-term outcomes following shunt implantation among patients who had PTH and kept chronic unconscious. Methods: A prospective study was performed to include patients who had PTH and remained in severe conscious disturbance from March 2010 to December 2010. All of included patients would have shunt implantation and be closely followed up at least for 2 years to assess final outcomes. Results: Fifteen patients having PTH were identified. Before shunt implantation, 2 patients kept vegetative state (Glasgow Outcome Scale [GOS] score 2), and 13 patients kept minimally consciousness with severe disability (GOS score 3). After shunt implantation, the shunt device was removed because of intracranial infection in 1 patient, and the other patient died because of allergic shock. Among the remaining 13 patients, finally 7 patients had improvement on GOS or Modified Barthel Index (MBI) score during the 2-year follow-up, but only 1 patient achieved a good outcome (GOS score 4, independent life). Among them, 5 patients' outcomes improved as assessed by GOS or MBI score during the first 3 months following shunt implantation. During the fourth to sixth month following shunt implantation, there were 2 patients who showed first rise on GOS or MBI score. Beyond 6 months, no patient showed initial improvement. And among patients who showed improvement, most of them kept improving during a certain time. Conclusions: A proportion of patients who had PTH and remained in severe conscious disturbance would benefit from shunt implantation, and the improvement may turn up late after this procedure.	[Huang Xin; Sun Yun; Xu Jun; Wen Liang; Cao Ye-Lin; Yang Xiao-Feng] Zhejiang Univ, Coll Med, Dept Neurosurg, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Coll Med, Dept Neurosurg, Affiliated Hosp 1, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	zjcswk@126.com			Science Technology Department of Zhejiang Province [2013C33160]	This work was supported by Science Technology Department of Zhejiang Province (2013C33160).	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Bech-Azeddine R, 2005, ACTA NEUROCHIR, V147, P1027, DOI 10.1007/s00701-005-0589-0; Bernat JL, 2010, NEUROLOGY, V75, pS33, DOI 10.1212/WNL.0b013e3181fb35dd; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Guyot LL, 2000, NEUROL RES, V22, P25; Hong Z, 2006, CHINESE J NEUROMEDIC, V5, P1238; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Licata C, 2001, J Neurosurg Sci, V45, P141; Low CYD, 2013, J CLIN NEUROSCI, V20, P867, DOI 10.1016/j.jocn.2012.06.007; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Meier U, 2004, EUR NEUROL, V51, P59, DOI 10.1159/000075345; Miki T, 2006, J TRAUMA, V61, P985, DOI 10.1097/01.ta.0000239665.39237.8c; Missori P, 2006, NEUROSURG REV, V29, P224, DOI 10.1007/s10143-006-0027-7; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Tribl G, 2000, BRAIN INJURY, V14, P345; Wen L, 2009, BRAIN INJURY, V23, P61, DOI 10.1080/02699050802635265	18	9	10	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	2014	25	4					1280	1283		10.1097/SCS.0000000000000583			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AN0EZ	WOS:000340257800076	25006909				2022-02-06	
J	Eismann, EA; Cosco, ED; Wall, EJ				Eismann, Emily A.; Cosco, Emily D.; Wall, Eric J.			Absence of Radiographic Abnormalities in Nursemaid's Elbows	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						radial head subluxation; pulled elbow; annular ligament; RCL; fat pad; proximal; radial length	RADIAL HEAD SUBLUXATION; FAT PAD SIGN; PULLED ELBOW; CHILDREN; INJURY; TRAUMA	Background: Disagreement exists between physicians on the usefulness of a prereduction radiograph for diagnosis and treatment of nursemaid's elbows in children. Some evidence suggests that nursemaid's elbows have identifying features on radiographs. This study compares the radiographs of nursemaid's elbows to normal, control elbows in children and hypothesizes that differentiating features do not exist on radiograph. Methods: For this retrospective case-control study, hospital billing records were searched to identify all patients under age 6 treated with closed reduction for a nursemaid's elbow between November 2005 and October 2009. Twenty-seven nursemaid's elbows were age-matched and sex-matched to 27 normal "comparison view," control elbows. Radiocapitellar line offset, proximal radial length, anterior fat pad angle, and visibility of the posterior fat pad were measured on the radiographs by 2 raters. Their interrater reliability was assessed with intraclass correlations, and the nursemaid's and control elbow measures were compared using Wilcoxon tests. Results: Nursemaid's elbows and healthy control elbows did not differ significantly in offset of the radiocapitellar line from the capitellum center on anteroposterior (P = 0.49) or lateral views (P = 0.67), in proximal radial length (P = 0.95), anterior fat pad angle (P = 0.49), or posterior fat pad visibility (P = 1.00) on lateral views. Conclusions: Nursemaid's elbows are indistinguishable from healthy elbows on radiograph. Thus, the term "radial head subluxation" appears to be a misnomer, and prereduction radiographs should only be used to eliminate the possibility of fracture. From a radiologic perspective, nursemaid's elbows remain a diagnosis of exclusion.	[Eismann, Emily A.; Cosco, Emily D.; Wall, Eric J.] Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, Cincinnati, OH 45229 USA		Wall, EJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, 3333 Burnet Ave,MLC 2017, Cincinnati, OH 45229 USA.	eric.wall@cchmc.org			Division of Orthopaedic Surgery at Cincinnati Children's Hospital Medical Center	This study was internally supported by the Division of Orthopaedic Surgery at Cincinnati Children's Hospital Medical Center. No external funding was secured for this study. The authors have no financial relationships relevant to this article to disclose.	Blumberg SM, 2011, PEDIATR EMERG CARE, V27, P596, DOI 10.1097/PEC.0b013e318222553b; BRETLAND PM, 1994, BRIT J RADIOL, V67, P1176, DOI 10.1259/0007-1285-67-804-1176; Diab HS, 2010, J CHILD ORTHOP, V4, P539, DOI 10.1007/s11832-010-0298-y; FRUMKIN K, 1985, ANN EMERG MED, V14, P690, DOI 10.1016/S0196-0644(85)80890-8; Green N. E, 2009, SKELETAL TRAUMA CHIL, V3, P207; ILLINGWORTH CM, 1975, BRIT MED J, V2, P672, DOI 10.1136/bmj.2.5972.672; Iyer RS, 2012, AM J ROENTGENOL, V198, P1053, DOI 10.2214/AJR.10.7314; KOSUWON W, 1993, J BONE JOINT SURG BR, V75, P421, DOI 10.1302/0301-620X.75B3.8496211; Kraus R, 2010, ACTA ORTHOP BELG, V76, P312; Kunkel S, 2011, J PEDIATR ORTHOPED, V31, P628, DOI 10.1097/BPO.0b013e3182210988; MCCARTHY SM, 1982, SKELETAL RADIOL, V7, P239, DOI 10.1007/BF00361979; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; MEHARA AK, 1995, INT ORTHOP, V19, P174; MILLER TO, 1975, NEW YORK STATE J MED, V75, P80; QUAN L, 1985, AM J DIS CHILD, V139, P1194, DOI 10.1001/archpedi.1985.02140140028018; Rodts MF, 2009, ORTHOP NURS, V28, P163, DOI 10.1097/NOR.0b013e3181ada7b1; SACCHETTI A, 1990, Journal of Emergency Medicine, V8, P151, DOI 10.1016/0736-4679(90)90224-J; SALTER RB, 1971, CLIN ORTHOP RELAT R, P134; Sankar NS, 1999, J ROY SOC MED, V92, P462, DOI 10.1177/014107689909200907; Skaggs DL, 1999, J BONE JOINT SURG AM, V81A, P1429, DOI 10.2106/00004623-199910000-00007; SNYDER H S, 1990, Journal of Emergency Medicine, V8, P265, DOI 10.1016/0736-4679(90)90003-E	21	9	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JUN	2014	34	4					426	431					6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	AJ5RQ	WOS:000337745100011	24276229				2022-02-06	
J	Huff, JS; Jahar, S				Huff, J. Stephen; Jahar, Sandeep			Differences in interpretation of cranial computed tomography in ED traumatic brain injury patients by expert neuroradiologists	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article								Cranial computed tomography (CT) is generally regarded as the standard for evaluation of structural brain injury in patients with traumatic brain injury (TBI) presenting to the emergency department (ED). However, the subjective nature of the visual interpretations of CT scans and the qualitative nature of reporting may lead to poor interrater reliability. This is significant because CT positive scans include a continuum of structural injury with differences in treatment. The purpose of the present study was to evaluate the consistency of readings of head CT scans obtained within 24 hours after mild TBI in the ED, as assessed by an independent adjudication panel of 3 experienced neuroradiologists. In 80.1% of the cases, all 3 adjudicators agreed with the determination of the presence of structural injury. However, when interrater agreement was assessed with respect to the specific classification of the injury, agreement was poor, with a. of 0.3 (0.29-0.316; confidence interval [CI] 95%). When classification was collapsed, considering only the presence or absence of hematomas, agreement among all 3 adjudicators improved to 55%, but the. of 0.355, (0.332-0.78; CI 95%) was still only fair. The data suggest the need for improved recognition and quantification of specific structural injuries in the TBI population for better identification of patients requiring clinical intervention. (C) 2014 Elsevier Inc. All rights	[Huff, J. Stephen] Univ Virginia, Dept Emergency Med, Charlottesville, VA 22908 USA; [Huff, J. Stephen] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA; [Jahar, Sandeep] UCONN Sch Med, Dept Emergency Med, Farmington, CT USA		Huff, JS (corresponding author), Univ Virginia, Dept Emergency Med, POB 800699, Charlottesville, VA 22908 USA.	huff@virginia.edu			BrainScope Company, Inc, Bethesda, MD; Department of DefenseUnited States Department of Defense [W911QY-12-C-0004]	This research was supported in part by BrainScope Company, Inc, Bethesda, MD, who granted expenses related to data acquisition and in part from the Department of Defense, contract no. W911QY-12-C-0004, Assessment of Head Injury in the Emergency Department.	Erly WK, 2002, AM J NEURORADIOL, V23, P103; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Khoo NC, 2007, EMERG MED AUSTRALAS, V19, P122, DOI 10.1111/j.1742-6723.2007.00914.x; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Molina DK, 2007, J TRAUMA, V63, P625, DOI 10.1097/01.ta.0000236055.33085.77; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Stiell IG, 2010, ACAD EMERG MED, V7, P572; Viera AJ, 2005, FAM MED, V37, P360	8	9	9	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUN	2014	32	6					606	608		10.1016/j.ajem.2014.03.010			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AI1AK	WOS:000336581800022	24731934				2022-02-06	
J	Vaaramo, K; Puljula, J; Tetri, S; Juvela, S; Hillbom, M				Vaaramo, Kalle; Puljula, Jussi; Tetri, Sami; Juvela, Seppo; Hillbom, Matti			Predictors of new-onset seizures: a 10-year follow-up of head trauma subjects with and without traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							RANDOMIZED CONTROLLED-TRIAL; BRIEF INTERVENTION; EMERGENCY-DEPARTMENT; SUBSTANCE MISUSE; DRINKING; OUTCOMES	Background It is not known whether alcohol-related head trauma predicts the new-onset seizures, particularly alcohol-related seizures. Objective We investigated risk factors for new-onset seizures in a cohort of 739 head trauma subjects. Methods All subjects with head trauma attending Oulu University Hospital during 1999, including children and very old people but excluding persons with previous seizures and/or neurological diseases, were enrolled and followed up until the end of 2009. The Finnish National Hospital Discharge Register was used to identify all visits due to seizures during the 10-year follow-up. Dates of death were obtained from the official Cause-of-Death Statistics. Cox proportional hazard regression models and Kaplan-Meier survival curves were used to identify predictors of new-onset seizures. Results New-onset seizures were observed in 42 out of the 739 subjects (5.7%). An alcohol-related index injury (adjusted HR 2.50, 95% CI 1.30 to 4.82, p=0.006), moderate-to-severe traumatic brain injury (TBI) as the index trauma (3.13, 1.46 to 6.71, p=0.003) and preceding psychiatric disease (3.23, 1.23 to 9.21, p=0.028) were significant predictors of new-onset seizures during the follow-up after adjustment for age and sex. An alcohol-related index injury was the only independent predictor of the occurrence of an alcohol-related new-onset seizure (adjusted HR 12.13, 95% CI 2.70 to 54.50, p=0.001), and these seizures (n=19) developed more frequently among subjects without (n=14) than with (n=5) TBI. Conclusions We conclude that alcohol-related head trauma predicts new-onset seizures, particularly alcohol-related seizures. A brief intervention is needed in order to prevent the development of alcohol-related seizures.	[Vaaramo, Kalle; Puljula, Jussi; Hillbom, Matti] Oulu Univ Hosp, Dept Neurol, Oulu 90029, Finland; [Tetri, Sami] Oulu Univ Hosp, Dept Neurosurg, Oulu 90029, Finland; [Juvela, Seppo] Univ Helsinki, Dept Clin Neurosci, Helsinki, Finland		Tetri, S (corresponding author), Oulu Univ Hosp, Dept Neurosurg, Kajaanintie 52, Oulu 90029, Finland.	sami.tetri@oulu.fi		Juvela, Seppo/0000-0003-4944-4983			Adelow C, NEUROLOGY; American College of Surgeons, 2006, RES OPT CAR INJ PAT; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Blow FC, 2006, J STUD ALCOHOL, V67, P568, DOI 10.15288/jsa.2006.67.568; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; CHAN AWK, 1985, EPILEPSIA, V26, P323, DOI 10.1111/j.1528-1157.1985.tb05658.x; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; De Reuck J, 2011, CLIN NEUROL NEUROSUR, V113, P469, DOI 10.1016/j.clineuro.2011.02.004; EARNEST MP, 1976, EPILEPSIA, V17, P387, DOI 10.1111/j.1528-1157.1976.tb04450.x; HILLBOM ME, 1980, EPILEPSIA, V21, P459, DOI 10.1111/j.1528-1157.1980.tb04296.x; Murthy P, 2012, CURR OPIN PSYCHIATR, V25, P194, DOI 10.1097/YCO.0b013e328351a3e0; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; PIENINKEROINEN IP, 1992, ALCOHOL CLIN EXP RES, V16, P955, DOI 10.1111/j.1530-0277.1992.tb01899.x; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Sander AM, 2012, J HEAD TRAUMA REHAB, V27, P319, DOI 10.1097/HTR.0b013e318269838c; Shetty V, 2011, J ORAL MAXIL SURG, V69, P2396, DOI 10.1016/j.joms.2010.12.040; Smith AJ, 2003, ADDICTION, V98, P43, DOI 10.1046/j.1360-0443.2003.00251.x; VICTOR M., 1967, EPILEPSIA, V8, P1; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	23	9	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2014	85	6					598	602		10.1136/jnnp-2012-304457			5	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	AH4UP	WOS:000336124400006	23761917	Green Published, Bronze			2022-02-06	
J	Leroux, P; Omouendze, PL; Roy, V; Dourmap, N; Gonzalez, BJ; Brasse-Lagnel, C; Carmeliet, P; Leroux-Nicollet, I; Marret, S				Leroux, Philippe; Omouendze, Priscilla L.; Roy, Vincent; Dourmap, Nathalie; Gonzalez, Bruno J.; Brasse-Lagnel, Carole; Carmeliet, Peter; Leroux-Nicollet, Isabelle; Marret, Stephane			Age- Dependent Neonatal Intracerebral Hemorrhage in Plasminogen Activator Inhibitor 1 Knockout Mice	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Brain hemorrhage; Hyperactivity; Mouse; Neonate; Plasminogen activator inhibitor 1 (PAI-1); Preterm; Tissue plasminogen activator (t-PA)	MICROVASCULAR ENDOTHELIAL-CELLS; ISCHEMIC BRAIN-INJURY; GENE DEFICIENT MICE; GERMINAL MATRIX; PREMATURE-INFANTS; INTRAVENTRICULAR HEMORRHAGE; STROMELYSIN-1 MMP-3; CEREBRAL-CORTEX; PRETERM INFANTS; CHILDREN BORN	Intracerebral-intraventricular hemorrhages (ICH/IVH) in very preterm neonates are responsible for high mortality and subsequent disabilities. In humans, tissue plasminogen activator (t-PA) initiates fibrinolysis and activates endoluminal-endothelial receptors; dysfunction of the t-PA inhibitor (PAI-1) results in recurrent hemorrhages. We used PAI-1 knockout (PAI-1(-/-)) mice to examine the role of t-PA in age-dependent intracranial hemorrhages as a possible model of preterm ICH/IVH. Intracortical injection of 2 L of phosphate-buffered saline produced a small traumatic injury and a high rate of hemorrhage in PAI-1(-/-) pups at postnatal day 3 (P3) or P5, whereas it had no effect in wild-type neonates. This resulted in white matter and cortical lesions, ventricle enlargement, hyperlocomotion, and altered cortical levels of serotonin and dopamine in the adult PAI(-/-) mice. N-methyl-D-aspartate receptor blockers, plasmin- and matrix metalloproteinases inhibitors reduced hemorrhage and tissue lesions. In contrast to P3 to P5, no significant hemorrhages were induced in P10 PAI-1(-/-) pups and there were no behavioral or neurochemical alterations in adulthood. These data suggest that microvascular immaturity up to P5 in mice is a determinant factor required for t-PA-dependent vascular rupture. Neonatal PAI-1(-/-) mice could be a useful ICH/IVH model for studying the ontogenic window of vascular immaturity and vascular protection against later neurodisabilities.	[Leroux, Philippe; Omouendze, Priscilla L.; Dourmap, Nathalie; Gonzalez, Bruno J.; Brasse-Lagnel, Carole; Leroux-Nicollet, Isabelle; Marret, Stephane] Univ Rouen, PSY NCA, Lab Microvasc Endothelium & Neonate Brain Les, Rouen, France; [Roy, Vincent] Univ Rouen, PSY NCA, Inst Res & Innovat Biomed, INSERM,Reg Haute Normandie Team,ERI 28, Rouen, France; [Roy, Vincent] Univ Rouen, PSY NCA, Lab Psychol & Neurosci Cognit & Affects, Rouen, France; [Brasse-Lagnel, Carole] Rouen Univ Hosp, Dept Biochem, Rouen, France; [Marret, Stephane] Rouen Univ Hosp, IBC, Rouen, France; [Marret, Stephane] Rouen Univ Hosp, Dept Neonatal Pediat & Intens Care, Rouen, France; [Carmeliet, Peter] VIB, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, Ghent, Belgium; [Carmeliet, Peter] Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium		Leroux, P (corresponding author), INSERM, Fac Med & Pharm, Microvasc Endothelium & Neonatal Brain Les Lab Ne, ERI 28, 22 Blvd Gambetta, F-76183 Rouen, France.	philippe.leroux@univ-rouen.fr	Gonzalez, Bruno/E-6103-2016; Carmeliet, Peter/AAQ-5140-2020; Roy, Vincent/B-7910-2008; Leroux, Philippe/M-2002-2018	Gonzalez, Bruno/0000-0002-7176-1320; Carmeliet, Peter/0000-0001-7961-1821; Omouendze Mouaragadja, Priscilla/0000-0002-0340-2895; DOURMAP, nathalie/0000-0002-9453-5828; leroux-nicollet, isabelle/0000-0001-6134-3304; Roy, Vincent/0000-0002-1460-3932; Marret, Stephane/0000-0002-2858-148X	Region Haute-NormandieRegion Normandie; INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; Rouen University; FEDEREuropean Commission; European Leucodystrophies Association; Naitre et Vivre Haute NormandieRegion Normandie; Gabon Republic; Flemish GovernmentEuropean Commission; Belgian Research Fund (FWO)	Supported by Region Haute-Normandie, INSERM, Rouen University, FEDER, European Leucodystrophies Association and Naitre et Vivre Haute Normandie. PO received a doctoral fellowship of Gabon Republic. PC is supported by long-term Methusalem Funding from the Flemish Government and by the Belgian Research Fund (FWO).	Ballabh P, 2004, PEDIATR RES, V56, P117, DOI 10.1203/01.PDR.0000130472.30874.FF; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Casse F, 2012, J NEUROSCI, V32, P5186, DOI 10.1523/JNEUROSCI.5296-11.2012; Chen JP, 1996, BLOOD COAGUL FIBRIN, V7, P289, DOI 10.1097/00001721-199604000-00002; El-Khoury N, 2006, PEDIATR RES, V59, P673, DOI 10.1203/01.pdr.0000214975.85311.9c; Georgiadis P, 2008, STROKE, V39, P3378, DOI 10.1161/STROKEAHA.107.510883; Henry VJ, 2013, NEUROBIOL DIS, V50, P201, DOI 10.1016/j.nbd.2012.10.020; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Hultman K, 2010, NEUROSCIENCE, V166, P408, DOI 10.1016/j.neuroscience.2010.01.002; Kim JA, 2006, J CEREBR BLOOD F MET, V26, P209, DOI 10.1038/sj.jcbfm.9600181; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Legros H, 2009, J CEREBR BLOOD F MET, V29, P1146, DOI 10.1038/jcbfm.2009.39; Leroux P, 2013, ARCH DIS CHILD-FETAL, V98, pF281, DOI 10.1136/archdischild-2012-303603; Lijnen HR, 2000, J BIOL CHEM, V275, P37645, DOI 10.1074/jbc.M006475200; MARRET S, 1995, J NEUROPATH EXP NEUR, V54, P358, DOI 10.1097/00005072-199505000-00009; Marret S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062683; Marret S, 2010, PEDIATRICS, V125, pE29, DOI 10.1542/peds.2009-0994; Marsden CA, 2009, NEUROPHARMACOLOGY, V57, P577, DOI 10.1016/j.neuropharm.2009.08.016; Mehta R, 2008, HAEMOPHILIA, V14, P1255, DOI 10.1111/j.1365-2516.2008.01834.x; Nagai N, 2005, J THROMB HAEMOST, V3, P1379, DOI 10.1111/j.1538-7836.2005.01466.x; Nassar T, 2004, BLOOD, V103, P897, DOI 10.1182/blood-2003-05-1685; Nelson KB, 2005, PEDIATR RES, V57, P494, DOI 10.1203/01.PDR.0000156477.00386.E7; Omouendze PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071263; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Puumala T, 1998, NEUROSCIENCE, V83, P489, DOI 10.1016/S0306-4522(97)00392-8; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sentilhes L, 2011, J PEDIATR-US, V158, P377, DOI 10.1016/j.jpeds.2010.08.033; Suzuki Y, 2007, J THROMB HAEMOST, V5, P1732, DOI 10.1111/j.1538-7836.2007.02628.x; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Volpe JJ, 2008, NEUROLOGY NEWBORN, V5th, P517; Whitelaw A, 2010, PEDIATRICS, V125, pE852, DOI 10.1542/peds.2009-1960; YANG DC, 2013, SCI TRANSL MED, V2084, P5; Yang D, 2013, STROKE, V44, P2623, DOI 10.1161/STROKEAHA.113.001233; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212	39	9	9	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	MAY	2014	73	5					387	402		10.1097/NEN.0000000000000062			16	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	AF9BY	WOS:000335011300002	24709679	Bronze			2022-02-06	
J	Mahmood, A; Wu, HT; Qu, CS; Mahmood, S; Xiong, Y; Kaplan, DL; Chopp, M				Mahmood, Asim; Wu, Hongtao; Qu, Changsheng; Mahmood, Selina; Xiong, Ye; Kaplan, David L.; Chopp, Michael			Suppression of neurocan and enhancement of axonal density in rats after treatment of traumatic brain injury with scaffolds impregnated with bone marrow stromal cells	JOURNAL OF NEUROSURGERY			English	Article						bone marrow stromal cells; neurocan; scaffolds; traumatic brain injury	CHONDROITIN SULFATE PROTEOGLYCAN; SPINAL-CORD-INJURY; MYELIN-ASSOCIATED GLYCOPROTEIN; PROMOTES FUNCTIONAL RECOVERY; CEREBRAL-ARTERY OCCLUSION; NEURITE GROWTH-INHIBITORS; CENTRAL-NERVOUS-SYSTEM; ADULT-RAT; NOGO-A; REACTIVE ASTROCYTES	Object. Neurocan is a major form of growth-inhibitory molecule (growth-IM) that suppresses axonal regeneration after neural injury. Bone marrow stromal cells (MSCs) have been shown to inhibit neurocan expression in vitro and in animal models of cerebral ischemia. Therefore, the present study was designed to investigate the effects of treatment of MSCs impregnated with collagen scaffolds on neurocan expression after traumatic brain injury (TBI). Methods. Adult male Wistar rats were injured with controlled cortical impact and treated with saline, human MSCs (hMSCs) (3 x 10(6)) alone, or hMSCs (3 x 10(6)) impregnated into collagen scaffolds (scaffold + hMSCs) transplanted into the lesion cavity 7 days after TBI (20 rats per group). Rats were sacrificed 14 days after TBI, and brain tissues were harvested for immunohistochemical studies, Western blot analyses, laser capture microdissections, and quantitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR) to evaluate neurocan protein and gene expressions after various treatments. Results. Animals treated with scaffold + hMSCs after TBI showed increased axonal and synaptic densities compared with the other groups. Scaffold + hMSC treatment was associated with reduced TBI-induced neurocan protein expression and upregulated growth-associated protein 43 (GAP-43) and synaptophysin expression in the lesion boundary zone. In addition, animals in the scaffold + hMSC group had decreased neurocan transcription in reactive astrocytes after TBI. Reduction of neurocan expression was significantly greater in the scaffold + hMSC group than in the group treated with hMSCs alone. Conclusions. The results of this study show that transplanting hMSCs with scaffolds enhances the effect of hMSCs on axonal plasticity in TBI rats. This enhanced axonal plasticity may partially be attributed to the downregulation of neurocan expression by hMSC treatment after injury.	[Mahmood, Asim; Wu, Hongtao; Qu, Changsheng; Mahmood, Selina; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Boston, MA 02111 USA		Mahmood, A (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	AMAHM002@hfhs.org		Xiong, Ye/0000-0001-9770-6031			Ahmed Z, 2006, BRAIN, V129, P1517, DOI 10.1093/brain/awl080; Asher R A, 2001, Prog Brain Res, V132, P611; Asher RA, 2000, J NEUROSCI, V20, P2427; Aya-ay J, 2005, EXP NEUROL, V193, P149, DOI 10.1016/j.expneurol.2004.11.021; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brosamle C, 2000, J NEUROSCI, V20, P8061; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Deguchi K, 2005, BRAIN RES, V1037, P194, DOI 10.1016/j.brainres.2004.12.016; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Katoh-Semba R, 1998, NEUROSCI RES, V31, P273, DOI 10.1016/S0168-0102(98)00047-9; Katsman D, 2003, J CEREBR BLOOD F MET, V23, P997, DOI 10.1097/01.WCB.0000084252.20114.BE; Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lemons ML, 1999, EXP NEUROL, V160, P51, DOI 10.1006/exnr.1999.7184; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahmood A, 2013, J NEUROSURG, V118, P381, DOI 10.3171/2012.11.JNS12753; Margolis RK, 1996, PERSPECT DEV NEUROBI, V3, P273; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; MATSUI F, 1994, NEUROCHEM INT, V25, P425, DOI 10.1016/0197-0186(94)90018-3; Matsui F, 2002, NEUROSCIENCE, V112, P773, DOI 10.1016/S0306-4522(02)00136-7; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Moon LDF, 2002, NEUROSCIENCE, V109, P101, DOI 10.1016/S0306-4522(01)00457-2; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; VITKOVIC L, 1988, P NATL ACAD SCI USA, V85, P8296, DOI 10.1073/pnas.85.21.8296; WATANABE E, 1995, EUR J NEUROSCI, V7, P547, DOI 10.1111/j.1460-9568.1995.tb00659.x; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Wright KT, 2007, BIOCHEM BIOPH RES CO, V354, P559, DOI 10.1016/j.bbrc.2007.01.013; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	61	9	12	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2014	120	5					1147	1155		10.3171/2013.12.JNS131362			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AF7OD	WOS:000334903500018	24460490				2022-02-06	
J	Pedersen, HA; Ferraro, FR; Himle, M; Schultz, C; Poolman, M				Pedersen, Heather A.; Ferraro, F. Richard; Himle, Michael; Schultz, Caitlin; Poolman, Mark			Neuropsychological Factors Related to College Ice Hockey Concussions	AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS			English	Article						ice hockey; sports; concussion; impact; cognition; head injury		We analyzed data from 74 male collegiate hockey players. Each athlete's season began with a baseline administration of the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) neuropsychology test battery. Fourteen athletes sustained a sport-related head injury and were readministered the test to assess the impact of the injury. A significant decrease in performance (compared to baseline) on immediate and delayed word recall and designs followed the first concussion. Following a second sport-related concussion, the 4 affected athletes showed significant decrease in visual motor speed. Performance improved on 2 response speed measures (Ps < .01). More errors occurred during a visual processing/discrimination task and immediate recall of designs declined (Ps < .05). We discuss the results in light of recent work related to the impact of early-life concussions and head injury on late-life consequences, such as chronic traumatic encephalopathy, and more immediate issues such as return-to-play decisions for athletes.	[Pedersen, Heather A.] Memphis VA Med Ctr, Memphis, TN USA; [Ferraro, F. Richard] Univ N Dakota, Dept Psychol, Grand Forks, ND 58202 USA; [Himle, Michael] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Schultz, Caitlin] Bastyr Univ, Dept Psychol, Seattle, WA USA; [Poolman, Mark] Univ N Dakota, Athlet Dept, Grand Forks, ND 58202 USA		Ferraro, FR (corresponding author), Univ N Dakota, Dept Psychol, Corwin Larimore Rm 215,319 Harvard St,Stop 8380, Grand Forks, ND 58202 USA.	f.richard.ferraro@email.und.edu					Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Diaz-Arrastia R, 2013, JAMA NEUROL, V70, P301, DOI 10.1001/jamaneurol.2013.1930; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harzati LN, 2013, FRONT HUM NEUROSCI, V7, P222; ImPACT Applications Inc. Impact, 2007, IMP 2007 6 0 CLIN IN; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Shuttleworth-Edwards AB, 2011, S AFR J SPORTS MED, V23, P134; Smith A, 2011, CLIN NEUROPSYCHOL, V25, P689, DOI 10.1080/13854046.2011.586561; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3; Zillmer EA, 2003, APPL NEUROPSYCHOL, V10, P1, DOI 10.1207/S15324826AN1001_1	18	9	9	1	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1533-3175	1938-2731		AM J ALZHEIMERS DIS	Am. J. Alzheimers Dis. Other Dement.	MAY	2014	29	3					201	204		10.1177/1533317513517036			4	Geriatrics & Gerontology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	AI0HL	WOS:000336527000003	24370620				2022-02-06	
J	Sozda, CN; Muir, JJ; Springer, US; Partovi, D; Cole, MA				Sozda, Christopher N.; Muir, James J.; Springer, Utaka S.; Partovi, Diana; Cole, Michael A.			Differential Learning and Memory Performance in OEF/OIF Veterans for Verbal and Visual Material	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; Operation Iraqi Freedom; Operation Enduring Freedom; memory; veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; DIGIT SPAN; IRAQ; DEPRESSION; DEPLOYMENT	Objective: Memory complaints are particularly salient among veterans who experience combat-related mild traumatic brain injuries and/or trauma exposure, and represent a primary barrier to successful societal reintegration and everyday functioning. Anecdotally within clinical practice, verbal learning and memory performance frequently appears differentially reduced versus visual learning and memory scores. We sought to empirically investigate the robustness of a verbal versus visual learning and memory discrepancy and to explore potential mechanisms for a verbal/visual performance split. Method: Participants consisted of 103 veterans with reported history of mild traumatic brain injuries returning home from U. S. military Operations Enduring Freedom and Iraqi Freedom referred for outpatient neuropsychological evaluation. Results: Findings indicate that visual learning and memory abilities were largely intact while verbal learning and memory performance was significantly reduced in comparison, residing at approximately 1.1 SD below the mean for verbal learning and approximately 1.4 SD below the mean for verbal memory. This difference was not observed in verbal versus visual fluency performance, nor was it associated with estimated premorbid verbal abilities or traumatic brain injury history. In our sample, symptoms of depression, but not posttraumatic stress disorder, were significantly associated with reduced composite verbal learning and memory performance. Conclusions: Verbal learning and memory performance may benefit from targeted treatment of depressive symptomatology. Also, because visual learning and memory functions may remain intact, these might be emphasized when applying neuro-cognitive rehabilitation interventions to compensate for observed verbal learning and memory difficulties.	[Sozda, Christopher N.; Muir, James J.; Springer, Utaka S.; Partovi, Diana; Cole, Michael A.] Vet Affairs Northern Calif Hlth Care Syst, Neuropsychol Serv, Martinez, CA USA; [Cole, Michael A.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Cole, Michael A.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA		Cole, MA (corresponding author), VA Northern Calif Hlth Care Syst, TBI Polytrauma Program, 150 Muir Rd, Martinez, CA 94553 USA.	michael.cole5@va.gov			Veterans Affairs Research and Development Career Development Award	Support for this work was provided by a Veterans Affairs Research and Development Career Development Award to Michael A. Cole.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Biringer E, 2007, J CLIN EXP NEUROPSYC, V29, P879, DOI 10.1080/13803390601147686; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Cohen J., 2013, STAT POWER ANAL BEHA; Coolican H., 2009, RES METHODS STAT PSY, V5th; Defense and Veterans Brain Injury Center, 2013, DOD WORLDW NUMB TBI; Delis DC., 2001, DELIS KAPLAN EXECUTI; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Hecht D, 2010, NEUROSCI RES, V68, P77, DOI 10.1016/j.neures.2010.06.013; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Matsuo K, 2007, MOL PSYCHIATR, V12, P158, DOI 10.1038/sj.mp.4001894; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Weathers F. W., 1993, ANN M INT SOC TRAUMA; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Werner NS, 2009, J AFFECT DISORDERS, V119, P124, DOI 10.1016/j.jad.2009.03.003; [No title captured]	34	9	10	0	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2014	28	3					347	352		10.1037/neu0000043			6	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AG3QH	WOS:000335334000003	24245926				2022-02-06	
J	Le Marrec-Croq, F; Bocquet-Garcon, A; Vizioli, J; Vancamp, C; Drago, F; Franck, J; Wisztorski, M; Salzet, M; Sautiere, PE; Lefebvre, C				Le Marrec-Croq, Francoise; Bocquet-Garcon, Annelise; Vizioli, Jacopo; Vancamp, Christelle; Drago, Francesco; Franck, Julien; Wisztorski, Maxence; Salzet, Michel; Sautiere, Pierre-Eric; Lefebvre, Christophe			Calreticulin contributes to C1q-dependent recruitment of microglia in the leech Hirudo medicinalis following a CNS injury	MEDICAL SCIENCE MONITOR			English	Article						Head Injuries, Closed; Complement C1q; Calreticulin; Microglia	CENTRAL-NERVOUS-SYSTEM; COMPLEMENT COMPONENT C1Q; ENDOPLASMIC-RETICULUM; ALZHEIMERS-DISEASE; A-BETA; RECOGNITION SUBCOMPONENT; SERINE PROTEASES; MOUSE MODELS; BINDING-SITE; P-DOMAIN	Background: The medicinal leech is considered as a complementary and appropriate model to study immune functions in the central nervous system (CNS). In a context in which an injured leech's CNS can naturally restore normal synaptic connections, the accumulation of microglia (immune cells of the CNS that are exclusively resident in leeches) has been shown to be essential at the lesion to engage the axonal sprouting. HmC1q (Hm for Hirudo medicinalis) possesses chemotactic properties that are important in the microglial cell recruitment by recognizing at least a C1q binding protein (HmC1qBP alias gC1qR). Material/Methods: Recombinant forms of C1q were used in affinity purification and in vitro chemotaxis assays. Anti-calreticulin antibodies were used to neutralize C1q-mediated chemotaxis and locate the production of calreticulin in leech CNS. Results: A newly characterized leech calreticulin (HmCalR) has been shown to interact with C1q and participate to the HmC1q-dependent microglia accumulation. HmCalR, which has been detected in only some microglial cells, is consequently a second binding protein for HmC1q, allowing the chemoattraction of resident microglia in the nerve repair process. Conclusions: These data give new insight into calreticulin/C1q interaction in an immune function of neuroprotection, suggesting another molecular target to use in investigation of microglia reactivity in a model of CNS injury.	[Le Marrec-Croq, Francoise; Bocquet-Garcon, Annelise; Vizioli, Jacopo; Vancamp, Christelle; Drago, Francesco; Franck, Julien; Wisztorski, Maxence; Salzet, Michel; Sautiere, Pierre-Eric; Lefebvre, Christophe] Univ Lille 1, Univ Lille Nord France, Lab Spectrometrie Masse Biol Fondamentale & Appl, EA4550, F-59655 Villeneuve Dascq, France		Lefebvre, C (corresponding author), Univ Lille 1, Univ Lille Nord France, Lab Spectrometrie Masse Biol Fondamentale & Appl, EA4550, F-59655 Villeneuve Dascq, France.	christophe.lefebvre@univ-lille1.fr	Drago, Francesco/H-7563-2019; Wisztorski, Maxence/F-4380-2010; Franck, Julien/AAS-4444-2021; Lefebvre, christophe/J-7396-2013; Salzet, Michel/A-7675-2011	Wisztorski, Maxence/0000-0003-1320-075X; Lefebvre, christophe/0000-0002-2690-373X; Salzet, Michel/0000-0003-4318-0817; Franck, Julien/0000-0002-7443-1706; vizioli, jacopo/0000-0002-4310-8033; SAUTIERE, Pierre-Eric/0000-0003-4974-7116	Le Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MENESR, France); L'Agence Nationale de la Recherche (MIMIC)French National Research Agency (ANR) [ANR-11-JSV4-005]	This work was supported by grants from Le Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MENESR, France) and from L'Agence Nationale de la Recherche (MIMIC, ANR-11-JSV4-005)	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arafah K, 2013, GLIA, V61, P636, DOI 10.1002/glia.22462; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BAYLOR DA, 1971, NATURE, V232, P268, DOI 10.1038/232268a0; Benoit ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/jbc.M112.400168; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Bergamaschini L, 2001, MECH AGEING DEV, V122, P1971, DOI 10.1016/S0047-6374(01)00311-6; Bohlson SS, 2007, MOL IMMUNOL, V44, P33, DOI 10.1016/j.molimm.2006.06.021; Chen PC, 2002, ASIAN PAC J ALLERGY, V20, P223; COGGESHALL RE, 1964, J NEUROPHYSIOL, V27, P229, DOI 10.1152/jn.1964.27.2.229; Croq F, 2010, GLIA, V58, P1649, DOI 10.1002/glia.21036; Del Rio-Hortega P., 1920, TRAB LAB INVEST BIOL, V18, P37; Duan YL, 2009, DEV NEUROBIOL, V69, P60, DOI 10.1002/dneu.20689; Ellgaard L, 2001, FEBS LETT, V488, P69, DOI 10.1016/S0014-5793(00)02382-6; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Farber K, 2009, J NEUROSCI RES, V87, P644, DOI 10.1002/jnr.21875; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Fonseca MI, 2004, NEUROBIOL DIS, V15, P40, DOI 10.1016/j.nbd.2003.09.004; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; GHEBREHIWET B, 1995, J IMMUNOL, V155, P2614; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; JANSEN JKS, 1972, P NATL ACAD SCI USA, V69, P636, DOI 10.1073/pnas.69.3.636; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; KOHIDAI L, 1995, CURR MICROBIOL, V30, P251, DOI 10.1007/BF00293642; KRAUSE KH, 1991, FEBS LETT, V285, P225, DOI 10.1016/0014-5793(91)80806-E; Kuna P, 1996, CLIN IMMUNOL IMMUNOP, V81, P48, DOI 10.1006/clin.1996.0156; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Le Marrec-Croq F, 2013, CLIN DEV IMMUNOL, V2013, P12; Leigh LEA, 1998, BIOCHEM J, V330, P247; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Lynch NJ, 2004, MOL IMMUNOL, V40, P709, DOI 10.1016/j.molimm.2003.08.009; Mariani MM, 2009, J NEUROIMMUNE PHARM, V4, P448, DOI 10.1007/s11481-009-9170-6; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; MILNER RE, 1991, J BIOL CHEM, V266, P7155; MORGESE VJ, 1983, BRAIN RES, V272, P166, DOI 10.1016/0006-8993(83)90375-X; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; NARDELLHAEFLIGER D, 1992, DEVELOPMENT, V116, P697; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; Nayak A, 2010, IMMUNOL LETT, V131, P139, DOI 10.1016/j.imlet.2010.03.012; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; Ngu EM, 2007, J COMP NEUROL, V503, P101, DOI 10.1002/cne.21386; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Pagh R, 2008, FEBS J, V275, P515, DOI 10.1111/j.1742-4658.2007.06218.x; Penfield W., 1932, CYTOLOGY CELLULAR PA, V2, P482; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ramirez G, 2011, IMMUNOBIOLOGY, V216, P265, DOI 10.1016/j.imbio.2010.04.001; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; ROKEACH LA, 1991, PROTEIN ENG, V4, P981, DOI 10.1093/protein/4.8.981; Samuels SE, 2010, J GEN PHYSIOL, V136, P425, DOI 10.1085/jgp.201010476; Schikorski D, 2009, J IMMUNOL, V183, P7119, DOI 10.4049/jimmunol.0900538; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Sieger D, 2013, GLIA, V61, P3, DOI 10.1002/glia.22385; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; Tahtouh M, 2009, MOL IMMUNOL, V46, P523, DOI 10.1016/j.molimm.2008.07.026; Tahtouh M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-37; Trendelenburg M, 2005, SPRINGER SEMIN IMMUN, V27, P276, DOI 10.1007/s00281-005-0007-y; Vegh Z, 2006, MOL IMMUNOL, V43, P1402, DOI 10.1016/j.molimm.2005.07.030; VONBERNHARDI R, 1995, J NEUROBIOL, V27, P353, DOI 10.1002/neu.480270308; Wang HC, 2007, DEV COMP IMMUNOL, V31, P672, DOI 10.1016/j.dci.2006.11.001; Watthanasurorot A, 2010, J VIROL, V84, P10844, DOI 10.1128/JVI.01045-10; Webster SD, 2000, EXP NEUROL, V161, P127, DOI 10.1006/exnr.1999.7260	72	9	9	0	6	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	APR 19	2014	20						644	653					10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AF2XG	WOS:000334575200001	24747831	Green Published, Green Submitted			2022-02-06	
J	Peran, P; Catani, S; Caravasso, CF; Nemmi, F; Sabatini, U; Formisano, R				Peran, Patrice; Catani, Sheila; Caravasso, Chiara Falletta; Nemmi, Federico; Sabatini, Umberto; Formisano, Rita			Supplementary Motor Area Activation Is Impaired in Severe Traumatic Brain Injury Parkinsonism	JOURNAL OF NEUROTRAUMA			English	Article						parkinsonism; adult brain injury; MRI; head trauma	VERB GENERATION; HEAD-INJURY; DISEASE; REPRESENTATIONS; MODULATION; FMRI	A high percentage of survivors of severe traumatic brain injury present diffuse axonal injury and extrapyramidal symptoms. The association between diffuse cerebral damage and parkinsonian symptoms is probably because of the interruption of nigro-striato-frontal pathways. While functional magnetic resonance imaging (fMRI) has been widely used to investigate parkinsonism in idiopathic Parkinson disease, little is known about functional brain modifications related to post-traumatic parkinsonism (PTP). The aim of this study is to assess cerebral activity of the action-related network in patients with PTP comparing these patients to matched healthy controls. In the fMRI scanner, we proposed to 12 PTP patients and 12 healthy control participants a continuum of tasks involving action-related word production, mental simulation of action, and miming of action triggered by external stimuli such as drawings of objects. Patients with PTP showed a main effect similar to that of healthy controls in all the tasks. Direct comparison revealed hypoactivation of areas in the action-related network in patients with PTP for all the tasks. During the mime of action, which involved actual movement, the hypoactivation was localized to the motor network. Our results suggest that patients with PTP showed a cerebral reorganization for motor tasks in agreement with the cerebral reorganization observed in idiopathic Parkinson disease. For patients with PTP, supplementary motor area impairment seems to play a central role in parkinsonism, in line with the brain reorganization of action-related tasks.	[Peran, Patrice; Nemmi, Federico] Ctr Hosp Univ Toulouse, INSERM, Toulouse, France; [Peran, Patrice; Nemmi, Federico] Univ Toulouse 3, Ctr Hosp Univ Toulouse, UPS, F-31062 Toulouse, France; [Catani, Sheila; Formisano, Rita] Santa Lucia Fdn, Postcoma Unit, Rome, Italy; [Caravasso, Chiara Falletta; Sabatini, Umberto] Santa Lucia Fdn, Dept Radiol, Rome, Italy		Peran, P (corresponding author), CHU Purpan, Pl Dr Baylac Pavillon Baudot, F-31059 Toulouse 9, France.	patrice.peran@inserm.fr	Peran, Patrice/N-7561-2015; Sabatini, Umberto/K-4659-2016	Peran, Patrice/0000-0001-7200-0139; Sabatini, Umberto/0000-0001-5321-8626; Nemmi, Federico/0000-0001-9806-8326; Falletta Caravasso, Chiara/0000-0003-3389-2853			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams R. D., 1976, PRINCIPLES NEUROLOGY; Basso MA, 1996, J NEUROSCI, V16, P7318; Bianciardi M, 2004, NEUROIMAGE, V22, P1351, DOI 10.1016/j.neuroimage.2004.02.039; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Doder M, 1999, J NEUROL NEUROSUR PS, V66, P380, DOI 10.1136/jnnp.66.3.380; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Formisano R, 2005, ACT NEUR S, V93, P201; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Formisano R, 2009, MED SCI MONITOR, V15, pCR101; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Giugni E, 2006, HIGH FIELD BRAIN MRI: USE IN CLINICAL PRACTICE, P169, DOI 10.1007/3-540-31776-7_13; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; KARSON CN, 1982, ANN NEUROL, V12, P580, DOI 10.1002/ana.410120614; Marie RM, 1999, NEUROSCI LETT, V260, P77, DOI 10.1016/S0304-3940(98)00928-8; Peppe A, 1998, ELECTROEN CLIN NEURO, V106, P374, DOI 10.1016/S0013-4694(97)00075-8; Peran P, 2003, MOVEMENT DISORD, V18, P150, DOI 10.1002/mds.10306; Peran P, 2008, PSYCHOPHARMACOLOGY, V195, P487, DOI 10.1007/s00213-007-0939-0; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Peran P, 2010, BRAIN RES, V1328, P89, DOI 10.1016/j.brainres.2010.02.082; Peran P, 2009, CORTEX, V45, P960, DOI 10.1016/j.cortex.2009.02.019; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Rascol O, 1998, BRAIN, V121, P527, DOI 10.1093/brain/121.3.527; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041	27	9	9	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2014	31	7					642	648		10.1089/neu.2013.3103			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD7PB	WOS:000333455000005	24168468				2022-02-06	
J	Rosenblum, RK; Sprague-McRae, J				Rosenblum, Ruth K.; Sprague-McRae, Julie			Using Principles of Quality and Safety Education for Nurses in School Nurse Continuing Education	JOURNAL OF SCHOOL NURSING			English	Article						parent/family; safety/injury prevention; best practices/practice guidelines; school nurse education; middle/junior/high school	RETURN	School nurses require ongoing continuing education in a number of areas. The Quality and Safety Education for Nurses (QSEN) framework can be utilized in considering school nurses' roles and developing continuing education. Focusing on neurology continuing education, the QSEN framework is illustrated with the example of concussion management in athletes. QSEN strategies can stimulate change to the status quo and outline the knowledge, skills, and attitudes that need to be adapted. With their competencies and knowledge, professional school nurses can incorporate evidence-based practices in conjunction with input from health care providers and families to create high-quality care and positive outcomes for students.	[Rosenblum, Ruth K.] San Jose State Univ, San Jose, CA 95192 USA; [Sprague-McRae, Julie] Kaiser Permanente Med Ctr, Fremont, CA USA		Rosenblum, RK (corresponding author), San Jose State Univ, Valley Fdn Sch Nursing, One Washington Sq, San Jose, CA 95192 USA.	ruth.rosenblum@sjsu.edu					Adams S, 2010, J NURS MEAS, V18, P3, DOI 10.1891/1061-3749.18.1.3; Adams S, 2009, J SCH NURS, V25, P302, DOI 10.1177/1059840509335008; Adams Susan, 2005, J Sch Nurs, V21, P258; American Academy of Neurology, 2013, POS STAT SPROTS CONC; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Centers for Disease Control Prevention [CDC], 2007, HEADS CONC YOUTH SPO; Cronenwett L, 2007, NURS OUTLOOK, V55, P122, DOI 10.1016/j.outlook.2007.02.006; Cronenwett L, 2009, NURS OUTLOOK, V57, P338, DOI 10.1016/j.outlook.2009.07.009; Giza CC, 2013, SUMMARY EVIDENCE BAS; Krause-Parello CA, 2011, COMPR CHILD ADOLES N, V34, P26, DOI 10.3109/01460862.2011.555273; Kruger BJ, 2009, J SCHOOL HEALTH, V79, P337, DOI 10.1111/j.1746-1561.2009.00419.x; Pohl JM, 2009, NURS OUTLOOK, V57, P349, DOI 10.1016/j.outlook.2009.08.002; Sherwood G, 2011, J RES NURS, V16, P226, DOI 10.1177/1744987111400960; Sprague-McRae J. M., 2009, CHILD NEUROLOGY TELE; Theye Fred, 2004, Clin Med Res, V2, P165; Vought-O'Sullivan Victoria, 2006, J Sch Nurs, V22, P2	18	9	9	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.	APR	2014	30	2					97	102		10.1177/1059840513489710			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	AC9IB	WOS:000332846700003	23674553				2022-02-06	
J	Solomon, GS; Kuhn, A				Solomon, Gary S.; Kuhn, Andrew			Relationship Between Concussion History and Neurocognitive Test Performance in National Football League Draft Picks	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						Wonderlic; National Football League; neurocognitive testing; ImPACT; concussion	TEST-RETEST RELIABILITY; CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; BIOPSYCHOSOCIAL CHARACTERISTICS; IMPACT; PLAYERS; SPORT	Background: There are limited empirical data available regarding the relationship between concussion history and neurocognitive functioning in active National Football League (NFL) players in general and NFL draft picks in particular. Potential NFL draft picks undergo 2 neurocognitive tests at the National Invitational Camp (Scouting Combine) every year: the Wonderlic and, since 2011, the Immediate Post-concussion Assessment and Cognitive Testing (ImPACT). After conclusion of the combine and before the draft, NFL teams invite potential draft picks to their headquarters for individual visits where further assessment may occur. Purpose: To examine the relationship between concussion history and neurocognitive performance (ImPACT and Wonderlic) in a sample of elite NFL draft picks. Study Design: Cohort study; Level of evidence, 3. Methods: Over 7 years, 226 potential draft picks were invited to visit a specific NFL team's headquarters after the combine. The athletes were divided into 3 groups based on self-reported concussion history: no prior concussions, 1 prior concussion, and 2 or more prior concussions. Neurocognitive measures of interest included Wonderlic scores (provided by the NFL team) and ImPACT composite scores (administered either at the combine or during a visit to the team headquarters). The relationship between concussion history and neurocognitive scores was assessed, as were the relationships among the 2 neurocognitive tests. Results: Concussion history had no relationship to neurocognitive performance on either the Wonderlic or ImPACT. Conclusion: Concussion history did not affect performance on either neurocognitive test, suggesting that for this cohort, a history of concussion may not have adverse effects on neurocognitive functioning as measured by these 2 tests. This study reveals no correlation between concussion history and neurocognitive test scores (ImPACT, Wonderlic) in soon-to-be active NFL athletes.	[Solomon, Gary S.; Kuhn, Andrew] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA		Solomon, GS (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Dept Neurol Surg, Nashville, TN 37232 USA.	Gary.solomon@vanderbilt.edu	Kuhn, Andrew W/AAM-4820-2020; Solomon, Gary/K-9011-2019	Kuhn, Andrew W/0000-0003-1836-7575; 			[Anonymous], 2002, IMPACT CONC MAN SOFT; [Anonymous], 1993, MICR VERS 2 1; Bleiberg J, 2004, NEUROSURGERY, V55, P1304; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 2006, NEUROSURGERY, V58, P273; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; IBM Corp, 2013, IBM SPSS STAT VERS 2; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Kelly DF, 2004, NEUROSURGERY, V54, P1048; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kutner K, 2006, NEUROSURGERY, V58, P273; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lovell MR, IMPACT 2007 6 0 CLIN; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon JC, 2004, NEUROSURGERY, V55, P1305; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Solomon GS, 2013, ARCH CLIN NEUROPSYCH, V28, P9, DOI 10.1093/arclin/acs108; Wonderlic EF, 1939, J APPL PSYCHOL, V23, P685, DOI 10.1037/h0056432; Wonderlic E. F., 1992, WONDERLIC PERSONNEL; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	47	9	9	0	39	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	APR	2014	42	4					934	939		10.1177/0363546513518742			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	AE0WD	WOS:000333686100027	24496507				2022-02-06	
J	Thompson, MC; Wheeler, KK; Shi, JX; Smith, GA; Groner, JI; Haley, KJ; Xiang, HY				Thompson, Meghan C.; Wheeler, Krista K.; Shi, Junxin; Smith, Gary A.; Groner, Jonathan I.; Haley, Kathryn J.; Xiang, Huiyun			Surveillance of paediatric traumatic brain injuries using the NEISS: Choosing an appropriate case definition	BRAIN INJURY			English	Article						Injury surveillance; International Classification of Diseases; Ninth Revision; Clinical Modification; National Electronic Injury Surveillance System; traumatic brain injury	EMERGENCY-DEPARTMENTS; CASE ASCERTAINMENT; UNITED-STATES; CHILDREN; CODES	Objective: To evaluate the definition of traumatic brain injury (TBI) in the National Electronic Injury Surveillance System (NEISS) and compare TBI case ascertainment using NEISS vs. ICD-9-CM diagnosis coding. Methods: Two data samples from a NEISS participating emergency department (ED) in 2008 were compared: (1) NEISS records meeting the recommended NEISS TBI definition and (2) Hospital ED records meeting the ICD-9-CM CDC recommended TBI definition. The sensitivity and positive predictive value were calculated for the NEISS definition using the ICD-9-CM definition as the gold standard. Further analyses were performed to describe cases characterized as TBIs in both datasets and to determine why some cases were not classified as TBIs in both datasets. Results: There were 1834 TBI cases captured by the NEISS and 1836 TBI cases captured by the ICD-9-CM coded ED record, but only 1542 were eligible for inclusion in NEISS. There were 1403 cases classified as TBIs by both the NEISS and ICD-9-CM diagnosis codes. The NEISS TBI definition had a sensitivity of 91.0% (95% CI = 89.6-92.4%) and positive predictive value of 76.5% (95% CI = 74.6-78.4%). Conclusions: Using the NEISS TBI definition presented in this paper would standardize and improve the accuracy of TBI research using the NEISS.	[Thompson, Meghan C.; Wheeler, Krista K.; Shi, Junxin; Smith, Gary A.; Groner, Jonathan I.; Xiang, Huiyun] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Thompson, Meghan C.; Smith, Gary A.; Groner, Jonathan I.; Xiang, Huiyun] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Groner, Jonathan I.; Haley, Kathryn J.] Nationwide Childrens Hosp, Dept Pediat Surg, Trauma Program, Columbus, OH 43205 USA		Xiang, HY (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	huiyun.xiang@nationwidechildrens.org	Groner, Jonathan/E-3156-2011; Xiang, Huiyun/E-4335-2011	Thompson, Meghan/0000-0003-1462-4802	National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, US Department of Health and Human Services [1R49CE000241-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000241] Funding Source: NIH RePORTER	This study was funded by a research grant from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, US Department of Health and Human Services (Grant #:1R49CE000241-01; PI: Dr Huiyun Xiang).	Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buck CJ, 2009, ICDPIC STATA MODULE, V3; Buck CJ, 2009, ICDPIC STATA MODULE, V1; Buck CJ, 2009, ICDPIC STATA MODULE, V2; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Disease Control and Prevention, 2007, MMWR-MORBID MORTAL W, V56, P734; Centers for Disease Control and Prevention, 2003, WEB BAS INJ STAT QUE; Clark DE, 2009, ICDPIC STATA MODULE; Consumer Product Safety Commission, 2007, SPEC STUD TRAUM BRAI; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halpin J, 2009, INJURY PREV, V15, P328, DOI 10.1136/ip.2009.021691; Horan JM, 2003, EPIDEMIOL REV, V25, P24, DOI 10.1093/epirev/mxg010; Howell CA, 2010, PEDIATRICS, V126, P517, DOI 10.1542/peds.2009-1499; Inter-University Consortium for Political and Social Research, 2007, ICDPIC STATA MODULE; Marr A., 2004, CENTRAL NERVOUS SYST; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Myers RJ, 2010, WEST J EMERG MED, V11, P442; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nelson NG, 2011, AM J SPORT MED, V39, P404, DOI 10.1177/0363546510383478; Randazzo C, 2010, PEDIATRICS, V126, P727, DOI 10.1542/peds.2009-2497; Schootman M, 2000, J TRAUMA, V48, P70, DOI 10.1097/00005373-200001000-00012; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; U.S. Consumer Product Safety Commission, 2012, NEISS CODING MANUAL; US Consumer Product Safety Commission, 2013, NEISS COD MAN; US Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	29	9	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					431	437		10.3109/02699052.2014.887146			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900005	24564802				2022-02-06	
J	Wang, CL; Lin, HY; Xu, JW; Jiang, FF; Yang, M; Wang, JH; Huang, XQ				Wang, Chuan-Liu; Lin, Hai-Yan; Xu, Jian-Wei; Jiang, Fei-Fei; Yang, Ming; Wang, Jin-Hua; Huang, Xiu-Qing			Blood levels of adrenomedullin on admission predict outcomes after acute intracerebral hemorrhage	PEPTIDES			English	Article						Early neurological deterioration; Adrenomedullin; Intracerebral hemorrhage; Outcome; Stroke	ISCHEMIC NEUROLOGICAL DEFICITS; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; HYPOTENSIVE PEPTIDE	Increased plasma adrenomedullin level has been associated with critical illness. This study aimed to investigate the correlations of plasma adrenomedullin concentration with 3-month clinical outcomes and early neurological deterioration of patients with acute intracerebral hemorrhage. One hundred fourteen patients and 112 healthy controls were recruited. Relationships of plasma adrenomedullin concentrations with early neurological deterioration, 3-month mortality and unfavorable outcome (modified Rankin Scale score >2) were evaluated. Plasma adrenomedullin concentrations were increased in patients than in healthy individuals and were highly associated with National Institutes of Health Stroke Scale scores. A multivariate analysis selected plasma adrenomedullin concentration as an independent predictor for 3-month clinical outcomes and early neurological deterioration. A receiver operating characteristic curve analysis showed plasma adrenomedullin concentration predicted 3-month clinical outcomes and early neurological deterioration with high area under curves. The predictive value of adrenomedullin was similar to that of National Institutes of Health Stroke Scale score. In a combined logistic-regression model, adrenomedullin did not improve the predictive value of National Institutes of Health Stroke Scale score. Thus, elevated plasma adrenomedullin concentration is highly associated with 3-month clinical outcomes and early neurological deterioration of patients with acute intracerebral hemorrhage. (c) 2014 Elsevier Inc. All rights reserved.	[Wang, Chuan-Liu; Lin, Hai-Yan; Jiang, Fei-Fei; Yang, Ming; Wang, Jin-Hua] Quzhou Peoples Hosp, Dept Neurol, Quzhou 324000, Peoples R China; [Xu, Jian-Wei] Quzhou Peoples Hosp, Dept Urol, Quzhou 324000, Peoples R China; [Huang, Xiu-Qing] Quzhou Peoples Hosp, Dept Rehabil, Quzhou 324000, Peoples R China		Lin, HY (corresponding author), Quzhou Peoples Hosp, Dept Neurol, 2 Zhongloudi Rd, Quzhou 324000, Peoples R China.	quzhou2014@163.com					Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brunswick AS, 2012, J NEUROL SCI, V321, P1, DOI 10.1016/j.jns.2012.06.008; Fernandez AP, 2008, P NATL ACAD SCI USA, V105, P12581, DOI 10.1073/pnas.0803174105; ICHIKI Y, 1994, FEBS LETT, V338, P6, DOI 10.1016/0014-5793(94)80106-1; ISHIMITSU T, 1994, J CLIN INVEST, V94, P2158, DOI 10.1172/JCI117573; Kataoka Y, 2010, J CARDIOVASC PHARM, V56, P413, DOI 10.1097/FJC.0b013e3181f15b45; Kikumoto K, 1998, ANESTH ANALG, V87, P859, DOI 10.1097/00000539-199810000-00021; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V194, P720, DOI 10.1006/bbrc.1993.1881; Kothari RU, 1996, STROKE, V27, P1304; Kubo Y, 2008, CEREBROVASC DIS, V25, P164, DOI 10.1159/000113734; Kubo Y, 2013, NEUROL RES, V35, P713, DOI 10.1179/1743132813Y.0000000222; Miyamoto N, 2009, J CEREBR BLOOD F MET, V29, P1769, DOI 10.1038/jcbfm.2009.92; Miyashita K, 2006, ENDOCRINOLOGY, V147, P1642, DOI 10.1210/en.2005-1038; Robertson CL, 2000, ACT NEUR S, V76, P419; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; SATOH F, 1995, J CLIN ENDOCR METAB, V80, P1750, DOI 10.1210/jc.80.5.1750; Serrano J, 2002, NEUROSCIENCE, V109, P717, DOI 10.1016/S0306-4522(01)00532-2; Wong Hoi Kin, 2012, JRSM Cardiovasc Dis, V1, DOI 10.1258/cvd.2012.012003; Xia CF, 2006, EXP NEUROL, V197, P521, DOI 10.1016/j.expneurol.2005.10.027; Yan J, 2013, INT J NEUROSCI; Yu CM, 2001, HEART, V86, P155, DOI 10.1136/heart.86.2.155; Zhang H, 2014, PEPTIDES, V52, P44, DOI 10.1016/j.peptides.2013.11.025; Zudaire E, 2004, BIOCHEM BIOPH RES CO, V321, P859, DOI 10.1016/j.bbrc.2004.07.032	26	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0196-9781	1873-5169		PEPTIDES	Peptides	APR	2014	54						27	32		10.1016/j.peptides.2014.01.005			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AF1XY	WOS:000334508400004	24457114				2022-02-06	
J	Griffiths, CL; Gutierrez, KC; Pitt, RD; Lovell, RD				Griffiths, Carrie L.; Gutierrez, Kristofer C.; Pitt, Renee D.; Lovell, Roger D.			Eosinophilic pneumonia induced by ceftaroline	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article							LUNG-DISEASE; FOSAMIL; INFECTIONS; CEPHALOSPORIN; ENDOCARDITIS; THERAPY; SAFETY; SKIN	Purpose. A case of eosinophilic pneumonia in a patient receiving ceftaroline for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is reported. Summary. A 65-year-old woman was admitted to a medical intensive care unit after arriving at the emergency room with complaints of progressively worsening shortness of breath. Her medical history included chronic obstructive pulmonary disease, acute respiratory distress syndrome, recent traumatic brain injury, tobacco use,. and alcohol abuse. Within the first few days of hospitalization, the patient was diagnosed with MRSA pneumonia based on microbiological data from bronchoscopy bronchial washings. Her renal function liver enzyme levels were within normal limits. Empirical antibiotic therapy included i.v. vancomycin and meropenem and was narrowed to i.v. linezolid monotherapy based on culture and sensitivity results. After 10 days of treatment with linezolid, the patient was persistently febrile, and cultures remained positive. It was decided to switch therapy to a course of i.v. ceftaroline, an anti-MRSA cephalosporin. On the fifth day of treatment with ceftaroline, the patient developed respiratory decompensation and peripheral eosinophilia of 40%. Bronchoalveolar lavage (BAL) results indicated the presence of pulmonary eosinophilia of 13%. Chest radiographs revealed pulmonary infiltrates, and the computed tomography angiography showed no evidence of pulmonary embolism. Ceftaroline was discontinued, and the patient was started on vancomycin and methylprednisolone. The patient responded to methylprednisolone therapy, with repeat BAL and peripheral blood counts showing resolved eosinophilia. Conclusion. A patient with risk factors for respiratory disease developed eosinophilic pneumonia after receiving ceftaroline for the treatment of MRSA pneumonia. Eosinophilia resolved after ceftaroline was discontinued and i.v. methylprednisolone was initiated.	[Griffiths, Carrie L.] Wingate Univ Sch Pharm WUSOP, Wingate, NC 28174 USA; [Griffiths, Carrie L.] Carolinas Med Ctr, Dept Pharm, Charlotte, NC 28203 USA; [Gutierrez, Kristofer C.; Pitt, Renee D.] WUSOP, Wingate, NC USA; [Lovell, Roger D.] Univ N Carolina, Dept Internal Med, Sch Med, Charlotte, NC 28223 USA		Griffiths, CL (corresponding author), Wingate Univ Sch Pharm WUSOP, Wingate, NC 28174 USA.	clgriffiths@wingate.edu					Allen J, 2006, SEMIN RESP CRIT CARE, V27, P142, DOI 10.1055/s-2006-939517; Allen JN, 2004, CLIN CHEST MED, V25, P77, DOI 10.1016/S0272-5231(03)00141-2; [Anonymous], 2011, MED LETT DRUGS THER, V53, P5; [Anonymous], 2010, TEFL CEFT FOS PACK I; Biek D, 2010, J ANTIMICROB CHEMOTH, V65, piv9, DOI 10.1093/jac/dkq251; Campagna JD, 2012, J EMERG MED, V42, P612, DOI 10.1016/j.jemermed.2011.05.035; Corrado ML, 2010, J ANTIMICROB CHEMOTH, V65, piv67, DOI 10.1093/jac/dkq256; Cottin V, 2005, ALLERGY, V60, P841, DOI 10.1111/j.1398-9995.2005.00812.x; Desai KR, 2013, PHARMACOTHERAPY, V33, pE166, DOI 10.1002/phar.1286; DREIS DF, 1984, CHEST, V86, P138, DOI 10.1378/chest.86.1.138; Elsevier/Gold Standard, DAPT MON; Elsevier/Gold Standard, CEFD MON; File TM, 2012, CLIN INFECT DIS, V55, pS173, DOI 10.1093/cid/cis559; Goodman JJ, 2012, THER CLIN RISK MANAG, V8, P149, DOI 10.2147/TCRM.S17413; Gotlib J, 2011, AM J HEMATOL, V86, P678, DOI 10.1002/ajh.22062; Ho TT, 2012, J ANTIMICROB CHEMOTH, V67, P1267, DOI 10.1093/jac/dks006; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; IRIE M, 1990, Japanese Journal of Thoracic Diseases, V28, P1353; Jantz MA, 1999, AM J RESP CRIT CARE, V160, P1079, DOI 10.1164/ajrccm.160.4.9901075; Jeong YJ, 2007, RADIOGRAPHICS, V27, P617, DOI 10.1148/rg.273065051; Lee M, 2009, BASIC SKILLS INTERPR, P347; LIEBOW AA, 1969, MEDICINE, V48, P251, DOI 10.1097/00005792-196907000-00001; Lin JC, 2013, J INFECT CHEMOTHER, V19, P42, DOI 10.1007/s10156-012-0449-9; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; OLSSON I, 1979, ALLERGY, V34, P353, DOI 10.1111/j.1398-9995.1979.tb02005.x; Rank DR, 2011, J ANTIMICROB CHEMOTH, V66, pIII53, DOI 10.1093/jac/dkr099; SMITH JH, 1987, BRIT MED J, V294, P776, DOI 10.1136/bmj.294.6574.776-d; Sohn JW, 2013, TUBERC RESPIR DIS, V74, P51, DOI 10.4046/trd.2013.74.2.51; Solomon J, 2006, SEMIN RESP CRIT CARE, V27, P192, DOI 10.1055/s-2006-939522; WALLEN N, 1991, J IMMUNOL, V147, P3490; Zainah H, 2013, INFECT DIS CLIN PRAC, V21, P58	32	9	10	0	1	AMER SOC HEALTH-SYSTEM PHARMACISTS	BETHESDA	7272 WISCONSIN AVE, BETHESDA, MD 20814 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	MAR 1	2014	71	5					403	406		10.2146/ajhp130441			4	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AC3TS	WOS:000332444700013	24534595				2022-02-06	
J	Huynh, TK; Costello, JL; Rebuck, JA				Huynh, Thao K.; Costello, Jennifer L.; Rebuck, Jill A.			Optimizing the Dose of Three-Factor Prothrombin Complex Concentrate in Traumatic Brain Injury Patients on Warfarin Therapy	PHARMACOTHERAPY			English	Article						traumatic brain injury; warfarin; factor IX; outcome; trauma; prothrombin complex concentrate; coagulopathy	INTRACEREBRAL HEMORRHAGE; EMERGENCY REVERSAL; ANTICOAGULATION; COAGULOPATHY; EXPERIENCE	Study Objective To determine the percentage of patients with correction of their first international normalized ratio (INR)less than1.5 after administration of moderate-dose three-factor prothrombin complex concentrate (PCC), 35 IU/kg compared with low-dose PCC, 25 IU/kg. Design Retrospective review. Setting Community teaching hospital. Patients A total of 42 adult patients diagnosed with warfarin-associated traumatic brain injury (TBI) presented with an INRof1.5 or more and received at least one dose of PCC during a 19-month study period. The low-dose group received PCC 25 IU/kg from November 2011-July 2012 and the moderate-dose group received PCC 35 IU/kg from August 2012-May 2013. Measurements and Main Results Of the 42 patients, 25 were in the low-dose group and 17 were in the moderate-dose group. Baseline characteristics were similar between both groups in regard to age, sex, weight, creatinine clearance, weekly warfarin dose, initial INR, initial Glasgow Coma Score, and injury severity score. Of the patients in the low-dose group, 12% achieved INR reversal with first measured INR after PCC administration compared with 69% in the moderate-dose group (p<0.001). The median time to INR reversal was 6.9hours in the low-dose PCC group and 1.9hours in the moderate-dose PCC group (p=0.04). There were no differences between the groups in other secondary end points, including stabilization of TBI, days in the intensive care unit, total days of hospitalization, blood product administration, and adverse events. Conclusions Moderately dosed PCC at 35 IU/kg compared with a lower dosage of 25 IU/kg was associated with a higher percentage of INR reversal and more rapid time to INR normalization in patients with TBI. Future randomized controlled studies to further investigate this novel dose and the impact on potential reductions in the use of fresh frozen plasma are warranted.	[Huynh, Thao K.; Costello, Jennifer L.; Rebuck, Jill A.] Lancaster Gen Hlth, Dept Pharm, Lancaster, PA USA		Costello, JL (corresponding author), Lancaster Gen Hosp, Serv Pharm, 555 North Duke St, Lancaster, PA 17603 USA.	jlcostel@lghealth.org					Barillari G, 2012, BLOOD TRANSFUS-ITALY, V10, P87, DOI [10.2450/2011.0030-1, 10.2450/2011.0030-11]; Chapman SA, 2011, ANN PHARMACOTHER, V45, P869, DOI 10.1345/aph.1P605; Chong CT, 2010, ANAESTH INTENS CARE, V38, P474, DOI 10.1177/0310057X1003800310; Dager WE, 2011, ANN PHARMACOTHER, V45, P1016, DOI 10.1345/aph.1Q288; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Holland L, 2009, TRANSFUSION, V49, P1171, DOI 10.1111/j.1537-2995.2008.02080.x; Kuwashiro T, 2011, CEREBROVASC DIS, V31, P170, DOI 10.1159/000321766; Majeed A, 2012, THROMB RES, V129, P146, DOI 10.1016/j.thromres.2011.07.024; Patanwala AE, 2011, ANN PHARMACOTHER, V45, P990, DOI 10.1345/aph.1Q096; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Sarode R, 2012, J NEUROSURG, V116, P491, DOI 10.3171/2011.11.JNS11836; Switzer JA, 2012, STROKE, V43, P2500, DOI 10.1161/STROKEAHA.112.661454; Toth P, 2012, BLOOD TRANSFUS, V10, P1, DOI 10.2450/2012.0113-12	13	9	12	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	MAR	2014	34	3					260	264		10.1002/phar.1384			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AB9YI	WOS:000332151200006	24338807				2022-02-06	
J	Jain, P; Spaeder, MC; Donofrio, MT; Sinha, P; Jonas, RA; Levy, RJ				Jain, Parag; Spaeder, Michael C.; Donofrio, Mary T.; Sinha, Pranava; Jonas, Richard A.; Levy, Richard J.			Detection of Alpha II-Spectrin Breakdown Products in the Serum of Neonates With Congenital Heart Disease	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						biomarker; brain injury; congenital heart disease; neonate; serum; spectrin	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; PROTEIN; S100B; CHILDREN; SEVERITY; INFANTS; MARKERS	Objectives: To determine if alpha II-spectrin breakdown products can be detected in the serum of neonates with congenital heart disease in the perioperative period. Design: Prospective observational cohort study. Setting: Pediatric cardiac ICU in an urban tertiary care academic center. Patients: Neonates with congenital heart disease undergoing surgical repair or palliation. Interventions: Serial blood sampling for measurement of 120 and 150 kDa spectrin breakdown products. Measurements and Main Results: Fourteen neonates with congenital heart disease undergoing cardiac surgery were evaluated. Nine infants underwent open-heart surgery and five underwent closed-heart surgery. Serum spectrin breakdown products were measured with sandwich enzyme-linked immunosorbent assay preoperatively and then 6, 24, 48, 72, and 96 hours following surgery. Brain imaging was obtained as part of routine clinical care in 12 patients preoperatively and six patients postoperatively. Six patients had normal preoperative imaging (three closed-heart surgery and three open-heart surgery), whereas six had evidence of neurologic injury prior to surgery (one closed-heart surgery and five open-heart surgery). Only one patient had a postoperative imaging study that lacked injury. All others demonstrated infarction or hemorrhage. Spectrin breakdown product 120 kDa significantly increased 24 hours after open-heart surgery compared to preoperative values and time-matched closed-heart surgery levels. Spectrin breakdown product 150 kDa significantly increased 6 hours after open-heart surgery compared to preoperative values. There was no significant change in spectrin breakdown products following closed-heart surgery. Peak spectrin breakdown products significantly increased following open-heart surgery compared to closed-heart surgery. Conclusions: Spectrin breakdown products can be detected in the serum of neonates with congenital heart disease in the perioperative period and levels increased to a greater degree in infants following open-heart surgery. These findings suggest that, in future work, serum spectrin breakdown products may potentially be developed as biomarkers for brain necrosis and apoptosis in infants with congenital heart disease.	[Jain, Parag; Spaeder, Michael C.] George Washington Univ, Sch Med & Hlth Sci, Div Crit Care Med, Childrens Natl Med Ctr, Washington, DC 20052 USA; [Donofrio, Mary T.] George Washington Univ, Sch Med & Hlth Sci, Div Cardiol, Childrens Natl Med Ctr, Washington, DC 20052 USA; [Sinha, Pranava; Jonas, Richard A.] George Washington Univ, Sch Med & Hlth Sci, Div Cardiovasc Surg, Childrens Natl Med Ctr, Washington, DC 20052 USA; [Levy, Richard J.] George Washington Univ, Sch Med & Hlth Sci, Div Anesthesiol & Pain Med, Childrens Natl Med Ctr, Washington, DC 20052 USA		Levy, RJ (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Div Anesthesiol & Pain Med, Childrens Natl Med Ctr, Washington, DC 20052 USA.	rlevy@cnmc.org	Spaeder, Michael C./I-7764-2019; Jain, Parag/AAB-8360-2020	Spaeder, Michael C./0000-0002-6175-8435; Jain, Parag/0000-0002-2114-2740	Children's National Medical Center Institutional Bridge Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM103842] Funding Source: NIH RePORTER	Dr. Levy is supported by Children's National Medical Center Institutional Bridge Fund. Dr. Spaeder received support for travel from the National Center for the Study of Preparedness and Catastrophic Event Response and from the Society of Critical Care Medicine. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1173, DOI 10.1515/CCLM.2000.181; Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Baburamani AA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00424; Bennett PM, 2004, J MUSCLE RES CELL M, V25, P119, DOI 10.1023/B:JURE.0000035892.77399.51; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bhutta AT, 2012, PEDIATR CRIT CARE ME, V13, P328, DOI 10.1097/PCC.0b013e31822f18f9; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bokesch PM, 2002, ANESTH ANALG, V95, P889, DOI 10.1097/00000539-200210000-00018; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Hirsch JC, 2012, ANN THORAC SURG, V94, P1365, DOI 10.1016/j.athoracsur.2012.05.135; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Lardner D, 2004, PEDIATR ANESTH, V14, P495, DOI 10.1111/j.1460-9592.2004.01230.x; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Lindberg L, 2003, BRIT J ANAESTH, V90, P728, DOI 10.1093/bja/aeg125; Liu Y, 2009, PEDIATR CARDIOL, V30, P893, DOI 10.1007/s00246-009-9454-x; Matheis G, 2000, THORAC CARDIOV SURG, V48, P263, DOI 10.1055/s-2000-7879; Menascu S, 2010, PEDIATR NEUROSURG, V46, P82, DOI 10.1159/000319004; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	23	9	9	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2014	15	3					229	235		10.1097/PCC.0000000000000059			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	AG3PL	WOS:000335331700009	24395002	Green Accepted			2022-02-06	
J	Leininger, S; Strong, CAH; Donders, J				Leininger, Shelley; Strong, Carrie-Ann H.; Donders, Jacobus			Predictors of Outcome After Treatment of Mild Traumatic Brain Injury: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mild traumatic brain injury; outcome measurement; rehabilitation	COGNITIVE REHABILITATION; SYMPTOMS; TRIAL	Objective: To determine factors affecting outcome of comprehensive outpatient rehabilitation of individuals who sustained a mild traumatic brain injury. Participants: From a 4-year series of referrals, 49 nonconsecutive participants met criteria for mild traumatic brain injury (ie, loss of consciousness <30 minutes, Glasgow Coma Scale score >12). Setting: Outpatient, community-based postconcussion clinic at a rehabilitation hospital. Main Measures: Participants and therapy staff completed the Mayo-Portland Adaptability Inventory-Fourth Edition (MPAI-4) at the initiation and conclusion of treatment. Participants were also administered the Trail Making Test at the start of treatment. Results: Participants generally gave poorer adaptability ratings than staff at the beginning and discharge of treatment. Regression analyses revealed that after controlling for baseline ratings, psychiatric history was associated with worse participant-rated MPAI-4 Adjustment scores at treatment discharge, whereas better Trail Making Test Part B performance at initiation of treatment predicted better participant-rated MPAI-4 Ability at treatment discharge. Conclusions: Premorbid demographic and baseline neurocognitive factors should be taken into account prior to comprehensive treatment of mild traumatic brain injury, as they can influence long-term outcomes. Adaptability ratings from both staff and participants can be useful in gaining different perspectives and assessing factors affecting recovery.	[Leininger, Shelley; Strong, Carrie-Ann H.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Grand Rapids, MI 49503 USA		Leininger, S (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	carrie.strong@maryfreebed.com			Campbell Foundation	This work was supported by a grant from the Campbell Foundation.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Allen EA, 2007, TRAUMA, V9, P181, DOI 10.1177/1460408607087717; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P1016, DOI 10.1080/13854040802441135; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Fox J., 1991, REGRESSION DIAGNOSTI; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harrell FE Jr, 2017, REGRESSION MODELING; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Malec J., 2005, MAYO PORTLAND ADAPTA; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; McCrea M., 2008, MILD TRAUMATIC BRAIN; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Murphy KR, 2004, STAT POWER ANAL; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Reitan R, 1985, HALSTEAD REITAN NEUR; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; TEASDALE G, 1974, LANCET, V2, P81; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	36	9	9	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2014	29	2					109	116		10.1097/HTR.0b013e3182860506			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9ZH	WOS:000336504600004	23474883				2022-02-06	
J	Martin, KJ; Chounthirath, T; Xiang, HY; Smith, GA				Martin, Keith J.; Chounthirath, Thiphalak; Xiang, Huiyun; Smith, Gary A.			Pediatric Shopping-Cart-Related Injuries Treated in US Emergency Departments, 1990-2011	CLINICAL PEDIATRICS			English	Article						injury; falls; trauma; shopping carts; grocery carts; children; pediatric; emergency department	SAFETY-BELT USE; HEAD-INJURY; CHILDREN; CHILDHOOD; EPIDEMIOLOGY	This study investigates the effect of the 2004 US shopping cart safety standard on shopping-cart-related injuries among children younger than 15 years of age by retrospectively analyzing data from the National Electronic Injury Surveillance System. An estimated 530 494 children younger than 15 years were treated in US emergency departments for shopping-cart-related injuries from 1990 to 2011, averaging 24 113 children annually. The most commonly injured body region was the head (78.1%). The annual concussion/closed head injury rate per 10 000 children increased significantly (P < .001) by 213.3% from 0.64 in 1990 to 2.02 in 2011. Although a shopping cart safety standard was implemented in the United States in 2004, the overall number and rate of injuries associated with shopping carts have not decreased. In fact, the number and rate of concussions/closed head injuries have continued to climb. Increased prevention efforts are needed to address these injuries among children.	[Martin, Keith J.; Chounthirath, Thiphalak; Xiang, Huiyun; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Martin, Keith J.] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [Xiang, Huiyun; Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org	Xiang, Huiyun/E-4335-2011; Martin, Keith/AAG-3204-2020	Martin, Keith/0000-0002-1194-9858	National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention [1R49CE001172]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention (grant 1R49CE001172), which provided a student research stipend for Martin while he worked on this study.	[Anonymous], 2006, PEDIATRICS, V118, P825; [Anonymous], 2012, NC EST2011 ALLD MONT; [Anonymous], 2011, F237204 ASTM INT, DOI [10.1520/F2372-11A, DOI 10.1520/F2372-11A.AVAILABLE]; [Anonymous], 1998, 192911998 EN EUR COM; Barker MR, 2004, J APPL BEHAV ANAL, V37, P527, DOI 10.1901/jaba.2004.37-527; BARNARD JD, 1977, J APPL BEHAV ANAL, V10, P49, DOI 10.1901/jaba.1977.10-49; CAMPBELL M, 1990, BRIT MED J, V301, P1370, DOI 10.1136/bmj.301.6765.1370; FERRARI JR, 1989, ENVIRON BEHAV, V21, P603, DOI 10.1177/0013916589215005; Harrell WA, 1997, ARCH PEDIAT ADOL MED, V151, P105, DOI 10.1001/archpedi.1997.02170380109022; Harrell WA, 2003, PSYCHOL REP, V92, P889, DOI 10.2466/pr0.2003.92.3.889; Jensen L, 2008, J FORENSIC SCI, V53, P1178, DOI 10.1111/j.1556-4029.2008.00799.x; Lee E., 2002, ATLANTA J CONST 0610, pE1; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Parry ML, 2002, J PAEDIATR CHILD H, V38, P51, DOI 10.1046/j.1440-1754.2002.00708.x; Roche J., SHOPPING CART PREVEN; Showalter K., 2000, COLUMBUS BUSINE 1127, pA1; Smith GA, 1996, PEDIATRICS, V97, P161; SMITH GA, 1995, ARCH PEDIAT ADOL MED, V149, P1207, DOI 10.1001/archpedi.1995.02170240025003; Smith GA, 2006, PEDIATRICS, V118, pE540, DOI 10.1542/peds.2006-1216; Smith GA, 2006, PEDIATRICS, V118, P739, DOI 10.1542/peds.2006-0711; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Tinsworth DK., 2008, SHOPPING CART RELATE; U.S. Census Bureau, 2004, US EST90INT 07 INT E; U.S. Census Bureau, 2011, US EST00INT ALLDATA; U. S. Consumer Product Safety Commission, 2000, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1994, SHOPP CART PET BRIEF; *US CONS PROD SAF, 2006, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1977, BRIEF PACK CP 75 23; *US CONS PROD SAF, 1998, SHOPP CART PET BRIEF; US Consumer Product Safety Commission, 2013, NEISS PROD COD COMP; US Consumer Product Safety Commission, 2012, CPSC SAF AL FALLS SH; US Consumer Product Safety Commission, 2009, SHOPP CART INJ CHILD; US Consumer Product Safety Commission, 1992, MMWR-MORBID MORTAL W, V41, P271; US Consumer Product Safety Commission, 1993, NAT INJ INF CLEAR HO; Vilke GM, 2004, PEDIATR EMERG CARE, V20, P660, DOI 10.1097/01.pec.0000142949.81135.3d; Woo EK, 2003, J PAEDIATR CHILD H, V39, P157, DOI 10.1046/j.1440-1754.2003.t01-2-00121.x; Wright JW, 2008, ACCIDENT ANAL PREV, V40, P1253, DOI 10.1016/j.aap.2007.12.005	37	9	9	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	MAR	2014	53	3					277	285		10.1177/0009922813513322			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AA8TY	WOS:000331369100012	24351504	Green Submitted			2022-02-06	
J	Sieswerda-Hoogendoorn, T; Robben, SGF; Karst, WA; Moesker, FM; van Aalderen, M; Lameris, JS; van Rijn, RR				Sieswerda-Hoogendoorn, T.; Robben, S. G. F.; Karst, W. A.; Moesker, F. M.; van Aalderen, M.; Lameris, J. S.; van Rijn, R. R.			Abusive head trauma: Differentiation between impact and non-impact cases based on neuroimaging findings and skeletal surveys	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Abusive head trauma; Child abuse; Head injury, closed; Haematoma, subdural; Forensic medicine	CHILDREN; INFANTS; INJURY	Objectives: To determine whether imaging findings can be used to differentiate between impact and non-impact head trauma in a group of fatal and non-fatal abusive head trauma (AHT) victims. Methods: We included all AHT cases in the Netherlands in the period 2005-2012 for which a forensic report was written for a court of law, and for which imaging was available for reassessment. Neuroradiological and musculoskeletal findings were scored by an experienced paediatric radiologist. Results: We identified 124 AHT cases; data for 104 cases (84%) were available for radiological reassessment. The AHT victims with a skull fracture had fewer hypoxic ischaemic injuries than AHT victims without a skull fracture (p = 0.03), but the relative difference was small (33% vs. 57%). There were no significant differences in neuroradiological and musculoskeletal findings between impact and non-impact head trauma cases if the distinction between impact and non-impact head trauma was based on visible head injuries, as determined by clinical examination, as well as on the presence of skull fractures. Conclusions: Neuroradiological and skeletal findings cannot discriminate between impact and non-impact head trauma in abusive head trauma victims. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Sieswerda-Hoogendoorn, T.; van Rijn, R. R.] Netherlands Forens Inst, Dept Forens Med, The Hague, Netherlands; [Sieswerda-Hoogendoorn, T.; van Rijn, R. R.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Robben, S. G. F.] Maastricht Univ, Med Ctr, NL-6202 AZ Maastricht, Netherlands; [Karst, W. A.] Netherlands Forens Inst, Dept Forens Med, NL-2490 AA The Hague, Netherlands; [Moesker, F. M.] Univ Amsterdam, Acad Med Ctr, Fac Med, NL-1105 AZ Amsterdam, Netherlands; [van Aalderen, M.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat, NL-1105 AZ Amsterdam, Netherlands; [Lameris, J. S.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands		Sieswerda-Hoogendoorn, T (corresponding author), Netherlands Forens Inst, Dept Forens Med, The Hague, Netherlands.	t.sieswerda@amc.nl; s.robben@maastrichtuniversity.nl; w.karst@nfi.minvenj.nl; f.moesker@erasmusmc.nl; w.m.vanaalderen@amc.nl; j.s.lameris@amc.nl; r.r.vanrijn@amc.nl	van Rijn, Rick/H-5526-2019	van Rijn, Rick/0000-0002-8876-6515	Netherlands Forensic Institute; Maastricht University Medical Centre; Emma's Children Hospital; Academic Medical Hospital Amsterdam	TS, WK and RR are paid employees from the Netherlands Forensic Institute. SR is a paid employee from the Maastricht University Medical Centre. FM was a medical student at the time of the data collection. WA is a paid employees by the Emma's Children Hospital. JL is a paid employee by the Academic Medical Hospital Amsterdam. The employers did not have any influence on design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; [Anonymous], 2013, DOES YOUR STUD HAV B; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Hughes-Roberts Y, 2012, CLIN RADIOL, V67, P868, DOI 10.1016/j.crad.2012.01.020; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Kleinman PK, 2011, AM J ROENTGENOL, V197, P1005, DOI 10.2214/AJR.11.6540; Maguire SA, 2013, EYE, V27, P28, DOI 10.1038/eye.2012.213; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545	13	9	9	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	MAR	2014	83	3					584	588		10.1016/j.ejrad.2013.11.015			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	AA5BQ	WOS:000331111000035	24360233				2022-02-06	
J	Baby, N; Li, YL; Ling, EA; Lu, J; Dheen, ST				Baby, Nimmi; Li, Yali; Ling, Eng-Ang; Lu, Jia; Dheen, S. Thameem			Runx1t1 (Runt-Related Transcription Factor 1; Translocated to, 1) Epigenetically Regulates the Proliferation and Nitric Oxide Production of Microglia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITOR; CELL-CYCLE PROGRESSION; TRAUMATIC BRAIN-INJURY; FUSION PARTNER; AMYLOID-BETA; ETO; ACTIVATION; COREPRESSOR; EXPRESSION	Background: Microglia, the resident immune cells of the brain, undergo rapid proliferation and produce several proinflammatory molecules and nitric oxide (NO) when activated in neuropathological conditions. Runx1t1 (Runt-related transcription factor 1, translocated to 1) has been implicated in recruiting histone deacetylases (HDACs) for transcriptional repression, thereby regulating cell proliferation. In the present study, Runx1t1 expression was shown to localize in amoeboid microglial cells of the postnatal rat brain, being hardly detectable in ramified microglia of the adult brain. Moreover, a marked expression of Runx1t1 was induced and translocated to nuclei in activated microglia in vitro and in vivo. In view of these findings, it was hypothesized that Runx1t1 regulates microglial functions during development and in neuropathological conditions. Methods and Findings: siRNA-mediated knockdown of Runx1t1 significantly decreased the expression level of cell cycle-related gene, cyclin-dependent kinase 4 (Cdk4) and proliferation index in activated BV2 microglia. It was also shown that HDAC inhibitor (HDACi) treatment mimics the effects of Runx1t1 knockdown on microglial proliferation, confirming that microglial proliferation is associated with Runx1t1 expression and HDACs activity. Further, Runx1t1 and HDACs were shown to promote neurotoxic effect of microglia by repressing expression of LAT2, L-aminoacid transporter-2 (cationic amino acid transporter, y+ system), which normally inhibits NO production. This was confirmed by chromatin immunoprecipitation (ChIP) assay, which revealed that Runx1t1 binds to the promoter region of LAT2 and this binding increased upon microglial activation. However, the enhanced binding of Runx1t1 to the LAT2 promoter could not repress the LAT2 expression when the BV2 microglia cells were treated with HDACi, indicating that Runx1t1 requires HDACs to transcriptionally repress the expression of LAT2. Conclusion/Interpretation: In conclusion, it is suggested that Runx1t1 controls proliferation and the neurotoxic effect of microglia by epigenetically regulating Cdk4 and LAT2 via its interaction with HDACs.	[Baby, Nimmi; Li, Yali; Ling, Eng-Ang; Dheen, S. Thameem] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Lu, Jia] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore		Dheen, ST (corresponding author), Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117548, Singapore.	antstd@nus.edu.sg	Dheen, S. Thameem/AAU-8627-2020; BABY, NIMMI/AAK-2245-2020	BABY, NIMMI/0000-0001-8344-8684; Dheen, S. Thameem/0000-0001-9600-6789	ASTAR-MINDEF-NUS, Singapore [09/1/50/19/621, R-181-000-141-305]	This research was supported by the joint ASTAR-MINDEF-NUS grant (09/1/50/19/621 and R-181-000-141-305), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdanipour Alireza, 2012, Iranian Biomedical Journal, V16, P90, DOI 10.6091/ibj.1060.2012; Baumann P, 2012, BRIT J HAEMATOL, V156, P633, DOI 10.1111/j.1365-2141.2011.08983.x; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; Das SK, 2005, BBA-GEN SUBJECTS, V1726, P328, DOI 10.1016/j.bbagen.2005.09.007; Davis JN, 2003, GENE, V303, P1, DOI 10.1016/S0378-1119(02)01172-1; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Faraco G, 2009, NEUROBIOL DIS, V36, P269, DOI 10.1016/j.nbd.2009.07.019; Ferreira R, 2001, EMBO REP, V2, P794, DOI 10.1093/embo-reports/kve173; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; HAGOPIAN HK, 1977, CELL, V12, P855, DOI 10.1016/0092-8674(77)90284-7; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; Kaur C, 2007, ACTA PHARMACOL SIN, V28, P1087, DOI 10.1111/j.1745-7254.2007.00625.x; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Mathew OP, 2010, BIOMED PHARMACOTHER, V64, P733, DOI 10.1016/j.biopha.2010.09.017; Melnick AM, 2000, MOL CELL BIOL, V20, P2075, DOI 10.1128/MCB.20.6.2075-2086.2000; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Oakford PC, 2010, LEUKEMIA RES, V34, P1203, DOI 10.1016/j.leukres.2010.03.029; Okumura AJ, 2007, EXP HEMATOL, V35, P978, DOI 10.1016/j.exphem.2007.03.002; Parakalan R, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-64; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Soliman ML, 2012, J NEUROCHEM, V123, P555, DOI 10.1111/j.1471-4159.2012.07955.x; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Zhang JS, 2001, MOL CELL BIOL, V21, P156, DOI 10.1128/MCB.21.1.156-163.2001; Zhang LT, 2009, EUR J HUM GENET, V17, P1010, DOI 10.1038/ejhg.2008.269; Zhou Q, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-50; Zielinska M, 2011, NEUROCHEM INT, V58, P190, DOI 10.1016/j.neuint.2010.11.015	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89326	10.1371/journal.pone.0089326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	WOS:000331711900125	24586690	Green Published, Green Submitted, gold			2022-02-06	
J	Huang, XJ; Li, WP; Lin, Y; Feng, JF; Jia, F; Mao, Q; Jiang, JY				Huang, Xian-jian; Li, Wei-ping; Lin, Yong; Feng, Jun-feng; Jia, Feng; Mao, Qing; Jiang, Ji-yao			Blockage of the Upregulation of Voltage-Gated Sodium Channel Na(v)1.3 Improves Outcomes after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						antisense oligodeoxynucleotides; intracerebroventicular administration; Na(v)1; 3; traumatic brain injury; voltage-gated sodium channels	FLUID-PERCUSSION MODEL; SPINAL-CORD-INJURY; COGNITIVE DYSFUNCTION; RAT; EDEMA; PROTEOLYSIS; INHIBITOR; ANTISENSE; TETRODOTOXIN; MIPOMERSEN	Excessive active voltage-gated sodium channels are responsible for the cellular abnormalities associated with secondary brain injury following traumatic brain injury (TBI). We previously presented evidence that significant upregulation of Na(v)1.3 expression occurs in the rat cortex at 2h and 12h post-TBI and is correlated with TBI severity. In our current study, we tested the hypothesis that blocking upregulation of Na(v)1.3 expression in vivo in the acute stage post-TBI attenuates the secondary brain injury associated with TBI. We administered either antisense oligodeoxynucleotides (ODN) targeting Na(v)1.3 or artificial cerebrospinal fluid (aCSF) at 2h, 4h, 6h, and 8h following TBI. Control sham animals received aCSF administration at the same time points. At 12h post-TBI, Na(v)1.3 messenger ribonucleic acid (mRNA) levels in bilateral hippocampi of the aCSF group were significantly elevated, compared with the sham and ODN groups (p<0.01). However, the Na(v)1.3 mRNA levels in the uninjured contralateral hippocampus of the ODN group were significantly lowered, compared with the sham group (p<0.01). Treatment with antisense ODN significantly decreased the number of degenerating neurons in the ipsilateral hippocampal CA3 and hilar region (p<0.01). A set of left-to-right ratio value analyzed by magnetic resonance imaging T2 image on one day, three days, and seven days post-TBI showed marked edema in the ipsilateral hemisphere of the aCSF group, compared with that of the ODN group (p<0.05). The Morris water maze memory retention test showed that both the aCSF and ODN groups took longer to find a hidden platform, compared with the sham group (p<0.01). However, latency in the aCSF group was significantly higher than in the ODN group (p<0.05). Our in vivo Na(v)1.3 inhibition studies suggest that therapeutic strategies to block upregulation of Na(v)1.3 expression in the brain may improve outcomes following TBI.	[Huang, Xian-jian; Lin, Yong; Feng, Jun-feng; Jia, Feng; Mao, Qing; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China; [Huang, Xian-jian; Li, Wei-ping] Second Peoples Hosp Shenzhen, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China		Mao, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.	maoq@netease.com; Jiangjyb@online.sh.cn			National Science and Nature Grant [81071542, 30973086, 30901543, 81000829, 81301062]; National Health Science Grant [200802093]; National Key Basic Research ProjectNational Basic Research Program of China [2012CB518100]; International Collaboration Project of Shenzhen Science, Technology and Innovation Committee [GJHZ20120614154914623]; Science and Technology Committee of ShanghaiShanghai Science & Technology Committee [10JC1409800, 08411951900]; Program for Shanghai Outstanding Medical Academic Leaders	This work was supported by grants from National Science and Nature Grant (No. 81071542, No. 30973086, No. 30901543, No. 81000829, and No. 81301062), National Health Science Grant (No. 200802093), National Key Basic Research Project (No. 2012CB518100), International Collaboration Project of Shenzhen Science, Technology and Innovation Committee (No. GJHZ20120614154914623), Science and Technology Committee of Shanghai (No. 10JC1409800 and No. 08411951900), and Program for Shanghai Outstanding Medical Academic Leaders. We thank Ken C. Van, Department of Neurological Surgery, University of California Davis, for his editorial support and critical review of the article.	Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; DeKosky ST, 2004, J NEUROCHEM, V90, P998, DOI 10.1111/j.1471-4159.2004.02575.x; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dore-Duffy P, 2011, NEUROL RES, V33, P176, DOI 10.1179/016164111X12881719352372; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Estacion M, 2010, EXP NEUROL, V224, P362, DOI 10.1016/j.expneurol.2010.04.012; Feng JF, 2011, BRAIN RES, V1395, P62, DOI 10.1016/j.brainres.2011.04.022; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guo F, 2008, J ELECTRON MATER, V37, P1, DOI 10.1007/s11664-007-0302-6; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; Hains BC, 2003, J NEUROSCI, V23, P8881; Holland KD, 2008, NEUROSCI LETT, V433, P65, DOI 10.1016/j.neulet.2007.12.064; Huang XJ, 2013, J NEUROTRAUM, V30, P39, DOI 10.1089/neu.2012.2508; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kling J, 2010, NAT BIOTECHNOL, V28, P295, DOI 10.1038/nbt0410-295; Leterrier C, 2010, NEUROSCI LETT, V486, P92, DOI 10.1016/j.neulet.2010.08.079; Mao Q, 2010, NEUROSURGERY, V66, P1134, DOI 10.1227/01.NEU.0000369612.31946.A2; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schoch KM, 2013, J NEUROCHEM, V125, P909, DOI 10.1111/jnc.12144; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P295, DOI 10.1196/annals.1403.022; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Siqueira SRDT, 2009, NEUROSCIENCE, V164, P573, DOI 10.1016/j.neuroscience.2009.08.037; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Walberer M, 2007, J NEUROSURG ANESTH, V19, P105, DOI 10.1097/ANA.0b013e31802c7e33; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wu ZL, 2013, NEUROL RES, V35, P255, DOI 10.1179/1743132813Y.0000000165; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635	42	9	9	3	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2014	31	4					346	357		10.1089/neu.2013.2899			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AA7PY	WOS:000331290600007	24313291	Green Published			2022-02-06	
J	Jia, F; Mao, Q; Liang, YM; Jiang, JY				Jia, Feng; Mao, Qing; Liang, Yu-min; Jiang, Ji-Yao			The Effect of Hypothermia on the Expression of TIMP-3 after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; mild hypothermia; TIMP-3; traumatic brain injury	TISSUE INHIBITOR; THERAPEUTIC HYPOTHERMIA; NEURONAL DEATH; TNF-ALPHA; POSTTRAUMATIC HYPOTHERMIA; MODERATE HYPOTHERMIA; HOUSEKEEPING GENES; CELL-DEATH; METALLOPROTEINASE-3; TEMPERATURE	Here we investigate the effect of hypothermia on the expression of apoptosis-regulating protein TIMP-3 after fluid percussion traumatic brain injury (TBI) in rats. We began with 210 adult male Sprague-Dawley rats and randomly assigned them to three groups: TBI with hypothermia treatment (32 degrees C), TBI with normothermia (37 degrees C), and sham-injured controls. TBI was induced by a fluid percussion TBI device. Mild hypothermia (32 degrees C) was achieved by partial immersion in a water bath (0 degrees C) under general anesthesia for 4h. The rats were killed at 4, 6, 12, 24, 48, and 72h and 1 week after TBI. The mRNA and protein level of TIMP-3 in both the injured and uninjured hemispheres of the brains from each group were measured using RT-PCR and Western blotting. In the normothermic group, TIMP-3 levels in both the injured and uninjured hemispheres were significantly increased after TBI compared with those of sham-injured animals (p<0.01). In contrast, post-traumatic hypothermia significantly attenuated this increase. According to the RT-PCR and Western blot analyses, the maximum mRNA levels of TIMP-3 were reduced to 60.60 +/- 2.30%, 55.83 +/- 1.80%, 66.03 +/- 2.10%, and 64.51 +/- 1.50%, respectively, of the corresponding values in the normothermic group in the injured and uninjured hemispheres (cortex and hippocampus) of the hypothermia group (p<0.01), while the respective maximum protein levels of TIMP-3 were reduced to 57.50 +/- 1.50, 52.67 +/- 2.20, 60.31 +/- 2.50 and 54.76 +/- 1.40 (p<0.01). Our data suggest that moderate fluid percussion brain injury significantly upregulates TIMP-3 expression, and that this increase may be suppressed by hypothermia treatment.	[Jia, Feng; Mao, Qing; Liang, Yu-min; Jiang, Ji-Yao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China; [Jia, Feng] Jiangsu Univ, Yixing Peoples Hosp, Affiliated Hosp, Dept Neurosurg, Yixing City, Jiangsu, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, RenJi Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.	jiangjyb@online.sh.ch			National Key Basic Research ProjectNational Basic Research Program of China [2005CB522604]; National Science and Nature Grant [30571908]; Science and Technology Committee of ShanghaiShanghai Science & Technology Committee [07JC14038]; Program for Shanghai Outstanding Medical Academic Leader	This work was supported by grants from the National Key Basic Research Project (no. 2005CB522604), National Science and Nature Grant (no. 30571908), the Science and Technology Committee of Shanghai (no. 07JC14038), and the Program for Shanghai Outstanding Medical Academic Leader.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Aswal APS, 2008, ANIM REPROD SCI, V103, P164, DOI 10.1016/j.anireprosci.2007.04.012; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; Bond M, 2002, J BIOL CHEM, V277, P13787, DOI 10.1074/jbc.M111507200; Bond M, 2000, J BIOL CHEM, V275, P41358, DOI 10.1074/jbc.M007929200; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Chetty C, 2008, CANCER RES, V68, P4736, DOI 10.1158/0008-5472.CAN-07-6612; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Deng XY, 2006, EUR J CANCER, V42, P3267, DOI 10.1016/j.ejca.2006.07.003; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faden AI, 1996, JAMA-J AM MED ASSOC, V276, P569, DOI 10.1001/jama.276.7.569; Fassina G, 2000, CLIN EXP METASTAS, V18, P111, DOI 10.1023/A:1006797522521; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hayashi N, 1997, NEUROCHEMISTRY, P97; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Jiang C., 2009, INFLAMM RES; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Mun-Bryce S, 1998, AM J PHYSIOL-REG I, V274, pR1203, DOI 10.1152/ajpregu.1998.274.5.R1203; Qiu JH, 2002, J NEUROSCI, V22, P3504; Smith MR, 1997, CYTOKINE, V9, P770, DOI 10.1006/cyto.1997.0233; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Wallace JA, 2002, J CEREBR BLOOD F MET, V22, P1303, DOI 10.1097/01.WCB.0000040943.89393.c1; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yamashita A, 2007, ARCH HISTOL CYTOL, V70, P197, DOI 10.1679/aohc.70.197; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	46	9	9	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2014	31	4					387	394		10.1089/neu.2008.0814			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AA7PY	WOS:000331290600011	23256480	Green Published			2022-02-06	
J	Berg, GM; Hervey, AM; Atterbury, D; Cook, R; Mosley, M; Grundmeyer, R; Acuna, D				Berg, Gina M.; Hervey, Ashley M.; Atterbury, Dusty; Cook, Ryan; Mosley, Mark; Grundmeyer, Raymond; Acuna, David			Evaluating the quality of online information about concussions	JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS			English	Article						Internet; review; concussion; return to play; online; health information	WORLD-WIDE-WEB; ASSOCIATION POSITION STATEMENT; HEALTH INFORMATION; INTERNET; SPORT	Objectives: Compare and assess information available on the Internet about the definition, symptoms, treatment, and return to play recommendations after a concussion. Methods: The top 10 websites generated by a Google search on the keyword "concussion" were evaluated by two independent researchers and three medical professionals for definition, signs, symptoms, home treatment, care-seeking advice, and return to play recommendations. The medical professionals also rated their willingness to recommend each website to patients. Results: Each website contained a general list of signs, symptoms, and home treatment. One website advised the use of ibuprofen, four advised against ibuprofen, and five made no medication recommendations. Nine websites contained guidance on seeking physician care, and eight recommended athletes not return to play until cleared by a healthcare professional. Conclusion: Nine of the websites contained information for each section evaluated; however, information was inconsistent. Healthcare providers should be aware of the variable quality of information available on the Internet and guide patients to more optimal resources.	[Berg, Gina M.; Mosley, Mark; Acuna, David] Wesley Med Ctr, Wichita, KS 67214 USA; [Hervey, Ashley M.] Univ Kansas, Sch Med, Wichita, KS 67214 USA; [Atterbury, Dusty; Cook, Ryan] Wichita State Univ, Wichita, KS 67260 USA; Abay Neurosci Ctr, Wichita, KS USA		Berg, GM (corresponding author), Wesley Med Ctr, Wichita, KS 67214 USA.						Almasi Stephen J, 2012, WMJ, V111, P21; [Anonymous], 2011, IBM SPSS WIND COMP P; Bernstam EV, 2008, CANCER-AM CANCER SOC, V112, P1206, DOI 10.1002/cncr.23308; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Cline RJW, 2001, HEALTH EDUC RES, V16, P671, DOI 10.1093/her/16.6.671; Crawford M., 2011, JACA, V48, P8; Diaz JA, 2002, J GEN INTERN MED, V17, P180, DOI 10.1046/j.1525-1497.2002.10603.x; Eysenbach G, 2002, BMJ-BRIT MED J, V324, P573, DOI 10.1136/bmj.324.7337.573; Fisher J, 2004, TOP EMERG MED, V26, P260; Fjordbak B., 2011, ASHA LEADER, V16, P1; Fox S, 2003, INTERNET HLTH RESOUR; Griffiths KM, 2000, BMJ-BRIT MED J, V321, P1511, DOI 10.1136/bmj.321.7275.1511; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hendrick PA, 2012, MANUAL THER, V17, P318, DOI 10.1016/j.math.2012.02.019; Impicciatore P, 1997, BMJ-BRIT MED J, V314, P1875, DOI 10.1136/bmj.314.7098.1875; Isaac D, 2004, INJURY PREV, V10, P59, DOI 10.1136/ip.2003.003327; Jetha A, 2011, DISABIL HEALTH J, V4, P112, DOI 10.1016/j.dhjo.2010.07.001; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Martineau Chad, 2007, JAAPA, V20, P22; McClung HJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.6.e2; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McTavish J, 2011, ETHICS INF TECHNOL, V13, P227, DOI 10.1007/s10676-011-9272-8; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Moore D, 2011, ARCH WOMEN MENT HLTH, V14, P443, DOI 10.1007/s00737-011-0245-z; Morahan-Martin JM, 2004, CYBERPSYCHOL BEHAV, V7, P497, DOI 10.1089/cpb.2004.7.497; Murphy R, 2004, INT J EAT DISORDER, V35, P145, DOI 10.1002/eat.10245; Ostry A, 2008, HEALTH EDUC RES, V23, P648, DOI 10.1093/her/cym050; Quinn EM, 2012, BREAST, V21, P514, DOI 10.1016/j.breast.2012.01.020; Rainie L., 2000, ONLINE HLTH CARE REV; Schalnus R, 2010, OPHTHALMOLOGICA, V224, P30, DOI 10.1159/000233233; Tang HW, 2006, BRIT MED J, V333, P1143, DOI 10.1136/bmj.39003.640567.AE; van der Marel S, 2009, INFLAMM BOWEL DIS, V15, P1891, DOI 10.1002/ibd.20976; Wilkins AS, 1999, HEALTH CARE MANAGE R, V24, P30	37	9	10	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1547-1896	0893-7400		JAAPA-J AM ACAD PHYS	JAAPA-J. Am. Acad. Physician Assist.	FEB	2014	27	2								10.1097/01.JAA.0000442712.05009.b1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM3GB	WOS:000357568900001	24463744				2022-02-06	
J	Bolinger, E; Reese, C; Suhr, J; Larrabee, GJ				Bolinger, Elizabeth; Reese, Caitlin; Suhr, Julie; Larrabee, Glenn J.			Susceptibility of the MMPI-2-RF Neurological Complaints and Cognitive Complaints Scales to Over-reporting in Simulated Head Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Professional issues; Malingering; Traumatic brain injury	POSTCONCUSSION-LIKE SYMPTOMS; RESTRUCTURED FORM MMPI-2-RF; VALIDITY SCALES; BIAS; RBS; METAANALYSIS; EXPECTATION; UTILITY; VALIDATION	We examined the effect of simulated head injury on scores on the Neurological Complaints (NUC) and Cognitive Complaints (COG) scales of the Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF). Young adults with a history of mild head injury were randomly assigned to simulate head injury or give their best effort on a battery of neuropsychological tests, including the MMPI-2-RF. Simulators who also showed poor effort on performance validity tests (PVTs) were compared with controls who showed valid performance on PVTs. Results showed that both scales, but especially NUC, are elevated in individuals simulating head injury, with medium to large effect sizes. Although both scales were highly correlated with all MMPI-2-RF over-reporting validity scales, the relationship of Response Bias Scale to both NUC and COG was much stronger in the simulators than controls. Even accounting for over-reporting on the MMPI-2-RF, NUC was related to general somatic complaints regardless of group membership, whereas COG was related to both psychological distress and somatic complaints in the control group only. Neither scale was related to actual neuropsychological performance, regardless of group membership. Overall, results provide further evidence that self-reported cognitive symptoms can be due to many causes, not necessarily cognitive impairment, and can be exaggerated in a non-credible manner.	[Bolinger, Elizabeth; Reese, Caitlin; Suhr, Julie] Ohio Univ, Dept Psychol, Athens, OH 45701 USA		Suhr, J (corresponding author), Ohio Univ, Dept Psychol, 200 Porter Hall, Athens, OH 45701 USA.	suhr@ohio.edu					Ben-Porath, 2008, MINNESOTA MULTIPHASI; Ben-Porath Y., 2012, INTERPRETING MMPI 2; Ben-Porath Y.S., 2011, MMPI 2 RF MANUAL ADM; Ben-Porath Y. S., 2008, MMPI 2 RF MANULA ADM; Bootzin RR, 2005, J CLIN PSYCHOL, V61, P871, DOI 10.1002/jclp.20131; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; GREIFFENSTEIN MF, 2007, ASSESSMENT MALINGERE, P100; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; Locke DEC, 2010, EPILEPSY BEHAV, V17, P252, DOI 10.1016/j.yebeh.2009.12.004; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers R, 2011, J PSYCHOPATHOL BEHAV, V33, P355, DOI 10.1007/s10862-011-9222-0; Rohling ML, 2011, PSYCHOL BULL, V137, P708, DOI 10.1037/a0023327; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Wygant DB, 2011, PSYCHOL INJ LAW, V4, P13, DOI 10.1007/s12207-011-9098-z; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]	46	9	9	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2014	29	1					7	15		10.1093/arclin/act082			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AA1CA	WOS:000330832700002	24191968	Bronze			2022-02-06	
J	Cullen, N; Krakowski, A; Taggart, C				Cullen, Nora; Krakowski, Aneta; Taggart, Christina			Functional independence measure at rehabilitation admission as a predictor of return to driving after traumatic brain injury	BRAIN INJURY			English	Article						Automobile driving; outcome measures; recovery of function; rehabilitation; traumatic brain injury	DISABILITY RATING-SCALE; GLASGOW COMA SCALE; HEAD-INJURY; IMPAIRMENT; FUTURE; TESTS; DRS	Objective: To examine the utility of three common measures as predictors of return to driving after traumatic brain injury (TBI): Glasgow Coma Score (GCS) within the first 24 hours of injury and both Functional Independence Measure (FIM) and Disability Rating Scale (DRS) at rehabilitation admission. Methods: Seventy-two participants with TBI completed a questionnaire that assessed return to driving post-TBI, as measured by reinstatement of the driver's license. Participants who did not return to driving for non-medical reasons or who had not driven pre-injury and did not obtain a driver's license post-injury were excluded from analysis. This produced a final sample of 59 participants. Scores on GCS, FIM and DRS, leveraged from an existing database, were compared between participants who had and those who had not returned to driving post-injury. Multiple logistic regression analysis was performed to determine the relationship of each predictor variable to return to driving. Results: Only the FIM score at rehabilitation admission was significantly associated with return to driving (p<0.01). FIM score had a sensitivity of 72% and specificity of 73% with respect to return to driving. Conclusions: This study supports the use of FIM at rehabilitation admission as a predictor of return to driving. Future studies should be directed at identifying other measures to be used in combination with FIM to accurately predict return to driving post-TBI.	[Cullen, Nora; Taggart, Christina] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Cullen, Nora] Univ Toronto, Div Physiatry, Toronto, ON, Canada; [Krakowski, Aneta] Univ Toronto, Dept Med, Toronto, ON, Canada		Cullen, N (corresponding author), Toronto Rehab Univ Hlth Network, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	nora.cullen@uhn.ca		Cullen, Nora/0000-0001-6359-9418	Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Province of Ontario	The authors thank the staff members of the Toronto Rehabilitation Institute-University Health Network, ABI Service, for their assistance in data collection. The statistical advice of Ivan Steenstra and the research assistance of Patricia Aznar and Carolyn Go is also gratefully acknowledged. Equipment and space have been funded with grants from the Canada Foundation for Innovation and the Province of Ontario. The views expressed here do not necessarily reflect those of the Ontario Ministry of Health and Long-Term Care.	Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Campbell M., 2000, REHABILITATION TRAUM; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; LANGFITT TW, 1982, CLIN NEUR, V29, P353; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Neese LE, 2000, BRAIN INJURY, V14, P719; Ontario Ministry of Transportation, 2010, MED REV SECT FREQ AS; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; TEASDALE G, 1974, LANCET, V2, P81; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Yale Steven H, 2003, Clin Med Res, V1, P177; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	31	9	9	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2014	28	2					189	195		10.3109/02699052.2013.862738			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	302XR	WOS:000330638900008	24456058				2022-02-06	
J	Sikoglu, EM; Heffernan, ME; Tam, K; Sicard, KM; Bratane, BT; Quan, M; Fisher, M; King, JA				Sikoglu, Elif M.; Heffernan, Meghan E.; Tam, Kelly; Sicard, Kenneth M.; Bratane, Bernt T.; Quan, Meina; Fisher, Marc; King, Jean A.			Enhancement in cognitive function recovery by granulocyte-colony stimulating factor in a rodent model of traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Functional recovery; Granulocyte-colony stimulating factor; Morris Water Maze; Animal model	FOCAL CEREBRAL-ISCHEMIA; FACTOR G-CSF; WATER-MAZE; RAT; PHARMACOKINETICS; BEHAVIOR; STROKE; TRIAL	Traumatic brain injury (TBI) is characterized by neuronal damage and commonly, secondary cell death, leading to functional and neurological dysfunction. Despite the recent focus of TBI research on developing therapies, affective therapeutic strategies targeting neuronal death associated with TBI remain underexplored. This study explored the efficacy of granulocyte-colony stimulating factor (G-CSF) as an intervention for improving cognitive deficits commonly associated with TBI. Although G-CSF has been studied with histological techniques, to date, its effects on functional outcome remain unknown. To this end, we used a closed head injury (CHI) model in Wistar rats that were randomly assigned to one of four groups (untreated TBI, G-CSF treated TB!, G-CSF treated Control, Control). The treatment groups were administered subcutaneous injections of G-CSF 30 min (120 mu g/kg) and 12 h (60 mu g/kg) post-trauma. The Morris Water Maze test was used to measure any treatment-associated changes in cognitive deficits observed in TBI animals at days 2-6 post-injury. Our findings demonstrate a significant improvement in cognitive performance in the G-CSF treated TBI animals within a week of injury, compared to untreated TBI, indicative of immediate and beneficial effect of G-CSF on cognitive performance post CHI. Our model suggests that early G-CSF exposure may be a promising therapeutic approach in recovery of cognitive deficits due to TBI. (C) 2013 Elsevier B.V. All rights reserved.	[Sikoglu, Elif M.; Heffernan, Meghan E.; Tam, Kelly; Quan, Meina; King, Jean A.] Univ Massachusetts, Sch Med, Dept Psychiat, Ctr Comparat NeuroImaging, Worcester, MA 01655 USA; [Sicard, Kenneth M.; Bratane, Bernt T.; Fisher, Marc] Univ Massachusetts, Mem Med Ctr, Dept Neurol, Worcester, MA 01605 USA		King, JA (corresponding author), UMass Med Sch, 55 Lake Ave North, Worcester, MA 01655 USA.	Jean.King@umassmed.edu					Amsen Derk, 2009, V511, P107, DOI 10.1007/978-1-59745-447-6_5; Bratane BT, 2009, STROKE, V40, P3102, DOI 10.1161/STROKEAHA.109.553958; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Heffernan ME, 2013, J NEUROTRAUM, V30, P1007, DOI 10.1089/neu.2012.2366; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Kotto-Kome AC, 2004, PHARMACOL RES, V50, P55, DOI 10.1016/j.phrs.2003.12.011; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sheibani N, 2004, CRIT CARE MED, V32, P2274, DOI 10.1097/01.CCM.0000145998.11686.ED; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; TANAKA H, 1991, DRUG METAB DISPOS, V19, P200; Virley D, 2000, J CEREBR BLOOD F MET, V20, P563, DOI 10.1097/00004647-200003000-00015; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Whalen MJ, 2000, CRIT CARE MED, V28, P3710, DOI 10.1097/00003246-200011000-00029; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013	17	9	10	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 1	2014	259						354	356		10.1016/j.bbr.2013.11.008			3	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	AB3CA	WOS:000331667700043	24239694				2022-02-06	
J	Newberg, AB; Serruya, M; Gepty, A; Intenzo, C; Lewis, T; Amen, D; Russell, DS; Wintering, N				Newberg, Andrew B.; Serruya, Mijail; Gepty, Andrew; Intenzo, Charles; Lewis, Todd; Amen, Daniel; Russell, David S.; Wintering, Nancy			Clinical Comparison of Tc-99m Exametazime and I-123 Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; DOPAMINE TRANSPORTER DENSITY; EMISSION COMPUTED-TOMOGRAPHY; TECHNETIUM-99M-HMPAO SPECT; POSTTRAUMATIC HEADACHE; MIGRAINE; CONCUSSION; SEQUELAE; PAIN; CT	Background: This study evaluated the clinical interpretations of single photon emission computed tomography (SPECT) using a cerebral blood flow and a dopamine transporter tracer in patients with chronic mild traumatic brain injury (TBI). The goal was to determine how these two different scan might be used and compared to each other in this patient population. Methods and Findings: Twenty-five patients with persistent symptoms after a mild TBI underwent SPECT with both Tc-99m exametazime to measure cerebral blood flow (CBF) and I-123 ioflupane to measure dopamine transporter (DAT) binding. The scans were interpreted by two expert readers blinded to any case information and were assessed for abnormal findings in comparison to 10 controls for each type of scan. Qualitative CBF scores for each cortical and subcortical region along with DAT binding scores for the striatum were compared to each other across subjects and to controls. In addition, symptoms were compared to brain scan findings. TBI patients had an average of 6 brain regions with abnormal perfusion compared to controls who had an average of 2 abnormal regions (p<0.001). Patient with headaches had lower CBF in the right frontal lobe, and higher CBF in the left parietal lobe compared to patients without headaches. Lower CBF in the right temporal lobe correlated with poorer reported physical health. Higher DAT binding was associated with more depressive symptoms and overall poorer reported mental health. There was no clear association between CBF and DAT binding in these patients. Conclusions: Overall, both scans detected abnormalities in brain function, but appear to reflect different types of physiological processes associated with chronic mild TBI symptoms. Both types of scans might have distinct uses in the evaluation of chronic TBI patients depending on the clinical scenario.	[Newberg, Andrew B.; Gepty, Andrew; Wintering, Nancy] Thomas Jefferson Univ, Myrna Brind Ctr Integrat Med, Philadelphia, PA 19107 USA; [Serruya, Mijail] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Intenzo, Charles] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Lewis, Todd] Magee Mem Rehabilitat Ctr, Philadelphia, PA USA; [Amen, Daniel] Amen Clin Inc, Newport Beach, CA USA; [Russell, David S.] Inst Neurodegenerat Disorders, New Haven, CT USA; [Russell, David S.] Yale Univ, Sch Med, New Haven, CT USA		Newberg, AB (corresponding author), Thomas Jefferson Univ, Myrna Brind Ctr Integrat Med, Philadelphia, PA 19107 USA.	Andrew.newberg@jefferson.edu			GE Healthcare, Princeton, NJGeneral ElectricGE Healthcare	This work was supported by a grant from GE Healthcare, Princeton, NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Amen Daniel G, 2011, Open Neuroimag J, V5, P40, DOI 10.2174/1874440001105010040; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Amsterdam JD, 2012, J AFFECT DISORDERS, V141, P425, DOI 10.1016/j.jad.2012.03.007; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; Basoglu T, 1996, J NUCL MED, V37, P1172; Baulieu F, 2001, J NEUROIMAGING, V11, P112, DOI 10.1111/j.1552-6569.2001.tb00020.x; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; BELYI BI, 1987, INT J NEUROSCI, V32, P799, DOI 10.3109/00207458709043334; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein C, 2012, J CLIN NEUROL, V8, P89, DOI 10.3988/jcn.2012.8.2.89; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; CORSELLIS JAN, 1989, BRIT MED J, V298, P105, DOI 10.1136/bmj.298.6666.105; DiPiero V, 1997, PAIN, V70, P185, DOI 10.1016/S0304-3959(96)03318-0; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fayol P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P497, DOI 10.1016/j.annrmp.2008.06.003; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Jean-Bay E, 2000, J Neurosci Nurs, V32, P169; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kjeldgaard D, 2013, CEPHALALGIA; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; McNair DM, 1992, MANUAL PROFILE MOOD; Moss A, FUNCTIONAL BRAIN IMA; Murakami T, 2013, AM J GERIAT PSYCHIAT, V21, P840, DOI 10.1016/j.jagp.2013.01.057; Musiek ES, 2012, ALZHEIMERS DEMENT, V8, P51, DOI 10.1016/j.jalz.2011.06.003; Newberg A, 2007, NUCL MED COMMUN, V28, P3, DOI 10.1097/MNM.0b013e328013dc9d; Newberg AB, 2012, J NUCL MED, V53, P902, DOI 10.2967/jnumed.111.099606; Obermann M, 2010, HEADACHE, V50, P710, DOI 10.1111/j.1526-4610.2010.01644.x; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; SCHLAKE HP, 1990, EUR NEUROL, V30, P153, DOI 10.1159/000117334; Sivan M, 2010, CLIN REHABIL, V24, P110, DOI 10.1177/0269215509343234; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	54	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87009	10.1371/journal.pone.0087009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	WOS:000330339800075	24475210	Green Published, gold			2022-02-06	
J	Becker, F; Kirmess, M; Tornas, S; Lovstad, M				Becker, Frank; Kirmess, Melanie; Tornas, Sveinung; Lovstad, Marianne			A description of cognitive rehabilitation at Sunnaas Rehabilitation Hospital - Balancing comprehensive holistic rehabilitation and retraining of specific functional domains	NEUROREHABILITATION			English	Article						Cognitive rehabilitation; stroke; traumatic brain injury	BRAIN-INJURY REHABILITATION; RANDOMIZED CONTROLLED-TRIAL; OF-THE-LITERATURE; NEUROPSYCHOLOGICAL REHABILITATION; PROGRAM; STROKE; NEUROREHABILITATION; RESILIENCE; PREDICTORS; THERAPY	BACKGROUND: Measures of cognitive rehabilitation should include comprehensive holistic rehabilitation as well as interventions targeting specific cognitive functions; it is however not clear how this knowledge should be put into practice. OBJECTIVE: To describe services provided at the cognitive rehabilitation unit at Sunnaas Rehabilitation Hospital (SRH), a regional rehabilitation centre in Norway. METHODS: Cognitive rehabilitation programs offered at SRH are described. For all patients served in 2011 and 2012, epidemiological and hospitalization related data were retrieved. Results from a patient satisfaction survey are presented. RESULTS: The services include individual holistic cognitive rehabilitation as well as group programs. 307 individual patients were served in 355 hospitalizations; 68.1% were male; age ranged from 18 to 78 years. The largest patient groups were stroke (46.6%) and traumatic brain injury (33.0%). Mean length of stay was 36.9 days. Median time post injury was 0.8 years (range 16 days - 14 years). More than 90% of the patients were satisfied with the services they received to a large or very large extent. CONCLUSIONS: Providing cognitive rehabilitation that encompasses both a holistic approach and targets specific cognitive functions is challenging. More research is warranted to illuminate further how cognitive rehabilitation services should be designed and conducted in practice.	[Becker, Frank; Kirmess, Melanie; Tornas, Sveinung; Lovstad, Marianne] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Becker, Frank] Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway; [Kirmess, Melanie] Univ Oslo, Dept Special Needs Educ, Oslo, Norway; [Tornas, Sveinung; Lovstad, Marianne] Univ Oslo, Dept Psychol, Oslo, Norway		Becker, F (corresponding author), Univ Oslo, Inst Clin Med, Pb 1171 Blindern, N-0316 Oslo, Norway.	frank.becker@medisin.uio.no		Becker, Frank/0000-0002-0857-0628	Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds	Research on the Sunnaas CILT program (SunCIST) is financially supported by the Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds.	[Anonymous], 2011, KOGNITIV TILRETTELEG; Bach B., 2010, 062010 NST; Becker F, 2007, J REHABIL MED, V39, P658, DOI 10.2340/16501977-0112; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Berthier ML, 2011, NAT REV NEUROL, V7, P86, DOI 10.1038/nrneurol.2010.201; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Bonanno GA, 2012, SOC SCI MED, V74, P753, DOI 10.1016/j.socscimed.2011.11.022; Braverman SE, 1999, BRAIN INJURY, V13, P405; Cappa SF, 2011, EUROPEAN HDB NEUROLO, VI, P545, DOI DOI 10.1002/9781444328394.CH40; Christensen A.L., 1995, TRAUMATIC BRAIN INJU, P88; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Dams-O'Connor K., 2013, BRAIN IMPAIR, P1; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; FINSET A, 1988, SCAND J PSYCHOL, V29, P9, DOI 10.1111/j.1467-9450.1988.tb00771.x; FINSET A, 1992, SCAND J REHABIL MED, P25; FINSET A, 1995, BRAIN INJURY, V9, P495, DOI 10.3109/02699059509008209; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Kirmess M, 2012, PROCD SOC BEHV, V61, P18, DOI 10.1016/j.sbspro.2012.10.059; Kirmess M., 2011, THESIS U OSLO OSLO; Kirmess M, 2010, APHASIOLOGY, V24, P725, DOI 10.1080/02687030903437682; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Klonoff PS, 2007, BRAIN INJURY, V21, P1097, DOI 10.1080/02699050701687342; Laatsch L, 2000, NEUROREHABILITATION, V15, P189; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lovstad M., 2012, THESIS U OSLO OSLO; Niemeier JP, 2005, NEUROPSYCHOL REHABIL, V15, P129, DOI 10.1080/09602010443000083; Nordvik JE, 2012, NEUROCASE, V18, P139, DOI 10.1080/13554794.2011.568501; Normann T., 2011, 022011 NST; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Rabipour S, 2012, BRAIN COGNITION, V79, P159, DOI 10.1016/j.bandc.2012.02.006; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; Reinvang I., 1985, APHASIA BRAIN ORG; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Saether K., 2003, 5 WORLD C BRAIN INJ; Saether K., 2001, 4 WORLD C BRAIN INJ; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Sarre S., 2013, DISABIL REHABIL, V25; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; Skogan A. H., 2001, 4 WORLD C BRAIN INJ; Sohlberg M., 2001, COGNITIVE REHABILITA; Stubberud J., 2013, J INT NEUROPSYCH SOC, V19, P1; SUNDET K, 1988, J CLIN EXP NEUROPSYC, V10, P363, DOI 10.1080/01688638808408245; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; Tomassini V, 2012, NEUROREHAB NEURAL RE, V26, P581, DOI 10.1177/1545968311433208; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; World Health Organization, 2007, INT CLASS FUNCT DIS	59	9	9	2	13	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	1					87	100		10.3233/NRE-131015			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AA4JN	WOS:000331062000011	24284466				2022-02-06	
J	Choi, BY; Lee, BE; Kim, JH; Kim, HJ; Sohn, M; Song, HK; Chung, TN; Suh, SW				Choi, Bo Young; Lee, Bo Eun; Kim, Jin Hee; Kim, Hyun Jung; Sohn, Min; Song, Hong Ki; Chung, Tae Nyoung; Suh, Sang Won			Colchicine induced intraneuronal free zinc accumulation and dentate granule cell degeneration	METALLOMICS			English	Article							HYPOGLYCEMIC NEURONAL DEATH; HIPPOCAMPAL MOSSY FIBERS; TRAUMATIC BRAIN-INJURY; ENRICHED ZEN TERMINALS; AXONAL-TRANSPORT; AXOPLASMIC-TRANSPORT; CORTICAL CULTURE; SELENIUM METHODS; VESICULAR ZINC; NADPH OXIDASE	Colchicine has been discovered to inhibit many inflammatory processes such as gout, familial Mediterranean fever, pericarditis and Behcet disease. Other than these beneficial anti-inflammatory effects, colchicine blocks microtubule-assisted axonal transport, which results in the selective loss of dentate granule cells of the hippocampus. The mechanism of the colchicine-induced dentate granule cell death and depletion of mossy fiber terminals still remains unclear. In the present study, we hypothesized that colchicine-induced dentate granule cell death may be caused by accumulation of labile intracellular zinc. 10 mu g kg(-1) of colchicine was injected into the adult rat hippocampus and then brain sections were evaluated at 1 day or 1 week later. Neuronal cell death was evaluated by H&E staining or Fluoro-Jade B. Zinc accumulation and vesicular zinc were detected by N-(6-methoxy-8-quinolyl)-para-toluene sulfonamide (TSQ) staining. To test whether an extracellular zinc chelator can prevent this process, CaEDTA was injected into the hippocampus over a 5 min period with colchicine. To test whether other microtubule toxins also produce similar effects as colchicine, vincristine was injected into the hippocampus. The present study found that colchicine injection induced intracellular zinc accumulation in the dentate granule cells and depleted vesicular zinc from mossy fiber terminals. Injection of a zinc chelator, CaEDTA, did not block the zinc accumulation and neuronal death. Vincristine also produced intracellular zinc accumulation and neuronal death. These results suggest that colchicine-induced dentate granule cell death is caused by blocking axonal zinc flow and accumulation of intracellular labile zinc.	[Choi, Bo Young; Lee, Bo Eun; Kim, Jin Hee; Kim, Hyun Jung; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Korea 200702, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea; [Song, Hong Ki] Hallym Univ, Coll Med, Inst Epilepsy Res, Dept Neurol, Chunchon, South Korea; [Chung, Tae Nyoung] CHA Univ, Sch Med, Dept Emergency Med, Bundang, South Korea		Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Physiol, 1-Okcheon Dong, Korea 200702, South Korea.	swsuh@hallym.ac.kr	Chung, Tae Nyoung/AAN-7886-2020	Chung, Tae Nyoung/0000-0003-3537-4136; Choi, Bo Young/0000-0002-9579-3503; SOHN, MIN/0000-0003-4021-2051	National Research Foundation of Korea (NRF) - Korea government (MEST)Ministry of Education, Science and Technology, Republic of KoreaNational Research Foundation of KoreaKorean Government [2012R1A2A2A01040132]; Hallym University Specialization Fund [HRF-S-51]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2012R1A2A2A01040132) and by a grant from the Hallym University Specialization Fund (HRF-S-51). We would like express our special thanks to Mrs. Tae Yul Kim helped us with excellent illustrations.	AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; Ahn YH, 1998, EXP NEUROL, V154, P47, DOI 10.1006/exnr.1998.6931; ANIKSZTEJN L, 1987, BRAIN RES, V404, P58, DOI 10.1016/0006-8993(87)91355-2; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BENCHETRIT E, 1991, SEMIN ARTHRITIS RHEU, V20, P241, DOI 10.1016/0049-0172(91)90019-V; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Christensen MK, 1998, J COMP NEUROL, V400, P375, DOI 10.1002/(SICI)1096-9861(19981026)400:3<375::AID-CNE7>3.0.CO;2-5; Craddock TJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033552; CULL RE, 1975, EXP BRAIN RES, V24, P97; DANSCHER G, 1985, J HISTOCHEM CYTOCHEM, V33, P706, DOI 10.1177/33.7.4008918; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; DANSCHER G, 1985, HISTOCHEMISTRY, V83, P419, DOI 10.1007/BF00509203; Danscher G, 1996, HISTOCHEM J, V28, P361, DOI 10.1007/BF02331399; EMERICH DF, 1990, BRAIN RES, V517, P157, DOI 10.1016/0006-8993(90)91021-8; Evereklioglu C, 2005, SURV OPHTHALMOL, V50, P297, DOI 10.1016/j.survophthal.2005.04.009; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; GOLDSCHMIDT RB, 1982, NEUROSCIENCE, V7, P695, DOI 10.1016/0306-4522(82)90075-6; GOLDSCHMIDT RB, 1980, P NATL ACAD SCI-BIOL, V77, P3047, DOI 10.1073/pnas.77.5.3047; GRAHAM W, 1953, ANN RHEUM DIS, V12, P16, DOI 10.1136/ard.12.1.16; HARTUNG EF, 1954, ANN RHEUM DIS, V13, P190, DOI 10.1136/ard.13.3.190; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Imazio M, 2005, ARCH INTERN MED, V165, P1987, DOI 10.1001/archinte.165.17.1987; Imazio M, 2007, J CARDIOVASC MED, V8, P613, DOI 10.2459/01.JCM.0000281702.46359.07; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; LASEK RJ, 1968, EXP NEUROL, V21, P41, DOI 10.1016/0014-4886(68)90032-0; Lee JM, 2002, NEUROSCIENCE, V115, P871, DOI 10.1016/S0306-4522(02)00513-4; NAKAGAWA Y, 1987, BRAIN RES, V408, P57, DOI 10.1016/0006-8993(87)90358-1; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; SAHENK Z, 1980, BRAIN RES, V186, P343, DOI 10.1016/0006-8993(80)90980-4; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Sheline CT, 2003, EUR J NEUROSCI, V18, P1402, DOI 10.1046/j.1460-9568.2003.02865.x; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; SLOMIANKA L, 1990, NEUROSCIENCE, V38, P843, DOI 10.1016/0306-4522(90)90076-G; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2005, NEUROSCI LETT, V377, P164, DOI 10.1016/j.neulet.2004.11.096; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2003, J NEUROSCI, V23, P10681; Suh SW, 2001, BRAIN RES, V895, P25, DOI 10.1016/S0006-8993(01)01996-5; Suh SW, 2001, NEUROREPORT, V12, P1523, DOI 10.1097/00001756-200105250-00044; Suh SW, 1999, J HISTOCHEM CYTOCHEM, V47, P969, DOI 10.1177/002215549904700715; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takeda A, 1998, BRAIN RES BULL, V47, P103, DOI 10.1016/S0361-9230(98)00070-7; Wang ZY, 2008, NEUROCHEM RES, V33, P2472, DOI 10.1007/s11064-008-9798-2; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	56	9	9	0	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1756-5901	1756-591X		METALLOMICS	Metallomics		2014	6	8					1513	1520		10.1039/c4mt00067f			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0RP	WOS:000341019600020	24874779				2022-02-06	
S	Hovda, DA		Niranjan, A; Lunsford, LD		Hovda, David A.			The Neurophysiology of Concussion	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CEREBRAL CONCUSSION; RAT-BRAIN; METABOLISM; PLASTICITY; EXERCISE; VULNERABILITY; MECHANISMS; DEPRESSION; INCREASES	The following report reviews our current understanding of the neurobiological response to concussion which is often referred to as mild traumatic brain injury. The historical accomplishments to reveal the brain's response to this injury are discussed along with the neurochemical and metabolic cascade that results in an energy crisis. The massive ionic flux induced by cerebral concussion is discussed as it pertains to primarily potassium and calcium. The ensuing metabolic demands placed on cells exposed to this ionic flux is discussed as it relates to an injury-induced diaschisis. As this cascade produces neuronal dysfunction and corresponding deficits, it also results in a state of vulnerability to secondary insults and long-term neurological problems. While experimental studies are the primary focus of this report, relevant human observations are discussed and put into context. It is now clear that cerebral concussion is not a benign event. It carries with it neuroscientific consequences that result in symptoms and an increase in risk for many other challenges to the central nervous system. (C) 2014 S. Karger AG, Basel	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA		Hovda, DA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, 10833 Le Conte Ave,18-228 Semel,Box 957039, Los Angeles, CA 90095 USA.	dhovda@mednet.ucla.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS27544, 5P01NS058489] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489, R01NS027544] Funding Source: NIH RePORTER		ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; BECKER DP, 1987, PHYSL BASIS MODERN S, P763; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon KC, 1940, LANCET, V2, P360; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gurkoff GG, 2009, NEUROSCIENCE, V164, P862, DOI 10.1016/j.neuroscience.2009.08.021; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Maeda T, 2005, J NEUROTRAUM, V22, P763, DOI 10.1089/neu.2005.22.763; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Otori T, 2004, J NEUROTRAUM, V21, P707, DOI 10.1089/0897715041269623; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Slobounov S, 2014, BRIT J SPORT MED, V48, P75, DOI 10.1136/bjsports-2013-092362; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103	29	9	10	2	13	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						28	37		10.1159/000358749	10.1159/isbn.978-3-318-02649-8		10	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000004	24923390				2022-02-06	
J	Israelsson, C; Flygt, J; Astrand, E; Kiwanuka, O; Bengtsson, H; Marklund, N				Israelsson, Charlotte; Flygt, Johanna; Astrand, Elaine; Kiwanuka, Olivia; Bengtsson, Henrik; Marklund, Niklas			Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						TBI; mice; Nogo-A; Lingo1; Nogo-66 receptor 1; oligodendrocyte-myelin glycoprotein; myelin-associated glycoprotein	CENTRAL-NERVOUS-SYSTEM; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; NOGO-A; NEURITE OUTGROWTH; AXONAL REGENERATION; FUNCTIONAL RECOVERY; CHONDROITIN SULFATE; SYNAPTIC PLASTICITY	Purpose: When central nervous system axons are injured, regeneration is partly inhibited by myelin-associated inhibitors (MAIs). Following traumatic brain injury (TBI) in the rat, pharmacological neutralisation of the MAIs Nogo-A and myelin-associated glycoprotein (MAG) resulted in improved functional outcome. In contrast, genetic or pharmacological neutralization of the MAI receptors Nogo-66 receptor 1 (NgR1) or paired-immunoglobulin like receptor-B (PirB) showed an unaltered or impaired outcome following TBI in mice. The aim of the present study was thus to evaluate the MAI expression levels following TBI in mice. Methods: Quantitative reverse transcriptase PCR (qRT-PCR) was used to measure total RNA isolated from brains of young adult male C57BL/6 mice at one, three or seven days following controlled cortical impact TBI or sham injury. Hippocampal and neocortical tissue ipsi- and contralateral to the injury was analyzed for Nogo-A, oligodendrocyte-myelin glycoprotein (OMgp), MAG, and the MAI receptors PirB and NgR1, including its co-receptor Lingo1. Results: Compared to sham-injured controls, PirB neocortical expression was significantly upregulated at one day and NgR1 expression downregulated at seven days post-TBI. In the hippocampus, transcriptional upregulation was observed in Nogo-A (one day post-injury), MAG and PirB at seven days post-injury. In contrast, the hippocampal transcripts of NgR1 and Lingo1 were decreased at seven days post-injury. The expression of OMgp was unaltered at all time points post-injury. Conclusion: These results suggest that early dynamic changes in MAI gene expression occur following TBI in the mouse, particularly in the hippocampus, which may play an inhibitory role for post-injury regeneration and plasticity.	[Israelsson, Charlotte; Bengtsson, Henrik] Uppsala Univ, Dept Neurosci, SE-75185 Uppsala, Sweden; [Flygt, Johanna; Astrand, Elaine; Kiwanuka, Olivia; Marklund, Niklas] Uppsala Univ, Dept Neurosci, SE-75185 Uppsala, Sweden		Marklund, N (corresponding author), Uppsala Univ, Dept Neurosurg, SE-75185 Uppsala, Sweden.	Niklas.Marklund@neuro.uu.se	Astrand, Elaine/AAL-3927-2021	Marklund, Niklas/0000-0002-9797-5626; Kiwanuka, Olivia/0000-0003-3562-5513	Uppsala University Hospital; Swedish research councilSwedish Research CouncilEuropean Commission	Anders Hanell and Fredrik Clausen are acknowledged for excellent technical assistance. Dr. Stephen Strittmatter, Department of Neurology, Yale University, USA kindly provided the anti-Nogo-A antibody. The study was supported by grants from the Uppsala University Hospital and the Swedish research council (to N.M).	Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Chang KJ, 2010, J NEUROSCI, V30, P14476, DOI 10.1523/JNEUROSCI.1698-10.2010; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Fang PC, 2010, STROKE, V41, P544, DOI 10.1161/STROKEAHA.109.572073; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; Gillani RL, 2010, BEHAV BRAIN RES, V208, P415, DOI 10.1016/j.bbr.2009.12.015; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Habib AA, 1998, J NEUROCHEM, V70, P1704; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Harrington AW, 2008, J BIOL CHEM, V283, P24690, DOI 10.1074/jbc.M802188200; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Huang JY, 2012, BRAIN RES, V1437, P1, DOI 10.1016/j.brainres.2011.12.008; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; Irving EA, 2005, J CEREBR BLOOD F MET, V25, P98, DOI 10.1038/sj.jcbfm.9600011; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kempf A, 2013, PHYSIOLOGY, V28, P151, DOI 10.1152/physiol.00052.2012; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Li HP, 2013, J NEUROTRAUM, V30, P413, DOI 10.1089/neu.2012.2513; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marcus J, 2002, J CELL BIOL, V156, P567, DOI 10.1083/jcb.200111047; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McDonald CL, 2011, CURR MED CHEM, V18, P234; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mi S, 2013, CNS DRUGS, V27, P493, DOI 10.1007/s40263-013-0068-8; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nguyen T, 2009, J NEUROSCI, V29, P630, DOI 10.1523/JNEUROSCI.5204-08.2009; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Perdigoto AL, 2011, MOL CELL NEUROSCI, V46, P235, DOI 10.1016/j.mcn.2010.09.006; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Rudick RA, 2008, EXPERT OPIN BIOL TH, V8, P1561, DOI 10.1517/14712598.8.10.1561 ; Satoh J, 2007, NEUROPATH APPL NEURO, V33, P99, DOI 10.1111/j.1365-2990.2006.00787.x; Schachner M, 2000, GLIA, V29, P154, DOI 10.1002/(SICI)1098-1136(20000115)29:2<154::AID-GLIA9>3.0.CO;2-3; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Starkey HDV, 2012, J MOL NEUROSCI, V48, P111, DOI 10.1007/s12031-012-9783-8; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Szpara ML, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-100; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Trifunovski A, 2004, NEUROREPORT, V15, P2397, DOI 10.1097/00001756-200410250-00019; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; VanGuilder HD, 2012, J NEUROCHEM, V121, P77, DOI 10.1111/j.1471-4159.2012.07671.x; VanGuilder HD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-138; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010	85	9	10	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2014	32	5					717	731		10.3233/RNN-140419			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR2NP	WOS:000343424900012	25079982				2022-02-06	
J	Jones, N; Fear, NT; Rona, R; Fertout, M; Thandi, G; Wessely, S; Greenberg, N				Jones, Norman; Fear, Nicola T.; Rona, Roberto; Fertout, Mohammed; Thandi, Gursimran; Wessely, Simon; Greenberg, Neil			Mild traumatic brain injury (mTBI) among UK military personnel whilst deployed in Afghanistan in 2011	BRAIN INJURY			English	Article						Concussion; cultural; evaluation; head injury; mild brain injury; neuropsychiatric	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; OUTCOMES; DEPRESSION; BLAST; WAR	Introduction: mTBI has been termed the `signature injury' of recent conflicts in Afghanistan and Iraq. Most mTBI research uses retrospective accounts of exposure and point of injury symptoms; mTBI is reportedly less common among UK than US Forces. Methods: This study examined the rate of mTBI exposure and symptoms in 1363 UK military personnel deployed in Afghanistan in 2011 using a self-report questionnaire. Data were collected in the operational location during the 5th month of a 6-month deployment. Personnel reported injuries and symptoms related to six events including fragmentation, blast, bullet, fall, motor vehicle accident and `other' exposure. Results: Eighty (5.9%) reported at least one potential mTBI exposure during the current deployment and 1.6% (n = 22) reported injury and one or more mTBI symptoms (1 year incidence rate 3.2%). Higher PTSD symptom scores were significantly associated with reporting potential mTBI (p <= 0.001) and mTBI with symptoms (p <= 0.001). Conclusion: This study used contemporaneous data gathered in the deployed location which are subject to less memory distortion than studies using post-deployment recall. The incidence of mTBI was substantially lower than those reported in both US and UK post-deployment studies which is consistent with inflated reporting of symptoms when measured post-deployment.	[Jones, Norman] Kings Ctr Mil Hlth, London SE5 9RJ, England; [Jones, Norman] Weston Educ Ctr, Inst Psychiat, Acad Dept Psychol Med, Acad Ctr Def Mental Hlth, London SE5 9RJ, England		Jones, N (corresponding author), Kings Ctr Mil Hlth, Cutcombe Rd, London SE5 9RJ, England.	norman.jones@kcl.ac.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929; greenberg, neil/0000-0003-4550-2971; Rona, Roberto/0000-0003-3739-5571; Fear, Nicola/0000-0002-5792-2925			Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jones N, 2012, PSYCHIATRY, V75, P49, DOI 10.1521/psyc.2012.75.1.49; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; McCourt A, 2008, J R Army Med Corps, V154, P257; Mulligan K, 2010, BRIT J PSYCHIAT, V197, P405, DOI 10.1192/bjp.bp.110.077263; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; RAPHAEL K, 1987, INT J EPIDEMIOL, V16, P167, DOI 10.1093/ije/16.2.167; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122	24	9	9	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					896	899		10.3109/02699052.2014.888479			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600002	24826954				2022-02-06	
J	Kip, KE; Rosenzweig, L; Hernandez, DF; Shuman, A; Diamond, DM; Girling, SA; Sullivan, KL; Wittenberg, T; Witt, AM; Lengacher, CA; Anderson, B; McMillan, SC				Kip, Kevin E.; Rosenzweig, Laney; Hernandez, Diego F.; Shuman, Amy; Diamond, David M.; Girling, Sue Ann; Sullivan, Kelly L.; Wittenberg, Trudy; Witt, Ann M.; Lengacher, Cecile A.; Anderson, Brian; McMillan, Susan C.			Accelerated Resolution Therapy for treatment of pain secondary to symptoms of combat-related posttraumatic stress disorder	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						Psychological trauma; PTSD; pain; exposure therapy; psychotherapy; imagery rescripting; prevalence; clinical trials; eye movements; combat	RANDOMIZED CONTROLLED-TRIAL; VETERANS; PTSD; METAANALYSIS; PREVALENCE; VALIDATION; MANAGEMENT; INVENTORY; IRAQ; OPIOIDS	Background: As many as 70% of veterans with chronic pain treated within the US Veterans Administration (VA) system may have posttraumatic stress disorder (PTSD), and conversely, up to 80% of those with PTSD may have pain. We describe pain experienced by US service members and veterans with symptoms of PTSD, and report on the effect of Accelerated Resolution Therapy (ART), a new, brief exposure-based therapy, on acute pain reduction secondary to treatment of symptoms of PTSD. Methods: A randomized controlled trial of ART versus an attention control (AC) regimen was conducted among 45 US service members/veterans with symptoms of combat-related PTSD. Participants received a mean of 3.7 sessions of ART. Results: Mean age was 41.0 + 12.4 years and 20% were female. Most veterans (93%) reported pain. The majority (78%) used descriptive terms indicative of neuropathic pain, with 29% reporting symptoms of a concussion or feeling dazed. Mean pre-/post-change on the Pain Outcomes Questionnaire (POQ) was -16.99 +/- 16.6 in the ART group versus -0.79 +/- 14.2 in the AC group (p = 0.0006). Among POQ subscales, treatment effects with ART were reported for pain intensity (effect size = 1.81, p = 0.006), pain-related impairment in mobility (effect size = 0.69, p = 0.01), and negative affect (effect size = 1.01, p = 0.001). Conclusions: Veterans with symptoms of combat-related PTSD have a high prevalence of significant pain, including neuropathic pain. Brief treatment of symptoms of combat-related PTSD among veterans by use of ART appears to acutely reduce concomitant pain.	[Kip, Kevin E.; Rosenzweig, Laney; Hernandez, Diego F.; Girling, Sue Ann; Wittenberg, Trudy; Lengacher, Cecile A.; McMillan, Susan C.] Univ S Florida, Coll Nursing, Tampa, FL USA; [Shuman, Amy] Western New England Univ, Springfield, MA USA; [Diamond, David M.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Diamond, David M.] Univ S Florida, Dept Mol Pharmacol & Physiol, Ctr Preclin Clin Res PTSD, Tampa, FL USA; [Sullivan, Kelly L.] Univ S Florida, Morsani Coll Med, Tampa, FL USA; [Witt, Ann M.] PieWiseLiving LLC, Tampa, FL USA; [Anderson, Brian] Pasco Cty Vet Serv Off, Port Richey, FL USA		Kip, KE (corresponding author), Univ S Florida, Res Ctr, Coll Nursing, Tampa, FL 33620 USA.	kkip@health.usf.edu					Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Basler HD, 1997, PATIENT EDUC COUNS, V31, P113, DOI 10.1016/S0738-3991(97)00996-8; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Broekmans S, 2004, INT J NURS STUD, V41, P183, DOI 10.1016/S0020-7489(03)00129-9; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Clark ME, 2003, J REHABIL RES DEV, V40, P381, DOI 10.1682/JRRD.2003.09.0381; Defrin R, 2008, PAIN, V138, P450, DOI 10.1016/j.pain.2008.05.006; Derogatis L. R., 2001, BRIEF SYMPTOM INVENT; Dunne RL, 2012, CLIN J PAIN, V28, P755, DOI 10.1097/AJP.0b013e318243e16b; Edwards H E, 2001, Nurs Health Sci, V3, P149, DOI 10.1046/j.1442-2018.2001.00080.x; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Iraq and Afghanistan Veterans of America, 2013, HON FALL; Jaspers JPC, 1998, DISABIL REHABIL, V20, P397, DOI 10.3109/09638289809166101; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kip KE, 2014, MIL MED, V179, P31, DOI 10.7205/MILMED-D-13-00229; Kip KE, 2013, MIL MED, V178, P1298, DOI 10.7205/MILMED-D-13-00298; Kip Kevin E, 2013, Front Psychiatry, V4, P11, DOI 10.3389/fpsyt.2013.00011; Kip KE, 2012, BEHAV SCI-BASEL, V2, P115, DOI 10.3390/bs2020115; Kraus A, 2009, PAIN, V143, P179, DOI 10.1016/j.pain.2008.12.018; Kubany ES, 1996, PSYCHOL ASSESSMENT, V8, P428, DOI 10.1037/1040-3590.8.4.428; Levy MH, 2008, CANCER J, V14, P401, DOI 10.1097/PPO.0b013e31818f5aa7; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Liberzon I, 2007, BIOL PSYCHIAT, V61, P1030, DOI 10.1016/j.biopsych.2006.06.021; LIPTAK JJ, 2001, TREATMENT PLANNING C; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; McCaffery Margo, 2005, Pain Manag Nurs, V6, P122, DOI 10.1016/j.pmn.2005.08.002; McMillan SC, 2000, CANCER NURS, V23, P327, DOI 10.1097/00002820-200010000-00001; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Muller Julia, 2009, Cognitive Behaviour Therapy, V38, P184, DOI 10.1080/16506070902815024; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; PITMAN RK, 1990, ARCH GEN PSYCHIAT, V47, P541; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ree MJ, 2008, BEHAV COGN PSYCHOTH, V36, P313, DOI 10.1017/S1352465808004232; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Stecker T, 2010, PSYCHOSOMATICS, V51, P503, DOI 10.1176/appi.psy.51.6.503; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; U. S. Department of Veterans Affairs, 2007, CHRON PAIN PTSD GUID; U. S. Department of Veterans Affairs & U. S. Department of Defense, 2010, VA DOD CLIN PRACT GU; US Department of Veterans Affairs, 2008, VHA HDB 1160 01 UN M; Vermetten E, 2002, DEPRESS ANXIETY, V16, P14, DOI 10.1002/da.10017; Wald Jaye, 2010, Cognitive Behaviour Therapy, V39, P104, DOI 10.1080/16506070903183570; Weathers F.W., 1993, 9 ANN C ISTSS; Zimmerman M, 2006, PSYCHOL MED, V36, P1601, DOI 10.1017/S0033291706008257; Zimmerman M, 2001, ARCH GEN PSYCHIAT, V58, P787, DOI 10.1001/archpsyc.58.8.787	59	9	9	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8198	2000-8066		EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.		2014	5								24066	10.3402/ejpt.v5.24066			12	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	AG5YI	WOS:000335494700001	24959325	Green Published, gold			2022-02-06	
J	Laxe, S; Zasler, N; Robles, V; Lopez-Blazquez, R; Tormos, JM; Bernabeu, M				Laxe, Sara; Zasler, Nathan; Robles, Veronica; Lopez-Blazquez, Raquel; Maria Tormos, Jose; Bernabeu, Montserrat			ICF profiling of patients with traumatic brain injury: an international professional survey	DISABILITY AND REHABILITATION			English	Article						Core sets; international classification of functioning; traumatic brain injury; World Health Organization	QUALITY-OF-LIFE; HEALTH ICF; DISABILITY; CLASSIFICATION; IDENTIFICATION; PREDICTORS; QOLIBRI	Purpose: A worldwide internet survey was conducted (1) to identify problems of individuals with traumatic brain injury (TBI) addressed by health professionals and (2) to summarize these problems using the International Classification of Functioning, Disability and Health (ICF). Method: A pool of professionals involved in the TBI rehabilitation process that included physicians, nurses, physical therapists, occupational therapists, social workers and psychologists were surveyed to identify problems in functioning and contextual factors of individuals with TBI using open-ended questions. All answers were translated ("linked") to the ICF based on established rules. The frequencies of the linked ICF categories were reported stratified based on context. Results: One-hundred thirty seven professionals from the six World Health Organization regions identified 5656 concepts. 92.66% could be linked to the ICF; 33.03% were related to the domain of body functions, 27.28% to activities and participation, 10.98% to structures and 21.38% to environmental factors. Conclusions: The complexity of TBI was described through the identification of a wide variety of ICF categories. ICF language proved to be a neutral framework allowing the comparison of answers between different professionals in different world regions.	[Laxe, Sara; Robles, Veronica; Lopez-Blazquez, Raquel; Bernabeu, Montserrat] Univ Autonoma Barcelona, Brain Injury Unit, Guttmann Inst Hosp Neurorehabil, Badalona 08916, Spain; [Zasler, Nathan] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Maria Tormos, Jose] Univ Autonoma Barcelona, Res Dept, Guttmann Inst Hosp Neurorehabil, Badalona 08916, Spain		Laxe, S (corresponding author), Univ Autonoma Barcelona, Brain Injury Unit, Guttmann Inst Hosp Neurorehabil, Cami de Can Ruti Sn, Badalona 08916, Spain.	slaxe@guttmann.com		Tormos Munoz, Jose Maria/0000-0002-8764-2289			Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bickenbach JE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S8; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Escorpizo R, 2011, J OCCUP REHABIL, V21, P147, DOI 10.1007/s10926-010-9276-y; Gradinger F, 2011, SLEEP MED, V12, P97, DOI 10.1016/j.sleep.2010.08.008; Gregorio GW, 2011, J REHABIL MED, V43, P190, DOI 10.2340/16501977-0633; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Labi MLC, 2003, BRAIN INJURY, V17, P265, DOI 10.1080/0269905021000038410; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; Laxe S, 2011, NEUROREHABILITATION, V29, P99, DOI 10.3233/NRE-2011-0683; Pistarini C, 2011, DISABIL REHABIL, V33, P2333, DOI 10.3109/09638288.2011.570414; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Scheuringer M, 2010, SPINAL CORD, V48, P529, DOI 10.1038/sc.2009.176; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Sveen U, 2012, DISABIL REHABIL; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; van der Mei SF, 2011, QUAL LIFE RES, V20, P1617, DOI 10.1007/s11136-011-9900-0; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	33	9	10	1	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2014	36	1					82	88		10.3109/09638288.2013.780641			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	270RD	WOS:000328335300011	23596999				2022-02-06	
J	Lin, HL; Lin, TY; Soo, KM; Chen, CW; Kuo, LC; Lin, YK; Lee, WC; Lin, CL				Lin, Hsing-Lin; Lin, Tsung-Ying; Soo, Kwan-Ming; Chen, Chao-Wen; Kuo, Liang-Chi; Lin, Yen-Ko; Lee, Wei-Che; Lin, Chih-Lung			The Effect of Alcohol Intoxication on Mortality of Blunt Head Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; MODERATE; LEVEL; ASSOCIATION; OUTCOMES	Alcohol is found to have neuroprotection in recent studies in head injuries. We investigated the association of blood alcohol concentration (BAC) with mortality of patients with blunt head injury after traffic accident. All patients sustaining blunt head injury caused by traffic accident brought to our emergency department who had obtained a brain computed tomography scans and BAC were analyzed. Patients with unknown mechanisms, transfers from outside hospitals, and incomplete data were excluded. Logistic regression was used to identify independent predictors of mortality. During the study period, 3,628 patients with brain computed tomography (CT) were included. Of these, BAC was measured in 556 patients. Patients with the lowest BAC (less than 8 mg/dl) had lower mortality; intoxicated patients with BAC between 8 and less than 100 mg/dl were associated with significantly higher mortality than those patients in other intoxicated groups. Adjusted logistic regression demonstrated higher BAC group and Glasgow coma scale (GCS) scores, and lower ISS and age were identified as independent predictors of reduced mortality. In our study, we found that patients who had moderate alcohol intoxication had higher risk of mortality. However, higher GCS scores, lower ISS, and younger age were identified as independent predictors of reduced mortality in the study patients.	[Lin, Hsing-Lin; Lin, Tsung-Ying; Soo, Kwan-Ming; Chen, Chao-Wen; Kuo, Liang-Chi; Lin, Yen-Ko; Lee, Wei-Che] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Trauma, Kaohsiung 807, Taiwan; [Lin, Hsing-Lin; Lin, Tsung-Ying; Soo, Kwan-Ming; Chen, Chao-Wen; Kuo, Liang-Chi; Lin, Yen-Ko; Lee, Wei-Che] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Emergency Med, Kaohsiung 807, Taiwan; [Lin, Hsing-Lin; Lee, Wei-Che; Lin, Chih-Lung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung 807, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Dept Surg, Div Neurosurg, Kaohsiung 807, Taiwan		Lee, WC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Trauma, Kaohsiung 807, Taiwan.	doctor.tezu@gmail.com; chihlung1@yahoo.com		Lin, Yen-Ko/0000-0002-1484-3215; Chen, Chao Wen/0000-0002-8405-342X			Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Biros MH, 1999, ACAD EMERG MED, V6, P1088, DOI 10.1111/j.1553-2712.1999.tb00109.x; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Porter RS, 2000, PEDIATR EMERG CARE, V16, P316, DOI 10.1097/00006565-200010000-00003; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Swearingen A, 2010, AM SURGEON, V76, P20; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Wang JY, 2000, CHINESE J PHYSIOL, V43, P131	16	9	10	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								619231	10.1155/2014/619231			4	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AN1ZB	WOS:000340381400001	25157364	Green Published, gold			2022-02-06	
J	Lin, WM; Chen, MH; Wang, HC; Lu, CH; Chen, PC; Chen, HL; Tsai, NW; Su, YJ; Li, SH; Kung, CT; Chiu, TM; Weng, HH; Lin, WC				Lin, Wei-Ming; Chen, Meng-Hsiang; Wang, Hung-Chen; Lu, Cheng-Hsien; Chen, Pei-Chin; Chen, Hsiu-Ling; Tsai, Nai-Wen; Su, Yu-Jih; Li, Shau-Hsuan; Kung, Chia-Te; Chiu, Tsui-Min; Weng, Hsu-Huei; Lin, Wei-Che			Association between Peripheral Oxidative Stress and White Matter Damage in Acute Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							FOCAL CEREBRAL-ISCHEMIA; WATER DIFFUSION; HEAD TRAUMA; NEUROPATHOLOGY; SEQUELAE	The oxidative stress is believed to be one of the mechanisms involved in the neuronal damage after acute traumatic brain injury (TBI). However, the disease severity correlation between oxidative stress biomarker level and deep brain microstructural changes in acute TBI remains unknown. In present study, twenty-four patients with acute TBI and 24 healthy volunteers underwent DTI. The peripheral blood oxidative biomarkers, like serum thiol and thiobarbituric acid-reactive substances (TBARS) concentrations, were also obtained. The DTI metrics of the deep brain regions, as well as the fractional anisotropy (FA) and apparent diffusion coefficient, were measured and correlated with disease severity, serum thiol, and TBARS levels. We found that patients with TBI displayed lower FAs in deep brain regions with abundant WMs and further correlated with increased serum TBARS level. Our study has shown a level of anatomic detail to the relationship between white matter (WM) damage and increased systemic oxidative stress in TBI which suggests common inflammatory processes that covary in both the peripheral and central reactions after TBI.	[Lin, Wei-Ming; Weng, Hsu-Huei] Chiayi Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi 61363, Taiwan; [Lin, Wei-Ming; Weng, Hsu-Huei] Chang Gung Univ, Coll Med, Chiayi 61363, Taiwan; [Chen, Meng-Hsiang; Chen, Pei-Chin; Chen, Hsiu-Ling; Chiu, Tsui-Min; Lin, Wei-Che] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung 83305, Taiwan; [Chen, Meng-Hsiang; Chen, Pei-Chin; Chen, Hsiu-Ling; Chiu, Tsui-Min; Lin, Wei-Che] Chang Gung Univ, Coll Med, Kaohsiung 83305, Taiwan; [Wang, Hung-Chen] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Wang, Hung-Chen; Su, Yu-Jih; Li, Shau-Hsuan; Kung, Chia-Te] Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan; [Lu, Cheng-Hsien; Tsai, Nai-Wen] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lu, Cheng-Hsien; Tsai, Nai-Wen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Hsiu-Ling] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Su, Yu-Jih; Li, Shau-Hsuan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung 83301, Taiwan; [Kung, Chia-Te] Kaohsiung Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung 83301, Taiwan		Lin, WC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, 123 Ta Pei Rd, Kaohsiung 83305, Taiwan.	linwc137@gmail.com	; Weng, Hsu-Huei/N-8329-2014	Su, Yu-Jih/0000-0002-7274-3458; Weng, Hsu-Huei/0000-0002-2020-8912	MRI Core Facility, CGMH	The authors acknowledge MR support from the MRI Core Facility, CGMH. The authors also thank Tsui-Min Chiu, YiFang Chaing, Yi-Wen Chen, and all subjects who participated in this study.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dewar D, 1997, ACTA NEUROPATHOL, V93, P71, DOI 10.1007/s004010050584; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Guha A, 2004, POSTGRAD MED J, V80, P650, DOI 10.1136/pgmj.2004.019570; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Jauch, 2012, ISRN EMERGENCY MED, V1, P1, DOI DOI 10.5402/2012/417313; Leinonen JS, 2000, STROKE, V31, P33, DOI 10.1161/01.STR.31.1.33; Lin WC, 2009, AM J NEURORADIOL, V30, P1248, DOI 10.3174/ajnr.A1517; Lu CH, 2011, AM J NEURORADIOL, V32, P1333, DOI 10.3174/ajnr.A2489; MARCOUX FW, 1982, STROKE, V13, P339, DOI 10.1161/01.STR.13.3.339; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Naito Y, 1998, FREE RADICAL BIO MED, V24, P494, DOI 10.1016/S0891-5849(97)00323-7; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Schootman M, 2000, BRAIN INJURY, V14, P373; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Thom SR, 2004, P NATL ACAD SCI USA, V101, P13660, DOI 10.1073/pnas.0405642101; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Yam PS, 1998, J NEUROTRAUM, V15, P441, DOI 10.1089/neu.1998.15.441; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	30	9	9	0	7	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								340936	10.1155/2014/340936			8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AE7VQ	WOS:000334207800001	24804213	Green Published, Green Submitted, gold			2022-02-06	
J	Linnemann, M; Tibaek, M; Kammersgaard, LP				Linnemann, Mia; Tibaek, Maiken; Kammersgaard, Lars Peter			Hydrocephalus during rehabilitation following severe TBI. Relation to recovery, outcome, and length of stay	NEUROREHABILITATION			English	Article						Brain injury; traumatic; hydrocephalus; rehabilitation; outcome; prediction	SEVERE HEAD-INJURY; VENTRICULAR ENLARGEMENT; SHUNT	BACKGROUND: Post traumatic hydrocephalus (PTH) is a frequent complication during rehabilitation following severe TBI. However, the diagnosis of PTH is not straightforward and despite shunting recovery may be delayed. OBJECTIVE: To study the influence of PTH on recovery and outcome during rehabilitation. METHODS: We studied 417 patients with severe TBI admitted consecutively to a single hospital-based neurorehabilitation department serving Eastern Denmark between 2000 and 2010. Demographics (age and gender) and clinical characteristics (length of acute treatment, post traumatic amnesia (PTA), level of consciousness, injury severity (ISS), and admission FIM (TM)), and PTH were related to recovery (discharge FIM (TM)), outcome (GOS), and length of rehabilitation stay. RESULTS: Patients with PTH were older, brain injury more severe, and acute treatment was longer. At discharge they had more disability, longer rehabilitation stays, and unfavorable outcome. However, after adjusted multiple regression analyses PTH was not associated with disability at discharge or outcome. Instead, PTH was associated with longer stay for rehabilitation. CONCLUTIONS: Shunting for PTH does not affect recovery and outcome per se, but prolongs lengths of stay by almost 3 weeks. Therefore, patients treated for PTH are as likely to benefit from rehabilitation as patients without, but require longer rehabilitation stays.	[Linnemann, Mia; Tibaek, Maiken; Kammersgaard, Lars Peter] Copenhagen RUBRIC, Res Unit Brain Injury Rehabil, Copenhagen, Denmark		Kammersgaard, LP (corresponding author), Copenhagen Univ Hosp, Res Unit Brain Injury Rehabil, Copenhagen RUBRIC, Dept Neurorehabil,TBI Unit, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	kammersgaard@dadlnet.dk					Bauer DF, 2011, NEUROSURGERY, V68, P85, DOI 10.1227/NEU.0b013e3181fd85f4; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Giacino JT, 1997, J HEAD TRAUMA REHAB, P12; Groswasser Z, 1988, Brain Inj, V2, P267, DOI 10.3109/02699058809150897; Guyot LL, 2000, NEUROL RES, V22, P25; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; JENNETT B, 1975, LANCET, V1, P480; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Licata C, 2001, J Neurosurg Sci, V45, P141; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Palmer CS, 2013, INJURY, V44, P1437, DOI 10.1016/j.injury.2012.08.033; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; TEASDALE G, 1974, LANCET, V2, P81; Tribl G, 2000, BRAIN INJURY, V14, P345	18	9	13	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	4					755	761		10.3233/NRE-141160			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW4HK	WOS:000346241600013	25318768				2022-02-06	
J	Lu, W; Cantor, J; Aurora, RN; Nguyen, M; Ashman, T; Spielman, L; Ambrose, A; Krellman, JW; Gordon, W				Lu, William; Cantor, Joshua; Aurora, R. Nisha; Nguyen, Michael; Ashman, Teresa; Spielman, Lisa; Ambrose, Anne; Krellman, Jason W.; Gordon, Wayne			Variability of respiration and sleep during polysomnography in individuals with TBI	NEUROREHABILITATION			English	Article						Traumatic brain injury; sleep; obstructive sleep apnea; polysomnography	TRAUMATIC BRAIN-INJURY; NEGATIVE POLYSOMNOGRAM; APNEA SYNDROME; HEART HEALTH; NIGHT SLEEP; DISORDERS; ACCIDENTS; DISTURBANCES; SYMPTOMS; RECOVERY	BACKGROUND: Obstructive sleep apnea (OSA) is commonly found in individuals with traumatic brain injury (TBI) and may exacerbate TBI-related symptoms. Nocturnal polysomnography (NPSG) is considered the gold standard for detecting the presence of sleep apnea. However, there is a limitation with its use known as the "first-night effect" (aberrant polysomnography findings on the first night in a sleep lab). OBJECTIVE: The primary objectives were to investigate the night-to-night consistency of diagnosing and classifying obstructive sleep apnea in individuals with TBI, and ascertain if individuals with TBI are prone to a first-night effect. METHODS: 47 community-dwelling adults with self-reported mild-to-severe TBI underwent two nights of in-laboratory NPSG to examine variability between the first and second night with regards to OSA diagnosis and severity as well as sleep architecture. RESULTS: OSA detection and severity were consistent from night-to-night in 89% of participants with TBI. Participants with TBI demonstrated longer REM latency on the first night compared to the second night of sleep study. CONCLUSIONS: These findings indicate that two nights of in-laboratory NPSG are generally consistent in reliably diagnosing OSA in individuals with TBI and that first-night effects are minimal. One night of NPSG has diagnostic utility in the evaluation of sleep disorders in individuals with TBI.	[Lu, William; Cantor, Joshua; Nguyen, Michael; Spielman, Lisa; Ambrose, Anne; Krellman, Jason W.; Gordon, Wayne] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Aurora, R. Nisha] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Ashman, Teresa] Shepherd Ctr, Atlanta, GA USA		Lu, W (corresponding author), 1 Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.	william.lu@mountsinai.org	Ambrose, Anne Felicia/ABE-4161-2020; Ambrose, Anne Felicia/AAQ-9668-2021		National Institute on Disability and Rehabilitation Research [H133A070033]	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133A070033). No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P271; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Crispim CA, 2011, J CLIN SLEEP MED, V7, P659, DOI 10.5664/jcsm.1476; DEAN RJ, 1992, CHEST, V101, P105, DOI 10.1378/chest.101.1.105; DERDERIAN SS, 1988, CHEST, V94, P1023, DOI 10.1378/chest.94.5.1023; Engleman HM, 2000, SLEEP, V23, pS102; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fortier-Brochu E, 2010, J PSYCHOSOM RES, V69, P475, DOI 10.1016/j.jpsychores.2010.05.005; GEORGE B, 1981, NEUROCHIRURGIE, V27, P35; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Horstmann S, 2000, SLEEP, V23, P383; Hutchison KN, 2008, J CLIN SLEEP MED, V4, P119; Kristo DA, 2009, SLEEP BREATH, V13, P271, DOI 10.1007/s11325-008-0235-1; Le Bon O, 2001, J PSYCHIATR RES, V35, P165, DOI 10.1016/S0022-3956(01)00019-X; Le Bon O, 2003, PSYCHIAT RES, V120, P191, DOI 10.1016/S0165-1781(03)00185-9; Le Bon O, 2000, CHEST, V118, P353, DOI 10.1378/chest.118.2.353; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; MENDELS J, 1967, ELECTROEN CLIN NEURO, V22, P556, DOI 10.1016/0013-4694(67)90063-6; MENDELSON WB, 1994, CLEV CLIN J MED, V61, P299, DOI 10.3949/ccjm.61.4.299; MEYER TJ, 1993, CHEST, V103, P756, DOI 10.1378/chest.103.3.756; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pietzsch JB, 2011, SLEEP, V34, P695, DOI 10.5665/SLEEP.1030; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Quan SF, 2002, SLEEP, V25, P843; Rodway GW, 2003, SLEEP MED REV, V7, P391, DOI 10.1053/smrv.2002.0272; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Walsleben JA, 2004, SLEEP, V27, P293, DOI 10.1093/sleep/27.2.293; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; WITTIG RM, 1984, AM REV RESPIR DIS, V129, P244; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608	38	9	9	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	2					245	251		10.3233/NRE-141117			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AQ7OE	WOS:000343007000009	24990025				2022-02-06	
J	Matarazzo, BB; Hoffberg, AS; Clemans, TA; Signoracci, GM; Simpson, GK; Brenner, LA				Matarazzo, Bridget B.; Hoffberg, Adam S.; Clemans, Tracy A.; Signoracci, Gina M.; Simpson, Grahame K.; Brenner, Lisa A.			Cross-cultural adaptation of the Window to Hope: A psychological intervention to reduce hopelessness among US Veterans with traumatic brain injury	BRAIN INJURY			English	Article						Cognitive behaviour therapy; mental health; suicide prevention	SUICIDE-PREVENTION; MILITARY PERSONNEL; EVENTUAL SUICIDE; FOLLOW-UP; STRATEGIES; SERVICES; IDEATION	Primary objective: To conduct a cross-cultural adaptation of Window to Hope (WtoH), a treatment to reduce hopelessness after traumatic brain injury (TBI), from the Australian civilian context to that of US Veterans. Research design: Three-stage mixed-methods approach. Methods: Stage 1: Consensus conference with stakeholders to revise the manual. Stage 2: Pilot study of the revised manual with US Veterans to examine acceptability, feasibility and fidelity. Stage 3: Review of results with consensus conference attendees and further revisions. Results: Stage 1: Conference attendees reached 100% consensus regarding changes made to the manual. Stage 2: Qualitative results yielded themes that suggest that participants benefitted from the intervention and that multiple factors contributed to successful implementation (Narrative Evaluation of Intervention Interview, User Feedback Survey-Modified, Post-Treatment Interviews). Therapists achieved 100% treatment fidelity. Quantitative results from the Client Satisfaction Questionnaire-8 suggest that the intervention was acceptable. Stage 3: The culturally adapted manual was finalized. Conclusions: Results of this study suggest that the revised WtoH manual is acceptable and feasible. US therapists exhibited adherence to the protocol. The three-stage methodology was successfully employed to cross-culturally adapt an intervention that is well-suited for a Phase II randomized controlled trial among US military Veterans.	[Matarazzo, Bridget B.; Hoffberg, Adam S.; Clemans, Tracy A.; Signoracci, Gina M.; Brenner, Lisa A.] VISN 19 MIRECC, Denver, CO 80220 USA; [Matarazzo, Bridget B.; Clemans, Tracy A.; Signoracci, Gina M.; Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Psychiat, Denver, CO 80262 USA; [Simpson, Grahame K.] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Simpson, Grahame K.] Ingham Inst Appl Med Res, Sydney, NSW, Australia; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Neurol, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Denver, CO USA		Matarazzo, BB (corresponding author), VISN 19 MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	bridget.matarazzo@va.gov	Simpson, Grahame K/W-1074-2019; Signoracci, Gina M./Q-3782-2019; Brenner, Lisa A./AAG-2442-2019	Simpson, Grahame K/0000-0001-8156-9060; Clemans, Tracy/0000-0001-5994-1508; Hoffberg, Adam/0000-0002-7036-936X	Military Suicide Research Consortium (MSRC); Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0178]	The views in this paper are those of the authors and do not necessarily represent the official policy or position of the Department of Veterans Affairs or the United States Government. This work was in part supported by the Military Suicide Research Consortium (MSRC), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. (W81XWH-10-2-0178). Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the MSRC or the Department of Defense.	ACHTE KA, 1971, ACTA PSYCHIAT SCAND, P1; [Anonymous], 2013, PSYCH DAT BRAIN IMP; [Anonymous], VETPOP2011 LIV VET A; *ARM SUIC PREV TAS, 2010, ARM HLTH PROM RISK R; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Beck, 1980, COGNITIVE THERAPY SC; BECK AT, 1989, J CONSULT CLIN PSYCH, V57, P309, DOI 10.1037/0022-006X.57.2.309; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryan CJ, 2012, ARCH SUICIDE RES, V16, P95, DOI 10.1080/13811118.2012.667321; Cardemil EV, 2010, COGN BEHAV PRACT, V17, P188, DOI 10.1016/j.cbpra.2010.01.005; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Department of Defense, 2013, THEAT MED DAT STOR D; Department of Defense Task Force on the Prevention of Suicide by Members of the Armed Forces, 2010, EX SUMM; Department of Veterans Affairs, 2013, MAK CONN; Desmarais S., 2009, MANUAL SHORT TERM AS; Feeley N, 2009, CAN J NURS RES, V41, P84; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; GASTON L, 1992, EVAL PROGRAM PLANN, V15, P227, DOI 10.1016/0149-7189(92)90085-9; Griner D, 2006, PSYCHOTHERAPY, V43, P531, DOI 10.1037/0033-3204.43.4.531; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hasson-Ohayon I., 2006, PSYCHOL SERV, V3, P262, DOI [DOI 10.1037/1541-1559.3.4.262, 10.1037/1541-1559.3.4.262]; Hussler C, 2011, TECHNOL FORECAST SOC, V78, P1642, DOI 10.1016/j.techfore.2011.07.008; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Malik K., 2013, SUMMARY HUMAN DEV RE; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Matarazzo BB, 2013, BRAIN IMPAIR, V14, P42, DOI 10.1017/BrImp.2013.4; Nguyen T D, 1983, Eval Program Plann, V6, P299, DOI 10.1016/0149-7189(83)90010-1; Pernin C.G., 2011, WAR PREVENTING SUICI; Reger MA, 2008, MIL PSYCHOL, V20, P21, DOI 10.1080/08995600701753144; Roe D, 2009, PSYCHIATR REHABIL J, V32, P285, DOI 10.2975/32.4.2009.285.291; Rubin H., 1995, QUALITATIVE INTERVIE; RUSSELL WR, 1951, J NEUROL NEUROSUR PS, V14, P35, DOI 10.1136/jnnp.14.1.35; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson GK, 2013, BRAIN IMPAIRMENT, V14; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Strom TQ, 2012, TRAIN EDUC PROF PSYC, V6, P67, DOI 10.1037/a0028275; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Zayas LH, 2012, DISSEMINATION IMPLEM, P483, DOI DOI 10.1093/ACPROF:OSO/9780199751877.003.0023	45	9	9	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1238	1247		10.3109/02699052.2014.916419			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900002	24946053				2022-02-06	
J	Meyers, JE; Miller, RM; Tuita, ARR				Meyers, John E.; Miller, Ronald M.; Tuita, Alexa R. R.			Using Pattern Analysis Matching to Differentiate TBI and PTSD in a Military Sample	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						artificial neural network; pattern analysis; PTSD; TBI	TRAUMATIC BRAIN-INJURY; ARTIFICIAL NEURAL-NETWORKS; POSTCONCUSSION-SYNDROME; HEAD-INJURY; VALIDATION; DEPRESSION; ANXIETY; SYMPTOMS; BATTERY	Distinguishing between traumatic brain injury (TBI) residuals and the effects of posttraumatic stress disorder (PTSD) during neuropsychological evaluation can be difficult because of significant overlap of symptom presentation. Using a standardized battery of tests, an artificial neural network was used to create an algorithm to perform pattern analysis matching (PAM) functions that can be used to assist with diagnosis. PAM analyzes a patient's neuropsychological data and provides a best fit classification, according to one of four groups: TBI, PTSD, malingering/invalid data, or "other'' (depressed/anxious/postconcussion syndrome/normal). The original PAM was modeled on civilian data; the current study was undertaken using a database of 100 active-duty army service personnel who were referred for neuropsychological assessment in a military TBI clinic. The PAM classifications showed 90% overall accuracy when compared with clinicians' diagnoses. The PAM function is able to classify detailed neuropsychological profiles from a military population with a high degree of accuracy and is able to distinguish between TBI, PTSD, malingering/invalid data, or "other.'' PAM is a useful tool to help with clinical decision-making.	[Meyers, John E.] Concuss Clin, Schofield Barracks, HI 96857 USA; [Miller, Ronald M.; Tuita, Alexa R. R.] Brigham Young Univ Hawaii, Dept Psychol, Laie, HI USA		Meyers, JE (corresponding author), Concuss Clin, Schofield Barracks, HI 96857 USA.	jmeyersneuro@yahoo.com					Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bishop C. M., 1995, NEURAL NETWORKS PATT; BRANDT J, 1985, ANN NY ACAD SCI, V444, P502, DOI 10.1111/j.1749-6632.1985.tb37625.x; Buscema M, 2004, NEUROINFORMATICS, V2, P399, DOI 10.1385/NI:2:4:399; Bush S. S., 2011, ENCY CLIN NEUROPSYCH; CARLING A, 1992, INTRO NEURAL NETWORK; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Das R, 2009, EXPERT SYST APPL, V36, P7675, DOI 10.1016/j.eswa.2008.09.013; Di Luca M., 2005, J TRANSL MED, V27, P3; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FELDMAN JA, 1982, COGNITIVE SCI, V6, P205, DOI 10.1207/s15516709cog0603_1; Francis L., 2003, CASUALTY ACTUARIAL S, P75; French BM, 1997, ARCH NEUROL-CHICAGO, V54, P1001, DOI 10.1001/archneur.1997.00550200057011; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Kozel JJ, 1998, ARCH CLIN NEUROPSYCH, V13, P327, DOI 10.1016/S0887-6177(97)00036-X; Levine D. S., 1998, FUNDAMENTALS NEURAL; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; McClelland J. L., 1986, PARALLEL DISTRIBUTED; Meyers J. E., 1999, ELECT MANUAL MNB; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P79, DOI 10.1016/S0887-6177(00)00105-0; Meyers JE., 1995, REY COMPLEX FIGURE T; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Miller JB, 2010, CLIN NEUROPSYCHOL, V24, P678, DOI 10.1080/13854041003601493; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Parsons TD, 2004, J CLIN EXP NEUROPSYC, V26, P95, DOI 10.1076/jcen.26.1.95.23932; Perez M.L., 2003, APLICACIONES REDES N; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; Quintana M, 2012, J CLIN EXP NEUROPSYC, V34, P195, DOI 10.1080/13803395.2011.630651; Reitan R, 1985, HALSTEAD REITAN NEUR; Ripley B., 1996, PATTERN RECOGN; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Sawrie SM, 2000, BRAIN, V123, P770, DOI 10.1093/brain/123.4.770; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; StatSoft, 2012, STAT VERS 11; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tellegen, 2008, MINNESOTA MULTIPHASI; Tsushima WT, 2005, ARCH CLIN NEUROPSYCH, V20, P667, DOI 10.1016/j.acn.2005.04.003; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M	51	9	9	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2014	21	1					60	68		10.1080/09084282.2012.737881			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AM9VH	WOS:000340228600009	24826497				2022-02-06	
J	Ness, BM; Rocke, MR; Harrist, CJ; Vroman, KG				Ness, Bryan M.; Rocke, Maya R.; Harrist, Christopher J.; Vroman, Kerryellen G.			College and combat trauma: An insider's perspective of the post-secondary education experience shared by service members managing neurobehavioral symptoms	NEUROREHABILITATION			English	Article						Neurobehavioral symptoms; post-secondary experience; service member/veteran; combat; TBI/PTSD	POSTTRAUMATIC-STRESS-DISORDER; BRAIN-INJURY; COPING STRATEGIES; MILITARY SERVICE; VETERANS; IRAQ; REINTEGRATION; AFGHANISTAN; COMMUNITY	BACKGROUND: Enrolling in post-secondary education is common among military service members returning from combat deployments, but recent research shows service members who present with neurobehavioral symptoms consistent with traumatic brain injury (TBI) and/or post-traumatic stress disorder (PTSD) are at risk for psychosocial and academic difficulty. OBJECTIVE: This exploratory study was conducted to examine the academic experiences of service members through in-depth qualitative analysis. METHODS: An initial survey was conducted at a public university to measure self-reported academic achievement and neurobehavioral symptoms experienced by service members (n = 48). Then, follow-up interviews were solicited from a sub-sample (n = 5) of participants to gain an in-depth understanding of their transition, social, and academic experiences. RESULTS: The results revealed both the day-to-day challenges participants faced while adjusting to post-secondary life and how neurobehavioral symptoms associated with combat trauma interacted with their learning experiences. The findings indicated participants did not perceive neurobehavioral symptoms as particularly deleterious to their learning thereby highlighting the potentially integral role of coping strategies and motivation in post-secondary success. CONCLUSIONS: This study underscores the importance of understanding not only the adverse impact of neurobehavioral symptoms but the factors that promote resilience among military service members in post-secondary education.	[Ness, Bryan M.; Rocke, Maya R.; Harrist, Christopher J.; Vroman, Kerryellen G.] Univ New Hampshire, Durham, NH 03824 USA		Ness, BM (corresponding author), Univ New Hampshire, Commun Sci & Disorders Dept, 4 Lib Way,151 Hewitt Hall, Durham, NH 03824 USA.	Bryan.Ness@unh.edu					Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; Bell NS, 2011, J TRAUMA STRESS, V24, P34, DOI 10.1002/jts.20612; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Church TE, 2009, J POSTSECOND EDUC DI, V22, P43; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Finset A, 2000, BRAIN INJURY, V14, P887; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Linnenbrink EA, 2002, SCHOOL PSYCHOL REV, V31, P313; Livingston WG, 2011, J STUD AFF RES PRACT, V48, P315, DOI 10.2202/1949-6605.6292; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; National Center for PTSD, 2011, DSM CRIT PTSD; Ness BM, 2014, J HEAD TRAUMA REHAB, V29, P33, DOI 10.1097/HTR.0b013e3182a1cd4e; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Rumann CB, 2010, J HIGH EDUC, V81, P431, DOI 10.1353/jhe.0.0103; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Steele J. L., 2010, MILITARY VETERANS EX; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; U.S. Department of Education National Center for Education Statistics, 2009, 2003 04 2007 08 NAT; U. S. Department of Veteran Affairs, 2012, POST 9 11 GI BILL; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Widome R, 2011, AM J HEALTH BEHAV, V35, P387, DOI 10.5993/AJHB.35.4.1	29	9	9	0	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	1					147	158		10.3233/NRE-141098			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP0PN	WOS:000341764700018	24990013				2022-02-06	
J	Pala, PA; N'Kaoua, B; Mazaux, JM; Simion, A; Lozes, S; Sorita, E; Sauzeon, H				Pala, P. Arvind; N'Kaoua, B.; Mazaux, J. -M.; Simion, A.; Lozes, S.; Sorita, E.; Sauzeon, H.			Everyday-like memory and its cognitive correlates in healthy older adults and in young patients with traumatic brain injury: a pilot study based on virtual reality	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Aging; everyday memory; executive and memory functioning; subjective memory complaints; traumatic brain injury; virtual reality-based assessment		Purpose State: A pilot-study with a comparison approach between aging and traumatic brain injury (TBI) is proposed to investigate everyday object memory patterns using a virtual HOMES test. Methods: Sixteen young controls, 15 older adults and 15 TBI patients underwent the HOMES test and traditional tests. Results: Older adults and TBI patients exhibited similar HOMES performances: poor recall, a greater recognition benefit, high false recognitions, but intact clustering and proactive interference effects. The age-related differences for HOMES measures were mainly mediated by executive functioning, while the HOMES performances in the TBI group were correlated with memory measures. Conclusion: The differential cognitive mediating effects for a similar everyday-like memory pattern are discussed by highlighting the need for more cautious interpretations of cognitive mechanisms behind similar behavioral patterns in different populations especially in clinical and rehabilitation settings.	[Pala, P. Arvind; N'Kaoua, B.; Mazaux, J. -M.; Sorita, E.; Sauzeon, H.] Univ Bordeaux, Handicap & Syst Nerveux, Lab EA4136, Bordeaux, France; [N'Kaoua, B.; Sauzeon, H.] Ctr Inria Bordeaux Sud Ouest, Equipe Phoenix, Talence, France; [Mazaux, J. -M.; Simion, A.; Lozes, S.; Sorita, E.] CHU Bordeaux, Serv Reeduc & Med Phys, Bordeaux, France		Sauzeon, H (corresponding author), Univ Bordeaux, Handicap & Syst Nerveux, Lab EA4136, Bordeaux, France.	helene.sauzeon@u-bordeaux2.fr	N'Kaoua, Bernard/T-3577-2019; Sorita, eric/T-5004-2019; Sauzeon, Helene/T-1178-2019	Sorita, eric/0000-0002-5841-0972; Sauzeon, Helene/0000-0001-5781-9891			Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Baudouin A, 2009, BRAIN COGNITION, V71, P240, DOI 10.1016/j.bandc.2009.08.007; Beaudoin M, 2011, PSYCHOL BULL, V137, P211, DOI 10.1037/a0022106; BOLLA KI, 1991, ARCH NEUROL-CHICAGO, V48, P61, DOI 10.1001/archneur.1991.00530130069022; Braver T. S., 2008, HDB AGING COGNITION, P311; Brooks BL, 2006, CLIN NEUROPSYCHOL, V20, P230, DOI 10.1080/13854040590947461; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; Bryan J, 1996, PSYCHOL AGING, V11, P3, DOI 10.1037/0882-7974.11.1.3; Budson AE, 2000, NEUROPSYCHOLOGY, V14, P277, DOI 10.1037//0894-4105.14.2.277; Bugaiska A, 2007, CONSCIOUS COGN, V16, P797, DOI 10.1016/j.concog.2006.11.007; Calabria M, 2011, AGING CLIN EXP RES, V23, P67, DOI 10.1007/BF03324954; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chiou KS, 2012, J INT NEUROPSYCH SOC, V18, P379, DOI 10.1017/S1355617711001846; Chiou KS, 2011, J INT NEUROPSYCH SOC, V17, P720, DOI 10.1017/S1355617711000658; Clement F, 2008, J INT NEUROPSYCH SOC, V14, P222, DOI 10.1017/S1355617708080260; Constantinidou F, 2002, BRAIN LANG, V82, P296, DOI 10.1016/S0093-934X(02)00018-4; CRAIK FIM, 1990, PSYCHOL AGING, V5, P148, DOI 10.1037/0882-7974.5.1.148; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; Crawford JR, 2000, AGING NEUROPSYCHOL C, V7, P9, DOI 10.1076/anec.7.1.9.806; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Davies G. M., 1988, MEMORY CONTEXT CONTE; Delis D.C., 1991, PSYCHOL ASSESS, V3, P19, DOI [10.1037/1040-3590.3.1.19, DOI 10.1037/1040-3590.3.1.19]; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; DYWAN J, 1994, PSYCHOL AGING, V9, P568, DOI 10.1037/0882-7974.9.4.568; Ebert PL, 2009, J INT NEUROPSYCH SOC, V15, P83, DOI 10.1017/S1355617708090115; Ehlhardt LA, 2005, BRAIN INJURY, V19, P569, DOI 10.1080/002699050400013550; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; FLICKER C, 1993, J AM GERIATR SOC, V41, P1029, DOI 10.1111/j.1532-5415.1993.tb06448.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Gallo DA., 2006, ASS ILLUSIONS MEMORY; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; GREEN RC, 1995, J NEUROPSYCH CLIN N, V7, P357; Hasher L, 2002, CAN J EXP PSYCHOL, V56, P200, DOI 10.1037/h0087397; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Herzog C., 2002, APPL METACOGNITION, P169, DOI [10.1017/CBO9780511489976.009, DOI 10.1017/CBO9780511489976.009]; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kramer JH, 2005, NEUROPSYCHOLOGY, V19, P799, DOI 10.1037/0894-4105.19.6.799; Krueger LE, 2011, AM J PSYCHOL, V124, P291, DOI 10.5406/amerjpsyc.124.3.0291; Lee T, 2012, NEUROPSYCHOLOGY, V26, P776, DOI 10.1037/a0030053; Lemoncello R, 2011, NEUROPSYCHOL REHABIL, V21, P825, DOI 10.1080/09602011.2011.618661; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Levine B, 1997, NEUROPSYCHOLOGY, V11, P367, DOI 10.1037/0894-4105.11.3.367; Lieury A, 1976, NORMES DASSOCIATIONS; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P536, DOI 10.1076/jcen.20.4.536.1469; Magnussen S, 2007, EVERYDAY MEMORY, P1; Martins IP, 2012, EUR J NEUROL, V19, P666, DOI 10.1111/j.1468-1331.2011.03635.x; Matteau E, 2011, AM J ALZHEIMERS DIS, V26, P389, DOI 10.1177/1533317511412046; McCullagh S., 2011, TRAUMATIC BRAIN INJU, P279; Moffat SD, 2001, NEUROBIOL AGING, V22, P787, DOI 10.1016/S0197-4580(01)00251-2; Morrow DG, 2008, HUM FACTORS, V50, P589, DOI 10.1518/001872008X312251; Nilsson LG, 2007, EVERYDAY MEMORY, P275; Ossher L, 2013, AGING NEUROPSYCHOL C, V20, P220, DOI 10.1080/13825585.2012.690365; Ozen LJ, 2010, J INT NEUROPSYCH SOC, V16, P556, DOI 10.1017/S1355617710000202; Paolo AM, 1997, J CLIN EXP NEUROPSYC, V19, P220, DOI 10.1080/01688639708403853; Pearman A, 2004, J GERONTOL B-PSYCHOL, V59, pP4, DOI 10.1093/geronb/59.1.P4; Pierce BH, 2005, NEUROPSYCHOLOGY, V19, P411, DOI 10.1037/0894-4105.19.4.411; Plancher G, 2010, NEUROPSYCHOLOGY, V24, P379, DOI 10.1037/a0018680; Plancher G, 2009, NEUROPSYCHOLOGIA, V47, P2527, DOI 10.1016/j.neuropsychologia.2009.04.026; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Reitan RM, 1992, TRAIL MAKING TEST MA; Richardson AE, 1999, MEM COGNITION, V27, P741, DOI 10.3758/BF03211566; Rogers WA, 2010, J GERONTOL B-PSYCHOL, V65, P645, DOI 10.1093/geronb/gbq065; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sauzeon H, 2012, EXP PSYCHOL, V59, P99, DOI 10.1027/1618-3169/a000131; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Scherer M. J., 2012, ASSISTIVE TECHNOLOGI; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schmand B, 1997, BRIT J PSYCHIAT, V171, P373, DOI 10.1192/bjp.171.4.373; Schmitter-Edgecombe M, 2012, J CLIN EXP NEUROPSYC, V34, P256, DOI 10.1080/13803395.2011.633497; Sedikides C, 2008, PERSPECT PSYCHOL SCI, V3, P102, DOI 10.1111/j.1745-6916.2008.00068.x; Sorita E, 2013, DISABIL REHABIL, V35, P1371, DOI 10.3109/09638288.2012.738761; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Stuss DT, 1996, PSYCHOL AGING, V11, P387, DOI 10.1037/0882-7974.11.3.387; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Taillade M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067193; Taillade M, 2013, AGING NEUROPSYCHOL C, V20, P298, DOI 10.1080/13825585.2012.706247; TEASDALE G, 1974, LANCET, V2, P81; TROYER AK, 1994, AGING COGNITION, V0001, P00045, DOI DOI 10.1080/09289919408251449; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; Veterans Health Initiative, 2010, TRAUMATIC BRAIN INJU; Volz-Sidiropoulou E, 2012, PSYCHOL AGING, V27, P440, DOI 10.1037/a0025384; Wechsler D., 1997, WECHSLER MEMORY SCAL; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001	101	9	9	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2014	9	6					463	473		10.3109/17483107.2014.941952			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V07EX	WOS:000213992200003	25030298				2022-02-06	
J	Rainio, R; Mannermaa, K				Rainio, Riitta; Mannermaa, Kristiina			Tracing the rattle of animal tooth pendants from the Middle Neolithic graves of Ajvide, Gotland, Sweden	WORLD ARCHAEOLOGY			English	Article						Music archaeology; rattles; burial finds; tooth pendants; Middle Neolithic; North Europe; use-wear analysis	BIRDS; AGE	Strung rattles of teeth, shells and hooves have traditionally been thought to be among the earliest musical instruments. These sound producers, which are suspended from the neck, arms, legs or clothing, are often used to highlight dancing. This study seeks to explore whether similar rattles can be traced to the northern European Middle Neolithic. The research material comprised fifty-three animal tooth pendants from graves at Ajvide, Gotland, Sweden (c. 2900-2300 cal. BC). Microscopic analysis showed that the pendants from Ajvide are well-worn and abraded, especially on their opposing perforated sides. Because the pendants usually appear in clusters or hem-like rows on the hips or legs of the deceased, a plausible explanation for their use-wear is that they once struck each other. This concussion resulting from the wearer's movements would have created a rattling sound. The acoustical properties of this sound can be demonstrated with copies of animal teeth. This article aims to provide insight into the previously little explored world of Neolithic sound.	[Rainio, Riitta; Mannermaa, Kristiina] Univ Helsinki, Dept Philosophy Hist Culture & Art Studies Musico, FIN-00014 Helsinki, Finland		Rainio, R (corresponding author), Univ Helsinki, Dept Philosophy Hist Culture & Art Studies Musico, POB 59, FIN-00014 Helsinki, Finland.	riitta.rainio@helsinki.fi		Rainio, Riitta/0000-0003-0995-3900			ALBRETHSEN SE, 1976, ACTA ARCHAEOL-DEN, V47, P1; Berzin, 2004, BAR INT SERIES, V1292; Blades J, 1970, PERCUSSION INSTRUMEN; BURENHULT G, 1997, AJVIDE MODERNA ARKEO, P52; Burenhult G., 2002, REMOTE SENSING APPL, P31; BURENHULT G, 1997, REMOTE SENSING APPL, V1; Choyke A., 2010, ANTHR APPROACHES ZOO, P197; Choyke A.M., 2001, CRAFTING BONE SKELET, P251; Choyke A.M., 2009, MAT MEMORY ARCHAEOLO, P21; D'Errico F, 2002, J ARCHAEOL SCI, V29, P211, DOI 10.1006/jasc.2001.0687; David E., 2004, THESIS U PARIS 10 PA; Duffy P., 2013, 78 ANN M SOC AM ARCH; Garwood P., 2011, OXFORD HDB ARCHAEOLO; Gurina N. N, 1956, OLENEOSTROVSKIJ MOGI; Hayden B., 2003, SHAMANS SORCERERS SA; Hickmann E, 1997, MUSIK GESCH GEGENWAR, V6, P929; Ho'oulu Cambra Z., 1984, NEW GROVE DICT MUSIC, P487; Ho'oulu Cambra Z., 1984, NEW GROVE DICT MUSIC, P697; IBM SPSS Statistics, 2011, CORR AN; Jaanits L., 1957, SUOMEN MUINAISMUISTO, V58, P80; JANZON GO, 1974, GOTLANDS MELLANNEOLI; King C.D., 1974, ANTAP CALIFORNIA IND, V2, P75; Krause A, 1956, TLINGIT INDIANS RESU; L?ugas L., 2000, MUINASAJA TEADUS, V8, P223; Larsson L., 2006, ACTA ARCHAEOLOGICA L, P153; Larsson L., 1988, FANGSTSAMHALLE 7000; Lassfolk K., 2001, SPECTUTILS HOME PAGE; Lassfolk K., 2001, USING LINUX BASED TO; Lindqvist C, 1997, AJVIDE MODERNA ARKEO, P71; Lougas L., 2006, ACTA ARCHAEOLOGICA L, V52, P75; Lund C. S., 1979, SVENSK TIDSKRIFT MUS, V61, P95; Lund C.S., 1984, SOUNDS PREHISTORIC S; Mannermaa K, 2006, INT J OSTEOARCHAEOL, V16, P429, DOI 10.1002/oa.884; Mannermaa K, 2008, J ANTHROPOL ARCHAEOL, V27, P201, DOI 10.1016/j.jaa.2008.01.001; Molnar P., 2008, JAKOBS AJVIDE UNDERS, V3, P276; NMAI (National Museum of the American Indian), 2013, ONL COLL COLL SEARCH; Norderang J., 2008, JAKOBS AJVIDE UNDERS, P296; Norderang J., 2007, AJVIDEBOPLATSEN RAPP; Norderang J., 2009, AJVIDEBOPLATSEN RAPP; OLSON C, 2002, REMOTE SENSING, V2, P375; Osterholm I., 2008, JAKOBS AJVIDE UNDERS, V3; Passeniers O., 2013, 78 ANN M SOC AM ARCH; Petasch C., 2011, MITTELDEUTSCHE  1205; Poplin F, 1972, ARCHAOL KORRESPONDEN, V2, P235; Ray Dorothy Jean, 1967, ESKIMO MASKS ART CER; Sachs C., 1965, GEIST WERDEN MUSIKIN; Stenberger M., 1943, GRABFELT VASTERBJERS; Stora J, 2002, REMOTE SENSING, V2, P387; Van Gijn A.L., 2006, SCHIPLUIDEN HARNASCH, P195; Vanhaeren M, 2005, J ANTHROPOL ARCHAEOL, V24, P117, DOI 10.1016/j.jaa.2005.01.001; Vanhaeren M, 2004, J ARCHAEOL SCI, V31, P1481, DOI 10.1016/j.jas.2004.03.011; Velazquez Castro A., 2010, STUDIEN MUSIKARCHAOL, P243	52	9	9	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0043-8243	1470-1375		WORLD ARCHAEOL	World Archaeol.		2014	46	3			SI		332	348		10.1080/00438243.2014.909105			17	Archaeology	Arts &amp; Humanities Citation Index (A&amp;HCI)	Archaeology	AO5TU	WOS:000341409000005					2022-02-06	
J	Rau, TF; Kothiwal, A; Rova, A; Rhoderick, JF; Poulsen, DJ				Rau, Thomas F.; Kothiwal, Aakriti; Rova, Annela; Rhoderick, Joseph F.; Poulsen, David J.			Phenoxybenzamine Is Neuroprotective in a Rat Model of Severe Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; neuroprotection; phenoxybenzamine; morris water maze	MONOCYTE CHEMOATTRACTANT PROTEIN-1; 88 MYD88; CHEMOKINES; EXPRESSION; CATECHOLAMINES; CYTOKINE; PATHWAYS; RELEASE; BINDING; MCP-1	Phenoxybenzamine (PBZ) is an FDA approved alpha-1 adrenergic receptor antagonist that is currently used to treat symptoms of pheochromocytoma. However, it has not been studied as a neuroprotective agent for traumatic brain injury (TBI). While screening neuroprotective candidates, we found that phenoxybenzamine reduced neuronal death in rat hippocampal slice cultures following exposure to oxygen glucose deprivation (OGD). Using this system, we found that phenoxybenzamine reduced neuronal death over a broad dose range (0.1 mu M-1 mM) and provided efficacy when delivered up to 16 h post-OGD. We further tested phenoxybenzamine in the rat lateral fluid percussion model of TBI. When administered 8 h after TBI, phenoxybenzamine improved neurological severity scoring and foot fault assessments. At 25 days post injury, phenoxybenzamine treated TBI animals also showed a significant improvement in both learning and memory compared to saline treated controls. We further examined gene expression changes within the cortex following TBI. At 32 h post-TBI phenoxybenzamine treated animals had significantly lower expression of pro-inflammatory signaling proteins CCL2, IL1 beta, and MyD88, suggesting that phenoxybenzamine may exert a neuroprotective effect by reducing neuroinflammation after TBI. These data suggest that phenonxybenzamine may have application in the treatment of TBI.	[Rau, Thomas F.; Kothiwal, Aakriti; Rova, Annela; Rhoderick, Joseph F.; Poulsen, David J.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA		Poulsen, DJ (corresponding author), Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.	Thomas.Rau@mso.umt.edu; aakriti_kothiwal@yahoo.com; annela.rova@umconnect.umt.edu; fred.rhoderick@mso.umt.edu; david.poulsen@umontana.edu			University of Montana Drug Discovery Program	This work was supported through the University of Montana Drug Discovery Program.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Barth JT, 1996, CLIN ELECTROENCEPHAL, V27, P183; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; BUCHWEITZ E, 1982, J PHARMACOL EXP THER, V223, P322; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CAINE M, 1978, BRIT J UROL, V50, P551, DOI 10.1111/j.1464-410X.1978.tb06210.x; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; CIMINO M, 1988, BIOCHEM PHARMACOL, V37, P2739, DOI 10.1016/0006-2952(88)90036-6; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Faul M, 2006, TRAUMATIC BRAIN INJU; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HAMILTON CA, 1984, N-S ARCH PHARMACOL, V325, P34, DOI 10.1007/BF00507051; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Ling HP, 2013, J SURG RES, V179, pE227, DOI 10.1016/j.jss.2012.03.030; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; PRODJOSUDJADI W, 1995, CLIN NEPHROL, V44, P148; PRODJOSUDJADI W, 1995, KIDNEY INT, V48, P1477, DOI 10.1038/ki.1995.437; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Selkirk JV, 2005, EUR J NEUROSCI, V21, P2291, DOI 10.1111/j.1460-9568.2005.04059.x; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; SOZZANI S, 1994, J IMMUNOL, V152, P3615; SOZZANI S, 1994, BIOCHEM BIOPH RES CO, V199, P761, DOI 10.1006/bbrc.1994.1294; STOKES GS, 1984, METHOD FIND EXP CLIN, V6, P197; STROSBERG AD, 1993, PROTEIN SCI, V2, P1198, DOI 10.1002/pro.5560020802; Te AE, 2002, CLIN THER, V24, P851, DOI 10.1016/S0149-2918(02)80003-0; Tomycz N. D., 2011, NEUROSURGERY, V68, pN16; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1988, AM J PHYSIOL, V254, pE287, DOI 10.1152/ajpendo.1988.254.3.E287; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	52	9	10	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JAN	2014	15	1					1402	1417		10.3390/ijms15011402			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	AG9YM	WOS:000335776100083	24447929	Green Published, gold, Green Submitted			2022-02-06	
J	Richardson, C; McKay, A; Ponsford, JL				Richardson, Cally; McKay, Adam; Ponsford, Jennie L.			The trajectory of awareness across the first year after traumatic brain injury: The role of biopsychosocial factors	BRAIN INJURY			English	Article						Acute; biopsychosocial; Self-awareness; self-awareness of deficits interview (SADI); traumatic brain injury; model	IMPAIRED SELF-AWARENESS; CLOSED-HEAD INJURY; FRONTAL LOBES; POSTTRAUMATIC AMNESIA; EXECUTIVE FUNCTIONS; DEPRESSION SCALE; HOSPITAL ANXIETY; DEFICITS; REHABILITATION; VALIDITY	Objective: To examine self-awareness over the first year following traumatic brain injury (TBI) and the association of demographic, biological, cognitive, psychological and social-environmental factors with change in awareness. Research design: Using a longitudinal design the progression of awareness and association of demographic and biopsychosocial factors with its trajectory were analysed using random effects regression. Methods and procedures: Sixty individuals with mainly moderate-to-severe TBI completed assessments at 3, 6 and/or 12 months post-injury. Measures of awareness (Self-Awareness of Deficits Interview; SADI), demographic (age at time of injury and gender), injury severity (post-traumatic amnesia duration), cognitive (Trails Making Test-Part B), psychological (Hospital Anxiety and Depression Scale) and social-environmental (return to pre-injury activities) factors were administered. Main outcomes and results: Awareness improved over the first year post-injury. Analysis of SADI sub-scales revealed that females had greater awareness in terms of setting more realistic goals early in recovery compared to males. Models including demographic, biological, cognitive, psychological and social-environmental factors did not contribute significantly to prediction of awareness on the SADI above the influence of time. Conclusions: Time post-injury had the strongest influence on the development of awareness. This understanding may be important in determining the optimal timing of rehabilitative intervention.	[Richardson, Cally; McKay, Adam; Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [Richardson, Cally; McKay, Adam; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Richardson, Cally] Alfred Hosp, Natl Trauma Res Inst, Ctr Excellence Traumat Brain Injury Res, Melbourne, Vic, Australia		Richardson, C (corresponding author), Monash Univ, Bldg 17,Clayton Campus,Wellington Rd, Melbourne, Vic 3800, Australia.	cally.richardson@monash.edu	McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681			Benson D.F., 1986, FRONTAL LOBES; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fitzmaurice G.M., 2004, APPL LONGITUDINAL AN, Ved; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Jones SJ., 2008, BRIT J OCCUP THER, V71, P44, DOI DOI 10.1177/030802260807100202; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Newman AC, 2000, BRAIN INJURY, V14, P333; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; Reitan R, 1988, HALSTEAD REITAN NEUR; Richardson C, 2014, J HEAD TRAUMA REHABI; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Snaith R., 1983, HOSP ANXIETY DEPRESS; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Turner GR, 2004, SCI PRACT NEUROPSYCH, P224; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007	67	9	9	0	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1711	1720		10.3109/02699052.2014.954270			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600010	25255045				2022-02-06	
J	Sasse, N; Gibbons, H; Wilson, L; Martinez, R; Sehmisch, S; von Wild, K; von Steinbuchel, N				Sasse, Nadine; Gibbons, Henning; Wilson, Lindsay; Martinez, Ramon; Sehmisch, Stephan; von Wild, Klaus; von Steinbuechel, Nicole			Coping strategies in individuals after traumatic brain injury: associations with health-related quality of life	DISABILITY AND REHABILITATION			English	Article						Coping with illness; health-related quality of life; traumatic brain injury	GLASGOW OUTCOME SCALE; PSYCHIATRIC-DISORDERS; HOSPITAL ANXIETY; SOCIAL SUPPORT; DEPRESSION; VALIDITY; QOLIBRI; REHABILITATION; STYLES	Purpose: This study investigates coping strategies after traumatic brain injury (TBI) and their associations with health-related quality of life (HRQoL). Methods: Participants were 141 adults followed up 3 months to 15 years after TBI of all severity degrees. Coping was assessed by the Freiburg Questionnaire of Coping with Illness (FQCI) and HRQoL by the Quality of Life after Brain Injury (QOLIBRI) scale and the Short Form-36 Health Survey (SF-36). Coping dimensions were extracted by principal component analysis. Multiple linear regression analysis was used to identify predictors of coping strategies. Results: Two factors for coping after TBI were extracted: Action/Distraction and Trivialisation/Resignation. The Trivialisation/Resignation strategy was negatively correlated with all aspects of HRQoL, while relationships with the Action/Distraction strategy were positive and significant for two domains. These two factors also showed significant associations with anxiety, depression, recovery, cognitive status, mood states and trauma severity. Multiple regression analysis identified recovery status as a predictor for the maladaptive Trivialisation/Resignation strategy. Conclusion: Two coping factors were identified, which were differentially associated with HRQoL. Maladaptive coping strategies play a particularly important role, and less reliance on such strategies is associated with better HRQoL; use of adaptive strategies should correspondingly be fostered.	[Sasse, Nadine; Gibbons, Henning; von Steinbuechel, Nicole] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany; [Gibbons, Henning] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Wilson, Lindsay] Univ Med Ctr, Dept Neurosurg, Gottingen, Germany; [Martinez, Ramon] Univ Med Ctr, Dept Trauma Surg Plast & Reconstruct Surg, Gottingen, Germany; [Sehmisch, Stephan] KvW Neurosci Consulting, Munster, Germany; [von Wild, Klaus] Univ Bonn, Dept Psychol, Bonn, Germany		Sasse, N (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany.	n.sasse@-med.uni-goettingen.de	Wilson, Lindsay/O-8883-2019; Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328	ZNS-Hannelore Kohl Foundation, Germany [2008014]	The authors report no declarations of interest. This study was funded by the ZNS-Hannelore Kohl Foundation, Germany (project number 2008014).	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; BERGNER M, 1987, QUALITY LIFE ASSESSM, P79; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bullinger M, 1990, Z DIFFER DIAGNOSTISC, V11, P53; Bullinger M., 1995, J PUBLIC HEALTH-UK, V3, P21, DOI [10.1007/BF02959944, DOI 10.1007/BF02959944]; Costello A., 2005, PAN PACIFIC MANAGEME, V10, P1, DOI DOI 10.7275/JYJ1-4868; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Curtiss G, 2000, J HEAD TRAUMA REHAB, V15, P1113, DOI 10.1097/00001199-200010000-00005; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2006, BRAIN COGNITION, V60, P214; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Finset A, 2000, BRAIN INJURY, V14, P887; Folstein M, 1988, NEUROPSY NEUROPSY BE, V1, P111; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Hardt J, 2003, Z KL PSYCH PSYCHOTH, V32, P41, DOI 10.1026//1616-3443.32.1.41; Hastie T., 2009, LINEAR METHODS REGRE, P43, DOI [10.1007/978-0-387-84858-7_3, DOI 10.1007/978-0-387-84858-7_3]; Hepp U, 2005, PSYCHOTHER PSYCHOSOM, V74, P379, DOI 10.1159/000087786; Herrmann M, 2000, DISABIL REHABIL, V22, P539, DOI 10.1080/096382800416788; Herrmann-Lingen C., 1995, HOSP ANXIETY DEPRESS; JENNETT B, 1975, LANCET, V1, P480; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Lazarus RS., 1984, STRESS APPRAISAL COP, P141; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; McNair DM, 1971, EITS MANUAL PROFILE; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P899, DOI 10.1080/09602011.2010.517688; Muthny F, 1989, PSYCHOSOZIALE ONKOLO, P86; Muthny F.A., 1989, FREIBURGER FRAGEBOGE, V1st ed.; Prigatano GP., 1999, PRINCIPLES NEUROPSYC, P48; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Spilker B., 1996, QUALITY LIFE PHARMAC, P337; TEASDALE G, 1974, LANCET, V2, P81; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Velikonja D, 2013, BRAIN INJURY, V27, P158, DOI 10.3109/02699052.2012.729289; von Steinbuchel N, J NEUROL NEURO UNPUB; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	9	9	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2014	36	25					2152	2160		10.3109/09638288.2014.893029			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AW1PB	WOS:000346060300006	24579650				2022-02-06	
J	Vassilyadi, M; Macartney, G; Barrowman, N; Anderson, P; Dube, K				Vassilyadi, Michael; Macartney, Gail; Barrowman, Nick; Anderson, Peter; Dube, Karen			Symptom Experience and Quality of Life in Children after Sport-Related Head Injuries: A Cross-Sectional Study	PEDIATRIC NEUROSURGERY			English	Article						Paediatric patients; Concussion; Sports; Mild traumatic brain injury; Quality of life	TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE PERFORMANCE; POSTCONCUSSIVE SYMPTOMS; CONCUSSION SYMPTOMS; HIGH-SCHOOL; BASE-LINE; IMPACT; EPIDEMIOLOGY; RELIABILITY; POPULATION	Background: Sports are a major cause of concussions, and little is known about the symptom experience and health-related quality of life (HRQL) in children who remain symptomatic for over 3 months following such head injuries. Methods: A cross-sectional study of children aged 10-18 years was performed who were referred to the Neurosurgery Clinic at our centre following a head injury. Symptom experience was measured using the modified Concussion Symptom Scale, and HRQL was measured using the Pediatric Quality of Life Inventory (PedsQL). The Immediate Post-concussion Assessment and Cognitive Test (ImPACT) was administered to assess neurocognitive and neurobehavioural sequelae. Results: Symptoms with the highest mean symptom scores on a Likert scale of 0-6 in 35 children at the time of assessment included headaches (3.1), poor concentration (2.7), memory problems (2.1), fatigue (2.1) and sensitivity to noise (2.0). Compared with normative data, children in this study had ImPACT summary scores between the 28th and 38th percentiles and a comparably low Cognitive Efficiency Index score. Mean scores for females were consistently statistically significantly lower (p < 0.05) than for males across all of the HRQL domains. Trouble falling asleep and memory problems explained 62% of the variance in the PedsQL total scores. Conclusions: Children continue to experience many symptoms at least 3 months following sport-related head injuries that significantly impact their HRQL and neurocognitive abilities. (C) 2015 S. Karger AG, Basel	[Vassilyadi, Michael; Macartney, Gail; Dube, Karen] Childrens Hosp Eastern Ontario, Div Neurosurg, Ottawa, ON K1H 8L1, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Behav Neurosci & Consultat Liaison Team, Ottawa, ON K1H 8L1, Canada; [Vassilyadi, Michael; Macartney, Gail; Barrowman, Nick; Anderson, Peter] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada		Vassilyadi, M (corresponding author), Childrens Hosp Eastern Ontario, Div Neurosurg, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	vassilyadi@cheo.on.ca	Meijer, Anna/K-5118-2016; Barrowman, Nick/AAL-3166-2020	Barrowman, Nick/0000-0002-4704-9595; Macartney, Gail/0000-0003-3288-4886	Giannopoulos Family in Ottawa	We would like to thank Chelsea Lanos, an undergraduate summer student, for her assistance with some of the data collection and literature review, and Mr. Johnny Chehade (former University of Western Ontario Football player) for his support and sponsoring of the patient ImPACT testing. We would also like the Giannopoulos Family in Ottawa for funding the establishment of the Concussion Research Project Clinic at the CHEO.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gomez JE, 2013, J ADOLESCENT HEALTH, V53, P311, DOI 10.1016/j.jadohealth.2013.06.018; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Kirkwood M, 2012, MILD TRAUMATIC BRAIN; Kozlowski KF, 2007, NEUROREHABILITATION, V22, P191; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Morgan CD, 2015, J NEUROSURG PEDIAT; Munro BH, 2005, STAT METHODS HLTH CA, V5th; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Varni JW, 2007, J PEDIATR PSYCHOL, V32, P1151, DOI 10.1093/jpepsy/jsm008; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Webbe F, 2010, HDB SPORT NEUROPSYCH; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	38	9	8	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2014	50	4					196	203		10.1159/000431232			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	CQ5DS	WOS:000360624100003	26113135				2022-02-06	
J	Zhu, YN; Li, ZJ; Bai, LJ; Tao, Y; Sun, CZ; Li, M; Zheng, LM; Zhu, B; Yao, J; Zhou, HP; Zhang, M				Zhu, Yanan; Li, Zhengjun; Bai, Lijun; Tao, Yin; Sun, Chuanzhu; Li, Min; Zheng, Longmei; Zhu, Bao; Yao, Jun; Zhou, Heping; Zhang, Ming			Loss of Microstructural Integrity in the Limbic-Subcortical Networks for Acute Symptomatic Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							DIFFUSE AXONAL INJURY; WHITE-MATTER INJURY; HEAD-INJURY; IMPAIRMENT	Previous studies reported discrepant white matter diffusivity in mild traumatic brain injury (mTBI) on the base of Glasgow Coma Scale, which are unreliable for some TBI severity indicators and the frequency of missing documentation in the medical record. In the present study, we adopted the Mayo classification system for TBI severity. In this system, the mTBI is also divided into two groups as "probable and symptomatic" TBI. We aimed to investigate altered microstructural integrity in symptomatic acute TBI (<1 week) by using tract-based spatial statics (TBSS) approach. A total of 12 patients and 13 healthy volunteers were involved and underwent MRI scans including conventional scan, and SWI and DTI. All the patients had no visible lesions by using conventional and SWI neuroimaging techniques, while showing widespread declines in the fractional anisotropy (FA) of gray matter and white matter throughout the TBSS skeleton, particularly in the limbic-subcortical structures. By contrast, symptomatic TBI patients showed no significant enhanced changes in FA compared to the healthy controls. A better understanding of the acute changes occurring following symptomatic TBI may increase our understanding of neuroplasticity and continuing degenerative change, which, in turn, may facilitate advances in management and intervention.	[Zhu, Yanan; Li, Min; Zhang, Ming] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Med Imaging, Xian 710061, Peoples R China; [Zhu, Yanan; Li, Zhengjun; Zheng, Longmei; Zhu, Bao; Yao, Jun; Zhou, Heping] An Kang Cent Hosp, Med Imaging Ctr, Ankang 725000, Peoples R China; [Bai, Lijun; Tao, Yin; Sun, Chuanzhu] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Peoples R China		Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Peoples R China.	bailj4152615@gmail.com; profzmmri@gmail.com	Bai, Lijun/C-5119-2015	Bai, Lijun/0000-0001-8790-5424	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81071217, 81371630, 81371530]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities; Beijing Nova programBeijing Municipal Science & Technology Commission [Z111101054511116]; Beijing Natural Science FoundationBeijing Natural Science Foundation [4122082]	This study was supported by the National Natural Science Foundation of China (Grant nos. 81071217, 81371630, and 81371530), the Fundamental Research Funds for the Central Universities, the Beijing Nova program (Grant no. Z111101054511116), and the Beijing Natural Science Foundation (Grant no. 4122082).	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Alkonyi B, 2011, AM J NEURORADIOL, V32, P962, DOI 10.3174/ajnr.A2417; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Green Robin, 2010, Neuropsychol Rehabil, V20, P471, DOI 10.1080/09602011003693298; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	32	9	9	1	11	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								548392	10.1155/2014/548392			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AC1VJ	WOS:000332284600001	24695757	Green Published, Green Submitted, gold			2022-02-06	
J	Buster, T; Burnfield, J; Taylor, AP; Stergiou, N				Buster, Thad; Burnfield, Judith; Taylor, Adam P.; Stergiou, Nicholas			Lower Extremity Kinematics During Walking and Elliptical Training in Individuals With and Without Traumatic Brain Injury	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						gait; locomotor training; nonlinear; physical rehabilitation; variability	NONLINEAR DYNAMICS; VARIABILITY; GAIT; STROKE	Background and Purpose: Elliptical training may be an option for practicing walking-like activity for individuals with traumatic brain injuries (TBI). Understanding similarities and differences between participants with TBI and neurologically healthy individuals during elliptical trainer use and walking may help guide clinical applications incorporating elliptical trainers. Methods: Ten participants with TBI and a comparison group of 10 neurologically healthy participants underwent 2 familiarization sessions and 1 data collection session. Kinematic data were collected as participants walked on a treadmill or on an elliptical trainer. Gait-related measures, including coefficient of multiple correlations (a measure of similarity between ensemble joint movement profiles; coefficient of multiple correlations [CMCs]), critical event joint angles, variability of peak critical event joint angles (standard deviations [SDs]) of peak critical event joint angles, and maximum Lyapunov exponents (a measure of the organization of the variability [LyEs]) were compared between groups and conditions. Results: Coefficient of multiple correlations values comparing the similarity in ensemble motion profiles between the TBI and comparison participants exceeded 0.85 for the hip, knee, and ankle joints. The only critical event joint angle that differed significantly between participants with TBI and comparison participants was the ankle during terminal stance. Variability was higher for the TBI group (6 of 11 comparisons significant) compared with comparison participants. Hip and knee joint movement patterns of both participants with TBI and comparison participants on the elliptical trainer were similar to walking (CMCs >= 0.87). Variability was higher during elliptical trainer usage compared with walking (5 of 11 comparisons significant). Hip LyEs were higher during treadmill walking. Ankle LyEs were greater during elliptical trainer usage. Discussion and Conclusions: Movement patterns of participants with TBI were similar to, but more variable than, those of comparison participants while using both the treadmill and the elliptical trainer. If incorporation of complex movements similar to walking is a goal of rehabilitation, elliptical training is a reasonable alternative to treadmill-based training. Video Abstract available (see Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A65) for more insights from the authors.	[Buster, Thad; Burnfield, Judith; Taylor, Adam P.] Madonna Rehabil Hosp, Inst Rehabil Sci & Engn, Movement & Neurosci Ctr, Lincoln, NE 68506 USA; [Buster, Thad; Stergiou, Nicholas] Univ Nebraska, Nebraska Biomechan Core Fac, Omaha, NE 68182 USA		Buster, T (corresponding author), Madonna Rehabil Hosp, Inst Rehabil Sci & Engn, 5401 South St, Lincoln, NE 68506 USA.	tbuster@madonna.org	Burnfield, Judith M/K-6087-2015	Buster, Thad/0000-0001-7454-1748; Burnfield, Judith/0000-0001-6184-5179	Bill Kubly student research scholarship	This study was funded, in part, by The Bill Kubly student research scholarship grant awarded to Thad W. Buster. For the remaining authors, none were declared.	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Burnfield JM, 2011, PHYS THER, V91, P1604, DOI 10.2522/ptj.20100332; Burnfield JM, 2010, PHYS THER, V90, P289, DOI 10.2522/ptj.20090033; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Cignetti F, 2012, ANN BIOMED ENG, V40, P1122, DOI 10.1007/s10439-011-0474-3; Cooper A, 2005, CLIN REHABIL, V19, P760, DOI 10.1191/0269215505cr888oa; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hislop H.J., 2007, DANIELS WORTHINGHAMS; Huisinga JM, 2012, J APPL BIOMECH, V28, P249, DOI 10.1123/jab.28.3.249; Huisinga JM, 2011, J REHABIL RES DEV, V48, P881, DOI 10.1682/JRRD.2010.08.0152; Jackson K, 2010, J NEUROL PHYS THER, V34, P168, DOI 10.1097/NPT.0b013e3181ee682c; KADABA MP, 1989, J ORTHOPAED RES, V7, P849, DOI 10.1002/jor.1100070611; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Myers SA, 2009, J VASC SURG, V49, P924, DOI 10.1016/j.jvs.2008.11.020; Nelson CA, 2011, J MED DEVICES, V5, DOI 10.1115/1.4003693; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; OSullivan S., 2006, PHYS REHABILITATION, VFifth; Pardasaney PK, 2012, PHYS THER, V92, P388, DOI 10.2522/ptj.20100398; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Stergiou N, 2004, INNOVATIVE ANAL HUMA; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Summers MJ, 2006, BRAIN INJURY, V20, P51, DOI 10.1080/02699050500309742; TALMAGE EW, 1983, PHYS THER, V63, P2010, DOI 10.1093/ptj/63.12.2010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Whitney Susan, 2003, Physiother Res Int, V8, P178, DOI 10.1002/pri.288; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9	34	9	9	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	DEC	2013	37	4					176	186		10.1097/NPT.0000000000000022			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	299FO	WOS:000330381400005	24189335				2022-02-06	
J	Klevay, LM				Klevay, Leslie M.			Myelin and traumatic brain injury: The copper deficiency hypothesis	MEDICAL HYPOTHESES			English	Article							DEMYELINATION; HOMOCYSTEINE; MYELOPATHY; CUPRIZONE; DISEASE; PLASMA; MODES; CNS	Nearly two million people suffer traumatic brain injury in the US each year. These injuries alter adversely the metabolism of myelin, a major lipid material in brain, both in people and in experimental injuries of animals. A newly discovered and severe human neuropathy from copper deficiency provides evidence that some people in the US are malnourished in copper. As it is well known among copper cognoscenti that it is impossible to synthesize myelin if copper nutriture is inadequate, it seems reasonable to assume that repair will be poor in this situation. Copper status of patients should be evaluated and experiments with injured animals should be repeated with graded doses of copper to determine if copper metabolism is important in this illness. (C) 2013 Elsevier Ltd. All rights reserved.	[Klevay, Leslie M.] Univ N Dakota, Sch Med & Hlth Sci, Dept Internal Med, Grand Forks, ND 58201 USA; [Klevay, Leslie M.] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58201 USA		Klevay, LM (corresponding author), 223 27th Ave South, Grand Forks, ND 58201 USA.	leslie.klevay@med.und.edu					Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; [Anonymous], 2012, COPPER GLANCE; [Anonymous], 2013, TRAUMATIC BRAIN INJU, V36, P366; [Anonymous], 2003, DIETARY REFERENCE IN, P2; Benetti F, 2010, NEUROTOXICOLOGY, V31, P509, DOI 10.1016/j.neuro.2010.05.008; Berg JM, 2007, BIOCHEMISTRY; CARRICO RJ, 1969, J BIOL CHEM, V244, P6087; Collins JF, 2011, ADV NUTR, V2, P520, DOI 10.3945/an.111.001222; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Davies KM, 2013, METALLOMICS, V5, P43, DOI 10.1039/c2mt20151h; Davis G.K., 1987, TRACE ELEMENTS HUMAN, P301, DOI DOI 10.1016/B978-0-08-092468-7.50014-4; Devlin TM., 2011, TXB BIOCH CLIN CORRE, V7th ed, pxxxii, 1204; Doucette JR, 2010, CELL MOL NEUROBIOL, V30, P607, DOI 10.1007/s10571-009-9486-z; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; EVERSON GLADYS J., 1967, J NUTR, V93, P533; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Follis Jr RH, 1948, PATHOLOGY NUTR DIS; Gertz SD, 2007, LIEBMANS NEUROANATOM; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hauser SL, 2013, HARRISONS PRINCIPLES; Jaiser SR, 2010, J NEUROL, V257, P869, DOI 10.1007/s00415-010-5511-x; Kelkar Praful, 2008, J Clin Neuromuscul Dis, V10, P1, DOI 10.1097/CND.0b013e3181828cf7; Khaleeli Z, 2010, BMJ-BRIT MED J, V340, P864; Klevay L. M., 2010, ENCY DIETARY SUPPLEM, P175; Klevay LM, 2008, REJUV RES, V11, P697, DOI 10.1089/rej.2008.0703; Klevay LM, 2012, AM J CLIN NUTR, V95, P1293, DOI 10.3945/ajcn.112.035352; Klevay LM, 2011, J TRACE ELEM MED BIO, V25, P204, DOI 10.1016/j.jtemb.2011.08.146; KLEVAY LM, 1984, METABOLISM, V33, P1112, DOI 10.1016/0026-0495(84)90096-9; KLEVAY LM, 1988, MED HYPOTHESES, V27, P65, DOI 10.1016/0306-9877(88)90086-2; KLEVAY LM, 1993, P SOC EXP BIOL MED, V203, P214, DOI 10.3181/00379727-203-43594; Klevay LM, 2001, J TRACE ELEM MED BIO, V14, P237, DOI 10.1016/S0946-672X(01)80009-2; KLEVAY LM, 1986, NUTR REP INT, V33, P371; KOH ET, 1989, J NUTR, V119, P453, DOI 10.1093/jn/119.3.453; Kumar N, 2006, MAYO CLIN PROC, V81, P1371, DOI 10.4065/81.10.1371; Linder MC, 1991, BIOCH COPPER; Liu PC, 2005, MOL GENET METAB, V85, P291, DOI 10.1016/j.ymgme.2005.04.007; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; MILNE DB, 1988, NUTR RES, V8, P865, DOI 10.1016/S0271-5317(88)80126-X; Narayan SK, 2006, NEUROL INDIA, V54, P110, DOI 10.4103/0028-3886.25146; Owen CA, 1982, PHYSL ASPECTS COPPER; Owen Jr CA, 1982, BIOCH ASPECTS COPPER, P1; Pepys M.B., 1996, OXFORD TXB MED, P1527; PLETCHER JM, 1983, J S AFR VET ASSOC, V54, P43; PRATT WB, 1985, AM J CLIN NUTR, V42, P681, DOI 10.1093/ajcn/42.4.681; Prodan Calin I, 2011, J Clin Neuromuscul Dis, V12, P122, DOI 10.1097/CND.0b013e3181dc34c0; PROHASKA JR, 1990, J NUTR BIOCHEM, V1, P452, DOI 10.1016/0955-2863(90)90080-5; Prohaska JR, 2001, ARCH BIOCHEM BIOPHYS, V393, P170, DOI 10.1006/abbi.2001.2470; Raymond GV, 2010, J NEUROL SCI, V290, P70, DOI 10.1016/j.jns.2009.11.005; Ropper AH, 2009, ADAMS VICTORS PRINCI, P1120; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Schlief ML, 2006, MOL NEUROBIOL, V33, P81, DOI 10.1385/MN:33:2:81; Su E, 2012, NEUROCRIT CARE, V17, P401, DOI 10.1007/s12028-012-9767-0; Sundsten Nolte J., 2009, HUMAN BRAIN; Tamura T, 2004, NUTRITION, V20, P757, DOI 10.1016/j.nut.2004.05.011; Tamura T, 1999, BBA-GEN SUBJECTS, V1427, P351, DOI 10.1016/S0304-4165(99)00043-4; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Voet D, 2004, BIOCHEMISTRY; Voet D., 2011, BIOCHEMISTRY, V4th; Zara G, 2009, J NEUROL SCI, V277, P184, DOI 10.1016/j.jns.2008.10.017	63	9	9	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	DEC	2013	81	6					995	998		10.1016/j.mehy.2013.09.011			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	284QJ	WOS:000329334800005	24120700				2022-02-06	
J	Roscigno, CI; Grant, G; Savage, TA; Philipsen, G				Roscigno, Cecelia I.; Grant, Gerald; Savage, Teresa A.; Philipsen, Gerry			Parent perceptions of early prognostic encounters following children's severe traumatic brain injury: 'Locked up in this cage of absolute horror'	BRAIN INJURY			English	Article						Communication; disability; ethnography of speaking; hope; prognostication or prognosis; speech codes theory; traumatic brain injury; truth-telling	HEAD-INJURY; CARE; UNCERTAINTY; HOPE; COMMUNICATION; COMPETENCE; CLASH; TALK; NEWS	Objective: Little guidance exists for discussing prognosis in early acute care with parents following children's severe traumatic brain injury (TBI). Providers' beliefs about truth-telling can shape what is said, how it is said and how providers respond to parents. Methods: This study was part of a large qualitative study conducted in the US (42 parents/37 families) following children's moderate-to-severe TBI (2005-2007). Ethnography of speaking was used to analyse interviews describing early acute care following children's severe TBI (29 parents/25 families). Results: Parents perceived that: (a) parents were disadvantaged by provider delivery; (b) negative outcome values dominated some provider's talk; (c) truth-telling involves providers acknowledging all possibilities; (d) framing the child's prognosis with negative medical certainty when there is some uncertainty could damage parent-provider relationships; (e) parents needed to remain optimistic; and (f) children's outcomes could differ from providers' early acute care prognostications. Conclusion: Parents blatantly and tacitly revealed their beliefs that providers play an important role in shaping parent reception of and synthesis of prognostic information, which constructs the family's ability to cope and participate in shared decision-making. Negative medical certainty created a fearful or threatening environment that kept parents from being fully informed.	[Roscigno, Cecelia I.] Univ N Carolina, Sch Nursing, Chapel Hill, NC 27599 USA; [Grant, Gerald] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Savage, Teresa A.] Univ Illinois, Coll Nursing, Chicago, IL USA; [Philipsen, Gerry] Univ Washington, Dept Commun, Seattle, WA 98195 USA		Roscigno, CI (corresponding author), Univ N Carolina, Sch Nursing, Carrington Hall,CB 7460, Chapel Hill, NC 27599 USA.	croscign@email.unc.edu			National Institutes of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [5T32NR007091-17]; NINR Ruth L. Kirschstein Predoctoral Research Fellowship [1 F31 NR009599-02]; Psi Chapter of Sigma Theta Tau Grant; American Nurses Foundation Martha E. Brill Scholars Award; University of Washington School of Nursing Hester McLaws Scholarship Fund; University of Washington LEND Training Grant [6 T73 MC 00041-11-03]; University of Washington Gatzert Child Welfare Fellowship; Integra Lifesciences Grant; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR009599, T32NR007091] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, training and/or authorship of this article: This secondary analysis was funded by the Society of Pediatric Nurses. The first author's post-doctoral training during the secondary analysis was funded by the Irving B. Harris Foundation Faculty Scholars Initiative at the College of Nursing, University of Illinois at Chicago (PI: R. White-Traut, PhD) and the authorship of the manuscript was funded by a National Institutes of Nursing Research post-doctoral fellowship, Interventions for Preventing and Managing Chronic Illness (5T32NR007091-17; PI: M. Mishel, PhD), at the School of Nursing, University of North Carolina, Chapel Hill. The original research study and training was funded by a NINR Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02); a Psi Chapter of Sigma Theta Tau Grant; a 2006 American Nurses Foundation Martha E. Brill Scholars Award; a University of Washington School of Nursing Hester McLaws Scholarship Fund; a University of Washington LEND Training Grant (TG #6 T73 MC 00041-11-03); a University of Washington Gatzert Child Welfare Fellowship; and an Integra Lifesciences Grant. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of any of the funders.	Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Albrecht TL, 2009, J HEALTH COMMUN, V14, P47, DOI 10.1080/10810730902806794; Ammentorp J, 2005, ARCH PEDIAT ADOL MED, V159, P127, DOI 10.1001/archpedi.159.2.127; Back Anthony L, 2003, Ann Intern Med, V138, P439; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Boss P., 2006, LOSS TRAUMA RESILIEN, P280; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Clark HH, 1996, USING LANGUAGE, P446; COHEN MH, 1995, QUAL HEALTH RES, V5, P63, DOI 10.1177/104973239500500105; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Duff Diane, 2006, Axone, V27, P9; Feudtner C, 2007, PEDIATR CLIN N AM, V54, P583, DOI 10.1016/j.pcl.2007.07.008; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; FORMAN EN, 1989, AM J PEDIAT HEMATOL, V11, P463; Fox RC, 2005, NEW ENGL J MED, V353, P1316, DOI 10.1056/NEJMp058066; FRADER JE, 1981, SOC SCI MED-MED PSYC, V15, P267, DOI 10.1016/0271-5384(81)90002-8; Frankl V, 1984, MANS SEARCH MEANING, P221; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; GERRITY MS, 1990, MED CARE, V28, P724, DOI 10.1097/00005650-199008000-00005; Gilligan C., 1982, DIFFERENT VOICE PSYC, P216; Gillotti C, 2002, SOC SCI MED, V54, P1011, DOI 10.1016/S0277-9536(01)00073-9; Henry MS, 2006, J MED ETHICS, V32, P321, DOI 10.1136/jme.2005.013987; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Hinds PS, 2009, J CLIN ONCOL, V27, P5979, DOI 10.1200/JCO.2008.20.0204; Hinds PS, 1997, QUAL HEALTH RES, V7, P408, DOI 10.1177/104973239700700306; Hymes D., 1962, ANTHR HUMAN BEHAV, P13; Hymes D., 1972, DIRECTIONS SOCIOLING, P35; Institute of Medicine, 2001, CROSSING QUALITY CHA, P360; Jurkovich GJ, 2000, J TRAUMA, V48, P865, DOI 10.1097/00005373-200005000-00009; Kincaid DL, 1988, INT INTERCULTURAL AN, P280; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KRAHN GL, 1993, PEDIATRICS, V91, P578; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lefebvre H, 2006, BRAIN INJURY, V20, P711, DOI 10.1080/02699050600744244; LONGMORE PK, 1995, J LAW MED ETHICS, V23, P82, DOI 10.1111/j.1748-720X.1995.tb01335.x; Mack JW, 2007, J CLIN ONCOL, V25, P5636, DOI 10.1200/JCO.2007.12.6110; Mattingly C, 2010, PARADOX HOPE JOURNEY, P268; McMillan SC, 2006, CANCER, V106, P214, DOI 10.1002/cncr.21567; Melnyk B M, 2001, Pediatr Nurs, V27, P548; Mishel M H, 1997, Annu Rev Nurs Res, V15, P57; Morse J, 2011, J MED HUMANIT, V32, P187, DOI 10.1007/s10912-011-9138-4; Morse JM, 1995, QUALITATIVE RES METH, P272; Mulholland J., 1994, HDB PERSUASIVE TACTI, P432; MUMBY DK, 1987, COMMUN MONOGR, V54, P113, DOI 10.1080/03637758709390221; Murray SO, 1993, THEORY GROUPS STUDY, P617; National Public Radio Robert Wood Johnson Foundation Harvard School of Public Health, 2012, POLL SICK AM SUMM; Padayachy LC, 2012, CHILD NERV SYST, V28, P1911, DOI 10.1007/s00381-012-1837-2; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Philipsen G, 2005, LEA COMMUN SER, P355; Philipsen G., 2005, THEORIZING INTERCULT, P55; Philipsen G, 1992, SPEAKING CULTURALLY, P168; Philipsen G., 1997, DEV COMMUNICATION TH, P119; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; POMERANTZ A, 1986, HUM STUD, V9, P219, DOI 10.1007/BF00148128; Reder EAK, 2009, ARCH PEDIAT ADOL MED, V163, P653, DOI 10.1001/archpediatrics.2009.87; Revenson T. A., 2012, HDB HLTH PSYCHOL, P193; Roscigno CI, 2013, SOC SCI MED, V90, P32, DOI 10.1016/j.socscimed.2013.04.017; Roscigno CI, 2012, QUAL HEALTH RES, V22, P1232, DOI 10.1177/1049732312449210; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Scaife ER, 2010, CURR OPIN PEDIATR, V22, P339, DOI 10.1097/MOP.0b013e3283395f2b; Snyder CR, 2003, AM PSYCHOL, V58, P820, DOI 10.1037/0003-066X.58.10.820; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; Swanson K M, 1993, Image J Nurs Sch, V25, P352; Szabo V, 1997, ADV NURS SCI, V20, P66, DOI 10.1097/00012272-199712000-00008; Tasker RC, 2011, BRIT J NEUROSURG, V25, P68, DOI 10.3109/02688697.2010.538770; Thorne S E, 1989, Image J Nurs Sch, V21, P153; Thorne Sally, 2007, Palliat Support Care, V5, P227; Thorne SE, 1993, NEGOTIATING HLTH CAR, P81; U. S. Centers for Disease Control and Prevention [ internet], 2013, INJ PREV CONTR TRAUM	72	9	9	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1536	1548		10.3109/02699052.2013.831122			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400007	24087991	Green Accepted, Green Submitted			2022-02-06	
J	Van Haren, RM; Thorson, CM; Ogilvie, MP; Valle, EJ; Guarch, GA; Jouria, JA; Busko, AM; Harris, LT; Bullock, MR; Jagid, JR; Livingstone, AS; Proctor, KG				Van Haren, Robert M.; Thorson, Chad M.; Ogilvie, Michael P.; Valle, Evan J.; Guarch, Gerardo A.; Jouria, Jassin A.; Busko, Alexander M.; Harris, Leo T.; Bullock, M. Ross; Jagid, Jonathan R.; Livingstone, Alan S.; Proctor, Kenneth G.			Vasopressin for cerebral perfusion pressure management in patients with severe traumatic brain injury: Preliminary results of a randomized controlled trial	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	43rd Annual Meeting of the Western-Trauma-Association	MAR 03-08, 2013	Snowmass, CO	Western Trauma Assoc		Traumatic brain injury; cerebral perfusion pressure; vasopressors; catecholamines	LOW-DOSE VASOPRESSIN; ARGININE-VASOPRESSIN; NOREPINEPHRINE INFUSION; INDUCED HYPERTENSION; TISSUE OXYGENATION; HEMORRHAGIC-SHOCK; BLOOD-FLOW; RESUSCITATION; EPINEPHRINE; SURVIVAL	BACKGROUND: After traumatic brain injury (TBI), catecholamines (CAs) may be needed to maintain adequate cerebral perfusion pressure (CPP), but there are no recommended alternative vasopressor therapies. This is an interim report of the first study to test the hypothesis that arginine vasopressin (AVP) is a safe and effective alternative to CAs for the management of CPP in patients with severe TBI. METHODS: Since 2008, all TBI patients requiring intracranial pressure monitoring at this Level 1 trauma center have been eligible for a randomized trial to receive either CA or AVP if vasopressors were required to maintain CPP greater than 60 mm Hg. RESULTS: To date, 96 patients have been consented and randomized. Demographics, vital signs, and laboratory values were similar. As treated, 60 required no vasopressors and were the least severely injured group with the best outcomes. Twenty-three patients received CA (70% levophed, 22% dopamine, 9% phenylephrine) and 12 patients received AVP. The two vasopressor groups had similar demographics, but Injury Severity Score (ISS) and fluid requirements on intensive care unit Day 1 were worse in the AVP versus the CA groups (all p < 0.05) before treatment. These differences indicate more severe injury with accompanying hemodynamic instability. Nevertheless, adverse events were not increased with AVP versus CA. Trends favored AVP versus CA, but no apparent differences were statistically significant at this interim point. There was no difference in mortality rates between CA and AVP. CONCLUSION: These preliminary results suggest that AVP is a safe and effective alternative to CA for the management of CPP after TBI and support the continued investigation and use of AVP when vasopressors are required for CPP management in TBI patients. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Ryder Trauma Ctr, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Neurosurg, Ryder Trauma Ctr, Miami, FL 33136 USA		Proctor, KG (corresponding author), Univ Miami, Sch Med, Div Trauma Crit Care, Daughtry Family Dept Surg,Ryder Trauma Ctr, 1800 NW 10th Ave, Miami, FL 33136 USA.	kproctor@miami.edu	Livingstone, Alan/AAA-4026-2019; Van Haren, Robert/T-8218-2019; Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628; Thorson, Chad/0000-0002-2533-6622			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chieregato A, 2003, ACTA NEUROCHIR SUPPL, V86, P361; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cornwell E, 1999, J TRAUMA, V47, P703; DeWitt DS, 2000, CRIT CARE MED, V28, P3933, DOI 10.1097/00003246-200012000-00036; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Earle SA, 2007, J AM COLL SURGEONS, V204, P261, DOI 10.1016/j.jamcollsurg.2006.11.014; Faul M, 2010, TRAUMATIC BRAIN INJU; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Feinstein AJ, 2005, J TRAUMA, V59, P882; Ferguson-Myrthil N, 2012, CARDIOL REV, V20, P153, DOI 10.1097/CRD.0b013e31824e2294; Holmes Cheryl L, 2004, Curr Opin Crit Care, V10, P442, DOI 10.1097/01.ccx.0000144769.19213.0c; Holmes CL, 2008, BEST PRAC RES-CL ANA, V22, P275, DOI 10.1016/j.bpa.2008.03.002; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Krismer Anette C, 2004, Crit Care Med, V32, pS432, DOI 10.1097/01.CCM.0000134267.91520.C0; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Lienhart HG, 2007, ANAESTHESIST, V56, P145, DOI 10.1007/s00101-006-1114-4; Lienhart HG, 2008, CURR OPIN CRIT CARE, V14, P247, DOI 10.1097/MCC.0b013e3282fce62a; Malay MB, 1999, J TRAUMA, V47, P699, DOI 10.1097/00005373-199910000-00014; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robin JK, 2003, J TRAUMA, V54, pS149, DOI 10.1097/01.TA.0000064523.93060.60; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Russell JA, 2009, CRIT CARE MED, V37, P811, DOI 10.1097/CCM.0b013e3181961ace; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Yeh CC, 2003, ANESTH ANALG, V97, P577, DOI 10.1213/01.ANE.0000070231.16378.A6	37	9	10	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2013	75	6					1024	1030		10.1097/TA.0b013e3182a99d48			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	300IR	WOS:000330458100021	24256677				2022-02-06	
J	Yadav, NK; Ciuffreda, KJ				Yadav, Naveen K.; Ciuffreda, Kenneth J.			Optimization of the pattern visual evoked potential (VEP) in the visually-normal and mild traumatic brain injury (mTBI) populations	BRAIN INJURY			English	Article						Check size; contrast; mild traumatic brain injury (mTBI); optimization; protocol; VEP amplitude; VEP latency; visual-evoked potential (VEP)	CRITICAL FLICKER FREQUENCY; MULTIPLE-SCLEROSIS; ATTENTION DEFICITS; CHECK SIZES; REVERSAL; CHILDREN; CONCUSSION; STIMULATION; TOPOGRAPHY; DIAGNOSIS	Primary objective: The purpose of this study was to assess the effect of check size (CS) and contrast (C) on VEP amplitude and latency in visually-normal (VN) and in mild traumatic brain injury (mTBI) adults to develop an optimized test protocol in each group. Research design and methods: Subjects were comprised of VN (n = 19) and individuals with mTBI (n = 16). Full-field, pattern VEP testing was employed with three different CSs (10, 20 and 40 min arc) and at two C levels (20 and 85%). Results: There was a significant effect of CS and C on the VEP amplitude and latency in both groups. The 20 min arc CS at both contrast levels produced the largest VEP amplitude, in conjunction with normative latency values, in both populations. There was a significant differential effect of CS and C on VEP responses in the visually symptomatic vs. asymptomatic mTBI sub-groups. A significant correlation was found between time since their most recent brain injury and VEP amplitude for the 20 min arc CS at low contrast. Conclusions: Use of the 20 min arc CS at both contrast levels represents an optimized clinical VEP test protocol in both the VN and mTBI groups. This protocol is rapid, high yield, and targeted for each diagnostic group.	[Yadav, Naveen K.; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Yadav, NK (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	nyadav@sunyopt.edu					Ahmadi H, 2007, OPHTHALMIC GENET, V28, P210, DOI 10.1080/13816810701538554; American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P107; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BIERSDORF WR, 1987, DOC OPHTHALMOL, V66, P313, DOI 10.1007/BF00213659; BODISWOLLNER I, 1979, ANN NEUROL, V5, P40, DOI 10.1002/ana.410050107; CARROLL WM, 1982, NEURO-OPHTHALMOLOGY, V2, P237, DOI 10.3109/01658108209009705; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda KJ, 2013, BRAIN INJURY, V27, P41, DOI 10.3109/02699052.2012.700088; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gottlob I, 1990, J Pediatr Ophthalmol Strabismus, V27, P40; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HAIMOVIC IC, 1982, ELECTROEN CLIN NEURO, V54, P111, DOI 10.1016/0013-4694(82)90153-5; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Kandel ER, 2000, PRINCIPLES NEURAL SC, P523; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KURITATASHIMA S, 1991, ELECTROEN CLIN NEURO, V80, P161, DOI 10.1016/0168-5597(91)90118-H; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LUDLAM WM, 1970, AMER J OPT ARCH AM A, V47, P505; MACKIE RT, 1995, BRIT J OPHTHALMOL, V79, P290, DOI 10.1136/bjo.79.3.290; MATTHEWS WB, 1977, J NEUROL NEUROSUR PS, V40, P1009, DOI 10.1136/jnnp.40.10.1009; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; MEREDITH JT, 1982, ELECTROEN CLIN NEURO, V53, P243, DOI 10.1016/0013-4694(82)90082-7; MICHAEL WF, 1971, BRAIN RES, V32, P311, DOI 10.1016/0006-8993(71)90327-1; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; NOVAK GP, 1988, ELECTROEN CLIN NEURO, V71, P1, DOI 10.1016/0168-5597(88)90013-5; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; ODOM JV, 1984, ACTA OPHTHALMOL, V62, P993; OISHI M, 1985, NEUROLOGY, V35, P1461, DOI 10.1212/WNL.35.10.1461; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; ONOFRJ M, 1993, CLIN VISION SCI, V8, P529; Onofrj Marco, 1995, Brain Topography, V7, P217, DOI 10.1007/BF01202381; Osterberg G, 1935, ACTA OPHTHALMOL, V13, P102; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; PAPATHANASOPOULOS P, 1994, EUR NEUROL, V34, P268, DOI 10.1159/000117054; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; RISTANOVIC D, 1981, ELECTROEN CLIN NEURO, V51, P599, DOI 10.1016/0013-4694(81)90204-2; Schroeder CE, 1995, EEG CL N SU, P55; Schrupp LE, 2009, OPTOMETRY, V80, P642, DOI 10.1016/j.optm.2009.04.097; Simon JW, 2004, J AAPOS, V8, P549, DOI 10.1016/j.jaapos.2004.08.009; SKARF B, 1999, NEUROOPHTHALMOLOGY, P7; SOKOL S, 1983, VISION RES, V23, P723, DOI 10.1016/0042-6989(83)90214-6; Solan Harold A, 2004, Optometry, V75, P640, DOI 10.1016/S1529-1839(04)70211-0; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; TARVER SG, 1974, J LEARN DISABIL, V7, P560, DOI 10.1177/002221947400700906; Thiabault LE, 1990, 34 ANN P ASS ADV AUT, V34, P337; TOBIMATSU S, 2002, INT C SER, V1232, P207, DOI DOI 10.1016/S0531-5131(01)00840-8; TOROK B, 1992, ELECTROEN CLIN NEURO, V84, P13, DOI 10.1016/0168-5597(92)90063-H; TOWLE VL, 1983, INVEST OPHTH VIS SCI, V24, P175; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Willeford KT, 2013, DOC OPHTHALMOL, V126, P105, DOI 10.1007/s10633-012-9363-9; Willeford KT, 2013, DOC OPHTHALMOL, V126, P29, DOI 10.1007/s10633-012-9357-7; Yadav NK, 2012, DOC OPHTHALMOL, V124, P177, DOI 10.1007/s10633-012-9319-0	66	9	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1631	1642		10.3109/02699052.2013.844856			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400019	24111626				2022-02-06	
J	Harvey, J; Hux, K; Scott, N; Snell, J				Harvey, Judy; Hux, Karen; Scott, Nikki; Snell, Jeffry			Text-to-speech technology effects on reading rate and comprehension by adults with traumatic brain injury	BRAIN INJURY			English	Article						Assistive technology; cognitive intervention; reading intervention; traumatic brain injury	COMPUTER SPEECH; INSTRUCTION; REHABILITATION; DISORDERS; BENEFITS; STUDENTS; CHILDREN; SKILLS	Objective: This study's purpose was to examine the comprehension, rate and perceptions and reading preferences of adults with severe traumatic brain injury (TBI) when reading passages with and without computerized text-to-speech (TTS) support. Design and methods: Nine adults with severe TBI read 24 passages in two conditions: with and without TTS support. The researchers compared reading rate and comprehension accuracy across conditions. Also, participants rated their perceived performance and reading preferences via a follow-up questionnaire. Results: Comparison to normative data revealed that all nine participants read slower than average neurotypical readers. As a group, participants read significantly faster with TTS support than without such support, even though the TTS reading rate was roughly comparable to the oral rather than silent reading rate of neurotypical adults. No significant differences in comprehension resulted between the two conditions. Over half of the participants preferred the TTS condition over the no-TTS condition. In general, participants were inaccurate in judging their relative reading rates and comprehension accuracy across conditions. Conclusions: TTS may improve reading efficiency without compromising reading comprehension accuracy for adults with TBI. Given this finding, some survivors may find use of TTS technology contributes to increased participation in and efficiency when performing reading activities.	[Harvey, Judy; Hux, Karen; Scott, Nikki] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA; [Snell, Jeffry] Qual Living, Omaha, NE USA		Harvey, J (corresponding author), Univ Nebraska, Barkley Mem Ctr 276, Lincoln, NE 68583 USA.	harvey.judy@gmail.com	Hux, Karen/AAQ-2078-2020				ABELSON AG, 1983, PERCEPT MOTOR SKILL, V57, P567, DOI 10.2466/pms.1983.57.2.567; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Brown J, 1993, NELSON DENNY READING; Cengage Learning, 2012, STUD RES CTR READ AC; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cook L. G., 2011, SIG 2 PERSPECTIVES N, V21, P33, DOI DOI 10.1044/NNSLD21.1.33; Dawson L, 2000, BEHAV DISORDERS, V25, P105; Elkind J, 1996, ANN DYSLEXIA, V46, P159, DOI 10.1007/BF02648175; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; Goddard Y, 2009, REM SPEC EDUC, V30, P283, DOI 10.1177/0741932508321008; Hale AD, 2005, PSYCHOL SCHOOLS, V42, P39, DOI 10.1002/pits.20027; Hasbrouck J, 2006, READ TEACH, V59, P636, DOI 10.1598/RT.59.7.3; Hecker L, 2002, ANN DYSLEXIA, V52, P243, DOI 10.1007/s11881-002-0015-8; Hiebert EH, 2012, LIT RES INSTR, V51, P110, DOI 10.1080/19388071.2010.531887; Hudac CM, 2012, EYE BRAIN, V4, P1, DOI 10.2147/EB.S27290; LOVETT MW, 1994, BRAIN LANG, V47, P117, DOI 10.1006/brln.1994.1045; Montali J, 1996, J LEARN DISABIL, V29, P271, DOI 10.1177/002221949602900305; Moorman A, 2010, LEARN DISABIL-MULTI, V16, P41; OLSON R, 1986, BEHAV RES METH INSTR, V18, P93, DOI 10.3758/BF03201007; Readability Formulas, 2012, FREE READ CONS CALC; REITSMA P, 1988, READ RES QUART, V23, P219, DOI 10.2307/747803; Russell N, 1993, LANG SPEECH HEAR SER, V24, P67; Schmitt A. J., 2009, J EVIDENCE BASED PRA, V10, P95; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Williams JR, 1998, HUM FAC ERG SOC P, P1447	28	9	9	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1388	1394		10.3109/02699052.2013.823649			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500008	24102239				2022-02-06	
J	Blijdorp, K; Khajeh, L; Ribbers, GM; Sneekes, EM; Heijenbrok-Kal, MH; van den Berg-Emons, HJG; van der Lely, AJ; van Kooten, F; Neggers, SJCMM				Blijdorp, K.; Khajeh, L.; Ribbers, G. M.; Sneekes, E. M.; Heijenbrok-Kal, M. H.; van den Berg-Emons, H. J. G.; van der Lely, A. J.; van Kooten, F.; Neggers, S. J. C. M. M.			Diagnostic value of a ghrelin test for the diagnosis of GH deficiency after subarachnoid hemorrhage	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ANTERIOR-PITUITARY FUNCTION; GROWTH-HORMONE DEFICIENCY; NEUROENDOCRINE DYSFUNCTION; LONG-TERM; HIGH-RISK; ACUTE-PHASE; HYPOPITUITARISM; PREVALENCE; ADULTS	Objective: To determine the diagnostic value of a ghrelin test in the diagnosis of GH deficiency (GHD) shortly after aneurysmal subarachnoid hemorrhage (SAH). Design: Prospective single-center observational cohort study. Methods: A ghrelin test was assessed after the acute phase of SAH and a GH-releasing hormone (GHRH)-arginine test 6 months post SAH. Primary outcome was the diagnostic value of a ghrelin test compared with the GHRH-arginine test in the diagnosis of GHD. The secondary outcome was to assess the safety of the ghrelin test, including patients' comfort, adverse events, and idiosyncratic reactions. Results: Forty-three survivors of SAH were included (15 males, 35%, mean age 56.6 +/- 11.7). Six out of 43 (14%) SAH survivors were diagnosed with GHD by GHRH-arginine test. In GHD subjects, median GH peak during ghrelin test was significantly lower than that of non-GHD subjects (5.4 vs 16.6, P=0.002). Receiver operating characteristics analysis showed an area under the curve of 0.869. A cutoff limit of a GH peak of 15 mu g/l corresponded with a sensitivity of 100% and a false-positive rate of 40%. No adverse events or idiosyncratic reactions were observed in subjects undergoing a ghrelin test, except for one subject who reported flushing shortly after ghrelin infusion. Conclusion: Owing to its convenience, validity, and safety, the ghrelin test might be a valuable GH provocative test, especially in the early phase of SAH.	[Blijdorp, K.; van der Lely, A. J.; Neggers, S. J. C. M. M.] Erasmus Univ, Med Ctr Rotterdam, Dept Med Endocrinol, NL-3000 CA Rotterdam, Netherlands; [Khajeh, L.; van Kooten, F.] Erasmus Univ, Med Ctr Rotterdam, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Ribbers, G. M.; Sneekes, E. M.; Heijenbrok-Kal, M. H.; van den Berg-Emons, H. J. G.] Erasmus Univ, Med Ctr Rotterdam, Dept Rehabil Med, NL-3000 CA Rotterdam, Netherlands; [Heijenbrok-Kal, M. H.] Rijndam Rehabil Ctr, Rotterdam, Netherlands		Khajeh, L (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Neurol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	l.khajeh@erasmusmc.nl	Ribbers, Gerard M/C-1454-2014; Ribbers, Gerard/N-3623-2019	Ribbers, Gerard M/0000-0002-6114-349X; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	PfizerPfizer; Dutch Brain Foundation	This study was financially supported by an unrestricted grant of Pfizer and by the Dutch Brain Foundation.	Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2002, CLIN ENDOCRINOL, V56, P765, DOI 10.1046/j.1365-2265.2002.01547.x; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Gasco V, 2013, EUR J ENDOCRINOL, V168, P23, DOI 10.1530/EJE-12-0584; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Ghigo E, 1997, J CLIN ENDOCR METAB, V82, P2439, DOI 10.1210/jc.82.8.2439; Ghigo E, 1998, BAILLIERE CLIN ENDOC, V12, P341, DOI 10.1016/S0950-351X(98)80027-X; Hataya Y, 2001, J CLIN ENDOCR METAB, V86, P4552, DOI 10.1210/jc.86.9.4552; Health BNIo. NIohN National Heart Lung and Blood Institute (NHBLI), NIH PUBL; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; KHOSLA T, 1967, BRIT J PREV SOC MED, V21, P122; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2008, EXP CLIN ENDOCR DIAB, V116, P276, DOI 10.1055/s-2007-1004552; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; LEALCERRO A, 1995, EUR J ENDOCRINOL, V132, P712, DOI 10.1530/eje.0.1320712; Nieuwkamp DJ, 2013, INT J STROK IN PRESS, DOI [10.1111/j.1747-4949.2012.00875.x, DOI 10.1111/J.1747-4949.2012.00875.X)]; Peino R, 2000, EUR J ENDOCRINOL, V143, pR11, DOI 10.1530/eje.0.143R011; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029	32	9	9	0	5	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643			EUR J ENDOCRINOL	Eur. J. Endocrinol.	OCT	2013	169	4					497	502		10.1530/EJE-13-0436			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	228RD	WOS:000325204000017	24037787	Green Published, Green Submitted, hybrid			2022-02-06	
J	Schwartz, JA; Beaver, KM				Schwartz, Joseph A.; Beaver, Kevin M.			Serious Fighting-Related Injuries Produce a Significant Reduction in Intelligence	JOURNAL OF ADOLESCENT HEALTH			English	Article						Fighting; Injury; Intelligence; Longitudinal; Adolescence	TRAUMATIC BRAIN-INJURY; VIOLENT VICTIMIZATION; SUBSTANCE USE; MENTAL-HEALTH; IQ; CONCUSSION; CHILDREN; COHORT; YOUTH	Purpose: Fighting-related injuries are common among adolescents within the United States, but how such injuries relate to subsequent cognitive functioning remains unclear. In particular, the long-term effect of fighting-related injuries suffered during important developmental periods, such as adolescence, on subsequent cognitive functioning has been overlooked by previous studies. The purpose of this study is to examine the association between sustaining serious fighting-related injuries and changes in verbal intelligence (IQ) over a 5- to 6-year time period. Methods: Longitudinal multivariate statistical models were used to analyze data from the National Longitudinal Study of Adolescent Health collected between 1994 and 2002 and analyzed in 2013. Results: Even a single fighting-related injury resulted in a significant reduction in IQ over time even after controlling for age, race, sex, and changes in socioeconomic status (SES) over the study period. Additionally, females experienced a significantly greater reduction in IQ from each fighting-related injury than males. Conclusions: Fighting-related injuries have a significant impact on subsequent cognitive functioning and intelligence. The implications for future policies and research are discussed in more detail. (C) 2013 Society for Adolescent Health and Medicine. All rights reserved.	[Schwartz, Joseph A.; Beaver, Kevin M.] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA; [Beaver, Kevin M.] King Abdulaziz Univ, Ctr Social & Humanities Res, Jeddah 21413, Saudi Arabia		Schwartz, JA (corresponding author), Florida State Univ, Coll Criminol & Criminal Justice, 634 W Call St, Tallahassee, FL 32306 USA.	jas10t@my.fsu.edu	Beaver, Kevin M./B-4631-2013		Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD031921] Funding Source: NIH RePORTER	The authors wish to thank the anonymous reviewers for their insightful comments and suggestions. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due to Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health Web site (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis.	Allison P. D., 1990, SOCIOLOGICAL METHODO, V20, P93, DOI [10.2307/271083, DOI 10.2307/271083]; Biebl SJW, 2011, J PEDIATR PSYCHOL, V36, P868, DOI 10.1093/jpepsy/jsr025; BONEYMCCOY S, 1995, J CONSULT CLIN PSYCH, V63, P726, DOI 10.1037/0022-006X.63.5.726; Catalano S.M., 2004, CRIMINAL VICTIMIZATI; Christiansen EJ, 2005, J EARLY ADOLESCENCE, V25, P298, DOI 10.1177/0272431605276931; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; DeLisi M, 2011, J CRIM JUST, V39, P289, DOI 10.1016/j.jcrimjus.2011.05.001; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Doherty EE, 2012, ADDICTION, V107, P339, DOI 10.1111/j.1360-0443.2011.03665.x; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; ESBENSEN FA, 1991, YOUTH SOC, V23, P202, DOI 10.1177/0044118X91023002003; Finkelhor D, 2009, PEDIATRICS, V124, P1411, DOI 10.1542/peds.2009-0467; Foer F, 2009, B OBAMA IS NOT PLEAS; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris K.M., 2003, NATL LONGITUDINAL ST; Hashima PY, 1999, J INTERPERS VIOLENCE, V14, P799, DOI 10.1177/088626099014008002; Jennings WG, 2012, AGGRESS VIOLENT BEH, V17, P16, DOI 10.1016/j.avb.2011.09.003; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Lopez B, 2008, J PRIM PREV, V29, P5, DOI 10.1007/s10935-007-0119-3; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Menard S., 2002, YOUTH VIOLENCE RES B; Miller G, 2009, SCIENCE, V325, P670, DOI 10.1126/science.325_670; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Polito MZ, 2010, J AM ACAD NURSE PRAC, V22, P504, DOI 10.1111/j.1745-7599.2010.00540.x; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rowe DC, 1999, CHILD DEV, V70, P1151, DOI 10.1111/1467-8624.00084; Sampson RJ, 2008, P NATL ACAD SCI USA, V105, P845, DOI 10.1073/pnas.0710189104; Schwartz JA, 2013, J NEURAL TRANSM, V120, P477, DOI 10.1007/s00702-012-0881-0; Sell A, 2012, HUM NATURE-INT BIOS, V23, P30, DOI 10.1007/s12110-012-9131-2; Swahn MH, 2012, INT J PUBLIC HEALTH, V57, P95, DOI 10.1007/s00038-011-0255-7; Taris T.W., 2000, PRIMER LONGITUDINAL; Turner HA, 2006, SOC SCI MED, V62, P13, DOI 10.1016/j.socscimed.2005.05.030; Udry J.R., 2003, NATL LONGITUDINAL ST; Vaughn MG, 2010, ANN EPIDEMIOL, V20, P281, DOI 10.1016/j.annepidem.2009.11.011; Wall SE, 2010, J NEUROL NEUROSUR PS, V77, P518; Whalley LJ, 2001, BRIT MED J, V322, P1, DOI DOI 10.1136/BMJ.322.7290.819	39	9	9	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	OCT	2013	53	4					520	525		10.1016/j.jadohealth.2013.06.007			6	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	221WA	WOS:000324689500016	23890775				2022-02-06	
J	De Beaumont, L; Fiocco, AJ; Quesnel, G; Lupien, S; Poirier, J				De Beaumont, Louis; Fiocco, Alexandra J.; Quesnel, Genevieve; Lupien, Sonia; Poirier, Judes			Altered declarative memory in introverted middle-aged adults carrying the BDNF val66met allele	BEHAVIOURAL BRAIN RESEARCH			English	Article						BDNF val66met; Extraversion; Introversion; Declarative memory; Cognitive decline; Ageing; Behavioural neuroscience	DEPENDENT SYNAPTIC PLASTICITY; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; HPA-AXIS REACTIVITY; VAL(66)MET POLYMORPHISM; ALZHEIMER-DISEASE; STRESS; PERSONALITY; GENE; HIPPOCAMPUS	Background: The val66met polymorphism of the brain-derived neurotrophic factor gene (BDNFMet) is associated with impaired learning/memory function, affective dysregulation and maladaptive personality traits. Here, we examine the potential relationship between the BDNFMet allele, introversion and declarative memory in middle-age adults. Methods: A total of 132 middle-aged healthy adults took part in this study that included taking a blood sample for genetic profiling, a short battery of neuropsychological tests and the NEO-Five Factor Inventory (NEO-FFI), widely used to assess the Big Five personality. Results: Controlling for age, level of education and sex, a multiple analysis of covariance (MANCOVA) computing the effect of BDNF polymorphism on extraversion and declarative memory revealed a significant association (D-1,D-128 = 4.79; p = 0.03; eta(2)(p) = 0.053). Using the Sobel Goodman Mediation Test, it was found that 25.61% of the relationship between genotype and declarative memory performance was mediated by introversion. Subsequent correlational analyses yielded a strong and significant correlation (beta = 0.53; p < 0.001) between introversion and declarative memory specific to BDNFMet individuals. Conclusion: this study highlights the pertinence of further investigating gene x personality x environment interactions to account for the significant variability that is observed in cognitive function in late life. (C) 2013 Elsevier B.V. All rights reserved.	[De Beaumont, Louis; Quesnel, Genevieve] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ G9A 5H7, Canada; [De Beaumont, Louis] Montreal Sacred Heart Hosp, Res Ctr, Montreal, PQ, Canada; [Fiocco, Alexandra J.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Lupien, Sonia] Louis H Lafontaine Hosp, Mental Hlth Res Ctr Fernand Seguin, Ctr Studies Human Stress, Montreal, PQ, Canada; [Poirier, Judes] Douglas Mental Hlth Univ Inst, Verdun, PQ, Canada		De Beaumont, L (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Michel Sarrazin Hall,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	louis.debeaumont@uqtr.ca		Fiocco, Alexandra/0000-0002-9353-476X	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds le la Recherche en Sante du Quebec	We wish to thank Louise Theroux and Doris Dea for their technical skill in the determination of the BDNF polymorphisms. This work was supported by the Canadian Institute of Health Research (L.D.B., J.P, S.L., A.J.F.) and the Fonds le la Recherche en Sante du Quebec (J.P.).	Alexander N, 2010, PSYCHONEUROENDOCRINO, V35, P949, DOI 10.1016/j.psyneuen.2009.12.008; Amrhein PC, 1999, J GEN PSYCHOL, V126, P149, DOI 10.1080/00221309909595358; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Casey BJ, 2009, NEUROSCIENCE, V164, P108, DOI 10.1016/j.neuroscience.2009.03.081; CASTORINA M, 1994, NEUROCHEM RES, V19, P795, DOI 10.1007/BF00967446; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Colzato LS, 2011, PSYCHONEUROENDOCRINO, V36, P1562, DOI 10.1016/j.psyneuen.2011.04.010; CONLEY JJ, 1985, J PERS SOC PSYCHOL, V49, P1266, DOI 10.1037/0022-3514.49.5.1266; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Costa P. T., 1992, REVISED NEO PERSONAL; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Crowe M, 2006, PSYCHOL AGING, V21, P573, DOI 10.1037/0882-7974.21.3.573; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fiocco AJ, 2009, NEUROBIOL AGING, V30, P1001, DOI 10.1016/j.neurobiolaging.2007.09.008; Fiocco AJ, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/003.2007, 10.3389/neuro.08.003.2007]; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; LEZAK MD, 1995, NEUROPSYCHYOLOGICAL; Matthews G, 1992, EXTRAVERSION VOL STA; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Pruessner JC, 2004, ANN NY ACAD SCI, V1032, P186, DOI 10.1196/annals.1314.017; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Shalev I, 2009, PSYCHONEUROENDOCRINO, V34, P382, DOI 10.1016/j.psyneuen.2008.09.017; Small BJ, 2003, J GERONTOL B-PSYCHOL, V58, pP166, DOI 10.1093/geronb/58.3.P166; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Terracciano A, 2010, NEUROPSYCHOPHARMACOL, V35, P1083, DOI 10.1038/npp.2009.213; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Yamagata S, 2006, J PERS SOC PSYCHOL, V90, P987, DOI 10.1037/0022-3514.90.6.987	37	9	9	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	SEP 15	2013	253						152	156		10.1016/j.bbr.2013.07.002			5	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	222GZ	WOS:000324720500020	23835043				2022-02-06	
J	Garner, AA; Fearnside, M; Gebski, V				Garner, Alan A.; Fearnside, Michael; Gebski, Val			The study protocol for the Head Injury Retrieval Trial (HIRT): a single centre randomised controlled trial of physician prehospital management of severe blunt head injury compared with management by paramedics	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Brain injury; Prehospital; Physician; Paramedic; Intubation	EMERGENCY CARE; IMPACT; TEAM	Background: The utility of advanced prehospital interventions for severe blunt traumatic brain injury (BTI) remains controversial. Of all trauma patient subgroups it has been anticipated that this patient group would most benefit from advanced prehospital interventions as hypoxia and hypotension have been demonstrated to be associated with poor outcomes and these factors may be amenable to prehospital intervention. Supporting evidence is largely lacking however. In particular the efficacy of early anaesthesia/muscle relaxant assisted intubation has proved difficult to substantiate. Methods: This article describes the design and protocol of the Head Injury Retrieval Trial (HIRT) which is a randomised controlled single centre trial of physician prehospital care (delivering advanced interventions such as rapid sequence intubation and blood transfusion) in addition to paramedic care for severe blunt TBI compared with paramedic care alone. Results: Primary endpoint is Glasgow Outcome Scale score at six months post injury. Issues with trial integrity resulting from drop ins from standard care to the treatment arm as the result of policy changes by the local ambulance system are discussed. Conclusion: This randomised controlled trial will contribute to the evaluation of the efficacy of advance prehospital interventions in severe blunt TBI. Trial Registration: ClinicalTrials.gov:NCT00112398	[Garner, Alan A.] CareFlight Ltd, Westmead, NSW, Australia; [Fearnside, Michael] Westmead Hosp, Sydney, NSW, Australia; [Gebski, Val] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia		Garner, AA (corresponding author), CareFlight Ltd, Westmead, NSW, Australia.	alang@careflight.org	Garner, Alan/AAN-1513-2020	Garner, Alan/0000-0002-4010-9137; Gebski, Val/0000-0001-8748-1844			Bartolacci RA, 1998, MED J AUSTRALIA, V169, P612, DOI 10.5694/j.1326-5377.1998.tb123435.x; BAXT WG, 1987, JAMA-J AM MED ASSOC, V257, P3246, DOI 10.1001/jama.257.23.3246; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Celli P, 1997, Minerva Chir, V52, P1467; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Dybkowska K, 1998, Przegl Lek, V55, P650; Garner A, 1999, AUST NZ J SURG, V69, P697, DOI 10.1046/j.1440-1622.1999.01688.x; Garner A, 2001, INJURY, V32, P455, DOI 10.1016/S0020-1383(01)00013-4; Garner AA, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-82; JENNETT B, 1975, LANCET, V1, P480; Marshall LF, 1987, NEUROBEHAVIORAL RECO, P206; National Health and Medical Research Council Australian Research Council & Australian Vice-Chancellors' Committee, 2007, NAT STA TETH COND HU; Oppe S, 2001, ACCIDENT ANAL PREV, V33, P129, DOI 10.1016/S0001-4575(00)00023-3; SINGBARTL G, 1985, ANASTH INTENSIV NOTF, V20, P251, DOI 10.1055/s-2007-1003119; Soon PSH, 1999, AUST N Z J SURG, V69, pA88; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	17	9	9	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	SEP 14	2013	21								69	10.1186/1757-7241-21-69			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	217UT	WOS:000324388200001	24034628	Green Published, gold			2022-02-06	
J	Domachevsky, L; Rachmany, L; Barak, Y; Rubovitch, V; Abramovich, A; Pick, CG				Domachevsky, L.; Rachmany, L.; Barak, Y.; Rubovitch, V.; Abramovich, A.; Pick, C. G.			HYPERBARIC OXYGEN-INDUCED SEIZURES CAUSE A TRANSIENT DECREMENT IN COGNITIVE FUNCTION	NEUROSCIENCE			English	Article						behavioral tests; convulsions; neurologic damage; oxygen toxicity	TRAUMATIC BRAIN-INJURY; OBJECT RECOGNITION; MICE; EPILEPSY; DEFICITS; MEMORY	Hyperbaric oxygen-induced seizures are classified as brief, generalized tonic-clonic seizures. They are believed to cause no residual cognitive damage, although this has not been investigated in depth. In the present study, we examined whether hyperbaric oxygen-induced seizures cause impairment of behavioral and cognitive abilities. Cognitive status was assessed using four behavioral tests: Y-maze, novel object recognition, the elevated plus maze, and a passive avoidance task. Three time intervals were examined: 24 h, and 7 and 30 days after the seizures. We found transient impairment of performance in the compressed group on three tests (the novel object recognition paradigm, the Y-maze paradigm, and the passive avoidance task). On the elevated plus maze test, the impairment persisted. The time interval to the appearance of deficits and to eventual recovery was not the same for the different tests. We conclude that hyperbaric oxygen-induced seizures result in transient impairment of performance on behavioral tests in a mouse model. Further investigation is required to establish the mechanism and location of injury, and to determine whether the performance decrement on the elevated plus maze test represents permanent damage or transient damage with slow resolution. These new findings should be taken into account when planning hyperbaric oxygen treatments, to ensure that the chosen protocol is therapeutic yet minimizes the risk of CNS oxygen toxicity. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Domachevsky, L.; Abramovich, A.] IDF Med Corps, Israel Naval Med Inst, IL-3109601 Haifa, Israel; [Rachmany, L.; Barak, Y.; Rubovitch, V.; Pick, C. G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Pick, C. G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel		Domachevsky, L (corresponding author), IDF Med Corps, Israel Naval Med Inst, Box 89,Rambam Hlth Care Campus,POB 9602, IL-3109601 Haifa, Israel.	liranura@gmail.com	Pick, Chaim/D-4789-2009		Israel Defense Forces Medical Corps [4440162662]	This study was supported by research Grant No. 4440162662 from the Israel Defense Forces Medical Corps. The authors thank Mr. R. Lincoln for skillful editing of the manuscript. The opinions and assertions contained herein are the private ones of the authors, and are not to be construed as official or as reflecting the views of the Israel Naval Medical Institute.	Aikia M, 1999, EPILEPSIA, V40, P100; Alcalay RN, 2004, NEUROSCI LETT, V361, P128, DOI 10.1016/j.neulet.2003.12.005; Bert P., 1978, BAROMETRIC PRESSURE; BUTLER FK, 1986, UNDERSEA BIOMED RES, V13, P193; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute to Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dodrill CB, 2002, PROG BRAIN RES, V135, P399; DODRILL CB, 1992, EPILEPSIA, V33, P327, DOI 10.1111/j.1528-1157.1992.tb02323.x; Dodrill CB, 2004, EPILEPSY BEHAV, V5, pS21, DOI 10.1016/j.yebeh.2003.11.004; Donald K., 1992, OXYGEN DIVER; DONALD KW, 1947, BRIT MED J, V1, P712, DOI 10.1136/bmj.1.4507.712; Gesell LB, HYPERBARIC OXYGEN TH; GUNDLACH AL, 1995, BRAIN RES, V672, P214, DOI 10.1016/0006-8993(94)01338-I; HOROWITZ SW, 1992, J COMPUT ASSIST TOMO, V16, P814, DOI 10.1097/00004728-199209000-00025; Janigro D, 1999, EPILEPSY RES, V37, P223, DOI 10.1016/S0920-1211(99)00074-1; Kotloski R, 2002, PROG BRAIN RES, V135, P95; LAMBERTSEN CHRISTIAN J., 1965, HANDBOOK PHYSIOL, V2, P1027; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Wall CJ, 2000, AM J NEURORADIOL, V21, P1841; Yarbrough OD, 1947, 0147 NAV EXP DIV UN; Zhang LX, 1998, MOL BRAIN RES, V55, P198, DOI 10.1016/S0169-328X(97)00316-1; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	26	9	10	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 5	2013	247						328	334		10.1016/j.neuroscience.2013.05.052			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298OX	WOS:000330335100032	23732232				2022-02-06	
J	Chen, YC; Tseng, TC; Hung, TH; Hsieh, CC; Chen, FC; Stoffregen, TA				Chen, Yi-Chou; Tseng, Tzu-Chiang; Hung, Ting-Hsuan; Hsieh, City C.; Chen, Fu-Chen; Stoffregen, Thomas A.			Cognitive and postural precursors of motion sickness in adolescent boxers	GAIT & POSTURE			English	Article						Athletics; Posture; Cognitive performance; Motion sickness	STANCE WIDTH; SWAY; PERFORMANCE; CONCUSSION; STABILITY; TASK	Athletic head trauma (both concussive and sub-concussive) is common among adolescents. Concussion typically is followed by motion sickness-like symptoms, by changes in cognitive performance, and by changes in standing body sway. We asked whether pre-bout body sway would differ between adolescent boxers who experienced post-bout motion sickness and those who did not. In addition, we asked whether pre-bout cognitive performance would differ as a function of adolescent boxers' post-bout motion sickness. Nine of nineteen adolescent boxers reported motion sickness after a bout. Pre-bout measures of cognitive performance and body sway differed between boxers who reported post-bout motion sickness and those who did not. The results suggest that susceptibility to motion sickness-like symptoms in adolescent boxers may be manifested in characteristic patterns of body sway and cognitive performance. It may be possible to use pre-bout data to predict susceptibility to post-bout symptoms. (c) 2013 Elsevier B.V. All rights reserved.	[Chen, Yi-Chou; Stoffregen, Thomas A.] Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA; [Tseng, Tzu-Chiang] Chinese Cultural Univ, Grad Inst Sport Coaching Sci, Taipei, Taiwan; [Hung, Ting-Hsuan] Edgewood Coll, Off Inst Res, Madison, WI USA; [Hsieh, City C.] YuanPei Univ, Coll Well Being, Hsinchu, Taiwan; [Chen, Fu-Chen] Natl Pingtung Univ Sci & Technol, Dept Recreat Sport & Hlth Promot, Pingtung, Taiwan		Stoffregen, TA (corresponding author), Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA.	tas@umn.edu	Stoffregen, Thomas/ABC-8710-2021				Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chang CH, 2012, EXP BRAIN RES, V217, P299, DOI 10.1007/s00221-011-2993-4; Chen FC, 2011, RES DEV DISABIL, V32, P1948, DOI 10.1016/j.ridd.2011.03.027; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046136; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Koslucher F, 2012, GAIT POSTURE, V36, P605, DOI 10.1016/j.gaitpost.2012.05.027; Kotz C, 1998, BOXING EVERYONE GET; Lam LT, 2006, J PEDIAT, V142, P546; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Moriarity J. M., 2012, BRIT J SPORTS MED; Ohhashi G, 2002, BRIT J SPORT MED, V36, P346, DOI 10.1136/bjsm.36.5.346; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Stoffregen TA, 2000, HUM MOVEMENT SCI, V19, P203, DOI 10.1016/S0167-9457(00)00009-9; Stoffregen TA., 2011, SCI MOTRICITE, V74, P19, DOI [DOI 10.1051/SM/2011111, 10.1051/sm/2011111]; Stoffregen TA, 2007, J MOTOR BEHAV, V39, P126, DOI 10.3200/JMBR.39.2.126-138; Stoffregen TA, 2010, ECOL PSYCHOL, V22, P169, DOI 10.1080/10407413.2010.496645; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yu YW, 2013, GAIT POSTURE, V37, P103, DOI 10.1016/j.gaitpost.2012.06.021	26	9	9	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	SEP	2013	38	4					795	799		10.1016/j.gaitpost.2013.03.023			5	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	231MV	WOS:000325421900042	23680426				2022-02-06	
J	Wang, K; Liu, ZY; Chen, XZ; Lou, MQ; Yin, J				Wang, Ke; Liu, Zhiyu; Chen, Xianzhen; Lou, Meiqing; Yin, Jia			Clinical Characteristics and Outcomes of Patients with Cerebral Herniation During Continuous Lumbar Drainage	TURKISH NEUROSURGERY			English	Article						Cerebral herniation; Transtentorial herniation; Lumbar drainage; Lumbar puncture; Decompressive craniectomy	CEREBROSPINAL-FLUID FISTULA; PARADOXICAL TRANSTENTORIAL HERNIATION; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE; PUNCTURE; COMPLICATIONS; SAFETY	AIM: The aim of this study was to investigate the clinical characteristics and outcomes of patients who developed cerebral herniation after continuous lumbar cerebrospinal fluid (CSF) drainage. MATERIAL and METHODS: We retrospectively reviewed eight patients who developed cerebral herniation after receiving continuous lumbar drainage between January 2009 and March 2012 in our department. RESULTS: All eight patients were male, aged from 21 to 66 years old. All eight patients received surgical treatment and exhibited impaired consciousness before lumbar drainage, and five (62.5%) also underwent decompressive craniectomy. The average drainage speed in these patients varied from 8.3 mL/h to 20.0 mL/h, demonstrating an inverse correlation with the latency period of brain herniation after initiation of the drainage (p=0.017). Four (50.0%) patients experienced cardiopulmonary instability at the onset of cerebral herniation, requiring immediate resuscitation. After drainage clamping and supportive treatment, seven (87.5%) patients displayed complete reversal of cerebral herniation within 48 h. CONCLUSION: Cerebral herniation induced by continuous lumbar drainage is mostly reversible if early identification and prompt management are realized. Faster drainage speed may be associated with earlier occurrence of brain herniation during lumbar drainage.	[Wang, Ke; Liu, Zhiyu; Chen, Xianzhen; Lou, Meiqing; Yin, Jia] Shanghai Tenth Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China		Yin, J (corresponding author), Shanghai Tenth Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China.	trizzt@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201708]	This study is funded by the National Natural Science Foundation of China (No. 81201708).	Acikbas SC, 2002, ACTA NEUROCHIR, V144, P475, DOI 10.1007/s007010200068; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Bloch J, 2003, J NEUROL NEUROSUR PS, V74, P992, DOI 10.1136/jnnp.74.7.992; Dalgic A, 2008, MINIM INVAS NEUROSUR, V51, P154, DOI 10.1055/s-2008-1042437; Fields JD, 2006, NEUROLOGY, V67, P1513, DOI 10.1212/01.wnl.0000242889.02957.b6; GOWER DJ, 1987, J NEUROL NEUROSUR PS, V50, P1071, DOI 10.1136/jnnp.50.8.1071; GRAF CJ, 1981, J NEUROSURG, V54, P392, DOI 10.3171/jns.1981.54.3.0392; Jung HJ, 2012, J KOREAN NEUROSURG S, V51, P102, DOI 10.3340/jkns.2012.51.2.102; Kapadia FN, 1996, BRIT J NEUROSURG, V10, P585; Klimo P, 2004, J NEUROSURG, V100, P215, DOI 10.3171/jns.2004.100.2.0215; Lenfeldt N, 2007, NEUROLOGY, V68, P155, DOI 10.1212/01.wnl.0000250270.54587.71; Oyelese AA, 2005, NEUROSURGERY, V57, P594, DOI 10.1227/01.NEU.0000170437.79760DF; Saito K, 2009, NEUROL MED-CHIR, V49, P252, DOI 10.2176/nmc.49.252; SHAPIRO SA, 1992, NEUROSURGERY, V30, P241, DOI 10.1227/00006123-199202000-00015; Sharp C G, 1987, Pediatr Emerg Care, V3, P39, DOI 10.1097/00006565-198703000-00012; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293	17	9	10	0	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	SEP	2013	23	5					653	657		10.5137/1019-5149.JTN.7954-13.0			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	260DN	WOS:000327575300012	24101314				2022-02-06	
J	Miscusi, M; Arangio, P; De Martino, L; De-Giorgio, F; Cascone, P; Raco, A				Miscusi, Massimo; Arangio, Paolo; De Martino, Luca; De-Giorgio, Fabio; Cascone, Piero; Raco, Antonino			An unusual case of orbito-frontal rod fence stab injury with a good outcome	BMC SURGERY			English	Article						Rod; Penetrating head injury; Orbital trauma; Cranial reconstruction	BRAIN; MANAGEMENT; WOUNDS	Background: High-energy non-missile penetrating injuries (stab injuries) account for a small percentage of penetrating head injuries and they present a series of special features. Case presentation: A 35-year-old man suffered orbito-frontal? and trans-cranial injuries after falling five meters from a terrace onto a rod iron fence. The removal of the metal rod was performed outside the operating room. The orbital roof was exposed and repaired through a bifrontal craniotomy and the frontal sinuses were cranialised. The orbital floor and zygoma were plated with micro-screws. Conclusion: The patient recovered without significant complications, apart from a slight paresis of the right superior rectus; the ocular globe remained intact. The positive outcome obtained in this very challenging case is attributable to the competency of the Neurotrauma Unit and to the use of a synergistic approach which involved the contribution of neurosurgeons, maxillo-facial surgeons, radiologists and anaesthesiologists.	[Miscusi, Massimo; Arangio, Paolo] Dept Med & Surg Sci & Biotechnol, Rome, Italy; [De Martino, Luca; Raco, Antonino] NESMOS Dept, Rome, Italy; [De-Giorgio, Fabio] Univ Cattolica Sacro Cuore, Inst Med Legale, I-00168 Rome, Italy; [Cascone, Piero] Univ Roma La Sapienza, Dept Odontostomatol & Maxillofacial Sci, I-00185 Rome, Italy		De-Giorgio, F (corresponding author), Univ Cattolica Sacro Cuore, Inst Med Legale, I-00168 Rome, Italy.	fabio.degiorgio@rm.unicatt.it	De Giorgio, Fabio/AAB-7163-2022; Miscusi, Massimo/AAQ-6203-2020	Miscusi, Massimo/0000-0002-5101-9073; De Giorgio, Fabio/0000-0001-7433-0924			Bozzeto-Ambrosi P, 2008, ARQ NEURO-PSIQUIAT, V66, P93, DOI 10.1590/S0004-282X2008000100024; Bruyn, 1975, HDB CLIN NEUROLOGY, P477; Chibbaro S, 2006, ACTA NEUROCHIR, V148, P937, DOI 10.1007/s00701-006-0794-5; de Villiers J C, 1975, J Neurol Neurosurg Psychiatry, V38, P822, DOI 10.1136/jnnp.38.8.822-a; Di Roio C, 2000, CHILD NERV SYST, V16, P503, DOI 10.1007/s003810000291; Domenicucci M, 1999, J Neurosurg Sci, V43, P229; DOOLING JA, 1967, J NEUROSURG, V26, P636, DOI 10.3171/jns.1967.26.6.0636; Gulati Aakshay, 2010, Ann R Coll Surg Engl, V92, pW41, DOI 10.1308/147870810X12699662981672; Iwakura M, 2005, NEUROL MED-CHIR, V45, P172, DOI 10.2176/nmc.45.172; Karim Tanweer, 2010, J Emerg Trauma Shock, V3, P197, DOI 10.4103/0974-2700.62113; KHALIL N, 1991, SURG NEUROL, V35, P294, DOI 10.1016/0090-3019(91)90008-W; Kim SW, 2012, J CRANIOFAC SURG, V23, pE140, DOI 10.1097/SCS.0b013e31824cdc2b; Lindenberg R, 1971, PATHOLOGY NERVOUS SY, V2, P1721; MARKHAM JW, 1964, J NEUROSURG, V21, P1095, DOI 10.3171/jns.1964.21.12.1095; Mason F, 1870, LANCET, V1, P700; Mitilian D, 2009, ACTA NEUROCHIR, V151, P1295, DOI 10.1007/s00701-009-0418-y; Okunaga Tomohiro, 2010, No Shinkei Geka, V38, P293; Pascual JM, 2009, ACTA NEUROCHIR, V151, P689, DOI 10.1007/s00701-009-0222-8; Penfield W, 1928, ARCH NEURO PSYCHIATR, V20, P1; Pilcher C, 1936, ANN SURG, V103, P173, DOI 10.1097/00000658-193602000-00003; REGEV E, 1990, INJURY, V21, P414, DOI 10.1016/0020-1383(90)90138-K; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; STONE JL, 1981, SURG NEUROL, V15, P369, DOI 10.1016/0090-3019(81)90173-7; VILLIERS JCD, 1975, BRIT J OPHTHALMOL, V59, P52, DOI 10.1136/bjo.59.1.52	24	9	9	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2482			BMC SURG	BMC Surg.	AUG 13	2013	13								31	10.1186/1471-2482-13-31			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	207BB	WOS:000323570400001	23941677	gold, Green Published			2022-02-06	
J	Kiss, P; Szabadfi, K; Horvath, G; Tamas, A; Farkas, J; Gabriel, R; Reglodi, D				Kiss, Peter; Szabadfi, Krisztina; Horvath, Gabor; Tamas, Andrea; Farkas, Jozsef; Gabriel, Robert; Reglodi, Dora			Gender-Dependent Effects of Enriched Environment and Social Isolation in Ischemic Retinal Lesion in Adult Rats	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						retina; BCCAO; enriched environment; social isolation; gender	SEX-DIFFERENCES; CHRONIC STRESS; GROWTH-FACTOR; BRAIN-INJURY; FEMALE RATS; PLASTICITY; RECOVERY; EXPOSURE; DAMAGE; AGE	Exposure to an enriched environment has been shown to have many positive effects on brain structure and function. Numerous studies have proven that enriched environment can reduce the lesion induced by toxic and traumatic injuries. Impoverished environment, on the other hand, can have deleterious effects on the outcome of neuronal injuries. We have previously shown that enriched conditions have protective effects in retinal injury in newborn rats. It is well-known that the efficacy of neuroprotective strategies can depend on age and gender. The aim of the present study, therefore, was to examine the effects of environmental enrichment and social isolation in retinal ischemia. We used bilateral common carotid artery occlusion to induce retinal hypoperfusion in adult Wistar rats of both genders. Groups were housed in standard, enriched or impoverished conditions. Impoverished environment was induced by social isolation. Retinas were processed for histological analysis after two weeks of survival. In the present study, we show that (1) enriched environment has protective effects in adult ischemic retinal lesion, while (2) impoverished environment further increases the degree of ischemic injury, and (3) that these environmental effects are gender-dependent: females are less responsive to the positive effects of environmental enrichment and more vulnerable to retinal ischemia in social isolation. In summary, our present study shows that the effects of both positive and negative environmental stimuli are gender-dependent in ischemic retinal lesions.	[Kiss, Peter; Horvath, Gabor; Tamas, Andrea; Farkas, Jozsef; Reglodi, Dora] Univ Pecs, PTE MTA Lendulet PACAP Res Team, Dept Anat, H-7624 Pecs, Hungary; [Szabadfi, Krisztina; Gabriel, Robert] Univ Pecs, Dept Expt Zool & Neurobiol, H-7624 Pecs, Hungary; [Gabriel, Robert] Univ Pecs, Janos Szentagothai Res Ctr, H-7624 Pecs, Hungary		Reglodi, D (corresponding author), Univ Pecs, PTE MTA Lendulet PACAP Res Team, Dept Anat, H-7624 Pecs, Hungary.	peter.kiss@aok.pte.hu; kriszta.szabadfi@gmail.com; gabor.horvath@aok.pte.hu; andreatamassz@gmail.com; jozsef.farkas@aok.pte.hu; gabriel@ttk.pte.hu; dora.reglodi@aok.pte.hu			OTKAOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K104984, 100144, PD109644]; TAMOP [4.2.1.B-10/2/KONV-2010-002, 4.2.2.B-10/1-2010-0029, 4.2.2.A-11/1/KONV-2012-0024]; Arimura Foundation; PTE-MTA; Bolyai ScholarshipHungarian Academy of Sciences; University of Pecs; Richter Gedeon Centenary Foundation [4.2.4.A/2-11-1-2012-0001]	This study was supported by OTKA K104984, 100144, PD109644, TAMOP (4.2.1.B-10/2/KONV-2010-002, 4.2.2.B-10/1-2010-0029, 4.2.2.A-11/1/KONV-2012-0024), Arimura Foundation, PTE-MTA "Lendulet" Program, Bolyai Scholarship, University of Pecs Research Grant AOK-KA 2013, Richter Gedeon Centenary Foundation, 4.2.4.A/2-11-1-2012-0001 National Excellence Program.	Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Arranza L, 2011, J ALZHEIMERS DIS, V25, P727, DOI 10.3233/JAD-2011-110236; Atlasz T, 2007, NEUROTOX RES, V12, P105, DOI 10.1007/BF03033919; Barone H., 2012, PLOS ONE, V11; Bishnoi M, 2011, NEUROTOX RES, V20, P215, DOI 10.1007/s12640-010-9229-4; BROWN KJ, 1995, PHYSIOL BEHAV, V58, P1085, DOI 10.1016/0031-9384(95)02043-8; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Chourbaji S, 2012, NEUROSCIENCE, V220, P267, DOI 10.1016/j.neuroscience.2012.06.016; Dorfman D, 2013, EXP NEUROL, V240, P146, DOI 10.1016/j.expneurol.2012.11.017; Fabricius K, 2011, INT J DEV NEUROSCI, V29, P347, DOI 10.1016/j.ijdevneu.2010.09.003; Farrell R, 2001, NEUROSCIENCE, V107, P585, DOI 10.1016/S0306-4522(01)00386-4; del Barco DG, 2011, NEUROTOX RES, V19, P195, DOI 10.1007/s12640-010-9160-8; Hong SZ, 2012, PHYSIOL BEHAV, V105, P269, DOI 10.1016/j.physbeh.2011.08.036; Jain V., 2013, PLOS ONE, V8; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Kalonia H, 2012, NEUROTOX RES, V22, P310, DOI 10.1007/s12640-012-9315-x; Kazl C, 2009, BRAIN RES, V1285, P174, DOI 10.1016/j.brainres.2009.05.082; Kiss P, 2011, NEUROSCI LETT, V487, P400, DOI 10.1016/j.neulet.2010.10.065; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Landi S, 2007, FASEB J, V21, P130, DOI 10.1096/fj.06-6083com; Landi S, 2009, J NEUROSCI, V29, P10809, DOI 10.1523/JNEUROSCI.1857-09.2009; Lang JT, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-33; Leasure JL, 2009, HIPPOCAMPUS, V19, P907, DOI 10.1002/hipo.20563; Lee MY, 2013, NEUROREHAB NEURAL RE, V27, P561, DOI 10.1177/1545968313481277; Mainardi M, 2010, J NEUROSCI RES, V88, P3048, DOI 10.1002/jnr.22461; Markham JA, 2009, BRAIN RES, V1288, P9, DOI 10.1016/j.brainres.2009.06.087; Martinez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016726; Mester L, 2009, NEUROTOX RES, V16, P68, DOI 10.1007/s12640-009-9049-6; Mracsko E, 2010, BRAIN RES, V1321, P13, DOI 10.1016/j.brainres.2009.11.080; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Ortuzar N, 2011, J NEURAL TRANSM, V118, P135, DOI 10.1007/s00702-010-0496-2; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pena Y, 2006, BEHAV BRAIN RES, V174, P181, DOI 10.1016/j.bbr.2006.07.007; Prilloff S, 2010, J NEUROTRAUM, V27, P2295, DOI 10.1089/neu.2010.1439; Qiu X, 2012, BRAIN RES, V1465, P26, DOI 10.1016/j.brainres.2012.05.025; Reglodi D, 2006, NEUROPEPTIDES, V40, P265, DOI 10.1016/j.npep.2006.06.001; Ronnback A, 2005, NEUROSCI LETT, V385, P173, DOI 10.1016/j.neulet.2005.05.016; Sale A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001160; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Saucier DM, 2007, BRAIN RES, V1170, P31, DOI 10.1016/j.brainres.2007.07.020; Saucier DM, 2010, BEHAV BRAIN RES, V214, P48, DOI 10.1016/j.bbr.2010.04.039; Schneider JS, 2001, BRAIN RES, V896, P48, DOI 10.1016/S0006-8993(00)03249-2; Soeda F, 2010, NEUROSCIENCE, V169, P223, DOI 10.1016/j.neuroscience.2010.04.047; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Szabadfi K, 2010, INT J MOL SCI, V11, P544, DOI 10.3390/ijms11020544; Szabadfi K, 2009, BRAIN RES, V1259, P107, DOI 10.1016/j.brainres.2009.01.004; TAKEMOTO TI, 1975, TOHOKU J EXP MED, V117, P153, DOI 10.1620/tjem.117.153; Tamas A, 2006, ENDOCRINE, V29, P275, DOI 10.1385/ENDO:29:2:275; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Varga B, 2011, J MOL NEUROSCI, V43, P44, DOI 10.1007/s12031-010-9406-1; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Westenbroek C, 2005, HORM BEHAV, V47, P620, DOI 10.1016/j.yhbeh.2005.01.004; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Yamamoto H, 2006, EXP EYE RES, V82, P767, DOI 10.1016/j.exer.2005.09.019; Yang S, 2012, ANAT REC, V295, P1406, DOI 10.1002/ar.22526; Young D., 2012, BEHAV BRAIN RES, V230, P92; Zakharova E, 2012, BEHAV BRAIN RES, V230, P92, DOI 10.1016/j.bbr.2012.01.052; Zeynalov E, 2006, J CEREBR BLOOD F MET, V26, P414, DOI 10.1038/sj.jcbfm.9600196; Zhu H, 2011, NEUROSCI LETT, V502, P71, DOI 10.1016/j.neulet.2011.04.015	61	9	11	0	19	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	AUG	2013	14	8					16111	16123		10.3390/ijms140816111			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	272ZE	WOS:000328501300047	23921682	Green Published, gold			2022-02-06	
J	Kitagawa, RS; Van Haren, RM; Yokobori, S; Cohen, D; Beckerman, SR; Ahmad, F; Bullock, MR				Kitagawa, Ryan S.; Van Haren, Robert M.; Yokobori, Shoji; Cohen, David; Beckerman, Samuel R.; Ahmad, Faiz; Bullock, M. Ross			Management of simultaneous traumatic brain injury and aortic injury Clinical article	JOURNAL OF NEUROSURGERY			English	Article						aortic injury; traumatic brain injury; aortic stent	OUTCOMES; SURGERY; REPAIR	Object. Simultaneous traumatic brain injury (TBI) and aortic injury has been considered unsurvivable for many years because treatments such as sedation and blood pressure goals conflict for these 2 conditions. Additionally, surgical interventions for aortic injury often require full anticoagulation, which is contraindicated in patients with TBI. For these reasons, and due to the relative rarity of aortic injury/TBI, little data are available to guide treating physicians. Methods. A retrospective review was performed on all simultaneous TBI and aortic injury cases from 2000 to 2012 at a university-affiliated, Level I trauma center. Patient demographics, imaging studies, interventions, and outcomes were analyzed. Traumatic brain injury/aortic injury cases treated with endovascular stenting were specifically studied to determine trends in procedure timing, use of anticoagulation, and neurological outcome. Results. Thirty-three patients with concurrent TBI and aortic injury were identified over a 12-year period. The median patient age was 44 years (range 16-86 years) and the overall mortality rate after imaging diagnosis was 46%. All surviving patients were awake and neurologically functional at discharge, and 83% were discharged home or to rehabilitation facilities. Patients who died had a higher Injury Severity Scale score (p = 0.006). Severe TBI (p = 0.045) or hemodynamic instability (p = 0.015) upon arrival to the hospital was also correlated with increased mortality rates. Thirty-three percent of aortic injury/TBI patients (n = 11) underwent endovascular stenting, and 7 of these patients received intravenous anticoagulation therapy at the time of surgery. Six of these 7 anticoagulation-treated patients experienced no significant progression on postoperative brain CT, whereas 1 patient died of hemodynamic instability prior to undergoing further imaging. Conclusions. Simultaneous TBI and aortic injury is a rare condition with a historically poor prognosis. However, these results suggest that many patients can survive with a good quality of life. Technological advances such as endovascular aortic stenting may improve patient outcome, and anticoagulation is not absolutely contraindicated after TBI.	[Kitagawa, Ryan S.; Yokobori, Shoji; Cohen, David; Beckerman, Samuel R.; Ahmad, Faiz; Bullock, M. Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Van Haren, Robert M.] Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Miami, FL 33136 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan		Bullock, MR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, 1095 NW 14th Terrace, Miami, FL 33136 USA.	rbullock@med.miami.edu	Van Haren, Robert/T-8218-2019				Aladham F, 2010, J COMPUT ASSIST TOMO, V34, P388, DOI 10.1097/RCT.0b013e3181d0728f; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Arthurs ZM, 2009, J VASC SURG, V49, P988, DOI 10.1016/j.jvs.2008.11.052; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dake MD, 2011, J VASC SURG, V53, P1091, DOI 10.1016/j.jvs.2010.11.126; de Mestral C, 2012, J VASC SURG, V56, P656, DOI 10.1016/j.jvs.2012.02.027; Demetriades D, 2009, J TRAUMA, V66, P967, DOI 10.1097/TA.0b013e31817dc483; Duwayri Y, 2008, ANN VASC SURG, V22, P309, DOI 10.1016/j.avsg.2007.09.012; Harris T, 2012, POSTGRAD MED J, V88, P595, DOI 10.1136/postgradmedj-2011-130285; Hong MS, 2011, J VASC SURG, V53, P36, DOI 10.1016/j.jvs.2010.08.009; Kurimoto Y, 2006, CIRC J, V70, P198, DOI 10.1253/circj.70.198; Mosquera VX, 2011, J THORAC CARDIOV SUR, V142, P614, DOI 10.1016/j.jtcvs.2010.10.044; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; Paul JS, 2011, J TRAUMA, V71, P1519, DOI 10.1097/TA.0b013e31823b9811; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Steenburg SD, 2008, RADIOLOGY, V248, P748, DOI 10.1148/radiol.2483071416; Steuer J, 2012, J VASC SURG, V56, P973, DOI 10.1016/j.jvs.2012.03.259; Trace L, 2012, THESCIENTIFICWORLDJO, V2012	20	9	9	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2013	119	2					324	331		10.3171/2013.5.JNS1397			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	187CL	WOS:000322094400011	23767893				2022-02-06	
J	Liimatainen, SP; Jylhava, J; Raitanen, J; Peltola, JT; Hurme, MA				Liimatainen, Suvi P.; Jylhava, Juutia; Raitanen, Jani; Peltola, Jukka T.; Hurme, Mikko A.			The concentration of cell-free DNA in focal epilepsy	EPILEPSY RESEARCH			English	Article						Cell-free DNA; Neurodegeneration; Inflammation; Focal Epilepsy; Etiology	TEMPORAL-LOBE EPILEPSY; CIRCULATING NUCLEIC-ACIDS; NEURON-SPECIFIC ENOLASE; PLASMA DNA; RECEPTOR ANTAGONIST; STATUS EPILEPTICUS; PROGNOSTIC MARKER; VIDEO-EEG; SEIZURES; DAMAGE	Background: Increased production of cell-free DNA (cf-DNA), a marker of inflammation, cell death and degeneration, has been observed in stroke and severe traumatic brain injury among other medical conditions. The purpose of the present study was to evaluate the significance of cf-DNA in patients with focal epilepsy. Methods: cf-DNA was measured in 167 consecutive well-evaluated patients with focal epilepsy (147 with refractory epilepsy). Epilepsy was characterized based on the patient history, electroclinical findings, neuroimaging results and etiology. 250 healthy individuals served as control subjects. Results: The majority of the patients (125/167; 74.8%) had increased concentrations of cf-DNA. The median concentration of cf-DNA was significantly higher in the patients (0.867 mu g/ml) compared to the control group (0.759 mu g/ml) (p < 0.001). Symptomatic etiology was associated with increased concentrations of cf-DNA compared to probably symptomatic etiology (p = 0.036). Conclusions: The study confirms that the release of cf-DNA is more active in symptomatic refractory focal epilepsy, whereas this process is less pronounced in patients with unknown cause of epilepsy. (C) 2013 Elsevier B.V. All rights reserved.	[Liimatainen, Suvi P.; Peltola, Jukka T.] Tampere Univ Hosp, Dept Neurol & Rehabil, Tampere 33521, Finland; [Jylhava, Juutia; Hurme, Mikko A.] Univ Tampere, Sch Med, Dept Microbiol & Immunol, Tampere 33560, Finland; [Raitanen, Jani] Univ Tampere, Sch Hlth Sci, Tampere 33014, Finland; [Raitanen, Jani] UKK Inst Hlth Promot, Tampere 33501, Finland; [Hurme, Mikko A.] Tampere Univ Hosp, Lab Ctr, Tampere 33521, Finland		Liimatainen, SP (corresponding author), Tampere Univ Hosp, Dept Neurol & Rehabil, POB 2000, Tampere 33521, Finland.	suvi.liimatainen@fimnet.fi	Raitanen, Jani/AAW-9233-2021	Raitanen, Jani/0000-0001-7674-0978; Jylhava, Juulia/0000-0003-0250-4491; Hurme, Mikko/0000-0002-8614-1044	Tampere University Hospital, Finland	We thank Sinikka Repo-Koskinen for her assistance with cf-DNA measurements. The study is supported by the grant from the Medical Research Fund of Tampere University Hospital, Finland.	Alapirtti T, 2009, J NEUROL SCI, V280, P94, DOI 10.1016/j.jns.2009.02.355; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bengzon J, 2002, PROG BRAIN RES, V135, P111; Bernasconi A, 2002, PROG BRAIN RES, V135, P297; Callenbach PMC, 2003, CLIN EXP IMMUNOL, V132, P144, DOI 10.1046/j.1365-2249.2003.02097.x; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Eriksson K, 2001, EPILEPSY RES, V46, P129, DOI 10.1016/S0920-1211(01)00273-X; Gahan PB, 2008, ANN NY ACAD SCI, V1137, P7, DOI 10.1196/annals.1448.046; Jylhava J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035426; Kakviainen R, 2002, PROG BRAIN RES, V135, P279; Kalviainen R, 1998, NEUROLOGY, V50, P1377, DOI 10.1212/WNL.50.5.1377; Kotloski R, 2002, PROG BRAIN RES, V135, P95; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lam NYL, 2006, RESUSCITATION, V68, P71, DOI 10.1016/j.resuscitation.2005.05.021; Lehtimaki KA, 2004, J NEUROIMMUNOL, V152, P121, DOI 10.1016/j.jneuroim.2004.01.024; Lehtimaki KA, 2003, MOL BRAIN RES, V110, P253, DOI 10.1016/S0169-328X(02)00654-X; Liimatainen S., 2011, EPILEPSY RES; Liimatainen SP, 2008, J NEUROL NEUROSUR PS, V79, P808, DOI 10.1136/jnnp.2007.132811; Liimatainen S, 2009, J NEUROL, V256, P796, DOI 10.1007/s00415-009-5021-x; Mittra I, 2012, J BIOSCIENCES, V37, P301, DOI 10.1007/s12038-012-9192-8; Palmio J, 2001, J NEUROL SCI, V183, P27, DOI 10.1016/S0022-510X(00)00478-0; Palmio J, 2008, EPILEPSY RES, V81, P155, DOI 10.1016/j.eplepsyres.2008.05.006; Peltola JT, 2000, AM J MED, V109, P712, DOI 10.1016/S0002-9343(00)00617-3; Peters DL, 2011, CLIN CHIM ACTA, V412, P806, DOI 10.1016/j.cca.2011.01.026; Pitkanen A, 2002, PROG BRAIN RES, V135, P67; Ravizza T, 2006, NEUROBIOL DIS, V24, P128, DOI 10.1016/j.nbd.2006.06.003; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Scalzo PL, 2009, NEUROSCI LETT, V452, P5, DOI 10.1016/j.neulet.2009.01.031; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x; Sutula T, 2002, PROG BRAIN RES, V135, P211; Swarup V, 2011, DNA CELL BIOL, V30, P389, DOI 10.1089/dna.2010.1165; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036; Tsang JCH, 2007, PATHOLOGY, V39, P197, DOI 10.1080/00313020701230831; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; Vezzani A., 2007, EPILEPSY COMPREHENSI, P267; Wijeratne S, 2004, ANN NY ACAD SCI, V1022, P232, DOI 10.1196/annals.1318.036; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160	39	9	9	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	AUG	2013	105	3					292	298		10.1016/j.eplepsyres.2013.03.005			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190RG	WOS:000322357300005	23582956				2022-02-06	
J	Linsler, S; Schmidtke, M; Steudel, WI; Kiefer, M; Oertel, J				Linsler, Stefan; Schmidtke, Mareike; Steudel, Wolf Ingo; Kiefer, Michael; Oertel, Joachim			Automated intracranial pressure-controlled cerebrospinal fluid external drainage with LiquoGuardA (R)	ACTA NEUROCHIRURGICA			English	Article						CSF drainage; ICP monitoring; Traumatic brain injury; Subarachnoid haemorrhage; Neurointensive care; Liquoguard	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; MANAGEMENT; TRANSDUCER; GUIDELINES; EXPERIENCE; OUTCOMES	LiquoGuard is a new device for intracranial pressure (ICP)-controlled drainage of cerebrospinal fluid (CSF). This present study evaluates the accuracy of ICP measurement via the LiquoGuard device in comparison with Spiegelberg. Thus, we compared data ascertained from simultaneous measurement of ICP using tip-transducer and tip-sensor devices. A total of 1,764 monitoring hours in 15 patients (range, 52-219 h) were analysed. All patients received an intraventricular Spiegelberg III probe with the drainage catheter connected to the LiquoGuard system. ICP reading of both devices was performed on an hourly basis. Statistical analysis was done by applying Pearson correlation and Wilcoxon-matched pair test (p < 0.05). Mean ICP values were 11 +/- 5 mmHg (Spiegelberg) and 10 +/- 7 mmHg (LiquoGuard); the values measured with both devices correlated well (p = 0.001; Pearson correlation =0.349; n = 1,764). In two of the 15 patients with slit ventricles, episodes of significant differences in measured values could be observed. Both patients suffering from slit ventricles failed to produce reliable measurement with the external transducer of the LiquoGuard. LiquoGuard is a valuable new device for ICP-controlled CSF drainage. However, LiquoGuard tends to provide misleading results in slit ventricles. Thus, before these drawbacks are further analysed, the authors recommend additional ICP measurement with internal tip-sensor devices to avoid dangerous erroneous interpretation of ICP data.	[Linsler, Stefan; Schmidtke, Mareike; Steudel, Wolf Ingo; Kiefer, Michael; Oertel, Joachim] Univ Saarland, Dept Neurosurg, D-66421 Homburg, Saar, Germany		Linsler, S (corresponding author), Univ Saarland, Dept Neurosurg, D-66421 Homburg, Saar, Germany.	stefan.linsler@uks.eu	Oertel, Joachim/AAO-5012-2021; Kiefer, Michael/H-3733-2011	Kiefer, Michael/0000-0001-8634-5963			Acikbas SC, 2002, ACTA NEUROCHIR, V144, P475, DOI 10.1007/s007010200068; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CAO MH, 1984, J NEUROSURG, V61, P707, DOI 10.3171/jns.1984.61.4.0707; Caruselli G, 1992, J Neurosurg Sci, V36, P219; Chambers IR, 2001, J NEUROL NEUROSUR PS, V71, P383, DOI 10.1136/jnnp.71.3.383; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; Eide PK, 2007, ACTA ANAESTH SCAND, V51, P501, DOI 10.1111/j.1399-6576.2007.01269.x; Eymann R, 2012, ACTA NEUROCHIR SUPPL, V113, P181, DOI 10.1007/978-3-7091-0923-6_36; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Feldman Z, 1993, HEAD INJURY, P247; Freiman TM, 2008, ACTA NEUROCHIR, V150, P1081, DOI 10.1007/s00701-008-0023-5; Ghajar J, 1995, New Horiz, V3, P395; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; Kanter M J, 1991, Neurosurg Clin N Am, V2, P257; Kiefer M, 2002, UNFALLCHIRURG, V105, P578, DOI 10.1007/s00113-002-0469-5; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; MILLER JD, 1973, BRIT J SURG, V60, P316; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; PAPO I, 1981, ACTA NEUROCHIR, V56, P191, DOI 10.1007/BF01407230; Piper I, 2001, NEUROSURGERY, V49, P1158, DOI 10.1097/00006123-200111000-00026; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Staykov D, 2011, NEUROSURGERY, V68, P1187, DOI 10.1227/NEU.0b013e31820c0274; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	32	9	10	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	AUG	2013	155	8					1589	1595		10.1007/s00701-012-1562-3			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	187JK	WOS:000322113500034	23188469				2022-02-06	
J	Pretorius, C; Broodryk, M				Pretorius, C.; Broodryk, M.			Misconceptions about traumatic brain injuries among South African university students	SOUTH AFRICAN JOURNAL OF PSYCHIATRY			English	Article								Objective. To investigate the incidence and type of misconceptions about traumatic brain injuries (TBIs) harboured by university students. Method. A convenience sample of 705 university students were recruited and data were collected using an electronic survey. The link to the survey was sent via e-mail to all registered students at Stellenbosch University. The participants had to complete the Common Misconceptions about Traumatic Brain Injury (CM-TBI) questionnaire. Results., The findings of this study suggest that the students subscribe to misconceptions from each of the 7 categories of misconceptions about TBIs. The mean percentages of misconceptions about TBIs were calculated and the amnesia (mean 49.7%) and unconsciousness (mean 46.1%) categories were identified as the categories about which the respondents had the most misconceptions, while the mean percentages of misconceptions were lower for the categories of recovery (mean 27.6%), rehabilitation (mean 26.56%), prevention (mean 20.8%), brain injury sequelae (mean 18.7%) and brain damage (mean 8.4%). Conclusion. Generally, these findings appear to be in keeping with previous literature, which suggests that misconceptions about TBIs are common among the general population. This study's identification of these misconceptions could help create awareness, provide a focus for information provision, and contribute to the development of educational intervention programmes tailored for the South, African context.	[Pretorius, C.; Broodryk, M.] Univ Stellenbosch, Dept Psychol, ZA-7600 Stellenbosch, South Africa		Pretorius, C (corresponding author), Univ Stellenbosch, Dept Psychol, ZA-7600 Stellenbosch, South Africa.	chrismapretorius@sun.ac.za	Pretorius, Chrisma/U-8258-2017	Pretorius, Chrisma/0000-0002-9188-0255; Broodryk, Mandi/0000-0003-1868-0502			Baxendale S, 2004, BMJ-BRIT MED J, V329, P1480, DOI 10.1136/bmj.329.7480.1480; Brain Injury Association of America, 2011, TRAUM BRAIN INJ PREV; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Faul M, 2010, TRAUMATIC BRAIN INJU; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Logue S., 2006, INT EDUC J, V7, P553; National Health Laboratory Service, 2011, WORLD HEAD INJ AW DA; Novack T, 2013, WHAT EXPECT TBI; O'Jile JR, 2007, INT J REHABIL HLTH, V3, P61; Pappadis MR, 2010, J HEAD TRAUMA REHAB, V26, P301; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; [No title captured]	21	9	9	0	3	AOSIS	CAPE TOWN	POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH AFRICA	1608-9685			SAJP-S AFR J PSYCHI	SAJP	AUG	2013	19	3					75	79		10.7196/SAJP.436			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	228ZO	WOS:000325231800004		gold			2022-02-06	
J	Zhu, F; Chou, CC; Yang, KH; King, AI				Zhu, Feng; Chou, Cliff C.; Yang, King H.; King, Albert I.			SOME CONSIDERATIONS ON THE THRESHOLD AND INTER-SPECIES SCALING LAW FOR PRIMARY BLAST-INDUCED TRAUMATIC BRAIN INJURY: A SEMI-ANALYTICAL APPROACH	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Primary injury; bTBI; threshold; scaling law; logistic regression analysis	EXPOSURE; MODEL	Blast-induced traumatic brain injury (bTBI) has become a signature injury in recent military conflicts and terrorist attacks. However, the mechanisms and thresholds for such injury are still unknown. In this paper, effort has been made toward establishing the threshold due to primary blast based on the published injury data in the rat. Peak incident overpressure and pulse duration of the incident wave were used as predictors and the injury risk curves for the rat were derived via a linear logistic regression analysis. A scaling law based on body mass was then used to scale the tolerance curves from the rat to the pig and the human. The injury risk curve for bTBI was compared with that for the lung. The results reveal different injury mechanisms between these two organs. The developed injury curves can be used in the design of personal protective equipment against primary bTBI.	[Zhu, Feng; Chou, Cliff C.; Yang, King H.; King, Albert I.] Wayne State Univ, Ctr Bioengn, Detroit, MI 48201 USA		Zhu, F (corresponding author), Wayne State Univ, Ctr Bioengn, Detroit, MI 48201 USA.	fengzhume@gmail.com		Chou, Clifford/0000-0002-9127-1660	Small Business Innovation Research (SBIR) Contract [W81XWH-09-C-0068]; Bioengineering Center, Wayne State University	This research was supported through Small Business Innovation Research (SBIR) Contract #W81XWH-09-C-0068, and in part by the Bioengineering Center, Wayne State University. The financial support is gratefully acknowledged.	Baker W.E., 1983, EXPLOSION HAZARDS EV; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bowen IG, 1966, DASA1857 DEP DEF; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Long J. B., 2009, J NEUROTRAUM, V26, P1; Moore DF, 2011, RTOMPHRM207 NATO; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Richmond DR, 1966, DASA1854 DEP DEF; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; White CS, 1971, DNA1971 DEP DEF; Yang KH, 2010, BIOMECHANICS BRAIN	21	9	9	1	15	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	AUG	2013	13	4							UNSP 1350065	10.1142/S0219519413500656			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	179IP	WOS:000321513800015					2022-02-06	
J	Chang, WTW; Nyquist, PA				Chang, Wan-Tsu W.; Nyquist, Paul A.			Strategies for the Use of Mechanical Ventilation in the Neurologic Intensive Care Unit	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Mechanical ventilation; Brain injury; Intracranial pressure; Cerebral edema	TRAUMATIC BRAIN-INJURY; ACUTE LUNG INJURY; CEREBRAL PERFUSION-PRESSURE; NEUROGENIC PULMONARY-EDEMA; END-EXPIRATORY PRESSURE; SEVERE HEAD-INJURY; BALLOON PUMP COUNTERPULSATION; RESPIRATORY-DISTRESS-SYNDROME; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE	Mechanical ventilation in neurologically injured patients presents unique challenges. Patients with acute neurologic injuries may require mechanical ventilation for reasons beyond respiratory failure. There is also a subset of pulmonary pathologic abnormality directly associated with neurologic injuries. Balancing the need to maintain brain oxygenation, cerebral perfusion, and control of intracranial pressure can be in conflict with concurrent ventilator strategies aimed at lung protection. Weaning and liberation from mechanical ventilation also require special considerations. These issues are examined in the ventilator management of the neurologically injured patient.	[Chang, Wan-Tsu W.; Nyquist, Paul A.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Chang, Wan-Tsu W.; Nyquist, Paul A.] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Chang, Wan-Tsu W.; Nyquist, Paul A.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA		Nyquist, PA (corresponding author), 600 North Wolfe St,Meyer 8-140, Baltimore, MD 21287 USA.	pnyquis1@jhmi.edu					[Anonymous], 1984, SHINKEI GEKA S3; Apostolides PJ, 1996, NEUROSURGERY, V38, P1056, DOI 10.1097/00006123-199605000-00042; BERTHIAUME Y, 1988, J APPL PHYSIOL, V65, P585, DOI 10.1152/jappl.1988.65.2.585; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; BRAZIAS PW, 2001, LOCALIZATION CLIN NE, P559; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; BURCHIEL KJ, 1981, NEUROSURGERY, V8, P443, DOI 10.1227/00006123-198104000-00007; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; DARRAGH TM, 1985, ANN NEUROL, V17, P565, DOI 10.1002/ana.410170606; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Ely EW, 2001, CHEST, V120, p454S, DOI 10.1378/chest.120.6_suppl.454S; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Fletcher SJ, 2003, BRIT J ANAESTH, V90, P238, DOI 10.1093/bja/aeg026; Georgiadis D, 2002, INTENS CARE MED, V28, P1089, DOI 10.1007/s00134-002-1351-1; GREENHOO.JH, 1969, J NEUROSURG, V30, P521, DOI 10.3171/jns.1969.30.5.0521; Gruber A, 1998, NEUROSURGERY, V42, P258, DOI 10.1097/00006123-199802000-00032; Harviel JD, 2000, J TRAUMA, V48, P882; Hoesch RE, 2012, CRIT CARE MED, V40, P587, DOI 10.1097/CCM.0b013e3182329617; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; HURST JM, 1984, NEUROSURGERY, V15, P530, DOI 10.1227/00006123-198410000-00010; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; JASKULKA R, 1993, UNFALLCHIRURG, V96, P138; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; Karanjia N, 2011, NEUROCRIT CARE, V15, P4, DOI 10.1007/s12028-011-9528-5; Kerwin AJ, 2000, J TRAUMA, V48, P878, DOI 10.1097/00005373-200005000-00011; Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403; Lazaridis C, 2010, NEUROCRIT CARE, V13, P101, DOI 10.1007/s12028-010-9358-x; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; MARON MB, 1994, J APPL PHYSIOL, V77, P1155, DOI 10.1152/jappl.1994.77.3.1155; Mascia L, 2008, MINERVA ANESTESIOL, V74, P325; Moutier F., 1918, PRESSE MED, V26, P108; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; PAINE R, 1952, JAMA-J AM MED ASSOC, V149, P643, DOI 10.1001/jama.1952.02930240021008; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Pulm F, 1980, DIS NERVOUS SYSTEM C; PULM F, 1980, DIAGNOSIS STUPOR COM; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Salim A, 2004, J TRAUMA, V57, P542, DOI 10.1097/01.TA.0000135159.94744.5F; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; SCHIEVINK WI, 1995, NEUROLOGY, V45, P871, DOI 10.1212/WNL.45.5.871; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Shanahan WT, 1908, N Y MED J, V37, P54; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; SIMMONS RL, 1969, J TRAUM, V9, P760, DOI 10.1097/00005373-196909000-00002; SJOSTRAND U, 1980, CRIT CARE MED, V8, P345; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Taplu A, 2003, EUR J ANAESTH, V20, P690, DOI 10.1097/00003643-200309000-00003; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; van Hulst RA, 2002, INTENS CARE MED, V28, P68, DOI 10.1007/s00134-001-1157-6; Videtta W, 2002, ACT NEUR S, V81, P93; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	58	9	10	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					407	+		10.1016/j.nec.2013.02.004			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100009	23809034				2022-02-06	
J	Glass, L; Krueger, F; Solomon, J; Raymont, V; Grafman, J				Glass, Leila; Krueger, Frank; Solomon, Jeffrey; Raymont, Vanessa; Grafman, Jordan			Mental Paper Folding Performance Following Penetrating Traumatic Brain Injury in Combat Veterans: A Lesion Mapping Study	CEREBRAL CORTEX			English	Article						inferior parietal; left hippocampal gyms; lesion analysis; mental paper folding; penetrating head injury	POSTERIOR PARIETAL CORTEX; FUNCTIONAL ACTIVATION; COGNITIVE DECLINE; NEURAL MECHANISMS; SEX-DIFFERENCES; HEAD-INJURY; ROTATION; MRI; CATEGORIZATION; TRANSFORMATION	Mental paper folding is a complex measure of visuospatial ability involving a coordinated sequence of mental transformations and is often considered a measure of mental ability. The literature is inconclusive regarding the precise neural architecture that underlies performance. We combined the administration of the Armed Forces Qualification Test boxes subtest measuring mental paper folding ability, with a voxel-based lesion symptom mapping approach to identify brain regions associated with impaired mental paper folding ability. Using a large sample of subjects with penetrating traumatic brain injury and defined lesions studied over 2 time points, roughly 15 and 35 years post-injury, enabled us to answer the causal questions regarding mental paper folding impairment. Our results revealed that brain injury significantly exacerbates the decline of performance on mental paper folding tasks over time. Our study adds novel neuropsychological and neuroimaging support for parietal lobe involvement; specifically the right inferior parietal lobule (Broadmann's Area [BA] 40) and the left parahippocampal region (BAs 19, 36). Both areas were consistently associated with mental paper folding performance and demonstrate that the right parietal lobe and the left parahippocampal gyrus play an integral role in mental paper folding tasks.	[Glass, Leila; Krueger, Frank; Raymont, Vanessa; Grafman, Jordan] NINDS, Cognit Neurosci Sect, NIH, Bethesda, MD 20892 USA; [Glass, Leila] SDSU UCSD Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Krueger, Frank] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Solomon, Jeffrey] Expert Image Anal LLC, Potomac, MD USA; [Raymont, Vanessa] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Raymont, Vanessa] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Grafman, Jordan] Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, W Orange, NJ USA		Krueger, F (corresponding author), George Mason Univ, Dept Mol Neurosci, 4400 Univ Dr,Mail Stop 2A1, Fair, VA 22030 USA.	fkrueger@gmu.edu		Grafman, Jordan H./0000-0001-8645-4457	US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD17-01-1-0675]; National Navy Medical Center [B03-043]	This study was conducted by the US National Institute of Neurological Disorders and Stroke Intramural Research Program and an individual project grant (DAMD17-01-1-0675) from the US Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: A 30-year post-injury follow-up study). It took place at the National Navy Medical Center (project number B03-043). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defence, nor the US Government. For further information about the Vietnam Head Injury Study, contact J. G. at jgrafman@kesslerfoundation.org.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Amick MM, 2006, NEUROPSYCHOLOGIA, V44, P339, DOI 10.1016/j.neuropsychologia.2005.06.002; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Anderson, 1963, DEV ARMED FORCES QUA; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; BAYROFF AG, 1956, AM PSYCHOL, V11, P427; Booth JR, 2000, DEV NEUROPSYCHOL, V18, P139, DOI 10.1207/S15326942DN1802_1; Buiatti T, 2011, CORTEX, V47, P166, DOI 10.1016/j.cortex.2009.10.006; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; COOPER LA, 1973, VISUAL INFORM PROCES, P00075; CORKIN S, 1989, J NEUROSCI, V9, P3876; DITUNNO PL, 1990, CORTEX, V26, P177, DOI 10.1016/S0010-9452(13)80349-8; DROR IE, 1994, PSYCHOL AGING, V9, P90, DOI 10.1037/0882-7974.9.1.90; Ekstrom RB., 1976, MANUAL KIT FACTOR RE; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Gauthier I, 2002, NEURON, V34, P161, DOI 10.1016/S0896-6273(02)00622-0; Geiser C, 2008, INTELLIGENCE, V36, P556, DOI 10.1016/j.intell.2007.12.003; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Gogos A, 2010, NEUROPSYCHOLOGIA, V48, P529, DOI 10.1016/j.neuropsychologia.2009.10.013; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; Harris IM, 2002, NEUROPSYCHOLOGY, V16, P524, DOI 10.1037//0894-4105.16.4.524; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Just MA, 2001, J EXP PSYCHOL GEN, V130, P493, DOI 10.1037/0096-3445.130.3.493; Kaplan H., 1983, BOSTON NAMING TEST; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Koscik T, 2009, BRAIN COGNITION, V69, P451, DOI 10.1016/j.bandc.2008.09.004; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee AC, 1998, NEUROPSYCHOLOGIA, V36, P109, DOI 10.1016/S0028-3932(97)00017-1; Lequerica A, 2010, J CLIN EXP PSYCHOL, V24, P1103; Lohman DF, 2000, HDB INTELLIGENCE; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Milivojevic B, 2003, NEUROPSYCHOLOGIA, V41, P1345, DOI 10.1016/S0028-3932(03)00060-5; Milivojevic B, 2009, J COGNITIVE NEUROSCI, V21, P945, DOI 10.1162/jocn.2009.21085; Olesen PJ, 2007, BEHAV NEUROSCI, V121, P1163, DOI 10.1037/0735-7044.121.6.1163; Parsons LM, 2003, TRENDS COGN SCI, V7, P515, DOI 10.1016/j.tics.2003.10.002; Platek S.M., 2005, EVOL PSYCHOL, V3, p147470490500300, DOI [10.1177/147470490500300116, DOI 10.1177/147470490500300116]; Podzebenko K, 2005, J COGNITIVE NEUROSCI, V17, P24, DOI 10.1162/0898929052879996; Podzebenko K, 2002, NEUROIMAGE, V15, P547, DOI 10.1006/nimg.2001.0999; RATCLIFF G, 1979, NEUROPSYCHOLOGIA, V17, P49, DOI 10.1016/0028-3932(79)90021-6; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Roberts JE, 2003, INT J PSYCHOPHYSIOL, V50, P235, DOI 10.1016/S0167-8760(03)00195-8; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schendan HE, 2008, CEREB CORTEX, V18, P1695, DOI 10.1093/cercor/bhm197; Schendan HE, 2007, NEUROIMAGE, V35, P1264, DOI 10.1016/j.neuroimage.2007.01.012; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; SHEPARD RN, 1972, COGNITIVE PSYCHOL, V3, P228, DOI 10.1016/0010-0285(72)90005-9; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Silverman W, 2010, INTELLIGENCE, V38, P242, DOI 10.1016/j.intell.2009.12.005; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomsen T, 2000, Med Sci Monit, V6, P1186; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhlaner JE, 1952, 976 PRS US ARM PERS; Warrington E. K., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wolbers T, 2006, NEUROIMAGE, V32, P1450, DOI 10.1016/j.neuroimage.2006.05.011; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Wright R, 2008, PSYCHON B REV, V15, P763, DOI 10.3758/PBR.15.4.763; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	67	9	9	2	14	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JUL	2013	23	7					1663	1672		10.1093/cercor/bhs153			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	174NW	WOS:000321163700016	22669970	Green Published, Bronze			2022-02-06	
J	Kempe, CB; Sullivan, KA; Edmed, SL				Kempe, Chloe B.; Sullivan, Karen A.; Edmed, Shannon L.			CE The Effect of Varying Diagnostic Terminology Within Patient Discharge Information on Expected Mild Traumatic Brain Injury Outcome	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychology; Head injury; Acquired brain injury; Neurocognitive disorder; Posttraumatic stress disorder; Postconcussion syndrome; Mild traumatic brain injury; Patient information	POST-CONCUSSION SYNDROME; HEAD-INJURY; POSTCONCUSSION SYNDROME; COGNITIVE PERFORMANCE; EMERGENCY-DEPARTMENTS; EARLY INTERVENTION; SERVICE MEMBERS; SYMPTOM REPORT; RECOMMENDATIONS; NEUROPSYCHOLOGY	This study aimed to determine if systematic variation of the diagnostic terminology embedded within written discharge information (i.e., concussion or mild traumatic brain injury, mTBI) would produce different expected symptoms and illness perceptions. We hypothesized that compared to concussion advice, mTBI advice would be associated with worse outcomes. Sixty-two volunteers with no history of brain injury or neurological disease were randomly allocated to one of two conditions in which they read a mTBI vignette followed by information that varied only by use of the embedded terms concussion (n = 28) or mTBI (n = 34). Both groups reported illness perceptions (timeline and consequences subscale of the Illness Perception Questionnaire-Revised) and expected Postconcussion Syndrome (PCS) symptoms 6 months post injury (Neurobehavioral Symptom Inventory, NSI). Statistically significant group differences due to terminology were found on selected NSI scores (i.e., total, cognitive and sensory symptom cluster scores (concussion > mTBI)), but there was no effect of terminology on illness perception. When embedded in discharge advice, diagnostic terminology affects some but not all expected outcomes. Given that such expectations are a known contributor to poor mTBI outcome, clinicians should consider the potential impact of varied terminology on their patients.	[Kempe, Chloe B.; Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, QUT	Queensland University of Technology granted an occupational workplace health and safety clearance for this study. Project funding was provided by the School of Psychology and Counselling, QUT. We thank the following individuals and organizations for supplying us materials used in this study: Liz Gee and David Andrews (Motor Accidents Authority of New South Wales, Australia), Tom Peachey (University of Warwick, Coventry, United Kingdom), and the local hospitals that supplied their discharge advice sheets. We also thank our two study recruitment sites for their assistance (QUT and the JMC Academy and Jazz Music Institute, respectively), and Ms Hannah Blaine who undertook independent cross-scoring of the data. The authors declare no conflict of interest. The views expressed in this paper are those of the authors and not of the individuals or organizations named in these acknowledgements.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Anderson-Barnes Victoria C, 2010, Continuum (Minneap Minn), V16, P17, DOI 10.1212/01.CON.0000391450.48225.73; Bay E, 2011, ADV EMERG NURS J, V33, P71, DOI 10.1097/TME.0b013e318207e851; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Cox CM, 2010, J PEDIATR PSYCHOL, V35, P581, DOI 10.1093/jpepsy/jsp095; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Goka R. S., 2000, MINOR TRAUMATIC BRAI; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kenardy J, 2008, EUR CHILD ADOLES PSY, V17, P316, DOI 10.1007/s00787-007-0673-5; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kerr J, 2007, EMERG MED J, V24, P330, DOI 10.1136/emj.2006.044230; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; King P A, 2011, PSYCHOMETRIC STUDY N; Macdonald S, 2010, EMERG MED J, V27, P279, DOI 10.1136/emj.2009.075424; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Moore C, 2004, NZ MED J, V117; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Motor Accidents Authority of NSW, 2008, GUIDL MILD TRAUM BRA; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; NSW Ministry of Health, 2011, IN MAN CLOS HEAD INJ, V2nd; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Parsley J, 1997, J ACCID EMERG MED, V14, P238; Peachey T, 2011, EMERG MED J, V28, P707, DOI 10.1136/emj.2010.093872; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Reed D, 2007, ADULT TRAUMA CLIN PR; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Suhr J. A., 2013, SECONDARY INFLUENCES, P182; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan K. A., J HEAD TRAU IN PRESS; Sullivan KA, 2013, BRAIN INJURY, V27, P19, DOI 10.3109/02699052.2012.698360; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	55	9	9	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 1	2013	27	5					762	778		10.1080/13854046.2013.795245			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	170OR	WOS:000320863200002	23662647				2022-02-06	
J	Munivenkatappa, A; Devi, BI; Gregor, TI; Bhat, DI; Kumarsamy, AD; Shukla, DP				Munivenkatappa, Ashok; Devi, Bhagavatula Indira; Gregor, Thomas Issac; Bhat, Dhananjay I.; Kumarsamy, Akhil Deepika; Shukla, Dhaval P.			Bicycle accident-related head injuries in India	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Bicycle; glasgow outcome scale; head injury; outcome; rivermead post-concussion symptom questionnaire	EPIDEMIOLOGY	Objectives: To describe the epidemiology of head injuries sustained due to bicycle accidents in India. Materials and Methods: Data were retrospectively collected over a period of six months (15 May 2011 to 15 November 2011). Demography of patients, Glasgow coma scale (GCS), clinical and imaging findings, and mortality and outcome using Glasgow outcome scale (GOS), Rivermead post-concussion symptom questionnaire (RPCSQ) and Rivermead head injury follow-up questionnaire (RHFUQ), were analyzed. Outcome was assessed by telephonic interview. Results: There were 108 patients (100 males) with mean age of 27.7 years. Seventy-four (68.5%) were from rural areas. Accidents due to vehicular collision accounted for 60 (55.6%) cases. None wore a helmet. The admission GCS was 14-15 in 68.5% cases, 13-3 in 31.5%. The risk of moderate to severe injuries was increased among working laborers (OR = 5), and patients with loss of consciousness (OR = 4). Sixty-three (49%) patients had abnormal computed tomography (CT) findings; most common finding was skull fracture 25 (23.1%). Four patients needed surgery. The GOS assessment at three to six months revealed favorable outcome in 66 patients (61.1%) and death in 8 (7.4%). The common post-concussion symptoms were headache, fatigue, and poor concentration. Conclusion: The majority of hospitalized cyclists were from a rural background and of the lower income group. After three months the majority of patients had good recovery with few persistent concussion symptoms.	[Munivenkatappa, Ashok; Devi, Bhagavatula Indira; Gregor, Thomas Issac; Bhat, Dhananjay I.; Kumarsamy, Akhil Deepika; Shukla, Dhaval P.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore, Karnataka, India		Shukla, DP (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Hosur Rd, Bangalore 560029, Karnataka, India.	neurodhaval@rediffmail.com	Munivenkatappa, Ashok/ABA-5952-2021				Crippen DW, HEAD TRAUMA TREATMEN; Davidson JA, 2005, EUR J EMERG MED, V12, P24, DOI 10.1097/00063110-200502000-00007; Eid H. O., 2007, SMJ Singapore Medical Journal, V48, P884; FRANK E, 1995, ACAD EMERG MED, V2, P200, DOI 10.1111/j.1553-2712.1995.tb03198.x; Gururaj G., 1995, NEUROL INDIA, V43, P95; Gururaj G, 2011, ROAD SAFETY INDIA FR; Hefny AF, 2012, INJURY, V43, P1547, DOI 10.1016/j.injury.2011.05.016; Karkhaneh M, 2008, ACCIDENT ANAL PREV, V40, P192, DOI 10.1016/j.aap.2007.05.006; Kiss K, 2010, ACCIDENT ANAL PREV, V42, P1566, DOI 10.1016/j.aap.2010.03.014; Klin B, 2009, INJURY, V40, P1011, DOI 10.1016/j.injury.2009.01.135; Mohan D., 2004, ROAD AHEAD TRAFFIC I; Munivenkatappa A, 2013, J NEUROSCI RURAL PRA, V4, P19, DOI 10.4103/0976-3147.105604; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Powell EC, 2000, ARCH PEDIAT ADOL MED, V154, P1096, DOI 10.1001/archpedi.154.11.1096; Reynolds CCO, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-47; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Schepers JP, 2011, ACCIDENT ANAL PREV, V43, P853, DOI 10.1016/j.aap.2010.11.005; SELBST SM, 1987, AM J DIS CHILD, V141, P140, DOI 10.1001/archpedi.1987.04460020030021; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sikic M, 2009, MED J AUSTRALIA, V190, P353, DOI 10.5694/j.1326-5377.2009.tb02446.x; Uibel S, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-9	22	9	9	0	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL-SEP	2013	4	3					262	266		10.4103/0976-3147.118764			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3W4E	WOS:000218648300006	24250156	Green Published, gold			2022-02-06	
J	Salem, AMO; Jaumally, BA; Bayanzay, K; Khoury, K; Torkaman, A				Salem, A. M. O.; Jaumally, B. A.; Bayanzay, K.; Khoury, K.; Torkaman, A.			Traumatic brain injuries from work accidents: a retrospective study	OCCUPATIONAL MEDICINE-OXFORD			English	Article						Construction; head injury; traumatic brain injury; UAE	EPIDEMIOLOGY	Background The United Arab Emirates is a rapidly developing country with recent expansion in construction and manufacturing. Aims To investigate the occurrence and outcomes following occupational traumatic brain injury (TBI) requiring hospital admission. Methods Records for all TBI cases admitted to an Abu Dhabi hospital between 2005 and 2009 were reviewed. Data on mechanisms of occupational injuries, Glasgow Coma Scale (GCS) on admission and Glasgow Outcome Scale (GOS) on follow-up, were analysed. Results Of 581 TBI cases reviewed, 56 (10%) cases were reported as occupational by either the patient or the informant accompanying the patient. All cases were male migrants, and 63% were aged 25-44. Falls accounted for 63% of cases, falling objects 34% and motor vehicle collisions 4%. Median GCS score was 13 for all cases. Median hospital stay was 7.5 days. Intensive care unit admission data were available in 47 cases, of which 34% (16) were admitted with a median stay of 5 days. GOS data were available in 95% (53) of cases, with good recovery in 81% cases, moderate-to-severe disability in 11% of cases and death in 8% (4) cases. Conclusions Occupational TBI requiring hospitalization is most frequently due to falls and falling objects, with potentially grave consequences. This study further highlights the urgent need to implement preventative measures to improve construction worker safety.	[Salem, A. M. O.] Univ Edinburgh, Coll Med & Vet Med, Sch Clin Sci, Edinburgh EH16 4SA, Midlothian, Scotland; [Bayanzay, K.; Khoury, K.; Torkaman, A.] Gulf Med Univ, Ajman, U Arab Emirates		Salem, AMO (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Sch Clin Sci, Edinburgh EH16 4SA, Midlothian, Scotland.	ahmed.salem@ed.ac.uk		Salem, Ahmed/0000-0001-9589-7305			Barss P, 2009, OCCUP MED-OXFORD, V59, P493, DOI 10.1093/occmed/kqp101; Chi CF, 2005, APPL ERGON, V36, P391, DOI 10.1016/j.apergo.2004.09.011; Health Statistics 2011, 2011, HLTH STAT 2011; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kim H, 2006, NEUROREHABILITATION, V21, P269; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Statistics Center, 2009, STAT YB AB DHAB 2009; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007	10	9	9	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0962-7480	1471-8405		OCCUP MED-OXFORD	Occup. Med.-Oxf.	JUL	2013	63	5					358	360		10.1093/occmed/kqt037			3	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	183NX	WOS:000321824300009	23599178	Bronze			2022-02-06	
J	Lu, XCM; Dave, JR; Chen, ZY; Cao, Y; Liao, ZL; Tortella, FC				Lu, Xi-Chun May; Dave, Jitendra R.; Chen, Zhiyong; Cao, Ying; Liao, Zhilin; Tortella, Frank C.			Nefiracetam attenuates post-ischemic nonconvulsive seizures in rats and protects neuronal cell death induced by veratridine and glutamate	LIFE SCIENCES			English	Article						Brain ischemia; Nonconvulsive seizures; Nefiracetam; EEG; Veratridine; Glutamate; Rat	CONVULSIVE STATUS EPILEPTICUS; NICOTINIC ACETYLCHOLINE-RECEPTORS; SUSTAINED CEREBRAL-ISCHEMIA; NATIONWIDE INPATIENT SAMPLE; NOOTROPIC AGENT NEFIRACETAM; TRAUMATIC BRAIN-INJURY; ANTIEPILEPTIC DRUGS; SUBARACHNOID HEMORRHAGE; CORTICAL-NEURONS; ANTICONVULSANT	Aims: Stroke patients are at a high risk of developing post-ischemic seizures and cognitive impairment. Nefiracetam (NEF), a pyrrolidone derivative, has been shown to possess both anti-epileptic and cognitive-enhancing properties. In this study the anti-seizure effects of NEF were evaluated in a rat model of post-ischemic nonconvulsive seizures (NCSs). Its potential mechanisms were investigated in neuronal cell culture assays of neurotoxicity associated with ischemic brain injury and epileptogenesis. Main methods: In the in vivo study, rats received 24 h permanent middle cerebral artery occlusion. NEF was administered intravenously either at 15 min post-injury but prior to the first NCS event (30 mg/kg, pre-NCS treatment) or immediately after the first NCS occurred (30 or 60 mg/kg, post-NCS treatment). In the in vitro study, neuronal cell cultures were exposed to veratridine or glutamate and treated with NEF (1-500 nM). Key findings: The NEF pre-NCS treatment significantly reduced the NCS frequency and duration, whereas the higher NEF dose (60 mg/kg) was required to achieve similar effects when given after NCS occurred. The NEF treatment also dose-dependently (5-500 nM) protected against neuronal cell death induced by veratridine as measured by MTT cell viability assay, but higher doses (250-500 nM) were required against glutamate toxicity. Significance: The anti-seizure property of NEF was demonstrated in a clinically relevant rat model of post-ischemic NCS. The preferential effects of NEF against in vitro veratridine toxicity suggest the involvement of its modulation of sodium channel malfunction. Future studies are warranted to study the mechanisms of NEF against ischemic brain injury and post-ischemic seizures. Published by Elsevier Inc.	[Lu, Xi-Chun May; Dave, Jitendra R.; Chen, Zhiyong; Cao, Ying; Liao, Zhilin; Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma & Neuroprotect & Neurorestora, Silver Spring, MD 20910 USA		Lu, XCM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma & Neuroprotect & Neurorestora, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	may.lu@us.army.mil	Dave, Jitendra R/A-8940-2011				Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; Claassen J, 2007, NEUROSURGERY, V61, P60, DOI 10.1227/01.neu.0000279724.05898.e7; Claassen J, 2007, NEUROSURGERY, V61, P64, DOI 10.1227/01.NEU.0000255504.51096.DE; Crespi F, 2002, CURR OPIN INVEST DR, V3, P788; Czapinski P, 2005, CURR TOP MED CHEM, V5, P3, DOI 10.2174/1568026053386962; Dave JR, 2001, NEUROTOX RES, V3, P381, DOI 10.1007/BF03033199; DeFord SM, 2001, PHARMACOL BIOCHEM BE, V69, P611, DOI 10.1016/S0091-3057(01)00559-7; Guimaraes J, 2010, NEUROLOGIST, V16, P353, DOI 10.1097/NRL.0b013e3181dba5d3; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; Kitano Y, 2005, BRAIN RES, V1057, P168, DOI 10.1016/j.brainres.2005.07.052; Kitano Y, 2005, EPILEPSIA, V46, P1561, DOI 10.1111/j.1528-1167.2005.00261.x; Kitano Y, 2005, EPILEPSIA, V46, P811, DOI 10.1111/j.1528-1167.2005.66504.x; Le D T, 2001, J Stroke Cerebrovasc Dis, V10, P99, DOI 10.1053/jscd.2001.25454; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Maganti R, 2008, EPILEPSY BEHAV, V12, P572, DOI 10.1016/j.yebeh.2007.12.002; Moriguchi S, 2003, J PHARMACOL EXP THER, V307, P160, DOI 10.1124/jpet.103.050823; Narahashi T, 2003, LIFE SCI, V74, P281, DOI 10.1016/j.lfs.2003.09.015; SAKURAI T, 1989, JPN J PHARMACOL, V50, P47, DOI 10.1254/jjp.50.47; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; Stafstrom CE, 2010, CURR OPIN NEUROL, V23, P157, DOI 10.1097/WCO.0b013e32833735b5; Takeo S, 2003, BRIT J PHARMACOL, V138, P642, DOI 10.1038/sj.bjp.0705096; Takeo S, 2003, J PHARMACOL EXP THER, V304, P513, DOI 10.1124/jpet.102.043653; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Williams AJ, 2002, BRAIN RES, V932, P45, DOI 10.1016/S0006-8993(02)02275-8; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2008, NEUROSCI LETT, V430, P7, DOI 10.1016/j.neulet.2007.09.052; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Woodruff-Pak D, 2002, MED SCI MONIT, V8, pBR105; Woodruff-Pak DS, 2002, BEHAV BRAIN RES, V136, P299, DOI 10.1016/S0166-4328(02)00186-9; Zhao XL, 2001, MOL PHARMACOL, V59, P674, DOI 10.1124/mol.59.4.674	35	9	9	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205			LIFE SCI	Life Sci.	JUN 13	2013	92	22					1055	1063		10.1016/j.lfs.2013.04.004			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	160AJ	WOS:000320088100003	23603142				2022-02-06	
J	Cappell, J; Kernie, SG				Cappell, Joshua; Kernie, Steven G.			Advances in Pediatric Neurocritical Care	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Neurocritical care; Advances; Pediatrics; Intensive care units	NONCONVULSIVE STATUS EPILEPTICUS; GUILLAIN-BARRE-SYNDROME; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; RECEPTOR ENCEPHALITIS; AMERICAN ACADEMY; CHILDREN; SUBCOMMITTEE; PREDICTION; PROGNOSIS	Because pediatric intensive care units (PICUs) improve survival for a range of acute diseases, attention has turned toward ensuring the best possible functional outcomes after critical illness. The neurocritical care of children is of increasing interest. However, the pediatric population encompasses a heterogeneous set of neurologic conditions, with several possible models of how best to address them. This article reviews the special challenges faced by PICUs with regards to diseases, technologies, and skills and the progress that has been made in treatment, monitoring, and prognostication. Recent advances in translational research expected to modify the field in the near-term are described.	[Cappell, Joshua; Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pediat, Morgan Stanley Childrens Hosp, Columbia Univ Med Ctr, New York, NY 10032 USA; [Cappell, Joshua] Columbia Univ Med Ctr, Dept Neurol, New York, NY 10032 USA; [Kernie, Steven G.] Columbia Univ Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA		Kernie, SG (corresponding author), Columbia Univ Coll Phys & Surg, Morgan Stanley Childrens Hosp, 3959 Broadway,CHN 10-24, New York, NY 10032 USA.	sk3516@columbia.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549			Abend NS, 2012, PEDIATR CRIT CARE ME, V13, P32, DOI 10.1097/PCC.0b013e3182196a7b; Abend NS, 2010, SEMIN PEDIATR NEUROL, V17, P169, DOI 10.1016/j.spen.2010.06.005; Absoud M, 2011, MULT SCLER J, V17, P1258, DOI 10.1177/1352458510382554; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Al Thenayan E, 2008, NEUROLOGY, V71, P1535, DOI 10.1212/01.wnl.0000334205.81148.31; Albaramki JH, 2009, PEDIATR NEPHROL, V24, P1749, DOI 10.1007/s00467-009-1186-x; [Anonymous], 2012, LANCET NEUROL, V11, P119, DOI 10.1016/S1474-4422(12)70008-X; Ashida S, 2002, J CANCER RES CLIN, V128, P561, DOI 10.1007/s00432-002-0374-x; Au AK, 2011, PEDIATR CRIT CARE ME, V12, P566, DOI 10.1097/PCC.0b013e3181fe3420; BARRATTBOYES BG, 1971, CIRCULATION, V43, pI25, DOI 10.1161/01.CIR.43.5S1.I-25; Bell MJ, 2012, NEUROCRIT CARE, V17, P468, DOI 10.1007/s12028-012-9731-z; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Bonifacio SL, 2011, NAT REV NEUROL, V7, P485, DOI 10.1038/nrneurol.2011.119; Bouwes A, 2012, ANN NEUROL, V71, P206, DOI 10.1002/ana.22632; Burghes AHM, 2010, GENE DEV, V24, P1574, DOI 10.1101/gad.1961710; Carrai R, 2010, INTENS CARE MED, V36, P1112, DOI 10.1007/s00134-010-1884-7; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Eberly AL, 2008, PHARMACOTHERAPY, V28, P1502, DOI 10.1592/phco.28.12.1502; El-Bayoumi MA, 2011, CRIT CARE, V15, DOI 10.1186/cc10305; Emerson RG, 2012, J CLIN NEUROPHYSIOL, V29, P149, DOI 10.1097/WNP.0b013e31824f854b; Friess SH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/361310; Friess SH, 2010, PEDIATR CRIT CARE ME, V11, P758, DOI 10.1097/PCC.0b013e3181d8e292; Gasperino J, 2011, HEALTH POLICY, V102, P223, DOI 10.1016/j.healthpol.2011.02.005; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Harambat J, 2011, PEDIATR CRIT CARE ME, V12, pE90, DOI 10.1097/PCC.0b013e3181e89f8f; Heemskerk J, 2012, NEUROPSYCHOPHARMACOL, V37, P287, DOI 10.1038/npp.2011.177; Hirsch LJ, 2012, NEW ENGL J MED, V366, P659, DOI 10.1056/NEJMe1114206; Hoffmann GF, 2010, INHERITED METABOLIC, P386; Hull J, 2012, THORAX, V67, P1, DOI 10.1136/thoraxjnl-2012-201964; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Isaacson J, 2011, NEUROIMAG CLIN N AM, V21, P179, DOI 10.1016/j.nic.2011.02.005; Jordan LC, 2011, NAT REV NEUROL, V7, P199, DOI 10.1038/nrneurol.2011.23; Kashyape P, 2012, EUR J PAEDIATR NEURO, V16, P74, DOI 10.1016/j.ejpn.2011.07.005; Kasman N, 2011, PEDIATR ANESTH, V21, P473, DOI 10.1111/j.1460-9592.2011.03549.x; Kim S, 2010, PEDIATR RADIOL, V40, P82, DOI 10.1007/s00247-009-1457-5; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; LaRovere KL, 2008, NEUROLOGY, V70, pE89, DOI 10.1212/01.wnl.0000313379.57609.25; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; Markandaya M, 2012, NEUROCRIT CARE, V16, P72, DOI 10.1007/s12028-011-9628-2; McCoy B, 2011, J CHILD NEUROL, V26, P218, DOI 10.1177/0883073810378536; Moler FW, 2011, CRIT CARE MED, V39, P141, DOI 10.1097/CCM.0b013e3181fa3c17; Murphy S, 2012, NEUROTHERAPEUTICS, V9, P3, DOI 10.1007/s13311-011-0093-6; Nuwer MR, 2012, NEUROLOGY, V78, P585, DOI 10.1212/WNL.0b013e318247fa0e; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Paulides FM, 2012, INTENS CARE MED, V38, P847, DOI 10.1007/s00134-012-2545-9; Robson WLM, 2002, PEDIATRICS, V109, P322, DOI 10.1542/peds.109.2.322; Roodbol J, 2011, NEUROLOGY, V76, P807, DOI 10.1212/WNL.0b013e31820e7b62; Rossetti AO, 2012, NEUROLOGY, V78, P796, DOI 10.1212/WNL.0b013e318249f6bb; Samaniego EA, 2011, CURR NEUROL NEUROSCI, V11, P111, DOI 10.1007/s11910-010-0148-9; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; Soni S, 2012, PEDIATR BLOOD CANCER, V59, P762, DOI 10.1002/pbc.24126; Statler KD, 2011, CHILD NERV SYST, V27, P565, DOI 10.1007/s00381-010-1292-x; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tasker RC, 2009, CURR OPIN PEDIATR, V21, P724, DOI 10.1097/MOP.0b013e328331e813; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Varelas PN, 2010, NEUROCRIT CARE, V13, P228, DOI 10.1007/s12028-010-9371-0; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wolf A, 2001, LANCET, V357, P606, DOI 10.1016/S0140-6736(00)04064-2	64	9	9	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	JUN	2013	60	3					709	+		10.1016/j.pcl.2013.02.008			17	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	153UK	WOS:000319627800012	23639664				2022-02-06	
J	Lin, DS; Lian, KJ; Chen, ZW; Wang, L; Hao, JM; Zhang, HT				Lin, Dasheng; Lian, Kejian; Chen, Zhiwen; Wang, Lei; Hao, Jianming; Zhang, Huantang			Emergent Surgical Reduction and Fixation for Pipkin Type I Femoral Fractures	ORTHOPEDICS			English	Article							POSTERIOR HIP DISLOCATIONS; HEAD	The purpose of this study was to assess the effect of timing of large fragment fixation in patients with Pipkin type-I fractures. Patients with Pipkin type-I fractures from the authors' trauma center were prospectively observed between July 2007 and July 2010. Fragments that constituted more than one-fourth of the femoral head were included. Thirty-six patients were equally randomized to undergo emergent surgical reduction and fixation or secondary operative fixation after emergent closed reduction. No significant differences existed between the 2 groups with regard to the baseline characteristics, operating time, and blood loss (P>.05). However, the emergent surgical reduction and fixation group had a shorter hospital stay (P<.05). The results after more than 2-year follow-up showed that the complication and avascular necrosis rates were higher in the secondary operative fixation after emergent closed reduction group compared with the emergent surgical reduction and fixation group (P<.05). It was difficult to achieve an anatomically reduced femoral head when the fragments constituted more than one-fourth of the femoral head. Patients who underwent secondary operative fixation after emergent closed reduction had a high avascular necrosis rate and a relatively poor outcome. Emergent surgical reduction and fixation should be performed shortly after injury to enhance the treatment outcome.	[Lin, Dasheng; Lian, Kejian; Chen, Zhiwen; Wang, Lei; Hao, Jianming; Zhang, Huantang] Xiamen Univ, Orthopaed Ctr Peoples Liberat Army, Dept Orthopaed Surg, Affiliated Southeast Hosp, Zhangzhou 363000, Peoples R China		Lian, KJ (corresponding author), Xiamen Univ, Orthopaed Ctr Peoples Liberat Army, Dept Orthopaed Surg, Affiliated Southeast Hosp, Zhangzhou 363000, Peoples R China.	enschor98@126.com			Nanjing Military Region [10MA073]	This study was supported by key projects from Nanjing Military Region (No. 10MA073).	BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Chen ZW, 2011, INT ORTHOP, V35, P1077, DOI 10.1007/s00264-010-1087-4; d'Aubigne R, 2009, CLIN ORTHOP RELAT R, V467, P7, DOI 10.1007/s11999-008-0572-1; Droll KP, 2007, J AM ACAD ORTHOP SUR, V15, P716, DOI 10.5435/00124635-200712000-00005; DUNCAN CP, 1977, SURG GYNECOL OBSTET, V144, P185; Elliott J, 2006, ANZ J SURG, V76, P398, DOI 10.1111/j.1445-2197.2006.03730.x; EPSTEIN HC, 1974, J BONE JOINT SURG AM, VA 56, P1103, DOI 10.2106/00004623-197456060-00001; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; Giannoudis PV, 2009, INJURY, V40, P1245, DOI 10.1016/j.injury.2009.10.024; HOUGAARD K, 1987, J BONE JOINT SURG AM, V69A, P679, DOI 10.2106/00004623-198769050-00007; Kain MS, 2010, ROCKWOOD GREENS FRAC, P1556; Marchetti ME, 1996, J ORTHOP TRAUMA, V10, P455, DOI 10.1097/00005131-199610000-00002; ROEDER LF, 1980, CLIN ORTHOP RELAT R, P121; SHIM SS, 1979, CLIN ORTHOP RELAT R, P255; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; Torzilli PA, 1999, J BIOMECH ENG-T ASME, V121, P433, DOI 10.1115/1.2835070; Yue JJ, 1996, J ORTHOP TRAUMA, V10, P447, DOI 10.1097/00005131-199610000-00001	17	9	10	0	5	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447			ORTHOPEDICS	Orthopedics	JUN	2013	36	6					778	782		10.3928/01477447-20130523-24			5	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	179EL	WOS:000321502300015	23746015				2022-02-06	
J	Niemeier, JP; Marwitz, JH; Walker, WC; Davis, LC; Bushnik, T; Ripley, DL; Ketchum, JM				Niemeier, Janet P.; Marwitz, Jennifer H.; Walker, William C.; Davis, Lynne C.; Bushnik, Tamara; Ripley, David L.; Ketchum, Jessica M.			Are there cognitive and neurobehavioural correlates of hormonal neuroprotection for women after TBI?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Post-menopausal; Hormonal neuroprotection; Neuropsychological outcome	TRAUMATIC BRAIN-INJURY; ESTROGEN PLUS PROGESTIN; RANDOMIZED CONTROLLED-TRIAL; HEALTH INITIATIVE MEMORY; POSTMENOPAUSAL WOMEN; MENOPAUSE TRANSITION; GENDER-DIFFERENCES; PREFRONTAL CORTEX; CONTUSION INJURY; SEX-DIFFERENCES	This study examined possible cognitive correlates of hormonal neuroprotection following traumatic brain injury (TBI) using archival neuropsychological findings for 1563 individuals undergoing acute TBI rehabilitation between 1989 and 2002. Presumed age of menopause was based on the STRAW (Stages of Reproductive Aging) staging system (Soules, 2005; Soules et al., 2001) and general linear model (GLM) analysis of performance on neuropsychological testing by participants across gender and age groups (2534, 3544, 4554, and 5564) was performed. Hypotheses were (1) women with TBI in the oldest age group would have lower scores on neuropsychological tests and functional outcome measures than women in the younger groups, and (2) men in the oldest age group would have higher scores than women of the same age group. Analyses revealed that oldest females had significantly worse Trails B and SDMT written and oral scores than the youngest females. In addition, oldest females had significantly better Trails B, Rey AVLT and SDMT written scores than the oldest males. Possible cohort exposure to hormone replacement therapy, unknown hormonal status at time of testing, and sample-specific injury characteristics may have contributed to these findings.	[Niemeier, Janet P.] Carolinas Healthcare Syst, Carolinas Rehabil, Charlotte, NC 28203 USA; [Marwitz, Jennifer H.; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Davis, Lynne C.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Bushnik, Tamara] NYU, Langone Sch Med, Rusk Inst Rehabil, Dept Rehabil Med, New York, NY USA; [Ripley, David L.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Dept Biostat, Richmond, VA USA		Niemeier, JP (corresponding author), Carolinas Healthcare Syst, Carolinas Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.	Janet.Niemeier@carolinashealthcare.org	Ketchum, Jessica/AAE-8200-2020; Walker, William C/N-3162-2014	Bushnik, Tamara/0000-0003-3328-257X; Ripley, David/0000-0002-5349-1830; Ketchum, Jessica/0000-0002-5566-3691	National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Department of Education, Washington, DC, USA [H133A070036]	This work was supported by Grant # H133A070036 from the National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Department of Education, Washington, DC, USA	American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, 2008, Obstet Gynecol, V112, P1189, DOI 10.1097/AOG.0b013e31818e8782; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Benton A, 2000, MULTILINGUAL APHASIA; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Greendale GA, 2009, NEUROLOGY, V72, P1850, DOI 10.1212/WNL.0b013e3181a71193; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Masood DEN, 2010, CURR DRUG METAB, V11, P693, DOI 10.2174/138920010794233477; Mauritz W, 2009, EUR J EMERG MED, V16, P153, DOI 10.1097/MEJ.0b013e32832a0864; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Parks Jennifer K, 2010, Proc (Bayl Univ Med Cent), V23, P355; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reitan RM, 1992, TRAIL MAKING TEST MA; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schmidt M., 1996, REY AUDITORY VERBAL; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Smith, 1973, SYMBOL DIGIT MODALIT; Soules M R, 2001, Menopause, V8, P402, DOI 10.1097/00042192-200111000-00004; Soules MR, 2005, MENOPAUSE, V12, P117, DOI 10.1097/00042192-200512020-00001; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Vliet EL, 2002, PRIMARY CARE, V29, P43, DOI 10.1016/S0095-4543(03)00073-3; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wright DW, 2008, BRAIN INJURY, V22, P107, DOI 10.1080/02699050701867399; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46	63	9	9	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUN 1	2013	23	3					363	382		10.1080/09602011.2012.761944			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	145UT	WOS:000319044500004	23362827				2022-02-06	
J	Pansard, E; Schnitzler, A; Lautridou, C; Judet, T; Denormandie, P; Genet, F				Pansard, Erwan; Schnitzler, Alexis; Lautridou, Christine; Judet, Thierry; Denormandie, Philippe; Genet, Francois			Heterotopic ossification of the shoulder after central nervous system lesion: indications for surgery and results	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Heterotopic ossification; shoulder; surgical approaches	SPINAL-CORD-INJURY; METAPHYSEAL REGION; BRAIN; IMMOBILIZATION; HIP; POPULATION; ANATOMY	Background: Heterotopic ossification (HO) of the shoulder after central nervous system damage has seldom been studied. Materials and methods: We performed a single-center retrospective study from 1993 to 2009 including patients who underwent surgery for troublesome shoulder HO. Demographic data, HO location, surgical approach, preoperative and postoperative shoulder range of motion, etiologies, and postoperative complications were collected from patients' files. Results: We found 19 shoulder HOs in 16 patients (traumatic brain injury in 11, spinal cord injury in 2, stroke in 1, and cerebral anoxia in 2). The data in 2 files were incomplete and were therefore not used. HO locations around the joint were anteroinferomedial in 4 (21.1%), posteroinferomedial in 5 (26.3%), encircling in 3 (15.8%), superior in 1 (5.3%), and mixed (2 associated HOs that are not encircling) in 6 (31.6%). The surgical approaches were as follows: deltopectoral, 5 (26.3%); Neer, 3 (15.8%); posterior, 5 (26.3%); axillary, 1 (5.3%); Martini, 2 (10.5%); posterior associated with deltopectoral, 2 (10.5%); and Neer (superolateral) associated with deltopectoral, 1 (5.3%). The mean range of motion increased significantly (gain at follow-up of 69 degrees, 60 degrees, and 13 degrees in forward elevation, abduction, and lateral rotation, respectively). Regarding postoperative complications, there was 1 case of capsulitis and 1 reoperation for insufficient excision (because of hemorrhage during surgery). There were no other side effects. Conclusion: Anatomic relations with nerves and vessels, as well as limited range of motion, require a case-by-case surgical approach, a preoperative scan (looking for a gutter), and sometimes, electromyography. Surgical indications depend on the degree of loss of function or hygiene, control of comorbid factors, and discussion with the patient and his or her family. Level of evidence: Level IV, Case Series, Treatment Study. (C) 2013 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Pansard, Erwan; Lautridou, Christine; Judet, Thierry; Denormandie, Philippe] Hop Raymond Poincare, Serv Chirurg Orthoped & Traumatol, F-92380 Garches, France; [Schnitzler, Alexis; Genet, Francois] Hop Raymond Poincare, Serv Med Phys & Readaptat, F-92380 Garches, France; [Genet, Francois] Univ Versailles St Quentin, Versailles, France		Genet, F (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, 104 Blvd Raymond Poincare, F-92380 Garches, France.	francois.genet@rpc.aphp.fr					ABBOTT LC, 1949, J BONE JOINT SURG AM, V31-A, P235, DOI 10.2106/00004623-194931020-00002; AKESON WH, 1987, CLIN ORTHOP RELAT R, P28; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; BAIRD EO, 2009, J ORTHOPAEDIC SURG R, V20, P4; Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Baldwin KA, 2011, PUBLIC HEALTH NURS, V28, P57, DOI 10.1111/j.1525-1446.2010.00899.x; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Bono CM, 2000, CLIN ORTHOP RELAT R, P259; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; da Paz AC, 2007, MED HYPOTHESES, V68, P67, DOI 10.1016/j.mehy.2006.06.035; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286, DOI 10.1302/0301-620X.43B2.286; ENNEKING WF, 1972, J BONE JOINT SURG AM, VA 54, P973, DOI 10.2106/00004623-197254050-00003; FLATOW EL, 1991, J BONE JOINT SURG AM, V73A, P1213, DOI 10.2106/00004623-199173080-00011; Freebourn TM, 1999, SPINAL CORD, V37, P50, DOI 10.1038/sj.sc.3100719; Fuller DA, 2012, J SHOULDER ELBOW SUR; Gagey O, 2001, J SHOULDER ELB SURG, V10, P47, DOI 10.1067/mse.2001.109383; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; HARAN M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003321.PUB3; Issel LM, 2011, PUBLIC HEALTH NURS, V28, P24, DOI 10.1111/j.1525-1446.2010.00885.x; Jaovisidha S, 1998, SPINAL CORD, V36, P647, DOI 10.1038/sj.sc.3100701; Keenan MAE, 2004, J HEAD TRAUMA REHAB, V19, P143, DOI 10.1097/00001199-200403000-00006; Kjaersgaard-Andersen P, 1989, J Arthroplasty, V4, P99; LOOMER R, 1989, CLIN ORTHOP RELAT R, P100; MARTINI M, 1976, J BONE JOINT SURG AM, V58, P377, DOI 10.2106/00004623-197658030-00015; MARTINI M, 1981, REV CHIR ORTHOP, V67, P631; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Namdari S, 2011, ORTHOPEDICS, V34, pE541, DOI 10.3928/01477447-20110714-09; Narmoneva DA, 2002, J ORTHOP RES, V20, P83, DOI 10.1016/S0736-0266(01)00076-6; Pelissier J., 2002, Annales de Readaptation et de Medecine Physique, V45, P188, DOI 10.1016/S0168-6054(02)00202-7; Robinson CM, 2007, J ORTHOP TRAUMA, V21, P657, DOI 10.1097/BOT.0b013e3180ce833e; SUNDERLAND S, 1990, MUSCLE NERVE, V13, P771, DOI 10.1002/mus.880130903; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; WENNER SM, 1986, CLIN ORTHOP RELAT R, P231; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010	41	9	9	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	JUN	2013	22	6					767	774		10.1016/j.jse.2012.08.017			8	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	172IP	WOS:000320995800014	23246198				2022-02-06	
J	Perel, P; Prieto-Merino, D; Shakur, H; Roberts, I				Perel, P.; Prieto-Merino, D.; Shakur, H.; Roberts, I.			Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial	HEALTH TECHNOLOGY ASSESSMENT			English	Article							MAJOR TRAUMA; BRAIN-INJURY; VITAL SIGNS; PREVENTABLE DEATHS; MANAGEMENT; CARE; IMPACT; INTERVENTIONS; EPIDEMIOLOGY; HYPOTENSION	Background: Severe bleeding accounts for about one-third of in-hospital trauma deaths. Patients with a high baseline risk of death have the most to gain from the use of life-saving treatments. An accurate and user-friendly prognostic model to predict mortality in bleeding trauma patients could assist doctors and paramedics in pre-hospital triage and could shorten the time to diagnostic and life-saving procedures such as surgery and tranexamic acid (TXA). Objectives: The aim of the study was to develop and validate a prognostic model for early mortality in patients with traumatic bleeding and to examine whether or not the effect of TXA on the risk of death and thrombotic events in bleeding adult trauma patients varies according to baseline risk. Design: Multivariable logistic regression and risk-stratified analysis of a large international cohort of trauma patients. Setting: Two hundred and seventy-four hospitals in 40 high-, medium-and low-income countries. Participants: We derived prognostic models in a large placebo-controlled trial of the effects of early administration of a short course of TXA [Clinical Randomisation of an Anti.brinolytic in Significant Haemorrhage (CRASH-2) trial]. The trial included 20,127 trauma patients with, or at risk of, significant bleeding, within 8 hours of injury. We externally validated the model on 14,220 selected trauma patients from the Trauma Audit and Research Network (TARN), which included mainly patients from the UK. We examined the effect of TXA on all-cause mortality, death due to bleeding and thrombotic events (fatal and non-fatal myocardial infarction, stroke, deep-vein thrombosis and pulmonary embolism) within risk strata in the CRASH-2 trial data set and we estimated the proportion of premature deaths averted by applying the odds ratio (OR) from the CRASH-2 trial to each of the risk strata in TARN. Interventions: For the stratified analysis according baseline risk we considered the intervention TXA (1 g over 10 minutes followed by 1 g over 8 hours) or matching placebo. Main outcome measures: For the prognostic models we included predictors for death in hospital within 4 weeks of injury. For the stratified analysis we reported ORs for all causes of death, death due to bleeding, and fatal and non-fatal thrombotic events associated with the use of TXA according to baseline risk. Results: A total of 3076 (15%) patients died in the CRASH-2 trial and 1705 (12%) in the TARN data set. Glasgow Coma Scale score, age and systolic blood pressure were the strongest predictors of mortality. Discrimination and calibration were satisfactory, with C-statistics > 0.80 in both CRASH-2 trial and TARN data sets. A simple chart was constructed to readily provide the probability of death at the point of care, while a web-based calculator is available for a more detailed risk assessment. TXA reduced all-cause mortality and death due to bleeding in each stratum of baseline risk. There was no evidence of heterogeneity in the effect of TXA on all-cause mortality (p-value for interaction = 0.96) or death due to bleeding (p = 0.98). There was a significant reduction in the odds of fatal and non-fatal thrombotic events with TXA (OR = 0.69, 95% confidence interval 0.53 to 0.89; p = 0.005). There was no evidence of heterogeneity in the effect of TXA on the risk of thrombotic events (p = 0.74). Conclusions: This prognostic model can be used to obtain valid predictions of mortality in patients with traumatic bleeding. TXA can be administered safely to a wide spectrum of bleeding trauma patients and should not be restricted to the most severely injured. Future research should evaluate whether or not the use of this prognostic model in clinical practice has an impact on the management and outcomes of trauma patients.	[Perel, P.; Prieto-Merino, D.; Shakur, H.; Roberts, I.] London Sch Hyg & Trop Med, London WC1, England		Perel, P (corresponding author), London Sch Hyg & Trop Med, London WC1, England.		; Hemingway, Harry/C-1219-2009	Prieto-Merino, David/0000-0001-5001-0061; Hemingway, Harry/0000-0003-2279-0624; Shakur-Still, Haleema/0000-0002-6511-109X	National Institute for Health Research Health Technology Assessment programmeNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0902393] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K006584/1, MC_PC_13041, G0902393] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [06/303/20, 11/01/04, 09/22/165] Funding Source: researchfish	The National Institute for Health Research Health Technology Assessment programme.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.3.CO;2-X; ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; BULL JP, 1964, PROG SURG, V27, P35; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Christensen MC, 2008, INJURY, V39, P1013, DOI 10.1016/j.injury.2008.01.012; Cocchi MN, 2007, EMERG MED CLIN N AM, V25, P623, DOI 10.1016/j.emc.2007.06.001; Dutton Richard P, 2007, Anesthesiol Clin, V25, P23, DOI 10.1016/j.atc.2006.11.007; FISHER RB, 1990, BRIT MED J, V300, P1560, DOI 10.1136/bmj.300.6739.1560; Freeman Jenny, 2006, J Health Serv Res Policy, V11, P101, DOI 10.1258/135581906776318857; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Godier A, 2012, CRIT CARE, V16, DOI 10.1186/cc11374; Grove WM, 2000, PSYCHOL ASSESSMENT, V12, P19, DOI 10.1037/1040-3590.12.1.19; Guly HR, 2011, RESUSCITATION, V82, P556, DOI 10.1016/j.resuscitation.2011.01.013; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Holcomb JB, 2005, J TRAUMA, V59, P821, DOI 10.1097/01.ta.0000188125.44129.7c; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Jimenez JJ, 2007, CRIT CARE, V11, DOI 10.1186/cc6173; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Kilner T, 2002, EMERG MED J, V19, P348, DOI 10.1136/emj.19.4.348; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Liao L, 2003, J AM COLL CARDIOL, V42, P851, DOI 10.1016/S0735-1097(03)00836-2; LITTLE RA, 1995, J ACCID EMERG MED, V12, P1; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mabry R, 2008, CRIT CARE MED, V36, pS258, DOI 10.1097/CCM.0b013e31817da674; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Moore L, 2006, J TRAUMA, V60, P305, DOI 10.1097/01.ta.0000200840.89685.b0; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; Parks JK, 2006, AM J SURG, V192, P727, DOI 10.1016/j.amjsurg.2006.08.034; Patton K, 2001, J TRAUMA, V50, P914, DOI 10.1097/00005373-200105000-00023; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-72; RADY MY, 1994, ANN EMERG MED, V24, P685, DOI 10.1016/S0196-0644(94)70279-9; Redelmeier DA, 2001, JAMA-J AM MED ASSOC, V285, P3024, DOI 10.1001/jama.285.23.3024; Rehn M, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-17; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schull MJ, 2001, CAN MED ASSOC J, V164, P1170; Shah AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000439; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; Smeeth L, 2010, NAT REV CARDIOL, V7, P409, DOI 10.1038/nrcardio.2010.64; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Steyerberg, 2019, CLIN PREDICTION MODE; Tall Gary, 2003, Emerg Med (Fremantle), V15, P318, DOI 10.1046/j.1442-2026.2003.00469.x; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; van der Velden MWA, 2008, EMERG MED J, V25, P444, DOI 10.1136/emj.2007.052662; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5; Wardle TD, 1999, BRIT MED BULL, V55, P744, DOI 10.1258/0007142991902754; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; 2000, BETT CAR SEV INJ; 2008, BMJ, V12, P12; 2006, PLOS CLIN TRIALS, V1, pE30	67	9	10	1	9	NIHR JOURNALS LIBRARY	SOUTHAMPTON	UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND	1366-5278	2046-4924		HEALTH TECHNOL ASSES	Health Technol. Assess.	JUN	2013	17	24					1	+		10.3310/hta17240			43	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	167AP	WOS:000320602800001	23782457	Green Accepted, Green Published, gold			2022-02-06	
J	Ruedl, G; Kopp, M; Burtscher, M; Bauer, R; Benedetto, K				Ruedl, G.; Kopp, M.; Burtscher, M.; Bauer, R.; Benedetto, K.			Causes and Factors Associated with Collisions on Ski Slopes	SPORTVERLETZUNG-SPORTSCHADEN			German	Article						alpine skiing; ski injury; collision; ski helmet	INJURIES; RISK; SNOWBOARDERS; TIME	Background: Annually, in Austria more than 10 million people participate in winter sport activities such as alpine skiing, snowboarding, cross country skiing and ski touring. About 80 - 90 % of all accidents are caused by a fall without other people involved and about 10% are caused by collisions between people. Methods: In the winter season 2011/2012, skiers and snowboarders injured due to a fall or a collision on a ski slope have been interviewed about potential intrinsic and extrinsic risk factors in the Austrian province Vorarlberg. Results: In total, 1741 people injured by a self-inflicted fall and 137 people injured due to a collision have been interviewed. People injured due to a collision showed more often a head injury (15 vs. 8%) and more often a concussion (15 vs. 6%). Furthermore, people injured due to a collision were significantly older (41 vs. 33 years) and showed a higher proportion of skiers (86 vs. 79%) as well as of higher skilled people (83 vs. 74%) compared to those injured by a self-inflicted fall. Collisions between sport participants incurred significantly more often on slope intersections (11 vs. 4%), when more people were on ski slopes (30 vs. 12%) and when the sun was shining (85 vs. 69%). Conclusion: According to the results of this study, preventive recommendations to reduce the risk of a collision include an adaptation of the individual skiing or snowboarding behaviour and the actual speed on skill level, weather conditions and number of other skiers and snowboarders on ski slopes. In addition, influences of adaptive visual information and supervision systems at slope intersections and in relation to weather and traffic conditions should be evaluated.	[Ruedl, G.; Kopp, M.; Burtscher, M.] Inst Sportwissensch Innsbruck, Innsbruck, Austria; [Bauer, R.] KFV Kuratorium Verkehrssicherheit, Salzburg, Austria; [Benedetto, K.] Landeskrankenhaus Feldkirch, Feldkirch, Austria		Ruedl, G (corresponding author), Univ Innsbruck, Inst Sportwissensch, Furstenweg 185, A-6020 Innsbruck, Austria.	gerhard.ruedl@uibk.ac.at	Kopp, Martin/K-1369-2017; Burtscher, Martin/M-7015-2019	Kopp, Martin/0000-0002-3011-387X; Burtscher, Martin/0000-0002-5232-3632			[Anonymous], 2007, UNFALLCHIRURG, V4, P301; [Anonymous], 2007, AC SCOTL 17 INT S SK; [Anonymous], 2011, ZAHLEN; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Burtscher M., 2009, SCI SKIING, P183; Burtscher M, 2008, CLIN J SPORT MED, V18, P355, DOI 10.1097/MJT.0b013e31815fd0fe; Burtscher M, 2010, PROG CARDIOVASC DIS, V52, P507, DOI 10.1016/j.pcad.2010.02.008; Ekeland Arne, 2010, Journal of ASTM International, V7, DOI 10.1520/JAI102817; Hildebrandt C, 2011, ACCIDENT ANAL PREV, V43, P1421, DOI 10.1016/j.aap.2011.02.018; Kim S, 2012, AM J SPORT MED, V40, P770, DOI 10.1177/0363546511433279; Meyers AR, 1997, AM SOC TEST MATER, V1289, P14, DOI 10.1520/STP18284S; Meyers MC, 2007, SPORTS MED, V37, P485, DOI 10.2165/00007256-200737060-00003; Mote CD, 1997, ASTM STP, V1289, P73; Muser MH, 2009, DEUT Z SPORTMED, V60, P315; Ruedl G, 2012, SCAND J MED SCI SPOR, V22, P185, DOI 10.1111/j.1600-0838.2011.01286.x; Ruedl G, 2010, SPORTVERLETZ SPORTSC, V24, P150, DOI 10.1055/s-0029-1245578; Ruedl G, 2010, DEUT Z SPORTMED, V61, P97; Ruedl G, 2013, ACCIDENT ANAL PREV, V50, P1221, DOI 10.1016/j.aap.2012.09.019; Ruedl G, 2012, ACCIDENT ANAL PREV, V48, P292, DOI 10.1016/j.aap.2012.01.031; Ruedl G, 2011, WILD ENVIRON MED, V22, P326, DOI 10.1016/j.wem.2011.06.008; Ruedl G, 2009, KNEE SURG SPORT TR A, V17, P1393, DOI 10.1007/s00167-009-0860-7; Sulheim S, 2007, KNEE SURG SPORT TR A, V15, P665, DOI 10.1007/s00167-006-0122-x	22	9	9	4	25	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0932-0555	1439-1236		SPORTVERLETZ SPORTSC	Sportverletz. Sportschaden	JUN	2013	27	2					100	104		10.1055/s-0032-1330767			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	187AL	WOS:000322087700005	23404456				2022-02-06	
J	Yoon, MK; Parsa, AT; Horton, JC				Yoon, Michael K.; Parsa, Andrew T.; Horton, Jonathan C.			Skull thickening, paranasal sinus expansion, and sella turcica shrinkage from chronic intracranial hypotension	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						enophthalmos; ventriculoperitoneal shunt; cerebrospinal fluid; hydrocephalus; pneumocephalus; Sunken Eyes, Sagging Brain Syndrome	BILATERAL ENOPHTHALMOS; BRAIN-SYNDROME; HYDROCEPHALUS; SHUNTS; MANAGEMENT; PRESSURE; VALVE	In children or young adults, the morphology of the skull can be altered by excessive drainage of CSF following placement of a ventriculoperitoneal (VP) shunt. In Sunken Eyes, Sagging Brain Syndrome, gradual enlargement of the orbital cavity occurs from low or negative intracranial pressure (ICP), leading to progressive bilateral enophthalmos. The authors report several heretofore unrecognized manifestations of this syndrome, which developed in a 29-year-old man with a history of VP shunt placement following a traumatic brain injury at the age of 9 years. Magnetic resonance imaging showed typical features of chronic intracranial hypotension, and lumbar puncture yielded an unrecordable subarachnoid opening pressure. The calvaria was twice its normal thickness, owing to contraction of the inner table. The paranasal sinuses were expanded, with aeration of the anterior clinoid processes, greater sphenoid wings, and temporal bones. The sella turcica showed a 50% reduction in cross-sectional area as compared with that in control subjects, resulting in partial extrusion of the pituitary gland. These new features broaden the spectrum of clinical findings associated with low ICP. Secondary installation of a valve to restore normal ICP is recommended to halt progression of these rare complications of VP shunt placement.	[Yoon, Michael K.] Harvard Univ, Sch Med, Dept Ophthalmol, Cambridge, MA 02138 USA; [Yoon, Michael K.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Parsa, Andrew T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Horton, Jonathan C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Horton, Jonathan C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Horton, Jonathan C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA		Horton, JC (corresponding author), Univ Calif San Francisco, 10 Koret Way, San Francisco, CA 94143 USA.	hortonj@vision.ucsf.edu		Yoon, Michael/0000-0002-8793-7685	National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY10217]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R56EY010217, R01EY010217] Funding Source: NIH RePORTER	This work was supported by National Eye Institute Grant No. EY10217 and Research to Prevent Blindness.	ANDERSON R, 1970, AMER J ROENTGENOL RA, V110, P96, DOI 10.2214/ajr.110.1.96; Arriada N, 2004, J NEUROSURG, V101, P762, DOI 10.3171/jns.2004.101.5.0762; Aschoff A, 1999, NEUROSURG REV, V22, P67, DOI 10.1007/s101430050035; Bernardini FP, 2009, OPHTHAL PLAST RECONS, V25, P434, DOI 10.1097/IOP.0b013e3181b80d2d; Browd SR, 2006, PEDIATR NEUROL, V34, P171, DOI 10.1016/j.pediatrneurol.2005.05.021; Chan WO, 2009, CLIN EXP OPHTHALMOL, V37, P496, DOI 10.1111/j.1442-9071.2009.02087.x; Cruz AAV, 2008, OPHTHAL PLAST RECONS, V24, P152, DOI 10.1097/IOP.0b013e318166dc91; Davidson JK, 1999, ARCH OPHTHALMOL-CHIC, V117, P1653; DIROCCO C, 1994, CHILD NERV SYST, V10, P321, DOI 10.1007/BF00335171; Drake JM, 2000, CHILD NERV SYST, V16, P800, DOI 10.1007/s003810000351; Durig J, 1998, KLIN MONATSBL AUGENH, V212, P397, DOI 10.1055/s-2008-1034917; Fishman R. A., 1992, CEREBROSPINAL FLUID, V2nd; Fishman RA, 1997, J NEUROSURG, V86, P165; Ganchi PA, 2004, J CRANIOFAC SURG, V15, P84, DOI 10.1097/00001665-200401000-00024; GRISCOM NT, 1970, AMER J ROENTGENOL RA, V110, P106, DOI 10.2214/ajr.110.1.106; HORTON JC, 1994, OPHTHALMOLOGY, V101, P244; Hwang K, 1997, J CRANIOFAC SURG, V8, P208, DOI 10.1097/00001665-199705000-00013; Hwang TN, 2011, OPHTHALMOLOGY, V118, P2286, DOI 10.1016/j.ophtha.2011.04.031; KAUFMAN B, 1970, RADIOLOGY, V97, P537, DOI 10.1148/97.3.537; Kestle JRW, 2005, J NEUROSURG, V102, P141, DOI 10.3171/jns.2005.102.2.0141; Kestle JRW, 2003, NEUROL CLIN, V21, P883, DOI 10.1016/S0733-8619(03)00016-1; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Meyer DR, 1996, ARCH OPHTHALMOL-CHIC, V114, P1206, DOI 10.1001/archopht.1996.01100140406007; MOSELEY JE, 1966, RADIOLOGY, V87, P1105, DOI 10.1148/87.6.1105; Naradzay JFX, 1999, J EMERG MED, V17, P311, DOI 10.1016/S0736-4679(98)00168-1; NULSEN FE, 1951, SURG FORUM, V2, P399; Numa WA, 2005, ANN OTO RHINOL LARYN, V114, P688, DOI 10.1177/000348940511400906; PANNULLO SC, 1993, NEUROLOGY, V43, P919, DOI 10.1212/WNL.43.5.919; Poca MA, 2006, NEUROSURGERY, V58, P899, DOI 10.1227/01.NEU.0000209915.16235.6D; Robinson S, 2002, PEDIATR NEUROSURG, V37, P287, DOI 10.1159/000066307; Sivasubramaniam R, 2011, J LARYNGOL OTOL, V125, P1239, DOI 10.1017/S0022215111001952; Weinzweig J, 2008, PLAST RECONSTR SURG, V122, P1171, DOI 10.1097/PRS.0b013e3181858c84; Yoon MK, 2011, STRABISMUS, V19, P142, DOI 10.3109/09273972.2011.620060	33	9	9	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2013	11	6					667	672		10.3171/2013.2.PEDS12560			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	150CD	WOS:000319366900009	23540524	Green Submitted			2022-02-06	
J	Redelmeier, DA; Markel, F; Scales, DC				Redelmeier, Donald A.; Markel, Frank; Scales, Damon C.			Organ donation after death in Ontario: a population-based cohort study	CANADIAN MEDICAL ASSOCIATION JOURNAL			English	Article							KIDNEY-TRANSPLANTATION; DONORS; OLDER; CONSENT; NUMBER; AUDIT; CARE	Background: Shortfalls in deceased organ donation lead to shortages of solid organs available for transplantation. We assessed rates of deceased organ donation and compared hospitals that had clinical services for transplant recipients (transplant hospitals) to those that did not (general hospitals). Methods: We conducted a population-based cohort analysis involving patients who died from traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage or other catastrophic neurologic conditions in Ontario, Canada, between Apr. 1, 1994, and Mar. 31, 2011. We distinguished between acute care hospitals with and without transplant services. The primary outcome was actual organ donation determined through the physician database for organ procurement procedures. Results: Overall, 87 129 patients died from catastrophic neurologic conditions during the study period, of whom 1930 became actual donors. Our primary analysis excluded patients from small hospitals, reducing the total to 79 746 patients, of whom 1898 became actual donors. Patients who died in transplant hospitals had a distribution of demographic characteristics similar to that of patients who died in other large general hospitals. Transplant hospitals had an actual donor rate per 100 deaths that was about 4 times the donor rate at large general hospitals (5.0 v. 1.4, p < 0.001). The relative reduction in donations at general hospitals was accentuated among older patients, persisted among patients who were the most eligible candidates and amounted to about 121 fewer actual donors per year (adjusted odds ratio 0.58, 95% confidence interval 0.36-0.92). Hospital volumes were only weakly correlated with actual organ donation rates. Interpretation: Optimizing organ donation requires greater attention to large general hospitals. These hospitals account for most of the potential donors and missed opportunities for deceased organ donation.	[Redelmeier, Donald A.; Scales, Damon C.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Redelmeier, Donald A.; Scales, Damon C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Markel, Frank] Trillium Gift Life Network, Toronto, ON, Canada; [Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada		Redelmeier, DA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	dar@ices.on.ca			Canada Research Chair in Medical Decision SciencesCanada Research Chairs; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Physicians' Services Incorporated Foundation; Trillium Gift of Life Network	This project was supported by the Canada Research Chair in Medical Decision Sciences, a New Investigator Award from the Canadian Institutes of Health Research, a Fellowship in Translational Health Research from the Physicians' Services Incorporated Foundation, and an unrestricted grant from the Trillium Gift of Life Network. The funding organizations had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript.	Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Chavalitdhamrong D, 2008, TRANSPLANTATION, V85, P1573, DOI 10.1097/TP.0b013e31817059a1; Cloutier R, 2006, CAN J ANAESTH, V53, P716, DOI 10.1007/BF03021631; Ghorbani F, 2011, TRANSPL P, V43, P405, DOI 10.1016/j.transproceed.2011.01.031; Gortmaker SL, 1996, CRIT CARE MED, V24, P432, DOI 10.1097/00003246-199603000-00012; Greer DM, 2008, NEUROLOGY, V70, P284, DOI 10.1212/01.wnl.0000296278.59487.c2; Hauptman PJ, 1997, NEW ENGL J MED, V336, P422, DOI 10.1056/NEJM199702063360607; Horvat LD, 2010, ANN INTERN MED, V153, P641, DOI 10.7326/0003-4819-153-10-201011160-00006; Hubbard WJ, 2011, AGING DIS, V2, P181; Iron K, 2008, CIHI DATA QUALITY ST; Jassal SV, 2003, J AM SOC NEPHROL, V14, P187, DOI 10.1097/01.ASN.0000042166.70351.57; Kahneman D., 2012, THINKING FAST SLOW; Kennedy I, 1998, LANCET, V351, P1650, DOI 10.1016/S0140-6736(97)08212-3; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; Lai Q, 2011, J GASTROINTEST LIVER, V20, P383; LeBoeuf RA, 2010, ORGAN BEHAV HUM DEC, V111, P48, DOI 10.1016/j.obhdp.2009.08.004; Opdam HI, 2004, INTENS CARE MED, V30, P1390, DOI 10.1007/s00134-004-2185-9; Rachlin H, 2011, BEHAV PROCESS, V87, P25, DOI 10.1016/j.beproc.2010.12.004; Remuzzi G, 2006, NEW ENGL J MED, V354, P343, DOI 10.1056/NEJMoa052891; Ross L., 1991, PERSON SITUATION PER; Scales DC, 2005, PRINCIPLES CITICAL C; Schull M.J., 2010, DEV CONSENSUS EVIDEN; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; Shemie SD, 2006, CAN MED ASSOC J, V174, pS13, DOI 10.1503/cmaj.045131; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Simpkin AL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b991; Singhal A, 2010, EXP CLIN TRANSPLANT, V8, P196; Wilkins, 2004, AUTOMATED GEOGRAPHIC; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103; Young A, 2011, AM J TRANSPLANT, V11, P743, DOI 10.1111/j.1600-6143.2011.03442.x	31	9	9	0	6	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0820-3946	1488-2329		CAN MED ASSOC J	Can. Med. Assoc. J.	MAY 14	2013	185	8					E337	E344		10.1503/cmaj.122047			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180XM	WOS:000321632500015	23549970	gold, Green Published			2022-02-06	
J	Straka, L; Novomesky, F; Stuller, F; Janik, M; Krajcovic, J; Hejna, P				Straka, Lubomir; Novomesky, Frantisek; Stuller, Frantisek; Janik, Martin; Krajcovic, Jozef; Hejna, Petr			A planned complex suicide by gunshot and vehicular crash	FORENSIC SCIENCE INTERNATIONAL			English	Article						Forensic science; Forensic pathology; Complex suicide; Gunshot injury; Vehicular crash	HEAD; ACCIDENTS	Complex suicide is usually defined as the application of more than one killing mechanism to ensure a fatal outcome. Herein we report an unusual case of a planned complex suicide of a 20 year old-male combining gunshot with coincidental intentional vehicular crash. The case was initially assumed to be a simple traffic accident until a rimfire pistol was found in close proximity to the deceased as well as gunshot wound of the head. This paper demonstrates the importance of careful inspection of the death scene, as well as the complex performance of autopsy examination to explain the manner of death and distinguish accidental deaths from suicides in such cases. Nevertheless, this assessment might by very difficult or even impossible. It has to be assumed that a high number of suicides in road traffic remain undetected. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Straka, Lubomir; Novomesky, Frantisek; Stuller, Frantisek; Janik, Martin; Krajcovic, Jozef] Comenius Univ, Univ Hosp, Jessenius Fac Med, Inst Forens Med & Medicolegal Expertises, Martin 03659, Slovakia; [Hejna, Petr] Charles Univ Prague, Fac Med, Inst Forens Med, CR-11636 Prague 1, Czech Republic; [Hejna, Petr] Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic		Straka, L (corresponding author), Comenius Univ, Univ Hosp, Jessenius Fac Med, Inst Forens Med & Medicolegal Expertises, Martin 03659, Slovakia.	lubomir.straka@unm.sk	Krajcovic, Jozef/X-8330-2018; Hejna, Petr/AAN-8336-2021; Janik, Martin/X-6757-2018; Novomesky, Frantisek/Y-3714-2018	Hejna, Petr/0000-0002-9308-624X; Janik, Martin/0000-0002-5020-5018			Altun G, 2006, FORENSIC SCI INT, V157, P83, DOI 10.1016/j.forsciint.2005.04.039; BARZ J, 1973, Z RECHTSMED, V73, P61, DOI 10.1007/BF02114775; BlancoPampin JM, 1997, AM J FOREN MED PATH, V18, P104, DOI 10.1097/00000433-199703000-00020; Bohnert M, 2003, FORENSIC SCI INT, V131, P197, DOI 10.1016/S0379-0738(02)00449-8; Bohnert M, 2004, FOREN PATHOL REV, V2, P127; Bohnert Michael, 2004, Archiv fuer Kriminologie, V213, P138; Byard R W, 2001, J Clin Forensic Med, V8, P1, DOI 10.1054/jcfm.2000.0457; Cingolani M, 2000, AM J FOREN MED PATH, V21, P255, DOI 10.1097/00000433-200009000-00015; Connolly J F, 1995, Crisis, V16, P85, DOI 10.1027/0227-5910.16.2.85; FATTEH A, 1980, J FORENSIC SCI, V25, P883; Germerott T, 2010, FORENSIC SCI INT, V202, pE35, DOI 10.1016/j.forsciint.2010.04.053; Grellner Wolfgang, 2000, Archiv fuer Kriminologie, V205, P162; Hejna P, 2012, FORENSIC SCI MED PAT, V8, P296, DOI 10.1007/s12024-011-9304-z; Hernetkoski K, 1998, ACCIDENT ANAL PREV, V30, P697, DOI 10.1016/S0001-4575(97)00092-4; Keskinen E., 1990, J TRAFFIC MED, V18, P179; Kucerova S, 2012, Soud Lek, V57, P51; Kuchta J, 2009, J FORENSIC LEG MED, V16, P159, DOI 10.1016/j.jflm.2008.07.008; Kuroda N., 1994, J TRAFFIC MED, V23, P67; LUTZ FU, 1981, Z RECHTSMED, V86, P145; MARCINKOWSKI T, 1974, FORENSIC SCI, V3, P95, DOI 10.1016/0300-9432(74)90013-2; Murphy GK, 1997, AM J FOREN MED PATH, V18, P295, DOI 10.1097/00000433-199709000-00014; MURPHY GK, 1989, AM J FOREN MED PATH, V10, P285, DOI 10.1097/00000433-198912000-00002; Nikolic S, 2011, J FORENSIC SCI, V56, P248, DOI 10.1111/j.1556-4029.2010.01507.x; Ohberg A, 1997, BRIT J PSYCHIAT, V171, P468, DOI 10.1192/bjp.171.5.468; Padosch SA, 2006, FORENSIC SCI INT, V158, P224, DOI 10.1016/j.forsciint.2005.05.024; Parra MW, 2006, AM SURGEON, V72, P454; Parroni E, 2002, AM J FOREN MED PATH, V23, P329, DOI 10.1097/00000433-200212000-00005; Pelissier-Alicot AL, 2008, J FORENSIC SCI, V53, P968, DOI 10.1111/j.1556-4029.2008.00754.x; Perdekamp MG, 2011, INT J LEGAL MED, V125, P479, DOI 10.1007/s00414-010-0517-6; Petkovic S, 2011, J FORENSIC SCI, V56, P1368, DOI 10.1111/j.1556-4029.2011.01821.x; Pompili M, 2012, FORENSIC SCI INT, V223, P1, DOI 10.1016/j.forsciint.2012.04.012; Racette S, 2007, J FORENSIC SCI, V52, P449, DOI 10.1111/j.1556-4029.2007.00387.x; ROGERS DR, 1989, AM J FOREN MED PATH, V10, P338, DOI 10.1097/00000433-198912000-00013; SCHMIDT CW, 1977, AM J PSYCHIAT, V134, P175; Toero K, 2009, FORENSIC SCI INT, V184, P6, DOI 10.1016/j.forsciint.2008.10.020; Turk EE, 2004, FORENSIC SCI INT, V139, P35, DOI 10.1016/j.forsciint.2003.09.013; Viel G, 2009, FORENSIC SCI INT, V187, pE7, DOI 10.1016/j.forsciint.2009.01.022; Wyatt JP, 2009, J FORENSIC LEG MED, V16, P212, DOI 10.1016/j.jflm.2008.12.003	38	9	9	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	MAY 10	2013	228	1-3					E50	E53		10.1016/j.forsciint.2013.02.016			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	129HF	WOS:000317829100010	23465546				2022-02-06	
J	dos Reis, HFC; Almeida, MLO; da Silva, MF; Rocha, MD				Correia dos Reis, Helena Franca; Oliveira Almeida, Monica Lajana; da Silva, Mario Ferreira; Rocha, Mario de Seixas			Extubation failure influences clinical and functional outcomes in patients with traumatic brain injury	JORNAL BRASILEIRO DE PNEUMOLOGIA			Portuguese	Article						Brain injuries; Ventilator weaning; Intensive care units; Glasgow outcome scale	INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; FAILED EXTUBATION; REINTUBATION; PREDICTORS	Objective: To evaluate the association between extubation failure and outcomes (clinical and functional) in patients with traumatic brain injury (TBI). Methods: A prospective cohort study involving 311 consecutive patients with TBI. The patients were divided into two groups according to extubation outcome: extubation success; and extubation failure (defined as reintubation within 48 h after extubation). A multivariate model was developed in order to determine whether extubation failure was an independent predictor of in-hospital mortality. Results: The mean age was 35.7 +/- 13.8 years. Males accounted for 92.3%. The incidence of extubation failure was 13.8%. In-hospital mortality was 4.5% and 20.9% in successfully extubated patients and in those with extubation failure, respectively (p = 0.001). Tracheostomy was more common in the extubation failure group (55.8% vs. 1.9%; p < 0.001). The median length of hospital stay was significantly greater in the extubation failure group than in the extubation success group (44 days vs. 27 days; p = 0.002). Functional status at discharge was worse among the patients in the extubation failure group. The multivariate analysis showed that extubation failure was an independent predictor of in-hospital mortality (OR = 4.96; 95% CI, 1.86-13.22). Conclusions: In patients with TBI, extubation failure appears to lengthen hospital stays; to increase the frequency of tracheostomy and of pulmonary complications; to worsen functional outcomes; and to increase mortality.	[Correia dos Reis, Helena Franca; Oliveira Almeida, Monica Lajana; da Silva, Mario Ferreira; Rocha, Mario de Seixas] Escola Bahiana Med & Saude Publ, Programa Posgrad Med & Saude Humana, Salvador, BA, Brazil		dos Reis, HFC (corresponding author), Rua Comendador Pereira da Silva,174,Brotas, BR-40285040 Salvador, BA, Brazil.	lenafran@gmail.com					Anderson CD, 2011, NEUROCRIT CARE, V15, P490, DOI 10.1007/s12028-010-9369-7; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Cheng AC, 2011, INT J GERONTOL, V5, P206, DOI 10.1016/j.ijge.2011.09.021; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Epstein SK, 2002, INTENS CARE MED, V28, P535, DOI 10.1007/s00134-002-1268-8; Epstein SK, 1998, AM J RESP CRIT CARE, V158, P489, DOI 10.1164/ajrccm.158.2.9711045; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Frutos-Vivar F, 2011, J CRIT CARE, V26, P502, DOI 10.1016/j.jcrc.2010.12.015; Garnacho-Montero J, 2005, CRIT CARE MED, V33, P349, DOI 10.1097/01.CCM.0000153521.41848.7E; Goldwasser Rosane, 2007, J Bras Pneumol, V33 Suppl 2S, pS128; Gowardman John R, 2006, Crit Care Resusc, V8, P328; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Karanjia N, 2011, NEUROCRIT CARE, V15, P4, DOI 10.1007/s12028-011-9528-5; Krinsley JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11185; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Menon N, 2012, RESP CARE, V57, P1555, DOI 10.4187/respcare.01617; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Rothaar Robert C, 2003, Curr Opin Crit Care, V9, P59, DOI 10.1097/00075198-200302000-00011; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; Saugel B, 2012, J CRIT CARE, V27, P571, DOI 10.1016/j.jcrc.2012.01.010; Savi A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.079; Seymour CW, 2004, CRIT CARE, V8, pR322, DOI 10.1186/cc2913; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Teixeira C, 2012, J BRAS PNEUMOL, V38, P364, DOI 10.1590/S1806-37132012000300012; Thille AW, 2011, CRIT CARE MED, V39, P2612, DOI 10.1097/CCM.0b013e3182282a5a; TORRES A, 1995, AM J RESP CRIT CARE, V152, P137, DOI 10.1164/ajrccm.152.1.7599812; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135; Vidotto MC, 2011, BRAZ J MED BIOL RES, V44, P1291, DOI [10.1590/S0100-879X2011007500146, 10.1590/S0100-879X2011001200014]	30	9	12	1	1	SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA	BRASILIA DF	SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145, BRAZIL	1806-3713	1806-3756		J BRAS PNEUMOL	J. Bras. Pneumol.	MAY-JUN	2013	39	3					330	338		10.1590/S1806-37132013000300010			9	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	168CV	WOS:000320684200010	23857695	Green Submitted, Green Published, gold			2022-02-06	
J	Holland, SR; Apodaca, A; Mabry, RL				Holland, Seth R.; Apodaca, Amy; Mabry, Robert L.			MEDEVAC: Survival and Physiological Parameters Improved With Higher Level of Flight Medic Training	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; RESUSCITATION; CARE; INTUBATION; DOCTOR	Objective: Determine if a higher level of Army flight medic (AFM) training was associated with improved physiological state on arrival to a combat support hospital (CSH). Methods: A retrospective study comparing casualties who were evacuated by two AFM units with only Emergency Medical Technicians-Basic (EMT-Bs) to an Army National Guard unit with Critical Care Flight Paramedics (CCFPs) in Afghanistan with an injury severity score >16 in different time periods looking at their 48-hour mortality, hematocrit (HCT), base deficit (BD), oxygen saturation (SpO(2)), and physiological parameters on arrival to the CSH. Results: The CCFP group had better HCT [36.5 (8.8)] than the EMT-B group [33.1 (11.4); p <= 0.001]. BD and SpO(2) were better in the CCFP group [-3.2 (4.7)]/[97.8 (4.8)] than the EMT-B group [-4.4 (5.5)]/[96.3 (10.9)] [p <= 0.014]. The CCFP group had a 72% lower estimated risk ratio of mortality with an associated improvement in 48-hour survivability of 4.9% versus 15.8% for the EMT-B-group. Conclusions: There is a statistically significant improvement in the HCT, BD, SpO(2), and 48-hour survivability at the CSH in the cohort transported by the CCFP group when compared to the cohort transported by the EMT-B group.	[Holland, Seth R.; Apodaca, Amy; Mabry, Robert L.] US Army Inst Surg Res, Ft Sam Houston, TX 78234 USA		Holland, SR (corresponding author), US Army Inst Surg Res, 3698 Chambers Pass,Bldg 3611, Ft Sam Houston, TX 78234 USA.						Alam HB, 2009, J TRAUMA, V67, P856, DOI 10.1097/TA.0b013e3181b5ae75; Bledsoe BE, 2004, J TRAUMA, V56, P1325, DOI 10.1097/01.TA.0000109001.35996.AF; Bledsoe BE, 2006, J TRAUMA, V60, P1257, DOI 10.1097/01.ta.0000196489.19928.c0; Bledsoe Bryan E, 2003, Emerg Med Serv, V32, P88; Calderbank P, 2011, EMERG MED J, V28, P882, DOI 10.1136/emj.2010.097642; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Defense Health Board, TACT EV CAR IMPR DEP; Eastridge Brian J, 2009, Am J Surg, V198, P852, DOI 10.1016/j.amjsurg.2009.04.029; Elliott DC, 1998, J AM COLL SURGEONS, V187, P536, DOI 10.1016/S1072-7515(98)00232-4; Fouche Y, 2010, CRIT CARE MED, V38, pS411, DOI 10.1097/CCM.0b013e3181ec5bdf; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; Greaves I, 2009, J R Army Med Corps, V155, P9; Hodgetts T J, 2009, J R Army Med Corps, V155, P4; Holcomb JB, 2003, J TRAUMA, V54, pS46, DOI 10.1097/01.TA.0000051936.91915.A2; Holleran Renee, 2004, Air Med J, V23, P15, DOI 10.1016/j.amj.2004.06.005; Hotvedt R, 2000, BRIT J GEN PRACT, V50, P41; Kincaid EH, 1998, J AM COLL SURGEONS, V187, P384, DOI 10.1016/S1072-7515(98)00202-6; Kurola J, 2002, ACTA ANAESTH SCAND, V46, P779, DOI 10.1034/j.1399-6576.2002.460704.x; Lemonick DM, 2009, AM J CLIN MED, V6, P5; Mabry Robert L, 2011, US Army Med Dep J, P92; Mabry Robert L, 2011, US Army Med Dep J, P87; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; McCowan CL, 2007, PREHOSP EMERG CARE, V11, P383, DOI 10.1080/10903120701536867; McCowan Christy L, 2008, Air Med J, V27, P78, DOI 10.1016/j.amj.2007.10.001; McLeod J, 2007, J R Army Med Corps, V153, P266; Nijboer JMM, 2007, J TRAUMA, V62, P1310, DOI 10.1097/TA.0b013e3180341f54; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Paramedics IAoF, 2009, CRIT CAR PAR POS STA; Pennardt A, 2010, J SPEC OPER MED, V10, P97; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Ringburg Akkie N, 2009, Air Med J, V28, P298, DOI 10.1016/j.amj.2009.03.007; Smith I, 2001, INTENS CARE MED, V27, P74, DOI 10.1007/s001340051352; Thomas Stephen H, 2002, Prehosp Emerg Care, V6, P359, DOI 10.1080/10903120290938508; (USASAM) USASoA, 2011, FLIGHT MED COURS DES; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wish John R, 2005, J Long Term Eff Med Implants, V15, P79, DOI 10.1615/JLongTermEffMedImplants.v15.i1.90	38	9	13	0	3	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2013	178	5					529	536		10.7205/MILMED-D-12-00286			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V39YX	WOS:000209447400011	23756012	Bronze			2022-02-06	
J	Hsieh, JH; Lin, WM; Chiang, H; Chang, LY; Wu, CT; Pu, CM; Wu, JT; Hsieh, ST				Hsieh, Jung-Hsien; Lin, Whei-Min; Chiang, Hao; Chang, Liang-Yi; Wu, Chun-Ting; Pu, Chi-Ming; Wu, June-Tai; Hsieh, Sung-Tsang			Patterns of Target Tissue Reinnervation and Trophic Factor Expression after Nerve Grafting	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							SWEAT GLAND INNERVATION; AXON REGENERATION; FUNCTIONAL RECOVERY; EXPERIMENTAL STRATEGIES; SENSORY NEURONS; MESSENGER-RNA; MOTOR-NEURONS; SCHWANN-CELLS; INJURY; SKIN	Background: Reinnervation of target tissues determines functional outcomes after nerve grafting, which is important in traumatic injury caused by accidents or consequences resulting from surgical removal of tumors. Previous studies documented the influences of nerve repair mainly based on nerve morphometry but rarely compared the final outcomes according to target reinnervation patterns by nerve fibers of different categories. Methods: In a mouse model of nerve grafting, the authors analyzed the innervation indexes of different target tissues after transection-reimplantation on the sciatic nerve, which were defined as a parameter on the operated side normalized to that on the control side. Results: Muscle reinnervation appeared to be the best compared with skin reinnervation (p < 0.0001) and sweat gland reinnervation (p < 0.0001) at postoperative month 3. The sudomotor reinnervation was relatively higher than the cutaneous reinnervation (p = 0.014). The abundance of trophin transcripts for brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), and neurotrophin 3 (NT3) was higher in plantar muscles on the operated side than those on the control side. In contrast, transcripts of BDNF, GDNF, nerve growth factor, and NT3 were all similar in the footpad skin between the operated and control sides. Conclusions: The results suggested that, compared with the skin, muscles achieved the best reinnervation after nerve grafting, which was related to higher expression of BDNF, GDNF, and NT3 in muscles than in the skin.	Natl Taiwan Univ, Grad Inst Mol Med, Grad Inst Brain & Mind Sci, Dept Anat,Coll Med,Sch Med,Dept Surg, Taipei 10764, Taiwan; Natl Taiwan Univ, Grad Inst Mol Med, Grad Inst Brain & Mind Sci, Dept Anat,Coll Med,Sch Med,Dept Neurol, Taipei 10764, Taiwan; Natl Taiwan Univ, Grad Inst Mol Med, Grad Inst Brain & Mind Sci, Dept Cell Biol,Coll Med,Sch Med,Dept Surg, Taipei 10764, Taiwan; Natl Taiwan Univ, Grad Inst Mol Med, Grad Inst Brain & Mind Sci, Dept Cell Biol,Coll Med,Sch Med,Dept Neurol, Taipei 10764, Taiwan; Cathay Gen Hospital, Dept Surg, Taipei, Taiwan		Hsieh, ST (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, 7 Chung Shan South Rd, Taipei 10002, Taiwan.	junetai@ntuh.gov.tw; shsieh@ntu.edu.tw	Hsieh, Sung-Tsang/J-5994-2019	Hsieh, Sung-Tsang/0000-0002-3188-8482; HSIEH, JUNG-HSIEN/0000-0002-3157-3560; WU, JUNE-TAI/0000-0002-4023-7315	National Science CouncilMinistry of Science and Technology, Taiwan [NSC97-2320-B-002-042-MY3, 100-2320-B-002-083-MY3]; National Health Research InstituteNational Health Research Institutes - Taiwan [NHRI-EX100-10045NI]; National Taiwan University College of MedicineNational Taiwan University; National Taiwan University HospitalNational Taiwan University [100C101-201]	This work was supported by the National Science Council (NSC97-2320-B-002-042-MY3 and 100-2320-B-002-083-MY3), the National Health Research Institute (NHRI-EX100-10045NI), and the Translational Medicine Project of National Taiwan University College of Medicine and National Taiwan University Hospital (100C101-201).	Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; BENNETT MR, 1973, J PHYSIOL-LONDON, V233, P481, DOI 10.1113/jphysiol.1973.sp010319; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; Bosse F, 2012, CELL TISSUE RES, V349, P5, DOI 10.1007/s00441-012-1389-5; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Chuang David Chwei-Chin, 2009, Plast Reconstr Surg, V124, pe359, DOI 10.1097/PRS.0b013e3181bcf16c; Costa LM, 2009, INT REV NEUROBIOL, V87, P127, DOI 10.1016/S0074-7742(09)87007-4; Eberhardt KA, 2006, EXP NEUROL, V198, P500, DOI 10.1016/j.expneurol.2005.12.018; El Bejjani R, 2012, NEURON, V73, P268, DOI 10.1016/j.neuron.2011.11.017; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; Gardiner NJ, 2011, DEV NEUROBIOL, V71, P1054, DOI 10.1002/dneu.20950; Geddes AJ, 2006, DEV DYNAM, V235, P2175, DOI 10.1002/dvdy.20877; Gibbons CH, 2009, NEUROLOGY, V72, P1479, DOI 10.1212/WNL.0b013e3181a2e8b8; GLOSTER A, 1992, J COMP NEUROL, V326, P363, DOI 10.1002/cne.903260305; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Gordon T, 2009, NEUROSURGERY, V65, pA132, DOI 10.1227/01.NEU.0000335650.09473.D3; Gorodetskaya N, 2009, J NEUROPHYSIOL, V102, P3129, DOI 10.1152/jn.00203.2009; Gould TW, 2009, NEUROSCIENTIST, V15, P105, DOI 10.1177/1073858408324787; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Griffin JW, 2010, EXP NEUROL, V223, P60, DOI 10.1016/j.expneurol.2009.12.033; Grothe C, 2006, BRAIN RES REV, V51, P293, DOI 10.1016/j.brainresrev.2005.12.001; Guntinas-Lichius O, 2007, LARYNGOSCOPE, V117, P421, DOI 10.1097/MLG.0b013e31802d83df; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Hsieh YL, 2008, J NEUROPATH EXP NEUR, V67, P93, DOI 10.1097/nen.0b013e3181630bb8; Hsieh YL, 2009, J NEUROPATH EXP NEUR, V68, P1269, DOI 10.1097/NEN.0b013e3181c17b46; Irintchev A, 2011, ANN ANAT, V193, P276, DOI 10.1016/j.aanat.2011.02.019; Iseli TA, 2010, LARYNGOSCOPE, V120, P478, DOI 10.1002/lary.20789; Jones RHB, 2010, AUST DENT J, V55, P112, DOI 10.1111/j.1834-7819.2010.01216.x; KENNEDY WR, 1988, MUSCLE NERVE, V11, P603, DOI 10.1002/mus.880110613; Koltzenburg M, 1996, J AUTONOM NERV SYST, V60, P193, DOI 10.1016/0165-1838(96)00052-5; Lin YY, 2008, EXP NEUROL, V213, P388, DOI 10.1016/j.expneurol.2008.07.001; Luo KR, 2011, J NEUROPATH EXP NEUR, V70, P930, DOI 10.1097/NEN.0b013e318230b0f4; MCLACHLAN EM, 1994, NEUROSCI LETT, V176, P147, DOI 10.1016/0304-3940(94)90069-8; MEAROW KM, 1993, NEUROREPORT, V4, P351, DOI 10.1097/00001756-199304000-00002; MEAROW KM, 1994, J NEUROBIOL, V25, P127, DOI 10.1002/neu.480250205; Mehta RP, 2009, CLIN EXP OTORHINOLAR, V2, P1, DOI 10.3342/ceo.2009.2.1.1; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; Michalski B, 2008, J NEUROCHEM, V105, P1244, DOI 10.1111/j.1471-4159.2008.05224.x; Montano JA, 2010, MICROSC RES TECHNIQ, V73, P513, DOI 10.1002/jemt.20790; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; NAVARRO X, 1994, EXP NEUROL, V129, P217, DOI 10.1006/exnr.1994.1163; NAVARRO X, 1989, EXP NEUROL, V104, P229, DOI 10.1016/0014-4886(89)90034-4; Negredo P, 2004, NEUROSCIENCE, V128, P605, DOI 10.1016/j.neuroscience.2004.07.017; Pan CL, 2003, BRAIN, V126, P386, DOI 10.1093/brain/awg039; Patodia S, 2012, CELL TISSUE RES, V349, P15, DOI 10.1007/s00441-012-1416-6; Po MD, 2012, NEURON, V73, P207, DOI 10.1016/j.neuron.2012.01.002; Rajan B, 2003, J COMP NEUROL, V457, P24, DOI 10.1002/cne.10460; Rovak Jason M, 2004, Semin Plast Surg, V18, P23, DOI 10.1055/s-2004-823120; Sahenk Z, 2005, NEUROLOGY, V65, P681, DOI 10.1212/01.WNL.0000171978.70849.c5; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Stephens HE, 2005, INT J DEV NEUROSCI, V23, P613, DOI 10.1016/j.ijdevneu.2005.07.002; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Teng KK, 2010, DEV NEUROBIOL, V70, P350, DOI 10.1002/dneu.20768; Udina E, 2011, ANN ANAT, V193, P347, DOI 10.1016/j.aanat.2011.02.012; Verdu E, 1997, EXP NEUROL, V146, P187, DOI 10.1006/exnr.1997.6517; Vilches JJ, 2002, AUTON NEUROSCI-BASIC, V95, P80, DOI 10.1016/S1566-0702(01)00359-9; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zochodne DW, 2012, J PERIPHER NERV SYST, V17, P1, DOI 10.1111/j.1529-8027.2012.00378.x	60	9	9	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	MAY	2013	131	5					989	1000		10.1097/PRS.0b013e3182870445			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	138WG	WOS:000318540700045	23385987				2022-02-06	
J	Auer, M; Stalla, GK; Athanasoulia, AP				Auer, M.; Stalla, G. K.; Athanasoulia, A. P.			Isolated gonadotropic deficiency after multiple concussions in a professional soccer player	DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT			German	Article						sports; traumatic brain injury; hypopituitarism; hypogonadism	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; HIGH-RISK; HYPOPITUITARISM; DYSFUNCTION; HEAD	History and clinical presentation: A 27-year-old man was admitted to our outpatient clinic with symptoms of loss at libido, erectile dysfunction and fatigue. He had been playing soccer from the age of 7, for the last 10 years as a high-level professional. During that time repeated mild head-trauma without loss of consciousness had occurred, mainly triggered by excessive header-training and occasional collisions. Investigations: Serum levels of testosterone and luteinizing hormone were low. A gonadotropin releasing hormone loading test revealed significant gonadotropin responses, therefore pituitary gonadotropic insufficiency was unlikely. Further pituitary insufficiency of any other axis was also excluded by insulin hypoglycemia test. Magnetic resonance imaging of the brain revealed no significant abnormalities of the hypothalamic-pituitary unit. Treatment and course: Testosterone substitution, at first applied transdermally, then intramuscularly, was initiated after approval by the National Anti Doping Agency. Four months later most of the symptoms had regressed. Conclusion: Pituitary deficiency in the course of craniocerebral trauma is frequent and may be transient or permanent, mostly affecting somatotropic or gonadotropic function. Hormonal imbalances may also be observed after mild but repeated trauma without loss of consciousness and should be considered in cases of isolated pituitary dysfunction, since such traumas may often occur in contacts sports such as boxing or intensive soccer play.	[Auer, M.; Stalla, G. K.; Athanasoulia, A. P.] Max Planck Inst Psychiat, Abt Innere Med Endokrinol & Diabet, D-80804 Munich, Germany		Auer, M (corresponding author), Max Planck Inst Psychiat, Abt Innere Med Endokrinol & Diabet, Kraepelinstr 10, D-80804 Munich, Germany.	mauer@mpipsykl.mpg.de	Auer, Matthias/AAI-5449-2021				Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; DANIEL PM, 1959, LANCET, V2, P927; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Iglesias P, 1996, J ENDOCRINOL INVEST, V19, P320, DOI 10.1007/BF03347870; Ives JC, 2007, J ATHL TRAINING, V42, P431; Kim NBC, 2011, RAD SOC N AM 2011 AN; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, EUR J ENDOCRINOL, V162, P861; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126	19	9	9	0	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0012-0472			DEUT MED WOCHENSCHR	Dtsch. Med. Wochenschr.	APR 19	2013	138	16					831	833		10.1055/s-0033-1343099			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DP	WOS:000320097500004	23589045				2022-02-06	
J	Abookasis, D; Shochat, A; Mathews, MS				Abookasis, David; Shochat, Ariel; Mathews, Marlon S.			Monitoring hemodynamic and morphologic responses to closed head injury in a mouse model using orthogonal diffuse near-infrared light reflectance spectroscopy	JOURNAL OF BIOMEDICAL OPTICS			English	Article						closed-head injury; diffuse reflectance; optical properties; absorbance; cerebral hemodynamics; scattering.	REDUCED SCATTERING COEFFICIENT; TISSUE OPTICAL-PROPERTIES; TRAUMATIC BRAIN EDEMA; IN-VIVO DETERMINATION; NONINVASIVE DETERMINATION; COGNITIVE DEFICITS; APPROXIMATION; ABSORPTION; MEDIA; HEMOGLOBIN	The authors' aim is to assess and quantitatively measure brain hemodynamic and morphological variations during closed-head injury (CHI) in mice using orthogonal diffuse near-infrared reflectance spectroscopy (o-DRS). CHI is a type of injury to the head that does not penetrate the skull. Usually, it is caused by mechanical blows to the head and frequently occurs in traffic accidents, falls, and assaults. Measurements of brain optical properties, namely absorption and reduced scattering coefficients in the wavelength range from 650 to 1000 nm were carried out by employing different source-detector distance and locations to provide depth sensitivity on an intact scalp over the duration of the whole experiment. Furthermore, alteration in both cortical hemodynamics and morphologic markers, i.e., scattering power and amplitude properties were derived. CHI was induced in anesthetized male mice by a weight-drop model using similar to 50 g cylindrical metal falling from a height of 90 cm onto the intact scalp producing an impact of 4500 g cm. With respect to baseline, difference in brain physiological properties was observed following injury up to 1 h post-trauma. Additionally, the reduced scattering spectral shapes followed Mie scattering theory was quantified and clearly shows changes in both scattering amplitude and power from baseline indicating structural variations likely from evolving cerebral edema during CHI. We further demonstrate high correlation between scattering amplitude and scattering power, with more than 20% difference in slope in comparison to preinjury. This result indicates the possibility of using the slope also as a marker for detection of structural changes. Finally, experiments investigating brain function during the first 20 min post-injury were conducted and changes in chromophore concentrations and scattering were observed. Overall, our experiments demonstrate the potential of using the proposed technique as a valuable quantitative noninvasive tool for monitoring brain physiology following CHI injury at the bedside and/or at the field. (C) 2013 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Abookasis, David; Shochat, Ariel] Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel; [Mathews, Marlon S.] Univ Calif Irvine, Dept Neurol Surg, Med Ctr, Orange, CA 92868 USA		Abookasis, D (corresponding author), Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel.	davida@ariel.ac.il					Abookasis D, 2008, PROC SPIE, V6842, DOI 10.1117/12.760516; Abookasis D, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.119801; Abookasis D, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116709; Adibhatla RM, 2006, AAPS J, V8, pE314; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Antonsson J, 2008, J NEURAL ENG, V5, P185, DOI 10.1088/1741-2560/5/2/009; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; ARONSON AE, 1994, BRAIN INJURY, V8, P663, DOI 10.3109/02699059409151019; Bevilacqua F, 1999, APPL OPTICS, V38, P4939, DOI 10.1364/AO.38.004939; Boas D. A., 2011, HDB BIOMEDICAL OPTIC, P166; Calderon-Arnulphi M, 2007, J NEUROSURG, V106, P283, DOI 10.3171/jns.2007.106.2.283; Chai CG, 2007, APPL OPTICS, V46, P4843, DOI 10.1364/AO.46.004843; Choi J, 2004, J BIOMED OPT, V9, P221, DOI 10.1117/1.1628242; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Eker C., 1999, THESIS LUND I TECHNO; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gill AS, 2011, J NEUROSURG, V114, P470, DOI 10.3171/2010.2.JNS091017; GRAAFF R, 1992, APPL OPTICS, V31, P1370, DOI 10.1364/AO.31.001370; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Hallacoglu B, 2011, J CEREBR BLOOD F MET, V31, P1482, DOI 10.1038/jcbfm.2011.13; HASKELL RC, 1994, J OPT SOC AM A, V11, P2727, DOI 10.1364/JOSAA.11.002727; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Hueber DM, 2001, PHYS MED BIOL, V46, P41, DOI 10.1088/0031-9155/46/1/304; Jia YL, 2011, MICROVASC RES, V81, P73, DOI 10.1016/j.mvr.2010.11.003; Johns M, 2005, OPT EXPRESS, V13, P4828, DOI 10.1364/OPEX.13.004828; Johnson LJ, 2000, J NEUROSCI METH, V98, P21, DOI 10.1016/S0165-0270(00)00187-4; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950312; Khan T, 2003, J OPT A-PURE APPL OP, V5, P137, DOI 10.1088/1464-4258/5/2/310; Kienle A, 1996, APPL OPTICS, V35, P2304, DOI 10.1364/AO.35.002304; Kim AD, 1998, APPL OPTICS, V37, P5313, DOI 10.1364/AO.37.005313; Kim A, 2010, OPT EXPRESS, V18, P5580, DOI 10.1364/OE.18.005580; Kim AD, 2011, J OPT SOC AM A, V28, P1007, DOI 10.1364/JOSAA.28.001007; Kumar G, 1997, APPL OPTICS, V36, P2286, DOI 10.1364/AO.36.002286; Larsson M, 2003, APPL OPTICS, V42, P124, DOI 10.1364/AO.42.000124; Li WT, 2012, PROC SPIE, V8207, DOI 10.1117/12.903859; Lin WC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505012; Machida M, 2009, J OPT SOC AM A, V26, P1291, DOI 10.1364/JOSAA.26.001291; Marmarou A, 2003, ACT NEUR S, V86, P7; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; Nachabe R, 2010, BIOMED OPT EXPRESS, V1, P1432, DOI 10.1364/BOE.1.001432; Richardson J.T.E., 2002, CLIN NEUROPSYCHOLOGI, V2nd; Rodnitzky R.L., 1982, ARCH NEUROL-CHICAGO, V39, P675; Rodriguez J, 2001, P SOC PHOTO-OPT INS, V4241, P88, DOI 10.1117/12.431509; Sato H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1960907; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Swartling J, 2003, APPL OPTICS, V42, P4612, DOI 10.1364/AO.42.004612; TUCHIN VV, 2007, TISSUE OPTICS LIGHT; van Veen R. L. P., 2004, BIOM TOP M OPT SOC A; vanHouten JP, 1996, PEDIATR RES, V39, P470, DOI 10.1203/00006450-199603000-00015; VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507; Venugopalan V, 1998, PHYS REV E, V58, P2395, DOI 10.1103/PhysRevE.58.2395; Wang X, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2098607; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; Xie JR, 2010, APPL OPTICS, V49, P5407, DOI 10.1364/AO.49.005407; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhao J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1891345; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814; Zijlistra WG, 2000, VISIBLE NEAR INFRARE; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	61	9	9	0	5	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	APR	2013	18	4							045003	10.1117/1.JBO.18.4.045003			11	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	190JX	WOS:000322336900008	23558510				2022-02-06	
J	Bradley, CF; Geyer, PD; Ebener, DJ				Bradley, Cecil F.; Geyer, Paul D.; Ebener, Deborah J.			Contributors to Successful VR Outcomes among Non-Latino (Caucasian) and Latino Consumers with Hearing Loss	JOURNAL OF REHABILITATION			English	Article							VOCATIONAL-REHABILITATION SERVICES; TRAUMATIC BRAIN-INJURY; EMPLOYMENT OUTCOMES; MENTAL-RETARDATION; ACCEPTANCE RATES; DEAF; RACE; DISABILITIES; DISPARITIES; COUNSELORS	The authors explored the relationship between vocational rehabilitation (VR) case outcomes and ten consumer, service, and counselor characteristics to determine whether or not there are significant differences in vocational rehabilitation outcomes between two groups of consumers with hearing loss, specifically non-Latinos (Caucasians) and Latinos who identified their race as White. The participants in this study consisted of 481 Non-Latino (Caucasian) and Latino consumers with hearing loss whose VR cases with the Florida Division of Vocational Rehabilitation were closed either successfully or unsuccessfully during 2002-2004. The study results showed that five consumer variables (gender, education, age, hearing loss, and support) and one VR service (job placement) variable were found to be significantly associated with a successful VR outcome. However, consumer ethnicity and all three counselor characteristics (ethnicity, training, and communication skills) were not. Implications for VR counseling and research are discussed.	[Bradley, Cecil F.] Florida Dept Educ, Pam Steart, FL USA; [Geyer, Paul D.] Keiser Univ, Ft Lauderdale, FL 33309 USA; [Ebener, Deborah J.] Florida State Univ, Tallahassee, FL 32306 USA		Bradley, CF (corresponding author), Dept Educ, Div Vocat Rehabil, 2002 Old St Augustine Rd, Tallahassee, FL 32301 USA.	cfbradley9@gmail.com					Accordino M.P., 2000, J MENTAL HEALTH COUN, V22, P268; Bat-Chava Y, 2002, J REHABIL, V68, P33; BOLTON B, 1975, J REHABIL DEAF, V9, P36; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; Boutin DL, 2010, J REHABIL, V76, P40; Boutin DL, 2009, J REHABIL, V75, P36; Bromet E., 2005, DISS ABSTR INT, V66, P2549; Bursell L. M., 1997, DISS ABSTR INT, V58, P4628; Capella ME, 2003, J REHABIL, V69, P39; Capella ME, 2002, REHABIL COUNS BULL, V45, P143, DOI 10.1177/003435520204500303; Cartwright BY, 2006, J REHABIL, V72, P41; Cavenaugh BS, 2006, J VISUAL IMPAIR BLIN, V100, P425; Cohen J., 1983, MULTIPLE REGRESSION; Cohen O. P., 1990, HABILITATION REHABIL; COHEN OP, 1990, AM ANN DEAF, V135, P67, DOI 10.1353/aad.2012.1202; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; FEISTPRICE S, 1994, J REHABIL, V60, P13; FEISTPRICE S, 1995, REHABIL COUNS BULL, V39, P119; Frain MP, 2006, J REHABIL, V72, P10; Gamble D, 2003, J REHABIL, V69, P31; Hayward B. J., 2003, LONGITUDINAL STUDY V; Herbert J.T., 1992, J JOB PLACEMENT, V8, P10; Hollar D., 2008, J APPL REHABILITATIO, V39, P25; Joyce E. F., 1986, J REHABILITATION DEA, V20, P5; KAMPFE CM, 1990, J REHABIL, V56, P41; LAFITTE JA, 1978, AM ANN DEAF, V123, P580; Marini I., 2001, J APPL REHABIL COUS, V32, P36, DOI [10.1891 /0047-2220.32.1.36, DOI 10.1891/0047-2220.32.1.36]; McAweeney M., 2008, J APPL REHABILITATIO, V39, P30; Moore C. L., 2001, J AM DEAFNESS REHABI, V35, P26; Moore CL, 2002, J REHABIL, V68, P14; Moore CL, 2002, REHABIL COUNS BULL, V45, P233, DOI 10.1177/00343552020450040601; Moore CL, 2002, REHABIL COUNS BULL, V45, P162, DOI 10.1177/003435520204500305; Moore CL, 2001, REHABIL COUNS BULL, V44, P144, DOI 10.1177/003435520104400304; MOORE CL, 2001, J APPL REHABIL COUS, V32, P15; National Center for Health Statistics, 2010, DIS FUNCT; Olney MF, 2002, REHABIL COUNS BULL, V45, P177, DOI 10.1177/003435520204500307; PEDERSEN P, 2003, MULTICULTURAL COUNSE; Pitts J., 1980, J APPL REHABILITATIO, V11, P200; Rogers JB, 2005, J REHABIL, V71, P5; Rosenthal DA, 2005, J REHABIL, V71, P36; Rosenthal DA, 2004, REHABIL COUNS BULL, V47, P131, DOI 10.1177/00343552040470030201; Schaller J., 2007, J APPL REHABIL COUS, V38, P32, DOI [10.1891/0047-2220.38.1.32, DOI 10.1891/0047-2220.38.1.32]; Smith M. L., 1987, RES EVALUATION ED SO; Statistical Package for Social Sciences (SPSS), 1997, STAT PACK SOC SCI VE; STEWART LG, 1976, J REHABIL DEAF, V10, P19; Sue D.W., 2003, COUNSELING CULTURALL, V4th ed.; Syzmanski E. M., 1991, REHABILITATION COUNS, V35, P23; SZYMANSKI EM, 1992, J REHABIL, V58, P49; United States Department of Education, 2003, 2 US DOE OFF SPEC ED; United States Department of Education, 2003, 1 US DOE OFF SPEC ED; United States Department of Education, 2005, 3 US DOE OFF SPEC ED; US Census Bureau, 2011, OVERVIEW RACE HISPAN; Van Cleve J. V., 1987, GALLAUDET ENCY DEAF; Walker-Vann C, 1998, AM ANN DEAF, V143, P46, DOI 10.1353/aad.2012.0068; Walls RT, 2002, J REHABIL, V68, P4; Watson D., 1972, DISS ABSTR INT, V33, P3296; Wheaton JE, 1996, REHABIL COUNS BULL, V40, P116; WILSON K, 2002, J APPL REHABILITATIO, V33, P26; Wilson K. B., 2001, J APPL REHABILITATIO, V32, P24; Wilson K. B., 2005, J APPL REHABILITATIO, V36, P4; Wilson KB, 2005, J COUNS DEV, V83, P86, DOI 10.1002/j.1556-6678.2005.tb00583.x; Wilson KB, 2002, REHABIL COUNS BULL, V45, P132, DOI 10.1177/003435520204500302; [No title captured]	63	9	9	0	0	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	2013	79	2					24	33					10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	AU8ZE	WOS:000345881000003					2022-02-06	
J	Dethier, M; Blairy, S; Rosenberg, H; McDonald, S				Dethier, Marie; Blairy, Sylvie; Rosenberg, Hannah; McDonald, Skye			Emotional Regulation Impairments Following Severe Traumatic Brain Injury: An Investigation of the Body and Facial Feedback Effects	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Affective symptoms; Anger; Brain injuries; Emotion; Facial expression; Posture	BODILY POSTURES; ALEXITHYMIA; EXPRESSIONS; PERCEPTION; RECOGNITION; EXPERIENCE; SEQUELAE; DEFICITS; EMPATHY; ADJUSTMENT	The object of this study was to evaluate the combined effect of body and facial feedback in adults who had suffered from a severe traumatic brain injury (TBI) to gain some understanding of their difficulties in the regulation of negative emotions. Twenty-four participants with TBI and 28 control participants adopted facial expressions and body postures according to specific instructions and maintained these positions for 10s. Expressions and postures entailed anger, sadness, and happiness as well as a neutral (baseline) condition. After each expression/posture manipulation, participants evaluated their subjective emotional state (including cheerfulness, sadness, and irritation). TBI participants were globally less responsive to the effects of body and facial feedback than control participants, F(1,50) = 55.89, p = .02, eta(2) = .11. More interestingly, the TBI group differed from the Control group across emotions, F(8,400) = 2.51, p = .01, eta(2) = .05. Specifically, participants with TBI were responsive to happy but not to negative expression/posture manipulations whereas control participants were responsive to happy, angry, and sad expression/posture manipulations. In conclusion, TBI appears to impair the ability to recognize both the physical configuration of a negative emotion and its associated subjective feeling. (JINS, 2013, 19, 367-379)	[Dethier, Marie; Blairy, Sylvie] Univ Liege, Dept Psychol Cognit & Behav, B-4000 Liege, Belgium; [Rosenberg, Hannah; McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia		Dethier, M (corresponding author), Univ Liege, Dept Psychol Cognit & Behav, Unit Cognit & Behav Clin Psychol, Blvd Rectorat 3,B33, B-4000 Liege, Belgium.	marie.dethier@ulg.ac.be	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094	University of LiegeUniversity of Liege	This study was supported by a research grant from the University of Liege. This study is the result of collaboration between the University of New South Wales and the University of Liege and was conducted while the first author was visiting the University of New South Wales. The authors thank all the people with traumatic brain injuries and community controls who willingly donated their time to participate in this research. We also acknowledge the contribution of Rebekah Randall who assisted with data collection and entry. The authors have no competing or conflicts of interest to report.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Allerdings MD, 2001, BRAIN COGNITION, V47, P304; Andreasson P, 2008, J NONVERBAL BEHAV, V32, P215, DOI 10.1007/s10919-008-0052-z; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Becerra R, 2002, BRAIN INJURY, V16, P633, DOI 10.1080/02699050110119817; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Burgess P.W., 1997, HAYLING BRIXTON TEST; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; Darwin C., 1965, EXPRESS EMOT MAN; Davis JI, 2009, J RES PERS, V43, P822, DOI 10.1016/j.jrp.2009.06.005; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Dethier M, 2012, J CLIN EXP NEUROPSYC, V34, P936, DOI 10.1080/13803395.2012.702734; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Doherty RW, 1998, MOTIV EMOTION, V22, P187, DOI 10.1023/A:1022368805803; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Duclos SE, 2001, COGNITION EMOTION, V15, P27, DOI 10.1080/0269993004200088; DUCLOS SE, 1989, J PERS SOC PSYCHOL, V57, P100, DOI 10.1037/0022-3514.57.1.100; EKMAN P, 1992, PHILOS T ROY SOC B, V335, P63, DOI 10.1098/rstb.1992.0008; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; Flack WF, 2006, COGNITION EMOTION, V20, P177, DOI 10.1080/02699930500359617; Flack WF, 1999, J CLIN PSYCHOL, V55, P1; Flack WF, 1999, EUR J SOC PSYCHOL, V29, P203, DOI 10.1002/(SICI)1099-0992(199903/05)29:2/3<203::AID-EJSP924>3.0.CO;2-8; GELLHORN E, 1964, PSYCHOL REV, V71, P457, DOI 10.1037/h0039834; Gosling J, 1999, BRAIN INJURY, V13, P785; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Gundel H, 2004, PSYCHOSOM MED, V66, P132, DOI 10.1097/01.PSY.0000097348.45087.96; Hatfield E., 1992, EMOTION SOCIAL BEHAV, P151, DOI DOI 10.1017/CBO9781139174138; Herwig U, 2010, NEUROIMAGE, V50, P734, DOI 10.1016/j.neuroimage.2009.12.089; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Houtveen JH, 1997, J PSYCHOPHYSIOL, V11, P147; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; James W., 1890, PRINCIPLES PSYCHOL; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Laird J. D., 1974, THINKING FEELING COG, P239; Laird J. D., 1992, EMOTION ED, P213; LAIRD JD, 1984, J PERS SOC PSYCHOL, V47, P909, DOI 10.1037/0022-3514.47.4.909; LAIRD JD, 1994, MOTIV EMOTION, V18, P231, DOI 10.1007/BF02254830; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Lane RD, 1997, BIOL PSYCHIAT, V42, P834, DOI 10.1016/S0006-3223(97)00050-4; LEVENSON RW, 1990, PSYCHOPHYSIOLOGY, V27, P363, DOI 10.1111/j.1469-8986.1990.tb02330.x; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2011, BRAIN IMPAIR, V12, P165; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McIntosh DN, 1996, MOTIV EMOTION, V20, P121, DOI 10.1007/BF02253868; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rapson R., 1994, EMOTIONAL CONTAGION; Reitan RM, 1992, TRAIL MAKING TEST; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schnall S, 2003, COGNITION EMOTION, V17, P787, DOI 10.1080/02699930302286; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; Spreen O, 1991, COMPENDIUM NEUROPSYC; StatSoft, 2011, STATISTICA DAT AN SO; Stel M, 2008, J AUTISM DEV DISORD, V38, P1250, DOI 10.1007/s10803-007-0505-y; STEPPER S, 1993, J PERS SOC PSYCHOL, V64, P211, DOI 10.1037/0022-3514.64.2.211; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; Subic-Wrana C, 2005, PSYCHOSOM MED, V67, P483, DOI 10.1097/01.psy.0000160461.19239.13; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tomkins S., 1963, AFFECT IMAGERY CONSC, VII; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416	93	9	9	0	19	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2013	19	4					367	379		10.1017/S1355617712001555			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	127DI	WOS:000317675500001	23351364				2022-02-06	
J	Escudero, D; Cofino, L; Gracia, D; Palacios, M; Casares, M; Cabre, L; Simon, P; Miranda, P; Martinez, K; Iribarren, S; Saralegui, I; Simo, RM; de Leon, B; Espanol, V				Escudero, D.; Cofino, L.; Gracia, D.; Palacios, M.; Casares, M.; Cabre, L.; Simon, P.; Miranda, P.; Martinez, K.; Iribarren, S.; Saralegui, I.; Simo, R. M.; de Leon, B.; Espanol, V.			Cranioplasty with bandaging. new forms of limitation of life support and organ donation	MEDICINA INTENSIVA			Spanish	Article						Ethics; Organ donation; Brain death; Life-sustaining treatment limitation	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY	Most of transplanted organs are obtained from brain death (BD) donors. In neurocritical patients with catastrophic injuries and decompressive craniectomy (DC), which show a dreadful development in spite of this treatment, DC could be a futile tool to avoid natural progress to BD. We propose if cranial compressive bandage (cranioplasty with bandage) could be an ethically correct practice, similar to other life-sustaining treatment limitation (LSTL) common methods. Based on a clinical case, we contacted with the Assistance Ethics Committee and some bioethics professionals asking them two questions: 1) Is ethically correct to perform a cranioplasty with bandage in those patients with LSTL indication? 2) Thinking in organ donation possibility, is this option preferable? Conclusions 1) Cranioplasty with bandage could be considered an ethically acceptable LSTL practice, similar to other procedures. 2) It facilitates organ donation for transplant, which provides value-added because of its own social good. 3) In these cases, it is necessary to know previous patient's will or, in absentia, to obtain family consent after a detailed procedure report. (C) 2012 Elsevier Espana, S.L. and SEMICYUC. All rights reserved.	[Escudero, D.; Cofino, L.] Hosp Univ Cent Asturias, Serv Med Intens, Oviedo, Spain; [Gracia, D.] Univ Complutense Madrid, E-28040 Madrid, Spain; [Casares, M.] Hosp Univ Getafe, CEAS, Madrid, Spain; [Cabre, L.] Hosp Barcelona, Serv Med Intens, SCIAS, Barcelona, Spain; [Cabre, L.] Univ Barcelona, Assoc Bioet & Dret, E-08007 Barcelona, Spain; [Cabre, L.] Hosp Barcelona, SCIAS, CEA, Barcelona, Spain; [Simon, P.] Escuela Andaluza Salud Publ, Granada, Spain; [Miranda, P.] Hosp Univ 12 Octubre, Serv Ginecol & Obstet, Madrid, Spain; [Martinez, K.] Hosp Navarra, Serv Med Intens, Asociac Bioet Fundamental & Clin, Navarra, Spain; [Iribarren, S.] Hosp Univ Araba Sede Txagorritxu, Serv Med Intens, Santiago, Spain; [Saralegui, I.] Hosp Univ Alava Santiago, Unidad Med Intens, Com Et Asistencial, Vitoria, Spain; [Simo, R. M.] Hosp Univ Cent Asturias, Area Sanitaria 4, Com Et Asistencial, Oviedo, Spain		Escudero, D (corresponding author), Hosp Univ Cent Asturias, Serv Med Intens, Oviedo, Spain.	dolores.escudero@sespa.princast.es		Escudero, Dolores/0000-0002-9037-3411			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; [Anonymous], 2008, REV ESP CARDIOL, V61, P1178; [Anonymous], 1992, REV ESP TRASP, V1-2, P168; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cabré Pericas L.l., 2006, Med. Intensiva, V30, P68, DOI 10.1016/S0210-5691(06)74471-0; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; de la Rosa G, 2012, AM J TRANSPLANT, V12, P2507, DOI 10.1111/j.1600-6143.2012.04138.x; Escudero D, 2009, MED INTENSIVA, V33, P185, DOI 10.1016/S0210-5691(09)71215-X; Gracia D, 2001, NEFROLOGIA, V21, P13; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Lubillo S, 2009, MED INTENSIVA, V33, P74, DOI 10.1016/S0210-5691(09)70685-0; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Matesanz R, 2009, TRANSPL P, V41, P3453, DOI 10.1016/j.transproceed.2009.09.011; Matesanz R., 2008, MODELO ESPANOL DONAC, P11; Matesanz R, 2011, TRANSPL INT, V24, P333, DOI 10.1111/j.1432-2277.2010.01204.x; Marin JLM, 2008, MED INTENSIVA, V32, P121, DOI 10.1016/S0210-5691(08)70922-7; Organizacion Medica Cotegial de Espana, 2011, COD DEONT MED GUIA E; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Registro espanol de trasplante hepatico (RETH), MEM RES 2010; Rubio O, 2012, MED INTENSIVA; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SARALEGUI I, 2004, MED INTENSIVA, V28, P256; Schnitzler MA, 2005, AM J TRANSPLANT, V5, P2289, DOI 10.1111/j.1600-6143.2005.01021.x; The Hastings Center, 1996, HASTINGS CTR REPO S6, V26, P513	25	9	9	0	7	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	APR	2013	37	3					180	184		10.1016/j.medin.2012.12.008			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139LE	WOS:000318583400007	23473740				2022-02-06	
J	Kozlowski, AJ; Heinemann, AW				Kozlowski, Allan J.; Heinemann, Allen W.			Using Individual Growth Curve Models to Predict Recovery and Activities of Daily Living After Spinal Cord Injury: An SCIRehab Project Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Longitudinal studies; Rehabilitation; Spinal cord injuries; Treatment outcome	UNIFORM DATA SYSTEM; FUNCTIONAL INDEPENDENCE MEASURE; MEDICAL REHABILITATION REPORT; TRAUMATIC BRAIN-INJURY; THERAPY TREATMENT TIME; STROKE REHABILITATION; NATIONAL INSTITUTE; DISABILITY; PROGRAMS; OUTCOMES	Objective: To evaluate change in functional outcomes over 1 year after spinal cord injury (SCI). Design: Observational longitudinal secondary analysis. Setting: Six rehabilitation facilities participating in the SCIRehab project. Participants: Patients (N=1146) with SCI enrolled from 2007 to 2010. Interventions: Not applicable. Main Outcome Measures: FIM instrument 13-item and 11-item motor, 3-item transfer, 6-item self-care, 3-item self-care upper-extremity, and 3-item self-care lower-extremity subscores modeled as trajectories of change. Results: Patients were on average 37 years old, non-Hispanic white, with high school or higher education, a body mass index of 25, and a Comprehensive Severity Index score of 20. Most were men with paraplegia (37%) or high tetraplegia (27%). Median time frames were 22 days from injury to admission, 46 days from admission to discharge, 407 days from admission to follow-up, and 44 days for rehabilitation length of stay. The motor subscores were higher on admission for paraplegia and American Spinal Injury Association (ASIA) Impairment Scale (MS) grade D groups, and recovered faster for the AIS grade D group. Lower function at admission was associated with older age, higher Comprehensive Severity Index score, longer length of stay, fewer physical therapy and therapeutic recreation hours, and more occupational therapy hours. Slower recovery rates were associated with older age, more days from injury to admission, and fewer physical therapy hours per week. Conclusions: Longitudinal outcomes modeled as individual trajectories of change are clinically meaningful. Individual growth curve models could facilitate recovery prediction and outcome evaluation at individual and group levels. However, assessment of the effects of treatment on outcome trajectories will require the addition of outcome measures at time points during intervention and may require the use of outcome measures specific to aspects of rehabilitation, such as mobility and self-care. Archives of Physical Medicine and Rehabilitation 2013;94(4 Suppl 2):S154-64 (C) 2013 by the American Congress of Rehabilitation Medicine	[Kozlowski, Allan J.; Heinemann, Allen W.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Kozlowski, Allan J.] Northwestern Univ, Ctr Healthcare Studies, Feinberg Med Sch, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Med Sch, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Kozlowski, AJ (corresponding author), Rehabil Inst Chicago, 345 E Ontario St, Chicago, IL 60611 USA.	akozlowski@ric.org	Heinemann, Allen W/K-6283-2012; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W/0000-0003-2782-7326; Heinemann, Allen W./0000-0003-2782-7326	National Institute on Disability and Rehabilitation Research [H133B090024, H133N110014, H133A060103]	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133B090024, H133N110014, and H133A060103).	Backus D, 2013, ARCH PHYS MED REHAB, V94, pS165, DOI 10.1016/j.apmr.2013.01.012; Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; duToit M, 2011, HLM 7 HIERARCHICAL L; Foy T, 2011, J SPINAL CORD MED, V34, P162, DOI 10.1179/107902611X12971826988093; Gassaway J, 2011, J SPINAL CORD MED, V34, P176, DOI 10.1179/107902611X12971826988138; Granger CV, 2012, AM J PHYS MED REHAB, V91, P289, DOI 10.1097/PHM.0b013e31824ad2fd; Granger CV, 2010, AM J PHYS MED REHAB, V89, P781, DOI 10.1097/PHM.0b013e3181f1c83a; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; GREY N, 1993, PARAPLEGIA, V31, P457, DOI 10.1038/sc.1993.74; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; International Severity Information Systems Inc, 2012, CSI COMPR SEV IND; Jorgensen V, 2011, SPINAL CORD, V49, P838, DOI 10.1038/sc.2011.9; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P535, DOI 10.1179/204577211X13207446293695; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; ROGOSA DR, 1985, PSYCHOMETRIKA, V50, P203, DOI 10.1007/BF02294247; Stenson KW, 2011, ARCH PHYS MED REHAB, V92, P384, DOI 10.1016/j.apmr.2010.07.235; Taylor-Schroeder S, 2011, J SPINAL CORD MED, V34, P149, DOI 10.1179/107902611X12971826988057; van Middendorp JJ, 2011, LANCET, V377, P1004, DOI 10.1016/S0140-6736(10)62276-3; Warschausky S, 2001, ARCH PHYS MED REHAB, V82, P329, DOI 10.1053/apmr.2001.21510; Whiteneck G, 2011, J SPINAL CORD MED, V34, P133, DOI 10.1179/107902611X12971826988011; Whiteneck G, 2009, J SPINAL CORD MED, V32, P251, DOI 10.1080/10790268.2009.11760779; Whiteneck GG, 2013, ARCH PHYS MED REHAB, V94, pS67, DOI 10.1016/j.apmr.2012.12.022; Wilson JR, 2012, J NEUROSURG-SPINE, V17, P11, DOI 10.3171/2012.4.AOSPINE1245	28	9	9	0	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2013	94	4		2			S154	S164		10.1016/j.apmr.2012.11.050			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	120LP	WOS:000317172100011	23527771				2022-02-06	
J	Matsumoto, JH; Caplan, R; McArthur, DL; Forgey, MJ; Yudovin, S; Giza, CC				Matsumoto, Joyce H.; Caplan, Rochelle; McArthur, David L.; Forgey, Marcy J.; Yudovin, Sue; Giza, Christopher C.			Prevalence of epileptic and nonepileptic events after pediatric traumatic brain injury	EPILEPSY & BEHAVIOR			English	Article						Traumatic brain injury; Pediatric; Nonepileptic; Epilepsy	EARLY POSTTRAUMATIC SEIZURES; PSYCHOGENIC SEIZURES; HEAD-INJURY; PSYCHOSOCIAL CHARACTERISTICS; PSYCHIATRIC-DISORDERS; CHILDREN; ADOLESCENTS; ADULTS; VIDEO; PSEUDOSEIZURES	Though posttraumatic epilepsy (PTE) is a prominent sequela of traumatic brain injury (TBI), other nonepileptic phenomena also warrant consideration. Within two UCLA pediatric TBI cohorts, we categorized five spell types: 1) PIE; 2) Epilepsy with other potential etiologies (cortical dysplasia, primary generalized); 3) Psychopathology; 4) Behavior misinterpreted as seizures; and 5) Other neurologic events. The two cohort subsets differed slightly in injury severity, but they were otherwise similar. Overall, PTE occurred in 40%, other epilepsy etiologies in 14%, and nonepileptic spells collectively in 46%. Among children with spells, PTE was associated with severe TBI (p = 0.001), whereas psychopathology (p = 0.014) and epilepsy with other etiologies (p = 0.006) were associated with milder TB! severity. Posttraumatic epilepsy (p = 0.002) and misinterpreted behavior (p = 0.049) occurred with younger injury age. Psychopathology (p = 0.020) and other neurologic events (p = 0.002) occurred with older injury age. In evaluating possible PTE, clinicians should maintain a broad differential diagnosis to prevent misdiagnosis and inappropriate treatment. (C) 2013 Elsevier Inc. All rights reserved.	[Matsumoto, Joyce H.; Yudovin, Sue; Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Neurol, Dept Pediat, Los Angeles, CA 90095 USA; [Caplan, Rochelle; Forgey, Marcy J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Div Child & Adolescent Psychiat, Los Angeles, CA 90095 USA; [McArthur, David L.; Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Caplan, Rochelle; Forgey, Marcy J.] Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Matsumoto, Joyce H.; McArthur, David L.; Yudovin, Sue; Giza, Christopher C.] UCLA Brain Injury Res Ctr, Los Angeles, CA USA		Matsumoto, JH (corresponding author), Univ Calif Los Angeles, Div Pediat Neurol, Mattel Childrens Hosp, 22-474 MDCC,Box 951752, Los Angeles, CA 90095 USA.	jmatsumoto@mednet.ucla.edu	McArthur, David/E-6442-2013	McArthur, David/0000-0003-3385-1314	Child Neurology Foundation/Winokur Family Foundation; Today's and Tomorrow's Children Fund; Thrasher Research Foundation; UCLA Brain Injury Research Center	The authors thank Hannah Valino and Andrew Ng for their assistance with database entry and management. This study was supported by the Child Neurology Foundation/Winokur Family Foundation, the Today's and Tomorrow's Children Fund, the Thrasher Research Foundation and the UCLA Brain Injury Research Center.	Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asano E, 2005, EPILEPSY RES, V66, P129, DOI 10.1016/j.eplepsyres.2005.07.012; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; Bhatia MS, 2005, CLIN PEDIATR, V44, P617, DOI 10.1177/000992280504400710; BLACK P, 1981, BRAIN DYSFUNCTION CH, P171; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bye AME, 2000, J PAEDIATR CHILD H, V36, P244, DOI 10.1046/j.1440-1754.2000.00496.x; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Chinta SS, 2008, ANN INDIAN ACAD NEUR, V11, P159, DOI 10.4103/0972-2327.42935; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Ettinger AB, 1999, EPILEPSIA, V40, P1292, DOI 10.1111/j.1528-1157.1999.tb00860.x; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Gudmundsson O, 2001, DEV MED CHILD NEUROL, V43, P547, DOI 10.1017/S0012162201000986; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kotagal P, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e46; Kutluay E, 2010, EPILEPSY BEHAV, V17, P272, DOI 10.1016/j.yebeh.2009.12.020; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LEMPERT T, 1990, J NEUROL, V237, P35, DOI 10.1007/BF00319665; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; MAX J, 1997, J AM ACAD CHILD ADOL, V39, P1278; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Pakalnis A, 2000, J CHILD NEUROL, V15, P78, DOI 10.1177/088307380001500202; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; Reuber M, 2002, NEUROLOGY, V58, P493, DOI 10.1212/WNL.58.3.493; Riquet A, 2011, SEIZURE-EUR J EPILEP, V20, P18, DOI 10.1016/j.seizure.2010.09.011; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; Sigurdardottir KR, 1998, EPILEPSIA, V39, P749, DOI 10.1111/j.1528-1157.1998.tb01161.x; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; WYLLIE E, 1990, PEDIATRICS, V85, P480; WYLLIE E, 1991, NEUROLOGY, V41, P742, DOI 10.1212/WNL.41.5.742	40	9	9	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	APR	2013	27	1					233	237		10.1016/j.yebeh.2013.01.024			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	118MG	WOS:000317029000042	23480860				2022-02-06	
J	Nigrovic, LE; Lillis, K; Atabaki, SM; Dayan, PS; Hoyle, J; Tunik, MG; Jacobs, ES; Monroe, D; Wootton-Gorges, SW; Miskin, M; Holmes, JF; Kuppermann, N				Nigrovic, Lise E.; Lillis, Kathleen; Atabaki, Shireen M.; Dayan, Peter S.; Hoyle, John; Tunik, Michael G.; Jacobs, Elizabeth S.; Monroe, David; Wootton-Gorges, Sandra W.; Miskin, Michelle; Holmes, James F.; Kuppermann, Nathan		Pediat Emergency Care Appl Res Net	The Prevalence of Traumatic Brain Injuries After Minor Blunt Head Trauma in Children With Ventricular Shunts	ANNALS OF EMERGENCY MEDICINE			English	Article							HYDROCEPHALUS; EPIDEMIOLOGY	Study objective: We compare the prevalence of clinically important traumatic brain injuries and the use of cranial computed tomography (CT) in children with minor blunt head trauma with and without ventricular shunts. Methods: We performed a secondary analysis of a prospective observational cohort study of children with blunt head trauma presenting to a participating Pediatric Emergency Care Applied Research Network emergency department. For children with Glasgow Coma Scale (GCS) scores greater than or equal to 14, we compared the rates of clinically important traumatic brain injuries (defined as a traumatic brain injury resulting in death, neurosurgical intervention, intubation for more than 24 hours, or hospital admission for at least 2 nights for management of traumatic brain injury in association with positive CT scan) and use of cranial CT for children with and without ventricular shunts. Results: Of the 39,732 children with blunt head trauma and GCS scores greater than or equal to 14, we identified 98 (0.2%) children with ventricular shunts. Children with ventricular shunts had more frequent CT use: (45/98 [46%] with shunts versus 13,858/39,634 [35%] without; difference 11%; 95% confidence interval 1% to 21%) but a similar rate of clinically important traumatic brain injuries (1/98 [1%] with shunts versus 346/39,619 [0.9%] without; difference 0.1%; 95% confidence interval -0.3% to 5%). The One child with a ventricular shunt who had a clinically important traumatic brain injury had a known chronic subdural hematoma that was larger after the head trauma compared with previous CT; the child underwent hematoma evacuation. Conclusion: Children with ventricular shunts had higher CT use with similar rates of clinically important traumatic brain injuries after minor blunt head trauma compared with children without ventricular shunts. [Ann Emerg Med. 2013;61:389-393.]	[Nigrovic, Lise E.] Harvard Univ, Div Emergency Med, Boston Childrens Hosp, Sch Med, Boston, MA USA; [Lillis, Kathleen] SUNY Buffalo, Dept Pediat, Sch Med, Buffalo, NY 14260 USA; [Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Pediat, Childrens Natl Med Ctr, Washington, DC 20052 USA; [Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Emergency Med, Childrens Natl Med Ctr, Washington, DC USA; [Dayan, Peter S.] Columbia Univ, Dept Pediat, Morgan Stanley Childrens Hosp New York Presbyteri, Coll Phys & Surg, New York, NY 10027 USA; [Hoyle, John] Michigan State Univ, Helen DeVos Childrens Hosp, Div Emergency Med, Sch Med, Grand Rapids, MI USA; [Tunik, Michael G.] NYU, Bellevue Hosp Ctr, Sch Med, Dept Emergency Med & Pediat, New York, NY 10016 USA; [Jacobs, Elizabeth S.] Holy Cross Hosp, Dept Pediat, Silver Spring, MD USA; [Jacobs, Elizabeth S.] Brown Univ, Sch Med, Hasbro Childrens Hosp,Warren Alpert Sch Med, Div Emergency Med, Providence, RI 02912 USA; [Monroe, David] Howard Cty Gen Hosp, Dept Pediat, Columbia, MD USA; [Wootton-Gorges, Sandra W.] Univ Calif Davis, Davis Sch Med, Med Ctr, Dept Radiol, Davis, CA 95616 USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Davis Sch Med, Med Ctr, Dept Emergency Med, Davis, CA 95616 USA; [Kuppermann, Nathan] Univ Calif Davis, Davis Sch Med, Med Ctr, Dept Pediat, Davis, CA 95616 USA; [Miskin, Michelle] Univ Utah, Sch Med, Salt Lake City, UT USA		Kuppermann, N (corresponding author), Univ Calif Davis, Davis Sch Med, Med Ctr, Dept Emergency Med, Davis, CA 95616 USA.	nkuppermann@ucdavis.edu		Nigrovic, Lise/0000-0002-6369-3997; Tunik, Michael/0000-0002-2368-5933; Holubkov, Richard/0000-0003-0431-3381	Health Resources and Services Administration (HRSA)/MCHB, Division of Research, Training and Education; EMSC Program [R40MC02461]; EMSC program of the MCHB/HRSA [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008]	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. This work was supported by a grant from the Health Resources and Services Administration (HRSA)/MCHB, Division of Research, Training and Education, and the EMSC Program (R40MC02461). The Pediatric Emergency Care Applied Research Network is supported by cooperative agreements U03MC00001, U03MC00003, U03MC00006, U03MC00007, and U03MC00008 from the EMSC program of the MCHB/HRSA.	AOKI N, 1988, SURG NEUROL, V29, P22, DOI 10.1016/0090-3019(88)90118-8; BLACKBURN BL, 1994, AM J MED GENET, V52, P123, DOI 10.1002/ajmg.1320520202; Bondurant CP, 1995, PEDIATR NEUROSURG, V23, P254, DOI 10.1159/000120968; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Holmedal LJ, 2007, PEDIATR RADIOL, V37, P1209, DOI 10.1007/s00247-007-0625-8; Kraus R, 2004, CHILD NERV SYST, V20, P68, DOI 10.1007/s00381-003-0858-2; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I	9	9	9	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	APR	2013	61	4					389	393		10.1016/j.annemergmed.2012.08.030			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	123GP	WOS:000317376700004	23122954				2022-02-06	
J	Skilbeck, C; Dean, T; Thomas, M; Slatyer, M				Skilbeck, Clive; Dean, Tracey; Thomas, Matt; Slatyer, Mark			Impaired National Adult Reading Test (NART) performance in traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Impaired NART; TBI recovery; Age; Education; Mood	ESTIMATING PREMORBID INTELLIGENCE; INTELLECTUAL ABILITY; DEMOGRAPHIC EQUATION; WECHSLER TEST; DEMENTIA; IQ; PREDICTION; VALIDATION; VALIDITY; DECLINE	Some research suggests the National Adult Reading Test (NART) may be impaired by traumatic brain injury (TBI). To investigate this, a prospective, longitudinal study included 214 Australian TBI participants given the NART within 1 month post-injury, and at 6 and 12 months. TBI severity, age, education, sex, and mood (HADS) were examined, and significant improvement in NART- estimated full-scale IQ (FSIQ) was noted over time (p<.001). A three-way interaction of time, severity, and age showed younger and middle-aged mild TBI sub-groups improved significantly between 1 and 6 months post-injury, and the older sub-group between 6 and 12 months. In severe TBI, significant NART-estimated FSIQ improvement was noted only for the middle-aged and only between 6 and 12 months post-TBI. NART administration soon after TBI underestimated premorbid IQ, with a complex relationship between time post-injury, severity, and age. Participants with a longer education had higher NART FSIQs, although those with less education gained more IQ points between initial and 6 months assessments suggesting higher initial NART impairment. Regression equations predicted NART FSIQ at 6 (R=0.813) and 12 months post-trauma (R=0.7920.845), their effectiveness being confirmed via cross-validation. No significant relationships were noted between NART-estimated FSIQ and mood variables, or evidence of significant gains in estimated FSIQ between 12 and 24 months post-injury.	[Skilbeck, Clive; Dean, Tracey; Slatyer, Mark] Univ Tasmania, Sch Psychol, Hobart, Tas 7001, Australia; [Skilbeck, Clive; Slatyer, Mark] Royal Hobart Hosp, Hobart, Tas, Australia; [Thomas, Matt] Charles Sturt Univ, Sch Psychol, Bathurst, NSW 2795, Australia		Skilbeck, C (corresponding author), Univ Tasmania, Sch Psychol, Hobart, Tas 7001, Australia.	clive.skilbeck@utas.edu.au		Dean, Tracey/0000-0001-9074-7383			[Anonymous], 1999, JAMA, V282, P974; Cockburn J, 2000, J CLIN EXP NEUROPSYC, V22, P508, DOI 10.1076/1380-3395(200008)22:4;1-0;FT508; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P793, DOI 10.1016/0191-8869(89)90126-8; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P267, DOI 10.1111/j.2044-8260.1989.tb01376.x; CRAWFORD JR, 1988, BRIT J CLIN PSYCHOL, V27, P181, DOI 10.1111/j.2044-8260.1988.tb00770.x; Deary IJ, 1998, INTELLIGENCE, V26, P357, DOI 10.1016/S0160-2896(99)00005-7; Dragovic M, 2008, AUST NZ J PSYCHIAT, V42, P814, DOI 10.1080/00048670802277214; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Freeman J, 2000, BRIT J CLIN PSYCHOL, V39, P95, DOI 10.1348/014466500163130; Freeman J, 2001, BRIT J CLIN PSYCHOL, V40, P221, DOI 10.1348/014466501163562; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Griffin SL, 2002, ARCH CLIN NEUROPSYCH, V17, P497, DOI 10.1016/S0887-6177(01)00136-6; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mathias JL, 2007, AUST PSYCHOL, V42, P49, DOI 10.1080/00050060600827599; Morris PG, 2005, BRIT J CLIN PSYCHOL, V44, P209, DOI 10.1348/014466505X34174; Nelson H. E., 1991, NATL ADULT READING T, P14; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nelson HE., 1982, NATL ADULT READING T, P1; OCARROLL RE, 1987, BRIT J CLIN PSYCHOL, V26, P229, DOI 10.1111/j.2044-8260.1987.tb01352.x; OCARROLL RE, 1986, BRIT J CLIN PSYCHOL, V25, P157, DOI 10.1111/j.2044-8260.1986.tb00690.x; Paolo AM, 1997, J CLIN PSYCHOL, V53, P713, DOI 10.1002/(SICI)1097-4679(199711)53:7<713::AID-JCLP8>3.0.CO;2-I; Perez SA, 1996, ARCH CLIN NEUROPSYCH, V11, P491; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Skilbeck C, 2005, NEUROPSYCHOL REHABIL, V15, P69, DOI 10.1080/09602010443000056aa; Skilbeck C, 2011, BRAIN IMPAIR, V12, P22, DOI 10.1375/brim.12.1.22; Snaith R., 1994, HOSP ANXIETY DEPRESS; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Taylor KI, 1996, J CLIN EXP NEUROPSYC, V18, P883, DOI 10.1080/01688639608408309; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Wechsler D., 2011, TEST PREMORBID FUNCT; WechslerD, 2001, WECHSLER TEST ADULT	36	9	9	1	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 1	2013	23	2					234	255		10.1080/09602011.2012.747968			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	105KU	WOS:000316068800005	23245593				2022-02-06	
J	Cieza, A; Bostan, C; Ayuso-Mateos, JL; Oberhauser, C; Bickenbach, J; Raggi, A; Leonardi, M; Vieta, E; Chatterji, S				Cieza, Alarcos; Bostan, Cristina; Luis Ayuso-Mateos, Jose; Oberhauser, Cornelia; Bickenbach, Jerome; Raggi, Alberto; Leonardi, Matilde; Vieta, Eduard; Chatterji, Somnath			The psychosocial difficulties in brain disorders that explain short term changes in health outcomes	BMC PSYCHIATRY			English	Article						Psychosocial; Psychiatric disorders; Neurological disorders; Disability	DISABILITY ASSESSMENT SCHEDULE; INTERNATIONAL CLASSIFICATION; MENTAL-DISORDERS; ICF; EUROPE; DEPRESSION; ILLNESS; BURDEN; DISEASES; STIGMA	Background: This study identifies a set of psychosocial difficulties that are associated with short term changes in health outcomes across a heterogeneous set of brain disorders, neurological and psychiatric. Methods: Longitudinal observational study over approximately 12 weeks with three time points of assessment and 741 patients with bipolar disorders, depression, migraine, multiple sclerosis, parkinson's disease, stroke and traumatic brain injury. The data on disability was collected with the checklist of the International Classification of Functioning, Disability and Health. The selected health outcomes were the Short Form 36 and the World Health Organization Disability Assessment Schedule. Multilevel models for change were applied controlling for age, gender and disease severity. Results: The psychosocial difficulties that explain the variability and change over time of the selected health outcomes were energy and drive, sleep, and emotional functions, and a broad range of activities and participation domains, such as solving problems, conversation, areas of mobility and self-care, relationships, community life and recreation and leisure. Conclusions: Our findings are of interest to researchers and clinicians for interventions and health systems planning as they show that in addition to difficulties that are diagnostic criteria of these disorders, there are other difficulties that explain small changes in health outcomes over short periods of time.	[Cieza, Alarcos] Univ Southampton, Sch Psychol, Fac Social & Human Sci, Southampton SO17 1BJ, Hants, England; [Cieza, Alarcos; Oberhauser, Cornelia] Univ Munich, Chair Publ Hlth & Hlth Serv Res, Res Unit Biopsychosocial Hlth, Dept Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Cieza, Alarcos; Bostan, Cristina; Bickenbach, Jerome] Swiss Parapleg Res, Nottwil, Switzerland; [Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, CIBERSAM, Hosp Univ Princesa, Dept Psychiat, Madrid, Spain; [Raggi, Alberto; Leonardi, Matilde] Neurol Inst C Besta IRRCS Fdn Neurol, Publ Hlth & Disabil Unit, Milan, Italy; [Vieta, Eduard] Univ Barcelona, Inst Neurosci, CIBERSAM, Bipolar Disorders Program,Hosp Clin,IDIBAPS, Barcelona, Spain; [Chatterji, Somnath] WHO, Dept Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland		Cieza, A (corresponding author), Univ Southampton, Sch Psychol, Fac Social & Human Sci, Bldg 44,Highfield Campus, Southampton SO17 1BJ, Hants, England.	a.cieza@soton.ac.uk	Vieta, Eduard/Y-2919-2019; CHATTERJI, Somnath/ABE-6832-2020; Vieta, Eduard/I-6330-2013; leonardi, matilde/J-9997-2018; Raggi, Alberto/K-5787-2016	Vieta, Eduard/0000-0002-0548-0053; Vieta, Eduard/0000-0002-0548-0053; leonardi, matilde/0000-0003-0552-8923; Raggi, Alberto/0000-0002-7433-7779; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X	EUEuropean Commission	During the development of this paper, Cristina Bostan was supported by a Marie Curie Fellowship from the EU funded project MURINET.	Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P28, DOI 10.1111/j.1468-1331.2005.01194.x; Avila CC, 2010, BIPOLAR DISORD, V12, P473, DOI 10.1111/j.1399-5618.2010.00833.x; Bickenbach JE, 1999, SOC SCI MED, V48, P1173, DOI 10.1016/S0277-9536(98)00441-9; Chwastiak LA, 2003, J CLIN EPIDEMIOL, V56, P507, DOI 10.1016/S0895-4356(03)00051-9; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Cieza A, 2004, J REHABIL MED, V36, P128, DOI 10.1080/16501960410016055; Corrigan PW, 2008, J PSYCHOSOC NURS MEN, V46, P42, DOI 10.3928/02793695-20080101-04; Dunn EC, 2010, AM J ORTHOPSYCHIAT, V80, P185, DOI 10.1111/j.1939-0025.2010.01022.x; Francescutti C, 2009, DISABIL REHABIL, V31, pS46, DOI 10.3109/09638280903317757; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Holper L, 2010, J NEUROL, V257, P103, DOI 10.1007/s00415-009-5282-4; Kessler, 2008, WHO WORLD MENTAL HLT; Killeen MB, 2004, PSYCHIATR REHABIL J, V28, P157, DOI 10.2975/28.2004.157.163; Leonardi M, 2010, HEADACHE, V50, P1576, DOI 10.1111/j.1526-4610.2010.01770.x; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Raggi A, 2010, INT J REHABIL RES, V33, P225, DOI 10.1097/MRR.0b013e3283375e53; Rao D, 2009, QUAL LIFE RES, V18, P585, DOI 10.1007/s11136-009-9475-1; Rose Diana, 2010, Epidemiol Psichiatr Soc, V19, P140; Ustun T, 2010, MEASURING HLTH DISAB; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2000, WORLD HLTH REP 2000; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Wittchen HU, 1996, BRIT J PSYCHIAT, V168, P9, DOI 10.1192/S000712500029836X; World Health Organisation, 2005, MENT HLTH ATL; World Health Organization, 2004, ATL COUNTR RES NEUR; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured]	32	9	9	1	18	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-244X			BMC PSYCHIATRY	BMC Psychiatry	MAR 11	2013	13								78	10.1186/1471-244X-13-78			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	141AV	WOS:000318698600001	23497332	gold, Green Published, Green Accepted			2022-02-06	
J	Gilad, R; Boaz, M; Sadeh, M; Eilam, A; Dabby, R; Lampl, Y				Gilad, Ronit; Boaz, Mona; Sadeh, Menachem; Eilam, Anda; Dabby, Ron; Lampl, Yair			Seizures after Very Mild Head or Spine Trauma	JOURNAL OF NEUROTRAUMA			English	Article						epilepsy; road accident; whiplash injury	POSTTRAUMATIC SEIZURES; BRAIN-INJURY; EPILEPSY; RISK	Traumatic brain injury (TBI) is a major cause of seizures in the general population. Several studies have shown an increased risk of epilepsy after traumatic brain injury, depending on risk factors, such as severity and time post trauma. The aim of our study was to evaluate the appearance of late seizures after a very mild head trauma or whiplash injury. All patients admitted to the emergency room after a very mild head trauma or whiplash injury during 2008-2010 were evaluated prospectively within 24 hours of the event and followed up 1 year later for evaluation of seizure appearance. The appearance of seizures in the head trauma or whiplash injury group was compared to a control group of orthopedic injury patients. A total of 2999 patients were included in the study-2005 patients with involvement of head and spine trauma and 994 in an orthopedic control group. Three patients (0.1%) out of the whole study group developed seizures: 2 (0.18%) in the head trauma group and 1 (0.1%) in the control group. The conclusion of the study was that post trauma seizure incidence is not significantly different in patients with very mild head or spine trauma and is similar respective to subjects with no non-head or cervical spine injury. This may have medico-legal repercussions.	[Gilad, Ronit; Sadeh, Menachem; Eilam, Anda; Dabby, Ron; Lampl, Yair] Tel Aviv Univ, Dept Neurol, Edith Wolfson Med Ctr, Sackler Fac Med, IL-58100 Tel Aviv, Israel; [Boaz, Mona] Tel Aviv Univ, Epidemiol Unit, Edith Wolfson Med Ctr, Sackler Fac Med, IL-58100 Tel Aviv, Israel		Gilad, R (corresponding author), Tel Aviv Univ, Dept Neurol, Edith Wolfson Med Ctr Holon, Sackler Fac Med, IL-58100 Tel Aviv, Israel.	gilad-ar@zahav.net.il	Boaz, Mona/O-6940-2014	Boaz, Mona/0000-0002-3920-7549			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beghi E, 2003, EPILEPSIA, V44, P11; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; DASILVA AM, 1990, ACT NEUR S, V50, P48; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Jensen FE, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2008.02003.x; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Ottman R, 2010, EPILEPSIA, V51, P191, DOI 10.1111/j.1528-1167.2009.02274.x; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; The Brain Trauma Foundation, 2000, NEUROTRAUMA, V7, P49; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334	19	9	9	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2013	30	6					469	472		10.1089/neu.2012.2625			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	127ZK	WOS:000317737400005	23227924				2022-02-06	
J	Gubert, F; Zaverucha-do-Valle, C; Figueiredo, FR; Bargas-Rega, M; Paredes, BD; Mencalha, AL; Abdelhay, E; Gutfilen, B; da Fonseca, LMB; Mendez-Otero, R; Santiago, MF				Gubert, Fernanda; Zaverucha-do-Valle, Camila; Figueiredo, Fernanda Ribeiro; Bargas-Rega, Michelle; Paredes, Bruno Diaz; Mencalha, Andre Luiz; Abdelhay, Eliana; Gutfilen, Bianca; Barbosa da Fonseca, Lea Mirian; Mendez-Otero, Rosalia; Santiago, Marcelo Felippe			Bone-marrow cell therapy induces differentiation of radial glia-like cells and rescues the number of oligodendrocyte progenitors in the subventricular zone after global cerebral ischemia	STEM CELL RESEARCH			English	Article							NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ADULT DENTATE GYRUS; SPINAL-CORD INJURY; MONONUCLEAR-CELLS; STROMAL CELLS; NEUROTROPHIC FACTOR; WHITE-MATTER; RAT-BRAIN	The subventricular zone (SVZ) is recognized as one of the neurogenic regions in the adult mammalian central nervous system and the presence of cells that share similar characteristics with developmental radial glia, the radial glia-like cells (RGLCs) has been demonstrated in this region. In this study, we investigated whether and how SVZ cells respond to global ischemia and/or to the intravenous transplant of bone-marrow mononuclear cells (BMMCs). Adult rats were subjected to bilateral common carotid ligation (BCCL) and after 1 day 2x10(7) BMMCs or saline injection. The BMMC transplant stimulated a transitory increase in the proliferation of SVZ cells in the BCCL group. We observed a significant increase in the number of RGLCs 3 days after ischemia, in both BCCL and BCCL+BAAMC groups. However, this increase persisted in the subsequent days only in BCCL animals that received the transplant. BMMC transplantation also inhibits the reduction of NG2-positive oligodendrocyte progenitors in the SVZ observed in the BCCL group. Interestingly, brain-derived neurotrophic factor (BDNF) expression was up-regulated in the SVZ in the treated animals, but not in the other groups. These data thus suggest that BMMC transplantation modulates the phenotype of RGLCs/progenitors in the SVZ and could have a protective role after ischemia. (C) 2012 Elsevier B.V. All rights reserved.	[Gubert, Fernanda; Zaverucha-do-Valle, Camila; Figueiredo, Fernanda Ribeiro; Bargas-Rega, Michelle; Paredes, Bruno Diaz; Mendez-Otero, Rosalia; Santiago, Marcelo Felippe] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil; [Mencalha, Andre Luiz; Abdelhay, Eliana] Ctr Nacl Transplante Medula Ossea, Inst Nacl Canc, Lab Celulas Tronco, BR-20230130 Rio De Janeiro, Brazil; [Gutfilen, Bianca; Barbosa da Fonseca, Lea Mirian] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Radiol, Rio De Janeiro, Brazil		Gubert, F (corresponding author), Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Sala G2-028,Cidade Univ, BR-21941902 Rio De Janeiro, Brazil.	fegubert@biof.ufrj.br	Mencalha, A/F-6677-2012; Paredes, Bruno/ABE-6217-2021; Mencalha, Andre Luiz/Y-2522-2019; Gutfilen, Bianca/C-3116-2013; Santiago, Marcelo Felippe/AAZ-3553-2020; Mendez-Otero, Rosalia/AAL-7551-2020; Santiago, Marcelo F/H-3943-2011; Mencalha, Andre/AAC-6700-2019; Gubert, Fernanda/G-7619-2014	Paredes, Bruno/0000-0001-5711-0604; Santiago, Marcelo Felippe/0000-0003-2428-9606; Mendez-Otero, Rosalia/0000-0002-1798-9930; Santiago, Marcelo F/0000-0003-2428-9606; Gubert, Fernanda/0000-0002-0568-7935; Mencalha, Andre Luiz/0000-0003-3229-8094	Ministry of Health (MS/SCTIE/DECIT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (Inbeb); Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPERJFundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ); Financiadora de Estudos e Projetos (FINEP)Financiadora de Inovacao e Pesquisa (Finep)	This study was supported by grants from the Ministry of Health (MS/SCTIE/DECIT), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (Inbeb), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). EA is supported by the CNPq, FAPERJ, and Financiadora de Estudos e Projetos (FINEP). We thank Suelen Serio and Felipe Marins for technical assistance.	Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Alves JAJ, 2002, J NEUROBIOL, V52, P251, DOI 10.1002/neu.10087; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Baetas-da-Cruz W., 2012, BRAIN RES; da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010; da Fonseca LMB, 2009, CIRCULATION, V120, P539, DOI 10.1161/CIRCULATIONAHA.109.863084; Barkho BZ, 2011, CURR STEM CELL RES T, V6, P327; Bath K.G., 2011, DEV PSYCHOBIOL; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Costa MR, 2010, BRAIN RES REV, V63, P47, DOI 10.1016/j.brainresrev.2010.01.002; Costa-Ferro ZSM, 2012, NEUROBIOL DIS, V46, P302, DOI 10.1016/j.nbd.2011.12.001; Craig CG, 1996, J NEUROSCI, V16, P2649; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; Friedrich MAG, 2012, CELL TRANSPLANT, V21, pS13, DOI 10.3727/096368912X612512; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gao Q, 2008, NEUROSCIENCE, V152, P646, DOI 10.1016/j.neuroscience.2007.10.069; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Gonzalez-Perez O, 2011, BRAIN RES REV, V67, P147, DOI 10.1016/j.brainresrev.2011.01.001; Gregg C, 2003, J NEUROSCI, V23, P11587; Gubert F, 2009, BRAIN RES, V1258, P43, DOI 10.1016/j.brainres.2008.12.021; Gutfilen B, 1999, J Clin Lab Immunol, V51, P1; Ikeda O, 2002, J NEUROPATH EXP NEUR, V61, P142, DOI 10.1093/jnen/61.2.142; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kan I, 2011, STEM CELL REV REP, V7, P404, DOI 10.1007/s12015-010-9190-x; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Koda M, 2002, J NEUROTRAUM, V19, P777, DOI 10.1089/08977150260139147; Kokaia Z, 2006, CEREB CORTEX, V16, pI162, DOI 10.1093/cercor/bhj174; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Kurumatani T, 1998, STROKE, V29, P1058, DOI 10.1161/01.STR.29.5.1058; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; Liu JL, 1998, J NEUROSCI, V18, P7768; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Makar TK, 2008, J NEUROL SCI, V270, P70, DOI 10.1016/j.jns.2008.02.011; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Ohta H, 1997, NEUROSCIENCE, V79, P1039, DOI 10.1016/S0306-4522(97)00037-7; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Parnavelas JG, 2001, NEURON, V31, P881, DOI 10.1016/S0896-6273(01)00437-8; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Ribeiro-Resende VT, 2009, NEUROSCIENCE, V159, P540, DOI 10.1016/j.neuroscience.2008.12.059; Rost N.S., 2012, J NEUROINTERV SURG; Rothstein RP, 2005, DEV NEUROSCI-BASEL, V27, P149, DOI 10.1159/000085987; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Seki M, 2005, NEUROCHEM RES, V30, P1163, DOI 10.1007/s11064-005-7936-7; Shapiro LA, 2005, BRAIN RES, V1040, P81, DOI 10.1016/j.brainres.2005.01.098; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Talbott JF, 2005, EXP NEUROL, V192, P11, DOI 10.1016/j.expneurol.2004.05.038; Thwaites JW, 2012, REGEN MED, V7, P387, DOI [10.2217/RME.12.2, 10.2217/rme.12.2]; TSUCHIYA M, 1992, EXP BRAIN RES, V89, P87; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vasconcelos-dos-Santos A, 2012, STEM CELL RES, V9, P1, DOI 10.1016/j.scr.2012.02.002; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wakita H, 2002, BRAIN RES, V924, P63, DOI 10.1016/S0006-8993(01)03223-1; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zaverucha-do-Valle C, 2011, CELL TRANSPLANT, V20, P391, DOI 10.3727/096368910X524764; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430; Zhou RX, 2001, BRAIN RES BULL, V56, P37, DOI 10.1016/S0361-9230(01)00591-3	85	9	9	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	MAR	2013	10	2					241	256		10.1016/j.scr.2012.11.009			16	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology	099GL	WOS:000315609400010	23314663	Bronze			2022-02-06	
J	Itoh, T; Imano, M; Nishida, S; Tsubaki, M; Nakayama, T; Mizuguchi, N; Yamanaka, S; Tabuchi, M; Munakata, H; Hashimoto, S; Ito, A; Satou, T				Itoh, Tatsuki; Imano, Motohiro; Nishida, Shozo; Tsubaki, Masahiro; Nakayama, Takashi; Mizuguchi, Nobuyuki; Yamanaka, Shigeaki; Tabuchi, Masaki; Munakata, Hiroshi; Hashimoto, Shigeo; Ito, Akihiko; Satou, Takao			Appearance of neural stem cells around the damaged area following traumatic brain injury in aged rats	JOURNAL OF NEURAL TRANSMISSION			English	Article						Aged rat; Neural stem cell; Traumatic brain injury; Apoptosis; Oxidative stress	IMPROVES CEREBRAL FUNCTION; CENTRAL-NERVOUS-SYSTEM; MITOCHONDRIAL DYSFUNCTION; SPINAL-CORD; PROLIFERATION; HIPPOCAMPUS; EXPRESSION; NEURONS; CORTEX; PROTECTS	We have previously reported free radical production after traumatic brain injury (TBI), which induces neural stem cell (NSC) degeneration and death. However, the effects of aging on NSC proliferation around the damaged area following TBI have not been investigated. Therefore, in this study, we used 10-week (young group) and 24-month-old (aged group) rat TBI models to investigate the effects of aging on NSC proliferation around damaged tissue using immunohistochemical and ex vivo techniques. Young and aged rats received TBI. At 1, 3 and 7 days after TBI, immunohistochemical and lipid peroxidation studies were performed. Immunohistochemistry revealed that the number of nestin-positive cells around the damaged area after TBI in the aged group decreased significantly when compared with those in the young group (P < 0.01). However, the number of 8-hydroxy-2'-deoxyguanosine-, 4-hydroxy-2-nonenal- and single-stranded DNA (ssDNA)-positive cells and the level of peroxidation around the damaged area after TBI significantly increased in the aged group, compared with those in the young group (P < 0.01). Furthermore, almost all ssDNA-positive cells in young and aged groups co-localized with NeuN and nestin staining. Ex vivo studies revealed that neurospheres, which differentiated into neurons and glia in culture, could only be isolated from injured brain tissue in young and aged groups at 3 days after TBI. These results indicate that, although there were fewer NSCs that have the potential to differentiate into neurons and glia, these NSCs escaped free radical-induced degeneration around the damaged area after TBI in the aged rat brain.	[Itoh, Tatsuki; Ito, Akihiko; Satou, Takao] Kinki Univ, Fac Med, Dept Pathol, Osaka 5898511, Japan; [Imano, Motohiro] Kinki Univ, Fac Med, Dept Surg, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro; Nakayama, Takashi] Kinki Univ, Fac Pharmaceut Sci, Osaka 5898511, Japan; [Mizuguchi, Nobuyuki; Yamanaka, Shigeaki] Kinki Univ, Life Sci Res Inst, Osaka 5898511, Japan; [Tabuchi, Masaki; Munakata, Hiroshi] Kinki Univ, Fac Med, Dept Biochem, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Dept Pathol, Osaka, Japan; [Satou, Takao] Kinki Univ Hosp, Fac Med, Div Hosp Pathol, Osaka, Japan		Itoh, T (corresponding author), Kinki Univ, Fac Med, Dept Pathol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp					Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Belluardo N, 2008, BRAIN RES, V1193, P12, DOI 10.1016/j.brainres.2007.11.069; Campuzano O, 2009, J NEUROSCI RES, V87, P2484, DOI 10.1002/jnr.22074; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; DAS S, 2008, CURR AGING SCI, P1; DiNapoli VA, 2010, NEUROSCIENCE, V170, P633, DOI 10.1016/j.neuroscience.2010.07.011; Douen AG, 2004, BRAIN RES, V1008, P139, DOI 10.1016/j.brainres.2003.08.070; Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2006, NEUROCHEM RES, V31, P1381, DOI 10.1007/s11064-006-9186-8; Itoh T, 2011, NEUROMOL MED, V13, P300, DOI 10.1007/s12017-011-8162-x; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Lynch AM, 2002, EUR J NEUROSCI, V15, P1779, DOI 10.1046/j.1460-9568.2002.02012.x; Molteni R, 2010, NEUROBIOL DIS, V37, P747, DOI 10.1016/j.nbd.2009.12.014; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004; Parent JM, 1997, J NEUROSCI, V17, P3727; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rocha RA, 2011, TOXICOL LETT, V203, P237, DOI 10.1016/j.toxlet.2011.03.023; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shi SS, 2010, YONSEI MED J, V51, P661, DOI 10.3349/ymj.2010.51.5.661; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Terry AV, 2011, PHYSIOL BEHAV, V102, P149, DOI 10.1016/j.physbeh.2010.11.005; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Wasserman JK, 2008, EXP NEUROL, V214, P266, DOI 10.1016/j.expneurol.2008.08.010; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xu K, 2008, ADV EXP MED BIOL, V614, P379, DOI 10.1007/978-0-387-74911-2_42; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Yurek DM, 2001, BRAIN RES, V891, P228, DOI 10.1016/S0006-8993(00)03217-0	40	9	9	0	23	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564			J NEURAL TRANSM	J. Neural Transm.	MAR	2013	120	3					361	374		10.1007/s00702-012-0895-7			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	093BB	WOS:000315165600001	22955958				2022-02-06	
J	Tate, RL; Taylor, C; Aird, V				Tate, Robyn L.; Taylor, Christine; Aird, Vanessa			Applying Empirical Methods in Clinical Practice: Introducing the Model for Assessing Treatment Effect	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aphasia; cognitive-communication disorder; evidence-based clinical practice; ICF; methodology; n-of-1 trial; rehabilitation; single-subject design; traumatic brain injury; treatment	SINGLE-SUBJECT DESIGNS; INTERNATIONAL CLASSIFICATION; COMMUNICATION; APHASIA; DISABILITY; HEALTH; OUTCOMES; TRIALS; SPEECH; TOOL	Background: One challenge in rehabilitation is determining whether improvement in the patient is a treatment-specific effect or due to extraneous factors (eg, the passage of time, spontaneous recovery). Design: Descriptive, model building, and 2 cases illustrating the model. Method: The Model for Assessing Treatment Effect (MATE) incorporates the conceptual frameworks of the International Classification of Functioning, Disability, and Health (ICF), along with single-case experimental methodology. Results: The MATE contains 7 levels organized in a hierarchy, representing (i) increasing specificity of evaluation procedures and (ii) control of extraneous variables during therapy. Two illustrative cases of patients with traumatic brain injury undergoing inpatient rehabilitation for, inter alia, cognitive-communication impairments are described to illustrate common clinical practice (level 2 of MATE) and a superior method using a multiple-baseline design across behaviors, enabling rigorous evaluation of treatment effect (level 6 of MATE). Conclusions: The MATE offers a systematic, evidence-based approach for implementing ICF-informed goals into clinical practice. It also provides a benchmark against which a clinical service can be evaluated in terms of the rigor of its therapy program.	[Tate, Robyn L.] Univ Sydney, Rehabil Studies Unit, Northern Clin Sch, Sydney Med Sch, Sydney, NSW 2006, Australia; [Taylor, Christine] Macquarie Univ, Fac Human Sci, Dept Linguist, Sydney, NSW 2109, Australia; [Taylor, Christine; Aird, Vanessa] Cortex Commun Partners, Sydney, NSW, Australia		Tate, RL (corresponding author), Rehabil Studies Unit, POB 6, Sydney, NSW 1680, Australia.	rtate@med.usyd.edu.au					ALDERMAN N, 1995, NEUROPSYCHOL REHABIL, V5, P193, DOI 10.1080/09602019508401467; Alderman N, 1997, BRAIN INJURY, V11, P79, DOI 10.1080/026990597123683; Barlow DH, 2009, SINGLE CASE EXPT SIG; Bastiaanse R, 2006, APHASIOLOGY, V20, P298, DOI 10.1080/02687030500474922; Beeson PM, 2006, NEUROPSYCHOL REV, V16, P161, DOI 10.1007/s11065-006-9013-7; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ellmo W., 1995, MCLA MEASURE COGNITI; GUYATT G, 1986, NEW ENGL J MED, V314, P889, DOI 10.1056/NEJM198604033141406; Guyatt G., 2008, USERS GUIDE MED LIT, V2nd; Herson M, 1976, SINGLE CASE EXPT DES; Hopper T, 2002, APHASIOLOGY, V16, P745, DOI 10.1080/02687030244000059; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; Howick J, 2011, 2011 OXFORD CEBM EVI; Johnson RK, 2008, AUGMENT ALTERN COMM, V24, P269, DOI 10.1080/07434610802463957; Kazdin A., 1982, SINGLE CASE RES DESI; Kazdin AE., 2011, SINGLE CASE RES DESI; Kratochwill T.R., 2010, SINGLE CASE DESIGNS; Larkins B, 2008, BRAIN IMPAIR, V9, P247, DOI 10.1375/brim.9.3.247; Lustig AP, 2002, APHASIOLOGY, V16, P507, DOI 10.1080/02687030244000211; Martinoff J. T., 1981, LANGUAGE REHABILITAT; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Powell T, 2003, BRAIN INJURY WORKBOO; Simpson F, 2006, MT WILGA HIGH LEVEL, V1; STINEMAN MG, 2005, PHYS MED REHABILITAT, P1099; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tate RL, 2008, BRAIN IMPAIR, V9, P282, DOI 10.1375/brim.9.3.282; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; Wade D. T., 2005, EFFECTIVENESS REHABI; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; World Health Organization, 2007, INT CLASS FUNCT DIS; Worrall LE, 2008, INT J SPEECH-LANG PA, V10, P72, DOI 10.1080/17549500701852148	32	9	9	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2013	28	2					77	88		10.1097/HTR.0b013e31824e103e			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	105HU	WOS:000316058300001	22647962				2022-02-06	
J	Ahlering, TE; Gordon, A; Morales, B; Skarecky, DW				Ahlering, Thomas E.; Gordon, Adam; Morales, Blanca; Skarecky, Douglas W.			Preserving Continence During Robotic Prostatectomy	CURRENT UROLOGY REPORTS			English	Article						Continence; Radical prostatectomy; Laparoscopy; Robotic surgery; Minimally invasive surgery; Patient-related factors	TRAUMATIC BRAIN-INJURY; LAPAROSCOPIC RADICAL PROSTATECTOMY; URINARY CONTINENCE; SEXUAL FUNCTION; HYPOTHERMIA; IMPACT; RHABDOSPHINCTER; COMPLICATIONS; INCONTINENCE; MECHANISMS	Preservation of postoperative urinary continence remains the primary concern of all men and their surgeons following robot-assisted radical prostatectomy (RARP). Without doubt, continence is the most important quality of life issue following radical prostatectomy. Identification of difficulties and lessons learned over time has helped focus efforts in order to improve urinary quality of life and continence. This review will examine definitions of continence and urinary quality of life evaluation, technical aspects and the impact of patient-related factors affecting time to and overall continence.	[Ahlering, Thomas E.; Gordon, Adam; Morales, Blanca; Skarecky, Douglas W.] Univ Calif Irvine, Dept Urol, Irvine, CA 92697 USA		Ahlering, TE (corresponding author), Univ Calif Irvine, Dept Urol, Irvine, CA 92697 USA.	tahlerin@uci.edu		Gordon, Adam/0000-0003-2760-0172; Skarecky, Douglas/0000-0002-9234-6716; Ahlering, Thomas/0000-0002-6492-4910			Adachi M, 2001, PEDIATR RES, V50, P590, DOI 10.1203/00006450-200111000-00010; Ahlering TE, 2005, UROLOGY, V65, P740, DOI 10.1016/j.urology.2004.10.061; Ahlering T, 2012, J ENDOUROL, V26, pA132; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Ates M, 2007, EUR UROL, V52, P178, DOI 10.1016/j.eururo.2006.12.022; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Castle EP, 2008, WORLD J UROL, V26, P91, DOI 10.1007/s00345-007-0217-0; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Eastham JA, 1996, J UROLOGY, V156, P1707, DOI 10.1016/S0022-5347(01)65488-0; Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Finley DS, 2010, J ENDOUROL, V24, P1111, DOI 10.1089/end.2010.0122; Finley DS, 2009, UROLOGY, V73, P691, DOI 10.1016/j.urology.2008.09.085; Hammerer P, 1997, J UROLOGY, V157, P233, DOI 10.1016/S0022-5347(01)65334-5; Hildebrand Frank, 2005, Surg Technol Int, V14, P41; Kundu SD, 2004, J UROLOGY, V172, P2227, DOI 10.1097/01.ju.0000145222.94455.73; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; Link BA, 2008, J UROLOGY, V180, P928, DOI 10.1016/j.juro.2008.05.029; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liss M, 2013, UROLOGY IN PRESS; Liss MA, 2010, J UROLOGY, V183, P1464, DOI 10.1016/j.juro.2009.12.009; Loughlin KR, 2010, J UROLOGY, V183, P871, DOI 10.1016/j.juro.2009.11.011; Majoros A, 2006, NEUROUROL URODYNAM, V25, P2, DOI 10.1002/nau.20190; Ning XH, 2002, J APPL PHYSIOL, V92, P2200, DOI 10.1152/japplphysiol.01035.2001; Novara G, 2010, J UROLOGY, V184, P1028, DOI 10.1016/j.juro.2010.04.069; Perimenis P, 2004, EUR UROL, V46, P604, DOI 10.1016/j.eururo.2004.07.009; Pick DL, 2011, BJU INT, V108, P1492, DOI 10.1111/j.1464-410X.2010.10015.x; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Povlishock JT, 1999, ACT NEUR S, V73, P15; Rocco F, 2006, J UROLOGY, V175, P2201, DOI 10.1016/S0022-5347(06)00262-X; Rodriguez E, 2006, UROLOGY, V67, P785, DOI 10.1016/j.urology.2005.10.006; Shikanov S, 2010, J UROLOGY, V183, P1803, DOI 10.1016/j.juro.2010.01.016; Skarecky D, 2011, J ENDOUROL, V25, P1451, DOI 10.1089/end.2011.0013; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Strasser H, 1996, PROSTATE, V28, P24, DOI 10.1002/(SICI)1097-0045(199601)28:1<24::AID-PROS4>3.0.CO;2-O; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Teber D, 2010, J UROLOGY, V183, P1087, DOI 10.1016/j.juro.2009.11.033; Twiss C, 2000, J UROLOGY, V164, P1241, DOI 10.1016/S0022-5347(05)67148-0; Tzou DT, 2009, UROL ONCOL-SEMIN ORI, V27, P358, DOI 10.1016/j.urolonc.2008.01.013; Van Kampen M, 2009, J UROLOGY, V181, P2641, DOI 10.1016/j.juro.2009.02.025; Van Velthoven RF, 2003, UROLOGY, V61, P699, DOI 10.1016/S0090-4295(02)02543-8; van Velthoven R, 2007, J ENDOUROL, V21, pA64; Walsh PC, 2000, UROLOGY, V55, P58, DOI 10.1016/S0090-4295(99)00397-0; Wei J T, 2000, Semin Urol Oncol, V18, P76; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; ZVARA P, 1994, BRIT J UROL, V74, P182, DOI 10.1111/j.1464-410X.1994.tb16583.x	47	9	10	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1527-2737	1534-6285		CURR UROL REP	Curr. Urol. Rep.	FEB	2013	14	1					52	58		10.1007/s11934-012-0295-4			7	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	AI1EX	WOS:000336594200010	23239360				2022-02-06	
J	Chiaramonte, R; Bonfiglio, M; D'Amore, A; Viglianesi, A; Cavallaro, T; Chiaramonte, I				Chiaramonte, R.; Bonfiglio, M.; D'Amore, A.; Viglianesi, A.; Cavallaro, T.; Chiaramonte, I.			Traumatic Labyrinthine Concussion in a Patient with Sensorineural Hearing Loss	NEURORADIOLOGY JOURNAL			English	Article						temporal region trauma; post-concussion symptoms; CT and MR imaging; labyrinth diseases; sensorineural hearing loss		Blunt head trauma without any temporal bone fracture or longitudinal temporal bone fracture, with an associated fracture of the labyrinth may cause labyrinthine injury with sensor neural hearing loss and vertigo because of a concussive injury to the membranous labyrinth. Sudden sensory neural hearing loss is relatively frequent. In most cases, the etiology is not discovered. One of the possible causes for sudden deafness is inner labyrinth bleeding or concussion, which were difficult to diagnose before the advent of magnetic resonance imaging. Vertigo without a demonstrable fracture may also be the result of labyrinthine concussion, cupololithiasis and perilymphatic fistula. We describe the clinical case of a patient with acute traumatic hearing loss and vertigo, without skull base fracture detected on computed tomography. Magnetic resonance study was also performed. We have integrated the discussion with features that allow the differential diagnosis from other similar conditions.	[Chiaramonte, R.; Bonfiglio, M.] Univ Hosp Catania, Dept Otorhinolaryngol, Catania, Italy; [D'Amore, A.; Viglianesi, A.; Cavallaro, T.] Univ Hosp Catania, Dept Med Diagnost Specialties, Sect Radiol Sci, Via Santa Sofia 78, I-95100 Catania, Italy; [Chiaramonte, I.] Univ Hosp Catania, Dept Neuroradiol, Catania, Italy		D'Amore, A (corresponding author), Univ Hosp Catania, Dept Med Diagnost Specialties, Sect Radiol Sci, Via Santa Sofia 78, I-95100 Catania, Italy.	ritachiaramonte@alice.it	Chiaramonte, Rita/AAW-8967-2020	Chiaramonte, Rita/0000-0003-1256-7605; D'Amore, Alessandro/0000-0001-8418-9821; CHIARAMONTE, Ignazio/0000-0002-5460-928X; Bonfiglio, Marco/0000-0002-8322-248X			Adil EA, 2011, EMERG RADIOL, V18, P43, DOI 10.1007/s10140-010-0902-y; Aralasmak A, 2009, DIAGN INTERV RADIOL, V15, P239, DOI 10.4261/1305-3825.DIR.1621-08.1; Bamiou DE, 1999, CLIN OTOLARYNGOL, V24, P31, DOI 10.1046/j.1365-2273.1999.00203.x; Brusis T, 2011, LARYNGO RHINO OTOL, V90, P73, DOI 10.1055/s-0030-1267938; Casselman JW, 1997, RADIOLOGE, V37, P954, DOI 10.1007/s001170050307; Flint P, 2004, CUMMINGS OTOLARYNGOL, P149; Hiroual MR, 2010, J RADIOL, V91, P53, DOI 10.1016/S0221-0363(10)70006-8; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hunchaisri Niran, 2009, J Med Assoc Thai, V92 Suppl 3, pS76; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Polyakova E. P., 2006, Vestnik Otorinolaringologii, P34; Salomone Raquel, 2008, Braz J Otorhinolaryngol, V74, P776, DOI 10.1016/S1808-8694(15)31390-2; TAYLOR AR, 1967, BRIT MED J, V3, P67, DOI 10.1136/bmj.3.5557.67; Valvassori GE, 2003, BALLENGERS OTORHINOL, P195	14	9	10	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1971-4009	2385-1996		NEURORADIOL J	Neuradiology J.	FEB	2013	26	1					52	55		10.1177/197140091302600109			4	Neuroimaging	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3U4I	WOS:000218596700009	23859168	Green Published			2022-02-06	
J	Cripps, A; Livingston, SC				Cripps, Andrea; Livingston, Scott C.			The Value of Balance-Assessment Measurements in Identifying and Monitoring Acute Postural Instability Among Concussed Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						mild traumatic brain injury; sports; Sensory Organization Test; Balance Error Scoring System	STABILITY	Clinical Scenario: Sport-related concussions are a significant health issue due to the high incidence of concussions sustained each sports season. Current approaches to the evaluation of acutely concussed athletes include the use of balance assessments to identify and monitor underlying postural instability arising from concussion. Balance assessment has been recommended as a primary measurement tool for monitoring recovery and for making return-to-play decisions. Balance impairments have been shown to occur in the initial postconcussion period (ie, 1-10 d). Numerous clinical and laboratory measures have been used in the assessment of balance immediately after concussion, and clinicians are faced with deciding which measures to use. Focused Clinical Question: How do clinical or field-based balance-assessment tools compare to laboratory-based balance measures in identifying deficits in postural stability among acutely concussed athletes?	[Cripps, Andrea; Livingston, Scott C.] Univ Kentucky, Rehabil Sci Dept, Lexington, KY 40506 USA		Cripps, A (corresponding author), Univ Kentucky, Rehabil Sci Dept, Lexington, KY 40506 USA.						Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2009, ARCH PHYS MED REHAB, V90, P145, DOI 10.1016/j.apmr.2008.06.025; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19	7	9	9	0	9	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716			J SPORT REHABIL	J. Sport Rehabil.	FEB	2013	22	1					67	71		10.1123/jsr.22.1.67			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	094GY	WOS:000315252200010	23037313				2022-02-06	
J	Griesbach, GS; Tio, DL; Nair, S; Hovda, DA				Griesbach, Grace S.; Tio, Delia L.; Nair, Shyama; Hovda, David A.			Temperature and Heart Rate Responses to Exercise following Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; CBT; circadian; corticosterone; exercise; fatigue; HR	RATE-VARIABILITY; HYPERTHERMIA WORSENS; NEUROTROPHIC FACTOR; FATIGUE; STRESS; CONCUSSION; SLEEP; CONSEQUENCES; EPIDEMIOLOGY; VOLUNTARY	We have previously reported that mild fluid percussion injury (FPI) is associated with a heightening of the hypothalamic-pituitary-adrenal axis response during the first post-injury weeks. This is the same time period when rehabilitative exercise has been strongly suggested to be ineffective. Here, we explored whether cardiac and temperature autonomic function may also be compromised during this early post-injury period. Following an FPI or sham injury, rats were exercised with forced (fRW) or voluntary (vRW) running wheels on post-injury days 0-4 and 7-11. Results indicated that overall activity levels were decreased and circadian rhythm was affected after FPI. Autonomic disruptions became evident when exercise was introduced, and these disruptions were dependent upon the characteristics of exercise. Elevations in heart rate (HR) and core body temperature (CBT) were observed as a response to vRW and fRW. FPI animals had more pronounced increases in HR as a result of vRW. Likewise, increases in HR were observed with fRW in all animals. A strong stress response has recently been associated with fRW exercise. FPI rats exposed to fRW were more responsive to experimental manipulations and had higher a CBT after the FRW session. The results suggest that subacute exercise, particularly if linked to a strong stress response, may be counterproductive. Here we show that cardiac and temperature autonomic function are compromised during the subacute period following a mild TBI.	[Griesbach, Grace S.; Nair, Shyama; Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Tio, Delia L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Griesbach, Grace S.; Nair, Shyama; Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Griesbach, GS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 957039, Los Angeles, CA 90095 USA.	ggriesbach@mednet.ucla.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS06190]; UCLA Brain Injury Research Center	We thank Ramin Rajaii and Parastoo Modirshahla for their assistance. This research was supported by NIH grant NS06190 to GSG and the UCLA Brain Injury Research Center.	Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Ashman TA, 2006, MT SINAI J MED, V73, P999; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Chinevere TD, 2008, EUR J APPL PHYSIOL, V103, P307, DOI 10.1007/s00421-008-0707-9; DeKeyser FG, 2000, NEUROIMMUNOMODULAT, V7, P182, DOI 10.1159/000026437; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hayashi K, 2006, J APPL PHYSIOL, V100, P414, DOI 10.1152/japplphysiol.00541.2005; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; KATSUMURA H, 1995, ACTA NEUROCHIR, V135, P62, DOI 10.1007/BF02307416; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; LIN WJ, 1989, EUR J PHARMACOL, V171, P9, DOI 10.1016/0014-2999(89)90424-X; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Ohmoto Y, 1996, INT J HYPERTHER, V12, P321, DOI 10.3109/02656739609022521; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; Sharma HS, 2006, J NEURAL TRANSM, V113, P497, DOI 10.1007/s00702-005-0406-1; Steele DL, 2005, CHRONOBIOL INT, V22, P89, DOI 10.1081/CBI-200042428; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004	41	9	9	0	14	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2013	30	4					281	291		10.1089/neu.2012.2616			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	093CM	WOS:000315169300005	23009619	Green Published			2022-02-06	
J	Niemeier, JP; Perrin, PB; Holcomb, MG; Nersessova, KS; Rolston, CD				Niemeier, Janet P.; Perrin, Paul B.; Holcomb, Megan G.; Nersessova, Karine S.; Rolston, Cynthia D.			Factor Structure, Reliability, and Validity of the Frontal Systems Behavior Scale (FrSBe) in an Acute Traumatic Brain Injury Population	REHABILITATION PSYCHOLOGY			English	Article						acute traumatic brain injury; FrSBe; psychometrics	FRONTOTEMPORAL DEMENTIA; NEUROBEHAVIORAL INTERVENTION; ALZHEIMERS-DISEASE; PRACTICAL SCALE; SAMPLE-SIZE; HEAD-INJURY; SYMPTOMS; EPIDEMIOLOGY; INDIVIDUALS; DYSFUNCTION	Objective: This study investigated the psychometric properties of the Frontal Systems Behavior Scale (FrSBe) in an acute traumatic brain injury (TBI) population across indices of factor structure, reliability, and validity. Method: Data were collected from 101 individuals undergoing acute rehabilitation for moderate and severe TBI both upon emergence from posttraumatic amnesia and at hospital discharge, as well as from their family members or caregivers. Results: Four separate confirmatory factor analyses (CFAs) suggested that the FrSBe's three-factor/three-subscale solution did not fit the data well, and follow-up CFAs employing a one-factor structure similarly yielded poor fit indices. Four exploratory factor analyses (EFAs) failed to produce factor solutions consistent with each other or that resembled the factor solution retained in the EFA during the FrSBe's initial construction. The FrSBe had sufficiently high internal consistency at the total-score and subscale-score levels, good convergent validity with other indices of TBI functioning, and good test retest reliability in the family administration of the measure, but not in the patient administration. Conclusions: The FrSBe is an appropriate measure for use in an inpatient TBI population when using the total score and the family administration, though its subscales and patient administration warrant more rigorous examination.	[Niemeier, Janet P.; Holcomb, Megan G.; Nersessova, Karine S.; Rolston, Cynthia D.] Virginia Commonwealth Univ, Inpatient Dept Neuropsychol & Rehabil Psychol, Richmond, VA 23284 USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Niemeier, JP (corresponding author), VA Commonwealth Univ, Sch Med, Inpatient Dept Neuropsychol & Rehabil Psychol, Room 2007B,N Hosp Bldg,POB Box 980661, Richmond, VA 23298 USA.	Janet.niemeier@carolinashealthcare.org	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD052922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000058] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR00058] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD052922, 1R01HD052922-01A2] Funding Source: Medline		ARBUCKLE JL, 2007, AMOS 16 0 COMPUTER S; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Banihashemian K, 2011, BRAIN INJURY, V25, P1249, DOI 10.3109/02699052.2011.608208; Caracuel A, 2008, ARCH CLIN NEUROPSYCH, V23, P447, DOI 10.1016/j.acn.2008.03.004; Clarke DE, 2011, J PSYCHOSOM RES, V70, P73, DOI 10.1016/j.jpsychores.2010.01.012; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Denheyer M, 2009, NEUROPSYCHOLOGIA, V47, P3203, DOI 10.1016/j.neuropsychologia.2009.07.022; Gagne P, 2006, MULTIVAR BEHAV RES, V41, P65, DOI 10.1207/s15327906mbr4101_5; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grace J, 2001, FRSBE FRONTAL SYSTEM; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Malloy P, 2007, ALZHEIMERS DEMENT, V3, P200, DOI 10.1016/j.jalz.2007.04.374; Marsh H. W., 2012, DEV PSYCHOL; Marsh HW, 2010, PSYCHOL ASSESSMENT, V22, P471, DOI 10.1037/a0019227; McKinlay A, 2008, AGING MENT HEALTH, V12, P647, DOI 10.1080/13607860802343225; Mioshi E, 2009, ALZ DIS ASSOC DIS, V23, P70, DOI 10.1097/WAD.0b013e318182d293; Niemeier JP, 2011, BRAIN INJURY, V25, P680, DOI 10.3109/02699052.2011.573520; Niemeier JP, 2005, NEUROPSYCHOL REHABIL, V15, P129, DOI 10.1080/09602010443000083; Paulsen JS, 2000, J INT NEUROPSYCH SOC, V6, P815, DOI 10.1017/S1355617700677081; Prigatano G. P, 1986, NEUROPSYCHOLGICAL RE; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; TEASDALE G, 1974, LANCET, V2, P81; Terada T, 2011, J NEUROL SCI, V309, P136, DOI 10.1016/j.jns.2011.06.049; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Zamboni G, 2010, DEMENT GERIATR COGN, V29, P88, DOI 10.1159/000255141	35	9	9	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2013	58	1					51	63		10.1037/a0031612			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	095VA	WOS:000315361900007	23438000				2022-02-06	
J	Weng, JF; Chen, J; Hong, WC; Luo, LF; Yu, W; Luo, SD				Weng, Jian-Feng; Chen, Jun; Hong, Wei-Cong; Luo, Li-Feng; Yu, Wei; Luo, Shi-Da			Plasma visfatin, associated with a genetic polymorphism-1535C > T, is correlated with C-reactive protein in Chinese Han patients with traumatic brain injury	PEPTIDES			English	Article						Visfatin; Polymorphism; C-reactive protein; Traumatic brain injury; Inflammatory reaction	COLONY-ENHANCING FACTOR; HUMAN FETAL MEMBRANES; RESISTIN; TRIGLYCERIDE; INFLAMMATION	Visfatin is a newly identified pro-inflammatory adipokine and a genetic polymorphism -1535 C>T located in the visfatin gene promoter has been suggested to be associated with the regulation of visfatin expression in some inflammatory illness. However, there were some conflicting results regarding whether this variant is functional or not. This study aimed to examine the relations of the -1535 C>T single nucleotide polymorphism (SNP) of visfatin gene to the plasma visfatin and C-reactive protein concentrations in traumatic brain injury (TBI). 318 Chinese Han patients with TBI were recruited in this study. Plasma visfatin and C-reactive protein levels were significantly different between the genotypes in the SNP-1535 C>T even after adjustment for age, sex and body mass index. The genotype C-C had the highest plasma visfatin and C-reactive protein concentrations. The plasma visfatin and C-reactive protein concentrations between the variant genotypes C-T and T-T did not differ significantly. Plasma visfatin level was significantly associated with plasma C-reactive protein level using multivariate linear regression. Thus, the SNP-1535 C>T of visfatin gene seemed to be potentially involved in the inflammatory component of TBI through a decreased production of visfatin. (C) 2012 Elsevier Inc. All rights reserved.	[Weng, Jian-Feng; Chen, Jun; Hong, Wei-Cong; Luo, Li-Feng; Yu, Wei; Luo, Shi-Da] Second Peoples Hosp Cixi City, Dept Neurosurg, Cixi 315315, Peoples R China		Chen, J (corresponding author), Second Peoples Hosp Cixi City, Dept Neurosurg, 77 Datong Rd, Guanhaiwei Dist 315315, Cixi, Peoples R China.	cieycjwjf@163.com			Ningbo Municipal Natural Science Foundation of China [2011A610045]	This work is financially supported by Ningbo Municipal Natural Science Foundation of China (grant no. 2011A610045).	Carrero JJ, 2010, NEPHROL DIAL TRANSPL, V25, P901, DOI 10.1093/ndt/gfp587; Chen J, 2012, PEPTIDES, V38, P8, DOI 10.1016/j.peptides.2012.08.016; Daniel P, 2010, PANCREATOLOGY, V10, P477, DOI 10.1159/000276986; Favis R, 2000, NAT BIOTECHNOL, V18, P561, DOI 10.1038/75452; Huang Q, 2013, PEPTIDES, V39, P55, DOI 10.1016/j.peptides.2012.11.006; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI 10.1172/JCI19930; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; La Favor JD, 2011, SPINAL CORD, V49, P961, DOI 10.1038/sc.2011.56; Liu P, 2009, J BIOL CHEM, V284, P27344, DOI 10.1074/jbc.M109.002519; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; Mazaki-Tovi S, 2010, AM J REPROD IMMUNOL, V63, P252, DOI 10.1111/j.1600-0897.2009.00804.x; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Ognjanovic S, 2001, J MOL ENDOCRINOL, V26, P107, DOI 10.1677/jme.0.0260107; Ognjanovic S, 2003, AM J OBSTET GYNECOL, V189, P1187, DOI 10.1067/S0002-9378(03)00591-X; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Tokunaga A, 2008, ENDOCR J, V55, P205, DOI 10.1507/endocrj.K07E-039; Wang LS, 2011, MOL BIOL REP, V38, P819, DOI 10.1007/s11033-010-0171-6; Xiao ZX, 2006, HEPATOL RES, V34, P150, DOI 10.1016/j.hepres.2005.12.007; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Zhang WP, 2010, J CEREBR BLOOD F MET, V30, P1962, DOI 10.1038/jcbfm.2010.71; Zhang YY, 2006, OBESITY, V14, P2119, DOI 10.1038/oby.2006.247	22	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781			PEPTIDES	Peptides	FEB	2013	40						8	12		10.1016/j.peptides.2012.12.017			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	153XG	WOS:000319635500002	23270673				2022-02-06	
S	Bast, T; Carmant, L		Dulac, O; Lassonde, M; Sarnat, HB		Bast, T.; Carmant, L.			Febrile and other occasional seizures	PEDIATRIC NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							EARLY POSTTRAUMATIC SEIZURES; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; DRUG-INDUCED SEIZURES; CLINICAL CHARACTERISTICS; UNPROVOKED SEIZURES; CONTROLLED-TRIAL; IRON-DEFICIENCY; RISK-FACTORS; CHILDREN		[Bast, T.] Epilepsy Ctr Kork, Kehl, Germany; [Carmant, L.] Univ Montreal, Dept Pediat, CHU St Justine, Montreal, PQ H3C 3J7, Canada		Bast, T (corresponding author), Epilepsiezentrum Kork, Klin Kinder & Jugendliche, Landstr 1, D-77694 Kehl, Germany.	tbast@epilepsiezentrum.de					Aicardi J, 1994, CHILD NEUROLOGY; Annegers J., 1990, EPILEPSY RES, V66, P1009; ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ANNEGERS JF, 1994, NEUROL CLIN, V12, P15, DOI 10.1016/S0733-8619(18)30108-7; [Anonymous], 1993, EPILEPSIA, V34, P592; Appleton R, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001905; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Audenaert D, 2006, NEUROLOGY, V67, P687, DOI 10.1212/01.wnl.0000230145.73496.a2; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; Babb TL, 1987, EPILEPSY, P412; Baumann RJ, 1996, PEDIATRICS, V97, P773; Baumann RJ, 2000, PEDIATR NEUROL, V23, P11, DOI 10.1016/S0887-8994(00)00148-X; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Berg AT, 1996, EPILEPSIA, V37, P126, DOI 10.1111/j.1528-1157.1996.tb00003.x; BERG AT, 1990, J PEDIATR-US, V116, P329, DOI 10.1016/S0022-3476(05)82816-1; Berg AT, 1997, ARCH PEDIAT ADOL MED, V151, P371, DOI 10.1001/archpedi.1997.02170410045006; BERG AT, 1992, NEW ENGL J MED, V327, P1122, DOI 10.1056/NEJM199210153271603; Bergman DA, 1996, PEDIATRICS, V97, P769; BETHUNE P, 1993, AM J DIS CHILD, V147, P35, DOI 10.1001/archpedi.1993.02160250037013; Birca A, 2005, EUR J PAEDIATR NEURO, V9, P339, DOI 10.1016/j.ejpn.2005.03.001; Bocti C, 2003, NEUROLOGY, V60, P191, DOI 10.1212/01.WNL.0000044055.73747.9F; CAMFIELD P, 1994, DEV MED CHILD NEUROL, V36, P887; CAMFIELD PR, 1980, J PEDIATR-US, V97, P16, DOI 10.1016/S0022-3476(80)80122-3; Capovilla G, 2009, EPILEPSIA, V50, P2, DOI 10.1111/j.1528-1167.2008.01963.x; Carroll W, 2002, ARCH DIS CHILD, V87, P238, DOI 10.1136/adc.87.3.238; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; CENDES F, 1993, NEUROLOGY, V43, P1083, DOI 10.1212/WNL.43.6.1083; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Chin RFM, 2005, ARCH DIS CHILD, V90, P66, DOI 10.1136/adc.2003.038844; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Darwish T, 2008, NEW ZEAL MED J, V121, P104; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; DOOSE H, 1983, NEUROPEDIATRICS, V14, P81, DOI 10.1055/s-2008-1059558; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; ELLENBERG JH, 1984, ANN NEUROL, V15, P127, DOI 10.1002/ana.410150204; ELLENBERG JH, 1978, ARCH NEUROL-CHICAGO, V35, P17, DOI 10.1001/archneur.1978.00500250021004; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Fetveit A, 2008, EUR J PEDIATR, V167, P17, DOI 10.1007/s00431-007-0577-x; FORSGREN L, 1990, ACTA PAEDIATR SCAND, V79, P550, DOI 10.1111/j.1651-2227.1990.tb11510.x; FRANTZEN E, 1968, ELECTROEN CLIN NEURO, V24, P197, DOI 10.1016/0013-4694(68)90001-1; FREEMAN JM, 1980, PEDIATRICS, V66, P1009; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; GREEN SM, 1993, PEDIATRICS, V92, P527; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Harkin LA, 2007, BRAIN, V130, P843, DOI 10.1093/brain/awm002; Hartfield DS, 2009, CLIN PEDIATR, V48, P420, DOI 10.1177/0009922809331800; HAUSER WA, 1985, NEUROLOGY, V35, P1268, DOI 10.1212/WNL.35.9.1268; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Heida JG, 2009, BRAIN DEV-JPN, V31, P388, DOI 10.1016/j.braindev.2008.11.013; Hodgson ES, 2008, PEDIATRICS, V121, P1281, DOI 10.1542/peds.2008-0939; HOPKINS A, 1991, BRIT MED J, V303, P634; Jain KK, 2001, DRUG INDUCED NEUROLO, P147; Jerrell JM, 2008, J CHILD NEUROL, V23, P1392, DOI 10.1177/0883073808319070; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Jones Tonia, 2007, Int J Med Sci, V4, P110; Joshi C, 2005, SEIZURE-EUR J EPILEP, V14, P429, DOI 10.1016/j.seizure.2005.07.006; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; KNUDSEN FU, 1985, ARCH DIS CHILD, V60, P1045, DOI 10.1136/adc.60.11.1045; Knudsen FU, 2000, EPILEPSIA, V41, P2, DOI 10.1111/j.1528-1157.2000.tb01497.x; KNUDSEN FU, 1978, ARCH DIS CHILD, V53, P660, DOI 10.1136/adc.53.8.660; Kolfen W, 1998, DEV MED CHILD NEUROL, V40, P667; Kumar R, 2003, AM J NEURORADIOL, V24, P218; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; McIntyre J, 2005, LANCET, V366, P205, DOI 10.1016/S0140-6736(05)66909-7; MESSING RO, 1984, NEUROLOGY, V34, P1582, DOI 10.1212/WNL.34.12.1582; Millichap JG, 2006, PEDIATR NEUROL, V35, P165, DOI 10.1016/j.pediatrneurol.2006.06.004; Montgomery SA, 2005, INT J CLIN PRACT, V59, P1435, DOI 10.1111/j.1368-5031.2005.00731.x; Nakayama J, 2009, BRAIN DEV-JPN, V31, P359, DOI 10.1016/j.braindev.2008.11.014; NELSON KB, 1978, PEDIATRICS, V61, P720; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; Norgaard M, 2009, J PEDIATR-US, V155, P404, DOI 10.1016/j.jpeds.2009.04.003; Offringa M, 1991, Paediatr Perinat Epidemiol, V5, P181, DOI 10.1111/j.1365-3016.1991.tb00699.x; OFFRINGA M, 1994, J PEDIATR-US, V124, P574, DOI 10.1016/S0022-3476(05)83136-1; OLSON KR, 1993, AM J EMERG MED, V11, P565, DOI 10.1016/0735-6757(93)90001-R; Pesola GR, 2002, J EMERG MED, V22, P235, DOI 10.1016/S0736-4679(01)00474-7; Pisacane A, 1996, BMJ-BRIT MED J, V313, P343, DOI 10.1136/bmj.313.7053.343; Pisani F, 2002, DRUG SAFETY, V25, P91, DOI 10.2165/00002018-200225020-00004; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; PORTER J, 1977, LANCET, V1, P587; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Rosman N Paul, 2003, Paediatr Drugs, V5, P457, DOI 10.2165/00148581-200305070-00003; ROSMAN NP, 1993, NEW ENGL J MED, V329, P79, DOI 10.1056/NEJM199307083290202; RUSSELL WR, 1952, J NEUROL NEUROSUR PS, V15, P93, DOI 10.1136/jnnp.15.2.93; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Seltz LB, 2009, PEDIATR EMERG CARE, V25, P494, DOI 10.1097/PEC.0b013e3181b0a095; Serdaroglu G, 2009, PEDIATR NEUROL, V40, P113, DOI 10.1016/j.pediatrneurol.2008.10.004; Shinnar S, 2008, NEUROLOGY, V71, P170, DOI 10.1212/01.wnl.0000310774.01185.97; Sillanpaa M, 2008, PEDIATR NEUROL, V38, P391, DOI 10.1016/j.pediatrneurol.2008.02.006; SOFIJANOV N, 1992, EPILEPSIA, V33, P52, DOI 10.1111/j.1528-1157.1992.tb02282.x; STANHOPE JM, 1972, AM J EPIDEMIOL, V95, P299, DOI 10.1093/oxfordjournals.aje.a121397; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thundiyil JG, 2007, J MED TOXICOL, V3, P15, DOI 10.1007/BF03161033; TSUBOI T, 1977, NEUROPADIATRIE, V8, P209, DOI 10.1055/s-0028-1091518; TSUBOI T, 1984, NEUROLOGY, V34, P175, DOI 10.1212/WNL.34.2.175; van Esch A, 1998, EUR J PEDIATR, V157, P340, DOI 10.1007/s004310050824; van Stuijvenberg M, 1999, ACTA PAEDIATR, V88, P618, DOI 10.1080/08035259950169260; VanLandingham KE, 1998, ANN NEUROL, V43, P413, DOI 10.1002/ana.410430403; VERITY CM, 1985, BRIT MED J, V290, P1307, DOI 10.1136/bmj.290.6478.1307; VERITY CM, 1985, BMJ-BRIT MED J, V290, P1311, DOI 10.1136/bmj.290.6478.1311; Verity CM, 1998, NEW ENGL J MED, V338, P1723, DOI 10.1056/NEJM199806113382403; Vestergaard M, 2002, EPIDEMIOLOGY, V13, P282, DOI 10.1097/00001648-200205000-00008; Vestergaard M, 2005, SCHIZOPHR RES, V73, P343, DOI 10.1016/j.schres.2004.07.004; Vestergaard M, 2008, LANCET, V372, P457, DOI 10.1016/S0140-6736(08)61198-8; Vestergaard M, 2009, BRAIN DEV-JPN, V31, P372, DOI 10.1016/j.braindev.2008.11.012; Virta N, 2002, PEDIATR NEUROL, V26, P192, DOI 10.1016/S0887-8994(01)00380-0; Walker AE, 1961, FOLLOW UP STUDY HEAD, P1; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; Warden CR, 2003, ANN EMERG MED, V41, P215, DOI 10.1067/mem.2003.48; Waruiru C, 2004, ARCH DIS CHILD, V89, P751, DOI 10.1136/adc.2003.028449; WEINSTEIN L, 1964, NEW ENGL J MED, V271, P525, DOI 10.1056/NEJM196409102711101; WEISS GH, 1972, J NEUROSURG, V37, P164, DOI 10.3171/jns.1972.37.2.0164; Willmore LJ, 1992, MED TREATMENT EPILEP, P73; Wong J, 2007, CAN J PSYCHIAT, V52, P457, DOI 10.1177/070674370705200708; Yalug I, 2007, J NEUROPSYCH CLIN N, V19, P341, DOI 10.1176/appi.neuropsych.19.3.341; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016; Zagnoni PG, 2002, EPILEPSIA, V43, P28, DOI 10.1046/j.1528-1157.2002.043s2028.x	120	9	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-444-62698-1; 978-0-444-52891-9	HAND CLINIC			2013	111						477	491					15	Clinical Neurology; Pediatrics	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Pediatrics	BA6KF	WOS:000337167000054	23622197				2022-02-06	
J	Bor-Seng-Shu, E; Paiva, WS; Figueiredo, EG; Fujimoto, Y; de Andrade, AF; Fonoff, ET; Teixeira, AJ				Bor-Seng-Shu, Edson; Paiva, Wellingson Silva; Figueiredo, Eberval G.; Fujimoto, Yasunori; de Andrade, Almir Ferreira; Fonoff, Erich Talamoni; Teixeira, Andmanoel Jacobsen			Posttraumatic Refractory Intracranial Hypertension and Brain Herniation Syndrome: Cerebral Hemodynamic Assessment before Decompressive Craniectomy	BIOMED RESEARCH INTERNATIONAL			English	Article							HEAD-INJURY; BLOOD-FLOW; VASOSPASM; PRESSURE; CHILDREN; METABOLISM; REACTIVITY; MANAGEMENT; HYPEREMIA; PERFUSION	Background. The pathophysiology of traumatic brain swelling remains little understood. An improved understanding of intracranial circulatory process related to brain herniation may have treatment implications. Objective. To investigate the cerebral hemodynamic changes associated with brain herniation syndrome due to traumatic brain swelling. Methods. Nineteen head-injured patients with evidence of refractory intracranial hypertension and transtentorial herniation were prospectively studied. Cerebral hemodynamic assessment by transcranial Doppler (TCD) ultrasonography was performed prior to decompressive craniectomy. Patients and their cerebral hemispheres were classified according to TCD-hemodynamic patterns, and the data correlated with neurological status, midline shift on CT scan, and Glasgow outcome scale scores at 6 months after injury. Results. A wide variety of cerebral hemodynamic findings were observed. Ten patients (52.7%) presented with cerebral oligoemia, 3 patients (15.8%) with cerebral hyperemia, and 6 patients with nonspecific circulatory pattern. Circulatory disturbances were more frequently found in the side of maximal cerebral swelling than in the opposite side. Pulsatility index (PI) values suggested that ICP varied from acceptable to considerably high; patients with increased PI, indicating higher microvascular resistance. No correlation was found between cerebral hemodynamic findings and outcome. Conclusions. There is a marked heterogeneity of cerebral hemodynamic disturbances among patients with brain herniation syndrome.	[Bor-Seng-Shu, Edson; Paiva, Wellingson Silva; Figueiredo, Eberval G.; de Andrade, Almir Ferreira; Fonoff, Erich Talamoni; Teixeira, Andmanoel Jacobsen] Univ Sao Paulo, Sch Med, Hosp Clin, Div Neurol Surg, BR-05403010 Sao Paulo, Brazil; [Fujimoto, Yasunori] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan		Paiva, WS (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Div Neurol Surg, 255 Eneas Aguiar St,Off 4079, BR-05403010 Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Figueiredo, Eberval Gadelha/H-3488-2012; Paiva, Wellingson S/G-5517-2013; Figueiredo, Eberval G/E-2071-2016; BOR-SENG-SHU, EDSON/AAC-9762-2019; Fonoff, Erich Talamoni/E-4327-2012	Paiva, Wellingson S/0000-0002-5165-7040; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Fonoff, Erich Talamoni/0000-0001-7831-9941			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bor-Seng-Shu E, 2004, ARQ NEURO-PSIQUIAT, V62, P715, DOI 10.1590/S0004-282X2004000400028; Bor-Seng-Shu E, 2007, J NEUROSURG, V106, P728, DOI 10.3171/jns.2007.106.4.728; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bor-Seng-Shu E, 2012, ARQ NEURO-PSIQUIAT, V70, P357, DOI 10.1590/S0004-282X2012000500010; Bor-Seng-Shu E, 2010, J NEUROSURG, V112, P1351, DOI 10.3171/2009.10.JNS091426; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; de Andrade AF, 2011, ARQ NEURO-PSIQUIAT, V69, P79, DOI 10.1590/S0004-282X2011000100016; De Bonis P, 2013, NEW ENGL J MED, V368, P1749, DOI 10.1056/NEJMc1301076; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Hu K, 2009, J NEUROTRAUM, V26, P227, DOI 10.1089/neu.2008.0643; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	38	9	10	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								750809	10.1155/2013/750809			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	265OO	WOS:000327961700001	24377095	gold, Green Published, Green Submitted			2022-02-06	
J	Forbes, JA; Zuckerman, SL; He, L; McCalley, E; Lee, YM; Solomon, GS; Halstead, PD; Sills, AK				Forbes, Jonathan A.; Zuckerman, Scott L.; He, Lucy; McCalley, Elizabeth; Lee, Young M.; Solomon, Gary S.; Halstead, P. David; Sills, Allen K.			Subdural Hemorrhage in Two High-School Football Players: Post-Injury Helmet Testing	PEDIATRIC NEUROSURGERY			English	Article						Concussion; Football; Subdural hemorrhage; Helmet safety	ARACHNOID CYST; HEAD-INJURY; HEMATOMA; IMPACT; CONCUSSION	The incidence of catastrophic head injury in American football is at a 30-year high; over 90% of these injuries are secondary to subdural hemorrhage (SDH). At the present time, it is unknown why the incidence of this devastating injury complex continues to rise. Because previous investigations have documented deficiencies in the process of equipment certification at youth and high-school levels, we sought to investigate the adequacy of headgear worn by two athletes who suffered contact-related SDH on the football field and presented to Vanderbilt Children's Hospital between 2009 and 2011. Helmets worn by the struck players at the time of collision (Medium Schutt Air Advantage 7888 and Large Schutt Air XP 7890) were obtained for formal biomechanical testing at a National Operating Committee on the Safety of Athletic Equipment (NOCSAE)-certified facility. Both helmets were found to be compliant with a modified version of the NOCSAE standard ND002-11m12. Based on the aforementioned tests, it can be concluded that headgear worn by both players who suffered SDH was not substandard, as defined by contemporary helmet quality assurance criteria. To the authors' knowledge, this is the first published report of helmet testing following sports-related helmeted collisions resulting in severe traumatic intracranial injuries. (C) 2013 S. Karger AG, Basel	[Forbes, Jonathan A.; Zuckerman, Scott L.; He, Lucy; Solomon, Gary S.; Sills, Allen K.] Dept Neurol Surg, Nashville, TN USA; [Lee, Young M.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [McCalley, Elizabeth; Halstead, P. David] Southern Impact Res Ctr, Rockford, TN USA		Forbes, JA (corresponding author), T-4224 Med Ctr North, Nashville, TN 37232 USA.	jonathan.a.forbes@gmail.com	Solomon, Gary/K-9011-2019				Bilginer B, 2009, CHILD NERV SYST, V25, P119, DOI 10.1007/s00381-008-0728-z; BISHOP PJ, 1984, AM J SPORT MED, V12, P233, DOI 10.1177/036354658401200313; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Demetriades AK, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.005710; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Hilker Christopher E, 2002, Stapp Car Crash J, V46, P417; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Kersey RD, 1998, J ATHL TRAINING, V33, P264; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Litt David W., 1995, Journal of Athletic Training, V30, P69; Liu DS, 2003, ENG FAIL ANAL, V10, P581, DOI 10.1016/S1350-6307(03)00040-2; Logan SM, 2001, J ATHL TRAINING, V36, P433; Matsuda W, 2008, J TRAUMA, V65, P461, DOI 10.1097/01.ta.0000202465.13784.2a; Mori K, 2002, J NEUROTRAUM, V19, P1017, DOI 10.1089/089771502760341938; Mueller FO, ANN SURVEY CATASTROP; Pintar F A, 2000, Stapp Car Crash J, V44, P77; Prabhu VC, 2002, NEUROSURGERY, V50, P195; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Schwarz A, 2008, NY TIMES, pB12; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Zeng T, 2011, CHIN J TRAUMATOL, V14, P174, DOI 10.3760/cma.j.issn.1008-1275.2011.03.010; Zhang H, 2007, CHINESE MED J-PEKING, V120, P2339, DOI 10.1097/00029330-200712020-00042	27	9	9	0	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2013	49	1					43	49		10.1159/000355121			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	280TS	WOS:000329054300009	24192427				2022-02-06	
B	Gan, C; DePompei, R; Lash, M		Zasler, ND; Katz, DI; Zafonte, RD		Gan, Caron; DePompei, Roberta; Lash, Marilyn			Family Assessment and Intervention	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; TREATING FAMILIES; REHABILITATION; CHILDREN; ADOLESCENTS; RESILIENCE; PREDICTORS; OUTCOMES; SUPPORT; BURDEN		[Gan, Caron] Holland Bloorview Kids Rehabil Hosp, Family Support Serv, Brain Injury Rehabil Team, Toronto, ON, Canada; [DePompei, Roberta] Univ Akron, Coll Hlth Profess, Akron, OH 44325 USA; [Lash, Marilyn] Lash & Associates PublishingTraining Inc, Youngsville, NC USA		Gan, C (corresponding author), Holland Bloorview Kids Rehabil Hosp, Family Support Serv, Brain Injury Rehabil Team, Toronto, ON, Canada.						Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Alderfer MA, 2008, J PEDIATR PSYCHOL, V33, P1046, DOI 10.1093/jpepsy/jsm083; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Baskin A, 2006, MORE MOM LIVING FULL; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Blosser JL, 2003, PEDIAT TRAUMATIC BRA; Boschen K, 2007, NEUROREHABILITATION, V22, P19; Boss P., 1999, AMBIGUOUS LOSS LEARN; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Butera-Prinzi F, 2010, NEUROREHABILITATION, V27, P31, DOI 10.3233/NRE-2010-0579; Charles N, 2007, NEUROREHABILITATION, V22, P61; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; Cole WR, 2009, DEV DISABIL RES REV, V15, P159, DOI 10.1002/ddrr.58; Condeluci A, 2002, OPENING DOORS COMMUN; Condeluci A, 2008, TOGETHER IS BETTER; Condeluci A., 2008, ESSENCE INTERDEPENDE; Conoley J, 2005, J LEARNING DISABILIT, V29, P662, DOI 10.1177/002221949602900610; DEPOMPEI R, 1999, REHABILITATION ADULT, P393; DePompei R, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P817; DiScala C, 2001, NATL PEDIATRIC TRAUM; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gan Caron, 2008, Can J Occup Ther, V75, P96; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gillette Y, 2004, NEUROREHABILITATION, V19, P233; Holland A. L., 2007, COUNSELING COMMUNICA, V2nd; Kay, 1991, HEAD INJURY FAMILY M, P81; Kay Thomas, 1994, P533; Kimes K, 2008, STUDENTS BRAIN INJUR; King, 1995, MEASURE PROCESSES CA; King G, 1994, INTERPERSONAL ASPECT; King S, 2000, PERCEPTIONS FAMILY C; Kubler-Ross E, 1973, DEATH DYING; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; Lash M, 2003, BRAIN INJURY SOU SPR, P20; Lash M, 1995, ED MANUAL WHAT EDUCA, P40; Lash M, 1996, CHILDREN ABI ED SUPP; Law M, 2001, FACTORS AFFECTING FA; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCCUBBIN HI, 1981, FAMILY ASSESSMENT RE, P407; McMahon MA, 2001, J HEAD TRAUMA REHAB, V16, P587, DOI 10.1097/00001199-200112000-00006; Miller S.D., 2000, HEROIC CLIENT DOING; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Rolland JS, 2006, CURR OPIN PEDIATR, V18, P527, DOI 10.1097/01.mop.0000245354.83454.68; Rolland JS, 1994, FAMILIES ILLNESS DIS; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Russell D, 2007, ESSENTIAL BRAIN INJU; Sambuco M, 2011, J HEAD TRAUMA REHABI; Sambuco M, 2008, BRAIN INJURY, V22, P7, DOI 10.1080/02699050701822022; Savage R. C., 2003, BRAIN INJ SOURCE, V6, P8; Savage RC, 2001, NEUROREHABILITATION, V16, P49; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; SELEKMAN M, 1997, SOLUTION FOCUSED THE; Shakespeare T., 1999, EXPLORING DISABILITY; Sherk Consulting Group, 1999, PROV REV SERV CHILDR; Skinner H, 2000, J FAM THER, V22, P190, DOI 10.1111/1467-6427.00146; Sohlberg MM, 2001, J HEAD TRAUMA REHAB, V16, P498, DOI 10.1097/00001199-200110000-00008; SPINA S, 2005, BRAIN IMPAIR, V6, P33, DOI DOI 10.1375/BRIM.6.1.33.65478; Stein REK, 2003, J DEV BEHAV PEDIATR, V24, P9, DOI 10.1097/00004703-200302000-00004; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; Wade S, 2010, HDB REHABILITATION P, P345; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Walsh F, 1996, FAM PROCESS, V35, P261, DOI 10.1111/j.1545-5300.1996.00261.x; Walsh F., 2006, STRENGTHENING FAMILY; Walsh F., 1991, LIVING LOSS DEATH FA; Wilkins S, 2001, Can J Occup Ther, V68, P70	81	9	9	0	0	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							621	634					14	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100038					2022-02-06	
B	Martelli, MF; Nicholson, K; Zasler, ND; Bender, MC		Zasler, ND; Katz, DI; Zafonte, RD		Martelli, Michael F.; Nicholson, Keith; Zasler, Nathan D.; Bender, Mark C.			Assessing and Addressing Response Bias	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ADULT INTELLIGENCE SCALE; MEMORY MALINGERING TOMM; FORCED-CHOICE METHOD; TEST-PERFORMANCE; NEUROPSYCHOLOGICAL ASSESSMENT; INADEQUATE EFFORT; HEAD TRAUMA; VALIDITY; IMPAIRMENT		[Martelli, Michael F.] Chapman Senior Care, Senior Serv, NeuroLife Rehab, Richmond, VA 23238 USA; [Nicholson, Keith] Toronto Western Hosp, Comprehens Pain Program, Toronto, ON M5T 2S8, Canada; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Sheltering Arms Hosp, iWalk Program, Richmond, VA USA; [Zasler, Nathan D.] VCU Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan D.] Int Brain Injury Assoc, Alexandria, VA USA; [Bender, Mark C.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Bender, Mark C.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Martelli, MF (corresponding author), Chapman Senior Care, Senior Serv, NeuroLife Rehab, Richmond, VA 23238 USA.						Allen LM, 1995, COMPUTERIZED ASSESSM; Allen LM, 2002, J FORENSIC NEUROPSYC, V3, P205; Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Babitsky S, 2000, SYMPTOM MAGNIFICATIO; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Ben-Porath YS., 2009, MMPI 2 SYMPTOM VALID; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2009, PSYCHOL INJ LAW; Bigler ED, 2011, J INT NEUROPSYCH SOC, V17, P751, DOI 10.1017/S1355617711000555; BINDER LM, 1992, ARCH PHYS MED REHAB, V73, P377, DOI 10.1016/0003-9993(92)90013-M; Binder LM, 2004, J CLIN EXP NEUROPSYC, V26, P369, DOI 10.1080/13803390490510095; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P852; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BLAU TH, 1984, PSYCHOL EXPERT WITNE; Boone K. B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; BOONE KB, 2007, ASSESSMENT MALINGERE, P27; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Braverman M, 1978, Occup Health Saf, V47, P36; Bush, 2012, MILD TRAUMATIC BRAIN; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; CLIFFE MJ, 1992, BRIT J CLIN PSYCHOL, V31, P207, DOI 10.1111/j.2044-8260.1992.tb00985.x; CULLUM CM, 1991, FORENSIC NEUROPSYCHO; CUMMINGS JL, 1996, NEUROLOGY, V47, P592; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Daniel A E, 1987, Bull Am Acad Psychiatry Law, V15, P301; Delis DC, 1987, CALIFORNIA VERBAL LE; Dwyer CA, 1996, PSYCHOL ASSESSMENT, V8, P360, DOI 10.1037/1040-3590.8.4.360; Ensalada LH, 1998, AMA GUIDES NEWSL MAY, P4; FAUST D, 1990, J CONSULT CLIN PSYCH, V58, P248, DOI 10.1037/0022-006X.58.2.248; FAUST D, 1995, NEUROL CLIN, V13, P255, DOI 10.1016/S0733-8619(18)30044-6; Faust D., 2011, COPING PSYCHIAT PSYC; Fishbain DA, 2003, PAIN MED, V4, P141, DOI 10.1046/j.1526-4637.2003.03015.x; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P, 2003, ARCH CLIN NEUROPSYCH, V18, P625, DOI 10.1016/S0887-6177(03)00094-5; Green P., 2005, WORD MEMORY TEST WIN; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greer S, 2005, J FAM PRACTICE, V54, P719; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GRILLO J, 1994, J CLIN PSYCHOL, V50, P651, DOI 10.1002/1097-4679(199407)50:4<651::AID-JCLP2270500424>3.0.CO;2-C; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; HALL HV, 2000, DETECTING MALINGERIN; Hayes JS, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P249; Heilbronner RL, 2002, J CONTROVERSIAL MED, V9, P1; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Hom J, 2002, J FORENSIC NEUROPSYC, V2, P1; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; IVERSON GL, 1994, ARCH CLIN NEUROPSYCH, V9, P437, DOI 10.1016/0887-6177(94)90006-X; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Iverson GL, 1996, ANN M NAT AC NEUR NE; Iverson GL, 1999, J COGN REHABIL   MAR, P2; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; KAUFMAN DM, 2001, CLIN NEUROLOGY PSYCH; L. Alles M., 2011, PSYCHOL INJ LAW, P1, DOI [10.1109/SOI.2011.6081714, DOI 10.1109/SOI.2011.6081714]; Larrabee G.J., 2011, FORENSIC NEUROPSYCHO; Larrabee G.J., 2005, FORENSIC NEUROPSYCHO; Larrabee G. J., 2007, ASSESSMENT MALINGERE, P80; Larrabee G. J., 1992, NEUROPSYCHOLOGY, V6, DOI https://doi.org/10.1037/0894-4105.6.1.23; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; Lees-Haley PR, 2003, ARCH CLIN NEUROPSYCH, V18, P585; Lees-Haley PR, 2002, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; LEESHALEY PR, 1992, PERCEPT MOTOR SKILL, V75, P531, DOI 10.2466/PMS.75.5.531-544; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LeesHaley PR, 1997, ASSESSMENT, V4, P321, DOI 10.1177/107319119700400402; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Mailis A, 2001, J RHEUMATOL, V28, P1385; Mailis-Gagnon A, 2011, CLIN J PAIN, V27, P76, DOI 10.1097/AJP.0b013e3181e8d9cc; MAIN CJ, 1995, J PSYCHOSOM RES, V39, P737, DOI 10.1016/0022-3999(95)00040-P; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; Martelli MF, 2001, PAIN MANAGEMENT PRAC, P789; MARTELLI MF, 2001, J CONTROVERSIAL MED, V8, P13; Martelli MF, 2006, PRACTICES BRAIN INJU; Martelli MF, 2002, PHYS MED REHABILITAT, P169; Martelli MF, 2002, J LEGAL NURSE CONSUL, V13, P7; MARTELLI MF, 2003, INT J FORENSIC PSYCH, V1, P26; Martelli MF, 2002, J CONTROVERSIAL MED, V9, P19; Matheson L, 1988, WORK INJURY, P48; Matheson L, 1991, IND REHABIL Q, V4, P1; Matheson L, 1990, IND REHAB Q, V3, P1; May RV, 1998, GUIDE FUNCTIONAL CAP, P21; McGrath RE, 2011, PSYCHOL BULL, V137, P713, DOI 10.1037/a0023645; McGrath RE, 2010, PSYCHOL BULL, V136, P450, DOI 10.1037/a0019216; Merskey H, 1994, CLASSIFICATION CHRON; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Meyers J., 1995, REY COMPLEX FIGURE R; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; MILLON T, 1997, MCMI 3 MANUAL; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Nicholson K, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P335, DOI 10.1007/0-387-25610-5_18; Nicholson K, 2001, PAIN MANAGEMENT PRAC, P465; Nicholson K., 2007, CAUSALITY PSYCHOL IN, P374; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; PANKRATZ L, 1979, J CONSULT CLIN PSYCH, V47, P409, DOI 10.1037/0022-006X.47.2.409; Ranks D, 2005, PROBLEM ANAL SYMPTOM; Ranney D, 2011, AM J PHYS MED REHAB, V90, P433, DOI 10.1097/01.phm.0000396916.54818.73; Ranney D, 2010, AM J PHYS MED REHAB, V89, P1036, DOI 10.1097/PHM.0b013e3181f70eae; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R, 2011, ANN FOR MENT HLTH AS; Rogers R., 2008, CLIN ASSESSMENT MALI; Rogers R, 2011, PSYCHOL INJ LAW, V4, P147, DOI 10.1007/s12207-011-9107-2; Rohling ML, 2011, PSYCHOL BULL, V137, P708, DOI 10.1037/a0023327; Ruchinskas R, 2002, PHYS MED REHABILITAT, P113; Rutherford WH, 1989, MILD HEAD INJURY, P229; Samuel R.Z., 2005, PRIMARY PSYCHIAT, V12, P60; Sbordone RJ, 2000, ARCH CLIN NEUROPSYCH, V15, P465; Schacter DL, 1986, BEHAV SCI LAW, V4, P47, DOI DOI 10.1002/BSL.2370040104; Schenk K, 2010, J CLIN EXP NEUROPSYC, V32, P752, DOI 10.1080/13803390903512678; Senior G, 2001, NEUROREHABILITATION, V16, P203; Simmonds MJ, 1996, DISABIL REHABIL, V18, P161, DOI 10.3109/09638289609166295; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Sreenivasan S, 2003, J AM ACAD PSYCHIATRY, V31, P220; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Sullivan K, 2002, ARCH CLIN NEUROPSYCH, V17, P691, DOI 10.1016/S0887-6177(01)00171-8; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tellegen A., 2003, MMPI 2 RESTRUCTURED; Thompson SB, 2011, WEBMEDCENTRAL REHABI, V2; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Vanderploeg RD, 2001, NEUROREHABILITATION, V16, P245; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; WADDELL G, 1984, SPINE, V9, P209, DOI 10.1097/00007632-198403000-00013; Wedding D, 1998, ARCH CLIN NEUROPSYCH, V4, P233; Whiteside DM, 2012, J CLIN EXP NEUROPSYC, V34, P172, DOI 10.1080/13803395.2011.630648; Williams AD, 2001, NEUROREHABILITATION, V16, P221; WILLIAMS JM, 1992, MEMORY ASSESSMENT SC; Willis PF, 2011, MIL MED, V176, P1426, DOI 10.7205/MILMED-D-11-00168; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3; ZASLER ND, 1998, AMA GUIDES NEWSL NOV, P1; [No title captured]	163	9	9	0	5	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							1415	1436					22	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100085					2022-02-06	
J	Martens, KM; Vonder Haar, C; Hutsell, BA; Hoane, MR				Martens, Kris M.; Vonder Haar, Cole; Hutsell, Blake A.; Hoane, Michael R.			The Dig Task: A Simple Scent Discrimination Reveals Deficits Following Frontal Brain Damage	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 71; Medicine; Neurobiology; Anatomy; Physiology; Psychology; Behavior; cognitive assessment; dig task; scent discrimination; olfactory; brain injury; traumatic brain injury; TBI; brain damage; rats; animal model		Cognitive impairment is the most frequent cause of disability in humans following brain damage, yet the behavioral tasks used to assess cognition in rodent models of brain injury is lacking. Borrowing from the operant literature our laboratory utilized a basic scent discrimination paradigm(1-4) in order to assess deficits in frontally-injured rats. Previously we have briefly described the Dig task and demonstrated that rats with frontal brain damage show severe deficits across multiple tests within the task(5). Here we present a more detailed protocol for this task. Rats are placed into a chamber and allowed to discriminate between two scented sands, one of which contains a reinforcer. The trial ends after the rat either correctly discriminates (defined as digging in the correct scented sand), incorrectly discriminates, or 30 sec elapses. Rats that correctly discriminate are allowed to recover and consume the reinforcer. Rats that discriminate incorrectly are immediately removed from the chamber. This can continue through a variety of reversals and novel scents. The primary analysis is the accuracy for each scent pairing (cumulative proportion correct for each scent). The general findings from the Dig task suggest that it is a simple experimental preparation that can assess deficits in rats with bilateral frontal cortical damage compared to rats with unilateral parietal damage. The Dig task can also be easily incorporated into an existing cognitive test battery. The use of more tasks such as this one can lead to more accurate testing of frontal function following injury, which may lead to therapeutic options for treatment. All animal use was conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee.	[Martens, Kris M.; Vonder Haar, Cole; Hutsell, Blake A.; Hoane, Michael R.] Southern Illinois Univ Carbondale, Dept Psychol, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), Southern Illinois Univ Carbondale, Dept Psychol, Carbondale, IL 62901 USA.	mhoane@siu.edu	Hutsell, Blake/ABD-8248-2020	Vonder Haar, Cole/0000-0001-7949-2068	ARRA funds from NINDS [NS045647]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647] Funding Source: NIH RePORTER	Funding for this project was provided by ARRA funds from NINDS grant NS045647.	BAUM WM, 1974, J EXP ANAL BEHAV, V22, P231, DOI 10.1901/jeab.1974.22-231; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; BURKETT EE, 1966, J COMP PHYSIOL PSYCH, V62, P468, DOI 10.1037/h0023924; CDC, 2010, INJ PREV CONTR TRAUM; EICHENBAUM H, 1986, J NEUROSCI, V6, P1876; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Kaiser DH, 2006, BEHAV PROCESS, V73, P164, DOI 10.1016/j.beproc.2006.05.003; Martens K.M., 2012, J NEUROTRAU IN PRESS; MITCHELL D, 1976, J COMP PHYSIOL PSYCH, V90, P190, DOI 10.1037/h0077196; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Porter MC, 2000, BEHAV BRAIN RES, V109, P69, DOI 10.1016/S0166-4328(99)00161-8; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Swets J A, 2000, Psychol Sci Public Interest, V1, P1, DOI 10.1111/1529-1006.001; Walton ME, 2003, J NEUROSCI, V23, P6475; Writing Group M, 2012, CIRCULATION, V125, P188, DOI [10.1161/CIR.0b013e3182456d46, DOI 10.1161/CIR.0b013e3182456d46]	16	9	9	0	4	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JAN	2013		71							e50033	10.3791/50033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36QO	WOS:000209226200027	23328920	Green Published, Bronze			2022-02-06	
J	Min, K; Song, J; Lee, JH; Kang, MS; Jang, SJ; Kim, SH; Kim, M				Min, Kyunghoon; Song, Junyoung; Lee, Ji Hyun; Kang, Myung Seo; Jang, Su Jin; Kim, Sang Heum; Kim, MinYoung			Allogenic umbilical cord blood therapy combined with erythropoietin for patients with severe traumatic brain injury: Three case reports	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Umbilical cord blood; erythropoietin; safety; efficacy; traumatic brain injury	STEM-CELLS; TRANSPLANTATION; SCALE; EPIDEMIOLOGY; RELIABILITY; INFUSION; STROKE; RATS; NEUROPROTECTION; SUPPRESSION	Objective: To report the safety and efficacy of a novel therapeutic trial with umbilical cord blood (UCB) and concomitant recombinant human erythropoietin (rhEPO), which was tried for three cases of severe traumatic brain injury (TBI) in rehabilitation. Design: Case series. Setting: University hospital setting. Participants: Three patients with TBI over 6-months post-injury. Interventions: Intravascular administration of allogenic UCB and injection of rhEPO, and rehabilitation therapy. Outcomes: For safety, adverse events, symptom, vital signs, blood chemistry, and hematologic study; for efficacy, modified Barthel index, motor assessment scale, Fugl-Meyer assessment of upper extremity, motor-free visual perception test, mini-mental screening examination, and brain images. Results: There were no serious adverse events and the participants showed improvements during the follow-up periods in various aspects. Patient 1 demonstrated improvements in motor and cognitive function. Diffusion tensor images showed increased nerve fibers. Patient 2 displayed improvements in activities of daily living. In Patient 3, neurogenic fever vanished and Brain PET revealed increased glucose metabolism at basal ganglia, thalami, and cerebellum. Conclusions: The allogenic UCB therapy combined with rhEPO in the present study was safe and suggested potential therapeutic efficacy for patients with TBI. Controlled clinical trials are now needed to document efficiacy and safety in a larger patient sample.	[Min, Kyunghoon; Song, Junyoung; Lee, Ji Hyun; Kim, MinYoung] CHA Univ, CHA Bundang Med Ctr, Dept Rehabil Med, Songnam, South Korea; [Kang, Myung Seo] CHA Univ, CHA Bundang Med Ctr, Dept Lab Med, Songnam, South Korea; [Kang, Myung Seo] CHA Med Ctr, Cord Blood Bank, Songnam, South Korea; [Jang, Su Jin] CHA Univ, CHA Bundang Med Ctr, Dept Nucl Med, Songnam, South Korea; [Kim, Sang Heum] CHA Univ, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea		Kim, M (corresponding author), 59 Yatap Ro, Songnam, Gyeonggi Do, South Korea.	kmin@cha.ac.kr			SungKwang Medical Foundation	The authors declare no conflicts of interest and this study was funded by SungKwang Medical Foundation.; We appreciate SungKwang Medical Foundation for the support.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Besarab A, 2008, NEW ENGL J MED, V358, P433, DOI 10.1056/NEJMc076523; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Colarusso R.P., 2003, MOTOR FREE VISUAL PE; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cramer SC, 2007, STROKE, V38, P2108, DOI 10.1161/STROKEAHA.107.485631; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Fisher JW, 1996, BRIT J HAEMATOL, V95, P27, DOI 10.1046/j.1365-2141.1996.d01-1864.x; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Gluckman E, 2011, BLOOD REV, V25, P255, DOI 10.1016/j.blre.2011.06.003; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jing M, 2009, BRAIN RES, V1295, P203, DOI 10.1016/j.brainres.2009.07.079; Jung HY, 2007, ANN REHABIL MED-ARM, V31, P283; Kurtzberg J, 2008, BLOOD, V112, P4318, DOI 10.1182/blood-2007-06-098020; Kurtzberg J, 2009, CURR OPIN PEDIATR, V21, P22, DOI 10.1097/MOP.0b013e32832130bc; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu C, 1997, J BIOL CHEM, V272, P32395, DOI 10.1074/jbc.272.51.32395; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mazariegos G V, 2001, Paediatr Drugs, V3, P661, DOI 10.2165/00128072-200103090-00004; Mazur M, 2010, J NEUROSURG-PEDIATR, V6, P206, DOI 10.3171/2010.5.PEDS1032; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Paternostro-Sluga T, 2008, J REHABIL MED, V40, P665, DOI 10.2340/16501977-0235; Pavlica S, 2012, BRAIN RES, V1452, P18, DOI 10.1016/j.brainres.2012.02.043; Ponce LL, 2012, PATHOPHYSIOLOGY; Riordan NH, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-8; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; SANFORD J, 1993, PHYS THER, V73, P447, DOI 10.1093/ptj/73.7.447; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Shaw K.E., 2012, J NEUROTRAUMA; Sorror ML, 2004, BLOOD, V104, P961, DOI 10.1182/blood-2004-02-0545; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Talving P, 2012, ARCH SURG-CHICAGO, V147, P251, DOI 10.1001/archsurg.2011.1838; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba	49	9	9	0	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2013	31	4					397	410		10.3233/RNN-120289			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171NC	WOS:000320935100005	23515110				2022-02-06	
J	Seghatoleslam, M; Jalali, M; Nikravesh, MR; Alamdari, DH; Hosseini, M; Fazel, A				Seghatoleslam, Masoumeh; Jalali, Mehdi; Nikravesh, Mohammad Reza; Alamdari, Daryoush Hamidi; Hosseini, Mahmoud; Fazel, Alireza			Intravenous administration of human umbilical cord blood-mononuclear cells dose-dependently relieve neurologic deficits in rat intracerebral hemorrhage model	ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER			English	Article						Cell transplantation; Functional recovery; Human umbilical cord blood-mononuclear cells (HUC-MCs); Intracerebral hemorrhage (ICH)	MARROW STROMAL CELLS; PROMOTES FUNCTIONAL RECOVERY; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; NERVE GROWTH-FACTOR; BEHAVIORAL DEFICITS; STROKE MODEL; CEREBRAL-ISCHEMIA; PROGENITOR CELLS; INFARCT VOLUME	Human umbilical cord blood (HUCB) is now considered as a valuable source for stem cell-based therapies. Previous studies showed that intravascular injection of the HUCB significantly improves neurological functional recovery in a model of intracerebral hemorrhage (ICH). To extend these findings, we examined the behavioral recovery and injured volume in the presence of increasing doses of human umbilical cord blood derived mononuclear cells (HUC-MCs) after intracerebral hemorrhage in rats. The experimental ICH was induced by intrastriatal administration of bacterial collagenase IV in adult rats. One day after the surgery, the rats were randomly divided into 4 groups to receive intravenously either BrdU positive human UC-MCs (4 x 10(6), 8 x 10(6) and 16 x 10(6) cells in 1 ml saline, n = 10, respectively) as treated groups or the same amount of saline as lesion group (n = 10). There was also one group (control n = 10) that received only the vehicle solution of collagenase. The animals were evaluated for 14 days with modified limb placing and corner turn tests. The transplanted human UC-MCs were also detected by immunohistochemistly with labeling of BrdU. Two weeks after infusion, there was a significant recovery in the behavioral performance when 4 x 106 or more UC-MCs were delivered (P < 0.05-0.001). Injured volume measurements disclosed an inverse relationship between UC-MCs dose and damage reaching significance at the higher UC-MCs doses. Moreover, human UC-MCs were localized by immunohistochemistry only in the injured area. Intravenously transplanted UC-MCs can accelerate the neurological function recovery of ICH rat and diminish the striatum lesion size by demonstrating a dose relationship between them. (C) 2012 Elsevier GmbH. All rights reserved.	[Seghatoleslam, Masoumeh; Jalali, Mehdi; Nikravesh, Mohammad Reza; Fazel, Alireza] Mashhad Univ Med Sci, Dept Anat & Cell Biol, Fac Med, Khorasan Razavi, Iran; [Alamdari, Daryoush Hamidi] Mashhad Univ Med Sci, Fac Med, Stem Cell Lab, Biochem & Nutr Res Ctr,Dept Biochem, Khorasan Razavi, Iran; [Hosseini, Mahmoud] Mashhad Univ Med Sci, Fac Med, Dept Physiol, Neurosci Res Ctr, Khorasan Razavi, Iran		Jalali, M (corresponding author), Mashhad Univ Med Sci, Dept Anat & Cell Biol, Fac Med, Pardis Complex,Azadi Sq, Mashhad 9177948564, Iran.	JalaliM@mums.ac.ir	Fazel, Alireza/J-2187-2015	Fazel, Alireza/0000-0002-1470-619X; Fazel, Ali Reza/0000-0001-8520-128X; Hosseini, Mahmoud/0000-0001-6425-5123	Office of Vice-Chancellor for Research Affairs of Mashhad University of Medical Sciences [88391]	This study was supported by the research grant number 88391 from Office of Vice-Chancellor for Research Affairs of Mashhad University of Medical Sciences. The authors wish to thank them for their financial support and since this manuscript is a part of a thesis, the co-authors designed the study and supervised the experiments and the first author (Ph.D. student) did the experiments. We also want to thank Mrs. Motejadded for her expert histological technical assistance.	Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Bracci-Laudiero L, 2003, J NEUROIMMUNOL, V136, P130, DOI 10.1016/S0165-5728(03)00007-9; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2004, BRAIN RES, V1005, P21, DOI 10.1016/j.brainres.2003.11.080; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chouthai NS, 2003, PEDIATR RES, V53, P965, DOI 10.1203/01.PDR.0000061588.39652.26; de Paula S, 2009, PEDIATR RES, V65, P631, DOI 10.1203/PDR.0b013e31819ed5c8; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Harris DT, 2008, STEM CELL REV, V4, P269, DOI 10.1007/s12015-008-9039-8; Hassanein SMA, 2011, J MATERN-FETAL NEO M, V24, P229, DOI 10.3109/14767058.2010.482606; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Kawasaki-Oyama RS, 2008, REV BRAS CIR CARDIOV, V23, P29; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Lapchak Paul A, 2002, Curr Neurol Neurosci Rep, V2, P38, DOI 10.1007/s11910-002-0051-0; Larsson LC, 2001, EXP NEUROL, V172, P100, DOI 10.1006/exnr.2001.7738; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Lequeux C, 2011, MOL CELL BIOCHEM, V351, P65, DOI 10.1007/s11010-011-0712-x; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Liao WB, 2009, CELL PHYSIOL BIOCHEM, V24, P307, DOI 10.1159/000233255; Liao YL, 2011, EXP HEMATOL, V39, P393, DOI 10.1016/j.exphem.2011.01.002; Liu AM, 2010, NEUROSURGERY, V67, P357, DOI 10.1227/01.NEU.0000371983.06278.B3; Liu HY, 2006, CHINESE MED J-PEKING, V119, P1744, DOI 10.1097/00029330-200610020-00013; Madlambayan G, 2006, REGEN MED, V1, P777, DOI 10.2217/17460751.1.6.777; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Makinen S, 2006, BRAIN RES, V1123, P207, DOI 10.1016/j.brainres.2006.09.056; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Newcomb JD, 2006, CELL TRANSPLANT, V15, P213, DOI 10.3727/000000006783982043; Newman M, 2003, EXP NEUROL, V181, P84; Nonaka M, 2004, NEUROL RES, V26, P265, DOI 10.1179/016164104225014049; Pan Y, 2005, EXP NEUROL, V192, P365, DOI 10.1016/j.expneurol.2004.11.011; Park DH, 2009, CELL TRANSPLANT, V18, P985, DOI 10.3727/096368909X471279; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P351, DOI 10.1089/scd.2009.0049; Pomyje J, 2003, EUR J HAEMATOL, V70, P143, DOI 10.1034/j.1600-0609.2003.00040.x; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rainsford E, 2002, BRIT J HAEMATOL, V116, P702, DOI 10.1046/j.0007-1048.2001.03321.x; Ribo M, 2006, CURR NEUROL NEUROSCI, V6, P17, DOI 10.1007/s11910-996-0004-0; Riegelsberger UM, 2011, EXP NEUROL, V227, P218, DOI 10.1016/j.expneurol.2010.11.008; Riordan NH, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-8; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Sherrard RM, 2001, NEUROREPORT, V12, P2871, DOI 10.1097/00001756-200109170-00023; Sirchia G, 1999, HAEMATOLOGICA, V84, P738; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; WALKER P, 1981, J CLIN ENDOCR METAB, V53, P218, DOI 10.1210/jcem-53-1-217; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI 10.1111/j.1582-4934.2008.00671.x; Zawadzka M, 2009, ACTA NEUROBIOL EXP, V69, P46; Zhang HB, 2006, NEUROL RES, V28, P104, DOI 10.1179/016164106X91960; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	69	9	10	0	12	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-9602			ANN ANAT	Ann. Anat.-Anat. Anz.		2013	195	1					39	49		10.1016/j.aanat.2012.05.002			11	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	129WL	WOS:000317874600008	22770555				2022-02-06	
J	Shahlaie, K; Gurkoff, GG; Lyeth, BG; Muizelaar, JP; Berman, RF				Shahlaie, Kiarash; Gurkoff, Gene G.; Lyeth, Bruce G.; Muizelaar, J. Paul; Berman, Robert F.			Neuroprotective effects of SNX-185 in an In Vitro model of TBI with a second insult	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						In Vitro; traumatic brain injury; ischemia; hypoxia; neuronal cell death; rat	TRAUMATIC BRAIN-INJURY; CHANNEL BLOCKER ZICONOTIDE; CEREBRAL-BLOOD-FLOW; SECONDARY ISCHEMIA; TISSUE OXYGEN; MITOCHONDRIAL DYSFUNCTION; INTRACELLULAR PH; CARBON-DIOXIDE; HEAD-INJURY; CALCIUM	Purpose: Second insults following traumatic brain injury (TBI), such as ischemia and hypoxia, significantly worsen outcome in patients and in experimental models of TBI. Following TBI there is a pathological increase in intracellular calcium, triggering cellular mechanisms of dysfunction and death. N-type specific voltage gated calcium channel (VGCC) blockers reduce cell death in both in vitro mechanical strain injury (MSI) and in vivo models of TBI, but they have not been previously explored in a model of TBI followed by a second insult. Methods: In the following studies, cortical neurons and astrocytes experienced MSI followed by incubation in 20% CO2. Cultures were treated with the N-type VGCC blocker, omega-conopeptide SNX-185 (1 mu M), 5-minutes post-injury and intracellular calcium accumulation was assessed at 3, 6 and 24 h. Neuronal viability was assessed 24 h after MSI. Results: Increasing incubator CO2 to 20% significantly increased calcium accumulation and cell death regardless of MSI severity. Treatment with 1 mu M of SNX-185 significantly reduced the accumulation of calcium 3 hours following injury and increased the number of viable neurons 24 h post-injury and incubation in 20% CO2. Conclusions: In vitro models provide a critical tool for identifying roles of cell specific mechanisms involved in neuronal dysfunction and death following injury. These data demonstrate the potential of N-type VGCC blockers in reducing the damaging effects of TBI and second insults.	[Shahlaie, Kiarash; Gurkoff, Gene G.; Lyeth, Bruce G.; Muizelaar, J. Paul; Berman, Robert F.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA		Shahlaie, K (corresponding author), UC Davis Sch Med, Dept Neurol Surg, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA.	kiarash.shahlaie@ucdmc.ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 39090, NS 29995, NS 45136]; UC Davis Bronte Epilepsy Research Program; UCLA Brain Injury Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039090, R01NS045136, R01NS029995] Funding Source: NIH RePORTER	SNX-185 was generously provided by George Miljanich of Elan Pharmaceuticals, (San Francisco, CA). We would also like to thank Dr. Candace Floyd for her technical and scientific contribution to the study design. This research was supported by NIH NS 39090 (RFB), NIH NS 29995 (BGL), NS 45136 (BGL), the UC Davis Bronte Epilepsy Research Program, and the UCLA Brain Injury Research Center.	Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Buki A, 2000, J NEUROSCI, V20, P2825; Cain CK, 2002, J NEUROSCI, V22, P9113; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Engel DC, 2005, NEUROPHARMACOLOGY, V49, P985, DOI 10.1016/j.neuropharm.2005.05.021; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Filippi R, 2000, NEUROSURG REV, V23, P94; Glass TF, 2002, NEUROSCI LETT, V328, P133, DOI 10.1016/S0304-3940(02)00510-4; GLOBUS MYT, 1995, J CEREBR BLOOD F MET, V15, P904, DOI 10.1038/jcbfm.1995.115; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; GOPLERUD JM, 1992, BIOL NEONATE, V61, P33, DOI 10.1159/000243528; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hayes RL, 1998, DRUG NEWS PERSPECT, V11, P215; Hoffman WE, 1996, ANESTH ANALG, V82, P582, DOI 10.1097/00000539-199603000-00027; Hoffman WE, 1996, NEUROL RES, V18, P54, DOI 10.1080/01616412.1996.11740378; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; MACMILLAN V, 1984, BRAIN RES, V303, P125, DOI 10.1016/0006-8993(84)90219-1; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McKinley BA, 1996, CRIT CARE MED, V24, P1858, DOI 10.1097/00003246-199611000-00016; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; MEYER FB, 1989, BRAIN RES REV, V14, P227, DOI 10.1016/0165-0173(89)90002-7; Muellner A, 2003, J NEUROTRAUM, V20, P745, DOI 10.1089/089771503767869971; OORSCHOT DE, 1989, EXP BRAIN RES, V78, P132; PALMER GC, 1985, NEUROPHARMACOLOGY, V24, P509, DOI 10.1016/0028-3908(85)90056-5; Pignataro G, 2004, NEUROPHARMACOLOGY, V46, P439, DOI 10.1016/j.neuropharm.2003.09.015; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raghupathi R, 1998, P W PHARMACOL SOC, V41, P241; ROBERTSON CS, 1992, J NEUROTRAUM, V9, pS349; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; Shahlaie K, 2010, J NEUROTRAUM, V27, P175, DOI 10.1089/neu.2009.1003; Siesjo BK, 1996, ACT NEUR S, V66, P8; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SMITH ML, 1986, J CEREBR BLOOD F MET, V6, P574, DOI 10.1038/jcbfm.1986.104; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; TOMLINSON FH, 1993, EPILEPSY RES, V14, P123, DOI 10.1016/0920-1211(93)90017-2; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	58	9	10	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2013	31	2					141	153		10.3233/RNN-120243			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	112SN	WOS:000316613700004	23247061				2022-02-06	
J	Stockman, I; Bohman, K; Jakobsson, L; Brolin, K				Stockman, Isabelle; Bohman, Katarina; Jakobsson, Lotta; Brolin, Karin			Kinematics of Child Volunteers and Child Anthropomorphic Test Devices During Emergency Braking Events in Real Car Environment	TRAFFIC INJURY PREVENTION			English	Article						child volunteers; kinematics; rear seat; braking maneuver; child restraint systems	INJURY CAUSATION SCENARIOS; VEHICLE CRASHES; HEAD	Objectives: The objective of this study was to present, compare, and discuss the kinematic response of children and child anthropomorphic test devices (ATDs) during emergency braking events in different restraint configurations in a passenger vehicle. Methods: A driving study was conducted on a closed-circuit test track comprising 16 children aged 4 to 12years old and the Q3, Hybrid III (HIII) 3-year-old, 6-year-old, and 10-year-old ATDs restrained on the right rear seat of a modern passenger vehicle. The children were exposed to one braking event in each of the 2 restraint systems and the ATDs were exposed to 2 braking events in each restraint system. All events had a deceleration of 1.0g. Short children (stature 107123cm) and the Q3, HIII 3-year-old, and 6-year-old were restrained on booster cushions as well as high-back booster seats. Tall children (stature 135150cm) and HIII 10-year-old were restrained on booster cushions or restrained by 3-point belts directly on the car seat. Vehicle data were collected and synchronized with video data. Forward trajectories for the forehead and external auditory canal (ear) were determined as well as head rotation and shoulder belt force. Results: A total of 40 trials were analyzed. Child volunteers had greater maximum forward displacement of the head and greater head rotation compared to the ATDs. The average maximum displacement for children ranged from 165 to 210mm and 155 to 195mm for the forehead and ear target, respectively. Corresponding values for the ATDs were 55 to 165mm and 50 to 160mm. The change in head angle was greater for short children than for tall children. Shoulder belt force was within the same range for short children when restrained on booster cushions or high-back booster seats. For tall children, the shoulder belt force was greater when restrained on booster cushions compared to being restrained by seat belts directly on the car seat. Conclusions: The forward displacement was within the same range for all children regardless of stature and restraint system. However, the maximum forward position depended on the initial seated posture and shoulder belt position on the shoulder. Differences could also be seen in the curvature of the neck and spine. Short children exhibited a greater flexion motion of the head, whereas a more upright posture at maximum forward position was exhibited by the tall children. The ATDs displayed less forward displacement compared to the children. Supplemental materials are available for this article. Go to the publisher's online edition of Traffic Injury Prevention to view the supplemental file.	[Stockman, Isabelle; Jakobsson, Lotta; Brolin, Karin] Chalmers, Dept Appl Mech, SE-41296 Gothenburg, Sweden; [Bohman, Katarina] Autoliv Res, Vargarda, Sweden; [Bohman, Katarina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Jakobsson, Lotta] Volvo Car Corp, Gothenburg, Sweden		Stockman, I (corresponding author), Chalmers, Dept Appl Mech, SE-41296 Gothenburg, Sweden.	isabelle.stockman@chalmers.se	Brolin, Karin/A-4801-2016	Brolin, Karin/0000-0002-9173-2498	Fordonsstrategisk Forsknings och Innovation, Vinnova, Sweden	This study was carried out at the SAFER Vehicle and Traffic Safety Centre at Chalmers, Sweden, and partly financed by Fordonsstrategisk Forsknings och Innovation, Vinnova, Sweden.	[Anonymous], 2007, PARTN CHILD PASS SAF; [Anonymous], 2009, CHILD RESTR SYST COD, V6, P855; Arbogast KB, 2009, STAPP CAR CRASH JO, V53, P329; Ash J, 2009, 21 INT TECHN C ENH S; Behr M, 2010, ACCIDENT ANAL PREV, V42, P797, DOI 10.1016/j.aap.2009.04.010; Bidez M, 2007, PROT CHILDR CARS 5 I; Bohman Katarina, 2011, Ann Adv Automot Med, V55, P15; Bohman K, 2011, TRAFFIC INJ PREV, V12, P62, DOI 10.1080/15389588.2010.526159; Carlsson S, 2011, IRCOBI C SEPT 14 16, P1416; Durbin DR, 2003, JAMA-J AM MED ASSOC, V289, P2835, DOI 10.1001/jama.289.21.2835; Howard A, 2004, J TRAUMA, V56, P1276, DOI 10.1097/01.TA.0000078883.74947.EB; Humanetics. About child dummies, 2011, CHILD DUMM; Kumpfbeck M, 1999, IRCOBI C SEPT 23 24, P2324; Lopez-Valdes Francisco J, 2009, Ann Adv Automot Med, V53, P237; Maltese MR, 2007, STAPP CAR CRASH JO, V51, P299; McCray L, 2006, SAE GOV IND M MAY 10; Morris R., 2005, 19 INT TECHN C ENH S; National Highway Traffic Safety Administration, 2004, 809671 DOT HS NAT HI; National Highway Traffic Safety Administration, 2005, 809784 DOT HS NAT HI; Seacrist Thomas, 2010, Ann Adv Automot Med, V54, P97; Sherwood C P, 2003, Traffic Inj Prev, V4, P206, DOI 10.1080/15389580309885; Talmor D, 2010, ACCIDENT ANAL PREV, V42, P672, DOI 10.1016/j.aap.2009.10.015; Wismans J, 2008, 514 EUR ENH VEH SAF; Zuppichini F, 1997, IRCOBI C SEPT 24 26, P2426	24	9	9	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1538-9588			TRAFFIC INJ PREV	Traffic Inj. Prev.	JAN 1	2013	14	1					92	102		10.1080/15389588.2012.688151			11	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	116UX	WOS:000316909600013	23259524				2022-02-06	
J	Tailor, YI; Suskauer, SJ; Sepeta, LN; Ewen, JB; DeMatt, EJ; Trovato, MK; Salorio, CF; Slomine, BS				Tailor, Yogita I.; Suskauer, Stacy J.; Sepeta, Leigh N.; Ewen, Joshua B.; DeMatt, Ellen J.; Trovato, Melissa K.; Salorio, Cynthia F.; Slomine, Beth S.			Functional status of children with encephalitis in an inpatient rehabilitation setting: A case series	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Encephalitis; children and adolescents; functional independence measure; outcome; rehabilitation	TRAUMATIC BRAIN-INJURY; ASPARTATE-RECEPTOR ENCEPHALITIS; INDEPENDENCE MEASURE; VIRAL ENCEPHALITIS; OUTCOMES; ETIOLOGIES; TERM	INTRODUCTION: Patterns and predictors of recovery from encephalitis are poorly understood. METHODS: This study examined functional status and reviewed charts of all children who presented to a pediatric inpatient rehabilitation facility with encephalitis between 1996 and 2010. Functional status at admission and discharge from inpatient rehabilitation was evaluated using the Functional Independence Measure for Children (WeeFIM) Self-care, Mobility, Cognitive, and Total Developmental Functional Quotient scores (DFQ,% of age-appropriate function). Charts were reviewed to characterize key clinical features and findings. RESULTS: Of the 13 children identified, the mean age was 9 years (range 5-16) with 54% males. Mean WeeFIM Total DFQ at admission was 37 (range: 15-90) and at discharge was 64 (range: 16-96). Average change in WeeFIM Total DFQ from admission to discharge was 26.7(range 0-55, p < 0.001). WeeFIM domain scores improved between admission and discharge (Self-Care: p < 0.001, Cognition: p < 0.01, Mobility: p < 0.001). Eleven children displayed significant impairments in functional skills, defined as DFQ of <= 85, at discharge. Key clinical features and findings were diverse and not related to functional outcome. CONCLUSIONS: Results suggest that significant functional improvement in children with encephalitis occurs during inpatient rehabilitation. Further research is necessary to identify predictors of outcome in children with encephalitis.	[Tailor, Yogita I.] Sinai Hosp, Dept Phys Med & Rehabil, Baltimore, MD 21215 USA; [Suskauer, Stacy J.; Ewen, Joshua B.; DeMatt, Ellen J.; Trovato, Melissa K.; Salorio, Cynthia F.; Slomine, Beth S.] Kennedy Krieger Inst, Baltimore, MD USA; [Sepeta, Leigh N.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Salorio, Cynthia F.; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Suskauer, Stacy J.; Trovato, Melissa K.; Salorio, Cynthia F.; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Ewen, Joshua B.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA		Slomine, BS (corresponding author), Kennedy Krieger Inst, Dept Neuropsychol, ABPP, 707 North Broadway, Baltimore, MD 21205 USA.	slomine@kennedykrieger.org		Ewen, Joshua/0000-0002-9203-9564	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS073626]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS073626] Funding Source: NIH RePORTER	The preparation of this manuscript was supported in part by NINDS award# K23 NS073626, NICHD award# K23HD061611.	Ambrose HE, 2011, J CLIN MICROBIOL, V49, P3576, DOI 10.1128/JCM.00862-11; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; [Anonymous], 2006, WEEFIM 2 CLIN GUID V; Azaula M, 2000, ARCH PHYS MED REHAB, V81, P307, DOI 10.1016/S0003-9993(00)90076-5; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Christie LJ, 2007, PEDIATRICS, V120, P305, DOI 10.1542/peds.2007-0240; Dalmau Josep, 2010, Community Oncol, V7, P219; Elbers JM, 2007, PEDIATRICS, V119, pE399, DOI 10.1542/peds.2006-1494; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Gable MS, 2012, CLIN INFECT DIS, V54, P899, DOI 10.1093/cid/cir1038; Granerod J, 2010, EPIDEMIOL INFECT, V138, P783, DOI 10.1017/S0950268810000725; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Hamid JS, 2010, BMC INFECT DIS, V10, P364; Houtrow AJ, 2012, AM J PHYS MED REHAB, V91, P435, DOI 10.1097/PHM.0b013e3182465da6; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Kramer ME, 2012, J HEAD TRAUMA REHABI; Mailles A, 2012, CLIN INFECT DIS, V54, P1455, DOI 10.1093/cid/cis226; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Misra UK, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01751.x; Moorthi S, 1999, BRAIN INJURY, V13, P139, DOI 10.1080/026990599121809; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Poloni C, 2010, DEV MED CHILD NEUROL, V52, pe78, DOI 10.1111/j.1469-8749.2009.03542.x; Rao N, 2005, ARCH PHYS MED REHAB, V86, P449, DOI 10.1016/j.apmr.2004.10.019; Rayamajhi A, 2007, PEDIATR INT, V49, P978, DOI 10.1111/j.1442-200X.2007.02495.x; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Rosenfeld MR, 2011, CURR TREAT OPTION NE, V13, P324, DOI 10.1007/s11940-011-0116-y; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Weinberg A, 2002, ANN NEUROL, V52, P543, DOI 10.1002/ana.10321; Willoughby RE, 2003, ELSEVIER SCI, P291; Wilson MR, 2011, SEMIN NEUROL, V31, P245, DOI 10.1055/s-0031-1287650; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91	34	9	9	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2013	6	3					163	173		10.3233/PRM-130248			11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7KN	WOS:000448281300005	24240837	Green Accepted			2022-02-06	
J	Temme, L; Bleiberg, J; Reeves, D; Still, DL; Levinson, D; Browning, R				Temme, Leonard; Bleiberg, Joseph; Reeves, Dennis; Still, David L.; Levinson, Dan; Browning, Rebecca			Uncovering latent deficits due to mild traumatic brain injury by using normobaric hypoxia stress	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; normobaric hypoxia; cognitive stress test; concussion; BrainCheckers; automated neuropsychological assessment metrics; mTBI biomarkers; hypoxic challenge		Memory deficits and other cognitive symptoms frequently associated with mTBI are commonly thought to resolve within 7-10 days. This generalization is based principally on observations made in individuals who are in the unstressed environmental conditions typical of a clinic and so does not consider the impact of physiologic, environmental, or psychological stress. Normobaric hypoxic stress can be generated with normal mean sea level (MSL) air, which is about 21 % oxygen (O-2) and 78% nitrogen (N), by reducing the percentage of O-2 and increasing the percentage of N so that the resultant mixed-gas has a partial pressure of O-2 approximating that of specified altitudes. This technique was used to generate normobaric hypoxic equivalents of 8,000, 12,000, and 14,000 feet above MSL in a group of 36 volunteers with a mTBI history and an equal number of controls matched on the basis of age, gender, tobacco smoking consumption, weight, height, and body mass index. Short-term visual memory was tested using the Matching to Sample (M2S) subtest of the BrainCheckers analog of the Automated Neuropsychological Assessment Metrics. Although there were no significant differences in M2S performance between the two groups of subjects at MSL, with increased altitude, the mTBI group performance was significantly worse than that of the control group. When the subjects were returned to MSL, the difference disappeared. This finding suggests that the "hypoxic challenge" paradigm developed here has potential clinical utility for assessing the effects of mTBI in individuals who appear asymptomatic under normal conditions.	[Temme, Leonard; Still, David L.] US Army, Aeromed Res Lab, Sensory Res Div, Vis Sci Branch, 6901 Andrews Ave,POB 620577, Ft Rucker, AL 36362 USA; [Bleiberg, Joseph] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Reeves, Dennis; Browning, Rebecca] Clinvest Res, Springfield, MO USA; [Levinson, Dan] Alliant Int Univ Irvine, Calif Sch Forens Studies, Irvine, CA USA		Temme, L (corresponding author), US Army, Aeromed Res Lab, Sensory Res Div, Vis Sci Branch, 6901 Andrews Ave,POB 620577, Ft Rucker, AL 36362 USA.	Leonard.A.Temme.civ@mail.mil		Bleiberg, Joseph/0000-0003-0867-5494	Congressionally Directed Medical Research Program TBI, PTSD Programs Award [W81XWH-08-2-0052 PTO75175]	This research was supported in part by the Congressionally Directed Medical Research Program TBI, PTSD Programs Award Number W81XWH-08-2-0052 PTO75175: the effects hypoxia on cognitive function in aviators and complex system operators that have had a mild traumatic brain injury.	Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Elsmore TF, 2007, ARCH CLIN NEUROPSYCH, V22, pS135, DOI 10.1016/j.acn.2006.10.009; Environics Inc., 2012, ROBD2 RED OX BREATH; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; McCrory P., 2005, BRIT J SPORT MED, V15, P48; Petrassi FA, 2012, AVIAT SPACE ENVIR MD, V83, P975, DOI 10.3357/ASEM.3315.2012; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Still DL, 2012, AVIAT SPACE ENVIR MD, V83, P902, DOI 10.3357/ASEM.3046.2012; Temme LA, 2010, AVIAT SPACE ENVIR MD, V81, P654, DOI 10.3357/ASEM.2690.2010	14	9	10	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2013	4								41	10.3389/fneur.2013.00041			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QT	WOS:000209629000040	23641232	Green Published, gold			2022-02-06	
J	Thompson, A; Bertocci, G; Pierce, MC				Thompson, Angela; Bertocci, Gina; Pierce, Mary C.			Assessment of injury potential in pediatric bed fall experiments using an anthropomorphic test device	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Accidental falls; Biomechanics; Child abuse; Injury assessment	FEET-1ST FREE FALLS; LOW-HEIGHT FALLS; HEAD-INJURY; YOUNG-CHILDREN; FRACTURES; INFANTS; BIOMECHANICS; ABUSE; AGE; LIKELIHOOD	Falls from beds and other furniture are common scenarios provided to conceal child abuse but are also common occurrences in young children. A better understanding of injury potential in short-distance falls could aid clinicians in distinguishing abusive from accidental injuries. Therefore, this study investigated biomechanical outcomes related to injury potential in falls from beds and other horizontal surfaces using an anthropomorphic test device representing a 12-month-old child. The potential for head, neck, and extremity injuries and differences due to varying impact surfaces were examined. Linoleum over concrete was associated with the greatest potential for head and neck injury compared to other evaluated surfaces (linoleum over wood, carpet, wood, playground foam). The potential for severe head and extremity injuries was low for most evaluated surfaces. However, results suggest that concussion and humerus fracture may be possible in these falls. More serious head injuries may be possible particularly for falls onto linoleum over concrete. Neck injury potential in pediatric falls should be studied further as limitations in ATD biofidelity and neck injury thresholds based solely on sagittal plane motion reduce accuracy in pediatric neck injury assessment. In future studies, limitations in AID biofidelity and pediatric injury thresholds should be addressed to improve accuracy in injury potential assessments for pediatric short-distance falls. Additionally, varying initial conditions or pre-fall positioning should be examined for their influence on injury potential. (C) 2012 Elsevier Ltd. All rights reserved.	[Thompson, Angela; Bertocci, Gina] Univ Louisville, Louisville, KY 40202 USA; [Pierce, Mary C.] Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Chicago, IL 60614 USA		Bertocci, G (corresponding author), Univ Louisville, 500 S Preston St,Hlth Sci Res Tower,Rm 204, Louisville, KY 40202 USA.	angela.thompson@louisville.edu; g.bertocci@louisville.edu; mpierce@luriechildrens.org					[Anonymous], 2003, J211 SAE; Bertocci GE, 2004, INJURY, V35, P417, DOI 10.1016/S0020-1383(03)00062-7; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; CHIAVIELLO CT, 1994, PEDIATRICS, V94, P679; CHUNG SMK, 1976, J BONE JOINT SURG AM, V58, P94, DOI 10.2106/00004623-197658010-00017; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Cory CZ, 2001, FORENSIC SCI INT, V123, P89, DOI 10.1016/S0379-0738(01)00523-0; CURREY JD, 1975, J BONE JOINT SURG BR, V57, P810; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Eppinger R., 1999, DEV IMPROVED INJURY; Gennarelli T.A., 1996, NEUROSURGERY, P2611; HELFER RE, 1977, PEDIATRICS, V60, P533; Hennrikus WL, 2003, CLIN ORTHOP RELAT R, P148, DOI 10.1097/01.blo.0000043059.62337.97; HIRSCH C, 1965, ACTA ORTHOP SCAND, V35, P300, DOI 10.3109/17453676508989361; Ibrahim NG, 2010, J NEUROSURG-PEDIATR, V6, P57, DOI 10.3171/2010.3.PEDS09357; Irwin A.L., 1997, CHILD OCCUPANT PROTE; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; Levine R, 1993, ACCIDENTAL INJURY BI, P460; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MILTNER E, 1989, Z RECHTSMED, V102, P535; MOHAN D, 1979, J BIOMECH ENG-T ASME, V101, P250, DOI 10.1115/1.3426254; Nahum A., 2002, ACCIDENTAL INJURY BI; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Scherl SA, 2000, CLIN ORTHOP RELAT R, P96; Shaw BA, 1997, J PEDIATR ORTHOPED, V17, P293, DOI 10.1097/00004694-199705000-00005; STRAIT RT, 1995, PEDIATRICS, V96, P667; Sturtz G, 1980, 24 STAPP CAR CRASH C; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Thompson AK, 2009, J TRAUMA, V66, P1019, DOI 10.1097/TA.0b013e31817dac8b; Tuttle ME, 1981, EXP TECH, V5, P19	37	9	9	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	JAN	2013	50						16	24		10.1016/j.aap.2012.09.011			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	079SD	WOS:000314191600003	23131474				2022-02-06	
J	Vrettou, CS; Zakynthinos, SG; Malachias, S; Mentzelopoulos, SD				Vrettou, Charikleia S.; Zakynthinos, Spyros G.; Malachias, Sotirios; Mentzelopoulos, Spyros D.			High-frequency oscillation and tracheal gas insufflation in patients with severe acute respiratory distress syndrome and traumatic brain injury: an interventional physiological study	CRITICAL CARE			English	Article							ACUTE LUNG INJURY; INTRACRANIAL-PRESSURE; TIDAL VOLUME; VENTILATION; RECRUITMENT; ADULTS; STRATEGY; FLOW	Introduction: In acute respiratory distress syndrome (ARDS), combined high-frequency oscillation (HFO) and tracheal gas insufflation (TGI) improves gas exchange compared with conventional mechanical ventilation (CMV). We evaluated the effect of HFO-TGI on PaO2/fractional inspired O-2 (FiO(2)) and PaCO2, systemic hemodynamics, intracranial pressure (ICP), and cerebral perfusion pressure (CPP) in patients with traumatic brain injury (TBI) and concurrent severe ARDS. Methods: We studied 13 TBI/ARDS patients requiring anesthesia, hyperosmolar therapy, and ventilation with moderate-to-high CMV-tidal volumes for ICP control. Patients had PaO2/FiO(2) < 100 mm Hg at end-expiratory pressure >= 10 cm H2O. Patients received consecutive, daily, 12-hour rescue sessions of HFO-TGI interspersed with 12-hour periods of CMV. HFO-TGI was discontinued when the post-HFO-TGI PaO2/FiO(2) exceeded 100 mm Hg for >12 hours. Arterial/central-venous blood gases, hemodynamics, and ICP were recorded before, during (every 4 hours), and after HFO-TGI, and were analyzed by using repeated measures analysis of variance. Respiratory mechanics were assessed before and after HFO-TGI. Results: Each patient received three to four HFO-TGI sessions (total sessions, n = 43). Pre-HFO-TGI PaO2/FiO(2) (mean +/- standard deviation (SD): 83.2 +/- 15.5 mm Hg) increased on average by approximately 130% to 163% during HFO-TGI (P < 0.01) and remained improved by approximately 73% after HFO-TGI (P < 0.01). Pre-HFO-TGI CMV plateau pressure (30.4 +/- 4.5 cm H2O) and respiratory compliance (37.8 +/- 9.2 ml/cm H2O), respectively, improved on average by approximately 7.5% and 20% after HFO-TGI (P < 0.01 for both). During HFO-TGI, systemic hemodynamics remained unchanged. Transient improvements were observed after 4 hours of HFO-TGI versus pre-HFO-TGI CMV in PaCO2 (37.7 +/- 9.9 versus 41.2 +/- 10.8 mm Hg; P < 0.01), ICP (17.2 +/- 5.4 versus 19.7 +/- 5.9 mm Hg; P < 0.05), and CPP (77.2 +/- 14.6 versus 71.9 +/- 14.8 mm Hg; P < 0.05). Conclusions: In TBI/ARDS patients, HFO-TGI may improve oxygenation and respiratory mechanics, without adversely affecting PaCO2, hemodynamics, or ICP. These findings support the use of HFO-TGI as a rescue ventilatory strategy in patients with severe TBI and imminent oxygenation failure due to severe ARDS.	[Vrettou, Charikleia S.; Zakynthinos, Spyros G.; Malachias, Sotirios; Mentzelopoulos, Spyros D.] Univ Athens, Sch Med, Evaggelismos Gen Hosp, Dept Intens Care Med 1, Athens 11528, Greece		Mentzelopoulos, SD (corresponding author), Univ Athens, Sch Med, Evaggelismos Gen Hosp, Dept Intens Care Med 1, Athens 11528, Greece.	sdm@hol.gr		Vrettou, Charikleia/0000-0002-1067-8849	European Union (European Social Fund, ESF)European Social Fund (ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Heracleitus II, Investing in Knowledge Society through the European Social Fund	The authors thank Dr. Stelios Kokkoris for his contribution in the collection of clinical data. This research was co-financed by the European Union (European Social Fund, ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Heracleitus II, Investing in Knowledge Society through the European Social Fund.	Bein T, 2002, INTENS CARE MED, V28, P554, DOI 10.1007/s00134-002-1273-y; Bein T, 2005, J TRAUMA, V58, P1294, DOI 10.1097/01.TA.0000173275.06947.5C; Bennett SS, 2007, NEUROCRIT CARE, V7, P221, DOI 10.1007/s12028-007-0084-y; Borges JB, 2006, AM J RESP CRIT CARE, V174, P268, DOI 10.1164/rccm.200506-976OC; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; BURTON GG, 1991, CHEST, V99, P1520, DOI 10.1378/chest.99.6.1520; Combes A, 2012, CURR OPIN CRIT CARE, V18, P99, DOI 10.1097/MCC.0b013e32834ef412; David M, 2005, ACTA ANAESTH SCAND, V49, P209, DOI 10.1111/j.1399-6576.2004.00570.x; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; Derdak S, 2003, CRIT CARE MED, V31, pS317, DOI 10.1097/01.CCM.0000057910.50618.EB; Ferguson ND, 2005, CRIT CARE MED, V33, P479, DOI 10.1097/01.CCM.0000155785.23200.9E; Ferguson ND, 2008, J APPL PHYSIOL, V104, P1230, DOI 10.1152/japplphysiol.01226.2007; Gattinoni L, 2004, CRIT CARE, V8, P350, DOI 10.1186/cc2854; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Gupta AK, 1997, ANESTH ANALG; Hager DN, 2007, CRIT CARE MED, V35, P1522, DOI 10.1097/01.CCM.0000266586.04676.55; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Imai Yumiko, 2005, Crit Care Med, V33, pS129, DOI 10.1097/01.CCM.0000156793.05936.81; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martinez-Perez M, 2004, INTENSIVE CARE MED; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; McGuire G, 1997, CRIT CARE MED, V25, P1059, DOI 10.1097/00003246-199706000-00025; Mentzelopoulos SD, 2012, EUR RESPIR J, V39, P635, DOI 10.1183/09031936.00158810; Mentzelopoulos SD, 2007, CRIT CARE MED, V35, P1500, DOI 10.1097/01.CCM.0000265738.80832.BE; Mentzelopoulos SD, 2011, INTENS CARE MED, V37, P990, DOI 10.1007/s00134-011-2162-z; Mentzelopoulos SD, 2010, INTENS CARE MED, V36, P810, DOI 10.1007/s00134-010-1822-8; Muellenbach RM, 2007, INTENS CARE MED, V33, P1423, DOI 10.1007/s00134-007-0708-x; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Nahum, 1998, Crit Care, V2, P43; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Stocchetti N, 2008, INTENSIVE CARE MED; SZNAJDER JI, 1989, J APPL PHYSIOL, V67, P1489, DOI 10.1152/jappl.1989.67.4.1489; The Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, P7; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa; Young NH, 2011, NEUROCRIT CARE, V15, P623, DOI 10.1007/s12028-011-9550-7	38	9	9	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2013	17	4							R136	10.1186/cc12815			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1GO	WOS:000331539700010	23844839	Green Published, gold			2022-02-06	
J	Wood, RL				Wood, Rodger Ll.			Recognising and assessing neurobehavioural disability after traumatic brain injury	NEUROREHABILITATION			English	Article						Neurobehavioural; disability; traumatic brain injury; assessment	BLUNT HEAD-INJURY; ECOLOGICAL VALIDITY; NEUROPSYCHOLOGY BEHAVIOR; EPISODIC DISORDERS; RECOGNITION; PERSONALITY; EMOTION; INDIVIDUALS; PERCEPTION; DYSCONTROL	BACKGROUND: Neurobehavioural disability often leads to serious social handicap. Many individuals never recover full social independence and will remain largely dependent upon family support, imposing a significant and potentially life-long psychological burden on those who care for injured relatives. Close relationships are at risk and many partnerships break down, increasing the risk of social isolation and subsequent psychological distress to the survivor. OBJECTIVES: The aim of this paper is to examine the nature of some cardinal features of neurobehavioural disability that contribute to poor psychosocial outcome; consider their organic origins, and problems associated with standardised methods of assessment. METHODS: A review of clinical literature addressing neurobehavioural disability after TBI. RESULTS: Many forms of neurobehavioural disability are subtle but have a pervasive impact on psychosocial outcome in general and relationships in particular. CONCLUSIONS: Caution is recommended when employing standardised tests to identify the complex and often subtle nature of neurobehavioural disorders. More work is needed to define the nature and impact of different forms of neurobehavioural disorders that comprise this complex form of disability.	Swansea Univ, Coll Human & Hlth Sci, Swansea SA2 8PP, W Glam, Wales		Wood, RL (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Vivian Bldg, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swansea.ac.uk					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alderman N, 2011, BRAIN INJURY, V25, P83, DOI 10.3109/02699052.2010.532849; Alexander M. P., 2002, PRINCIPLES FRONTAL L; BAJO A, 2001, 4 WORLD C BRAIN INJ; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Barratt ES, 1997, BIOL PSYCHIAT, V41, P1045, DOI 10.1016/S0006-3223(96)00175-8; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Benson D.F., 1986, FRONTAL LOBES; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 2002, PRINCIPLES FRONTAL L; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess P. W., 2000, PSYCHOL RES, V13, P25; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Damasio A., 1994, DESCARTES ERROR EMOT; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; Eslinger PJ, 2002, BEHAV BRAIN SCI, V25, P34, DOI 10.1017/S0140525X02360011; GARDNER DL, 1986, AM J PSYCHIAT, V143, P519; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Knight R. T., 2002, PRINCIPLES FRONTAL L; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; Lane M. D., 2000, COGNITIVE NEUROSCIEN; LEWIN J, 1992, BRIT J PSYCHIAT, V161, P261, DOI 10.1192/bjp.161.2.261; Lishman W. A., 1987, ORGANIC PSYCHIAT; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Rolls E.T., 1999, BRAIN EMOTION; Rolls E. T., 2002, PRINCIPLES FRONTAL L; Satz P, 1996, PSYCHOL ASSESSMENT, V8, P115; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; STOKES N, 2003, BRAIN INJURY, V17, P174; STUSS DT, 1983, NEUROPSYCHOLOGIA, V21, P235, DOI 10.1016/0028-3932(83)90040-4; Taylor G. J., 1997, DISORDERS AFFECT REG; Teuber H. L., 1964, FRONTAL GRANULAR COR; Tranel D., 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Walsh K. W., 1985, UNDERSTANDING BRAIN; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wood R. L., 1987, BRAIN INJURY REHABIL; Wood R. L. L., 1989, PHYS MED REHABIL, V3, P123; Wood R. L. L., 1981, APPL CONDITIONING TH; Wood R. L. L., 1984, CLOSED HEAD INJURY P; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 2005, PSYCHOLOGIST, V18, P138; Wood RL, 2004, NEUROPSYCHOL REHABIL, V14, P329, DOI 10.1080/09602010343000255; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1; WOOD RLL, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P3; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Wood RL, 2011, J HEAD TRAUMA REHAB, V26, P202, DOI 10.1097/HTR.0b013e318217b46d; Worthington A. D., 2008, PSYCHOL APPROACHES R; Zald D. H., 2006, ORBITOFRONTAL CORTEX	82	9	10	1	13	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	4					699	706		10.3233/NRE-130895			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	184QF	WOS:000321907100002	23867397				2022-02-06	
J	Wu, JCC; Chen, KY; Yo, YW; Huang, SW; Shih, HM; Chiu, WT; Chiang, YH; Shiau, CY				Wu, John Chung-Che; Chen, Kai-Yun; Yo, Yo-Wen; Huang, Song-Wei; Shih, Hsiu-Ming; Chiu, Wen-Ta; Chiang, Yung-Hsiao; Shiau, Chia-Yang			Different sham procedures for rats in traumatic brain injury experiments induce corresponding increases in levels of trauma markers	JOURNAL OF SURGICAL RESEARCH			English	Article						Craniectomy; Sham; Traumatic brain injury; Controlled cortical impact; Marker	SPINAL-CORD-INJURY; DECOMPRESSIVE CRANIECTOMY; OXIDATIVE DAMAGE; PEROXYNITRITE	Background: In traumatic brain injury animal models, sham or naive control groups are often used for the analysis of injured animals; however, the existence and/or significance of differences in the control groups has yet to be studied. In addition, recent controversies regarding the decompressive craniectomy trial in which decompressive craniectomies in patients with severe traumatic brain injury and refractory increased intracranial pressure remains unsettled. Although the report demonstrated that the procedure may result in less favorable long-term outcomes despite the decrease in intracranial pressure and shorter length of intensive care unit stay, the study has been criticized, and the debate is still inconclusive partly because of a lack of mechanistic explanation. We have recently discovered epithelial and endothelial tyrosine kinase (Etk) to exhibit upregulation after traumatic neural injury and will compare the effects of craniectomy procedure with those of other procedures inducing different levels of severity. Materials and methods: Four groups of rats receiving different procedures (controlled cortical impact, craniectomy, bicortical drilling, and unicortical drilling [UD]) were compared. Polymerase chain reaction, Western blot analysis, and immunoflorescence staining of Etk, S100, and glial fibrillary acidic protein levels were used to analyze the results and compare the different groups. Results: Etk upregulation was statistically significant between craniectomy and UD groups. The level of change for glial fibrillary acidic protein and S100 was only significant when cortex was impacted. Conclusions: UD may be preferable as a sham control procedure over craniectomy or bicortical drilling. Increases in the expression of Etk in the craniectomy group suggest a possible mechanism by which unfavorable outcome occurs in patients receiving craniectomy procedures. (C) 2013 Elsevier Inc. All rights reserved.	[Chen, Kai-Yun; Yo, Yo-Wen; Huang, Song-Wei; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Dept Surg, Taipei 110, Taiwan; [Wu, John Chung-Che; Shiau, Chia-Yang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei 114, Taiwan; [Wu, John Chung-Che] Taitung Christian Hosp, Taitung, Taiwan; [Wu, John Chung-Che; Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chen, Kai-Yun; Yo, Yo-Wen; Chiang, Yung-Hsiao] Coll Med Sci & Technol, Neural Regenerat Program, Taipei, Taiwan; [Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan		Chiang, YH (corresponding author), Taipei Med Univ, Coll Med, Dept Surg, 252 Wu Hsing St, Taipei 110, Taiwan.	ychiang@tmu.edu.tw; cys@ndmctsgh.edu.tw	Shih, Hsiu-Ming/S-7023-2018	YU, YU-WEN/0000-0002-7279-2532	Taipei Medical University-Shuang Ho Hospital [100TMU-SHH-12]; National Taipei University of Technology-Taipei Medical University [NTUT-TMU-100-08]; Center of Excellence for Clinical Trial and Research in NeurologyNeurosurgery [DOH99-TD-B-111-003]; National Science CouncilMinistry of Science and Technology, Taiwan [NSC98-2314-B038-011-MY3, NSC101-2632-B-038-001-MY3]; Cheng-Hsin Research Grant [100-23]	Funding provided by Taipei Medical University-Shuang Ho Hospital 100TMU-SHH-12, National Taipei University of Technology-Taipei Medical University NTUT-TMU-100-08, Center of Excellence for Clinical Trial and Research in Neurology&Neurosurgery DOH99-TD-B-111-003, and National Science Council Grant NSC98-2314-B038-011-MY3, NSC101-2632-B-038-001-MY3, Cheng-Hsin Research Grant 100-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Chen KY, 2012, CELL TRANSPLANT, V21, P345, DOI 10.3727/096368911X582741; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Jasielska M., INVEST OPHTHALMOL VI, V51, P3874; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kobbe P, 2008, J ORTHOP TRAUMA, V22, P385, DOI 10.1097/BOT.0b013e318175dd88; Paavonen K, 2004, MOL BIOL CELL, V15, P4226, DOI 10.1091/mbc.E04-03-0241; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Wu JCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039226; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	24	9	9	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2013	179	1					138	144		10.1016/j.jss.2012.09.013			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	051LW	WOS:000312129700058	23122667				2022-02-06	
J	Ying, Z; Feng, C; Agrawal, R; Zhuang, YM; Gomez-Pinilla, F				Ying, Zhe; Feng, Cameron; Agrawal, Rahul; Zhuang, Yumei; Gomez-Pinilla, Fernando			Dietary Omega-3 Deficiency from Gestation Increases Spinal Cord Vulnerability to Traumatic Brain Injury-Induced Damage	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; MEMBRANE HOMEOSTASIS; PHOSPHOLIPASE A(2); RAT; SUPPLEMENTATION	Although traumatic brain injury (TBI) is often associated with gait deficits, the effects of TBI on spinal cord centers are poorly understood. We seek to determine the influence of TBI on the spinal cord and the potential of dietary omega-3 (n-3) fatty acids to counteract these effects. Male rodents exposed to diets containing adequate or deficient levels of n-3 since gestation received a moderate fluid percussion injury when becoming 14 weeks old. TBI reduced levels of molecular systems important for synaptic plasticity (BDNF, TrkB, and CREB) and plasma membrane homeostasis (4-HNE, iPLA2, syntaxin-3) in the lumbar spinal cord. These effects of TBI were more dramatic in the animals exposed to the n-3 deficient diet. Results emphasize the comprehensive action of TBI across the neuroaxis, and the critical role of dietary n-3 as a means to build resistance against the effects of TBI.	[Ying, Zhe; Feng, Cameron; Agrawal, Rahul; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Zhuang, Yumei; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA USA		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS050465, R01 NS056413] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056413, R01NS050465] Funding Source: NIH RePORTER		Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Fedorova I, 2009, BEHAV NEUROSCI, V123, P196, DOI 10.1037/a0013801; FITZPATRICK JS, 1994, DEV BRAIN RES, V78, P81, DOI 10.1016/0165-3806(94)90012-4; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Joseph MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041288; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Nagappan G, 2005, TRENDS NEUROSCI, V28, P464, DOI 10.1016/j.tins.2005.07.003; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Suzuki H, 1998, MECH AGEING DEV, V101, P119, DOI 10.1016/S0047-6374(97)00169-3; Wolf MJ, 1995, FEBS LETT, V377, P358, DOI 10.1016/0014-5793(95)01371-7; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706	23	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52998	10.1371/journal.pone.0052998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	WOS:000313051500099	23300842	Green Submitted, gold, Green Published			2022-02-06	
J	Aldrich, EM; Obrzut, JE				Aldrich, Erin M.; Obrzut, John E.			Assisting Students With a Traumatic Brain Injury in School Interventions	CANADIAN JOURNAL OF SCHOOL PSYCHOLOGY			English	Article						traumatic brain injury; pediatric TBI; classification of TBI; school interventions		Traumatic brain injury (TBI) in children and adolescents can significantly affect their lives and educational needs. Deficits are often exhibited in areas such as attention, concentration, memory, executive function, emotional regulation, and behavioral functioning, but specific outcomes are not particular to any one child or adolescent with a TBI. Therefore, educators must provide specific interventions to accommodate the needs of each individual student with a TBI. This article, first, addresses the definition of TBI in the schools and provides an overview of TBI including causes, classifications, and the primary areas of head injury. Second, the article presents recommendations and suggestions for school interventions for children and adolescents with TBI.	[Aldrich, Erin M.] Univ Arizona, Sch Psychol Program, Tucson, AZ USA; [Obrzut, John E.] Univ Arizona, Coll Educ, Sch Psychol, Dept Disabil & Psychoeduc Studies, Tucson, AZ USA		Aldrich, EM (corresponding author), Univ Arizona, Coll Educ, Dept Disabil & Psychoeduc Studies, Tucson, AZ 85721 USA.	ealdrich@email.arizona.edu					Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; [Anonymous], 2004, ASS STAT ED CHILDR D; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; Davies SC, 2010, J APPL SCH PSYCHOL, V26, P308, DOI 10.1080/15377903.2010.518587; Delis DC., 1994, CALIFORNIA VERBAL LE; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Dykeman B, 2009, EDUCATION, V130, P295; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Havey M. J., 2002, BEST PRACTICES SCH P, VIV, P1433; Heller J. L., 2010, MEDLINE PLUS; Hooper S. R., 2001, HDB PSYCHOL SERVICES, P267; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Prinz R., 1987, ADV BEHAV ASSESSMENT, P57; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Semrud-Clikeman M., 2005, HDB SCH NEUROPSYCHOL, P425; SZEKERES SF, 1994, TOP LANG DISORD, V15, P21, DOI 10.1097/00011363-199411000-00004; TEASDALE G, 1974, LANCET, V2, P81; Zimmerman RA, 1989, NEUROPSYCHOLOGY, V3, P191, DOI 10.1037/h0091791	34	9	9	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0829-5735	2154-3984		CAN J SCH PSYCHOL	Can. J. Sch. Psychol.	DEC	2012	27	4					291	301		10.1177/0829573512455016			11	Psychology, Educational	Emerging Sources Citation Index (ESCI)	Psychology	V1V9S	WOS:000217284700002					2022-02-06	
J	Parabucki, AB; Bozic, ID; Bjelobaba, IM; Lavrnja, IC; Brkic, PD; Jovanovic, TS; Savic, DZ; Stojiljkovic, MB; Pekovic, SM				Parabucki, Ana B.; Bozic, Iva D.; Bjelobaba, Ivana M.; Lavrnja, Irena C.; Brkic, Predrag D.; Jovanovic, Tomislav S.; Savic, Danijela Z.; Stojiljkovic, Mirjana B.; Pekovic, Sanja M.			Hyperbaric oxygenation alters temporal expression pattern of superoxide dismutase 2 after cortical stab injury in rats	CROATIAN MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; LIPID-PEROXIDATION; MESSENGER-RNA; UP-REGULATION; FLUORO-JADE; HEAD-INJURY; THERAPY; CORTEX	Aim To evaluate the effect of hyperbaric oxygen therapy (HBOT) on superoxide dismutase 2 (SOD2) expression pattern after the cortical stab injury (CSI). Methods CSI was performed on 88 male Wistar rats, divided into control, sham, lesioned, and HBO groups. HBOT protocol was the following: pressure applied was 2.5 absolute atmospheres, for 60 minutes, once a day for consecutive 3 or 10 days. The pattern of SOD2 expression and cellular localization was analyzed using real-time polymerase chain reaction, Western blot, and double-label fluorescence immunohistochemistry. Neurons undergoing degeneration were visualized with Fluoro-Jade (R) B. Results CSI induced significant transient increase in SOD2 protein levels at day 3 post injury, which was followed by a reduction toward control levels at post-injury day 10. At the same time points, mRNA levels for SOD2 in the injured cortex were down-regulated. Exposure to HBO for 3 days considerably down-regulated SOD2 protein levels in the injured cortex, while after 10 days of HBOT an up-regulation of SOD2 was observed. HBOT significantly increased mRNA levels for SOD2 at both time points compared to the corresponding L group, but they were still lower than in controls. Double immunofluorescence staining revealed that 3 days after CSI, up-regulation of SOD2 was mostly due to an increased expression in reactive astrocytes surrounding the lesion site. HBOT attenuated SOD2 expression both in neuronal and astroglial cells. Fluoro-Jade (R) B labeling showed that HBOT significantly decreased the number of degenerating neurons in the injured cortex. Conclusion HBOT alters SOD2 protein and mRNA levels after brain injury in a time-dependent manner.	[Parabucki, Ana B.; Bozic, Iva D.; Bjelobaba, Ivana M.; Lavrnja, Irena C.; Savic, Danijela Z.; Stojiljkovic, Mirjana B.; Pekovic, Sanja M.] Univ Belgrade, Inst Biol Res Sinisa Stankov, Dept Neurobiol, Belgrade 11060, Serbia; [Brkic, Predrag D.; Jovanovic, Tomislav S.] Univ Belgrade, Sch Med, Inst Med Physiol Richard Burian, Belgrade 11060, Serbia; [Jovanovic, Tomislav S.] Ctr Hyperbar Med, Belgrade, Serbia		Parabucki, AB (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankov, Dept Neurobiol, Neurochem Lab, Blvd Despota Stefana 142, Belgrade 11060, Serbia.	aparabucki@ibiss.bg.ac.rs	Savic, Danijela/I-7471-2019; Bjelobaba, Ivana/ABA-1538-2020; Lavrnja, Irena/ABA-1558-2020	Savic, Danijela/0000-0001-7411-4527; Bjelobaba, Ivana/0000-0002-7649-0304; Lavrnja, Irena/0000-0002-0607-5594; Bozic, Iva/0000-0002-8550-0359	Ministry of Education, Science and Technological Development, Republic of Serbia [III41014]	This study was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia, grant number III41014.	[Anonymous], 2003, BRAIN INJURY, V17, P225, DOI [10.1080/0269905021000030814, DOI 10.1080/0269905021000030814]; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Benedetti S, 2004, CLIN BIOCHEM, V37, P312, DOI 10.1016/j.clinbiochem.2003.12.001; Bennett MH, 2005, COCHRANE DB SYST REV, V20; Bidmon HJ, 1998, STROKE, V29, P203, DOI 10.1161/01.STR.29.1.203; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Bitterman N, 2004, UNDERSEA HYPERBAR M, V31, P63; Brkic P, 2012, BRAIN INJURY, V26, P1273, DOI 10.3109/02699052.2012.667593; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Chan PH, 2005, ANN NY ACAD SCI, V1042, P203, DOI 10.1196/annals.1338.022; Chen YM, 2001, GLIA, V33, P343, DOI 10.1002/1098-1136(20010315)33:4<343::AID-GLIA1033>3.0.CO;2-H; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Feldmeier JJ, 2003, HYPERBARIC OXYGEN TH; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Hampson NB, 1996, UNDERSEA HYPERBAR M, V23, P215; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Keller JN, 1998, J NEUROSCI, V18, P687; Kifle Y, 1996, J NEUROCHEM, V66, P2128; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Kundrotiene J, 2004, ACTA NEUROBIOL EXP, V64, P153; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landriscina M, 1996, BRIT J CANCER, V74, P1877, DOI 10.1038/bjc.1996.648; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028033, 10.1371/journal.pone.0050296, 10.1371/journal.pone.0044670, 10.1186/1747-597X-7-11]; LIU XH, 1994, BRAIN RES, V644, P257, DOI 10.1016/0006-8993(94)91688-8; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Methy D, 2004, BRAIN RES, V1003, P151, DOI 10.1016/j.brainres.2003.12.031; Nedeljkovic N, 2006, CELL BIOL INT, V30, P541, DOI 10.1016/j.cellbi.2006.03.001; Nie H, 2006, J CEREBR BLOOD F MET, V26, P666, DOI 10.1038/sj.jcbfm.9600221; Noack H, 1998, GLIA, V23, P285, DOI 10.1002/(SICI)1098-1136(199808)23:4<285::AID-GLIA1>3.0.CO;2-2; Oter S, 2005, INTENS CARE MED, V31, P1262, DOI 10.1007/s00134-005-2701-6; Oter S, 2005, CLIN BIOCHEM, V38, P706, DOI 10.1016/j.clinbiochem.2005.04.005; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Pekovic S, 2006, NEUROBIOLOGICAL STUDIES - FROM GENES TO BEHAVIOUR 2006, P143; Peluffo H, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-12; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Roje Z, 2008, CROAT MED J, V49, P224, DOI 10.3325/cmj.2008.2.224; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shaw IC, 1995, NEURODEGENERATION, V4, P391, DOI 10.1006/neur.1995.0047; Shen CY, 2008, TRANSPL P, V40, P2182, DOI 10.1016/j.transproceed.2008.07.080; Smerz RW, 2004, UNDERSEA HYPERBAR M, V31, P199; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SUKOFF MH, 1982, NEUROSURGERY, V10, P29, DOI 10.1227/00006123-198201000-00006; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Todorovic A, 2005, ANN NY ACAD SCI, V1048, P369, DOI 10.1196/annals.1342.041; Wada K, 2000, ACT NEUR S, V76, P285; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WOOD JD, 1969, J NEUROCHEM, V16, P281, DOI 10.1111/j.1471-4159.1969.tb10366.x; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Xu LJ, 2010, GLIA, V58, P1042, DOI 10.1002/glia.20985; Yang ZJ, 2010, EUR J APPL PHYSIOL, V108, P513, DOI 10.1007/s00421-009-1229-9; Zhang T, 2010, BRAIN INJURY, V24, P1350, DOI 10.3109/02699052.2010.504525	64	9	10	0	7	MEDICINSKA NAKLADA	ZAGREB	VLASKA 69, HR-10000 ZAGREB, CROATIA	0353-9504	1332-8166		CROAT MED J	Croat. Med. J.	DEC	2012	53	6					586	597		10.3325/cmj.2012.53.586			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	082SD	WOS:000314411700009	23275324	Green Published, gold			2022-02-06	
J	Ramanoudjame, M; Vandenbussche, E; Baring, T; Solignac, N; Augereau, B; Gregory, T				Ramanoudjame, M.; Vandenbussche, E.; Baring, T.; Solignac, N.; Augereau, B.; Gregory, T.			Fibular nonunion after closed-wedge high tibial osteotomy	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Gonarthrosis; Closed-wedge osteotomy; Fibular nonunion; Fibular osteotomy; Fibula	CLOSING-WEDGE; PERONEAL NERVE; FOLLOW-UP; ARTHRITIS; KNEE	Closed-wedge valgus high tibial osteotomy (HTO) has been reported to be an effective procedure for the treatment of medial compartment osteoarthritis of the knee. It requires shortening the fibula, for which many techniques have been described. Dislocation of the proximal tibiofibular joint limits the correction angle of the procedure and the osteotomy of the fibular head runs the rare but dramatic risk of common fibular nerve palsy, which is why many surgeons perform the osteotomy more distally at the shaft. However, the potential complications of fibula shaft osteotomy in closed-wedge proximal tibial osteotomy have been poorly reported. The purpose of this study is to accurately define the incidence and risk of fibular complications. Materials and methods: One hundred and eight patients (59 men, 49 women, 53 +/- 10 years old, preoperative varus: 6.7 degrees +/- 4 degrees) underwent a closed-wedge HTO with fibular shaft osteotomy between 1999 and 2004. They were followed up prospectively for clinical and radiological evaluation (2 years of follow-up). The main evaluation criterion was the presence of fibular nonunion. Results: Eighteen knees (16.6%) underwent fibular complications: 15 nonunions were indexed (13.9%); 11 of them (10.1%) required surgical revision. Three knees had nerve injury, with spontaneous recovery for two of them. Discussion: Fibular nonunion is the most frequent complication, which often leads to revision procedures. Nonunion was correlated to the preoperative body mass index, the obliquity of the osteotomy plane, and the fragmentary contact. No nonunion was reported when the obliquity of the osteotomy plane was above 50 degrees or the fragment contact greater than 50%. Level of evidence: Level IV, therapeutic study. (C) 2012 Elsevier Masson SAS. All rights reserved.	[Ramanoudjame, M.; Vandenbussche, E.; Solignac, N.; Augereau, B.; Gregory, T.] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Orthoped, Paris, France; [Baring, T.; Gregory, T.] Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, London, England		Ramanoudjame, M (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Orthoped, Paris, France.	ramanoudjame.mira@yahoo.fr					Abisset-bouvier C, 1987, THESIS; Akizuki S, 2008, J BONE JOINT SURG BR, V90B, P592, DOI 10.1302/0301-620X.90B5.20386; Aydogdu S, 1996, Acta Orthop Belg, V62, P156; BERMAN AT, 1991, CLIN ORTHOP RELAT R, P192; Brouwer RW, 2006, J BONE JOINT SURG BR, V88B, P1454, DOI 10.1302/0301-620X.88B11.17743; COVENTRY MB, 1973, J BONE JOINT SURG AM, VA 55, P23, DOI 10.2106/00004623-197355010-00002; COVENTRY MB, 1985, J BONE JOINT SURG AM, V67A, P1136, DOI 10.2106/00004623-198567070-00025; CURLEY P, 1990, J BONE JOINT SURG BR, V72, P405, DOI 10.1302/0301-620X.72B3.2341437; Ducat A, 2012, ORTHOP TRAUMATOL-SUR, V98, P68, DOI 10.1016/j.otsr.2011.08.013; Flecher X, 2006, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000229362.12244.f6; INSALL JN, 1976, J BONE JOINT SURG AM, V58, P754, DOI 10.2106/00004623-197658060-00003; JOKIO P J, 1986, Italian Journal of Orthopaedics and Traumatology, V12, P41; KIRGIS A, 1992, J BONE JOINT SURG AM, V74A, P1180, DOI 10.2106/00004623-199274080-00007; Kurosaka H, 2000, INT ORTHOP, V24, P227, DOI 10.1007/s002640000151; MABREY JD, 1987, SOUTHERN MED J, V80, P975, DOI 10.1097/00007611-198708000-00010; RUPP RE, 1994, J ORTHOP TRAUMA, V8, P54, DOI 10.1097/00005131-199402000-00012; Soejima O, 1994, Orthop Rev, V23, P244; Spahn Gunter, 2004, Arch Orthop Trauma Surg, V124, P649, DOI 10.1007/s00402-003-0588-7; Takizawa T, 1995, KNEE, V2, P19; Weill D, 1982, Acta Orthop Belg, V48, P131; WOOTTON JR, 1995, ANN ROY COLL SURG, V77, P31	21	9	11	0	0	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	DEC	2012	98	8					863	867		10.1016/j.otsr.2012.09.010			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	052GR	WOS:000312186200002	23158781	hybrid			2022-02-06	
J	Figueroa, CE; Reider, P; Burckel, P; Pinkerton, AA; Prud'homme, RK				Figueroa, Carlos E.; Reider, Paul; Burckel, Pannee; Pinkerton, A. Alan; Prud'homme, Robert K.			Highly loaded nanoparticulate formulation of progesterone for emergency traumatic brain injury treatment	THERAPEUTIC DELIVERY			English	Article								Background: Progesterone (PG), a promising therapeutic for treating traumatic brain injury, has been difficult to formulate into a high-dose/low-volume form for emergency intravenous administration due to its hydrophobicity and crystallinity. Results: This work demonstrates the use of Flash NanoPrecipitation to produce 300-nm PG-loaded polymeric nanoparticles with approximately 24 wt% drug loading using only components that are classified by the US FDA as generally recognized as safe. Approximately 80% of the encapsulated PG is in dissolved, rather than crystalline form. For prolonged stability, the nanoparticles are freeze-dried with Pluronic F68 and can be reproducibly reconstituted by hand agitation for 1 min without particle aggregation to produce injectable formulations with approximately 30-mg/ml PG, which is more than ten-times higher than has been previously reported. Conclusion: This formulation can allow for administration of therapeutically viable concentrations of PG, which has been impossible with all previously reported nanoparticulate formulations because of low drug loadings and concentrations.	[Figueroa, Carlos E.; Prud'homme, Robert K.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Reider, Paul] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Burckel, Pannee; Pinkerton, A. Alan] Univ Toledo, Dept Chem, Toledo, OH 43606 USA		Prud'homme, RK (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	prudhomm@princeton.edu		pinkerton, alan/0000-0002-2239-1992	National Science Foundation through the NIRT 'Nanoscale Interdisciplinary Research Teams' [CTS0506966]; Helen Shipley Hunt Fund	This work was made possible through support from the National Science Foundation through the NIRT 'Nanoscale Interdisciplinary Research Teams' (CTS0506966) and the Helen Shipley Hunt Fund. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017; Akbulut M, 2009, ADV FUNCT MATER, V19, P718, DOI 10.1002/adfm.200801583; [Anonymous], ANN EMERG MED, V49, P391; Ansell SM, 2008, J MED CHEM, V51, P3288, DOI 10.1021/jm800002y; Cavalli R, 1999, INT J PHARM, V182, P59, DOI 10.1016/S0378-5173(99)00066-6; Cendejas-Santana G, 2002, MATER RES INNOV, V6, P252, DOI 10.1007/s10019-002-0207-1; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; D'Addio SM, 2011, ADV DRUG DELIVER REV, V63, P417, DOI 10.1016/j.addr.2011.04.005; DATTA R, 1995, FEMS MICROBIOL REV, V16, P221; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Duchene D, 1999, J CONTROL RELEASE, V62, P263, DOI 10.1016/S0168-3659(99)00046-2; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Han J, 2012, J PHARM SCI-US, V101, P4018, DOI 10.1002/jps.23259; Hao PP, 2007, FOOD CHEM, V105, P1732, DOI 10.1016/j.foodchem.2007.04.058; HENDRY EB, 1961, CLIN CHEM, V7, P156; Hu KL, 2009, J CONTROL RELEASE, V134, P55, DOI 10.1016/j.jconrel.2008.10.016; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Johnson BK, 2003, AUST J CHEM, V56, P1021, DOI 10.1071/CH03115; Johnson BK, AICHE, V49, P2264; Johnson BK, PHYS REV LETT, V91; Karst D, 2005, J APPL POLYM SCI, V96, P416, DOI 10.1002/app.21456; Kumar V, 2008, J PHARM SCI-US, V97, P4904, DOI 10.1002/jps.21342; Kumar V, 2010, SMALL, V6, P2907, DOI 10.1002/smll.201001199; Kumar V, 2009, MOL PHARMACEUT, V6, P1118, DOI 10.1021/mp900002t; Laermer S. F., 1992, Journal of Plastic Film & Sheeting, V8, P228, DOI 10.1177/875608799200800306; Layre AM, 2006, DRUG DEV IND PHARM, V32, P839, DOI 10.1080/03639040600685134; Matsumoto J, 1999, INT J PHARM, V185, P93, DOI 10.1016/S0378-5173(99)00153-2; Memisoglu E, 2003, INT J PHARMACEUT, V251, P143, DOI 10.1016/S0378-5173(02)00593-8; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Payne RS, 1999, INT J PHARM, V177, P231, DOI 10.1016/S0378-5173(98)00348-2; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Salnikova MS, J PHARM SCI, V97, P4194; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; THURMAN D, 2001, HEAD TRAUMA BASIC PR; VERRECCHIA T, 1995, J CONTROL RELEASE, V36, P49, DOI 10.1016/0168-3659(95)00053-B; Wang F, 2000, ORG PROCESS RES DEV, V4, P391, DOI 10.1021/op000210w; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yuan H, 2007, COLLOID SURFACE B, V60, P174, DOI 10.1016/j.colsurfb.2007.06.011	44	9	9	0	15	FUTURE SCI LTD	LONDON	UNITED HOUSE, 2 ALBERT PL, LONDON, N3 1QB, ENGLAND	2041-5990	2041-6008		THER DELIV	Ther. Deliv.	NOV	2012	3	11					1269	1279		10.4155/TDE.12.115			11	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	V2Y5Y	WOS:000218028900011	23259248				2022-02-06	
J	Rodriguez-Bailon, M; Trivino, M; Lupianez, J				Rodriguez-Bailon, Maria; Trivino, Monica; Lupianez, Juan			Executive Attention and Personality Variables in Patients with Frontal Lobe Damage	SPANISH JOURNAL OF PSYCHOLOGY			English	Article						executive control; attention; personality; brain injury	INDEPENDENCE; INHIBITION; NETWORKS; CORTEX	Executive Control is required to deal with novel situations or when an action plan is needed. This study aimed to highlight the executive attention deficits of patients with frontal lobe damage. To do so, the ANT-I task (Attention Network Test-Interactions) was administered for the first time to a group of 9 patients with frontal damage caused by traumatic brain injury (TBI) and a matched control group. This task made it possible to measure the three attentional networks proposed by Posner and Dehaene (1994) and their interactions. Results on the alerting and orienting networks did not show any significant differences between the groups. However, a significant effect of group on the executive control network was observed. In addition, participants' personality was assessed with a clinical inventory (the Millon Personality Inventory) that showed a significant positive correlation between borderline personality disorder and the conflict index. These results suggest that frontal lobe damage causes an exclusive impairment in the conflict resolution network that is related to personality traits characterized by a lack of behavioral control. More research will be necessary to study this causal relationship.	[Rodriguez-Bailon, Maria] Univ Granada, Fac Psicol, Dept Psicol Expt & Fisiol Comportamiento, E-18071 Granada, Spain		Rodriguez-Bailon, M (corresponding author), Univ Granada, Fac Psicol, Dept Psicol Expt & Fisiol Comportamiento, Campus Univ Cartuja S-N, E-18071 Granada, Spain.	mariarbailon@ugr.es	Rodriguez-Bailon, Maria/H-1018-2018; Lupianez, Juan/G-1453-2010; Trivino, Monica/K-9589-2017	Lupianez, Juan/0000-0001-6157-9894; BAILON PRADO, MARIA JULISA/0000-0001-9628-9176; Trivino, Monica/0000-0003-2498-318X			Alexander MP, 2007, NEUROLOGY, V68, P1515, DOI 10.1212/01.wnl.0000261482.99569.fb; Amado I, 2012, MODULATION COGNITIVE; American Psychiatric Association, 2003, DSM 4 TR BREV CRIT D; Baddeley A.D., 1986, WORKING MEMORY; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Callejas A, 2005, EXP BRAIN RES, V167, P27, DOI 10.1007/s00221-005-2365-z; Callejas A, 2004, BRAIN COGNITION, V54, P225, DOI 10.1016/j.bandc.2004.02.012; Chica AB, 2012, CORTEX, V48, P654, DOI 10.1016/j.cortex.2011.01.009; Assef ECD, 2007, SPAN J PSYCHOL, V10, P33, DOI 10.1017/S1138741600006296; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fu CHY, 2001, NEUROIMAGE, V13, pS402; Harrison BJ, 2005, NEUROIMAGE, V24, P181, DOI 10.1016/j.neuroimage.2004.08.033; Hooker C. I., 2008, ORBITOFRONTAL CORTEX; Funes MJ, 2009, COGN PROCESS, V10, pS153; Lin FC, 2011, J AFFECT DISORDERS, V131, P299, DOI 10.1016/j.jad.2010.12.018; Millon T., 1987, MCMI 2 INVENTARIO MU; Miro E, 2011, PSYCHOL HEALTH, V26, P765, DOI 10.1080/08870446.2010.493611; Mitchell RLC, 2005, BRAIN COGNITION, V59, P23, DOI 10.1016/j.bandc.2005.04.001; Mullane JC, 2011, J ATTEN DISORD, V15, P310, DOI 10.1177/1087054710366384; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; NORMAN DA, 1983, B PSYCHONOMIC SOC, V21, P354; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Pacheco-Unguetti AP, 2010, PSYCHOL SCI, V21, P298, DOI 10.1177/0956797609359624; Pizzi AM, 2009, EPILEPSY BEHAV, V15, P225, DOI 10.1016/j.yebeh.2009.03.028; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2002, P NATL ACAD SCI USA, V99, P16366, DOI 10.1073/pnas.252644699; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Rugg M. D., 1992, NEUROPSYCHOLOGY CONS, P91, DOI [10.1016/B978-0-12-498045-7.50010-4, DOI 10.1016/B978-0-12-498045-7.50010-4]; Schmahl C, 2006, J PSYCHIATR RES, V40, P419, DOI 10.1016/j.jpsychires.2005.08.011; Sohlberg M. M., 1989, INTRO COGNITIVE REHA, P232; Soloff PH, 2003, PSYCHIAT RES-NEUROIM, V123, P153, DOI 10.1016/S0925-4927(03)00064-7; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Szatkowska I, 2007, EXP BRAIN RES, V181, P109, DOI 10.1007/s00221-007-0906-3; Tirapu-Ustarroz J, 2008, REV NEUROLOGIA, V46, P684, DOI 10.33588/rn.4611.2008119; Trivino M, 2010, BRAIN, V133, P1173, DOI 10.1093/brain/awp346; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019	43	9	9	1	38	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1138-7416	1988-2904		SPAN J PSYCHOL	Span. J. Psychol.	NOV	2012	15	3					967	977		10.5209/rev_SJOP.2012.v15.n3.39388			11	Psychology; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	055SO	WOS:000312437600010	23156906				2022-02-06	
J	Smith, CJ; Johnson, BN; Elkind, JA; See, JM; Xiong, GX; Cohen, AS				Smith, Colin J.; Johnson, Brian N.; Elkind, Jaclynn A.; See, Jill M.; Xiong, Guoxiang; Cohen, Akiva S.			Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 69; Medicine; Anatomy; Physiology; hippocampus; traumatic brain injury; electrophysiology; patch clamp; voltage sensitive dye; extracellular recording; high-performance liquid chromatography; gas chromatography-mass spectrometry		Traumatic Brain Injury (TBI) afflicts more than 1.7 million people in the United States each year and even mild TBI can lead to persistent neurological impairments (1). Two pervasive and disabling symptoms experienced by TBI survivors, memory deficits and a reduction in seizure threshold, are thought to be mediated by TBI-induced hippocampal dysfunction (2,3). In order to demonstrate how altered hippocampal circuit function adversely affects behavior after TBI in mice, we employ lateral fluid percussion injury, a commonly used animal model of TBI that recreates many features of human TBI including neuronal cell loss, gliosis, and ionic perturbation (4-6). Here we demonstrate a combinatorial method for investigating TBI-induced hippocampal dysfunction. Our approach incorporates multiple ex vivo physiological techniques together with animal behavior and biochemical analysis, in order to analyze post- TBI changes in the hippocampus. We begin with the experimental injury paradigm along with behavioral analysis to assess cognitive disability following TBI. Next, we feature three distinct ex vivo recording techniques: extracellular field potential recording, visualized whole-cell patch- clamping, and voltage sensitive dye recording. Finally, we demonstrate a method for regionally dissecting subregions of the hippocampus that can be useful for detailed analysis of neurochemical and metabolic alterations post- TBI. These methods have been used to examine the alterations in hippocampal circuitry following TBI and to probe the opposing changes in network circuit function that occur in the dentate gyrus and CA1 subregions of the hippocampus (see Figure 1). The ability to analyze the post- TBI changes in each subregion is essential to understanding the underlying mechanisms contributing to TBI-induced behavioral and cognitive deficits. The multi-faceted system outlined here allows investigators to push past characterization of phenomenology induced by a disease state (in this case TBI) and determine the mechanisms responsible for the observed pathology associated with TBI.	[Smith, Colin J.; Johnson, Brian N.; Elkind, Jaclynn A.; See, Jill M.; Xiong, Guoxiang; Cohen, Akiva S.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Smith, Colin J.] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA		Cohen, AS (corresponding author), Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA.	cohena@email.chop.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD059288, R01NS069629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629, R01NS045975] Funding Source: NIH RePORTER	The authors would like to thank Elliot Bourgeois for his technical assistance. This work was funded by the National Institutes of Health grants R01HD059288 and R01NS069629.	Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faul M, 2010, TRAUMATIC BRAIN INJU; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Toth Z, 1997, J NEUROSCI, V17, P8106; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052	11	9	9	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	NOV	2012		69							e4411	10.3791/4411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36QM	WOS:000209226000038	23183856	Green Accepted, Green Published			2022-02-06	
J	Sullivan, SJ; Alla, S; Lee, H; Schneiders, AG; Ahmed, OH; McCrory, PR				Sullivan, S. John; Alla, Sridhar; Lee, Hopin; Schneiders, Anthony G.; Ahmed, Osman Hassan; McCrory, Paul R.			The understanding of the concept of 'rest' in the management of a sports concussion by physical therapy students: A descriptive study	PHYSICAL THERAPY IN SPORT			English	Article						Brain concussion; Return-to-play; Rest; Physiotherapy; Knowledge transfer	INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYMPTOMS; PLAY GUIDELINES; RUGBY PLAYERS; STATEMENT; RETURN; COACHES; STRESS; INJURY	Objectives: To investigate physical therapy students' understanding of the concept of rest following a sport concussion and to ascertain if this understanding changes following a lecture based on current best practice concussion knowledge. Design: Pre-post observational survey. Setting: University classroom setting. Participants: A cohort of 118 (40 male, 78 female) physical therapy students participating in volunteer sports medic training. Results: Participants provided 320 (pre) and 350 (post) responses depicting activities which should be restricted following a concussion. The responses were classified into three rest-related categories: 'Physical rest', 'Cognitive rest and 'Mixed' (a combination of physical and cognitive rest). Pre-lecture, approximately 74% of the student's responses were categorized as Physical rest, and 25% under Mixed. There was a shift in the response pattern post-lecture, with 96% of the responses falling in the Mixed category. Conclusions: The results of the study highlight a lack of understanding of the concept of cognitive rest in concussion management among trainee sport medics. The need for wider dissemination of this concept as recommended by the recent consensus statement on sports concussion is indicated. (C) 2011 Elsevier Ltd. All rights reserved.	[Sullivan, S. John] Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, Dunedin 9054, New Zealand; [McCrory, Paul R.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia		Sullivan, SJ (corresponding author), Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, POB 56, Dunedin 9054, New Zealand.	sjohn.sullivan@otago.ac.nz	McCrory, Paul/Q-8688-2019; Schneiders, Anthony/F-4212-2015	Schneiders, Anthony/0000-0002-1583-3879; McCrory, Paul/0000-0003-4850-0568; Lee, Hopin/0000-0001-5692-0314			Alla S, 2011, BRIT J SPORT MED, V45, P132, DOI 10.1136/bjsm.2010.074088; Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; [Anonymous], 2005, MED SCI SPORT EXER, V37, P2012, DOI 10.1249/01.mss.0000186726.18341.70; [Anonymous], 2009, BR J SPORTS MED S1, V43, pi85; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Gagnon I, 2009, J HEAD TRAUMA REHAB, V24, P355, DOI 10.1097/HTR.0b013e3181b97a4e; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Sullivan SJ, 2008, BRIT J SPORT MED, V42, P175, DOI 10.1136/bjsm.2007.039297; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511	27	9	9	0	20	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	NOV	2012	13	4					209	213		10.1016/j.ptsp.2011.10.004			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	034GX	WOS:000310862000003	23068894				2022-02-06	
J	Wong, R; Ray, D; Kendall, DA				Wong, Raymond; Ray, David; Kendall, David A.			Progesterone pharmacokinetics in the mouse: implications for potential stroke therapy	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						brain; pharmacokinetics; plasma; progesterone; stroke	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; FEMALE RATS; ISCHEMIC-STROKE; INFARCT VOLUME; METABOLISM; MICE; ALLOPREGNANOLONE; NEUROPROTECTION; NEUROSTEROIDS	Objectives Progesterone has been shown to be neuroprotective in a number of preclinical central nervous system injury models including cerebral ischaemia. The aim of this study was to clarify differences in outcomes owing to different dosing regimens and the pharmacokinetic profile of progesterone, particularly in relation to brain levels. Methods Male C57 Bl/6 mice were injected intraperitoneally with progesterone (8 mg/kg in dimethylsulfoxide) or with a bolus injection followed by continuous subcutaneous infusion (1.0 mu l/h of a 50 mg/ml progesterone solution) via implanted osmotic minipumps. Plasma and brain samples were collected over 24 h from bolus-injected mice and 48 h from mice implanted with minipumps. Progesterone concentrations were measured by an enzyme-linked immunoassay and pharmacokinetic profiles were constructed. Key findings Intraperitoneally injected progesterone had a short half-life (fast component half-life of 0.2 h) in both plasma and brain. Minipump delivery resulted in higher concentrations of progesterone in plasma and particularly in brain over a longer period. The volume of distribution with intraperitoneal injection was 172.78 versus 1641.84 ng/h per g via minipump in the first 24 h. Conclusions A bolus intraperitoneal loading dose of progesterone followed by continuous delivery via osmotic minipump is an effective way of delivering progesterone to the brain.	[Wong, Raymond] Univ Nottingham, Div Stroke, Nottingham NG5 1PB, England; [Ray, David; Kendall, David A.] Univ Nottingham, Sch Biomed Sci, Sch Med, Queens Med Ctr, Nottingham NG5 1PB, England		Wong, R (corresponding author), Univ Nottingham, Div Stroke, Clin Sci Bldg,City Hosp Campus,Hucknall Rd, Nottingham NG5 1PB, England.	msxrw@nottingham.ac.uk			Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800129]	This work was supported by the Medical Research Council (grant number G0800129).	Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; BARRETTCONNOR E, 1991, JAMA-J AM MED ASSOC, V265, P1861, DOI 10.1001/jama.265.14.1861; Beckley EH, 2007, PHARMACOL BIOCHEM BE, V87, P412, DOI 10.1016/j.pbb.2007.05.017; BILLIAR RB, 1975, BRAIN RES, V94, P99, DOI 10.1016/0006-8993(75)90880-X; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1602/neurorx.1.1.36; Coomber B, 2010, BRAIN RES, V1361, P124, DOI 10.1016/j.brainres.2010.09.037; Corpechot C, 1997, BRAIN RES, V766, P276, DOI 10.1016/S0006-8993(97)00749-X; Falcao ALE, 2004, ANN NEUROL, V56, P695, DOI 10.1002/ana.20265; Frye CA, 1998, BRAIN RES, V808, P72, DOI 10.1016/S0006-8993(98)00764-1; GAVER RC, 1985, SEMIN ONCOL, V12, P17; GIBALDI M, 1982, PHARMACOKINETICS, P433; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gibson CL, 2006, J CEREBR BLOOD F MET, V26, P1103, DOI 10.1038/sj.jcbfm.9600270; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Goletiani NV, 2007, EXP CLIN PSYCHOPHARM, V15, P427, DOI 10.1037/1064-1297.15.5.427; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; Ho PW, 2005, STROKE, V36, P2742, DOI 10.1161/01.STR.0000189748.52500.a7; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; JOHNSON WA, 1976, BRAIN RES, V111, P147, DOI 10.1016/0006-8993(76)91055-6; KANNEL WB, 1994, HEART, P185; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Lephart ED, 2001, BRAIN RES REV, V37, P25, DOI 10.1016/S0165-0173(01)00111-4; LITTLE BC, 1974, J NERV MENT DIS, V159, P256, DOI 10.1097/00005053-197410000-00004; Lobo RA, 2000, MENOPAUSE BIOL PATHO, P422; Martin B. K., 1986, HDB CLIN DRUG RES, P59; MCCORMACK JT, 1974, J ENDOCRINOL, V62, P101, DOI 10.1677/joe.0.0620101; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; PARDRIDGE WM, 1979, J CLIN INVEST, V64, P145, DOI 10.1172/JCI109433; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Sharpe C, 2000, MED PRIN PRACT, V9, P1, DOI 10.1159/000026115; VENGPEDERSEN P, 1989, CLIN PHARMACOKINET, V17, P424, DOI 10.2165/00003088-198917060-00005; VIRGO BB, 1974, ENDOCRINOLOGY, V95, P1486, DOI 10.1210/endo-95-5-1486; WENGER NK, 1993, NEW ENGL J MED, V329, P247, DOI 10.1056/NEJM199307223290406; Wolfe C, 1996, STROKE SERVICES RES; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zhu D, 2004, BRIT J ANAESTH, V93, P560, DOI 10.1093/bja/aeh233	50	9	10	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	NOV	2012	64	11					1614	1620		10.1111/j.2042-7158.2012.01537.x			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	021WA	WOS:000309914900008	23058048				2022-02-06	
J	Xia, X; Xiang, J; Shao, JB; Smith, GA; Yu, CH; Zhu, HP; Xiang, HY				Xia, Xin; Xiang, Joe; Shao, Jianbo; Smith, Gary A.; Yu, Chuanhua; Zhu, Huiping; Xiang, Huiyun			Characteristics and Trends of Hospitalized Pediatric Abuse Head Trauma in Wuhan, China: 2002-2011	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						abusive head trauma; child abuse; children; China	SHAKEN-BABY-SYNDROME; AGE-RELATED INCIDENCE; BRAIN-INJURY; YOUNG-CHILDREN; TRIGGER	This study investigated characteristics and trends of hospitalized abuse-related traumatic brain injuries (TBI) treated at a large pediatric medical center in Wuhan, China during the past 10 years. De-identified hospital discharge data for patients 0-4 years old hospitalized at the Wuhan Medical Care Center for Women and Children were analyzed, and ICD-10 codes were used to identify cases of TBI. Medical notes provided by doctors in the medical record were used to identify TBI cases in which suspected child abuse was the cause. From 2002 to 2011, 3,061 pediatric TBI patients were hospitalized and 4.6% (140) of these cases were suspected child abuse-related. The majority of suspected child abuse cases involved children younger than 1 year of age (68.6%) and usually affected males (63.6%). Children with non-Abusive Head Trauma (AHT) were more likely to have full recovery outcome (68.4%, 95% CI: 66.6%-70.0%) than children with suspected AHT (44.3%, 95% CI: 36.1%-52.5%). The proportion of all childhood TBI attributable to abuse did not appear to have increased in the 10-year period at this medical center. This is the first comprehensive study highlighting the important role of suspected child abuse in causing TBIs among Chinese children. Child abuse as a major cause of TBIs among infants in China should be studied further, and there should be greater awareness of this important social and medical problem in China.	[Zhu, Huiping] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing 100069, Peoples R China; [Xia, Xin; Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Wuhan 430071, Peoples R China; [Xiang, Joe] Case Western Reserve Univ, Cleveland, OH 44120 USA; [Shao, Jianbo] Wuhan Childrens Hosp, Wuhan 430016, Peoples R China; [Smith, Gary A.; Xiang, Huiyun] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.; Xiang, Huiyun] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Zhu, HP (corresponding author), Capital Med Univ, Sch Publ Hlth & Family Med, 10 Xitoutiao, Beijing 100069, Peoples R China.	xiaxin84@163.com; yxx125@case.edu; shaojb2002@sina.com; Gary.Smith@nationwidechildrens.org; yuchua@163.com; zhuhuiping@ccmu.edu.cn; Huiyun.Xiang@nationwidechildrens.org	Xiang, Huiyun/E-4335-2011				Al-Saadoon Muna, 2011, Sultan Qaboos Univ Med J, V11, P322; Altimier L, 2008, J PERINAT NEONAT NUR, V22, P68, DOI 10.1097/01.JPN.0000311877.32614.69; Appel AE, 1998, J FAM PSYCHOL, V12, P578, DOI 10.1037/0893-3200.12.4.578; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Diaz-Olavarrieta C, 2011, CHILD ABUSE NEGLECT, V35, P915, DOI 10.1016/j.chiabu.2011.05.017; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jenny C, 2007, PEDIATRICS, V119, P1232, DOI 10.1542/peds.2007-0883; Keenan HT, 2008, AM J PREV MED, V34, pS120, DOI 10.1016/j.amepre.2007.11.001; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Loh JK, 2002, SURG NEUROL, V58, P218, DOI 10.1016/S0090-3019(02)00830-3; Louwers ECFM, 2011, ARCH DIS CHILD, V96, P422, DOI 10.1136/adc.2010.202358; Louwers ECFM, 2010, ARCH DIS CHILD, V95, P214, DOI 10.1136/adc.2008.151654; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Matschke J, 2009, DTSCH ARZTEBL INT, V106, P211, DOI 10.3238/arztebl.2009.0211; Meng Q.Y., 1994, CHINESE SOCIAL MED, V50</IT, P10; Minns RA, 2005, CLIN DEV MED, P1; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Newton AW, 2006, CURR OPIN PEDIATR, V18, P196, DOI 10.1097/01.mop.0000193296.32764.1e; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Pounder DJ, 1997, AM J FOREN MED PATH, V18, P321, DOI 10.1097/00000433-199712000-00001; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Runyan DK, 2008, AM J PREV MED, V34, pS163, DOI 10.1016/j.amepre.2008.01.010; Ryan MAK, 2008, AM J PREV MED, V34, pS143, DOI 10.1016/j.amepre.2007.12.020; Tenney-Soeiro R, 2004, CURR OPIN PEDIATR, V16, P233, DOI 10.1097/00008480-200404000-00022; Woodman J, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12330; World Health Organization, 2002, World Report on Violence and Health; Zhang TH, 2012, COMPR PSYCHIAT, V53, P829, DOI 10.1016/j.comppsych.2011.10.004; Zhao YD, 2001, WORLD J SURG, V25, P1202	39	9	9	1	16	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2012	9	11					4187	4196		10.3390/ijerph9114187			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	041TH	WOS:000311423600025	23202840	gold, Green Published			2022-02-06	
J	Shen, LH; Ye, M; Ding, XS; Han, Q; Zhang, C; Liu, XF; Huang, H; Wu, EB; Huang, HF; Gu, XS				Shen, L. H.; Ye, M.; Ding, X. S.; Han, Q.; Zhang, C.; Liu, X. F.; Huang, H.; Wu, E. B.; Huang, H. F.; Gu, X. S.			PROTECTIVE EFFECTS OF MCI-186 ON TRANSPLANTATION OF BONE MARROW STROMAL CELLS IN RAT ISCHEMIC STROKE MODEL	NEUROSCIENCE			English	Article						Bone marrow stromal cells (BMSCs); Ischemic stroke; MCI-186; Growth factor; Oxygen free-radical; Neurons	NEURAL STEM-CELLS; FREE-RADICAL SCAVENGER; ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; CEREBRAL INFARCTION; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; NITRIC-OXIDE; IN-VITRO	Transplantation of bone marrow stromal cells (BMSCs) is a potential therapy for ischemic stroke, but poor environmental conditions in brain lesions, such as insufficient nutrition and oxygen free radical toxicity, limit the efficacy of stem cell therapy. Here, we hypothesized that MCI-186, a free radical scavenger, would have protective effects on transplantation of BMSCs in a rat ischemia model. In vitro, flow cytometry showed the apoptotic rates of BMSCs after simulated ischemia-reperfusion (I/R) injury was significantly decreased when treated with MCI-186 (P < 0.01). In vivo, rat transient middle cerebral artery occlusion (MCAO) model was established. Two separate MCAO groups were administered with either MCI-186 or phosphate-buffered solution (PBS) immediately after artery occlusion. MCI-186 significantly up-regulated the secretion of brain-derived neurotrophic factor, vascular endothelial growth factor and superoxide dismutase in ischemic brain, while malondialdehyde decreased and neuronal apoptosis was inhibited. Furthermore, another four MCAO groups were administered with either PBS, MCI-186, BMSCs (2 x 106) or a combination of MCI-186 and BMSCs. When compared with BMSCs or MCI-186 monotherapy, combination therapy significantly improved functional restoration, decreased infarct volume, and increased the number of engrafted-BMSCs and neurons in ischemic brain. The number of engrafted-BMSCs and neurons was significantly correlated with functional outcomes. This study suggests that MCI-186 may improve the environment of the injured brain, enhance the survival of engrafted-BMSCs and neurotization in ischemic brain and produce protective effects on BMSCs transplantation. Crown Copyright (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Shen, L. H.; Ding, X. S.] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurol, Nanjing 210029, Jiangsu, Peoples R China; [Shen, L. H.; Han, Q.; Zhang, C.; Liu, X. F.; Wu, E. B.; Gu, X. S.] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Peoples R China; [Ye, M.; Ding, X. S.] Nanjing Med Univ, BenQ Neurol Inst, Nanjing 210036, Peoples R China; [Huang, H.] Nantong Univ, Affiliated Hosp, Dept Pathol, Nantong 226001, Peoples R China; [Huang, H. F.] Nantong Univ, Affiliated Hosp, Dept Anesthesiol, Nantong 226001, Peoples R China		Ding, XS (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurol, 300 GuangZhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	xinshengding139@yeah.net		gu, xiaosu/0000-0001-7862-0590	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30971022]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK2008471]	This work was supported by the National Natural Science Foundation of China (No. 30971022) and Natural Science Foundation of Jiangsu Province (No. BK2008471)	Amemiya S, 2005, EUR J PHARMACOL, V516, P125, DOI 10.1016/j.ejphar.2005.04.036; Andres RH, 2008, REGEN MED, V3, P893, DOI 10.2217/17460751.3.6.893; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Bin Deng Y, 2010, NEUROL RES, V32, P148, DOI 10.1179/174313209X414434; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chamorro A, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000075297; Chang YC, 2007, CELL TRANSPLANT, V16, P171; Chen JL, 2009, J CELL MOL MED, V13, P1348, DOI 10.1111/j.1582-4934.2008.00380.x; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Conti L, 2003, PHARMACOL RES, V47, P289, DOI 10.1016/S1043-6618(03)00038-0; Cui QL, 2007, J NEUROCHEM, V100, P1480, DOI 10.1111/j.1471-4159.2006.04329.x; Cui X, 2009, NEUROBIOL DIS, V36, P35, DOI 10.1016/j.nbd.2009.06.012; Deng WW, 2004, STEM CELLS, V22, P1279, DOI 10.1634/stemcells.2004-0032; Gorski JA, 2003, J NEUROSCI, V23, P6856; Gu WD, 2012, NEUROL RES, V34, P172, DOI 10.1179/1743132811Y.0000000068; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Higashi Y, 2009, EXPERT OPIN PHARMACO, V10, P323, DOI [10.1517/14656560802636888, 10.1517/14656560802636888 ]; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158; Ishii J, 2007, NEUROSCI LETT, V423, P225, DOI 10.1016/j.neulet.2007.07.029; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Itoh T, 2009, NEUROTOX RES, V16, P378, DOI 10.1007/s12640-009-9081-6; Junn E, 2002, NEUROSCI LETT, V320, P146, DOI 10.1016/S0304-3940(02)00016-2; Katai N, 1999, INVEST OPHTH VIS SCI, V40, P2697; Kikuchi K, 2009, J PHARMACOL EXP THER, V329, P865, DOI 10.1124/jpet.108.149484; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Madhavan L, 2008, STEM CELLS, V26, P254, DOI 10.1634/stemcells.2007-0221; Niyaz M, 2007, J NEUROSCI RES, V85, P2933, DOI 10.1002/jnr.21412; Otero L, 2012, CYTOTHERAPY, V14, P34, DOI 10.3109/14653249.2011.608349; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Qi X, 2010, J CLIN NEUROSCI, V17, P908, DOI 10.1016/j.jocn.2009.10.013; Rao P, 2005, TRANSPL P, V37, P3457, DOI 10.1016/j.transproceed.2005.09.072; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schmidt NO, 2009, BRAIN RES, V1268, P24, DOI 10.1016/j.brainres.2009.02.065; Scotto-Lomassese S, 2003, J NEUROSCI, V23, P9289; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shichinohe H, 2010, NEUROPATHOLOGY, V30, P113, DOI 10.1111/j.1440-1789.2009.01050.x; Shishido Y, 2001, PHARMACOL BIOCHEM BE, V69, P469, DOI 10.1016/S0091-3057(01)00572-X; Song Y, 2008, ACTA PHARMACOL SIN, V29, P823, DOI 10.1111/j.1745-7254.2008.00822.x; Takizawa Y, 2009, PEDIATR RES, V65, P636, DOI 10.1203/PDR.0b013e3181a16a9f; Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107; Wang GH, 2007, NEUROPHARMACOLOGY, V52, P1199, DOI 10.1016/j.neuropharm.2006.10.022; Watanabe T, 2004, YAKUGAKU ZASSHI, V124, P99, DOI 10.1248/yakushi.124.99; Wu T, 2006, BIOL PHARM BULL, V29, P1613, DOI 10.1248/bpb.29.1613; Yao XM, 2010, NEUROSCI LETT, V472, P179, DOI 10.1016/j.neulet.2010.02.002; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	53	9	11	1	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	OCT 25	2012	223						315	324		10.1016/j.neuroscience.2012.08.001			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	018VM	WOS:000309694700032	22885235				2022-02-06	
J	Leidel, BA; Bogner, V; Zock, M; Kanz, KG				Leidel, B. A.; Bogner, V.; Zock, M.; Kanz, K. -G.			Serological determination of protein S100B	UNFALLCHIRURG			German	Article						Craniocerebral trauma; Serological protein S100; Cranial computed tomography; Emergency diagnosis; Meta-analysis	MINOR HEAD-INJURY; TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; METAANALYSIS; SERUM; MULTICENTER; S-100B; DAMAGE; BIAS	Patients presenting in the emergency department with a mild injury to the head pose a particular challenge due to their high prevalence but low rate of traumatic brain injury. However, missed traumatic brain injuries may result in fatal consequences. Therefore we investigated the diagnostic performance of serological protein S100B measurement in adult patients presenting with mild head injury and a GCS 13-15 to identify traumatic brain injury. We conducted a systematic review of the literature. Two reviewers screened potential studies for inclusion and independently extracted study data. For all included studies, we applied the QUADAS quality assessment tool for systematic reviews of diagnostic accuracy and abstracted the raw data for every included study. Included studies presented results either in 2x2 contingency tables or provided data allowing their construction. Of 76 studies identified, 8 met the inclusion criteria. Methodology quality was moderate and all studies fulfilled at least 50% of the QUADAS criteria. Overall, the sensitivity to detect intracranial lesions was 94% (95% CI 88-98%) and specificity was 44% (95% CI 30-58%). The subgroup analysis showed significant differences only between studies with different S100B cutoff values (0.10 mu g/l versus > 0.10 mu g/l). The combined odds ratio was 10.3 (95 CI 4.2-24.9). Serological protein S100B measurement may be helpful as a screening test to identify patients with higher risk of traumatic brain injury for further diagnostic assessment.	[Leidel, B. A.] Charite, D-12200 Berlin, Germany; [Leidel, B. A.] Charite, ADAC Luftrettung GmbH, Luftrettungszentrum Christoph 31, D-12200 Berlin, Germany; [Bogner, V.; Zock, M.; Kanz, K. -G.] Klinikum Univ Munchen, Chirurg Klin & Poliklin Innenstadt, Munich, Germany		Leidel, BA (corresponding author), Charite, Campus Benjamin Franklin, D-12200 Berlin, Germany.	bernd.a.leidel@charite.de		LEIDEL, Bernd A./0000-0002-5149-8764			Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; American College of Emergency Physicians/Centers for Disease Control and Prevention, 2008, PRACT RES CLIN POL M; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Cochrane Collaboration, 2010, HDB DTA REV; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deutsche Gesellschaft fur Neurochirurgie, 2007, LEITL SCHAD HIRN TRA; Deutsche Gesellschaft fur Neurologie, 2008, LEITL DIAGN THER NEU; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gavaghan DJ, 2000, PAIN, V85, P415, DOI 10.1016/S0304-3959(99)00302-4; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Meads CA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-3; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Rickels E, 2009, CHIRURG, V80, P153, DOI 10.1007/s00104-008-1655-y; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	27	9	9	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	OCT	2012	115	10					903	912		10.1007/s00113-010-1946-x			10	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	014AC	WOS:000309346400009	21344309				2022-02-06	
J	Kibayashi, K; Shimada, R; Nakao, K; Ro, A				Kibayashi, Kazuhiko; Shimada, Ryo; Nakao, Ken-ichiro; Ro, Ayako			Analysis of Pituitary Lesions in Fatal Closed Head Injury	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						traumatic brain injury; pituitary gland; subdural hematoma; fall; survival time	TRAUMATIC BRAIN-INJURY; DIABETES-INSIPIDUS; GLAND; ABNORMALITIES; DISEASES	We analyzed forensic autopsy findings of 66 consecutive patients with fatal closed head injury who survived up to 48 days after trauma to ascertain the causal factors and the time course of development of posttraumatic pituitary lesions. Pituitary lesions were identified in 27 patients. In patients with pituitary lesions, posterior lobe hemorrhage was observed in 21 patients, followed by anterior lobe hemorrhage in 10 patients and anterior lobe infarct in 7 patients. Comparisons between patients with and without pituitary lesions showed that falls and subdural hematoma were significantly frequent in patients with pituitary lesions. Immunohistochemistry of neurophysin showed increased immunoreactivity in the hypothalamus of patients with pituitary lesions and brain edema, providing morphologic evidence of pituitary dysfunction. Hemorrhage in the anterior or posterior lobe was identifiable in patients with short survival periods, whereas infarct in the anterior lobe appeared in patients surviving at least 14 hours. These data further our understanding of the mechanisms of pituitary dysfunctions and help in the estimation of the survival period after head trauma.	[Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, Tokyo 1628666, Japan; [Nakao, Ken-ichiro] Saga Univ, Fac Med, Dept Forens Med, Saga 840, Japan		Kibayashi, K (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	kibayash@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [19390186, 21659177]	This work was supported in part by grants from the Japan Society for the Promotion of Science (nos. 19390186 and 21659177 to Dr Kibayashi).	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Carpenter MB, 1991, CORE TEXT NEUROANATO; Chaturvedi D, 2010, J TRAUMA, V69, P290, DOI 10.1097/TA.0b013e3181b403b5; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KAWAI K, 1995, J NEUROSURG, V83, P368, DOI 10.3171/jns.1995.83.2.0368; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kibayashi K, 2003, INT J LEGAL MED, V117, P282, DOI 10.1007/s00414-003-0386-3; Kibayashi K, 2007, AM J FOREN MED PATH, V28, P73, DOI 10.1097/01.paf.0000257428.80088.94; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Noback CR, 1996, HUMAN NERVOUS SYSTEM; ROCKEN C, 1995, ARCH PATHOL LAB MED, V119, P1055; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Song JK, 1999, J NEUROSURG, V90, P1141, DOI 10.3171/jns.1999.90.6.1141; SUGIMOTO T, 1992, ACTA NEUROCHIR, V115, P31, DOI 10.1007/BF01400587; Treip CS, 1970, J CLIN PATHOL, V23, P178, DOI DOI 10.1136/JCP.S3-4.1.178; WINTERNITZ WW, 1976, J NEUROSURG, V44, P504, DOI 10.3171/jns.1976.44.4.0504	22	9	9	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2012	33	3					206	210		10.1097/PAF.0b013e3181fe33e8			5	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	995WN	WOS:000308045500009	21030847				2022-02-06	
J	Mainwaring, L; Hutchison, M; Camper, P; Richards, D				Mainwaring, Lynda; Hutchison, Michael; Camper, Paul; Richards, Doug			Examining Emotional Sequelae of Sport Concussion	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						concussion; emotion; mood; athletic injury; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE PERFORMANCE; PSYCHIATRIC-DISORDERS; PROFESSIONAL FOOTBALL; COGNITIVE FUNCTION; INTEGRATED VIEW; NEGATIVE AFFECT; HEAD-INJURY; DEPRESSION; SYMPTOMS	Depression, fatigue, irritability, confusion, and general mood disturbance are frequently reported after cerebral concussion in sport. Recent trends in research point to the importance of examining postconcussive emotional disturbances more thoroughly, empirically, and clinically. An overview of the complexity of human emotion and its study is provided herein, followed by a review of emotional correlates identified in the existing sparse literature. The significance and clinical implications of identifying emotional correlates of concussion in sport and athletics are discussed.	[Mainwaring, Lynda; Hutchison, Michael; Camper, Paul; Richards, Doug] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada		Mainwaring, L (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.						Alzate Saez de Heredia R, 2004, RES SPORTS MED, V12, P15, DOI DOI 10.1080/15438620490280567; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Antony M, 1996, ANXIETY DISORDERS TH; Arnold M.B., 1960, EMOTION PERSONALITY; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barth JT, 1989, MILD HEAD INJURY, P257; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Ben-Ze'ev, 2000, SUBTLETY EMOTIONS; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J., 2006, SPORTS NEUROPSYCHOLO, P263; Brewer B, 2004, PSYCHOL PHYS MANUAL; BREWER BW, 1995, CLIN J SPORT MED, V5, P241, DOI 10.1097/00042752-199510000-00006; Brewer BW, 2000, REHABIL PSYCHOL, V45, P20, DOI 10.1037/0090-5550.45.1.20; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown SC, 2002, PAIN, V96, P279, DOI 10.1016/S0304-3959(01)00457-2; Bruce JM, 2004, NEUROLOGY, V63, P1516; BUCK R, 1985, PSYCHOL REV, V92, P389; Cacioppo JT, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P1, DOI 10.2277/ 0521844711; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; CROSSMAN J, 1990, PERCEPT MOTOR SKILL, V71, P848, DOI 10.2466/pms.1990.71.3.848; Damasio AR, 2001, ANN NY ACAD SCI, V935, P101; de Sousa Ronald., 1987, RATIONALITY EMOTION; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; EICH E, 1989, J EXP PSYCHOL LEARN, V15, P443, DOI 10.1037/0278-7393.15.3.443; EKMAN P, 1994, PSYCHOL BULL, V115, P268, DOI 10.1037/0033-2909.115.2.268; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; Ekman P, 1994, NATURE EMOTION FUNDA, P411; Ekman P., 1972, EMOTION HUMAN FACE G; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Ford SM, 2002, ARCH CLIN NEUROPSYCH, V17, P767; FORGAS JP, 1988, AFFECT COGNITION SOC, P183; Frijda N.H., 1986, EMOTIONS STUDIES EMO; Gayman A. M., 2003, Journal of Sport Behavior, V26, P255; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gordon S., 1991, AUST J SCI MED SPORT, V23, P53, DOI [https://doi.org/10.1016/S0031-9406(10)61642-2, DOI 10.1016/S0031-9406(10)61642-2]; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Gray JA., 2000, NEUROPSYCHOLOGY ANXI; GROVE JR, 1992, INT J SPORT PSYCHOL, V23, P93; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haga SM, 2009, J HAPPINESS STUD, V10, P271, DOI 10.1007/s10902-007-9080-3; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hippocrates, 1972, GENUINE WORKS HIPPOC; Hovland D., 2000, NEUROPSYCHOLOGICAL M, P171; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Izard C. E, 1977, HUMAN EMOTION; James W., 1884, MIND, V9, P188, DOI 10.1093/mind/os-IX.34.188, os-IX; Johnson DR, 2008, ARCH CLIN NEUROPSYCH, V23, P73, DOI 10.1016/j.acn.2007.10.001; Johnson-Laird, 1987, COGNITION EMOTION, V1, P29, DOI DOI 10.1080/02699938708408362; Jorge R, 2002, NEUROREHABILITATION, V17, P311; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P581; Kemp AH, 2003, BRAIN COGNITION, V51, P198; Kessler R.C., 2005, ARCH GEN PSYCHIAT, V62, P717; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KLEINGINNA P R JR, 1981, Motivation and Emotion, V5, P345, DOI 10.1007/BF00992553; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Lane AM, 2000, J APPL SPORT PSYCHOL, V12, P16, DOI 10.1080/10413200008404211; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P347, DOI 10.1080/02701367.1994.10607639; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEUNES A, 1998, J SPORT BEHAV, V21, P53; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Lewis MD, 2005, BEHAV BRAIN SCI, V28, P169, DOI 10.1017/S0140525X0500004X; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Mainwaring L., 2011, HDB SPORT NEUROPSYCH, P251; Mainwaring L, 1999, CAN J REHABIL, V12, P145; Mainwaring L., 2006, UT TRI CONCUSSION ST; Mainwaring L., 2009, UT TRI CONCUSSION ST; Mainwaring L., 2008, SPORT CONC S ANN M N; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Maletic V, 2007, INT J CLIN PRACT, V61, P2030, DOI 10.1111/j.1742-1241.2007.01602.x; MARTINOT JL, 1990, AM J PSYCHIAT, V147, P1313; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McDonald SA, 1990, SPORT PSYCHOL, V4, P261; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McNair DM, 1992, MANUAL PROFILE MOOD; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morey, 1991, PERSONALITY ASSESSME; MORGAN WP, 1980, PSYCHOL TODAY, V14, P92; Morrey MA, 1999, CLIN J SPORT MED, V9, P63, DOI 10.1097/00042752-199904000-00004; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Panksepp, 1998, AFFECTIVE NEUROSCIEN; Pascual-Leone J, 2005, BEHAV BRAIN SCI, V28, P213, DOI 10.1017/S0140525X0542004X; Pearsall J., 2002, OXFORD ENGLISH REFER, p1483b; Pearson L, 1992, PHYSIOTHERAPY, V78, P762, DOI DOI 10.1016/S0031-9406(10)61642-2; Perna F., 1998, J APPL SPORT PSYCHOL, V10, pS54; Plutchik Robert, 1994, PSYCHOL BIOL EMOTION; Quinn AM, 1999, J APPL SPORT PSYCHOL, V11, P210, DOI 10.1080/10413209908404201; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; REEVES D, 1996, ANAM V3 11A 96 USERS; Roberts R., 2003, EMOTIONS ESSAY AID M; ROSE J, 1993, SPORT PSYCHOL, V7, P309, DOI 10.1123/tsp.7.3.309; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Scherer K. R., 2000, NEUROPSYCHOLOGY EMOT, P137; Scherer K. R., 1999, HDB COGNITION EMOTIO, P637, DOI [DOI 10.1002/0470013494.CH30, 10.1002/0470013494.ch30]; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Skinner BF., 1953, SCI HUMAN BEHAV; SMITH AM, 1993, MAYO CLIN PROC, V68, P939, DOI 10.1016/S0025-6196(12)62265-4; SMITH AM, 1990, MAYO CLIN PROC, V65, P38, DOI 10.1016/S0025-6196(12)62108-9; STAVRAKAKI C, 1986, BRIT J PSYCHIAT, V149, P7, DOI 10.1192/bjp.149.1.7; Stuss DT, 2003, BRAIN COGNITION, V51, P162; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Treacy S H, 1997, Am J Orthop (Belle Mead NJ), V26, P25; Udry E, 1997, J SPORT EXERCISE PSY, V19, P229, DOI 10.1123/jsep.19.3.229; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; [No title captured]	146	9	9	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	SEP	2012	6	3					247	274		10.1123/jcsp.6.3.247			28	Psychology, Applied	Emerging Sources Citation Index (ESCI)	Psychology	V22SM	WOS:000215041500004					2022-02-06	
J	Master, CL; Grady, MF				Master, Christina L.; Grady, Matthew F.			Office-Based Management of Pediatric and Adolescent Concussion	PEDIATRIC ANNALS			English	Article							EPIDEMIOLOGY; CHILDREN		[Master, Christina L.; Grady, Matthew F.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Master, Christina L.; Grady, Matthew F.] Univ Penn, Perelman Sch Med, Div Pediat Orthoped & Sports Med, Dept Surg, Philadelphia, PA 19104 USA; [Master, Christina L.; Grady, Matthew F.] Univ Penn, Perelman Sch Med, Div Pediat Orthoped & Sports Med, Dept Pediat, Philadelphia, PA 19104 USA		Master, CL (corresponding author), Childrens Hosp Philadelphia, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	masterc@email.chop.edu		Master, Christina/0000-0002-6717-4270			Centers for Disease Control, 2007, NONF TRAUM BRAIN INJ; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Faul M, 2010, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BK, 2011, AM J SPORTS MED; Lavrich JB, 2010, CURR OPIN OPHTHALMOL, V21, P356, DOI 10.1097/ICU.0b013e32833cf03a; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Pardini D., 2004, BR J SPORTS MED, V38, P661; Reddy CC, 2012, J HEAD TRAUMA REHABI; Scheiman M, 2010, OPTOMETRY VISION SCI, V87, P593, DOI 10.1097/OPX.0b013e3181e61bad; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	14	9	9	0	5	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	SEP	2012	41	9					E174	E179		10.3928/00904481-20120827-08			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	082NM	WOS:000314398700001	22953974				2022-02-06	
J	Pereyra, C; Mori, LB; Schoon, P; Violi, D; Jacintho, P; Segui, G; Losio, D; Lugaro, M; Benavent, G; Prieto, M; Strati, J; Diaz, G				Pereyra, C.; Benito Mori, L.; Schoon, P.; Violi, D.; Jacintho, P.; Segui, G.; Losio, D.; Lugaro, M.; Benavent, G.; Prieto, M.; Strati, J.; Diaz, G.			Decompressive Craniectomy and Brain Death Prevalence and Mortality: 8-Year Retrospective Review	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	35th Annual Congress of the Italian-Society-of-Organ-Transplantation (SITO)	OCT 27-29, 2011	Rome, ITALY	Italian Soc Organ Transplantat, Cathol Univ Sch Med Policlinico A. Gemelli, Div Organ Transplantat			EVACUATION	Decompressive craniectomy (DC) is a surgical practice that has been used since the late 19th century. The cerebral blood flow increase after the performance of a DC can delay and even prevent the development of cerebral circulatory arrest and brain death (BD). We aimed to determine the prevalence of BD, the use of DC, and the evolution to BD with versus without DC. This retrospective, observational, cross-sectional study was performed in a single high-intensity center in Argentina from January 2003 to December 2010. Inclusion criteria were all patients with Glasgow Coma Score of at most 7 on admission or during their stay in the intensive care units. Exclusion criteria were patients with incomplete data. In cases of death, we assessed whether they fulfilled BD criteria or if the cause of death was a cardiac arrest (CA). The 698 patients considered for analysis showed a 60% (n = 418) global mortality rate. The causes were: CA (n = 270); BD (n = 108) and others considered to be "undefined," namely not assessed completely for the diagnosis of BD (n = 40). According to diagnosis category, traumatic brain injury (TBI) was largest (nearly 50%). The DC group (n = 206) showed significant differences regarding sex and diagnosis category versus no DC group. Mortality was significantly lower in this group (48% versus 65%, P < .001). No significant differences were observed comparing causes of death (CA, BD, or undefined). The use of DC did not influence the frequency of BD development (24% versus 26%, P = .72). The average DC rate was 30% and of BD 16%. The prevalence of DC and better survival were recorded compared with subjects without DC. The prevalence of BD was lower than expected in accordance with national registries; however, among our group, DC did not seem to modify the evolution to BD.	[Pereyra, C.; Benito Mori, L.; Schoon, P.; Violi, D.; Jacintho, P.; Segui, G.; Losio, D.; Lugaro, M.; Benavent, G.; Prieto, M.; Strati, J.; Diaz, G.] Hosp Interzonal Gen Agudos Prof Dr Luis Guemes, Intens Care Unit, RA-1706 Buenos Aires, DF, Argentina		Pereyra, C (corresponding author), Hosp Interzonal Gen Agudos Prof Dr Luis Guemes, Intens Care Unit, 2 Rivadavia 15000, RA-1706 Buenos Aires, DF, Argentina.	cfpereyra75@hotmail.com					Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; [Anonymous], 2010, B OFFICIAL REPUBLICA, V31844, P21; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Meier U, 2008, ACTA NEUROCHIR SUPPL, V102, P29, DOI 10.1007/978-3-211-85578-2_6; MOLLARET P., 1959, REV NEUROL [PARIS], V101, P3; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Murthy JMK, 2005, NEUROCRIT CARE, V2, P258, DOI 10.1385/NCC:2:3:258; Procurar para curar, 2009, PROC CUR MAN MANT PO; Sahuquillo J, 2009, COCHRANE DB SYST REV, V4, P1; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616	19	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	SEP	2012	44	7					2181	2184		10.1016/j.transproceed.2012.07.107			4	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	011ET	WOS:000309148300109	22974950				2022-02-06	
J	Post, A; Walsh, ES; Hoshizaki, TB; Gilchrist, MD				Post, Andrew; Walsh, Evan S.; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Analysis of loading curve characteristics on the production of brain deformation metrics	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Finite element modelling; traumatic brain injury; reconstruction; injury biomechanics; concussion	HEAD-INJURY CRITERIA; INTRACRANIAL-PRESSURE; ANGULAR ACCELERATION; ELEMENT; TISSUE; IMPACT; BIOMECHANICS; PREDICTORS; MOTION	Traumatic and mild traumatic brain injuries are incurred as a result of the complex motions of the head after an impact. These motions can be quantified in terms of linear and rotational accelerations which cause the injurious levels of brain deformation. Currently, it is unclear what aspects of the linear and rotational acceleration loading curves influence injurious brain deformation. This research uses the University College Dublin Brain Trauma Model to analyse the loading curve shapes from a series of centric and non-centric impacts to a Hybrid III headform fitted with different hockey helmets. The results found that peak resultant linear acceleration did not always correlate with brain deformation measures. The results also indicated that, due to the complex nature of the interaction between loading curve characteristic and tissue parameters, there was no commonality in curve shape which produced large magnitudes of brain deformation. However, the discriminant function did show that angular acceleration loading curve characteristics would predict brain deformation more reliably than linear acceleration loading curves.	[Post, Andrew; Walsh, Evan S.; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON K1S 5S9, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, 200 Lees Ave,A-106, Ottawa, ON K1S 5S9, Canada.	apost@uottawa.ca	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X; Post, Andrew/0000-0002-5960-5552			Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Canadian Standard Association, 2009, Z262109200938 CANCSA, P38; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Gennarelli T, 1971, P 15 STAPP CAR CRASH; Gennarelli TA, 1972, 19720970 SAE; GOLDSMITH W, 1981, J BIOMECH, V14, P883, DOI 10.1016/0021-9290(81)90016-6; GURDJIAN ES, 1947, JAMA-J AM MED ASSOC, V134, P1072, DOI 10.1001/jama.1947.02880300014005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan T, 2005, THESIS U COLL DUBLIN; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2006, BIORHEOLOGY, V43, P623; King AI, 2003, IRCOBI C LISB PORT; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller R., 1998, 19983154 SAE; Nahum A. M., 1977, 19770922 SAE; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A, 2011, COMPUT METH BIOMECH; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rashid B, 2012, J MECH BEHA IN PRESS; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang L, 2001, Stapp Car Crash J, V45, P369	32	9	9	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371			P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		200	207		10.1177/1754337112449420			8	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	999NH	WOS:000308320000007		Green Submitted			2022-02-06	
J	Bloch, Y; Applebaum, J; Osher, Y; Amar, S; Azab, AN; Agam, G; Belmaker, RH; Bersudsky, Y				Bloch, Yehudit; Applebaum, Julia; Osher, Yamima; Amar, Shirly; Azab, Abed N.; Agam, Galila; Belmaker, R. H.; Bersudsky, Yuly			Normobaric Hyperoxia Treatment of Schizophrenia	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Article						schizophrenia; oxygen; treatment; cognitive dysfunction	NEUROLEPTIC-NAIVE PATIENTS; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; CLUSTER HEADACHE; BLOOD-FLOW; OXYGEN; EXPRESSION; METABOLISM; STROKE	Several studies of normobaric hyperoxia in neurological conditions have found positive results. The impaired energy metabolism due to mitochondrial dysfunction and frontal lobe hypofunction in schizophrenia might be improved by increasing O-2 supply to the brain. Normobaric hyperoxia may be a potential treatment for schizophrenia. Participants in this study, outpatients with chronic schizophrenia and inhabitants of community-based psychiatric institutions (hostels), underwent baseline psychiatric/cognitive assessment and were randomly assigned to either a treatment intervention of oxygen-enriched air inhalation (normobaric hyperoxia of 40% fraction of inspired oxygen) or regular air inhalation (21% fraction of inspired oxygen), through a nasal tube, for 4 weeks. Patients were given the air/oxygen inhalations during the night (mainly while sleeping) for at least 7 hours a night. After completing 4 weeks of treatment, patients were switched (crossed over) to the other treatment intervention. Fifteen patients completed the entire study. Five additional patients completed phase A only. There was significant improvement in total Positive and Negative Symptoms Scale score of patients who received oxygen compared with the control group. There were positive effects of oxygen on memory and attention in neuropsychological performance tests. The effect size is small despite the statistical significance, but the patient group was extremely chronic and severely impaired. These results are a proof of concept, and normobaric hyperoxia should be studied in patients with milder forms of the illness and earlier in the course of illness.	[Bloch, Yehudit; Applebaum, Julia; Osher, Yamima; Amar, Shirly; Azab, Abed N.; Agam, Galila; Belmaker, R. H.; Bersudsky, Yuly] Ben Gurion Univ Negev, Beersheva Mental Hlth Ctr, IL-84105 Beer Sheva, Israel		Bersudsky, Y (corresponding author), Ben Gurion Univ Negev, Beersheva Mental Hlth Ctr, IL-84105 Beer Sheva, Israel.	yuly@bgu.ac.il	, Yamima/F-1359-2012	, Yamima/0000-0002-9635-7973	National Alliance for Research on Schizophrenia and Depression (NARSAD)French National Research Agency (ANR)NARSAD	This study was funded by the National Alliance for Research on Schizophrenia and Depression (NARSAD).	Amar S, 2007, SCHIZOPHR RES, V94, P354, DOI 10.1016/j.schres.2007.04.020; Amar S, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-40; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; [Anonymous], 2002, OX THER PROC MED GAS; Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x; Campbell JA, 1927, J PHYSIOL-LONDON, V63, P325, DOI 10.1113/jphysiol.1927.sp002407; CLARK JM, 1971, J APPL PHYSIOL, V30, P739, DOI 10.1152/jappl.1971.30.5.739; CLARK JM, 1974, AM REV RESPIR DIS, V110, P40; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Cohen AS, 2009, JAMA-J AM MED ASSOC, V302, P2451, DOI 10.1001/jama.2009.1855; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1; Ford JM, 2005, NEUROIMAGE, V26, P922, DOI 10.1016/j.neuroimage.2005.03.001; Gangadhar BN, 2004, AM J PSYCHIAT, V161, P1304, DOI 10.1176/appi.ajp.161.7.1304; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; HEMPEL FG, 1977, J APPL PHYSIOL, V43, P873, DOI 10.1152/jappl.1977.43.5.873; Henninger N, 2007, J CEREBR BLOOD F MET, V27, P1632, DOI 10.1038/sj.jcbfm.9600463; Hinkelbein J, 2010, MOL CELL BIOCHEM, V339, P9, DOI 10.1007/s11010-009-0365-1; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Karry R, 2004, BIOL PSYCHIAT, V55, P676, DOI 10.1016/j.biopsych.2003.12.012; King L, 1999, SYNAPSE, V31, P67, DOI 10.1002/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-#; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Michalski D, 2011, ACTA NEUROL SCAND, V123, P85, DOI 10.1111/j.1600-0404.2010.01363.x; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115; SCIAMANNA MA, 1993, ARCH BIOCHEM BIOPHYS, V305, P215, DOI 10.1006/abbi.1993.1414; Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Stoneham MD, 2008, ANESTH ANALG, V107, P1670, DOI 10.1213/ane.0b013e318184d6c3; Tang XQ, 2010, BRAIN RES, V1348, P174, DOI 10.1016/j.brainres.2010.05.082; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Torelli P, 2004, NEUROL SCI, V25, pS119, DOI 10.1007/s10072-004-0267-7	38	9	10	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	AUG	2012	32	4					525	530		10.1097/JCP.0b013e31825d70b8			6	Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Psychiatry	970GE	WOS:000306115300013	22722511				2022-02-06	
J	Koucky, EM; Galovski, TE; Nixon, RDV				Koucky, Ellen M.; Galovski, Tara E.; Nixon, Reginald D. V.			Acute Stress Disorder: Conceptual Issues and Treatment Outcomes	COGNITIVE AND BEHAVIORAL PRACTICE			English	Article						acute stress disorder; treatment; trauma; cognitive behavioral therapy	COGNITIVE-BEHAVIOR THERAPY; RANDOMIZED CONTROLLED-TRIAL; VEHICLE ACCIDENT SURVIVORS; TRAUMATIC BRAIN-INJURY; DSM-IV DIAGNOSIS; EARLY INTERVENTION; FOLLOW-UP; PTSD; DISSOCIATION; VICTIMS	Acute stress disorder (ASD) was included as a diagnosis to the 4th edition of the Diagnostic and Statistical Manual (American Psychiatric Association, 1994) as a way of describing pathological reactions in the first month following a trauma. Since that time ASD has been the focus of some controversy, particularly regarding the theoretical basis and practical utility of the disorder. Despite this controversy, ASD has demonstrated usefulness in identifying individuals experiencing a high level of distress in the acute aftermath of a trauma as well as those at risk for developing posttraumatic stress disorder (PTSD). This paper reviews the clinical application of ASD, the current controversy surrounding its conceptual basis, and then discusses the dilemmas regarding this diagnosis that might occur in clinical practice. A review of the randomized control trial treatment outcome literature for ASD is also included in an effort to assist clinicians selecting interventions for clients recently exposed to traumatic events. Throughout this paper, the relationship between research and applied clinical practice is highlighted.	[Koucky, Ellen M.] Univ Missouri, Ctr Trauma Recovery, Dept Psychol, St Louis, MO 63121 USA; [Nixon, Reginald D. V.] Flinders Univ S Australia, Adelaide, SA, Australia		Koucky, EM (corresponding author), Univ Missouri, Ctr Trauma Recovery, Dept Psychol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	ellen.koucky@gmail.com	Nixon, Reginald/A-6095-2015	Nixon, Reginald/0000-0003-1507-8428			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2004, PRACT GUID TREATM PA; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association, 2010, DSM 5 DEV; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Australian Centre for Posttraumatic Mental Health, 2007, AUSTR GUID TREATM AD; Benedek DM, 2009, GUIDELINE WATCH MARC; Bisson JI, 2008, J TRAUMA STRESS, V21, P507, DOI 10.1002/jts.20375; Blanchard EB, 2002, J TRAUMA STRESS, V15, P199, DOI 10.1023/A:1015299126858; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brewin CR, 1999, AM J PSYCHIAT, V156, P360; Briere J, 2005, AM J PSYCHIAT, V162, P2295, DOI 10.1176/appi.ajp.162.12.2295; Bryant R., 2000, PTSD RES Q, V11, P1; Bryant R. A., 2003, CLIN PSYCHOL, V7, P67, DOI DOI 10.1080/13284200410001707523; Bryant R. A., 2003, POSTTRAUMATIC STRESS, P187; Bryant RA, 2003, BIOL PSYCHIAT, V53, P789, DOI 10.1016/S0006-3223(02)01895-4; Bryant RA, 1999, AM J PSYCHIAT, V156, P1780; Bryant RA, 1998, J CONSULT CLIN PSYCH, V66, P862, DOI 10.1037/0022-006X.66.5.862; Bryant RA, 2005, J CONSULT CLIN PSYCH, V73, P334, DOI 10.1037/0022-006X.73.2.334; Bryant RA, 2003, BEHAV RES THER, V41, P489, DOI 10.1016/S0005-7967(02)00179-1; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 1997, CLIN PSYCHOL REV, V17, P757, DOI 10.1016/S0272-7358(97)00052-4; Bryant RA, 2001, AM J PSYCHIAT, V158, P600, DOI 10.1176/appi.ajp.158.4.600; Bryant RA, 2008, ARCH GEN PSYCHIAT, V65, P659, DOI 10.1001/archpsyc.65.6.659; Bryant RA, 2007, J ANXIETY DISORD, V21, P183, DOI 10.1016/j.janxdis.2006.09.012; Bryant RA, 2006, BEHAV RES THER, V44, P1331, DOI 10.1016/j.brat.2005.04.007; Bryant RA, 2011, J CLIN PSYCHIAT, V72, P233, DOI 10.4088/JCP.09r05072blu; Butler LD, 2000, AM J PSYCHIAT, V157, P1889, DOI 10.1176/appi.ajp.157.11.1884-c; Butler LD, 1996, AM J PSYCHIAT, V153, P42; Creamer M, 2004, BEHAV RES THER, V42, P315, DOI 10.1016/S0005-7967(03)00141-4; Ehlers A, 2003, ARCH GEN PSYCHIAT, V60, P1024, DOI 10.1001/archpsyc.60.10.1024; Evans B. J., 2003, AUSTR J CLIN EXPT HY, V31, P54; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; FOA EB, 1995, J CONSULT CLIN PSYCH, V63, P948, DOI 10.1037/0022-006X.63.6.948; FOA EB, 1995, CURR DIR PSYCHOL SCI, V4, P61, DOI 10.1111/1467-8721.ep10771786; FRANCES A, 1991, European Psychiatry, V6, P307; Freyth C, 2010, J ANXIETY DISORD, V24, P909, DOI 10.1016/j.janxdis.2010.06.016; Gutner CA, 2006, J TRAUMA STRESS, V19, P813, DOI 10.1002/jts.20158; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Harvey AG, 2002, PSYCHOL BULL, V128, P886, DOI 10.1037//0033-2909.128.6.886; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Koopman C, 2000, AM J PSYCHIAT, V157, P1888, DOI 10.1176/appi.ajp.157.11.1888; Litz BT, 2002, CLIN PSYCHOL-SCI PR, V9, P112, DOI 10.1093/clipsy/9.2.112; Lynch SM, 2008, J TRAUMA DISSOCIATIO, V9, P301, DOI 10.1080/15299730802139063; Lynn SJ, 2007, INT J CLIN EXP HYP, V55, P167, DOI 10.1080/00207140601177905; Marshall RD, 1999, AM J PSYCHIAT, V156, P1677; McNally Richard J, 2003, Psychol Sci Public Interest, V4, P45, DOI 10.1111/1529-1006.01421; Murphy RT, 2009, PSYCHOL SERV, V6, P264, DOI 10.1037/a0017577; Nixon R. D. V., 2007, INNOVATIONS ADV COGN, P185; Resnick H, 2007, BEHAV RES THER, V45, P2432, DOI 10.1016/j.brat.2007.05.002; RIGGS DS, 1995, J INTERPERS VIOLENCE, V10, P201, DOI 10.1177/0886260595010002005; ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1007/BF00977239; Rufer M, 2006, PSYCHOTHER PSYCHOSOM, V75, P40, DOI 10.1159/000089225; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Simeon D, 2000, AM J PSYCHIAT, V157, P1888, DOI 10.1176/appi.ajp.157.11.1888-a; Spitzer C, 2007, AUST NZ J PSYCHIAT, V41, P682, DOI 10.1080/00048670701449146; WIDIGER TA, 1991, J ABNORM PSYCHOL, V100, P280, DOI 10.1037/0021-843X.100.3.280	58	9	9	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1077-7229			COGN BEHAV PRACT	Cogn. Behav. Pract.	AUG	2012	19	3					437	450					14	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	967OU	WOS:000305918500007					2022-02-06	
J	Lescot, T; Boroli, F; Reina, V; Chauvet, D; Boch, AL; Puybasset, L				Lescot, T.; Boroli, F.; Reina, V.; Chauvet, D.; Boch, A. -L.; Puybasset, L.			Effect of continuous cerebrospinal fluid drainage on therapeutic intensity in severe traumatic brain injury	NEUROCHIRURGIE			English	Article						Intracranial pressure; Cerebrospinal fluid drainage; External ventricular drain; Traumatic brain injury	INTRACRANIAL-PRESSURE; HEAD-INJURY; PROPOFOL	Background. - The aim of this study in patients with traumatic brain injury (TBI) was to assess the effectiveness of continuous cerebrospinal fluid (CSF) drainage in controlling intracranial pressure (ICP) and minimizing the use of other ICP-lowering interventions potentially associated with serious adverse events. Methods. - We studied 20 TBI patients. In each patient, we compared four consecutive 12-hour periods covering the 24 hours before CSF drainage (NoDr1 and NoDr2) and the 24 first hours of drainage (DO and Dr2). During each period, we recorded ICP, cerebral perfusion pressure (CPP), sedation, propofol infusion rate, and number of hypertonic saline boluses. Results. - With continuous CSF drainage, ICP decreased significantly from 18 +/- 6 mmHg (NoDr1) and 19 +/- 7 mmHg (NoDr2) to 11 +/- 5 mmHg (DO) and 12 +/- 7 mmHg (Dr2). CPP increased significantly with drainage. Drainage led to a significant decrease in the number of hypertonic saline boluses required for ICP elevation, from 35 in 16 patients (80%) (NoDr1/2) to eight in five patients (25%) (Dr3/4). Drainage was not associated with changes in the midazolam or sufentanil infusion rates. The propofol infusion rate was non-significantly lower with drainage. No significant differences in serum sodium, body temperature, or PaCO2 occurred across the four 12-hour periods. Conclusion. - CSF drainage may not only lower ICP levels, but also decreases treatment intensity during the 24 hours following EVD placement in TBI patients. Because EVD placement may be associated with adverse event, the exact role for each of the available ICP-lowering interventions remains open to discussion. (c) 2012 Elsevier Masson SAS. All rights reserved.	[Lescot, T.; Boroli, F.; Puybasset, L.] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Dept Anesthesie Reanimat,Unite Neuroreanimat, F-75651 Paris 13, France; [Reina, V.; Chauvet, D.; Boch, A. -L.] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Serv Neurochirurg, F-75013 Paris, France		Lescot, T (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Dept Anesthesie Reanimat,Unite Neuroreanimat, 47-83 Blvd Hop, F-75651 Paris 13, France.	thomas.lescot@psl.aphp.fr					CAO MH, 1984, J NEUROSURG, V61, P707, DOI 10.3171/jns.1984.61.4.0707; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Kim GS, 2011, NEUROCRIT CARE, V14, P68, DOI 10.1007/s12028-010-9401-y; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Langfitt T W, 1969, Clin Neurosurg, V16, P436; Lescot T, 2008, CURR OPIN CRIT CARE, V14, P129, DOI 10.1097/MCC.0b013e3282f63c51; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; REULEN HJ, 1978, J NEUROSURG, V48, P754, DOI 10.3171/jns.1978.48.5.0754; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; Wijdicks EFM, 2002, TRANSPLANT P, V34, P1220, DOI 10.1016/S0041-1345(02)02804-X	18	9	11	0	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	AUG	2012	58	4					235	240		10.1016/j.neuchi.2012.03.010			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	004YC	WOS:000308716400006	22613876				2022-02-06	
J	Matsui, T; Tasaki, M; Yoshioka, T; Motoki, Y; Tsuneoka, H; Nojima, J				Matsui, Tomohiro; Tasaki, Moe; Yoshioka, Takahiro; Motoki, Yukari; Tsuneoka, Hidehiro; Nojima, Junzo			Temperature- and time-dependent changes in TLR2-activated microglial NF-kappa B activity and concentrations of inflammatory and anti-inflammatory factors	INTENSIVE CARE MEDICINE			English	Article						Microglia; Hypothermia; Hyperthermia; Toll-like receptor 2; Nuclear factor-kappa B; Cytokines	TRAUMATIC BRAIN-INJURY; TOLL-LIKE RECEPTORS; FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; MODERATE HYPOTHERMIA; REPERFUSION INJURY; RAT MICROGLIA; IN-VIVO; ACTIVATION; CELLS	Therapeutic hypothermia protects neurons following injury to the central nervous system (CNS). Microglia express toll-like receptors (TLRs) that play significant roles in pathological processes in sterile CNS injury. We have examined the effects of culture temperature on the TLR2-activated microglial production of cytokines and nitric oxide (NO), which are known to be associated with CNS damage, and the possible involvement of nuclear factor-kappa B (NF-kappa B) activation underlying such effects. Rat microglia were cultured with a selective TLR2 agonist, Pam(3)CSK(4), under hypothermic, normothermic, and hyperthermic conditions, and with Pam(3)CSK(4) in the presence of a NF-kappa B activation inhibitor at 37 A degrees C. Cytokine and NO levels and NF-kappa B p65 activation were measured. The production of tumor necrosis factor-alpha (TNF-alpha), interleukin-10 (IL-10), and NO and the activation of NF-kappa B p65 were reduced by hypothermia, but augmented by hyperthermia at 3-6, 24-48, 48, and 0.5 h, post-treatment initiation, respectively. Pharmacological inhibition of NF-kappa B activation impaired the Pam(3)CSK(4)-induced TNF-alpha, IL-10, and NO production. In TLR2-activated microglia, hypothermia reduced, while hyperthermia increased, the early activation of NF-kappa B and the subsequent NF-kappa B-mediated production of TNF-alpha, IL-10, and NO in a time-dependent manner, suggesting that attenuation of these factors via suppression of NF-kappa B in microglia is one possible neuroprotective mechanism of therapeutic hypothermia. Moreover, temperature-dependent changes in microglial TNF-alpha production during the early phase and IL-10 and NO production during the late phase indicate that these factors might be useful as clinical markers to monitor hypothermia-related neuronal protection and hyperthermia-related neuronal injury.	[Matsui, Tomohiro; Tasaki, Moe; Yoshioka, Takahiro; Motoki, Yukari; Tsuneoka, Hidehiro; Nojima, Junzo] Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, Ube, Yamaguchi 7558505, Japan		Matsui, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	giants@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22791435]	This research was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Young Scientists (B), No. 22791435 to T.M.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BESSLER WG, 1982, H-S Z PHYSIOL CHEM, V363, P767; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Hoffmann O, 2007, J IMMUNOL, V178, P6476, DOI 10.4049/jimmunol.178.10.6476; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; KINOUCHI H, 1993, J CEREBR BLOOD F MET, V13, P105, DOI 10.1038/jcbfm.1993.13; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lancelot E, 1998, NEUROSCI LETT, V242, P131, DOI 10.1016/S0304-3940(98)00095-0; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Maekawa S, 2002, CRIT CARE MED, V30, P2700, DOI 10.1097/00003246-200212000-00014; MALEFYT RD, 1991, J EXP MED, V174, P1209; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Pappas TC, 2003, AGING CELL, V2, P83, DOI 10.1046/j.1474-9728.2003.00039.x; Si QS, 1997, NEUROSCIENCE, V81, P223, DOI 10.1016/S0306-4522(97)00172-3; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wada K, 1996, NEUROCHEM INT, V29, P461, DOI 10.1016/0197-0186(96)82655-6; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yamaguchi S, 2000, NEUROL RES, V22, P657; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	42	9	10	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	AUG	2012	38	8					1392	1399		10.1007/s00134-012-2591-3			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	976GY	WOS:000306570100019	22653369				2022-02-06	
J	Poltavtseva, RA; Silachev, DN; Pavlovich, SV; Kesova, MI; Yarygin, KN; Lupatov, AY; Van'ko, LV; Shuvalova, MP; Sukhikh, GT				Poltavtseva, R. A.; Silachev, D. N.; Pavlovich, S. V.; Kesova, M. I.; Yarygin, K. N.; Lupatov, A. Yu; Van'ko, L. V.; Shuvalova, M. P.; Sukhikh, G. T.			Neuroprotective Effect of Mesenchymal and Neural Stem and Progenitor Cells on Sensorimotor Recovery after Brain Injury	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						local brain injury; neurological status disturbances; rat survival; intravenous transplantation of fetal multipotent mesenchymal stromal cells and human neural stem and progenitor cells	FOCAL CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTORS	We studied the effect of systemic administration of multipotent stem cells on impaired neurological status in rats with brain injury. It was found that transplantation of multipotent mesenchymal stromal cells of the bone marrow or human neural stem and progenitor cells to rats with local brain injury promoted recovery of the brain control over locomotor function and proprioceptive sensitivity of forelegs. The dynamics of neurological recovery was similar after transplantation of fetal neural stem and progenitor cells and multipotent mesenchymal stromal cells. Transplantation of cell cultures improved survival of experimental animals. It should be noted that administration of neural stem and progenitor cells prevented animal death not only in the acute traumatic period, but also in delayed periods.	[Silachev, D. N.] MV Lomonosov Moscow Med Univ, AN Belozerskii Inst Physicochem Biol, Moscow, Russia; [Yarygin, K. N.; Lupatov, A. Yu] Russian Acad Med Sci, VN Orekhovich Res Inst Biomed Chem, Moscow, Russia			rimpol@mail.ru	Silachev, Denis/ABE-8515-2020; Silachev, Denis N/C-9464-2012; Yarygin, Konstantin N/C-4047-2009; Lupatov, Alexey/ABF-7776-2020; Sukhikh, Gennady T/J-1496-2012; Poltavtseva, Rimma Alekseevna/Q-6824-2016	Yarygin, Konstantin N/0000-0002-2261-851X; Poltavtseva, Rimma Alekseevna/0000-0001-8625-9205; Silachev, Denis/0000-0003-0581-9755; Suhih, Gennadii Tihonovic/0000-0002-7712-1260	Ministry of Education and Science of the Russian FederationMinistry of Education and Science, Russian Federation [02.740.11.0297]	The study was supported by Ministry of Education and Science of the Russian Federation within the framework of Federal Scientific Program "Scientific and Educational Cadres of Innovative Russia, 2009-2013" (state contract No. 02.740.11.0297).	Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Poltavtseva R. A., 2003, Ontogenez, V34, P211; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Tsyb A. F., 2009, KLETOCH TEKHNOL BIOL, P23; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279	13	9	11	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4888	1573-8221		B EXP BIOL MED+	Bull. Exp. Biol. Med.	AUG	2012	153	4					586	590		10.1007/s10517-012-1772-y			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	025VH	WOS:000310223200044	22977876				2022-02-06	
J	Swanson, JO; Vavilala, MS; Wang, J; Pruthi, S; Fink, J; Jaffe, KM; Durbin, D; Koepsell, T; Temkin, N; Rivara, FP				Swanson, Jonathan O.; Vavilala, Monica S.; Wang, Jin; Pruthi, Sumit; Fink, James; Jaffe, Kenneth M.; Durbin, Dennis; Koepsell, Thomas; Temkin, Nancy; Rivara, Frederick P.			Association of initial CT findings with quality-of-life outcomes for traumatic brain injury in children	PEDIATRIC RADIOLOGY			English	Article						Traumatic brain injury; Quality of life; CT; Pediatric	COMPUTERIZED-TOMOGRAPHY; PROGNOSTIC VALUE; CLASSIFICATION; RELIABILITY; PREDICTORS; INVENTORY; VALIDITY; SCALE	Traumatic brain injury (TBI) is a leading cause of acquired disability in children and adolescents. To demonstrate the association between specific findings on initial noncontrast head CT and long-term outcomes in children who have suffered TBI. This was an IRB-approved prospective study of children ages 2-17 years treated in emergency departments for TBI and who underwent a head CT as part of the initial work-up (n = 347). The change in quality of life at 12 months after injury was measured by the PedsQL scale. Children with TBI who had intracranial injuries identified on the initial head CT had a significantly lower quality-of-life scores compared to children with TBI whose initial head CTs were normal. In multivariate analysis, children whose initial head CT scans demonstrated intraventricular hemorrhage, parenchymal injury, midline shift a parts per thousand yen5 mm, hemorrhagic shear injury, abnormal cisterns or subdural hematomas a parts per thousand yen3 mm had lower quality of life scores 1 year after injury than children whose initial CTs did not have these same injuries. Associations exist between findings from the initial noncontrast head CT and quality of life score 12 months after injury in children with TBI.	[Swanson, Jonathan O.] Seattle Childrens Hosp, Dept Radiol, Seattle, WA 98105 USA; [Vavilala, Monica S.; Wang, Jin; Rivara, Frederick P.] Univ Washington, Dept Pediat, Harborview Med Ctr, Seattle, WA 98105 USA; [Pruthi, Sumit] Vanderbilt Univ, Dept Radiol, Monroe Carell Jr Childrens Hosp, Nashville, TN USA; [Fink, James] Univ Washington, Dept Radiol, Seattle, WA 98105 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98105 USA; [Durbin, Dennis] Univ Penn, Dept Pediat, Ctr Injury Res & Prevent, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Koepsell, Thomas] Univ Washington, Dept Epidemiol, Seattle, WA 98105 USA		Swanson, JO (corresponding author), Seattle Childrens Hosp, Dept Radiol, 4800 Sand Point Way NE,M-S R-5417, Seattle, WA 98105 USA.	jonathan.swanson@seattlechildrens.org	Durbin, Dennis/AAD-7829-2022				Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Guice KS, 2007, J TRAUMA, V63, pS68, DOI 10.1097/TA.0b013e31815acbb6; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; McCarthy ML, 2007, J TRAUMA, V63, pS122, DOI 10.1097/TA.0b013e31815accdf; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Odetola FO, 2010, ARCH PEDIAT ADOL MED, V164, P277, DOI 10.1001/archpediatrics.2009.285; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; World Health Organization, 2007, INT CLASS FUNCT DIS	21	9	9	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	AUG	2012	42	8					974	981		10.1007/s00247-012-2372-8			8	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	987HF	WOS:000307407100011	22434553				2022-02-06	
J	Gill, RS; Lee, TF; Liu, JQ; Chaudhary, H; Brocks, DR; Bigam, DL; Cheung, PY				Gill, Richdeep S.; Lee, Tze-Fun; Liu, Jiang-Qin; Chaudhary, Hetal; Brocks, Dion R.; Bigam, David L.; Cheung, Po-Yin			Cyclosporine Treatment Reduces Oxygen Free Radical Generation and Oxidative Stress in the Brain of Hypoxia-Reoxygenated Newborn Piglets	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; N-ACETYLCYSTEINE IMPROVES; ISCHEMIC ENCEPHALOPATHY; DOSE-RESPONSE; CELL-DEATH; 100-PERCENT OXYGEN; CEREBRAL HYPOXIA; INJURY; NIM811; RATS	Oxygen free radicals have been implicated in the pathogenesis of hypoxic-ischemic encephalopathy. It has previously been shown in traumatic brain injury animal models that treatment with cyclosporine reduces brain injury. However, the potential neuroprotective effect of cyclosporine in asphyxiated neonates has yet to be fully studied. Using an acute newborn swine model of hypoxia-reoxygenation, we evaluated the effects of cyclosporine on the brain, focusing on hydrogen peroxide (H2O2) production and markers of oxidative stress. Piglets (1-4 d, 1.4-2.5 kg) were block-randomized into three hypoxia-reoxygenation experimental groups (2 h hypoxia followed by 4 h reoxygenation)(n = 8/group). At 5 min after reoxygenation, piglets were given either i.v. saline (placebo, controls) or cyclosporine (2.5 or 10 mg/kg i.v. bolus) in a blinded-randomized fashion. An additional sham-operated group (n = 4) underwent no hypoxia-reoxygenation. Systemic hemodynamics, carotid arterial blood flow (transit-time ultrasonic probe), cerebral cortical H2O2 production (electrochemical sensor), cerebral tissue glutathione (ELISA) and cytosolic cytochrome-c (western blot) levels were examined. Hypoxic piglets had cardiogenic shock (cardiac output 40-48% of baseline), hypotension (mean arterial pressure 27-31 mmHg) and acidosis (pH 7.04) at the end of 2 h of hypoxia. Post-resuscitation cyclosporine treatment, particularly the higher dose (10 mg/kg), significantly attenuated the increase in cortical H2O2 concentration during reoxygenation, and was associated with lower cerebral oxidized glutathione levels. Furthermore, cyclosporine treatment significantly attenuated the increase in cortical cytochrome-c and lactate levels. Carotid blood arterial flow was similar among groups during reoxygenation. Conclusively, post-resuscitation administration of cyclosporine significantly attenuates H2O2 production and minimizes oxidative stress in newborn piglets following hypoxia-reoxygenation.	[Gill, Richdeep S.; Bigam, David L.; Cheung, Po-Yin] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Lee, Tze-Fun; Liu, Jiang-Qin; Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Chaudhary, Hetal; Brocks, Dion R.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada		Gill, RS (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	poyin@ualberta.ca	Cheung, Po-Yin/C-2804-2013	Cheung, Po-Yin/0000-0002-7141-1523	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP53116]; Women and Children's Health Research Institute at the University of Alberta; Clinician Investigator Program of the Royal College of Physicians and Surgeons of Canada; Alberta Innovates Health Solutions	This work was supported by Canadian Institutes of Health Research, MOP53116, www.cihr-irsc.ca, the Women and Children's Health Research Institute at the University of Alberta, www.wchri.srv.ualberta.ca (operating funds), the Clinician Investigator Program of the Royal College of Physicians and Surgeons of Canada and the Alberta Innovates Health Solutions (salary awards to Dr. Richdeep S. Gill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri B, 1999, ACT NEUR S, V75, P21; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; dos Santos AB, 2009, TOXICON, V54, P16, DOI 10.1016/j.toxicon.2009.03.004; Frantseva MV, 2001, FREE RADICAL BIO MED, V31, P1216, DOI 10.1016/S0891-5849(01)00705-5; Gratton R, 1996, J SOC GYNECOL INVEST, V3, P60, DOI 10.1016/1071-5576(95)00047-X; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hwang JH, 2010, BRAIN RES, V1359, P208, DOI 10.1016/j.brainres.2010.08.047; Jacobs SE, 2010, J PAEDIATR CHILD H, V46, P568, DOI 10.1111/j.1440-1754.2010.01880.x; Jacobson J, 2002, J CELL SCI, V115, P1175; Johnson ST, 2007, SHOCK, V28, P484, DOI 10.1097/shk.0b013e31804f775d; Joynt C, 2009, SHOCK, V31, P292, DOI 10.1097/SHK.0b013e31817fd752; Kanduru SV, 2010, BIOMED CHROMATOGR, V24, P148, DOI 10.1002/bmc.1263; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kutzsche S, 1999, BIOL NEONATE, V76, P153, DOI 10.1159/000014155; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lee TF, 2008, INTENS CARE MED, V34, P190, DOI 10.1007/s00134-007-0880-z; Leger PL, 2011, EXP NEUROL, V230, P58, DOI 10.1016/j.expneurol.2010.06.009; Liu JQ, 2010, J NEUROTRAUM, V27, P1865, DOI 10.1089/neu.2010.1325; Martin LJ, 1997, J COMP NEUROL, V377, P262, DOI 10.1002/(SICI)1096-9861(19970113)377:2<262::AID-CNE8>3.0.CO;2-1; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Nakai A, 2004, PEDIATR NEUROL, V30, P247, DOI 10.1016/j.pediatrneurol.2003.09.006; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Pacheco-Lopez G, 2012, INT J NEUROPSYCHOPH, V5, P1; Piilgaard H, 2011, J CEREBR BLOOD F MET, V31, P1588, DOI 10.1038/jcbfm.2011.28; Puka-Sundvall M, 2001, DEV NEUROSCI-BASEL, V23, P192, DOI 10.1159/000046142; Richards JG, 2006, RESUSCITATION, V69, P319, DOI 10.1016/j.resuscitation.2005.08.012; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rodrigo J, 2005, FREE RADICAL BIO MED, V39, P26, DOI 10.1016/j.freeradbiomed.2005.02.010; Segawa D, 1998, J THORAC CARDIOV SUR, V115, P925, DOI 10.1016/S0022-5223(98)70375-7; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; Vannucci RC, 2000, AM J PERINAT, V17, P113, DOI 10.1055/s-2000-9293; VANNUCCI RC, 1990, PEDIATRICS, V85, P961; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zuckerman SL, 1992, HEART CIRC PHYSL, V35, pH2198	40	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2012	7	7							e40471	10.1371/journal.pone.0040471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973IV	WOS:000306354700054	22792343	Green Submitted, gold, Green Published			2022-02-06	
J	Armstead, WM; Riley, J; Cines, DB; Higazi, AAR				Armstead, William M.; Riley, John; Cines, Douglas B.; Higazi, Abd Al-Roof			Combination therapy with glucagon and a novel plasminogen activator inhibitor-1-derived peptide enhances protection against impaired cerebrovasodilation during hypotension after traumatic brain injury through inhibition of ERK and JNK MAPK	NEUROLOGICAL RESEARCH			English	Article						Newborn; Cerebral circulation; TBI; Plasminogen activators; Signal transduction	NMDA CEREBROVASODILATION; CEREBRAL HEMODYNAMICS; TPA; LRP; POTASSIUM; INCREASES; RECEPTOR; NOC/OFQ	Objective: Outcome of traumatic brain injury (TBI) is impaired by hypotension and glutamate, and TBI-associated release of endogenous tissue plasminogen activator (tPA) impairs cerebral autoregulation. Glucagon decreases central nervous system glutamate, lessens neuronal cell injury, and improves neurological score in mice after TBI. Glucagon partially protects against impaired cerebrovasodilation during hypotension after TBI in piglets by upregulating cAMP which decreases release of tPA. Pial artery dilation during hypotension is due to release of cAMP-dependent dilator prostaglandins (PG), such as PGE2 and PGI2. TBI impairs PGE2 and PGI2-mediated pial artery dilation, which contributes to disturbed cerebral autoregulation post-insult, by upregulating mitogen-activated protein kinase (MAPK). This study was designed to investigate relationships between tPA, prostaglandins, and MAPK as a mechanism to improve the efficacy of glucagon-mediated preservation of cerebrovasodilation during hypotension after TBI. Methods: Lateral fluid percussion brain injury (FPI) was induced in piglets equipped with a closed cranial window. ERK and JNK MAPK concentrations in cerebrospinal fluid were quantified by enzyme-linked immunosorbent assay. Results: Cerebrospinal fluid JNK MAPK was increased by FPI, but blunted by glucagon and the novel plasminogen activator inhibitor-1-derived peptide (PAI-1DP), Ac-RMAPEEIIMDRPFLYVVR-amide. FPI modestly increased, while glucagon and PAI-1DP decreased ERK MAPK. PGE2, PGI2, N-methyl-D-aspartate, and hypotension-induced pial artery dilation was blunted after FPI, partially protected by glucagon, and fully protected by glucagon + PAI-1DP, glucagon + JNK antagonist SP600125 or glucagon vertical bar ERK inhibitor U 0126. Discussion: Glucagon + PAI-1DP act in concert to protect against impairment of cerebrovasodilation during hypotension after TBI via inhibition of ERK and JNK MAPK.	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Cines, Douglas B.; Higazi, Abd Al-Roof] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Higazi, Abd Al-Roof] Hebrew Univ Hadassah Med Sch Jerusalem, Dept Clin Biochem, Jerusalem, Israel		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS53410, HD57355, HL76406, CA83121, HL76206, HL07971, HL81864, HL77760, HL82545]; University of Pennsylvania Research Foundation; University of Pennsylvania Institute for Translational Medicine and Therapeutics; Israeli Science FoundationIsrael Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA083121] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL076206, P01HL076406, R01HL077760, R21HL081864, T32HL007971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053410] Funding Source: NIH RePORTER	This research was supported by grants from the National Institutes of Health, NS53410 and HD57355 (WMA), HL76406, CA83121, HL76206, HL07971, and HL81864 (DBC), HL77760 and HL82545 (AARH), the University of Pennsylvania Research Foundation (WMA), the University of Pennsylvania Institute for Translational Medicine and Therapeutics (DBC), and the Israeli Science Foundation (AARH).	Abu Fanne R, 2010, NEUROPHARMACOLOGY, V58, P972, DOI 10.1016/j.neuropharm.2009.12.017; Akkawi S, 2006, AM J PHYSIOL-HEART C, V291, pH1351, DOI 10.1152/ajpheart.01042.2005; Armstead WM, 2008, BRAIN RES, V1231, P121, DOI 10.1016/j.brainres.2008.06.115; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Armstead WM, 2010, AM J PHYSIOL-REG I, V299, pR480, DOI 10.1152/ajpregu.00256.2010; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 1998, J NEUROTRAUM, V15, P721, DOI 10.1089/neu.1998.15.721; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; MERCHANT RE, 1999, ANN NY ACAD SCI, V890, P41; Nassar T, 2004, BLOOD, V103, P897, DOI 10.1182/blood-2003-05-1685; Nassar T, 2002, J BIOL CHEM, V277, P40499, DOI 10.1074/jbc.M207172200; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Tan ZJ, 2009, BRAIN RES, V1281, P84, DOI 10.1016/j.brainres.2009.05.042; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228	25	9	10	0	2	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	JUL	2012	34	6					530	537		10.1179/1743132812Y.0000000039			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974VE	WOS:000306464700002	22642975	Green Accepted			2022-02-06	
J	Dutta, P; Mukherjee, KK; Chaudhary, PK; Masoodi, SR; Anand, S; Pathak, A; Shah, VN; Mathuriya, SN				Dutta, Pinaki; Mukherjee, Kanchan K.; Chaudhary, Prashant K.; Masoodi, Shriq Rashid; Anand, Srinivasan; Pathak, Ashis; Shah, Viral N.; Mathuriya, Suresh Narain			Pituitary dysfunction in survivors of spontaneous subarachnoid hemorrhage of anterior communicating artery and middle cerebral artery aneurysms: A comparative study	NEUROLOGY INDIA			English	Article						Aneurysm; subarachnoid hemorrhage; hypopituitarism	TRAUMATIC BRAIN-INJURY; HYPOPITUITARISM; NEUROENDOCRINE; DEFICIENCY; RUPTURE; RISK	Background: The data on incidence of hypopituitarism after SAH are conflicting. Furthermore, it is still not known whether there is any difference in hormonal deficiencies between SAH due to anterior communicating artery (A-com) and middle cerebral artery (MCA) aneurysms. Materials and Methods: This study includes both retrospective and prospective arms. The data collected included baseline demographic profile, clinical severity on admission to the hospital by the Hunt and Hess grading system and World Federation of Neurological Surgeons (WFNS) grading, radiological severity of bleed by the Fisher's classification, and treatment details. All the patients underwent detailed hormonal evaluation at baseline and 6 months in prospective group while at the end of 1 year in the retrospective group. Hormonal deficiencies between patients with A-com and MCA aneurysmal SAH were compared using appropriate statistical tests. Results: Of 60 patients studied, 47 patients (A-com: 28 and MCA: 19) were in the retrospective group, while 13 patients (A-com-9, MCA-4) were in the prospective group. The baseline data were comparable between the two groups. At or after 6 months follow-up, 19 (31.6%) patients, 10 patients with A-com and 9 patients with MCA aneurysmal SAH, had some form of hormone deficiency. Furthermore, there was no difference in endocrine dysfunctions between the two groups. There was no correlation between the severity of hormonal deficiency and the clinical severity of SAH grade by Hunt and Hess and radiological grade of SAH by Fisher's grade. Conclusion: Hormonal deficiencies are not uncommon in patients with SAH. There is no difference in hormonal deficiencies and severity of hypopituitarism in patients with SAH due to A-com and MCA bleed.	[Mukherjee, Kanchan K.; Chaudhary, Prashant K.; Pathak, Ashis; Mathuriya, Suresh Narain] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India; [Dutta, Pinaki; Shah, Viral N.] Postgrad Inst Med Educ & Res, Dept Endocrinol, Chandigarh 160012, India; [Anand, Srinivasan] Postgrad Inst Med Educ & Res, Dept Pharmacol, Chandigarh 160012, India; [Masoodi, Shriq Rashid] PGIMER, Dept Endocrinol, Sher E Kashmir Inst, Dept Neurosurg, Chandigarh, Jammu & Kashmir, India		Mukherjee, KK (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India.	kk_mukherjee@hotmail.com	Masoodi, Shariq/AAV-7265-2020; Shah, Viral N./H-2855-2019	Masoodi, Shariq/0000-0002-8664-9614; Shah, Viral N./0000-0002-3827-7107			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; Bhagwati SN, 1998, NEUROL MED-CHIR, V38, P128, DOI 10.2176/nmc.38.suppl_128; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gupta SK, 2011, NEUROL INDIA, V59, P212, DOI 10.4103/0028-3886.79144; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Kreitschmann-Andermahr Ilonka, 2005, Pituitary, V8, P219, DOI 10.1007/s11102-006-6044-2; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249	17	9	11	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	JUL-AUG	2012	60	4					390	394		10.4103/0028-3886.100729			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	003KY	WOS:000308611600005	22954974				2022-02-06	
J	Harrison, JE; Berry, JG; Jamieson, LM				Harrison, James E.; Berry, Jesia G.; Jamieson, Lisa M.			Head and traumatic brain injuries among Australian youth and young adults, July 2000-June 2006	BRAIN INJURY			English	Article						Head injury; traumatic brain injury; hospitalizations; rural health; male	NEW-ZEALAND; DIAGNOSIS; OUTCOMES; ENGLAND; BURDEN; WALES	Objectives: To describe rates of hospitalization for head and traumatic brain injury (TBI) among Australian adults aged 15-24 years. Design: Descriptive analysis of the Australian Institute of Health and Welfare National Hospital Morbidity Database, using data from 1 July 2000 to 30 June 2006. Results: The rate of hospitalization for head injury was 618.5 per 100 000, with 148.1 per 100 000 being high threat to life injuries. In multivariate analysis, males had 3.2-times the rate of females. Youth and young adults living in remote and very remote areas had a 2.6-3.2-fold greater rate of head injury than city-dwellers and a 2.3-2.7-fold greater rate of injuries that were high threat to life. The rate of TBI was 169.3 per 100 000, with 87.1 per 100 000 being high threat to life injuries. In multivariate analysis, males had 3.2-times the rate of females. Youth and young adults living in very remote and remote areas had a 2.5-3.0-fold greater rate of TBI than city-dwellers and a 2.1-2.3-fold greater rate of high threat to life TBI. Conclusions: Males and youth and young adults living remotely were disproportionately represented among those sustaining head injuries. A quarter of hospitalized head injuries were coded as having TBI.	[Jamieson, Lisa M.] Univ Adelaide, Australian Res Ctr Populat Oral Hlth, Adelaide, SA 5005, Australia; [Harrison, James E.; Berry, Jesia G.] Flinders Univ S Australia, Res Ctr Injury Studies, Adelaide, SA, Australia		Jamieson, LM (corresponding author), Univ Adelaide, Australian Res Ctr Populat Oral Hlth, Adelaide, SA 5005, Australia.	lisa.jamieson@adelaide.edu.au	Jamieson, Lisa M/M-5914-2014; Harrison, James/B-8958-2009	Harrison, James/0000-0001-9893-8491; Berry, Jesia/0000-0002-4446-7927			Australian Institute of Health and Welfare, 2007, AUSTR I HLTH WELF B; Australian Institute of Health and Welfare, 2004, RUR REG REM HLTH GUI; Australian Institute of Health and Welfare, 2010, AUSTR HLTH 2010; Bureau of Infrastructure Transport and Regional Economics, 2010, INF SHEET 38 ROAD DE; Bureau of Statistics Australian, 2001, AUSTR STAND GEOGR CL; Chiang MF, 2006, SURG NEUROL, V66, pS14, DOI 10.1016/j.surneu.2006.08.029; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cryer C, 2006, INJURY PREV, V12, P202, DOI 10.1136/ip.2006.011635; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Du W, 2007, MED J AUSTRALIA, V187, P515, DOI 10.5694/j.1326-5377.2007.tb01393.x; Gruen RL, 2006, LANCET, V368, P130, DOI 10.1016/S0140-6736(06)68812-0; Hartling L, 2004, COCHRANE DB SYST REV, V2; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Helps YLM, 2006, INJURY TECHNICAL PAP; Jones Judith A, 2006, Aust Health Rev, V30, P322; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Kiely JM, 2006, J TRAUMA, V61, P791, DOI 10.1097/01.ta.0000239360.29852.1d; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kreisfeld R, 2010, HOSP SEPARATIONS DUE; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kypri K, 2002, INJ PREV, V8, P32, DOI 10.1136/ip.8.1.32; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; National Center for Injury Prevention and Control Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; National Centre for Classification in Health, 1998, ICD 9 CM ICD 10 AM; National Public Health Partnership, 2005, NAT INJ PREV SAF PRO; Newstead, 2009, VEHICLE SAFETY YOUNG; Pikoulis E, 2006, Int J Inj Contr Saf Promot, V13, P190, DOI 10.1080/17457300500294547; Public Health Intelligence, 2001, BURD DIS INJ NZ; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; Smith N, 2009, EUR J CARDIO-THORAC, V36, P340, DOI 10.1016/j.ejcts.2009.03.048; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Stevenson MR, 2005, MED J AUSTRALIA, V182, P102, DOI 10.5694/j.1326-5377.2005.tb06605.x; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ., 1995, GUIDELINES SURVEILLA	36	9	10	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2012	26	7-8					996	1004		10.3109/02699052.2012.660515			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	957CB	WOS:000305135100011	22571368				2022-02-06	
J	Ide, S; Uchida, K; Inoue, M; Koike, Y; Otake, K; Matsushita, K; Hashimoto, K; Nagano, Y; Inoue, H; Isaji, S; Kusunoki, M				Ide, Shozo; Uchida, Keiichi; Inoue, Mikihiro; Koike, Yuhki; Otake, Kohei; Matsushita, Kohei; Hashimoto, Kiyoshi; Nagano, Yuka; Inoue, Hiroyuki; Isaji, Shuji; Kusunoki, Masato			Tumor enucleation with preoperative endoscopic transpapillary stenting for pediatric insulinoma	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Enucleation; Pancreatic resection; Pancreatic stenting; Insulinoma; Children; ERCP	PANCREATIC-DUCT; MANAGEMENT; RESECTION; FISTULA; ERCP	The 13-year-old boy underwent tumor enucleation for pancreatic head insulinoma close to the pancreatic main duct after a preoperative endoscopic pancreatic stent placed by endoscopic retrograde cholangiopancreatography. The tumor was safely excised by identifying the indwelled pancreatic stent during the surgical procedure without pancreatic duct injury or postoperative complications.	[Ide, Shozo; Uchida, Keiichi; Inoue, Mikihiro; Koike, Yuhki; Otake, Kohei; Matsushita, Kohei; Hashimoto, Kiyoshi; Nagano, Yuka; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 5148507, Japan; [Inoue, Hiroyuki] Mie Univ, Grad Sch Med, Dept Gastroenterol, Tsu, Mie 5148507, Japan; [Isaji, Shuji] Mie Univ, Grad Sch Med, Dept Hepatobiliary Pancreat & Transplant Surg, Tsu, Mie 5148507, Japan		Uchida, K (corresponding author), Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	ucchie@clin.medic.mie-u.ac.jp					Al-Shanafey S, 2004, J PEDIATR SURG, V39, P1062, DOI 10.1016/j.jpedsurg.2004.03.071; Grant CS, 2005, BEST PRACT RES CL GA, V19, P783, DOI 10.1016/j.bpg.2005.05.008; Hackert T, 2011, SURG-J R COLL SURG E, V9, P211, DOI 10.1016/j.surge.2010.10.011; Hirota M, 2007, AM J SURG, V194, P308, DOI 10.1016/j.amjsurg.2007.01.027; Iqbal CW, 2009, J PEDIATR GASTR NUTR, V49, P430, DOI 10.1097/01.mpg.0000361657.54810.19; Iqbal S, 2011, DIGEST DIS SCI, V56, P260, DOI 10.1007/s10620-010-1262-x; Kim HS, 2001, GASTROINTEST ENDOSC, V54, P49, DOI 10.1067/mge.2001.115733; KOZAREK RA, 1991, GASTROENTEROLOGY, V100, P1362; MONTORSI M, 1995, SURGERY, V117, P26, DOI 10.1016/S0039-6060(05)80225-9; Okamoto T, 2008, DIGEST SURG, V25, P175, DOI 10.1159/000140683; Otto AK, 2011, SURG ENDOSC, V25, P2536, DOI 10.1007/s00464-011-1582-8; Rocca R, 2005, DIGEST LIVER DIS, V37, P357, DOI 10.1016/j.dld.2004.09.030; SAEED ZA, 1993, GASTROENTEROLOGY, V105, P1213, DOI 10.1016/0016-5085(93)90970-N; Shimura T, 2007, AM J SURG, V194, P553, DOI 10.1016/j.amjsurg.2006.11.043; Sugiyama M, 2001, HEPATO-GASTROENTEROL, V48, P1625; Tucker ON, 2006, BRIT J SURG, V93, P264, DOI 10.1002/bjs.5280; Zhao YP, 2011, J SURG ONCOL, V103, P169, DOI 10.1002/jso.21773	17	9	10	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358			PEDIATR SURG INT	Pediatr. Surg. Int.	JUL	2012	28	7					707	709		10.1007/s00383-012-3104-8			3	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	961OX	WOS:000305476600010	22576843				2022-02-06	
J	Linsler, S; Ketter, R; Eichler, H; Schwerdtfeger, K; Steudel, WI; Oertel, J				Linsler, Stefan; Ketter, Ralf; Eichler, Hermann; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim			Red blood cell transfusion in neurosurgery	ACTA NEUROCHIRURGICA			English	Article						Neurosurgical procedures; Red blood cells; Transfusion; C/T ratio	TRAUMATIC BRAIN-INJURY; EXPECTED HEMOTHERAPY; COGNITIVE FUNCTION; SURGERY; ANEMIA; QUALITY; MEMORY; OXYGEN	The necessity of red blood cell (RBC) transfusions in neurosurgical procedures is under debate. Although detailed recommendations exist for many other surgical disciplines, there are very limited data on the probability of transfusions during neurosurgical procedures. Three-thousand and twenty-six consecutive adult patients undergoing neurosurgical procedures at Saarland University Hospital from December 2006 to June 2008 were retrospectively analyzed for administration of RBCs. The patients were grouped into 11 main diagnostic categories for analysis. The transfusion probability and cross-match to transfusion ratio (C/T ratio) were calculated. Overall, the transfusion probability for neurosurgical procedures was 1.7 % (52/3,026). The probability was 6.5 % for acute subdural hematoma (7/108), 6.2 % for spinal tumors (5/80), 4.6 % for intracerebral hemorrhage (ICH, 4/98), 2.8 % for abscess (3/108), 2.4 % for traumatic brain injury (4/162), 2.3 % for cerebral ischemia (1/44), 1.9 % for subarachnoid hemorrhage (SAH) /aneurysms (4/206), 1.4 % for brain tumors (10/718), 0.8 % for hydrocephalus (2/196), 0.4 % for degenerative diseases of the spine (5/1290), including 3.6 % (3/82) for posterior lumbar interbody fusion (PLIF) and 0 % for epidural hematoma (0/15). The transfusion probabilities for clipping and coiling of SAH were 2.9 % (2/68) and 1.7 % (2/120) respectively. The probability of blood transfusion during neurosurgical procedures is well below the 10 % level which is generally defined as the limit for preoperative appropriation of RBCs. Patients with spinal tumors, acute subdural hematomas or ICH, i.e., patients undergoing large decompressive procedures of bone or soft tissue, had a higher probability of transfusion.	[Linsler, Stefan; Ketter, Ralf; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim] Univ Saarland, Dept Neurosurg, D-66421 Homburg, Saarland, Germany; [Eichler, Hermann] Univ Saarland, Dept Hemostaseol, D-66421 Homburg, Saarland, Germany		Linsler, S (corresponding author), Univ Saarland, Dept Neurosurg, D-66421 Homburg, Saarland, Germany.	stefan.linsler@uks.eu	Oertel, Joachim/AAO-5012-2021				Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198; ARGOV S, 1981, AM J SURG, V142, P370, DOI 10.1016/0002-9610(81)90351-2; Barr PJ, 2011, TRANSFUS MED REV, V25, P304, DOI 10.1016/j.tmrv.2011.04.003; Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3; BOYD PR, 1980, AM J CLIN PATHOL, V73, P694, DOI 10.1093/ajcp/73.5.694; Cataldi S, 1997, NEUROSURGERY, V40, P765, DOI 10.1097/00006123-199704000-00021; Couture DE, 2002, STROKE, V33, P994, DOI 10.1161/hs0402.105296; FRIEDMAN BA, 1979, TRANSFUSION, V19, P268, DOI 10.1046/j.1537-2995.1979.19379204208.x; FRIEDMAN BA, 1979, TRANSFUSION, V19, P788, DOI 10.1046/j.1537-2995.1979.19680104113.x; Garcia-Erce JA, 2007, VOX SANG, V93, P89, DOI 10.1111/j.1423-0410.2007.00914.x; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; Goodnough LT, 1999, TRANSFUSION, V39, P1031, DOI 10.1046/j.1537-2995.1999.39091031.x; GRZESKIEWICZ JL, 1989, ORTHOPEDICS, V12, P549; Hare GMT, 2008, ANESTH ANALG, V107, P1356, DOI 10.1213/ane.0b013e318184cfe9; Hendrickson JE, 2009, ANESTH ANALG, V108, P759, DOI 10.1213/ane.0b013e3181930a6e; Hopf HW, 2000, ARCH SURG-CHICAGO, V135, P1443, DOI 10.1001/archsurg.135.12.1443; JENKINS AD, 1981, J UROLOGY, V126, P497, DOI 10.1016/S0022-5347(17)54595-4; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Liang H, 2009, SURG NEUROL, V71, P74, DOI 10.1016/j.surneu.2007.11.015; McEwen J, 2009, CURR OPIN ANESTHESIO, V22, P566, DOI 10.1097/ACO.0b013e32832ff4a2; MINTZ PD, 1976, NEW YORK STATE J MED, V76, P532; MINTZ PD, 1978, JAMA-J AM MED ASSOC, V239, P623, DOI 10.1001/jama.239.7.623; Diaz MQ, 2009, MED INTENSIVA, V33, P8; Reulen H-J, 2011, SONDERAUSGABE MI APR; SARMA DP, 1980, JAMA-J AM MED ASSOC, V243, P1536, DOI 10.1001/jama.243.15.1536; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Sharma S, 2011, AM FAM PHYSICIAN, V83, P719; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Tinmouth AT, 2006, TRANSFUSION, V46, P1072, DOI 10.1111/j.1537-2995.2006.00886.x; Turgeon AF, 2006, CAN J ANAESTH, V53, P344, DOI 10.1007/BF03022497; Verlicchi F, 2011, BLOOD TRANSFUS, P1; Verlicchi F, 2011, BLOOD TRANSFUS-ITALY, V9, P430, DOI 10.2450/2011.0023-10; Weinberg JA, 2011, TRANSFUSION, V51, P867, DOI 10.1111/j.1537-2995.2011.03098.x; Weiskopf RB, 2002, ANESTHESIOLOGY, V96, P871, DOI 10.1097/00000542-200204000-00014; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023	36	9	9	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2012	154	7					1303	1308		10.1007/s00701-012-1373-6			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	964EW	WOS:000305677700031	22585030				2022-02-06	
J	Rosi, J; Figueiredo, EG; Rocha, EP; Andrade, AF; Rasslan, S; Teixeira, MJ				Rosi Junior, Jefferson; Figueiredo, Eberval Gadelha; Rocha, Edson Pedro; Andrade, Almir Ferreira; Rasslan, Samir; Teixeira, Manoel Jacobsen			Whole-body computerized tomography and concomitant spine and head injuries A study of 355 cases	NEUROSURGICAL REVIEW			English	Article						Spine injury; Brain injury; Fracture; Vertebra; Whole-body computed tomography	TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE; VERTEBRAL ARTERY; CORD-INJURY; EPIDEMIOLOGY; FRACTURES; INSTRUMENTATION; HEMATOMAS; FIXATION; ANTERIOR	The authors present a prospective study on the coexistence of spinal injury (SI) and severe traumatic brain injury (TBI) in patients who were involved in traffic accidents and arrived at the Emergency Department of Hospital das Clinicas of the University of Sao Paulo between September 1, 2003 and December 31, 2009. A whole-body computed tomography was the diagnostic method employed in all cases. Both lesions were observed simultaneously in 69 cases (19.4%), predominantly in males (57 individuals, 82.6%). Cranial injuries included epidural hematoma, acute subdural hematoma, brain contusion, ventricular hemorrhage and traumatic subarachnoid hemorrhage. The transverse processes were the most fragile portion of the vertebrae and were more susceptible to fractures. The seventh cervical vertebra was the most commonly affected segment, with 24 cases (34.78%). The distribution of fractures was similar among the other cervical vertebrae, the first four thoracic vertebrae and the lumbar spine. Neurological deficit secondary to SI was detected in eight individuals (11.59%) and two individuals (2.89%) died. Traumatic subarachnoid hemorrhage was the most common intracranial finding (82.6%). Spinal surgery was necessary in 24 patients (34.78%) and brain surgery in 18 (26%). Four patients (5.79%) underwent cranial and spinal surgeries. The authors conclude that it is necessary a judicious assessment of the entire spine of individuals who presented in coma after suffering a brain injury associated to multisystemic trauma and whole-body CT scan may play a major role in this scenario.	[Rosi Junior, Jefferson; Figueiredo, Eberval Gadelha; Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Fac Med, Div Neurol Surg, Hosp Clin, Sao Paulo, Brazil; [Rocha, Edson Pedro] Univ Sao Paulo, Fac Med, ICU, Surg Emergency Dept,Hosp Clin, Sao Paulo, Brazil; [Rasslan, Samir] Univ Sao Paulo, Dept Surg, Sao Paulo, Brazil		Figueiredo, EG (corresponding author), Univ Sao Paulo, Fac Med, Div Neurol Surg, Hosp Clin, Rua Eneas C Aguiar 255, Sao Paulo, Brazil.	ebgadelha@yahoo.com	Figueiredo, Eberval G/E-2071-2016; Teixeira, Manoel J/E-3110-2012; Figueiredo, Eberval Gadelha/H-3488-2012				Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Bambakidis NC, 2008, J NEUROSURG-SPINE, V8, P143, DOI 10.3171/SPI/2008/8/2/143; Cardenas RJ, 2010, NEUROSURGERY, V66, pONS314, DOI 10.1227/01.NEU.0000370200.74098.CC; Carmody MA, 2010, NEUROSURGERY, V67, pE210, DOI 10.1227/01.NEU.0000370012.34424.30; Dailey AT, 2010, J NEUROSURG-SPINE, V12, P1, DOI 10.3171/2009.7.SPINE08589; Duthie G, 2009, BRIT J NEUROSURG, V23, P596, DOI 10.3109/02688690902978157; Fassett DR, 2008, J SPINAL DISORD TECH, V21, P252, DOI 10.1097/BSD.0b013e3180cab162; Freslon M, 2008, REV CHIR ORTHOP, V94, pS22, DOI 10.1016/j.rco.2008.03.007; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Figueiredo EG, 2006, MINIM INVAS NEUROSUR, V49, P37, DOI 10.1055/s-2006-932146; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P233; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Keita M, 2010, Med Trop (Mars), V70, P172; Kiboi J G, 2009, East Afr Med J, V86, P300; Kirkpatrick John S, 2003, J Am Acad Orthop Surg, V11, P355; Li Tao, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P415; Marco RAW, 2009, J BONE JOINT SURG AM, V91A, P20, DOI 10.2106/JBJS.G.01668; Martin MD, 2010, NEUROSURGERY, V66, P1148, DOI 10.1227/01.NEU.0000369611.97009.B2; Martins F, 1998, SPINAL CORD, V36, P574, DOI 10.1038/sj.sc.3100657; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McCulloch PT, 2005, J BONE JOINT SURG AM, V87A, P2388, DOI 10.2106/JBJS.E.00208; Miller CP, 2010, SPINE, V35, P1271, DOI 10.1097/BRS.0b013e3181c0ddad; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Nujaimin U, 2009, ASIAN J SURG, V32, P157, DOI 10.1016/S1015-9584(09)60387-0; Pedram H, 2010, CHIN J TRAUMATOL, V13, P3, DOI 10.3760/cma.j.issn.1008-1275.2010.01.001; Razak M, 1998, Med J Malaysia, V53 Suppl A, P1; Robert O, 2002, ANN FR ANESTH, V21, P347, DOI 10.1016/S0750-7658(02)00635-4; Rosi J, 2005, NEURONIO PERGUNTAS R; Shiraga Shunsuke, 2010, No Shinkei Geka, V38, P365; Song KJ, 2008, J CLIN NEUROSCI, V15, P36, DOI 10.1016/j.jocn.2007.05.010; Teixeira MJ, 1999, ARQ BRAS NEUROCIR, V18, P203; Venturini DA, 2007, REV ESC ENFERM USP, V41, P589, DOI 10.1590/S0080-62342007000400008; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Yang HY, 2010, SPINE, V35, pE295, DOI 10.1097/BRS.0b013e3181c392b9; Zheng Yuan-hua, 2010, Zhongguo Gu Shang, V23, P268	38	9	9	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	JUL	2012	35	3					437	444		10.1007/s10143-012-0379-0			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	958IM	WOS:000305230000029	22391772				2022-02-06	
J	Sullivan, KA; Edmed, SL				Sullivan, Karen A.; Edmed, Shannon L.			An Examination of the Expected Symptoms of Postconcussion Syndrome in a Nonclinical Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; mild traumatic brain injury; neuropsychology; postconcussion syndrome; symptom expectation	MINOR HEAD-INJURY; TRAUMATIC BRAIN-INJURY; EXPECTATION; KNOWLEDGE; PEOPLE	Objectives: This study examined the robustness of the postconcussion syndrome (PCS) expectation-as-etiology hypothesis using a variation on the typical study design and different symptom assessment methods. Methods: Participants were 51 university students with no history of brain injury or neurological disease. Participants reported expected PCS symptoms after being exposed to an established vignette in which they were asked to imagine that they had had a car accident (expectation condition). One week later, they reported their current symptoms (control condition). Symptoms were elicited in both test sessions using each of 3 methods administered in the following fixed order: an open-ended question (eg, how have you been feeling over the past couple of weeks?), prompted interview questions (eg, have you experienced any troubling physical symptoms over the past few weeks?), and checklist (the British Columbia Postconcussion Symptom Inventory). All 3 methods were administered in a paper-and-pencil format. Results: Findings revealed that (a) when responding to structured interview questions or the checklist, participants expected more PCS symptoms from an imagined mild traumatic brain injury when compared with their baseline, (b) the expectation effect was not present when symptoms were elicited by an open-ended question, and (c) almost all participants (approximately 98% of those reporting expected symptoms) met a caseness criterion when symptoms were assessed using a checklist or structured interview. Contrary to predictions, personal knowledge of someone with mild traumatic brain injury did not alter PCS expectancies. Conclusions: The expectation-as-etiology hypothesis, which is one of several factors that has been associated with PCS, may be partly dependent on method of symptom assessment.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia; [Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, O Block,B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC # 1000000311) approved this research. This project was granted an occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. The authors thank the panel of experts who commented on an early draft of the interview materials that were used in this study, Dr Janine Beck for statistical advice, and the study volunteers.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Carr J, 2007, TRAUMA, V9, P21, DOI 10.1177/1460408607082845; Edmed S.L., APPL NEUROP IN PRESS; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Powell GE, 2008, J NEUROL NEUROSUR PS, V79, P237, DOI 10.1136/jnnp.2007.131722; Rogers R., 1997, CLIN ASSESSMENT MALI; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Sullivan K. A., J HEAD TRAU IN PRESS; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; World Health Organization, 2004, ICD 10 INT STAT CLAS	28	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2012	27	4					293	301		10.1097/HTR.0b013e31822123ce			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	975PJ	WOS:000306523000006	21829136				2022-02-06	
J	Cai, Y; Zhu, HX; Li, JM; Luo, XG; Patrylo, PR; Rose, GM; Streeter, J; Hayes, R; Wang, KKW; Yan, XX; Jeromin, A				Cai, Yan; Zhu, Hai-Xia; Li, Jian-Ming; Luo, Xue-Gang; Patrylo, Peter R.; Rose, Gregory M.; Streeter, Jackson; Hayes, Ron; Wang, Kevin K. W.; Yan, Xiao-Xin; Jeromin, Andreas			Age-Related Intraneuronal Elevation of alpha II-Spectrin Breakdown Product SBDP120 in Rodent Forebrain Accelerates in 3 x Tg-AD Mice	PLOS ONE			English	Article							TRIPLE-TRANSGENIC MODEL; ALZHEIMERS-DISEASE; OLFACTORY-BULB; BRAIN SPECTRIN; MOUSE MODEL; CALPAIN; PROTEOLYSIS; BETA; ACTIVATION; MEMBRANE	Spectrins line the intracellular surface of plasmalemma and play a critical role in supporting cytoskeletal stability and flexibility. Spectrins can be proteolytically degraded by calpains and caspases, yielding breakdown products (SBDPs) of various molecular sizes, with SBDP120 being largely derived from caspase-3 cleavage. SBDPs are putative biomarkers for traumatic brain injury. The levels of SBDPs also elevate in the brain during aging and perhaps in Alzheimer's disease (AD), although the cellular basis for this change is currently unclear. Here we examined age-related SBDP120 alteration in forebrain neurons in rats and in the triple transgenic model of AD (3xTg-AD) relative to non-transgenic controls. SBDP120 immunoreactivity (IR) was found in cortical neuronal somata in aged rats, and was prominent in the proximal dendrites of the olfactory bulb mitral cells. Western blot and densitometric analyses in wild-type mice revealed an age-related elevation of intraneuronal SBDP120 in the forebrain which was more robust in their 3xTg-AD counterparts. The intraneuronal SBDP120 occurrence was not spatiotemporally correlated with transgenic amyloid precursor protein (APP) expression, beta-amyloid plaque development, or phosphorylated tau expression over various forebrain regions or lamina. No microscopically detectable in situ activated caspase-3 was found in the nuclei of SBDP120-containing neurons. The present study demonstrates the age-dependent intraneuronal presence of an alpha II-spectrin cleavage fragment in mammalian forebrain which is exacerbated in a transgenic model of AD. This novel neuronal alteration indicates that impairments in membrane protein metabolism, possibly due to neuronal calcium mishandling and/or enhancement of calcium sensitive proteolysis, occur during aging and in transgenic AD mice.	[Cai, Yan; Luo, Xue-Gang; Yan, Xiao-Xin] Cent S Univ, Dept Anat & Neurobiol, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Zhu, Hai-Xia] Third Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Li, Jian-Ming] Changsha Med Univ, Neurosci Res Ctr, Changsha, Hunan, Peoples R China; [Patrylo, Peter R.; Rose, Gregory M.] So Illinois Univ, Sch Med, Dept Anat, Carbondale, IL 62901 USA; [Patrylo, Peter R.; Rose, Gregory M.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Patrylo, Peter R.; Rose, Gregory M.; Yan, Xiao-Xin] So Illinois Univ, Sch Med, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA; [Streeter, Jackson; Hayes, Ron; Wang, Kevin K. W.; Jeromin, Andreas] Banyan Biomarkers, Alachua, FL USA		Cai, Y (corresponding author), Cent S Univ, Dept Anat & Neurobiol, Xiangya Med Sch, Changsha, Hunan, Peoples R China.	yanxiaoxin@csu.edu.cn; ajeromin@banyanbio.com		Wang, Kevin/0000-0002-9343-6473	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21NS056371]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171091]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS056371] Funding Source: NIH RePORTER	This work was supported by National Institute of Health (P.R.P., X.X.Y., 1R21NS056371), National Natural Science Foundation of China (X.X.Y., 81171091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; Ayala-Grosso C, 2006, NEUROSCIENCE, V141, P863, DOI 10.1016/j.neuroscience.2006.04.041; BAHR BA, 1991, NEUROSCI LETT, V131, P237, DOI 10.1016/0304-3940(91)90622-Z; Baines AJ, 2010, TRANSFUS CLIN BIOL, V17, P95, DOI 10.1016/j.tracli.2010.06.008; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, J CELL BIOCHEM, V18, P49, DOI 10.1002/jcb.1982.240180106; Bernath E, 2006, NEUROBIOL AGING, V27, P624, DOI 10.1016/j.neurobiolaging.2005.02.013; BHATNAGAR KP, 1987, ANAT REC, V218, P73, DOI 10.1002/ar.1092180112; Bi XN, 1996, BRAIN RES, V726, P98, DOI 10.1016/0006-8993(95)01360-1; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cai Y, 2012, NEUROTOX RES, V21, P160, DOI 10.1007/s12640-011-9256-9; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; Cassano T, 2011, BEHAV BRAIN RES, V224, P408, DOI 10.1016/j.bbr.2011.06.029; Ennis M, 1998, ANN NY ACAD SCI, V855, P457, DOI 10.1111/j.1749-6632.1998.tb10606.x; Gaczynska M., 1992, Cytobios, V72, P197; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Grubb MS, 2010, CURR OPIN NEUROBIOL, V20, P481, DOI 10.1016/j.conb.2010.04.012; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Hwang IK, 2008, NEUROSCI LETT, V435, P251, DOI 10.1016/j.neulet.2008.02.050; ISAYAMA T, 1991, J NEUROSCI, V11, P3531; Keil U, 2006, J ALZHEIMERS DIS, V9, P139; Kudryashova I V, 2009, Neurosci Behav Physiol, V39, P13, DOI 10.1007/s11055-008-9089-z; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee A, 2001, J BIOL CHEM, V276, P20735, DOI 10.1074/jbc.M009723200; Leissring MA, 2001, NEUROBIOL DIS, V8, P469, DOI 10.1006/nbdi.2001.0382; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; MASLIAH E, 1990, BRAIN RES, V531, P36, DOI 10.1016/0006-8993(90)90755-Z; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Nath R, 2000, NEUROCHEM INT, V37, P351, DOI 10.1016/S0197-0186(00)00040-1; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; Newcomb JK, 2000, METH MOL B, V144, P219; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; PETERSON C, 1991, NEUROSCI LETT, V121, P239, DOI 10.1016/0304-3940(91)90694-O; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Ramser EM, 2010, MOL CELL NEUROSCI, V45, P66, DOI 10.1016/j.mcn.2010.05.013; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Rohn TT, 2008, REV NEUROSCIENCE, V19, P383; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Stankewich MC, 2010, P NATL ACAD SCI USA, V107, P6022, DOI 10.1073/pnas.1001522107; STRUBLE RG, 1992, NEUROBIOL AGING, V13, P469, DOI 10.1016/0197-4580(92)90074-8; Susuki K, 2011, P NATL ACAD SCI USA, V108, P8009, DOI 10.1073/pnas.1019600108; Tamada Y, 2005, BRAIN RES, V1050, P148, DOI 10.1016/j.brainres.2005.05.048; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Warren MW, 2007, INT J NEUROPSYCHOPH, V10, P479, DOI 10.1017/S1461145706007061; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Westphal D, 2010, J BIOL CHEM, V285, P42046, DOI 10.1074/jbc.M110.177147; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	58	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37599	10.1371/journal.pone.0037599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	WOS:000305583300007	22723836	Green Published, Green Submitted, gold			2022-02-06	
J	Ferreros, I; Peiro, S; Chirivella-Garrido, J; Duque, P; Gagliardo, P; Perez-Vicente, R; Librero, J				Ferreros, Inmaculada; Peiro, Salvador; Chirivella-Garrido, Javier; Duque, Pablo; Gagliardo, Pablo; Perez-Vicente, Raquel; Librero, Julian			Incidence of hospitalization for traumatic brain injury in children and adolescents (Valencia Community, Spain, 2002-2009)	REVISTA DE NEUROLOGIA			Spanish	Article						Adolescent; Child; Hospitalization; Traumatic brain injury	QUALITY-OF-LIFE; PEDIATRIC TRAUMA; SEVERITY SCORE; INTERNATIONAL CLASSIFICATION; UNITED-STATES; EPIDEMIOLOGY; TRENDS; CARE; PREVALENCE; DISEASES	Introduction. Traumatic brain injuries (TBI) are a major cause of morbidity and mortality in children and adolescents but there are hardly any studies on the incidence and temporal evolution. Aim. To describe recent trends (2002-2009) in the incidence of hospitalization for TBI in children and adolescents in the region of Valencia. Patients and methods. Emergency admissions were identified in hospitals in the Valencian Health Agency from patients aged 0-19 years with a diagnosis of TBI (codes of the International Classification of Diseases 800, 801, 803, 804 and 850 to 854) during 2002 to 2009. The severity was classified using the fifth digit of these codes and the crude and standardized rates per 100,000 children were estimated stratified by age, sex and severity. Results. From 2002 to 2009 a total of 5,504 TBI in children up to age of 19 years were hospitalized (mild: 92.9%; moderate to severe: 7.1%). In-hospital mortality was 0.6% for mild TBI and 15.7% for moderate-severe. Crude rates of mild head injury per 100,000 children fell from 85.9 to 55.4 in 2002-2009 (boys: 114.1 to 68.3, girls: 56.1 to 41.8), especially in the 15-19 years. For moderate-severe TBI, rates decreased from 5.73 to 2.78 per 100,000 in 2002-2009 (boys: 8.69 to 3.67; girls: 2.59 to 1.84). Conclusions. The incidence of pediatric TBI in the Valencia region has decreased significantly in the period 2002-2009, but their medical, legal, societal and family consequences still represents a substantial burden.	[Ferreros, Inmaculada; Peiro, Salvador; Perez-Vicente, Raquel; Librero, Julian] Ctr Super Invest Salad Publ, E-46020 Valencia, Spain; [Chirivella-Garrido, Javier; Duque, Pablo; Gagliardo, Pablo] FIVAN, Fdn Inst Valenciano Neurorrehabilitac, Valencia, Spain; [Chirivella-Garrido, Javier; Duque, Pablo; Gagliardo, Pablo] Hosp NISA Aguas Vivas, Serv Dano Cerebral, Valencia, Spain; [Librero, Julian] Inst Aragones Ciencias Salad, Zaragoza, Spain		Peiro, S (corresponding author), Ctr Super Invest Salad Publ, Avda Cataluna 21, E-46020 Valencia, Spain.	peiro_bor@gva.es	Librero, Julian/F-4947-2017; Peiro, Salvador/H-5778-2017	Librero, Julian/0000-0002-4859-9054; Peiro, Salvador/0000-0002-3902-569X			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Fallat ME, 2009, J TRAUMA, V67, pS106, DOI 10.1097/TA.0b013e3181af04ff; Furnival RA, 1999, PEDIATR EMERG CARE, V15, P215, DOI 10.1097/00006565-199906000-00013; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Grupo de Trabajo sobre la Medida del Impact en Salud de las Lesiones por Traumatismos. Direccion General de Salud Publica del Ministerio de Sanidad y Politics Social, 2010, LES MED TRAUM TRAUM; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Kim J, 2009, ACAD EMERG MED, V16, P454, DOI 10.1111/j.1553-2712.2009.00412.x; Lacerda-Gallardo AJ, 2003, REV NEUROLOGIA, V36, P108, DOI 10.33588/rn.3602.2002213; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; *NAT CTR INJ PREV, 1999, TRAUM BRAIN INJ US R; Orient-Lopez F, 2004, REV NEUROLOGIA, V39, P901, DOI 10.33588/rn.3910.2004302; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Ponsky TA, 2005, J TRAUMA, V59, P1292, DOI 10.1097/01.ta.0000197439.19171.25; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rogers SC, 2010, J TRAUMA, V69, pS209, DOI 10.1097/TA.0b013e3181f1e9fe; Rutledge R, 1998, J TRAUMA, V44, P41, DOI 10.1097/00005373-199801000-00003; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; WATERS M, 1990, ARCH EMERG MED, V7, P9	34	9	9	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	JUN 16	2012	54	12					719	728		10.33588/rn.5412.2011701			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	972FR	WOS:000306263200003	22673948				2022-02-06	
J	Lee, IN; Lin, MHC; Chung, CY; Lee, MH; Weng, HH; Yang, JT				Lee, I-Neng; Lin, Martin Hsiu-Chu; Chung, Chiu-Yen; Lee, Ming-Hsueh; Weng, Hsu-Huei; Yang, Jen-Tsung			Chronic cigarette smoke exposure enhances brain-derived neurotrophic factor expression in rats with traumatic brain injury	METABOLIC BRAIN DISEASE			English	Article						Brain-derived neurotrophic factor; Traumatic brain injury; Cigarette smoke; Apoptosis	NERVOUS-SYSTEM; MESSENGER-RNA; RETROGRADE TRANSPORT; CARBON-MONOXIDE; NICOTINE; RECEPTORS; NEURONS; GENE; BDNF; MECHANISMS	The involvement of brain-derived neurotrophic factor (BDNF) in regulating neuronal survival during neuron differentiation, growth, and maturation, and during the regeneration of injured nerve cells, has already been documented. In experimental Parkinson's disease, chronic exposure to cigarette smoke increased BDNF levels and survival of dopaminergic neurons. BDNF is also elevated in traumatic brain injury (TBI), where it is potentially involved in post-injury repair and regeneration. The aim of this study was to investigate the effects of chronic exposure to cigarette smoke on BDNF expression and apoptosis in rats with TBI. Three groups of rats were compared: rats with TBI after chronic exposure to cigarette smoke, rats with TBI and no exposure to cigarette smoke, and sham-operated rats. BDNF mRNA expression in the hippocampus increased from 2 to 24 h after TBI, and chronic exposure to cigarette smoke upregulated TBI-induced BDNF mRNA elevation at 0, 2, 4, 12, and 24 h after head injury. The BDNF protein levels generally corresponded to the mRNA levels in the hippocampal region. Compared to the TBI group without smoke exposure, chronic cigarette smoke exposure in rats inhibited the decrease of the Bcl-2/Bax ratio and reduced P53 expression and apoptosis 24 h after TBI. In addition, neuronal damage in the parietal and cingulate cortex 7 days after TBI was less extensive in rats exposed to cigarette smoke. In conclusion, although chronic exposure to cigarette smoke is a risk factor for myocardial and pulmonary disease, cigarette smoke exposure increases BDNF expression after TBI and thereby can play a neuroprotective role.	[Lee, I-Neng; Lin, Martin Hsiu-Chu; Lee, Ming-Hsueh; Yang, Jen-Tsung] Chang Gung Mem Hosp, Dept Neurosurg, Pu Tz City, Chia Yi, Taiwan; [Chung, Chiu-Yen] Natl Chung Cheng Univ, Dept Chem Engn, Chiayi, Taiwan; [Weng, Hsu-Huei] Chang Gung Mem Hosp, Dept Diagnost Radiol, Pu Tz City, Chia Yi, Taiwan; [Weng, Hsu-Huei] Chang Gung Inst Technol, Dept Resp Care, Chiayi, Taiwan; [Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan		Yang, JT (corresponding author), Chang Gung Mem Hosp, Dept Neurosurg, 6,Sec W,Chia Pu Rd, Pu Tz City, Chia Yi, Taiwan.	jents716@ms32.hinet.net	Lee, Ming-Hsueh/H-8034-2015; Weng, Hsu-Huei/N-8329-2014	Lee, Ming-Hsueh/0000-0001-5341-7764; Weng, Hsu-Huei/0000-0002-2020-8912	Chang Gung Medical Research Council [CMRPG 670281, 670282]; National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 98-2314-B-182-025-MY2]	This work was supported by Grant CMRPG 670281 and 670282 from the Chang Gung Medical Research Council and Grant NSC 98-2314-B-182-025-MY2 from the National Science Council of Taiwan.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; ALLEN DR, 1988, J VASC SURG, V7, P139, DOI 10.1067/mva.1988.avs0070139; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Finkbeiner S, 2000, CELL MOL LIFE SCI, V57, P394, DOI 10.1007/PL00000701; Fukuchi M, 2005, J PHARMACOL SCI, V98, P212, DOI 10.1254/jphs.FMJ05001X4; Garraway SM, 2011, NEUROSCIENCE, V199, P86, DOI 10.1016/j.neuroscience.2011.10.007; Garraway SM, 2011, NEUROSCIENCE, DOI S0306-4522(11)01210-3; Hernan MA, 2001, ANN NEUROL, V50, P780, DOI 10.1002/ana.10028; Hrabovszky E, 2002, J HISTOCHEM CYTOCHEM, V50, P1389, DOI 10.1177/002215540205001012; Hu YH, 2008, J NEUROCHEM, V105, P1, DOI 10.1111/j.1471-4159.2008.05237.x; KAUFMAN T, 1984, ANN PLAS SURG, V13, P468, DOI 10.1097/00000637-198412000-00002; Lee TH, 2004, J NEUROSCI RES, V76, P705, DOI 10.1002/jnr.20097; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; Linert W, 1999, BBA-MOL BASIS DIS, V1454, P143, DOI 10.1016/S0925-4439(99)00029-0; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Maggio R, 1997, J NEURAL TRANSM, V104, P1113, DOI 10.1007/BF01273324; Malik SZ, 2011, J NEUROTRAUM, V28, P415, DOI 10.1089/neu.2010.1487; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MUFSON EJ, 1994, EXP NEUROL, V129, P15, DOI 10.1006/exnr.1994.1143; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Serres F, 2006, BRAIN RES, V1101, P36, DOI 10.1016/j.brainres.2006.05.023; Sobreviela T, 1996, J COMP NEUROL, V375, P417; Tabuchi A, 2008, BIOL PHARM BULL, V31, P327, DOI 10.1248/bpb.31.327; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tongiorgi E, 2008, NEUROSCI RES, V61, P335, DOI 10.1016/j.neures.2008.04.013; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Yang JT, 2002, CRIT CARE MED, V30, P913, DOI 10.1097/00003246-200204000-00034; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	31	9	9	1	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490			METAB BRAIN DIS	Metab. Brain Dis.	JUN	2012	27	2					197	204		10.1007/s11011-012-9294-x			8	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	940BO	WOS:000303865200012	22476923				2022-02-06	
J	Lee, LC; Lieu, FK; Chen, YH; Hung, TH; Chen, SF				Lee, Lin-Chien; Lieu, Fu-Kong; Chen, Yu-Hsuan; Hung, Tai-Ho; Chen, Szu-Fu			Tension Pneumocephalus as a Complication of Hyperbaric Oxygen Therapy in a Patient with Chronic Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Tension Pneumocephalus; Hyperbaric Oxygen Therapy; Traumatic Brain Injury; Complication	CRANIOFACIAL RESECTION; RARE COMPLICATION; MANAGEMENT	Lee L-C, Lieu F-K, Chen Y-H, Hung T-H, Chen S-F: Tension pneumocephalus as a complication of hyperbaric oxygen therapy in a patient with chronic traumatic brain injury. Am J Phys Med Rehabil 2012;91:528-532. Although hyperbaric oxygen therapy has not been accepted as a standard therapy for traumatic brain injuries, it has been used, along with rehabilitative exercises, for traumatic brain injuries, and the standard protocol has a low risk of complications. We report a case of chronic traumatic brain injury that progressed to tension pneumocephalus after hyperbaric oxygen therapy. The patient was a 25-yr-old man who presented with left occipital bone fracture and subarachnoid and subdural hemorrhage after being hit by a car. He underwent craniectomy to remove the hematoma and cerebrospinal fluid diversion with a ventriculoperitoneal shunt for the treatment of hydrocephalus. Fifteen months after the trauma, the patient received hyperbaric oxygen therapy to promote functional recovery. Tension pneumocephalus developed after the first session of hyperbaric oxygen therapy, and immediate burr hole drainage followed by ligation of the ventriculoperitoneal shunt was performed. The patient's consciousness recovered gradually, and he was discharged home. We suggest that patients with unrepaired skull base fracture and cerebrospinal fluid diversion should be carefully evaluated before receiving hyperbaric oxygen therapy.	[Lee, Lin-Chien; Lieu, Fu-Kong; Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Yu-Hsuan] Cheng Hsin Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Hung, Tai-Ho] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Def Med Ctr, Taipei, Taiwan		Chen, SF (corresponding author), Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, 45 Cheng Hsin St, Taipei, Taiwan.		Hung, Tai-Ho/C-7584-2011; Chen, Szu-Fu/K-5040-2012; Hung, Tai-Ho/ABD-1800-2020	Hung, Tai-Ho/0000-0003-2354-7060			Ambiru S, 2008, J CRIT CARE, V23, P295, DOI 10.1016/j.jcrc.2007.08.002; Bennett Michael H, 2004, COCHRANE DB SYST REV, V18; Budal OH, 2011, UNDERSEA HYPERBAR M, V38, P73; Bunc G, 2001, PEDIATR NEUROSURG, V34, P239, DOI 10.1159/000056029; Clevens RA, 1999, OTOLARYNG HEAD NECK, V120, P579, DOI 10.1053/hn.1999.v120.a83901; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Kemmer A, 2006, HDB HYPERBARIC MED, P655; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Lee CH, 2009, AM J EMERG MED, V27, P257; Lee CH, 2009, AM J EMERG MED, V27, pe1; Lin JW, 2008, ACT NEUR S, V101, P113; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Masel BE, 2011, ARCH PHYS MED REHAB, V92, P1519, DOI 10.1016/j.apmr.2011.06.011; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Michel L, 2007, J TRAUMA, V63, P961, DOI 10.1097/01.ta.0000218060.49040.ab; Ren H, 2001, Chin J Traumatol, V4, P239; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Schrijver HM, 2003, NEUROLOGY, V60, P345, DOI 10.1212/01.WNL.0000033802.04869.14; Shi Xiao-yan, 2003, Chin J Traumatol, V6, P346; Sprague A, 1999, J CLIN NEUROSCI, V6, P418, DOI 10.1016/S0967-5868(99)90040-1; Suri A, 2000, CHILD NERV SYST, V16, P196, DOI 10.1007/s003810050495; Tugcu B, 2009, TURK NEUROSURG, V19, P276; Uemura K, 1997, BRIT J NEUROSURG, V11, P253, DOI 10.1080/02688699746366; Ugarriza LF, 2001, BRIT J NEUROSURG, V15, P161; WANAMAKER JR, 1995, HEAD NECK-J SCI SPEC, V17, P152, DOI 10.1002/hed.2880170215; Webber-Jones Joan E, 2005, J Neurosci Nurs, V37, P272; Zasler ND, 1999, J HEAD TRAUMA REHAB, V14, P81, DOI 10.1097/00001199-199902000-00009	30	9	10	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUN	2012	91	6					528	532		10.1097/PHM.0b013e31824ad556			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	946SK	WOS:000304374600009	22377825				2022-02-06	
J	Nakagawa, K; Chang, CWJ; Koenig, MA; Yu, M; Tokumaru, S				Nakagawa, Kazuma; Chang, Cherylee W. J.; Koenig, Matthew A.; Yu, Mihae; Tokumaru, Sheri			Treatment of refractory intracranial hypertension with 23.4% saline in children with severe traumatic brain injury	JOURNAL OF CLINICAL ANESTHESIA			English	Article						Hypertonic saline; Intracranial hypertension; Pediatric neurotrauma; Traumatic brain injury	HYPERTONIC SALINE; PRESSURE; EPIDEMIOLOGY; MANAGEMENT	The safety and efficacy of osmotic therapy with mannitol and 3% saline in the pediatric head-injured population has been widely reported; the use of 23.4% saline in children for the treatment of refractory intracranial hypertension has not. The clinical and physiologic responses of multiple 23.4% saline boluses in two children with severe traumatic brain injury (TBI) are presented. No complications were associated with the use of 23.4% saline in either patient. (C) 2012 Elsevier Inc. All rights reserved.	[Nakagawa, Kazuma; Chang, Cherylee W. J.; Koenig, Matthew A.] Queens Med Ctr, Inst Neurosci, Honolulu, HI 96813 USA; [Nakagawa, Kazuma; Chang, Cherylee W. J.; Koenig, Matthew A.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96813 USA; [Chang, Cherylee W. J.; Yu, Mihae] Univ Hawaii, John A Burns Sch Med, Dept Surg, Honolulu, HI 96813 USA; [Tokumaru, Sheri] Univ Hawaii, Coll Pharm, Hilo, HI 96720 USA		Nakagawa, K (corresponding author), Queens Med Ctr, Inst Neurosci, 1301 Punchbowl St, Honolulu, HI 96813 USA.	kazuma.nakagawa@hawaii.edu	Chang, Cherylee/Y-8450-2019; Chang, Cherylee/ABG-2080-2020				Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dominguez TE, 2004, CRIT CARE MED, V32, P1438, DOI 10.1097/01.CCM.0000124860.91886.C2; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Morrow SE, 2010, SEMIN PEDIATR SURG, V19, P279, DOI 10.1053/j.sempedsurg.2010.07.001; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	17	9	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	JUN	2012	24	4					318	323		10.1016/j.jclinane.2011.10.011			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	951QS	WOS:000304735700011	22608588				2022-02-06	
J	Ramaswamy, R; Ashton, K; Lea, R; Roberts, P; Davis, CH; Golash, A; Dawson, T				Ramaswamy, Raghu; Ashton, Katherine; Lea, Robert; Roberts, Philip; Davis, Charles H.; Golash, Aprajay; Dawson, Timothy			Study of effectiveness of mifepristone for glioma cell line growth suppression	BRITISH JOURNAL OF NEUROSURGERY			English	Article						cell lines; glioblastoma multiforme; growth suppression; mifepristone; progesterone receptors	TRAUMATIC BRAIN-INJURY; PROGESTERONE-RECEPTORS; ESTROGEN-RECEPTORS; MENINGIOMAS; EXPRESSION; RATS; NEUROFIBROMAS; TAMOXIFEN; TUMORS; RU486	Objective. Glioblastoma multiforme is a malignant primary brain tumour with very limited treatment options. Any addition to existing treatment options which can improve prognosis and life expectancy is useful. In our study, we look at the usefulness of anti-progestogen mifepristone in causing growth suppression of glioma cell lines in the laboratory. Methods. We cultured five cell lines in the lab and exposed them to mifepristone in different doses for a total of 96 h. Five different doses of mifepristone were used. Progesterone and dexamethasone were also used as growth stimulants. Immunostaining was used to identify progesterone receptors (PRs) in the cell lines. Results. U257/7 and IN1265 showed statistically significant growth suppression (36% and 11%, P = 0.001 and 0.03 respectively), maximal at 96 h. Growth suppression in U257/7 showed a dose response progression except with the lowest dose which was not explicable. The response of IN1265 was seen only with the highest dose of mifepristone. There was no significant growth stimulation with either dexamethasone or progesterone. None of the cell lines showed any significant positivity for PRs. Conclusion. We were able to produce enough growth suppression of glioma cell lines using mifepristone. This is in keeping with some of the published results in literature. This raises the possibility of using mifepristone in treating GBMs which have very limited treatment options. This, however, needs further work probably on primary glioma cultures first followed by in vivo studies before it can be used in patients.	[Ramaswamy, Raghu; Ashton, Katherine; Davis, Charles H.; Golash, Aprajay] Royal Preston Hosp, Dept Neurosurg, Preston PR2 6NG, Lancs, England; [Dawson, Timothy] Royal Preston Hosp, Dept Neuropathol, Preston PR2 6NG, Lancs, England; [Lea, Robert; Roberts, Philip] Univ Cent Lancashire, Preston PR1 2HE, Lancs, England		Ramaswamy, R (corresponding author), Royal Preston Hosp, Dept Neurosurg, 6 Otters Close, Preston PR2 6NG, Lancs, England.	ramaswamy_mr@yahoo.co.uk					Ashok Premila W., 2002, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V2, P71, DOI 10.2174/1568013023358924; Blankenstein MA, 2000, STEROIDS, V65, P795, DOI 10.1016/S0039-128X(00)00193-8; Claus EB, 2008, CANCER RES, V68, P314, DOI 10.1158/0008-5472.CAN-07-1796; Gonzalez-Aguero G, 2007, ENDOCRINE, V32, P129, DOI 10.1007/s12020-007-9023-0; Gonzalez-Aguero G, 2001, BRAIN RES BULL, V56, P43, DOI 10.1016/S0361-9230(01)00590-1; GRUNBERG SM, 1991, J NEUROSURG, V74, P861, DOI 10.3171/jns.1991.74.6.0861; Grunberg SM, 2006, CANCER INVEST, V24, P727, DOI 10.1080/07357900601062339; Gupta Vinay, 2006, Neurosurg Focus, V20, pE20, DOI 10.3171/foc.2006.20.4.13; Hsu DW, 1997, J NEUROSURG, V86, P113, DOI 10.3171/jns.1997.86.1.0113; Inoue T, 2002, J CLIN ENDOCR METAB, V87, P5325, DOI 10.1210/jc.2002-012096; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; LAMBERTS SWJ, 1992, J NEUROL NEUROSUR PS, V55, P486, DOI 10.1136/jnnp.55.6.486; Lammert M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-16; Maiuri F, 2007, J NEURO-ONCOL, V82, P63, DOI 10.1007/s11060-005-9078-9; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Och W, 2001, Neurol Neurochir Pol, V35 Suppl 5, P110; Overdiek A, 2008, PEDIATR RES, V64, P40, DOI 10.1203/PDR.0b013e31817445b8; PINSKI J, 1993, J CLIN ENDOCR METAB, V77, P1388, DOI 10.1210/jc.77.5.1388; Pollack IF, 1997, CLIN CANCER RES, V3, P1109; Pravdenkova S, 2006, J NEUROSURG, V105, P163, DOI 10.3171/jns.2006.105.2.163; Puchner MA, 2002, ANTICANCER RES, V22, P45; Quadros PS, 2002, J NEUROENDOCRINOL, V14, P761, DOI 10.1046/j.1365-2826.2002.00827.x; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Tsutsui K, 2006, CEREBELLUM, V5, P89, DOI 10.1080/14734220600697211; Verheijen FM, 2001, EUR J CANCER, V37, P1488, DOI 10.1016/S0959-8049(01)00146-0; Wei MX, 2007, ANTICANCER RES, V27, P953; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656	28	9	9	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2012	26	3					336	339		10.3109/02688697.2011.629696			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	948TA	WOS:000304524300010	22103566				2022-02-06	
J	Yeo, SS; Kim, SH; Kim, OL; Kim, MS; Jang, SH				Yeo, Sang Seok; Kim, Seong Ho; Kim, Oh Lyong; Kim, Min-Su; Jang, Sung Ho			Optic radiation injury in a patient with traumatic brain injury	BRAIN INJURY			English	Article						Optic radiation; head trauma; brain injury; hemianopia; diffusion tensor imaging	DIFFUSION TENSOR TRACTOGRAPHY; TEMPORAL-LOBE RESECTION; HOMONYMOUS HEMIANOPIA; AXONAL INJURY; MAGNETIC-RESONANCE; FIBER TRACKING; RECONSTRUCTION; VISION; MRI; DTI	Primary objective: This study reports on a patient who showed an optic radiation (OR) injury on diffusion tensor imaging (DTI) following head trauma. The patient, who had suffered a traffic accident, underwent conservative management for diffuse axonal injury and contusions in the left midbrain, temporal lobe and anterior to mid-portion of left OR. He complained of right homonymous hemianopsia from the onset of TBI and right bilateral homonymous hemianopsia was detected at the 6-month Humphrey visual field test. Methods and procedures: A 20 year-old man with traumatic brain injury (TBI) and eight age-matched normal subjects were recruited for this study. Main outcomes and results: The left OR of the patient showed a discontinuation around the mid-portion. The FA (fractional anisotropy) values of the posterior portions of left OR decreased over two standard deviations of normal controls, but the ADC (apparent diffusion coefficient) values of these sites increased over two standard deviations of normal controls. Conclusions: Consequently, it was assumed that the main injury site of the left OR was located around the posterior portion of the left OR. This results suggest that DTI may be a useful technique for detection of an OR injury in patients with TBI.	[Yeo, Sang Seok; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea; [Kim, Seong Ho; Kim, Oh Lyong; Kim, Min-Su] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Yeungnam University Medical Center	The authors report no conflicts of interest and no financial relationships. This research was supported by a grant of Yeungnam University Medical Center (2011).	Athanasiadis I, 2010, BRAIN INJURY, V24, P914, DOI 10.3109/02699051003709615; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; Chen ZQ, 2010, J MAGN RESON IMAGING, V31, P1054, DOI 10.1002/jmri.22142; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; ELISEVICH KV, 1984, SURG NEUROL, V22, P565, DOI 10.1016/0090-3019(84)90433-6; Glass HC, 2010, AM J NEURORADIOL, V31, P1424, DOI 10.3174/ajnr.A2110; Hassan A, 2002, CLIN EXP OPHTHALMOL, V30, P273, DOI 10.1046/j.1442-9071.2002.00534.x; Hofer S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00015; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kelts EA, 2010, NEUROREHABILITATION, V27, P223, DOI 10.3233/NRE-2010-0601; Kwak SY, 2010, EUR NEUROL, V63, P149, DOI 10.1159/000281108; Kwon HG, 2011, NEUROREHABILITATION, V28, P383, DOI 10.3233/NRE-2011-0667; Mahmutyazicioglu Kamran, 2005, Diagn Interv Radiol, V11, P19; Marriott Elizabeth, 2007, Semin Ophthalmol, V22, P3, DOI 10.1080/08820530601182543; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Powell HWR, 2005, NEUROLOGY, V65, P596, DOI 10.1212/01.wnl.0000172858.20354.73; Ripley DL, 2010, NEUROREHABILITATION, V27, P215, DOI 10.3233/NRE-2010-0599; Segal L, 2009, J NEURO-OPHTHALMOL, V29, P308, DOI 10.1097/WNO.0b013e3181c1cefd; Seghier ML, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-17; Shinoura N, 2010, ACTA NEUROCHIR, V152, P637, DOI 10.1007/s00701-009-0582-0; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Staempfli P, 2007, J MAGN RESON IMAGING, V26, P886, DOI 10.1002/jmri.21098; TANAKA R, 1992, NEUROSURGERY, V31, P787; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114; Yoshida M, 2006, J NEURO-OPHTHALMOL, V26, P11, DOI 10.1097/01.wno.0000205620.60510.01; Zhang X, 2006, NEUROLOGY, V66, P906, DOI 10.1212/01.wnl.0000203913.12088.93	30	9	9	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2012	26	6					891	895		10.3109/02699052.2012.661119			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500012	22583181				2022-02-06	
J	Argenta, LC; Zheng, ZL; Bryant, A; Tatter, SB; Morykwas, MJ				Argenta, Louis C.; Zheng, Zhenlin; Bryant, Allyson; Tatter, Stephen B.; Morykwas, Michael J.			A New Method for Modulating Traumatic Brain Injury With Mechanical Tissue Resuscitation	NEUROSURGERY			English	Article						Subatmospheric pressure treatment; Tissue resuscitation; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; SEVERE HEAD-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; VACUUM-ASSISTED CLOSURE; RAT-BRAIN; SUBATMOSPHERIC PRESSURE; COMPARTMENT SYNDROME; COGNITIVE DEFICITS; MR SPECTROSCOPY; CEREBRAL EDEMA	BACKGROUND: Traumatic brain injuries remain a treatment enigma with devastating late results. As terminally differentiated tissue, the brain retains little capacity to regenerate, making early attempts to preserve brain cells after brain injury essential. OBJECTIVE: To resuscitate damaged tissue by modulating edema, soluble cytokines, and metabolic products in the "halo" of damaged tissue around the area of central injury that progressively becomes compromised. By re-equilibrating the zone of injury milieu, it is postulated neurons in this area will survive and function. METHODS: Mechanical tissue resuscitation used localized, controlled, subatmospheric pressure directly to the area of controlled cortical impact injury and was compared with untreated injured controls and with sham surgery in a rat model. Functional outcome, T2 magnetic resonance imaging hyperintense volume, magnetic resonance imaging spectroscopy metabolite measurement, tissue water content, injury cavity area, and cortical volume were compared. RESULTS: There were significant differences between mechanical tissue resuscitation treated and untreated groups in levels of myoinositol, N-acetylaspartate, and creatine. Treated animals had significantly less tissue swelling and density than the untreated animals. Nonviable brain tissue areas were smaller in treated animals than in untreated animals. Treated animals performed better than untreated animals in functional tests. Histological analysis showed the remaining viable ipsilateral cerebral area was 58% greater for treated animals than for untreated animals, and the cavity for treated animals was 95% smaller than for untreated animals 1 month after injury. CONCLUSION: Mechanical tissue resuscitation with controlled subatmospheric pressure can significantly modulate levels of excitatory amino acids and lactate in traumatic brain injury, decrease the water content and volume of injured brain, improve neuronal survival, and speed functional recovery.	[Argenta, Louis C.; Zheng, Zhenlin; Bryant, Allyson; Morykwas, Michael J.] Wake Forest Univ Hlth Sci, Dept Plast & Reconstruct Surg, Winston Salem, NC USA; [Tatter, Stephen B.] Wake Forest Univ Hlth Sci, Dept Neurosurg, Winston Salem, NC USA		Argenta, LC (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Plast & Reconstruct Surg, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	largenta@wfubmc.edu	Tatter, Stephen/AAD-6524-2021	Tatter, Stephen/0000-0002-1063-0431	Wake Forest University Department of Plastic and Reconstructive Surgery; REPAIRx Laboratories of the Department of Plastic and Reconstructive Surgery	This study was supported in part by funds from the Cheek Endowment of Wake Forest University Department of Plastic and Reconstructive Surgery. Support was also obtained from REPAIRx Laboratories of the Department of Plastic and Reconstructive Surgery. Wake Forest Health Sciences has applied for patents related to this material. No licenses or royalties have been granted. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Alessandri B, 1999, ACT NEUR S, V75, P21; ANDERSEN BJ, 1992, BRAIN RES, V585, P190, DOI 10.1016/0006-8993(92)91206-T; Atwood T, 2007, RADIAT RES, V168, P574, DOI 10.1667/RR0735.1; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bardt TF, 1998, ACT NEUR S, V71, P153; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Becerra GD, 2007, BEHAV BRAIN RES, V179, P118, DOI 10.1016/j.bbr.2007.01.024; Blaumanis O R, 1990, Adv Neurol, V52, P385; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clauss RP, 2010, MED HYPOTHESES, V75, P287, DOI 10.1016/j.mehy.2010.03.005; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; Gharbawie OA, 2004, BEHAV BRAIN RES, V151, P125, DOI 10.1016/j.bbr.2003.08.009; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Kawamata T, 2007, PROG BRAIN RES, V161, P235, DOI 10.1016/S0079-6123(06)61016-9; Lee AT, 2005, J ORTHOP TRAUMA, V19, P748, DOI 10.1097/01.bot.0000154482.44336.19; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; McIntosh TK, 1996, LAB INVEST, V74, P315; McKeating EG, 1998, BRIT J ANAESTH, V80, P77, DOI 10.1093/bja/80.1.77; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Morykwas MJ, 1999, J BURN CARE REHABIL, V20, P15, DOI 10.1097/00004630-199901001-00003; Morykwas MJ, 2002, J TRAUMA, V53, P537, DOI 10.1097/00005373-200209000-00023; Moues CM, 2008, WOUND REPAIR REGEN, V16, P488, DOI 10.1111/j.1524-475X.2008.00395.x; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Perez D, 2007, J AM COLL SURGEONS, V205, P586, DOI 10.1016/j.jamcollsurg.2007.05.015; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Schuhmann MU, 2000, ACTA NEUROCHIR SUPPL, V76, P3; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Stechmiller JK, 2006, WOUND REPAIR REGEN, V14, P371, DOI 10.1111/j.1743-6109.2006.00134.x; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Thomale UW, 2007, NEUROL RES, V29, P594, DOI 10.1179/016164107X166272; Thomale UW, 2002, ACTA NEUROCHIR SUPPL, V81, P229; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Ward NS, 2006, J PHYSIOL-PARIS, V99, P425, DOI 10.1016/j.jphysparis.2006.03.002; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whalen MJ, 1998, ACT NEUR S, V71, P212; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Yang Charlie C, 2006, J Surg Orthop Adv, V15, P19; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812	79	9	10	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	2012	70	5					1281	1295		10.1227/NEU.0b013e3182446760			15	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	933VA	WOS:000303390400060	22157550				2022-02-06	
J	Bonilla, C; Zurita, M; Otero, L; Aguayo, C; Rico, MA; Vaquero, J				Bonilla, Celia; Zurita, Mercedes; Otero, Laura; Aguayo, Concepcion; Rico, Miguel A.; Vaquero, Jesus			The severity of brain damage determines bone marrow stromal cell therapy efficacy in a traumatic brain injury model	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; cell therapy; bone marrow stromal cells	PROMOTES FUNCTIONAL RECOVERY; SPINAL-CORD REPAIR; OXIDATIVE STRESS; ADULT RATS; PATHOPHYSIOLOGY; TRANSPLANTATION; NEUROGENESIS; EPIDEMIOLOGY; PHARMACOLOGY; INCREASES	BACKGROUND: Patients who survive traumatic brain injury (TBI) can undergo serious sensorial and motor function deficits. Once damage occurs, there is no effective treatment to bring patients to full recovery. Recent studies, however, show bone marrow stromal cells (BMSC) as a potential therapy for TBI. METHODS: This study was designed to determine whether the degree of neurologic deficits influences the efficacy of cell therapy using intracerebral transplantation of BMSC in an experimental model of chronically established TBI. Adult Wistar rats were subjected to weight-drop impact causing TBI. Two months later, the animals were classified according to levels of neurologic deficits. To achieve this, we used two different functional tests: the modified Neurologic Severity Score test and internal zone Permanence Time in Video-Tracking-Box analysis. Saline only or saline containing BMSC was injected into injured brain tissue of the animals that were classified having moderate or severe neurologic damage depending on the level of established functional deficits. All experimental groups were evaluated in the course of the following 2 months to study the efficacy of BMSC administration. The animals were then killed and their brains were studied. RESULTS: Our results showed that significant functional improvement was seen when BMSC was injected into animals with moderate brain damage, but no significant improvement was found in animals with severe functional deficits when compared with controls. CONCLUSION: These findings suggest that the severity of neurologic damage may determine the potential effect of cell therapy when applied to chronically established TBI. (J Trauma. 2012; 72: 1203-1212. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Bonilla, Celia; Zurita, Mercedes; Otero, Laura; Aguayo, Concepcion; Rico, Miguel A.; Vaquero, Jesus] Puerta de Hierro Hosp, Neurosci Unit, Madrid 28222, Spain; [Vaquero, Jesus] Puerta de Hierro Hosp, Serv Neurosurg, Madrid 28222, Spain		Vaquero, J (corresponding author), Puerta de Hierro Hosp, Neurosci Unit, Joaquin Rodrigo 2, Madrid 28222, Spain.	jvaqueroc@telefonica.net		Otero Ortega, Laura/0000-0001-8765-6341	Mapfre Foundation; MM Foundation; Institute of Health Carlos III (FIS)Instituto de Salud Carlos III [PI060650]	Supported by grants from the Mapfre Foundation, MM Foundation, and the Institute of Health Carlos III (FIS, PI060650).	Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Houchens DP, 1978, P S US ATH NUD MIC C, P266; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Morales C, 2002, J NEURO-ONCOL, V56, P219, DOI 10.1023/A:1015014623569; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Otero L, 2010, J NEUROSCI METH, V188, P53, DOI 10.1016/j.jneumeth.2010.01.036; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061; Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069; Zurita M, 2010, CYTOTHERAPY, V12, P522, DOI 10.3109/14653241003615164	47	9	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1203	1211		10.1097/TA.0b013e318248bdcf			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	944JD	WOS:000304195100019	22673246				2022-02-06	
J	Hong, JH; Jang, SH; Kim, OL; Kim, SH; Ahn, SH; Byun, WM; Hong, CP; Lee, DH				Hong, Ji Heon; Jang, Sung Ho; Kim, Oh Lyong; Kim, Seong Ho; Ahn, Sang Ho; Byun, Woo Mok; Hong, Cheol Pyo; Lee, Dong Hoon			Neuronal Loss in the Medial Cholinergic Pathway From the Nucleus Basalis of Meynert in Patients With Traumatic Axonal Injury: A Preliminary Diffusion Tensor Imaging Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognition; diffusion tensor imaging; diffusion tensor tractography; memory; traumatic axonal injury	BRAIN-INJURY; MEMORY IMPAIRMENT; FORNIX INJURY; TRACTOGRAPHY; MILD; CINGULUM; TRACKING	Objective: The recent development of diffusion tensor imaging (DTI) allows visualization and estimation of the medial cholinergic pathway (MCP), which originates from the nucleus basalis of Meynert and provides cortical cholinergic innervation to the cerebral cortex. We investigated the injury to the MCP in patients with traumatic axonal injury (TAI), using DTI. Design: Retrospective survey. Participants: Fourteen patients with chronic TAI and 14 age-and sex-matched normal control subjects. Main Outcome Measures: Using the Functional Magnetic Resonance Imaging of the Brain (FMRIB) Software Library (FMRIB analysis group, Oxford University, United Kingdom), diffusion tensor images were acquired by using a sensitivity-encoding head coil at 1.5 T DTIs. Fractional anisotropy (FA), mean diffusivity (MD), and tract volume of the MCP were measured. Results: The FA value and tract volume were significantly decreased in the group with TAI compared with those of the control group (P<.05); in contrast, there was no difference in the MD value between the 2 groups (P>.05). Conclusions: Changes in DTI parameters of the TAI group appear to be due to neuronal loss of the MCP. We believe that DTI would be useful for the evaluation of the MCP in patients with TAI.	[Jang, Sung Ho; Ahn, Sang Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Hong, Ji Heon] Sun Moon Univ, Dept Phys Therapy, Asan, Chungnam, South Korea; [Kim, Oh Lyong; Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea; [Byun, Woo Mok] Yeungnam Univ, Coll Med, Dept Diagnost Radiol, Taegu 705717, South Korea; [Hong, Cheol Pyo; Lee, Dong Hoon] Yonsei Univ, Coll Hlth Sci, Dept Radiol Sci, Seoul 120749, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	stro-kerehab@hanmail.net	Lee, Dong-Hoon/G-4959-2016	Lee, Dong-Hoon/0000-0002-5013-4440	National Research Foundation of KoreaNational Research Foundation of Korea; Korean GovernmentKorean Government [KRF-2008-314-E00173]	This work was supported by National Research Foundation of Korea Grant funded by the Korean Government (KRF-2008-314-E00173).	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Benarroch EE, 2010, NEUROLOGY, V75, P659, DOI 10.1212/WNL.0b013e3181ee267e; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hong JH, 2010, BRAIN RES, V1346, P190, DOI 10.1016/j.brainres.2010.05.088; Hong JH, 2010, EUR NEUROL, V63, P252, DOI 10.1159/000277477; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jang SH, 2009, ARCH NEUROL-CHICAGO, V66, P1424, DOI 10.1001/archneurol.2009.242; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Mesulam MM, 2004, PROG BRAIN RES, V145, P67, DOI 10.1016/S0079-6123(03)45004-8; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mufson EJ, 2003, J CHEM NEUROANAT, V26, P233, DOI 10.1016/S0891-0618(03)00068-1; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stadlbauer A, 2008, EUR RADIOL, V18, P130, DOI 10.1007/s00330-007-0733-8; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler, 1997, WECHSLER ADULT INTEL; Williams JM., 1991, MAS MEMORY ASSESSMEN; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	33	9	9	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2012	27	3					172	176		10.1097/HTR.0b013e318217192d			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941CV	WOS:000303941500005	21522026				2022-02-06	
J	Kim, DY; Kobayashi, L; Barmparas, G; Fortlage, D; Curry, T; Coimbra, R				Kim, Dennis Y.; Kobayashi, Leslie; Barmparas, Galinos; Fortlage, Dale; Curry, Terry; Coimbra, Raul			Venous thromboembolism in the elderly: The result of comorbid conditions or a consequence of injury?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Thromboembolism; deep vein thrombosis; pulmonary embolism; geriatric trauma; risk factors; outcomes	RISK-FACTORS; TRAUMA PATIENTS; MAJOR TRAUMA; PREVENTION; PROPHYLAXIS; THROMBOSIS; HEPARIN	BACKGROUND: Venous thromboembolism (VTE) is a common complication in trauma patients. Several risk factors have been identified that may place patients at in increased risk for VTE including preexisting medical conditions, iatrogenic factors, and injury-related factors. Advanced age has also been implicated as a risk factor for VTE. The purpose of this study was to determine the incidence and outcomes of VTE in geriatric trauma patients as well as to identify risk factors for VTE in this population. METHODS: We performed a 10-year retrospective review of all trauma patients aged 65 years or older discharged with a diagnosis of VTE. Demographic data, injuries, mechanism, Injury Severity Score, Abbreviated Injury Score, Glasgow Coma Scale, length of stay, and mortality were collected. RESULTS: Of 2,521 trauma patients aged 65 years or older, 82 (3.2%) were diagnosed with VTE. Seventy-two of 82 patients were diagnosed with deep vein thrombosis, and pulmonary embolism was found in 8 patients. Two patients had both a deep vein thrombosis and pulmonary embolism. Independent predictors of VTE included traumatic brain injury (p < 0.05); chest Abbreviated Injury Score >= 3 (p < 0.001); mechanical ventilation (p < 0.001); major operation (p < 0.001); and history of VTE (p = 0.05). Other comorbid conditions were not significantly associated with VTE. Preinjury anticoagulation had a trend toward a protective effect. Although length of stay was longer in patients with VTE (adjusted mean difference 14.7 days, p < 0.001), mortality for patients with and without VTE was 8.5% and 7.0%, respectively (p = 0.59). CONCLUSION: VTE is associated with prolonged length of stay and duration of mechanical ventilation as well as continued medical dependence after discharge. Several risk factors place the elderly trauma patient at an increased risk for VTE, and trauma or injury-related risk factors seem to have a greater impact on the development of VTE in comparison to underlying conditions or increasing patient age (> 65 years). (J Trauma. 2012;72: 1286-1291. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Kim, Dennis Y.; Kobayashi, Leslie; Fortlage, Dale; Curry, Terry; Coimbra, Raul] Univ Calif San Diego, Med Ctr, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA; [Barmparas, Galinos] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Coimbra, R (corresponding author), 200 W Arbor Dr,8896, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020; Barmparas, Galinos/L-6530-2019	Coimbra, Raul/0000-0002-3759-6851; 			ABBATE R, 1993, INT J CLIN LAB RES, V23, P1, DOI 10.1007/BF02592271; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; DEMARIA EJ, 1987, J TRAUMA, V27, P1200; Franchini M, 2006, CRIT REV ONCOL HEMAT, V60, P144, DOI 10.1016/j.critrevonc.2006.06.004; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Greenfield LJ, 1997, J TRAUMA, V42, P100, DOI 10.1097/00005373-199701000-00017; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; KNUDSON MM, 1994, J TRAUMA, V37, P480, DOI 10.1097/00005373-199409000-00025; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Kopelman TR, 2010, J TRAUMA, V68, P1294; Martin JT, 2010, AM SURGEON, V76, P65; Martinelli I, 2010, CRIT CARE MED, V38, pS3, DOI 10.1097/CCM.0b013e3181c9cbd9; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Rogers SO, 2007, J TRAUMA, V62, P562; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; Seamon MJ, 2010, J TRAUMA, V68, P1289, DOI 10.1097/TA.0b013e3181db05dc; Selby R, 2009, THROMB RES, V124, P281, DOI 10.1016/j.thromres.2008.10.002; Sellier E, 2008, J AM GERIATR SOC, V56, P224, DOI 10.1111/j.1532-5415.2007.01545.x; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; Slavik RS, 2007, J TRAUMA, V62, P1075, DOI 10.1097/TA.0b013e31804fa177; SPANNAGEL U, 1993, SEMIN THROMB HEMOST, V19, P131; TRACY RP, 1992, ARCH PATHOL LAB MED, V116, P1307; U. S. Census Bureau, 2000, US CENS 2000; UPCHURCH GR, 1995, AM SURGEON, V61, P749; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3; Velmahos GC, 2000, J TRAUMA, V49, P140, DOI 10.1097/00005373-200007000-00021; Weill-Engerer S, 2004, J AM GERIATR SOC, V52, P1299, DOI 10.1111/j.1532-5415.2004.52359.x; Wilkerson WR, 2002, SEMIN THROMB HEMOST, V28, P555, DOI 10.1055/s-2002-36700	32	9	10	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1286	1291		10.1097/TA.0b013e31824ef9ec			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	944JD	WOS:000304195100033	22673256				2022-02-06	
J	Oliveira, E; Lavrador, JP; Santos, MM; Antunes, JL				Oliveira, Edson; Lavrador, Jose Pedro; Santos, Maria Manuel; Antunes, Joao Lobo			Traumatic Brain Injury: Integrated Approach	ACTA MEDICA PORTUGUESA			Portuguese	Article							SPINAL-CORD-INJURY; SEVERE HEAD-INJURY; HETEROTOPIC OSSIFICATION; EXTRADURAL HEMATOMA; VENOUS THROMBOEMBOLISM; PITUITARY DYSFUNCTION; SUBDURAL-HEMATOMA; SLEEP DISTURBANCE; PREHOSPITAL CARE; LEVEL-I	Traumatic brain injury is a public health problem with significant economic and social impact. Its incidence has increased worldwide at the expense of developing countries and remains as the major cause of morbidity and mortality among young adults. The authors present a general and integrated approach of this pathology contextualizing epidemiological, pathophysiological, clinical and therapeutical aspects.	[Oliveira, Edson; Lavrador, Jose Pedro; Santos, Maria Manuel; Antunes, Joao Lobo] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Serv Neurocirurgia, Lisbon, Portugal		Oliveira, E (corresponding author), Hosp Santa Maria, Ctr Hosp Lisboa Norte, Serv Neurocirurgia, Lisbon, Portugal.			Lavrador, Jose Pedro/0000-0002-9518-111X			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BAXT WG, 1983, JAMA-J AM MED ASSOC, V249, P3047, DOI 10.1001/jama.249.22.3047; Becker DP, 1994, CRANIOCEREBRAL TRAUM; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Calland V, 2005, EMERG MED J, V22, P817, DOI 10.1136/emj.2004.022616; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHESNUT R, 1999, TRAUMATIC BRAIN INJU, P81; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Di Bartolomeo S, 2001, ARCH SURG-CHICAGO, V136, P1293, DOI 10.1001/archsurg.136.11.1293; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Firsching R, 2001, WORLD J SURG, V25, P1221; Forsyth RJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003984.pub2; GALLAGHE.JP, 1968, J NEUROSURG, V29, P1, DOI 10.3171/jns.1968.29.1.0001; Gennarelli T., 1983, HEAD INJURY, P137; GENTLEMAN D, 1992, INT SURG, V77, P297; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Gottesman RF, 2003, INT REV PSYCHIATR, V15, P302, DOI 10.1080/09540260310001606683; Graham D.I., 1996, NEUROTRAUMA, P43; Gray P, 2007, EXPERT OPIN PHARMACO, V8, P3035, DOI 10.1517/14656566.8.17.3035; Greenberg M, 2010, HDB NEUROSURGERY THI, P860; GREENBERG RP, 1981, J NEUROSURG, V54, P740, DOI 10.3171/jns.1981.54.6.0740; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; GUSS DA, 1989, ANN EMERG MED, V18, P1141, DOI 10.1016/S0196-0644(89)80048-4; Guyot LL, 2000, NEUROL RES, V22, P25; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Heiskanen O, 1975, Surg Neurol, V4, P23; Holbourn AHS, 1943, LANCET, V2, P438; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee A, 2003, INJURY, V34, P815, DOI 10.1016/S0020-1383(02)00395-9; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Lindenberg R, 1971, PATHOLOGY NERVOUS SY, V2, P1705; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Lombardi F., 2002, COCHRANE DB SYST REV, V2002, DOI DOI 10.1002/14651858.CD001427; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MALONEY AFJ, 1969, BRIT J SURG, V56, P23, DOI 10.1002/bjs.1800560106; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; McCabe Candida S, 2009, Curr Rheumatol Rep, V11, P461; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Miller WG, 1986, NEUROPSYCHOLOGY HDB, P347; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NORWOOD S, 1995, J TRAUMA, V39, P240, DOI 10.1097/00005373-199508000-00009; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Page RB, 2004, NEUROSURGERY, V54, P143, DOI 10.1227/01.NEU.0000097514.60813.1B; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Reale F, 1984, J Neurosurg Sci, V28, P9; REILLY P, 2005, HEAD INJURY PATHOPHY; RIBAS GC, 1992, J NEUROTRAUM, V9, pS265; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Santos Maria Emilia, 2003, Acta Med Port, V16, P71; Sawauchi S, 2008, ACTA NEUROCHIR, V150, P531, DOI 10.1007/s00701-007-1497-2; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SEELIG JM, 1981, J NEUROSURG, V55, P516, DOI 10.3171/jns.1981.55.4.0516; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Solomon S, 2001, MED CLIN N AM, V85, P987, DOI 10.1016/S0025-7125(05)70355-2; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; STRICH SJ, 1961, LANCET, V2, P443; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G., 1996, MANUAL NEUROSURGERY, P544; Terre R, 2009, NEUROGASTROENT MOTIL, V21, P361, DOI 10.1111/j.1365-2982.2008.01208.x; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P539; Thurman, 2001, HEAD TRAUMA BASIC PR, P1193; U. S. National Institutes of Health, 1998, REH PERS TRAUM BRAIN; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vergouwen MDI, 2008, CURR OPIN CRIT CARE, V14, P149, DOI 10.1097/MCC.0b013e3282f57540; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wiffen PJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006044.pub3; Willis C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003986.PUB2; Wilmink ABM, 1996, INJURY, V27, P21, DOI 10.1016/0020-1383(95)00162-X; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Winn HR, 2011, YOUMANS NEUROLOGICAL, V4, P3305; Winn HR, 2011, YOUMANS NEUROLOGICAL, V4, P3270; Winn HR, 2011, YOUMANS NEUROLOGICAL, V4, P3362; WINTZEN AR, 1984, ANN NEUROL, V16, P553, DOI 10.1002/ana.410160505; Yanagawa T, 2002, COCHRANE DB SYST REV; Zhuo M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-31; ZIMMERMAN RA, 1978, AM J ROENTGENOL, V131, P27, DOI 10.2214/ajr.131.1.27; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729	135	9	12	0	3	ORDEM MEDICOS	LISBON	AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL	1646-0758			ACTA MEDICA PORT	Acta Medica Port.	MAY-JUN	2012	25	3					179	192					14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012AV	WOS:000309208700007	23069239				2022-02-06	
J	Oostra, KM; Vereecke, A; Jones, K; Vanderstraeten, G; Vingerhoets, G				Oostra, Kristine M.; Vereecke, Annelies; Jones, Kim; Vanderstraeten, Guy; Vingerhoets, Guy			Motor Imagery Ability in Patients With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Mediterranean Congress of Physical and Rehabilitation Medicine	SEP 29-OCT 02, 2010	Limassol, CYPRUS			Brain injuries; Rehabilitation	MENTAL PRACTICE; POSTSTROKE HEMIPARESIS; GAIT REHABILITATION; CHRONIC STROKE; UPPER-LIMB; ANOSOGNOSIA; REPRESENTATIONS; HEMIPLEGIA	Oostra KM, Vereecke A, Jones K, Vanderstraeten G, Vingerhoets G. Motor imagery ability in patients with traumatic brain injury. Arch Phys Med Rehabil 2012;93:828-33. Objective: To assess motor imagery (MI) ability in patients with moderate to severe traumatic brain injury (TBI). Design: Prospective, cohort study. Setting: University hospital rehabilitation unit. Participants: Patients with traumatic brain injury (mean coma duration, 18d) undergoing rehabilitation (n=20) and healthy controls (n=17) matched for age and education level. Interventions: Not applicable. Main Outcome Measures: The vividness of MI was assessed using a revised version of the Movement Imagery Questionnaire-Revised second version (MIQ-RS); the temporal features were assessed using the time-dependent motor imagery (TDMI) screening test, the temporal congruence test, and a walking trajectory imagery test; and the accuracy of MI was assessed using a mental rotation test. Results: The MIQ-RS revealed a decrease of MI vividness in the TBI group. An increasing number of stepping movements was observed with increasing time periods in both groups during the TDMI screening test. The TBI group performed a significantly smaller number of imagery movements in the same movement time. The temporal congruence test revealed a significant correlation between imagery and actual stepping time in both groups. The walking trajectory test revealed an increase of the imagery and actual walking time with increasing path length in both groups, but the ratio of imaginary walking over actual walking time was significantly greater than 1 in the TBI group. Results of the hand mental rotation test indicated significant effects of rotation angles on imagery movement times in both groups, but rotation time was significantly slower in the TBI group. Conclusions: Our patients with TBI demonstrated a relatively preserved MI ability indicating that MI could be used to aid rehabilitation and subsequent functional recovery.	[Oostra, Kristine M.; Vereecke, Annelies; Vanderstraeten, Guy] Ghent Univ Hosp, Dept Phys & Rehabil Med, Ghent, Belgium; [Jones, Kim] Ghent Univ Hosp, Gait & Movement Anal Lab, Ghent, Belgium; [Vingerhoets, Guy] Univ Ghent, Neuropsychol Lab, B-9000 Ghent, Belgium		Oostra, KM (corresponding author), DePintelaan 185, B-9000 Ghent, Belgium.	kristine.oostra@UZGent.be	Oostra, Kristine/AAI-7317-2020				Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; Battaglia F, 2006, CLIN NEUROPHYSIOL, V117, P1009, DOI 10.1016/j.clinph.2006.01.008; Caeyenberghs K, 2009, BRAIN COGNITION, V69, P154, DOI 10.1016/j.bandc.2008.07.001; Craje C, 2010, RES DEV DISABIL, V31, P1313, DOI 10.1016/j.ridd.2010.07.010; Crosbie JH, 2004, CLIN REHABIL, V18, P60, DOI 10.1191/0269215504cr702oa; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Decety Jean, 1995, Behavioural Brain Research, V72, P127, DOI 10.1016/0166-4328(96)00141-6; Dickstein R, 2004, PHYS THER, V84, P1167, DOI 10.1093/ptj/84.12.1167; Dijkerman HC, 2004, CLIN REHABIL, V18, P538, DOI 10.1191/0269215504cr769oa; DOMINEY P, 1995, NEUROPSYCHOLOGIA, V33, P727, DOI 10.1016/0028-3932(95)00008-Q; Dunsky A, 2008, ARCH PHYS MED REHAB, V89, P1580, DOI 10.1016/j.apmr.2007.12.039; Gregg M, 2010, EVID-BASED COMPL ALT, V7, P249, DOI 10.1093/ecam/nem170; HALL C, 1989, J HUM MOVEMENT STUD, V17, P89; HALL C, 1985, HUM MOVEMENT SCI, V4, P107, DOI 10.1016/0167-9457(85)90006-5; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jenkinson PM, 2009, NEUROPSYCHOLOGIA, V47, P481, DOI 10.1016/j.neuropsychologia.2008.10.004; Johnson SH, 2002, J COGNITIVE NEUROSCI, V14, P841, DOI 10.1162/089892902760191072; Kimberley TJ, 2006, NEUROREHAB NEURAL RE, V20, P268, DOI 10.1177/1545968306286958; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Malouin F, 2008, NEUROREHAB NEURAL RE, V22, P330, DOI 10.1177/1545968307313499; Malouin Francine, 2007, J Neurol Phys Ther, V31, P20; Malouin F, 2008, ARCH PHYS MED REHAB, V89, P311, DOI 10.1016/j.apmr.2007.11.006; Malouin F, 2010, PHYS THER, V90, P240, DOI 10.2522/ptj.20090029; McAvinue LP, 2008, EUR J COGN PSYCHOL, V20, P232, DOI 10.1080/09541440701394624; McAvinue LP, 2007, PERCEPT MOTOR SKILL, V104, P823, DOI 10.2466/PMS-104.3.823-843; Mutsaarts M, 2007, NEUROPSYCHOLOGIA, V45, P853, DOI 10.1016/j.neuropsychologia.2006.08.020; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc	32	9	11	0	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2012	93	5					828	833		10.1016/j.apmr.2011.11.018			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	939DV	WOS:000303788500014	22365480	Green Published			2022-02-06	
J	Sondergaard, M; Fisher, AG				Sondergaard, Mette; Fisher, Anne G.			Sensitivity of the Evaluation of Social Interaction Measures Among People With and Without Neurologic or Psychiatric Disorders	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						interpersonal relations; mental disorders; nervous system diseases; personality assessment; sensitivity and specificity	TRAUMATIC BRAIN-INJURY; PERCEPTION DEFICITS; SKILLS PERFORMANCE; SCHIZOPHRENIA; COMMUNICATION; TRIAL	OBJECTIVE. To determine whether the Evaluation of Social Interaction (ESI) is sensitive enough to differentiate between people without identified diagnoses and those with neurologic or psychiatric disorders in terms of their observed quality of social interaction. METHOD. Participants were age 16-69 and were without identified diagnoses (n = 304) or had neurologic (n = 77) or psychiatric (n = 104) disorders. They were evaluated using the ESI. RESULTS. Nonparametric Kruskal-Wallis tests and post hoc Mann-Whitney U tests revealed that the group without identified diagnoses had significantly better quality of social interaction than did either group with disabilities (Us = 3,172 and 3,189, respectively; p <= .001). CONCLUSION. The ESI is sensitive with regard to detecting differences in quality of social interaction among groups expected to differ, suggesting that it is valid for use when the desired purpose is to identify people with diminished quality of social interaction.	[Fisher, Anne G.] Umea Univ, Dept Community Med & Rehabil, Div Occupat Therapy, Umea, Sweden; [Fisher, Anne G.] AMPS Project Int, Ft Collins, CO 80527 USA			anne.fisher@ampsintl.com					Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Coster WJ, 2008, AM J OCCUP THER, V62, P743, DOI 10.5014/ajot.62.6.743; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Doble S. E., 1991, CANADIAN J OCCUPATIO, V58, P241; Doble SE., 1992, CJOT, V59, P141, DOI [10.1177/000841749205900304, DOI 10.1177/000841749205900304]; Englund B, 1995, SCAND J OCCUP THER, V2, P17, DOI DOI 10.3109/11038129509106794; Englund B, 1997, BSI BEDOMNING UNPUB; Fisher A. G., 2010, EVALUATION SOCIAL IN, V2nd; Fisher AG, 2009, OCCUPATIONAL THERAPY; Forsyth K., 1998, USERS GUIDE ASSESSME; Forsyth K, 1996, VALIDITY ASSES UNPUB; Forsyth K., 1999, BRIT J OCCUP THER, V62, P69, DOI [10.1177/030802269906200208, DOI 10.1177/030802269906200208]; HALFORD WK, 1995, SOC PSYCH PSYCH EPID, V30, P14, DOI 10.1007/BF00784429; Harvey PD, 2007, SCHIZOPHRENIA BULL, V33, P1138, DOI 10.1093/schbul/sbm040; LINACRE J, 1993, MANY FACET RASCH MEA; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Patterson TL, 2001, SCHIZOPHR RES, V48, P351, DOI 10.1016/S0920-9964(00)00109-2; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; Segrin C, 2003, LEA COMMUN SER, P135; Simmons CD, 2010, AM J OCCUP THER, V64, P10, DOI 10.5014/ajot.64.1.10; Sitzer DI, 2008, PSYCHOL MED, V38, P755, DOI 10.1017/S0033291707001304; Smith TE, 1996, CLIN PSYCHOL REV, V16, P599, DOI 10.1016/S0272-7358(96)00025-6; Stevens J, 1999, INTERMEDIATE STAT MO; Walker D., 1999, HDB SCH PSYCHOL, P686; Yilmaz M, 2008, SCAND J OCCUP THER, V15, P162, DOI 10.1080/11038120802022102	27	9	9	0	3	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	MAY-JUN	2012	66	3					356	362		10.5014/ajot.2012.003582			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	942VP	WOS:000304078400013	22549601				2022-02-06	
J	Hutchinson, EB; Rutecki, PA; Alexander, AL; Sutula, TP				Hutchinson, Elizabeth B.; Rutecki, Paul A.; Alexander, Andrew L.; Sutula, Thomas P.			Fisher statistics for analysis of diffusion tensor directional information	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Diffusion tensor MRI; Fisher statistics; Eigenvector orientation; Hippocampus; Epilepsy; Traumatic brain injury	ORIENTATION; MRI	A statistical approach is presented for the quantitative analysis of diffusion tensor imaging (DTI) directional information using Fisher statistics, which were originally developed for the analysis of vectors in the field of paleomagnetism. In this framework, descriptive and inferential statistics have been formulated based on the Fisher probability density function, a spherical analogue of the normal distribution. The Fisher approach was evaluated for investigation of rat brain DTI maps to characterize tissue orientation in the corpus callosum, fornix, and hilus of the dorsal hippocampal dentate gyrus, and to compare directional properties in these regions following status epilepticus (SE) or traumatic brain injury (TBI) with values in healthy brains. Direction vectors were determined for each region of interest (ROI) for each brain sample and Fisher statistics were applied to calculate the mean direction vector and variance parameters in the corpus callosum, fornix, and dentate gyrus of normal rats and rats that experienced TBI or SE. Hypothesis testing was performed by calculation of Watson's F-statistic and associated p-value giving the likelihood that grouped observations were from the same directional distribution. In the fornix and midline corpus callosum, no directional differences were detected between groups, however in the hilus, significant (p < 0.0005) differences were found that robustly confirmed observations that were suggested by visual inspection of directionally encoded color DTI maps. The Fisher approach is a potentially useful analysis tool that may extend the current capabilities of DTI investigation by providing a means of statistical comparison of tissue structural orientation. (C) 2012 Elsevier B.V. All rights reserved.	[Hutchinson, Elizabeth B.; Rutecki, Paul A.; Sutula, Thomas P.] Univ Wisconsin, Dept Neurol, Madison, WI 53705 USA; [Rutecki, Paul A.] William S Middleton Mem VA Hosp, Dept Neurol, Madison, WI 53705 USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, Wisconsin Inst Med Res, Madison, WI 53705 USA		Hutchinson, EB (corresponding author), 1760 Med Sci Ctr, 1300 Univ Ave, Madison, WI 53706 USA.	ehutchinson@wisc.edu; rutecki@neurology.wisc.edu; alalexander2@wisc.edu; sutula@neurology.wisc.edu		Hutchinson, Elizabeth/0000-0002-3374-5469	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 25020]; Department of DefenseUnited States Department of Defense [DR080424]; Lily's Fund for Epilepsy Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS025020] Funding Source: NIH RePORTER	The authors thank Sue Osting and Craig Levenick for their technical assistance with animal surgeries and sample preparation. This work was funded by the following sources: NINDS R01 25020 and Department of Defense DR080424. EH is funded in part by an award from the Lily's Fund for Epilepsy Research.	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Butler R.F., 1992, PALEOMAGNETISM MAGNE; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dudek FE, 2002, PROG BRAIN RES, V135, P53; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Koay CG, 2006, J MAGN RESON, V182, P115, DOI 10.1016/j.jmr.2006.06.020; Kuo LW, 2008, NEUROIMAGE, V41, P789, DOI 10.1016/j.neuroimage.2008.03.013; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; MCFADDEN PL, 1980, GEOPHYS J ROY ASTR S, V60, P397, DOI 10.1111/j.1365-246X.1980.tb04816.x; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A; Tauxe L., 2010, ESSENTIALS PALEOMAGN; Wang JJ, 2008, MAGN RESON MED, V59, P764, DOI 10.1002/mrm.21458; Watson C., 1986, RAT BRAIN STEREOTAXI; Watson G.S., 1956, GEOPHYS SUPPL MON NO, V7, P153, DOI [10.1111/j.1365-246x.1956.tb05560.x, DOI 10.1111/J.1365-246X.1956.TB05560.X]; Wu YC, 2004, MAGN RESON MED, V52, P1146, DOI 10.1002/mrm.20254	17	9	9	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	APR 30	2012	206	1					40	45		10.1016/j.jneumeth.2012.02.004			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	928JW	WOS:000302980000006	22342971	Green Accepted			2022-02-06	
J	Zhao, JJ; Chen, NY; Shen, N; Zhao, H; Wang, DL; Shi, J; Wang, Y; Cui, XF; Yan, ZY; Xue, H				Zhao, Junjian; Chen, Naiyao; Shen, Na; Zhao, Hui; Wang, Dali; Shi, Jun; Wang, Yang; Cui, Xiufeng; Yan, Zhenyu; Xue, Hui			Transplantation of human umbilical cord blood mesenchymal stem cells to treat a rat model of traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						angiogenesis; basic fibroblast growth factor; brain-derived neurotrophic factor; human umbilical cord blood mesenchymal stem cells; nerve growth factor; traumatic brain injury; vascular endothelial growth factor	MARROW STROMAL CELLS; EXPRESSION; ANGIOGENESIS; NEUROTROPHINS; NEURONS; NEOVASCULARIZATION; RECOVERY; THERAPY; STROKE; DEATH	In the present study, human umbilical cord blood mesenchymal stem cells were injected into a rat model of traumatic brain injury via the tail vein. Results showed that 5-bromodeoxyuridine-labeled cells aggregated around the injury site, surviving up to 4 weeks post-transplantation. In addition, transplantation-related death did not occur, and neurological functions significantly improved. Histological detection revealed attenuated pathological injury in rat brain tissues following human umbilical cord blood mesenchymal stem cell transplantation. In addition, the number of apoptotic cells decreased. Immunohistochemistry and in situ hybridization showed increased expression of brain-derived neurotrophic factor, nerve growth factor, basic fibroblast growth factor, and vascular endothelial growth factor, along with increased microvessel density in surrounding areas of brain injury. Results demonstrated migration of transplanted human umbilical cord blood mesenchymal stem cells into the lesioned boundary zone of rats, as well as increased angiogenesis and expression of related neurotrophic factors in the lesioned boundary zone.	[Zhao, Junjian; Chen, Naiyao; Shen, Na; Zhao, Hui; Wang, Dali; Shi, Jun; Cui, Xiufeng; Yan, Zhenyu; Xue, Hui] Hebei United Univ, Affiliated Hosp, Tangshan 063000, Hebei Province, Peoples R China; [Zhao, Hui] Tianjin Univ Commerce, Tianjin Key Lab Food Biotechnol, Tianjin 300134, Peoples R China; [Wang, Yang] Hebei United Univ, Coll Life Sci, Tangshan 063000, Hebei Province, Peoples R China		Chen, NY (corresponding author), Hebei United Univ, Affiliated Hosp, Tangshan 063000, Hebei Province, Peoples R China.	nychenncmc@yahoo.com	Zhao, Hui/AAB-2163-2019		Hebei Provincial Health Department [20100131]	The study was supported by Medical Scientific Research Program of Hebei Province in 2010, Hebei Provincial Health Department, No. 20100131.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; [陈乃耀 CHEN Nai-Yao], 2010, [中国全科医学, Chinese General Practice], V13, P947; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Fatar M, 2008, NEUROSCI LETT, V443, P174, DOI 10.1016/j.neulet.2008.07.077; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ferrer I, 1998, BRAIN PATHOL, V8, P253; Jin KL, 2006, J NEUROBIOL, V66, P236, DOI 10.1002/neu.20215; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Li N, 2009, STEM CELLS, V27, P961, DOI 10.1002/stem.6; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Newman MP, 2000, NEUROSCIENCE, V99, P343, DOI 10.1016/S0306-4522(00)00194-9; Park HJ, 2008, J NEUROCHEM, V107, P141, DOI 10.1111/j.1471-4159.2008.05589.x; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; RINK A, 1995, AM J PATHOL, V147, P1575; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wu KH, 2007, ANN THORAC SURG, V83, P1491, DOI 10.1016/j.athoracsur.2006.10.066; Zadeh G, 2003, NEUROSURGERY, V53, P1362, DOI 10.1227/01.NEU.0000093425.98136.31; Zhou B, 2007, MED HYPOTHESES, V68, P1268, DOI 10.1016/j.mehy.2006.09.066	43	9	12	0	17	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR 5	2012	7	10					741	748		10.3969/j.issn.1673-5374.2012.10.004			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	939BB	WOS:000303778200004	25737696				2022-02-06	
J	Artsy, E; McCarthy, DC; Hurwitz, S; Pavlova, MK; Dworetzky, BA; Lee, JW				Artsy, Elinor; McCarthy, David C.; Hurwitz, Shelley; Pavlova, Milena K.; Dworetzky, Barbara A.; Lee, Jong Woo			Use of modafinil in patients with epilepsy	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Fatigue; Modafinil; Seizures	EXCESSIVE DAYTIME SLEEPINESS; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; RANDOMIZED-TRIAL; INDUCED WAKEFULNESS; FATIGUE; METHYLPHENIDATE; SOMNOLENCE; NARCOLEPSY; DISTURBANCES	Fatigue and excessive daytime sleepiness are common symptoms in patients with neurological injury. Modafinil has been shown to ameliorate these symptoms, but its use in patients with seizures has been limited because of safety concerns. Using a large centralized clinical registry, we performed a retrospective chart review of patients with a diagnosis of epilepsy who were given modafinil over a 10-year period. A total of 205 patients were analyzed. There were 91 patients who had seizures while taking modafinil; there was no relationship between modafinil dosage and whether the patient had seizures. There were 6 patients in whom modafinil was discontinued because of concern for seizure exacerbation, and 4 patients had de novo seizures after starting modafinil. In 29 patients with epilepsy only, no major seizure exacerbation was seen. Modafinil is potentially safe in patients with epilepsy, but further prospective studies are needed to fully determine its safety and efficacy. (C) 2012 Elsevier Inc. All rights reserved.	[Artsy, Elinor; McCarthy, David C.; Pavlova, Milena K.; Lee, Jong Woo] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Hurwitz, Shelley; Dworetzky, Barbara A.] Brigham & Womens Hosp, Dept Biostat, Boston, MA 02115 USA		Lee, JW (corresponding author), Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA.	jlee38@partners.org	Pavlova, Milena/AAK-1844-2020; Lee, Jongwoo/AAI-3617-2020	Lee, Jongwoo/0000-0001-5283-7476; Dworetzky, Barbara/0000-0002-3364-2347	Cephalon, Inc.	This study was funded by a research grant provided by Cephalon, Inc.	Adler CH, 2003, MOVEMENT DISORD, V18, P287, DOI 10.1002/mds.10390; Bazil Carl W., 2000, Current Opinion in Neurology, V13, P171, DOI 10.1097/00019052-200004000-00010; Becker PM, 2000, NEUROLOGY, V54, P1166; Black JE, 2005, SLEEP, V28, P464, DOI 10.1093/sleep/28.4.464; Boutrel B, 2004, SLEEP, V27, P1181, DOI 10.1093/sleep/27.6.1181; Brown JWL, 2011, EPILEPSIA, V52, P401, DOI 10.1111/j.1528-1167.2010.02924.x; Chatterjie N, 2004, NEUROCHEM RES, V29, P1481, DOI 10.1023/B:NERE.0000029559.20581.1a; Chen CR, 2007, NEUROPHARMACOLOGY, V53, P534, DOI 10.1016/j.neuropharm.2007.06.017; Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; Deroche-Gamonet V, 2002, PSYCHOPHARMACOLOGY, V161, P387, DOI 10.1007/s00213-002-1080-8; Foldvary-Schaefer N, 2009, SEMIN NEUROL, V29, P419, DOI 10.1055/s-0029-1237115; Gucuyener K, 2003, J CHILD NEUROL, V18, P109, DOI 10.1177/08830738030180020601; Hirshkowitz M, 2007, CNS DRUGS, V21, P407, DOI 10.2165/00023210-200721050-00004; Ishizuka T, 2010, NEUROSCI LETT, V483, P193, DOI 10.1016/j.neulet.2010.08.005; Ivanenko A, 2003, SLEEP MED, V4, P579, DOI 10.1016/S1389-9457(03)00162-X; Jasinski DR, 2000, CLIN NEUROPHARMACOL, V23, P149, DOI 10.1097/00002826-200005000-00004; Jasinski DR, 2000, J PSYCHOPHARMACOL, V14, P53, DOI 10.1177/026988110001400107; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Lin JS, 1996, P NATL ACAD SCI USA, V93, P14128, DOI 10.1073/pnas.93.24.14128; MacDonald JR, 2002, NEUROLOGY, V59, P1876, DOI 10.1212/01.WNL.0000037481.08283.51; Carrion MJM, 2010, EPILEPSY BEHAV, V17, P120, DOI 10.1016/j.yebeh.2009.11.008; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Mitler MM, 1998, ANN NEUROL, V43, P88; Nalichowski Ruth, 2006, AMIA Annu Symp Proc, P1044; Piperidou C, 2008, SEIZURE-EUR J EPILEP, V17, P588, DOI 10.1016/j.seizure.2008.02.005; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Rabkin JG, 2009, MUSCLE NERVE, V39, P297, DOI 10.1002/mus.21245; Rammohan KW, 2002, J NEUROL NEUROSUR PS, V72, P179, DOI 10.1136/jnnp.72.2.179; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Scammell TE, 2000, J NEUROSCI, V20, P8620, DOI 10.1523/JNEUROSCI.20-22-08620.2000; Senol V, 2007, EPILEPSY BEHAV, V10, P96, DOI 10.1016/j.yebeh.2006.08.006; Smith BW, 2003, EPILEPSY BEHAV, V4, P352, DOI 10.1016/S1525-5050(03)00058-1; Stankoff B, 2005, NEUROLOGY, V64, P1139, DOI 10.1212/01.WNL.0000158272.27070.6A; van Golde EGA, 2011, SLEEP MED REV, V15, P357, DOI 10.1016/j.smrv.2011.01.002; Vosburg SK, 2010, DRUG ALCOHOL DEPEN, V106, P233, DOI 10.1016/j.drugalcdep.2009.09.002; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Xu X, 2006, EPILEPSIA, V47, P1176, DOI 10.1111/j.1528-1167.2006.00591.x	40	9	9	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050			EPILEPSY BEHAV	Epilepsy Behav.	APR	2012	23	4					405	408		10.1016/j.yebeh.2012.02.011			4	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	918YS	WOS:000302288200002	22420936				2022-02-06	
J	Dusick, JR; Wang, CT; Cohan, P; Swerdloff, R; Kelly, DF				Dusick, Joshua R.; Wang, Christina; Cohan, Pejman; Swerdloff, Ronald; Kelly, Daniel F.			Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury	PITUITARY			English	Article						Traumatic brain injury; Pituitary; Hypopituitarism; Pathophysiology	CRITICALLY-ILL PATIENTS; SEVERE HEAD-INJURY; ANTERIOR-PITUITARY FUNCTION; GROWTH-HORMONE; POSTTRAUMATIC HYPOPITUITARISM; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; ADRENAL INSUFFICIENCY; DIABETES-INSIPIDUS; ACUTE-PHASE	The complex pathophysiology of traumatic brain injury (TBI) involves not only the primary mechanical event but also secondary insults such as hypotension, hypoxia, raised intracranial pressure and changes in cerebral blood flow and metabolism. It is increasingly evident that these initial insults as well as transient events and treatments during the early injury phase can impact hypothalamic-pituitary function both acutely and chronically after injury. In turn, untreated pituitary hormonal dysfunction itself can further hinder recovery from brain injury. Secondary adrenal insufficiency, although typically reversible, occurs in up to 50% of intubated TBI victims and is associated with lower systemic blood pressure. Chronic anterior hypopituitarism, although reversible in some patients, persists in 25-40% of moderate and severe TBI survivors and likely contributes to long-term neurobehavioral and quality of life impairment. While the rates and risk factors of acute and chronic pituitary dysfunction have been documented for moderate and severe TBI victims in numerous recent studies, the pathophysiology remains ill-defined. Herein we discuss the hypotheses and available data concerning hypothalamic-pituitary vulnerability in the setting of head injury. Four possible pathophysiological mechanisms are considered: (1) the primary brain injury event, (2) secondary brain insults, (3) the stress of critical illness and (4) medication effects. Although each of these factors appears to be important in determining which hormonal axes are affected, the severity of dysfunction, their time course and possible reversibility, this process remains incompletely understood.	[Kelly, Daniel F.] St Johns Hlth Ctr, John Wayne Canc Inst, Neuroendocrine Tumor Ctr, Santa Monica, CA 90404 USA; [Dusick, Joshua R.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; [Wang, Christina; Swerdloff, Ronald] Harbor UCLA Med Ctr, Dept Med, Div Endocrinol, Torrance, CA 90509 USA; [Wang, Christina; Swerdloff, Ronald] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Cohan, Pejman] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol, Los Angeles, CA 90095 USA; [Cohan, Pejman] Univ Calif Los Angeles, David Geffen Sch Med, Gonda Diabet Ctr, Los Angeles, CA 90095 USA		Kelly, DF (corresponding author), St Johns Hlth Ctr, John Wayne Canc Inst, Neuroendocrine Tumor Ctr, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.	kellyd@jwci.org			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000124] Funding Source: NIH RePORTER		Absalom A, 1999, ANAESTHESIA, V54, P861; ADAMS JH, 1966, ACTA ENDOCRINOL-COP, V51, P377, DOI 10.1530/acta.0.0510377; Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; AITKENHEAD AR, 1989, LANCET, V2, P704, DOI 10.1016/S0140-6736(89)90770-8; [Anonymous], 1999, JAMA, V282, P974; Asa Sylvia L., 1995, P3; Bavisetty S, 2008, NEUROSURGER IN PRESS, V62; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BISTRITZER T, 1981, AM J DIS CHILD, V135, P966, DOI 10.1001/archpedi.1981.02130340070022; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; BROOKS SM, 1972, NEW ENGL J MED, V286, P1125, DOI 10.1056/NEJM197205252862103; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Ceballos R, 1966, Ala J Med Sci, V3, P185; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Choileain NN, 2006, SURG-J R COLL SURG E, V4, P23, DOI 10.1016/S1479-666X(06)80018-1; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; CROZIER TA, 1987, ANESTHESIOLOGY, V66, P628, DOI 10.1097/00000542-198705000-00006; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; DANIEL P M, 1963, Sci Basis Med Annu Rev, P83; DANIEL PM, 1959, LANCET, V2, P927; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Dimopoulou I, 2005, NEUROCRIT CARE, V3, P224, DOI 10.1385/NCC:3:3:224; Dimopoulou I, 2005, INTENS CARE MED, V31, P1020, DOI 10.1007/s00134-005-2689-y; EDWARDS OM, 1986, MEDICINE, V65, P281; Estes Susie M, 2005, Pituitary, V8, P267, DOI 10.1007/s11102-006-6053-1; FELLOWS IW, 1983, BRIT MED J, V287, P1835, DOI 10.1136/bmj.287.6408.1835; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; GIRARD J, 1977, J PEDIATR-US, V90, P241, DOI 10.1016/S0022-3476(77)80637-9; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; GORCZYCA W, 1987, NEUROSURGERY, V20, P369, DOI 10.1227/00006123-198703000-00003; HALIMI P, 1988, J COMPUT ASSIST TOMO, V12, P135, DOI 10.1097/00004728-198801000-00026; Hana V, 2002, EUR J ENDOCRINOL, V147, P333, DOI 10.1530/eje.0.1470333; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Ho HC, 2004, ARCH SURG-CHICAGO, V139, P1199, DOI 10.1001/archsurg.139.11.1199; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Iglesias P, 1996, J ENDOCRINOL INVEST, V19, P320, DOI 10.1007/BF03347870; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KLINGBEIL GEG, 1985, ARCH PHYS MED REHAB, V66, P44; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maas AIR, 2004, ACT NEUR S, V89, P113; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; MASSOL J, 1987, NEURORADIOLOGY, V29, P299, DOI 10.1007/BF00451773; MILLER WL, 1980, NEW ENGL J MED, V302, P724, DOI 10.1056/NEJM198003273021305; Napoli R, 2003, J CLIN ENDOCR METAB, V88, P2817, DOI 10.1210/jc.2003-030144; NEWMAN LH, 1987, ANAESTHESIA, V42, P929, DOI 10.1111/j.1365-2044.1987.tb05362.x; Nierman DM, 1999, CRIT CARE MED, V27, P2418, DOI 10.1097/00003246-199911000-00016; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Rhoton AL, 2002, NEUROSURGERY, V51, pS335, DOI 10.1227/01.NEU.0000028680.51299.00; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Scheepens A, 2000, J PEDIATR ENDOCR MET, V13, P1483; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; SHEEHAN HL, 1971, AM J OBSTET GYNECOL, V111, P852, DOI 10.1016/0002-9378(71)90500-X; Silha JV, 2005, CLIN ENDOCRINOL, V63, P79, DOI 10.1111/j.1365-2265.2005.02303.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; TEASDALE G, 1974, LANCET, V2, P81; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; Van den Berghe G, 2002, VERH K ACAD GENEESKD, V64, P187; Van den Berghe Greet, 2002, Verh K Acad Geneeskd Belg, V64, P167; Vanhorebeek I, 2006, NAT CLIN PRACT ENDOC, V2, P20, DOI 10.1038/ncpendmet0071; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; Ye P, 1999, ENDOCRINOLOGY, V140, P3063, DOI 10.1210/en.140.7.3063; Ye P, 2002, J NEUROSCI, V22, P6041; Zhong J, 2005, J NEUROSCI RES, V80, P481, DOI 10.1002/jnr.20490	94	9	9	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1386-341X	1573-7403		PITUITARY	Pituitary	MAR	2012	15	1					2	9		10.1007/s11102-008-0130-6			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	904IG	WOS:000301187500001		Green Accepted			2022-02-06	
J	Noda, D; Yoshimura, I; Kanazawa, K; Hagio, T; Naito, M				Noda, Daisuke; Yoshimura, Ichiro; Kanazawa, Kazuki; Hagio, Tomonobu; Naito, Masatoshi			Subcutaneous Rupture of the Flexor Hallucis Longus Tendon: A Case Report	JOURNAL OF FOOT & ANKLE SURGERY			English	Article						great toe; injury; phalanx; surgery; tendinitis; tenosynovitis; trauma	TRAUMATIC RUPTURE; BALLET DANCERS; RUNNER	It is well known that rupture of the flexor hallucis longus tendon can be associated with open injuries and that closed rupture of the flexor hallucis longus tendon is rare. Tendon injuries of the foot can occur secondary to direct, indirect, or repetitive injury. Repetitive tendon injuries can cause tendinitis or stenosing tenosynovitis. Tendinitis is associated with internal tendon injury that can present with tendon thickening, mucinoid degeneration, nodule development, or in situ partial tears. Stenosing tenosynovitis is the development of tendon adhesions within the tendon sheath that interfere with tendon gliding, known as trigger toe. The flexor hallucis longus tendon is susceptible to injury along its entire course. A total of 35 cases of complete or partial closed ruptures of the flexor hallucis longus tendon have been reported. We present the case of complete subcutaneous rupture of the flexor hallucis longus tendon associated with trauma at the proximal phalangeal head. (C) 2012 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Noda, Daisuke] Fukuoka Univ, Sch Med, Dept Orthopaed Surg, Jounann Ku, Fukuoka 8140180, Japan		Noda, D (corresponding author), Fukuoka Univ, Sch Med, Dept Orthopaed Surg, Jounann Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	daisukemakichacha@yahoo.co.jp					Boruta PM, 1997, FOOT ANKLE INT, V18, P243, DOI 10.1177/107110079701800411; COGHLAN BA, 1993, AM J SPORT MED, V21, P617, DOI 10.1177/036354659302100422; Hashizume H, 1993, RINSHO SEIKEI GEKA, V28, P617; Hinokida T, 2005, RINSHO SEIKEI GEKA, V40, P209; HOLT KWG, 1990, AM J SPORT MED, V18, P645, DOI 10.1177/036354659001800616; Inokuchi S, 1997, FOOT ANKLE INT, V18, P47, DOI 10.1177/107110079701800110; Inoue S, 1995, RINSHO SEIKEI GEKA, V30, P1331; Kolettis GJ, 1996, J BONE JOINT SURG AM, V78A, P1386, DOI 10.2106/00004623-199609000-00014; KRACKOW KA, 1980, CLIN ORTHOP RELAT R, P261; Oloff L M, 1998, J Foot Ankle Surg, V37, P101; Ouchi K, 2008, J JPN SOC SURG FOOT, V29, pS101; RASMUSSEN RB, 1990, FOOT ANKLE, V10, P288, DOI 10.1177/107110079001000509; Reinherz R P, 1984, J Foot Surg, V23, P366; ROMASH MM, 1994, FOOT ANKLE INT, V15, P433, DOI 10.1177/107110079401500806; SAMMARCO GJ, 1979, J BONE JOINT SURG AM, V61, P149, DOI 10.2106/00004623-197961010-00031; Sammarco GJ, 1998, FOOT ANKLE INT, V19, P356, DOI 10.1177/107110079801900603; Sato K, 1983, RINSHO SEIKEI GEKA, V18, P1317; Scaduto A A, 2000, Foot Ankle Clin, V5, P725; Schulhofer S David, 2002, Clin Podiatr Med Surg, V19, P411, DOI 10.1016/S0891-8422(02)00014-9; THOMPSON FM, 1993, FOOT ANKLE, V14, P15, DOI 10.1177/107110079301400103; TREPMAN E, 1995, FOOT ANKLE INT, V16, P227, DOI 10.1177/107110079501600412; Wei SY, 1998, FOOT ANKLE INT, V19, P472, DOI 10.1177/107110079801900709	22	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	MAR-APR	2012	51	2					234	236		10.1053/j.jfas.2011.10.030			3	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	894TT	WOS:000300450500022	22153296				2022-02-06	
J	Salunke, P; Savardekar, A; Sura, S				Salunke, Pravin; Savardekar, Amey; Sura, Sukumar			Delayed-onset bilateral abducens paresis after head trauma	INDIAN JOURNAL OF OPHTHALMOLOGY			English	Article						Bilateral abducens nerve; delayed onset paresis; head injury	NERVE PALSY	Bilateral sixth nerve paresis following closed head injury, though rare, is a known entity. However, delayed-onset post-traumatic bilateral abducens paresis is extremely rare. We present two cases. The first patient had onset of bilateral abducens paresis 2 weeks after closed head injury and the second patient after 3 days. The cause in the former was detected to be chronic subdural hematoma and in the latter is speculated to be edema/ischemia due to injury to soft tissue structures housing these nerves. The delayed onset of bilateral abducens paresis following head injury may vary according to the cause. There may be another mechanism of injury apart from direct trauma. Though rare, it needs to be evaluated and may have a treatable cause like elevated intracranial pressure.	[Salunke, Pravin; Savardekar, Amey; Sura, Sukumar] PGIMER, Dept Neurosurg, Chandigarh 160012, India		Salunke, P (corresponding author), PGIMER, Dept Neurosurg, Sect 12, Chandigarh 160012, India.	drpravin_salunke@yahoo.co.uk	Savardekar, Amey/AAV-6000-2021	Savardekar, Amey/0000-0002-9305-7457			Advani RM, 2003, ANN EMERG MED, V41, P27, DOI 10.1067/mem.2003.46; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Kim MS, 2008, J KOREAN NEUROSURG S, V44, P396, DOI 10.3340/jkns.2008.44.6.396; KOBAYASHI S, 1988, Neurological Surgery, V16, P869; Rotondo M, 2010, ACTA NEUROCHIR, V152, P1705, DOI 10.1007/s00701-010-0747-x	5	9	9	0	0	ALL INDIA OPHTHALMOLOGICAL SOC	HYDERABAD	C/O L V PRASAD EYE INST, L V PRASAD MARG, BANJARA HILLS, HYDERABAD, ANDHRA PRADESH 00000, INDIA	0301-4738			INDIAN J OPHTHALMOL	Indian J. Ophthalmol.	MAR-APR	2012	60	2					149	150		10.4103/0301-4738.90491			2	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	921DX	WOS:000302459300017	22446916	Green Published, gold			2022-02-06	
J	Sanborn, B; Nie, X; Chen, W; Weerasooriya, T				Sanborn, B.; Nie, X.; Chen, W.; Weerasooriya, T.			Inertia effects on characterization of dynamic response of brain tissue	JOURNAL OF BIOMECHANICS			English	Article						Brain tissue; Shear response; Radial inertia; Mechanical behavior; Dynamic response	MECHANICAL-BEHAVIOR; BAR	Modeling and simulation of traumatic brain injury (TB!) resulted from collision or blast loading requires characterization of mechanical response over a wide range of loading rates under valid testing conditions. In this study, mechanical response of fresh bovine brain tissue was studied using the two modified Kolsky bar techniques. Radial deformation behavior of annular specimens, which are typically used to characterize the dynamic uniaxial compressive response of biological tissues, was examined using a modified Kolsky bar and a high speed camera to collect images while the specimen deforms at an axial strain rate of 2000 s(-1). The high-speed images revealed inhomogeneous specimen deformation possibly brought about by radial inertia and causing a multi-axial stress state. To acquire valid stress-strain results that can be used to produce constitutive behavior of the soft materials, a novel torsion technique was developed to obtain pure shear response at dynamic loading rates. Experimental results show clear differences in the material response using the two methods. These results indicate that the previously demonstrated annular specimen geometry aimed at reducing inertia induced stress components for high rate soft materials uniaxial-compressive testing may still possess a significant component of radial inertia induced radial stress which consequently caused the observed inhomogeneous deformation in brain tissue test samples. (C) 2011 Elsevier Ltd. All rights reserved.	[Nie, X.; Chen, W.] Purdue Univ, Sch Aeronaut Astronaut, W Lafayette, IN 47907 USA; [Sanborn, B.; Weerasooriya, T.] USA, Res Lab, Aberdeen Proving Ground, MD 21005 USA; [Nie, X.; Chen, W.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA		Chen, W (corresponding author), Purdue Univ, Sch Aeronaut Astronaut, 701 W Stadium Ave, W Lafayette, IN 47907 USA.	wchen@purdue.edu			US Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL); Purdue University	This research is supported by a collaborative program between US Army Research Laboratory and Purdue University.	Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Casem D, 2005, EXP MECH, V45, P368, DOI 10.1177/0014485105056090; Chen W, 1999, EXP MECH, V39, P81, DOI 10.1007/BF02331109; Chen W, 2000, EXP MECH, V40, P1, DOI 10.1007/BF02327540; Chen W, 2005, LAT AM J SOLIDS STRU, V2, P113; Chen WNW, 2011, MECH ENG SER, P1, DOI 10.1007/978-1-4419-7982-7; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Estes M., 1970, P 4 ASME BIOM C, P1; Garo A, 2007, BIORHEOLOGY, V44, P51; Gilat A., 2000, ASM HDB, V8, P505; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Kolsky H., 1949, Proceedings of the Physical Society. Section B, V62, P676, DOI 10.1088/0370-1301/62/11/302; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Nie X, 2011, EXP MECH, V51, P1527, DOI 10.1007/s11340-011-9481-4; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Scheidler M., 2010, ARLTR5301; Song B, 2007, EXP MECH, V47, P659, DOI 10.1007/s11340-006-9017-5; Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Warren T.L., 2010, EXPT MECH, V50, P1; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024	23	9	10	2	25	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	FEB 2	2012	45	3					434	439		10.1016/j.jbiomech.2011.12.017			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	900CG	WOS:000300863600004	22226509				2022-02-06	
J	Ma, MR; Li, LC; Wang, XR; Bull, DL; Shofer, FS; Meaney, DF; Neumar, RW				Ma, Marek; Li, Luchuan; Wang, Xinran; Bull, Diana L.; Shofer, Frances S.; Meaney, David F.; Neumar, Robert W.			Short-Duration Treatment with the Calpain Inhibitor MDL-28170 Does Not Protect Axonal Transport in an in Vivo Model of Traumatic Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; animal studies; axonal injury; axonal transport; traumatic brain injury	BRAIN-INJURY; SODIUM-CHANNELS; STRETCH-INJURY; OPTIC-NERVE; IMPACT; MICE; TETRODOTOXIN; ISCHEMIA; DISEASE	Traumatic axonal injury is characterized by early cytoskeletal proteolysis and disruption of axonal transport. Calpain inhibition has been shown to protect axons in rodent models of traumatic brain injury. However, in these models, both white and gray matter are injured, making it difficult to determine if calpain inhibitors are directly protecting injured axons. To address this issue, we used our rat optic nerve stretch model to test the hypothesis that early calpain inhibition directly protects central nervous system (CNS) axons following stretch injury. Rats were given an intravenous bolus of the calpain inhibitor MDL-28170 (30 mg/kg) 30 min prior to unilateral optic nerve stretch, followed by a 15 mg/kg/h intravenous infusion over the next 2.5h. Immunohistochemical analysis of optic nerves 30 min after stretch injury revealed variable increases of calpain-cleaved a-spectrin that appeared less evident in stretched nerves from drug-treated rats, although this difference was not statistically significant. Retrograde axonal transport measured by Fluorogold (R) labeling of retinal ganglion cells was significantly impaired after stretch injury. However, there was no difference in the number of Fluorogold-labeled cells in the vehicle vs. drug treatment groups. These results suggest that early short-duration calpain inhibitor therapy with MDL-28170 is not an effective strategy to prevent disruption of axonal transport following isolated axonal stretch injury in the CNS.	[Ma, Marek; Li, Luchuan; Wang, Xinran; Bull, Diana L.; Shofer, Frances S.; Neumar, Robert W.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Ma, Marek; Wang, Xinran; Bull, Diana L.; Neumar, Robert W.] Univ Penn, Ctr Resuscitat Sci, Philadelphia, PA 19104 USA; [Li, Luchuan] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan 250100, Shandong, Peoples R China		Ma, MR (corresponding author), Univ Penn, Dept Emergency Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	mamarek@uphs.upenn.edu		Meaney, David/0000-0002-0954-4122	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS055880]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS055880] Funding Source: NIH RePORTER	Research was supported by the National Institutes of Health grant NS055880 (MM).	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Czeiter E, 2009, MOLECULES, V14, P5115, DOI 10.3390/molecules14125115; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hirano Asao, 1995, P49; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Neumar RW, 1998, J CEREBR BLOOD F MET, V18, P876, DOI 10.1097/00004647-199808000-00007; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Uceyler N, 2010, MOLECULES, V15, P3038, DOI 10.3390/molecules15053038; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhao Jun-ping, 2007, Zhonghua Yi Xue Za Zhi, V87, P999	29	9	10	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					445	451		10.1089/neu.2011.2060			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300023	22077394	Green Published			2022-02-06	
J	Murakami, Y; Wei, G; Yang, XF; Lu, XCM; Leung, LY; Shear, DA; Tortella, FC				Murakami, Yuki; Wei, Guo; Yang, Xiaofang; Lu, Xi-Chun May; Leung, Lai Yee; Shear, Deborah A.; Tortella, Frank C.			Brain oxygen tension monitoring following penetrating ballistic-like brain injury in rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Brain tissue oxygen tension (PbtO(2)); Hypoxia; Traumatic brain injury (TBI); Penetrating ballistic-like brain injury (PBBI); Fraction of inspired oxygen (FiO(2))	SEVERE HEAD-INJURY; NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN; TISSUE OXYGEN; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; CEREBRAL-ISCHEMIA; NONCONVULSIVE SEIZURES; TEMPERATURE; VENTILATION	While brain oxygen tension (PbtO(2)) monitoring is an important parameter for evaluating injury severity and therapeutic efficiency in severe traumatic brain injury (TBI) patients, many factors affect the monitoring. The goal of this study was to identify the effects of FiO(2) (fraction of inspired oxygen) on PbtO(2) in uninjured anesthetized rats and measure the changes in PbtO(2) following penetrating ballistic-like brain injury (PBBI). Continuous PbtO(2) monitoring in uninjured anesthetized rats showed that PbtO(2) response was positively correlated with FiO(2) (0.21-0.35) but PbtO(2) remained stable when FiO(2) was maintained at 0.26. Importantly, although increasing FiO(2) from 0.21 to 0.35 improved PaO2, it concomitantly reduced pH levels and elevated PaCO2 values out of the normal range. However, when the FiO(2) was maintained between 0.26 and 0.30, the pH and PaO2 levels remained within the normal or clinically acceptable range. In PBBI rats, PbtO(2) was significantly reduced by 40% (16.9 +/- 1.2 mmHg) in the peri-lesional region immediately following unilateral, frontal 10% PBBI compared to sham rats (28.6 +/- 1.7 mmHg; mean SEM, p < 0.05) and the PBBI-induced reductions in PbtO(2) were sustained for at least 150 min post-PBBI. Collectively, these results demonstrate that FiO(2) affects PbtO(2) and that PBBI produces acute and sustained hypoxia in the peri-lesional region of the brain injury. This study provides important information for the management of PbtO(2) monitoring in this brain injury model and may offer insight for therapeutic strategies targeted to improve the hypoxia/ischemia state in the penetrating-type brain injury. Published by Elsevier B.V.	[Murakami, Yuki; Wei, Guo; Yang, Xiaofang; Lu, Xi-Chun May; Leung, Lai Yee; Shear, Deborah A.; Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA		Wei, G (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	murakamiy@hs.med.kyoto-u.ac.jp; Guo.Wei@US.ARMY.MIL; Xiaofang.Yang@us.army.mil; may.lu@us.army.mil; laiyee.leung@us.army.mil; eborah.a.shear@us.army.mil; frank.c.tortella@us.army.mil	Shear, Deborah/B-3607-2011; Leung, Lai Yee/H-8204-2013		U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	This work was supported by core funding provided by the U.S. Army Medical Research and Materiel Command, combat Casualty Care Research Program.	BARACH E, 1986, J TRAUMA, V26, P225, DOI 10.1097/00005373-198603000-00003; Beaumont A, 1999, CRIT REV NEUROSURG, V9, P207, DOI 10.1007/s003290050135; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS45; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Chen ZY, 2011, BRAIN RES, V1368, P71, DOI 10.1016/j.brainres.2010.10.028; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; Chesnut R M, 1995, New Horiz, V3, P366; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Hemphill JC, 2005, AM J NEURORADIOL, V26, P1095; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kishimoto K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-42; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; MARCOUX FW, 1982, STROKE, V13, P339, DOI 10.1161/01.STR.13.3.339; Marmarou A, 2003, ACT NEUR S, V86, P7; McLeod AD, 2003, ANESTH ANALG, V97, P851, DOI 10.1213/01.ANE.0000072541.57132.BA; MICHENFELDER JD, 1991, ANESTHESIOLOGY, V75, P130, DOI 10.1097/00000542-199107000-00021; PUCCIO AM, 2009, J NEUROTRAUMA; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; SHEAR DA, 2010, J NEUROTRAUMA; SHEAR DA, 2011, J NEUROTRAUMA; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; Shoja MM, 2008, LIFE SCI, V83, P381, DOI 10.1016/j.lfs.2008.07.007; Sola A, 2008, CURR OPIN ANESTHESIO, V21, P332, DOI 10.1097/ACO.0b013e3282f8ad8d; Stewart C, 2008, NEUROSURGERY, V63, P1159, DOI 10.1227/01.NEU.0000333265.19131.7C; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Thorat JD, 2008, J CLIN NEUROSCI, V15, P143, DOI 10.1016/j.jocn.2006.08.014; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; WEI G, 2011, HYPOTHERM TEMP MANAG, V1, P33; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828	54	9	9	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 15	2012	203	1					115	121		10.1016/j.jneumeth.2011.09.025			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	859SM	WOS:000297896100013	21983109				2022-02-06	
J	Andersson, EE; Sejdhage, R; Wage, V				Andersson, Elisabeth Elgmark; Sejdhage, Rebecca; Wage, Victoria			Mild traumatic brain injuries in children between 0-16 years of age: A survey of activities and places when an accident occurs	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Epidemiology; injury; occupational therapy; occurrence; playgrounds; prevention	HEAD-INJURIES; CONCUSSION; ADOLESCENTS; POPULATION; SYMPTOMS	Objective: The aim of this study was to identify what activities cause most mild traumatic brain injury (MTBI) among boys and girls between 0-16 years of age. Methods: Based on a randomized controlled study, a retrospective analysis was conducted among 765 children. Result: The most common causes of injury were falls from a height and falls from the same level. The most common place where the accident occurred was at 'home' followed by 'pre-school/school'. The highest incidence was 'play' followed by 'hit by another person', thereafter 'baby nursing'. Boys are more often injured than girls, but with no difference between boys and girls in terms of which activities that cause MTBI. Conclusion: Supervision during play at home as well as better designed schoolyards and playgrounds are required to prevent accidents. Furthermore, well-documented medical records are necessary to identify activities causing MTBI among children.	[Andersson, Elisabeth Elgmark] Jonkoping Univ, Dept Rehabil Med, Sch Hlth Sci, S-55111 Jonkoping, Sweden; [Sejdhage, Rebecca] Smalandsstenar Care Ctr, Smalandsstenar, Sweden; [Wage, Victoria] Primary Hlth Care, S-51434 Tranemo, Sweden		Andersson, EE (corresponding author), Jonkoping Univ, Dept Rehabil Med, Sch Hlth Sci, Box 1026, S-55111 Jonkoping, Sweden.	elisabeth.elgmark@hhj.hj.se			Health and Medical Care Executive Board of the Vastra Gotaland Region, Sweden; School of Health Sciences, Department of Rehabilitation, Jonkoping University, Sweden	The study was supported by the Health and Medical Care Executive Board of the Vastra Gotaland Region, Sweden. We thank the secretary at AUW Consulting, Falkenberg, Sweden, and we are grateful for the support of Torbjorn Falkmer, OT, PhD, Professor at School of Health Sciences, Department of Rehabilitation, Jonkoping University, Sweden.	Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Anderson V, 1999, DEV NEUROREHABILITAT, V3, P137; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Andersson EE, 2010, DEV NEUROREHABIL, V13, P346, DOI 10.3109/17518423.2010.503671; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Kozlowski KF, 2007, NEUROREHABILITATION, V22, P191; McKinlay A, 2009, J CHILD CARE HLTH DE, V36, P3; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; The Swedish council on technology assessment in health care (SBU), 2006, 153 SBU SWED COUNC T; WHO and Swedish Council ICD-10, 1996, WHO SWED COUNC ICD 1; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	20	9	9	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2012	15	1					26	30		10.3109/17518423.2011.633570			5	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	878YZ	WOS:000299295400004	22256831				2022-02-06	
J	Koch, MJ; Wells, L				Koch, Matthew J.; Wells, Lawrence			Proximal Clavicle Physeal Fracture With Posterior Displacement: Diagnosis, Treatment, and Prevention	ORTHOPEDICS			English	Article							STERNOCLAVICULAR JOINT; DISLOCATION; MIGRATION; TRAUMA	Posterior sternoclavicular fracture displacement can present as a posterior sternoclavicular joint dislocation and is rare in the pediatric population. This article provides an algorithm for evaluation and management. A 14-year-old boy with a previously undiagnosed posterior sternoclavicular displacement presented with persistent 7/10 shoulder pain extending into his neck after undergoing nonoperative treatment for an unconfirmed diagnosis at another emergency department. Plain radiographs revealed a displacement of the right medial clavicle, and the position of the clavicular head indicated advanced imaging. Computed tomography showed the posterior portion of the clavicular head butting against the left braciocephalic vein at its confluence with the superior vena cava. The patient underwent open reduction and internal fixation. After exposing the sternoclavicular joint, a Salter-Harris I fracture with no evidence of vascular injury was confirmed. The fracture was reduced and stabilized using figure-eight #5 Ethibond sutures (Ethicon, Somerville, New Jersey), and the patient was placed in an immobilizer for 1 week. At 1 year postoperatively, the patient regained full range of motion and was completely healed. Posterior clavicle displacements are potentially devastating injuries that are difficult to diagnose. Coordinating operative treatment with orthopedic and general surgery is indicated to manage the fracture or displacement and potential vascular injury. Due to difficulties in maintaining a closed reduction, open reduction and internal fixation is the preferred mode of treatment for the reduction of all posterior clavicular fracture displacements.	[Wells, Lawrence] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Koch, Matthew J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA		Wells, L (corresponding author), Childrens Hosp Philadelphia, Wood Bldg,Floor 2,34th St & Civ Ctr Bldg, Philadelphia, PA 19104 USA.	wellsl@email.chop.edu					Beecroft M, 2007, J EMERG MED, V33, P245, DOI 10.1016/j.jemermed.2007.01.004; BENSON LS, 1991, J ULTRAS MED, V10, P115; Brinker MR, 1997, J ORTHOP TRAUMA, V11, P378, DOI 10.1097/00005131-199707000-00016; BUCKERFIELD CT, 1984, J BONE JOINT SURG AM, V66A, P379, DOI 10.2106/00004623-198466030-00010; Buckley Byron J, 2008, J Emerg Med, V34, P331, DOI 10.1016/j.jemermed.2007.03.052; Carmichael KD, 2006, SKELETAL RADIOL, V35, P608, DOI 10.1007/s00256-005-0076-y; Fenig M, 2010, AM J EMERG MED, V28, p385e5; Garretson RB, 2003, CLIN SPORT MED, V22, P239, DOI 10.1016/S0278-5919(03)00008-5; Jaggard MKJ, 2009, J TRAUMA, V66, P576, DOI 10.1097/TA.0b013e31817fd96b; Kumar P, 2002, J ROY SOC MED, V95, P198, DOI 10.1258/jrsm.95.4.198; Mazet R, 1943, J BONE JOINT SURG, V25, P477; McCulloch P, 2001, AM J ROENTGENOL, V176, P1534, DOI 10.2214/ajr.176.6.1761534; Ogden J, 2000, SKELETAL INJURY CHIL, P2; Rajaratnam S, 2002, CLIN ANAT, V15, P108, DOI 10.1002/ca.1104; Resnick D, 1996, BONE JOINT IMAGING, P821; Rockwood CA, 2001, ROCKWOOD GREENS FRAC, P1418; Rockwood Jr CA, 2003, SHOULDER, P527; Rockwood Jr CA, 1998, SHOULDER, P555; Rudzki JR, 2003, CLIN SPORT MED, V22, P387, DOI 10.1016/S0278-5919(03)00013-9; Salgado R A, 2002, Emerg Radiol, V9, P323; Southworth S R, 1988, Orthop Rev, V17, P789; Thomas DP, 1999, ANN ROY COLL SURG, V81, P201; WASYLENKO MJ, 1981, CAN J SURG, V24, P626; Waters PM, 2003, J PEDIATR ORTHOPED, V23, P464, DOI 10.1097/00004694-200307000-00010; Yang J, 1996, Am J Orthop (Belle Mead NJ), V25, P565; ZANCA P, 1971, AMER J ROENTGENOL RA, V112, P493, DOI 10.2214/ajr.112.3.493	26	9	9	0	6	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447	1938-2367		ORTHOPEDICS	Orthopedics	JAN	2012	35	1					E108	E111		10.3928/01477447-20111122-39			4	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	894JO	WOS:000300423200021	22229601				2022-02-06	
J	Kumar, MA				Kumar, Monisha A.			Red Blood Cell Transfusion in the Neurological ICU	NEUROTHERAPEUTICS			English	Article						Anemia; Transfusion; ICU; Erythrocytes; Hemoglobin; Neurocritical care	ANEURYSMAL SUBARACHNOID HEMORRHAGE; ACUTE LUNG INJURY; TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; RANDOMIZED CONTROLLED-TRIAL; INDEPENDENT RISK FACTOR; HEMOGLOBIN CONCENTRATION; CEREBRAL OXYGENATION; CARDIAC-SURGERY; ACUTE STROKE	Red blood cell transfusion (RBCT) is a common therapy used in the intensive care unit to treat anemia. However, due to deleterious side effects and questionable efficacy, the clinical benefit of RBCT in patients who are not actively bleeding is unclear. The results of randomized controlled trials suggest there is no benefit to a liberal transfusion practice in general critical care populations. Whether the results of these trials are applicable to brain injured patients is unknown, as patients with primary neurological injury were excluded. This article reviews the efficacy and complications of RBCT, as well as the relationship between RBCT and its outcome in both the general intensive care unit and neurologically critically ill populations.	[Kumar, Monisha A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Kumar, Monisha A.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Kumar, Monisha A.] Univ Penn, Perelman Sch Med, Dept Anesthesiol, Philadelphia, PA 19104 USA; [Kumar, Monisha A.] Univ Penn, Perelman Sch Med, Dept Crit Care, Philadelphia, PA 19104 USA		Kumar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, 3400 Spruce St,3 W Gates, Philadelphia, PA 19104 USA.	Monisha.Kumar@uphs.upenn.edu					AGARWAL N, 1993, ARCH SURG-CHICAGO, V128, P171; Allport LE, 2005, NEUROLOGY, V65, P1382, DOI 10.1212/01.wnl.0000183057.96792.a8; APSTEIN CS, 1985, AM J PHYSIOL, V248, pH508, DOI 10.1152/ajpheart.1985.248.4.H508; Asplund K., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000103; Bahrainwala ZS, 2011, ANN THORAC SURG, V91, P1113, DOI 10.1016/j.athoracsur.2010.12.049; BAKER CH, 1986, CIRC SHOCK, V20, P127; Benjamin RJ, 2011, BLOOD, V117, P4163, DOI 10.1182/blood-2011-03-338913; Berezina TL, 2002, J SURG RES, V102, P6, DOI 10.1006/jsre.2001.6306; BEUTLER E, 1982, BLOOD, V59, P1141; Bidot L, 2008, J THROMB HAEMOST, V6, P913, DOI 10.1111/j.1538-7836.2008.02963.x; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; BOWDEN RA, 1986, NEW ENGL J MED, V314, P1006, DOI 10.1056/NEJM198604173141602; CARD RT, 1982, TRANSFUSION, V22, P96, DOI 10.1046/j.1537-2995.1982.22282177134.x; CARD RT, 1983, BRIT J HAEMATOL, V53, P237, DOI 10.1111/j.1365-2141.1983.tb02016.x; Chelemer SB, 2002, ANN THORAC SURG, V73, P138, DOI 10.1016/S0003-4975(01)03308-2; Chu R. W., 1999, Hong Kong Medical Journal, V5, P280; Claridge JA, 2002, AM SURGEON, V68, P566; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; De Georgia MA, 2007, STROKE, V38, P544; Dechant VE, 2010, NEUROCRIT CARE, V13, pS14; DeFoe GR, 2001, ANN THORAC SURG, V71, P769, DOI 10.1016/S0003-4975(00)02393-6; Dexter F, 1997, BRIT J ANAESTH, V79, P346, DOI 10.1093/bja/79.3.346; Dhar R, 2009, STROKE, V40, P3039, DOI 10.1161/STROKEAHA.109.556159; Diamond PT, 2003, ARCH PHYS MED REHAB, V84, P964, DOI 10.1016/S0003-9993(03)00009-1; DIETRICH KA, 1990, CRIT CARE MED, V18, P940, DOI 10.1097/00003246-199009000-00007; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Dunne James R, 2004, Surg Infect (Larchmt), V5, P395, DOI 10.1089/sur.2004.5.395; Dunne JR, 2002, J SURG RES, V102, P237, DOI 10.1006/jsre.2001.6330; Dzik WH, 2002, TRANSFUSION, V42, P1114, DOI 10.1046/j.1537-2995.2002.00182.x; EDNA TH, 1992, J TRAUMA, V33, P659, DOI 10.1097/00005373-199211000-00010; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Goldman M, 2005, TRANSFUS MED REV, V19, P2, DOI 10.1016/j.tmrv.2004.10.001; Goodnough LT, 2003, CRIT CARE MED, V31, pS678, DOI 10.1097/01.CCM.0000100124.50579.D9; Gramm J, 1996, SHOCK, V5, P190, DOI 10.1097/00024382-199603000-00004; GROTTA J, 1982, STROKE, V13, P296, DOI 10.1161/01.STR.13.3.296; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; HARRISON MJG, 1981, LANCET, V2, P114, DOI 10.1016/S0140-6736(81)90298-1; Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618, DOI 10.1164/ajrccm.155.5.9154866; Hebert PC, 2003, JAMA-J AM MED ASSOC, V289, P1941, DOI 10.1001/jama.289.15.1941; HEDDLE NM, 1993, TRANSFUSION, V33, P794, DOI 10.1046/j.1537-2995.1993.331094054613.x; Hovav T, 1999, TRANSFUSION, V39, P277, DOI 10.1046/j.1537-2995.1999.39399219284.x; HURD TC, 1988, ARCH SURG-CHICAGO, V123, P217; Irace C, 2003, CORONARY ARTERY DIS, V14, P279, DOI 10.1097/01.mca.0000071769.74379.49; JY WC, 1995, THROMB RES, V80, P471, DOI 10.1016/0049-3848(95)00202-2; Jy W, 2011, TRANSFUSION, V51, P886, DOI 10.1111/j.1537-2995.2011.03099.x; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; KAHN RC, 1986, INTENS CARE MED, V12, P22, DOI 10.1007/BF00315364; Karkouti K, 2005, ANN THORAC SURG, V80, P1381, DOI 10.1016/j.athoracsur.2005.03.137; Kellert L, 2011, STROKE, V42, P1; Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x; KNIGHT JA, 1992, TRANSFUSION, V32, P354, DOI 10.1046/j.1537-2995.1992.32492263451.x; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Kumar MA, 2009, CRIT CARE MED, V37, P1442, DOI 10.1097/CCM.0b013e31819ced3a; LANGENFELD JE, 1991, SURGERY, V110, P398; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; Leal-Noval SR, 2003, ANESTHESIOLOGY, V98, P815, DOI 10.1097/00000542-200304000-00005; Lee EJ, 2001, J NEUROL SCI, V190, P3, DOI 10.1016/S0022-510X(01)00567-6; Levine J, 2010, NEUROSURGERY, V66, P312, DOI 10.1227/01.NEU.0000363747.47587.6C; LOWE GDO, 1983, LANCET, V1, P784; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; McIntyre L, 2004, J TRAUMA, V57, P563, DOI 10.1097/01.TA.0000136158.93864.54; MINK RB, 1990, CRIT CARE MED, V18, P1087, DOI 10.1097/00003246-199010000-00007; Moore FA, 1997, ARCH SURG-CHICAGO, V132, P620; Naidech AM, 2010, NEUROCRIT CARE, V13, P313, DOI 10.1007/s12028-010-9424-4; Nathens AB, 2006, SHOCK, V26, P342, DOI 10.1097/01.shk.0000228171.32587.a1; Nishiyama T, 2001, CRIT CARE MED, V29, P1979, DOI 10.1097/00003246-200110000-00021; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711; Parsons EC, 2011, CRIT CARE, V15, DOI 10.1186/cc10458; Phelan HA, 2010, J TRAUMA, V69, P330, DOI 10.1097/TA.0b013e3181e0b253; Purdy FR, 1997, CAN J ANAESTH, V44, P1256, DOI 10.1007/BF03012772; Raghavan M, 2005, CHEST, V127, P295, DOI 10.1378/chest.127.1.295; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; REESE EP, 1975, TRANSFUSION, V15, P583; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rizk A, 2001, TRANSFUSION, V41, P264, DOI 10.1046/j.1537-2995.2001.41020264.x; Sacco S, 2007, EUR NEUROL, V58, P233, DOI 10.1159/000107946; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; SAVAGEAU JA, 1982, J THORAC CARDIOV SUR, V84, P585; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; SHAH DM, 1982, J TRAUMA, V22, P741, DOI 10.1097/00005373-198209000-00004; Shander A, 2005, CHEST, V128, p598S, DOI 10.1378/chest.128.5_suppl_2.598S; Sheth KN, 2011, NEUROSURGERY, V68, P1286, DOI 10.1227/NEU.0b013e31820cccb2; Shorr AF, 2005, CHEST, V127, P1722, DOI 10.1378/chest.127.5.1722; Silliman CC, 2003, BLOOD, V101, P454, DOI 10.1182/blood-2002-03-0958; SILLIMAN CC, 1994, J LAB CLIN MED, V124, P684; Silliman CC, 2011, TRANSFUSION, Vxx, pxx; SILVERMAN HJ, 1992, CHEST, V102, P184, DOI 10.1378/chest.102.1.184; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Springer MV, 2009, NEUROSURGERY, V65, P1043, DOI 10.1227/01.NEU.0000359317.15269.20; STEC N, 1986, TRANSFUSION, V26, P225, DOI 10.1046/j.1537-2995.1986.26386209373.x; Suassuna JHR, 1997, NEPHRON, V77, P368, DOI 10.1159/000190309; Tanne D, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-22; Taylor RW, 2002, CRIT CARE MED, V30, P2249, DOI 10.1097/00003246-200210000-00012; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Tseng MY, 2008, BRIT J NEUROSURG, V22, P257, DOI 10.1080/02688690701832100; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2006, CURR OPIN CRIT CARE, V12, P119, DOI 10.1097/01.ccx.0000216577.57180.bd; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; WADE JPH, 1987, STROKE, V18, P68, DOI 10.1161/01.STR.18.1.68; WANNAMETHEE G, 1994, J INTERN MED, V235, P163, DOI 10.1111/j.1365-2796.1994.tb01050.x; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Watkins TR, 2008, CRIT CARE MED, V36, P1493, DOI 10.1097/CCM.0b013e318170a9ce; WOBBES T, 1990, SURG GYNECOL OBSTET, V171, P59; Zallen G, 2000, SHOCK, V13, P29, DOI 10.1097/00024382-200013010-00006; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	117	9	9	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213			NEUROTHERAPEUTICS	Neurotherapeutics	JAN	2012	9	1					56	64		10.1007/s13311-011-0094-5			9	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	891AG	WOS:000300187900007	22203525	Green Published, Bronze			2022-02-06	
J	Mills, JD; Bailes, JE; Turner, RC; Dodson, SC; Sakai, J; Maroon, JC				Mills, James D.; Bailes, Julian E.; Turner, Ryan C.; Dodson, Sean C.; Sakai, Jun; Maroon, Joseph C.			Anabolic Steroids and Head Injury	NEUROSURGERY			English	Article						Concussion; Steroids; Traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; RECURRENT CONCUSSION; FOOTBALL PLAYERS; APOPTOSIS; TESTOSTERONE; ADOLESCENTS	BACKGROUND: The suggestion has been made that neurological changes seen in the syndrome of chronic traumatic encephalopathy may be due to exogenous anabolic steroid use rather than traumatic brain injury. OBJECTIVE: To determine whether administration of anabolic steroids alters the pathophysiology of traumatic brain injury. METHODS: Sixty adult male Sprague-Dawley rats and a linear acceleration model of traumatic brain injury were used. Experimental groups were (1) preinjury anabolic steroids, (2) preinjury placebo carrier, (3) anabolic steroids without injury, (4) no steroids and no injury, (5) postinjury placebo carrier, and (6) postinjury anabolic steroids. Following a 30-day recovery, rats were euthanized, and brainstem white matter tracts underwent fluorescent immunohistochemical processing and labeling of beta-amyloid precursor protein (APP), a marker of axonal injury. Digital imaging and statistical analyses were used to determine whether anabolic steroid administration resulted in a significant change in the number of injured axons. RESULTS: There was no statistically significant difference in number of APP-positive axons by immunohistochemical analysis between respective anabolic steroid and placebo groups. CONCLUSION: Using a standard acceleration-deceleration model of mild traumatic brain injury, we have shown successful visualization of traumatically injured axons with antibody staining of APP. Our results indicate no statistically significant effect of anabolic steroids on the number of APP-positive axons. With the use of this model, and within its limitations, we see no adverse effect or causative role of anabolic steroid administration on the brain following mild traumatic brain injury using APP counts as a marker for anatomic injury.	[Mills, James D.; Bailes, Julian E.; Turner, Ryan C.; Dodson, Sean C.; Sakai, Jun] W Virginia Univ, Dept Neurosurg, Morgantown, VA USA; [Maroon, Joseph C.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA		Bailes, JE (corresponding author), Univ Chicago, Pritzker Sch Med, NorthShore Univ HealthSyst, 2650 Ridge Ave, Evanston, IL 60201 USA.	JBailes@northshore.org		Turner, Ryan/0000-0001-5523-0645			Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Buki A, 2000, J NEUROSCI, V20, P2825; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Evans NA, 2004, AM J SPORT MED, V32, P534, DOI 10.1177/0363546503262202; Faul M, 2010, TRAUMATIC BRAIN INJU; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Horn S, 2009, AM J PHYS MED REHAB, V88, P192, DOI 10.1097/PHM.0b013e318198b622; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mills JD, 2003, J BIOMED OPT, V8, P347, DOI 10.1117/1.1584443; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Scott DM, 1996, AM J HEALTH-SYST PH, V53, P2068, DOI 10.1093/ajhp/53.17.2068; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Talih F, 2007, CLEV CLIN J MED, V74, P341, DOI 10.3949/ccjm.74.5.341; van den Berg P, 2007, PEDIATRICS, V119, P476, DOI 10.1542/peds.2006-2529; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339	25	9	9	1	12	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2012	70	1					205	209		10.1227/NEU.0b013e3182250918			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	863EP	WOS:000298145900049	21606881				2022-02-06	
J	O'Neill, M; McMillan, TM				O'Neill, M.; McMillan, T. M.			Can deficits in empathy after head injury be improved by compassionate imagery?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; YOUNG-PEOPLE; ADULTS; PERSPECTIVE; DISABILITY; AWARENESS; THERAPY; TBI	Severe head injury (SHI) can result in problems in empathising, which in turn is associated with social difficulties. Compassionate imagery can increase compassion in non-brain injured people and can alter how they relate to themselves and others. This preliminary study investigates whether compassionate imagery can increase empathy in those with low empathy after SHI. A between-group repeated measures design was used wth 24 participants with severe SHI and low empathy, randomly allocated to a single treatment session of compassionate imagery or a control condition of relaxation. Empathy, self-compassion and relaxation were assessed pre- and post-intervention and fear of compassion pre-intervention as a potential covariate. A group effect of compassionate imagery on empathy was not found, F(1, 21) = 0.12, p = .73. A non-specific increase in self-compassion approached significance, T = 78.00, p = 0.07, r = -.26. Fear of compassion did not correlate significantly with changes in self-compassion or empathy. Demographic and injury factors associated with SHI that may impact on treatment effectiveness are discussed. Further research that takes these factors into account is warranted.	[O'Neill, M.; McMillan, T. M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Gartnavel Royal Hosp, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	thomas.mcmillan@glasgow.ac.uk			NHS Education Scotland	This study was partly funded by NHS Education Scotland. Thanks are due to Dr N. Paterson for assistance with recruitment and assessment and to Professor A. Gumley for discussion and providing the compassionate imagery script.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Block-Lerner J, 2007, J MARITAL FAM THER, V33, P501, DOI 10.1111/j.1752-0606.2007.00034.x; Conrad A, 2007, J ANXIETY DISORD, V21, P243, DOI 10.1016/j.janxdis.2006.08.001; Davis JR, 2011, PERS INDIV DIFFER, V50, P392, DOI 10.1016/j.paid.2010.10.031; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Gilbert, 2009, ADV PSYCHIAT TREATME, V15, P199, DOI [10.1192/apt.bp.107.005264, https://doi.org/10.1192/apt.bp.107.005264, DOI 10.1192/APT.BP.107.005264, 10.1192/apt.bp.107.005264.]; Gilbert P, 2004, MEMORY, V12, P507, DOI 10.1080/09658210444000115; Gilbert P, 2012, PSYCHOL PSYCHOTHER-T, V85, P374, DOI 10.1111/j.2044-8341.2011.02046.x; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; Gilbert P, 2011, PSYCHOL PSYCHOTHER-T, V84, P239, DOI 10.1348/147608310X526511; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; HOWITT D, 2002, FORENSIC CRIMINAL PS; Jacobson E., 1938, PROGR RELAXATION; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Kaukiainen A, 1999, AGGRESSIVE BEHAV, V25, P81, DOI 10.1002/(SICI)1098-2337(1999)25:2<81::AID-AB1>3.0.CO;2-M; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lutz A, 2008, PLOS ONE, V3; Macintosh M., 1993, SCOTTISH AFFAIRS, V5; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Mayhew SL, 2008, CLIN PSYCHOL PSYCHOT, V15, P113, DOI 10.1002/cpp.566; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Mehrabian A, 1997, AGGRESSIVE BEHAV, V23, P433, DOI 10.1002/(SICI)1098-2337(1997)23:6<433::AID-AB3>3.0.CO;2-H; Mehrabian A., 2000, MANUAL BALANCED EMOT; Milders M, 2003, NEUROPSYCHOLOGIA, V41, P1484, DOI 10.1016/S0028-3932(03)00079-4; Neff KD., 2006, 114 ANN M AM PSYCH A; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Rocklin H, 2008, CLIN NEUROPSYCHIATR, V5, P132; Rothwell NA, 1999, BRAIN INJURY, V13, P521; Russell WR, 1935, LANCET, V2, P762; Scottish Government, SCOTT IND MULT DEPR; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Shapiro SL, 2011, J CLIN PSYCHOL, V67, P267, DOI 10.1002/jclp.20761; Smith, 1973, SYMBOL DIGIT MODALIT; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037/0022-006X.68.4.615; The Scottish Government, 2009, SCOTT IND MULT DEPR; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; WechslerD, 2001, WECHSLER TEST ADULT; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	52	9	10	2	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2012	22	6					836	851		10.1080/09602011.2012.691886			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	039EQ	WOS:000311227300002	22670572				2022-02-06	
J	Rona, RJ; Jones, M; Fear, NT; Sundin, J; Hull, L; Wessely, S				Rona, Roberto J.; Jones, Margaret; Fear, Nicola T.; Sundin, Josefin; Hull, Lisa; Wessely, Simon			Frequency of Mild Traumatic Brain Injury in Iraq and Afghanistan: Are We Measuring Incidence or Prevalence?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						incidence; length deployment; mild traumatic brain injury; prevalence	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; HEALTH; WAR	Objective: Rates of mild traumatic brain injury (mTBI) differ considerably between US and UK forces, despite similar methodology and similar exposure risks. We assessed, in the UK forces, if the differences in rates based on last deployment can be explained by differences in deployment length, given that US forces deploy for approximately twice as long as UK forces. Participants: A total of 3763 personnel deployed to Iraq or Afghanistan who completed a questionnaire between 2007 and 2009. Main Outcome Measures: Mild traumatic brain injury in the last deployment contrasted to current posttraumatic stress disorder, psychological distress (General Health Questionnaire-12), multiple physical symptoms, and alcohol misuse. Results: In the Army and Royal Marines, there was an association between length of deployment (per month) and mTBI (odds ratio: 1.31, 95% confidence interval: 1.13-1.51), which remained significant after adjustment for confounders (odds ratio: 1.25, 95% confidence interval: 1.08-1.45). No other outcome was associated with length of deployment. Results based on the total sample were similar to those in the Royal Marine and Army sample, except for adjusted multiple physical symptoms. Conclusions: Comparisons of mTBI rates should take account of length of deployment when based on last deployment. Doing so reduces but does not eliminate the differences between UK and US forces.	[Rona, Roberto J.; Jones, Margaret; Hull, Lisa; Wessely, Simon] Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, London SE5 9RJ, England; [Fear, Nicola T.; Sundin, Josefin] Kings Coll London, Acad Ctr Def Mental Hlth, Weston Educ Ctr, London SE5 9RJ, England		Rona, RJ (corresponding author), Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, 10 Cutcombe Rd, London SE5 9RJ, England.	Roberto.rona@kcl.ac.uk	Sundin, Josefin/B-9666-2012; Fear, Nicola/A-1917-2012; Wessely, Simon C/A-8713-2008	Fear, Nicola/0000-0002-5792-2925; Sundin, Josefin/0000-0002-0609-586X; Wessely, Simon Charles/0000-0002-6743-9929; Rona, Roberto/0000-0003-3739-5571	UK Ministry of Defence	The UK Ministry of Defence funded this project.	Babor TF, 2001, AUDIT ALCOHOL USE DI; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Browne T, 2007, BRIT J PSYCHIAT, V190, P484, DOI 10.1192/bjp.bp.106.030544; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; General Accounting Office, 2008, VA HLTH CAR MILD TRA; GOLDBERG D, 1988, US GUID GEN HLTH QUE; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horn O, 2010, EUR J EPIDEMIOL, V25, P87, DOI 10.1007/s10654-009-9414-z; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004	19	9	9	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2012	27	1					75	82		10.1097/HTR.0b013e31823029f6			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	879JV	WOS:000299326400008	22143632				2022-02-06	
J	Safadieh, L; Sharara-Chami, R; Dabbagh, O				Safadieh, Layal; Sharara-Chami, Rana; Dabbagh, Omar			Paroxysmal Autonomic Instability with Dystonia after Pneumococcal Meningoencephalitis	CASE REPORTS IN MEDICINE			English	Article							STREPTOCOCCUS-PNEUMONIAE MENINGOENCEPHALITIS; SYMPATHETIC STORMS	Streptococcus pneumoniae is a common cause of bacterial meningitis, frequently resulting in severe neurological impairment. A seven-month-old child presenting with Streptococcus pneumoniae meningoencephalitis developed right basal ganglia and hypothalamic infarctions. Daily episodes of agitation, hypertension, tachycardia, diaphoresis, hyperthermia, and decerebrate posturing were observed. The diagnosis of paroxysmal autonomic instability with dystonia was established. The patient responded to clonidine, baclofen, and benzodiazepines. Although this entity has been reported in association with traumatic brain injury, and as a sequel to some nervous system infections, this is the first case, to our knowledge, associated with pneumococcal meningoencephalitis.	[Safadieh, Layal; Dabbagh, Omar] Amer Univ, Beirut Med Ctr, Dept Pediat & Adolescent Med, Div Neurol, POB 11-0236, Beirut 11072020, Lebanon; [Sharara-Chami, Rana] Amer Univ, Beirut Med Ctr, Dept Pediat & Adolescent Med, Div Crit Care Med, Beirut 11072020, Lebanon		Dabbagh, O (corresponding author), Amer Univ, Beirut Med Ctr, Dept Pediat & Adolescent Med, Div Neurol, POB 11-0236, Beirut 11072020, Lebanon.	od05@aub.edu.lb					Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Gil Anton J, 2004, An Pediatr (Barc), V61, P449; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Goh KYC, 1999, PEDIATR NEUROL, V21, P742, DOI 10.1016/S0887-8994(99)00069-7; Jorens PG, 2005, NEURORADIOLOGY, V47, P758, DOI 10.1007/s00234-005-1423-3; Jorens PG, 2008, EUR J PAEDIATR NEURO, V12, P127, DOI 10.1016/j.ejpn.2007.06.007; Magnus J, 2011, J CHILD NEUROL, V26, P1438, DOI 10.1177/0883073811409223; Ramdhani Navin A, 2010, J Med Case Rep, V4, P304, DOI 10.1186/1752-1947-4-304; Srinivasan S, 2007, CLIN AUTON RES, V17, P378, DOI 10.1007/s10286-007-0428-x; Wang VY, 2008, J TRAUMA, V64, P500, DOI 10.1097/TA.0b013e31804a5738	11	9	9	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9627	1687-9635		CASE REP MED	Case Rep. Med.		2012	2012								965932	10.1155/2012/965932			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V25VM	WOS:000215252100349	23093976	gold, Green Published, Green Submitted			2022-02-06	
J	Si, Y; Liu, L; Hu, J; Mu, J; Fang, JJ; An, DM; Zhao, LL; Tian, LY; Zhou, D				Si, Yang; Liu, Ling; Hu, Jia; Mu, Jie; Fang, Jia-jia; An, Dong-mei; Zhao, Li-li; Tian, Lin-yu; Zhou, Dong			Etiologic features of newly diagnosed epilepsy: Hospital-based study of 892 consecutive patients in West China	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Epilepsy; Symptomatic epilepsy; Etiologic factors	EPIDEMIOLOGY; ROCHESTER; MANAGEMENT; SEIZURES	Purpose: We evaluated data from a large cohort of newly diagnosed epilepsy patients from the biggest epilepsy center in West China. The aim was to determine the most prevalent etiologic factors in this region. Methods: From May 2008 to May 2010, the clinical data of patients with newly diagnosed epilepsy were consecutively, systematically and prospectively recorded in a database. The data were analyzed according to sex, age, seizure type, etiology, and other factors. Results: The present study examined 892 patients with newly diagnosed epilepsy. Among these patients, 346(38.8%) were confirmed as symptomatic, with the largest constituent ratio among the elderly (63.2%). In this symptomatic group, central nervous system (CNS) infections and traumatic brain injuries (TBI) were the two most common etiologies. When analyzed according to age bracket, cortical dysplasia, mesial temporal sclerosis, and CNS infection were the most frequent causes among young patients (<18 years). On the other hand, CNS infection and TBI were the two most common causes in patients between 18 and 60 years. Stroke was the most common cause of newly diagnosed symptomatic epilepsy in the elderly (>60 years). Conclusions: More than 30% of newly diagnosed epilepsy cases were shown to be symptomatic by medical history as well as careful clinical and laboratory examination. Detailed epilepsy assessments are essential to formulate a therapeutic plan and to improve prognosis. The etiology spectrum found in this large cohort forms a comparative baseline for future studies. (C) 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Si, Yang; Liu, Ling; Hu, Jia; Mu, Jie; Fang, Jia-jia; An, Dong-mei; Zhao, Li-li; Tian, Lin-yu; Zhou, Dong] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610041, Peoples R China		Liu, L (corresponding author), Sichuan Univ, W China Hosp, Dept Neurol, Wai Nan Guo Xue Lane 37, Chengdu 610041, Peoples R China.	zjllxx1968@yahoo.com.cn					Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; de Boer HM, 2002, EPILEPSIA, V43, P7, DOI 10.1046/j.1528-1157.43.s.6.4.x; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; Hui ACF, 2004, SEIZURE-EUR J EPILEP, V13, P244, DOI 10.1016/S1059-1311(03)00186-9; Jallon P, 2001, EPILEPSIA, V42, P464, DOI 10.1046/j.1528-1157.2001.31400.x; Li S, 2004, NEUROL ASIA S, V9, P12; LI SC, 1985, EPILEPSIA, V26, P391, DOI 10.1111/j.1528-1157.1985.tb05669.x; Liu L, 2010, EPILEPSY BEHAV, V17, P75, DOI 10.1016/j.yebeh.2009.10.013; Mac TL, 2007, LANCET NEUROL, V6, P533, DOI 10.1016/S1474-4422(07)70127-8; Stephen LJ, 2000, LANCET, V355, P1441, DOI 10.1016/S0140-6736(00)02149-8; Wang WZ, 2006, LANCET NEUROL, V5, P46, DOI 10.1016/S1474-4422(05)70254-4; Wang WZ, 2003, NEUROLOGY, V60, P1544, DOI 10.1212/01.WNL.0000059867.35547.DE	15	9	10	1	3	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	JAN	2012	21	1					40	44		10.1016/j.seizure.2011.09.008			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	900EV	WOS:000300870300009	22000953	Bronze			2022-02-06	
J	Bhat, AR; Kirmani, AR; Nizami, F; Kumar, A; Wani, MA				Bhat, Abdul Rashid; Kirmani, Altaf R.; Nizami, Furqan; Kumar, Ashish; Wani, Mohammed Afzal			"Sunken brain and scalp flap" syndrome following decompressive "extra-craniectomy"	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						cranioplasty; extra-craniectomy; low GCS; non-pulsatile sunken brain		The sinking brain and scalp syndrome associated with neurological deterioration after decompressive craniectomy in traumatic brain edema is an uncommon condition. The recovery of neurological and imaging deficits following cranioplasty is well known. Although lumbar puncture and ventriculo-peritoneal shunts have been labelled precipitating factors to induce sinking brain syndrome but occasionally "extra" decompressive craniectomy alone may be sufficient to cause it. Clinically the non-pulsatile depressed brain and scalp flap with a marked concavity in an obtunded patient and radiological features like midline shift, paradoxical herniation and 'kidney-bean' shaped brain (Axial CT) are remarkable. It is more like a dehydrated infant with non-pulsatile depressed fontanellae. The cranioplasty has a dramatic effect on the overall recovery of the patient. We present a patient of traumatic brain injury who developed the "non-pulsatile sunken brain syndrome" without VP shunt, lumbar puncture or a external ventricular drainage and recovered completely after cranioplasty. The extra component of craniectomy is likely cause.	[Bhat, Abdul Rashid; Kirmani, Altaf R.; Nizami, Furqan; Kumar, Ashish; Wani, Mohammed Afzal] Sherikashmir Inst Med Sci, Dept Neurosurg, C-O B-4 Fac Quarters, Srinagar, Jammu & Kashmir, India		Bhat, AR (corresponding author), Sherikashmir Inst Med Sci, Dept Neurosurg, C-O B-4 Fac Quarters, Srinagar, Jammu & Kashmir, India.	seven_rashid@rediffmail.com					Binder DK, 2002, NEUROSURGERY, V51, P830, DOI 10.1227/01.NEU.0000024286.95876.2F; Cho Hyun, 2006, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V40, P51; GEORGE AE, 1974, RADIOLOGY, V111, P627; Han PY, 2008, J KOREAN NEUROSURG S, V43, P51, DOI 10.3340/jkns.2008.43.1.51; Kelley GR, 2004, NEUROLOGY, V62, P157, DOI 10.1212/WNL.62.1.157; Komotar RJ, 2005, NEUROSURGERY, V57, P286, DOI 10.1227/01.NEU.0000166661.96546.33; Langfitt T.W, 1968, CLIN NEUROSURG, V16, P436; Liao CC, 2002, J CLIN NEUROSCI, V9, P553, DOI 10.1054/jocn.2002.1116; Oyelese AA, 2005, NEUROSURGERY, V57, P594, DOI 10.1227/01.NEU.0000170437.79760DF; Phuenpathom Nakornchai, 1999, Journal of the Medical Association of Thailand, V82, P46; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Schwab S, 1998, NERVENARZT, V69, P896, DOI 10.1007/s001150050360; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yamaura A, 1977, No Shinkei Geka, V5, P345	16	9	9	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2011	8	2					105	108		10.1016/S0973-0508(11)80009-2			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M2O	WOS:000218384100009					2022-02-06	
J	Honeybul, S				Honeybul, S.			An update on the management of traumatic brain injury	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; Hypothermia; Decompressive craniectomy	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; BLOOD-FLOW; POSTTRAUMATIC HYPOTHERMIA; MODERATE HYPOTHERMIA; OXYGEN-SATURATION; MANNITOL; IMPACT	The management of traumatic brain injury (TBI) continues to evolve in a number of key areas. In the first instance there have been major advances in clinical information gathering and interpretation such that there are mow sophisticated prognostic models readily available. Secondly, technological advances have allowed the introduction of advanced multimodal monitoring which can provide real time information regarding the complex physiological and biochemical derangements that occur following TBI. Finally recent clinical trials have raised important questions regarding the efficacy or otherwise of important therapeutic options most notably hypothermia and decompressive craniectomy. The aim of this update is to highlight some of the areas where there has been advancement and controversy.	[Honeybul, S.] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Honeybul, S.] Royal Perth Hosp, Perth, WA, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Akopian G, 2007, AM SURGEON, V73, P447; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Barazangi N, 2008, NEUROL INDIA, V56, P405; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bratton S.L., 2007, J NEUROTRAUMA S1, V24; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diedler J, 2010, NEUROCRIT CARE, V12, P313, DOI 10.1007/s12028-010-9350-5; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; JENNETT B, 1975, LANCET, V1, P480; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; Koerner IP, 2006, CURR OPIN ANESTHESIO, V19, P481, DOI 10.1097/01.aco.0000245271.84539.4c; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Macmillan CSA, 2000, INTENS CARE MED, V26, P1028, DOI 10.1007/s001340051315; MANNINEN PH, 1987, CAN J ANAESTH, V34, P442, DOI 10.1007/BF03014345; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Meier U, 2005, ACT NEUR S, V95, P55; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; NATH F, 1986, J NEUROSURG, V65, P41, DOI 10.3171/jns.1986.65.1.0041; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROL NEUROSUR PS, V34, P106, DOI 10.1136/jnnp.34.1.106-a; Ratanalert S, 2004, SURG NEUROL, V61, P429, DOI 10.1016/S0090-3019(03)00579-2; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Saltarini M, 2002, Eur J Emerg Med, V9, P262, DOI 10.1097/00063110-200209000-00011; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Sutcliffe IT, 2001, J CEREBR BLOOD F MET, V21, P1310, DOI 10.1097/00004647-200111000-00007; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; VARGHAKHADEM F, 1985, BRAIN LANG, V25, P167, DOI 10.1016/0093-934X(85)90128-2; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	100	9	10	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	DEC	2011	55	4					343	355					13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	885GC	WOS:000299765500005	22198586				2022-02-06	
J	Nielsen, TH; Engell, SI; Johnsen, RA; Schulz, MK; Gerke, O; Hjelmborg, J; Toft, P; Nordstrom, CH				Nielsen, Troels Halfeld; Engell, Susanne I.; Johnsen, Rikke Aagaard; Schulz, Mette K.; Gerke, Oke; Hjelmborg, Jacob; Toft, Palle; Nordstrom, Carl-Henrik			Comparison Between Cerebral Tissue Oxygen Tension and Energy Metabolism in Experimental Subdural Hematoma	NEUROCRITICAL CARE			English	Article						Brain tissue oxygen; Ischemia; Ischemic threshold; Microdialysis; Acute subdural hematoma; Experimental model	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; SPREADING DEPOLARIZATIONS; MICRODIALYSIS; PRESSURE; DELIVERY; SATURATION; RESUSCITATION; NEUROSURGERY; DIFFUSION	An experimental swine model (n = 7) simulating an acute subdural hematoma (ASDH) was employed (1) to explore the relation between the brain tissue oxygenation (PbtO(2)) and the regional cerebral energy metabolism as obtained by microdialysis, and (2) to define the lowest level of PbtO(2) compatible with intact energy metabolism. ASDH was produced by infusion of 7 ml of autologous blood (infusion rate 0.5 ml/min) by a catheter placed subdurally. PbtO(2) and microdialysis probes were placed symmetrically in the injured ("bad-side") and non-injured ("good-side") hemispheres. Intracranial pressure (ICP) was monitored in the "good-side." ICP, cerebral perfusion pressure (CPP), PbtO(2), glucose, lactate, pyruvate, lactate-pyruvate ratio (LP ratio), glutamate, and glycerol were recorded at baseline (60 min) and post trauma (360 min). After the creation of the ASDH, PbtO(2) decreased significantly in both the hemispheres (P < 0.001). No significant difference was found between the sides post trauma. The LP ratio, glutamate, and glycerol in the "bad-side" increased significantly over the "good-side" where the values remained within the normal limits. A PbtO(2) value below approximately 25 mmHg was found to be associated with disturbed energy metabolism in the "bad-side" but not in the "good-side." No correlation was found between the LP ratio and PbtO(2) in either hemisphere. PbtO(2) monitoring accurately describes tissue oxygenation but does not disclose whether the oxygen delivery is sufficient for maintaining cerebral energy metabolism. Accordingly, it may not be possible to define a threshold level for PbtO(2) below which energy failure and permanent tissue damage occurs.	[Nielsen, Troels Halfeld; Schulz, Mette K.; Nordstrom, Carl-Henrik] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense C, Denmark; [Gerke, Oke] Odense Univ Hosp, Dept Nucl Med, DK-5000 Odense C, Denmark; [Toft, Palle] Odense Univ Hosp, Dept Anesthesiol, DK-5000 Odense C, Denmark; [Hjelmborg, Jacob] Univ So Denmark, Dept Biostat, Odense C, Denmark; [Engell, Susanne I.; Johnsen, Rikke Aagaard] Univ So Denmark, Fac Hlth Sci, Odense C, Denmark		Nielsen, TH (corresponding author), Odense Univ Hosp, Dept Neurosurg, Sdr Blvd 29, DK-5000 Odense C, Denmark.	troels.halfeld.nielsen@ouh.regionsyddanmark.dk	Hjelmborg, Jacob/AAN-5966-2020; Nielsen, Troels Halfeld/G-3456-2015; Gerke, Oke/X-2197-2019	Hjelmborg, Jacob/0000-0001-9630-9149; Nielsen, Troels Halfeld/0000-0002-3943-8128; Gerke, Oke/0000-0001-6335-3303; Toft, Palle/0000-0002-3188-449X	Foundation for Medical Research in The County of Funen Island; Faculty of Health Science, University of Southern Denmark	This study was supported by grants from "The Foundation for Medical Research in The County of Funen Island'' and "Surgical Training and Research Program at the Faculty of Health Science, University of Southern Denmark.'' Licox probes were provided by Mediplast ncnielsen A/S, Denmark. The authors wish to thank the personnel at Biomedical Laboratory, Faculty of Health Science, University of Southern Denmark, for their great assistance and cooperation during the experiments.	Amer-Wahlin I, 2010, J MATERN-FETAL NEO M, V23, P158, DOI 10.3109/14767050903067360; Bhatia A, 2007, INTENS CARE MED, V33, P1322, DOI 10.1007/s00134-007-0660-9; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mazzeo AT, 2007, J NEUROL SCI, V261, P1, DOI 10.1016/j.jns.2007.04.026; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Nordstrom CH, 2010, CHILD NERV SYST, V26, P465, DOI 10.1007/s00381-009-1035-z; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Pennings FA, 2008, J NEUROTRAUM, V25, P1173, DOI 10.1089/neu.2007.0402; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Scheufler KM, 2002, ANESTH ANALG, V95, P1042, DOI 10.1097/00000539-200210000-00046; Siesj? BK., 1978, BRAIN ENERGY METABOL; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; Ungerstedt U, 1997, PHYSIOLOGY, STRESS, AND MALNUTRITION, P361; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	40	9	9	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2011	15	3					585	592		10.1007/s12028-011-9563-2			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	852NT	WOS:000297365400033	21638119				2022-02-06	
J	Nordstrom, A; Nordstrom, P				Nordstrom, Anna; Nordstrom, Peter			Cognitive Performance in Late Adolescence and the Subsequent Risk of Subdural Hematoma: An Observational Study of a Prospective Nationwide Cohort	PLOS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; INTELLIGENCE; DEMENTIA	Background: There are few identified risk factors for traumatic brain injuries such as subdural hematoma (SDH). The aim of the present study was to investigate whether low cognitive performance in young adulthood is associated with SDH later in life. A second aim was to investigate whether this risk factor was associated with education and physical fitness. Methods and Findings: Word recollection, logical, visuospatial, and technical performances were tested at a mean age of 18.5 years in a prospective nation-wide cohort of 440,742 men. An estimate of global intelligence was calculated from these four tests. Associations between cognitive performance, education, physical fitness, and SDH during follow-up were explored using Cox regression analyses. During a median follow-up of 35 years, 863 SDHs were diagnosed in the cohort. Low global intelligence was associated with an increased risk of SDH during follow-up (hazard ratio [HR]: 1.33, per standard deviation decrease, 95% CI = 1.25-1.43). Similar results were obtained for the other measures of cognitive performance (HR: 1.24-1.33, p<0.001 for all). In contrast, a high education (HR: 0.27, comparing more than 2 years of high school and 8 years of elementary school, 95% CI = 0.19-0.39), and a high level of physical fitness (HR: 0.76, per standard deviation increase, 95% CI = 0.70-0.83), was associated with a decreased risk of suffering from a SDH. Conclusions: The present findings suggest that reduced cognitive function in young adulthood is strongly associated with an increased risk of SDH later in life. In contrast, a higher level of education and a higher physical fitness were associated with a decreased risk of SDH.	[Nordstrom, Anna; Nordstrom, Peter] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden		Nordstrom, A (corresponding author), Umea Univ, Dept Community Med & Rehabil, Umea, Sweden.	anna.nordstrom@idrott.umu.se	Nordstrom, Anna/F-2238-2010; Nordstrom, Anna/O-2504-2018	Nordstrom, Anna/0000-0003-3534-456X; Nordstrom, Anna/0000-0003-3534-456X; Nordstrom, Peter/0000-0003-2924-508X	Vasterbotten County Council	The present study was supported by Vasterbotten County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen L. B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P143; ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021; Backman L, 2010, NEUROSCI BIOBEHAV R, V34, P670, DOI 10.1016/j.neubiorev.2009.12.008; CAMERON MM, 1978, J NEUROL NEUROSUR PS, V41, P834, DOI 10.1136/jnnp.41.9.834; CARLSTEDT B, 1993, SCAND J PSYCHOL, V34, P353, DOI 10.1111/j.1467-9450.1993.tb01131.x; Carlstedt B., 2000, COGNITIVE ABILITIES; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Denckla MB, 1996, DEV NEUROPSYCHOL, V12, P5, DOI 10.1080/87565649609540637; DRONFIELD MW, 1977, POSTGRAD MED J, V53, P57, DOI 10.1136/pgmj.53.616.57; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; KASTE M, 1979, ACTA NEUROCHIR, V48, P231, DOI 10.1007/BF02056971; Kushi H, 1999, ACT NEUR S, V75, P67; Lawlor DA, 2007, AM J PUBLIC HEALTH, V97, P291, DOI 10.2105/AJPH.2005.080168; Machulda MM, 2000, NEUROSURG CLIN N AM, V11, P473, DOI 10.1016/S1042-3680(18)30110-4; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Murray C. J., 1996, GLOBAL HLTH STAT COM; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Oyama H, 1998, No To Shinkei, V50, P249; PARY R, 1990, SOUTH MED J, V83, P1182, DOI 10.1097/00007611-199010000-00015; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; SCOTTI G, 1977, J NEUROSURG, V47, P311, DOI 10.3171/jns.1977.47.3.0311; SMITH DI, 1982, ACCIDENT ANAL PREV, V14, P439, DOI 10.1016/0001-4575(82)90057-4; Stahl N, 2003, ACTA NEUROL SCAND, V108, P211, DOI 10.1034/j.1600-0404.2003.00095.x; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; TSUBOI K, 1984, Neurological Surgery, V12, P275; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1676			PLOS MED	PLos Med.	DEC	2011	8	12							e1001151	10.1371/journal.pmed.1001151			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	870KM	WOS:000298668100016	22215989	gold, Green Published, Green Submitted			2022-02-06	
J	Yuan, KC; Hsu, YP; Wong, YC; Fang, JF; Lin, BC; Chen, HW				Yuan, Kuo-Ching; Hsu, Yu-Pao; Wong, Yon-Cheong; Fang, Jen-Feng; Lin, Being-Chung; Chen, Huan-Wu			Management of Complicated Lumbar Artery Injury After Blunt Trauma	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	17th Asian Congress of Surgery/68th Annual Meeting of the Taiwan-Surgical-Association	MAR 20-22, 2009	Taipei, TAIWAN	Taiwan Surg Assoc			EMBOLIZATION	Study objective: Lumbar artery injury after blunt trauma is not frequently discussed. We review our experience with blunt lumbar artery injury management, especially alternative treatments in which embolization is not feasible. Methods: We reviewed our trauma registry for 8 years 8 months. We sought all patients who sustained blunt torso trauma and had lumbar artery injury detected by angiography. Variables collected included demographic data, trauma mechanism, vital signs in triage, Injury Severity Score, associated injuries, computed tomography results, angiography results, embolizations, and outcome. Results: Sixteen of the 3,436 patients in the trauma registry system had a blunt lumbar artery injury verified by angiography. For patients with lumbar artery injury, the mean Injury Severity Score was 38.6 (SD 12), and 10 (63%) of these 16 patients were in shock and 12 patients (75%) had closed head injuries. Angioembolization caused bleeding cessation in 11 patients but failed in 5 patients, who were treated conservatively. The overall mortality rate of patients with lumbar artery injury was 50%. Conclusion: Lumbar artery injury in multiply injured patients with blunt trauma leads to a high mortality rate, especially if accompanied by head injury. Embolization often stops bleeding, but, if embolization is not feasible, conservative treatment without retroperitoneal surgery can be successful. [Ann Emerg Med. 2011;58:531-535.]	[Yuan, Kuo-Ching; Hsu, Yu-Pao; Fang, Jen-Feng; Lin, Being-Chung] Chang Gung Univ, Chang Gung Mem Hosp, Trauma & Crit Care Ctr, Div Gen Surg,Dept Surg, Linkou, Taiwan; [Wong, Yon-Cheong; Chen, Huan-Wu] Chang Gung Univ, Chang Gung Mem Hosp, Div Emergency & Crit Care Radiol, Dept Med Imaging & Intervent, Linkou, Taiwan		Yuan, KC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Trauma & Crit Care Ctr, Div Gen Surg,Dept Surg, Linkou, Taiwan.	traumayuan@gmail.com	Wong, Yon Cheong/F-8411-2010	Wong, Yon Cheong/0000-0001-8831-3295			Akpinar E, 2008, ANZ J SURG, V78, P683, DOI 10.1111/j.1445-2197.2008.04148.x; Bley TA, 2010, RADIOLOGY, V255, P873, DOI 10.1148/radiol.10091304; Boufi M, 2011, ANN VASC SURG, V25, P352, DOI 10.1016/j.avsg.2010.09.008; Coimbra R, 1996, AM J SURG, V172, P541, DOI 10.1016/S0002-9610(96)00231-0; Domenicucci M, 2008, SPINE, V33, pE81, DOI 10.1097/BRS.0b013e3181624b93; Hagiwara A, 2004, J TRAUMA, V57, P271, DOI 10.1097/01.TA.0000131198.79153.3C; HULNICK DH, 1984, J COMPUT ASSIST TOMO, V8, P570, DOI 10.1097/00004728-198406000-00044; SCLAFANI SJA, 1987, RADIOLOGY, V165, P709, DOI 10.1148/radiology.165.3.3685349; Sofocleous CT, 2005, CARDIOVASC INTER RAD, V28, P730, DOI 10.1007/s00270-003-0117-7	9	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	DEC	2011	58	6					531	535		10.1016/j.annemergmed.2011.07.002			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	864GI	WOS:000298224600008	21802772				2022-02-06	
J	Kane, MJ; Hatic, H; Delic, V; Dennis, JS; Butler, CL; Saykally, JN; Citron, BA				Kane, Michael J.; Hatic, Haris; Delic, Vedad; Dennis, John S.; Butler, Carrie L.; Saykally, Jessica N.; Citron, Bruce A.			Modeling the pathobiology of repetitive traumatic brain injury in immortalized neuronal cell lines	BRAIN RESEARCH			English	Article						HT22 hippocampal cell; SH-SY5Y neuroblastoma cell; Cell survival; Neurite; Traumatic brain injury	LONG-TERM POTENTIATION; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; FLUID PERCUSSION INJURY; IN-VITRO; HIPPOCAMPAL CELLS; FOOTBALL PLAYERS; HEAD-INJURY; CONCUSSION; STRETCH	Repetitive mild traumatic brain injury (mTBI) represents a major public health problem. Many individuals who suffer repetitive mTBIs suffer from Post-Concussion Syndrome, a constellation of neuropsychiatric symptoms that includes depression, anxiety, and problems with memory and other cognitive processes. Significantly, Post-Concussion Syndrome is resistant to existing therapeutic strategies. To provide better treatment options for this patient population, the underlying pathophysiology of repetitive mTBI must be understood. A first step in this process is the establishment of an in vitro model system that recapitulates the biological changes that occur in the brains of repetitively injured humans. The availability of a model with immortalized cell lines would remove the considerable barriers of time, expense, and difficulties with genetic manipulation that exist with the use of primary neuronal cultures. Here we report the development and functional characterization of an in vitro laboratory model of repetitive TBI using immortalized neuronal cell lines. These results indicate that the moderate, repetitive injury reduces viability, numbers and lengths of neurites, and that the neuronal loss mechanism includes caspase activation. Published by Elsevier B.V.	[Kane, Michael J.; Hatic, Haris; Delic, Vedad; Dennis, John S.; Butler, Carrie L.; Saykally, Jessica N.; Citron, Bruce A.] Bay Pines VA Healthcare Syst, Mol Biol Lab, Bay Pines, FL 33744 USA; [Kane, Michael J.; Butler, Carrie L.; Saykally, Jessica N.; Citron, Bruce A.] USF Coll Med, Dept Mol Med, Tampa, FL 33612 USA		Citron, BA (corresponding author), Bay Pines VA Healthcare Syst, Mol Biol Lab, Bldg 22,Room 123,POB 4125, Bay Pines, FL 33744 USA.	bruce.citron@va.gov			Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development)US Department of Veterans Affairs; Florida Department of Health; Bay Pines Foundation	This study was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development), the Florida Department of Health James and Esther King Biomedical Research Program, and the Bay Pines Foundation.	Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kane Michael J, 2009, Recent Pat CNS Drug Discov, V4, P190; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	49	9	9	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	NOV 24	2011	1425						123	131		10.1016/j.brainres.2011.09.047			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	862VN	WOS:000298122300013	22018688				2022-02-06	
J	Curaudeau, GA; Sharma, N; Rovin, RA				Curaudeau, Guillaume A.; Sharma, Nikhil; Rovin, Richard A.			Development of an iPhone application for sideline concussion testing	NEUROSURGICAL FOCUS			English	Article						sports-related concussion; iPhone app; Sport Concussion Assessment Tool	SPORT	Professional athletes are taking concussion very seriously, and missed play due to concussion is no longer stigmatized. One fortuitous consequence is increased awareness of the detrimental effects of concussion among student athletes. Whereas professional athletes have access to formal in-competition evaluation and out-of-competition monitoring programs, the majority of student athletes, especially at the middle school and high school levels, do not. The authors therefore set out to create an easy-to-use iPhone application for sideline concussion testing and serial monitoring of these at-risk athletes. (DOI: 10.3171/2011.8.FOCUS11186)	[Curaudeau, Guillaume A.; Sharma, Nikhil] Univ Michigan, Ann Arbor, MI 48109 USA; [Rovin, Richard A.] Marquette Gen Hosp, Brain & Spine Ctr, Marquette, MI USA		Rovin, RA (corresponding author), 580 W Coll Ave, Marquette, MI 49855 USA.	rarovin@gmail.com					Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; *NFL HLTH SAF, LYST LAW OV; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	5	9	9	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2011	31	5							E4	10.3171/2011.8.FOCUS11186			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	844QL	WOS:000296762300005	22044103				2022-02-06	
J	Jinguji, TM; Krabak, BJ; Satchell, EK				Jinguji, Thomas M.; Krabak, Brian J.; Satchell, Emma K.			Epidemiology of Youth Sports Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; High school athletes; Head injury; Youth	HIGH-SCHOOL SPORTS; STATES HIGH-SCHOOL; CATASTROPHIC HEAD-INJURIES; US EMERGENCY-DEPARTMENTS; UNITED-STATES; FOOTBALL PLAYERS; ICE HOCKEY; DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; LACROSSE INJURIES	The overall prevalence of concussion is high school sports is unknown. In general, concussions in this age range occur much more frequently in games than in practice. Also for sports in which both sexes participate, reported concussion rates are higher for female than male high school athletes. Recent data show that the time required for return to play and resolution of symptoms is similar for women and men. Very little is known about the epidemiology of concussions in middle school aged athletes and younger children.	[Jinguji, Thomas M.] Orthoped Adm, Seattle, WA 98195 USA; [Jinguji, Thomas M.; Satchell, Emma K.] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98105 USA; [Krabak, Brian J.] Seattle Childrens Sports Med, Seattle, WA USA; [Krabak, Brian J.] Seattle Univ Athlet, Seattle, WA USA; [Krabak, Brian J.] RacingThePlanet Ultramarathons, Seattle, WA USA		Jinguji, TM (corresponding author), Orthoped Adm, W 7706,4800 & Point Way NE, Seattle, WA 98195 USA.	Thomas.Jinguji@seattlechildrens.org					Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Boden BP, 2004, AM J SPORT MED, V32, P1189, DOI 10.1177/0363546503262161; Cantu RC, 2009, BRIT J SPORT MED, V43, P981, DOI 10.1136/bjsm.2009.067728; Collins CL, 2008, PEDIATRICS, V121, P1181, DOI 10.1542/peds.2007-2572; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P255; Echlin P. S., 2010, NEUROSURG FOCUS, V29, P1, DOI DOI 10.3171/2010.9FOCUS10187; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; FOMMER LJ, 2011, J ATHL TRAINING, V46, P76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; *GOV ACC OFF, CONC HIGH SCH SPORTS; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Huffman EA, 2008, J ATHL TRAINING, V43, P624, DOI 10.4085/1062-6050-43.6.624; Johnson LSM, 2011, CAN MED ASSOC J, V183, P921, DOI 10.1503/cmaj.110282; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawson BR, 2009, PEDIATRICS, V123, pE1028, DOI 10.1542/peds.2007-3796; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mueller FO, 2001, PHYSICIAN SPORTSMED, V29, P41, DOI 10.3810/psm.2001.07.874; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Mueller FO., CATASTROPHIC SPORTS; *NAT FED HLTH SCH, 2009 10 HIGH SCH ATH; Powell JW, 1999, J ATHL TRAINING, V34, P277; Powell JW, 2000, AM J SPORT MED, V28, P385, DOI 10.1177/03635465000280031801; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; SCHULTZ MR, 2004, AM J EPIDEMIOL, V160, P933; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	43	9	9	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					565	+		10.1016/j.pmr.2011.08.001			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	858SI	WOS:000297822600002	22050936				2022-02-06	
J	Yang, JJ; Ma, YL; Zhang, P; Chen, HQ; Liu, ZH; Qin, HL				Yang, Jian-Jun; Ma, Yan-Lei; Zhang, Peng; Chen, Hong-Qi; Liu, Zhi-Hua; Qin, Huan-Long			Histidine Decarboxylase Is Identified as a Potential Biomarker of Intestinal Mucosal Injury in Patients with Acute Intestinal Obstruction	MOLECULAR MEDICINE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; GLUTATHIONE-S-TRANSFERASE; SEVERE ACUTE-PANCREATITIS; TRAUMATIC BRAIN-INJURY; GUT BARRIER FAILURE; ISCHEMIA-REPERFUSION; COLORECTAL-CANCER; ESCHERICHIA-COLI; EARLY MARKER; D-LACTATE	Various biomarkers currently used for the diagnosis of intestinal mucosal injury (IMI) in patients with acute intestinal obstruction have low sensitivity and specificity. In the present study, IMI, as indicated by the impaired expression of tight junction proteins, including zonula occludens-1, occludin and claudin-1, and inflammation were determined in colonic tissues of patients with 45 strangulated intestinal obstruction (SIR-IO) and the adjacent "normal" colonic tissues of 35 patients with colon cancers by quantitative real-time polymerase chain reaction (QRT-PCR), Western blotting, immunohistochemistry and histological examination, respectively Then, two-dimensional fluorescent difference gel electrophoresis coupled with linear trap quadrupole mass spectrometry was used to screen for potential biomarkers of IMI in the serum samples of 10 SIR-IO, 10 simple intestinal obstruction (SIM-IO) and 10 normal healthy controls. A total of 35 protein spots were differentially expressed among the serum samples, and six of the proteins were identified as potential biomarkers. Among the six proteins, histidine decarboxylase (HDC) and ceruloplasmin (CP) were elevated significantly in patients with SIR-IO, compared with patients with SIM-IO and healthy controls. Thus, HDC and CP were further validated by QRT-PCR, Western blotting, immunohistochemistry and enzyme-linked immunosorbent assay, respectively in colonic tissues, serum and urine samples. Finally, the receiver operating characteristic curves were used to show the area under the curves of HDC, CP and several established biomarkers, followed by the determination of the appropriate cutoff values and their sensitivities and specificities. It was shown that for serum and urine, HDC levels achieved sensitivities and specificities compatible to or even greater than those of established biomarkers for the diagnosis of IMI in patients with acute intestinal obstruction, although further validation in a larger cohort is required. (C) 2011 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: http://www.molmed.org doi: 10.2119/molmed.2011.00107	[Yang, Jian-Jun; Ma, Yan-Lei; Zhang, Peng; Chen, Hong-Qi; Liu, Zhi-Hua; Qin, Huan-Long] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Surg, Shanghai 200233, Peoples R China		Qin, HL (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China.	huanlongqin0311@hotmail.com	huanlong, Qin/B-3844-2015	Liu, Zhihua/0000-0001-5784-9724	Shanghai Science and Technology Development Fund [05DJ14010]; Major Basic Research Program of Shanghai [07DZ19505]; National 973 Basic Research Program of ChinaNational Basic Research Program of China [2008CB517403]; Shanghai Rising-Star Program [11QA1404800]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81001069]	We are grateful to the staff in the Research Center for Proteome Analysis, Shanghai Institutes for Biological Sciences, for technical assistance and the staff in the Bioinformatics Center, Shanghai Institutes for Biological Sciences, for bioinformatic analysis. This work was supported by grants from the Shanghai Science and Technology Development Fund (05DJ14010), the Major Basic Research Program of Shanghai (07DZ19505) and the National 973 Basic Research Program of China (2008CB517403), Shanghai Rising-Star Program (No.11QA1404800) and the National Natural Science Foundation of China (No.81001069). We also thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.	Acosta S, 2004, BRIT J SURG, V91, P991, DOI 10.1002/bjs.4645; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Assadian A, 2006, EUR J VASC ENDOVASC, V31, P470, DOI 10.1016/j.ejvs.2005.10.031; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; BOUNOUS G, 1984, DIGEST DIS SCI, V29, P872, DOI 10.1007/BF01318436; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Chang TM, 2001, J SURG RES, V95, P133, DOI 10.1006/jsre.2000.5983; Costantini TW, 2009, J SURG RES, V156, P64, DOI 10.1016/j.jss.2009.03.066; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; de Haan JJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7910; Delaney CP, 1999, BRIT J SURG, V86, P1349, DOI 10.1046/j.1365-2168.1999.01245.x; Derikx JPM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003428; English JA, 2009, PROTEOMICS, V9, P3368, DOI 10.1002/pmic.200900015; Evennett NJ, 2009, WORLD J SURG, V33, P1374, DOI 10.1007/s00268-009-0074-7; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; FUJIMOTO K, 1992, J CLIN INVEST, V89, P126, DOI 10.1172/JCI115552; Gamagedara S, 2011, CLIN CHIM ACTA, V412, P120, DOI 10.1016/j.cca.2010.09.015; Gearhart SL, 2003, AM SURGEON, V69, P324; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Grzeskowiak JK, 2009, PROTEIN EXPRES PURIF, V66, P58, DOI 10.1016/j.pep.2009.01.007; Guan YF, 2009, AM J PHYSIOL-GASTR L, V297, pG187, DOI 10.1152/ajpgi.90595.2008; Gurleyik G, 2003, J INVEST SURG, V16, P283, DOI 10.1080/08941930390230423; Handley SA, 2006, P NATL ACAD SCI USA, V103, P9268, DOI 10.1073/pnas.0510414103; HERNANDEZ MFH, 1989, REV INVEST CLIN, V41, P123; Icoz G, 2006, WORLD J SURG, V30, P2165, DOI 10.1007/s00268-006-0138-x; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Jin W, 2009, J SURG RES, V157, P251, DOI 10.1016/j.jss.2008.08.003; KAHLSON G, 1968, PHYSIOL REV, V48, P155, DOI 10.1152/physrev.1968.48.1.155; LEFFALL L S D, 1970, American Journal of Surgery, V120, P756, DOI 10.1016/S0002-9610(70)80043-5; Liu WJ, 2010, MOL BIOL REP, V37, P3207, DOI 10.1007/s11033-009-9903-x; Ma YL, 2009, J PROTEOME RES, V8, P4525, DOI 10.1021/pr900365e; Ma YL, 2009, ELECTROPHORESIS, V30, P2591, DOI 10.1002/elps.200900082; Ma YL, 2009, MOL CELL PROTEOMICS, V8, P1878, DOI 10.1074/mcp.M800541-MCP200; Martin B, 2007, AACN ADV CRIT CARE, V18, P158, DOI 10.1097/01.AACN.0000269259.91546.d8; McCall IC, 2009, TOXICOL APPL PHARM, V241, P61, DOI 10.1016/j.taap.2009.08.002; Mei Q, 1999, DIGESTION, V60, P227, DOI 10.1159/000007663; Mittak M, 2008, Rozhl Chir, V87, P16; MURRAY MJ, 1994, AM J SURG, V167, P575, DOI 10.1016/0002-9610(94)90101-5; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Peng JY, 2009, ELECTROPHORESIS, V30, P2976, DOI 10.1002/elps.200900203; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Poeze M, 1999, BRIT J SURG, V86, P712, DOI 10.1046/j.1365-2168.1999.1104b.x; Polk JD, 2008, J TRAUMA, V64, P42, DOI 10.1097/TA.0b013e31815b846a; Qin HL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-63; Rahman SH, 2003, J GASTROINTEST SURG, V7, P26, DOI 10.1016/S1091-255X(02)00090-2; Rodriguez-Pineiro AM, 2010, J PROTEOMICS, V73, P1511, DOI 10.1016/j.jprot.2010.03.005; Roxas JL, 2010, LAB INVEST, V90, P1152, DOI 10.1038/labinvest.2010.91; SARR MG, 1983, AM J SURG, V145, P176, DOI 10.1016/0002-9610(83)90186-1; Schisterman EF, 2004, STAT MED, V23, P3319, DOI 10.1002/sim.1908; Seneviratne CJ, 2010, PROTEOMICS, V10, P1444, DOI 10.1002/pmic.200900611; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Thomas CE, 2010, CANCER EPIDEM BIOMAR, V19, P953, DOI 10.1158/1055-9965.EPI-10-0069; Tonge R, 2001, PROTEOMICS, V1, P377; Tumani H, 2009, J NEUROIMMUNOL, V214, P109, DOI 10.1016/j.jneuroim.2009.06.012; Tunc T, 2009, J SURG RES, V155, P210, DOI 10.1016/j.jss.2008.06.017; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Van den Bergh G, 2004, CURR OPIN BIOTECH, V15, P38, DOI 10.1016/j.copbio.2003.12.001; Wang N, 2010, SCAND J GASTROENTERO, V45, P191, DOI 10.3109/00365520903406701; WU ZD, 2004, SURGERY; Yan JX, 2002, PROTEOMICS, V2, P1682, DOI 10.1002/1615-9861(200212)2:12<1682::AID-PROT1682>3.0.CO;2-Y; Zhang Xi-ping, 2007, Journal of Zhejiang University-Science B, V8, P888, DOI 10.1631/jzus.2007.B0888; Zhang XP, 2008, PANCREAS, V37, pE74, DOI 10.1097/MPA.0b013e3181800d11; Zhou G, 2002, MOL CELL PROTEOMICS, V1, P117, DOI 10.1074/mcp.M100015-MCP200; Zipplies JK, 2010, INVEST OPHTH VIS SCI, V51, P375, DOI 10.1167/iovs.09-4094; Zubaidah RM, 2008, PROTEOMICS, V8, P5086, DOI 10.1002/pmic.200800322	67	9	10	0	5	FEINSTEIN INST MED RES	MANHASSET	350 COMMUNITY DR, MANHASSET, NY 11030 USA	1076-1551			MOL MED	Mol. Med.	NOV-DEC	2011	17	11-12					1323	1337		10.2119/molmed.2011.00107			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	860OY	WOS:000297958800023	21915437	Green Published, gold			2022-02-06	
J	Gillick, BT; Marshall, WJ; Rheault, W; Stoecker, J				Gillick, Bernadette T.; Marshall, Wendy J.; Rheault, Wendy; Stoecker, Judy			Mobility Criteria for Upright Sitting With Patients in the Neuro/Trauma Intensive Care Unit: An Analysis of Length of Stay and Functional Outcomes	NEUROHOSPITALIST			English	Article						outcomes; neurocritical care; brain hemorrhage; cerebrovascular trauma; physical therapy		Background and purpose: Few studies have explored optimal advancement and variation in mobility and length of stay (LOS) data with critically ill patients in the intensive care unit (ICU). The purpose of this study was to analyze the outcomes and LOS of critically ill patients in the neurotrauma ICU involved in rehabilitation. Methods: A bidirectional case-control study of a total of 30 patients admitted to a level 1 trauma hospital in the metropolitan Chicago area with Glasgow Coma Score (GCS) of <= 12 (3-12) were studied. Functional outcomes of a structured mobility group were compared at first upright sitting and at ICU discharge using the functional independence measure (FIM). Retrospective LOS review of a group (n = 15) with unstructured activity advancement was compared. Results: The main outcome measures were FIM scores and LOS in number of days. In the structured mobility group, a significant increase in functional performance between first upright sitting and ICU discharge was found (P < .005). Length of stay was shorter in the structured mobility groups but the difference was not statistically significant. Conclusions: Results from this study revealed favorable functional outcomes for patients involved in a structured mobility program with physical therapy in the neuro/trauma ICU.	[Gillick, Bernadette T.] Univ Minnesota, Neurosci, Rehabil Sci Minor, 420 Delaware St SE MMC 388, Minneapolis, MN 55455 USA; [Marshall, Wendy J.] St Joseph Med Ctr, Joliet, IL USA; [Marshall, Wendy J.] Morris Hosp, Ctr Surg & Breast Care, Joliet, IL USA; [Rheault, Wendy] Rosalind Franklin Sch Med, Coll Hlth Profess, N Chicago, IL USA; [Stoecker, Judy] Rosalind Franklin Sch Med, N Chicago, IL USA		Gillick, BT (corresponding author), Univ Minnesota, Neurosci, Rehabil Sci Minor, 420 Delaware St SE MMC 388, Minneapolis, MN 55455 USA.	bgillick@hotmail.com					[Anonymous], 1998, BIGSTEPS VERSION 2 7, P60637; [Anonymous], FUNCT IND MEAS COP C; BAGGERLY J, 1986, NURS CLIN N AM, V21, P577; Elliott Doug, 2004, Intensive Crit Care Nurs, V20, P366, DOI 10.1016/j.iccn.2004.07.001; EMHOFF TA, 1991, J TRAUMA, V31, P1227, DOI 10.1097/00005373-199109000-00005; Engelman RM, 1996, ANN THORAC SURG, V61, pS26, DOI 10.1016/0003-4975(95)01081-5; Fiedler RC, 1996, AM J PHYS MED REHAB, V75, P125, DOI 10.1097/00002060-199603000-00010; GEORGE ER, 1995, AM SURGEON, V61, P659; GORDON DL, 1979, AM SURGEON, V45, P223; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hodgin KE, 2009, CRIT CARE MED, V37, P561, DOI 10.1097/CCM.0b013e3181957449; KALRA L, 1994, STROKE, V25, P821, DOI 10.1161/01.STR.25.4.821; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Marciniak CM, 1996, ARCH PHYS MED REHAB, V77, P54, DOI 10.1016/S0003-9993(96)90220-8; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Mortifee PRS, 1996, ARCH PHYS MED REHAB, V77, P436, DOI 10.1016/S0003-9993(96)90030-1; NORRIS C, 1995, CAN J ANAESTH, V42, P192, DOI 10.1007/BF03010674; Patman S, 2009, INTENS CARE MED, V35, P258, DOI 10.1007/s00134-008-1278-2; Perme C, 2009, AM J CRIT CARE, V18, P212, DOI 10.4037/ajcc2009598; SCIAKY AJ, 1994, PHYS THER PRACT, V3, P69; SEGAL ME, 1993, PARAPLEGIA, V31, P622, DOI 10.1038/sc.1993.101; SJOSTRAND T, 1951, ACTA PHYSIOL SCAND, V22, P114, DOI 10.1111/j.1748-1716.1951.tb00760.x; SPENCER W A, 1965, Arch Phys Med Rehabil, V46, P89; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0	30	9	9	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1941-8744	1941-8752		NEUROHOSPITALIST	Neurohospitalist	OCT	2011	1	4					172	177		10.1177/1941874411415118			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VH9CO	WOS:000457804000002	23983852	Green Published			2022-02-06	
J	Haron, RH; Imran, MK; Haspani, MSM				Haron, Rahmat Harun; Imran, Musa Kamarul; Haspani, Mohammed Saffari Mohammed			An Observational Study of Blood Glucose Levels during Admission and 24 Hours Post-Operation in a Sample of Patients with Traumatic Injury in a Hospital in Kuala Lumpur	MALAYSIAN JOURNAL OF MEDICAL SCIENCES			English	Article						blood glucose; Glasgow Outcome Scale; surgery; trauma; traumatic brain injury; trauma severity index	SEVERE HEAD-INJURY; BRAIN-INJURY; HYPERGLYCEMIA; HOMEOSTASIS; MORBIDITY; PRESSURE	Background: Traumatic brain injury (TBI) has been associated with an acute stress response mediated by the sympathoadrenomedullary axis, which can be assessed by measuring blood glucose level. Methods: This prospective observational study was conducted for a year in 2007 among 294 patients who had been treated for TBI in Hospital Kuala Lumpur. Patients fulfilling the set criteria were recruited into the study and data, including blood glucose level and Glasgow Outcome Score at 3-month follow-up, were collected. Results: 294 patients were included in the study: 50 females (17.0%) and 244 males (83.0%). The majority of cases were young adult patients (mean age of 34.2 years, SD 13.0). The mean blood glucose level during admission and post-surgery were 6.26 mmol/L (SD 1.30, n = 294) and 6.66 mmol/L ( SD 1.44, n = 261), respectively. Specifically, the mean admission glucose level associated with mild TBI was 5.04 mmol/L (SD 0.71); moderate TBI, 5.78 mmol/L (SD 1.02); and severe TBI, 7.04 mmol/L (SD 1.18). The mean admission glucose level associated with a poor outcome in patients with isolated TBI was 6.98 mmol/L (SD 1.21). Patients with admission glucose of 5.56 mmol/L (SD 1.21) were more likely to have a favourable outcome. Conclusion: Mild, moderate, and severe TBI were associated with an increase in blood glucose levels during admission, and the mean increase in glucose levels is based on the severity of the isolated TBI. Surgical intervention did not cause further significant changes in blood glucose levels. Patients with isolated TBI and minimal increases in blood glucose levels were more likely to have a favourable outcome.	[Haron, Rahmat Harun; Haspani, Mohammed Saffari Mohammed] Hosp Kuala Lumpur, Bangunan IKTAR, Dept Neurosurg, Kuala Lumpur 50586, Malaysia; [Haron, Rahmat Harun] Univ Sains Malaysia Hlth Campus, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia; [Imran, Musa Kamarul] Univ Sains Malaysia Hlth Campus, Sch Med Sci, Dept Community Med, Kubang Kerian 16150, Kelantan, Malaysia		Haron, RH (corresponding author), Hosp Kuala Lumpur, Bangunan IKTAR, Dept Neurosurg, Kuala Lumpur 50586, Malaysia.	rahmat865@yahoo.com	Musa, Kamarul Imran/N-3198-2015	Musa, Kamarul Imran/0000-0002-3708-0628			Baranov Dimitry, 2007, Anesthesiol Clin, V25, P49, DOI 10.1016/j.atc.2006.11.003; Bochicchio GV, 2005, AM SURGEON, V71, P171; Cely CM, 2004, CHEST, V126, P879, DOI 10.1378/chest.126.3.879; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; CHIOLERO R, 1989, JPEN-PARENTER ENTER, V13, P5, DOI 10.1177/014860718901300105; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; He Zhao-hui, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P315; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Kraus J F, 2000, Neurosurg Focus, V8, pe5; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; MARION DW, 1999, TRAUMATIC BRAIN INJU; MERGUERIAN PA, 1981, CRIT CARE MED, V9, P838, DOI 10.1097/00003246-198112000-00007; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Sabariah F J, 2008, Med J Malaysia, V63 Suppl C, P45; Sabariah FJ, 2007, NATL TRAUMA DATABASE; Salim A, 2009, AM SURGEON, V75, P25; Stover JF, 2002, INTENS CARE MED, V28, P1491, DOI 10.1007/s00134-002-1431-2; Takanashi Y, 2001, No To Shinkei, V53, P61; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vogelzang M, 2006, J TRAUMA, V60, P873, DOI 10.1097/01.ta.0000195715.63978.80; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; Wintergerst KA, 2006, PEDIATRICS, V118, P173, DOI 10.1542/peds.2005-1819; Wong AA, 2008, NEUROLOGY, V70, P1036, DOI 10.1212/01.wnl.0000306635.08410.68; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; YOUNG JB, 1983, AM J PHYSIOL, V245, pE67, DOI 10.1152/ajpendo.1983.245.1.E67; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	32	9	9	0	0	UNIV SAINS MALAYSIA, SCH MEDICAL SCIENCES	KELANTAN	HEALTH CAMPUS, 16150 KUBANG KERIAN, KELANTAN, 00000, MALAYSIA	1394-195X	2180-4303		MALAYS J MED SCI	Malays. J. Med. Sci.	OCT-DEC	2011	18	4					69	77					9	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	V6N0Z	WOS:000420434000009	22589675				2022-02-06	
J	Lapitskaya, N; Nielsen, JF; Fuglsang-Frederiksen, A				Lapitskaya, Natallia; Nielsen, Joergen Feldbaek; Fuglsang-Frederiksen, Anders			Robotic gait training in patients with impaired consciousness due to severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; rehabilitation; electroencephalography; evoked potentials; sensory stimulation; robotic gait training	SOMATOSENSORY-EVOKED POTENTIALS; VEGETATIVE STATE; PROGNOSTIC VALUE; PREDICTIVE-VALUE; TILT-TABLE; COMA; SCALE; PLASTICITY; EEG; DISORDERS	Primary objective: This prospective controlled non-randomized study investigated the effects of robotic gait training on electroencephalographic (EEG) brain activity in patients with impaired consciousness due to severe traumatic brain injury (TBI). Methods: Twelve TBI patients and 14 healthy controls underwent a single training session on a computer-driven gait orthosis (Lokomat (R)). The sensory pathways were assessed using sensory evoked potentials (SEPs). The global delta-alpha EEG power ratio (DAR) and latency of the P300 component of the event-related potentials was assessed prior to and following a training session. Results: Baseline measurements showed impaired SEPs in the majority of patients and significantly larger DAR in patients compared to healthy controls. Robotic gait training resulted in a reduction of the DAR in healthy subjects but not in patients. No changes were observed in P300 latencies after training in either patients or healthy controls. Conclusion: The study showed that robotic gait training induced measurable changes in the EEG power spectrum in healthy individuals, while no changes were observed in patients with severe TBI. The absence of the EEG changes following training might be an indicator of the severity of brain dysfunction.	[Lapitskaya, Natallia; Nielsen, Joergen Feldbaek] Hammel Neurorehabil & Res Ctr, Res Dept, DK-8450 Hammel, Denmark; [Fuglsang-Frederiksen, Anders] Aarhus Univ Hosp, Dept Neurophysiol, DK-8000 Aarhus C, Denmark		Lapitskaya, N (corresponding author), Hammel Neurorehabil & Res Ctr, Res Dept, Voldbyvej 15, DK-8450 Hammel, Denmark.	natlap@rm.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Fuglsang-Frederiksen, Anders/0000-0003-3926-5287			ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Barbeau H, 1998, ANN NY ACAD SCI, V860, P377, DOI 10.1111/j.1749-6632.1998.tb09063.x; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Chang AT, 2004, AUST J PHYSIOTHER, V50, P51, DOI 10.1016/S0004-9514(14)60249-X; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colombo G, 2000, J REHABIL RES DEV, V37, P693; Dietz V, 2008, BRAIN RES BULL, V76, P459, DOI 10.1016/j.brainresbull.2008.02.034; Dobkin BH, 2004, ANN NY ACAD SCI, V1038, P148, DOI 10.1196/annals.1315.024; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Finnigan SP, 2007, CLIN NEUROPHYSIOL, V118, P2525, DOI 10.1016/j.clinph.2007.07.021; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Guerit JM, 2005, PROG BRAIN RES, V150, P415, DOI 10.1016/S0079-6123(05)50029-3; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; Guerit JM, 2005, NEUROPSYCHOL REHABIL, V15, P357, DOI 10.1080/09602010443000560; GUERIT JM, 1999, RECOMMENDATIONS PRAC, P117; HAGEN C, 1979, REHABILITATION HEAD, P8; Iriarte J, 2003, J CLIN NEUROPHYSIOL, V20, P249, DOI 10.1097/00004691-200307000-00004; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kotchoubey B, 2005, PROG BRAIN RES, V150, P427, DOI 10.1016/S0079-6123(05)50030-X; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Leon-Carrion J, 2009, CLIN NEUROPHYSIOL, V120, P1039, DOI 10.1016/j.clinph.2009.01.021; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; Luther MS, 2008, CLIN REHABIL, V22, P1034, DOI 10.1177/0269215508092821; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Neumann N, 2004, BRAIN RES PROTOC, V14, P25, DOI 10.1016/j.brainresprot.2004.09.001; Nuwer MR, 2003, CLIN NEUROPHYSIOL, V114, P2225, DOI 10.1016/S1388-2457(03)00310-9; POLICH J, 1989, ELECTROEN CLIN NEURO, V74, P312, DOI 10.1016/0168-5597(89)90061-0; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Robinson Lawrence R, 2004, Phys Med Rehabil Clin N Am, V15, P43, DOI 10.1016/S1047-9651(03)00102-5; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; TEASDALE G, 1974, LANCET, V2, P81; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113; Yang YR, 2010, ARCH PHYS MED REHAB, V91, P513, DOI 10.1016/j.apmr.2009.11.021; Young GB, 2004, J CLIN NEUROPHYSIOL, V21, P379; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006	54	9	9	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2011	25	11					1070	1079		10.3109/02699052.2011.607782			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WC	WOS:000295614900005	21870900				2022-02-06	
J	Zweckberger, K; Hackenberg, K; Jung, CS; Hertle, DN; Kiening, KL; Unterberg, AW; Sakowitz, OW				Zweckberger, Klaus; Hackenberg, Katharina; Jung, Carla S.; Hertle, Daniel N.; Kiening, Karl L.; Unterberg, Andreas W.; Sakowitz, Oliver W.			Cerebral metabolism after early decompression craniotomy following controlled cortical impact injury in rats	NEUROLOGICAL RESEARCH			English	Article						Traumatic brain injury; Cerebral metabolism; Decompression craniotomy; Controlled cortical impact	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL MICRODIALYSIS; ANEURYSM SURGERY; AMINO-ACIDS; HEAD-INJURY; CRANIECTOMY; GLUTAMATE; ISCHEMIA; CONTUSION; EEG	After traumatic brain injury, a cascade of metabolic changes promotes the development of secondary brain damage. In this study, we examined metabolic changes in rats in the acute stage after trauma. Furthermore, we investigated the effect of a very early decompression craniotomy on intracranial pressure (ICP) and on metabolic parameters. For this study, a moderate controlled cortical impact injury (CCII) on rats was performed. The observation time was 180 minutes after trauma. ICP was measured continuously and microdialysate samples were collected every 30 minutes from the peri-contusional region. As representative metabolic parameters, glutamate, lactate, lactate/pyruvate ratio (L/P ratio), and glucose concentrations were measured. Compared to sham-operated animals, a significant, sustained decrease in glucose concentration and increase in L/P ratio occurred immediately after CCII. Additionally, delayed increase in lactate and glutamate concentrations occurred 60 minutes after trauma. After this initial peak, glutamate concentrations declined continuously via the observation time and reached levels comparable to sham-operated animals. In our model, thus we could detect a very early deterioration of glucose utilization and energy supply after trauma that recovered, due to the moderate intensity of the trauma, within 60 minutes without leading to ischemia in the peri-contusional region. Following decompression craniotomy, the increase of intracranial pressure could be reduced significantly. Any significant beneficial effects on metabolic changes, however, could not be proven in this very early stage after moderate CCII.	[Zweckberger, Klaus; Hackenberg, Katharina; Jung, Carla S.; Hertle, Daniel N.; Kiening, Karl L.; Unterberg, Andreas W.; Sakowitz, Oliver W.] Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany		Zweckberger, K (corresponding author), Heidelberg Univ, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	zweckberger@med.uni-heidelberg.de		Sakowitz, Oliver/0000-0003-3248-6335			Adamides AA, 2009, J AM COLL SURGEONS, V209, P531, DOI 10.1016/j.jamcollsurg.2009.05.028; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chefer Vladimir I, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0701s47; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; De Los Rios JA, 2009, NEUROCIRUGIA, V20, P433; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; GAAB M, 1979, CHILD BRAIN, V5, P484; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hlatky Roman, 2003, Neurosurg Focus, V14, pe2; Hutchinson PJ, 1999, NEUROL RES, V21, P352, DOI 10.1080/01616412.1999.11740943; Hutchinson PJ, 2000, NEUROSURGERY, V46, P201, DOI 10.1093/neurosurgery/46.1.201; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kett-White R, 2002, ACT NEUR S, V81, P363; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; McCulloch J, 1993, Acta Neurochir Suppl (Wien), V57, P73; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Obrenovitch TP, 1999, ANN NY ACAD SCI, V890, P273, DOI 10.1111/j.1749-6632.1999.tb08004.x; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RINALDI A, 1990, ACT NEUR S, V51, P394; Rose ME, 2002, BRAIN RES, V935, P40, DOI 10.1016/S0006-8993(02)02445-9; SAITO N, 1990, ACT NEUR S, V51, P186; Sakowitz OW, 2005, BRIT J NEUROSURG, V19, P260, DOI 10.1080/02688690500208734; Sakowitz OW, 2002, ACT NEUR S, V81, P221; Sarrafzadeh A S, 2000, Neurosurg Focus, V9, pe2; Stover JF, 2003, J NEUROTRAUM, V20, P315, DOI 10.1089/089771503765172273; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2006, CURR OPIN CRIT CARE, V12, P119, DOI 10.1097/01.ccx.0000216577.57180.bd; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	51	9	9	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	OCT	2011	33	8					875	880		10.1179/1743132811Y.0000000017			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	834PB	WOS:000295973600013	22004712				2022-02-06	
J	Brorsson, C; Rodling-Wahlstrom, M; Olivecrona, M; Koskinen, LOD; Naredi, S				Brorsson, C.; Rodling-Wahlstrom, M.; Olivecrona, M.; Koskinen, L. -O. D.; Naredi, S.			Severe traumatic brain injury: consequences of early adverse events	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEAD-INJURY; CARE; RESUSCITATION; THERAPY; PROSTACYCLIN; VENTILATION; GUIDELINES; MANAGEMENT; MORTALITY	Background: Several factors associated with an unfavourable outcome after severe traumatic brain injury (TBI) have been described: prolonged pre-hospital time, secondary referral to a level 1 trauma centre, the occurrence of secondary insults such as hypoxia, hypotension or low end-tidal carbon dioxide (ETCO(2)). To determine whether adverse events were linked to outcome, patients with severe TBI were studied before arrival at a level 1 trauma centre. Methods: Prospective, observational study design. Patients with severe TBI (n = 48), admitted to Umea University Hospital between January 2002 to December 2005 were included. All medical records from the site of the accident to arrival at the level 1 trauma centre were collected and evaluated. Results: A pre-hospital time of >60 min, secondary referral to a level 1 trauma centre, documented hypoxia (oxygen saturation <95%), hypotension (systolic blood pressure <90 mmHg), hyperventilation (ETCO(2) <4.5 kPa) or tachycardia (heart rate >100 beats/min) at any time before arrival at a level 1 trauma centre were not significantly related to an unfavourable outcome (Glasgow Outcome Scale 1-3). Conclusion: Early adverse events before arrival at a level 1 trauma centre were without significance for outcome after severe TBI in the trauma system studied.	[Brorsson, C.; Rodling-Wahlstrom, M.; Naredi, S.] Umea Univ, Dept Anaesthesia & Intens Care, Inst Surg & Perioperat Sci, S-90187 Umea, Sweden; [Olivecrona, M.; Koskinen, L. -O. D.] Umea Univ, Inst Pharmacol & Clin Neurosci, Dept Neurosurg, S-90187 Umea, Sweden		Brorsson, C (corresponding author), Umea Univ, Dept Anaesthesia & Intens Care, Inst Surg & Perioperat Sci, S-90187 Umea, Sweden.	camilla.brorsson@anestesi.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502; Olivecrona, Magnus/0000-0001-8457-4711; Naredi, Silvana/0000-0002-4409-6089	Faculty of Medicine Umea University; Tore Nilsson foundation; Kempe foundation; Capio Research foundation	We thank the staff at the neurosurgical department and intensive care unit of Umea University Hospital for their dedicated work. We also thank all other staff involved in the care of these patients. Especially, we would like to express our gratitude to our research nurses. This study was financially supported by the Faculty of Medicine Umea University, Tore Nilsson foundation, Kempe foundation and Capio Research foundation.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brain Trauma Foundation T National Association of State EMS Officials T National Association of EMTs, 2007, PREHOSP EMERG CARE S, V12, P1; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2009, J TRAUMA, V67, P389, DOI 10.1097/TA.0b013e3181a8b26f; COWLEY RA, 1979, AM SURGEON, V45, P255; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MARMAROU A, 1991, J NEUROSURG S, V75, P59; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; Soreide E, 2005, INJURY, V36, P1001, DOI 10.1016/j.injury.2005.01.002; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; van der Velden MWA, 2008, EMERG MED J, V25, P444, DOI 10.1136/emj.2007.052662; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032	27	9	10	0	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	SEP	2011	55	8					944	951		10.1111/j.1399-6576.2011.02451.x			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	813HD	WOS:000294356500006	21574969	Green Submitted			2022-02-06	
J	Du, YL; Li, Y; Lan, Q				Du, Yanli; Li, Yu; Lan, Qing			H-1-Magnetic resonance spectroscopy correlates with injury severity and can predict coma duration in patients following severe traumatic brain injury	NEUROLOGY INDIA			English	Article						Choline; creatinine; lactic acid spectroscopy; N-acetylaspartate; traumatic brain injury	PROTON MR SPECTROSCOPY; COMPUTED-TOMOGRAPHY; N-ACETYLASPARTATE; TEMPORAL WINDOW; AXONAL INJURY; NEURONAL LOSS; HEAD-INJURY; MILD; CHILDREN; LACTATE	Background: Evaluation of the degree of severity of injury, coma duration, and prediction of outcome are integral parts of present-day management of severe traumatic brain injury (TBI). Objective: To investigate whether evaluation and prediction of outcome in early phase after severe TBI is possible by means of single-voxel proton magnetic resonance spectroscopy ( (1) H-MRS). Materials and Methods: Proton spectra were acquired from the posterior part of normal-appearing frontal lobes having predominantly white matter in 72 patients with severe TBI within a few days of trauma, mean 9.5 days and also in 30 controls. Results: (1) H-MRS studies revealed lower ratios of N-acetylaspartate (NAA)/Choline (Cho) and NAA/ Creatine (Cr) and higher ratios of Cho/Cr in patients with TBI when compared to the control group. In patients with severe TBI, NAA/Cr, NAA/Cho and Cho/Cr ratios were significantly correlated with the initial Glasgow Coma Scale score (GCS) (P=0.004, r =0.439, P=0.018, r =0.364, P=0.004, r = -0.762, respectively), and with the clinical outcome, Glasgow Outcome Scores (GOS) (P=0.006, r =0.414; P=0.007, r =0.412; P=0.016, r = -0.775, respectively). An equation including clinical and spectroscopic variables, which can predict coma duration fairly accurately, was also obtained. Conclusions: (1) H-MRS may be a novel method of assessing brain function, estimating coma duration, and predicting outcome in patients with severe TBI.	[Du, Yanli; Lan, Qing] Suzhou Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215004, Jiangsu, Peoples R China; [Du, Yanli; Li, Yu] Inner Mongolia Gen Forestry Hosp, Inner Mongolia, Peoples R China		Lan, Q (corresponding author), Suzhou Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215004, Jiangsu, Peoples R China.	zzyyy@163.com			Natural Science Foundation of Inner Mongolia, China [2010MS1137]	The Natural Science Foundation of Inner Mongolia, China (2010MS1137).	Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Broman S. H., 1995, TRAUMATIC HEAD INJUR; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Cimatti M, 2006, J Neurosurg Sci, V50, P83; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, INT J TRAUMA NURS, V3, P114; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Signoretti S, 2002, ACT NEUR S, V81, P373; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; TEASDALE G, 1974, LANCET, V2, P81; VAGNOZZI R, 1986, NEUROSURGERY, V62, P1295; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	37	9	10	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	SEP-OCT	2011	59	5					31	36		10.4103/0028-3886.86540			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	846TE	WOS:000296925300006	22019650				2022-02-06	
J	Hagen, EM; Eide, GE; Elgen, I				Hagen, E. M.; Eide, G. E.; Elgen, I.			Traumatic spinal cord injury among children and adolescents; a cohort study in western Norway	SPINAL CORD			English	Article						adolescence; children; epidemiology; aetiology; traumatic brain injury; traumatic spinal cord injury	EPIDEMIOLOGY; SWEDEN	Objective: The objective of this study is to assess the temporal trends in the incidence and demographic characteristics of traumatic spinal cord injury (TSCI) among children and adolescents in a geographically defined cohort in western Norway during 1952-2001. Methods: The patients included in this study were identified from the hospital records. Results: Of 336 patients, 13 (3.9%) patients were 0-14 years at time of injury, and 44 (13.1%) patients were 15-19 years at time of injury. The average age-adjusted incidence was 2.4 per million children and 25.1 per million adolescences. Children were injured in car and pedestrian accidents, whereas adolescences were injured in car and motorcycle accidents. Conclusions: The age-adjusted incidence of TSCI among the adolescents increased, whereas the age-adjusted incidence among children remained low during the 50 years. TSCI was highly associated with car and pedestrian accidents among children. Among adolescence, TSCI was associated with car and motorcycle accidents. Awareness of these factors is important in prevention planning strategies. Spinal Cord (2011) 49, 981-985; doi:10.1038/sc.2011.42; published online 10 May 2011	[Hagen, E. M.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Hagen, E. M.; Elgen, I.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Eide, G. E.] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Eide, G. E.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Elgen, I.] Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway		Hagen, EM (corresponding author), Haukeland Hosp, Dept Neurol, Jonas Lies Vei 65, N-5021 Bergen, Norway.	ellen.merete.hagen@helse-bergen.no	Hagen, Ellen Merete/F-8841-2014	Hagen, Ellen Merete/0000-0002-6925-6747			APPLE DF, 1995, CLIN PEDIATR, V34, P90, DOI 10.1177/000992289503400205; Augutis M, 2003, SPINAL CORD, V41, P328, DOI 10.1038/sj.sc.3101478; Augutis M, 2003, SPINAL CORD, V41, P337, DOI 10.1038/sj.sc.3101456; AUGUTIS M, 2007, THESIS KAROLINSKA I; Barker RN, 2009, SPINAL CORD, V47, P149, DOI 10.1038/sc.2008.82; Bilston LE, 2007, SPINE, V32, P2339, DOI 10.1097/BRS.0b013e3181558886; DeVivo MJ, 2004, J SPINAL CORD MED, V27, pS4, DOI 10.1080/10790268.2004.11753778; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hagen EM, 2010, SPINAL CORD, V48, P313, DOI 10.1038/sc.2009.133; Hagen EM, 2009, SPINAL CORD, V47, P367, DOI 10.1038/sc.2008.118; Hagen EM, 2010, J NEUROL NEUROSUR PS, V81, P368, DOI 10.1136/jnnp.2009.178798; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Puisto V, 2010, SPINE, V35, P104, DOI 10.1097/BRS.0b013e3181c64423; *STAT NOR, 2009, STAT YB NORW 2009; TEASDALE G, 1974, LANCET, V2, P81; Vitale MG, 2006, J PEDIATR ORTHOPED, V26, P745, DOI 10.1097/01.bpo.0000235400.49536.83; [No title captured]	19	9	9	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	SEP	2011	49	9					981	985		10.1038/sc.2011.42			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	814XQ	WOS:000294490900007	21556012	Bronze			2022-02-06	
J	Lipsanen, A; Hiltunen, M; Jolkkonen, J				Lipsanen, Anu; Hiltunen, Mikko; Jolkkonen, Jukka			Chronic ibuprofen treatment does not affect the secondary pathology in the thalamus or improve behavioral outcome in middle cerebral artery occlusion rats	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						beta-amyloid; Calcium; Ibuprofen; Inflammation; Middle cerebral artery occlusion; Thalamus	SPONTANEOUSLY HYPERTENSIVE-RATS; TRAUMATIC BRAIN-INJURY; BETA-AMYLOID DEPOSITS; ALZHEIMERS-DISEASE; CORTICAL INFARCTION; PROVIDES NEUROPROTECTION; CALCIUM HOMEOSTASIS; TRANSGENIC MICE; GAMMA-SECRETASE; MOUSE MODEL	Anti-inflammatory drug ibuprofen decreases the beta-amyloid (A beta) deposition and associated inflammation in transgenic Alzheimer disease mice. Based on this, we studied whether ibuprofen could modulate the secondary pathology described in the thalamus of middle cerebral artery occlusion (MCAO) rats. Our hypothesis was that ibuprofen could decrease inflammatory reaction and A beta load in the thalamus of MCAO rats, which in turn is reflected in improved behavioral outcome. Forty male Wistar rats (250-340 g) were subjected to sham-operation or transient occlusion of the right middle cerebral artery (120 min). Ibuprofen (40 mg/kg/day, per os) was administrated for 27 days beginning the treatment on post-operative day 2. MCAO controls were given vehicle. Sensorimotor impairment was assessed using the limb-placing, tapered ledged beam-walking and cylinder tests during the follow-up. The rats were perfused for histology on postoperative day 29. Histological data showed that ibuprofen did not affect A beta or calcium load in the thalamus of MCAO rats. In addition, behavioral tests did not show significant difference between vehicle- and ibuprofen-treated MCAO rats. The present data do not support the idea that ibuprofen reduces the secondary A beta/calcium pathology in the thalamus or associated sensorimotor impairment following cerebral ischemia. (C) 2011 Elsevier Inc. All rights reserved.	[Lipsanen, Anu; Hiltunen, Mikko; Jolkkonen, Jukka] Univ Eastern Finland, Inst Clin Med, Kuopio 70210, Finland		Jolkkonen, J (corresponding author), Univ Eastern Finland, Inst Clin Med, Yliopistonranta 1 C, Kuopio 70210, Finland.	jukka.jolkkonen@uef.fi	Lipsanen, Anu/C-7206-2014	Lipsanen, Anu/0000-0003-1696-224X	Paivikki and Sakari Sohlberg Foundation; Health Research Council of the Academy of FinlandAcademy of Finland	We thank Nanna Huuskonen and Laura Tolppanen for their expert technical help. The study was supported by the Paivikki and Sakari Sohlberg Foundation and the Health Research Council of the Academy of Finland.	Acarin L, 1999, NEUROSCIENCE, V89, P549, DOI 10.1016/S0306-4522(98)00331-5; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Antezana DF, 2003, J NEUROSURG, V98, P860, DOI 10.3171/jns.2003.98.4.0860; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Block F, 2005, PROG NEUROBIOL, V75, P342, DOI 10.1016/j.pneurobio.2005.03.004; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Choi JK, 2010, EXP NEUROL, V223, P377, DOI 10.1016/j.expneurol.2009.07.032; Clarke J, 2007, EUR J NEUROSCI, V26, P1845, DOI 10.1111/j.1460-9568.2007.05807.x; COLE DJ, 1993, J PHARMACOL EXP THER, V266, P1713; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Hiltunen M, 2009, NEUROBIOL DIS, V35, P103, DOI 10.1016/j.nbd.2009.04.009; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Iwata Y, 2010, J THORAC CARDIOV SUR, V139, P489, DOI 10.1016/j.jtcvs.2009.05.049; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Karhunen H, 2003, PHARMACOL BIOCHEM BE, V74, P663, DOI 10.1016/S0091-3057(02)01053-5; Kawahara M, 2000, BRAIN RES BULL, V53, P389, DOI 10.1016/S0361-9230(00)00370-1; Kumon Y, 1996, NEUROSCI LETT, V206, P141; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Loos M, 2003, NEUROSCIENCE, V122, P373, DOI 10.1016/S0306-4522(03)00498-6; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; Park EM, 2005, NEUROSCIENCE, V132, P625, DOI 10.1016/j.neuroscience.2005.01.021; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Puurunen K, 2001, NEUROPHARMACOLOGY, V40, P597, DOI 10.1016/S0028-3908(00)00182-9; Richardson RL, 2005, BEHAV PHARMACOL, V16, P531, DOI 10.1097/01.fbp.0000179278.03868.96; Richardson RL, 2002, BRAIN RES, V954, P1, DOI 10.1016/S0006-8993(02)03006-8; Rupalla K, 1998, ACTA NEUROPATHOL, V96, P172, DOI 10.1007/s004010050878; Sanz-Blasco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002718; Sorensen JC, 1996, EXP BRAIN RES, V112, P203; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; van Groen T, 2005, STROKE, V36, P1551, DOI 10.1161/01.STR.0000169933.88903.cf; Watanabe H, 1998, J CEREBR BLOOD F MET, V18, P686, DOI 10.1097/00004647-199806000-00011; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Willuweit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007931; YAMADA K, 1991, J CEREBR BLOOD F MET, V11, P472, DOI 10.1038/jcbfm.1991.90; Yan Q, 2003, J NEUROSCI, V23, P7504; Zhang YS, 2011, J CEREBR BLOOD F MET, V31, P572, DOI 10.1038/jcbfm.2010.127; Zhao CS, 2005, BEHAV BRAIN RES, V156, P85, DOI 10.1016/j.bbr.2004.05.011	44	9	10	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	SEP	2011	99	3					468	474		10.1016/j.pbb.2011.04.019			7	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	800OL	WOS:000293371100025	21557963				2022-02-06	
J	Pollard, KA; Shields, BJ; Smith, GA				Pollard, Katherine A.; Shields, Brenda J.; Smith, Gary A.			Pediatric Volleyball-Related Injuries Treated in US Emergency Departments, 1990-2009	CLINICAL PEDIATRICS			English	Article						volleyball; children; injury; sports	ANKLE SPRAINS; PROSPECTIVE COHORT; PREVENTION; EPIDEMIOLOGY; CHILDREN; PLAYERS; PROGRAM	This study describes the epidemiology of pediatric volleyball-related injuries treated in US hospital emergency departments. Data for children younger than 18 years obtained from the National Electronic Injury Surveillance System of the US Consumer Product Safety Commission from 1990 through 2009 were analyzed. An estimated 692 024 volleyball-related injuries to children younger than 18 years occurred during the study period. The annual number of injuries declined significantly by 23% during the study period; however, the annual injury rate remained unchanged, and the number of volleyball-related concussions/closed head injuries increased significantly. Upper (48%) and lower (39%) extremity injuries occurred most frequently, as did strains/sprains (54%). Contact with the net/pole was associated with concussions/closed head injury our findings indicate opportunities for making volleyball an even safer sport for children. Protective padding, complying with US volleyball standards, should cover all volleyball poles and protruding hardware to prevent impact-related injuries.	[Smith, Gary A.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [Pollard, Katherine A.; Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	smith@nationwidechildrens.org			National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention [1H75CE001491]; Ohio State University College of MedicineOhio State University; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [H75CE001491] Funding Source: NIH RePORTER	The authors gratefully acknowledge support from the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention (Grant No. 1H75CE001491) and from a medical student research scholarship from The Ohio State University College of Medicine, which provided a student research stipend for author KAP while she worked on this study.	Agel J, 2007, J ATHL TRAINING, V42, P295; Bahr R, 1997, SCAND J MED SCI SPOR, V7, P172, DOI 10.1111/j.1600-0838.1997.tb00135.x; Bahr R, 2003, AM J SPORT MED, V31, P119, DOI 10.1177/03635465030310010401; Ivins D, 2006, AM FAM PHYSICIAN, V74, P1714; Kessler E., 1999, NEISS SAMPLE DESIGN; KYLE SB, 1996, YOUTH BASEBALL PROTE; McGeehan J, 2004, PEDIATRICS, V114, P124, DOI 10.1542/peds.114.1.124; McKeon PO, 2008, CLIN SPORT MED, V27, P371, DOI 10.1016/j.csm.2008.02.004; MIDDLETON K, 2005, NAT HOSP AMB MED CAR, P1; *NFHS, 2008 09 HIGH SCH ATH; Ortega HW, 2004, CLIN PEDIATR, V43, P251, DOI 10.1177/000992280404300306; Osborne MD, 2003, SPORTS MED, V33, P1145, DOI 10.2165/00007256-200333150-00005; Reeser JC, 2006, BRIT J SPORT MED, V40, P594, DOI 10.1136/bjsm.2005.018234; Shields BJ, 2007, J BURN CARE RES, V28, P811, DOI 10.1097/BCR.0b013e3181599b51; Stasinopoulos D, 2004, BRIT J SPORT MED, V38, P182, DOI 10.1136/bjsm.2002.003947; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; *US BUR CENS, PART SEL SPORTS ACT; *US VOLL, 2009 2011 DOM COMP R; Verhagen E, 2004, AM J SPORT MED, V32, P1385, DOI 10.1177/0363546503262177; Verhagen EALM, 2004, BRIT J SPORT MED, V38, P477, DOI 10.1136/bjsm.2003.005785	20	9	9	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228			CLIN PEDIATR	Clin. Pediatr.	SEP	2011	50	9					844	852		10.1177/0009922811406262			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	815CU	WOS:000294504500008	21540280				2022-02-06	
J	Suehiro, E; Fujisawa, H; Koizumi, H; Nomura, S; Kajiwara, K; Fujii, M; Suzuki, M				Suehiro, Eiichi; Fujisawa, Hirosuke; Koizumi, Hiroyasu; Nomura, Sadahiro; Kajiwara, Koji; Fujii, Masami; Suzuki, Michiyasu			Significance of Differences Between Brain Temperature and Core Temperature (Delta T) During Mild Hypothermia in Patients With Diffuse Axonal Injury	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						brain temperature; cerebral perfusion pressure; decompressive craniectomy; jugular venous oxygen saturation; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACEREBRAL TEMPERATURE; INTRACRANIAL-PRESSURE; RAT; DAMAGE	The differences between brain and bladder temperature (delta T), and the relationship of delta T to cerebral perfusion pressure (CPP) and jugular venous oxygen saturation (SjO(2)) were studied during hypothermia in 11 patients with severe traumatic brain injury, of whom 5 underwent conservative treatment for diffuse axonal injury (DAI) (DAI group) and 6 who underwent decompressive craniectomy for hematoma (SDH group). All patients underwent hypothermia treatment. Brain temperature was monitored via an intraparenchymal catheter. Bladder temperature was used as the core temperature. SjO(2) was measured continuously. The outcome of all patients was evaluated at discharge using the Glasgow Outcome Scale. Delta T in the SDH group was significantly lower than that in the DAI group. No relationship was found between delta T and CPP during the investigation period. A significant correlation between delta T and SjO(2) was seen in the DAI group, but not in the SDH group. Decompressive craniectomy affects the brain temperature through external environmental factors. Measurement of brain temperature may be a reliable indicator of cerebral blood flow and brain metabolism in patients with DAI and closed cranium during hypothermia. Further experience is required to test this proposal.	[Suehiro, Eiichi; Fujisawa, Hirosuke; Koizumi, Hiroyasu; Nomura, Sadahiro; Kajiwara, Koji; Fujii, Masami; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi, Japan		Suehiro, E (corresponding author), Kenwakai Ohtemachi Hosp, Dept Neurosurg, Kokurakita Ku, 15-1 Ohte Machi, Fukuoka 8038543, Japan.	suehiro-nsu@umin.ac.jp	Suehiro, Eiichi/I-5852-2019				BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Clausen T, 2000, J NEUROSURG ANESTH, V12, P2, DOI 10.1097/00008506-200001000-00002; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Crowder CM, 1996, J NEUROSURG, V85, P98, DOI 10.3171/jns.1996.85.1.0098; Hirashima Y, 1998, J NEUROL NEUROSUR PS, V64, P792, DOI 10.1136/jnnp.64.6.792; HORROW JC, 1988, ANESTHESIOLOGY, V69, P986, DOI 10.1097/00000542-198812000-00037; LANIER WL, 1992, RESUSCITATION, V23, P121, DOI 10.1016/0300-9572(92)90197-K; LAUSBERG G, 1972, ACTA NEUROCHIR S, V19, P1; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MELLERGARD P, 1990, British Journal of Neurosurgery, V4, P31, DOI 10.3109/02688699009000679; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; STONE JG, 1995, ANESTHESIOLOGY, V82, P344, DOI 10.1097/00000542-199502000-00004; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; VERLOOY J, 1995, ACTA NEUROCHIR, V134, P76, DOI 10.1007/BF01428508; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616	21	9	10	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	7-3-1 HONGO BUNKYO-KU, TOKYO, 113-8655, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	AUG	2011	51	8					551	555		10.2176/nmc.51.551			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	809WJ	WOS:000294087100001	21869574	Bronze			2022-02-06	
J	Schulz, I; Engel, C; Niestroj, AJ; Zeitschel, U; Menge, K; Kehlen, A; Meyer, A; Rossner, S; Demuth, HU				Schulz, Ingo; Engel, Claudia; Niestroj, Andre J.; Zeitschel, Ulrike; Menge, Katja; Kehlen, Astrid; Meyer, Antje; Rossner, Steffen; Demuth, Hans-Ulrich			Heteroarylketones inhibit astroglial interleukin-6 expression via a STAT3/NF-kappa B signaling pathway	JOURNAL OF NEUROINFLAMMATION			English	Article						astrocytes; LPS mouse model; IL-6 expression; anti-inflammatory; STAT3 phosphorylation; p65 co-immunoprecipitation	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; FACTOR-KAPPA-B; ONCOSTATIN-M; SERINE PHOSPHORYLATION; NITRIC-OXIDE; PROLYL ENDOPEPTIDASE; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; NEURODEGENERATIVE DISEASES	Background: Elevated brain levels of the pleiotropic cytokine interleukin-6, which is mainly secreted from activated local astrocytes, contribute to pathological events including neuroinflammation and neurodegeneration. Thus, inhibition of pathological IL-6 expression provides a rationale strategy for targeting the onset or further progression of neurological disorders including Alzheimer's disease, multiple sclerosis, Parkinson's disease and traumatic brain injury. The purpose of this study was to identify and to characterize new potent inhibitors of astrocytic IL-6 expression for further therapeutic development of novel anti-inflammatory and neuroprotective drugs. Methods: Oncostatin M (OSM)-treated human glioma U343 cells were used as model for induction of astrocytic IL-6 expression. This model was characterized by immunoblotting, siRNA technique, ELISA and qRT-PCR and used to screen low molecular weight compound libraries for IL-6-lowering effects. To validate bioactive compounds identified from library screens, bacterial lipopolysaccharide was used to induce IL-6 expression in cultivated primary astrocytes and in mice in vivo. To dissect underlying molecular mechanisms, protein extracts from OSM-treated U343 cells were analyzed by phospho-specific immunoblotting and immunocytochemistry as well as by co-immunoprecipitation. Results: OSM-treatment (100 ng/ml; 24 h) led to 30-fold increase of IL-6 secretion from U343 cells. The temporal profile of IL-6 mRNA induction displayed a biphasic induction pattern with peak synthesis at 1 h (6.5-fold) and 16 h (5.5-fold) post stimulation. IL-6 protein release did not show that biphasic pattern and was detected as early as 3 h post stimulation reaching a maximum at 24 h. The screen of compound libraries identified a set of heteroarylketones (HAKs) as potent inhibitors of IL-6 secretion. HAK compounds affected the second peak in IL-6 mRNA synthesis, whereas the first peak was insensitive to HAK treatment. HAK compounds also suppressed lipopolysaccharide-induced IL-6 expression in primary murine astrocytes as well as in brain and plasma samples from lipopolysaccharide-treated mice. Finally, HAK compounds were demonstrated to specifically suppress the OSM-induced phosphorylation of STAT3 at serine 727 and the physical interaction of pSTAT3(5727) with p65. Conclusion: Heteroarylketone compounds are potent inhibitors of IL-6 expression in vitro and in vivo and may represent a new class of potent anti-inflammatory and neuroprotective drugs.	[Zeitschel, Ulrike; Rossner, Steffen] Univ Leipzig, Dept Cellular & Mol Mech Neurodegenerat, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Schulz, Ingo; Engel, Claudia; Niestroj, Andre J.; Menge, Katja; Kehlen, Astrid; Meyer, Antje; Demuth, Hans-Ulrich] Probiodrug AG, D-06120 Halle, Germany		Rossner, S (corresponding author), Univ Leipzig, Dept Cellular & Mol Mech Neurodegenerat, Paul Flechsig Inst Brain Res, Jahnallee 59, D-04109 Leipzig, Germany.	Steffen.Rossner@medizin.uni-leipzig.de; Hans-Ulrich.Demuth@probiodrug.de	Rossner, Steffen/A-5184-2017; Zeitschel, Ulrike/A-8930-2017		European CommissionEuropean CommissionEuropean Commission Joint Research Centre [NEUROPRO HEALTH-F2-2008-223077]	The authors would like to thank Susann Wendler, Heiderose Mosdzen, Mercedes Scharfe and Dr. Livia Bohme for superior technical assistance. We are also indebted to Diane Meitzner for LC-MS/MS analysis and to Dr. David Ruiz-Carrillo for providing recombinant prolyl endopeptidase. We also wish to acknowledge the expert assistance by Dr. Torsten Hoffmann concerning PREP activity assay. This work was supported by a grant from the European Commission FP7 Programme of Health (NEUROPRO HEALTH-F2-2008-223077).	Armenante F, 1999, NUCLEIC ACIDS RES, V27, P4483, DOI 10.1093/nar/27.22.4483; Baker BJ, 2008, GLIA, V56, P1250, DOI 10.1002/glia.20694; Benveniste EN, 1998, CYTOKINE GROWTH F R, V9, P259, DOI 10.1016/S1359-6101(98)00015-X; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chen SH, 2004, CYTOKINE GROWTH F R, V15, P379, DOI 10.1016/j.cytogfr.2004.06.002; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Conroy SM, 2004, J NEUROIMMUNOL, V155, P43, DOI 10.1016/j.jneuroim.2004.06.014; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Ding J, 2010, J NEUROCHEM, V114, P1619, DOI 10.1111/j.1471-4159.2010.06876.x; Eng LF, 1996, NEUROCHEM RES, V21, P511, DOI 10.1007/BF02527717; Escartin C, 2008, MOL NEUROBIOL, V38, P231, DOI 10.1007/s12035-008-8043-y; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Ginsberg M, 2007, MOL CELL BIOL, V27, P6300, DOI 10.1128/MCB.00613-07; GITTER BD, 1994, J NEUROIMMUNOL, V51, P101, DOI 10.1016/0165-5728(94)90134-1; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Halfter H, 1999, Mol Cell Biol Res Commun, V1, P109, DOI 10.1006/mcbr.1999.0117; Halfter H, 2000, J NEUROCHEM, V75, P973, DOI 10.1046/j.1471-4159.2000.0750973.x; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; James ML, 2010, J NEUROTRAUM, V27, P217, DOI 10.1089/neu.2009.1022; KELLER ET, 1996, FRONT BIOSCI, V1, P340, DOI DOI 10.2741/A136; Klein MA, 1997, GLIA, V19, P227, DOI 10.1002/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W; Kortylewski M, 2003, J BIOL CHEM, V278, P5242, DOI 10.1074/jbc.M205403200; Lacroix S, 2002, J COMP NEUROL, V454, P213, DOI 10.1002/cne.10407; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; LOFFNER F, 1986, BRAIN RES, V363, P205, DOI 10.1016/0006-8993(86)91006-1; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Nakajima Y, 2010, J NEUROTRAUM, V27, P403, DOI 10.1089/neu.2009.1044; Nakayama K, 2002, EMBO J, V21, P6174, DOI 10.1093/emboj/cdf596; Nelson TE, 2004, EUR J NEUROSCI, V20, P2387, DOI 10.1111/j.1460-9568.2004.03706.x; Nishibe T, 2001, BLOOD, V97, P692, DOI 10.1182/blood.V97.3.692; NORRIS JG, 1994, J IMMUNOL, V152, P841; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; PALMA C, 1995, J NEUROIMMUNOL, V59, P155, DOI 10.1016/0165-5728(95)00040-9; Park SY, 2008, CYTOKINE, V44, P126, DOI 10.1016/j.cyto.2008.07.006; Penttinen A, 2011, CNS NEUROL DISORD-DR, V10, P340, DOI 10.2174/187152711794653742; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P6415, DOI 10.1074/jbc.M608952200; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Qiu ZH, 1998, J NEUROSCI, V18, P10445; RAY A, 1989, ANN NY ACAD SCI, V557, P353; Sawada M, 2006, J NEURAL TRANSM-SUPP, P373; Schulz I, 2005, J NEUROCHEM, V94, P970, DOI 10.1111/j.1471-4159.2005.03237.x; Schulz I, 2002, EUR J BIOCHEM, V269, P5813, DOI 10.1046/j.1432-1033.2002.03297.x; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sun W, 2006, FEBS LETT, V580, P5880, DOI 10.1016/j.febslet.2006.09.054; TSUTSUMI S, 1995, ACTA CRYSTALLOGR C, V51, P1927, DOI 10.1107/S010827019500391X; Van Wagoner NJ, 2000, J NEUROCHEM, V75, P563, DOI 10.1046/j.1471-4159.2000.0750563.x; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; WESTERMARK B, 1973, ACTA PATH MICRO IM A, VA 81, P791; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Yu ZY, 2004, J AM SOC NEPHROL, V15, P585, DOI 10.1097/01.ASN.0000114556.19556.F9; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhao BY, 1998, J NEUROSCI RES, V52, P7, DOI 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I	69	9	10	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUL 29	2011	8								86	10.1186/1742-2094-8-86			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	811ZX	WOS:000294258600001	21801384	gold, Green Published			2022-02-06	
J	DeGeorge, ML; Marlowe, D; Werner, E; Soderstrom, KE; Stock, M; Mueller, A; Bohn, MC; Kozlowski, DA				DeGeorge, M. L.; Marlowe, D.; Werner, E.; Soderstrom, K. E.; Stock, M.; Mueller, A.; Bohn, M. C.; Kozlowski, D. A.			Combining glial cell line-derived neurotrophic factor gene delivery (AdGDNF) with L-arginine decreases contusion size but not behavioral deficits after traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Growth factor; Behavioral assessment; Forelimb sensorimotor cortex; Controlled cortical impact; Cerebral blood flow	CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; MEDIATED TRANSGENE EXPRESSION; FACTOR GDNF; SUBSTANTIA-NIGRA; NITRIC-OXIDE; DOPAMINERGIC-NEURONS; COMBINATION THERAPY; FUNCTIONAL RECOVERY; ARTERY OCCLUSION	Our laboratory has previously demonstrated that viral administration of glial cell line-derived neurotrophic factor (AdGDNF), one week prior to a controlled cortical impact (CCI) over the forelimb sensorimotor cortex of the rat (FL-SMC) is neuroprotective, but does not significantly enhance recovery of sensorimotor function. One possible explanation for this discrepancy is that although protected, neurons may not have been functional due to enduring metabolic deficiencies. Additionally, metabolic events following TBI may interfere with expression of therapeutic proteins administered to the injured brain via gene therapy. The current study focused on enhancing the metabolic function of the brain by increasing cerebral blood flow (CBF) with L-arginine in conjunction with administration of AdGDNF immediately following CCI. An adenoviral vector harboring human GDNF was injected unilaterally into FL-SMC of the rat immediately following a unilateral CCI over the FL-SMC. Within 30 min of the CCI and AdGDNF injections, some animals were injected with L-arginine (iv.). Tests of forelimb function and asymmetry were administered for 4 weeks post-injury. Animals were sacrificed and contusion size and GDNF protein expression measured. This study demonstrated that rats treated with AdGDNF and L-arginine post-CCI had a significantly smaller contusion than injured rats who did not receive any treatment, or injured rats treated with either AdGDNF or L-arginine alone. Nevertheless, no amelioration of behavioral deficits was seen. These findings suggest that AdGDNF alone following a CCI was not therapeutic and although combining it with L-arginine decreased contusion size, it did not enhance behavioral recovery. (C) 2011 Elsevier B.V. All rights reserved.	[DeGeorge, M. L.; Marlowe, D.; Werner, E.; Soderstrom, K. E.; Stock, M.; Mueller, A.; Kozlowski, D. A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA; [Bohn, M. C.] Northwestern Univ, Childrens Mem Res Ctr, Dept Pediat, Feinberg Sch Med, Chicago, IL 60614 USA		Kozlowski, DA (corresponding author), Depaul Univ, Dept Biol Sci, 2325 N Clifton, Chicago, IL 60614 USA.	dkozlows@depaul.edu		Mueller, Amanda/0000-0001-6412-4086	University of Iowa; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Roy J. Carver Foundation; NIHRNational Institute for Health Research (NIHR) [15 NS42583-01]; DePaul University; University Research Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS042583] Funding Source: NIH RePORTER	The authors would like to thank the University of Iowa Gene Transfer Vector Core, supported in part by the NIH and the Roy J. Carver Foundation for viral vector preparations. This study was supported by: NIHR-15 NS42583-01 (D.A.K.), DePaul University Liberal Arts & Sciences Research Grant and University Research Council Grants (D.A.K.).	Abe K, 1997, BRAIN RES, V763, P191, DOI 10.1016/S0006-8993(97)00389-2; Abe K, 1997, BRAIN RES, V776, P230, DOI 10.1016/S0006-8993(97)01041-X; Abe K, 1998, NEUROL RES, V20, P689; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Bohn MC, 2000, NOVART FDN SYMP, V231, P70, DOI 10.1002/0470870834.ch5; Bohn MC, 1999, HUM GENE THER, V10, P1175, DOI 10.1089/10430349950018166; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Choi-Lundberg DL, 1998, EXP NEUROL, V154, P261, DOI 10.1006/exnr.1998.6887; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Clarkson ED, 1997, CELL TISSUE RES, V289, P207, DOI 10.1007/s004410050867; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Connor B, 1999, GENE THER, V6, P1936, DOI 10.1038/sj.gt.3301033; Connor B, 2001, EXP NEUROL, V169, P83, DOI 10.1006/exnr.2001.7638; Giehl KM, 1998, J NEUROSCI, V18, P7351; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Grondin R, 2003, PROG DRUG RES, V61, P101; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HE Z, 1995, BRAIN RES, V699, P208, DOI 10.1016/0006-8993(95)00907-8; Hermann DM, 2001, NEUROBIOL DIS, V8, P964, DOI 10.1006/nbdi.2001.0448; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hovda D.A., 1996, NEUROTRAUMA, P1459; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Jin G, 2002, BRAIN RES, V958, P429, DOI 10.1016/S0006-8993(02)03521-7; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kitagawa H, 1999, J CEREBR BLOOD F MET, V19, P1336, DOI 10.1097/00004647-199912000-00007; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Kozlowski DA, 2000, EXP NEUROL, V166, P1, DOI 10.1006/exnr.2000.7463; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 2001, MOL THER, V3, P256, DOI 10.1006/mthe.2000.0256; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Meijs MFL, 2004, J NEUROTRAUM, V21, P1415, DOI 10.1089/neu.2004.21.1415; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Nicole O, 2001, J NEUROSCI, V21, P3024, DOI 10.1523/JNEUROSCI.21-09-03024.2001; Phillips RG, 2001, GENE THER, V8, P579, DOI 10.1038/sj.gt.3301397; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rosenblad C, 2000, EXP NEUROL, V161, P503, DOI 10.1006/exnr.1999.7296; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tai MH, 2003, EXP NEUROL, V183, P508, DOI 10.1016/S0014-4886(03)00130-4; Tehranian R, 2006, BRAIN RES, V1101, P126, DOI 10.1016/j.brainres.2006.05.049; Thomas CE, 2001, MOL THER, V3, P36, DOI 10.1006/mthe.2000.0224; Tsai TT, 2000, EXP NEUROL, V166, P266, DOI 10.1006/exnr.2000.7505; Wang Y, 2002, ANN NY ACAD SCI, V962, P423, DOI 10.1111/j.1749-6632.2002.tb04086.x; Weise J, 2000, NEUROBIOL DIS, V7, P212, DOI 10.1006/nbdi.2000.0285; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Zhang WR, 2002, BRAIN RES, V947, P140, DOI 10.1016/S0006-8993(02)02923-2; Zhao ZQ, 2004, EXP NEUROL, V190, P356, DOI 10.1016/j.expneurol.2004.06.015	60	9	11	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 27	2011	1403						45	56		10.1016/j.brainres.2011.05.058			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797UY	WOS:000293156800006	21672665	Green Accepted			2022-02-06	
J	Bingham, D; John, CM; Panter, SS; Jarvis, GA				Bingham, Deborah; John, Constance M.; Panter, S. Scott; Jarvis, Gary A.			Post-injury treatment with lipopolysaccharide or lipooligosaccharide protects rat neuronal and glial cell cultures	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Inflammation; LPS; Neuroprotection	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; INFLAMMATORY RESPONSE; ISCHEMIC TOLERANCE; IN-VITRO; PC12 CELLS; TNF-ALPHA; INTERLEUKIN-10; NEISSERIA; SERUM	Traumatic brain injury (TBI) is a major cause of disability in civilians and military personnel worldwide that is caused by the acceleration force of a primary shockwave, blast wind or the force of a direct contact. Following the primary injury, secondary injury is caused by activation of the immune response due to an influx of neuro-inflammatory cells, increased production of inflammatory cytokines, and edema. In ischemia models pre-conditioning with lipopolysaccharide (LPS) has been shown to be neuroprotective, and post-injury conditioning with LPS was found to be protective in a spinal cord and an acute brain injury model. In this study, we utilized an in vitro scratch model of TBI to assess the effect of post-injury treatment with Escherichia coli LPS and Neisseria meningitidis lipooligosaccharide (LOS) on cell death and cytokine induction by assessing the level of lactate dehydrodgenase released from cells and rat multiplex cytokine assays. Our results showed that post-injury treatment of C6 glioma cells with either the LPS or the LOS reduced cell death when compared to scratched controls treated with media only. Post-injury treatment of the primary mixed neuronal cultures with LPS reduced cell death and resulted in a significant up-regulation in IL-10 when compared to controls. With LOS post-scratch treatment of the primary cell cultures, we found that IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha were significantly upregulated in addition to IL-10 compared to the media-only controls. The results strongly support additional testing of the neuroprotective ability of post-injury treatment with LPS or LOS in models of TBI. (C) 2011 Elsevier Inc. All rights reserved.	[Jarvis, Gary A.] Vet Adm Med Ctr, Ctr Immunochem, Dept 111W1, San Francisco, CA 94121 USA; [Panter, S. Scott] Vet Adm Med Ctr, Dept Neurol, San Francisco, CA 94121 USA; [Jarvis, Gary A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Panter, S. Scott] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA		Jarvis, GA (corresponding author), Vet Adm Med Ctr, Ctr Immunochem, Dept 111W1, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Jarvis@ucsf.edu		Jarvis, Gary/0000-0002-7576-3702	Research Service of the U.S. Department of Veterans AffairsUS Department of Veterans Affairs; U.S. Department of DefenseUnited States Department of Defense [W81XWH-05-2-0094]	This work was supported by the Research Service of the U.S. Department of Veterans Affairs and by the U.S. Department of Defense under contract number W81XWH-05-2-0094. We thank Charles E. McCulloch of the Department of Epidemiology and Bio-statistics, University of California, San Francisco, for performing the SAS Proc Mixed analysis of the LDH data. This is paper number 107 from the Center for Immunochemistry.	Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; AHMED Z, 1983, J NEUROSCI, V3, P2448; APICELLA MA, 1994, METHOD ENZYMOL, V235, P242; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Bastide M, 2003, J CEREBR BLOOD F MET, V23, P399, DOI 10.1097/01.WCB.0000050064.57184.F2; BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; BOGDAN C, 1992, J BIOL CHEM, V267, P23301; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burda J, 2006, CELL MOL NEUROBIOL, V26, P1141, DOI 10.1007/s10571-006-9036-x; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Davis AEM, 2005, EUR J NEUROSCI, V22, P2441, DOI 10.1111/j.1460-9568.2005.04447.x; GENNARELLI TA, 1993, J EMERG MED, V1, P5; Goldberg MS, 2010, MIL MED, V175, P220, DOI 10.7205/MILMED-D-09-00130; Gonzalez P, 2009, J NEUROPATH EXP NEUR, V68, P391, DOI 10.1097/NEN.0b013e31819dca30; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; John CM, 2009, J BIOL CHEM, V284, P21515, DOI 10.1074/jbc.M109.004887; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Kunioku H, 2001, NEUROSCI LETT, V309, P13, DOI 10.1016/S0304-3940(01)02012-2; Lehotsky J, 2009, ANAT REC, V292, P2002, DOI 10.1002/ar.20970; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Majdalawieh A, 2007, MOL BIOL CELL, V18, P930, DOI 10.1091/mbc.E06-03-0217; McIntosh TK, 1996, LAB INVEST, V74, P315; Modur V, 1997, J CLIN INVEST, V100, P2752, DOI 10.1172/JCI119821; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nakajima A, 2002, FREE RADICAL BIO MED, V32, P1324, DOI 10.1016/S0891-5849(02)00845-6; Patrone JB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-7; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; Pignataro G, 2009, FEBS J, V276, P46, DOI 10.1111/j.1742-4658.2008.06769.x; Pridmore AC, 2003, INFECT IMMUN, V71, P3901, DOI 10.1128/IAI.71.7.3901-3908.2003; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; REGAN RF, 1995, BRAIN RES, V682, P144, DOI 10.1016/0006-8993(95)00330-S; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Torres PMM, 2001, J NEUROIMMUNOL, V117, P43, DOI 10.1016/S0165-5728(01)00303-4; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	54	9	11	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUL 15	2011	85	6					403	409		10.1016/j.brainresbull.2011.04.007			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	805II	WOS:000293719700013	21571046				2022-02-06	
J	De Reuck, J				De Reuck, Jacques			Risk factors for late-onset seizures related to cerebral contusions in adults with a moderate traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Epilepsy; Cerebral contusions; Topography; Seizure types; Vascular risk factors; Alcohol abuse; Outcome	POSTTRAUMATIC EPILEPSY; TERRITORIAL INFARCT; STROKE	Objectives: This prospective study compares the characteristics of patients with a moderately severe traumatic brain injury (TBI) and cerebral contusions who develop late-onset seizures to those who do not. Patients and methods: Thirty-nine adult TBI patients with cerebral contusions, who did not need a neurosurgical treatment, could be followed up for more than 3 years. Fourteen patients developed seizures during that period and 25 did not. The Glasgow Coma Scale (GCS) score on admission and the modified Rankin (mR) score on discharge from the hospital, the computed tomography (CT) and/or magnetic resonance imaging (MRI) findings, the electroencephalogram (EEG) patterns as well as the vascular and habit risk factors were compared between both groups. Results: The mean GCS and mR scores were moderately severe and comparable between both groups. Early-onset seizures represented 21.4%. The overall seizure recurrence was 85.7% after treatment with carbamazepine or valproate sodium. Still 3 patients did not remain seizure-free after addition of another antiepileptic drug. The average number of brain contusions on CT/MRI was approximately the same. Vascular risk factors and alcohol abuse were more observed in the seizure patients. Abnormal EEG findings on discharge from the hospital were significantly more frequent in the patients who developed late-onset seizures afterward (P < 0.05). Conclusions: Seizures after non-complicated cerebral contusions are difficult to treat. Vascular risk factors and alcohol abuse may also predispose to their occurrence. The EEG findings after the TBI are highly predictive. (C) 2011 Elsevier B.V. All rights reserved.	Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium		De Reuck, J (corresponding author), Ghent Univ Hosp, Dept Neurol, De Pintelaan 185, B-9000 Ghent, Belgium.	dereuck.j@gmail.com					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; De Reuck J, 2008, EUR NEUROL, V59, P225, DOI 10.1159/000115635; De Reuck J, 2008, CEREBROVASC DIS, V25, P100, DOI 10.1159/000111998; De Reuck J, 2006, EUR NEUROL, V55, P209, DOI 10.1159/000093871; De Reuck J, 2010, EUR NEUROL, V64, P355, DOI 10.1159/000322139; De Reuck J, 2009, EUR NEUROL, V62, P171, DOI 10.1159/000227289; De Reuck J, 2008, J NEUROL SCI, V271, P127, DOI 10.1016/j.jns.2008.04.005; De Reuck J, 2007, CLIN NEUROL NEUROSUR, V109, P501, DOI 10.1016/j.clineuro.2007.04.001; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; Li XH, 1997, EPILEPSIA, V38, P1216, DOI 10.1111/j.1528-1157.1997.tb01219.x; LOISEAU J, 1990, ANN NEUROL, V27, P232, DOI 10.1002/ana.410270304; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; Messori A, 2005, EPILEPSIA, V46, P1472, DOI 10.1111/j.1528-1167.2005.34004.x; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; SKULLERUD K, 1991, INT J LEGAL MED, V104, P209, DOI 10.1007/BF01369809; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMLIN NR, 2003, EPILIPSIA, V44, P18; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4	23	9	9	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2011	113	6					469	471		10.1016/j.clineuro.2011.02.004			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	788HX	WOS:000292437100007	21371813				2022-02-06	
J	Esfandiari, A; Broshek, DK; Freeman, JR				Esfandiari, Ali; Broshek, Donna K.; Freeman, Jason R.			Psychiatric and Neuropsychological Issues in Sports Medicine	CLINICS IN SPORTS MEDICINE			English	Article						Athletes; Psychiatry; Psychology; Neuropsychological; Therapy	SUBSTANCE USE; OVERTRAINING SYNDROME; EXERCISE PERFORMANCE; COLLEGE-STUDENTS; MENTAL-ILLNESS; STEROID USE; INJURIES; ATHLETE; INVOLVEMENT; CONCUSSION	This article reviews psychiatric/psychological issues in the athletic training room, including recognition of these issues and a framework for management. Because the majority of research has been conducted in college settings, most of the issues discussed are presented in the context of college sports, although the results generalize to other athletic arenas. Greater awareness of psychological issues, empirical research, and education about mental health issues in the sports medicine community are clearly needed.	[Esfandiari, Ali; Broshek, Donna K.; Freeman, Jason R.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Neurocognit Assessment Lab, Charlottesville, VA 22908 USA		Broshek, DK (corresponding author), Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Neurocognit Assessment Lab, POB 800203,W Complex,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	broshek@virginia.edu	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armstrong LE, 2002, SPORTS MED, V32, P185, DOI 10.2165/00007256-200232030-00003; Armstrong S, 2009, J AM COLL HEALTH, V57, P521, DOI 10.3200/JACH.57.5.521-526; Barkley Russell Alan, 2006, ATTENTION DEFICIT HY, V3rd; Baum AL, 2003, CURR PSYCHIAT, V2, P51; Baum AL, 2000, SPORT PSYCHIAT THEOR, P249; BEGEL D, 2000, SPORT PSYCHIAT THEOR, P191; Bowen William, 2003, RECLAIMING GAME COLL; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; BREWER BW, 2001, EXPLORIGN SPORT EXCE, P307; BROSHEK DK, 2001, NEUROLOGICAL SPORTS, P155; Burton R.W., 2000, SPORT PSYCHIAT THEOR, P61; CARMEN LR, 1968, MENT HYG, V52, P134; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Danish S. J., 1995, Sport psychology interventions., P19; DEE TS, 2009, NATL BUREAU EC RES W; Donohue B, 2004, J GEN PSYCHOL, V131, P29, DOI 10.3200/GENP.131.1.29-35; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Ford JA, 2007, J AM COLL HEALTH, V55, P367, DOI 10.3200/JACH.55.6.367-373; Freeman JR, 2005, TXB TRAUMATIC BRAIN, P453; Glick ID, 2005, CLIN SPORT MED, V24, P771, DOI 10.1016/j.csm.2005.03.007; Gould D, 1997, SPORT PSYCHOL, V11, P379, DOI 10.1123/tsp.11.4.379; Green GA, 2001, CLIN J SPORT MED, V11, P51, DOI 10.1097/00042752-200101000-00009; Hanin Y. L, 2000, EMOTIONS SPORT; HEIL J, ATTENTION DEFICIT HY; Hildebrand K. M., 2001, COLL STUDENT J, V35, P358; Hudd S, 2000, COLL STUD J, V34, P217; Johnson U, 2011, SCAND J MED SCI SPOR, V21, P129, DOI 10.1111/j.1600-0838.2009.01057.x; Junge A, 2000, AM J SPORT MED, V28, pS10; Kbler-Ross E., 1969, DEATH DYING; Kimball A, 2003, LEISURE SCI, V25, P115, DOI 10.1080/01490400306569; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P347, DOI 10.1080/02701367.1994.10607639; McCabe SE, 2007, DRUG ALCOHOL DEPEN, V90, P243, DOI 10.1016/j.drugalcdep.2007.04.004; Meeusen R, 2001, INT J SPORTS MED, V22, P329, DOI 10.1055/s-2001-15648; MORGAN WP, 1988, MED SCI SPORT EXER, V20, P408, DOI 10.1249/00005768-198808000-00014; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Nederhof E, 2006, SPORTS MED, V36, P817, DOI 10.2165/00007256-200636100-00001; Norton PJ, 2000, DEPRESS ANXIETY, V12, P193, DOI 10.1002/1520-6394(2000)12:4<193::AID-DA2>3.0.CO;2-X; Oler M J, 1994, Arch Fam Med, V3, P781, DOI 10.1001/archfami.3.9.781; PARHAM WD, 1993, COUNS PSYCHOL, V21, P411, DOI 10.1177/0011000093213005; Parise G, 2001, ARCH PHYS MED REHAB, V82, P867, DOI 10.1053/apmr.2001.23275; PIERCE RA, 1969, J AMER COLL HEALTH A, V17, P244; POPE HG, 1994, ARCH GEN PSYCHIAT, V51, P375, DOI 10.1001/archpsyc.1994.03950050035004; POPE HG, 1988, AM J PSYCHIAT, V145, P487; Powell DH, 2004, J CLIN PSYCHOL, V60, P801, DOI 10.1002/jclp.20038; PRENTICE WE, 1991, PREVENTION ATHLETIC, P101; Pritchard ME, 2007, J AM COLL HEALTH, V56, P15, DOI 10.3200/JACH.56.1.15-22; Raglin J, 2000, PEDIATR EXERC SCI, V12, P61, DOI 10.1123/pes.12.1.61; RAGLIN JS, 2011, PRAEGER HDB SPORTS M, V3, P63; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; Richards S, 1999, J COLL STUDENT DEV, V40, P211; Schwenk TL, 2000, BRIT J SPORT MED, V34, P4, DOI 10.1136/bjsm.34.1.4; Scully D, 1998, BRIT J SPORT MED, V32, P111, DOI 10.1136/bjsm.32.2.111; Stabeno M, 2004, ADHD AFFECTED ATHLET; Storch E. A., 2005, J SPORT BEHAV, V28, P86; Tricker R, 2000, J DRUG EDUC, V30, P313, DOI 10.2190/N1K3-V8BK-90GH-TTHU; Tricker R, 1997, J DRUG EDUC, V27, P105, DOI 10.2190/E8U0-42UM-PBLK-96RH; Watt S. K., 2001, NEW DIRECTIONS STUDE, V93, P7, DOI DOI 10.1002/SS.1; Wilens TE, 1997, J NERV MENT DIS, V185, P475, DOI 10.1097/00005053-199708000-00001; Williams J.M, 1986, APPL SPORT PSYCHOL P, P343; Williams JM, 2007, HDB SPORT PSYCHOL, P379, DOI DOI 10.1002/9781118270011.CH17; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	64	9	9	0	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JUL	2011	30	3					611	+		10.1016/j.csm.2011.03.002			19	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	783YC	WOS:000292119800010	21658551				2022-02-06	
J	Honeybul, S; O'Hanlon, S; Ho, KM; Gillett, G				Honeybul, S.; O'Hanlon, S.; Ho, K. M.; Gillett, G.			The influence of objective prognostic information on the likelihood of informed consent for decompressive craniectomy: a study of Australian anaesthetists	ANAESTHESIA AND INTENSIVE CARE			English	Article						decompressive craniectomy; clinical decision making; outcomes; neurotrauma	TRAUMATIC BRAIN-INJURY	The aim of this study was to assess the influence of detailed prognostic information on the likelihood of informed consent for decompressive craniectomy for severe traumatic brain injury. The study was a simulation exercise, asking anaesthetists to give opinions as if they themselves were the injured party. Anaesthetists were chosen as they represent a distinct group likely to be familiar with the procedure and the decision-making process, but not necessarily aware of the longer-tem outcomes. A two-part structured interview was used. Seventy-five anaesthetists were shown three cases of differing severity of traumatic brain injury. A visual analogue scale (1 to 10) was used to assess the strengths of their opinion. Initially they were asked their opinion with no predictive outcome data. They were then shown the prediction of an unfavourable outcome (Glasgow Outcome Scale severely disabled, vegetative state or dead) and the observed outcome at 18-month follow-up from a cohort of 147 patients (who had had a decompressive craniectomy for severe traumatic brain injury in Perth, Western Australia between the years 2004 and 2008). The opinions of the participants before and after seeing the prediction outcome data were compared. The participants' preferences to consent to the procedure changed after being informed of the predicted risks of unfavourable outcomes (P values < 0.01). The changes in attitude appeared to be independent of age group, amount of experience in caring for similar patients and religious background. These findings suggest that access to objective information on risks of unfavourable outcomes may influence opinions in relation to consent for decompressive craniectomy for traumatic brain injury.	[Honeybul, S.] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; Royal Perth Hosp, Perth, WA, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			30Beauchamp T. L., 2001, PRINCIPLES BIOMEDICA, P77; Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Beauchamp T. L., 2001, PRINCIPLES BIOMEDICA, V5th, P69; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Druml Christiane, 2004, Curr Opin Crit Care, V10, P570, DOI 10.1097/01.ccx.0000144765.73540.89; Dunn LB, 2006, AM J PSYCHIAT, V163, P1323, DOI 10.1176/appi.ajp.163.8.1323; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; JENNETT B, 1975, LANCET, V1, P480; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; *SUPPORT PRINC INV, CONTR TRIAL IMPR CAR; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	25	9	9	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0310-057X	1448-0271		ANAESTH INTENS CARE	Anaesth. Intensive Care	JUL	2011	39	4					659	665		10.1177/0310057X1103900420			7	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	799DP	WOS:000293264000021	21823386	Bronze			2022-02-06	
J	Nakstad, AR; Strand, T; Sandberg, M				Nakstad, Anders Rostrup; Strand, Terje; Sandberg, Marten			LANDING SITES AND INTUBATION MAY INFLUENCE HELICOPTER EMERGENCY MEDICAL SERVICES ON-SCENE TIME	JOURNAL OF EMERGENCY MEDICINE			English	Article						prehospital; helicopter; airway management; intubation; HEMS	RAPID-SEQUENCE INTUBATION; GROUND AMBULANCE TRANSPORT; TRAUMA PATIENTS; INJURED PATIENTS; PREHOSPITAL INTUBATION; AIR TRANSPORT; HEAD-INJURY; SYSTEM; MORTALITY; IMPACT	Background: Reduced transport time of patients from the scene of an accident to definitive surgical treatment is one important reason to employ ambulance helicopters on trauma missions. However, if the helicopter is unable to land close to the scene, the transport time may be increased compared to transport with ground ambulance, due to time-consuming transfer of the patient between vehicles. Objective: The objective of this study was to evaluate how the landing site, as determined by distance from the scene, and rapid sequence intubation (RSI) affected on-scene time (OST). Methods: This was a prospective observational study performed during a 12-month period in a mixed urban and rural anesthesiologist-staffed Helicopter Emergency Medical Service in Norway. Data regarding the landing sites, the accident, and patient treatment were recorded. Results: A total of 252 primary trauma missions were included in the study. In 75% of the missions, the aircraft landed <50 meters from the scene, and in 7% the distance exceeded 200 meters. Mean OST when the patient was not intubated was 14.5 min (median 14 min). When an RSI was performed, the mean OST was significantly higher (22.7 min, median 20 min; p < 0.001). Conclusion: Usually, a helicopter can land close to the accident scene and the location of the landing site does not contribute to a delay in arrival of the patient at the hospital. The OST is significantly higher, however, in those patients who receive endotracheal intubation before take-off. This reflects the time needed for intubation, as well as the increased complexity and workload when the patient is severely injured. (C) 2011 Elsevier Inc.	[Nakstad, Anders Rostrup; Strand, Terje; Sandberg, Marten] Oslo Univ Hosp, Air Ambulance Dept, Oslo, Norway; [Nakstad, Anders Rostrup] Oslo Univ Hosp, Dept Anesthesia, N-1474 Ulleval, Nordbyhagen, Norway		Sandberg, M (corresponding author), Oslo Univ Hosp, Air Ambulance Dept, Sykehusveien 1, N-1474 Ulleval, Nordbyhagen, Norway.			Sandberg, Marten/0000-0002-4812-0103			Adnet F, 1998, ANN EMERG MED, V32, P454, DOI 10.1016/S0196-0644(98)70175-1; BAXT WG, 1983, JAMA-J AM MED ASSOC, V249, P3047, DOI 10.1001/jama.249.22.3047; BAXT WG, 1985, ANN EMERG MED, V14, P859, DOI 10.1016/S0196-0644(85)80634-X; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Biewener A, 2004, J TRAUMA, V56, P94, DOI 10.1097/01.TA.0000061883.92194.50; Birk Hans O, 2002, Prehosp Disaster Med, V17, P167; Black JJM, 2004, EMERG MED J, V21, P355, DOI 10.1136/emj.2002.004473; Bledsoe BE, 2006, J TRAUMA, V60, P1257, DOI 10.1097/01.ta.0000196489.19928.c0; Brathwaite CEM, 1998, J TRAUMA, V45, P140, DOI 10.1097/00005373-199807000-00029; BURNEY RE, 1986, ANN EMERG MED, V15, P1491, DOI 10.1016/S0196-0644(86)80950-7; Carr BG, 2008, PREHOSP EMERG CARE, V12, P327, DOI 10.1080/10903120802096928; Chappell VL, 2002, J TRAUMA, V52, P486, DOI 10.1097/00005373-200203000-00012; Cocanour CS, 1997, J TRAUMA, V43, P83, DOI 10.1097/00005373-199707000-00019; COWLEY RA, 1973, J TRAUMA, V13, P1029, DOI 10.1097/00005373-197312000-00001; Cudnik MT, 2010, J EMERG MED, V38, P175, DOI 10.1016/j.jemermed.2008.01.022; Cunningham P, 1997, J TRAUMA, V43, P940, DOI 10.1097/00005373-199712000-00013; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Diaz MA, 2005, J TRAUMA, V58, P148, DOI 10.1097/01.TA.0000124264.43941.41; Eckstein M, 2002, J TRAUMA, V53, P340, DOI 10.1097/00005373-200208000-00025; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; Hotvedt R, 1996, LANCET, V347, P1362, DOI 10.1016/S0140-6736(96)91010-7; Hoyer CCS, 2006, EUR J EMERG MED, V13, P156; Karanicolas PJ, 2006, J TRAUMA, V61, P396, DOI 10.1097/01.ta.0000222974.31728.2a; Lerner EB, 1999, ACAD EMERG MED, V6, P1127, DOI 10.1111/j.1553-2712.1999.tb00115.x; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Nakstad AR, 2004, ACTA ANAESTH SCAND, V48, P588, DOI 10.1111/j.0001-5172.2004.00395.x; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Nickel EA, 2008, RESUSCITATION, V79, P212, DOI 10.1016/j.resuscitation.2008.06.020; Sampalis J S, 1994, Prehosp Disaster Med, V9, P178; SCHILLER WR, 1988, J TRAUMA, V28, P1127, DOI 10.1097/00005373-198808000-00004; Shatney CH, 2002, J TRAUMA, V53, P817, DOI 10.1097/00005373-200211000-00002; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Thomas SH, 2002, J TRAUMA, V52, P136, DOI 10.1097/00005373-200201000-00023; Veldman A, 2001, J TRAVEL MED, V8, P154; Weiss M, 2001, ANAESTHESIST, V50, P150, DOI 10.1007/s001010170030	36	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JUN	2011	40	6					651	657		10.1016/j.jemermed.2010.05.067			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	781TX	WOS:000291960500009	20739134				2022-02-06	
J	Tung, JY; Gage, WH; Zabjek, KF; Maki, BE; McIlroy, WE				Tung, James Y.; Gage, William H.; Zabjek, Karl F.; Maki, Brian E.; McIlroy, William E.			Frontal plane standing balance with an ambulation aid: Upper limb biomechanics	JOURNAL OF BIOMECHANICS			English	Article						Human balance; Ambulation aids; Quiet standing	EXERCISE CAPACITY; WALKER; MOVEMENTS; ROLLATOR; COPD	Despite widespread acceptance of clinical benefits, empirical evidence to evaluate the advantages and limitations of ambulation aids for balance control is limited. The current study investigates the upper limb biomechanical contributions to the control of frontal plane stability while using a 4-wheeled walker in quiet standing. We hypothesized that: (1) upper limb stabilizing moments would be significant, and (2) would increase under conditions of increased stability demand. Factors influencing upper limb moment generation were also examined. Specifically, the contributions of upper limb center-of-pressure (COP hands), vertical and horizontal loads applied to the assistive device were assessed. The results support a significant mechanical role for the upper limbs, generating 27.1% and 58.8% of overall stabilizing moments under baseline and challenged stability demand conditions, respectively. The increased moment was achieved primarily through the preferential use of phasic upper limb control, reflected by increased COP hand hands (baseline vs. challenged conditions: 0.29 vs. 0.72 cm). Vertical, but not horizontal, was the primary force direction contributing to stabilizing moments in quiet standing. The key finding that the upper limbs play an important role in effecting frontal plane balance control has important implications for ambulation aid users (e.g., elderly, stroke, and traumatic brain injury). (C) 2011 Elsevier Ltd. All rights reserved.	[Tung, James Y.; Zabjek, Karl F.; McIlroy, William E.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Gage, William H.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Zabjek, Karl F.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Tung, James Y.] Univ Waterloo, Dept Kinesiol, Fac Appl Hlth Sci, Waterloo, ON N2L 3G1, Canada; [Maki, Brian E.] Sunnybrook Res Inst, Ctr Studies Aging, Toronto, ON, Canada; [Maki, Brian E.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Tung, James Y.; Gage, William H.; Zabjek, Karl F.; Maki, Brian E.; McIlroy, William E.] Toronto Rehabil Inst, Toronto, ON, Canada		Tung, JY (corresponding author), Univ Waterloo, Dept Kinesiol, Fac Appl Hlth Sci, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	james.tung@uwaterloo.ca	Tung, James/J-6728-2019	Tung, James/0000-0002-0771-2313	Ministry of Health and Long Term Care in OntarioMinistry of Health and Long-Term Care, Ontario; National Institute on Disability and Rehabilitation Research (NIDRR) through the Rehabilitation Engineering Research Center on Universal Design; Built Environmen [H133E050004-08A]; Center for Inclusive Design and Environmental Access (IDEA)	We acknowledge the support from Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Toronto Rehabilitation Institute, who receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long Term Care in Ontario, and the National Institute on Disability and Rehabilitation Research (NIDRR) through the Rehabilitation Engineering Research Center on Universal Design and the Built Environment (grant #H133E050004-08A), a partnership with the Center for Inclusive Design and Environmental Access (IDEA).	[Anonymous], 1995, GAIT POSTURE; Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Bateni H, 2004, GAIT POSTURE, V20, P74, DOI 10.1016/S0966-6362(03)00098-5; CHARRON PM, 1995, AM J PHYS MED REHAB, V74, P237, DOI 10.1097/00002060-199505000-00011; CORDO PJ, 1982, J NEUROPHYSIOL, V47, P287, DOI 10.1152/jn.1982.47.2.287; Elger K, 1999, EXP BRAIN RES, V128, P52, DOI 10.1007/s002210050816; FAST A, 1995, ARCH PHYS MED REHAB, V76, P484, DOI 10.1016/S0003-9993(95)80584-2; Finkel J, 1997, Assist Technol, V9, P116; Jeka JJ, 1997, PHYS THER, V77, P476, DOI 10.1093/ptj/77.5.476; LAPLANTE MP, 1992, ADV DATA US VITAL HL, P13; Maki BE, 2008, J ELECTROMYOGR KINES, V18, P243, DOI 10.1016/j.jelekin.2007.06.005; PARDO RD, 1993, AM J PHYS MED REHAB, V72, P301, DOI 10.1097/00002060-199310000-00009; Probst VS, 2004, CHEST, V126, P1102, DOI 10.1378/chest.126.4.1102; Solway S, 2002, CHEST, V122, P56, DOI 10.1378/chest.122.1.56; *STAT CAN, 2007, 89628XIE FED GOV CAN; Tung J. Y., 2007, P 30 CAN MED BIOL EN; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334	17	9	9	1	15	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.	MAY 17	2011	44	8					1466	1470		10.1016/j.jbiomech.2011.03.015			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	771BA	WOS:000291131000006	21458816	Green Submitted			2022-02-06	
J	Allen, MD; Wu, TC; Bigler, ED				Allen, Mark D.; Wu, Trevor ChuangKuo; Bigler, Erin D.			Traumatic Brain Injury Alters Word Memory Test Performance by Slowing Response Time and Increasing Cortical Activation: An fMRI Study of a Symptom Validity Test	PSYCHOLOGICAL INJURY & LAW			English	Article						fMRI; Word Memory Test; Neuropsychological assessment; Symptom validity testing; Effort testing		The Word Memory Test (WMT) is an established symptom validity test that relies on verbal memory performance to make inferences about "effort." Previous studies, using a functional MRI (fMRI) adaptation of the WMT with healthy controls, have shown that successful completion of the WMT relies on a widespread network of neural systems associated with high cognitive effort. Additional studies using the same fMRI paradigm with patients with severe traumatic brain injury (TBI) suggest that increased activation of cortical regions associated with cognitive load are recruited to meet the cognitive challenges that the WMT places on a compromised neural system. This study builds on previous findings as a result of highly uncommon circumstances in which fMRI data on the WMT task were made available from the very same individual both 1 year before and 1 year after sustaining a TBI. Interestingly, the effect of TBI did not appear to impair performance on the WMT in terms of standard accuracy measurements, though response times were notably slower. The main fMRI finding was a significantly stronger and more widespread pattern of activation post-injury, particularly in the frontal and parietal brain regions, suggesting that stronger engagement of these networks was necessary to sustain accurate WMT performance compared to preinjury testing. This unique source of data, together with previous findings, suggests a more complex relationship between effort and performance levels on the WMT than what is commonly assumed.	[Allen, Mark D.; Wu, Trevor ChuangKuo; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 1022 SWKT, Provo, UT 84602 USA; [Allen, Mark D.; Wu, Trevor ChuangKuo; Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Brain Inst Utah, Salt Lake City, UT 84112 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [Allen, Mark D.] Riverwoods Imaging Ctr, Funct Imaging Unit, Provo, UT USA		Allen, MD (corresponding author), Brigham Young Univ, Dept Psychol, 1022 SWKT, Provo, UT 84602 USA.	m_allen@byu.edu; trevorwu2002@yahoo.com; erin_bigler@byu.edu					Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Allen MD, 2008, BEHAV NEUROL, V20, P127, DOI [10.3233/BEN-2008-0223, 10.1155/2008/713412]; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P., 2003, MANUAL WORD MEMORY T; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Larsen JD, 2010, BRAIN INJURY, V24, P89, DOI 10.3109/02699050903508218; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McGrath RE, 2010, PSYCHOL BULL, V136, P450, DOI 10.1037/a0019216; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Millis SR, 2009, J NEUROTRAUM, V26, P2409, DOI 10.1089/neu.2008.0530; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wu TC, 2010, PSYCHOL INJ LAW, V3, P50, DOI 10.1007/s12207-010-9067-y	25	9	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAY	2011	4	2	2		SI		140	146		10.1007/s12207-011-9105-4			7	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB4ED	WOS:000415464400003					2022-02-06	
J	Skilbeck, C; Holm, K; Slatyer, M; Thomas, M; Bell, T				Skilbeck, Clive; Holm, Kieran; Slatyer, Mark; Thomas, Matthew; Bell, Tony			The Factor Structure of the Hospital Anxiety and Depression Scale (HADS) in a Traumatic Brain Injury (TBI) Population	BRAIN IMPAIRMENT			English	Article						HADS; mood; TBI; factor analysis; age; gender	CONFIRMATORY FACTOR-ANALYSIS; INDIVIDUALS; RECOVERY; SEQUELAE	Primary Objectives: To examine the HADS structure in TBI, using Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA), and investigate the effects of TBI severity, Gender, and Age on factor scores. Methods and Procedures: HADS data from 186 TBI patients in a population study in Tasmania were subjected to EFA. HADS data from a second sample of 185 TBI participants in the same study underwent CFA. One-month follow-up data were used, allowing inclusion of severe TBI patients while still being early post-injury. Factor loadings were used to investigate the effects of demographic and clinical variables at 2 weeks post-injury. Results: While EFA suggested 2-factor (anxiety, depression) and 3-factor (anxiety, psychomotor, depression) structures provided adequate descriptions, CFA strongly supported the 3-factor model. Using this model, significant effects of TBI severity were noted on Psychomotor and Depression scores at 2 weeks post-injury. Males reported significantly fewer symptoms on all 3 factors, as did younger participants. Conclusions: CFA indicates that a 3-factor model provides the best fit for HADS data in TBI. One factor, Psychomotor, has been relatively neglected in the literature, and the current findings suggest its assessment and rehabilitation should receive more attention.	[Skilbeck, Clive; Holm, Kieran] Univ Tasmania, Sch Psychol, Hobart, Tas 7001, Australia; [Slatyer, Mark; Bell, Tony] Royal Hobart Hosp, Sch Med, Hobart, Tas, Australia; [Thomas, Matthew] Charles Sturt Univ, Sch Social Sci & Liberal Studies, Bathurst, NSW 2795, Australia		Skilbeck, C (corresponding author), Univ Tasmania, Sch Psychol, Sandy Bay Campus, Hobart, Tas 7001, Australia.	clive.skilbeck@utas.edu.au					Barth J., 2005, HEALTH QUAL LIFE OUT, V3, P1, DOI DOI 10.1186/1477-7525-3-15; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brandberg Y, 1992, PSYCHO-ONCOLOGY, V1, P71, DOI DOI 10.1002/PON.2960010204; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, AM J PSYCHIAT, V156, P374; Desmond DM, 2005, INT J GERIATR PSYCH, V20, P344, DOI 10.1002/gps.1289; Dunbar M, 2000, BRIT J CLIN PSYCHOL, V39, P79, DOI 10.1348/014466500163121; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FARACE E, 2000, NEUROSURGICAL FOCUS, V0008, P00001, DOI [DOI 10.3171/F0C.2000.8.1.152, DOI 10.3171/foc.2000.8.1.152]; Friedman S, 2001, PSYCHIAT RES, V104, P247, DOI 10.1016/S0165-1781(01)00309-2; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hillier SL, 1997, BRAIN INJURY, V11, P649; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lemke MR, 1999, ACTA PSYCHIAT SCAND, V99, P252, DOI 10.1111/j.1600-0447.1999.tb07221.x; Marinus J, 2002, CLIN NEUROPHARMACOL, V25, P318, DOI 10.1097/00002826-200211000-00008; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Martin C, 2004, PSYCHOL HEALTH MED, V9, P327, DOI DOI 10.1080/13548500410001721891; Martin C R, 2000, Psychol Health Med, V5, P193, DOI 10.1080/713690189; Martin CR, 2005, CURR PSYCHIATRY REV, V1, P69, DOI 10.2174/1573400052953510; Martin CR, 2003, PSYCHIAT RES, V120, P85, DOI 10.1016/S0165-1781(03)00162-8; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nelson H.E., 1982, NATL ADULT READING T; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Roy CW, 2002, BRAIN INJURY, V16, P1057, DOI 10.1080/02699050210154231; Sadock BJ, 2003, KAPLAN SADOCKS SYNOP; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Snaith R., 1994, HOSP ANXIETY DEPRESS; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Tabachnick B.G., 2001, USING MULTIVARIATE S; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]; [No title captured]; [No title captured]	45	9	9	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2011	12	1					22	32		10.1375/brim.12.1.22			11	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	795EH	WOS:000292953800003					2022-02-06	
J	Winder, MJ; Brett, K; Hurlbert, RJ				Winder, Mark J.; Brett, Kelly; Hurlbert, R. John			Spinal cord concussion in a professional ice hockey player	JOURNAL OF NEUROSURGERY-SPINE			English	Article						spinal cord concussion; neurapraxia; ice hockey; transient quadriplegia	TRANSIENT QUADRIPLEGIA; CERVICAL-SPINE; RADIOGRAPHIC ABNORMALITIES; COMPUTED-TOMOGRAPHY; FOOTBALL PLAYERS; STENOSIS; INJURY; NEURAPRAXIA; PATHOMECHANICS; GUIDELINES	Spinal cord concussion (SCC) is an uncommon injury resulting in transient quadriplegia. The pathophysiology of SCC has been related to underlying spinal canal stenosis in many cases, yet is not always identified. The authors present the case of a professional ice hockey player, without evidence of canal compromise, who sustained an SCC during a regulation game after being struck by a puck in the upper cervical spine. The unusual mechanism of injury is discussed along with a comprehensive review of the literature. (DOI: 10.3171/2011.1.SPINE10345)	[Winder, Mark J.] St Vincents Hosp, Dept Neurosurg, Sydney, NSW 2010, Australia; [Brett, Kelly] Univ Calgary, Ctr Sports Med, Calgary, AB T2N 1N4, Canada; [Winder, Mark J.; Hurlbert, R. John] Univ Calgary, Foothills Hosp, Dept Neurosurg, Calgary, AB T2N 1N4, Canada		Winder, MJ (corresponding author), Foothills Med Ctr, Dept Clin Neurosci, 12th Floor,1403 29 St NW, Calgary, AB, Canada.	mjwnsx@hotmail.com					Bailes JE, 2005, J NEUROSURG-SPINE, V2, P11, DOI 10.3171/spi.2005.2.1.0011; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; BREIG A, 1966, J NEUROSURG, V25, P45, DOI 10.3171/jns.1966.25.1.0045; BREIG A, 1966, ACTA RADIOL DIAGN, V4, P602, DOI 10.1177/028418516600400602; Cantu RC, 1998, CLIN SPORT MED, V17, P137, DOI 10.1016/S0278-5919(05)70068-5; Cantu RC, 1997, MED SCI SPORT EXER, V29, pS233; Cantu RC, 1998, CLIN SPORT MED, V17, P121, DOI 10.1016/S0278-5919(05)70066-1; DALY PJ, 1990, SPORTS MED, V10, P122, DOI 10.2165/00007256-199010020-00005; HERZOG RJ, 1991, SPINE, V16, pS178, DOI 10.1097/00007632-199106001-00001; Kasimatis GB, 2008, J TRAUMA, V65, P86, DOI 10.1097/TA.0b013e318157495a; Kothari P, 2000, J BONE JOINT SURG BR, V82B, P1034, DOI 10.1302/0301-620X.82B7.10641; Maroon JC, 2007, J NEUROSURG-SPINE, V6, P356, DOI 10.3171/spi.2007.6.4.13; Mower WR, 2002, J TRAUMA, V53, P1198, DOI 10.1097/00005373-200212000-00039; PANG D, 1982, J NEUROSURG, V57, P114, DOI 10.3171/jns.1982.57.1.0114; PARKINSON D, 1983, SURG NEUROL, V20, P456, DOI 10.1016/0090-3019(83)90027-7; PARKINSON D, 1981, SURG NEUROL, V16, P347, DOI 10.1016/0090-3019(81)90272-X; Smith M G, 1993, J Ky Med Assoc, V91, P273; Torg Joseph S, 2002, Curr Sports Med Rep, V1, P43; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; TORG JS, 1995, SPORTS MED, V20, P429, DOI 10.2165/00007256-199520060-00007; Torg JS, 2002, J BONE JOINT SURG AM, V84A, P112, DOI 10.2106/00004623-200201000-00017; TORG JS, 1995, CLIN ORTHOP RELAT R, P259; Vaccaro Alexander R, 2002, Spine J, V2, P351; Wennberg RA, 2008, NEUROL CLIN, V26, pxi; Werinberg RA, 2008, NEUROL CLIN, V26, P243, DOI 10.1016/j.ncl.2007.12.002; ZWIMPFER TJ, 1990, J NEUROSURG, V72, P894, DOI 10.3171/jns.1990.72.6.0894	27	9	9	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAY	2011	14	5					677	680		10.3171/2011.1.SPINE10345			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	755FY	WOS:000289914100019	21332276				2022-02-06	
J	Zock, M; Werner, JC; Bogner, V; Biberthaler, P; Kanz, KG; Leidel, BA				Zock, M.; Werner, J. C.; Bogner, V.; Biberthaler, P.; Kanz, K. -G.; Leidel, B. A.			Guidelines on indications for imaging in patients with suspected mild head injury	NOTFALL & RETTUNGSMEDIZIN			German	Article						Head injury; Brain injury; Imaging; Clinical policy, clinical decision rule; Guidelines	TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; COST-EFFECTIVENESS; CT; RULE; VALIDATION; RELIABILITY; MANAGEMENT; DIAGNOSIS	There are various guidelines, clinical policies and clinical decision rules available regarding imaging in patients with mild, minimal or minor head injury to identify suspected traumatic brain injury (TBI). To some extent the published recommendations are quite comprehensive but difficult to review and to interpret. In this study we analyzed the different recommendations with regards to methods, contents and implementation in adult patients presenting to the emergency department with suspected mild head injury. We conducted a systematic review of the literature in Pubmed about indications for imaging with computed tomography in adult patients with mild head injury (Glasgow Coma Scale 13-15 points) and suspected TBI published between January 2000 and February 2011. All retrieved references were checked manually for additional relevant articles. We applied the DELBI (German guidelines assessment instrument) tool based on the Appraisal of Guidelines Research & Evaluation (AGREE) instrument to assess the methodological quality of guidelines and clinical policies. To evaluate the quality of contents we compared the published recommendations particularly regarding patient inclusion criteria, indications for imaging and feasibility in daily clinical practice. Of the 142 publications identified, 3 clinical decision rules, 1 clinical policy and 3 guidelines on the diagnostic approach for patients with suspected mild TBI met the inclusion criteria. Methodological quality revealed overall DELBI standardized domain scores with a maximum variation between 0.01-1.0. Contents quality showed substantial differences in recommendations predominantly regarding the criteria loss of consciousness, amnesia, coagulation disorder and anticoagulation. Over all scientifically based guidelines, clinical policies and clinical decision rules on the subject of indications for imaging in adults with mild head injury were limited. There were considerable discrepancies in the quality of methods and contents between published recommendations. Local facility conditions and requirements should also be considered besides criteria of quality when implementation in daily practice is intended.	[Leidel, B. A.] Charite, Interdisziplinare Rettungsstelle Notfallaufnahme, Berlin, Germany; [Zock, M.; Werner, J. C.; Bogner, V.; Biberthaler, P.; Kanz, K. -G.] Klinikum Univ Munchen, Chirurg Klin & Poliklin, Munich, Germany		Leidel, BA (corresponding author), Charite, Interdisziplinare Rettungsstelle Notfallaufnahme, Campus Benjamin Franklin,Hindenburgdamm 3012200, Berlin, Germany.	bernd.a.leidel@charite.de					af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; American College of Surgeons, 2008, ADV TRAUM LIF SUPP D; [Anonymous], 2021, **NON-TRADITIONAL**, DOI DOI 10.1055/A-1334-1925; Bock W, 2006, SCHADEL HIRN VERLETZ; *DEUTSCH GES NEUR, 2007, LEITL SCHAD HIRN TRA; Deutsche Gesellschaft fur Neurologie, 2008, LEITL DIAGN THER NEU; Dunning J, 2004, EMERG MED J, V21, P404, DOI 10.1136/emj.2004.014944; Dziedzic L, 1998, AM J EMERG MED, V16, P686, DOI 10.1016/S0735-6757(98)90177-2; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; LEIDEL BA, 2011, UNFALLCHIRURG; *NAT I HLTH CLIN E, 2007, NICE CLIN GUID, V56; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Pachet A, 2010, J GERIATR PSYCH NEUR, V23, P3, DOI 10.1177/0891988709342727; Rickels E, 2009, CHIRURG, V80, P153, DOI 10.1007/s00104-008-1655-y; Rosengren David, 2004, Emerg Med Australas, V16, P195, DOI 10.1111/j.1742-6723.2004.00563.x; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; The AGREE Collaboration, APPR GUID RES EV	34	9	9	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	MAY	2011	14	4					275	285		10.1007/s10049-011-1422-3			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	771OT	WOS:000291171300005					2022-02-06	
J	Bay, E; Strong, C				Bay, Esther; Strong, Carrie			Mild Traumatic Brain Injury A Midwest Survey of Discharge Teaching Practices of Emergency Department Nurses	ADVANCED EMERGENCY NURSING JOURNAL			English	Article						acute concussion evaluation; brain concussion; discharge teaching; rehabilitation; mild traumatic brain injury		Research indicates that the assessment and discharge teaching practices for persons with traumatic brain injury are more focused on ruling out severe brain injury and informing the person about "red flags" warranting a return visit to the medical provider. Our primary purpose was to determine the extent to which discharge practices were aligned with the Centers for Disease Control and Prevention guidelines contained within the Acute Concussion Evaluation care plan. Responses from 87 nurses (25.0% response rate) to a tailored survey were analyzed to determine emergency department nurses' discharge teaching practices for adults who experienced a mild traumatic brain injury (MTBI). Results indicated that nurses in general were focused on injury-specific information and less often provided information about MTBI, symptom management, or strategies for preventing future brain damage. System improvements are justified to provide injured persons with a clearly defined diagnosis and instructions for follow-up and symptom management.	[Bay, Esther] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Strong, Carrie] Mary Free Bed Rehabil Hosp, Grand Rapids, MI USA		Bay, E (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA.	pdq@med.umich.edu			MSU College of Nursing; MI Blue Cross Blue Shield McDevitt Award	This study was funded by MSU College of Nursing, 2008 Summer Scholars Funds, and MI Blue Cross Blue Shield McDevitt Award. Statistical support was received from Chingju Grace Chen, PhD, Assistant Professor, University of Akron. Survey design feedback was given by from Milisa Manojlovich, Assistant Professor, University of Michigan, Larry A. Hembroff, PhD, Michigan State University, Senior Specialist in Research, and Jean Langlois, ScD, MPH, former Senior Epidemiologist with the CDC.	Bay E., 2010, ADV EMERGENCY NURSIN, V32, P1; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; (CDC). National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2010, TRAUM BRAIN INJ FACT; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dillman DA., 2000, MAIL INTERNET SURVEY; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Irvine D, 1998, NURS ECON, V16, P110; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Panel of the American College of Emergency Physicians/CDC to revise the 2002 Clinical Policy on Neuroimaging and Decision making, 2008, ANN EMERGENCY MED, V52, P714; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; THURMAN D, 2001, EPIDEMIOLOGY EC HEAD; Uomoto JM, 2004, REHABIL PSYCHOL, V49, P334, DOI 10.1037/0090-5550.49.4.334	32	9	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1931-4485	1931-4493		ADV EMERG NURS J	Adv. Emerg. Nurs. J.	APR-JUN	2011	33	2					181	192		10.1097/TME.0b013e318217c958			12	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V93PM	WOS:000213073300009	21543914				2022-02-06	
J	Fischer, M; Lackner, P; Beer, R; Helbok, R; Klien, S; Ulmer, H; Pfausler, B; Schmutzhard, E; Broessner, G				Fischer, Marlene; Lackner, Peter; Beer, Ronny; Helbok, Raimund; Klien, Stephanie; Ulmer, Hanno; Pfausler, Bettina; Schmutzhard, Erich; Broessner, Gregor			Keep the Brain Cool-Endovascular Cooling in Patients With Severe Traumatic Brain Injury: A Case Series Study	NEUROSURGERY			English	Article						Brain temperature; Intracranial pressure; Intravascular cooling; Prophylactic normothermia; Traumatic brain injury	CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; CONTROLLED NORMOTHERMIA; RECTAL TEMPERATURES; BODY-TEMPERATURE; HEAD-INJURY; HYPERTHERMIA; HYPOTHERMIA; CARE; FEVER	BACKGROUND: As brain temperature is reported to be extensively higher than core body temperature in traumatic brain injury (TBI) patients, posttraumatic hyperthermia is of particular relevance in the injured brain. OBJECTIVE: To study the influence of prophylactic normothermia on brain temperature and the temperature gradient between brain and core body in patients with severe TBI using an intravascular cooling system and to assess the relationship between brain temperature and intracranial pressure (ICP) under endovascular temperature control. METHODS: Prospective case series study conducted in the neurologic intensive care unit of a tertiary care university hospital. Seven patients with severe TBI with a Glasgow Coma Scale score of 8 or less were consecutively enrolled. Prophylactic normothermia, defined as a target temperature of 36.5 degrees C, was maintained using an intravascular cooling system. Simultaneous measurements of brain and urinary bladder temperature and ICP were taken over a 72-hour period. RESULTS: The mean bladder temperature in normothermic patients was 36.3 +/- 0.4 degrees C, and the mean brain temperature was determined as 36.4 +/- 0.5 degrees C. The mean temperature difference between brain and bladder was 0.1 degrees C. We found a significant direct correlation between brain and bladder temperature (r = 0.95). In 52.4% of all measurements, brain temperature was higher than core body temperature. The mean ICP was 18 +/- 8 mm Hg. CONCLUSION: Intravascular temperature management stabilizes both brain and body core temperature; prophylactic normothermia reduces the otherwise extreme increase of intracerebral temperature in patients with severe TBI. The intravascular cooling management proved to be an efficacious and feasible method to control brain temperature and to avoid hyperthermia in the injured brain. We could not find a statistically significant correlation between brain temperature and ICP.	[Fischer, Marlene; Lackner, Peter; Beer, Ronny; Helbok, Raimund; Klien, Stephanie; Pfausler, Bettina; Schmutzhard, Erich; Broessner, Gregor] Innsbruck Med Univ, Neurol Intens Care Unit, Dept Neurol, A-6020 Innsbruck, Austria; [Ulmer, Hanno] Innsbruck Med Univ, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria		Broessner, G (corresponding author), Innsbruck Med Univ, Neurol Intens Care Unit, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	gregor.broessner@i-med.ac.at	Helbok, Raimund/AAA-8361-2021; Ulmer, Hanno/S-6615-2019	Ulmer, Hanno/0000-0001-5911-1002; Schmutzhard, Erich/0000-0003-3295-7491			Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Broessner G, 2005, CRIT CARE, V9, pR498, DOI 10.1186/cc3771; Broessner G, 2007, CRIT CARE MED, V35, P2025, DOI 10.1097/01.ccm.0000281449.07719.2b; Broessner G, 2009, STROKE, V40, pE657, DOI 10.1161/STROKEAHA.109.557652; Castillo J, 1999, CEREBROVASC DIS, V9, P22, DOI 10.1159/000015891; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 2008, BRIT J NEUROSURG, V22, P486, DOI 10.1080/02688690802245541; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hinz J, 2007, J NEUROSURG ANESTH, V19, P130, DOI 10.1097/ANA.0b013e318032a208; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Laupland KB, 2008, CRIT CARE MED, V36, P1531, DOI 10.1097/CCM.0b013e318170efd3; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Portella G, 2000, ACT NEUR S, V76, P273; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Sahuquillo J, 2009, INTENS CARE MED, V35, P890, DOI 10.1007/s00134-008-1357-4; Schmutzhard E, 2002, CRIT CARE MED, V30, P2481, DOI 10.1097/00003246-200211000-00013; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Spiotta AM, 2008, NEUROSURGERY, V62, P864, DOI 10.1227/01.neu.0000316900.63124.ce; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Suz P, 2006, J NEUROSURG ANESTH, V18, P5, DOI 10.1097/01.ana.0000189079.26212.37; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; Tokutomi T, 2007, NEUROSURGERY, V61, P256, DOI [10.1227/01.NEU.00000038737.13185.C4, 10.1227/01.neu.0000279221.38257.1a]; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Whalen MJ, 1997, ACT NEUR S, V70, P260	50	9	11	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2011	68	4					867	873		10.1227/NEU.0b013e318208f5fb			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	731QA	WOS:000288123100029	21221030				2022-02-06	
J	Krishnan, M; Donders, J				Krishnan, Mohan; Donders, Jacobus			Embedded Assessment of Validity Using the Continuous Visual Memory Test in Patients with Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Forensic neuropsychology; Head injury; Learning and Memory; Malingering; symptom validity testing	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DETECTING EXAGGERATION; RESPONSE BIAS; INDICATORS; CUTOFFS; ISSUES; TRAIL	Retrospective review of a consecutive patient series (n = 115) referred for neuropsychological examinations for traumatic brain injury was undertaken to evaluate an embedded measure of symptom validity for the Continuous Visual Memory Test (CVMT). Performance on the Test of Memory Malingering (TOMM) and Word Memory Test (WMT) was used for classification. Individuals who failed the TOMM or WMT were almost six times more likely to fail the CVMT validity criteria than those who passed the TOMM or WMT. The addition of compensation seeking increased this odds ratio to 9.80. The area under the curve for the latter classification was 0.74. Maximum likelihood ratio optimization of the CVMT validity test cutoff score indicated sensitivity of 0.25 and specificity of 0.99 at a revised cutoff of < 12 items. Classification accuracy was 91%. The original cutoff score of < 14 items also performed acceptably, with a classification accuracy of 88%. While low sensitivity argues against use in isolation, the proposed measure has utility in conjunction with other established effort measures.	[Krishnan, Mohan; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, MANUAL WORD MEMORY T; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Horton AM, 2005, INT J NEUROSCI, V115, P1083, DOI 10.1080/00207450590897914; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; Locke DEC, 2008, NEUROREHABILITATION, V23, P273; Lynch W, 2004, J HEAD TRAUMA REHAB, V19, P277, DOI 10.1097/00001199-200405000-00008; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 2002, J FORENSIC NEUROPSYC, V3, P227, DOI DOI 10.1300/J151V03N01_03; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Streiner DL, 2003, J PERS ASSESS, V81, P209, DOI 10.1207/S15327752JPA8103_03; Strong CAH, 2008, J CLIN EXP NEUROPSYC, V30, P885, DOI 10.1080/13803390701858224; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trahan DE, 1988, CONTINUOUS VISUAL ME; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682	29	9	10	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2011	26	3					176	183		10.1093/arclin/acr010			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	756WV	WOS:000290046400002	21355004	Bronze			2022-02-06	
J	Ronning, PA; Pedersen, T; Skaga, NO; Helseth, E; Langmoen, IA; Stavem, K				Ronning, Pal A.; Pedersen, Tor; Skaga, Nils O.; Helseth, Eirik; Langmoen, Iver A.; Stavem, Knut			External Validation of a Prognostic Model for Early Mortality After Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Prognosis; Survival; Validation	GLASGOW COMA SCALE; ISOLATED HEAD-INJURY; PREDICTIVE MODEL; MAJOR TRAUMA; IMPACT; OUTCOMES; CLASSIFICATION; PERFORMANCE; SYSTEM; SCORES	Background: Traumatic brain injury (TBI) is a major cause of lost disability- adjusted life years, and a valid model allowing prediction of outcome would be welcome. For a clinical prediction model to be valid, generalization to other populations must be possible. The aim of this study was to externally validate a model for in-hospital mortality in patients with TBI, which was recently development at the University of Southern California (USC). Methods: The validation cohort was derived from a hospital-based, prospectively collected trauma registry in Oslo, Norway. We included patients admitted with a head injury without hypotension, severe thoracic, or abdominal injury (n = 3,136). We calculated the probability of death according to the USC model. The performance of the model was evaluated using measures of calibration and discrimination in the total sample and subgroups according to initial Glasgow Coma Scale (GCS) score. Results: The USC model provided excellent discrimination (area under the receiver operating characteristic curve, AUC = 0.93), but unsatisfactory calibration (p < 0.001) for the total sample (GCS 3-15). In the GCS 4-8 subgroup we found good discrimination (AUC = 0.89) but poor calibration (Hosmer-Lemeshow test, p < 0.001). Conclusion: The findings question the external validity of the USC model, suggesting that it should not be implemented as a tool for short-term mortality prediction in our TBI population.	[Ronning, Pal A.; Helseth, Eirik; Langmoen, Iver A.] Oslo Univ Hosp Ulleval, Dept Neurosurg, N-0407 Oslo, Norway; [Pedersen, Tor; Helseth, Eirik; Langmoen, Iver A.; Stavem, Knut] Univ Oslo, Fac Med, Oslo, Norway; [Pedersen, Tor; Helseth, Eirik; Langmoen, Iver A.; Stavem, Knut] Univ Oslo, Fac Med, Lorenskog, Norway; [Skaga, Nils O.] Oslo Univ Hosp Ulleval, Dept Anesthesiol, N-0407 Oslo, Norway; [Stavem, Knut] Akershus Univ Hosp, Dept Pulm Med, Lorenskog, Norway; [Stavem, Knut] Akershus Univ Hosp, Res Ctr, HOKH, Lorenskog, Norway		Ronning, PA (corresponding author), Oslo Univ Hosp Ulleval, Dept Neurosurg, N-0407 Oslo, Norway.	palronning@gmail.com	Helseth, Eirik/AAH-2466-2020				[Anonymous], 2007, J NEUROTRAUMA S1, V24; Bergeron E, 2004, J TRAUMA, V56, P760, DOI 10.1097/01.TA.0000119199.52226.C0; Brennan PW, 2002, J TRAUMA, V53, P333, DOI 10.1097/00005373-200208000-00024; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark DE, 1999, J TRAUMA, V47, pS92, DOI 10.1097/00005373-199909001-00021; Clark DE, 2004, J TRAUMA, V57, P501, DOI 10.1097/01.TA.0000141027.45623.8C; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Edwards P, 2005, LANCET, V365, P1957; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hosmer DW, 2000, APPL LOGISTIC REGRES, Vxii, P373; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Murano T, 2005, AM SURGEON, V71, P1009; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Ottochian M, 2009, J TRAUMA, V67, P81, DOI 10.1097/TA.0b013e318188b934; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Skaga NO, 2008, INJURY, V39, P612, DOI 10.1016/j.injury.2007.11.426; Skaga NO, 2007, J TRAUMA, V63, P972, DOI 10.1097/TA.0b013e31804a571c; Skaga NO, 2007, INJURY, V38, P84, DOI 10.1016/j.injury.2006.04.123; Skaga NO, 2006, J TRAUMA, V60, P538, DOI 10.1097/01.ta.0000205613.52586.d1; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165	31	9	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2011	70	4					E56	E61		10.1097/TA.0b013e3181e80f0a			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	750OV	WOS:000289558700001	20805767				2022-02-06	
J	Silverstein, JM; Musikantow, D; Puente, EC; Daphna-Iken, D; Bree, AJ; Fisher, SJ				Silverstein, Julie M.; Musikantow, Daniel; Puente, Erwin C.; Daphna-Iken, Dorit; Bree, Adam J.; Fisher, Simon J.			Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage	NEUROSCIENCE LETTERS			English	Article						Hippocampus; Cortex; Insulin; Memantine; Erythropoietin	TRAUMATIC BRAIN-INJURY; INSULIN-INDUCED HYPOGLYCEMIA; ERYTHROPOIETIN PROTECTS NEURONS; CEREBRAL GLUCOSE-METABOLISM; NMDA-RECEPTOR ANTAGONISTS; COGNITIVE FUNCTION; NEUROPSYCHOLOGICAL PROFILES; DIFFERENTIAL VULNERABILITY; EXTRACELLULAR FLUID; DIABETES-MELLITUS	Hypoglycemia is a common complication for insulin treated people with diabetes. Severe hypoglycemia, which occurs in the setting of excess or ill-timed insulin administration, has been shown to cause brain damage. Previous pre-clinical studies have shown that memantine (an N-methyl-D-aspartate receptor antagonist) and erythropoietin can be neuroprotective in other models of brain injury. We hypothesized that these agents might also be neuroprotective in reponse to severe hypoglycemia-induced brain damage. To test this hypothesis, 9-week old, awake, male Sprague-Dawley rats underwent hyperinsulinemic (0.2 U kg(-1) min(-1)) hypoglycemic clamps to induce severe hypoglycemia (blood glucose 10-15 mg/dl for 90 min). Animals were randomized into control (vehicle) or pharmacological treatments (memantine or erythropoietin). One week after severe hypoglycemia, neuronal damage was assessed by Fluoro-Jade B and hematoxylin and eosin staining of brain sections. Treatment with both memantine and erythropoietin significantly decreased severe hypoglycemia-induced neuronal damage in the cortex by 35% and 39%, respectively (both p < 0.05 vs. controls). These findings demonstrate that memantine and erythropoietin provide a protective effect against severe hypoglycemia-induced neuronal damage. 2011 Elsevier Ireland Ltd. All rights reserved.	[Silverstein, Julie M.; Puente, Erwin C.; Daphna-Iken, Dorit; Bree, Adam J.; Fisher, Simon J.] Washington Univ, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Musikantow, Daniel; Fisher, Simon J.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA		Fisher, SJ (corresponding author), Washington Univ, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis Campus,Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	sfisher@dom.wustl.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK073683, NS070235]; Washington University [NS057105]; Diabetes Research and Training Center [DK020579]; Clinical Nutrition Research Unit [DK056341]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK056341, P60DK020579, R01DK073683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS057105, R01NS070235] Funding Source: NIH RePORTER	We would like to extend thanks to Dr. K. Yamada for assistance with Fluoro-Jade staining. We gratefully acknowledge research support from the NIH (DK073683, NS070235) and the core grant support from the Washington University's Neuroscience Blueprint Core (NS057105), Diabetes Research and Training Center (DK020579) and Clinical Nutrition Research Unit (DK056341).	Alkire MT, 1999, ANESTHESIOLOGY, V90, P701, DOI 10.1097/00000542-199903000-00011; Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; AUER RN, 1988, ANN NEUROL, V24, P699, DOI 10.1002/ana.410240602; Austin EJ, 1999, DIABETES CARE, V22, P1273, DOI 10.2337/diacare.22.8.1273; Bernal F, 2000, EXP NEUROL, V161, P686, DOI 10.1006/exnr.1999.7293; Bjorgaas M, 1997, ACTA PAEDIATR, V86, P148, DOI 10.1111/j.1651-2227.1997.tb08856.x; Block F, 1996, NEUROSCI LETT, V208, P41, DOI 10.1016/0304-3940(96)12545-3; Bree AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE194, DOI 10.1152/ajpendo.91041.2008; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BUTCHER SP, 1987, J NEUROCHEM, V48, P722, DOI 10.1111/j.1471-4159.1987.tb05576.x; Canal CE, 2005, PHYSIOL BEHAV, V84, P245, DOI 10.1016/j.physbeh.2004.11.009; Cardoso S, 2010, BBA-MOL BASIS DIS, V1802, P942, DOI 10.1016/j.bbadis.2010.07.001; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Diabet Control Complications Trial Res Grp, 1996, ANN INTERN MED, V124, P379, DOI 10.7326/0003-4819-124-4-199602150-00001; Gorgulu A, 2000, ACTA NEUROCHIR, V142, P1287, DOI 10.1007/s007010070027; Hershey T, 2003, J INT NEUROPSYCH SOC, V9, P740, DOI 10.1017/S1355617703950077; JACOBSON AM, 2007, NEW ENGL J MED, V356, P1842; Jeong YB, 2006, J INT MED RES, V34, P374, DOI 10.1177/147323000603400406; Jiang XN, 2004, EXP NEUROL, V190, P224, DOI 10.1016/j.expneurol.2004.07.010; Johnson SA, 2008, J NEUROSURG ANESTH, V20, P21, DOI 10.1097/ANA.0b013e3181271850; Kaufman FR, 1999, J DIABETES COMPLICAT, V13, P31, DOI 10.1016/S1056-8727(98)00029-4; Kramer L, 1998, DIABETES, V47, P1909, DOI 10.2337/diabetes.47.12.1909; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Musen G, 2006, DIABETES, V55, P326, DOI 10.2337/diabetes.55.02.06.db05-0520; Nakao Y, 2001, P NATL ACAD SCI USA, V98, P7593, DOI 10.1073/pnas.121179898; NELLGARD B, 1992, EXP BRAIN RES, V92, P259; Northam EA, 2001, DIABETES CARE, V24, P1541, DOI 10.2337/diacare.24.9.1541; Northam EA, 1999, DIABETES CARE, V22, P1438, DOI 10.2337/diacare.22.9.1438; PAPAGAPIOU MP, 1990, J CEREBR BLOOD F MET, V10, P270, DOI 10.1038/jcbfm.1990.44; Puente EC, 2010, DIABETES, V59, P1055, DOI 10.2337/db09-1495; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Rao VLR, 2001, BRAIN RES, V911, P96; Rovet JF, 1999, J PEDIATR-US, V134, P503, DOI 10.1016/S0022-3476(99)70211-8; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Schoenle EJ, 2002, DIABETOLOGIA, V45, P108, DOI 10.1007/s125-002-8250-6; Srivastava A, 2005, TOXICOLOGY, V214, P123, DOI 10.1016/j.tox.2005.06.005; Strudwick SK, 2005, J PEDIATR-US, V147, P680, DOI 10.1016/j.jpeds.2005.06.010; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2005, DIABETES, V54, P500, DOI 10.2337/diabetes.54.2.500; Suh SW, 2003, J NEUROSCI, V23, P10681; Taoufik E, 2008, CURR PHARM DESIGN, V14, P3565, DOI 10.2174/138161208786848748; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Wakida K, 2007, NEUROSCIENCE, V148, P105, DOI 10.1016/j.neuroscience.2007.04.063; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; WIELOCH T, 1985, NEUROSCI LETT, V58, P25, DOI 10.1016/0304-3940(85)90323-4; Wysocki T, 2003, DIABETES CARE, V26, P1100, DOI 10.2337/diacare.26.4.1100; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	55	9	10	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 29	2011	492	1					23	28		10.1016/j.neulet.2011.01.045			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739QC	WOS:000288731800006	21272612	Green Accepted			2022-02-06	
J	Katusic, A				Katusic, Ana			EARLY BRAIN INJURY AND PLASTICITY: REORGANIZATION AND FUNCTIONAL RECOVERY	TRANSLATIONAL NEUROSCIENCE			English	Article						Early Brain Injury; Plasticity; Reorganization; Functional Outcome; Rehabilitation; Timely Appropriate Interventions	HEMIPLEGIC CEREBRAL-PALSY; CLOSED-HEAD-INJURY; CONGENITAL HEMIPARESIS; CORTICOSPINAL PROJECTIONS; DEVELOPMENTAL PLASTICITY; COGNITIVE-DEVELOPMENT; MOTOR REORGANIZATION; SOMATOSENSORY SYSTEM; HAND REPRESENTATION; CORTICAL LAMINATION	One of the most remarkable observations in developmental neuroscience is the plasticity of the developing brain. Although recent findings suggest that the developing brain possesses substantial compensatory potential, the mechanisms of reorganization and its limitations remain largely unknown. This review includes studies elucidating the complexities of brain reorganization in response to early brain injury. It describes the factors influencing the pattern and degree of brain plasticity, provides insight into the patterns of reorganization in different brain systems and offers guidelines for clinicians in the field of neurorehabilitation. This knowledge is crucial in clinical work when designing the appropriate type and timing of interventions for children with early brain injuries.	Ctr Rehabil Mali Dom Zagreb, Zagreb 10000, Croatia		Katusic, A (corresponding author), Ctr Rehabil Mali Dom Zagreb, Zagreb 10000, Croatia.	ana@malidom.hr	Katusic, Ana/AAP-6380-2020	Katusic, Ana/0000-0002-7648-131X			Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Aram DM, 1986, DEV NEUROPSYCHOL, V2, P155, DOI 10.1080/87565648609540339; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Badr LK, 2006, INFANT BEHAV DEV, V29, P80, DOI 10.1016/j.infbeh.2005.08.003; Ballantyne AO, 2008, BRAIN, V131, P2975, DOI 10.1093/brain/awn176; BANICH MT, 1990, NEUROPSYCHOLOGIA, V28, P35, DOI 10.1016/0028-3932(90)90084-2; Bates E, 1999, DEV COGN NEUROSCI, P533; Blauw-Hospers CH, 2005, DEV MED CHILD NEUROL, V47, P421, DOI 10.1017/S0012162205000824; BRIONES TL, 2000, BIOL RES NURS, V4, P299; CAO Y, 1994, P NATL ACAD SCI USA, V91, P9612, DOI 10.1073/pnas.91.20.9612; CARLSSON G, 1994, DEV MED CHILD NEUROL, V36, P503; CARR LJ, 1993, BRAIN, V116, P1223, DOI 10.1093/brain/116.5.1223; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P36, DOI 10.1097/00001199-199510000-00006; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, 1995, CONSEQUENCES TRAUMAT; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chilosi AM, 2008, BRAIN LANG, V106, P211, DOI 10.1016/j.bandl.2007.12.010; Chugani HT, 1996, BRAIN DEV-JPN, V18, P347, DOI 10.1016/0387-7604(96)00032-0; CONDIC ML, 2005, DEV NEUROBILOGY; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; DENNIS M, 1980, BRAIN LANG, V10, P287, DOI 10.1016/0093-934X(80)90058-9; Dennis M., 1989, CLIN NEUROPSYCHOLOGY; DUFFAU H, 2008, NEW INSIGHTS FUNCTIO; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Eyre JA, 2000, BRAIN, V123, P51, DOI 10.1093/brain/123.1.51; Eyre JA, 2001, NEUROLOGY, V57, P1543, DOI 10.1212/WNL.57.9.1543; EYRE JA, 2004, CLIN NEUROPHYSIOLOGY; Eyre JA, 2007, ANN NEUROL, V62, P493, DOI 10.1002/ana.21108; Feys H, 2010, EUR J PAEDIATR NEURO, V14, P169, DOI 10.1016/j.ejpn.2009.01.004; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gonzalez-Monge S, 2009, DEV MED CHILD NEUROL, V51, P959, DOI 10.1111/j.1469-8749.2009.03339.x; Goodman R, 1996, DEV MED CHILD NEUROL, V38, P881, DOI 10.1111/j.1469-8749.1996.tb15045.x; Guzzetta A, 2007, CLIN NEUROPHYSIOL, V118, P1110, DOI 10.1016/j.clinph.2007.02.014; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; HEBB DO, 2002, ORG BEHAV; Holmes JM, 2006, STRABISMUS, V14, P37, DOI 10.1080/09273970500536227; Holmstrom L, 2010, DEV MED CHILD NEUROL, V52, P145, DOI 10.1111/j.1469-8749.2009.03496.x; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Johnson MH, 2005, DEV PSYCHOBIOL, V46, P287, DOI 10.1002/dev.20057; Johnston M V, 2001, Adv Pediatr, V48, P1; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; JUDAS M, ANN NY ACAD IN PRESS; KARTJE GL, 2006, BASIC NEUROCHEMISTRY; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Kolb B., 1995, BRAIN PLASTICITY BEH; Kolb B, 2007, DEV PSYCHOBIOL, V49, P107, DOI 10.1002/dev.20199; Kostovi c I, 2007, PAEDIATR CROAT, V51, P93; Kostovic I, 2002, ANAT RECORD, V267, P1, DOI 10.1002/ar.10069; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Kostovic I, 2007, NEUROSCI BIOBEHAV R, V31, P1157, DOI 10.1016/j.neubiorev.2007.04.018; Krageloh-Mann I, 2004, EXP NEUROL, V190, pS84, DOI 10.1016/j.expneurol.2004.05.037; KURZ MJ, NEUROSCI LE IN PRESS, DOI DOI 10.1016/2010.11.053; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Levine SC, 2005, BRAIN COGNITION, V59, P114, DOI 10.1016/j.bandc.2005.05.008; Lidzba K, 2008, BRAIN LANG, V106, P165, DOI 10.1016/j.bandl.2008.05.003; Lidzba K, 2006, NEUROPSYCHOLOGIA, V44, P1088, DOI 10.1016/j.neuropsychologia.2005.10.022; Liegeois F, 2008, BRAIN LANG, V106, P195, DOI 10.1016/j.bandl.2008.01.010; Luciana M, 2003, DEV PSYCHOPATHOL, V15, P1017, DOI 10.1017/S095457940300049X; Maegaki Y, 1997, NEUROPEDIATRICS, V28, P168, DOI 10.1055/s-2007-973695; Martin JH, 1999, EXP BRAIN RES, V125, P184, DOI 10.1007/s002210050673; Martin JH, 1999, NEUROREPORT, V10, P2277, DOI 10.1097/00001756-199908020-00010; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; Meekes J, 2006, PEDIATRICS, V117, P2330, DOI 10.1542/peds.2006-0083; Pavlova M, 2003, BRAIN, V126, P692, DOI 10.1093/brain/awg062; Payne BR, 2002, NEUROSCIENTIST, V8, P174, DOI 10.1177/107385840200800212; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Rakic P., 2000, Novartis Foundation Symposium, V228, P30; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; RIVA D, 1986, NEUROPSYCHOLOGIA, V24, P423, DOI 10.1016/0028-3932(86)90029-1; Salimi I, 2004, J NEUROSCI, V24, P4952, DOI 10.1523/JNEUROSCI.0004-04.2004; Seghier ML, 2010, SEMIN PERINATOL, V34, P79, DOI 10.1053/j.semperi.2009.10.008; Staudt M, 2004, ANN NEUROL, V56, P854, DOI 10.1002/ana.20297; Staudt M, 2002, BRAIN, V125, P2222, DOI 10.1093/brain/awf227; Staudt M, 2001, NEUROLOGY, V57, P122, DOI 10.1212/WNL.57.1.122; Staudt M, 2007, NEUROSCI BIOBEHAV R, V31, P1150, DOI 10.1016/j.neubiorev.2007.05.005; Staudt M, 2010, SEMIN PERINATOL, V34, P87, DOI 10.1053/j.semperi.2009.10.009; Stiles J, 2005, TRENDS COGN SCI, V9, P136, DOI 10.1016/j.tics.2005.01.002; TEUBER HL, 1975, OUTCOME SEVERE DAMAG, V34, P159; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; Thomas MSC, 2008, CURR DIR PSYCHOL SCI, V17, P1, DOI 10.1111/j.1467-8721.2008.00537.x; Tillema JM, 2008, BRAIN LANG, V105, P99, DOI 10.1016/j.bandl.2007.07.127; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tranel D, 2000, DEV NEUROPSYCHOL, V18, P273, DOI 10.1207/S1532694201Tranel; VARGHAKHADEM F, 1992, BRAIN, V115, P315, DOI 10.1093/brain/115.1.315; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; Wilke M, 2009, HUM BRAIN MAPP, V30, P776, DOI 10.1002/hbm.20545	102	9	9	1	23	SCIENDO	WARSAW	DE GRUYTER POLAND SP Z O O, BOGUMILA ZUGA 32A STR, 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	MAR	2011	2	1					33	42		10.2478/s13380-011-0006-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	873MD	WOS:000298886500005					2022-02-06	
J	Namiranian, K; Brink, CD; Goodman, JC; Robertson, CS; Bryan, RM				Namiranian, Khodadad; Brink, Christa D.; Goodman, Jerry Clay; Robertson, Claudia S.; Bryan, Robert M., Jr.			Traumatic brain injury in mice lacking the K channel, TREK-1	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cortical contusion injury; KCNK2; neuroprotection; potassium channels; two-pore domain potassium channels (K-2P)	POLYUNSATURATED FATTY-ACIDS; CORTICAL IMPACT INJURY; POTASSIUM CHANNEL; CEREBRAL HEMODYNAMICS; GENERAL-ANESTHESIA; LINOLENIC ACID; K-2P CHANNELS; ISCHEMIA; NEUROPROTECTION; EXPRESSION	The purpose of this study was to determine whether the potassium channel, TREK-1, was neuroprotective after traumatic brain injury (TBI). Since there are no selective blockers, we used TREK-1 knockout (KO) mice for our study. Wild-type (WT) and TREK-1 KO mice were anesthetized and subjected to controlled-cortical impact injury (deformation of the brain by 1.5mm by a 3-mm diameter rod traveling at a 3 m/s). Laser Doppler perfusion (LDP) decreased by similar to 80% in the injured cortex and remained at that level in both WT and TREK-1 KO mice (n = 10 and 11, respectively). Laser Doppler perfusion decreased by 50% to 60% in cortical areas directly adjacent to the site of injury. There were no statistical differences in LDP between genotype. The contusion volume, determined 15 days after the TBI using hematoxylin and eosin-stained coronal brain sections, was 4.1 +/- 0.8 (n = 10) and 5.1 +/- 0.5 (n = 11) mm(3) for WT and TREK-1 KO, respectively (not significant, P = 0.34). Cell counts of viable neurons in the CA1 and CA3 regions of the hippocampus were similar between WT and TREK-1 KO mice (P = 0.51 and 0.84 for CA1 and CA3, respectively). We conclude that TREK-1 expression does not provide brain protection after TBI. Journal of Cerebral Blood Flow & Metabolism (2011) 31; doi:10.1038/jcbfm.2010.223; published online 15 December 2010	[Namiranian, Khodadad; Bryan, Robert M., Jr.] Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; [Brink, Christa D.; Goodman, Jerry Clay; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Goodman, Jerry Clay] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Bryan, Robert M., Jr.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Bryan, Robert M., Jr.] Baylor Coll Med, Dept Med Cardiovasc Sci, Houston, TX 77030 USA		Bryan, RM (corresponding author), Baylor Coll Med, Dept Anesthesiol, Room 434D,1 Baylor Plaza, Houston, TX 77030 USA.	rbryan@bcm.edu			American Heart Association, South Central AffiliateAmerican Heart Association [0815342F]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1 NS038660, R01 NS046666]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660, R01NS046666] Funding Source: NIH RePORTER	This study was supported by American Heart Association Predoctoral fellowship (0815342F) from the South Central Affiliate; NIH grants PO1 NS038660 and R01 NS046666.	Bantel C, 2009, ANESTHESIOLOGY, V110, P986, DOI 10.1097/ALN.0b013e31819dadc7; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Blondeau N, 2002, NEUROSCIENCE, V109, P231, DOI 10.1016/S0306-4522(01)00473-0; Blondeau N, 2002, J CEREBR BLOOD F MET, V22, P821, DOI 10.1097/00004647-200207000-00007; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Chen XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005811; Ehling Petra, 2010, Exp Transl Stroke Med, V2, P14, DOI 10.1186/2040-7378-2-14; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Janahmadi M, 2009, NEUROTOXICOLOGY, V30, P393, DOI 10.1016/j.neuro.2009.02.014; Lang-Lazdunski L, 2003, J VASC SURG, V38, P564, DOI 10.1016/S0741-5214(03)00473-7; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Liu CH, 2005, BRAIN RES, V1031, P164, DOI 10.1016/j.brainres.2004.10.029; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Meuth SG, 2009, NEUROBIOL DIS, V33, P1, DOI 10.1016/j.nbd.2008.09.006; Misonou H, 2010, NEUROSCIENTIST, V16, P51, DOI 10.1177/1073858409341085; Muhammad S, 2010, NEUROSCIENCE, V167, P758, DOI 10.1016/j.neuroscience.2010.02.024; Namiranian K, 2010, AM J PHYSIOL-REG I, V299, pR461, DOI 10.1152/ajpregu.00057.2010; Obrenovitch TP, 1997, INT REV NEUROBIOL, V40, P109; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001	28	9	9	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2011	31	3					E1	E6		10.1038/jcbfm.2010.223			6	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	727ZS	WOS:000287842700001	21157470	Green Published, Bronze			2022-02-06	
J	Reeser, JC; Payne, E; Kitchner, T; McCarty, CA				Reeser, Jonathan C.; Payne, Erin; Kitchner, Terrie; McCarty, Catherine A.			Apolipoprotein E4 Genotype Increases the Risk of Being Diagnosed With Posttraumatic Fibromyalgia	PM&R			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; STRESS; ASSOCIATION; SCIENCE; PAIN	Objective: To determine whether the apolipoprotein E4 (Apo E4) allele may be a genetic risk factor for fibromyalgia syndrome (FMS). Design: A retrospective assessment of associations between Apo E4 genotype and selected environmental exposures among a cohort diagnosed with FMS compared with control subjects. Setting: Marshfield Clinic Research Foundation's Personalized Medicine Research Project (PMRP) biobank. Participants: One hundred fifty-one case subjects with fibromyalgia and 300 age- and gender-matched control subjects. Methods: Fibromyalgia case subjects were identified according to a strict phenotypic definition from among the nearly 20,000 subjects enrolled in the PMRP. Age- and gender-matched control subjects also were identified from the PMRP in a 2:1 control/case ratio. Apo E4 genotype was determined by single nucleotide polymorphism analysis for both case subjects with fibromyalgia and control subjects. Case subjects with fibromyalgia and control subjects were asked to assess their level of function and stress by completing the Short Form-36 and the Perceived Stress Scale. Main Outcome Measures: Statistical associations between the Apo E4 genotype and phenotypic criteria (diagnosis of FMS) as well as historical environmental exposures as documented in the electronic medical record were assessed. Results: Approximately one quarter of both case subjects with fibromyalgia and control subjects were found to carry at least one Apo E4 allele. The odds ratio (OR) for case subjects with fibromyalgia who had ever been in a motor vehicle accident and subsequently had been diagnosed with FMS was increased among those with at least one copy of the Apo E4 allele (OR 7.04) compared with those without an Apo E4 allele (OR 1.90). The presence of an Apo E4 allele did not influence the degree of pain or level of function among those with FMS. Conclusions: These data suggest that specific interactions between genetically susceptible individuals (eg, those with at least one copy of the Apo E4 allele) and the environment (eg, involvement in a motor vehicle accident) may contribute to the risk of being diagnosed with FMS, although Apo E4 allele status does not appear to modulate perceived FMS severity. PM R2011;3:193-197	[Reeser, Jonathan C.] Marshfield Med Res Fdn, Off Res Integr & Protect, Marshfield, WI 54449 USA; [Payne, Erin] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Kitchner, Terrie; McCarty, Catherine A.] Marshfield Med Res Fdn, Dept Human Genet, Marshfield, WI USA		Reeser, JC (corresponding author), Marshfield Med Res Fdn, Off Res Integr & Protect, 1000 N Oak Ave, Marshfield, WI 54449 USA.	reeser.jonathan@marshfieldclinic.org		McCarty, Catherine/0000-0003-1089-0142	Marshfield Clinic Research Foundation's Physician Research Fund	This investigation was funded by a grant from the Marshfield Clinic Research Foundation's Physician Research Fund.	Aaron LA, 1997, ARTHRITIS RHEUM, V40, P453, DOI 10.1002/art.1780400311; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Buskila D, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2005; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cross DS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-17; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gupta A, 2004, ARTHRITIS RES THER, V6, P98, DOI 10.1186/ar1176; Hoffman DL, 2008, INT J CLIN PRACT, V62, P115, DOI 10.1111/j.1742-1241.2007.01638.x; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Martinez-Lavin M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2146; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; Mortensen EL, 2001, NEUROLOGY, V57, P89, DOI 10.1212/WNL.57.1.89; Samatovicz RA, 2000, J HEAD TRAUMA REHAB, V15, P869, DOI 10.1097/00001199-200006000-00002	16	9	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	MAR	2011	3	3					193	197		10.1016/j.pmrj.2010.12.009			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	961AX	WOS:000305437400002	21402364	Green Published			2022-02-06	
J	Sander, AM; Pappadis, MR; Clark, AN; Struchen, MA				Sander, Angelle M.; Pappadis, Monique R.; Clark, Allison N.; Struchen, Margaret A.			Perceptions of Community Integration in an Ethnically Diverse Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community integration; racial/ethnic diversity; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; QUALITY-OF-LIFE; REHABILITATION OUTCOMES; PARTICIPATION; RACE; QUESTIONNAIRE; PERSPECTIVES; SATISFACTION; AMERICANS	Objective: To investigate the meaning of community integration in an ethnically diverse sample. Design: Prospective study using mixed qualitative and quantitative methods. Setting: County level I trauma center. Participants: Fifty-eight blacks, 57 Hispanics, and 52 whites with traumatic brain injury living in the community 6 months postinjury. Main Measures: Open-ended interview questions and a questionnaire assessing perceived importance of community integration activities. Results: Resulting themes indicated that feeling part of the community was related to type and quality of community relationships, perceived safety and security, active involvement, feeling included and respected, and familiarity with the community. Themes regarding barriers included the following: environmental and social barriers; injury-related cognitive and physical changes; dissimilarities to others; relocation; and financial issues. Blacks and Hispanics placed more emphasis on domestic activities than did whites. Conclusions and Implications: Feeling integrated into the community relates to aspects of the environment as much as to involvement in specific activities. Environmental barriers can be just as important as injury-related changes. Different racial/ethnic groups place different value on participation activities. The results emphasize the importance of assessing subjective aspects of community integration, individualizing rehabilitation goals, and intervening in the environment to facilitate participation.	[Sander, Angelle M.; Clark, Allison N.; Struchen, Margaret A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77019 USA; [Sander, Angelle M.] Harris Cty Hosp Dist, Houston, TX USA; [Sander, Angelle M.; Pappadis, Monique R.; Clark, Allison N.; Struchen, Margaret A.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Pappadis, Monique R.] Univ Houston, Grad Coll Social Work, Houston, TX USA		Sander, AM (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77019 USA.	asander@bcm.edu	Pappadis, Monique/Q-8639-2016	Pappadis, Monique/0000-0003-4742-4380	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133B031117, H133B090023, H133A070043]	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, US Department of Education (grants H133B031117, H133B090023, and H133A070043). The authors thank the patients and staff of Harris County Hospital District's Ben Taub General Hospital and Quentin Mease Community Hospital, particularly Drs Shankar Gopinath, Claudia Robertson, and Faye Chiou-Tan.	Almeida J, 2009, SOC SCI MED, V68, P1852, DOI 10.1016/j.socscimed.2009.02.029; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Auerbach C., 2003, QUALITATIVE DATA INT; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Christenson OD, 2006, J LEISURE RES, V38, P475, DOI 10.1080/00222216.2006.11950088; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; FLOYD MF, 1994, J LEISURE RES, V26, P158, DOI 10.1080/00222216.1994.11969951; Glaser B., 1967, DISCOVERY GROUNDED T; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kamo Y, 2000, SOCIOL PERSPECT, V43, P211, DOI 10.2307/1389794; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kim HK, 1998, J COMP FAM STUD, V29, P313; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; QSR International Pty Ltd, 2008, NVIVO QUAL DAT AN SO; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Sarkisian N, 2006, FAM RELAT, V55, P331, DOI 10.1111/j.1741-3729.2006.00408.x; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; TEASDALE G, 1974, LANCET, V2, P81; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	42	9	10	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2011	26	2					158	169		10.1097/HTR.0b013e3181e7537e			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	732OR	WOS:000288197200006	20631629				2022-02-06	
J	Suehiro, E; Fujisawa, H; Koizumi, H; Yoneda, H; Ishihara, H; Nomura, S; Kajiwara, K; Fujii, M; Suzuki, M				Suehiro, Eiichi; Fujisawa, Hirosuke; Koizumi, Hiroyasu; Yoneda, Hiroshi; Ishihara, Hideyuki; Nomura, Sadahiro; Kajiwara, Koji; Fujii, Masami; Suzuki, Michiyasu			Survey of Current Neurotrauma Treatment Practice in Japan	WORLD NEUROSURGERY			English	Article						Guidelines; Neurosurgeon; Survey; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; GUIDELINES; MANAGEMENT; OUTCOMES; DAMAGE; MRI	BACKGROUND: The Japanese Society of Neurotraumatology announced guidelines for management of severe traumatic brain injury (TBI) in 2000. To evaluate subsequent implementation of these guidelines, we investigated current severe TBI practices in Japan. METHODS: A questionnaire regarding management of severe TBI was sent to each of the 384 Japanese Neurosurgical Society specialist training medical centers and answers were received by mail from 233 centers (60.7%). RESULTS: Of the medical centers, 29% have neurosurgeons in their emergency department. Initial TBI treatment responsibility resided in the Departments of Neurosurgery in 34% of the medical centers, in the emergency department in 29%, and in 36% responsibility is assigned to both departments. Surgery was performed by neurosurgeons in 90% of the centers and postoperative management was assigned to neurosurgeons in 76%. Acute stage magnetic resonance imaging was done in 52% of the centers. An intracranial pressure sensor was inserted in 55%, and jugular venous oxygen saturation was measured in 21%. Hypothermia therapy was performed in 47%, positive normothermia therapy was administered in 76%, and barbiturate therapy was administered in 70%. Of the centers, 94% acknowledged the guidelines but only 72% of the centers implemented protocols that conformed to the guidelines. CONCLUSIONS: Neurosurgeons in Japan are positively involved in management of severe TBI, but few medical centers monitor TBI patients. Many medical centers find it difficult to conform to the guidelines due to lack of neurosurgeons and equipment. These problems can be addressed by consolidation of neurosurgeons into centralized centers and improvement of the medical insurance system.	[Suehiro, Eiichi; Fujisawa, Hirosuke; Koizumi, Hiroyasu; Yoneda, Hiroshi; Ishihara, Hideyuki; Nomura, Sadahiro; Kajiwara, Koji; Fujii, Masami; Suzuki, Michiyasu] Yamaguchi Univ, Dept Neurosurg, Sch Med, Yamaguchi, Japan		Suehiro, E (corresponding author), Yamaguchi Univ, Dept Neurosurg, Sch Med, Yamaguchi, Japan.	suehiro-nsu@umin.ac.jp	Suehiro, Eiichi/I-5852-2019				Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Huang SJ, 2006, J CLIN NEUROSCI, V13, P818, DOI 10.1016/j.jocn.2005.11.034; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; You JS, 2010, EMERG MED J, V27, P131, DOI 10.1136/emj.2008.066399	15	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750			WORLD NEUROSURG	World Neurosurg.	MAR-APR	2011	75	3-4					563	568		10.1016/j.wneu.2010.09.013			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	793KK	WOS:000292820400056	21600513				2022-02-06	
J	Chatfield, DA; Brahmbhatt, DH; Sharp, T; Perkes, IE; Outrim, JG; Menon, DK				Chatfield, Doris A.; Brahmbhatt, Darshan H.; Sharp, Tilly; Perkes, Iain E.; Outrim, Joanne G.; Menon, David K.			Juguloarterial Endothelin-1 Gradients After Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Endothelin; Traumatic brain injury; Juguloarterial gradients; Humans	ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBROSPINAL-FLUID; CEREBRAL VASOSPASM; PLASMA ENDOTHELIN; HEAD TRAUMA; RAT; EXPRESSION; RECEPTORS; HYPOPERFUSION; HIPPOCAMPUS	Endothelin-1 (ET-1) is a potent vasoconstrictor and is thought to be responsible for secondary ischemia and vasogenic edema after traumatic brain injury (TBI). Both CSF and plasma concentrations have been shown to be increased after TBI, but there is little evidence to confirm an intracranial site of production. Using paired arterial and jugular venous bulb sampling, we measured arterial and jugular levels of ET-1 and its precursor, big endothelin (Big ET), and calculated juguloarterial (JA) gradients for the first 5 days post-TBI. Arterial levels of both Big ET and ET-1 were maximal on day 1 post-TBI, and decreased thereafter (P < 0.05). Arterial levels of Big ET and ET-1 showed correlation across all 5 days of the study (r (2) = 0.25, P < 0.001). While there was no significant JA gradient for Big ET, significant gradients were observed for ET-1 on days 1-4 post-TBI (P < 0.05). There was no correlation between JA gradients for Big ET and ET-1 (r (2) < 0.1, P > 0.9). These data suggest parenchymal production of ET-1 by brain tissue with spill over into the blood, rather than local intraluminal cleavage of Big ET in the cerebral vasculature. Systemic ET-1 levels and JA gradients of ET-1 were unrelated to the injury severity, APACHE II score, Marshall Grade, the presence of subarachnoid or subdural hemorrhage, or eventual outcome. These findings confirm the synthesis of Big ET and its cleavage to ET-1 within the brain after TBI. More work is needed to elucidate the pathophysiological role and the outcome impact of ET-1 generation after TBI.	[Chatfield, Doris A.; Brahmbhatt, Darshan H.; Perkes, Iain E.; Outrim, Joanne G.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge CB2 2QQ, England; [Sharp, Tilly] Total Sci, Cambridge CB22 3AT, England		Brahmbhatt, DH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Hills Rd, Cambridge CB2 2QQ, England.	dhb28@cam.ac.uk	Perkes, Iain/J-7001-2017; Brahmbhatt, Darshan/AAK-7339-2021	Perkes, Iain/0000-0001-8028-9032; Brahmbhatt, Darshan/0000-0003-3440-0523; Sharp, Tilly/0000-0002-3389-2119	Solvay Pharmaceuticals, BVSolvay SA; Wellcome TrustWellcome TrustEuropean Commission; Wellcome Trust and GlaxoSmithKline; Royal College of Anaesthetists; Medical Research Council, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Evelyn Trust; Queens' College, Cambridge; Cambridge Biomedical Research CentreGeneral Electric; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0001237, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0600986, G0001237] Funding Source: UKRI	These studies were supported by an unrestricted research grant from Solvay Pharmaceuticals, BV. DHB is supported by The Wellcome Trust and GlaxoSmithKline. DKM is a National Institute of Health Research Senior Investigator, and is supported by The British Oxygen Professorship of the Royal College of Anaesthetists, and grants from the Medical Research Council, UK, The Evelyn Trust, Queens' College, Cambridge, and the Cambridge Biomedical Research Centre.	[Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Beuth W, 2001, Neurol Neurochir Pol, V35 Suppl 5, P125; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Jaureguiberry MS, 2004, PEPTIDES, V25, P1133, DOI 10.1016/j.peptides.2004.04.005; Juvela S, 2000, J NEUROSURG, V92, P390, DOI 10.3171/jns.2000.92.3.0390; Kastner S, 2005, ACTA NEUROCHIR, V147, P1271, DOI 10.1007/s00701-005-0633-0; Kirilov G, 2003, EUR J ENDOCRINOL, V149, P549, DOI 10.1530/eje.0.1490549; Kleeberg J, 2004, AM J PHYSIOL-HEART C, V286, pH1339, DOI 10.1152/ajpheart.00227.2003; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; Maier B, 2007, SHOCK, V27, P610, DOI 10.1097/shk.0b013e31802f9eaf; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Menon DK, 2002, CLIN SCI, V103, p399S, DOI 10.1042/CS103S399S; Moldes O, 2008, STROKE, V39, P2006, DOI 10.1161/STROKEAHA.107.495044; Nakagomi S, 2000, NEUROSCIENCE, V101, P441, DOI 10.1016/S0306-4522(00)00345-6; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Rafols D, 2004, NEUROSCI LETT, V362, P154, DOI 10.1016/j.neulet.2004.03.021; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Siren AL, 2000, NEUROCHEM RES, V25, P957, DOI 10.1023/A:1007552408463; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Sutherland AJ, 2007, J HEART LUNG TRANSPL, V26, P1040, DOI 10.1016/j.healun.2007.07.013; Suzuki K, 2000, SURG NEUROL, V53, P131, DOI 10.1016/S0090-3019(99)00179-2; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	32	9	10	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2011	14	1					55	60		10.1007/s12028-010-9413-7			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	708WF	WOS:000286394300009	20652766				2022-02-06	
J	Shields, BJ; Burkett, E; Smith, GA				Shields, Brenda J.; Burkett, Elizabeth; Smith, Gary A.			Epidemiology of balcony fall-related injuries, United States, 1990-2006	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							CHILDHOOD INJURIES; ACCIDENTAL FALLS; WINDOW FALLS; CHILDREN; HEIGHTS; BUILDINGS; MORTALITY; SEVERITY; SURVEILLANCE; PATTERNS	Background: Falls from heights are common in urban areas in the United States. This study describes the epidemiology of balcony fall-related injuries requiring emergency department (ED) treatment among children and adults in the United States from 1990 through 2006. Methods: In 2009, a retrospective analysis of data from the National Electronic Injury Surveillance System of the US Consumer Product Safety Commission was conducted to describe the epidemiology of balcony fall-related injuries. Results: An estimated 86 500 (95% confidence interval [CI], 68 400-104 600) balcony fall-related injuries were treated in US hospital EDs from 1990 through 2006; 70% of cases were male; 63% were adults (>= 18 years old); 94% of injury events occurred at home; 24% of patients were hospitalized; and 8 patients died. The rate of balcony fall-related injuries among children decreased significantly during 1990 to 2006 and was similar to that of adults by the end of the study period. Fall heights ranged from 5 to 87.5 ft. Structural failure of the balcony was involved in an estimated 5600 cases. Patients younger than 18 years were more likely to sustain a concussion/closed head injury (relative risk, 2.42; 95% CI, 1.84-3.18) or skull fracture (relative risk, 5.86; 95% CI, 2.58-13.30) than adults. Conclusions: This is the first study of balcony fall-related injuries requiring emergency treatment using a nationally representative sample. Balcony falls are an important cause of injury in the United States. Age, male sex, and warm months of the year were associated with balcony fall-related injuries in our study population. (C) 2011 Elsevier Inc. All rights reserved.	[Shields, Brenda J.; Burkett, Elizabeth; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Shields, BJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA.	brenda.shields@nationwidechildrens.org					Agalar F, 1999, INT SURG, V84, P271; ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; Atanasijevic TC, 2005, J FORENSIC SCI, V50, P608; BARLOW B, 1983, J PEDIATR SURG, V18, P509, DOI 10.1016/S0022-3468(83)80210-3; Benoit R, 2000, J TRAUMA, V49, P477, DOI 10.1097/00005373-200009000-00015; BERGNER L, 1971, AM J PUBLIC HEALTH N, V61, P90, DOI 10.2105/AJPH.61.1.90; BIJUR PE, 1996, PEDIATR RES, V39, P102; Bull MJ, 2001, PEDIATRICS, V107, P1188, DOI 10.1542/peds.107.5.1188; Bulut M, 2006, EMERG MED J, V23, P540, DOI 10.1136/emj.2005.029439; *CDCP, 2006, WISQARS US UN INJ AL; Davis Y, 1996, J SAFETY RES, V27, P83, DOI 10.1016/0022-4375(96)00002-3; Demetriades D, 2005, J TRAUMA, V58, P342, DOI 10.1097/01.TA.0000135161.44100.D8; Flavin MP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-187; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; HEDGE A, 2007, REV FALL SAFETY CHIL; HINGSON R, 1987, J STUD ALCOHOL, V48, P212, DOI 10.15288/jsa.1987.48.212; Home Safety Council, 2008, NAT NONPR URG CAR PR; HOPKINS RS, 1989, AM J PREV MED, V5, P104, DOI 10.1016/S0749-3797(18)31112-7; Hussain N, 2007, ARCH DIS CHILD, V92, P90, DOI 10.1136/adc.2006.107219; Istre GR, 2003, INJURY PREV, V9, P349, DOI 10.1136/ip.9.4.349; Kohli A, 2006, MED SCI LAW, V46, P335, DOI 10.1258/rsmmsl.46.4.335; Lallier M, 1999, J PEDIATR SURG, V34, P1060, DOI 10.1016/S0022-3468(99)90564-X; LEHMAN D, 1993, PEDIATRICS, V92, P121; Lewis W S, 1965, J Trauma, V5, P812, DOI 10.1097/00005373-196511000-00018; LOWENSTEIN SR, 1989, ANN EMERG MED, V18, P161, DOI 10.1016/S0196-0644(89)80107-6; MATHIS RD, 1993, J TRAUMA, V34, P123, DOI 10.1097/00005373-199301000-00023; Mayer L, 2006, PEDIATR SURG INT, V22, P743, DOI 10.1007/s00383-006-1731-7; MIDDLETON KR, 2005, VITAL HLTH STAT, V366; MUSEMECHE CA, 1991, J TRAUMA, V31, P1347, DOI 10.1097/00005373-199110000-00004; O'Keefe JS, 1999, J EMERG MED, V17, P293, DOI 10.1016/S0736-4679(98)00165-6; Pressley JC, 2005, INJURY PREV, V11, P267, DOI 10.1136/ip.2004.007724; Randazzo C, 2009, ACAD EMERG MED, V16, P235, DOI 10.1111/j.1553-2712.2009.00352.x; Richter D, 1996, INJURY, V27, P655, DOI 10.1016/S0020-1383(96)00083-6; Sawyer JR, 2000, J PEDIATR ORTHOPED, V20, P197, DOI 10.1097/00004694-200003000-00013; Schroeder T., 2001, NEISS SAMPLE DESIGN; SPIEGEL CN, 1977, AM J PUBLIC HEALTH, V67, P1143, DOI 10.2105/AJPH.67.12.1143; Stone KE, 2000, J URBAN HEALTH, V77, P26, DOI 10.1007/BF02350960; *US BUR CENS, POP EST; Vish NL, 2005, INJURY PREV, V11, P300, DOI 10.1136/ip.2005.008664; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; Weir E, 2001, CAN MED ASSOC J, V165, P468; YAMAMOTO L G, 1991, Pediatric Emergency Care, V7, P267, DOI 10.1097/00006565-199110000-00002	42	9	9	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	FEB	2011	29	2					174	180		10.1016/j.ajem.2009.08.023			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	718QG	WOS:000287139800007	20825783				2022-02-06	
J	Constantinidou, F; Danos, MA; Nelson, D; Baker, S				Constantinidou, Fofi; Danos, Molly A.; Nelson, Daniel; Baker, Susan			Effects of Modality Presentation on Working Memory in School-age Children: Evidence for the Pictorial Superiority Hypothesis	CHILD NEUROPSYCHOLOGY			English	Article						Stimulus modality; Working memory; Verbal learning; Depression; Children; Age effects	VERBAL-LEARNING PERFORMANCE; CLOSED-HEAD INJURY; INDIVIDUAL-DIFFERENCES; STIMULUS MODALITY; PSYCHIATRIC SAMPLE; CAPACITY THEORY; CARPENTER 1992; BRAIN-INJURY; DEPRESSION; LANGUAGE	This study investigated the effects of stimulus presentation modality on working memory performance in elementary school-age children ages 7-13. The experimental paradigm implemented a multitrial learning task incorporating three presentation modalities: Auditory, Visual, and simultaneous Auditory plus Visual. The first experiment compared the learning and memory performance of older and younger elementary school children. The second experiment compared verbal learning and memory performance in elementary school children with major depressive disorder (MDD) to the performance of nondepressed children. All participants benefited from the pictorial presentation of information during learning and recall of information as compared to the auditory presentation alone. Both age and socioeconomic status affected working memory performance in typically developing children. Children with depression demonstrated a more passive learning style during the auditory list acquisition. The present study supports the pictorial superiority hypothesis in verbal learning tasks and the theory that working memory matures during elementary school years. Furthermore, current results indicate that complex working memory measures are not entirely independent of previous experience.	[Constantinidou, Fofi] Univ Cyprus, Dept Psychol, CY-1678 Nicosia, Cyprus; [Danos, Molly A.] Douglas Country Sch Dist, Castle Rock, CO USA; [Nelson, Daniel] Childrens Hosp, Med Ctr, Div Psychiat, Cincinnati, OH 45229 USA; [Baker, Susan] Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA		Constantinidou, F (corresponding author), Univ Cyprus, Dept Psychol, 75 Kallipoleos St,POB 20537, CY-1678 Nicosia, Cyprus.	fofic@ucy.ac.cy		Constantinidou, Fofi/0000-0002-7928-8363			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2002, NEUROPSYCHOLOGIA, V40, P1737, DOI 10.1016/S0028-3932(01)00146-4; BADDELEY A, 1988, J MEM LANG, V27, P586, DOI 10.1016/0749-596X(88)90028-9; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1986, WORKING MEMORY; Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851; Baddeley Alan, 1995, P755; Basso MR, 1999, NEUROPSYCHOLOGY, V13, P69, DOI 10.1037/0894-4105.13.1.69; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; Colflesh GJH, 2007, PSYCHON B REV, V14, P699, DOI 10.3758/BF03196824; Constantinidou F, 1999, J MED SPEECH-LANG PA, V7, P283; Constantinidou F, 1996, J GEN PSYCHOL, V123, P173, DOI 10.1080/00221309.1996.9921270; Constantinidou F, 2002, BRAIN LANG, V82, P296, DOI 10.1016/S0093-934X(02)00018-4; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; Constantinidou F., 1998, HEARSAY, V12, P20; CONSTANTINIDOU F, 2008, FORENSIC EVALUATION, P91; Constantinidou F, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P549, DOI 10.1201/9781439849828-c18; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Cummings J., 2003, NEUROPSYCHIATRY BEHA; Delis DC., 1994, CALIFORNIA VERBAL LE; Egeland J, 2005, SCAND J PSYCHOL, V46, P201, DOI 10.1111/j.1467-9450.2005.00449.x; ELBERT M, 1980, CONTRASTS PICTURE FI; Engel PMJ, 2008, J SPEECH LANG HEAR R, V51, P1580, DOI 10.1044/1092-4388(2008/07-0210); FARAH MJ, 1988, PSYCHOL REV, V95, P307, DOI 10.1037/0033-295X.95.3.307; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Herrmann D, 1997, APPL COGNITIVE PSYCH, V11, P113, DOI 10.1002/(SICI)1099-0720(199704)11:2<113::AID-ACP424>3.0.CO;2-F; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; KAUFMAN J, 1996, KIDDIE SADS PRESENT; King DA, 1998, J INT NEUROPSYCH SOC, V4, P115, DOI 10.1017/S1355617798001155; Kovacs M, 1985, CHILDHOOD DEPRESSION; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Landro NI, 2001, NEUROPSY NEUROPSY BE, V14, P233; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Montgomery JW, 2010, AM J SPEECH-LANG PAT, V19, P78, DOI 10.1044/1058-0360(2009/09-0028); Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; O'Jile JR, 2005, ARCH CLIN NEUROPSYCH, V20, P547, DOI 10.1016/j.acn.2004.12.001; ODONNELL JP, 1988, J GEN PSYCHOL, V115, P335; OOSTROM I, 2003, PSYCHIAT RES, V117, P25; PAPAGNO C, 1991, J MEM LANG, V30, P331, DOI 10.1016/0749-596X(91)90040-Q; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Sander AM, 2007, AM J SPEECH-LANG PAT, V16, P316, DOI 10.1044/1058-0360(2007/036); Schacter D. L., 1994, MEMORY SYSTEMS 1994; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Swanson HL, 1999, DEV PSYCHOL, V35, P986, DOI 10.1037/0012-1649.35.4.986; TANCER ME, 1990, PSYCHIAT RES, V31, P161, DOI 10.1016/0165-1781(90)90118-O; THOMPSON VA, 1994, CAN J EXP PSYCHOL, V48, P380, DOI 10.1037/1196-1961.48.3.380; Thorndike E. L., 1944, TEACHERS BOOK 30000; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Waters GS, 1996, PSYCHOL REV, V103, P761, DOI 10.1037/0033-295X.103.4.761; WECKOWICZ TE, 1972, CAN PSYCHIAT ASSOC J, V17, pS241; Weiland-Fiedler P, 2004, J AFFECT DISORDERS, V82, P253, DOI 10.1016/j.jad.2003.10.009	63	9	9	0	14	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2011	17	2					173	196	PII 932766173	10.1080/09297049.2010.525503			24	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	724MW	WOS:000287581600005	21271411				2022-02-06	
J	Costa, HC; Moreira, RJ; Fukunaga, P; Fernandes, RC; Boni, RC; Matos, AC				Costa, H. C.; Moreira, R. J.; Fukunaga, P.; Fernandes, R. C.; Boni, R. C.; Matos, A. C.			Anatomic Variations in Vascular and Collecting Systems of Kidneys From Deceased Donors	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	9th Luso Brazilian Congress of Transplant	OCT 02-05, 2010	Porto, PORTUGAL				ADDITIONAL RENAL-ARTERIES	Introduction. Nephroureterectomy for transplantation has increased owing to the greater number of deceased donors. Anatomic variations may complicate the procedure or, if unrecognized, compromise the viability of kidneys for transplantation. Methods. We reviewed 254 surgical descriptions of nephroureterectomy specimens from January 2008 to December 2009. All organs collected according by standard techniques were evaluated for age, cause of death, renal function, frequency of injury during the procedure, as well as variations in the vascular and collecting systems. Results. The mean donor age was 42 years (range, 2-74). The mean serum creatinine was 1.2 mg/dL (range, 1.0-7.0). The causes of death were cerebrovascular cause (stroke; n = 130), traumatic brain injury (n = 81) or other cause (n = 43). Among the anatomic variations: 8.6% (n = 22) were right arterial anatomical variations: 19 cases with 2 arteries and 3 cases with 3 arteries. In 25 cases (9.8%) the identified variation was the left artery: 2 arteries (n = 23), 3 arteries (n = 1) and 4 arteries (n = 1). We observed 9.8% on right side and 1.5% on left side venous anatomic variations, including 24 cases with 2 veins on the right side and 4 cases with 2 veins on the left side. Three cases of a retroaortic left renal vein and 1 case of a retro necklace vein (anterior and posterior to the aorta). Two cases of ureteral duplication were noted on the left and 1 on the right kidney. There were 3 horseshoe and 1 pelvic kidney. In 7.5% of cases, an injury to the graft included ureteral (n = 3), arterial (n = 10), or venous (n = 6). Conclusion. The most common anatomic variation was arterial (17.8%). Duplication of the renal vein was more frequent on the right. The high incidences of anatomic variations require more attention in the dissection of the renal hilum to avoid an injury that may compromise the graft.	[Costa, H. C.; Moreira, R. J.; Fernandes, R. C.; Matos, A. C.] Santa Casa Sao Paulo, Dept Urol Surg, Sao Paulo, Brazil; [Fukunaga, P.; Boni, R. C.] Santa Casa Misericordia Sao Paulo, Serv Captacao, Sao Paulo, Brazil		Costa, HC (corresponding author), Fortunato 252,Ap 34, BR-01224030 Sao Paulo, Brazil.	Hallison_castro@hotmail.com	Matos, Andre C/P-1045-2015	Matos, Andre C/0000-0002-5385-2253			Chai JW, 2008, KOREAN J RADIOL, V9, P333, DOI 10.3348/kjr.2008.9.4.333; HARRISON LH, 1978, ANN SURG, V188, P83, DOI 10.1097/00000658-197807000-00014; Janschek ECS, 2004, UROLOGY, V63, P660, DOI 10.1016/j.urology.2003.11.010; Saldarriaga B., 2008, Folia Morphologica, V67, P129; Satyapal KS, 1999, SURG RADIOL ANAT, V21, P77, DOI 10.1007/BF01635058; Satyapal KS, 2001, SURG RADIOL ANAT, V23, P33, DOI 10.1007/s00276-001-0033-y	6	9	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	JAN-FEB	2011	43	1					61	63		10.1016/j.transproceed.2010.12.013			3	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	725XB	WOS:000287679100009	21335155				2022-02-06	
J	Denman, A; Wilkinson, R				Denman, Ashleigh; Wilkinson, Ray			Applying conversation analysis to traumatic brain injury: investigating touching another person in everyday social interaction	DISABILITY AND REHABILITATION			English	Article						Touching; traumatic brain injury; conversation	BEHAVIOR	Purpose. Touching others, particularly the opposite sex, is a relatively common and problematic behaviour evident in many people with traumatic brain injury (TBI), in particular males. Here, we analyse this behaviour in a man with TBI (Richard) who regularly engages in inappropriate touching of women. The article draws on video-recordings of two naturally occurring social interactions between Richard and Joan (one of his carers) to analyse all six instances within these interactions where Richard touches Joan. Method. The recordings were made by leaving a video-recorder in Richard's home where he is supported by members of a care team. The socio-linguistic method of conversation analysis was used to transcribe and analyse the data. Results. The analysis shows that each of the six instances of the touching behaviour occurred not as a random or isolated event in the interaction but rather in accompaniment with talk as part of a particular conversational action. Specifically, the conversational action in each case was produced in an emphatic or heightened style, with this style constituted by Richard touching Joan as well as by his use of a number of other resources such as eye gaze and the use of stress. Conclusions. The analysis suggests that the touching behaviours in this case were linked not so much to physical opportunities (which were available through much of these interactions) but rather to what conversational action was being produced at that particular sequential context within the interaction. For example, several instances of touching occurred as part of emphatically produced conversational actions where a previous, non-emphatic, production of that action had not been accepted or responded to by Joan. Clinical implications, such as suggestions for prophylactic management on the part of those interacting with people with TBI, are discussed.	[Wilkinson, Ray] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Denman, Ashleigh] Gloucestershire Royal Hosp, Brain Injury Team, Gloucester GL1 3NN, England		Wilkinson, R (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	ray.wilkinson@manchester.ac.uk			Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/F029225/1] Funding Source: researchfish; ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/F029225/1] Funding Source: UKRI		Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Dickerson R, 2007, GESTURE, V7, P271; Edwards D, 2000, RES LANG SOC INTERAC, V33, P347, DOI 10.1207/S15327973RLSI3304_01; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Goodwin C., 2000, LANGUAGE CULTURE COG, P84, DOI DOI 10.1017/CBO9780511620850.006; HERITAGE J, 1988, ANAL EVERYDAY EXPLAN, P00127; Hutchby I., 2008, CONVERSATION ANAL, V2nd edn.; Johnson C, 2006, BRAIN INJURY, V20, P687, DOI 10.1080/02699050600744137; Lawrie Barbara, 2004, Rehabil Nurs, V29, P9; LeBaron Curtis, EMBODIED IN IN PRESS; Schegloff EA, 2005, DISCOURSE STUD, V7, P455, DOI 10.1177/1461445605054402; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P1, DOI 10.2277/ 0521532795; Wilkinson R., 2008, HDB CLIN LINGUISTICS, P92, DOI [10.1002/9781444301007.ch6, DOI 10.1002/9781444301007.CH6]	14	9	9	0	12	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2011	33	3					243	252		10.3109/09638288.2010.511686			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	697XR	WOS:000285553600009	21171839				2022-02-06	
B	Hanly, JG		Lahita, RG		Hanly, John G.			The Nervous System and Lupus	SYSTEMIC LUPUS ERYTHEMATOSUS, 5TH EDITION			English	Article; Book Chapter							GLUTAMATE-RECEPTOR ANTIBODIES; EMISSION COMPUTED-TOMOGRAPHY; RIBOSOMAL-P AUTOANTIBODIES; TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE; COGNITIVE FUNCTION; NEUROPSYCHIATRIC EVENTS; MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGICAL ASSESSMENT; INTRAVENOUS CYCLOPHOSPHAMIDE		[Hanly, John G.] Dalhousie Univ, Halifax, NS B3H 3J5, Canada								Ainiala H, 2001, ARTHRIT RHEUM-ARTHR, V45, P419, DOI 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X; Amit M, 1999, CLIN EXP RHEUMATOL, V17, P467; Arinuma Y, 2008, ARTHRITIS RHEUM-US, V58, P1130, DOI 10.1002/art.23399; Arnett FC, 1996, ARTHRITIS RHEUM, V39, P1833, DOI 10.1002/art.1780391109; Baca V, 1999, J RHEUMATOL, V26, P432; BARILE L, 1992, J RHEUMATOL, V19, P370; Barile-Fabris L, 2005, ANN RHEUM DIS, V64, P620, DOI 10.1136/ard.2004.025528; BELL CL, 1991, ARTHRITIS RHEUM, V34, P432, DOI 10.1002/art.1780340408; Belmont HM, 1996, ARTHRITIS RHEUM-US, V39, P9, DOI 10.1002/art.1780390103; BENCHETRIT E, 1990, CLIN EXP RHEUMATOL, V8, P71; Benzo R, 2000, J Cardiopulm Rehabil, V20, P231, DOI 10.1097/00008483-200007000-00003; Birnbaum J, 2007, ARTHRIT RHEUM-ARTHR, V57, P347, DOI 10.1002/art.22540; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; BLOCH SL, 1979, NEUROLOGY, V29, P1633, DOI 10.1212/WNL.29.12.1633-a; Bodani M, 2003, LUPUS, V12, P947, DOI 10.1191/0961203303lu507oa; Boers M, 2003, ARTHRITIS RHEUM, V48, P1771, DOI 10.1002/art.11156; BONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503; Bosma GPT, 2003, AM J NEURORADIOL, V24, P850; Bosma GPT, 2002, ARTHRITIS RHEUM, V46, P2665, DOI 10.1002/art.10574; Bosma GPT, 2000, ARTHRITIS RHEUM-US, V43, P48, DOI 10.1002/1529-0131(200001)43:1<48::AID-ANR7>3.0.CO;2-H; Bosma GPT, 2000, ARTHRITIS RHEUM-US, V43, P2428, DOI 10.1002/1529-0131(200011)43:11<2428::AID-ANR9>3.0.CO;2-H; BOUMPAS DT, 1991, Q J MED, V81, P975, DOI 10.1093/qjmed/81.3.975; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Briani C, 2009, J AUTOIMMUN, V32, P79, DOI 10.1016/j.jaut.2008.12.002; Brooks WM, 1999, J RHEUMATOL, V26, P81; CARBOTTE RM, 1995, J RHEUMATOL, V22, P863; CARBOTTE RM, 1986, J NERV MENT DIS, V174, P357, DOI 10.1097/00005053-198606000-00008; Carlomagno S, 2000, J NEUROL, V247, P273, DOI 10.1007/s004150050583; CAULI A, 1994, CLIN RHEUMATOL, V13, P615, DOI 10.1007/BF02243004; Cervera R, 1997, MEDICINE, V76, P203, DOI 10.1097/00005792-199705000-00006; CODDING C, 1991, ARTHRITIS RHEUM, V34, P1340; Crowther MA, 2003, NEW ENGL J MED, V349, P1133, DOI 10.1056/NEJMoa035241; Cush JJ, 2007, J RHEUMATOL, V34, P1; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; DENBURG SD, 1994, ARTHRITIS RHEUM, V37, P1311, DOI 10.1002/art.1780370907; DENBURG SD, 1987, J CLIN EXP NEUROPSYC, V9, P323, DOI 10.1080/01688638708405054; Denburg SD, 2003, LUPUS, V12, P883, DOI 10.1191/0961203303lu497oa; Denburg SD, 1997, J RHEUMATOL, V24, P998; DiFrancesco MW, 2007, ARTHRITIS RHEUM-US, V56, P4151, DOI 10.1002/art.23132; Diwadkar VA, 2002, J PSYCHOSOM RES, V53, P677, DOI 10.1016/S0022-3999(02)00422-1; Doraiswamy PM, 2004, NEUROLOGY, V63, P1552, DOI 10.1212/01.WNL.0000146628.30692.15; ELLIS SG, 1979, SEMIN ARTHRITIS RHEU, V8, P212, DOI 10.1016/S0049-0172(79)80009-8; ESCALANTE A, 1992, J RHEUMATOL, V19, P800; EYANSON S, 1980, ANN RHEUM DIS, V39, P377, DOI 10.1136/ard.39.4.377; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FEINGLASS EJ, 1976, MEDICINE, V55, P323, DOI 10.1097/00005792-197607000-00004; Fernandez-Nebro A, 1999, LUPUS, V8, P151, DOI 10.1191/096120399678847443; FISK JD, 1993, BRIT J RHEUMATOL, V32, P458; Fitzgibbon BM, 2008, RHEUMATOLOGY, V47, P50, DOI 10.1093/rheumatology/kem287; Galindo-Rodriguez G, 1999, AM J MED, V106, P65, DOI 10.1016/S0002-9343(98)00372-6; Ganly JG, 2005, RHEUM DIS CLIN N AM, V31, P273, DOI 10.1016/j.rdc.2005.01.007; Gerli R, 2002, RHEUMATOLOGY, V41, P1357, DOI 10.1093/rheumatology/41.12.1357; GILBERT GJ, 1989, SOUTHERN MED J, V82, P514, DOI 10.1097/00007611-198904000-00025; GINSBURG KS, 1992, ARTHRITIS RHEUM, V35, P776, DOI 10.1002/art.1780350711; GonzalezCrespo MR, 1995, BRIT J RHEUMATOL, V34, P1055; Gorman C, 2004, LUPUS, V13, P312, DOI 10.1191/0961203304lu1018oa; Graham JW, 2003, LUPUS, V12, P891, DOI 10.1191/0961203303lu498oa; GRINLINTON FM, 1991, ARTHRITIS RHEUM, V34, P916, DOI 10.1002/art.1780340719; Hanly JG, 2008, ARTHRIT RHEUM-ARTHR, V59, P721, DOI 10.1002/art.23566; Hanly JG, 2008, ARTHRITIS RHEUM-US, V58, P843, DOI 10.1002/art.23218; Hanly JG, 2007, ARTHRITIS RHEUM-US, V56, P265, DOI 10.1002/art.22305; Hanly JG, 2010, ANN RHEUM DIS, V69, P529, DOI 10.1136/ard.2008.106351; Hanly JG, 2008, LUPUS, V17, P1059, DOI 10.1177/0961203308097568; HANLY JG, 1994, J RHEUMATOL, V21, P1825; HANLY JG, 1992, J RHEUMATOL, V19, P732; Hanly JG, 2005, J RHEUMATOL, V32, P1459; Hanly JG, 2004, J RHEUMATOL, V31, P2156; Hanly JG, 1999, ARTHRITIS RHEUM, V42, P728, DOI 10.1002/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O; HANLY JG, 1992, J RHEUMATOL, V19, P562; Hanly JG, 2003, CAN MED ASSOC J, V168, P1675; Hanly JG, 1997, ANN NY ACAD SCI, V823, P60, DOI 10.1111/j.1749-6632.1997.tb48379.x; Hanly JG, 1997, ARTHRITIS RHEUM, V40, P1542, DOI 10.1002/art.1780400825; HANLY JG, 1994, LUPUS, V3, P193, DOI 10.1177/096120339400300311; Hanly JG, 1998, BAILLIERE CLIN RHEUM, V12, P415, DOI 10.1016/S0950-3579(98)80028-9; HANLY JG, 1993, BRIT J RHEUMATOL, V32, P291; Hanly John G, 2007, Curr Rheumatol Rep, V9, P116, DOI 10.1007/s11926-007-0005-2; Hanly JG, 2006, J RHEUMATOL, V33, P1553; Hanly JG, 2010, ARTHRITIS RHEUM-US, V62, P1478, DOI 10.1002/art.27404; Hanly JG, 2009, J RHEUMATOL, V36, P1449, DOI 10.3899/jrheum.081133; Harrison M.J., 2003, ARTHRITIS RHEUMATISM, V49, pS1058; Harrison M.J., 2003, ARTHRITIS RHEUMATISM, V49, pS1685; Harrison MJ, 2006, ARTHRITIS RHEUM, V54, P2515, DOI 10.1002/art.22030; Harrison MJ, 2004, ARTHRITIS RHEUM, V50, pS242; HAY EM, 1992, ARTHRITIS RHEUM, V35, P411, DOI 10.1002/art.1780350409; HAY EM, 1994, ANN RHEUM DIS, V53, P298, DOI 10.1136/ard.53.5.298; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; HOW A, 1985, ARTHRITIS RHEUM, V28, P789, DOI 10.1002/art.1780280710; Huizinga TWJ, 2001, CURR OPIN RHEUMATOL, V13, P383, DOI 10.1097/00002281-200109000-00007; Jennekens FGI, 2002, RHEUMATOLOGY, V41, P605, DOI 10.1093/rheumatology/41.6.605; JOHNSON RT, 1968, MEDICINE, V47, P337, DOI 10.1097/00005792-196807000-00002; Jonsen A, 2002, RHEUMATOLOGY, V41, P1308, DOI 10.1093/rheumatology/41.11.1308; JONSSON H, 1989, MEDICINE, V68, P141, DOI 10.1097/00005792-198905000-00002; Kanekura Takuro, 1993, Journal of Dermatology (Tokyo), V20, P566; Karassa FB, 2000, AM J MED, V109, P628, DOI 10.1016/S0002-9343(00)00603-3; Karassa FB, 2006, ARTHRITIS RHEUM-US, V54, P312, DOI 10.1002/art.21539; Karlson EW, 2004, ARTHRITIS RHEUM, V50, P1832, DOI 10.1002/art.20279; Katzav A, 2003, LUPUS, V12, P903, DOI 10.1191/0961203303lu500oa; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; Khanna D, 2005, J RHEUMATOL, V32, P832; KOREN E, 1992, J CLIN INVEST, V89, P1236, DOI 10.1172/JCI115707; Kovacs B, 2000, ANN RHEUM DIS, V59, P120, DOI 10.1136/ard.59.2.120; KOVACS JAJ, 1993, RHEUM DIS CLIN N AM, V19, P795; KOVACS JAJ, 1995, J RHEUMATOL, V22, P1247; Kozora E, 1996, ARTHRITIS RHEUM, V39, P2035, DOI 10.1002/art.1780391213; Krupp LB, 2004, NEUROLOGY, V63, P1579, DOI 10.1212/01.WNL.0000142989.09633.5A; Kur JK, 2006, J RHEUMATOL, V33, P2178; LANCMAN ME, 1989, CAN J NEUROL SCI, V16, P354, DOI 10.1017/S0317167100029231; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Leung FK, 2003, J RHEUMATOL, V30, P1871; Levinson D, 2005, ARCH CLIN NEUROPSYCH, V20, P403, DOI 10.1016/j.acn.2004.09.001; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Lewis M, 2003, LUPUS, V12, P857, DOI 10.1191/0961203303lu464cr; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; LIOTE F, 1994, ANN RHEUM DIS, V53, P671, DOI 10.1136/ard.53.10.671; LOWE LP, 1994, DIABETES CARE, V17, P891, DOI 10.2337/diacare.17.8.891; MartinezTaboada VM, 1996, LUPUS, V5, P74, DOI 10.1177/096120339600500114; Matus S, 2007, J EXP MED, V204, P3221, DOI 10.1084/jem.20071285; MCCUNE WJ, 1988, NEW ENGL J MED, V318, P1423, DOI 10.1056/NEJM198806023182203; MCCUNE WJ, 1988, ARTHRITIS RHEUM-US, V31, P159, DOI 10.1002/art.1780310202; McLaurin EY, 2005, NEUROLOGY, V64, P297, DOI 10.1212/01.WNL.0000149640.78684.EA; Menon S, 1999, ARTHRITIS RHEUM-US, V42, P735, DOI 10.1002/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L; Mitsikostas DD, 2004, BRAIN, V127, P1200, DOI 10.1093/brain/awh146; MODY GM, 1994, BRIT J RHEUMATOL, V33, P1151; Mok CC, 2003, AM J MED, V115, P59, DOI 10.1016/S0002-9343(03)00135-9; Mok CC, 1998, J RHEUMATOL, V25, P467; Moritani T, 2001, ACAD RADIOL, V8, P741, DOI 10.1016/S1076-6332(03)80581-0; NEUWELT CM, 1995, AM J MED, V98, P32, DOI 10.1016/S0002-9343(99)80078-3; NOSSENT JC, 1991, ARTHRITIS RHEUM-US, V34, P1397; Oku K, 2003, RHEUMATOLOGY, V42, P773, DOI 10.1093/rheumatology/keg216; Omdal R, 2005, EUR J NEUROL, V12, P392, DOI 10.1111/j.1468-1331.2004.00976.x; Omdal R, 2001, ACTA NEUROL SCAND, V103, P386, DOI 10.1034/j.1600-0404.2001.103006386.x; Peterson PL, 2003, LUPUS, V12, P897, DOI 10.1191/0961203303lu499oa; Petri M, 2008, J RHEUMATOL, V35, P1776; Prince MJ, 1996, BMJ-BRIT MED J, V312, P801; Ramos PC, 1996, CLIN EXP RHEUMATOL, V14, P295; Raskin N., 1998, HARRISONS PRINCIPLES, V14, P68; Reeves D.L., 1996, NCRFSR9601 NAT COGN; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reicker LI, 2007, ARCH CLIN NEUROPSYCH, V22, P655, DOI 10.1016/j.acn.2007.04.008; Roebuck-Spencer TM, 2006, ARTHRIT RHEUM-ARTHR, V55, P434, DOI 10.1002/art.21992; ROGERS MP, 1992, LUPUS, V1, P215, DOI 10.1177/096120339200100404; Rovaris M, 2000, J NEUROL NEUROSUR PS, V68, P170, DOI 10.1136/jnnp.68.2.170; RUBBERT A, 1993, ARTHRITIS RHEUM-US, V36, P1253, DOI 10.1002/art.1780360910; Sabet A, 1998, STROKE, V29, P2254, DOI 10.1161/01.STR.29.11.2254; Saito K, 2003, LUPUS, V12, P798, DOI 10.1191/0961203303lu450xx; SAMANTA A, 1991, ANN RHEUM DIS, V50, P490, DOI 10.1136/ard.50.7.490; Sanchez ML, 2004, ARTHRITIS RHEUM, V50, pS242; Sanna G, 2003, J RHEUMATOL, V30, P985; Sanna G, 2003, RHEUMATOLOGY, V42, P200, DOI 10.1093/rheumatology/keg080; Santer DM, 2009, J IMMUNOL, V182, P1192, DOI 10.4049/jimmunol.182.2.1192; SCHNEEBAUM AB, 1991, AM J MED, V90, P54, DOI 10.1016/0002-9343(91)90506-S; Sfikakis PP, 1998, BRIT J RHEUMATOL, V37, P300; Sibbitt WL, 1999, ARTHRITIS RHEUM-US, V42, P2026, DOI 10.1002/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J; Sibbitt WL, 2003, J RHEUMATOL, V30, P1983; Sibbitt WL, 2002, J RHEUMATOL, V29, P1536; SIBLEY JT, 1992, J RHEUMATOL, V19, P47; Steens SCA, 2003, ANN RHEUM DIS, V62, P583, DOI 10.1136/ard.62.6.583; Stein CM, 1996, ARTHRITIS RHEUM, V39, P461; STIMMLER MM, 1993, SEMIN ARTHRITIS RHEU, V22, P335, DOI 10.1016/S0049-0172(05)80012-5; Straub RH, 1996, J RHEUMATOL, V23, P87; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; TEH LS, 1994, ARTHRITIS RHEUM-US, V37, P307, DOI 10.1002/art.1780370303; Tokunaga M, 2007, ANN RHEUM DIS, V66, P470, DOI 10.1136/ard.2006.057885; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Trevisani V.F., 2000, COCHRANE DATABASE SY, V3; van Laarhoven HWM, 2001, NEPHROL DIAL TRANSPL, V16, P840, DOI 10.1093/ndt/16.4.840; Wajed J, 2004, RHEUMATOLOGY, V43, P7, DOI 10.1093/rheumatology/keg436; Waterloo K, 2002, RHEUMATOLOGY, V41, P411, DOI 10.1093/rheumatology/41.4.411; Waterloo K, 2001, J NEUROL, V248, P595, DOI 10.1007/s004150170138; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; WEKKING EM, 1991, PSYCHOTHER PSYCHOSOM, V55, P126, DOI 10.1159/000288419; WEST SG, 1994, RHEUM DIS CLIN N AM, V20, P129; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Yoshio T, 2006, ARTHRITIS RHEUM, V54, P675, DOI 10.1002/art.21547	177	9	9	0	1	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-08-096171-2; 978-0-12-374994-9				2011							727	746					20	Rheumatology	Book Citation Index – Science (BKCI-S)	Rheumatology	BEG25	WOS:000316462800043					2022-02-06	
J	Hassan, STS; Khaw, WF; Rosna, AR; Husna, J				Hassan, S. T. S.; Khaw, W. F.; Rosna, A. R.; Husna, J.			Traumatic Brain Injury: Caregivers' Problems and Needs	JOURNAL OF NEPAL MEDICAL ASSOCIATION			English	Article						caregivers; rehabilitation; traumatic brain injury	FAMILY CAREGIVERS	Traumatic brain injury (TBI) is an increasingly major world health problem. This short review using the most pertinent articles on TBI caregiving problems and needs highlights the pressing issues. Articles focusing on both TBI-caregivers' problems and needs are rarely found, especially for developing countries. Most TBI-caregiving is done by family members, whose altered lives portend burden and stresses which add to the overwhelming demand of caring for the TBI-survivor. Lack of information, financial inadequacy, anxiety, distress, coping deficits, poor adaptability, inadequate knowledge and skills, and a poor support system comprise the major problems. Dysfunctional communication between caregivers and care-receivers has been little researched. The major needs are focused on health and rehabilitation information, financial advice and assistance, emotional and social support, and positive psychological encouragement. In time, health information needs may be met, but not emotional support. Information on TBI caregiving problems and unmet needs is critical to all relevant healthcare stakeholders.	[Hassan, S. T. S.; Khaw, W. F.; Rosna, A. R.] Univ Putra Malaysia, Dept Med, Fac Med & Hlth Sci, Upm Serdang 43400, Malaysia; [Husna, J.] Univ Teknol MARA, Dept Comp Sci, Fac Informat Technol & Quantitat Sci, Shah Alam, Malaysia		Hassan, STS (corresponding author), Univ Putra Malaysia, Dept Med, Fac Med & Hlth Sci, Upm Serdang 43400, Malaysia.	tajuddin@medic.upm.edu.my		Khaw, Wan-Fei/0000-0002-0979-8819			Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Blake H, 2008, INT J THER REHABIL, V15, P263, DOI 10.12968/ijtr.2008.15.6.29878; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Bradley SE, 2009, J NEURO-ONCOL, V93, P333, DOI 10.1007/s11060-008-9778-z; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Marwitz J, 2000, FAILY NEEDS QUESTION; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Phelps AC, 2009, JAMA-J AM MED ASSOC, V301, P1140, DOI 10.1001/jama.2009.341; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002	10	9	9	0	16	NEPAL MEDICAL ASSOC	KATHMANDU	NMA BUILDING, SIDDIHI SADAN, PO BOX 189, EXHIBITION RD, KATHMANDU, 00000, NEPAL	0028-2715			J NEPAL MED ASSOC	J. Nepal Med. Assoc.	JAN-MAR	2011	50	1					53	55					3	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	905GR	WOS:000301260800012	22335097				2022-02-06	
J	Lin, K; Taylor, MJ; Heaton, R; Franklin, D; Jernigan, T; Fennema-Notestine, C; McCutchan, A; Atkinson, JH; Ellis, RJ; McArthur, J; Morgello, S; Simpson, D; Collier, AC; Marra, C; Gelman, B; Clifford, D; Grant, I				Lin, Kenny; Taylor, Michael J.; Heaton, Robert; Franklin, Donald; Jernigan, Terry; Fennema-Notestine, Christine; McCutchan, Allen; Atkinson, J. Hampton; Ellis, Ronald J.; McArthur, Justin; Morgello, Susan; Simpson, David; Collier, Ann C.; Marra, Christina; Gelman, Benjamin; Clifford, David; Grant, Igor		CHARTER Grp	Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Head injury; HIV associated neurocognitive disorder; Neuropsychological performance; Magnetic resonance spectroscopy; N-acetylaspartate	NEUROPSYCHOLOGICAL PERFORMANCE; BARRIER; DEPRESSION; SEQUELAE	We explored the possible augmenting effect of traumatic brain injury (TBI) history on HIV (human immunodeficiency virus) associated neurocognitive complications. HIV-infected participants with self-reported history of definite TBI were compared to HIV patients without TBI history. Groups were equated for relevant demographic and HIV-associated characteristics. The TBI group evidenced significantly greater deficits in executive functioning and working memory. N-acetylaspartate, a putative marker of neuronal integrity, was significantly lower in the frontal gray matter and basal ganglia brain regions of the TBI group. Together, these results suggest an additional brain impact of TBI over that from HIV alone. One clinical implication is that HIV patients with TBI history may need to be monitored more closely for increased risk of HIV-associated neurocognitive disorder signs or symptoms.	[Grant, Igor] Univ Calif San Diego, Sch Med, Dept Psychiat 0680, La Jolla, CA 92093 USA; [McArthur, Justin] Johns Hopkins Univ, Baltimore, MD USA; [Morgello, Susan; Simpson, David] Mt Sinai Sch Med, New York, NY USA; [Collier, Ann C.; Marra, Christina] Univ Washington, Seattle, WA 98195 USA; [Gelman, Benjamin] Univ Texas Med Branch, Galveston, TX USA; [Clifford, David] Washington Univ, St Louis, MO USA		Grant, I (corresponding author), Univ Calif San Diego, Sch Med, Dept Psychiat 0680, La Jolla, CA 92093 USA.	igrant@ucsd.edu	Ellis, Ronald/K-3543-2015	Ellis, Ronald/0000-0003-4931-752X; Fennema-Notestine, Christine/0000-0002-6527-6361	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [N01 MH22005]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [N01MH022005, P30MH062512] Funding Source: NIH RePORTER	CNS HIV Antiretroviral Therapy Effects Research (CHARTER) is supported by award N01 MH22005 from the National Institutes of Health.	ADAMS KM, 1986, J CLIN EXP NEUROPSYC, V8, P362, DOI 10.1080/01688638608401327; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; *CDC, 2009, HIV AIDS BAS STAT; *CDC, 2009, TRAUM BRAIN INJ; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chelune GJ, 1986, ADV CLIN NEUROPSYCHO, V3, P95, DOI [10.1007/978-1-4613-2211-5_4, DOI 10.1007/978-1-4613-2211-5_4]; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; COHEN J, 1988, STAT POWER ANAL BEHA, pR21; Cooper L, 1998, J PSYCHIATR RES, V32, P361, DOI 10.1016/S0022-3956(98)00021-1; FAY TB, 2009, J INT NEUROPSYCH SOC, V19, P1; Formisano R, 2009, MED SCI MONITOR, V15, pCR101; Grant I, 2008, INT REV PSYCHIATR, V20, P33, DOI 10.1080/09540260701877894; GREENWOOD J, 1991, NEURORADIOLOGY, V33, P95, DOI 10.1007/BF00588242; Heaton R. K., 2004, REVISED COMPREHENSIV; Hernandez TD, 2006, J NEUROTRAUM, V23, P1211, DOI 10.1089/neu.2006.23.1211; HESTAD K, 1995, SCAND J PSYCHOL, V36, P246, DOI 10.1111/j.1467-9450.1995.tb00984.x; Jaffe MP, 2000, BRAIN INJURY, V14, P35, DOI 10.1080/026990500120916; KEOGH BK, 1980, J ABNORM CHILD PSYCH, V8, P21, DOI 10.1007/BF00918159; Moody DM, 2006, SEMIN CARDIOTHORAC V, V10, P128, DOI 10.1177/1089253206288992; Paul RH, 2007, J NEUROPSYCH CLIN N, V19, P283, DOI 10.1176/appi.neuropsych.19.3.283; Price RW, 2007, NEUROLOGY, V69, P1781, DOI 10.1212/01.wnl.0000278457.55877.eb; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Reger M, 2002, J INT NEUROPSYCH SOC, V8, P410, DOI 10.1017/S1355617702813212; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Roberts TK, 2010, FRONT BIOSCI-LANDMRK, V15, P478, DOI 10.2741/3631; Schuff N, 2006, ADV EXP MED BIOL, V576, P241; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Taylor MJ, 2007, J NEUROVIROL, V13, P150, DOI 10.1080/13550280701194230; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Wohlschlaeger J, 2009, CLIN NEUROL NEUROSUR, V111, P422, DOI 10.1016/j.clineuro.2008.12.006; [No title captured]	38	9	9	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	3					326	334	PII 932229133	10.1080/13803395.2010.518140			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	733LH	WOS:000288263700006	21229435	Green Published			2022-02-06	
J	Lovell, MR; Solomon, GS				Lovell, Mark R.; Solomon, Gary S.			Psychometric Data for the NFL Neuropsychological Test Battery	APPLIED NEUROPSYCHOLOGY			English	Article						assessment/diagnosis; sports; tests	SPORT-RELATED CONCUSSION; PROFESSIONAL FOOTBALL; SCHOOL; PLAYERS; PERFORMANCE; MANAGEMENT; IMPACT	As part of a comprehensive league-wide study of concussion, the National Football League's Committee on Mild Traumatic Brain Injury sponsored a neuropsychological testing program from 1996 through 2001. Nearly 1,000 athletes participated voluntarily in the study. Traditional paper-and-pencil neuropsychological tests were used for baseline assessment. Neuropsychological tests used in the study included the Hopkins Verbal Learning Test-Revised, the Brief Visuospatial Memory Test-Revised, Trail-Making Tests (Parts A and B), and the Controlled Oral Word Association Test. We present a factor analysis of these baseline data on 513 athletes who completed all of the neuropsychological tests and present normative psychometric data on the multiple baseline tests employed.	[Lovell, Mark R.] Univ Pittsburgh, Dept Orthoped, Pittsburgh, PA USA; [Solomon, Gary S.] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA; [Solomon, Gary S.] Vanderbilt Univ, Dept Neurol Surg, Nashville, TN USA		Solomon, GS (corresponding author), 1500 21st Ave S,Suite 4340, Nashville, TN 37212 USA.	garysolomon17@yahoo.com	Solomon, Gary/K-9011-2019				Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A., 1978, MULTILINGUAL APHASIA; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brown TA., 2015, CONFIRMATORY FACTOR, V2; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Heaton R. K., 2004, REVISED COMPREHENSIV; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kim JO., 1978, FACTOR ANAL STAT MET; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell M. R., 2004, ANN MED C US SKI ASS; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; LOVELL MR, 2000, NEUROLOGIC ATHLETIC, P109; LOVELL MR, 1996, 1 ANN SPORTS REL MIL; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCaffrey RJ, 2000, PRACTITIONERS GUIDE; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McKeag DB, 2009, CLIN J SPORT MED, V19, P343, DOI 10.1097/JSM.0b013e3181b2c114; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Noursis M. J., 1993, SPSS WINDOWS PROFESS; OLVEY S, 2002, NEW DEV SPORTS REL C; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Smith A., 1982, SYMBOL DIGIT MODALIT; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Statistical Package for the Social Sciences, 2010, PASW STAT 18 COR SYS; Thompson B., 2004, EXPLORATORY CONFIRMA; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Woodard J., 2000, J INT NEUROPSYCH SOC, V6, P139	48	9	10	0	19	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2011	18	3					197	209		10.1080/09084282.2011.595446			13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	884YJ	WOS:000299744500006	21846219				2022-02-06	
J	Meissner, A; Timaru-Kast, R; Heimann, A; Hoelper, B; Kempski, O; Alessandri, B				Meissner, A.; Timaru-Kast, R.; Heimann, A.; Hoelper, B.; Kempski, O.; Alessandri, B.			Effects of a Small Acute Subdural Hematoma following Traumatic Brain Injury on Neuromonitoring, Brain Swelling and Histology in Pigs	EUROPEAN SURGICAL RESEARCH			English	Article						Traumatic brain injury; Acute subdural hematoma; Controlled cortical impact; Focal cerebral contusion; Neuromonitoring; Intracranial pressure; Microdialysis; Tissue oxygen tension; Somatosensory evoked potentials	CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; MATURATION-DEPENDENT RESPONSE; INTRACRANIAL-PRESSURE; PROGNOSTIC VALUE; TISSUE PO2; MODEL; VOLUME; DAMAGE; HYPOTENSION	An acute subdural hematoma (ASDH) induces pathomechanisms which worsen outcome after traumatic brain injury, even after a small hemorrhage. Synergistic effects of a small ASDH on brain damage are poorly understood, and were studied here using neuromonitoring for 10 h in an injury model of controlled cortical impact (CCI) and ASDH. Pigs (n = 32) were assigned to 4 groups: sham, CCI (2.5 m/s), ASDH (2 ml) and CCI + ASDH. Intracranial pressure was significantly increased above sham levels by all injuries with no difference between groups. CCI and ASDH reduced ptiO(2) by a maximum of 36 +/- 9 and 26 +/- 11%, respectively. The combination caused a 31 +/- 11% drop. ASDH alone and in combination with CCI caused a significant elevation in extracellular glutamate, which remained increased longer for CCI + ASDH. The same two groups had significantly higher peak lactate levels compared to sham. Somatosensory evoked potential (SSEP) amplitude was persistently reduced by combined injury. These effects translated into significantly elevated brain water content and histological damage in all injury groups. Thus, combined injury had stronger effects on glutamate and SSEP when compared to CCI and ASDH, but no clear-cut synergistic effects of 2 ml ASDH on trauma were observed. We speculate that this was partially due to the CCI injury severity. Copyright (C) 2011 S. Karger AG, Basel	[Meissner, A.; Timaru-Kast, R.; Heimann, A.; Kempski, O.; Alessandri, B.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neurosurg Pathophysiol, DE-55131 Mainz, Germany; [Hoelper, B.] Neurosurg Gelnhausen, Gelnhausen, Germany		Alessandri, B (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neurosurg Pathophysiol, Langenbeckstr 1, DE-55131 Mainz, Germany.	beat.alessandri@unimedizin-mainz.de		Heimann, Axel/0000-0003-2510-3228	Schwerpunkt Neurowissenschaften Mainz; 'Deutsche Forschungsgemeinschaft' DFGGerman Research Foundation (DFG) [KE338/6-2]	The data shown in the paper are part of the inaugural dissertations of A. M. and R. T.-K. We gratefully thank A. Ehlert, M. Malzahn and L. Kopacz for technical assistance. The study was supported by 'Schwerpunkt Neurowissenschaften Mainz' (R.T.) and by a grant of 'Deutsche Forschungsgemeinschaft' DFG (KE338/6-2; B.A. and O.K.)	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Alessandri B, 2000, NEUROL RES, V22, P705; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Bardt TF, 1998, ACT NEUR S, V71, P153; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Bullock R, 1997, HEAD INJURY PATHOPHY, P121; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Davis KL, 1998, J NEUROTRAUM, V15, P615, DOI 10.1089/neu.1998.15.615; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Halstead JC, 2007, EUR J CARDIO-THORAC, V32, P514, DOI 10.1016/j.ejcts.2007.06.013; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; INGLIS FM, 1990, ACT NEUR S, V51, P277; Karabiyikoglu M, 2005, NEUROSURGERY, V57, P565, DOI 10.1227/01.NEU.0000170435.47739.AE; Kempski O, 2007, BRAIN 07 BRAIN PET 0; Kiening KL, 1998, ACT NEUR S, V71, P172; KURODA Y, 1992, NEUROSURGERY, V30, P687; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Marion DW, 2006, NEUROSURGERY, V58, P655; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McKinely BA, 1999, J TRAUMA, V46, P271, DOI 10.1097/00005373-199902000-00013; Meixensberger J, 1998, LANGENBECK ARCH SURG, V383, P214, DOI 10.1007/s004230050121; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; ORLIN JR, 1993, ACTA NEUROCHIR, V122, P257, DOI 10.1007/BF01405539; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; Reilly P, 1997, HEAD INJURY PATHOPHY, P229; Sarrafzadeh A, 2005, J NEURORADIOLOGY, V32, P348, DOI 10.1016/S0150-9861(05)83168-2; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379; Zauner A, 1996, ACT NEUR S, V67, P40; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011; Zweckberger K, 2007, INTENSIVMED UP2DATE, V3, P121; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	55	9	9	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-312X	1421-9921		EUR SURG RES	Eur. Surg. Res.		2011	47	3					141	153		10.1159/000330756			13	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	846CC	WOS:000296873800005	21952222				2022-02-06	
J	Schmitter-Edgecombe, M; Seelye, AM				Schmitter-Edgecombe, Maureen; Seelye, Adriana M.			Predictions of verbal episodic memory in persons with Alzheimer's disease	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Metamemory; Alzheimer's disease; Memory self-monitoring; Memory awareness; Memory predictions	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; METAMEMORY ACCURACY; AWARENESS; DEMENTIA; METACOGNITION; PERFORMANCE; DEFICIT; AGE; ANOSOGNOSIA	This study examined awareness of memory problems and memory self-monitoring abilities in individuals with Alzheimer's disease (AD). Participants were 20 individuals with AD and 20 older adult controls. A global performance-prediction paradigm, which required participants to predict the number of words they would remember both prior to and after completing a list-learning memory task, was used as the online assessment measure. Offline assessment of memory involved contrasting self-ratings provided by participants about the frequency of everyday memory failures with ratings from knowledgeable informants. As expected, participants with AD demonstrated poorer recall for the word list than did controls. Participants with AD were also less accurate than controls in their preexperience memory predictions, and findings from the offline assessment method similarly revealed that the AD group overestimated their everyday memory abilities. Despite showing impaired understanding of personal memory ability, the AD group successfully modified their postexperience memory predictions so that they were more accurate following task exposure, demonstrating accurate memory self-monitoring abilities. These findings highlight the complex and multidimensional nature of metamemory. The findings further suggest that while AD patients appear able to immediately benefit from task experience, they have difficulty creating lasting awareness of memory abilities.	[Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			Edward R. Meyer Project Award	We thank Scott Creamer, Michelle Langill, Kimberly Lanni, and Alicia Rueda for their help in coordinating data collection. We also thank the members of the Aging and Dementia Research Team for their help in collecting and scoring the data. Portions of this research were presented at the American Academy of Clinical Neuropsychology's 7th Annual Conference & Workshops, San Diego, California, USA. This research was funded in part by an Edward R. Meyer Project Award. No financial or other relationships exist that could be interpreted as a conflict of interest pertaining to this manuscript.	Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; Anderson JW, 2010, J CLIN EXP NEUROPSYC, V32, P505, DOI 10.1080/13803390903224944; Ansell EL, 2006, NEUROPSYCHOLOGIA, V44, P1095, DOI 10.1016/j.neuropsychologia.2005.10.019; Bunnell JK, 1999, NEW ZEAL J PSYCHOL, V28, P23; Connor LT, 1997, PSYCHOL AGING, V12, P50, DOI 10.1037/0882-7974.12.1.50; Cosentino S, 2007, CORTEX, V43, P1004, DOI 10.1016/S0010-9452(08)70697-X; DEVOLDER PA, 1990, PSYCHOL AGING, V5, P291, DOI 10.1037/0882-7974.5.2.291; Duke LM, 2002, NEUROPSYCHOLOGY, V16, P359, DOI 10.1037//0894-4105.16.3.359; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P324, DOI 10.1006/ccog.2000.0449; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming JM, 1996, BRAIN INJURY, V10, P1; GILEWSKI MJ, 1990, PSYCHOL AGING, V5, P482, DOI 10.1037/0882-7974.5.4.482; HERTZOG C, 1994, AGING COGNITION, V1, P203, DOI DOI 10.1080/13825589408256577; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; KORIAT A, 1993, PSYCHOL REV, V100, P609, DOI 10.1037/0033-295X.100.4.609; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; MCGLYNN SM, 1991, J COGNITIVE NEUROSCI, V3, P183, DOI 10.1162/jocn.1991.3.2.183; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1991, NEUROLOGY, V41, P469, DOI 10.1212/WNL.41.4.469; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Moulin CJA, 2000, NEUROPSYCHOLOGIA, V38, P1242, DOI 10.1016/S0028-3932(00)00037-3; Moulin CJA, 2003, AGING NEUROPSYCHOL C, V10, P74, DOI 10.1076/anec.10.1.74.13456; Moulin CJA, 2000, AGING NEUROPSYCHOL C, V7, P230, DOI 10.1076/anec.7.4.230.796; Myers J. L., 2003, RES DESIGN STAT ANAL; PAPPAS BA, 1992, J GERONTOL, V47, pP159, DOI 10.1093/geronj/47.3.P159; Perrotin A, 2007, NEUROPSYCHOLOGIA, V45, P2811, DOI 10.1016/j.neuropsychologia.2007.05.003; PONSFORD JL, 1988, AUST PSYCHOL, V23, P349, DOI 10.1080/00050068808255617; Rueda AD, 2009, NEUROPSYCHOLOGY, V23, P178, DOI 10.1037/a0014289; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Souchay C, 2003, NEUROCASE, V9, P482, DOI 10.1076/neur.9.6.482.29376; Souchay C, 2002, NEUROPSYCHOLOGIA, V40, P2386, DOI 10.1016/S0028-3932(02)00075-1; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103	36	9	10	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	2					218	225	PII 926846609	10.1080/13803395.2010.507184			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	715OV	WOS:000286894700007	20839133				2022-02-06	
B	Schultz, IZ; Krupa, T; Rogers, ES		Schultz, IZ; Rogers, ES		Schultz, Izabela Z.; Krupa, Terry; Rogers, E. Sally			Best Practices in Accommodating and Retaining Persons with Mental Health Disabilities at Work: Answered and Unanswered Questions	WORK ACCOMMODATION AND RETENTION IN MENTAL HEALTH			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SUPPORTED EMPLOYMENT; VOCATIONAL-REHABILITATION; MUSCULOSKELETAL DISORDERS; MANAGEMENT PRACTICE; ILLNESS; WORKPLACE; RETURN; INTERVENTIONS; PEOPLE		[Schultz, Izabela Z.] Univ British Columbia, Vocat Rehabil Counselling Program, Scarfe Lib 297, Vancouver, BC V6T 1Z4, Canada; [Krupa, Terry] Queens Univ, Sch Rehabil Therapy, Kingston, ON K7L 3N6, Canada; [Rogers, E. Sally] Boston Univ, Sargent Coll Hlth & Rehabil, Ctr Psychiat Rehabil, Boston, MA 02215 USA		Schultz, IZ (corresponding author), Univ British Columbia, Vocat Rehabil Counselling Program, Scarfe Lib 297, 2125 Main Mall, Vancouver, BC V6T 1Z4, Canada.	ischultz@telus.net; terry.krupa@queensu.ca; erogers@bu.edu; ischultz@telus.net; erogers@bu.edu					Allen Paula, 2004, Healthc Pap, V5, P95; [Anonymous], 1989, PSYCHOSOCIAL REHABIL, DOI DOI 10.1037/H0099533]; Anthony WA., 2002, PSYCHIAT REHABILITAT, V2 ed; Arthur AR, 2000, BRIT J GUID COUNS, V28, P549, DOI 10.1080/03069880020004749; BALDWIN MW, 2010, HDB WORK ACCOMMODATI; Bender Ash, 2004, Healthc Pap, V5, P54; Berndt ER, 1998, J HEALTH ECON, V17, P511, DOI 10.1016/S0167-6296(97)00043-X; Bishop M, 2004, REHABIL COUNS BULL, V47, P112, DOI 10.1177/00343552030470020601; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Bond GR, 2001, PSYCHIATR SERV, V52, P313, DOI 10.1176/appi.ps.52.3.313; Bond GR, 1997, PSYCHIATR SERV, V48, P335; Bond GR, 1998, PSYCHIATR REHABIL J, V22, P11, DOI 10.1037/h0095271; Bruyere SM, 2000, EMPLOYING ACCOMMODAT; BURKEMILLER J, 2010, HDB WORK ACCOMMODATI; Carling P, 1993, CONSULTING PSYCHOL J, V45, P46; CENTER C, 2010, HDB WORK ACCOMMODATI; COOK JA, 1994, AM REHABILITATION, V20, P2; Crowther RE, 2001, BMJ-BRIT MED J, V322, P204, DOI 10.1136/bmj.322.7280.204; CROWTHER RE, 2001, COCHRANE LIB, V4; Currier KF, 2001, REHABIL COUNS BULL, V44, P133, DOI 10.1177/003435520104400303; DEWA CS, 2010, HDB WORK ACCOMMODATI; Drake RE, 2003, CURR OPIN PSYCHIATR, V16, P451, DOI 10.1097/01.yco.0000079209.36371.84; Drake RE, 1996, J CONSULT CLIN PSYCH, V64, P391, DOI 10.1037/0022-006X.64.2.391; Feuerstein M, 2005, J OCCUP REHABIL, V15, P451, DOI 10.1007/s10926-005-8026-z; Finch JR, 1999, REHABIL COUNS BULL, V42, P214; Franche RL, 2005, J OCCUP REHABIL, V15, P525, DOI 10.1007/s10926-005-8032-1; FRASER RT, 2010, HDB WORK ACCOMMODATI; GALLIC KA, 2010, HDB WORK ACCOMMODATI; Gates LB, 2000, J OCCUP REHABIL, V10, P85, DOI 10.1023/A:1009445929841; GATES LB, 2010, HDB WORK ACCOMMODATI; GERBER PJ, 1992, J LEARN DISABIL, V25, P475, DOI 10.1177/002221949202500802; Gerber PJ, 2003, LEARNING DISABILITIE, V18, P132; Gnam WH, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P371, DOI 10.1007/0-387-28919-4_20; GOLDBERG RJ, 2003, LEARNING DISABILITIE, V18, P222, DOI DOI 10.1111/1540-5826.00077; Habeck R.V., 1999, AM REHABILITATION, V25, P18; HAFFEY WJ, 1991, J HEAD TRAUMA REHAB, V6, P24; HARDER H, 2010, HDB WORK ACCOMMODATI; Haslam C, 2005, J AFFECT DISORDERS, V88, P209, DOI 10.1016/j.jad.2005.07.009; Holzberg Emily, 2001, Work, V16, P245; *JAN, 2007, ACC INFORM DIS MORG; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Kirkwood AD, 2006, PROF PSYCHOL-RES PR, V37, P472, DOI 10.1037/0735-7028.37.5.472; KIRSH B, 2010, HDB WORK ACCOMMODATI; KRUPA T, 2005, CANADIAN PUBLIC PO S, V31, P60; KRUPA T, 2010, HDB WORK ACCOMMODATI; Krupa T, 2007, CAN J PSYCHIAT, V52, P339, DOI 10.1177/070674370705200602; LERNER D, 2010, HDB WORK ACCOMMODATI; Linton SJ, 2005, J OCCUP REHABIL, V15, P459, DOI 10.1007/s10926-005-8028-x; Loisel P, 2005, J OCCUP REHABIL, V15, P581, DOI 10.1007/s10926-005-8036-x; Loisel P, 2005, J OCCUP REHABIL, V15, P507, DOI 10.1007/s10926-005-8031-2; MacDonald-Wilson K, 2001, J OCCUP REHABIL, V11, P217, DOI 10.1023/A:1013078628514; MACDONALDWILSON KL, 2002, COMMUNITY MENT HLTH, P38; MACDONALDWILSON KL, 2010, HDB WORK ACCOMMODATI; Macias C, 2001, ADM POLICY MENT HLTH, V28, P279, DOI 10.1023/A:1011185513720; Marrone J., 1998, J APPL REHABILITATIO, V29, P37; Massaro J., 2003, J VOCAT REHABIL, V18, P15; MEANS CD, 1997, J APPL REHABIL COUNS, V28, P13; Mueser K. T., 2001, J MENTAL HLTH, V10, P411, DOI DOI 10.1080/09638230120041173; MURAKAMI Y, 1999, WORK, V122, P181; Nimgade A, 2003, J HEAD TRAUMA REHAB, V18, P464, DOI 10.1097/00001199-200309000-00008; PEER J, 2010, HDB WORK ACCOMMODATI; Pransky G, 2005, J OCCUP REHABIL, V15, P453, DOI 10.1007/s10926-005-8027-y; RADLEY J, 2004, OCCUPATIONAL THERAPY, V6; Rogers ES, 2006, REHABIL PSYCHOL, V51, P247, DOI 10.1037/0090-5550.51.3.247; ROGERS ES, 2010, HDB WORK ACCOMMODATI; Scheid TL, 1998, J BEHAV HEALTH SER R, V25, P312, DOI 10.1007/BF02287470; Schultz I. Z., 2005, HDB COMPLEX OCCUPATI; Schultz IZ, 2000, J OCCUP REHABIL, V10, P271, DOI 10.1023/A:1009484416267; Schultz IZ., 2010, HDB WORK ACCOMMODATI; Schultz IZ, 2007, J OCCUP REHABIL, V17, P327, DOI 10.1007/s10926-007-9071-6; Scully SM, 1999, REHABIL COUNS BULL, V43, P20, DOI 10.1177/003435529904300105; Sherbourne CD, 2001, ARCH GEN PSYCHIAT, V58, P696, DOI 10.1001/archpsyc.58.7.696; Smith Jeffrey L, 2002, J Ment Health Policy Econ, V5, P43; Smith TE, 1996, CLIN PSYCHOL REV, V16, P599, DOI 10.1016/S0272-7358(96)00025-6; *STAND SEN COMM SO, 2005, OUT SHAD LAST TRANSF, P1; Sullivan MJL, 2005, J OCCUP REHABIL, V15, P475, DOI 10.1007/s10926-005-8029-9; Szymanski E. M., 2003, AUST J CAREER DEV, V12, P9, DOI [10.1177/103841620301200103, DOI 10.1177/103841620301200103]; Targett P., 2010, HDB WORK ACCOMMODATI; Tryssenaar J., 1994, CANADIAN J OCCUPATIO, V61, P198; TSE S, 2002, WORK J PREVENTION AS, V29, P167; Vezina Michel, 2004, Healthc Pap, V5, P32; WALD J, 2010, HDB WORK ACCOMMODATI; Wallace CJ, 1999, PSYCHIATR SERV, V50, P1147, DOI 10.1176/ps.50.9.1147; WANG JL, 2010, HDB WORK ACCOMMODATI; Warr P., 1987, WORK UNEMPLOYMENT ME; Westmorland M, 2002, DISABIL REHABIL, V24, P746, DOI 10.1080/09638280210124347; Wisenthal A., 2004, OCCUPATIONAL THERAPY, V6; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; 2005, GLOBAL BUSINESS EC R	89	9	9	0	5	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-0427-0				2011							445	465		10.1007/978-1-4419-0428-7_24	10.1007/978-1-4419-0428-7		21	Public, Environmental & Occupational Health; Psychology; Psychology, Multidisciplinary	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Public, Environmental & Occupational Health; Psychology	BSO47	WOS:000285117700024					2022-02-06	
J	Seter, C; Giovannetti, T; Kessler, RK; Worth, S				Seter, Colette; Giovannetti, Tania; Kessler, Rachel K.; Worth, Shataya			Everyday action planning in schizophrenia	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Everyday action; Planning; Schizophrenia; Activities of daily living; Instrumental activities of daily living; Naturalistic action	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; FRONTAL-LOBE; COMPENSATORY STRATEGIES; NEUROCOGNITIVE DEFICITS; ALZHEIMERS-DISEASE; IMPROVE COGNITION; FUNCTIONAL STATUS; OLDER PATIENTS; MENTAL STATE	Planning of everyday tasks was examined in 48 inpatients with schizophrenia and 26 healthy controls. Participants were administered the Naturalistic Action Test, which requires completion of three everyday tasks (e.g., make toast and coffee). Planning variables, including planning behaviours (e.g., gathering items before engaging in a subtask) and planning time (e.g., period between task instructions and first action) were coded to evaluate forward thinking in these tasks. Results showed that planning variables were reliably coded. Controls demonstrated more planning behaviours than participants with schizophrenia; however, this difference was accounted for by education. People with schizophrenia spent significantly less time planning when planning time was analysed as a proportion of the total time on tasks. Planning variables were related to the ability to accomplish everyday task steps and to perform everyday task steps accurately. Together these findings suggest that rehabilitation strategies that emphasise both planning time and planning behaviours may facilitate everyday functioning in people with schizophrenia.	[Seter, Colette; Giovannetti, Tania; Kessler, Rachel K.; Worth, Shataya] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA		Giovannetti, T (corresponding author), Temple Univ, Dept Psychol, 1701 N 13th St, Philadelphia, PA 19122 USA.	tgio@temple.edu	Giovannetti, Tania/H-3491-2019	Giovannetti, Tania/0000-0001-5661-152X			Allain P, 2005, BRAIN COGNITION, V57, P4, DOI 10.1016/j.bandc.2004.08.011; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andreasen N.C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1984, SCALE ASSESSMENT NEG; Barch DM, 2008, BIOL PSYCHIAT, V64, P11, DOI 10.1016/j.biopsych.2008.03.003; Barch DM, 2001, ARCH GEN PSYCHIAT, V58, P280, DOI 10.1001/archpsyc.58.3.280; Bettcher BM, 2008, J INT NEUROPSYCH SOC, V14, P199, DOI 10.1017/S1355617708080193; Bickerton WL, 2007, J INT NEUROPSYCH SOC, V13, P1035, DOI 10.1017/S1355617707071585; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Buxbaum LJ, 1998, COGNITIVE NEUROPSYCH, V15, P617, DOI 10.1080/026432998381032; Carlin D, 2000, NEUROPSYCHOLOGIA, V38, P655, DOI 10.1016/S0028-3932(99)00102-5; Carter CS, 2008, BIOL PSYCHIAT, V64, P4, DOI 10.1016/j.biopsych.2008.03.020; Chan RCK, 2004, EUR ARCH PSY CLIN N, V254, P256, DOI 10.1007/s00406-00-0492-3; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; COHEN J, 1988, STAT POWER ANAL BEHA, pR21; Cook LG, 2008, NEUROREHABILITATION, V23, P467; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Davalos DB, 2002, COMMUNITY MENT HLT J, V38, P403, DOI 10.1023/A:1019860428856; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Evans JD, 2003, BIOL PSYCHIAT, V53, P422, DOI 10.1016/S0006-3223(02)01476-2; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Field A, 2005, DISCOVERING STAT USI, P666; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gibbon M., 1997, USERS GUIDE STRUCTUR; Giovannetti T, 2006, J INT NEUROPSYCH SOC, V12, P45, DOI 10.1017/S1355617706060012; Giovannetti T, 2002, NEUROPSYCHOLOGIA, V40, P1220, DOI 10.1016/S0028-3932(01)00229-9; Giovannetti T, 2007, NEUROPSYCHOLOGY, V21, P448, DOI 10.1037/0894-4105.21.4.448; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 1996, AM J PSYCHIAT, V153, P321; Hanes KR, 1996, SCHIZOPHR RES, V19, P121, DOI 10.1016/0920-9964(95)00069-0; Harvey PD, 2004, J CLIN PSYCHIAT, V65, P361; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Joe WQ, 2002, NEUROCASE, V8, P135, DOI 10.1093/neucas/8.1.135; Kaplan E., 1991, WAIS R NI MANUAL; Keefe RSE, 2005, BIOL PSYCHIAT, V57, P688, DOI 10.1016/j.biopsych.2005.01.003; Kessler RK, 2007, NEUROPSYCHOLOGY, V21, P439, DOI 10.1037/0894-4105.21.4.439; Klapow JC, 1997, AM J PSYCHIAT, V154, P1022; Krabbendam L, 2003, PSYCHOPHARMACOLOGY, V169, P376, DOI 10.1007/s00213-002-1326-5; Kurtz MM, 2001, NEUROPSYCHOL REV, V11, P197, DOI 10.1023/A:1012953108158; LAWSON MJ, 1989, J CLIN EXP NEUROPSYC, V11, P842, DOI 10.1080/01688638908400939; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Luria A. R., 1978, FONCTIONS CORTICALES; Marder SR, 2004, SCHIZOPHR RES, V72, P5, DOI 10.1016/j.schres.2004.09.010; Matsui M, 2008, PROG NEURO-PSYCHOPH, V32, P280, DOI 10.1016/j.pnpbp.2007.08.019; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; Medalia A, 2009, NEUROPSYCHOL REV, V19, P353, DOI 10.1007/s11065-009-9097-y; Morice R, 1996, SCHIZOPHRENIA BULL, V22, P125, DOI 10.1093/schbul/22.1.125; MORRIS RG, 1995, SCHIZOPHR RES, V14, P235, DOI 10.1016/0920-9964(94)00044-9; Norman RMG, 1996, SCHIZOPHR RES, V19, P73, DOI 10.1016/0920-9964(95)00055-0; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; Pantelis C, 1997, BRAIN, V120, P1823, DOI 10.1093/brain/120.10.1823; Patterson TL, 1998, PSYCHIAT RES, V80, P41, DOI 10.1016/S0165-1781(98)00060-2; Patterson TL, 2001, SCHIZOPHRENIA BULL, V27, P235, DOI 10.1093/oxfordjournals.schbul.a006870; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; Pilling S, 2002, PSYCHOL MED, V32, P783, DOI 10.1017/S0033291702005640; Gouveia PAR, 2007, BRAIN COGNITION, V63, P240, DOI 10.1016/j.bandc.2006.09.001; Schwartz MF, 1999, NEUROPSYCHOLOGIA, V37, P51; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; Segal, 2003, NATURALISTIC ACTION; Semkovska M, 2004, SCHIZOPHR RES, V69, P289, DOI 10.1016/j.schres.2003.07.005; Semkovska M, 2002, BRAIN COGNITION, V48, P546, DOI 10.1006/brcg.2001.1415; SESTITO N, 2005, J INT NEUROPSYCHO S1, V1, P90; SEVY S, 1995, SCHIZOPHR RES, V17, P1, DOI 10.1016/0920-9964(95)00025-H; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sohlberg M., 2001, COGNITIVE REHABILITA; Staal WG, 2000, PSYCHIAT RES, V95, P227, DOI 10.1016/S0165-1781(00)00172-4; Suslow T, 2001, ACTA PSYCHIAT SCAND, V103, P15, DOI 10.1034/j.1600-0447.2001.00016.x; Twamley EW, 2003, SCHIZOPHRENIA BULL, V29, P359, DOI 10.1093/oxfordjournals.schbul.a007011; Unterrainer JM, 2004, J CLIN EXP NEUROPSYC, V26, P846, DOI 10.1080/13803390490509574; Unterrainer JM, 2003, COGNITIVE BRAIN RES, V17, P675, DOI 10.1016/S0926-6410(03)00191-5; Unterrainer JM, 2006, J PHYSIOL-PARIS, V99, P308, DOI 10.1016/j.jphysparis.2006.03.014; van Beilen M, 2005, J PSYCHIATR RES, V39, P585, DOI 10.1016/j.jpsychires.2005.02.001; van Beilen M, 2006, CLIN NEUROPSYCHOL, V20, P469, DOI 10.1080/13854040590967126; Velligan D I, 1999, Semin Clin Neuropsychiatry, V4, P24; Velligan DI, 2007, PSYCHIAT RES, V151, P55, DOI 10.1016/j.psychres.2006.10.007; Velligan DI, 2006, SCHIZOPHRENIA BULL, V32, P474, DOI 10.1093/schbul/sbj071; Velligan DI, 2002, SCHIZOPHRENIA BULL, V28, P283, DOI 10.1093/oxfordjournals.schbul.a006938; Velligan DI, 2000, AM J PSYCHIAT, V157, P1317, DOI 10.1176/appi.ajp.157.8.1317; Wilson B.A., 1997, METHODOLOGY FRONTAL, P239; [No title captured]	89	9	9	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	2					224	249	PII 933026218	10.1080/09602011.2010.544519			26	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	733NZ	WOS:000288270700005	21294047				2022-02-06	
J	Basheer, N; Gupta, D; Mahapatra, AK; Gurjar, H				Basheer, Noufal; Gupta, Deepak; Mahapatra, A. K.; Gurjar, Hitesh			Cranioplasty following decompressive craniectomy in traumatic brain injury: Experience at Level - I apex trauma centre	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Cranioplasty; decompressive craniectomy; severe head injury		Complications after cranioplasty following decompressive craniectomy are often underreported. A review of the complications helps to suggest measures to improve the care of these patients. We provide a review of all complications of cranioplasty with autologous or synthetic materials in this article. All patients who had undergone cranioplasty following decompressive craniectomy at JPN Apex trauma centre, AIIMS from Jan 2008 till 2010 April were included in the study. Demographic data, indications for craniectomy, materials used, methods of autologous bone storage and all perioperative complications were recorded. Total 114 patients were studied. Mean duration between decompressive craniectomy and cranioplasty was 207.6 +/- 28.2 days (Mean +/- SD) with a range of 50 to 840 days. The overall postoperative complication rate was 23% (26/114) of which 16 patients (14 %) had to undergo reoperation after cranioplasty. Bone flap infection was the commonest accounting for 10 (62.5 %) of the reoperations. Even though considered as simple procedure, cranioplasty is associated with significant complications requiring reoperation. There was no correlation of complications or need for reoperation with type of materials, storage of the bone or timing of surgery. A seemingly smaller neurosurgical operation requires good surgical approach to minimize morbidity associated with cranioplasty.	[Basheer, Noufal; Gupta, Deepak; Mahapatra, A. K.; Gurjar, Hitesh] AIIMS, JPN Apex Trauma Ctr, New Delhi, India		Gupta, D (corresponding author), AIIMS, Dept Neurosurg, New Delhi 110029, India.						Azmi A, 2004, Med J Malaysia, V59, P418; Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158; Ducic J, 2002, J ORAL MAXIL SURG, V60, P272, DOI 10.1053/joms.2002.30575; Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01290.8E; FOSTER R.D., 2000, SCHMIDEK SWEET OPERA, P29; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; OSAWA M, 1990, ACTA NEUROCHIR, V102, P38, DOI 10.1007/BF01402184; Pasaoglu A, 1996, NEUROSURG REV, V19, P153, DOI 10.1007/BF00512044; PETTY PG, 1974, MED J AUSTRALIA, V2, P806, DOI 10.5694/j.1326-5377.1974.tb71199.x; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986	17	9	9	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2010	7	2					139	144		10.1016/S0973-0508(10)80029-2			6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M1W	WOS:000218382300007					2022-02-06	
J	Cummins, FJ; Gentene, LJ				Cummins, Francis J., Jr.; Gentene, Laurie J.			Hyperbaric Oxygen Effect on MMP-9 After a Vascular Insult	JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH			English	Article						Hyperbaric oxygen; MMP-9; Matrix metalloproteinease-9; Atherosclerosis; Gelatinase B	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; MATRIX METALLOPROTEINASES; MATRIX-METALLOPROTEINASE-9 EXPRESSION; TISSUE INHIBITOR; THERAPY; ATHEROSCLEROSIS; ANGIOGENESIS; KNOCKOUT; BLOOD	Matrix metalloproteinease-9 (MMP-9) is involved in a host of processes. Many of its processes are physiologically beneficial as well as detrimental. The over-expression of this enzyme has been implicated as a contributory factor to some of the sequalae associated with cerebral ischemia, cell death, non-healing wounds, traumatic brain injury, aneurysms, and plaque instability in atherosclerosis. Several studies have examined the effect of hyperbaric oxygen (HBO) on MMP-9 expression. Because this proteinase is involved in both chronic and acute pathology, we wanted to investigate an acute expression model and see if, and how quickly, its expression would respond to HBO therapy. Our patient was scheduled to have elective surgery with an overnight stay followed by a series of HBO exposures. The patient served as her own control. An MMP-9 and urine pH was obtained prior to surgery to establish a baseline. On days 1, 3, and 4 post-op, samples were obtained before and after hyperbaric exposure. The patient was exposed to 100% O2 at 2.5 ATA for 60 min during each treatment for 5 days. The patient's MMP-9 values were dramatically elevated after surgery as compared to the baseline readings. The percentage increase from baseline was 400%. Our patient showed a significant reduction in MMP-9 expression after each hyperbaric exposure with the greatest decrease seen on post-op day 1 and subsequent exposures showing slightly less expression. Reduction in MMP-9 expression ranged from 46% on day 1 to 30% on post-op day 4. This case study suggests that if done relatively soon after a vascular or tissue insult, HBO can reduce MMP-9 expression. Chronic vascular pathologies, such as atherosclerotic plaque and aneurysms where over-expression of MMP-9 may result in acute coronary syndrome (ACS) or cerebral vascular accidents (CVAs), may be mitigated by a series of HBO treatments that reduce MMP-9 expression. Causality and/or contributory effects of MMP-9 expression in both pathologic and physiologic processes needs to be further elucidated. The understanding of how HBO therapy modulates these may provide an additional insight into mechanisms and future potential therapies for pathologic conditions such as those described above.	[Cummins, Francis J., Jr.; Gentene, Laurie J.] Healing Chambers Amer, San Diego, CA USA		Cummins, FJ (corresponding author), Healing Chambers Amer, 995 Gateway,Ctr Way,Suite 108,Suite 208, San Diego, CA USA.	FCumminsJr_DO@msn.com					Alleva R, 2008, MOL MED, V14, P175, DOI 10.2119/2007-00095.Alleva; ANDREW CL, 2008, ARTHRITIS RHEUMATISM, V58, P854; Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Baskovich B, 2008, INT WOUND J, V5, P543, DOI 10.1111/j.1742-481X.2007.00422.x; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Buras JA, 2000, AM J PHYSIOL-CELL PH, V278, pC292, DOI 10.1152/ajpcell.2000.278.2.C292; CUMMINS F, PRELIMINARY DA UNPUB; Ellestad MH, 2009, CARDIOL REV, V17, P280, DOI 10.1097/CRD.0b013e3181bad02d; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hu SL, 2008, ACTA NEUROCHIR SUPPL, V105, P191; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kudchodkar BJ, 2007, ATHEROSCLEROSIS, V193, P28, DOI 10.1016/j.atherosclerosis.2006.08.018; Kudchodkar BJ, 2000, ARTERIOSCL THROM VAS, V20, P1637, DOI 10.1161/01.ATV.20.6.1637; Kunz J, 2007, GERONTOLOGY, V53, P63, DOI 10.1159/000096351; Kurz B, 2005, ANN ANAT, V187, P473, DOI 10.1016/j.aanat.2005.07.003; Matchett GA, 2009, NEUROL RES, V31, P114, DOI 10.1179/174313209X389857; NIU CC, 2010, J ORTHOP RES; Ohshima S, 2010, J AM COLL CARDIOL, V55, P1240, DOI 10.1016/j.jacc.2009.11.056; Ostrowski RP, 2010, ACTA NEUROCHIR SUPPL, V106, P47, DOI 10.1007/978-3-211-98811-4_7; Park K, 2009, STROKE, V40, pE5, DOI 10.1161/STROKEAHA.108.531012; Peng ZR, 2010, UNDERSEA HYPERBAR M, V37, P141; Pinilla S, 2009, CANCER LETT, V284, P80, DOI 10.1016/j.canlet.2009.04.013; *R D SYST, HUM MMP 9 TOT IMM; Sander AL, 2009, WOUND REPAIR REGEN, V17, P179, DOI 10.1111/j.1524-475X.2009.00455.x; Sharifi M, 2004, AM J CARDIOL, V93, P1533, DOI 10.1016/j.amjcard.2004.03.009; Takeyama N, 2007, KNEE SURG SPORT TR A, V15, P443, DOI 10.1007/s00167-006-0241-4; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI [10.1089/neu.2009-0959, 10.1089/neu.2009.0959]; Tschesche H, 1992, Matrix Suppl, V1, P245; Veltkamp R, 2006, BRAIN RES, V1076, P231, DOI 10.1016/j.brainres.2006.01.013; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang HH, 2009, GLIA, V57, P24, DOI 10.1002/glia.20732; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wilson WRW, 2005, EUR J VASC ENDOVASC, V30, P259, DOI 10.1016/j.ejvs.2005.02.044	35	9	9	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1937-5387	1937-5395		J CARDIOVASC TRANSL	J. Cardiovasc. Transl. Res.	DEC	2010	3	6			SI		683	687		10.1007/s12265-010-9221-7			5	Cardiac & Cardiovascular Systems; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Research & Experimental Medicine	687LK	WOS:000284779800012	20824409				2022-02-06	
J	Inamasu, J; Nakatsukasa, M; Kuramae, T; Nakagawa, Y; Miyatake, S; Tomiyasu, K				Inamasu, Joji; Nakatsukasa, Masashi; Kuramae, Takumi; Nakagawa, Yuh; Miyatake, Satoru; Tomiyasu, Kazuhiro			Influence of Age and Anti-platelet/Anti-coagulant Use on the Outcome of Elderly Patients With Fall-Related Traumatic Intracranial Hemorrhage	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						age; anti-coagulant; anti-platelet; elderly; traumatic intracranial hemorrhage	HEAD-INJURY; BRAIN-INJURY; ANTIPLATELET; MORTALITY; MANAGEMENT; SYSTEM; IMPACT; OLDER; RISK	Ground-level fall is the most common cause of traumatic intracranial hemorrhage (TICH) in the elderly. Many studies on geriatric TICH have regarded patients aged a >= 65 years as a single group, but substantial heterogeneity is likely to exist within this population. Eighty-two elderly patients with fall-related TICH treated in our institution during a 6-year period were stratified into 3 age groups (65-74, 75-84, and >= 85 years), and intergroup differences in the demographics and outcomes at discharge were evaluated. The influence of the use of anti-platelet/anti-coagulant (AP/AC) agent on outcomes was also investigated. Comparison of demographic variables demonstrated significant differences in the frequency of preinjury alcohol consumption and use of AP/AC agents between the 3 groups, indicating that the causes or triggers of fall might be substantially different between the 65-74 years group and the other two groups combined. The frequency of unfavorable outcomes increased with age, and the increase was statistically significant. The 82 patients were divided into two subgroups depending on the use of AP/AC agents. The outcomes of the a >= 85 years group taking AP/AC agents were particularly poor compared with those of the a >= 85 years group not using AP/AC agents. Advancing age may be associated with unfavorable outcomes in elderly patients with fall-related TICH, and patients aged >= 85 years taking AP/AC have the greatest risk of unfavorable outcomes. Physicians must consider the risk/benefit analysis before prescribing AP/AC agents to patients aged >= 85 years.	[Inamasu, Joji; Nakatsukasa, Masashi; Kuramae, Takumi; Nakagawa, Yuh] Saiseikai Utsunomiya Hosp, Dept Neurosurg, Utsunomiya, Tochigi 3210974, Japan; [Inamasu, Joji; Miyatake, Satoru] Saiseikai Utsunomiya Hosp, Dept Emergency Med, Utsunomiya, Tochigi 3210974, Japan; [Tomiyasu, Kazuhiro] Saiseikai Utsunomiya Hosp, Dept Neurol, Utsunomiya, Tochigi 3210974, Japan		Inamasu, J (corresponding author), Saiseikai Utsunomiya Hosp, Dept Neurosurg, 911-1 Takebayashi, Utsunomiya, Tochigi 3210974, Japan.	ginamasu@aol.com	Inamasu, Joji/R-7314-2019				Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Downey DM, 2009, AM SURGEON, V75, P1100; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; JENNETT B, 1976, LANCET, V1, P1031; Kennedy RL, 2001, J TRAUMA, V51, P717, DOI 10.1097/00005373-200110000-00016; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Nagurney J T, 1998, J Emerg Med, V16, P709, DOI 10.1016/S0736-4679(98)00083-3; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Timaran CH, 2008, J VASC SURG, V48, P355, DOI 10.1016/j.jvs.2008.03.031; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Velmahos GC, 2001, J AM COLL SURGEONS, V192, P147, DOI 10.1016/S1072-7515(00)00790-0; Vietnam Ministry of Defense, 2009, WHIT PAP HLTH LAB WE, P38	17	9	9	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	7-3-1 HONGO BUNKYO-KU, TOKYO, 113-8655, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	DEC	2010	50	12					1051	1055		10.2176/nmc.50.1051			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	701EQ	WOS:000285797500001	21206177	Bronze			2022-02-06	
